PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Teplyuk, NM; Galindo, M; Teplyuk, VI; Pratap, J; Young, DW; Lapointe, D; Javed, A; Stein, JL; Lian, JB; Stein, GS; van Wijnen, AJ				Teplyuk, Nadiya M.; Galindo, Mario; Teplyuk, Viktor I.; Pratap, Jitesh; Young, Daniel W.; Lapointe, David; Javed, Amjad; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; van Wijnen, Andre J.			Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR EXPRESSION; TRANSCRIPTION FACTOR RUNX2; CELL-CYCLE; GENE-EXPRESSION; PARATHYROID-HORMONE; CHONDROCYTE PROLIFERATION; TGF-BETA; GPR30; BINDING; PHOSPHORYLATION	Runt-related transcription factor 2 (Runx2) controls lineage commitment, proliferation, and anabolic functions of osteoblasts as the subnuclear effector of multiple signaling axes (e. g. transforming growth factor-beta/BMP-SMAD, SRC/YES-YAP, and GROUCHO/TLE). Runx2 levels oscillate during the osteoblast cell cycle with maximal levels in G1. Here we examined what functions and target genes of Runx2 control osteoblast growth. Forced expression of wild type Runx2 suppresses growth of Runx2(-/-) osteoprogenitors. Point mutants defective for binding to WW domain or SMAD proteins or the nuclear matrix retain this growth regulatory ability. Hence, key signaling pathways are dispensable for growth control by Runx2. However, mutants defective for DNA binding or C-terminal gene repression/activation functions do not block proliferation. Target gene analysis by Affymetrix expression profiling shows that the C terminus of Runx2 regulates genes involved in G protein-coupled receptor signaling (e. g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, Gpr30, Gpr54, Gpr64, and Gna13). We further examined the function of two genes linked to cAMP signaling as follows: Gpr30 that is stimulated and Rgs2 that is down-regulated by Runx2. RNA interference of Gpr30 and forced expression of Rgs2 in each case inhibit osteoblast proliferation. Notwithstanding its growth-suppressive potential, our results surprisingly indicate that Runx2 may sensitize cAMP-relatedGprotein-coupled receptor signaling by activating Gpr30 and repressing Rgs2 gene expression in osteoblasts to increase responsiveness to mitogenic signals.	[van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Teplyuk, Nadiya M.; Galindo, Mario; Pratap, Jitesh; Young, Daniel W.; Lapointe, David; Javed, Amjad; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Teplyuk, Viktor I.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Lapointe, David] Univ Massachusetts, Sch Med, Informat Serv, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	van Wijnen, AJ (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	andre.vanwijnen@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Javed, Amjad/0000-0002-0847-8266	National Institutes of Health [R01 AR49069, R01 AR39588, P01 CA82834, P30 DK32520]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR045688, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR49069 (to A. v. W.) and R01 AR39588, P01 CA82834, and P30 DK32520 (to G. S. S. and J. B. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bertaux K, 2006, BONE, V38, P943, DOI 10.1016/j.bone.2005.11.025; Bertrand-Philippe M, 2004, J BIOL CHEM, V279, P24530, DOI 10.1074/jbc.M311804200; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chagin AS, 2007, J CLIN ENDOCR METAB, V92, P4873, DOI 10.1210/jc.2007-0814; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Drissi H, 1999, CANCER RES, V59, P3705; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Galindo M, 2006, J BONE MINER RES, V21, pS384; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Galindo M, 2007, J MOL HISTOL, V38, P501, DOI 10.1007/s10735-007-9143-0; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Harada Y, 2001, BIOCHEM BIOPH RES CO, V284, P714, DOI 10.1006/bbrc.2001.5005; Harrington KS, 2002, J CELL SCI, V115, P4167, DOI 10.1242/jcs.00095; Hinoi E, 2006, GENE DEV, V20, P2937, DOI 10.1101/gad.1482906; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Inman CK, 2003, J BIOL CHEM, V278, P48684, DOI 10.1074/jbc.M308001200; Javed A, 2000, J CELL SCI, V113, P2221; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanda N, 2004, J INVEST DERMATOL, V123, P319, DOI 10.1111/j.0022-202X.2004.12645.x; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kilbey A, 2007, CANCER RES, V67, P11263, DOI 10.1158/0008-5472.CAN-07-3016; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Manavathi B, 2006, J CELL PHYSIOL, V207, P594, DOI 10.1002/jcp.20551; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Pi M, 2005, J CELL BIOCHEM, V95, P1081, DOI 10.1002/jcb.20500; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2003, CANCER RES, V63, P5357; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rosen CJ, 2003, CRIT REV EUKAR GENE, V13, P25, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.30; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Selvamurugan Nagarajan, 2000, Molecular Cell Biology Research Communications, V3, P218, DOI 10.1006/mcbr.2000.0215; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Thirunavukkarasu K, 2002, J CELL BIOCHEM, V85, P837, DOI 10.1002/jcb.10176; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	75	102	108	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27585	27597		10.1074/jbc.M802453200	http://dx.doi.org/10.1074/jbc.M802453200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18625716	Green Published, hybrid			2022-12-25	WOS:000259719200029
J	Zaarur, N; Meriin, AB; Gabai, VL; Sherman, MY				Zaarur, Nava; Meriin, Anatoli B.; Gabai, Vladimir L.; Sherman, Michael Y.			Triggering aggresome formation - Dissecting aggresome-targeting and aggregation signals in synphilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; HEAT-SHOCK; NEURODEGENERATIVE DISORDERS; INTERACTING PROTEIN; DEGRADATION; CELLS; INHIBITION	Abnormal polypeptides that escape proteasome-dependent degradation and aggregate in cytosol can be transported via microtubules to an aggresome, a recently discovered organelle where aggregated proteins are stored or degraded by autophagy. We used synphilin 1, a protein implicated in Parkinson disease, as a model to study mechanisms of aggresome formation. When expressed in naive HEK293 cells, synphilin 1 forms multiple small highly mobile aggregates. However, proteasome or Hsp90 inhibition rapidly triggered their translocation into the aggresome, and surprisingly, this response was independent on the expression level of synphilin 1. Therefore, aggresome formation, but not aggregation of synphilin 1, represents a special cellular response to a failure of the proteasome/chaperone machinery. Importantly, translocation to aggresomes required a special aggresome-targeting signal within the sequence of synphilin 1, an ankyrin-like repeat domain. On the other hand, formation of multiple small aggregates required an entirely different segment within synphilin 1, indicating that aggregation and aggresome formation determinants can be separated genetically. Furthermore, substitution of the ankyrin-like repeat in synphilin 1 with an aggresome-targeting signal from huntingtin was sufficient for aggresome formation upon inhibition of the proteasome. Analogously, attachment of the ankyrin-like repeat to a huntingtin fragment lacking its aggresome-targeting signal promoted its transport to aggresomes. These findings indicate the existence of transferable signals that target aggregation-prone polypeptides to aggresomes.	[Zaarur, Nava; Meriin, Anatoli B.; Gabai, Vladimir L.; Sherman, Michael Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K323, Boston, MA 02118 USA.	sherma1@bu.edu	Gabai, Vladimir L/I-1650-2013	Gabai, Vladimir L/0000-0003-4505-4718; Meriin, Anatoli/0000-0003-0087-814X; Sherman, Michael/0000-0003-3345-073X				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Boeddrich Annett, 2003, Methods Mol Biol, V232, P217; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corboy Michael J., 2005, V301, P305; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs I, 2006, J MOL NEUROSCI, V29, P9, DOI 10.1385/JMN:29:1:9; Layfield R, 2005, ESSAYS BIOCHEM, V41, P157, DOI 10.1042/EB0410157; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luo GR, 2007, INT J BIOL SCI, V3, P20; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Shah Imtiaz M., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P250, DOI 10.2174/187152907782793572; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TSENG BP, 2007, NEUROBIOL A IN PRESS; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	45	68	69	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27575	27584		10.1074/jbc.M802216200	http://dx.doi.org/10.1074/jbc.M802216200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18635553	hybrid			2022-12-25	WOS:000259719200028
J	Motrescu, ER; Blaise, S; Etique, N; Messaddeq, N; Chenard, MP; Stoll, I; Tomasetto, C; Rio, MC				Motrescu, E. R.; Blaise, S.; Etique, N.; Messaddeq, N.; Chenard, M-P; Stoll, I.; Tomasetto, C.; Rio, M-C			Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions	ONCOGENE			English	Article						matrix metalloproteinase-11/stromelysin-3; collagen VI; adipocyte; fat tissue; breast cancer	STROMAL CELL-INTERACTIONS; BREAST-CANCER; IN-VIVO; HUMAN STROMELYSIN-3; C5 DOMAIN; DIFFERENTIATION; IDENTIFICATION; METALLOPROTEINASES; PROGRESSION; ADIPOCYTES	The substrate of matrix metalloproteinase 11 (MMP11) remains unknown. We have recently shown that MMP11 is a negative regulator of adipogenesis, able to reduce and even to revert mature adipocyte differentiation. Here, we have used mouse 3T3L1 cells and human U87MG and SaOS cells to show that MMP11 cleaves the native alpha 3 chain of collagen VI, which is an adipocyte-related extracellular matrix component. It is known that extracellular proteolytic processing of this chain is required for correct collagen VI folding. Interestingly, MMP11-deficient fat tissue is less cohesive and exhibits collagen VI alteration, dramatic adipocyte plasma and basement membrane abnormalities and lipid leakage. MMP11 is thus required for correct collagen VI folding and therefore for fat tissue cohesion and adipocyte function. Both MMP11 and collagen VI favor tumor progression. Similar spatio-temporal overexpression at the adipocyte-cancer cell interface has been reported for the two proteins. MMP11-dependent collagen VI processing might therefore be expected to occur during malignancy. Accordingly, collagen VI no longer delineates adipocytes located at the invasive front of breast carcinomas. In conclusion, the native a3 chain of collagen VI constitutes a specific MMP11 substrate. This MMP11 collagenolytic activity is functional in fat tissue ontogenesis as well as during cancer invasive steps.	[Motrescu, E. R.; Blaise, S.; Etique, N.; Messaddeq, N.; Stoll, I.; Tomasetto, C.; Rio, M-C] Univ Strasbourg 1, INSERM, Dept Canc Biol, Inst Genet & Biol Mol & Cellulaire,UMR 7104,U596, F-67404 Illkirch Graffenstaden, France; [Chenard, M-P] Ctr Hosp Univ Hautepierre, Serv Anat Pathol Gen, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Rio, MC (corresponding author), Univ Strasbourg 1, INSERM, Dept Canc Biol, Inst Genet & Biol Mol & Cellulaire,UMR 7104,U596, BP 10142, F-67404 Illkirch Graffenstaden, France.	rio@igbmc.u-strasbg.fr	Tomasetto, Catherine Laure/J-2783-2014; etique, nicolas/J-4159-2017; BLAISE, Sebastien/AAS-1022-2020; Chenard, Marie-Pierre/O-2373-2016	Tomasetto, Catherine Laure/0000-0002-1811-5848; etique, nicolas/0000-0001-6613-9257; BLAISE, Sebastien/0000-0003-3012-1500; 	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer and the Comites du Haut-Rhin et du Bas-Rhin; European Commission [FP6 LSHC-CT-2003-503297]; Cancer Degradome Project; Institut National du Cancer; Fond National pour la Sante [ACI 2004]; Canceropole Grand-Est and the 'Ruban Rose' prize	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer and the Comites du Haut-Rhin et du Bas-Rhin; European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Degradome Project(European Commission); Institut National du Cancer(Institut National du Cancer (INCA) France); Fond National pour la Sante; Canceropole Grand-Est and the 'Ruban Rose' prize	We thank Takako Sasaki from the Max-Planck-Institute for Biochemistry, Munich, Germany for his help. This study was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Hopital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, the Ligue Nationale Francaise contre le Cancer and the Comites du Haut-Rhin et du Bas-Rhin (equipe labellisee), the European Commission (FP6 LSHC-CT-2003-503297; Cancer Degradome Project), the Institut National du Cancer, Fond National pour la Sante ACI 2004 Canceropole Grand-Est and the 'Ruban Rose' prize. EM was a recipient of an EU fellowship.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; Boulay A, 2001, CANCER RES, V61, P2189; Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; HAN J, 1995, CONNECT TISSUE RES, V31, P161, DOI 10.3109/03008209509028404; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Kannan R, 1999, PROTEIN EXPRES PURIF, V16, P76, DOI 10.1006/prep.1999.1068; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; MOTRESCU ER, 2008, BIOL CHEM, V389; Myint E, 1996, CORNEA, V15, P490; Nakajima I, 2002, DIFFERENTIATION, V70, P84, DOI 10.1046/j.1432-0436.2002.700203.x; NOEL A, 1995, J BIOL CHEM, V270, P22866, DOI 10.1074/jbc.270.39.22866; Noel A, 2000, ONCOGENE, V19, P1605, DOI 10.1038/sj.onc.1203465; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; PEI DQ, 1994, J BIOL CHEM, V269, P25849; RIO MC, 2002, STROMELYSIN 3 PARTIC; Ruhl M, 1999, EXP CELL RES, V250, P548, DOI 10.1006/excr.1999.4540; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456	29	85	87	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	49					6347	6355		10.1038/onc.2008.218	http://dx.doi.org/10.1038/onc.2008.218			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	363JK	18622425				2022-12-25	WOS:000260263400004
J	Bruysters, M; Verhoef-Post, M; Themmen, APN				Bruysters, Martijn; Verhoef-Post, Miriam; Themmen, Axel P. N.			Asp(330) and Tyr(331) in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; PLATELET GLYCOPROTEIN-IB; STIMULATING-HORMONE; HINGE REGION; VONWILLEBRAND DISEASE; EXTRACELLULAR DOMAIN; TSH RECEPTOR; LH RECEPTOR; BINDING; AGONIST	The luteinizing hormone (LH) receptor plays an essential role in male and female gonadal function. Together with the follicle-stimulating hormone (FSH) and thyroid stimulating hormone (TSH) receptors, the LH receptor forms the family of glycoprotein hormone receptors. All glycoprotein hormone receptors share a common modular topography, with an N-terminal extracellular ligand binding domain and a C-terminal seven-transmembrane transduction domain. The ligand binding domain consists of 9 leucine-rich repeats, flanked by N-and C-terminal cysteine-rich regions. Recently, crystal structures have been published of the extracellular domains of the FSH and TSH receptors. However, the C-terminal cysteine-rich region (CCR), also referred to as the "hinge region," was not included in these structures. Both structure and function of the CCR therefore remain unknown. In this study we set out to characterize important domains within the CCR of the LH receptor. First, we mutated all cysteines and combinations of cysteines in the CCR to identify the most probable disulfide bridges. Second, we exchanged large parts of the LH receptor CCR by its FSH receptor counterparts, and characterized the mutant receptors in transiently transfected HEK 293 cells. We zoomed in on important regions by focused exchange and deletion mutagenesis followed by alanine scanning. Mutations in the CCR specifically decreased the potencies of LH and hCG, because the potency of the low molecular weight agonist Org 41841 was unaffected. Using this unbiased approach, we identified Asp(330) and Tyr(331) as key amino acids in LH/hCG mediated signaling.	[Bruysters, Martijn; Verhoef-Post, Miriam; Themmen, Axel P. N.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Themmen, APN (corresponding author), Erasmus MC, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.themmen@erasmusmc.nl			National Institutes of Health [5R01DK069711-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK069711-02 ( to A. P. N. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Basu A, 2005, J IMMUNOASS IMMUNOCH, V26, P313, DOI 10.1080/15321810500220910; Beinborn M, 2006, MOL PHARMACOL, V70, P1, DOI 10.1124/mol.106.025932.; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; COSTAGLIOLA S, 1992, J CLIN ENDOCR METAB, V75, P1540, DOI 10.1210/jc.75.6.1540; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Galet C, 2000, J ENDOCRINOL, V167, P117, DOI 10.1677/joe.0.1670117; Gromoll J, 2000, J CLIN ENDOCR METAB, V85, P2281, DOI 10.1210/jc.85.6.2281; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hong SH, 1998, J BIOL CHEM, V273, P13835, DOI 10.1074/jbc.273.22.13835; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; KELDER J, 2004, CHEMINFORMATICS DEV, V1, P111; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KRAAIJ R, 1995, J CLIN ENDOCR METAB, V80, P3168, DOI 10.1210/jc.80.11.3168; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; MINEGISHI T, 1994, J ENDOCRINOL, V141, P369, DOI 10.1677/joe.0.1410369; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moore S, 2006, J MED CHEM, V49, P3888, DOI 10.1021/jm060247s; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Muller T, 2003, J CLIN ENDOCR METAB, V88, P2242, DOI 10.1210/jc.2002-021946; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; RUSSELL SD, 1993, BLOOD, V81, P1787; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Themmen APN, 2005, REPRODUCTION, V130, P263, DOI 10.1530/rep.1.00663; Thomas D, 1996, MOL ENDOCRINOL, V10, P760, DOI 10.1210/me.10.6.760; van Straten NCR, 2002, CHEMBIOCHEM, V3, P1023, DOI 10.1002/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	36	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25821	25828		10.1074/jbc.M804395200	http://dx.doi.org/10.1074/jbc.M804395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18641392	Green Published, hybrid			2022-12-25	WOS:000259200100008
J	Wang, GL; Salisbury, E; Shi, X; Timchenko, L; Medrano, EE; Timchenko, NA				Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Lubov; Medrano, Estela E.; Timchenko, Nikolai A.			HDAC1 promotes liver proliferation in young mice via interactions with C/EBP beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-BETA; INCREASES TRANSLATION; MESSENGER-RNA; ALPHA; EXPRESSION; OVEREXPRESSION; INHIBITION; CUGBP1; AGE; DNA	HDAC1 (histone deacetylase 1) regulates a number of biological processes in cells. Our previous studies revealed that HDAC1 inhibits proliferation of the livers in old mice. We have surprisingly observed that HDAC1 is also increased in young livers proliferating after partial hepatectomy (PH) and in human liver tumors. Increased levels of HDAC1 after PH lead to its interaction with a member of the C/EBP family, C/EBP beta, which is also elevated after PH. At early time points after PH, the HDAC1-C/EBP beta complex binds to the C/EBP alpha promoter and represses expression of C/EBP alpha. A detailed analysis of the role of HDAC1 and C/EBP beta proteins in the regulation of C/EBP alpha promoter showed that, whereas C/EBP beta alone activates the promoter, HDAC1 represses the promoter in a C/EBP beta-dependent manner. The inhibition of HDAC1 in the livers of young mice inhibits liver proliferation after PH, which is associated with high levels of C/EBP alpha. Consistent with the positive role of HDAC1-C/EBP beta complexes in liver proliferation, we have found that the CUGBP1-HDAC1-C/EBP beta pathway is activated in human tumor liver samples, suggesting that HDAC1-C/EBP beta complexes are involved in the development of liver tumors. The causal role of the CUGBP1-HDAC1 pathway in liver proliferation was examined in CUGBP1 transgenic mice, which display high levels of the CUGBP1-eIF2 complex. We have demonstrated that elevation of the HDAC1-C/EBP beta complexes in CUGBP1 transgenic mice reduces expression of C/EBP alpha and increases the rate of liver proliferation. Thus, these studies have identified a new pathway that promotes liver proliferation in young mice and might contribute to the malignant transformations in the liver.	[Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Medrano, Estela E.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Salisbury, Elizabeth/0000-0003-3607-2367	National Institutes of Health [GM55188, CA100070, AG20752, AR49222, AR052781, AR44387, AG032135]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387, R01AR049222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020752, R01AG032135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.); AR49222, AR052781, and AR44387 (to L.T.T.); and AG032135. This work was also supported by an Ellison Medical Foundation grant ( to E. E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; BUCHER NLR, 1964, CANCER RES, V24, P509; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Lindemann RK, 2004, GENE THER MOL BIOL, V8, P61; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	22	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26179	26187		10.1074/jbc.M803545200	http://dx.doi.org/10.1074/jbc.M803545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18622014	hybrid, Green Published			2022-12-25	WOS:000259200100046
J	Slepenkov, SV; Korneeva, NL; Rhoads, RE				Slepenkov, Sergey V.; Korneeva, Nadejda L.; Rhoads, Robert E.			Kinetic mechanism for assembly of the m(7)GpppG center dot eIF4E center dot eIF4G complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING PROTEIN; MESSENGER-RNA-CAP; DEPENDENT TRANSLATION INITIATION; FACTOR EIF-4E; STOPPED-FLOW; FACTOR EIF4E; FACTOR 4E; AFFINITY; ANALOGS; YEAST	Interaction of the mRNA cap with the translational machinery is a critical and early step in the initiation of protein synthesis. To better understand this process, we determined kinetic constants for the interaction of m(7)GpppG with human eIF4E by stopped-flow fluorescence quenching in the presence of a 90-amino acid fragment of human eIF4G that contains the eIF4E-binding domain (eIF4G(557-646)). The values obtained, k(on) = 179 x 10(6) M-1 s(-1) and k(off) = 79 s(-1), were the same as reported previously in the absence of an eIF4G-derived peptide. We also used surface plasmon resonance to determine kinetic constants for the binding of eIF4E to eIF4G(557-646), both in the presence and absence of m7GpppG. The results indicated that eIF4G(557-646) binds eIF4E and eIF4E center dot m7GpppG at the same rate, with k(on) = 3 x 10(6) M-1 s(-1) and k(off) = 0.01 s(-1). Our data represent the first full kinetic description of the interaction of eIF4E with its two specific ligands. The results demonstrate that the formation of the m(7)GpppG center dot eIF4E center dot eIF4G(557-646) complex obeys a sequential, random kinetic mechanism and that there is no preferential pathway for its formation. Thus, even though eIF4G(557-646) binds eIF4E tightly, it does not increase the affinity of eIF4E for m7GpppG, as has been claimed in several previous publications. We did, in fact, observe increased binding to m(7)GTP-Sepharose in the presence of eIF4G(557-646), but only with recombinant eIF4E that was prepared from inclusion bodies.	[Slepenkov, Sergey V.; Korneeva, Nadejda L.; Rhoads, Robert E.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Rhoads, RE (corresponding author), 1501 Kings Highway, Shreveport, LA 71130 USA.	rrhoad@lsuhsc.edu			National Institutes of Health NIGMS [2R01GM20818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 2R01GM20818. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Bevington PR, 1969, DATA REDUCTION ERROR; Blachut-Okrasinska E, 2000, EUR BIOPHYS J BIOPHY, V29, P487, DOI 10.1007/s002490000096; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; EDERY I, 1988, GENE, V74, P517, DOI 10.1016/0378-1119(88)90184-9; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GOSS DJ, 1990, BIOCHIM BIOPHYS ACTA, V1050, P163, DOI 10.1016/0167-4781(90)90160-4; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Niedzwiecka A, 2005, NUCLEOS NUCLEOT NUCL, V24, P507, DOI 10.1081/NCN-200061784; Niedzwiecka A, 2005, J PHYS-CONDENS MAT, V17, pS1483, DOI 10.1088/0953-8984/17/18/006; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; RYCHLIK W, 1986, J BIOL CHEM, V261, P71; SHA M, 1995, J BIOL CHEM, V270, P29904; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Stepinski J, 2001, RNA, V7, P1486; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; TRYBUS KM, 1982, BIOCHEMISTRY-US, V21, P1284, DOI 10.1021/bi00535a028; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001	43	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25227	25237		10.1074/jbc.M801786200	http://dx.doi.org/10.1074/jbc.M801786200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614538	Green Published, hybrid			2022-12-25	WOS:000259012700015
J	Yin, S; Fan, X; Yu, S; Li, C; Sy, MS				Yin, Shaoman; Fan, Xingjun; Yu, Shuiliang; Li, Chaoyang; Sy, Man-Sun			Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID; PLASMID DNA; SPONGIFORM ENCEPHALOPATHY; THERMODYNAMIC STABILITY; CONFORMATIONAL-CHANGES; NUCLEOCAPSID PROTEIN; INSERTION MUTATIONS; HORIZONTAL TRANSFER; APOPTOTIC BODIES; SCRAPIE PRION	Recombinant prion protein, rPrP, binds DNA. Both the KKRPK motif and the octapeptide repeat region of rPrP are essential for maximal binding. rPrP with pathogenic insertional mutations binds more DNA than wild-type rPrP. DNA promotes the aggregation of rPrP and protects its N terminus from proteinase K digestion. When rPrP is mixed with an expression plasmid and Ca2+, the rPrP center dot DNA complex is taken up by mammalian cells leading to gene expression. In the presence of Ca2+, rPrP by itself is also taken up by cells in a temperature- and pinocytosis-dependent manner. Cells do not take up rPrP(Delta KKRPK), which lacks the KKRPK motif. Thus, rPrP is the carrier for DNA and the KKRPK motif is essential for its uptake. When mixed with DNA, a pentapeptide KKRPK, but not KKKKK, is sufficient for DNA internalization and expression. In contrast, whereas the normal cellular prion protein, PrPC, on the cell surface can also internalize DNA, the imported DNA is not expressed. These findings may have relevance to the normal functions of PrPC and the pathogenic mechanisms of human prion disease.	[Yin, Shaoman; Fan, Xingjun; Yu, Shuiliang; Li, Chaoyang; Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Sy, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Rm 5131,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	mxs92@po.cwru.edu			National Institutes of Health [NS-045981-01]; United States Department of Army [DAMD17-03-1-0286]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Army; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-045981-01 (to M. S. S.). This work was also supported by United States Department of Army Contract DAMD17-03-1-0286 (to M. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belting M, 2005, ADV DRUG DELIVER REV, V57, P505, DOI 10.1016/j.addr.2004.10.004; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; CAUGHEY B, 1994, ANN NY ACAD SCI, V724, P290, DOI 10.1111/j.1749-6632.1994.tb38918.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Esser D, 2000, NAT BIOTECHNOL, V18, P1211, DOI 10.1038/81221; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fritz JD, 1996, HUM GENE THER, V7, P1395, DOI 10.1089/hum.1996.7.12-1395; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; Huang Z, 1996, CURR TOP MICROBIOL, V207, P49; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Karpuj MV, 2007, MOL MED, V13, P190, DOI 10.2119/2006-00073.Karpuj; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; King DJ, 2007, J MOL BIOL, V369, P1001, DOI 10.1016/j.jmb.2007.02.004; Li CY, 2007, BIOCHEM J, V406, P333, DOI 10.1042/BJ20061857; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; NARANG HK, 1988, P NATL ACAD SCI USA, V85, P3575, DOI 10.1073/pnas.85.10.3575; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Sloots A, 2005, FEBS J, V272, P4221, DOI 10.1111/j.1742-4658.2005.04834.x; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WALTERS MNI, 1978, CRC CR REV TOXICOL, V5, P377, DOI 10.3109/10408447809081012; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; YAMAGUCHI H, 1965, J BIOCHEM, V57, P667; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	65	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25446	25454		10.1074/jbc.M800814200	http://dx.doi.org/10.1074/jbc.M800814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18622017	hybrid, Green Published			2022-12-25	WOS:000259012700040
J	Hoffert, JD; Fenton, RA; Moeller, HB; Simons, B; Tchapyjnikov, D; McDill, BW; Yu, MJ; Pisitkun, T; Chen, F; Knepper, MA				Hoffert, Jason D.; Fenton, Robert A.; Moeller, Hanne B.; Simons, Brigitte; Tchapyjnikov, Dmitry; McDill, Bradley W.; Yu, Ming-Jiun; Pisitkun, Trairak; Chen, Feng; Knepper, Mark A.			Vasopressin-stimulated increase in phosphorylation at Ser(269) potentiates plasma membrane retention of aquaporin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY COLLECTING DUCT; WATER CHANNEL; RAT; PERMEABILITY; ENDOCYTOSIS; PROTEIN; CELLS; TRAFFICKING; KINASE; LOCALIZATION	Vasopressin controls water excretion through regulation of aquaporin-2 (AQP2) trafficking in renal collecting duct cells. Using mass spectrometry, we previously demonstrated four phosphorylated serines (Ser(256), Ser(261), Ser(264), and Ser(269)) in the carboxyl-terminal tail of rat AQP2. Here, we used phospho-specific antibodies and protein mass spectrometry to investigate the roles of vasopressin and cyclic AMP in the regulation of phosphorylation at Ser(269) and addressed the role of this site in AQP2 trafficking. The V2 receptor-specific vasopressin analog dDAVP increased Ser(P)(269)-AQP2 abundance more than 10-fold, but at a rate much slower than the corresponding increase in Ser(256) phosphorylation. Vasopressin-mediated changes in phosphorylation at both sites were mimicked by cAMP addition and inhibited by protein kinase A (PKA) antagonists. In vitro kinase assays, however, demonstrated that PKA phosphorylates Ser(256), but not Ser(269). Phosphorylation of AQP2 at Ser(269) did not occur when Ser(256) was replaced by an unphosphorylatable amino acid, as seen in both S256L-AQP2 mutant mice and in Madin-Darby canine kidney cells expressing an S256A mutant, suggesting that Ser(269) phosphorylation depends upon prior phosphorylation at Ser256. Immunogold electron microscopy localized Ser(P)(269)-AQP2 solely in the apical plasma membrane of rat collecting duct cells, in contrast to the other three phospho-forms (found in both apical plasma membrane and intracellular vesicles). Madin-Darby canine kidney cells expressing an S269D "phosphomimic" AQP2 mutant showed constitutive localization at the plasma membrane. The data support a model in which vasopressin-mediated phosphorylation of AQP2 at Ser(269): (a) depends on prior PKA-mediated phosphorylation of Ser(256) and (b) enhances apical plasma membrane retention of AQP2.	[Hoffert, Jason D.; Simons, Brigitte; Tchapyjnikov, Dmitry; Yu, Ming-Jiun; Pisitkun, Trairak; Knepper, Mark A.] NHLBI, NIH, Bethesda, MD 20892 USA; [Fenton, Robert A.; Moeller, Hanne B.] Univ Aarhus, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; [Simons, Brigitte] Appl Biosyst MDS Sciex, Concord, ON L4K 4V8, Canada; [McDill, Bradley W.; Chen, Feng] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Aarhus University; Thermo Fisher Scientific; Applied Biosystems; Washington University (WUSTL)	Knepper, MA (corresponding author), NHLBI, NIH, 10 Ctr Dr,Bldg 10,Rm 6N260, Bethesda, MD 20892 USA.	KnepperM@nhlbi.nih.gov	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021; Knepper, Mark/AAF-8412-2020	Fenton, Robert/0000-0003-1623-199X; YU, MING-JIUN/0000-0003-0393-4696; Tchapyjnikov, Dmitry/0000-0001-5649-5880; Pisitkun, Trairak/0000-0001-6677-2271	National Institutes of Health [RO1DK067386, P30DK079333]; NHLBI [Z01-HL001285]; Danish National Research Foundation (Danmarks Grundforskningsfond); Department of Internal Medicine/Renal Division at Washington University School of Medicine; March of Dimes Award [FY06-343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067386, P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond); Department of Internal Medicine/Renal Division at Washington University School of Medicine; March of Dimes Award(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK067386 and P30DK079333 (to F. C.) and by NHLBI, National Institutes of Health Intramural Budget Project Z01-HL001285 (to J. D. H., M. Y., T. P., and M. A. K.). This work was also supported by a Marie Curie Intra-European Fellowship and funds from the Danish National Research Foundation (Danmarks Grundforskningsfond) (to R. A. F.) and by funds from the Department of Internal Medicine/Renal Division at Washington University School of Medicine and March of Dimes Award FY06-343 (to F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF78, DOI 10.1152/ajprenal.1995.269.1.F78; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; DIGIOVANNI SR, 1994, P NATL ACAD SCI USA, V91, P8984, DOI 10.1073/pnas.91.19.8984; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Katsura T, 1997, Am J Physiol, V272, pF817; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; Knepper MA, 2001, ACTA PHYSIOL SCAND, V173, P11, DOI 10.1046/j.1365-201X.2001.00880.x; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lande MB, 1996, J BIOL CHEM, V271, P5552, DOI 10.1074/jbc.271.10.5552; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pisitkun T, 2007, PHYSIOLOGY, V22, P390, DOI 10.1152/physiol.00025.2007; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; van Balkom BWM, 2004, AM J PHYSIOL-CELL PH, V286, pC372, DOI 10.1152/ajpcell.00271.2003; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200	43	183	186	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24617	24627		10.1074/jbc.M803074200	http://dx.doi.org/10.1074/jbc.M803074200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606813	hybrid, Green Published			2022-12-25	WOS:000258820000034
J	Kawashima, Y; Miyazaki, E; Muller, M; Tokuda, H; Nishiyama, K				Kawashima, Yosuke; Miyazaki, Emi; Mueller, Matthias; Tokuda, Hajime; Nishiyama, Ken-ichi			Diacylglycerol specifically blocks spontaneous integration of membrane proteins and allows detection of a factor-assisted integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M13 PROCOAT PROTEIN; F1F0 ATP SYNTHASE; PF3 COAT PROTEIN; ESCHERICHIA-COLI; SUBUNIT-C; PURIFIED COMPONENTS; DIGLYCERIDE KINASE; BOUND PHOSPHATASES; MANNITOL PERMEASE; PLASMA-MEMBRANE	We recently found that the spontaneous integration of M13 procoat is blocked by diacylglycerol (DAG) (Nishiyama, K., Ikegami, A., Moser, M., Schiltz, E., Tokuda, H., and Muller, M. (2006) J. Biol. Chem. 281, 35667-35676). Here, we demonstrate that the spontaneous integration of Pf3 coat, another membrane protein that has been thought to be integrated spontaneously into liposomes, can be blocked by DAG at physiological concentrations. Moreover, the spontaneous integration of the membrane potential-independent version of Pf3 coat (3L-Pf3 coat), which is independent of YidC, was also blocked by DAG. To clarify the mechanism by which DAG blocks spontaneous integration, we examined lipid compounds similar to DAG and DAG derivatives. The blockage of spontaneous integration was specific to DAG, as fatty acids, monoacylglycerol, and phosphatidic acids were not effective for the blockage. When the acyl chains in DAG were shortened even to octanoyl residues, it still blocked spontaneous integration, whereas diheptanoylglycerol did not block it at all. Triacylglycerol was more effective than DAG. However, the lipid A-derivative-dependent integration of M13 procoat could not be reconstituted when triacylglycerol was included in the liposomes. On the other hand, when DAG was included in the liposomes, we found that the integration of 3L-Pf3 coat was strictly dependent on the lipid A-derived integration factor. We propose that the bulky structure of DAG rather than changes in membrane curvature is essential for the blockage of spontaneous integration. We also demonstrated that the blockage of spontaneous integration by DAG is also operative in native membrane vesicles.	[Kawashima, Yosuke; Miyazaki, Emi; Tokuda, Hajime; Nishiyama, Ken-ichi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79104 Freiburg, Germany	University of Tokyo; University of Freiburg	Nishiyama, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	unishiy@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOECK H, 1992, BIOCHEMISTRY-US, V31, P623, DOI 10.1021/bi00117a046; FIEDLER W, 1985, J BIOL CHEM, V260, P4799; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; GELLER BL, 1985, J BIOL CHEM, V260, P3281; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; ICHO T, 1988, J BACTERIOL, V170, P5117, DOI 10.1128/jb.170.11.5117-5124.1988; JACKSON BJ, 1984, J BACTERIOL, V160, P976, DOI 10.1128/JB.160.3.976-981.1984; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; KUHN A, 1985, J BIOL CHEM, V260, P5914; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; ROTERING H, 1983, J BIOL CHEM, V258, P8068; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; SHIBUI T, 1988, AGR BIOL CHEM TOKYO, V52, P983; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Vervoort EB, 2005, J MOL BIOL, V346, P733, DOI 10.1016/j.jmb.2004.12.011; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhou C, 1997, BBA-LIPID LIPID MET, V1348, P273, DOI 10.1016/S0005-2760(97)00066-0	44	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24489	24496		10.1074/jbc.M801812200	http://dx.doi.org/10.1074/jbc.M801812200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614537	Green Published, hybrid			2022-12-25	WOS:000258820000024
J	Choi, E; Dial, JM; Jeong, DE; Hall, MC				Choi, Eunyoung; Dial, J. Michael; Jeong, Dah-Eun; Hall, Mark C.			Unique D box and KEN box sequences limit ubiquitination of Acm1 and promote pseudosubstrate inhibition of the anaphase-promoting complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; DESTRUCTION BOX; BUDDING YEAST; SUBSTRATE RECOGNITION; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEGRADATION; AURORA-A; APC/C	The anaphase-promoting complex (APC) regulates cell division in eukaryotes by targeting specific proteins for destruction. APC substrates generally contain one or more short degron sequences that help mediate their recognition and poly- ubiquitination by the APC. The most common and well characterized degrons are the destruction box ( D box) and the KEN box. The budding yeast Acm1 protein, an inhibitor of Cdh1- activated APC ( APCCdh1) also contains several conserved D and KEN boxes, and here we report that two of these located in the central region of Acm1 constitute a pseudosubstrate sequence required for APCCdh1 inhibition. Acm1 interacted with and inhibited substrate binding to the WD40 repeat domain of Cdh1. Combined mutation of the central D and KEN boxes strongly reduced both binding to the Cdh1 WD40 domain and APCCdh1 inhibition. Despite this, the double mutant, but not wild- type Acm1, was poly- ubiquitinated by APCCdh1 in vitro. Thus, unlike substrates in which D and KEN boxes promote ubiquitination, these same elements in the central region of Acm1 prevent ubiquitination. We propose that this unique property of the Acm1 degron sequences results from an unusually high affinity interaction with the substrate receptor site on theWD40domain of Cdh1 that may serve both to promote APC inhibition and protect Acm1 from destruction.	[Choi, Eunyoung; Jeong, Dah-Eun; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hall, Mark C.] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA; [Dial, J. Michael] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; University of North Carolina Chapel Hill	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011	Hall, Mark/0000-0001-6429-2506				Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; KEMP BE, 1989, CELL SIGNAL, V1, P303, DOI 10.1016/0898-6568(89)90049-1; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; OSTAPENKO D, 2008, MOL CELL BI IN PRESS; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sullivan M, 2007, J BIOL CHEM, V282, P19710, DOI 10.1074/jbc.M701507200; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2001, CURR BIOL, V11, pR834, DOI 10.1016/S0960-9822(01)00498-5; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	56	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23701	23710		10.1074/jbc.M803695200	http://dx.doi.org/10.1074/jbc.M803695200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596038	Green Published, hybrid			2022-12-25	WOS:000258638900024
J	Tang, Y; Liu, ZY; Zhao, L; Clemens, TL; Cao, X				Tang, Yi; Liu, Zhongyu; Zhao, Ling; Clemens, Thomas L.; Cao, Xu			Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; STABLE OVEREXPRESSION; NUCLEAR-LOCALIZATION; CARCINOMA CELLS; IN-VIVO; PROTEIN; CANCER; METASTASIS; EXPRESSION; IDENTIFICATION	beta-Catenin functions both as an adherens junction adhesion protein and as an essential mediator of the canonical Wnt signaling pathway. Wnts stabilize beta-catenin and promote its accumulation in the nucleus, where it regulates transcription of the target genes. Here we show that Smad7 promotes cell-cell adhesion by stabilizing beta-catenin and consequently increases the beta-catenin-E-cadherin complex level at the plasma membrane. A Smad7-Axin interaction disassociates GSK-3 beta and beta-catenin from Axin, as well as inhibits the recruitment of Smurf2, an E3 ligase, to beta-catenin, thus protecting beta-catenin from phosphorylation and degradation. Smad7 increases the stabilized beta-catenin to form a complex with E-cadherin and stabilizes the E-cadherin-beta-catenin complex. Thereby, rather than being translocated to the nucleus for regulating the target gene transcription, Smad7-stabilized-beta-catenin is shunted to the E-cadherin complex to modulate cell-cell adhesion.	[Tang, Yi; Liu, Zhongyu; Zhao, Ling; Clemens, Thomas L.; Cao, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Cao, X (corresponding author), 1670 Univ Blvd, Birmingham, AL 35294 USA.	cao@uab.edu			National Institutes of Health [DK57501]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DK57501 ( to X. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bitzer M, 2000, GENE DEV, V14, P187; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Fink SP, 2003, ONCOGENE, V22, P1317, DOI 10.1038/sj.onc.1206128; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Klingelhofer J, 2003, ONCOGENE, V22, P1181, DOI 10.1038/sj.onc.1206245; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Orsulic S, 1999, J CELL SCI, V112, P1237; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tsunobuchi H, 2004, BIOCHEM BIOPH RES CO, V316, P712, DOI 10.1016/j.bbrc.2004.02.104; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23956	23963		10.1074/jbc.M800351200	http://dx.doi.org/10.1074/jbc.M800351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593713	Green Published, hybrid			2022-12-25	WOS:000258638900051
J	Hartshorne, JK				Hartshorne, Joshua K.			Visual Working Memory Capacity and Proactive Interference	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; FIXED NUMBER; MECHANISMS; INTERNET; MIND; FAMILIARITY; RETENTION; LIMITS; WORDS	Background: Visual working memory capacity is extremely limited and appears to be relatively immune to practice effects or the use of explicit strategies. The recent discovery that visual working memory tasks, like verbal working memory tasks, are subject to proactive interference, coupled with the fact that typical visual working memory tasks are particularly conducive to proactive interference, suggests that visual working memory capacity may be systematically under-estimated. Methodology/Principal Findings: Working memory capacity was probed behaviorally in adult humans both in laboratory settings and via the Internet. Several experiments show that although the effect of proactive interference on visual working memory is significant and can last over several trials, it only changes the capacity estimate by about 15%. Conclusions/Significance: This study further confirms the sharp limitations on visual working memory capacity, both in absolute terms and relative to verbal working memory. It is suggested that future research take these limitations into account in understanding differences across a variety of tasks between human adults, prelinguistic infants and nonlinguistic animals.	[Hartshorne, Joshua K.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Hartshorne, JK (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	jharts@wjh.harvard.edu		Hartshorne, Joshua/0000-0003-1240-3598; Lauwereyns, Jan/0000-0003-0551-2550	Harvard University [start-up (seed)]	Harvard University	Funds to test participants were provided from a start-up (seed) grant to Yuhong Jiang from Harvard University. The granting organization had no further role.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD., 1990, HUMAN MEMORY THEORY; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bunting M, 2006, J EXP PSYCHOL LEARN, V32, P183, DOI 10.1037/0278-7393.32.2.183; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; CAREY S, ORIGINAL CO IN PRESS; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Davis G, 2005, MEM COGNITION, V33, P185, DOI 10.3758/BF03195307; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; ERICSSON KA, 1982, AM SCI, V70, P607; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flavell JH, 2004, MERRILL PALMER QUART, V50, P274, DOI 10.1353/mpq.2004.0018; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hedden T, 2006, NEUROPSYCHOLOGY, V20, P511, DOI 10.1037/0894-4105.20.5.511; HULME C, 1995, BRIT J PSYCHOL, V86, P527, DOI 10.1111/j.2044-8295.1995.tb02570.x; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Jarrold C, 1997, Cogn Neuropsychiatry, V2, P101, DOI 10.1080/135468097396351; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; KEPPEL G, 1962, J VERB LEARN VERB BE, V1, P153, DOI 10.1016/S0022-5371(62)80023-1; Kliegl R, 1987, COGNITION INSTRUCT; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Makovski T, 2008, MEM COGNITION, V36, P43, DOI 10.3758/MC.36.1.43; Mecklinger A, 2003, COGNITIVE BRAIN RES, V18, P26, DOI 10.1016/j.cogbrainres.2003.08.008; Meyerson P, 2003, BEHAV RES METH INS C, V35, P614, DOI 10.3758/BF03195541; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MONSELL S, 1978, COGNITIVE PSYCHOL, V10, P465, DOI 10.1016/0010-0285(78)90008-7; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2005, J EXP PSYCHOL HUMAN, V31, P889, DOI 10.1037/0096-1523.31.5.889; Olson IR, 2004, MEM COGNITION, V32, P1326, DOI 10.3758/BF03206323; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PETERSON LR, 1965, J EXP PSYCHOL, V70, P473, DOI 10.1037/h0022542; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Postle BR, 2004, COGN AFFECT BEHAV NE, V4, P379, DOI 10.3758/CABN.4.3.379; Salthouse TA, 2006, J MEM LANG, V55, P102, DOI 10.1016/j.jml.2006.03.006; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Spelke ES, 2002, LANGUAGES OF THE BRAIN, P239; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; ZHANG GJ, 1985, MEM COGNITION, V13, P193, DOI 10.3758/BF03197681	48	67	68	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2716	10.1371/journal.pone.0002716	http://dx.doi.org/10.1371/journal.pone.0002716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648493	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900003
J	Chan, WT; Sherer, NM; Uchil, PD; Novak, EK; Swank, RT; Mothes, W				Chan, Wai-Tsing; Sherer, Nathan M.; Uchil, Pradeep D.; Novak, Edward K.; Swank, Richard T.; Mothes, Walther			Murine Leukemia Virus Spreading in Mice Impaired in the Biogenesis of Secretory Lysosomes and Ca2+-Regulated Exocytosis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; REGULATES CA2+-DEPENDENT EXOCYTOSIS; INTRACELLULAR TRAFFICKING; INFECTIOUS HIV-1; PLASMA-MEMBRANE; LYTIC GRANULES; SYNDROME GENES; TYPE-1; CELLS; AP-3	Background: Retroviruses have been observed to bud intracellularly into multivesicular bodies (MVB), in addition to the plasma membrane. Release from MVB is thought to occur by Ca2+-regulated fusion with the plasma membrane. Principal Findings: To address the role of the MVB pathway in replication of the murine leukemia virus (MLV) we took advantage of mouse models for the Hermansky-Pudlak syndrome (HPS) and Griscelli syndrome. In humans, these disorders are characterized by hypopigmentation and immunological alterations that are caused by defects in the biogenesis and trafficking of MVBs and other lysosome related organelles. Neonatal mice for these disease models lacking functional AP-3, Rab27A and BLOC factors were infected with Moloney MLV and the spread of virus into bone marrow, spleen and thymus was monitored. We found a moderate reduction in MLV infection levels in most mutant mice, which differed by less than two-fold compared to wild-type mice. In vitro, MLV release form bone-marrow derived macrophages was slightly enhanced. Finally, we found no evidence for a Ca2+-regulated release pathway in vitro. Furthermore, MLV replication was only moderately affected in mice lacking Synaptotagmin VII, a Ca2+-sensor regulating lysosome fusion with the plasma membrane. Conclusions: Given that MLV spreading in mice depends on multiple rounds of replication even moderate reduction of virus release at the cellular level would accumulate and lead to a significant effect over time. Thus our in vivo and in vitro data collectively argue against an essential role for a MVB- and secretory lysosome-mediated pathway in the egress of MLV.	[Chan, Wai-Tsing; Sherer, Nathan M.; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Novak, Edward K.; Swank, Richard T.] Roswell Park Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY USA	Yale University; Roswell Park Cancer Institute	Chan, WT (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA.	walther.mothes@yale.edu		Uchil, Pradeep/0000-0002-7236-858X	National Institutes of Health [R21 AI065284]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health (NIH) R21 AI065284 to W.M.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 2005, TRAFFIC, V6, P243, DOI 10.1111/j.1600-0854.2005.00264.x; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clark R, 2003, CURR OPIN IMMUNOL, V15, P516, DOI 10.1016/S0952-7915(03)00113-4; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Finke D, 2001, INFEC DIS S, P125; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gottlinger HG, 2001, AIDS, V15, pS13; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; JOUVENET N, 2008, NATURE; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; OTT DE, 1992, J VIROL, V66, P6107, DOI 10.1128/JVI.66.10.6107-6116.1992; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Uittenbogaart CH, 1998, J VIROL, V72, P10118, DOI 10.1128/JVI.72.12.10118-10125.1998; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2713	10.1371/journal.pone.0002713	http://dx.doi.org/10.1371/journal.pone.0002713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629000	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200056
J	Gupta, P; Ho, PC; Huq, MDM; Khan, AA; Tsai, NP; Wei, LN				Gupta, Pawan; Ho, Ping-Chih; Huq, M. D. Mostaqul; Khan, Amjad Ali; Tsai, Nien-Pei; Wei, Li-Na			PKC epsilon Stimulated Arginine Methylation of RIP140 for Its Nuclear-Cytoplasmic Export in Adipocyte Differentiation	PLOS ONE			English	Article								Background: Receptor interacting protein 140 (RIP140) is a versatile transcriptional co-repressor that plays roles in diverse metabolic processes including fat accumulation in adipocytes. Previously we identified three methylated arginine residues in RIP140, which rendered its export to the cytoplasm; but it was unclear what triggered RIP140 arginine methylation. Methodology/Principal Findings: In this study, we determined the activated PKC epsilon as the specific trigger for RIP140 arginine methylation and its subsequent export. We identified two PKC epsilon-phosphorylated residues of RIP140, Ser-102 and Ser-1003, which synergistically stimulated direct binding of RIP140 by 14-3-3 that recruited protein arginine methyl transferase 1 to methylate RIP140. The methylated RIP140 then preferentially recruited exportin 1 for nuclear export. As a result, the nuclear gene-repressive activity of RIP140 was reduced. In RIP140 null adipocyte cultures, the defect in fat accumulation was effectively rescued by the phosphoylation-deficient mutant RIP140 that resided predominantly in the nucleus, but less so by the phospho-mimetic RIP140 that was exported to the cytoplasm. Conclusions/Significance: This study uncovers a novel means, via a cascade of protein modifications, to inactivate, or suppress, the nuclear action of an important transcription coregulator RIP140, and delineates the first specific phosphorylation-arginine methylation cascade that could alter protein subcellular distribution and biological activity.	[Gupta, Pawan; Ho, Ping-Chih; Huq, M. D. Mostaqul; Khan, Amjad Ali; Tsai, Nien-Pei; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gupta, P (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	weixx009@umn.edu			Philip Morris USA Inc; Philip Morris International; NIH [DK54733, DK60521, K02-DA13926, DA11190]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054733, R01DK060521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, K02DA013926] Funding Source: NIH RePORTER	Philip Morris USA Inc; Philip Morris International; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part by Philip Morris USA Inc. and Philip Morris International, and by NIH grants DK54733, DK60521, K02-DA13926 and DA11190 to L.-N. Wei.	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; England K, 2000, BIOCHEM J, V352, P19, DOI 10.1042/0264-6021:3520019; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fleming I, 1998, BIOCHEM J, V333, P719, DOI 10.1042/bj3330719; Frevert EU, 1996, BIOCHEM J, V316, P865, DOI 10.1042/bj3160865; Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200; Gupta P, 2007, NUCLEIC ACIDS RES, V35, P2269, DOI 10.1093/nar/gkl1147; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huq MDM, 2007, NAT CHEM BIOL, V3, P161, DOI 10.1038/nchembio861; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Huq MDM, 2005, PROTEOMICS, V5, P2157, DOI 10.1002/pmic.200401090; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LHorset F, 1996, MOL CELL BIOL, V16, P6029; Li JH, 2002, J BIOL CHEM, V277, P39967, DOI 10.1074/jbc.M200840200; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Parker M, 2003, FEBS LETT, V546, P149, DOI 10.1016/S0014-5793(03)00564-7; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Robb VA, 2004, ONCOGENE, V23, P3589, DOI 10.1038/sj.onc.1207445; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Wang H E, 2000, Prehosp Emerg Care, V4, P14, DOI 10.1080/10903120090941560; Wei LN, 2001, J BIOL CHEM, V276, P16107, DOI 10.1074/jbc.M010185200; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xu TR, 2004, FEBS LETT, V570, P20, DOI 10.1016/j.febslet.2004.05.080; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/me.15.4.501; 2002, SCI STKE, pTW101	47	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2658	10.1371/journal.pone.0002658	http://dx.doi.org/10.1371/journal.pone.0002658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628823	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200004
J	Balraj, P; El Karkouri, K; Vestris, G; Espinosa, L; Raoult, D; Renesto, P				Balraj, Premanand; El Karkouri, Khalid; Vestris, Guy; Espinosa, Leon; Raoult, Didier; Renesto, Patricia			RickA Expression Is Not Sufficient to Promote Actin-Based Motility of Rickettsia raoultii	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SHIGELLA-FLEXNERI; PLAQUE-FORMATION; GENE; SEQUENCE; IDENTIFICATION; CONORII; PROTEIN; PROWAZEKII; PEACOCKII	Background: Rickettsia raoultii is a novel Rickettsia species recently isolated from Dermacentor ticks and classified within the spotted fever group (SFG). The inability of R. raoultii to spread within L929 cells suggests that this bacterium is unable to polymerize host cell actin, a property exhibited by all SFG rickettsiae except R. peacocki. This result led us to investigate if RickA, the protein thought to generate actin nucleation, was expressed within this rickettsia species. Methodology/Principal Findings: Amplification and sequencing of R. raoultii rickA showed that this gene encoded a putative 565 amino acid protein highly homologous to those found in other rickettsiae. Using immunofluorescence assays, we determined that the motility pattern (i.e. microcolonies or cell-to-cell spreading) of R. raoultii was different depending on the host cell line in which the bacteria replicated. In contrast, under the same experimental conditions, R. conorii shares the same phenotype both in L929 and in Vero cells. Transmission electron microscopy analysis of infected cells showed that non-motile bacteria were free in the cytosol instead of enclosed in a vacuole. Moreover, western-blot analysis demonstrated that the defect of R. raoultii actin-based motility within L929 cells was not related to lower expression of RickA. Conclusion/Significance: These results, together with previously published data about R. typhi, strongly suggest that another factor, apart from RickA, may be involved with be responsible for actin-based motility in bacteria from the Rickettsia genus.	[Balraj, Premanand; El Karkouri, Khalid; Vestris, Guy; Espinosa, Leon; Raoult, Didier; Renesto, Patricia] Fac Med, Unite Rickettsies, CNRS, URMITE IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Balraj, P (corresponding author), Fac Med, Unite Rickettsies, CNRS, URMITE IRD UMR 6236, Marseille, France.	patricia.renesto@medecine.univ-mrs.fr	Renesto, patricia/M-6105-2014; RAOULT, Didier/A-8434-2008; renesto, patricia/T-6446-2019; Espinosa, Leon/V-8410-2017	RAOULT, Didier/0000-0002-0633-5974; renesto, patricia/0000-0002-6749-7862; 				Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Carlsson F, 2006, J CELL PHYSIOL, V209, P288, DOI 10.1002/jcp.20721; CORY J, 1974, APPL MICROBIOL, V27, P1157, DOI 10.1128/AEM.27.6.1157-1161.1974; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Hybiske K, 2008, NAT REV MICROBIOL, V6, P99, DOI 10.1038/nrmicro1821; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; JOHNSON JW, 1978, J CLIN MICROBIOL, V7, P389; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; MEDIANNIKOV O, 2008, INT J SYST EVOL MICR; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; OGATA H, 2006, PLOS BIOL; OGATA H, 2005, PLOS BIOL; OSTERMAN JV, 1974, INFECT IMMUN, V10, P1152, DOI 10.1128/IAI.10.5.1152-1155.1974; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renesto P, 2003, J INFECT DIS, V188, P1276, DOI 10.1086/379080; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Roberts AJ, 2006, FEMS MICROBIOL LETT, V254, P300, DOI 10.1111/j.1574-6968.2005.00041.x; ROUX V, 1993, J BACTERIOL, V175, P4895, DOI 10.1128/JB.175.15.4895-4904.1993; Rydkina E, 1999, EMERG INFECT DIS, V5, P811, DOI 10.3201/eid0506.990612; Simser J. A., 1999, American Journal of Tropical Medicine and Hygiene, V61, P359; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; SMIRNOVA NS, 1986, ACTA VIROL, V30, P436; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005; WIKE DA, 1972, INFECT IMMUN, V5, P715, DOI 10.1128/IAI.5.5.715-722.1972; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	42	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2582	10.1371/journal.pone.0002582	http://dx.doi.org/10.1371/journal.pone.0002582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612416	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800003
J	Pawar, A; Favrin, G				Pawar, Amol; Favrin, Giorgio			Finite Size Effects in Simulations of Protein Aggregation	PLOS ONE			English	Article								It is becoming increasingly clear that the soluble protofibrillar species that proceed amyloid fibril formation are associated with a range of neurodegenerative disorders such as Alzheimer's and Parkinson diseases. Computer simulations of the processes that lead to the formation of these oligomeric species are starting to make significant contributions to our understanding of the determinants of protein aggregation. We simulate different systems at constant concentration but with a different number of peptides and we study the how the finite number of proteins affects the underlying free energy of the system and therefore the relative stability of the species involved in the process. If not taken into account, this finite size effect can undermine the validity of theoretical predictions regarding the relative stability of the species involved and the rates of conversion from one to the other. We discuss the reasons that give rise to this finite size effect form both a probabilistic and energy fluctuations point of view and also how this problem can be dealt by a finite size scaling analysis.	[Pawar, Amol; Favrin, Giorgio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Pawar, A (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gf247@cam.ac.uk		Favrin, Giorgio/0000-0002-1884-7352	EPSRC-Life Science Interface fellowship; Engineering and Physical Sciences Research Council [EP/D06693X/1] Funding Source: researchfish; EPSRC [EP/D06693X/1] Funding Source: UKRI	EPSRC-Life Science Interface fellowship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was done with the aid of the EPSRC-Life Science Interface fellowship currently held by GF. This work was described in the fellowship application but EPSRC had no role in designing and conduct of the study.	ASPELMEIER T, 2007, ARXIV07113445; Auer S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178104; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Bellesia G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739547; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cheon M, 2008, FRONT BIOSCI-LANDMRK, V13, P5614; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839; Favrin G, 2001, J CHEM PHYS, V114, P8154, DOI 10.1063/1.1364637; Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Irback A, 2005, BIOPHYS J, V88, P1560, DOI 10.1529/biophysj.104.050427; Irback A, 2004, PROTEINS, V56, P110, DOI 10.1002/prot.20157; Irback A, 2003, BIOPHYS J, V85, P1466, DOI 10.1016/S0006-3495(03)74579-2; Irback A, 2006, J COMPUT CHEM, V27, P1548, DOI 10.1002/jcc.20452; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khare SD, 2005, PLOS COMPUT BIOL, V1, P230, DOI 10.1371/journal.pcbi.0010030; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Paci E, 2004, J MOL BIOL, V340, P555, DOI 10.1016/j.jmb.2004.05.009; Parisi G., 1998, STAT FIELD THEORY, V1; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SIMONA F, 2004, J MOL GRAPH MODEL, V263, P12; Soto P, 2007, BIOPHYS J, V93, P3015, DOI 10.1529/biophysj.107.112086; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiana G, 2004, J CHEM PHYS, V120, P8307, DOI 10.1063/1.1689293; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2641	10.1371/journal.pone.0002641	http://dx.doi.org/10.1371/journal.pone.0002641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612385	Green Submitted, gold, Green Published			2022-12-25	WOS:000264065800043
J	Yamaza, T; Miura, Y; Bi, YM; Liu, YZ; Akiyama, K; Sonoyama, W; Patel, V; Gutkind, S; Young, M; Gronthos, S; Le, A; Wang, CY; Chen, WJ; Shi, ST				Yamaza, Takayoshi; Miura, Yasuo; Bi, Yanming; Liu, Yongzhong; Akiyama, Kentaro; Sonoyama, Wataru; Patel, Voymesh; Gutkind, Silvio; Young, Marian; Gronthos, Stan; Le, Anh; Wang, Cun-Yu; Chen, WanJun; Shi, Songtao			Pharmacologic Stem Cell Based Intervention as a New Approach to Osteoporosis Treatment in Rodents	PLOS ONE			English	Article							BONE-MINERAL DENSITY; T-CELLS; OSTEOBLAST APOPTOSIS; STROMAL CELLS; MARROW; OSTEOCYTE; ASPIRIN; BISPHOSPHONATES; COMPLICATIONS; THERAPY	Background: Osteoporosis is the most prevalent skeletal disorder, characterized by a low bone mineral density (BMD) and bone structural deterioration, leading to bone fragility fractures. Accelerated bone resorption by osteoclasts has been established as a principal mechanism in osteoporosis. However, recent experimental evidences suggest that inappropriate apoptosis of osteoblasts/osteocytes accounts for, at least in part, the imbalance in bone remodeling as occurs in osteoporosis. The aim of this study is to examine whether aspirin, which has been reported as an effective drug improving bone mineral density in human epidemiology studies, regulates the balance between bone resorption and bone formation at stem cell levels. Methods and Findings: We found that T cell-mediated bone marrow mesenchymal stem cell (BMMSC) impairment plays a crucial role in ovariectomized-induced osteoporosis. Ex vivo mechanistic studies revealed that T cell-mediated BMMSC impairment was mainly attributed to the apoptosis of BMMSCs via the Fas/Fas ligand pathway. To explore potential of using pharmacologic stem cell based intervention as an approach for osteoporosis treatment, we selected ovariectomy (OVX)-induced ostoeporosis mouse model to examine feasibility and mechanism of aspirin-mediated therapy for osteoporosis. We found that aspirin can inhibit T cell activation and Fas ligand induced BMMSC apoptosis in vitro. Further, we revealed that aspirin increases osteogenesis of BMMSCs by aiming at telomerase activity and inhibits osteoclast activity in OVX mice, leading to ameliorating bone density. Conclusion: Our findings have revealed a novel osteoporosis mechanism in which activated T cells induce BMMSC apoptosis via Fas/Fas ligand pathway and suggested that pharmacologic stem cell based intervention by aspirin may be a new alternative in osteoporosis treatment including activated osteoblasts and inhibited osteoclasts.	[Yamaza, Takayoshi; Akiyama, Kentaro; Sonoyama, Wataru; Le, Anh; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Miura, Yasuo] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Bi, Yanming; Liu, Yongzhong; Patel, Voymesh; Gutkind, Silvio; Young, Marian; Chen, WanJun] NIH, NIDCR, Bethesda, MD USA; [Gronthos, Stan] Inst Med & Vet Sci, Div Haematol, Mesenchymal Stem Cell Grp, Adelaide, SA, Australia; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA USA	University of Southern California; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Institute Medical & Veterinary Science Australia; University of California System; University of California Los Angeles	Yamaza, T (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	wchen@mail.nih.gov; songtaos@usc.edu	Gronthos, Stan/Y-4419-2019; Sonoyama, Wataru/B-2160-2011; Gutkind, J. Silvio/J-1201-2016	Gronthos, Stan/0000-0002-6225-3084; Gutkind, J. Silvio/0000-0002-5150-4482; Young, Marian F/0000-0003-0929-8854; Miura, Yasuo/0000-0001-9654-1300; Yamaza, Takayoshi/0000-0001-7055-3370	University of Southern California School of Dentistry; NIH [R01DE17449]; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000101] Funding Source: NIH RePORTER	University of Southern California School of Dentistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by University of Southern California School of Dentistry starting fund for S.S., an extramural grant from NIH (NIDCR R01DE17449 for S.S.), and NIDCR intramural fund.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bauer DC, 1996, J BONE MINER RES, V11, P29; Bernstein CN, 2002, CURR OPIN GASTROEN, V18, P428, DOI 10.1097/00001574-200207000-00006; BERNSTEIN CN, 2006, OSTEOPOROS REP, V4, P116; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; BUKOWSKI JF, 2005, BIOCHEM BIOPH RES CO, V21, P373; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Chapurlat RD, 2006, NAT CLIN PRACT ENDOC, V2, P211, DOI 10.1038/ncpendmet0121; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Hock JM, 2001, J BONE MINER RES, V16, P975, DOI 10.1359/jbmr.2001.16.6.975; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kogianni G, 2004, LIFE SCI, V75, P2879, DOI 10.1016/j.lfs.2004.04.048; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Manolagas SC, 1999, ENDOCRINOLOGY, V140, P4377, DOI 10.1210/en.140.10.4377; Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; OWEN M, 1988, CIBA F SYMP, V136, P42; Pan BQ, 2004, BONE, V34, P112, DOI 10.1016/j.bone.2003.08.013; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Rothfuss KS, 2006, WORLD J GASTROENTERO, V12, P4819; Scholz M, 2005, MED RES REV, V25, P331, DOI 10.1002/med.20025; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sylvester FA, 2005, INFLAMM BOWEL DIS, V11, P1020, DOI 10.1097/01.MIB.0000188341.96726.15; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Whitfield JF, 2006, CURR OPIN INVEST DR, V7, P349; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072	40	138	164	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2615	10.1371/journal.pone.0002615	http://dx.doi.org/10.1371/journal.pone.0002615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612428	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800017
J	Fan, CY; Huang, CC; Chiu, WC; Lai, CC; Liou, GG; Li, HC; Chou, MY				Fan, Chia-Yu; Huang, Chuan-Chuan; Chiu, Wei-Chun; Lai, Chun-Chieh; Liou, Gunn-Guang; Li, Hsiu-Chuan; Chou, Min-Yuan			Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold	FASEB JOURNAL			English	Article						phage-display; single-chain antibody; EGFR; CD3	TRIPLE-HELIX FORMATION; SINGLE-CHAIN; ANTIBODY; ANTI-CD3; AFFINITY; ANTIGEN; HYDROXYPROLINE; TRANSITION; NUCLEATION; THERAPY	A class of multivalent protein binders was designed to overcome the limitations of low-affinity therapeutic antibodies. These binders, termed "collabodies," use a triplex-forming collagen-like peptide to drive the trimerization of a heterologous target-binding domain. Different forms of collabody, consisting of the human single-chain variable fragment ( scFv) fused to either the N or C terminus of the collagen-like peptide scaffold (Gly-Pro-Pro) 10, were stably expressed as soluble secretory proteins in mammalian cells. The collabody consisting of scFv fused to the N terminus of collagen scaffold is present as a homotrimer, whereas it exhibited a mixture of trimer and interchain disulfide-bonded hexamer when cysteine residues were introduced and flanked the scaffold. The collagenous motif in collabody is prolyl-hydroxylated, with remarkable thermal and serum stabilities. The collabody erb_scFvCol bound to the extracellular domain of epidermal growth factor receptor with a binding strength similar to 20- and 1000-fold stronger than the bivalent and monovalent counterparts, respectively. The trimeric collagen scaffold does not compromise the functionality of the binding moieties of parental immunoglobulin G (IgG); therefore, it could be applied to fuse other protein molecules to acquire significantly improved targeting-binding strengths.-Fan, C.-Y., Huang, C.-C., Chiu, W.-C., Lai, C.-C., Liou, G.-G., Li, H.-C., and Chou, M.-Y. Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold. FASEB J. 22, 3795-3804 (2008)	[Fan, Chia-Yu; Huang, Chuan-Chuan; Chiu, Wei-Chun; Li, Hsiu-Chuan; Chou, Min-Yuan] Ind Technol Res Inst, Biomed Engn Res Labs, Hsinchu 310, Taiwan; [Lai, Chun-Chieh; Liou, Gunn-Guang] Natl Hlth Res Inst, Div Mol & Genom Med, Taipei, Taiwan	Industrial Technology Research Institute - Taiwan; National Health Research Institutes - Taiwan	Chou, MY (corresponding author), Ind Technol Res Inst, Biomed Engn Res Labs, Bldg 53,195,Sec 4,Chung Hsing Rd, Hsinchu 310, Taiwan.	minyuanc@itri.org.tw	Liou, Gan-Guang/E-3976-2010; Liou, Gunn‐Guang/AAI-9787-2020		Ministry of Economic Affairs [7301XS5410]	Ministry of Economic Affairs	We thank Tsan-Lin Hu for conducting the pharmacokinetic analysis. This work was funded by the Ministry of Economic Affairs, grant 7301XS5410.	Adair John R., 1994, Human Antibodies and Hybridomas, V5, P41; Arakawa F, 1996, J BIOCHEM, V120, P657; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOPRA RK, 1982, P NATL ACAD SCI-BIOL, V79, P7180, DOI 10.1073/pnas.79.23.7180; Chou MY, 2002, GENOMICS, V79, P395, DOI 10.1006/geno.2002.6712; Cole MS, 1997, J IMMUNOL, V159, P3613; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; DUBEL S, 1995, J IMMUNOL METHODS, V178, P201, DOI 10.1016/0022-1759(94)00257-W; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Graversen JH, 2000, J BIOL CHEM, V275, P37390, DOI 10.1074/jbc.M004873200; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Kabat EA, 1991, SEQUENCES PROTEINS I; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Li HC, 2005, BIOCHEM BIOPH RES CO, V336, P375, DOI 10.1016/j.bbrc.2005.08.018; Li J, 2006, INT IMMUNOPHARMACOL, V6, P880, DOI 10.1016/j.intimp.2005.12.009; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Rheinnecker M, 1996, J IMMUNOL, V157, P2989; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837	31	40	45	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3795	3804		10.1096/fj.08-111484	http://dx.doi.org/10.1096/fj.08-111484			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18635738				2022-12-25	WOS:000260503000008
J	Cheng, GL; Basha, E; Wysocki, VH; Vierling, E				Cheng, Guilong; Basha, Eman; Wysocki, Vicki H.; Vierling, Elizabeth			Insights into small heat shock protein and substrate structure during chaperone action derived from hydrogen/deuterium exchange and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; ALPHA-B-CRYSTALLIN; SUBUNIT EXCHANGE; CONFORMATIONAL-CHANGES; A-CRYSTALLIN; DOMAIN; DYNAMICS; REVEALS; BINDING; STATES	Small heat shock proteins (sHSPs) and the related alpha-crystallins are ubiquitous chaperones linked to neurodegenerative diseases, myopathies, and cataract. To better define their mechanism of chaperone action, we used hydrogen/deuterium exchange and mass spectrometry (HXMS) to monitor conformational changes during complex formation between the structurally defined sHSPs, pea PsHsp18.1, and wheat TaHsp16.9, and the heat-denatured model substrates malate dehydrogenase (MDH) and firefly luciferase. Remarkably, we found that even when complexed with substrate, the highly dynamic local structure of the sHSPs, especially in the N-terminal arm (> 70% exchange in 5 s), remains unchanged. These results, coupled with sHSP-substrate complex stability, indicate that sHSPs do not adopt new secondary structure when binding substrate and suggest sHSPs are tethered to substrate at multiple sites that are locally dynamic, a feature that likely facilitates recognition and refolding of sHSP-bound substrate by the Hsp70/DnaK chaperone system. Both substrates were found to be stabilized in a partially unfolded state that is observed only in the presence of sHSP. Furthermore, peptide-level HXMS showed MDH was substantially protected in two core regions (residues 95-156 and 228-252), which overlap with the MDH structure protected in the GroEL-bound MDH refolding intermediate. Significantly, despite differences in the size and structure of TaHsp16.9-MDH and PsHsp18.1-MDH complexes, peptide-level HXMS patterns for MDH in both complexes are virtually identical, indicating that stabilized MDH thermal unfolding intermediates are not determined by the identity of the sHSP.	[Basha, Eman; Wysocki, Vicki H.; Vierling, Elizabeth] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Cheng, Guilong; Wysocki, Vicki H.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Vierling, E (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, 1007 E Lowell St, Tucson, AZ 85721 USA.	vierling@u.arizona.edu		Wysocki, Vicki/0000-0003-0495-2538; Vierling, Elizabeth/0000-0002-0066-4881	National Institutes of Health [GM42762, GM051387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42762 (to E. V.) and Grant GM051387 (to V. H. W.). This work was also supported by the 2005 - 2006 Pfizer Graduate Research Fellowship in Analytical Chemistry (to G. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cheng GL, 2006, J AM SOC MASS SPECTR, V17, P1518, DOI 10.1016/j.jasms.2006.04.028; Cheng GL, 2006, BIOCHEMISTRY-US, V45, P11744, DOI 10.1021/bi0608663; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; ENGLANDER JJ, 1985, ANAL BIOCHEM, V147, P234, DOI 10.1016/0003-2697(85)90033-8; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Kheterpal I, 2006, METHOD ENZYMOL, V413, P140, DOI 10.1016/S0076-6879(06)13008-6; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Komives EA, 2005, INT J MASS SPECTROM, V240, P285, DOI 10.1016/j.ijms.2004.09.016; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wintrode PL, 2003, BIOCHEMISTRY-US, V42, P10667, DOI 10.1021/bi034117m; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	49	58	60	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26634	26642		10.1074/jbc.M802946200	http://dx.doi.org/10.1074/jbc.M802946200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18621732	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000259341600039
J	Nair, MS; Dean, DH				Nair, Manoj S.; Dean, Donald H.			All domains of Cry1A toxins insert into insect brush border membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THURINGIENSIS DELTA-ENDOTOXIN; HORNWORM MANDUCA-SEXTA; PLANAR LIPID BILAYERS; BACILLUS-THURINGIENSIS; CRYSTAL-STRUCTURE; IRREVERSIBLE BINDING; CHANNEL FORMATION; LYMANTRIA-DISPAR; AMINOPEPTIDASE-N; LARVAL MIDGUT	A critical step in understanding the mode of action of insecticidal crystal toxins from Bacillus thuringiensis is their partitioning into membranes and, in particular, the insertion of the toxin into insect brush border membranes. The Umbrella and Penknife models predict that only alpha-helix 5 of domain I along with adjacent helices alpha-4 or alpha-6 insert into the brush border membranes because of their hydrophobic nature. By employing fluorescent-labeled cysteine mutations, we observe that all three domains of the toxin insert into the insect membrane. Using proteinase K protection assays, steady state fluorescence quenching measurements, and blue shift analysis of acrylodan-labeled cysteine mutants, we show that regions beyond those proposed by the two models insert into the membrane. Based on our studies, the only extended region that does not partition into the membrane is that of alpha-helix 1. Bioassays and voltage clamping studies show that all mutations examined, except certain domain II mutations in loop 2 (e.g. F371C and G374C), which disrupt membrane partitioning, retain their ability to form ion channels and toxicity in Manduca sexta larvae. This study confirms our earlier hypothesis that insertion of crystal toxin does not occur as separate helices alone, but virtually the entire molecule inserts as one or more units of the whole molecule.	[Nair, Manoj S.; Dean, Donald H.] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Dean, Donald H.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dean, DH (corresponding author), 772 Biosci Bldg,484 W 12th Ave, Columbus, OH 43210 USA.	dean.10@osu.edu	Nair, Manoj/B-4389-2009	Nair, Manoj/0000-0002-5994-3957	NIAID NIH HHS [R01 AI029092] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alzate O, 2006, BIOCHEMISTRY-US, V45, P13597, DOI 10.1021/bi061474z; Arnold S, 2001, FEBS LETT, V490, P70, DOI 10.1016/S0014-5793(01)02139-1; Aronson A, 2000, APPL ENVIRON MICROB, V66, P4568, DOI 10.1128/AEM.66.10.4568-4570.2000; Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Boonserm P, 2006, J BACTERIOL, V188, P3391, DOI 10.1128/JB.188.9.3391-3401.2006; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; CHAMBERLIN ME, 1994, PHYSIOL ZOOL, V67, P82, DOI 10.1086/physzool.67.1.30163836; Francis BR, 1997, INSECT BIOCHEM MOLEC, V27, P541, DOI 10.1016/S0965-1748(97)00029-5; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee MK, 1996, BIOCHEM BIOPH RES CO, V229, P139, DOI 10.1006/bbrc.1996.1770; LEE MK, 1992, J BIOL CHEM, V267, P3115; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LIEBIG B, 1995, J INSECT PHYSIOL, V41, P17, DOI 10.1016/0022-1910(94)00093-V; Loseva OI, 2001, BIOCHEMISTRY-US, V40, P14143, DOI 10.1021/bi010171w; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; Nair MS, 2008, BIOCHEMISTRY-US, V47, P5814, DOI 10.1021/bi7014234; Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8; Pitcher WH, 2002, BIOCHEM BIOPH RES CO, V296, P1352, DOI 10.1016/S0006-291X(02)02092-2; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SCHNEPF HE, 1981, P NATL ACAD SCI-BIOL, V78, P2893, DOI 10.1073/pnas.78.5.2893; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Tomimoto K, 2006, COMP BIOCHEM PHYS B, V144, P413, DOI 10.1016/j.cbpb.2006.04.013; Valaitis AP, 2001, ARCH INSECT BIOCHEM, V46, P186, DOI 10.1002/arch.1028; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3	40	25	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26324	26331		10.1074/jbc.M802895200	http://dx.doi.org/10.1074/jbc.M802895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635544	Green Published, hybrid			2022-12-25	WOS:000259341600005
J	Bjelke, JR; Olsen, OH; Fodje, M; Svensson, LA; Bang, S; Bolt, G; Kragelund, BB; Persson, E				Bjelke, Jais R.; Olsen, Ole H.; Fodje, Michel; Svensson, L. Anders; Bang, Susanne; Bolt, Gert; Kragelund, Birthe B.; Persson, Egon			Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; TRYPSINOGEN-TRYPSIN TRANSITION; TISSUE FACTOR-BINDING; FACTOR-X; POSTTRANSLATIONAL MODIFICATIONS; CATALYTIC FUNCTION; ANTITHROMBIN-III; PROTEASE DOMAIN; FACTOR-IX; ACTIVATION	The intrinsic activity of coagulation factor VIIa (FVIIa) is dependent on Ca2+ binding to a loop (residues 210-220) in the protease domain. Structural analysis revealed that Ca2+ may enhance the activity by attenuating electrostatic repulsion of Glu(296) and/or by facilitating interactions between the loop and Lys(161) in the N-terminal tail. In support of the first mechanism, the mutations E296V and D212N resulted in similar, about 2-fold, enhancements of the amidolytic activity. Moreover, mutation of the Lys(161)-interactive residue Asp(217) or Asp(219) to Ala reduced the amidolytic activity by 40-50%, whereas the K161A mutation resulted in 80% reduction. Hence one of these Asp residues in the Ca2+-binding loop appears to suffice for some residual interaction with Lys(161), whereas the more severe effect upon replacement of Lys(161) is due to abrogation of the interaction with the N-terminal tail. However, Ca2+ attenuation of the repulsion between Asp(212) and Glu(296) keeps the activity above that of apoFVIIa. Altogether, our data suggest that repulsion involving Asp(212) in the Ca2+-binding loop suppresses FVIIa activity and that optimal activity requires a favorable interaction between the Ca2+-binding loop and the N-terminal tail. Crystal structures of tissue factor-bound FVIIa(D212N) and FVIIa(V158D/E296V/M298Q) revealed altered hydrogen bond networks, resembling those in factor Xa and thrombin, after introduction of the D212N and E296V mutations plausibly responsible for tethering the N-terminal tail to the activation domain. The charge repulsion between the Ca2+-binding loop and the activation domain appeared to be either relieved by charge removal and new hydrogen bonds (D212N) or abolished (E296V). We propose that Ca2+ stimulates the intrinsic FVIIa activity by a combination of charge neutralization and loop stabilization.	[Olsen, Ole H.; Persson, Egon] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Bjelke, Jais R.; Fodje, Michel; Svensson, L. Anders] Novo Nordisk AS, Dept Prot Struct & Biophys, DK-2760 Malov, Denmark; [Bang, Susanne] Novo Nordisk AS, Dept Prot Purificat, DK-2760 Malov, Denmark; [Bolt, Gert] Novo Nordisk AS, Dept Mammalian Cell Technol, DK-2760 Malov, Denmark; [Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, NMR Lab, DK-2200 Copenhagen, Denmark	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; University of Copenhagen	Persson, E (corresponding author), Novo Nordisk AS, Dept Haemostasis Biochem, Novo Nordisk Pk, DK-2760 Malov, Denmark.	egpe@novonordisk.com	Kragelund, Birthe/M-3927-2014	Kragelund, Birthe/0000-0002-7454-1761; Fodje, Michel/0000-0003-1367-8868				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Bolt G, 2007, THROMB HAEMOSTASIS, V98, P988, DOI 10.1160/TH07-05-0332; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Cerenius Y, 2000, J SYNCHROTRON RADIAT, V7, P203, DOI 10.1107/S0909049500005331; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Dickinson CD, 1998, J MOL BIOL, V277, P959, DOI 10.1006/jmbi.1998.1639; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; LAWSON JH, 1993, J BIOL CHEM, V268, P767; MIYATA T, 1995, J BIOCHEM-TOKYO, V117, P836, DOI 10.1093/oxfordjournals.jbchem.a124784; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2002, EUR J BIOCHEM, V269, P5950, DOI 10.1046/j.1432-1033.2002.03323.x; PERSSON E, 1995, EUR J BIOCHEM, V234, P293, DOI 10.1111/j.1432-1033.1995.293_c.x; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 1996, FEBS LETT, V385, P241, DOI 10.1016/0014-5793(96)00400-0; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Petrovan RJ, 2001, J BIOL CHEM, V276, P6616, DOI 10.1074/jbc.M004726200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; RAO LVM, 1993, BLOOD, V81, P2600; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; SHERRILL GB, 1988, THROMB RES, V52, P53; Shobe J, 1999, BIOCHEMISTRY-US, V38, P2745, DOI 10.1021/bi981951g; Soejima K, 2001, J BIOL CHEM, V276, P17229, DOI 10.1074/jbc.M009206200; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; TORBET J, 1995, THROMB HAEMOSTASIS, V73, P785; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walsh PN, 2001, THROMB HAEMOSTASIS, V86, P75; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	45	13	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25863	25870		10.1074/jbc.M800841200	http://dx.doi.org/10.1074/jbc.M800841200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640965	Green Published, hybrid			2022-12-25	WOS:000259200100013
J	Koul, A; Vranckx, L; Dendouga, N; Balemans, W; Van den Wyngaert, I; Vergauwen, K; Goehlmann, HWH; Willebrords, R; Poncelet, A; Guillemont, J; Bald, D; Andries, K				Koul, Anil; Vranckx, Luc; Dendouga, Najoua; Balemans, Wendy; Van den Wyngaert, Ilse; Vergauwen, Karen; Goehlmann, Hinrich W. H.; Willebrords, Rudy; Poncelet, Alain; Guillemont, Jerome; Bald, Dirk; Andries, Koen			Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; GENE-EXPRESSION; TUBERCULOSIS; RESPIRATION; SYNTHASE; LATENCY; GROWTH; MICE; PERSISTENCE; ADAPTATION	An estimated one-third of the world population is latently infected with Mycobacterium tuberculosis. These nonreplicating, dormant bacilli are tolerant to conventional anti-tuberculosis drugs, such as isoniazid. We recently identified diarylquinoline R207910 (also called TMC207) as an inhibitor of ATP synthase with a remarkable activity against replicating mycobacteria. In the present study, we show that R207910 kills dormant bacilli as effectively as aerobically grown bacilli with the same target specificity. Despite a transcriptional down- regulation of the ATP synthase operon and significantly lower cellular ATP levels, we show that dormant mycobacteria do possess residual ATP synthase enzymatic activity. This activity is blocked by nanomolar concentrations of R207910, thereby further reducing ATP levels and causing a pronounced bactericidal effect. We conclude that this residual ATP synthase activity is indispensable for the survival of dormant mycobacteria, making it a promising drug target to tackle dormant infections. The unique dual bactericidal activity of diarylquinolines on dormant as well as replicating bacterial subpopulations distinguishes them entirely from the current anti-tuberculosis drugs and underlines the potential of R207910 to shorten tuberculosis treatment.	[Koul, Anil; Vranckx, Luc; Dendouga, Najoua; Balemans, Wendy; Vergauwen, Karen; Willebrords, Rudy; Andries, Koen] Johnson & Johnson Consumer Prod Inc, Tibotec NV, Dept Antimicrobial Res, B-2340 Beerse, Belgium; [Van den Wyngaert, Ilse; Goehlmann, Hinrich W. H.] Johnson & Johnson Consumer Prod Inc, Dept Funct Genom, B-2340 Beerse, Belgium; [Poncelet, Alain; Guillemont, Jerome] Johnson & Johnson Consumer Prod Inc, Tibotec NV, F-27106 Val De Reuil, France; [Bald, Dirk] Vrije Univ Amsterdam, Dept Biol Struct, NL-1081 HV Amsterdam, Netherlands	Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Vrije Universiteit Amsterdam	Koul, A (corresponding author), Johnson & Johnson Consumer Prod Inc, Tibotec NV, Dept Antimicrobial Res, Turnhoutseweg 30, B-2340 Beerse, Belgium.	akoul@prdbe.jnj.com						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brooks JV, 1999, ANTIMICROB AGENTS CH, V43, P1285, DOI 10.1128/AAC.43.5.1285; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; HIGASHI T, 1975, J BIOL CHEM, V250, P6541; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Mitchison DA, 2005, NAT BIOTECHNOL, V23, P187, DOI 10.1038/nbt0205-187; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; VEZIRIS N, 2007, INT C ANT AG CHEM CH; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	32	257	269	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25273	25280		10.1074/jbc.M803899200	http://dx.doi.org/10.1074/jbc.M803899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625705	hybrid, Green Published			2022-12-25	WOS:000259012700020
J	Seifert, EL; Bezaire, V; Estey, C; Harper, ME				Seifert, Erin L.; Bezaire, Veronic; Estey, Carmen; Harper, Mary-Ellen			Essential role for uncoupling protein-3 in mitochondrial adaptation to fasting but not in fatty acid oxidation or fatty acid anion export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; ACYL-COA THIOESTERASES; ACTIVATED-RECEPTOR-ALPHA; BROWN ADIPOSE-TISSUE; LIPID-METABOLISM; LIVER-MITOCHONDRIA; INSULIN-RESISTANCE; LONG-CHAIN; RAT-HEART; CELL-FREE	Uncoupling protein-3 (UCP3) is a mitochondrial inner membrane protein expressed most abundantly in skeletal muscle and to a lesser extent in heart and brown adipose tissue. Evidence supports a role for UCP3 in fatty acid oxidation (FAO); however, the underlying mechanism has not been explored. In 2001 we proposed a role for UCP3 in fatty acid export, leading to higher FAO rates (Himms-Hagen, J., and Harper, M. E. (2001) Exp. Biol. Med. (Maywood) 226, 78 -84). Specifically, this widely held hypothesis states that during elevated FAO rates, UCP3 exports fatty acid anions, thereby maintaining mitochondrial co-enzyme A availability; reactivation of exported fatty acid anions would ultimately enable increased FAO. Here we tested mechanistic aspects of this hypothesis as well as its functional implications, namely increased FAO rates. Using complementary mechanistic approaches in mitochondria from wild-type and Ucp3(-/-) mice, we find that UCP3 is not required for FAO regardless of substrate type or supply rate covering a 20-fold range. Fatty acid anion export and reoxidation during elevated FAO, although present in skeletal muscle mitochondria, are independent of UCP3 abundance. Interestingly, UCP3 was found to be necessary for the fasting-induced enhancement of FAO rate and capacity, possibly via mitigated mitochondrial oxidative stress. Thus, although our observations indicate that UCP3 can impact FAO rates, the mechanistic basis is not via an integral function for UCP3 in the FAO machinery. Overall our data indicate a function for UCP3 in mitochondrial adaptation to perturbed cellular energy balance and integrate previous observations that have linked UCP3 to reduced oxidative stress and FAO.	[Seifert, Erin L.; Bezaire, Veronic; Estey, Carmen; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	Maryellen.Harper@uottawa.ca		Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes); Canadian Diabetes Association; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes) (to M.-E. H.), the Canadian Diabetes Association (to E. L. S.), and the Natural Sciences and Engineering Research Council (to V. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bergmeyer HU., 1974, METHOD ENZYMAT AN, V1, P474; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; BEVILACQUA L, 2007, THESIS U OTTAWA OTTA; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; BRASS EP, 1980, BIOCHEM J, V190, P495, DOI 10.1042/bj1900495; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; GLATZ JFC, 1984, BIOCHIM BIOPHYS ACTA, V794, P454, DOI 10.1016/0005-2760(84)90012-2; Harper ME, 2001, BIOCHEM SOC T, V29, P768, DOI 10.1042/bst0290768; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hunt M, 1999, ADV EXP MED BIOL, V466, P195; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Hunt MC, 1999, J BIOL CHEM, V274, P34317, DOI 10.1074/jbc.274.48.34317; Hussain SNA, 2006, AM J PHYSIOL-LUNG C, V290, pL996, DOI 10.1152/ajplung.00337.2005; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Iossa S, 2001, FEBS LETT, V505, P53, DOI 10.1016/S0014-5793(01)02772-7; Jezek P, 2000, IUBMB LIFE, V49, P63; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; LIN CH, 1970, CAN J BIOCHEM CELL B, V48, P566, DOI 10.1139/o70-093; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Moreno M, 2003, FASEB J, V17, P1112, DOI 10.1096/fj.02-0839fje; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pedraza N, 2006, ENDOCRINOLOGY, V147, P4695, DOI 10.1210/en.2006-0226; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Riquet FB, 2003, BIOCHEM BIOPH RES CO, V311, P583, DOI 10.1016/j.bbrc.2003.10.034; Samec S, 1998, DIABETES, V47, P1693, DOI 10.2337/diabetes.47.11.1693; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; SRERE PA, 1969, METHOD ENZYMOL, V8, P3; STALLKNECHT B, 1991, AM J PHYSIOL, V261, pE410, DOI 10.1152/ajpendo.1991.261.3.E410; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; SVENSSON LT, 1995, J BIOL CHEM, V270, P12177, DOI 10.1074/jbc.270.20.12177; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; Wang S, 2003, DIABETES OBES METAB, V5, P295, DOI 10.1046/j.1463-1326.2003.00273.x	62	81	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25124	25131		10.1074/jbc.M803871200	http://dx.doi.org/10.1074/jbc.M803871200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628202	hybrid			2022-12-25	WOS:000259012700004
J	Caldwell, JH; Herin, GA; Nagel, G; Bamberg, E; Scheschonka, A; Betz, H				Caldwell, John H.; Herin, Greta Ann; Nagel, Georg; Bamberg, Ernst; Scheschonka, Astrid; Betz, Heinrich			Increases in intracellular calcium triggered by channelrhodopsin-2 potentiate the response of metabotropic glutamate receptor mGluR7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CEREBELLAR GRANULE CELLS; ACTIVATED K+ CHANNEL; XENOPUS OOCYTES; KINASE-C; NEURONS; INHIBITION; SYNAPSE; CA2+; DEPRESSION	The metabotropic glutamate receptor 7a (mGluR7a), a hepta-helical G alpha(i/o)-coupled protein, has been shown to be important for presynaptic feedback inhibition at central synapses and certain forms of long term potentiation and long term depression. The intracellular C terminus of mGluR7a interacts with calmodulin in a Ca2+-dependent manner, and calmodulin antagonists have been found to abolish presynaptic inhibition of glutamate release in neurons and mGluR7a-induced activation of G-protein-activated inwardly rectifying K+ channel (GIRK) channels in HEK293 cells. Here, we characterized the Ca2+ dependence of mGluR7a signaling in Xenopus oocytes by using channelrhodopsin-2 (ChR2), a Ca2+-permeable, light-activated ion channel for triggering Ca2+ influx, and a GIRK3.1/3.2 concatemer to monitor mGluR7a responses. Application of the agonist (S)-2-amino- 4-phosphonobutanoic acid (L-AP4) (1-100 mu M) caused a dose-dependent inward current in high K+ solutions due to activation of GIRK channels by G-protein beta gamma subunits released from mGluR7a. Elevation of intracellular free Ca2+ by light stimulation of ChR2 markedly increased the amplitude of L-AP4 responses, and this effect was attenuated by the calcium chelator 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester). L-AP4 responses were potentiated by submembranous [Ca2+] levels within physiological ranges and with a threshold close to resting [Ca2+](i) values, as determined by recording the endogenous Xenopus Ca2+-activated chloride conductance. Together, these results show that L-AP4-dependent mGluR7a signaling is potentiated by physiological levels of [Ca2+](i), consistent with a model in which presynaptic mGluR7a acts as a coincidence detector of Ca2+ influx and glutamate release.	[Caldwell, John H.] Univ Colorado Hlth Sci Ctr, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Caldwell, John H.; Herin, Greta Ann; Scheschonka, Astrid; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Nagel, Georg; Bamberg, Ernst] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Nagel, Georg] Univ Wurzburg, D-97082 Wurzburg, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; Max Planck Society; Max Planck Society; University of Wurzburg	Caldwell, JH (corresponding author), Univ Colorado Hlth Sci Ctr, Dept Cell & Dev Biol, Mail Stop 8315,POB 6511, Aurora, CO 80045 USA.	john.caldwell@uchsc.edu		Nagel, Georg/0000-0001-8174-8712	National Institutes of Health [R01 26505]; MaxPlanck-Gesellschaft; European Community [QLG3-CT-2001-00929]; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [SFB 472/P1, DFG-NA207/6]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MaxPlanck-Gesellschaft(Max Planck Society); European Community(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by National Institutes of Health Grant R01 26505 (to J. H. C.). Primary support for the work was from grants from MaxPlanck-Gesellschaft, European Community Grant QLG3-CT-2001-00929, and Fonds der Chemischen Industrie (to H. B.) and Deutsche Forschungsgemeinschaft (Grants SFB 472/P1 and DFG-NA207/6)(to G. N.).	AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; CHAVIS P, 1995, NEUROPHARMACOLOGY, V34, P929, DOI 10.1016/0028-3908(95)00082-H; Cho K, 2002, TRENDS NEUROSCI, V25, P405, DOI 10.1016/S0166-2236(02)02228-2; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dev KK, 2000, J NEUROSCI, V20, P7252; Dittman JS, 2000, J NEUROSCI, V20, P1374; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Evans DI, 2000, J NEUROPHYSIOL, V83, P2519, DOI 10.1152/jn.2000.83.5.2519; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GRAHAM ME, 1994, EUR J PHARM-MOLEC PH, V288, P115, DOI 10.1016/0922-4106(94)90016-7; Haase A, 2006, PFLUG ARCH EUR J PHY, V452, P81, DOI 10.1007/s00424-005-0004-y; Hill JJ, 2001, J BIOL CHEM, V276, P5505, DOI 10.1074/jbc.M008213200; Kobayashi K, 1999, EUR J NEUROSCI, V11, P1633, DOI 10.1046/j.1460-9568.1999.00578.x; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Lafon-Cazal M, 1999, EUR J NEUROSCI, V11, P663, DOI 10.1046/j.1460-9568.1999.00475.x; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Perroy J, 2000, J NEUROSCI, V20, P7896; Riccardi D, 2002, EXP PHYSIOL, V87, P403, DOI 10.1111/j.1469-445X.2002.tb00053.x; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SAUGSTAD JA, 1994, MOL PHARMACOL, V45, P367; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003	43	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24300	24307		10.1074/jbc.M802593200	http://dx.doi.org/10.1074/jbc.M802593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599484	hybrid, Green Published			2022-12-25	WOS:000258820000004
J	Ghosh, AK; Ramakrishnan, G; Chandramohan, C; Rajasekharan, R				Ghosh, Ananda K.; Ramakrishnan, Geetha; Chandramohan, Chitraju; Rajasekharan, Ram			CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING PEANUT COTYLEDONS; ALPHA/BETA-HYDROLASE FOLD; LIPID STORAGE DISEASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; ACYLTRANSFERASE; PHOSPHATASE; PERILIPIN; LIPOLYSIS; DROPLETS	cgi-58 (comparative gene identification-58) is a member of alpha/beta-hydrolase family of proteins. Mutations in CGI-58 are shown to be responsible for a rare genetic disorder known as Chanarin-Dorfman syndrome, characterized by an excessive accumulation of triacylglycerol in several tissues and ichthyosis. We have earlier reported that YLR099c encoding Ict1p in Saccharomyces cerevisiae can acylate lysophosphatidic acid to phosphatidic acid. Here we report that human CGI-58 is closely related to ICT1. To understand the biochemical function of cgi-58, the gene was overexpressed in Escherichia coli, and the purified recombinant protein was found to specifically acylate lysophosphatidic acid in an acyl-CoA-dependent manner. Overexpression of CGI-58 in S. cerevisiae showed an increase in the formation of phosphatidic acid resulting in an overall increase in the total phospholipids. However, the triacylglycerol level was found to be significantly reduced. In addition, the physiological significance of cgi-58 in mice white adipose tissue was studied. We found soluble lysophosphatidic acid acyltransferase activity in mouse white adipose tissue. Immunoblot analysis using anti-Ict1p antibodies followed by mass spectrometry of the immunocross-reactive protein in lipid droplets revealed its identity as cgi-58. These observations suggest the existence of an alternate cytosolic phosphatidic acid biosynthetic pathway in the white adipose tissue. Collectively, these results reveal the role of cgi-58 as an acyltransferase.	[Ghosh, Ananda K.; Chandramohan, Chitraju; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Ramakrishnan, Geetha; Rajasekharan, Ram] Monash Univ, Sch Sci, Petaling Jaya 46150, Malaysia	Indian Institute of Science (IISC) - Bangalore; Monash University; Monash University Sunway	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; R, Rajasekharan/D-3420-2009; Chitraju, Chandramohan/O-8188-2018	Ram, Rajasekharan/0000-0002-4114-0654; Chitraju, Chandramohan/0000-0001-8338-8976; Rajasekharan, Ram/0000-0002-2124-6013				Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HILTON S, 1991, J BIOL CHEM, V266, P997; Igal RA, 1998, J LIPID RES, V39, P31; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; MUSUMECI S, 1988, AM J MED GENET, V29, P377, DOI 10.1002/ajmg.1320290219; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shekar S, 2002, PLANT PHYSIOL, V128, P988, DOI 10.1104/pp.010654; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200	25	101	109	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24525	24533		10.1074/jbc.M801783200	http://dx.doi.org/10.1074/jbc.M801783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606822	Green Published, hybrid			2022-12-25	WOS:000258820000027
J	Harrington, AW; Li, QM; Tep, C; Park, JB; He, ZG; Yoon, SO				Harrington, Anthony W.; Li, Qi Ming; Tep, Chhavy; Park, Jong Bae; He, Zhigang; Yoon, Sung Ok			The Role of Kalirin9 in p75/Nogo Receptor-mediated RhoA Activation in Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; GDP/GTP EXCHANGE FACTOR; INHIBIT NEURITE OUTGROWTH; NOGO RECEPTOR; NEUROTROPHIN RECEPTOR; AXONAL REGENERATION; GEF TRIO; GROWTH; DROSOPHILA; INTERACTS	p75 and the Nogo receptor form a signaling unit for myelin inhibitory molecules, with p75 being responsible for RhoA activation. Because p75 lacks the GDP/GTP exchange factor domain, it has remained unclear how p75 activates RhoA. Here, we report that Kalirin9, a dual RhoGEF, binds p75 directly and regulates p75-Nogo receptor-dependent RhoA activation and neurite inhibition in response to myelin-associated glycoprotein. The region of p75 that Kalirin9 binds includes its mastoparan-like fifth helix, which was shown to recruit RhoGDI-RhoA. As predicted from the presence of a shared binding site, we found that Kalirin9 competes with RhoGDI for p75 binding in a dose-dependent manner in vitro. In line with these data, myelin-associated glycoprotein addition to cerebellar granule neurons resulted in a reduction in the association of Kalirin9 with p75, and a simultaneous increase in the binding of RhoGDI to p75. These results reveal a mechanism by which the fifth helix of p75 regulates RhoA activation.	[Harrington, Anthony W.; Li, Qi Ming; Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Harrington, Anthony W.; Tep, Chhavy] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Li, Qi Ming] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; [Park, Jong Bae] Natl Canc Ctr, Neurooncol Branch, Goyang Si 410769, South Korea	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital; Harvard Medical School; National Cancer Center - Korea (NCC)	Yoon, SO (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, 184 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	Yoon.84@osu.edu	Yoon, Sung Ok/C-5992-2012		National Institutes of Health [NS 39472, NS045758]; Christopher and Dana Reeve Paralysis Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051788, R01NS039472, R01NS050626, P30NS045758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher and Dana Reeve Paralysis Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 39472 (to S. O. Y.) and NS045758. This work was also supported by the Christopher and Dana Reeve Paralysis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Chakrabarti K, 2005, MOL CELL BIOL, V25, P5106, DOI 10.1128/MCB.25.12.5106-5118.2005; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hansel DE, 2001, J HISTOCHEM CYTOCHEM, V49, P833, DOI 10.1177/002215540104900704; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Low K, 2008, J NEUROSCI, V28, P1099, DOI 10.1523/JNEUROSCI.4906-07.2008; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231	28	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24690	24697		10.1074/jbc.M802188200	http://dx.doi.org/10.1074/jbc.M802188200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18625710	hybrid, Green Published			2022-12-25	WOS:000271617300003
J	Toyoda, E; Kagaya, S; Cowell, IG; Kurosawa, A; Kamoshita, K; Nishikawa, K; Iiizumi, S; Koyama, H; Austin, CA; Adachi, N				Toyoda, Eriko; Kagaya, Shigehide; Cowell, Ian G.; Kurosawa, Aya; Kamoshita, Keiichi; Nishikawa, Kiyohiro; Iiizumi, Susumu; Koyama, Hideki; Austin, Caroline A.; Adachi, Noritaka			NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-LIGASE-IV; STRAND BREAK REPAIR; CELL-CYCLE; V(D)J RECOMBINATION; COVALENT COMPLEXES; IN-SITU; BETA; EXPRESSION; GENE; INVOLVEMENT	Topoisomerase II ( Top2) is a ubiquitous nuclear enzyme that relieves torsional stress in chromosomal DNA during various cellular processes. Agents that target Top2, involving etoposide, doxorubicin, and mitoxantrone, are among the most effective anticancer drugs used in the clinic. Mammalian cells possess two genetically distinct Top2 isoforms, both of which are the target of these agents. Top2 beta is essential for cell proliferation and is highly expressed in vigorously growing cells, whereas Top2 beta is nonessential for growth and has recently been implicated in treatment- associated secondary malignancies, highlighting the validity of a Top2 beta-specific drug for future cancer treatment; however, no such agent has been hitherto reported. Here we show that NK314, a novel synthetic benzo[c] phenanthridine alkaloid, targets Top2 beta and not Top2 beta in vivo. Unlike other Top2 inhibitors, NK314 induces Top2- DNA complexes and double- strand breaks ( DSBs) in an beta isoform- specific manner. Heterozygous disruption of the humanTOP2 beta gene confers increased NK314 resistance, whereas TOP2 beta homozygous knock- out cells display increased NK314 sensitivity, indicating that the beta isoform is the cellular target. Wefurther show that the absence of Top2 beta does not alleviate NK314 hypersensitivity of cells deficient in non- homologous end- joining, a critical pathway for repairing Top2- mediated DSBs. Our results indicate that NK314 acts as a Top2 beta- specific poison in mammalian cells, with excellent potential as an efficacious and safe chemotherapeutic agent. We also suggest that a series of human knock- out cell lines are useful in assessingDNAdamage and repair induced by potential topoisomerase- targeting agents.	[Toyoda, Eriko; Kurosawa, Aya; Iiizumi, Susumu; Koyama, Hideki; Adachi, Noritaka] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Toyoda, Eriko; Kagaya, Shigehide; Kamoshita, Keiichi; Nishikawa, Kiyohiro] Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, Tokyo 1158588, Japan; [Cowell, Ian G.; Austin, Caroline A.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Yokohama City University; Nippon Kayaku Co., Ltd.; Newcastle University - UK	Adachi, N (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Kanazawa Ku, Seto 22-2, Yokohama, Kanagawa 2360027, Japan.	nadachi@yokohama-cu.ac.jp	Kurosawa, Aya/O-5165-2018	Kurosawa, Aya/0000-0001-8909-2789; Cowell, Ian/0000-0002-8606-0447; Austin, Caroline/0000-0002-1921-5947				Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Adachi N, 2000, GENE, V245, P49, DOI 10.1016/S0378-1119(00)00040-8; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Andoh T, 1998, BIOCHIMIE, V80, P235, DOI 10.1016/S0300-9084(98)80006-0; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Chaly N, 1996, CHROMOSOME RES, V4, P457, DOI 10.1007/BF02265053; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; CUMMINGS J, 1993, ANN ONCOL, V4, P533, DOI 10.1093/oxfordjournals.annonc.a058584; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Errington F, 1999, MOL PHARMACOL, V56, P1309, DOI 10.1124/mol.56.6.1309; Gao HL, 1999, P NATL ACAD SCI USA, V96, P12168, DOI 10.1073/pnas.96.21.12168; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; Guo L, 2007, MOL CANCER THER, V6, P1501, DOI 10.1158/1535-7163.MCT-06-0780; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KOBORI O, 1982, INT J CANCER, V30, P65, DOI 10.1002/ijc.2910300112; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Onda T, 2008, CANCER LETT, V259, P99, DOI 10.1016/j.canlet.2007.10.004; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Padget K, 2000, LEUKEMIA, V14, P1997, DOI 10.1038/sj.leu.2401928; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Sakaguchi A, 2002, J BIOCHEM, V132, P409, DOI 10.1093/oxfordjournals.jbchem.a003237; So S, 2006, GENES CELLS, V11, P363, DOI 10.1111/j.1365-2443.2006.00944.x; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; So S, 2007, DNA CELL BIOL, V26, P517, DOI 10.1089/dna.2007.0578; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; TRASK DK, 1988, P NATL ACAD SCI USA, V85, P1417, DOI 10.1073/pnas.85.5.1417; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Uegaki K, 2006, DNA REPAIR, V5, P303, DOI 10.1016/j.dnarep.2005.10.008; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zandvliet DWJ, 1996, BBA-GENE STRUCT EXPR, V1307, P239, DOI 10.1016/0167-4781(96)00063-2	56	85	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23711	23720		10.1074/jbc.M803936200	http://dx.doi.org/10.1074/jbc.M803936200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596031	Green Published, hybrid			2022-12-25	WOS:000258638900025
J	Zhang, P; Dixon, M; Zucchelli, M; Hambiliki, F; Levkov, L; Hovatta, O; Kere, J				Zhang, Pu; Dixon, Morag; Zucchelli, Marco; Hambiliki, Fredwell; Levkov, Lev; Hovatta, Outi; Kere, Juha			Expression Analysis of the NLRP Gene Family Suggests a Role in Human Preimplantation Development	PLOS ONE			English	Article								Background: The NLRP (Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing) family, also referred to as NALP family, is well known for its roles in apoptosis and inflammation. Several NLRPs have been indicated as being involved in reproduction as well. Methodology: We studied, using the unique human gametes and embryo materials, the expression of the NLRP family in human gametes and preimplantation embryos at different developmental stages, and compared the expression levels between normal and abnormal embryos using real-time PCR. Principal Findings: Among 14 members of the NLRP family, twelve were detected in human oocytes and preimplantation embryos, whereas seven were detected in spermatozoa. Eight NLRPs (NLRP4, 5, 8, 9, 11, 12, 13, and 14) showed a similar expression pattern: their expression levels were high in oocytes and then decreased progressively in embryos, resulting in a very low level in day 5 embryos. However, NLRP2 and NLRP7 showed a different expression pattern: their expression decreased from oocytes to the lowest level by day 3, but increased again by day 5. The expression levels of NLRP5, 9, and 12 were lower in day 1 abnormal embryos but higher in day3 and day5 arrested embryos, when compared with normal embryos at the same stages. NLRP7 was down-regulated in day 1 and day 5 abnormal embryos but over-expressed in day3 arrested embryos. Conclusions: According to our results, different NLRPs possibly work in a stage-dependent manner during human preimplantation development.	[Zhang, Pu; Dixon, Morag; Zucchelli, Marco; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr Novum, Huddinge, Sweden; [Hambiliki, Fredwell; Levkov, Lev; Hovatta, Outi] Karolinska Univ Hosp Huddinge, Dept Clin Sci, Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden; [Hambiliki, Fredwell] Uppsala Univ Hosp, Dept Gynecol, Ctr Reprod, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital	Zhang, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr Novum, Huddinge, Sweden.	juha.kere@biosci.ki.se	Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Tolvi, Morag/B-9491-2019	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Tolvi, Morag/0000-0002-8794-6661	Swedish Research Council; Stockholm County; Karolinska University Hospital; Academy of Finland; Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County(Stockholm County Council); Karolinska University Hospital(Karolinska Institutet); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was supported by grants from the Swedish Research Council, Stockholm County and Karolinska University Hospital (ALF), Academy of Finland and Sigrid Juselius Foundation.	Dade S, 2004, BIOCHEM BIOPH RES CO, V324, P547, DOI 10.1016/j.bbrc.2004.09.086; Dalbies-Tran R, 2005, MOL REPROD DEV, V71, P414, DOI 10.1002/mrd.20298; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Horikawa M, 2005, BIOL REPROD, V72, P879, DOI 10.1095/biolreprod.104.033753; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Rao KMK, 2006, J TOXICOL ENV HEAL A, V69, P481, DOI 10.1080/15287390500247025; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; ZHANG P, 2006, FERTIL STERIL	25	99	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2755	10.1371/journal.pone.0002755	http://dx.doi.org/10.1371/journal.pone.0002755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648497	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900025
J	Hao, M; Zhao, YQ; Chen, PZ; Huang, H; Liu, H; Jiang, HL; Zhang, RW; Wang, H				Hao, Miao; Zhao, Yuqing; Chen, Peizhan; Huang, He; Liu, Hong; Jiang, Hualiang; Zhang, Ruiwen; Wang, Hui			Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes	PLOS ONE			English	Article							INDIVIDUAL GINSENOSIDES; LIQUID-CHROMATOGRAPHY; ALPHA-NAPHTHOFLAVONE; ENDOGENOUS STEROIDS; CATALYTIC ACTIVITY; CYTOCHROME-P450; GINSENG; CYP3A4; TESTOSTERONE; INHIBITION	Ginseng, a traditional herbal medicine, may interact with several co-administered drugs in clinical settings, and ginsenosides, the major active components of ginseng, may be responsible for these ginseng-drug interactions (GDIs). Results from previous studies on ginsenosides' effects on human drug-metabolizing P450 enzymes are inconsistent and confusing. Herein, we first evaluated the inhibitory effects of fifteen ginsenosides and sapogenins on human CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 enzymes by using commercially available fluorescent probes. The structure-activity relationship of their effects on the P450s was also explored and a pharmacophore model was established for CYP3A4. Moreover, substrate-dependent phenomena were found in ginsenosides' effects on CYP3A4 when another fluorescent probe was used, and were further confirmed in tests with conventional drug probes and human liver microsomes. These substrate-dependent effects of the ginsenosides may provide an explanation for the inconsistent results obtained in previous GDI reports.	[Hao, Miao; Chen, Peizhan; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhao, Yuqing] Shenyang Pharm Univ, Shenyang, Peoples R China; [Huang, He; Liu, Hong; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China; [Zhang, Ruiwen] Univ Alabama Birmingham, Comprehensive Canc Ctr, Div Clin Pharmacol, Dept Pharmacol & Toxicol, Birmingham, AL USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Alabama System; University of Alabama Birmingham	Hao, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	hao, miao/HII-4487-2022		Science and Technology Commission of Shanghai Municipality; Pujiang Talent Program; Ministry of Science and Technology of China (973 Program); Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS; NIH/NCI;  [06DZ19021];  [06PJ14107];  [2007CB947100];  [R01 CA112029];  [R01 CA121211]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Pujiang Talent Program; Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS(Knowledge Innovation Program of the Chinese Academy of Sciences); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant (06DZ19021) from the Science and Technology Commission of Shanghai Municipality, Pujiang Talent Program (06PJ14107), a grant (2007CB947100) from the Ministry of Science and Technology of China (973 Program) and the Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS. R.Z. was supported in part by NIH/NCI grants R01 CA112029 and R01 CA121211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger DL, 2005, BRIT J PHARMACOL, V145, P926, DOI 10.1038/sj.bjp.0706255; Ansede JH, 2004, J PHARM SCI-US, V93, P239, DOI 10.1002/jps.10545; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Brown HS, 2006, CLIN PHARMACOKINET, V45, P1035, DOI 10.2165/00003088-200645100-00006; Cameron MD, 2005, BIOCHEMISTRY-US, V44, P14143, DOI 10.1021/bi051689t; Chang TKH, 2002, DRUG METAB DISPOS, V30, P378, DOI 10.1124/dmd.30.4.378; Cohen LH, 2003, DRUG METAB DISPOS, V31, P1005, DOI 10.1124/dmd.31.8.1005; de Groot MJ, 2006, DRUG DISCOV TODAY, V11, P601, DOI 10.1016/j.drudis.2006.05.001; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Fuzzati N, 2004, J CHROMATOGR B, V812, P119, DOI 10.1016/j.jchromb.2004.07.039; Gurley BJ, 2002, CLIN PHARMACOL THER, V72, P276, DOI 10.1067/mcp.2002.126913; Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4; He N, 2006, CLIN EXP PHARMACOL P, V33, P813, DOI 10.1111/j.1440-1681.2006.04445.x; He Nu, 2004, Am J Ther, V11, P206, DOI 10.1097/00045391-200405000-00009; Helms Steve, 2004, Altern Med Rev, V9, P259; Henderson GL, 1999, LIFE SCI, V65, pPL209, DOI 10.1016/S0024-3205(99)00407-5; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Ji HY, 2004, J PHARMACEUT BIOMED, V35, P207, DOI 10.1016/j.jpba.2003.12.020; Jiang XM, 2004, BRIT J CLIN PHARMACO, V57, P592, DOI 10.1111/j.1365-2125.2003.02051.x; Kim MJ, 2005, RAPID COMMUN MASS SP, V19, P2651, DOI 10.1002/rcm.2110; Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164; Lu P, 2001, DRUG METAB DISPOS, V29, P1473; Marks BD, 2003, AAPS PHARMSCI, V5; Marks BD, 2004, J BIOMOL SCREEN, V9, P439, DOI 10.1177/1087057104263440; Marks BD, 2002, ASSAY DRUG DEV TECHN, V1, P73, DOI 10.1089/154065802761001329; Nakamura H, 2003, DRUG METAB DISPOS, V31, P432, DOI 10.1124/dmd.31.4.432; Nakamura H, 2002, DRUG METAB DISPOS, V30, P534, DOI 10.1124/dmd.30.5.534; Nasrallah HA, 2006, J AFFECT DISORDERS, V95, P69, DOI 10.1016/j.jad.2006.04.030; Niwa T, 2005, BIOL PHARM BULL, V28, P1805, DOI 10.1248/bpb.28.1805; Patel Jignesh, 2004, Am J Ther, V11, P262, DOI 10.1097/01.mjt.0000101827.94820.22; Peebles CT, 2000, EPILEPSY BEHAV, V1, P74, DOI 10.1006/ebeh.2000.0031; Racha Jagdish K, 2003, Drug Metab Pharmacokinet, V18, P128, DOI 10.2133/dmpk.18.128; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; Sparreboom A, 2004, J CLIN ONCOL, V22, P2489, DOI 10.1200/JCO.2004.08.182; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Torimoto N, 2003, BIOCHEMISTRY-US, V42, P15068, DOI 10.1021/bi034409n; Trubetskoy O, 2005, AAPS J, V7, pE6, DOI 10.1208/aapsj070102; Trubetskoy OV, 2005, J BIOMOL SCREEN, V10, P56, DOI 10.1177/1087057104269731; Wang HL, 1999, J CHROMATOGR B, V731, P403, DOI 10.1016/S0378-4347(99)00238-8; Wang RW, 2000, DRUG METAB DISPOS, V28, P360; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Weaver R, 2003, DRUG METAB DISPOS, V31, P955, DOI 10.1124/dmd.31.7.955; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao Y, 2007, MED CHEM, V3, P51, DOI 10.2174/157340607779317508	46	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2697	10.1371/journal.pone.0002697	http://dx.doi.org/10.1371/journal.pone.0002697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628990	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200040
J	Milano, A; Pendergrass, SA; Sargent, JL; George, LK; McCalmont, TH; Connolly, MK; Whitfield, ML				Milano, Ausra; Pendergrass, Sarah A.; Sargent, Jennifer L.; George, Lacy K.; McCalmont, Timothy H.; Connolly, M. Kari; Whitfield, Michael L.			Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin	PLOS ONE			English	Article							HUMAN UROTENSIN-II; SYSTEMIC-SCLEROSIS; CLONING; CLASSIFICATION; RECEPTOR; PATTERNS; DISEASE; PROTEIN; IDENTIFICATION; ANTIGEN	Background: Scleroderma is a clinically heterogeneous disease with a complex phenotype. The disease is characterized by vascular dysfunction, tissue fibrosis, internal organ dysfunction, and immune dysfunction resulting in autoantibody production. Methodology and Findings: We analyzed the genome-wide patterns of gene expression with DNA microarrays in skin biopsies from distinct scleroderma subsets including 17 patients with systemic sclerosis (SSc) with diffuse scleroderma (dSSc), 7 patients with SSc with limited scleroderma (ISSc), 3 patients with morphea, and 6 healthy controls. 61 skin biopsies were analyzed in a total of 75 microarray hybridizations. Analysis by hierarchical clustering demonstrates nearly identical patterns of gene expression in 17 out of 22 of the forearm and back skin pairs of SSc patients. Using this property of the gene expression, we selected a set of 'intrinsic' genes and analyzed the inherent data-driven groupings. Distinct patterns of gene expression separate patients with dSSc from those with lSSc and both are easily distinguished from normal controls. Our data show three distinct patient groups among the patients with dSSc and two groups among patients with lSSc. Each group can be distinguished by unique gene expression signatures indicative of proliferating cells, immune infiltrates and a fibrotic program. The intrinsic groups are statistically significant (p < 0.001) and each has been mapped to clinical covariates of modified Rodnan skin score, interstitial lung disease, gastrointestinal involvement, digital ulcers, Raynaud's phenomenon and disease duration. We report a 177-gene signature that is associated with severity of skin disease in dSSc. Conclusions and Significance: Genome-wide gene expression profiling of skin biopsies demonstrates that the heterogeneity in scleroderma can be measured quantitatively with DNA microarrays. The diversity in gene expression demonstrates multiple distinct gene expression programs in the skin of patients with scleroderma.	[Milano, Ausra; Pendergrass, Sarah A.; Sargent, Jennifer L.; George, Lacy K.; Whitfield, Michael L.] Dartmouth Med Sch, Dept Genet, Hanover, NH USA; [Whitfield, Michael L.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH USA; [Connolly, M. Kari] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Connolly, M. Kari] Univ Calif San Francisco, Dept Med Rheumatol, San Francisco, CA USA; [McCalmont, Timothy H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Milano, A (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH USA.	michael.whitfield@dartmouth.edu	Whitfield, Michael/AAC-5010-2020	Pendergrass, Rion/0000-0002-0565-6522	Scleroderma Research Foundation; HHMI Biomedical Research Support Award [76200-560801]; Arthritis Foundation [Hulda Irene Duggan Arthritis Investigator Award]; National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS), NIH [AR007576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER	Scleroderma Research Foundation; HHMI Biomedical Research Support Award; Arthritis Foundation; National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research grants from the Scleroderma Research Foundation to MKC and MLW. Additional support for MLW came from HHMI Biomedical Research Support Award #76200-560801 to Dartmouth College. SAP and LKG received support from a Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation to MLW. AM and SAP also received support from NIH Autoimmunity and Connective Tissue Biology Training Grant (AR007576) from the National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS). The sponsors had no role in the design of the experiments, in the analysis of data or in the preparation and review of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Arm JP, 1997, J IMMUNOL, V159, P2342; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER E, 1994, IMMUNOGENETICS, V40, P235, DOI 10.1007/BF00167085; BARNETT AJ, 1988, J RHEUMATOL, V15, P276; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Clements PJ, 2000, ARTHRITIS RHEUM-US, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q; CLEMENTS PJ, 1990, ARTHRITIS RHEUM, V33, P1256, DOI 10.1002/art.1780330828; *COMM SFSCOTARADAT, 1980, PRELIMINARY CRITERIA, V23, P581; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FLEISCHMAJER R, 1977, ARTHRITIS RHEUM, V20, P975, DOI 10.1002/art.1780200410; FLEISCHMAJER R, 1977, J INVEST DERMATOL, V69, P379, DOI 10.1111/1523-1747.ep12510308; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; GORE Y, 2007, J BIOL CHEM; Grieco P, 2005, J MED CHEM, V48, P7290, DOI 10.1021/jm058043j; HALES DA, 1990, J CLUST SCI, V1, P127, DOI DOI 10.1007/BF00703589; HEID CA, 1996, REAL TIME QUANTITATI, V6, P986; Jensen PE, 1999, IMMUNOL REV, V172, P229, DOI 10.1111/j.1600-065X.1999.tb01368.x; Jensen PE, 1999, IMMUNOL RES, V20, P195, DOI 10.1007/BF02790403; KAZANDJIAN S, 1982, ACTA DERM-VENEREOL, V62, P425; Kojima F, 2003, ARTHRITIS RHEUM, V48, P2819, DOI 10.1002/art.11261; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Kraling BM, 1996, PATHOBIOLOGY, V64, P99, DOI 10.1159/000164015; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; LEDBETTER JA, 1981, J EXP MED, V153, P310, DOI 10.1084/jem.153.2.310; LEROY EC, 1988, J RHEUMATOL, V15, P202; LIU Y, 2007, J AM STAT ASS UNPUB; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolin AA, 2005, BIOINFORMATICS, V21, P3308, DOI 10.1093/bioinformatics/bti500; MASI AT, 1988, J RHEUMATOL, V15, P894; Mayes MD, 1998, SEMIN CUTAN MED SURG, V17, P22, DOI 10.1016/S1085-5629(98)80058-8; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; MEDSGER TA, 2001, ARTHRITIS ALLIED CON; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perera A, 2007, ARTHRITIS RHEUM, V56, P2740, DOI 10.1002/art.22747; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; PRZETAK MM, 1995, FEBS LETT, V364, P268, DOI 10.1016/0014-5793(95)00407-Z; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rajkumar VS, 2005, ARTHRITIS RES THER, V7, pR1113, DOI 10.1186/ar1790; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sakkas LI, 2002, J IMMUNOL, V168, P3649, DOI 10.4049/jimmunol.168.7.3649; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sayers TJ, 1996, J LEUKOCYTE BIOL, V59, P763, DOI 10.1002/jlb.59.5.763; Scussel-Lonzetti L, 2002, MEDICINE, V81, P154, DOI 10.1097/00005792-200203000-00005; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Seibold James R., 1997, Current Opinion in Rheumatology, V9, P571, DOI 10.1097/00002281-199711000-00014; SEWELL WA, 1986, P NATL ACAD SCI USA, V83, P8718, DOI 10.1073/pnas.83.22.8718; SEWELL WA, 1989, TRANSPLANT P, V21, P41; Shand L, 2007, ARTHRITIS RHEUM-US, V56, P2422, DOI 10.1002/art.22721; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; SMYTH MJ, 1995, IMMUNOGENETICS, V42, P101, DOI 10.1007/BF00178584; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2001, ARTHRITIS RHEUM, V44, P2828, DOI 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U; STUART JM, 2003, GENE COEXPRESSION NE, V392, P249; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; YUROVSKY VV, 1994, J IMMUNOL, V153, P881	86	281	282	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2696	10.1371/journal.pone.0002696	http://dx.doi.org/10.1371/journal.pone.0002696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648520	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200039
J	Qin, H; Lu, M; Goldfarb, DS				Qin, Hong; Lu, Meng; Goldfarb, David S.			Genomic Instability Is Associated with Natural Life Span Variation in Saccharomyces cerevisiae	PLOS ONE			English	Article								Increasing genomic instability is associated with aging in eukaryotes, but the connection between genomic instability and natural variation in life span is unknown. We have quantified chronological life span and loss-of-heterozygosity (LOH) in 11 natural isolates of Saccharomyces cerevisiae. We show that genomic instability increases and mitotic asymmetry breaks down during chronological aging. The age-dependent increase of genomic instability generally lags behind the drop of viability and this delay accounts for similar to 50% of the observed natural variation of replicative life span in these yeast isolates. We conclude that the abilities of yeast strains to tolerate genomic instability co-vary with their replicative life spans. To the best of our knowledge, this is the first quantitative evidence that demonstrates a link between genomic instability and natural variation in life span.	[Qin, Hong; Lu, Meng] Univ Rochester, Dept Biol, Ctr Aging & Dev Biol, Rochester, NY 14627 USA; [Goldfarb, David S.] Univ Rochester, Dept Biol, Rochester, NY USA	University of Rochester; University of Rochester	Qin, H (corresponding author), Univ Rochester, Dept Biol, Ctr Aging & Dev Biol, Rochester, NY 14627 USA.	hong.qin@tuskegee.edu		Qin, Hong/0000-0002-1060-6722	Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging; NIH/NIA [P30AG18254, R01GM67838, R03AG23270, R03MH76395]; Glenn Foundation for Medical Research through the University of Rochester [fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023270, P30AG018254] Funding Source: NIH RePORTER	Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research through the University of Rochester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is partially supported by a pilot grant to HQ from the Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging (NIH/NIA P30AG18254) and a fellowship to HQ from the Glenn Foundation for Medical Research through the University of Rochester. DSG acknowledges the support of NIH grants (R01GM67838, R03AG23270, and R03MH76395).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Hoopes LLM, 2002, MOL CELL BIOL, V22, P4136, DOI 10.1128/MCB.22.12.4136-4146.2002; Jazwinski SM, 2000, TRENDS GENET, V16, P506, DOI 10.1016/S0168-9525(00)02119-3; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lai CY, 2002, GENETICS, V162, P73; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701; Madia F, 2007, MECH AGEING DEV, V128, P45, DOI 10.1016/j.mad.2006.11.009; McMurray MA, 2004, CURR OPIN MICROBIOL, V7, P673, DOI 10.1016/j.mib.2004.10.008; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park PU, 2002, METHOD ENZYMOL, V351, P468; Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x; Preston CR, 2006, CURR BIOL, V16, P2009, DOI 10.1016/j.cub.2006.08.058; Qin H, 2006, EXP GERONTOL, V41, P448, DOI 10.1016/j.exger.2006.01.007; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vettraino J, 2001, J GERONTOL A-BIOL, V56, pB415, DOI 10.1093/gerona/56.10.B415; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; WILSON DL, 1993, MECH AGEING DEV, V66, P269, DOI 10.1016/0047-6374(93)90014-I	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2670	10.1371/journal.pone.0002670	http://dx.doi.org/10.1371/journal.pone.0002670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628831	gold, Green Submitted, Green Published			2022-12-25	WOS:000264057200015
J	Yizhar, O; Ashery, U				Yizhar, Ofer; Ashery, Uri			Modulating Vesicle Priming Reveals that Vesicle Immobilization Is Necessary but not Sufficient for Fusion-Competence	PLOS ONE			English	Article								In neurons and neuroendocrine cells, docked vesicles need to undergo priming to become fusion competent. Priming is a multi-step process that was shown to be associated with vesicle immobilization. However, it is not known whether vesicle immobilization is sufficient to acquire complete fusion competence. To extend our understanding of the physical manifestation of vesicle priming, we took advantage of tomosyn, a SNARE-related protein that specifically inhibits vesicle priming, and measured its effect on vesicle dynamics in live chromaffin cells using total internal reflection fluorescence microscopy. We show here that while in control cells vesicles undergo immobilization before fusion, vesicle immobilization is attenuated in tomosyn overexpressing cells. This in turn increases the turnover rate of vesicles near the membrane and attenuates the fusion of newcomer vesicles. Moreover, the release probability of immobile vesicles in tomosyn cells is significantly reduced, suggesting that immobilization is an early and necessary step in priming but is insufficient, as further molecular processes are needed to acquire complete fusion competence. Using tomosyn as a molecular tool we provide a mechanistic link between functional docking and priming and suggest that functional docking is the first step in vesicle priming, followed by molecular modifications that do not translate into changes in vesicle mobility.	[Yizhar, Ofer; Ashery, Uri] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Yizhar, O (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	uria@post.tau.ac.il	YIZHAR, OFER/AAV-8497-2021	Ashery, Uri/0000-0001-6338-7888; Yizhar, Ofer/0000-0003-4228-1448	Israel Science Foundation [424/02-16.6, 1211/07]; Adams Supercenter for Brain Studies; National Institutes of Health [RO1 NS053978]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Adams Supercenter for Brain Studies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Israel Science Foundation (grant 424/02-16.6 and 1211/07 to U.A.), the Adams Supercenter for Brain Studies, and the National Institutes of Health (RO1 NS053978; U.A.).	Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; DEGTYAR VE, 2007, P NATL ACAD SCI US; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; GRACHEVA EO, 2007, J PHYSL; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lonart G, 2000, J BIOL CHEM, V275, P27703; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neco P, 2002, BIOCHEM J, V368, P405, DOI 10.1042/BJ20021090; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; YIZHAR O, 2007, J NEUROCHEM IN PRESS; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2694	10.1371/journal.pone.0002694	http://dx.doi.org/10.1371/journal.pone.0002694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628949	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200037
J	Chen, YC; Hsu, HS; Chen, YW; Tsai, TH; How, CK; Wang, CY; Hung, SC; Chang, YL; Tsai, ML; Lee, YY; Ku, HH; Chiou, SH				Chen, Yu-Chih; Hsu, Han-Shui; Chen, Yi-Wei; Tsai, Tung-Hu; How, Chorng-Kuang; Wang, Chien-Ying; Hung, Shih-Chieh; Chang, Yuh-Lih; Tsai, Ming-Long; Lee, Yi-Yen; Ku, Hung-Hai; Chiou, Shih-Hwa			Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM; GENE-EXPRESSION; SIDE POPULATION; IDENTIFICATION; PLURIPOTENCY; CONTRIBUTE; PROMOTER; PROTEIN; TUMORS	CD133 (prominin-1), a 5-transmembrane glycoprotein, has recently been considered to be an important marker that represents the subset population of cancer stem-like cells. Herein we report the isolation of CD133-positive cells (LC-CD133(+)) and CD133-negative cells (LC-CD133(-)) from tissue samples of ten patients with non-small cell lung cancer (LC) and five LC cell lines. LC-CD133(+) displayed higher Oct-4 expressions with the ability to self-renew and may represent a reservoir with proliferative potential for generating lung cancer cells. Furthermore, LC-CD133(+), unlike LC-CD133(-), highly co-expressed the multiple drug-resistant marker ABCG2 and showed significant resistance to chemotherapy agents (i.e., cisplatin, etoposide, doxorubicin, and paclitaxel) and radiotherapy. The treatment of Oct-4 siRNA with lentiviral vector can specifically block the capability of LC-CD133(+) to form spheres and can further facilitate LC-CD133(+) to differentiate into LC-CD133(-). In addition, knock-down of Oct-4 expression in LC-CD133(+) can significantly inhibit the abilities of tumor invasion and colony formation, and increase apoptotic activities of caspase 3 and poly (ADP-ribose) polymerase ( PARP). Finally, in vitro and in vivo studies further confirm that the treatment effect of chemoradiotherapy for LC-CD133(+) can be improved by the treatment of Oct-4 siRNA. In conclusion, we demonstrated that Oct-4 expression plays a crucial role in maintaining the self-renewing, cancer stem-like, and chemoradioresistant properties of LC-CD133(+). Future research is warranted regarding the up-regulated expression of Oct-4 in LC-CD133(+) and malignant lung cancer.	[Chen, Yu-Chih; Hsu, Han-Shui; Chen, Yi-Wei; How, Chorng-Kuang; Wang, Chien-Ying; Hung, Shih-Chieh; Lee, Yi-Yen; Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Tung-Hu; Chang, Yuh-Lih] Natl Yang Ming Univ, Inst Traditional Med, Taipei, Taiwan; [Hsu, Han-Shui; How, Chorng-Kuang] Natl Yang Ming Univ, Inst Emergency & Critical Care Med, Taipei, Taiwan; [Ku, Hung-Hai] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan; [Hsu, Han-Shui] Natl Yang Ming Univ, Taipei Veterans Gen Hosp, Dept Surg, Div Thoracic Surg, Taipei, Taiwan; [Chen, Yi-Wei] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan; [How, Chorng-Kuang; Wang, Chien-Ying] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency, Taipei, Taiwan; [Hung, Shih-Chieh; Chang, Yuh-Lih; Tsai, Ming-Long; Chiou, Shih-Hwa] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Med Res & Ed, Taipei, Taiwan; [Tsai, Tung-Hu; Lee, Yi-Yen; Ku, Hung-Hai] Taipei City Hosp, Dept Med Res & Ed, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Ku, HH (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan.	hhku@ym.edu.tw; shchiou@vghtpe.gov.tw	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547	National Science Council [96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024]; Taipei Veterans General Hospital [V96C1-151, V96E1-004, V96ER2-016, V96E2-010]; Joint Projects of UTVGH [VGHUST96-P1-07]; Yen-Tjing-Ling Medical Foundation, Taipei City Hospital [96001-62-014, 96001-62-018, 96002-62-092]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint Projects of UTVGH; Yen-Tjing-Ling Medical Foundation, Taipei City Hospital; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024), Taipei Veterans General Hospital (V96C1-151, V96E1-004, V96ER2-016, V96E2-010), the Joint Projects of UTVGH (VGHUST96-P1-07), Yen-Tjing-Ling Medical Foundation, Taipei City Hospital (96001-62-014, 96001-62-018, 96002-62-092), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bernstein ED, 2006, ANN SURG ONCOL, V13, P291, DOI 10.1245/ASO.2006.01.015; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hsu HS, 2005, CLIN CANCER RES, V11, P5410, DOI 10.1158/1078-0432.CCR-05-0601; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Lamb KA, 1998, MOL REPROD DEV, V51, P218; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Socinski MA, 2007, J CLIN ONCOL, V25, P4137, DOI 10.1200/JCO.2007.11.5303; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	362	397	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2637	10.1371/journal.pone.0002637	http://dx.doi.org/10.1371/journal.pone.0002637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612434	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800039
J	Hirose, K; Abramovich, C; Argiropoulos, B; Humphries, RK				Hirose, K.; Abramovich, C.; Argiropoulos, B.; Humphries, R. K.			Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor	ONCOGENE			English	Article						homeodomain; nucleoporin; hematopoiesis	ACUTE MYELOID-LEUKEMIA; NUCLEAR-PORE COMPLEX; FUSION GENE; HOX GENES; HOMEOBOX GENE; FG REPEATS; PROTEIN; NUCLEOPORIN; TRANSCRIPTION; MEIS1	PMX1 is a member of a non-clustered homeobox gene family, not normally expressed in hematopoietic cells, and first identified for its role in enhancing the binding of the serum response factor (SRF) to the serum responsive element (SRE). PMX1 has never been linked to leukemia on its own, raising the possibility of unique mechanisms underlying the oncogenicity of NUP98-PMX1. To elucidate the leukemogenic potential of NUP98-PMX1, we compared the effects of PMX1 and NUP98-PMX1 and, through strategic mutations, the involvement of the SRE in NUP98-PMX1-mediated leukemia. NUP98-PMX1, but not PMX1, had potent ability to impair differentiation, promote proliferation of myeloid progenitors, induce lethal myeloproliferative disease and to activate a number of genes previously linked to leukemic stem cells. Similar to NUP98-HOX fusions, the transforming potential of NUP98-PMX1 required the NUP98 portion and DNA-binding capability of the PMX1 homeodomain and collaborated with Meis1 to induce more rapid onset myeloproliferative-like myeloid leukemia. The transforming activity of NUP98-PMX1 was independent of its ability to interact with SRF. These findings provide novel evidence of the contributory role of the NUP98 sequence in conferring leukemogenic properties on a partner gene and point to common leukemogenic pathways for NUP98-PMX1 and NUP98-clustered HOX fusions.	[Hirose, K.; Abramovich, C.; Argiropoulos, B.; Humphries, R. K.] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Humphries, R. K.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Humphries, RK (corresponding author), British Columbia Canc Res Ctr, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	khumphri@bccrc.ca	Hirose, Koichi/I-1506-2017	Hirose, Koichi/0000-0001-7498-9630; Humphries, Richard/0000-0003-0540-7005	Terry Fox Foundation of Canada; Canadian Institutes of Health for Research; Leukemia and Lymphoma Society of Canada	Terry Fox Foundation of Canada; Canadian Institutes of Health for Research(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada	This work was supported by the Terry Fox Foundation of Canada and by the Canadian Institutes of Health for Research. KH and BA were recipients of fellowships from the Leukemia and Lymphoma Society of Canada. We thank Drs Florian Kuchenbauer and Eric Yung for technical assistance.	ALEXANDRE C, 1991, ONCOGENE, V6, P543; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Eklund EA, 2006, CURR OPIN HEMATOL, V13, P67, DOI 10.1097/01.moh.0000208467.63861.d6; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; KERN MJ, 1994, GENOMICS, V19, P334, DOI 10.1006/geno.1994.1066; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Martin KA, 1997, DNA CELL BIOL, V16, P653, DOI 10.1089/dna.1997.16.653; McKean DM, 2003, J CELL BIOL, V161, P393, DOI 10.1083/jcb.jcb.200302126; Nakamura T, 2005, INT J HEMATOL, V82, P21, DOI 10.1532/IJH97.04160; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Simon KJ, 1997, MOL CELL BIOL, V17, P6653, DOI 10.1128/MCB.17.11.6653; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; ten Berge D, 1998, DEVELOPMENT, V125, P3831; ten Berge D, 2001, DEVELOPMENT, V128, P2929; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; VONLINDERN M, 1992, BAILLIERE CLIN HAEM, V5, P857, DOI 10.1016/S0950-3536(11)80049-1; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Zhang L, 2007, CANCER GENET CYTOGEN, V178, P42, DOI 10.1016/j.cancergencyto.2007.06.012	40	18	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2008	27	46					6056	6067		10.1038/onc.2008.210	http://dx.doi.org/10.1038/onc.2008.210			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18604245				2022-12-25	WOS:000259891600008
J	Xiao, YC; Bingham, JP; Zhu, WG; Moczydlowski, E; Liang, S; Cummins, TR				Xiao, Yucheng; Bingham, Jon-Paul; Zhu, Weiguo; Moczydlowski, Edward; Liang, Songping; Cummins, Theodore R.			Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain II voltage sensor in the closed configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	37th Annual Meeting of the Society-for-Neuroscience	NOV 03-07, 2007	San Diego, CA	Soc Neurosci			SPIDER SELENOCOSMIA-HUWENA; ROOT GANGLION NEURONS; SCORPION TOXIN; MOLECULAR DETERMINANTS; STATE INACTIVATION; CONFORMATIONAL-CHANGES; NA+ CHANNELS; ACTIVATION; NEUROTOXIN; CELLS	Peptide toxins with high affinity, divergent pharmacological functions, and isoform-specific selectivity are powerful tools for investigating the structure-function relationships of voltage-gated sodium channels (VGSCs). Although a number of interesting inhibitors have been reported from tarantula venoms, little is known about the mechanism for their interaction with VGSCs. We show that huwentoxin-IV (HWTX-IV), a 35-residue peptide from tarantula Ornithoctonus huwena venom, preferentially inhibits neuronal VGSC subtypes rNav1.2, rNav1.3, and hNav1.7 compared with muscle subtypes rNav1.4 and hNav1.5. Of the five VGSCs examined, hNav1.7 was most sensitive to HWTX-IV (IC50 similar to 26 nM). Following application of 1 mu M HWTX-IV, hNav1.7 currents could only be elicited with extreme depolarizations (>+ 100 mV). Recovery of hNav1.7 channels from HWTX-IV inhibition could be induced by extreme depolarizations or moderate depolarizations lasting several minutes. Site-directed mutagenesis analysis indicated that the toxin docked at neurotoxin receptor site 4 located at the extracellular S3-S4 linker of domain II. Mutations E818Q and D816N in hNav1.7 decreased toxin affinity for hNav1.7 by similar to 300-fold, whereas the reverse mutations in rNav1.4 (N655D/Q657E) and the corresponding mutations in hNav1.5 (R812D/S814E) greatly increased the sensitivity of the muscle VGSCs to HWTX-IV. Our data identify a novel mechanism for sodium channel inhibition by tarantula toxins involving binding to neurotoxin receptor site 4. In contrast to scorpion beta-toxins that trap the IIS4 voltage sensor in an outward configuration, we propose that HWTX-IV traps the voltage sensor of domain II in the inward, closed configuration.	[Xiao, Yucheng; Liang, Songping] Hunan Normal Univ, Life Sci Coll, Changsha 410081, Hunan, Peoples R China; [Xiao, Yucheng; Zhu, Weiguo; Cummins, Theodore R.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Bingham, Jon-Paul] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Moczydlowski, Edward] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA	Hunan Normal University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Hawaii System; Clarkson University	Liang, S (corresponding author), Hunan Normal Univ, Life Sci Coll, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; trcummin@iupui.edu	BINGHAM, Jon-Paul/AAW-9377-2021; Xiao, Yucheng/H-3600-2012; Moczydlowski, Edward G/D-1734-2013		NINDS NIH HHS [NS054642] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bendahhou S, 1997, AM J PHYSIOL-CELL PH, V272, pC592, DOI 10.1152/ajpcell.1997.272.2.C592; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins Theodore R, 2007, Expert Rev Neurother, V7, P1597, DOI 10.1586/14737175.7.11.1597; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; CUMMINS TR, 2004, SOC NEUR ANN M SAN D; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Matavel A, 2002, FEBS LETT, V523, P219, DOI 10.1016/S0014-5793(02)02988-5; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Saab CY, 2002, NEUROSCI LETT, V331, P79, DOI 10.1016/S0304-3940(02)00860-1; Sheets MF, 1999, J PHYSIOL-LONDON, V514, P425, DOI 10.1111/j.1469-7793.1999.425ae.x; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Shon KJ, 1998, J NEUROSCI, V18, P4473; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Szeto TH, 2000, FEBS LETT, V470, P293, DOI 10.1016/S0014-5793(00)01339-9; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2	54	142	155	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27300	27313		10.1074/jbc.M708447200	http://dx.doi.org/10.1074/jbc.M708447200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	353RT	18628201	hybrid, Green Published			2022-12-25	WOS:000259586600049
J	Fujikake, N; Nagai, Y; Popiel, HA; Okamoto, Y; Yamaguchi, M; Toda, T				Fujikake, Nobuhiro; Nagai, Yoshitaka; Popiel, H. Akiko; Okamoto, Yuma; Yamaguchi, Masamitsu; Toda, Tatsushi			Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE; AGGREGATE FORMATION; DROSOPHILA MODEL; PROTEIN-KINASE; HSP70; MODULATION; ACTIVATION; TOXICITY; HSP90	Many neurodegenerative diseases including Alzheimer, Parkinson, and polyglutamine ( polyQ) diseases are thought to be caused by protein misfolding. The polyQ diseases, including Huntington disease and spinocerebellar ataxias (SCAs), are caused by abnormal expansions of the polyQ stretch in disease-causing proteins, which trigger misfolding of these proteins, resulting in their deposition as inclusion bodies in affected neurons. Although genetic expression of molecular chaperones has been shown to suppress polyQ protein misfolding and neurodegeneration, toward developing a therapy, it is ideal to induce endogenous molecular chaperones by chemical administration. In this study, we assessed the therapeutic effects of heat shock transcription factor 1 ( HSF1)-activating compounds, which induce multiple molecular chaperones, on polyQ-induced neurodegeneration in vivo. We found that oral administration of 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) markedly suppresses compound eye degeneration and inclusion body formation in a Drosophila model of SCA. 17-AAG also dramatically rescued the lethality of the SCA model (74.1% rescue) and suppressed neurodegeneration in a Huntington disease model (46.3% rescue), indicating that 17-AAG is widely effective against various polyQ diseases. 17-AAG induced Hsp70, Hsp40, and Hsp90 expression in a dose-dependent manner, and the expression levels correlated with its therapeutic effects. Furthermore, knockdown of HSF1 abolished the induction of molecular chaperones and the therapeutic effect of 17-AAG, indicating that its therapeutic effects depend on HSF1 activation. Our study indicates that induction of multiple molecular chaperones by 17-AAG treatment is a promising therapeutic approach for a wide range of polyQ diseases and possibly other neurodegenerative diseases.	[Fujikake, Nobuhiro; Nagai, Yoshitaka; Popiel, H. Akiko; Okamoto, Yuma; Toda, Tatsushi] Osaka Univ, Grad Sch Med, Div Clin Genet, Dept Med Genet, Suita, Osaka 5650871, Japan; [Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Osaka University; Kyoto Institute of Technology	Nagai, Y (corresponding author), Osaka Univ, Grad Sch Med, Div Clin Genet, Dept Med Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nagai@clgene.med.osaka-u.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	Scientific Research on Priority Areas; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science	Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas (to Y.N.; Advanced Brain Science Project, Research on Patho-mechanisms of Brain Disorders, Life of Proteins, and Protein Community) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by a Grant-in-Aid for the Research Committee for Ataxic Diseases (to Y.N.) from the Ministry of Health, Labor and Welfare, Japan; and by Grants-in-Aid for Scientific Research (B) (to Y.N.) and for Young Scientists (B) (to N.F.) from the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Mitsui K, 2002, J NEUROSCI, V22, P9267; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagai Y, 1999, EXP NEUROL, V155, P195, DOI 10.1006/exnr.1998.6991; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Page J., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P308; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Sato T, 2006, BIOCHEM BIOPH RES CO, V346, P339, DOI 10.1016/j.bbrc.2006.05.133; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xia WL, 1999, CELL STRESS CHAPERON, V4, P8, DOI 10.1054/csac.1998.0113; Yamanaka K, 2003, J MOL CELL CARDIOL, V35, P785, DOI 10.1016/S0022-2828(03)00133-0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	166	170	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26188	26197		10.1074/jbc.M710521200	http://dx.doi.org/10.1074/jbc.M710521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632670	Green Published, hybrid			2022-12-25	WOS:000259200100047
J	Lamothe, B; Campos, AD; Webster, WK; Gopinathan, A; Hur, L; Darnay, BG				Lamothe, Betty; Campos, Alejandro D.; Webster, William K.; Gopinathan, Ambily; Hur, Lana; Darnay, Bryant G.			The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LYS63-LINKED POLYUBIQUITINATION; DEFECTIVE INTERLEUKIN-1; TRAF6-DEFICIENT MICE; UBIQUITIN LIGASE; CUTTING EDGE; ACTIVATION; RECEPTOR; KINASE; REQUIRES	TRAF6, a crucial adaptor molecule in innate and adaptive immunity, contains three distinct functional domains. The C-terminal TRAF domain facilitates oligomerization and sequence-specific interaction with receptors or other adaptor proteins. In conjunction with the dimeric E2 enzyme Ubc13-Uev1A, the N-terminal RING domain of TRAF6 functions as an E3 ubiquitin (Ub) ligase that facilitates its own site-specific ubiquitination through the generation of a Lys-63-linked poly-Ub chain. This modification does not cause its proteasomal degradation but rather serves as a scaffold to activate both the IKK and stress kinase pathways. Connecting the N- and C-terminal regions, the four internal zinc finger (ZF) motifs have yet to be functionally defined. In this study, we examined the role of the ZF domains in interleukin-1, lipopolysaccharide, and RANKL signaling by reconstitution of TRAF6-deficient cells with point mutations or deletions of these ZF motifs. Although ZF domains 2-4 are dispensable for activating IKK, p38, and JNK by interleukin-1 and lipopolysaccharide, the first ZF domain together with an intact RING domain of TRAF6 is essential for activating these pathways. Furthermore, TRAF6 autoubiquitination and its interaction with Ubc13 are dependent on ZF1 and an intact RING domain. Additionally, expression of TRAF6 lacking ZF2-4 in TRAF6-deficient monocytes rescues RANKL-mediated osteoclast differentiation and LPS-stimulated interleukin-6 production. These data provide evidence for the critical role of the Ub ligase activity of TRAF6, which is coordinated via the RING domain and ZF1 to supply the necessary elements in signaling by cytokines dependent upon TRAF6.	[Lamothe, Betty; Campos, Alejandro D.; Webster, William K.; Gopinathan, Ambily; Hur, Lana; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Darnay, BG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Box 143,1515 Holcombe Blvd, Houston, TX 77030 USA.	bdarnay@mdanderson.org			National Institutes of Health [RO1 AR053540]; NCI, National Institutes of Health [CA16672DAF]; University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR053540 (to B. G. D.). The DNA Sequencing Core facility is funded in part through NCI, National Institutes of Health, Grant CA16672DAF. This work was also supported in part by institutional start-up funds from the University of Texas M. D. Anderson Cancer Center.	Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Chung JY, 2002, J CELL SCI, V115, P679; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Darnay BG, 2007, ADV EXP MED BIOL, V597, P152; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; King CG, 2008, J IMMUNOL, V180, P34, DOI 10.4049/jimmunol.180.1.34; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	30	89	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24871	24880		10.1074/jbc.M802749200	http://dx.doi.org/10.1074/jbc.M802749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18617513	Green Published, hybrid			2022-12-25	WOS:000271617300006
J	Oh, DY; Jessen, H; Kucherer, C; Neumann, K; Oh, N; Poggensee, G; Bartmeyer, B; Jessen, A; Pruss, A; Schumann, RR; Hamouda, O				Oh, Djin-Ye; Jessen, Heiko; Kuecherer, Claudia; Neumann, Konrad; Oh, Nari; Poggensee, Gabriele; Bartmeyer, Barbara; Jessen, Arne; Pruss, Axel; Schumann, Ralf R.; Hamouda, Osamah			CCR5 Delta 32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5 Delta 32 Homozygous Individual	PLOS ONE			English	Article								Background: Homozygosity (Delta 32/Delta 32) for the 32 bp deletion in the chemokine receptor 5 (CCR5) gene is associated with strong resistance against HIV infection. Heterozygosity is associated with protection of HIV-1 disease progression. Methodology/Principal Findings: We genotyped a population of 737 HIV-positive adults and 463 healthy controls for the CCR5 Delta 32 deletion and found heterozygous frequencies of 16.2% (HIV-negative) and 17.5% (HIV-positive) among Caucasian individuals. Analysis of CCR5 Delta 32 influence on disease progression showed notably lower viral setpoints and a longer time to a CD4 count of <200 mu l(-1) in seroconverters heterozygous for the deletion. Furthermore, we identified one HIV-positive man homozygous for the Delta 32 deletion. Conclusions/Significance: The protective effect of CCR5 Delta 32 heterozygosity is confimed in a large cohort of German seroconverters. The HIV-infected CCR5 Delta 32 homozygous individual, however, displays extremely rapid disease progression. This is the 12th case of HIV-infection in this genotype described worldwide.	[Oh, Djin-Ye; Schumann, Ralf R.] Charite Univ Med Ctr, Inst Microbiol & Hyg, Berlin, Germany; [Jessen, Heiko; Oh, Nari; Jessen, Arne] Gemeinschaftspraxis Jessen Jessen Stein, Berlin, Germany; [Kuecherer, Claudia; Poggensee, Gabriele; Bartmeyer, Barbara; Hamouda, Osamah] Robert Koch Inst, Berlin, Germany; [Neumann, Konrad] Charite Univ Med Ctr, Dept Med Biomet & Clin Epidemiol, Berlin, Germany; [Pruss, Axel] Charite Univ Med Ctr, Inst Transfusion Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Oh, DY (corresponding author), Charite Univ Med Ctr, Inst Microbiol & Hyg, Berlin, Germany.	doh@tuftsmedicalcenter.org	Jessen, Heiko/P-2192-2019	Oh, Djin-Ye/0000-0003-0541-6155	Charite-Universitatsmedizin Berlin; Deutsche Forschungsgemeinschaft (DFG)	Charite-Universitatsmedizin Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	D.-Y. O. is a recipient of a Rahel Hirsch Grant of the Charite-Universitatsmedizin Berlin. R.R.S. was supported by grants obtained from the Deutsche Forschungsgemeinschaft (DFG).	Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Balotta C, 1997, AIDS, V11, pF67, DOI 10.1097/00002030-199710000-00001; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Gray L, 2006, J VIROL, V80, P3684, DOI 10.1128/JVI.80.7.3684-3691.2006; Heiken H, 1999, AIDS, V13, P529, DOI 10.1097/00002030-199903110-00017; Hendel H, 1998, J ACQ IMMUN DEF SYND, V19, P381, DOI 10.1097/00042560-199812010-00009; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hummel M, 2007, TRANSPL IMMUNOL, V17, P223, DOI 10.1016/j.trim.2006.11.004; Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007; Iversen AKN, 2003, J INFECT DIS, V187, P215, DOI 10.1086/345881; Kaur G, 2007, HUM IMMUNOL, V68, P454, DOI 10.1016/j.humimm.2007.01.016; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kreisberg JF, 2001, J VIROL, V75, P8842, DOI 10.1128/JVI.75.18.8842-8847.2001; Kristol D.M., 2001, ACM T INTERNET TECHN, V1, P151, DOI [DOI 10.1145/502152.502153, 10.1145/502152.502153]; Kuipers H, 1999, AIDS, V13, P433, DOI 10.1097/00002030-199902250-00025; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61; Michael NL, 1998, J VIROL, V72, P6040, DOI 10.1128/JVI.72.7.6040-6047.1998; Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277; Mulherin SA, 2003, AIDS, V17, P377, DOI 10.1097/00002030-200302140-00012; Neifer S, 2006, AIDS, V20, P2231, DOI 10.1097/QAD.0b013e328010ac6f; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; OH DY, 2008, J INFECT DI IN PRESS; Pasi KJ, 2000, BRIT J HAEMATOL, V111, P136, DOI 10.1046/j.1365-2141.2000.02325.x; Patke DS, 2002, J INFECT DIS, V186, P1177, DOI 10.1086/343811; Philpott S, 1999, J ACQ IMMUN DEF SYND, V21, P189, DOI 10.1097/00126334-199907010-00002; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Sheppard HW, 2002, J ACQ IMMUN DEF SYND, V29, P307, DOI 10.1097/00126334-200203010-00013; Speelmon EC, 2006, J VIROL, V80, P2463, DOI 10.1128/JVI.80.5.2463-2471.2006; Theodorou I, 1997, LANCET, V349, P1219; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	46	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2747	10.1371/journal.pone.0002747	http://dx.doi.org/10.1371/journal.pone.0002747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648518	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900018
J	Pastori, C; Librizzi, L; Breschi, GL; Regondi, C; Frassoni, C; Panzica, F; Frigerio, S; Gelati, M; Parati, E; De Simoni, MG; de Curtis, M				Pastori, Chiara; Librizzi, Laura; Breschi, Gian Luca; Regondi, Cristina; Frassoni, Carolina; Panzica, Ferruccio; Frigerio, Simona; Gelati, Maurizio; Parati, Eugenio; De Simoni, Maria Grazia; de Curtis, Marco			Arterially Perfused Neurosphere-Derived Cells Distribute Outside the Ischemic Core in a Model of Transient Focal Ischemia and Reperfusion In Vitro	PLOS ONE			English	Article								Background: Treatment with neural stem cells represents a potential strategy to improve functional recovery of post-ischemic cerebral injury. The potential benefit of such treatment in acute phases of human ischemic stroke depends on the therapeutic viability of a systemic vascular delivery route. In spite of the large number of reports on the beneficial effects of intracerebral stem cells injection in experimental stroke, very few studies demonstrated the effectiveness of the systemic intravenous delivery approach. Metodology/Principal Findings: We utilized a novel in vitro model of transient focal ischemia to analyze the brain distribution of neurosphere-derived cells (NCs) in the early 3 hours that follow transient occlusion of the medial cerebral artery (MCA). NCs obtained from newborn C57/BL6 mice are immature cells with self-renewal properties that could differentiate into neurons, astrocytes and oligodendrocytes. MCA occlusion for 30 minutes in the in vitro isolated guinea pig brain preparation was followed by arterial perfusion with 1 x 10(6) NCs charged with a green fluorescent dye, either immediately or 60 minutes after reperfusion onset. Changes in extracellular pH and K+ concentration during and after MCAO were measured through ion-sensitive electrodes. Conclusion/Significance: It is demonstrated that NCs injected through the vascular system do not accumulate in the ischemic core and preferentially distribute in non-ischemic areas, identified by combined electrophysiological and morphological techniques. Direct measurements of extracellular brain ions during and after MCA occlusion suggest that anoxia-induced tissue changes, such as extracellular acidosis, may prevent NCs from entering the ischemic area in our in vitro model of transitory focal ischemia and reperfusion suggesting a role played by the surrounding microenviroment in driving NCs outside the ischemic core. These findings strongly suggest that the potential beneficial effect of NCs in experimental focal brain ischemia is not strictly dependent on their homing into the ischemic region, but rather through a bystander mechanism possibly mediated by the release of neuroprotective factors in the peri-infarct region.	[Pastori, Chiara; Librizzi, Laura; Breschi, Gian Luca; Regondi, Cristina; Frassoni, Carolina; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unita Neurofisiol & Epilettol Sperimentale, Milan, Italy; [Panzica, Ferruccio] Fdn Ist Neurol Carlo Besta, Unita Neurofisiopatol Epilettol diagnost, Milan, Italy; [Frigerio, Simona; Gelati, Maurizio; Parati, Eugenio] Fdn Ist Neurol Carlo Besta, SDS Neurobiol Terapie Neuroriparat, Milan, Italy; [De Simoni, Maria Grazia] Ist Ric Farmacol Mario Negri, Milan, Italy; [Pastori, Chiara] Univ Milano Bicocca, Neurol Residency Sch, Monza, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milano-Bicocca	Pastori, C (corresponding author), Fdn Ist Neurol Carlo Besta, Unita Neurofisiol & Epilettol Sperimentale, Milan, Italy.	decurtis@istituto-besta.it	Parati, Eugenio A/G-8765-2011; Frassoni, Carolina CF/J-8337-2016; Gelati, Maurizio/T-4538-2019; de Curtis, Marco M/J-8704-2016; Pastori, Chiara/J-8826-2016; Librizzi, Laura/J-7889-2016; Frigerio, Simona/AAI-3264-2021; De Simoni, Maria Grazia/I-6021-2012; Parati, Eugenio Agostino/AAN-5893-2021; Panzica, Ferruccio/K-6711-2016; Regondi, Maria Cristina/AAJ-5601-2021	Frassoni, Carolina CF/0000-0002-9300-5139; Gelati, Maurizio/0000-0002-4828-9849; de Curtis, Marco M/0000-0001-7443-6737; Pastori, Chiara/0000-0002-9121-5087; Librizzi, Laura/0000-0002-2741-4452; Frigerio, Simona/0000-0001-7078-075X; De Simoni, Maria Grazia/0000-0001-6695-5297; Parati, Eugenio Agostino/0000-0001-5020-6523; Panzica, Ferruccio/0000-0002-0105-943X; Regondi, Maria Cristina/0000-0002-1398-7591; de Curtis, Marco/0000-0002-5608-929X	CARIPLO Foundation [2002.1915/10.4898]; Italian Health Ministry	CARIPLO Foundation(Fondazione Cariplo); Italian Health Ministry(Ministry of Health, Italy)	The study was partially funded by a CARIPLO Foundation grant (N. 2002.1915/10.4898) and by the Italian Health Ministry.	Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; de Curtis M, 1998, J NEUROSCI, V18, P7543; de Curtis M, 1991, Hippocampus, V1, P341, DOI 10.1002/hipo.450010402; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jiang FX, 2001, REPROD FERT DEVELOP, V13, P609, DOI 10.1071/RD01059; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kataoka H, 2004, J CEREBR BLOOD F MET, V24, P668, DOI 10.1097/01.WCB.0000117812.35136.5B; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kempski O, 1990, Adv Neurol, V52, P39; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Librizzi L, 2000, NEUROSCIENCE, V101, P283, DOI 10.1016/S0306-4522(00)00365-1; Librizzi L, 2006, NEUROSCIENCE, V137, P1211, DOI 10.1016/j.neuroscience.2005.10.041; Librizzi L, 1999, J COMP NEUROL, V411, P674, DOI 10.1002/(SICI)1096-9861(19990906)411:4<674::AID-CNE11>3.0.CO;2-O; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; LLINAS R, 1981, FED PROC, V40, P2240; Lo KC, 2003, J UROLOGY, V170, P2453, DOI 10.1097/01.ju.0000087170.97532.ff; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mazzetti S, 2004, BRAIN RES, V999, P81, DOI 10.1016/j.brainres.2003.11.032; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P131, DOI 10.1007/BF00693778; PALJARVI L, 1983, ACTA NEUROPATHOL, V60, P232, DOI 10.1007/BF00691871; Pastori C, 2007, EXP NEUROL, V204, P95, DOI 10.1016/j.expneurol.2006.09.023; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; PLUM F, 1983, NEUROLOGY, V33, P222, DOI 10.1212/WNL.33.2.222; Savitz Sean I, 2004, NeuroRx, V1, P406; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; VANHARREVELD A, 1953, AM J PHYSIOL, V173, P171, DOI 10.1152/ajplegacy.1953.173.1.171; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; Wong D, 1999, J NEUROPATH EXP NEUR, V58, P138, DOI 10.1097/00005072-199902000-00004; YOUNG JN, 1992, BRAIN RES, V573, P70, DOI 10.1016/0006-8993(92)90114-O	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2754	10.1371/journal.pone.0002754	http://dx.doi.org/10.1371/journal.pone.0002754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648648	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900024
J	Aidoudi, S; Bujakowska, K; Kieffer, N; Bikfalvi, A				Aidoudi, Sallouha; Bujakowska, Kinga; Kieffer, Nelly; Bikfalvi, Andreas			The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis	PLOS ONE			English	Article								The human CXC-chemokine CXCL4 is a potent inhibitor of tumor-induced angiogenesis. Considering that CXCL4 is sequestered in platelet alpha-granules and released following platelet activation in the vicinity of vessel wall injury, we tested the hypothesis that CXCL4 might function as a ligand for integrins. Integrins are a family of adhesion receptors that play a crucial role in angiogenesis by regulating early angiogenic processes, such as endothelial cell adhesion and migration. Here, we show that CXCL4 interacts with alpha v beta 3 on the surface of alpha v beta 3-CHO. More importantly, human umbilical vein endothelial cells adhere to immobilized CXCL4 through alpha v beta 3 integrin, and also through other integrins, such as alpha v beta 5 and alpha 5 beta 1. We further demonstrate that CXCL4-integrin interaction is of functional significance in vitro, since immobilized CXCL4 supported endothelial cell spreading and migration in an integrin-dependent manner. Soluble CXCL4, in turn, inhibits integrin-dependent endothelial cell adhesion and migration. As a whole, our study identifies integrins as novel receptors for CXCL4 that may contribute to its antiangiogenic effect.	[Aidoudi, Sallouha; Bujakowska, Kinga; Bikfalvi, Andreas] INSERM, U920, Talence, France; [Aidoudi, Sallouha; Bujakowska, Kinga; Bikfalvi, Andreas] Univ Bordeaux, Talence, France; [Kieffer, Nelly] Univ Luxembourg, Lab Biol Physiol Integree, CNRS GDRE ITI, Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Luxembourg	Aidoudi, S (corresponding author), INSERM, U920, Talence, France.	salouaaidoudi@yahoo.fr; a.bikfalvi@angio.u-bordeaux1.fr	Bujakowska, Kinga Maria/AGL-1293-2022	Bujakowska, Kinga/0000-0001-6809-9818	Agence Nationale de la Recherche (ANR); National French Cancer Institute (INCA); Ligue Nationale du Cancer; Association pour la Recherche sur le Cancer (ARC)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); National French Cancer Institute (INCA)(Institut National du Cancer (INCA) France); Ligue Nationale du Cancer; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work has been supported by grants from the Agence Nationale de la Recherche (ANR), the National French Cancer Institute (INCA), the Ligue Nationale du Cancer and the Association pour la Recherche sur le Cancer (ARC) to A.B. The sponsors had no role in designing the study or approving the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Ashton AW, 2004, CIRC RES, V94, P735, DOI 10.1161/01.RES.0000122043.11286.57; Bello L, 2002, CLIN CANCER RES, V8, P3539; Borgstrom P, 1998, ANTICANCER RES, V18, P4035; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FUKAMI MH, 2001, HEMOSTASIS THROMBOSI, P561; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Gentilini G, 1999, BLOOD, V93, P25, DOI 10.1182/blood.V93.1.25.401a47_25_33; Hagedorn M, 2001, FASEB J, V15, P550; HANSELL P, 1995, AM J PHYSIOL, V269, P829; Hsu AR, 2007, RECENT PAT ANTI-CANC, V2, P143, DOI 10.2174/157489207780832469; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOLBER DL, 1995, J NATL CANCER I, V87, P304, DOI 10.1093/jnci/87.4.304; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; LEVINE SP, 1976, J BIOL CHEM, V251, P324; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; MAIONE TE, 1991, CANCER RES, V51, P2077; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; Shiraga M, 1999, J CELL BIOL, V147, P1419, DOI 10.1083/jcb.147.7.1419; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Sulpice E, 2004, EUR J BIOCHEM, V271, P3310, DOI 10.1111/j.1432-1033.2004.04263.x; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Trikha M, 2002, CANCER RES, V62, P2824; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566	54	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2657	10.1371/journal.pone.0002657	http://dx.doi.org/10.1371/journal.pone.0002657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648521	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200003
J	Begley, EB; Jafa, K; Voetsch, AC; Heffelfinger, JD; Borkowf, CB; Sullivan, PS				Begley, Elin B.; Jafa, Krishna; Voetsch, Andrew C.; Heffelfinger, James D.; Borkowf, Craig B.; Sullivan, Patrick S.			Willingness of Men Who Have Sex with Men (MSM) in the United States to Be Circumcised as Adults to Reduce the Risk of HIV Infection	PLOS ONE			English	Article							CONSPIRACY BELIEFS; AFRICAN-AMERICANS; PREVENTION; HIV/AIDS; HEALTH; TRIAL; ACCEPTABILITY; CANCER; HERPES; KENYA	Background: Circumcision reduces HIV acquisition among heterosexual men in Africa, but it is unclear if circumcision may reduce HIV acquisition among men who have sex with men (MSM) in the United States, or whether MSM would be willing to be circumcised if recommended. Methods: We interviewed presumed-HIV negative MSM at gay pride events in 2006. We asked uncircumcised respondents about willingness to be circumcised if it were proven to reduce risk of HIV among MSM and perceived barriers to circumcision. Multivariate logistic regression was used to identify covariates associated with willingness to be circumcised. Results: Of 780 MSM, 133 (17%) were uncircumcised. Of these, 71 (53%) were willing to be circumcised. Willingness was associated with black race (exact odds ratio [OR]: 3.4, 95% confidence interval [CI]: 1.3-9.8), non-injection drug use (OR: 6.1, 95% CI: 1.8-23.7) and perceived reduced risk of penile cancer (OR: 4.7, 95% CI: 2.0-11.9). The most commonly endorsed concerns about circumcision were post-surgical pain and wound infection. Conclusions: Over half of uncircumcised MSM, especially black MSM, expressed willingness to be circumcised. Perceived risks and benefits of circumcision should be a part of educational materials if circumcision is recommended for MSM in the United States.	[Begley, Elin B.; Jafa, Krishna; Voetsch, Andrew C.; Heffelfinger, James D.; Borkowf, Craig B.; Sullivan, Patrick S.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Begley, EB (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.	EQB5@cdc.gov	Voetsch, Andrew/CAF-1978-2022	Voetsch, Andrew/0000-0002-0783-1312; Sullivan, Patrick Sean/0000-0002-7728-0587				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014; BRINTON LA, 1991, INT J CANCER, V47, P504, DOI 10.1002/ijc.2910470406; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; CDC, 2007, HIV AIDS SURV REP, P1; Fink KS, 2002, J UROLOGY, V167, P2113, DOI 10.1016/S0022-5347(05)65098-7; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HUNGFU T, 2001, CANCER CAUSE CONTROL, V12, P267; Hutchinson AB, 2007, JAIDS-J ACQ IMM DEF, V45, P603, DOI 10.1097/QAI.0b013e3181151262; Kalichman SC, 2007, LANCET, V369, P1597, DOI 10.1016/S0140-6736(07)60734-X; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Millett GA, 2007, JAIDS-J ACQ IMM DEF, V46, P643, DOI 10.1097/QAI.0b013e31815b834d; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Senkul T, 2004, UROLOGY, V63, P155, DOI 10.1016/j.urology.2003.08.035; Templeton DJ, 2007, 4 INT AIDS SOC C HIV; Weiss GN, 1997, PEDIATR INFECT DIS J, V16, P727, DOI 10.1097/00006454-199708000-00002; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04	26	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2731	10.1371/journal.pone.0002731	http://dx.doi.org/10.1371/journal.pone.0002731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628946	Green Published, gold			2022-12-25	WOS:000264057200067
J	Cunha-Rodrigues, M; Portugal, S; Prudencio, M; Goncalves, LA; Casalou, C; Buger, D; Sauerwein, R; Haas, W; Mota, MM				Cunha-Rodrigues, Margarida; Portugal, Silvia; Prudencio, Miguel; Goncalves, Ligia A.; Casalou, Cristina; Buger, Dominik; Sauerwein, Robert; Haas, Werner; Mota, Maria M.			Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy	PLOS ONE			English	Article								In tropical regions millions of people still live at risk of malaria infection. Indeed the emergence of resistance to chloroquine and other drugs in use in these areas reinforces the need to implement alternative prophylactic strategies. Genistein is a naturally occurring compound that is widely used as a food supplment and is thought to be effective in countering several pathologies. Results presented here show that genistein inhibits liver infection by the Plasmodium parasite, the causative agent of malaria. In vitro, genistein decreased the infection rates of both mouse and human hepatoma cells by inhibiting the early stages of the parasite's intracellular development. Oral or intraperitoneal administration of genistein decreased the liver parasite load of P. berghei-infected mice. Moreover, mice fed on a genistein-supplemented diet showed a significant reduction in Plasmodium liver infection as well as a reduced blood parasitemia and partial protection from severe disease. Since genistein is a safe, low-cost, natural compound that can be used permanently in a diet, we propose its use as a prophylactic agent against malaria for endemic populations and long-time travelers.	[Cunha-Rodrigues, Margarida; Portugal, Silvia; Prudencio, Miguel; Mota, Maria M.] Univ Lisbon, Fac Med, Unidade Malaria, Inst Mol Med, P-1699 Lisbon, Portugal; [Cunha-Rodrigues, Margarida; Prudencio, Miguel; Goncalves, Ligia A.; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Casalou, Cristina] Centro de Investigacao Patobiol Mol, Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Buger, Dominik] R&D Analytical Res Ctr, DSM Nutrition Products, Basel, Switzerland; [Sauerwein, Robert] Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Haas, Werner] Alfama, Porto Salvo, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Portuguese Institute of Oncology; DSM NV; Radboud University Nijmegen	Cunha-Rodrigues, M (corresponding author), Univ Lisbon, Fac Med, Unidade Malaria, Inst Mol Med, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Gonçalves, Lígia Antunes/F-6242-2014; Sauerwein, Robert/C-8519-2013; Casalou, Cristina/AAU-6804-2021; Prudêncio, Miguel/ABD-9282-2021; /AAD-5368-2019; Mota, Maria/AAF-2048-2019; Prudêncio, Miguel/D-2032-2012	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Casalou, Cristina/0000-0003-3198-2783; Prudêncio, Miguel/0000-0003-1746-6029; Prudêncio, Miguel/0000-0003-1746-6029; Portugal, Silvia/0000-0003-4567-9101; Mota, Maria Manuel/0000-0002-2858-1041	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Chang HC, 2000, TOXICOL APPL PHARM, V168, P244, DOI 10.1006/taap.2000.9019; Cimino CO, 1999, CLIN CHIM ACTA, V287, P69, DOI 10.1016/S0009-8981(99)00124-2; Cunha-Rodrigues Margarido, 2006, Biotechnology Journal, V1, P321, DOI 10.1002/biot.200500038; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; DAY K P, 1991, Immunology Today, V12, pA68; Dluzewski AR, 1996, EXPERIENTIA, V52, P621, DOI 10.1007/BF01969742; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gazarini ML, 2003, BRAZ J MED BIOL RES, V36, P1465, DOI 10.1590/S0100-879X2003001100003; Holzbeierlein JM, 2005, CURR OPIN UROL, V15, P17, DOI 10.1097/00042307-200501000-00005; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Klein CB, 2007, TOXICOL APPL PHARM, V224, P1, DOI 10.1016/j.taap.2007.06.022; Kraft C, 2000, J ETHNOPHARMACOL, V73, P131, DOI 10.1016/S0378-8741(00)00285-3; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; MARKOVITS J, 1989, CANCER RES, V49, P5111; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mezei O, 2003, J NUTR, V133, P1238; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; OKAJIMA F, 1994, BIOCHEM BIOPH RES CO, V203, P1488, DOI 10.1006/bbrc.1994.2353; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Padmanaban G, 2000, BIOCHEM BIOPH RES CO, V268, P665, DOI 10.1006/bbrc.1999.1892; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Setchell KDR, 2006, ENVIRON HEALTH PERSP, V114, pA332, DOI 10.1289/ehp.114-a332; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Suzuki K, 2002, INT J CANCER, V99, P846, DOI 10.1002/ijc.10428; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79	35	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2732	10.1371/journal.pone.0002732	http://dx.doi.org/10.1371/journal.pone.0002732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628947	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200068
J	Madi, A; Friedman, Y; Roth, D; Regev, T; Bransburg-Zabary, S; Ben Jacob, E				Madi, Asaf; Friedman, Yonatan; Roth, Dalit; Regev, Tamar; Bransburg-Zabary, Sharron; Ben Jacob, Eshel			Genome Holography: Deciphering Function-Form Motifs from Gene Expression Data	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CLUSTER-ANALYSIS; ORGANIZATION; SPORULATION; NETWORKS; PATTERNS; OPERON	Background: DNA chips allow simultaneous measurements of genome-wide response of thousands of genes, i.e. system level monitoring of the gene-network activity. Advanced analysis methods have been developed to extract meaningful information from the vast amount of raw gene-expression data obtained from the microarray measurements. These methods usually aimed to distinguish between groups of subjects (e. g., cancer patients vs. healthy subjects) or identifying marker genes that help to distinguish between those groups. We assumed that motifs related to the internal structure of operons and gene-networks regulation are also embedded in microarray and can be deciphered by using proper analysis. Methodology/Principal Findings: The analysis presented here is based on investigating the gene-gene correlations. We analyze a database of gene expression of Bacillus subtilis exposed to sub-lethal levels of 37 different antibiotics. Using unsupervised analysis (dendrogram) of the matrix of normalized gene-gene correlations, we identified the operons as they form distinct clusters of genes in the sorted correlation matrix. Applying dimension-reduction algorithm (Principal Component Analysis, PCA) to the matrices of normalized correlations reveals functional motifs. The genes are placed in a reduced 3-dimensional space of the three leading PCA eigen-vectors according to their corresponding eigen-values. We found that the organization of the genes in the reduced PCA space recovers motifs of the operon internal structure, such as the order of the genes along the genome, gene separation by non-coding segments, and translational start and end regions. In addition to the intra-operon structure, it is also possible to predict inter-operon relationships, operons sharing functional regulation factors, and more. In particular, we demonstrate the above in the context of the competence and sporulation pathways. Conclusions/Significance: We demonstrated that by analyzing gene-gene correlation from gene-expression data it is possible to identify operons and to predict unknown internal structure of operons and gene-networks regulation.	[Madi, Asaf; Friedman, Yonatan; Regev, Tamar; Bransburg-Zabary, Sharron; Ben Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Madi, Asaf; Roth, Dalit; Bransburg-Zabary, Sharron] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Friedman, Yonatan] MIT, Boston, MA USA; [Ben Jacob, Eshel] Univ Calif San Diego, Ctr Theoretical & Biol Phys, La Jolla, CA USA	Tel Aviv University; Tel Aviv University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Madi, A (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il	Friedman, Jonathan/I-6930-2019	Friedman, Jonathan/0000-0001-8476-8030; Regev, Tamar/0000-0003-0639-0890; Madi, Asaf/0000-0003-3441-3228	Maguy-Glass Chair in Physics of Complex Systems; Tauber Fund at Tel-Aviv University; NSF [PHY-0216576, PHY-0225630]; NIMH [R01 MH066962]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066962] Funding Source: NIH RePORTER	Maguy-Glass Chair in Physics of Complex Systems; Tauber Fund at Tel-Aviv University; NSF(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been supported in part by the Maguy-Glass Chair in Physics of Complex Systems, by the Tauber Fund at Tel-Aviv University, by the NSF-sponsored Center for Theoretical Biological Physics (grant numbers PHY-0216576 and PHY-0225630), and by NIMH sponsored grant (R01 MH066962).	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; AZEVEDO V, 1993, MOL MICROBIOL, V10, P397, DOI 10.1111/j.1365-2958.1993.tb02671.x; Baruchi I, 2006, CHAOS, V16, DOI 10.1063/1.2183408; Baruchi I, 2005, COMPLEXITY, V10, P38, DOI 10.1002/cplx.20065; Baruchi I, 2004, NEUROINFORMATICS, V2, P333, DOI 10.1385/NI:2:3:333; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Chander P, 2005, J BACTERIOL, V187, P1773, DOI 10.1128/JB.187.5.1773-1782.2005; CHEN NY, 1993, J BIOL CHEM, V268, P9448; DUBES R, 1980, ADV COMPUT, V19, P113; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Everitt B. S., 1993, CLUSTER ANAL; FAWCETT P, 2000, TRANSCRIPTIONAL PROF, P8064; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gidskehaug L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-346; Golub G., 1965, SIAM J NUMER ANAL, V2, P205, DOI DOI 10.1137/0702016; GOLUB TRS, 1999, MOL CLASSIFICATION C; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartuv E, 2000, INFORM PROCESS LETT, V76, P175, DOI 10.1016/S0020-0190(00)00142-3; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; LAST M, 2006, SPRINGER STUDIES COM, V23, P319; Lee JM, 2001, J BACTERIOL, V183, P7371, DOI 10.1128/JB.183.24.7371-7380.2001; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mirkin B., 1996, MATH CLASSIFICATION; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Otnes R. K., 1978, APPL TIME SERIES ANA, V1; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Quinlan J.R., 1992, PROGRAMS MACHINE LEA; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Rokhlenko O, 2007, BIOINFORMATICS, V23, P2139, DOI 10.1093/bioinformatics/btm319; Rumelhart D.E., 1985, LEARNING INTERNAL RE, DOI 10.1016/b978-1-4832-1446-7.50035-2; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; SIERRO N, 2007, NUCL ACIDS RES ADV A, V25, P1; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Yosef N, 2007, BIOINFORMATICS, V23, pE91, DOI 10.1093/bioinformatics/btl298	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2708	10.1371/journal.pone.0002708	http://dx.doi.org/10.1371/journal.pone.0002708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628959	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200051
J	Sanjuan, R; Nebot, MR				Sanjuan, Rafael; Nebot, Miguel R.			A Network Model for the Correlation between Epistasis and Genomic Complexity	PLOS ONE			English	Article								The study of genetic interactions (epistasis) is central to the understanding of genome organization and evolution. A general correlation between epistasis and genomic complexity has been recently shown, such that in simpler genomes epistasis is antagonistic on average (mutational effects tend to cancel each other out), whereas a transition towards synergistic epistasis occurs in more complex genomes (mutational effects strengthen each other). Here, we use a simple network model to identify basic features explaining this correlation. We show that, in small networks with multifunctional nodes, lack of redundancy, and absence of alternative pathways, epistasis is antagonistic on average. In contrast, lack of multi-functionality, high connectivity, and redundancy favor synergistic epistasis. Moreover, we confirm the previous finding that epistasis is a covariate of mutational robustness: in less robust networks it tends to be antagonistic whereas in more robust networks it tends to be synergistic. We argue that network features associated with antagonistic epistasis are typically found in simple genomes, such as those of viruses and bacteria, whereas the features associated with synergistic epistasis are more extensively exploited by higher eukaryotes.	[Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain; [Sanjuan, Rafael] Inst Biol Mol Celular Plantas CSIC UPV, Valencia, Spain; [Nebot, Miguel R.] Inst Superior Tecn, Ctr Fis Teorica Parteculas CFTP, Lisbon, Portugal; [Nebot, Miguel R.] Univ Studi Roma Tre, Dipartimento Fis Edoardo Amaldi, Sezione Roma Tre, Ist Nazl Fis Nucleare INFN, Rome, Italy	University of Valencia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universidade de Lisboa; Istituto Nazionale di Fisica Nucleare (INFN); Roma Tre University	Sanjuan, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain.	rafael.sanjuan@uv.es		Sanjuan, Rafael/0000-0002-1844-545X; Nebot Gomez, Miguel/0000-0001-9292-7855	Spanish Generalitat Valenciana [GV06/031]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal); CFTP-FCT UNIT 777 Heptools network [MRTN-CT-2006-035505];  [PDCT/FP/63912/2005];  [PDCT/FP/63914/2005]	Spanish Generalitat Valenciana; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); CFTP-FCT UNIT 777 Heptools network; ; 	Spanish Generalitat Valenciana (grant GV06/031) Fundacao para a Ciencia e a Tecnologia (FCT, Portugal), projects PDCT/FP/63912/2005, PDCT/FP/63914/2005, CFTP-FCT UNIT 777 Heptools network MRTN-CT-2006-035505	Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bruggeman FJ, 2000, BIOL CHEM, V381, P965, DOI 10.1515/BC.2000.119; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; BUTCHER D, 1995, GENETICS, V141, P431; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; DeWinter W, 1997, BIOL PHILOS, V12, P149, DOI 10.1023/A:1006590002756; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Edlund JA, 2004, ARTIF LIFE, V10, P167, DOI 10.1162/106454604773563595; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Freilich S, 2005, J MOL BIOL, V349, P745, DOI 10.1016/j.jmb.2005.04.027; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Omholt SW, 2000, GENETICS, V155, P969; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Sanjuan R, 2006, MOL BIOL EVOL, V23, P2123, DOI 10.1093/molbev/msl083; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wolf J.B., 2000, EPISTASIS EVOLUTIONA; Wright S., 1968, GENETIC BIOMETRIC FD	49	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2663	10.1371/journal.pone.0002663	http://dx.doi.org/10.1371/journal.pone.0002663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648534	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200009
J	Wellbrock, C; Rana, S; Paterson, H; Pickersgill, H; Brummelkamp, T; Marais, R				Wellbrock, Claudia; Rana, Sareena; Paterson, Hugh; Pickersgill, Helen; Brummelkamp, Thijn; Marais, Richard			Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF	PLOS ONE			English	Article								The Microphthalmia-associated transcription factor (MITF) is an important regulator of cell-type specific functions in melanocytic cells. MITF is essential for the survival of pigmented cells, but whereas high levels of MITF drive melanocyte differentiation, lower levels are required to permit proliferation and survival of melanoma cells. MITF is phosphorylated by ERK, and this stimulates its activation, but also targets it for degradation through the ubiquitin-proteosome pathway, coupling MITF degradation to its activation. We have previously shown that because ERK is hyper-activated in melanoma cells in which BRAF is mutated, the MITF protein is constitutively down-regulated. Here we describe another intriguing aspect of MITF regulation by oncogenic BRAF in melanoma cells. We show oncogenic BRAF up-regulates MITF transcription through ERK and the transcription factor BRN2 (N-Oct3). In contrast, we show that in melanocytes this pathway does not exist because BRN2 is not expressed, demonstrating that MITF regulation is a newly acquired function of oncogenic BRAF that is not performed by the wild-type protein. Critically, in melanoma cells MITF is required downstream of oncogenic BRAF because it regulates expression of key cell cycle regulatory proteins such as CDK2 and CDK4. Wild-type BRAF does not regulate this pathway in melanocytes. Thus, we show that oncogenic BRAF exerts exquisite control over MITF on two levels. It downregulates the protein by stimulating its degradation, but then counteracts this by increasing transcription through BRN2. Our data suggest that oncogenic BRAF plays a critical role in regulating MITF expression to ensure that its protein levels are compatible with proliferation and survival of melanoma cells. We propose that its ability to appropriate the regulation of this critical factor explains in part why BRAF is such a potent oncogene in melanoma.	[Wellbrock, Claudia; Rana, Sareena; Marais, Richard] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Signal Transduct Team, London, England; [Paterson, Hugh] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Oncogene Team, London, England; [Pickersgill, Helen; Brummelkamp, Thijn] Whitehead Inst Biomed Res, Cambridge, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wellbrock, C (corresponding author), Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Signal Transduct Team, London, England.	richard.marais@icr.ac.uk		Marais, Richard/0000-0001-7484-4183; Wellbrock, Claudia/0000-0002-3825-6381	Cancer Research UK [C107/A3096] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		ANGUS J, 1995, ONCOGENE, V11, P691; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Salti GI, 2000, CANCER RES, V60, P5012; Selzer E, 2002, CANCER RES, V62, P2098; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wu M, 2000, GENE DEV, V14, P301; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	28	193	196	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2734	10.1371/journal.pone.0002734	http://dx.doi.org/10.1371/journal.pone.0002734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628967	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200070
J	Cironi, L; Riggi, N; Provero, P; Wolf, N; Suva, ML; Suva, D; Kindler, V; Stamenkovic, I				Cironi, Luisa; Riggi, Nicolo; Provero, Paolo; Wolf, Natalie; Suva, Mario-Luca; Suva, Domizio; Kindler, Vincent; Stamenkovic, Ivan			IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells	PLOS ONE			English	Article								Background: The EWS-FLI-1 fusion protein is associated with 85-90% of Ewing's sarcoma family tumors (ESFT), the remaining 10-15% of cases expressing chimeric genes encoding EWS or FUS fused to one of several ets transcription factor family members, including ERG-1, FEV, ETV1 and ETV6. ESFT are dependent on insulin-like growth factor-1 (IGF-1) for growth and survival and recent evidence suggests that mesenchymal progenitor/stem cells constitute a candidate ESFT origin. Methodology/Principal Findings: To address the functional relatedness between ESFT-associated fusion proteins, we compared mouse progenitor cell (MPC) permissiveness for EWS-FLI-1, EWS-ERG and FUS-ERG expression and assessed the corresponding expression profile changes. Whereas all MPC isolates tested could stably express EWS-FLI-1, only some sustained stable EWS- ERG expression and none could express FUS-ERG for more than 3-5 days. Only 14% and 4% of the total number of genes that were respectively induced and repressed in MPCs by the three fusion proteins were shared. However, all three fusion proteins, but neither FLI-1 nor ERG-1 alone, activated the IGF1 promoter and induced IGF1 expression. Conclusion/Significance: Whereas expression of different ESFT-associated fusion proteins may require distinct cellular microenvironments and induce transcriptome changes of limited similarity, IGF1 induction may provide one common mechanism for their implication in ESFT pathogenesis.	[Cironi, Luisa; Riggi, Nicolo; Wolf, Natalie; Suva, Mario-Luca; Stamenkovic, Ivan] Univ Lausanne, CHUV, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Biol Genet & Biochem, Turin, Italy; [Suva, Domizio; Kindler, Vincent] Univ Geneva, Univ Hosp, Dept Orthoped, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Turin; University of Geneva	Cironi, L (corresponding author), Univ Lausanne, CHUV, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351; Kindler, Vincent/0000-0002-5349-1857	SNSF [3100A0-105833]; OCS [01656-02-2005]; NCCR Molecular Oncology	SNSF(Swiss National Science Foundation (SNSF)); OCS; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by SNSF grant 3100A0-105833, OCS grant 01656-02-2005 and the NCCR Molecular Oncology.	Alfieri CM, 2007, AM J PHYSIOL-CELL PH, V292, pC1887, DOI 10.1152/ajpcell.00506.2006; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Gerald WL, 2005, SEMIN CANCER BIOL, V15, P197, DOI 10.1016/j.semcancer.2005.01.005; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; LESSNICK SL, 1995, ONCOGENE, V10, P423; May WA, 1997, NAT GENET, V17, P495, DOI 10.1038/ng1297-495; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mittanck DW, 1997, MOL CELL ENDOCRINOL, V126, P153, DOI 10.1016/S0303-7207(96)03979-2; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1998, CANCER RES, V58, P4127; Scotlandi K, 2002, INT J CANCER, V101, P11, DOI 10.1002/ijc.10537; Shing DC, 2003, CANCER RES, V63, P4568; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; SUVA D, 2007, J CELL PHYSL; Thompson AD, 1999, ONCOGENE, V18, P5506, DOI 10.1038/sj.onc.1202928; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Wynes MW, 2005, AM J PHYSIOL-LUNG C, V288, pL1089, DOI 10.1152/ajplung.00352.2004; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9	39	82	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2634	10.1371/journal.pone.0002634	http://dx.doi.org/10.1371/journal.pone.0002634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648544	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800036
J	Martins, LD; Leal, E; Kishino, H				Martins, Leonardo de Oliveira; Leal, Elcio; Kishino, Hirohisa			Phylogenetic Detection of Recombination with a Bayesian Prior on the Distance between Trees	PLOS ONE			English	Article								Genomic regions participating in recombination events may support distinct topologies, and phylogenetic analyses should incorporate this heterogeneity. Existing phylogenetic methods for recombination detection are challenged by the enormous number of possible topologies, even for a moderate number of taxa. If, however, the detection analysis is conducted independently between each putative recombinant sequence and a set of reference parentals, potential recombinations between the recombinants are neglected. In this context, a recombination hotspot can be inferred in phylogenetic analyses if we observe several consecutive breakpoints. We developed a distance measure between unrooted topologies that closely resembles the number of recombinations. By introducing a prior distribution on these recombination distances, a Bayesian hierarchical model was devised to detect phylogenetic inconsistencies occurring due to recombinations. This model relaxes the assumption of known parental sequences, still common in HIV analysis, allowing the entire dataset to be analyzed at once. On simulated datasets with up to 16 taxa, our method correctly detected recombination breakpoints and the number of recombination events for each breakpoint. The procedure is robust to rate and transition: transversion heterogeneities for simulations with and without recombination. This recombination distance is related to recombination hotspots. Applying this procedure to a genomic HIV-1 dataset, we found evidence for hotspots and de novo recombination.	[Martins, Leonardo de Oliveira; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Leal, Elcio] Univ Fed Sao Paulo, Sao Paulo, Brazil	University of Tokyo; Universidade Federal de Sao Paulo (UNIFESP)	Martins, LD (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	leo@lbm.ab.a.u-tokyo.ac.jp	Kishino, Hirohisa/U-9311-2019; Leal, Elcio/J-6236-2016; Leal, Elcio/M-5275-2019; de Oliveira Martins, Leonardo/I-4606-2013	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492; de Oliveira Martins, Leonardo/0000-0001-5247-1320	Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/10372-3, 07/52841-8]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Japan Society for the Promotion of Science (JSPS). L.O.M. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarship. E.L. was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants no. 04/10372-3, 07/52841-8).	Al-Awadhi F, 2004, STAT PROBABIL LETT, V69, P189, DOI 10.1016/j.spl.2004.06.025; Allen BL, 2001, ANN COMB, V5, P1; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fang F, 2007, BIOINFORMATICS, V23, P507, DOI 10.1093/bioinformatics/btl613; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GOLDING GB, 1984, GENETICS, V108, P257; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; GRIFFITHS RC, 1981, THEOR POPUL BIOL, V19, P169, DOI 10.1016/0040-5809(81)90016-2; Hallett MT, 2001, P 5 ANN INT C COMP B, P149, DOI [DOI 10.1145/369133.369188, 10.1145/369133.369188]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HEIN J, 1993, J MOL EVOL, V36, P396, DOI 10.1007/BF00182187; HEIN MHS, 2005, GENE GENEALOGIES VAR; Hey J, 1997, GENETICS, V145, P833; HICKEY G, 2008, EVOLUTIONARY BIOINFO, V4, P4; Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2001, GENETICS, V159, P1805; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husmeier D, 2005, BIOINFORMATICS, V21, P166, DOI 10.1093/bioinformatics/bti1127; Husmeier D, 2001, Bioinformatics, V17 Suppl 1, pS123; Husmeier D, 2001, J COMPUT BIOL, V8, P401, DOI 10.1089/106652701752236214; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kuhner MK, 2000, GENETICS, V156, P1393; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27; McVean G, 2002, GENETICS, V160, P1231; Minin VN, 2007, GENETICS, V175, P1773, DOI 10.1534/genetics.106.066258; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Nakhleh L, 2005, J COMPUT BIOL, V12, P796, DOI 10.1089/cmb.2005.12.796; Nakhleh L, 2005, LECT NOTES COMPUT SC, V3595, P84, DOI 10.1007/11533719_11; Nielsen R, 2000, GENETICS, V154, P931; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; R Core Team, 2022, R LANG ENV STAT COMP; RAJARAM ML, 2007, BIOINF BIOENG 2007 B, P707; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Song Y. S., 2003, ANN COMB, V7, P365, DOI DOI 10.1007/S00026-003-0192-0; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Song YS, 2003, LECT N BIOINFORMAT, V2812, P287; STEEL M, 1993, INFORM PROCESS LETT, V48, P77, DOI 10.1016/0020-0190(93)90181-8; Suchard MA, 2005, GENETICS, V170, P419, DOI 10.1534/genetics.103.025692; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Wiuf C, 2003, GENETICS, V164, P407; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	63	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2651	10.1371/journal.pone.0002651	http://dx.doi.org/10.1371/journal.pone.0002651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612422	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800053
J	Valbuena, A; Blanco, S; Vega, FM; Lazo, PA				Valbuena, Alberto; Blanco, Sandra; Vega, Francisco M.; Lazo, Pedro A.			The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53	PLOS ONE			English	Article								Background: The vaccinia-related kinase 1 (VRK1) protein, an activator of p53, can be proteolytically downregulated by an indirect mechanism, which requires p53-dependent transcription. Principal Findings: In this work we have biochemically characterized the contribution of several p53 transcriptional cofactors with acetyl transferase activity to the induction of VRK1 downregulation that was used as a functional assay. Downregulation of VRK1 induced by p53 is prevented in a dose dependent manner by either p300 or CBP, but not by PCAF, used as transcriptional co-activators, suggesting that p53 has a different specificity depending on the relative level of these transcriptional cofactors. This inhibition does not require p53 acetylation, since a p53 acetylation mutant also induces VRK1 downregulation. PCAF can not revert the VRK1 protection effect of p300, indicating that these two proteins do not compete for a common factor needed to induce VRK1 downregulation. The protective effect is also induced by the C/H3 domain of p300, a region implicated in binding to several transcription factors and SV40 large T antigen; but the protective effect is lost when a mutant C/H3Del33 is used. The protective effect is a consequence of direct binding of the C/H3 domain to the transactivation domain of p53. A similar downregulatory effect can also be detected with VRK2 protein. Conclusions/Significance: Specific p53-dependent effects are determined by the availability and ratios of its transcriptional cofactors. Specifically, the downregulation of VRK1/VRK2 protein levels, as a consequence of p53 accumulation, is thus dependent on the levels of the p300/CBP protein available for transcriptional complexes, since in this context this cofactor functions as a repressor of the effect. These observations point to the relevance of knowing the cofactor levels in order to determine one effect or another.	[Valbuena, Alberto; Blanco, Sandra; Vega, Francisco M.; Lazo, Pedro A.] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Valbuena, A (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, E-37008 Salamanca, Spain.	plazozbi@usal.es	Blanco, Sandra/B-2070-2017; 2008, Ibsal/A-1268-2012; Lazo, Pedro A./M-6435-2014; Vega, Francisco M./C-4678-2008; IBIS, FISIOPATOLOGIA/O-9510-2015	Blanco, Sandra/0000-0001-7352-9392; Lazo, Pedro A./0000-0001-8997-3025; Vega, Francisco M./0000-0002-9015-864X; 	Ministerio de Educacion y Ciencia [predoctoral fellowships, SAF2007-60242]; Fundacion Ramon Areces [predoctoral fellowships]; Consolider-Ingenio-2010 [CSD-2007-0017]; Junta de Castilla y Leon [CSI05A05]; Fundacion de Investigacion Medica MM; Federacion de Cajas de Ahorro de Castilla y Leon	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Consolider-Ingenio-2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion de Investigacion Medica MM; Federacion de Cajas de Ahorro de Castilla y Leon	A.V. and S.B. have predoctoral fellowships from Ministerio de Educacion y Ciencia. F.M.V. has a predoctoral fellowship from Fundacion Ramon Areces. This work was funded by grants from Ministerio de Educacion y Ciencia (SAF2007-60242), Consolider-Ingenio-2010 (CSD-2007-0017), Junta de Castilla y Leon (CSI05A05), Fundacion de Investigacion Medica MM and Federacion de Cajas de Ahorro de Castilla y Leon.	Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehden GS, 2003, ONCOGENE, V22, P4111, DOI 10.1038/sj.onc.1206632; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; BOURDON JC, 2005, GENES DEV; Buschmann T, 2000, CANCER RES, V60, P896; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan SJ, 2002, CANCER RES, V62, P141; Ferrer M, 1999, ONCOGENE, V18, P2253, DOI 10.1038/sj.onc.1202551; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Moll UM, 2003, MOL CANCER RES, V1, P1001; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Roemer K, 1996, ONCOGENE, V12, P2069; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883	55	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2649	10.1371/journal.pone.0002649	http://dx.doi.org/10.1371/journal.pone.0002649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612383	gold, Green Submitted, Green Published			2022-12-25	WOS:000264065800051
J	Massacand, JC; Kaiser, P; Ernst, B; Tardivel, A; Burki, K; Schneider, P; Harris, NL				Massacand, Joanna C.; Kaiser, Patrick; Ernst, Bettina; Tardivel, Aubry; Buerki, Kurt; Schneider, Pascal; Harris, Nicola L.			Intestinal Bacteria Condition Dendritic Cells to Promote IgA Production	PLOS ONE			English	Article								Immunoglobulin (Ig) A represents the predominant antibody isotype produced at the intestinal mucosa, where it plays an important role in limiting the penetration of commensal intestinal bacteria and opportunistic pathogens. We show in mice that Peyer's Patch-derived dendritic cells (PP-DC) exhibit a specialized phenotype allowing the promotion of IgA production by B2 cells. This phenotype included increased expression of the retinaldehyde dehydrogenase 1 (RALDH1), inducible nitric oxide synthase (iNOS), B cell activating factor of the tumor necrosis family (BAFF), a proliferation-inducing ligand (APRIL), and receptors for the neuropeptide vasoactive intestinal peptide (VIP). The ability of PP-DC to promote anti-CD40 dependent IgA was partially dependent on retinoic acid (RA) and transforming growth factor (TGF)-beta, whilst BAFF and APRIL signaling were not required. Signals delivered by BAFF and APRIL were crucial for CD40 independent IgA production, although the contribution of B2 cells to this pathway was minimal. The unique ability of PP-DC to instruct naive B cells to differentiate into IgA producing plasma cells was mainly imparted by the presence of intestinal commensal bacteria, and could be mimicked by the addition of LPS to the culture. These data indicate that exposure to pathogen-associated molecular patterns present on intestinal commensal bacteria condition DC to express a unique molecular footprint that in turn allows them to promote IgA production.	[Massacand, Joanna C.; Kaiser, Patrick; Harris, Nicola L.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Ernst, Bettina] Swiss Fed Inst Technol, Inst Integrative Biol, Mol Biomed, Zurich, Switzerland; [Tardivel, Aubry; Schneider, Pascal] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Buerki, Kurt] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; University of Zurich	Massacand, JC (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	nharris@ethz.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation [310000-116498]; NCCR Molecular Oncology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	JCM and NLH were supported by the Swiss National Science Foundation (no. 310000-116498). PS was supported by grants from the Swiss National Science Foundation and the NCCR Molecular Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BOIRIVANT M, 1994, GASTROENTEROLOGY, V106, P576, DOI 10.1016/0016-5085(94)90688-2; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 1994, HDB MUCOSAL IMMUNOLO, P113; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; CEBRA JJ, 1991, IMMUNOL RES, V10, P389, DOI 10.1007/BF02919727; CEBRA JJ, 1995, ADV EXP MED BIOL, V371, P429; Chorny A, 2006, ANN NY ACAD SCI, V1088, P187, DOI 10.1196/annals.1366.004; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; FIERER J, 1993, INFECT AGENT DIS, V2, P255; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Gardby E, 1998, J IMMUNOL, V161, P49; HARRIS NL, 2006, J IMMUNOL; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KIMATA H, 1995, BLOOD, V85, P2098, DOI 10.1182/blood.V85.8.2098.bloodjournal8582098; Kushnir N, 1998, J IMMUNOL, V160, P1774; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; SCHRADER CE, 1990, INT IMMUNOL, V2, P563, DOI 10.1093/intimm/2.6.563; SCHRADER CE, 1993, ADV EXP MED BIOL, V329, P59; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; SPALDING DM, 1984, IMMUNOBIOLOGY, V168, P380, DOI 10.1016/S0171-2985(84)80124-2; SPALDING DM, 1984, J EXP MED, V160, P941, DOI 10.1084/jem.160.3.941; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Wykes M, 1998, J IMMUNOL, V161, P1313	57	83	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2588	10.1371/journal.pone.0002588	http://dx.doi.org/10.1371/journal.pone.0002588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596964	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200047
J	Csoka, B; Himer, L; Selmeczy, Z; Vizi, ES; Pacher, P; Ledent, C; Deitch, EA; Spolarics, Z; Nemeth, ZH; Hasko, G				Csoka, Balazs; Himer, Leondra; Selmeczy, Zsolt; Vizi, E. Sylvester; Pacher, Pal; Ledent, Catherine; Deitch, Edwin A.; Spolarics, Zoltan; Nemeth, Zoltan H.; Hasko, Gyoergy			Adenosine A(2A) receptor activation inhibits T helper 1 and T helper 2 cell development and effector function	FASEB JOURNAL			English	Article						autoimmunity; allergy; inflammation; rheumatoid arthritis; spleen and lymph nodes	ADENOSINE A(2A) RECEPTORS; HUMAN DENDRITIC CELLS; T-CELLS; EXTRACELLULAR ADENOSINE; POSTTRANSCRIPTIONAL MECHANISM; HUMAN NEUTROPHILS; HUMAN EOSINOPHILS; EXPRESSION; INFLAMMATION; MICE	Adenosine is an immunosuppressive nucleoside, and adenosine AA receptors inhibit T-cell activation. We investigated the role of A(2A) receptors in regulating T helper (Th)1- and Th2-cell development and effector function. A(2A)-receptor stimulation suppressed the development of Tell receptor (TCR) -stimulated naive T cells into both Th1 and Th2 cells, as indicated by decreased IFN-gamma production by cells developed under Th1-skewing conditions and decreased interleukin (IL)-4, IL-5, and IL-10 production by cells developed under Th2-skewing conditions. Using A(2A) receptor-deficient mice, we demonstrate that A(2A) receptor activation inhibits Th1- and Th2-cell development by decreasing the proliferation and IL,2 production of naive T cells, irrespective of whether the cells are expanded under Th1- or Th2-skewing environment. Using in vivo established Th1 and Th2 cells, we further demonstrate the nonselective nature of A(2A) receptor-mediated immunosuppressive effects, because A(2A) receptor activation decreased IFN-gamma and IL-4 secretion and mRNA level of TCR-stimulated effector Th1 and Th2 cells, respectively. A(2A) receptor mRNA expression in both Th1 and Th2 effector cells increased following TCR stimulation. In summary, these data demonstrate that A(2A) receptor activation has strong inhibitory actions during early developmental, as well as late effector, stages of Th1- and Th2-cell responses.	[Csoka, Balazs; Deitch, Edwin A.; Spolarics, Zoltan; Nemeth, Zoltan H.; Hasko, Gyoergy] Univ Med & Dent New Jersey, Dept Surg, New Jersey Med Sch, Newark, NJ 07103 USA; [Himer, Leondra; Selmeczy, Zsolt; Vizi, E. Sylvester; Hasko, Gyoergy] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Pacher, Pal] NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD USA; [Ledent, Catherine] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Nucl, Brussels, Belgium; [Nemeth, Zoltan H.] Morristown Mem Hosp, Dept Surg, Morristown, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Universite Libre de Bruxelles; Atlantic Health System	Hasko, G (corresponding author), Univ Med & Dent New Jersey, Dept Surg, New Jersey Med Sch, 185 S Orange Ave,Univ Hts, Newark, NJ 07103 USA.	haskoge@umdnj.edu	Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108; Csoka, Balazs/0000-0002-7562-1130	U.S. National Institutes of Health (NIH) [R01 GM66189]; National Institute on Alchol Abuse and Alcoholism; Hungarian Research Fund OTKA [T 049537]; Hungarian National RD Programme [1A/036/2004]; NATIONAL CANCER INSTITUTE [R01CA163739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alchol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National RD Programme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health (NIH) grant R01 GM66189 and the Intramural Research Program of NIH, National Institute on Alchol Abuse and Alcoholism, as well as Hungarian Research Fund OTKA (T 049537) and Hungarian National R&D Programme 1A/036/2004.	Apasov S, 2000, BLOOD, V95, P3859; Armstrong JM, 2001, BIOCHEM J, V354, P123, DOI 10.1042/0264-6021:3540123; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; Desai A, 2005, MOL PHARMACOL, V67, P1406, DOI 10.1124/mol.104.007807; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Fortin A, 2006, J LEUKOCYTE BIOL, V79, P574, DOI 10.1189/jlb.0505249; Fozard JR, 2003, CURR OPIN PHARMACOL, V3, P264, DOI 10.1016/S1471-4892(03)00039-0; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Harish A, 2003, INT J ONCOL, V23, P1245; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Hua XY, 2007, J EXP MED, V204, P117, DOI 10.1084/jem.20061372; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Knight D, 1997, J LEUKOCYTE BIOL, V62, P465, DOI 10.1002/jlb.62.4.465; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kohno Y, 1996, BLOOD, V88, P3569, DOI 10.1182/blood.V88.9.3569.bloodjournal8893569; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Ralevic V, 1998, PHARMACOL REV, V50, P413; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Rogachev B, 2006, KIDNEY INT, V70, P675, DOI 10.1038/sj.ki.5001609; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sullivan GW, 1999, J INFECT DIS, V180, P1550, DOI 10.1086/315084; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Williams BA, 1997, EXP CELL RES, V233, P187, DOI 10.1006/excr.1997.3530; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang H, 2004, J IMMUNOL, V173, P932, DOI 10.4049/jimmunol.173.2.932; Zhong HY, 2006, AM J RESP CELL MOL, V35, P587, DOI 10.1165/rcmb.2005-0476OC	49	130	132	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3491	3499		10.1096/fj.08-107458	http://dx.doi.org/10.1096/fj.08-107458			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18625677	Green Published			2022-12-25	WOS:000259642600011
J	Liu, L; Guo, C; Dammann, R; Tommasi, S; Pfeifer, GP				Liu, L.; Guo, C.; Dammann, R.; Tommasi, S.; Pfeifer, G. P.			RASSF1A interacts with and activates the mitotic kinase Aurora-A	ONCOGENE			English	Article						RASSF1A; Aurora-A; centrosome; mitosis	TUMOR-SUPPRESSOR RASSF1A; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; DEATH INDUCER C19ORF5; CENTROSOME SEPARATION; BINDING-PROTEIN; CHROMOSOME SEGREGATION; CANCER SUSCEPTIBILITY; MICROTUBULE STABILITY; SPINDLE FORMATION	The RAS association domain family 1A (RASSF1A) gene is located at chromosome 3p21.3 within a specific area of common heterozygous and homozygous deletions. RASSF1A frequently undergoes promoter methylation-associated inactivation in human cancers. Rassf1a(-/-) mice are prone to both spontaneous and carcinogen-induced tumorigenesis, supporting the notion that RASSF1A is a tumor suppressor. However, it is not fully understood how RASSF1A is involved in tumor suppression pathways. Here we show that overexpression of RASSF1A inhibits centrosome separation. RASSF1A interacts with Aurora-A, a mitotic kinase. Surprisingly, knockdown of RASSF1A by siRNA led to reduced activation of Aurora-A, whereas overexpression of RASSF1A resulted in increased activation of Aurora-A, suggesting that RASSF1A is involved in Aurora-A activation. Like other Aurora-A activators, RASSF1A was also a substrate of Aurora-A in vitro. The failure of recombinant RASSF1A to activate recombinant Aurora-A indicates that RASSF1A may not activate Aurora-A directly and suggests that RASSF1A may function as a scaffold to bring together Aurora-A and its activator(s). Inhibition of centrosome separation by RASSF1A overexpression is most likely a consequence of hyperstabilization of microtubules by this protein.	[Liu, L.; Guo, C.; Tommasi, S.; Pfeifer, G. P.] City Hope Canc Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Dammann, R.] Univ Giessen, Inst Genet, Giessen, Germany	City of Hope; Beckman Research Institute of City of Hope; Justus Liebig University Giessen	Pfeifer, GP (corresponding author), City Hope Canc Ctr, Beckman Res Inst, Div Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	gpfeifer@coh.org	Guo, Cai/E-8884-2010					ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Boveri T, 1888, JENA Z NATURWISS, V22, P685; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Doxsey SJ, 2001, NAT CELL BIOL, V3, pE105, DOI 10.1038/35074618; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lerman MI, 2000, CANCER RES, V60, P6116; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu L, 2007, CELL CYCLE, V6, P1663, DOI 10.4161/cc.6.13.4435; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mortlock A, 2005, CURR TOP MED CHEM, V5, P199, DOI 10.2174/1568026053507651; Naruganahalli KS, 2006, CURR OPIN INVEST DR, V7, P1044; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Tommasi S, 2005, CANCER RES, V65, P92; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; WATERS JC, 1993, J CELL BIOL, V122, P361, DOI 10.1083/jcb.122.2.361; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	72	28	28	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	47					6175	6186		10.1038/onc.2008.220	http://dx.doi.org/10.1038/onc.2008.220			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18641684				2022-12-25	WOS:000260083100010
J	Ozvegy-Laczka, C; Laczko, R; Hegedus, C; Litman, T; Varady, G; Goda, K; Hegedus, T; Dokholyan, NV; Sorrentino, BP; Varadi, A; Sarkadi, B				Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Litman, Thomas; Varady, Gyoergy; Goda, Katalin; Hegedus, Tamas; Dokholyan, Nikolay V.; Sorrentino, Brian P.; Varadi, Andras; Sarkadi, Balazs			Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RESISTANCE PROTEIN; DISCRETE MOLECULAR-DYNAMICS; DRUG TRANSPORT; BCRP/ABCG2; CELLS; SPECIFICITY; INHIBITION; EXPRESSION; SUBSTRATE; SURVIVAL	Human ABCG2 is a plasma membrane glycoprotein working as a homodimer or homo-oligomer. The protein plays an important role in the protection/detoxification of various tissues and may also be responsible for the multidrug-resistant phenotype of cancer cells. In our previous study we found that the 5D3 monoclonal antibody shows a function-dependent reactivity to an extracellular epitope of the ABCG2 transporter. In the current experiments we have further characterized the 5D3-ABCG2 interaction. The effect of chemical cross-linking and the modulation of extracellular S-S bridges on the transporter function and 5D3 reactivity of ABCG2 were investigated in depth. We found that several protein cross-linkers greatly increased 5D3 labeling in ABCG2 expressing HEK cells; however, there was no correlation between covalent dimer formation, the inhibition of transport activity, and the increase in 5D3 binding. Dithiothreitol treatment, which reduced the extracellular S-S bridge-forming cysteines of ABCG2, had no effect on transport function but caused a significant decrease in 5D3 binding. When analyzing ABCG2 mutants carrying Cys-to-Ala changes in the extracellular loop, we found that the mutant C603A (lacking the intermolecular S-S bond) showed comparable transport activity and 5D3 reactivity to the wild-type ABCG2. However, disruption of the intramolecular S-S bridge (in C592A, C608A, or C592A/C608A mutants) in this loop abolished 5D3 binding, whereas the function of the protein was preserved. Based on these results and ab initio folding simulations, we propose a model for the large extracellular loop of the ABCG2 protein.	[Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Varady, Gyoergy; Sarkadi, Balazs] Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1113 Budapest, Hungary; [Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Varady, Gyoergy; Sarkadi, Balazs] Natl Blood Ctr, H-1113 Budapest, Hungary; [Litman, Thomas] Univ Copenhagen, Bioinformat Ctr, DK-2100 Copenhagen, Denmark; [Goda, Katalin] Univ Debrecen, Dept Biophys & Cell Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Hegedus, Tamas] Univ N Carolina, Cyst Fibrosis Treatment & Res Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sorrentino, Brian P.] St Jude Childrens Res Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA; [Varadi, Andras] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; University of Copenhagen; University of Debrecen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; St Jude Children's Research Hospital; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Sarkadi, B (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, Dioszegi U 64, H-1113 Budapest, Hungary.	sarkadi@biomembrane.hu	Sarkadi, Balazs/I-5024-2013; Varadi, Andras/A-2055-2012; Laczka, Csilla/AAE-5543-2021; Goda, Katalin/L-8986-2019; Dokholyan, Nikolay/B-2238-2009; Hegedus, Tamas/P-8625-2015; Dokholyan, Nikolay/D-8081-2018; György, Várady/J-8118-2017	Dokholyan, Nikolay/0000-0002-8225-4025; Hegedus, Tamas/0000-0002-5195-749X; Dokholyan, Nikolay/0000-0002-8225-4025; Litman, Thomas/0000-0002-6068-901X	Hungarian Scientific Research Fund (OTKA) [AT 048986, NK72057]; National Research and Development Programmes (NKFP) [FP6-INTHER, FP6-MEMTRANS, NEDO]; National Health Council (ETT)	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Programmes (NKFP); National Health Council (ETT)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA) (AT 048986 and NK72057) National Research and Development Programmes (NKFP), FP6-INTHER, FP6-MEMTRANS, NEDO, and National Health Council (ETT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abbott BL, 2002, BLOOD, V100, P4594, DOI 10.1182/blood-2002-01-0271; Allen JD, 2002, MOL CANCER THER, V1, P417; Chandra P, 2004, PHARM RES-DORDR, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f; Ding F, 2005, TRENDS BIOTECHNOL, V23, P450, DOI 10.1016/j.tibtech.2005.07.001; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Krishnamurthy P, 2005, BIOMETALS, V18, P349, DOI 10.1007/s10534-005-3709-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Maliepaard M, 2001, CANCER RES, V61, P3458; Mitomo H, 2003, BIOCHEM J, V373, P767, DOI 10.1042/BJ20030150; Ozvegy C, 2001, BIOCHEM BIOPH RES CO, V285, P111, DOI 10.1006/bbrc.2001.5130; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SPACK EG, 1986, ANAL BIOCHEM, V158, P233, DOI 10.1016/0003-2697(86)90614-7; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Szollosi J, 1996, J IMMUNOL, V157, P2939; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26059	26070		10.1074/jbc.M803230200	http://dx.doi.org/10.1074/jbc.M803230200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644784	Green Published, hybrid			2022-12-25	WOS:000259200100034
J	Young, MT; Fisher, JA; Fountain, SJ; Ford, RC; North, RA; Khakh, BS				Young, Mark T.; Fisher, James A.; Fountain, Samuel J.; Ford, Robert C.; North, R. Alan; Khakh, Baljit S.			Molecular shape, architecture, and size of P2X(4) receptors determined using fluorescence resonance energy transfer and electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-GATED P2X(2); NICOTINIC ACETYLCHOLINE-RECEPTORS; INTERLEUKIN-1-BETA RELEASE; MEMBRANE-PROTEINS; ION CHANNELS; SUBUNITS; TRAFFICKING; RESOLUTION; NEURONS; DOMAIN	P2X receptors are ATP-gated nonselective cation channels with important physiological roles. However, their structures are poorly understood. Here, we analyzed the architecture of P2X receptors using fluorescence resonance energy transfer (FRET) microscopy and direct structure determination using electron microscopy. FRET efficiency measurements indicated that the distance between the C-terminal tails of P2X(4) receptors was 5.6 nm. Single particle analysis of purified P2X(4) receptors was used to determine the three-dimensional structure at a resolution of 21 angstrom; the orientation of the particle with respect to the membrane was assigned by labeling the intracellular C termini with 1.8-nm gold particles and the carbohydrate-rich ectodomain with lectin. We found that human P2X(4) is a globular torpedo-like molecule with an approximate volume of 270 nm(3) and a compact propeller-shaped ectodomain. In this structure, the distance between the centers of the gold particles was 6.1 nm, which closely matches FRET data. Thus, our data provide the first views of the architecture, shape, and size of single P2X receptors, furthering our understanding of this important family of ligand-gated ion channels.	[Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Young, Mark T.; Ford, Robert C.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Fisher, James A.; Khakh, Baljit S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fountain, Samuel J.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester; MRC Laboratory Molecular Biology; University of Manchester	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	North, Richard/GQA-6156-2022; Fountain, Samuel J/C-2142-2011; Young, Mark T/E-8928-2010	Young, Mark T/0000-0002-9615-9002; Ford, Robert/0000-0002-0958-1505	National Institutes of Health [GM070925]; Wellcome Trust; Medical Research Council; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health (to B. S. K., subcontract on Grant GM070925). This work was also supported by the Wellcome Trust (to R. A. N.), the Medical Research Council (to J. A. F. and B. S. K.), and the Human Frontier Science Program (to B. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; Bunt G, 2004, INT REV CYTOL, V237, P205, DOI 10.1016/S0074-7696(04)37005-1; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Egan TM, 1998, J NEUROSCI, V18, P2350; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; FORD RC, 1987, EMBO J, V6, P1581, DOI 10.1002/j.1460-2075.1987.tb02403.x; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; Le KT, 1998, J NEUROSCI, V18, P7152; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Nakazawa K, 2005, EUR J PHARMACOL, V518, P107, DOI 10.1016/j.ejphar.2005.06.018; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108	46	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26241	26251		10.1074/jbc.M804458200	http://dx.doi.org/10.1074/jbc.M804458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635539	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000259200100052
J	Kang, S; Kang, J; Kwon, H; Frueh, D; Yoo, SH; Wagner, G; Park, S				Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Frueh, Dominique; Yoo, Seung Hyun; Wagner, Gerhard; Park, Sunghyouk			Effects of redox potential and Ca2+ on the inositol 1,4,5-trisphosphate receptor L3-1 loop region - Implications for receptor regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; N-TERMINAL REGION; LUMINAL CA2+; SECRETORY GRANULES; CHROMOGRANIN-A; IP3 RECEPTORS; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS	Inositol 1,4,5-trisphosphate receptor (IP3R) is a major intracellular Ca2+ channel, modulated by many factors in the cytosolic and lumenal compartments. Compared with cytosolic control, lumenal-side regulation has been much less studied, and some of its mechanistic aspects have been controversial. Of particular interest with regard to lumenal regulation are whether it involves direct interactions between IP3R and the regulators, and whether it involves conformational changes of the lumenal regions of IP3R. To understand these lumenal-side regulation mechanisms, we studied the effects of two important lumenal regulatory factors, the redox potential and Ca2+, on the L3-1 lumenal loop region of IP3R. The redox potential exerted direct and significant effects on the conformation of the loop region. By sharp contrast, Ca2+ showed little effect on the L3-1 conformation, suggesting that the regulation of Ca2+ is indirect or involves other receptor regions. GSH/oxidized glutathione-mediated oxidation introduced a unique intramolecular disulfide bond between Cys(34) and Cys(42). A variety of NMR experiments revealed that oxidation also induces localized helical characteristics in the Cys(34)-Cys(42) region. Dynamics studies also showed reduced motions in the region upon oxidation, consistent with the conformational changes. The results raise the interesting possibility that Cys(34) and Cys(42) may act together as a reduction sensor, and that Cys(65) may function as an oxidation sensor. Overall, our studies suggest that the redox potential and Ca2+ can regulate IP3R through totally different mechanisms: Ca2+ by the indirect effect and the redox potential by direct action causing conformational changes.	[Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Dept Biochem, BK21 Project, Inchon 400712, South Korea; [Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Ctr Adv Med Educ, BK21 Project, Inchon 400712, South Korea; [Frueh, Dominique; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Inha University; Inha University; Harvard University; Harvard Medical School	Park, S (corresponding author), Inha Univ, Sch Med, Dept Biochem, BK21 Project, Chungsuk Bldg,Room 505,Shinheung Dong, Inchon 400712, South Korea.	spark@inha.ac.kr	Frueh, Dominique P/A-6462-2008; Kwon, Hyuk Nam/V-2301-2018	Frueh, Dominique P/0000-0003-4605-3776; Kwon, Hyuk Nam/0000-0003-4096-4712	Inha University	Inha University	This work was supported by Inha University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; BULENDA D, 1985, BIOCHEMISTRY-US, V24, P7760, DOI 10.1021/bi00347a039; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; COZENS B, 1984, J BIOL CHEM, V259, P6248; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; Hoch JC, 2001, METHOD ENZYMOL, V338, P159; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang JH, 2007, BBA-PROTEINS PROTEOM, V1774, P502, DOI 10.1016/j.bbapap.2007.02.007; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; Park S, 2000, FEBS LETT, V485, P81, DOI 10.1016/S0014-5793(00)02186-4; PARYS JB, 1993, J BIOL CHEM, V268, P25206; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SHUTTLEWORTH TJ, 1995, CELL CALCIUM, V17, P393, DOI 10.1016/0143-4160(95)90085-3; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Thrower EC, 2000, J BIOL CHEM, V275, P36049, DOI 10.1074/jbc.M000970200; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yoo SH, 2001, J BIOL CHEM, V276, P45806, DOI 10.1074/jbc.M107532200; YOO SH, 1991, J BIOL CHEM, V266, P7740; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	63	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25567	25575		10.1074/jbc.M803321200	http://dx.doi.org/10.1074/jbc.M803321200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635540	hybrid			2022-12-25	WOS:000259012700052
J	Missner, A; Kugler, P; Saparov, SM; Sommer, K; Mathai, JC; Zeidel, ML; Pohl, P				Missner, Andreas; Kuegler, Philipp; Saparov, Sapar M.; Sommer, Klaus; Mathai, John C.; Zeidel, Mark L.; Pohl, Peter			Carbon dioxide transport through membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; HUMAN ERYTHROCYTE-MEMBRANE; RED-BLOOD-CELLS; UNSTIRRED LAYERS; AMMONIA TRANSPORT; CO2 PERMEABILITY; OXYGEN-UPTAKE; PH PROFILES; AQUAPORIN 1; WATER	Several membrane channels, like aquaporin-1 (AQP1) and the RhAG protein of the rhesus complex, were hypothesized to be of physiological relevance for CO2 transport. However, the underlying assumption that the lipid matrix imposes a significant barrier to CO2 diffusion was never confirmed experimentally. Here we have monitored transmembrane CO2 flux (J(CO2)) by imposing a CO2 concentration gradient across planar lipid bilayers and detecting the resulting small pH shift in the immediate membrane vicinity. An analytical model, which accounts for the presence of both carbonic anhydrase and buffer molecules, was fitted to the experimental pH profiles using inverse problems techniques. At pH 7.4, the model revealed that J(CO2) was entirely rate-limited by near-membrane unstirred layers (USL), which act as diffusional barriers in series with the membrane. Membrane tightening by sphingomyelin and cholesterol did not alter J(CO2) confirming that membrane resistance was comparatively small. In contrast, a pH-induced shift of the CO2 hydration-dehydration equilibrium resulted in a relative membrane contribution of about 15% to the total resistance (pH 9.6). Under these conditions, a membrane CO2 permeability (3.2 +/- 1.6 cm/s) was estimated. It indicates that cellular CO2 uptake (pH 7.4) is always USL-limited, because the USL size always exceeds 1 mu m. Consequently, facilitation of CO2 transport by AQP1, RhAG, or any other protein is highly unlikely. The conclusion was confirmed by the observation that CO2 permeability of epithelial cell mono-layers was always the same whether AQP1 was overexpressed in both the apical and basolateral membranes or not.	[Missner, Andreas; Saparov, Sapar M.; Sommer, Klaus; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Kuegler, Philipp] Johannes Kepler Univ Linz, Inst Ind Mathemat, A-4040 Linz, Austria; [Kuegler, Philipp] Austrian Acad Sci, Johan Radon Inst Computat & Appl Math, A-4040 Linz, Austria; [Mathai, John C.; Zeidel, Mark L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mathai, John C.; Zeidel, Mark L.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Johannes Kepler University Linz; Johannes Kepler University Linz; Austrian Academy of Sciences; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pohl, P (corresponding author), Altenbergerstr 69, A-4040 Linz, Austria.	peter.pohl@jku.at	Pohl, Peter/A-5361-2008; Kügler, Philipp/B-4444-2015	Pohl, Peter/0000-0002-1792-2314; Kügler, Philipp/0000-0002-1041-9265	National Institutes of Health [DK43955, DK048217]; Austrian Science Fund [FWFW1201-N13]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048217, R01DK048217, R01DK043955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43955 and DK048217 (to M.Z.L. and J.C.M.). This work was also supported by Austrian Science Fund FWFW1201-N13 (to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3; ANTONENKO YN, 1993, BIOPHYS J, V64, P1701, DOI 10.1016/S0006-3495(93)81542-X; Antonenko YN, 1996, ARCH BIOCHEM BIOPHYS, V333, P225, DOI 10.1006/abbi.1996.0385; BARRY PH, 1984, PHYSIOL REV, V64, P763, DOI 10.1152/physrev.1984.64.3.763; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; COIN JT, 1979, J BIOL CHEM, V254, P1178; Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218; Cooper GJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1481, DOI 10.1152/ajpcell.1998.275.6.C1481; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Deuflhard P., 2004, SPR S COMP, V35; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; ENDEWARD V, 2007, FASEB J, V22, P1; ENGL HW, 2005, SERIES MATH IND, P3; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Forster RE, 1998, P NATL ACAD SCI USA, V95, P15815, DOI 10.1073/pnas.95.26.15815; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; GUTMAN M, 1995, BBA-BIOENERGETICS, V1231, P123, DOI 10.1016/0005-2728(95)00074-S; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; HUXLEY VH, 1981, J PHYSIOL-LONDON, V316, P75, DOI 10.1113/jphysiol.1981.sp013773; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1152, P155, DOI 10.1016/0005-2736(93)90242-R; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4; SMABY JM, 1994, BIOCHEMISTRY-US, V33, P9135, DOI 10.1021/bi00197a016; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2609; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686	40	122	123	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25340	25347		10.1074/jbc.M800096200	http://dx.doi.org/10.1074/jbc.M800096200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617525	hybrid, Green Published			2022-12-25	WOS:000259012700028
J	Oosterveer, MH; Van Dijk, TH; Grefhorst, A; Bloks, VW; Havinga, R; Kuipers, F; Reijngoud, DJ				Oosterveer, Maaike H.; Van Dijk, Theo H.; Grefhorst, Aldo; Bloks, Vincent W.; Havinga, Rick; Kuipers, Folkert; Reijngoud, Dirk-Jan			Lxr alpha deficiency hampers the hepatic adaptive response to fasting in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR LXR; DE-NOVO SYNTHESIS; X-RECEPTOR; LIVER; GLUCOSE; METABOLISM; ACTIVATION; GLYCOGEN; GENE; GLUCOSE-6-PHOSPHATE	Besides its well established role in control of cellular cholesterol homeostasis, the liver X receptor (LXR) has been implicated in the regulation of hepatic gluconeogenesis. We investigated the role of the major hepatic LXR isoform in hepatic glucose metabolism during the feeding-to-fasting transition in vivo. In addition, we explored hepatic glucose sensing by LXR during carbohydrate refeeding. Lxr alpha(-/-) mice and their wild-type littermates were subjected to a fasting-refeeding protocol and hepatic carbohydrate fluxes as well as whole body insulin sensitivity were determined in vivo by stable isotope procedures. Lxr alpha(-/-) mice showed an impaired response to fasting in terms of hepatic glycogen depletion and triglyceride accumulation. Hepatic glucose 6-phosphate turnover was reduced in 9-h fasted Lxr alpha(-/-) mice as compared with controls. Although hepatic gluconeogenic gene expression was increased in 9-h fasted Lxr alpha(-/-) mice compared with wild-type controls, the actual gluconeogenic flux was not affected by Lxr alpha deficiency. Hepatic and peripheral insulin sensitivity were similar in Lxr alpha(-/-) and wildtype mice. Compared with wild-type controls, the induction of hepatic lipogenic gene expression was blunted in carbohydrate-refed Lxr alpha(-/-) mice, which was associated with lower plasma triglyceride concentrations. Yet, expression of "classic" LXR target genes Abca1, Abcg5, and Abcg8 was not affected by Lxr alpha deficiency in carbohydrate-refed mice. In summary, these studies identify LXR alpha as a physiologically relevant mediator of the hepatic response to fasting. However, the data do not support a role for LXR in hepatic glucose sensing.	[Oosterveer, Maaike H.; Van Dijk, Theo H.; Grefhorst, Aldo; Bloks, Vincent W.; Havinga, Rick; Kuipers, Folkert; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands; [Van Dijk, Theo H.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, POB 30-001, NL-9700 RB Groningen, Netherlands.	M.H.Oosterveer@med.umcg.nl	Bloks, Vincent/A-7609-2012; oosterveer, maaike h/C-3374-2013	Bloks, Vincent/0000-0001-6493-7482; Reijngoud, Dirk-Jan/0000-0003-1157-4491; Kuipers, Folkert/0000-0003-2518-737X	Dutch Diabetes Foundation [2002.00.041]	Dutch Diabetes Foundation	This work was supported by the Dutch Diabetes Foundation (Grant 2002.00.041). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Grempler R, 2005, BIOCHEM BIOPH RES CO, V338, P981, DOI 10.1016/j.bbrc.2005.10.030; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; KEPPLER D, 1970, METHODEN ENZYMATISCH, V2, P1089; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; YOUN JH, 1990, AM J PHYSIOL, V258, pE899, DOI 10.1152/ajpendo.1990.258.6.E899	34	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25437	25445		10.1074/jbc.M801922200	http://dx.doi.org/10.1074/jbc.M801922200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18611859	hybrid, Green Published			2022-12-25	WOS:000259012700039
J	Pacquelet, S; Lehmann, M; Luxen, S; Regazzoni, K; Frausto, M; Noack, D; Knaus, UG				Pacquelet, Sandrine; Lehmann, Mandy; Luxen, Sylvia; Regazzoni, Karine; Frausto, Monika; Noack, Deborah; Knaus, Ulla G.			Inhibitory action of NoxA1 on dual oxidase activity in airway cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; EPITHELIAL-CELLS; HYDROGEN-PEROXIDE; SUPEROXIDE-PRODUCTION; ACTIVATION DOMAIN; HOST-DEFENSE; P67(PHOX); BINDING; GENE; DIFFERENTIATION	Imbalance between pro-and antioxidant mechanisms in the lungs can compromise pulmonary functions, including blood oxygenation, host defense, and maintenance of an anti-inflammatory environment. Thus, tight regulatory control of reactive oxygen species is critical for proper lung function. Increasing evidence supports a role for the NADPH oxidase dual oxidase (Duox) as an important source for regulated H2O2 production in the respiratory tract epithelium. In this study Duox expression, function, and regulation were investigated in a fully differentiated, mucociliary airway epithelium model. Duox-mediated H2O2 generation was dependent on calcium flux, which was required for dissociation of the NADPH oxidase regulatory protein Noxa1 from plasma membrane-bound Duox. A functional Duox1-based oxidase was reconstituted in model cell lines to permit mutational analysis of Noxa1 and Duox1. Although the activation domain of Noxa1 was not required for Duox function, mutation of a proline-rich domain in the Duox C terminus, a potential interaction motif for the Noxa1 Src homology domain 3, caused up-regulation of basal and stimulated H2O2 production. Similarly, knockdown of Noxa1 in airway cells increased basal H2O2 generation. Our data indicate a novel, inhibitory function for Noxa1 in Duox regulation. This represents a new paradigm for control of NADPH oxidase activity, where second messenger-promoted conformational change of the Nox structure promotes oxidase activation by relieving constraint induced by regulatory components.	[Pacquelet, Sandrine; Lehmann, Mandy; Luxen, Sylvia; Regazzoni, Karine; Frausto, Monika; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Knaus, UG (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	uknaus@scripps.edu		Pacquelet-Cheli, Sandrine/0000-0003-4958-2614	National Institutes of Health [AI024838, CI000095]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI024838 and CI000095 (to U. G. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Babior B M, 1995, Curr Opin Hematol, V2, P55; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; DE D, 2002, EXP CELL RES, V273, P187; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DUPUY C, 1992, BIOCHEM J, V283, P591, DOI 10.1042/bj2830591; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Pantano C, 2007, AM J RESP CELL MOL, V36, P473, DOI 10.1165/rcmb.2006-0109OC; Paquette JS, 2003, IN VITRO CELL DEV-AN, V39, P213; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Valente AJ, 2007, FREE RADICAL BIO MED, V43, P384, DOI 10.1016/j.freeradbiomed.2007.04.022; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Ward C, 2005, EUR J IMMUNOL, V35, P2728, DOI 10.1002/eji.200425561; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	42	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24649	24658		10.1074/jbc.M709108200	http://dx.doi.org/10.1074/jbc.M709108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606821	hybrid, Green Published			2022-12-25	WOS:000258820000036
J	Ram, N; Aroui, S; Jaumain, E; Bichraoui, H; Mabrouk, K; Ronjat, M; Lortat-Jacob, H; De Waard, M				Ram, Narendra; Aroui, Sonia; Jaumain, Emilie; Bichraoui, Hicham; Mabrouk, Kamel; Ronjat, Michel; Lortat-Jacob, Hugues; De Waard, Michel			Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; INTERNALIZATION; BINDING; MECHANISM; MEMBRANE; DOMAIN; ENTRY	Maurocalcine (MCa), initially identified from a tunisian scorpion venom, defines a new member of the family of cell penetrating peptides by its ability to efficiently cross the plasma membrane. The initiating mechanistic step required for the cell translocation of a cell penetrating peptide implicates its binding onto cell surface components such as membrane lipids and/or heparan sulfate proteoglycans. Here we characterized the interaction of wild-type MCa and MCa K20A, a mutant analogue with reduced cell-penetration efficiency, with heparin (HP) and heparan sulfates (HS) through surface plasma resonance. HP and HS bind both to MCa, indicating that heparan sulfate proteoglycans may represent an important entry route of the peptide. This is confirmed by the fact that (i) both compounds bind with reduced affinity to MCa K20A and (ii) the cell penetration of wild-type or mutant MCa coupled to fluorescent streptavidin is reduced by about 50% in mutant Chinese hamster ovary cell lines lacking either all glycosaminoglycans (GAGs) or just HS. Incubating MCa with soluble HS, HP, or chondroitin sulfates also inhibits the cell penetration of MCa-streptavidin complexes. Analyses of the cell distributions of MCa/streptavidin in several Chinese hamster ovary cell lines show that the distribution of the complex coincides with the endosomal marker Lyso-Tracker red and is not affected by the absence of GAGs. The distribution of MCa/streptavidin is not coincident with that of transferrin receptors nor affected by a dominant-negative dynamin 2 K44A mutant, an inhibitor of clathrin-mediated endocytosis. However, entry of the complex is greatly diminished by amiloride, indicating the importance of macropinocytosis in MCa/streptavidin entry. It is concluded that (i) interaction of MCa with GAGs quantitatively improves the cell penetration of MCa, and (ii) GAG-dependent and - independent MCa penetration rely similarly on the macropinocytosis pathway.	[Ram, Narendra; Aroui, Sonia; Jaumain, Emilie; Bichraoui, Hicham; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, Funct & Pathol Lab, Res Grp 3, INSERM,Grenoble Inst Neurosci,U836, F-38042 Grenoble 9, France; [Mabrouk, Kamel] Univ Aix Marseille 1, CNRS, UMR 6517, F-13397 Marseille 20, France; [Mabrouk, Kamel] Univ Aix Marseille 2, CNRS, UMR 6517, F-13397 Marseille 20, France; [Mabrouk, Kamel] Univ Aix Marseille 3, CNRS, UMR 6517, F-13397 Marseille 20, France; [Lortat-Jacob, Hugues] Univ Grenoble 1, Inst Biol Struct, UMR 5075, CEA,CNRS, F-38027 Grenoble 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	De Waard, M (corresponding author), Univ Grenoble 1, Funct & Pathol Lab, Res Grp 3, INSERM,Grenoble Inst Neurosci,U836, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Ronjat, Michel/0000-0002-9728-6425	INSERM; Universite Joseph Fourier; Commissariat a l'Energie Atomique (Saclay, France); Commissariat a l'Energie Atomique (Saclay, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Joseph Fourier; Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); Commissariat a l'Energie Atomique (Saclay, France(French Atomic Energy Commission)	This work was supported by INSERM, Universite Joseph Fourier, and Commissariat a l'Energie Atomique (Saclay, France). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Kurten RC, 2003, ADV DRUG DELIVER REV, V55, P1405, DOI 10.1016/j.addr.2003.07.003; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014; Mano M, 2005, BIOCHEM J, V390, P603, DOI 10.1042/BJ20050577; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rinne J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-1; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996	29	38	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24274	24284		10.1074/jbc.M709971200	http://dx.doi.org/10.1074/jbc.M709971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18603532	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000258638900081
J	Liu, YC; Li, F; Handler, J; Huang, CRL; Xiang, Y; Neretti, N; Sedivy, JM; Zeller, KI; Dang, CV				Liu, Yen-Chun; Li, Feng; Handler, Jesse; Huang, Cheng Ran Lisa; Xiang, Yan; Neretti, Nicola; Sedivy, John M.; Zeller, Karen I.; Dang, Chi V.			Global Regulation of Nucleotide Biosynthetic Genes by c-Myc	PLOS ONE			English	Article								Background: The c-Myc transcription factor is a master regulator and integrates cell proliferation, cell growth and metabolism through activating thousands of target genes. Our identification of direct c-Myc target genes by chromatin immunoprecipitation (ChIP) coupled with pair-end ditag sequencing analysis (ChIP-PET) revealed that nucleotide metabolic genes are enriched among c-Myc targets, but the role of Myc in regulating nucleotide metabolic genes has not been comprehensively delineated. Methodology/Principal Findings: Here, we report that the majority of genes in human purine and pyrimidine biosynthesis pathway were induced and directly bound by c-Myc in the P493-6 human Burkitt's lymphoma model cell line. The majority of these genes were also responsive to the ligand-activated Myc-estrogen receptor fusion protein, Myc-ER, in a Myc null rat fibroblast cell line, HO.15 MYC-ER. Furthermore, these targets are also responsive to Myc activation in transgenic mouse livers in vivo. To determine the functional significance of c-Myc regulation of nucleotide metabolism, we sought to determine the effect of loss of function of direct Myc targets inosine monophosphate dehydrogenases (IMPDH1 and IMPDH2) on c-Myc-induced cell growth and proliferation. In this regard, we used a specific IMPDH inhibitor mycophenolic acid (MPA) and found that MPA dramatically inhibits c-Myc-induced P493-6 cell proliferation through S-phase arrest and apoptosis. Conclusions/Significance: Taken together, these results demonstrate the direct induction of nucleotide metabolic genes by c-Myc in multiple systems. Our finding of an S-phase arrest in cells with diminished IMPDH activity suggests that nucleotide pool balance is essential for c-Myc's orchestration of DNA replication, such that uncoupling of these two processes create DNA replication stress and apoptosis.	[Liu, Yen-Chun; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Program Pathobiol, Baltimore, MD 21218 USA; [Li, Feng; Handler, Jesse; Xiang, Yan; Zeller, Karen I.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD USA; [Huang, Cheng Ran Lisa; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD USA; [Neretti, Nicola; Sedivy, John M.] Brown Univ, Ctr Genom & Proteom, Dept Mol Biol, Cell Biol & Biochem, Providence, RI USA; [Neretti, Nicola] Brown Univ, Inst Brain & Neural Syst, Providence, RI USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Brown University; Brown University	Liu, YC (corresponding author), Johns Hopkins Univ, Sch Med, Program Pathobiol, Baltimore, MD 21218 USA.	kzeller@jhmi.edu; cvdang@jhmi.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522; Handler, Jesse/0000-0001-5444-3905; Neretti, Nicola/0000-0002-9552-1663	NIH [CA57341, CA51497, R01 GM41690, R01 AG16694, K25 AG028753]; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA051497, R29CA051497, R37CA051497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016694, K25AG028753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was in part supported by NIH grants CA57341 and CA51497 to CVD, R01 GM41690 and R01 AG16694 to J.M.S., and grant K25 AG028753 to N.N. The sponsors have no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Burgin A, 1998, Results Probl Cell Differ, V22, P181; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cory S, 1987, Haematol Blood Transfus, V31, P248; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Marval PLM, 2004, MOL CELL BIOL, V24, P7538, DOI 10.1128/MCB.24.17.7538-7547.2004; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dominguez-Sola D, 2007, NATURE; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Yu CZ, 2005, INT J MOL MED, V16, P645; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	52	195	201	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2722	10.1371/journal.pone.0002722	http://dx.doi.org/10.1371/journal.pone.0002722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628958	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200060
J	Yao, YH; Richman, L; Morehouse, C; de los Reyes, M; Higgs, BW; Boutrin, A; White, B; Coyle, A; Krueger, J; Kiener, PA; Jallal, B				Yao, Yihong; Richman, Laura; Morehouse, Chris; de los Reyes, Melissa; Higgs, Brandon W.; Boutrin, Anmarie; White, Barbara; Coyle, Anthony; Krueger, James; Kiener, Peter A.; Jallal, Bahija			Type I Interferon: Potential Therapeutic Target for Psoriasis?	PLOS ONE			English	Article								Background: Psoriasis is an immune-mediated disease characterized by aberrant epidermal differentiation, surface scale formation, and marked cutaneous inflammation. To better understand the pathogenesis of this disease and identify potential mediators, we used whole genome array analysis to profile paired lesional and nonlesional psoriatic skin and skin from healthy donors. Methodology/Principal Findings: We observed robust overexpression of type I interferon (IFN)-inducible genes and genomic signatures that indicate T cell and dendritic cell infiltration in lesional skin. Up-regulation of mRNAs for IFN-alpha subtypes was observed in lesional skin compared with nonlesional skin. Enrichment of mature dendritic cells and 2 type I IFN-inducible proteins, STAT1 and ISG15, were observed in the majority of lesional skin biopsies. Concordant overexpression of IFN-gamma and TNF-alpha-inducible gene signatures occurred at the same disease sites. Conclusions/Significance: Up-regulation of TNF-alpha and elevation of the TNF-alpha-inducible gene signature in lesional skin underscore the importance of this cytokine in psoriasis; these data describe a molecular basis for the therapeutic activity of anti-TNF-alpha agents. Furthermore, these findings implicate type I IFNs in the pathogenesis of psoriasis. Consistent and significant up-regulation of type I IFNs and their associated gene signatures in psoriatic skin suggest that type I IFNs may be potential therapeutic targets in psoriasis treatment.	[Yao, Yihong; Richman, Laura; Morehouse, Chris; de los Reyes, Melissa; Higgs, Brandon W.; Boutrin, Anmarie; White, Barbara; Coyle, Anthony; Kiener, Peter A.; Jallal, Bahija] MedImmune Inc, Gaithersburg, MD USA; [Krueger, James] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY USA	AstraZeneca; Medimmune; Rockefeller University	Yao, YH (corresponding author), MedImmune Inc, Gaithersburg, MD USA.	YaoY@MedImmune.com		Higgs, Brandon/0000-0002-2951-0245				Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chamian F, 2004, CURR OPIN RHEUMATOL, V16, P331, DOI 10.1097/01.bor.0000129715.35024.50; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Downs AMR, 2000, CLIN EXP DERMATOL, V25, P351, DOI 10.1046/j.1365-2230.2000.00655-4.x; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Ketikoglou I, 2005, EUR J DERMATOL, V15, P107; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; LIVDEN JK, 1989, ARCH DERMATOL RES, V281, P392, DOI 10.1007/BF00455323; *MEDIMMUNE, DAT FIL; Mee JB, 2006, CYTOKINE, V33, P72, DOI 10.1016/j.cyto.2005.12.001; Nestle FO, 2005, J INVEST DERMATOL, V125, pXIV, DOI 10.1111/j.0022-202X.2005.23923.x; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; PAULUZZI P, 1993, ACTA DERM-VENEREOL, V73, P395; SCHMID P, 1994, J INTERFERON RES, V14, P229, DOI 10.1089/jir.1994.14.229; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	38	211	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2737	10.1371/journal.pone.0002737	http://dx.doi.org/10.1371/journal.pone.0002737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648529	gold, Green Submitted, Green Published			2022-12-25	WOS:000264057200073
J	Inderjit; Pollock, JL; Callaway, RM; Holben, W				Inderjit; Pollock, Jarrod L.; Callaway, Ragan M.; Holben, William			Phytotoxic Effects of (+/-)-Catechin In vitro, in Soil, and in the Field	PLOS ONE			English	Article							CENTAUREA-MACULOSA; ALLELOCHEMICAL (+/-)-CATECHIN; INVASIVE PLANT; ALLELOPATHY; WEAPONS; WEED; DYNAMICS	Background: Exploring the residence time of allelochemicals released by plants into different soils, episodic exposure of plants to allelochemicals, and the effects of allelochemicals in the field has the potential to improve our understanding of interactions among plants. Methodology/Principal Findings: We conducted experiments in India and the USA to understand the dynamics of soil concentrations and phytotoxicity of (+/-)-catechin, an allelopathic compound exuded from the roots of Centaurea maculosa, to other plants in vitro and in soil. Experiments with single and pulsed applications into soil were conducted in the field. Experimental application of (+/-)-catechin to soils always resulted in concentrations that were far lower than the amounts added but within the range of reported natural soil concentrations. Pulses replenished (+/-)-catechin levels in soils, but consistently at concentrations much lower than were applied, and even pulsed concentrations declined rapidly. Different natural soils varied substantially in the retention of (+/-)-catechin after application but consistent rapid decreases in concentrations over time suggested that applied experimental concentrations may overestimate concentrations necessary for phytotoxicity by over an order of magnitude. (+/-)-Catechin was not phytotoxic to Bambusa arundinacea in natural Indian soil in a single pulse, but soil concentrations at the time of planting seeds were either undetectable or very low. However, a single dose of (+/-)-catechin suppressed the growth of bamboo in sand, in soil mixed with organic matter, and Koeleria macrantha in soils from Montana and Romania, and in field applications at 40 mu g l(-1). Multiple pulses of (+/-)-catechin were inhibitory at very low concentrations in Indian soil. Conclusions/Significance: Our results demonstrate that (+/-)-catechin is highly dynamic in natural soils, but is phytotoxic well below natural concentrations measured in some soils and applied at low concentrations in the field. However, there is substantial conditionality in the effects of the allelochemical.	[Inderjit] Univ Delhi, CEMDE, Delhi 110007, India; [Pollock, Jarrod L.; Callaway, Ragan M.; Holben, William] Univ Montana, Div Biol Sci, Missoula, MT USA	University of Delhi; University of Montana System; University of Montana	Inderjit (corresponding author), Univ Delhi, CEMDE, Delhi 110007, India.	inderjit@cemde.du.ac.in	Pollock, Jarrod/F-4925-2010		University of Delhi, India; Ministry of Environment and Forests, India; Research Office at The University of Montana; Aldo Leopold Wilderness Center; USFS Fire Sciences Laboratory; Rocky Mountain Research Station; USDA; DoD SERDP; National Science Foundation; Civilian Research and Development Foundation	University of Delhi, India(University of Delhi); Ministry of Environment and Forests, India; Research Office at The University of Montana; Aldo Leopold Wilderness Center; USFS Fire Sciences Laboratory; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); USDA(United States Department of Agriculture (USDA)); DoD SERDP; National Science Foundation(National Science Foundation (NSF)); Civilian Research and Development Foundation	This work was supported by the University of Delhi, India; Ministry of Environment and Forests, India; Research Office at The University of Montana, the Aldo Leopold Wilderness Center, the USFS Fire Sciences Laboratory and Rocky Mountain Research Station, the USDA, DoD SERDP, the National Science Foundation, and the Civilian Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alford ER, 2007, SOIL BIOL BIOCHEM, V39, P1812, DOI 10.1016/j.soilbio.2007.01.020; Allen SE, 1989, CHEM ANAL ECOLOGICAL; An M, 2002, PLANT SOIL, V246, P11, DOI 10.1023/A:1021581412982; APPEL HM, 1993, J CHEM ECOL, V19, P1521, DOI 10.1007/BF00984895; Arunachalam M, 2003, MICROBIOL RES, V158, P37, DOI 10.1078/0944-5013-00174; Bais HP, 2002, PLANT PHYSIOL, V128, P1173, DOI 10.1104/pp.011019; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; BUTA JG, 1985, PHYTOCHEMISTRY, V25, P93, DOI 10.1016/S0031-9422(00)94508-4; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P341; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; D'Abrosca B, 2006, J CHEM ECOL, V32, P81, DOI 10.1007/s10886-006-9354-y; Djurisic AB, 2004, APPL PHYS A-MATER, V78, P375, DOI 10.1007/s00339-002-1915-5; Furubayashi A, 2007, J CHEM ECOL, V33, P239, DOI 10.1007/s10886-006-9218-5; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Huang ZQ, 2003, J CHEM ECOL, V29, P2263, DOI 10.1023/A:1026222414059; HUNECK S, 1986, PLANTA MED, V5, P343; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; INDERJIT, 1994, AM J BOT, V81, P799, DOI 10.2307/2445760; Inderjit, 2001, AGRON J, V93, P79; INDERJIT, 2005, PLANT SOIL, V53, P97; Iqbal Z, 2003, WEED SCI, V51, P657, DOI 10.1614/0043-1745(2003)051[0657:AAOBIA]2.0.CO;2; KELSEY RG, 1987, J CHEM ECOL, V13, P19, DOI 10.1007/BF01020348; Mallik AU, 2000, J CHEM ECOL, V26, P2197, DOI 10.1023/A:1005528701927; MARCO JA, 1992, PHYTOCHEMISTRY, V31, P3527, DOI 10.1016/0031-9422(92)83721-A; Paveto C, 2004, ANTIMICROB AGENTS CH, V48, P69, DOI 10.1128/AAC.48.1.69-74.2004; Pedrol N, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P171, DOI 10.1007/1-4020-4280-9_9; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Piper C.S., 1966, SOIL PLANT ANAL; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; RABOTNOV TA, 1982, EKOLOGIA         MAY, P5; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; RIDENOUR WM, ECOLOGY IN PRESS; Rudrappa T, 2007, J CHEM ECOL, V33, P1898, DOI 10.1007/s10886-007-9353-7; Simoes K, 2008, J CHEM ECOL, V34, P681, DOI 10.1007/s10886-008-9443-1; SPSS Inc., 2006, SPSS BAS 15 0 WIND U; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Thelen GC, 2005, ECOL LETT, V8, P209, DOI 10.1111/j.1461-0248.2004.00713.x; THORPE A, 2006, THESIS U MONTANA MIS; Thorpe AS, 2006, APPL SOIL ECOL, V32, P118, DOI 10.1016/j.apsoil.2005.02.018; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Weidenhamer J, 2005, J CHEM ECOL, V31, P221, DOI 10.1007/s10886-005-1337-x; Weir TL, 2006, PLANTA, V223, P785, DOI 10.1007/s00425-005-0192-x; Weir TL, 2003, J CHEM ECOL, V29, P2397, DOI 10.1023/A:1026313031091	51	64	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2536	10.1371/journal.pone.0002536	http://dx.doi.org/10.1371/journal.pone.0002536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648546	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200008
J	Krithika, S; Maji, S; Vasulu, TS				Krithika, S.; Maji, Suvendu; Vasulu, T. S.			A Microsatellite Guided Insight into the Genetic Status of Adi, an Isolated Hunting-Gathering Tribe of Northeast India	PLOS ONE			English	Article							15 STR LOCI; ALLELE FREQUENCY-DISTRIBUTION; ARUNACHAL-PRADESH; POPULATION-DATA; INTEGRATED SOFTWARE; PHYLOGENETIC TREES; ETHNIC POPULATIONS; HAN POPULATION; EASTERN; CHINESE	Tibeto-Burman populations of India provide an insight into the peopling of India and aid in understanding their genetic relationship with populations of East, South and Southeast Asia. The study investigates the genetic status of one such Tibeto-Burman group, Adi of Arunachal Pradesh based on 15 autosomal microsatellite markers. Further the study examines, based on 9 common microsatellite loci, the genetic relationship of Adi with 16 other Tibeto-Burman speakers of India and 28 neighboring populations of East and Southeast Asia. Overall, the results support the recent formation of the Adi sub-tribes from a putative ancestral group and reveal that geographic contiguity is a major influencing factor of the genetic affinity among the Tibeto-Burman populations of India.	[Krithika, S.; Maji, Suvendu; Vasulu, T. S.] Indian Stat Inst, Biol Anthropol Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Krithika, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Kolkata, India.	vasulu@isical.ac.in		T, VASULU/0000-0002-9084-798X	Indian Statistical Institute, Kolkata; Central Forensic Science Laboratory, Kolkata	Indian Statistical Institute, Kolkata; Central Forensic Science Laboratory, Kolkata	The funding for the work was provided by the Indian Statistical Institute, Kolkata and Central Forensic Science Laboratory, Kolkata. CFSL provided the lab infracture and other materials required for the laboratory analysis of the samples. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Bhasin MK., 2001, GENETICS CASTES TRIB; BHATTACHARJEE PN, 1954, B DEPT ANTHR, V3, P51; BLACKBURN S, 2003, EUROPEAN B HIMALAYAN, V2526, P15; Chakrabarti CS, 2002, ANN HUM GENET, V66, P361, DOI 10.1017/S000348000200132X; CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; CHAKRABORTY R, 1998, DNATYPE WINDOWS 95 N; Chattopadhyay P, 2001, J FORENSIC SCI, V46, P184; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Dani A.H., 1960, PREHISTORY PROTOHIST; DAS B M, 1980, Journal of the Indian Anthropological Society, V15, P153; De Ungria MCA, 2005, FORENSIC SCI INT, V152, P281, DOI 10.1016/j.forsciint.2004.09.125; DEKA R, 1988, HUM HERED, V38, P261, DOI 10.1159/000153796; *DEP PLANN GOV AR, 2006, AR PRAD HUM DEV REP; Dobashi Yuji, 2005, Legal Medicine, V7, P222, DOI 10.1016/j.legalmed.2005.04.001; Dutta R, 2002, HUM BIOL, V74, P33, DOI 10.1353/hub.2002.0002; Elwin Verrier, 1959, PHILOS NEFA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gadgil M, 1997, INDIAN HUMAN HERITAG; Gao YZ, 2005, FORENSIC SCI INT, V154, P78, DOI 10.1016/j.forsciint.2004.09.117; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hu SP, 2005, FORENSIC SCI INT, V152, P263, DOI 10.1016/j.forsciint.2004.09.119; Izuan M, 2005, J FORENSIC SCI, V50, P1225; JIAN T, 2006, J FORENSIC SCI, V51, P188; Kang LL, 2005, FORENSIC SCI INT, V155, P219, DOI 10.1016/j.forsciint.2004.12.022; Kang LL, 2007, FORENSIC SCI INT, V168, P236, DOI 10.1016/j.forsciint.2006.02.041; Kashyap VK, 2004, AM J HUM BIOL, V16, P311, DOI 10.1002/ajhb.20026; Kashyap VK, 2002, J FORENSIC SCI, V47, P1163; Kim YL, 2003, FORENSIC SCI INT, V136, P92, DOI 10.1016/S0379-0738(03)00255-X; KOLEY RN, 2007, PANGGIS IN PRESS; Kraaijenbrink T, 2007, FORENSIC SCI INT, V168, P227, DOI 10.1016/j.forsciint.2006.02.014; Kraaijenbrink T, 2007, FORENSIC SCI INT, V170, P68, DOI 10.1016/j.forsciint.2006.04.006; Krithika S, 2007, HUM BIOL, V79, P355, DOI 10.1353/hub.2007.0043; Krithika S, 2006, HUM BIOL, V78, P221, DOI 10.1353/hub.2006.0035; Krithika S., 2005, Legal Medicine, V7, P306, DOI 10.1016/j.legalmed.2005.04.002; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Krithika S., 2007, Legal Medicine, V9, P210, DOI 10.1016/j.legalmed.2007.01.002; Krithika S, 2007, J FORENSIC SCI, V52, P239, DOI 10.1111/j.1556-4029.2006.00347.x; KUMAR N, 1954, B DEP ANTHROP GOVT I, V3, P55; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumar V, 2004, AM J HUM BIOL, V16, P334, DOI 10.1002/ajhb.20027; Langstieh BT, 2004, HUM BIOL, V76, P569, DOI 10.1353/hub.2004.0057; LEGO N, 2005, HIST ADIS ARUNACHAL; LI KL, 2007, FORENSIC SCI INT, V169, P239; Maity B, 2003, FORENSIC SCI INT, V132, P216, DOI 10.1016/S0379-0738(02)00436-X; Maji S, 2007, HUM BIOL, V79, P321, DOI 10.1353/hub.2007.0044; Majumdar D. N., 1980, E HIMALAYAS STUDY AN; MALHOTRA KC, 1993, HUMAN POPULATION GENETICS, P207; Mastana SS, 2007, FORENSIC SCI INT, V169, P266, DOI 10.1016/j.forsciint.2006.03.019; NATH J, 2000, CULTURAL HERITAGE TR, V1; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Ota M, 2007, FORENSIC SCI INT, V169, P234, DOI 10.1016/j.forsciint.2006.03.010; Ota T, 1993, DISPAN GENETIC DISTA; Pritchard JK, 2000, GENETICS, V155, P945; RAPSON EJ, 1955, CAMBRIDGE HIST INDIA, V1, P33; Rerkamnuaychoke B, 2006, FORENSIC SCI INT, V158, P234, DOI 10.1016/j.forsciint.2005.05.020; ROYCHOUDHURY A K, 1981, Journal of the Indian Anthropological Society, V16, P153; ROYCHOUDHURY AK, 1992, ANN HUM BIOL, V19, P489, DOI 10.1080/03014469200002322; ROYCHOUDHURY AK, 1997, J INDIAN ANTHR SOC, V32, P1; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Sachin ROY, 1997, ASPECTS PADAM MINYON; Shimada I, 2002, INT J LEGAL MED, V116, P246, DOI 10.1007/s00414-002-0313-z; SINGH KS, 1998, PEOPLE INDIA INDIAS, V1; Tabi T, 2006, ADIS; Takezaki N, 1996, GENETICS, V144, P389; Tie J, 2006, J FORENSIC SCI, V51, P188, DOI 10.1111/j.1556-4029.2005.00037.x; Trivedi R, 2002, FORENSIC SCI INT, V127, P150; WALTER H, 1986, HUM HERED, V36, P388, DOI 10.1159/000153663; Wang CW, 2003, FORENSIC SCI INT, V138, P119, DOI 10.1016/j.forsciint.2003.09.006; Wang ZY, 2005, FORENSIC SCI INT, V147, P89, DOI 10.1016/j.forsciint.2004.04.008; Yan JW, 2007, FORENSIC SCI INT, V169, pE3, DOI 10.1016/j.forsciint.2007.02.008; Yang BQ, 2005, FORENSIC SCI INT, V151, P293, DOI 10.1016/j.forsciint.2005.02.001; Yong RYY, 2004, FORENSIC SCI INT, V141, P175, DOI 10.1016/j.forsciint.2004.01.004; Zeng Zhao Shu, 2007, Legal Medicine, V9, P30, DOI 10.1016/j.legalmed.2006.08.002; Zhang HJ, 2007, FORENSIC SCI INT, V171, P222, DOI 10.1016/j.forsciint.2006.05.039	78	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2549	10.1371/journal.pone.0002549	http://dx.doi.org/10.1371/journal.pone.0002549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596928	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200018
J	Jirasko, V; Montserret, R; Appel, N; Janvier, A; Eustachi, L; Brohm, C; Steinmann, E; Pietschmann, T; Penin, F; Bartenschlager, R				Jirasko, Vlastimil; Montserret, Roland; Appel, Nicole; Janvier, Anne; Eustachi, Leah; Brohm, Christiane; Steinmann, Eike; Pietschmann, Thomas; Penin, Francois; Bartenschlager, Ralf			Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; NS2 PROTEIN; P7; REPLICATION; EXPRESSION; PREDICTION; STABILITY; TOPOLOGY; IDENTIFICATION; DETERMINANT	The hepatitis C virus (HCV) is a flavivirus replicating in the cytoplasm of infected cells. The HCV genome is a single-stranded RNA encoding a polyprotein that is cleaved by cellular and viral proteases into 10 different products. While the structural proteins core protein, envelope protein 1 (E1) and E2 build up the virus particle, most nonstructural (NS) proteins are required for RNA replication. One of the least studied proteins is NS2, which is composed of a C-terminal cytosolic protease domain and a highly hydrophobic N-terminal domain. It is assumed that the latter is composed of three trans-membrane segments (TMS) that tightly attach NS2 to intracellular membranes. Taking advantage of a system to study HCV assembly in a hepatoma cell line, in this study we performed a detailed characterization of NS2 with respect to its role for virus particle assembly. In agreement with an earlier report (Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J., and Rice, C. M. (2007) J. Virol. 81, 8374-8383), we demonstrate that the protease domain, but not its enzymatic activity, is required for infectious virus production. We also show that serine residue 168 in NS2, implicated in the phosphorylation and stability of this protein, is dispensable for virion formation. In addition, we determined the NMR structure of the first TMS of NS2 and show that the N-terminal segment (amino acids 3-11) forms a putative flexible helical element connected to a stable alpha-helix (amino acids 12-21) that includes an absolutely conserved helix side in genotype 1b. By using this structure as well as the amino acid conservation as a guide for a functional study, we determined the contribution of individual amino acid residues in TMS1 for HCV assembly. We identified several residues that are critical for virion formation, most notably a central glycine residue at position 10 of TMS1. Finally, we demonstrate that mutations in NS2 blocking HCV assembly can be rescued by trans-complementation.	[Jirasko, Vlastimil; Appel, Nicole; Eustachi, Leah; Brohm, Christiane; Steinmann, Eike; Pietschmann, Thomas; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany; [Montserret, Roland; Janvier, Anne; Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,BioSci Gerland Lyon Sud IFR, F-69367 Lyon 07, France	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf.bartenschlager@med.uni-heidelberg.de	Pietschmann, Thomas/E-9241-2015; Bartenschlager, Ralf/L-2582-2015	Pietschmann, Thomas/0000-0001-5138-6239; Bartenschlager, Ralf/0000-0001-5601-9307; Steinmann, Eike/0000-0002-3654-9965; Jirasko, Vlastimil/0000-0003-1561-1499	Ministry of Science, Research, and the Arts of Baden-Wurrttemberg [Az 23-7532.24-22-21-12/1]; German Research Council [BA 1505/2-1]; CNRS; Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales	Ministry of Science, Research, and the Arts of Baden-Wurrttemberg; German Research Council(German Research Foundation (DFG)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported by the Bioquant Ph. D. program, Ministry of Science, Research, and the Arts of Baden-Wurrttemberg Grant Az 23-7532.24-22-21-12/1 (to R. B. and T. P.), German Research Council Grants BA 1505/2-1 (to N. A. and R. B.), SFB 638, Teilprojekt A5 ( to R. B.), and grants from the CNRS ( to F. P.) and the Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (to F. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Behrens SE, 1998, J VIROL, V72, P2364, DOI 10.1128/JVI.72.3.2364-2372.1998; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang DR, 2005, J VIROL METHODS, V129, P170, DOI 10.1016/j.jviromet.2005.05.026; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kiiver K, 2006, VIRUS RES, V117, P264, DOI 10.1016/j.virusres.2005.10.021; Kim KM, 2007, BIOCHEM BIOPH RES CO, V356, P948, DOI 10.1016/j.bbrc.2007.03.070; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; MIZUSHIMA H, 1994, J VIROL, V68, P2731, DOI 10.1128/JVI.68.4.2731-2734.1994; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Opella SJ, 1997, NAT STRUCT BIOL, V4, P845; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; ROST B, 1995, PROTEIN SCI, V4, P521; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VANDENHOFF MJB, 1990, NUCLEIC ACIDS RES, V18, P6464, DOI 10.1093/nar/18.21.6464; VANREGENMORTEL MHV, 2000, VIRUS TAXONOMY 7 REP, P872; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	69	121	128	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28546	28562		10.1074/jbc.M803981200	http://dx.doi.org/10.1074/jbc.M803981200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18644781	Green Published, hybrid			2022-12-25	WOS:000259969300058
J	Brunk, I; Blex, C; Sanchis-Segura, C; Sternberg, J; Perreau-Lenz, S; Bilbao, A; Hortnagl, H; Baron, J; Juranek, J; Laube, G; Birnbaumer, L; Spanagel, R; Ahnert-Hilger, G				Brunk, Irene; Blex, Christian; Sanchis-Segura, Carles; Sternberg, Jan; Perreau-Lenz, Stephanie; Bilbao, Ainhoa; Hoertnagl, Heide; Baron, Jens; Juranek, Judyta; Laube, Gregor; Birnbaumer, Lutz; Spanagel, Rainer; Ahnert-Hilger, Gudrun			Deletion of Go2 alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system	FASEB JOURNAL			English	Article						vesicular regulation; VMAT2; locomotor activity; psychostimulants	VESICULAR MONOAMINE; PROTEIN; REWARD; VMAT2; MICE; TRANSPORTERS; EXPRESSION; LOCOMOTION; RESPONSES; KNOCKOUT	The alpha-subunits of the trimeric Go class of GTPases, comprising the splice variants Go1 alpha and Go2 alpha, are abundantly expressed in brain and reside on both plasma membrane and synaptic vesicles. Go2 alpha is involved in the vesicular storage of monoamines but its physiological relevance is still obscure. We now show that genetic depletion of Go2 alpha reduces motor activity induced by dopamine-enhancing drugs like cocaine, as repeated injections of cocaine fail to provoke behavioral sensitization in Go2 alpha(-/-) mice. In Go2 alpha(-/-) mice, D1 receptor signaling in the striatum is attenuated due to a reduced expression of Golf alpha and Gs alpha. Following cocaine treatment, Go2 alpha(-/-) mice have lower D1 and higher D2 receptor amounts compared to wild-type mice. The lack of behavioral sensitization correlates with reduced dopamine levels in the striatum and decreased expression of tyrosine hydroxylase. One reason for the neurochemical changes may be a reduced uptake of monoamines by synaptic vesicles from Go2 alpha(-/-) mice as a consequence of a lowered set point for filling. We conclude that Go2 alpha optimizes vesicular filling which is instrumental for normal dopamine functioning and for the development of drug-induced behavioral sensitization.	[Sanchis-Segura, Carles; Perreau-Lenz, Stephanie; Bilbao, Ainhoa; Spanagel, Rainer] Cent Inst Mental Hlth, Dept Psychopharmacol, D-68159 Mannheim, Germany; [Brunk, Irene; Blex, Christian; Sternberg, Jan; Baron, Jens; Juranek, Judyta; Laube, Gregor; Ahnert-Hilger, Gudrun] Charite, Ctr Anat, Inst Integrat Neuroanat, Berlin, Germany; [Sanchis-Segura, Carles; Perreau-Lenz, Stephanie; Bilbao, Ainhoa; Spanagel, Rainer] Charite, Inst Pharmacol, Berlin, Germany; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA	Central Institute of Mental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Spanagel, R (corresponding author), Cent Inst Mental Hlth, Dept Psychopharmacol, J5, D-68159 Mannheim, Germany.	gudrun.ahnert@charite.de; rainer.spanagel@zi-mannheim.de	s, c/Y-9655-2019; Perreau-Lenz, Stephanie/D-2309-2014; Juranek, Judyta/AAH-6473-2020; Juranek, Judyta K/I-1120-2013; Baron, Jens M/N-2934-2016; Sanchis-Segura, Carla/C-5222-2012; Bilbao, Ainhoa/AAW-6230-2020	s, c/0000-0002-6951-5972; Perreau-Lenz, Stephanie/0000-0001-9529-6403; Juranek, Judyta/0000-0001-8665-6606; Baron, Jens M/0000-0002-1174-6946; Sanchis-Segura, Carla/0000-0002-6951-5972; Brunk, Irene/0000-0002-2668-7002; Blex, Christian/0000-0002-8493-3523	Deutsche Forshungsgemeinschaft [AH 67/3-3]; Forschungsforderung der Charite; German Federal Ministry of Education and Research (BMBF; Nationales Genomforschungsnetz); Intramural Research Program of the National Institutes of Health [Z01ES01643]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101643, ZIGES101643] Funding Source: NIH RePORTER	Deutsche Forshungsgemeinschaft(German Research Foundation (DFG)); Forschungsforderung der Charite; German Federal Ministry of Education and Research (BMBF; Nationales Genomforschungsnetz)(Federal Ministry of Education & Research (BMBF)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Deutsche Forshungsgemeinschaft (AH 67/3-3), the Forschungsforderung der Charite to G.A.H., by the German Federal Ministry of Education and Research (BMBF; Nationales Genomforschungsnetz) to R.S., and by the Intramural Research Program of the National Institutes of Health to L.B. (Z01ES01643). Technical assistance of Marion Mobes and Birgit Metze (both Charite) is gratefully acknowledged.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; BARDO MT, 1995, NEUROSCI BIOBEHAV R, V19, P39, DOI 10.1016/0149-7634(94)00021-R; Becher A, 1999, J NEUROSCI, V19, P1922; Brunk I, 2006, HANDB EXP PHARM, V175, P305; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Corvol JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1109, DOI 10.1038/sj.npp.1301230; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Frank ST, 2008, SYNAPSE, V62, P243, DOI 10.1002/syn.20489; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; GERMAN DC, 1981, BRAIN RES BULL, V6, P131, DOI 10.1016/S0361-9230(81)80037-8; Holtje M, 2000, J NEUROSCI, V20, P2131; HORTNAGL H, 1993, J NEUROSCI, V13, P2939; Hummel M, 2002, J CELL PHYSIOL, V191, P17, DOI 10.1002/jcp.10078; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; LEOPOLDT D, 1997, N-S ARCH PHARMACOL, V356, P116; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Pahner I, 2003, MOL CELL NEUROSCI, V23, P398, DOI 10.1016/S1044-7431(03)00059-9; Pothos EN, 2000, J NEUROSCI, V20, P7297; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Uhl GR, 2000, FASEB J, V14, P2459, DOI 10.1096/fj.00-0205rev; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; Winter S, 2005, J NEUROSCI, V25, P4672, DOI 10.1523/JNEUROSCI.0549-05.2005; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	35	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3736	3746		10.1096/fj.08-111245	http://dx.doi.org/10.1096/fj.08-111245			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606864	Green Published			2022-12-25	WOS:000259642600034
J	Dobrosi, N; Toth, BI; Nagy, G; Dozsa, A; Geczy, T; Nagy, L; Zouboulis, CC; Paus, R; Kovacs, L; Biro, T				Dobrosi, Nora; Toth, Balazs I.; Nagy, Georgina; Dozsa, Aniko; Geczy, Tamas; Nagy, Laszlo; Zouboulis, Christos C.; Paus, Ralf; Kovacs, Laszlo; Biro, Tamas			Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling	FASEB JOURNAL			English	Article						cannabinoid receptor subtypes; human sebaceous gland-derived SZ95 sebocytes; acne vulgaris; signal transduction; peroxisome proliferator-activated receptor; gene expression	PROLIFERATOR-ACTIVATED RECEPTOR; PROTEIN-KINASE-C; SEBACEOUS GLAND; PPAR-GAMMA; ENDOGENOUS CANNABINOIDS; PROSTAGLANDIN E-2; SYSTEM; CB2; ANANDAMIDE; DIFFERENTIATION	We had previously shown that both locally produced endocannabinoids and exocannabinoids, via cannabinoid receptor-1 (CBI), are powerful inhibitors of human hair growth. To further investigate the role of the cannabinoid system in pilosebaceous unit biology, we have explored in the current study whether and how endocannabinoids have an impact on human sebaceous gland biology, using human SZ95 sebocytes as cell culture model. Here, we provide the first evidence that SZ95 sebocytes express CB2 but not CBI. Also, prototypic endocannabinoids (arachidonoyl ethanolamide/anandamide, 2-arachidonoyl glycerol) are present in SZ95 sebocytes and dose-dependently induce lipid production and (chiefly apoptosis-driven) cell death. Endocannabinoids also up-regulate the expression of key genes involved in lipid synthesis (e.g., PPAR transcription factors and some of their target genes). These actions are selectively mediated by CB2-coupled signaling involving the MAPK pathway, as revealed by specific agonists/antagonists and by RNA interference. Because cells with "silenced" CB2 exhibited significantly suppressed basal lipid production, our results collectively suggest that human sebocytes utilize a paracrine-autocrine, endogenously active, CB2-mediated endocannabinoid signaling system for positively regulating lipid production and cell death. CB2 antagonists or agonists therefore deserve to be explored in the management of skin disorders characterized by sebaceous gland dysfunctions (e.g., acne vulgaris, seborrhea, dry skin).	[Dobrosi, Nora; Toth, Balazs I.; Geczy, Tamas; Kovacs, Laszlo; Biro, Tamas] Univ Debrecen, Dept Physiol, Med & Hlth Sci Ctr, Res Ctr Mol Med, H-4032 Debrecen, Hungary; [Nagy, Georgina] Univ Debrecen, Dept Dermatol, Med & Hlth Sci Ctr, Res Ctr Mol Med, H-4032 Debrecen, Hungary; [Dozsa, Aniko; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, Res Ctr Mol Med, H-4032 Debrecen, Hungary; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, Dessau, Germany; [Zouboulis, Christos C.] Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Charite, Lab Biogerontol Dermatopharmacol & Dermatoendocri, Berlin, Germany; [Paus, Ralf] Med Univ Lubeck, Univ Hosp Schleswig Holstein, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester M13 9PL, Lancs, England	University of Debrecen; University of Debrecen; University of Debrecen; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Manchester	Biro, T (corresponding author), Univ Debrecen, Dept Physiol, Med & Hlth Sci Ctr, Res Ctr Mol Med, Nagyerdei Krt 98,POB 22, H-4032 Debrecen, Hungary.	biro@phys.dote.hu	Paus, Ralf/F-6243-2011; Zouboulis, Christos C./I-4493-2013; Tóth, Balázs István/K-1214-2013; Nagy, Laszlo/A-3814-2008	Zouboulis, Christos C./0000-0003-1646-2608; Tóth, Balázs István/0000-0002-4103-4333; Nagy, Laszlo/0000-0001-6653-2155; Geczy, Tamas/0000-0002-8199-8831	Hungarian research [OTKA T049231, OTKA K063153, ETT 480/2006, ETT 482/2006, RET 06/2004]; DFG [Pa 345/11-2]; European Academy of Dermatology, and Venereology (EADV) European Dermatology Research Award; Janos Bolyai scholarship of the Hungarian Academy of Sciences	Hungarian research(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); DFG(German Research Foundation (DFG)); European Academy of Dermatology, and Venereology (EADV) European Dermatology Research Award; Janos Bolyai scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported in part, by Hungarian research grants (OTKA T049231, OTKA K063153, ETT 480/2006, ETT 482/2006, RET 06/2004) to T.B., by a DFG grant (Pa 345/11-2) to R.P., and by the European Academy of Dermatology, and Venereology (EADV) European Dermatology Research Award to C.C.Z. The authors declare no competing financial interests. T.B. is a recipient of the Janos Bolyai scholarship of the Hungarian Academy of Sciences.	Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; Bodo E, 2004, J INVEST DERMATOL, V123, P410, DOI 10.1111/j.0022-202X.2004.23209.x; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen WC, 2003, J INVEST DERMATOL, V121, P441, DOI 10.1046/j.1523-1747.2003.12411.x; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Ganceviciene R, 2007, EXP DERMATOL, V16, P547, DOI 10.1111/j.1600-0625.2007.00565.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griger Z, 2007, J MOL MED-JMM, V85, P1031, DOI 10.1007/s00109-007-0209-y; Huffman JW, 2000, CURR PHARM DESIGN, V6, P1323, DOI 10.2174/1381612003399347; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lenman A, 2007, BRIT J PHARMACOL, V151, P1343, DOI 10.1038/sj.bjp.0707352; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Maccarrone M, 2000, FEBS LETT, V468, P176, DOI 10.1016/S0014-5793(00)01223-0; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Maldonado R, 2002, J NEUROSCI, V22, P3326; Matias I, 2008, NEUROPHARMACOLOGY, V54, P206, DOI 10.1016/j.neuropharm.2007.06.011; Nong L, 2001, ADV EXP MED BIOL, V493, P229; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Papp H, 2004, CELL MOL LIFE SCI, V61, P1095, DOI 10.1007/s00018-004-4014-2; Paradisi A, 2008, J BIOL CHEM, V283, P6005, DOI 10.1074/jbc.M707964200; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Rajesh M, 2008, BRIT J PHARMACOL, V153, P347, DOI 10.1038/sj.bjp.0707569; Shappell SB, 2001, CANCER RES, V61, P497; Sharkey KA, 2007, EUR J NEUROSCI, V25, P2773, DOI 10.1111/j.1460-9568.2007.05521.x; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; Toth BI, 2005, J INVEST DERMATOL, V124, pA68; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; Trivedi NR, 2006, J INVEST DERMATOL, V126, P2002, DOI 10.1038/sj.jid.5700336; Vellani V, 2008, NEUROPHARMACOLOGY, V55, P1274, DOI 10.1016/j.neuropharm.2008.01.010; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wagner JA, 2005, J CARDIOVASC PHARM, V46, P348, DOI 10.1097/01.fjc.0000175437.87283.f2; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486; Wrobel A, 2003, J INVEST DERMATOL, V120, P175, DOI 10.1046/j.1523-1747.2003.12029.x; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang QW, 2006, J INVEST DERMATOL, V126, P42, DOI 10.1038/sj.jid.5700028; Zouboulis CC, 2005, EXP DERMATOL, V14, P144, DOI 10.1111/j.0906-6705.2005.0285c.x; Zouboulis CC, 2004, EXP DERMATOL, V13, P31, DOI 10.1111/j.1600-0625.2004.00254.x; Zouboulis CC, 2003, J INVEST DERMATOL, V120, pXIV, DOI 10.1046/j.1523-1747.2003.12263.x; Zouboulis CC, 2002, P NATL ACAD SCI USA, V99, P7148, DOI 10.1073/pnas.102180999; Zouboulis CC, 1998, DERMATOLOGY, V196, P21, DOI 10.1159/000017861; Zouboulis CC, 1999, J INVEST DERMATOL, V113, P1011, DOI 10.1046/j.1523-1747.1999.00771.x	63	100	103	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3685	3695		10.1096/fj.07-104877	http://dx.doi.org/10.1096/fj.07-104877			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18596221				2022-12-25	WOS:000259642600029
J	Fan, XJ; Krieg, S; Kuo, CJ; Wiegand, SJ; Rabinovitch, M; Druzin, ML; Brenner, RM; Giudice, LC; Nayak, NR				Fan, Xiujun; Krieg, Sacha; Kuo, Calvin J.; Wiegand, Stanley J.; Rabinovitch, Marlene; Druzin, Maurice L.; Brenner, Robert M.; Giudice, Linda C.; Nayak, Nihar R.			VEGF blockade inhibits angiogenesis and reepithelialization of endometrium	FASEB JOURNAL			English	Article						VEGF Trap; luminal epithelium; rhesus macaque; mouse; hypoxia	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTORS; FACTOR EXPRESSION; STROMAL CELLS; MOUSE UTERUS; NEUROPILIN-1; PROLIFERATION; LOCALIZATION; RECEPTORS; ACID	Despite extensive literature on vascular endothelial growth factor (VEGF) expression and regulation by steroid hormones, the lack of clear understanding of the mechanisms of angiogenesis in the endometrium is a major limitation for use of antiangiogenic therapy targeting endometrial vessels. In the current work, we used the rhesus macaque as a primate model and the decidualized mouse uterus as a murine model to examine angiogenesis during endometrial breakdown and regeneration. We found that blockade of VEGF action with VEGF Trap, a potent VEGF blocker, completely inhibited neovascularization during endometrial regeneration in both models but had no marked effect on preexisting or newly formed vessels, suggesting that VEGF is essential for neoangiogenesis but not survival of mature vessels in this vascular bed. Blockade of VEGF also blocked reepithelialization in both the postmenstrual endometrium and the mouse uterus after decidual breakdown, evidence that VEGF has pleiotropic effects in the endometrium. In vitro studies with a scratch wound assay showed that the migration of luminal epithelial cells during repair involved signaling through VEGF receptor 2-neuropilin 1 (VEGFR2-NP1) receptors on endometrial stromal cells. The leading front of tissue growth during endometrial repair was strongly hypoxic, and this hypoxia was the local stimulus for VEGF expression and angiogenesis in this tissue. In summary, we provide novel experimental data indicating that VEGF is essential for endometrial neoangiogenesis during postmenstrual/postpartum repair.	[Fan, Xiujun; Krieg, Sacha; Druzin, Maurice L.; Nayak, Nihar R.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Kuo, Calvin J.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Rabinovitch, Marlene] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Wiegand, Stanley J.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Brenner, Robert M.] Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Giudice, Linda C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; Regeneron; Oregon Health & Science University; Oregon National Primate Research Center; University of California System; University of California San Francisco	Nayak, NR (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, 300 Pasteur Dr,HH-333, Stanford, CA 94305 USA.	nayakn@stanford.edu		Druzin, Maurice/0000-0001-7185-6664; Kuo, Calvin/0000-0002-7427-5985	Andrew Mellon Foundation; U.S. National Institutes of Health (NIH); NIH [1U54HD055769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764] Funding Source: NIH RePORTER	Andrew Mellon Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Andrew Mellon Foundation, the U.S. National Institutes of Health (NIH) Building Interdisciplinary Research Careers in Women's Health, the Children Health Initiative at Stanford to N.R.N., and NIH Specialized Cooperative Centers Program in Reproduction (SCCPR) 1U54HD055769. We thank Sabita Dhal (Stanford University, Stanford, CA, USA), Kunie Mall (Oregon National Primate Research Center, Beaverton, OR, USA), and Kim Chi Vo (University of California, San Francisco, CA, USA) for technical assistance. S.J.W. is an employee of Regeneron Pharmaceuticals, holds an equity position in the company, anti is an inventor on several patents related to the VEGF Trap.	Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; FERENCZY A, 1979, AM J OBSTET GYNECOL, V133, P859, DOI 10.1016/0002-9378(79)90302-8; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Franck-Lissbrant I, 1998, ENDOCRINOLOGY, V139, P451, DOI 10.1210/en.139.2.451; Germeyer A, 2005, J CLIN ENDOCR METAB, V90, P1783, DOI 10.1210/jc.2004-1769; Girling Jane E., 2005, Angiogenesis, V8, P89, DOI 10.1007/s10456-005-9006-9; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hastings JM, 2003, ENDOCRINOLOGY, V144, P326, DOI 10.1210/en.2002-220641; Heryanto B, 2003, REPRODUCTION, V125, P337, DOI 10.1530/reprod/125.3.337; HESS AP, 2005, KNOBIL NEILLS PHYSL, V1, P337; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Lathi RB, 2005, J CLIN ENDOCR METAB, V90, P1599, DOI 10.1210/jc.2004-1676; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Nayak NR, 2005, MOL HUM REPROD, V11, P791, DOI 10.1093/molehr/gah237; Nayak NR, 2002, J CLIN ENDOCR METAB, V87, P1845, DOI 10.1210/jc.87.4.1845; Popovici RM, 1999, J CLIN ENDOCR METAB, V84, P2245, DOI 10.1210/jc.84.6.2245; Rak J, 1996, EUR J CANCER, V32A, P2438, DOI 10.1016/S0959-8049(96)00396-6; Raleigh JA, 1998, CANCER RES, V58, P3765; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Sharkey AM, 2000, J CLIN ENDOCR METAB, V85, P402, DOI 10.1210/jc.85.1.402; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith SK, 2001, TRENDS ENDOCRIN MET, V12, P147, DOI 10.1016/S1043-2760(01)00379-4; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Zhang J, 2002, HUM REPROD, V17, P265, DOI 10.1093/humrep/17.2.265	35	144	151	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3571	3580		10.1096/fj.08-111401	http://dx.doi.org/10.1096/fj.08-111401			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606863	Green Published			2022-12-25	WOS:000259642600019
J	Mazan-Mamczarz, K; Hagner, PR; Corl, S; Srikantan, S; Wood, WH; Becker, KG; Gorospe, M; Keene, JD; Levenson, AS; Gartenhaus, RB				Mazan-Mamczarz, K.; Hagner, P. R.; Corl, S.; Srikantan, S.; Wood, W. H.; Becker, K. G.; Gorospe, M.; Keene, J. D.; Levenson, A. S.; Gartenhaus, R. B.			Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype	ONCOGENE			English	Article						post-transcriptional operon; MCT-1 oncogene; TSP1; HuR; RNA-binding protein; tumor angiogenesis	BINDING PROTEIN HUR; RNA-STABILITY FACTOR; MESSENGER-RNA; RIBONUCLEOPROTEIN COMPLEXES; TRANSLATIONAL REPRESSION; EXPRESSION; RICH; REGION; STABILIZATION; TRANSLOCATION	In a breast tumor xenograft model, the MCT-1 oncogene increases the in vivo tumorgenicity of MCF7 cells by promoting angiogenesis and inhibiting apoptosis. Increases in the tumor microvascular density are accompanied by a strong reduction in the levels of the angiogenesis inhibitor thrombospondin-1 (TSP1), but the mechanisms underlying this process are unknown. We show that TSP1 expression is controlled, at least in part, by post-transcriptional events. Using RNA interference to knock down the expression of the RNA-binding protein HuR in MCF7 cells as well as HuR overexpression, we demonstrate that HuR plays an important role in translation of the TSP1 mRNA. Furthermore, employing the RIP-Chip assay yielded 595 transcripts with significantly altered binding to HuR in the more tumorigenic breast cancer clones compared with the weakly tumorigenic clones. These mRNAs clustered in several pathways implicated in the transformed phenotype, such as the RAS pathway (involved in mitogenesis), the PI3K pathway (evasion of apoptosis) and pathways mediating angiogenesis and the cellular response to hypoxia. These findings demonstrate for the first time that global changes in HuR-bound mRNAs are implicated in the evolution to a more tumorigenic phenotype in an in vivo tumor model and underscore the role of global mRNA-protein interactions toward tumor progression.	[Mazan-Mamczarz, K.; Hagner, P. R.; Corl, S.; Gartenhaus, R. B.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Srikantan, S.; Gorospe, M.] NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; [Wood, W. H.; Becker, K. G.] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Keene, J. D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Levenson, A. S.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Levenson, A. S.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Gartenhaus, RB (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, 9-011 BRB,655 W Baltimore St,22 S Greene St, Baltimore, MD 21201 USA.	rgartenhaus@som.umaryland.edu	, Jack/L-6806-2019	srikantan, subramanya/0000-0003-1810-6519; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging Intramural Research Program; NIH; NATIONAL INSTITUTE ON AGING [Z01AG000392, ZICAG000616, Z01AG000511, ZIAAG000511, Z01AG000616, ZIAAG000392] Funding Source: NIH RePORTER	National Institute on Aging Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr Y Zhang for assistance with the statistical analysis of the RIP-Chip array data and Dr J Hasday for technical support. A Merit Review Award from the Department of Veterans Affairs to RBG supported this work. MG and SS were supported by the National Institute on Aging Intramural Research Program, NIH.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; AGHIB DF, 1990, ONCOGENE, V5, P707; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; De Silanes IL, 2004, GENE EXPRESSION, V12, P49, DOI 10.3727/000000004783992215; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOLLIS GF, 1988, MOL CELL BIOL, V8, P124, DOI 10.1128/MCB.8.1.124; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Levenson AS, 2005, CANCER RES, V65, P10651, DOI 10.1158/0008-5472.CAN-05-0845; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Nabors LB, 2001, CANCER RES, V61, P2154; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Prosniak M, 1998, CANCER RES, V58, P4233; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Sheflin LG, 2004, BIOCHEM BIOPH RES CO, V322, P644, DOI 10.1016/j.bbrc.2004.07.173; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; WANG RK, 2000, P SOC PHOTO-OPT INS, V1, P12; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209	49	98	102	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6151	6163		10.1038/onc.2008.215	http://dx.doi.org/10.1038/onc.2008.215			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18641687	Green Accepted			2022-12-25	WOS:000260083100008
J	Okada, S; Misaka, T; Tanaka, Y; Matsumoto, I; Ishibashi, K; Sasaki, S; Abe, K				Okada, Shinji; Misaka, Takumi; Tanaka, Yasuko; Matsumoto, Ichiro; Ishibashi, Kenichi; Sasaki, Sei; Abe, Keiko			Aquaporin-11 knockout mice and polycystic kidney disease animals share a common mechanism of cyst formation	FASEB JOURNAL			English	Article						subcellular aquaporin; DNA microarray; histochemical analysis; ER stress	ENDOPLASMIC-RETICULUM STRESS; EPIDERMAL GROWTH-FACTOR; RENAL EPITHELIAL-CELLS; PRIMARY CILIA; AUTOSOMAL-DOMINANT; DOMAIN PROTEIN; SUBCELLULAR-LOCALIZATION; RETINAL DEGENERATION; EXTRACELLULAR-MATRIX; MESSENGER-RNA	Aquaporin-11 (AQP11), a new member of the aquaporin family, is localized in the endoplasmic reticulum (ER). Aqp11(-/-) mice neonatally suffer from polycystic kidneys derived from the proximal tubule. Its onset is proceeded by the vacuolization of ER. However, the mechanism for the formation of vacuoles and cysts remains to be clarified. Here, we show that Aqp11(-/-) mice and polycystic kidney disease (PKD) animals share a common pathogenic mechanism of cyst formation. We performed microarray analyses and histochemical staining to characterize the effects of the disruption of Aqp11 on kidneys of 1-wk-old mice. Microarray analyses revealed that the significantly changed functional categories in Aqp11(-/-) mice were similar to those in PKD animals. Histochemical studies showed expression changes of 3 genes, Myc, Egfr, Egf, which are assumed to be involved in the proliferation of cystic cells in PKD. We actually confirmed the activation of cell proliferation in the proximal tubule cells with vacuolized ER. Furthermore, three genes associated with the remodeling of the extracellular matrix, Mmp12, Timp1, Tgfb1, were up-regulated in the fibroblasts. We also demonstrated the activation of apoptosis via the ER-stress pathway in the proximal tubule cells with vacuolized ER. These results provide new insights into the physiological roles of AQP11.	[Okada, Shinji; Misaka, Takumi; Matsumoto, Ichiro; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Tanaka, Yasuko; Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan; [Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo, Japan	University of Tokyo; Meiji Pharmaceutical University; Tokyo Medical & Dental University (TMDU)	Abe, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aka7308@mail.ecc.u-tokyo.ac.jp	OKADA, Shinji/AFS-7710-2022	OKADA, Shinji/0000-0002-4465-9961; Misaka, Takumi/0000-0002-9547-5767	Ministry of, Education, Culture. Sports, Science and Technology [161080044, 17780099]; Salt Science Research Foundation [0745]	Ministry of, Education, Culture. Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation	The work was partly supported by grants-in-aid 161080044 (to K.A.) and 17780099 (to S.O.) from the Ministry of, Education, Culture. Sports, Science and Technology, and 0745 (to S.O.) from the Salt Science Research Foundation.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisceglia M, 2006, ADV ANAT PATHOL, V13, P26, DOI 10.1097/01.pap.0000201831.77472.d3; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cowley BD, 1995, J AM SOC NEPHROL, V6, P1679; COWLEY BD, 1987, P NATL ACAD SCI USA, V84, P8394, DOI 10.1073/pnas.84.23.8394; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Gattone VH, 2002, KIDNEY INT, V62, P1560, DOI 10.1046/j.1523-1755.2002.00632.x; Gorelick Daniel A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-14; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ishibashi K, 2006, CELL MOL BIOL, V52, P20, DOI 10.1170/T745; Ishibashi K, 2006, BBA-BIOMEMBRANES, V1758, P989, DOI 10.1016/j.bbamem.2006.02.024; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lee DCW, 1998, J UROLOGY, V159, P291, DOI 10.1016/S0022-5347(01)64084-9; Lee JE, 2004, J BIOCHEM MOL BIOL, V37, P612; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Obermuller N, 2001, AM J PHYSIOL-RENAL, V280, pF540, DOI 10.1152/ajprenal.2001.280.3.F540; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parker E, 2007, KIDNEY INT, V72, P157, DOI 10.1038/sj.ki.5002229; Ramasubbu K, 1998, J AM SOC NEPHROL, V9, P937; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sugiyama N, 2006, GENES CELLS, V11, P1213, DOI 10.1111/j.1365-2443.2006.01011.x; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WU Z, 2004, DEPARTMENT BIOSTATIS; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	42	43	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3672	3684		10.1096/fj.08-111872	http://dx.doi.org/10.1096/fj.08-111872			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606867				2022-12-25	WOS:000259642600028
J	Nolen, BJ; Pollard, TD				Nolen, Brad J.; Pollard, Thomas D.			Structure and biochemical properties of fission yeast Arp2/3 complex lacking the Arp2 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP FAMILY PROTEINS; WASP/SCAR PROTEINS; ACTIN-BINDING; ACTIVATION; ROLES; POLYMERIZATION; IDENTIFICATION; CYTOKINESIS; EFFICIENT; INTERACTS	Arp2/3 (actin-related protein 2/3) complex is a seven-subunit complex that nucleates branched actin filaments in response to cellular signals. Nucleation-promoting factors such as WASp/Scar family proteins activate the complex by facilitating the activating conformational change and recruiting the first actin monomer for the daughter branch. Here we address the role of the Arp2 subunit in the function of Arp2/3 complex by isolating a version of the complex lacking Arp2 (Arp2 Delta Arp2/3 complex) from fission yeast. An x-ray crystal structure of the Delta Arp2 Arp2/3 complex showed that the rest of the complex is unperturbed by the loss of Arp2. However, the Arp2 Delta Arp2/3 complex was inactive in actin nucleation assays, indicating that Arp2 is essential to form a branch. A fluorescence anisotropy assay showed that Arp2 does not contribute to the affinity of the complex for Wsp1-VCA, a Schizosaccharomyces pombe nucleation-promoting factor protein. Fluorescence resonance energy transfer experiments showed that the loss of Arp2 does not prevent VCA from recruiting an actin monomer to the complex. Truncation of the N terminus of ARPC5, the smallest subunit in the complex, increased the yield of Arp2 Delta Arp2/3 complex during purification but did not compromise nucleation activity of the full Arp2/3 complex.	[Nolen, Brad J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Nolen, BJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	bradley.nolen@yale.edu			National Institutes of Health [GM066311, GM074374-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074374, P01GM066311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066311. This work was also supported by National Institutes of Health Ruth Kirschstein postdoctoral fellowship GM074374-02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguda AH, 2005, EMBO REP, V6, P220, DOI 10.1038/sj.embor.7400363; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KEENEY JB, 1994, GENETICS, V136, P849; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; WELCH MD, 1994, CURR OPIN CELL BIOL, V6, P110, DOI 10.1016/0955-0674(94)90124-4; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	44	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26490	26498		10.1074/jbc.M802607200	http://dx.doi.org/10.1074/jbc.M802607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640983	Green Published, hybrid			2022-12-25	WOS:000259341600025
J	Pagant, S; Brovman, EY; Halliday, JJ; Miller, EA				Pagant, Silvere; Brovman, Ethan Y.; Halliday, John J.; Miller, Elizabeth A.			Mapping of interdomain interfaces required for the functional architecture of yor1p, a eukaryotic ATP-binding cassette (ABC) transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; CHLORIDE CHANNEL ACTIVITY; DELTA-F508 MUTATION; CYTOPLASMIC LOOP; P-GLYCOPROTEIN; DOMAIN; MECHANISM; COMPLEX; SIGNAL	ATP-binding cassette (ABC) transporters are a large superfamily of proteins that mediate substrate translocation across biological membranes. Our goal was to define the intramolecular interactions that contribute to quaternary assembly of a eukaryotic ABC transporter and determine how the architecture of this protein influences its biogenesis within the secretory pathway. We used chemical cross-linking approaches to map interdomain interactions in the yeast ABC transporter, Yor1p, which functions as a pleiotropic drug pump at the plasma membrane. We have defined interactions between the two nucleotide-binding domains (NBDs) and between the NBDs and specific intracellular loops (ICLs) that are consistent with current structural models of bacterial ABC exporters. Furthermore, we detected relatively weak NBD-NBD and ICL-ICL interactions that may correspond to transient sites of cross-talk between domains required for coupling of ATP hydrolysis with substrate translocation. Mutation of a key residue in ICL2 caused misassembly of the altered protein, leading to increased sensitivity to the mitochondrial poison, oligomycin. We identified intragenic suppressing mutations that rescued the oligomycin resistance associated with this aberrant protein and demonstrated that the suppressing mutations restored multiple interdomain interfaces. Together, our biochemical and genetic approaches contribute to a greater understanding of the architecture of this important class of proteins and provide insight into the quality control surveillance that regulates their biogenesis and deployment within the eukaryotic cell.	[Pagant, Silvere; Brovman, Ethan Y.; Halliday, John J.; Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Miller, EA (corresponding author), 617A Fairchild Ctr, MC 2456, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078186 (to E. M.). This work was also supported by Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	26	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26444	26451		10.1074/jbc.M803912200	http://dx.doi.org/10.1074/jbc.M803912200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18644782	Green Published, hybrid			2022-12-25	WOS:000259341600019
J	Szczesny, B; Tann, AW; Longley, MJ; Copeland, WC; Mitra, S				Szczesny, Bartosz; Tann, Anne W.; Longley, Matthew J.; Copeland, William C.; Mitra, Sankar			Long patch base excision repair in mammalian mitochondrial Genomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-GAMMA; OXIDATIVE DAMAGE; ABASIC SITES; HUMAN-CELLS; IDENTIFICATION; NUCLEAR; ENDONUCLEASE; BINDING; URACIL; PURIFICATION	The mitochondrial genome is highly susceptible to damage by reactive oxygen species (ROS) generated endogenously as a by-product of respiration. ROS-induced DNA lesions, including oxidized bases, abasic (AP) sites, and oxidized AP sites, cause DNA strand breaks and are repaired via the base excision repair (BER) pathway in both the nucleus and mitochondria. Repair of damaged bases and AP sites involving 1-nucleotide incorporation, named single nucleotide (SN)-BER, was observed with mitochondrial and nuclear extracts. During SN-BER, the 5'-phosphodeoxyribose (dRP) moiety, generated by AP-endonuclease (APE1), is removed by the lyase activity of DNA polymerase gamma (pol gamma) and polymerase beta in the mitochondria and nucleus, respectively. However, the repair of oxidized deoxyribose fragments at the 5' terminus after strand break would require 5'-exo/endonuclease activity that is provided by the flap endonuclease (FEN-1) in the nucleus, resulting in multinucleotide repair patch (long patch (LP)-BER). Here we show the presence of a 5'-exo/endonuclease in the mitochondrial extracts of mouse and human cells that is involved in the repair of a lyase-resistant AP site analog via multinucleotide incorporation, upstream and downstream to the lesion site. We conclude that LP-BER also occurs in the mitochondria requiring the 5'-exo/endonuclease and pol gamma with 3'-exonuclease activity. Although a FEN-1 antibody cross-reacting species was detected in the mitochondria, it was absent in the LP-BER-proficient APE1 immunocomplex isolated from the mitochondrial extract that contains APE1, pol gamma, and DNA ligase 3. The LP-BER activity was marginally affected in FEN-1-depleted mitochondrial extracts, further supporting the involvement of an unidentified 5'-exo/endonuclease in mitochondrial LP-BER.	[Szczesny, Bartosz; Tann, Anne W.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Longley, Matthew J.; Copeland, William C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mitra, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	samitra@utmb.edu	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	National Institutes of Health; United States Public Health Service [P01 AG10514, R01 CA53791]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health intramural research funds (to W. C. C.). This work was also supported by United States Public Health Service Grants P01 AG10514 and R01 CA53791 (to S. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; Bouex P, 2002, BBA-GENE STRUCT EXPR, V1574, P72, DOI 10.1016/S0167-4781(01)00347-5; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Laquel-Robert P, 2007, BBA-GEN SUBJECTS, V1770, P527, DOI 10.1016/j.bbagen.2006.10.003; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Roginskaya M, 2005, RADIAT RES, V163, P85, DOI 10.1667/RR3288; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Szczesny B, 2005, MECH AGEING DEV, V126, P1071, DOI 10.1016/j.mad.2005.04.001; Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100	37	122	126	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26349	26356		10.1074/jbc.M803491200	http://dx.doi.org/10.1074/jbc.M803491200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635552	Green Published, hybrid			2022-12-25	WOS:000259341600008
J	Romanowska, E; Kargul, J; Powikrowska, M; Finazzi, G; Nield, J; Drozak, A; Pokorska, B				Romanowska, Elzbieta; Kargul, Joanna; Powikrowska, Marta; Finazzi, Giovanni; Nield, Jon; Drozak, Anna; Pokorska, Berenika			Structural organization of photosynthetic apparatus in agranal chloroplasts of Maize	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLE-SHEATH CHLOROPLASTS; PLANT PHOTOSYSTEM-I; HARVESTING-COMPLEX-II; PROTEIN COMPLEXES; C-4 PHOTOSYNTHESIS; THYLAKOID MEMBRANE; PROTEOMIC APPROACH; ZEA-MAYS; SUPRAMOLECULAR ORGANIZATION; DIFFERENTIAL EXPRESSION	We investigated the organization of photosystem II (PSII) in agranal bundle sheath thylakoids from a C-4 plant maize. Using blue native/SDS-PAGE and single particle analysis, we show for the first time that PSII in the bundle sheath (BS) chloroplasts exists in a dimeric form and forms light-harvesting complex II (LHCII)center dot PSII supercomplexes. We also demonstrate that a similar set of photosynthetic membrane complexes exists in mesophyll and agranal BS chloroplasts, including intact LHCI center dot PSI supercomplexes, PSI monomers, PSII core dimers, PSII monomers devoid of CP43, LHCII trimers, LHCII monomers, ATP synthase, and cytochrome b(6)f complex. Fluorescence functional measurements clearly indicate that BS chloroplasts contain PSII complexes that are capable of performing charge separation and are efficiently sensitized by the associated LHCII. We identified a fraction of LHCII present within BS thylakoids that is weakly energetically coupled to the PSII reaction center; however, the majority of BS LHCII is shown to be tightly connected to PSII. Overall, we demonstrate that organization of the photosynthetic apparatus in BS agranal chloroplasts of a model C-4 plant is clearly distinct from that of the stroma lamellae of the C-3 plants. In particular, supramolecular organization of the dimeric LHCII center dot PSII in the BS thylakoids strongly suggests that PSII in the BS agranal membranes may donate electrons to PSI. We propose that the residual PSII activity may supply electrons to poise cyclic electron flow around PSI and prevent PSI overoxidation, which is essential for the CO2 fixation in BS cells, and hence, may optimize ATP production within this compartment.	[Romanowska, Elzbieta; Powikrowska, Marta; Drozak, Anna; Pokorska, Berenika] Warsaw Univ, Dept Plant Physiol, PL-02096 Warsaw, Poland; [Kargul, Joanna] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England; [Nield, Jon] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Finazzi, Giovanni] Univ Paris 06, F-75005 Paris, France; [Finazzi, Giovanni] CNRS, UMR 7141, F-75005 Paris, France	University of Warsaw; Imperial College London; University of London; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Romanowska, E (corresponding author), Warsaw Univ, Dept Plant Physiol, Miecznikowa 1, PL-02096 Warsaw, Poland.	romanela@biol.uw.edu.pl	Kargul, Joanna/AGD-9163-2022; Kargul, Joanna/AAN-4227-2021; Drozak, Anna/AAJ-8794-2021; Nield, Jon/C-5892-2013	Kargul, Joanna/0000-0003-1410-1905; Nield, Jon/0000-0001-9983-0239; Drozak, Anna/0000-0002-9616-0214; Romanowska, Elzbieta/0000-0002-7359-0537	Polish Ministry of Science and High Education [N303 036 31/1086]	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	The work was supported by Polish Ministry of Science and High Education Grant N303 036 31/1086. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; AMESZ J, 1962, BIOCHIM BIOPHYS ACTA, V64, P261, DOI 10.1016/0006-3002(62)90736-9; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ANDERSEN KS, 1972, PLANT PHYSIOL, V49, P461, DOI 10.1104/pp.49.4.461; ANDERSON JM, 1971, BIOCHIM BIOPHYS ACTA, V245, P398, DOI 10.1016/0005-2728(71)90158-7; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; BASSI R, 1986, CARLSBERG RES COMMUN, V51, P363, DOI 10.1007/BF02907312; BASSI R, 1995, EUR J BIOCHEM, V233, P709, DOI 10.1111/j.1432-1033.1995.709_3.x; BASSI R, 1985, EUR J BIOCHEM, V146, P589, DOI 10.1111/j.1432-1033.1985.tb08692.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BISHOP DG, 1970, PHOTOSYNTHESIS PHOTO, P323; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; BUTLER WL, 1979, BIOCHIM BIOPHYS ACTA, V545, P309, DOI 10.1016/0005-2728(79)90208-1; CHAPMAN KSR, 1980, ARCH BIOCHEM BIOPHYS, V202, P330, DOI 10.1016/0003-9861(80)90435-X; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Darie CC, 2006, J PLANT PHYSIOL, V163, P800, DOI 10.1016/j.jplph.2005.11.014; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DOWNTON W. J. S., 1971, Photosynthesis and photorespiration, P3; Drozak A, 2006, BBA-BIOENERGETICS, V1757, P1539, DOI 10.1016/j.bbabio.2006.09.001; DUYSENS L. N. M., 1963, P353; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Ivanov B, 2005, PLANTA, V220, P572, DOI 10.1007/s00425-004-1367-6; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAETSCH W. M., 1971, Photosynthesis and photorespiration. Proceedings of a Conference held at Australian National University, Canberra, 23 November-5 December 1970. Sponsored by the Australian Academy of Sciences under the auspices of the Australia-U.S. Agreement on Scientific and Technical Cooperation., P323; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; Leegood RC, 2002, J EXP BOT, V53, P581, DOI 10.1093/jexbot/53.369.581; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Mamedov F, 2003, PHYSIOL PLANTARUM, V119, P328, DOI 10.1034/j.1399-3054.2003.00187.x; MAYNE BC, 1970, PHOTOSYNTHESIS PHOTO, P361; MEIERHOFF K, 1993, PLANTA, V191, P23, DOI 10.1007/BF00240892; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; OSWALD A, 1990, EUR J BIOCHEM, V190, P185, DOI 10.1111/j.1432-1033.1990.tb15563.x; Pfundel E, 1996, PLANT PHYSIOL, V112, P1055, DOI 10.1104/pp.112.3.1055; Pokorska B, 2007, FUNCT PLANT BIOL, V34, P844, DOI 10.1071/FP07067; Romanowska E, 2006, J PLANT PHYSIOL, V163, P607, DOI 10.1016/j.jplph.2005.06.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SCHUSTER G, 1985, J BIOL CHEM, V260, P1866; SHEEN JY, 1986, P NATL ACAD SCI USA, V83, P7811, DOI 10.1073/pnas.83.20.7811; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P425, DOI 10.1016/j.bbabio.2008.02.001; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; WOO KC, 1970, P NATL ACAD SCI USA, V67, P18, DOI 10.1073/pnas.67.1.18; Yoshimura Y, 2004, PLANTA, V220, P307, DOI 10.1007/s00425-004-1335-1	63	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26037	26046		10.1074/jbc.M803711200	http://dx.doi.org/10.1074/jbc.M803711200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632664	hybrid, Green Published			2022-12-25	WOS:000259200100032
J	Farin, HF; Mansouri, A; Petry, M; Kispert, A				Farin, Henner F.; Mansouri, Ahmed; Petry, Marianne; Kispert, Andreas			T-box protein Tbx18 interacts with the paired box protein Pax3 in the development of the paraxial mesoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; BOUNDARY FORMATION; VERTEBRAL COLUMN; NOTCH ACTIVITY; MESSENGER-RNA; PROXIMAL RIBS; MOUSE GENE; EXPRESSION; SOMITE; MESP2	The compartmentalization of somites along their anterior-posterior axis is crucial to the segmental organization of the vertebral column. Anterior-posterior somite polarity is generated in the anterior presomitic mesoderm by Mesp2 and Delta/Notch signaling and is further maintained by two transcriptional regulators, Uncx4.1 and Tbx18, acting in the posterior and anterior somite compartment, respectively. Here, we report that the paired box transcription factor Pax3 cooperates with the T-box protein Tbx18 in maintaining anterior somite half identity. Our findings that both genes are co-expressed in the anterior presomitic mesoderm and in early somites, that Pax3 and Tbx18 proteins physically interact, and that the loss of Pax3 gene function enhances the vertebral defects (i.e. the gain of vertebral elements derived from posterior somite halves in Tbx18 mutant mice) suggests that the two proteins cooperatively regulate the gene expression program necessary for maintaining anterior-posterior somite polarity. Genetic interaction of Pax3 with Tbx18 and the closely related T-box gene Tbx15 was also observed in the development of the scapula blade, indicating an additional cooperative function for these genes in the paraxial mesoderm.	[Farin, Henner F.; Petry, Marianne; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Hannover Medical School; Max Planck Society	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, OE5250,Carl Neuberg Str 1, D-30625 Hannover, Germany.	kispert.andreas@mh-hannover.de	Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366	German Research Council; REBIRTH	German Research Council(German Research Foundation (DFG)); REBIRTH	This work was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft (DFG)) and by the DFG-funded cluster of excellence "REBIRTH" (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Aoyama H, 2000, MECH DEVELOP, V99, P71, DOI 10.1016/S0925-4773(00)00481-0; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; BOBER E, 1994, DEVELOPMENT, V120, P603; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Christ B, 2007, DEV DYNAM, V236, P2382, DOI 10.1002/dvdy.21189; Daston G, 1996, DEVELOPMENT, V122, P1017; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GOLDSTEIN RS, 1992, DEVELOPMENT, V116, P441; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Huang RJ, 2006, ANAT EMBRYOL, V211, pS65, DOI 10.1007/s00429-006-0126-9; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Leitges M, 2000, DEVELOPMENT, V127, P2259; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2006, DEV BIOL, V300, P687, DOI 10.1016/j.ydbio.2006.08.043; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takahashi Y, 2007, DEV DYNAM, V236, P1484, DOI 10.1002/dvdy.21178; Takahashi Y, 2007, DEV BIOL, V304, P593, DOI 10.1016/j.ydbio.2007.01.007; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	44	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25372	25380		10.1074/jbc.M802723200	http://dx.doi.org/10.1074/jbc.M802723200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644785	hybrid, Green Published			2022-12-25	WOS:000259012700032
J	Gaspar, ML; Jesch, SA; Viswanatha, R; Antosh, AL; Brown, WJ; Kohlwein, SD; Henry, SA				Gaspar, Maria L.; Jesch, Stephen A.; Viswanatha, Raghuvir; Antosh, Amy L.; Brown, William J.; Kohlwein, Sepp D.; Henry, Susan A.			A block in endoplasmic reticulum-to-golgi trafficking inhibits phospholipid synthesis and induces neutral lipid accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; VESICLE FORMATION; GENE-EXPRESSION; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; INO1 EXPRESSION; SEC13P COMPLEX; BIOSYNTHESIS	Seeking to better understand how membrane trafficking is coordinated with phospholipid synthesis in yeast, we investigated lipid synthesis in several Sec(-) temperature-sensitive mutants, including sec13-1. Upon shift of sec13-1 cells to the restrictive temperature of 37 degrees C, phospholipid synthesis decreased dramatically relative to the wild type control, whereas synthesis of neutral lipids, especially triacylglycerol ( TAG), increased. When examined by fluorescence microscopy, the number of lipid droplets appeared to increase and formed aggregates in sec13-1 cells shifted to 37 degrees C. Electron microscopy confirmed the increase in lipid droplet number and revealed that many were associated with the vacuole. Analysis of lipid metabolism in strains lacking TAG synthase genes demonstrated that the activities of the products of these genes contribute to accumulation of TAG in sec13-1 cells after the shift to 37 degrees C. Furthermore, the permissive temperature for growth of the sec13-1 strain lacking TAG synthase genes was 3 degrees C lower than sec13-1 on several different growth media, indicating that the synthesis of TAG has physiological significance under conditions of secretory stress. Together these results suggest that following a block in membrane trafficking, yeast cells channel lipid metabolism from phospholipid synthesis into synthesis of TAG and other neutral lipids to form lipid droplets. We conclude that this metabolic switch provides a degree of protection to cells during secretory stress.	[Gaspar, Maria L.; Jesch, Stephen A.; Viswanatha, Raghuvir; Antosh, Amy L.; Brown, William J.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Cornell University; University of Graz	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 260 Roberts Hall, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014; Brown, William/GXN-2777-2022	Kohlwein, Sepp Dieter/0000-0002-1030-0598	National Institutes of Health [GM019629, DK51596]; NIGMS; NIDDK; Austrian Science Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051596, R56DK051596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019629, R37GM019629] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grants GM019629 ( to S. A. H.) and DK51596 ( to W. J. B.) from the NIGMS and NIDDK, respectively. This work was also supported by SFB Lipotox P3005 of the Austrian Science Fund ( to S. D. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arvindekar AU, 2002, YEAST, V19, P131, DOI 10.1002/yea.802; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1977, J BACTERIOL, V132, P806, DOI 10.1128/JB.132.3.806-817.1977; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Block-Alper L, 2002, MOL BIOL CELL, V13, P40, DOI 10.1091/mbc.01-07-0366; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Cahill G, 2000, BIOTECHNOL BIOENG, V69, P312, DOI 10.1002/1097-0290(20000805)69:3<312::AID-BIT9>3.3.CO;2-P; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CASEY WM, 1993, BIOCHEM BIOPH RES CO, V193, P1297, DOI 10.1006/bbrc.1993.1766; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Fatal N, 2002, MOL BIOL CELL, V13, P4130, DOI 10.1091/mbc.02-05-0082; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gilstring CF, 1999, MOL BIOL CELL, V10, P3549, DOI 10.1091/mbc.10.11.3549; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kirchhausen T, 2007, CELL, V129, P1251, DOI 10.1016/j.cell.2007.06.015; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Larson LL, 2002, YEAST, V19, P373, DOI 10.1002/yea.839; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; LETTS VA, 1983, J BACTERIOL, V156, P212, DOI 10.1128/JB.156.1.212-221.1983; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MORI K, 1993, CELL, V74, P743; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; RAMIREZ RM, 1983, J BACTERIOL, V154, P1276, DOI 10.1128/JB.154.3.1276-1283.1983; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryan KJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-17; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; WOLINSKI H, 2008, METHODS MOL IN PRESS; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Yamanushi T, 1996, J BIOCHEM-TOKYO, V120, P452; Zhang SR, 1999, GENETICS, V151, P473; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	67	53	54	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25735	25751		10.1074/jbc.M802685200	http://dx.doi.org/10.1074/jbc.M802685200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614533	Green Published, hybrid			2022-12-25	WOS:000259012700068
J	Kyriazis, GA; Wei, Z; Vandermey, M; Jo, DG; Xin, O; Mattson, MP; Chan, SL				Kyriazis, George A.; Wei, Zelan; Vandermey, Miriam; Jo, Dong-Gyu; Xin, Ouyang; Mattson, Mark P.; Chan, Sic L.			Numb Endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner - Implications for Alzheimer disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; FATE DETERMINANT NUMB; CELL FATE; MAMMALIAN NUMB; MEDIATED ENDOCYTOSIS; BETA-PROTEIN; PTB DOMAIN; INTRACELLULAR DOMAIN; CALCIUM HOMEOSTASIS; GAMMA-SECRETASE	Central to the pathogenesis of Alzheimer disease is the aberrant processing of the amyloid precursor protein (APP) to generate amyloid beta-peptide (A beta), the principle component of amyloid plaques. The cell fate determinant Numb is a phosphotyrosine binding domain (PTB)-containing endocytic adapter protein that interacts with the carboxyl-terminal domain of APP. The physio-logical relevance of this interaction is unknown. Mammals produce four alternatively spliced variants of Numb that differ in the length of their PTB and proline-rich region. In the current study, we determined the influence of the four human Numb isoforms on the intracellular trafficking and processing of APP. Stable expression of Numb isoforms that differ in the PTB but not in the proline-rich region results in marked differences in the sorting of APP to the recycling and degradative pathways. Neural cells expressing Numb isoforms that lack the insert in the PTB (short PTB (SPTB)) exhibited marked accumulation of APP in Rab5A-labeled early endosomal and recycling compartments, whereas those expressing isoforms with the insertion in the PTB (long PTB (LPTB)) exhibited reduced amounts of cellular APP and its proteolytic derivatives relative to parental control cells. Neither the activities of the beta- and gamma-secretases nor the expression of APP mRNA were significantly different in the stably transfected cells, suggesting that the differential effects of the Numb proteins on APP metabolism is likely to be secondary to altered APP trafficking. In addition, the expression of SPTB-Numb increases at the expense of LPTB-Numb in neuronal cultures subjected to stress, suggesting a role for Numb in stress-induced A beta production. Taken together, these results suggest distinct roles for the human Numb isoforms in APP metabolism and may provide a novel potential link between altered Numb isoform expression and increased A beta generation.	[Kyriazis, George A.; Wei, Zelan; Vandermey, Miriam; Chan, Sic L.] Univ Cent Florida, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea; [Xin, Ouyang; Mattson, Mark P.] NIA, Neurosci Lab, Natl Inst Hlth, Intramural Res Program, Baltimore, MD 21224 USA	State University System of Florida; University of Central Florida; Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chan, SL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Biomol Sci Ctr, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	schan@mail.ucf.edu	Mattson, Mark P/F-6038-2012; Jo, Dong-Gyu/AAN-9278-2021	Jo, Dong-Gyu/0000-0003-2271-1076; Kyriazis, George/0000-0001-9514-3482	NATIONAL INSTITUTE ON AGING [Z01AG000314, ZIAAG000317, ZIAAG000312, Z01AG000312, ZIAAG000314, Z01AG000317] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chan SL, 2002, NEUROMOL MED, V1, P55; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GANDY S, 1994, NEUROBIOL AGING, V15, P253, DOI 10.1016/0197-4580(94)90125-2; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOO EH, 1994, J BIOL CHEM, V269, P17386; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Pedersen WA, 2002, J NEUROCHEM, V82, P976, DOI 10.1046/j.1471-4159.2002.01036.x; Rebel VI, 1999, BLOOD, V93, P2217, DOI 10.1182/blood.V93.7.2217.407a01_2217_2224; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; STEIN BS, 1984, J BIOL CHEM, V259, P4762; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verbeek MM, 2002, J HISTOCHEM CYTOCHEM, V50, P681, DOI 10.1177/002215540205000509; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; ZMITH CA, 2004, MOL BIOL CELL, V15, P3698; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	60	62	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25492	25502		10.1074/jbc.M802072200	http://dx.doi.org/10.1074/jbc.M802072200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18599481	hybrid, Green Published			2022-12-25	WOS:000259012700045
J	Quintanilla, RA; Jin, YN; Fuenzalida, K; Bronfman, M; Johnson, GVW				Quintanilla, Rodrigo A.; Jin, Youngnam N.; Fuenzalida, Karen; Bronfman, Miguel; Johnson, Gail V. W.			Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells - Possible role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the pathogenesis of Huntington disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID NEURODEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; STRIATAL CELLS; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; TRINUCLEOTIDE REPEAT; INSULIN-RESISTANCE; OXIDATIVE STRESS; AGONISTS; NEURONS	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a member of the PPAR family of transcription factors. Synthetic PPAR gamma agonists are used as oral anti-hyperglycemic drugs for the treatment of non-insulin-dependent diabetes. However, emerging evidence indicates that PPAR gamma activators can also prevent or attenuate neurodegeneration. Given these previous findings, the focus of this report is on the potential neuroprotective role of PPAR gamma activation in preventing the loss of mitochondrial function in Huntington disease (HD). For these studies we used striatal cells that express wild-type (STHdh(Q7/Q7)) or mutant (STHdh(Q111/Q111)) huntingtin protein at physiological levels. Treatment of mutant cells with thapsigargin resulted in a significant decrease in mitochondrial calcium uptake, an increase in reactive oxygen species production, and a significant decrease in mitochondrial membrane potential. PPAR gamma activation by rosiglitazone prevented the mitochondrial dysfunction and oxidative stress that occurred when mutant striatal cells were challenged with pathological increases in calcium. The beneficial effects of rosiglitazone were likely mediated by activation of PPAR gamma, as all protective effects were prevented by the PPAR gamma antagonist GW9662. Additionally, the PPAR gamma signaling pathway was significantly impaired in the mutant striatal cells with decreases in PPAR gamma expression and reduced PPAR gamma transcriptional activity. Treatment with rosiglitazone increased mitochondrial mass levels, suggesting a role for the PPAR gamma pathway in mitochondrial function in striatal cells. Altogether, this evidence indicates that PPAR gamma activation by rosiglitazone attenuates mitochondrial dysfunction in mutant huntingtin-expressing striatal cells, and this could be an important therapeutic avenue to ameliorate the mitochondrial dysfunction that occurs in HD.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Jin, Youngnam N.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Fuenzalida, Karen; Bronfman, Miguel] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Ctr Regulac Celular & Patol Joaquin V Luca, Santiago, Chile; [Fuenzalida, Karen; Bronfman, Miguel] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millennium Inst Fundamental & Appl Biol, Santiago, Chile	University of Rochester; University of Rochester; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Courier Rm 4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Jin, Youngnam/G-2655-2012; QUINTANILLA, RODRIGO/ABG-8829-2021		National Institutes of Health [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS041744. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Garcia-Bueno B, 2007, NEUROPSYCHOPHARMACOL, V32, P1251, DOI 10.1038/sj.npp.1301252; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jung TW, 2006, BIOCHEM BIOPH RES CO, V340, P221, DOI 10.1016/j.bbrc.2005.11.177; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Landreth G, 2006, EXP NEUROL, V199, P245, DOI 10.1016/j.expneurol.2006.04.006; Lee KJ, 2008, EUR J NEUROSCI, V27, P334, DOI 10.1111/j.1460-9568.2007.06007.x; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; STAHL WL, 1974, NEUROLOGY, V24, P813, DOI 10.1212/WNL.24.9.813; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Zhu LP, 2000, CELL CALCIUM, V28, P107, DOI 10.1054/ceca.2000.0138	50	105	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25628	25637		10.1074/jbc.M804291200	http://dx.doi.org/10.1074/jbc.M804291200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640979	Green Published, hybrid			2022-12-25	WOS:000259012700058
J	Hayakawa, F; Abe, A; Kitabayashi, I; Pandolfi, PP; Naoe, T				Hayakawa, Fumihiko; Abe, Akihiro; Kitabayashi, Issay; Pandolfi, Pier Paolo; Naoe, Tomoki			Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC-TRIOXIDE; TRANSCRIPTIONAL REPRESSION; NUCLEAR-BODIES; CELLS; SUMO-1; PHOSPHORYLATION; LOCALIZATION; SUMOYLATION; INDUCTION	PML is a potent tumor suppressor and proapoptotic factor and is functionally regulated by post-translational modifications such as phosphorylation, sumoylation, and ubiquitination. Histone deacetylase (HDAC) inhibitors are a promising class of targeted anticancer agents and induce apoptosis in cancer cells by largely unknown mechanisms. We report here a novel post-transcriptional modification, acetylation, of PML. PML exists as an acetylated protein in HeLa cells, and its acetylation is enhanced by coexpression of p300 or treatment with a HDAC inhibitor, trichostatin A. Increased PML acetylation is associated with increased sumoylation of PML in vitro and in vivo. PML is involved in trichostatin A-induced apoptosis and PML with an acetylation-defective mutation shows an inability to mediate apoptosis, suggesting the importance of PML acetylation. Our work provides new insights into PML regulation by post-translational modification and new information about the therapeutic mechanism of HDAC inhibitors.	[Hayakawa, Fumihiko; Abe, Akihiro; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Genet Program, Boston, MA 02215 USA	Nagoya University; National Cancer Center - Japan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hayakawa, F (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	bun-hy@med.nagoya-u.ac.jp	Naoe, Tomoki/I-1888-2012; Hayakawa, Fumihiko/I-7288-2014; Kitabayashi, Issay/G-2204-2017	Kitabayashi, Issay/0000-0002-8409-0407	Uehara Memorial Foundation; National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Uehara Memorial Foundation, the National Institute of Biomedical Innovation, and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Terui T, 2003, CANCER RES, V63, P8948; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	28	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24420	24425		10.1074/jbc.M802217200	http://dx.doi.org/10.1074/jbc.M802217200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621739	Green Published, hybrid			2022-12-25	WOS:000258820000017
J	Slugoski, MD; Smith, KM; Mulinta, R; Ng, AML; Yao, SYM; Morrison, EL; Lee, QOT; Zhang, J; Karpinski, E; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Smith, Kyla M.; Mulinta, Ras; Ng, Amy M. L.; Yao, Sylvia Y. M.; Morrison, Ellen L.; Lee, Queenie O. T.; Zhang, Jing; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONCENTRATIVE NUCLEOSIDE TRANSPORTERS; H+/NUCLEOSIDE COTRANSPORTER CACNT; FUNCTIONAL EXPRESSION; SCANNING MUTAGENESIS; GLUCOSE-TRANSPORTER; MOLECULAR-CLONING; CANDIDA-ALBICANS; PROTEINS HCNT3; IDENTIFICATION; TOPOLOGY	In humans, the SLC28 concentrative nucleoside transporter (CNT) protein family is represented by three Na+-coupled members; human CNT1 (hCNT1) and hCNT2 are pyrimidine and purine nucleoside-selective, respectively, whereas hCNT3 transports both purine and pyrimidine nucleosides and nucleoside drugs. Belonging to a phylogenetic CNT subfamily distinct from hCNT1/2, hCNT3 also mediates H+/nucleoside cotransport. Using heterologous expression in Xenopus oocytes, we have characterized a cysteineless version of hCNT3 (hCNT3C-). Processed normally to the cell surface, hCNT3C-exhibited hCNT3-like transport properties, but displayed a decrease in apparent affinity specific for Na+ and not H+. Site-directed mutagenesis experiments in wild-type and hCNT3C- backgrounds identified intramembranous Cys-561 as the residue responsible for this altered Na+-binding phenotype. Alanine at this position restored Na+-binding affinity, whereas substitution with larger neutral amino acids ( threonine, valine, and isoleucine) abolished hCNT3 H+-dependent nucleoside transport activity. Independent of these findings, we have established that Cys-561 is located in a mobile region of the hCNT3 translocation pore adjacent to the nucleoside binding pocket and that access of p-chloromercuribenzene sulfonate to this residue reports a specific H+-induced conformational state of the protein (Slugoski, M. D., Ng, A. M. L., Yao, S.Y.M., Smith, K. M., Lin, C. C., Zhang, J., Karpinski, E., Cass, C. E., Baldwin, S. A., and Young, J. D. ( 2008) J. Biol. Chem. 283, 8496 - 8507). The present investigation validates hCNT3C - as a template for substituted cysteine accessibility method studies of CNTs and reveals a pivotal functional role for Cys-561 in Na+-as well as H+-coupled modes of hCNT3 nucleoside transport.	[Slugoski, Melissa D.; Smith, Kyla M.; Mulinta, Ras; Ng, Amy M. L.; Yao, Sylvia Y. M.; Morrison, Ellen L.; Lee, Queenie O. T.; Karpinski, Edward; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Zhang, Jing; Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			National Cancer Institute of Canada; Canadian Cancer Society; Alberta Cancer Board	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Board	This work was supported in part by the National Cancer Institute of Canada, with funds from the Canadian Cancer Society and the Alberta Cancer Board. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Pastor-Anglada M, 2007, J PHYSIOL BIOCHEM, V63, P97, DOI 10.1007/BF03174089; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, MOL MEMBR BIOL, V18, P65, DOI 10.1080/09687680010026313; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slugoski MD, 2004, YEAST, V21, P1269, DOI 10.1002/yea.1178; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	44	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24922	24934		10.1074/jbc.M801793200	http://dx.doi.org/10.1074/jbc.M801793200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621735	Green Published, hybrid			2022-12-25	WOS:000258820000055
J	Nakajima, A; Kurihara, H; Yagita, H; Okumura, K; Nakano, H				Nakajima, Akihito; Kurihara, Hidetake; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu			Mitochondrial extrusion through the cytoplasmic vacuoles during cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; JNK ACTIVATION; C-FLIPL; APOPTOSIS; AUTOPHAGY; ACCUMULATION; MECHANISM; PROTEIN	Under various conditions, noxious stimuli damage mitochondria, resulting in mitochondrial fragmentation; however, the mechanisms by which fragmented mitochondria are eliminated from the cells remain largely unknown. Here we show that cytoplasmic vacuoles originating from the plasma membrane engulfed fragmented mitochondria and subsequently extruded them into the extracellular spaces in undergoing acute tumor necrosis factor alpha-induced cell death in a caspase-dependent fashion. Notably, upon fusion of the membrane encapsulating mitochondria to the plasma membrane, naked mitochondria were released into the extracellular spaces in an exocytotic manner. Mitochondrial extrusion was specific to tumor necrosis factor alpha-induced cell death, because a genotoxic stress-inducing agent such as cisplatin did not elicit mitochondrial extrusion. Moreover, intact actin and tubulin cytoskeletons were required for mitochondrial extrusion as well as membrane blebbing. Furthermore, fragmented mitochondria were engulfed by cytoplasmic vacuoles and extruded from hepatocytes of mice injected with anti-Fas antibody, suggesting that mitochondrial extrusion can be observed in vivo under pathological conditions. Mitochondria are eliminated during erythrocyte maturation under physiological conditions, and anti-mitochondrial antibody is detected in some autoimmune diseases. Thus, elucidating the mechanism underlying mitochondrial extrusion will open a novel avenue leading to better understanding of various diseases caused by mitochondrial malfunction as well as mitochondrial biology.	[Nakajima, Akihito; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Nakajima, A (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	anakaji@med.juntendo.ac.jp; hnakano@med.juntendo.ac.jp		Nakano, Hiroyasu/0000-0003-4843-1427	21st Century Center of Excellence Research; High-Tech Research Center Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science, Japan; Tokyo Biochemical Research Foundation; Mitsubishi Pharma Foundation; NOVARTIS Foundation (Japan)	21st Century Center of Excellence Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation; Mitsubishi Pharma Foundation; NOVARTIS Foundation (Japan)(Novartis)	This work was supported in part by grants-in-aid for 21st Century Center of Excellence Research, High-Tech Research Center Project for Private Universities; a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and Scientific Research (B) and (C), and Young Scientists (B) from Japan Society for the Promotion of Science, Japan; and grants from the Tokyo Biochemical Research Foundation, the Mitsubishi Pharma Foundation, and NOVARTIS Foundation (Japan) for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lyamzaev KG, 2008, BBA-BIOENERGETICS, V1777, P817, DOI 10.1016/j.bbabio.2008.03.027; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; Stollar BD, 2002, LUPUS, V11, P787, DOI 10.1191/0961203302lu318oa; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang XD, 2001, GENE DEV, V15, P2922; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	30	50	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24128	24135		10.1074/jbc.M802996200	http://dx.doi.org/10.1074/jbc.M802996200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593703	Green Published, hybrid			2022-12-25	WOS:000258638900066
J	Zhang, Y; Liao, MJ; Dufau, ML				Zhang, Ying; Liao, Mingjuan; Dufau, Maria L.			Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITOR; KINASE-C ZETA; REGULATE TRANSCRIPTION; SP1 SITES; PROMOTER; ACETYLATION; EXPRESSION; COMPLEX; PHOSPHORYLATION; RECRUITMENT	Our previous studies demonstrated that the histone deacetylase inhibitor, trichostatin A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitment of the pRB homologue p107 repressor from the promoter in JAR and MCF-7 cancer cells. TSA initiates a mechanism whereby the phosphatidylinositol 3-kinase/protein kinase zeta (PKC zeta) cascade phosphorylates Sp1 at Ser-641, which is essential for the release of the repression of LHR transcription. The present studies have revealed that dissociation of serine/threonine protein phosphatases PP2A and PP1 from the LHR promoter mediates TSA-induced activation of LHR gene transcription in a cell-specific manner. Changes in chromatin structure induced by TSA cause the release of PP2A in JAR cells or of PP1 in MCF-7 cells, which is associated with Sp1 directly or through histone deacetylase 1/2, respectively, at the promoter. This favors the phosphorylation of Sp1 mediated by the phosphatidylinositol 3-kinase/PKC zeta pathway, which in turn causes the release of the p107 inhibitor from Sp1 and marked transcriptional activation of the LHR. These findings reveal the importance of phosphatases in the control of LHR transcription, where the balance between phosphatidylinositol 3-kinase/PKC zeta and phosphatases could be critical for up- and down-regulation of LHR gene expression in physiological and pathological settings.	[Zhang, Ying; Liao, Mingjuan; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Endocrinol & Reprod Res Branch, Program Dev Endocrinol & Genet,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), NIH, Bldg 49,Rm 6A-36,49 Convent Dr,MSC 4510, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov			National Institutes of Health (Intramural Research Program of the NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000150] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NICHD). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Eickhoff B, 2000, BIOL CHEM, V381, P107, DOI 10.1515/BC.2000.015; Espinos E, 1999, MOL CELL BIOL, V19, P3474; Geng Y, 1999, BIOCHEM BIOPH RES CO, V263, P366, DOI 10.1006/bbrc.1999.1374; Hsu LC, 2007, BIOCHEM BIOPH RES CO, V360, P507, DOI 10.1016/j.bbrc.2007.06.090; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Mustelin Tomas, 2007, V365, P9; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Sowa Y, 1999, CANCER RES, V59, P4266; TSAIMORRIS CH, 1994, J BIOL CHEM, V269, P15868; TSAIMORRIS CH, 1993, J BIOL CHEM, V268, P4447; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhou CL, 2006, INT J ONCOL, V29, P269	31	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24039	24046		10.1074/jbc.M801878200	http://dx.doi.org/10.1074/jbc.M801878200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596044	Green Published, hybrid			2022-12-25	WOS:000258638900059
J	Herrada, EA; Tessone, CJ; Klemm, K; Eguiluz, VM; Hernandez-Garcia, E; Duarte, CM				Herrada, E. Alejandro; Tessone, Claudio J.; Klemm, Konstantin; Eguiluz, Victor M.; Hernandez-Garcia, Emilio; Duarte, Carlos M.			Universal Scaling in the Branching of the Tree of Life	PLOS ONE			English	Article								Understanding the patterns and processes of diversification of life in the planet is a key challenge of science. The Tree of Life represents such diversification processes through the evolutionary relationships among the different taxa, and can be extended down to intra-specific relationships. Here we examine the topological properties of a large set of interspecific and intraspecific phylogenies and show that the branching patterns follow allometric rules conserved across the different levels in the Tree of Life, all significantly departing from those expected from the standard null models. The finding of non-random universal patterns of phylogenetic differentiation suggests that similar evolutionary forces drive diversification across the broad range of scales, from macro-evolutionary to micro-evolutionary processes, shaping the diversity of life on the planet.	[Herrada, E. Alejandro; Tessone, Claudio J.; Eguiluz, Victor M.; Hernandez-Garcia, Emilio] UIB, CSIC, IFISC, Palma de Mallorca, Spain; [Tessone, Claudio J.] Swiss Fed Inst Technol, Zurich, Switzerland; [Klemm, Konstantin] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Duarte, Carlos M.] CSIC UIB, Inst Mediterraneo Estudios Avanzados, IMEDEA, Esporles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Herrada, EA (corresponding author), UIB, CSIC, IFISC, Palma de Mallorca, Spain.	victor@ifisc.uib-csic.es	Hernandez-Garcia, Emilio/B-1271-2008; Klemm, Konstantin/GYU-3511-2022; Duarte, Carlos M/A-7670-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Klemm, Konstantin/L-8426-2018; Eguíluz, Víctor M./B-9655-2008	Hernandez-Garcia, Emilio/0000-0002-9568-8287; Duarte, Carlos M/0000-0002-1213-1361; Eguíluz, Víctor M./0000-0003-1133-1289; Tessone, Claudio J./0000-0001-7733-6221	MEC (Spain); FEDER; FISICOS; CSIC (Spain) [PIE 200750I016]; SBF (Switzerland) [C05.0148]; European Commission through the NEST-Complexity project EDEN	MEC (Spain)(Spanish Government); FEDER(European Commission); FISICOS; CSIC (Spain); SBF (Switzerland); European Commission through the NEST-Complexity project EDEN	We acknowledge financial support from MEC (Spain) and FEDER, project FISICOS, from CSIC (Spain) project PIE 200750I016, from SBF (Switzerland) through project C05.0148 (Physics of Risk), and from the European Commission through the NEST-Complexity project EDEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barthelemy M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/07/L07002; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caldarelli G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.035101; Camacho J, 2005, NATURE, V435, pE3, DOI 10.1038/nature03839; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cracraft J., 2004, ASSEMBLING TREE LIFE; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Erwin DH, 2000, EVOL DEV, V2, P78, DOI 10.1046/j.1525-142x.2000.00045.x; Ford, 2006, THESIS STANFORD U; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Grantham T, 2007, PALAEONTOLOGY, V50, P75, DOI 10.1111/j.1475-4983.2006.00603.x; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; HARVEY PH, 1983, ANNU REV ECOL SYST, V14, P189, DOI 10.1146/annurev.es.14.110183.001201; Holman EW, 2005, SYSTEMATIC BIOL, V54, P895, DOI 10.1080/10635150500354696; Klemm K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128701; Kutschera U, 2004, NATURWISSENSCHAFTEN, V91, P255, DOI 10.1007/s00114-004-0515-y; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; MAKARIEVA AM, 2005, J THEOR BIOL, V291, P1997; MAYR E, 1982, EVOLUTION, V36, P1119, DOI 10.1111/j.1558-5646.1982.tb05483.x; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Pinelis I, 2003, P ROY SOC B-BIOL SCI, V270, P1425, DOI 10.1098/rspb.2003.2374; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Rokas A, 2006, SCIENCE, V313, P1897, DOI 10.1126/science.1134490; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; SIMON HA, 1955, BIOMETRIKA, V42, P425; SIMON HA, 2001, PHYS REV E, V64; Simons AM, 2002, J EVOLUTION BIOL, V15, P688, DOI 10.1046/j.1420-9101.2002.00437.x; Webb JK, 2002, ECOL RES, V17, P59, DOI 10.1046/j.1440-1703.2002.00463.x; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	35	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2757	10.1371/journal.pone.0002757	http://dx.doi.org/10.1371/journal.pone.0002757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648500	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900027
J	Huge, V; Lauchart, M; Forderreuther, S; Kaufhold, W; Valet, M; Azad, SC; Beyer, A; Magerl, W				Huge, Volker; Lauchart, Meike; Foerderreuther, Stefanie; Kaufhold, Wibke; Valet, Michael; Azad, Shahnaz Christina; Beyer, Antje; Magerl, Walter			Interaction of Hyperalgesia and Sensory Loss in Complex Regional Pain Syndrome Type I (CRPS I)	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; FACILITATED NEUROGENIC INFLAMMATION; CORTICAL REORGANIZATION; NERVOUS-SYSTEM; SYMPTOMS; ABNORMALITIES; ISCHEMIA; PATTERNS; MODEL; SIGNS	Background: Sensory abnormalities are a key feature of Complex Regional Pain Syndrome (CRPS). In order to characterise these changes in patients suffering from acute or chronic CRPS I, we used Quantitative Sensory Testing (QST) in comparison to an age and gender matched control group. Methods: 61 patients presenting with CRPS I of the upper extremity and 56 healthy subjects were prospectively assessed using QST. The patients' warm and cold detection thresholds (WDT; CDT), the heat and cold pain thresholds (HPT; CPT) and the occurrence of paradoxical heat sensation (PHS) were observed. Results: In acute CRPS I, patients showed warm and cold hyperalgesia, indicated by significant changes in HPT and CPT. WDT and CDT were significantly increased as well, indicating warm and cold hypoaesthesia. In chronic CRPS, thermal hyperalgesia declined, but CDT as well as WDT further deteriorated. Solely patients with acute CRPS displayed PHS. To a minor degree, all QST changes were also present on the contralateral limb. Conclusions: We propose three pathomechanisms of CRPS I, which follow a distinct time course: Thermal hyperalgesia, observed in acute CRPS, indicates an ongoing aseptic peripheral inflammation. Thermal hypoaesthesia, as detected in acute and chronic CRPS, signals a degeneration of A-delta and C-fibres, which further deteriorates in chronic CRPS. PHS in acute CRPS I indicates that both inflammation and degeneration are present, whilst in chronic CRPS I, the pathomechanism of degeneration dominates, signalled by the absence of PHS. The contralateral changes observed strongly suggest the involvement of the central nervous system.	[Huge, Volker; Lauchart, Meike; Kaufhold, Wibke; Azad, Shahnaz Christina; Beyer, Antje] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Foerderreuther, Stefanie] Univ Munich, Dept Neurol, Munich, Germany; [Valet, Michael] Tech Univ Munich, Dept Neurol, Munich, Germany; [Magerl, Walter] Heidelberg Univ, Medi Fac Mannheim, Dept Neurobiol, Ctr Biomed & Med Technol CBTM, Mannheim, Germany; [Magerl, Walter] Johannes Gutenberg Univ Mainz, Dept Physiol & Pathophysiol, Mainz, Germany	University of Munich; University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Huge, V (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	vhuge@med.uni-muenchen.de		Valet, Michael/0000-0003-3828-9164	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) [01EM0118]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF))	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) (01EM0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Atherton DD, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-21; Birklein F, 1998, CLIN AUTON RES, V8, P79, DOI 10.1007/BF02267817; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; Birklein F, 2001, NEUROLOGY, V57, P2179, DOI 10.1212/WNL.57.12.2179; Blumberg H, 1997, BEHAV BRAIN SCI, V20, P426, DOI 10.1017/S0140525X97271487; Bonica J.J., 1990, MANAGEMENT PAIN, P220; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Coderre TJ, 2004, PAIN, V112, P94, DOI 10.1016/j.pain.2004.08.001; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Darian-Smith C, 2000, NAT NEUROSCI, V3, P476, DOI 10.1038/74852; Eisenberg E, 2005, PAIN, V113, P99, DOI 10.1016/j.pain.2004.09.030; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; FRUHSTORFER H, 1984, PAIN, V20, P355, DOI 10.1016/0304-3959(84)90112-X; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; GEBER C, 2008, PAIN; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gradl G, 2006, NEUROSCI LETT, V402, P267, DOI 10.1016/j.neulet.2006.04.007; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Helyes Z, 2004, ARTHRITIS RHEUM-US, V50, P1677, DOI 10.1002/art.20184; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Kosek E, 2002, EUR J PAIN, V6, P413, DOI 10.1016/S1090-3801(02)00041-1; Leis S, 2004, NEUROSCI LETT, V359, P163, DOI 10.1016/j.neulet.2004.02.025; LEVINE JD, 1985, J IMMUNOL, V135, pS843; LEVINE JD, 1985, J NEUROSCI, V5, P1380; Loseth S, 2006, EUR J NEUROL, V13, P105, DOI 10.1111/j.1468-1331.2006.01232.x; Ludwig J, 2007, EUR J PAIN, V11, P677, DOI 10.1016/j.ejpain.2006.10.005; Magerl W, 2004, NEUROSCI LETT, V361, P136, DOI 10.1016/j.neulet.2003.12.001; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Moriwaki K, 1999, PAIN, V81, P1, DOI 10.1016/S0304-3959(98)00257-7; NOLANO M, 2008, BRAIN; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Oaklander AL, 2004, ANN NEUROL, V55, P639, DOI 10.1002/ana.20048; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; OAKLANDER AL, 2006, CRPS CURRENT DIAGNOS, P59; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Rommel O, 2001, PAIN, V93, P279, DOI 10.1016/S0304-3959(01)00332-3; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Sinay VJ, 2003, CEPHALALGIA, V23, P541, DOI 10.1046/j.1468-2982.2003.00581.x; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Thimineur M, 1998, CLIN J PAIN, V14, P256, DOI 10.1097/00002508-199809000-00013; Treede RD, 2004, PROG PAIN RES MANAG, V30, P3; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; VERDUGO R, 1992, BRAIN, V115, P893, DOI 10.1093/brain/115.3.893; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Weber M, 2001, PAIN, V91, P251, DOI 10.1016/S0304-3959(00)00445-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; YARNITSKY D, 1991, BRAIN, V114, P907, DOI 10.1093/brain/114.2.907	56	56	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2742	10.1371/journal.pone.0002742	http://dx.doi.org/10.1371/journal.pone.0002742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648647	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900013
J	Salmi, C; Loncle, C; Vidal, N; Letourneux, Y; Fantini, J; Maresca, M; Taieb, N; Pages, JM; Brunel, JM				Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Letourneux, Yves; Fantini, Jacques; Maresca, Marc; Taieb, Nadira; Pages, Jean-Marie; Brunel, Jean Michel			Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?	PLOS ONE			English	Article							TOLC EFFLUX PUMP; OUTER-MEMBRANE; ANTIBIOTIC SUSCEPTIBILITY; PERMEABILITY BARRIER; PEPTIDES; LIPOPOLYSACCHARIDE; INHIBITOR; SPERMINE; COLISTIN; INCREASE	We reported that squalamine is a membrane-active molecule that targets the membrane integrity as demonstrated by the ATP release and dye entry. In this context, its activity may depend on the membrane lipid composition. This molecule shows a preserved activity against bacterial pathogens presenting a noticeable multi-resistance phenotype against antibiotics such as polymyxin B. In this context and because of its structure, action and its relative insensitivity to efflux resistance mechanisms, we have demonstrated that squalamine appears as an alternate way to combat MDR pathogens and by pass the gap regarding the failure of new active antibacterial molecules.	[Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Letourneux, Yves; Pages, Jean-Marie] Fac Med & Pharm, UMR MD1, Marseille, France; [Brunel, Jean Michel] Univ Mediterranee, Fac Med, URMITE, UMR 6236, Marseille, France; [Fantini, Jacques; Maresca, Marc; Taieb, Nadira] Univ Paul Cezanne, Fac Sci St Jerome, CRN2M, CNRS UMR 6231, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Salmi, C (corresponding author), Fac Med & Pharm, UMR MD1, Marseille, France.	bruneljm@yahoo.fr	PAGES, jean-marie/F-2555-2013; Maresca, Marc/AAG-9148-2019	PAGES, jean-marie/0000-0001-7092-7977; Maresca, Marc/0000-0002-3585-4765; Fantini, Jacques/0000-0001-8653-5521; jean michel, brunel/0000-0002-9355-8980				Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Armstrong D, 1995, MICROB DRUG RESIST, V1, P1, DOI 10.1089/mdr.1995.1.1; Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; Brunel JM, 2005, CURR CANCER DRUG TAR, V5, P267, DOI 10.2174/1568009054064642; Brunel JM, 2003, EUR J ORG CHEM, V2003, P3897, DOI 10.1002/ejoc.200300167; Burns MR, 2005, BIOORGAN MED CHEM, V13, P2523, DOI 10.1016/j.bmc.2005.01.038; Dean CR, 2005, ANTIMICROB AGENTS CH, V49, P3129, DOI 10.1128/AAC.49.8.3129-3135.2005; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; LABISCHINSKI H, 1985, J BACTERIOL, V162, P9, DOI 10.1128/JB.162.1.9-20.1985; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Niven GW, 1998, J APPL MICROBIOL, V84, P90, DOI 10.1046/j.1365-2672.1997.00316.x; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Rao MN, 2000, J NAT PROD, V63, P631, DOI 10.1021/np990514f; Selinsky BS, 1998, BBA-BIOMEMBRANES, V1370, P218, DOI 10.1016/S0005-2736(97)00265-4; Sol V, 2004, BIOORG MED CHEM LETT, V14, P4207, DOI 10.1016/j.bmcl.2004.06.016; STONE R, 1993, SCIENCE, V259, P1125, DOI 10.1126/science.8438163; Thiolas A, 2005, ANTIMICROB AGENTS CH, V49, P1354, DOI 10.1128/AAC.49.4.1354-1358.2005; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Yasuda K, 2004, INT J ANTIMICROB AG, V24, P67, DOI 10.1016/j.ijantimicag.2004.01.006; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U; ZASLOFF M, 1994, PHYLOGENET PERSPECT, P31; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	41	39	47	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2765	10.1371/journal.pone.0002765	http://dx.doi.org/10.1371/journal.pone.0002765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648511	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900035
J	Buschdorf, JP; Chew, LL; Soh, UJK; Liou, YC; Low, BC				Buschdorf, Jan Paul; Chew, Li Li; Soh, Unice Jim Kim; Liou, Yih-Cherng; Low, Boon Chuan			Nerve Growth Factor Stimulates Interaction of Cayman Ataxia Protein BNIP-H/Caytaxin with Peptidyl-Prolyl Isomerase Pin1 in Differentiating Neurons	PLOS ONE			English	Article							DEPENDENT PROLINE ISOMERIZATION; CDC42GAP HOMOLOGY/SEC14P-LIKE; SIGNALING PATHWAYS; CARBOXYL-TERMINUS; CYCLIN-E; S-ALPHA; PHOSPHORYLATION; DOMAIN; APOPTOSIS; CAYTAXIN	Mutations in ATCAY that encodes the brain-specific protein BNIP-H (or Caytaxin) lead to Cayman cerebellar ataxia. BNIP-H binds to glutaminase, a neurotransmitter-producing enzyme, and affects its activity and intracellular localization. Here we describe the identification and characterization of the binding between BNIP-H and Pin1, a peptidyl-prolyl cis/trans isomerase. BNIP-H interacted with Pin1 after nerve growth factor-stimulation and they co-localized in the neurites and cytosol of differentiating pheochromocytoma PC12 cells and the embryonic carcinoma P19 cells. Deletional mutagenesis revealed two cryptic binding sites within the C-terminus of BNIP-H such that single point mutants affecting the WW domain of Pin1 completely abolished their binding. Although these two sites do not contain any of the canonical Pin1-binding motifs they showed differential binding profiles to Pin1 WW domain mutants S16E, S16A and W34A, and the catalytically inert C113A of its isomerase domain. Furthermore, their direct interaction would occur only upon disrupting the ability of BNIP-H to form an intramolecular interaction by two similar regions. Furthermore, expression of Pin1 disrupted the BNIP-H/ glutaminase complex formation in PC12 cells under nerve growth factor-stimulation. These results indicate that nerve growth factor may stimulate the interaction of BNIP-H with Pin1 by releasing its intramolecular inhibition. Such a mechanism could provide a post-translational regulation on the cellular activity of BNIP-H during neuronal differentiation. (213 words)	[Buschdorf, Jan Paul; Chew, Li Li; Soh, Unice Jim Kim; Liou, Yih-Cherng; Low, Boon Chuan] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Buschdorf, JP (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/H-8049-2012; Low, Boon Chuan/AAU-7685-2021	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X	Young Investigator Award; Biomedical Research Council of Singapore	Young Investigator Award; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Young Investigator Award to B.C.L. and a grant from the Biomedical Research Council of Singapore.	Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Dourlen P, 2007, BBA-MOL CELL RES, V1773, P1428, DOI 10.1016/j.bbamcr.2007.05.012; Gilbert N, 2004, HUM MUTAT, V24, P9, DOI 10.1002/humu.20060; Grelle G, 2006, MOL CELL PROTEOMICS, V5, P234, DOI 10.1074/mcp.M500198-MCP200; Hayakawa Y, 2007, BRAIN RES, V1129, P100, DOI 10.1016/j.brainres.2006.10.068; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kapfhamer D, 1996, GENOMICS, V35, P533, DOI 10.1006/geno.1996.0394; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Li MG, 2008, BIOCHEMISTRY-US, V47, P292, DOI 10.1021/bi701819k; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Lua BL, 2004, MOL BIOL CELL, V15, P2873, DOI 10.1091/mbc.E04-02-0141; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xiao J, 2007, NEUROSCIENCE, V144, P439, DOI 10.1016/j.neuroscience.2006.09.042; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2006, ONCOGENE, V25, P2393, DOI 10.1038/sj.onc.1209274; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200	46	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2686	10.1371/journal.pone.0002686	http://dx.doi.org/10.1371/journal.pone.0002686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628984	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200030
J	Davidson, RJ; Davis, I; Willey, BM; Rizg, K; Bolotin, S; Porter, V; Polsky, J; Daneman, N; McGeer, A; Yang, P; Scolnik, D; Rowsell, R; Imas, O; Silverman, MS				Davidson, Ross J.; Davis, Ian; Willey, Barbara M.; Rizg, Keyro; Bolotin, Shelly; Porter, Vanessa; Polsky, Jane; Daneman, Nick; McGeer, Allison; Yang, Paul; Scolnik, Dennis; Rowsell, Roy; Imas, Olga; Silverman, Michael S.			Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FLUOROQUINOLONE RESISTANCE; ANTIBIOTIC-RESISTANCE; SALMONELLA-ENTERICA; DNA; INHIBITION; ASSOCIATION; CHLOROQUINE; PNEUMONIAE; AGENTS	Background: Bacterial resistance to antibiotics is thought to develop only in the presence of antibiotic pressure. Here we show evidence to suggest that fluoroquinolone resistance in Escherichia coli has developed in the absence of fluoroquinolone use. Methods: Over 4 years, outreach clinic attendees in one moderately remote and five very remote villages in rural Guyana were surveyed for the presence of rectal carriage of ciprofloxacin-resistant Gram-negative bacilli (GNB). Drinking water was tested for the presence of resistant GNB by culture, and the presence of antibacterial agents and chloroquine by HPLC. The development of ciprofloxacin resistance in E. coli was examined after serial exposure to chloroquine. Patient and laboratory isolates of E. coli resistant to ciprofloxacin were assessed by PCR-sequencing for quinolone-resistance-determining-region (QRDR) mutations. Results: In the very remote villages, 4.8% of patients carried ciprofloxacin-resistant E. coli with QRDR mutations despite no local availability of quinolones. However, there had been extensive local use of chloroquine, with higher prevalence of resistance seen in the villages shortly after a Plasmodium vivax epidemic (p<0.01). Antibacterial agents were not found in the drinking water, but chloroquine was demonstrated to be present. Chloroquine was found to inhibit the growth of E. coli in vitro. Replica plating demonstrated that 2-step QRDR mutations could be induced in E. coli in response to chloroquine. Conclusions: In these remote communities, the heavy use of chloroquine to treat malaria likely selected for ciprofloxacin resistance in E. coli. This may be an important public health problem in malarious areas.	[Davidson, Ross J.] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada; [Davidson, Ross J.; Rizg, Keyro] Dalhousie Univ, Halifax, NS, Canada; [Davis, Ian; Rowsell, Roy; Silverman, Michael S.] Lakeridge Hlth Ctr, Oshawa, Canada; [Davis, Ian; Bolotin, Shelly; Daneman, Nick; McGeer, Allison; Scolnik, Dennis; Silverman, Michael S.] Univ Toronto, Toronto, ON, Canada; [Willey, Barbara M.; Porter, Vanessa; McGeer, Allison; Imas, Olga] Mt Sinai Hosp, Dept Microbiol, Toronto Med Lab, Toronto, ON, Canada; [Polsky, Jane] St Michaels Hosp, Dept Family Community Med, Toronto, ON, Canada; [Yang, Paul] Ontario Minist Environm, Etobicoke, Canada	Dalhousie University; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Davidson, RJ (corresponding author), Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada.	msilverman@rogers.com	mcgeer, allison/H-7747-2014; Silverman, Michael/J-3776-2014; McGeer, Allison/AAB-6885-2020	mcgeer, allison/0000-0001-5647-6137; Silverman, Michael/0000-0002-0389-7656; McGeer, Allison/0000-0001-5647-6137				[Anonymous], 2003, AFR MAL REP 2003; ANSELMO L, 1988, STAT PAR VILL CAPT M; Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; Arrow KJ, 2005, NEW ENGL J MED, V353, P333, DOI 10.1056/NEJMp058168; BARRETT TJ, 1994, J CLIN MICROBIOL, V32, P3013, DOI 10.1128/JCM.32.12.3013-3017.1994; Brenwald NP, 1997, J ANTIMICROB CHEMOTH, V40, P458, DOI 10.1093/jac/40.3.458; *BRIT GUYAN, 1959, 91 AM DIS BRIT GUYAN; BYRD TF, 1991, J CLIN INVEST, V88, P351, DOI 10.1172/JCI115301; *CDCP DEP HLTH HUM, GUID TREATM MAL US; Ciarrocchi G, 1999, ANTIMICROB AGENTS CH, V43, P2766, DOI 10.1128/AAC.43.11.2766; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; COHEN SN, 1965, P NATL ACAD SCI USA, V54, P521, DOI 10.1073/pnas.54.2.521; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hakanen A, 2001, EMERG INFECT DIS, V7, P996, DOI 10.3201/eid0706.010613; Hao CY, 2006, ANAL BIOANAL CHEM, V384, P505, DOI 10.1007/s00216-005-0199-y; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Jain Sudhir K., 2003, Indian Journal of Microbiology, V43, P147; JAMES T, 2003, IND RIGHTS COMM CAR; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lautenbach E, 2005, CLIN INFECT DIS, V41, P923, DOI 10.1086/432940; LESHER GY, 1962, J MED PHARMACEUT CH, V5, P1063, DOI 10.1021/jm01240a021; Leslie T, 2007, JAMA-J AM MED ASSOC, V297, P2201, DOI 10.1001/jama.297.20.2201; Liesegang A, 2002, INT J MED MICROBIOL, V291, P645, DOI 10.1078/1438-4221-00180; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Popelka P, 2003, B VET I PULAWY, V47, P203; Ruiz-Irastorza G, 2000, EXPERT OPIN INV DRUG, V9, P1581, DOI 10.1517/13543784.9.7.1581; SMITH KT, 1989, ARCH MICROBIOL, V152, P251, DOI 10.1007/BF00409659; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turnidge J, 2005, LANCET, V365, P548; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; WILLEMS TE, 2007, 47 INT C ANT AG CHEM, pA1290; 1991, 2 C AM PEOPL GUYAN A	36	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2727	10.1371/journal.pone.0002727	http://dx.doi.org/10.1371/journal.pone.0002727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648533	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200065
J	Endo, Y; Deonauth, K; Prahalad, P; Hoxter, B; Zhu, YL; Byers, SW				Endo, Yoshimi; Deonauth, Kamla; Prahalad, Priya; Hoxter, Becky; Zhu, Yuelin; Byers, Stephen W.			Role of Sox-9, ER81 and VE-Cadherin in Retinoic Acid-Mediated Trans-Differentiation of Breast Cancer Cells	PLOS ONE			English	Article								Many aspects of development, tumor growth and metastasis depend upon the provision of an adequate vasculature. This can be a result of regulated angiogenesis, recruitment of circulating endothelial progenitors and/or vascular trans-differentiation. The present study demonstrates that treatment of SKBR-3 breast cancer cells with retinoic acid (RA), an important regulator of embryogenesis, cancer and other diseases, stimulates the formation of networks in Matrigel. RA-treatment of SKBR-3 cells co-cultured with human umbilical vein endothelial cells resulted in the formation of mixed structures. RA induces expression of many endothelial genes including vascular endothelial (VE) cadherin. VE-cadherin was also induced by RA in a number of other breast cancer cells. We show that RA-induced VE-cadherin is responsible for the RA-induced morphological changes. RA rapidly induced the expression of Sox-9 and ER81, which in turn form a complex on the VE-cadherin promoter and are required to mediate the transcriptional regulation of VE-cadherin by RA. These data indicate that RA may promote the expression of endothelial genes resulting in endothelial-like differentiation, or provide a mechanism whereby circulating endothelial progenitor cells could be incorporated into a growing organ or tumor.	[Endo, Yoshimi; Deonauth, Kamla; Prahalad, Priya; Hoxter, Becky; Zhu, Yuelin; Byers, Stephen W.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Deonauth, Kamla] Howard Univ, Dept Biol, Washington, DC USA	Georgetown University; Howard University	Endo, Y (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu	Zhu, Yuelin/ABD-5743-2021	Zhu, Yuelin/0000-0003-2762-0755	NIH [DK058196, U54CA100971, CA129813]; DOD [W81XWH-08-1-0103]; NATIONAL CANCER INSTITUTE [U54CA100971, R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to acknowledge the support of NIHDK058196, NIHU54CA100971 and NIH CA129813 (SWB), DOD W81XWH-08-1-0103 (PP) and the following LCCC Core Facilities: microscopy, tissue culture, macromolecular analysis and microarray.	Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Birchmeier C, 1996, ACTA ANAT, V156, P217; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cavallaro U, 2006, EXP CELL RES, V312, P659, DOI 10.1016/j.yexcr.2005.09.019; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2000, BREAST CANCER RES, V2, P417, DOI 10.1186/bcr88; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lelievre E, 2001, B CANCER, V88, P137; Lelievre E, 2000, ONCOGENE, V19, P2438, DOI 10.1038/sj.onc.1203563; Liao F, 2000, CANCER RES, V60, P6805; Lionneton F, 2003, ONCOGENE, V22, P9156, DOI 10.1038/sj.onc.1207241; Montero JA, 2002, MECH DEVELOP, V118, P199, DOI 10.1016/S0925-4773(02)00249-6; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Rahkonen O, 2003, HISTOCHEM CELL BIOL, V120, P103, DOI 10.1007/s00418-003-0549-9; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shirakawa K, 2002, BRIT J CANCER, V87, P1454, DOI 10.1038/sj.bjc.6600610; Shirakawa K, 2002, CANCER RES, V62, P560; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu K, 2000, CLIN CANCER RES, V6, P3696; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; N ENGL J MED, V330, P1029	42	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2714	10.1371/journal.pone.0002714	http://dx.doi.org/10.1371/journal.pone.0002714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628953	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200057
J	Hemelrijk, CK; Wantia, J; Isler, K				Hemelrijk, Charlotte K.; Wantia, Jan; Isler, Karin			Female Dominance over Males in Primates: Self-Organisation and Sexual Dimorphism	PLOS ONE			English	Article							BONOBOS PAN-PANISCUS; AGGRESSIVE-BEHAVIOR; JAPANESE MACAQUES; ANIMAL SOCIETIES; SOCIAL-STRUCTURE; MATING SEASON; CAPTIVE GROUP; BODY-WEIGHT; MONKEYS; HIERARCHIES	The processes that underlie the formation of the dominance hierarchy in a group are since long under debate. Models of self-organisation suggest that dominance hierarchies develop by the self-reinforcing effects of winning and losing fights (the so-called winner-loser effect), but according to 'the prior attribute hypothesis', dominance hierarchies develop from pre-existing individual differences, such as in body mass. In the present paper, we investigate the relevance of each of these two theories for the degree of female dominance over males. We investigate this in a correlative study in which we compare female dominance between groups of 22 species throughout the primate order. In our study female dominance may range from 0 (no female dominance) to 1 (complete female dominance). As regards ` the prior attribute hypothesis', we expected a negative correlation between female dominance over males and species-specific sexual dimorphism in body mass. However, to our surprise we found none (we use the method of independent contrasts). Instead, we confirm the self-organisation hypothesis: our model based on the winner-loser effect predicts that female dominance over males increases with the percentage of males in the group. We confirm this pattern at several levels in empirical data (among groups of a single species and between species of the same genus and of different ones). Since the winner-loser effect has been shown to work in many taxa including humans, these results may have broad implications.	[Hemelrijk, Charlotte K.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [Wantia, Jan] Univ Zurich, Dept Informat, Zurich, Switzerland; [Isler, Karin] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Groningen; University of Zurich; University of Zurich	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands.	C.K.Hemelrijk@rug.nl	Isler, Karin/A-9566-2008; Hemelrijk, Charlotte K./E-4828-2013	Isler, Karin/0000-0002-2391-1523; Hemelrijk, Charlotte K./0000-0001-6160-077X	Swiss National Science Foundation [3100-065444, 3100A0-117789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are grateful to the Swiss national Science foundation for partial support to Jan Wantia (grant no. 3100-065444) and Karin (grant no. 3100A0-117789).	Barchas P. R., 1984, SOCIAL HIERARCHIES E, P81; BEACHAM JL, 1988, ANIM BEHAV, V36, P621, DOI 10.1016/S0003-3472(88)80042-3; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; Bernstein I.S., 1983, P535; BERNSTEIN IS, 1985, INT J PRIMATOL, V6, P209; BERNSTEIN IS, 1980, ANIM BEHAV, V28, P1033, DOI 10.1016/S0003-3472(80)80092-3; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; Bout N, 2005, INT J PRIMATOL, V26, P1215, DOI 10.1007/s10764-005-8850-1; Brosnan SF, 2003, ETHOLOGY, V109, P823, DOI 10.1046/j.0179-1613.2003.00928.x; Butovskaya M, 1996, PRIMATES, V37, P261, DOI 10.1007/BF02381858; CALDECOTT JO, 1986, ANIM BEHAV, V34, P208, DOI 10.1016/0003-3472(86)90025-4; Chase ID, 2003, BEHAVIOUR, V140, P1193, DOI 10.1163/156853903771980558; CHASE ID, 1974, BEHAV SCI, V19, P374, DOI 10.1002/bs.3830190604; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; CHASE ID, 1982, SCIENCE, V216, P439, DOI 10.1126/science.216.4544.439; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Cooper MA, 2008, INT J PRIMATOL, V29, P225, DOI 10.1007/s10764-008-9236-y; DIGBY LJ, 1995, PRIMATES, V36, P361, DOI 10.1007/BF02382859; Digby LJ, 2002, PRIMATES, V43, P191, DOI 10.1007/BF02629647; DIJKSTRA PD, 2006, THESIS U GRONINGEN N; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P433, DOI 10.1098/rspb.1998.0313; Dugatkin LA, 2001, BEHAV ECOL, V12, P348, DOI 10.1093/beheco/12.3.348; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; EATON GG, 1984, INT J PRIMATOL, V5, P145, DOI 10.1007/BF02735738; ELLIS L, 1994, SOCIAL STRATIFICATIO, V2, P145; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; ESTRADA A, 1977, Primates, V18, P647, DOI 10.1007/BF02383141; Feistner AT., 1989, THESIS U STIRLING ST; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GIROD P, 2002, SELF ORG EVOLUTION S, P115; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hemelrijk Charlotte K., 2004, Interaction Studies, V5, P131, DOI 10.1075/is.5.1.07hem; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, NEUROSCI BIOBEHAV R, V29, P125, DOI 10.1016/j.neubiorev.2004.07.003; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1247, DOI 10.1163/156853903771980585; Hemelrijk CK, 2002, BEHAVIOUR, V139, P729, DOI 10.1163/156853902320262790; Hemelrijk CK, 1999, LECT NOTES ARTIF INT, V1674, P524; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; HEMELRIJK CK, 2004, MACAQUE SOC MODEL ST, P295; HEMELRIJK CK, 2002, PRIMATOLOGY ANTHR S1, V1, P91; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; Johnstone RA, 2000, P ROY SOC B-BIOL SCI, V267, P17, DOI 10.1098/rspb.2000.0960; JONES C B, 1980, Primates, V21, P389, DOI 10.1007/BF02390468; Kappeler Peter M., 1993, Perspectives in Ethology, V10, P143; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; Kappeler PM, 1993, LEMUR SOCIAL SYSTEMS; Magnhagen C, 2006, ANIM BEHAV, V71, P879, DOI 10.1016/j.anbehav.2005.07.017; Marvan R, 2006, FOLIA PRIMATOL, V77, P364, DOI 10.1159/000093702; MASATAKA N, 1987, BEHAVIOUR, V101, P311, DOI 10.1163/156853987X00035; MEDER A, 1985, ZOO BIOL, V4, P1, DOI 10.1002/zoo.1430040102; MEHLMAN PT, 1988, PRIMATES, V29, P195, DOI 10.1007/BF02381122; MENDOZA SP, 1983, J HUM EVOL, V12, P185, DOI 10.1016/S0047-2484(83)80023-2; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; OI T, 1990, INT J PRIMATOL, V11, P339, DOI 10.1007/BF02193005; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Ostner J, 1999, ANIM BEHAV, V58, P1069, DOI 10.1006/anbe.1999.1222; Ostner J, 2003, NATURWISSENSCHAFTEN, V90, P141, DOI 10.1007/s00114-003-0404-9; Overdorff DJ, 2005, AM J PRIMATOL, V66, P7, DOI 10.1002/ajp.20125; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; Parish AR, 2000, ANN NY ACAD SCI, V907, P97; PEREIRA ME, 1990, FOLIA PRIMATOL, V55, P96, DOI 10.1159/000156505; Plavcan JM, 1997, AM J PHYS ANTHROPOL, V103, P37, DOI 10.1002/(SICI)1096-8644(199705)103:1<37::AID-AJPA4>3.0.CO;2-A; POCHRON ST, 2005, AM J PRIMATOL, V61, P173; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RHINE R J, 1972, Primates, V13, P181, DOI 10.1007/BF01840879; RHINE R J, 1972, Primates, V13, P19, DOI 10.1007/BF01757933; RHINE R J, 1973, Primates, V14, P21, DOI 10.1007/BF01730513; Rosenblum L.A., 1971, INFLUENCE HORMONES N, P388; Rowe N, 1996, PICTORIAL GUIDE LIVI; Sade D.S., 1967, P99; SADE DS, 1972, FOLIA PRIMATOL, V18, P196, DOI 10.1159/000155480; SAPOLSKY RM, 1994, AM J PRIMATOL, V32, P261, DOI 10.1002/ajp.1350320404; SAUTHER ML, 1993, LEMUR SOCIAL SYSTEMS; Setchell JM, 2006, AM J PRIMATOL, V68, P411, DOI 10.1002/ajp.20234; Smuts B.B., 1987, P400; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Soltis J, 1999, PRIMATES, V40, P453, DOI 10.1007/BF02557581; Sommer V, 2002, ANIM BEHAV, V63, P637, DOI 10.1006/anbe.2001.1897; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Sterck EHM, 1997, BEHAVIOUR, V134, P749, DOI 10.1163/156853997X00052; STRUHSAK.TT, 1967, BEHAVIOUR, V29, P83, DOI 10.1163/156853967X00073; THERAULAZ G, 1995, J THEOR BIOL, V174, P313, DOI 10.1006/jtbi.1995.0101; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; THIERRY B, 1990, INT J PRIMATOL, V11, P357, DOI 10.1007/BF02193006; Thierry Bernard, 2000, P106; VARLEY M, 1966, BEHAVIOUR, V27, P54, DOI 10.1163/156853966X00100; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; Verbeek MEM, 1999, BEHAVIOUR, V136, P23, DOI 10.1163/156853999500659; Vervaecke H, 2000, BEHAVIOUR, V137, P1463, DOI 10.1163/156853900502673; Waeber PO, 2003, BEHAVIOUR, V140, P1235, DOI 10.1163/156853903771980576; WANTIA J, 2007, THESIS RIJKS U GRONI; [No title captured]	107	53	53	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2678	10.1371/journal.pone.0002678	http://dx.doi.org/10.1371/journal.pone.0002678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628830	Green Submitted, Green Published, gold			2022-12-25	WOS:000264057200023
J	Kamrud, KI; Alterson, KD; Andrews, C; Copp, LO; Lewis, WC; Hubby, B; Patel, D; Rayner, JO; Talarico, T; Smith, JF				Kamrud, Kurt I.; Alterson, Kim D.; Andrews, Chasity; Copp, Laura O.; Lewis, Whitney C.; Hubby, Bolyn; Patel, Deepa; Rayner, Jonathan O.; Talarico, Todd; Smith, Jonathan F.			Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats	PLOS ONE			English	Article							PROTECT GUINEA-PIGS; MAJOR ENVELOPE PROTEINS; ALPHA/BETA-INTERFERON; BOTULINUM NEUROTOXIN; ATTENUATED MUTANTS; IMMUNE-RESPONSES; RAPID CLEARANCE; ARTERITIS VIRUS; MARBURG VIRUS; IN-VITRO	Background: The Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein ( GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo. Methodology/Principal Findings: The VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers. Conclusions/Significance: We suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.	[Kamrud, Kurt I.; Alterson, Kim D.; Andrews, Chasity; Lewis, Whitney C.; Patel, Deepa; Talarico, Todd; Smith, Jonathan F.] AlphaVax Inc, Res Triangle Pk, NC USA; [Copp, Laura O.; Hubby, Bolyn] Liquidia Technol Inc, Res Triangle Pk, NC USA; [Rayner, Jonathan O.] Midwest Res Inst, Kansas City, MO USA		Kamrud, KI (corresponding author), AlphaVax Inc, Res Triangle Pk, NC USA.	kamrud@alphavax.com		Rayner, Jonathan/0000-0002-2091-7604	NIH [5U01AI53876-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI053876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant 5U01AI53876-02	Aronson JF, 2000, VIROLOGY, V270, P111, DOI 10.1006/viro.2000.0241; Balasuriya UBR, 2002, VACCINE, V20, P1609, DOI 10.1016/S0264-410X(01)00485-6; Balasuriya UBR, 2000, J VIROL, V74, P10623, DOI 10.1128/JVI.74.22.10623-10630.2000; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; DAVIS NL, 1995, VIROLOGY, V212, P102, DOI 10.1006/viro.1995.1458; Davis NL, 2002, IUBMB LIFE, V53, P209, DOI 10.1080/15216540212657; Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; DAVIS NL, 1991, VIROLOGY, V183, P20, DOI 10.1016/0042-6822(91)90114-Q; DAVIS NL, 1994, ARCH VIROL, P99; GRIEDER FB, 1995, VIROLOGY, V206, P994, DOI 10.1006/viro.1995.1022; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; JAHRLING PB, 1977, INFECT IMMUN, V17, P356, DOI 10.1128/IAI.17.2.356-360.1977; JOHNSTON RE, 1988, VIROLOGY, V162, P437, DOI 10.1016/0042-6822(88)90484-9; Johnston RE, 2005, VACCINE, V23, P4969, DOI 10.1016/j.vaccine.2005.05.034; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; Lee JS, 2006, VACCINE, V24, P6886, DOI 10.1016/j.vaccine.2006.06.004; Lee JS, 2002, J INFECT DIS, V185, P1192, DOI 10.1086/339677; Lee JS, 2003, INFECT IMMUN, V71, P1491, DOI 10.1128/IAI.71.3.1491-1496.2003; Lee JS, 2001, INFECT IMMUN, V69, P5709, DOI 10.1128/IAI.69.9.5709-5715.2001; Ludwig George V., 2001, American Journal of Tropical Medicine and Hygiene, V64, P49; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Montgomery SA, 2006, J VIROL, V80, P7729, DOI 10.1128/JVI.00425-06; Nelson EL, 2003, BREAST CANCER RES TR, V82, P169, DOI 10.1023/B:BREA.0000004373.09678.bb; NELSON EL, 2004, CANC DRUG DISC DEV, P203; Nishimoto KP, 2007, VIRAL IMMUNOL, V20, P88, DOI 10.1089/vim.2006.0090; Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003; Pushko P, 1997, VIROLOGY, V239, P389, DOI 10.1006/viro.1997.8878; Pushko P, 2001, J VIROL, V75, P11677, DOI 10.1128/JVI.75.23.11677-11685.2001; Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4; Reap EA, 2007, CLIN VACCINE IMMUNOL, V14, P748, DOI 10.1128/CVI.00037-07; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Schultz-Cherry S, 2000, VIROLOGY, V278, P55, DOI 10.1006/viro.2000.0635; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Turell MJ, 1999, AM J TROP MED HYG, V60, P1041, DOI 10.4269/ajtmh.1999.60.1041; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wilson JA, 2001, VIROLOGY, V286, P384, DOI 10.1006/viro.2001.1012; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001	45	7	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2709	10.1371/journal.pone.0002709	http://dx.doi.org/10.1371/journal.pone.0002709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628938	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200052
J	Konrad, R; Ferry, N; Gatehouse, AMR; Babendreier, D				Konrad, Roger; Ferry, Natalie; Gatehouse, Angharad M. R.; Babendreier, Dirk			Potential Effects of Oilseed Rape Expressing Oryzacystatin-1 (OC-1) and of Purified Insecticidal Proteins on Larvae of the Solitary Bee Osmia bicornis	PLOS ONE			English	Article							BT CORN POLLEN; APIS-MELLIFERA; HONEY-BEES; PROTEASE INHIBITORS; SNOWDROP LECTIN; TRANSGENE PRODUCTS; LIGNARIA HYMENOPTERA; LEARNING-ABILITIES; DIGESTIVE ENZYMES; RISK-ASSESSMENT	Despite their importance as pollinators in crops and wild plants, solitary bees have not previously been included in nontarget testing of insect-resistant transgenic crop plants. Larvae of many solitary bees feed almost exclusively on pollen and thus could be highly exposed to transgene products expressed in the pollen. The potential effects of pollen from oilseed rape expressing the cysteine protease inhibitor oryzacystatin-1 (OC-1) were investigated on larvae of the solitary bee Osmia bicornis (= O. rufa). Furthermore, recombinant OC-1 (rOC-1), the Bt toxin Cry1Ab and the snowdrop lectin Galanthus nivalis agglutinin (GNA) were evaluated for effects on the life history parameters of this important pollinator. Pollen provisions from transgenic OC-1 oilseed rape did not affect overall development. Similarly, high doses of rOC-1 and Cry1Ab as well as a low dose of GNA failed to cause any significant effects. However, a high dose of GNA (0.1%) in the larval diet resulted in significantly increased development time and reduced efficiency in conversion of pollen food into larval body weight. Our results suggest that OC-1 and Cry1Ab expressing transgenic crops would pose a negligible risk for O. bicornis larvae, whereas GNA expressing plants could cause detrimental effects, but only if bees were exposed to high levels of the protein. The described bioassay with bee brood is not only suitable for early tier non-target tests of transgenic plants, but also has broader applicability to other crop protection products.	[Konrad, Roger; Babendreier, Dirk] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Ferry, Natalie; Gatehouse, Angharad M. R.] Newcastle Univ, Sch Biol, Inst Res Env & Sustainabil, Newcastle Upon Tyne, Tyne & Wear, England	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Newcastle University - UK	Konrad, R (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	roger.konrad@art.admin.ch		Gatehouse, Angharad/0000-0002-6406-2927; Ferry, Natalie/0000-0003-3728-4302	Swiss Office for the Environment (FOEN)	Swiss Office for the Environment (FOEN)	This research was financially supported by the Swiss Office for the Environment (FOEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1987, AGR BIOL CHEM TOKYO, V51, P2763; Abel CA, 2003, J ENTOMOL SCI, V38, P545, DOI 10.18474/0749-8004-38.4.545; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2008, ENTOMOL EXP APPL, V126, P148, DOI 10.1111/j.1570-7458.2007.00652.x; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Bell HA, 2004, AGR FOREST ENTOMOL, V6, P215, DOI 10.1111/j.1461-9555.2004.00225.x; BELZUNCES LP, 1994, COMP BIOCHEM PHYS B, V109, P63, DOI 10.1016/0305-0491(94)90142-2; BONADEBOTTINO M, 1993, DEFENCE COLZA INSECT; Bosch J, 2006, J ECON ENTOMOL, V99, P408, DOI 10.1603/0022-0493-99.2.408; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; BOSCH J, BEE POLLINA IN PRESS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Burgess EPJ, 1996, J INSECT PHYSIOL, V42, P823, DOI 10.1016/0022-1910(96)00045-5; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Cox D.R., 1990, ANAL SURVIVAL DATA; Down RE, 1996, J INSECT PHYSIOL, V42, P1035, DOI 10.1016/S0022-1910(96)00065-0; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2003, MOL ECOL, V12, P493, DOI 10.1046/j.1365-294X.2003.01736.x; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gatehouse AMR, 1997, MOL BREEDING, V3, P49, DOI 10.1023/A:1009600321838; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Girard C, 1998, TRANSGENIC RES, V7, P239, DOI 10.1023/A:1008813910751; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hanley AV, 2003, J APICULT RES, V42, P77, DOI 10.1080/00218839.2003.11101097; HILDER VA, 1995, TRANSGENIC RES, V4, P18, DOI 10.1007/BF01976497; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; HOGERVORST PAM, 2008, AGR ENTOMOL IN PRESS; HOLM S, 1979, SCAND J STAT, V6, P65; JAMES C, 2007, ISAAA BRIEF; JOUANIN L, 2000, RECOMBINANT PROTEASE, P179; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LEACH ML, 1994, J ECON ENTOMOL, V87, P311, DOI 10.1093/jee/87.2.311; Lehrman Anna, 2007, Environmental Biosafety Research, V6, P271, DOI 10.1051/ebr:2007039; MALONE LA, 1995, J ECON ENTOMOL, V88, P46, DOI 10.1093/jee/88.1.46; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; Malone LA, 1998, J INSECT PHYSIOL, V44, P141, DOI 10.1016/S0022-1910(97)00096-6; McGregor S. E., 1976, Agriculture Handbook, United States Department of Agriculture; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; O'Toole Christopher, 1993, P169; Pham-Delegue MH, 2000, ENTOMOL EXP APPL, V95, P21, DOI 10.1023/A:1003923309473; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; RAW A, 1974, OIKOS, V25, P54, DOI 10.2307/3543545; Romeis J, 2003, OECOLOGIA, V134, P528, DOI 10.1007/s00442-002-1144-9; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Roshchina VV., 1993, EXCRETORY FUNCTION H, DOI [10.1007/978-3-642-78130-8, DOI 10.1007/978-3-642-78130-8]; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sick Martina, 2004, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V14, P423; TASEI JN, 1988, APIDOLOGIE, V19, P291, DOI 10.1051/apido:19880308; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Tesoriero Donato, 2003, Bulletin of Insectology, V56, P169; Thompson HM, 1999, ECOTOXICOLOGY, V8, P147, DOI 10.1023/A:1026444029579; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Westcott L, 2001, BEE WORLD, V82, P115, DOI 10.1080/0005772X.2001.11099514; Westerkamp C, 2000, CROP SCI, V40, P1209, DOI 10.2135/cropsci2000.4051209x; Westrich P., 1990, WILDBIENEN BADEN WUR; Wilkaniec Z, 2003, J APICULT RES, V42, P29, DOI 10.1080/00218839.2003.11101084; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x	67	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2664	10.1371/journal.pone.0002664	http://dx.doi.org/10.1371/journal.pone.0002664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628826	Green Published, Green Accepted, gold			2022-12-25	WOS:000264057200010
J	Long, HH; Schmidt, DD; Baldwin, IT				Long, Hoang Hoa; Schmidt, Dominik D.; Baldwin, Ian T.			Native Bacterial Endophytes Promote Host Growth in a Species-Specific Manner; Phytohormone Manipulations Do Not Result in Common Growth Responses	PLOS ONE			English	Article								Background: All plants in nature harbor a diverse community of endophytic bacteria which can positively affect host plant growth. Changes in plant growth frequently reflect alterations in phytohormone homoeostasis by plant-growth-promoting (PGP) rhizobacteria which can decrease ethylene (ET) levels enzymatically by 1-aminocyclopropane-1-carboxylate (ACC) deaminase or produce indole acetic acid (IAA). Whether these common PGP mechanisms work similarly for different plant species has not been rigorously tested. Methodology/Principal Findings: We isolated bacterial endophytes from field-grown Solanum nigrum; characterized PGP traits (ACC deaminase activity, IAA production, phosphate solubilization and seedling colonization); and determined their effects on their host, S. nigrum, as well as on another Solanaceous native plant, Nicotiana attenuata. In S. nigrum, a majority of isolates that promoted root growth were associated with ACC deaminase activity and IAA production. However, in N. attenuata, IAA but not ACC deaminase activity was associated with root growth. Inoculating N. attenuata and S. nigrum with known PGP bacteria from a culture collection (DSMZ) reinforced the conclusion that the PGP effects are not highly conserved. Conclusions/Significance: We conclude that natural endophytic bacteria with PGP traits do not have general and predictable effects on the growth and fitness of all host plants, although the underlying mechanisms are conserved.	[Long, Hoang Hoa; Schmidt, Dominik D.; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Jena, Germany	Max Planck Society	Long, HH (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society.	ABDULBAK.AA, 1973, CROP SCI, V13, P630, DOI 10.2135/cropsci1973.0011183X001300060013x; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Bent E, 1998, CAN J MICROBIOL, V44, P980, DOI 10.1139/cjm-44-10-980; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Cakmakci R, 2007, J PLANT NUTR SOIL SC, V170, P288, DOI 10.1002/jpln.200625105; CARROLL GC, 1999, FORAGING ASCOMYCETE, P309; Chanway CP, 1997, FOREST SCI, V43, P99; Chanway CP, 2000, FOREST ECOL MANAG, V133, P81, DOI 10.1016/S0378-1127(99)00300-X; COSTA JM, 1994, MOL PLANT MICROBE IN, V7, P440, DOI 10.1094/MPMI-7-0440; Diallo MD, 2004, SYST APPL MICROBIOL, V27, P238, DOI 10.1078/072320204322881862; Domenech J, 2007, PLANT SOIL, V290, P43, DOI 10.1007/s11104-006-9089-0; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kogel KH, 2006, CURR OPIN PLANT BIOL, V9, P358, DOI 10.1016/j.pbi.2006.05.001; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Long HH, 2003, J FAC AGR KYUSHU U, V48, P21; Madhaiyan M, 2006, PLANTA, V224, P268, DOI 10.1007/s00425-005-0211-y; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Oldroyd GED, 2005, PLANT PHYSIOL, V137, P1205, DOI 10.1104/pp.104.057661; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Prayitno J, 2006, PLANT PHYSIOL, V142, P168, DOI 10.1104/pp.106.080093; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schmidt DD, 2004, MOL ECOL, V13, P981, DOI 10.1111/j.1365-294X.2004.02111.x; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sergeeva E, 2007, PLANT SOIL, V297, P1, DOI 10.1007/s11104-007-9314-5; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; von Dahl CC, 2007, J PLANT GROWTH REGUL, V26, P201, DOI 10.1007/s00344-007-0014-4; Wakelin SA, 2004, BIOL FERT SOILS, V40, P36, DOI 10.1007/s00374-004-0750-6; Wang K, 2007, NEW PHYTOL, V174, P212, DOI 10.1111/j.1469-8137.2007.01999.x; Wold A, 1996, SEED SCI TECHNOL, V24, P95; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zinniel DK, 2002, APPL ENVIRON MICROB, V68, P2198, DOI 10.1128/AEM.68.5.2198-2208.2002	40	161	171	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2702	10.1371/journal.pone.0002702	http://dx.doi.org/10.1371/journal.pone.0002702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628963	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200045
J	Yu, Y; Zhang, HM; Tian, F; Zhang, WS; Fang, HB; Song, JZ				Yu, Ying; Zhang, Huanmin; Tian, Fei; Zhang, Wensheng; Fang, Hongbin; Song, Jiuzhou			An Integrated Epigenetic and Genetic Analysis of DNA Methyltransferase Genes (DNMTs) in Tumor Resistant and Susceptible Chicken Lines	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER METHYLATION; MAREKS-DISEASE; DE-NOVO; CANCER; EXPRESSION; EVOLUTION; VARIANTS; PATTERNS; STRAINS	Both epigenetic alterations and genetic variations play essential roles in tumorigenesis. The epigenetic modification of DNA methylation is catalyzed and maintained by the DNA methyltransferases (DNMT3a, DNMT3b and DNMT1). DNA mutations and DNA methylation profiles of DNMTs themselves and their relationships with chicken neoplastic disease resistance and susceptibility are not yet defined. In the present study, we analyzed the complexity of the DNA methylation variations and DNA mutations in the first exon of three DNMTs genes over generations, tissues, and ages among chickens of two highly inbred White Leghorn lines, Marek's disease-resistant line 6(3) and -susceptible line 7(2), and six recombinant congenic strains (RCSs). Among them, tissue-specific methylation patterns of DNMT3a were disclosed in spleen, liver, and hypothalamus in lines 6(3) and 7(2). The methylation level of DNMT3b on four CpG sites was not significantly different among four tissues of the two lines. However, two line-specific DNA transition mutations, CpG -> TpG (Chr20:10203733 and 10203778), were discovered in line 72 compared to the line 63 and RCSs. The methylation contents of DNMT1 in blood cell showed significant epimutations in the first CpG site among the two inbred lines and the six RCSs (P<0.05). Age-specific methylation of DNMT1 was detected in comparisons between 15 month-old and 2 month-old chickens in both lines except in spleen samples from line 72. No DNA mutations were discovered on the studied regions of DNMT1 and DNMT3a among the two lines and the six RCSs. Moreover, we developed a novel method that can effectively test the significance of DNA methylation patterns consisting of continuous CpG sites. Taken together, these results highlight the potential of epigenetic alterations in DNMT1 and DNMT3a, as well as the DNA mutations in DNMT3b, as epigenetic and genetic factors to neoplastic diseases of chickens.	[Yu, Ying; Tian, Fei; Zhang, Wensheng; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Zhang, Huanmin] USDA, ARS, Avian Dis & Oncol Lab, E Lansing, MI USA; [Fang, Hongbin] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Div Biostat, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore	Yu, Y (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020; Zhang, Huanmin/M-9792-2019	Zhang, Huanmin/0000-0003-4896-2391	Maryland State Funds	Maryland State Funds	Maryland State Funds	Bacon LD, 2004, AVIAN PATHOL, V33, P233, DOI 10.1080/0307943042000195731; Bacon LD, 2001, CURR TOP MICROBIOL, V255, P121; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Fadly A, 2003, DIS POULTRY, V11, P465; Gokul G, 2007, EPIGENETICS-US, V2, P80, DOI 10.4161/epi.2.2.3692; Jones JS, 2006, CANCER EPIDEM BIOMAR, V15, P886, DOI 10.1158/1055-9965.EPI-05-0644; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; LAUTER J, 1995, BIOMETRICS, P964; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nair V, 2005, VET J, V170, P175, DOI 10.1016/j.tvjl.2004.05.009; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Piyathilake CJ, 2001, HUM PATHOL, V32, P856, DOI 10.1053/hupa.2001.26471; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ray D, 2006, J GERONTOL A-BIOL, V61, P115, DOI 10.1093/gerona/61.2.115; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seligman SJ, 2006, J INFECT DIS, V193, P1187, DOI 10.1086/501504; Szyf M, 2006, B CANCER, V93, P961; Tebbutt SJ, 2007, CHEST, V131, P1216, DOI 10.1378/chest.06-2252; TOST J, 2008, EPIGENETICS CAISTER; Tost Jorg, 2007, V373, P89; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang YZ, 2007, CANCER CELL, V11, P308, DOI 10.1016/j.ccr.2007.03.017; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; Zhang HM, 2007, AVIAN PATHOL, V36, P283, DOI 10.1080/03079450701449248; Zhang HM, 2006, POULTRY SCI, V85, P844, DOI 10.1093/ps/85.5.844; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	50	21	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2672	10.1371/journal.pone.0002672	http://dx.doi.org/10.1371/journal.pone.0002672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648519	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200017
J	Graham, LA; Lougheed, SC; Ewart, KV; Davies, PL				Graham, Laurie A.; Lougheed, Stephen C.; Ewart, K. Vanya; Davies, Peter L.			Lateral Transfer of a Lectin-Like Antifreeze Protein Gene in Fishes	PLOS ONE			English	Article							EVOLUTION; GENOME; RESISTANCE; ENHANCEMENT; SIMILARITY; ELEMENTS; REVEALS; WATER; DNA	Fishes living in icy seawater are usually protected from freezing by endogenous antifreeze proteins (AFPs) that bind to ice crystals and stop them from growing. The scattered distribution of five highly diverse AFP types across phylogenetically disparate fish species is puzzling. The appearance of radically different AFPs in closely related species has been attributed to the rapid, independent evolution of these proteins in response to natural selection caused by sea level glaciations within the last 20 million years. In at least one instance the same type of simple repetitive AFP has independently originated in two distant species by convergent evolution. But, the isolated occurrence of three very similar type II AFPs in three distantly related species (herring, smelt and sea raven) cannot be explained by this mechanism. These globular, lectin-like AFPs have a unique disulfide-bonding pattern, and share up to 85% identity in their amino acid sequences, with regions of even higher identity in their genes. A thorough search of current databases failed to find a homolog in any other species with greater than 40% amino acid sequence identity. Consistent with this result, genomic Southern blots showed the lectin-like AFP gene was absent from all other fish species tested. The remarkable conservation of both intron and exon sequences, the lack of correlation between evolutionary distance and mutation rate, and the pattern of silent vs non-silent codon changes make it unlikely that the gene for this AFP pre-existed but was lost from most branches of the teleost radiation. We propose instead that lateral gene transfer has resulted in the occurrence of the type II AFPs in herring, smelt and sea raven and allowed these species to survive in an otherwise lethal niche.	[Graham, Laurie A.; Davies, Peter L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Lougheed, Stephen C.; Davies, Peter L.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Ewart, K. Vanya; Davies, Peter L.] NRC Inst Marine Biosci, Halifax, NS, Canada	Queens University - Canada; Queens University - Canada; National Research Council Canada	Graham, LA (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca			Canadian Institutes for Health Research; Natural Sciences and Engineering Research Councils	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Councils	This work was funded by grants to P.L.D. and K.V.E. from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Councils, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Cheng CHC, 2007, PHILOS T R SOC B, V362, P2215, DOI 10.1098/rstb.2006.1946; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Davies PL, 1993, FISH BIOCH MOL BIOL, P279; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; DUNDAS IED, 1986, MAR ECOL PROG SER, V30, P287, DOI 10.3354/meps030287; Ewart K. Vanya, 1993, Molecular Marine Biology and Biotechnology, V2, P20; EWART KV, 1992, BIOCHEM BIOPH RES CO, V185, P335, DOI 10.1016/S0006-291X(05)90005-3; Ewart KV, 1996, J BIOL CHEM, V271, P16627, DOI 10.1074/jbc.271.28.16627; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 2007, J MOL EVOL, V64, P387, DOI 10.1007/s00239-005-0256-3; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; HARTLEY BS, 1965, NATURE, V207, P1157, DOI 10.1038/2071157a0; HOURSTON AS, 1976, J FISH RES BOARD CAN, V33, P1788, DOI 10.1139/f76-226; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kordis D, 1998, P NATL ACAD SCI USA, V95, P10704, DOI 10.1073/pnas.95.18.10704; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Luo HBR, 1999, RNA, V5, P893, DOI 10.1017/S1355838299990520; MADDISON DR, MACCLADE VERSION 4 0; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson J.S., 1984, FISHES WORLD, V2nd, P523; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; NG NFL, 1992, J BIOL CHEM, V267, P16069; NYLANDER JAA, 2006, MRDMODELTEST V2 2 PR; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; Patil JG, 1996, J EXP ZOOL, V274, P121, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;121::AID-JEZ5&gt;3.0.CO;2-R; PEDEN JF, 1999, THESIS U NOTTINGHAM; RAMBAUT A, 2003, TRACER VERSION 1 2 1; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOTT GK, 1985, P NATL ACAD SCI USA, V82, P2613, DOI 10.1073/pnas.82.9.2613; SCOTT GK, 1986, CAN J FISH AQUAT SCI, V43, P1028, DOI 10.1139/f86-128; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Venugopal T, 2004, J EXP ZOOL PART A, V301A, P477, DOI 10.1002/jez.a.78; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Yamashita Y, 2003, BIOSCI BIOTECH BIOCH, V67, P461, DOI 10.1271/bbb.67.461; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	61	63	69	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2616	10.1371/journal.pone.0002616	http://dx.doi.org/10.1371/journal.pone.0002616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612417	Green Published, gold			2022-12-25	WOS:000264065800018
J	Hojgaard, B; Gyrd-Hansen, D; Olsen, KR; Sogaard, J; Sorensen, TIA				Hojgaard, Betina; Gyrd-Hansen, Dorte; Olsen, Kim Rose; Sogaard, Jes; Sorensen, Thorkild I. A.			Waist Circumference and Body Mass Index as Predictors of Health Care Costs	PLOS ONE			English	Article								Background: In the present study we analyze the relationship between body mass index (BMI) and waist circumference (WC) and future health care costs. On the basis of the relation between these anthropometric measures and mortality, we hypothesized that for all levels of BMI increased WC implies added future health care costs (Hypothesis 1) and for given levels of WC increased BMI entails reduced future health care costs (Hypothesis 2). We furthermore assessed whether a combination of the two measures predicts health care costs better than either individual measure. Research Methodology/Principal Findings: Data were obtained from the Danish prospective cohort study Diet, Cancer and Health. The population includes 15,334 men and 16,506 women 50 to 64 years old recruited in 1996 to 1997. The relationship between future health care costs and BMI and WC in combination was analyzed by use of categorized and continuous analyses. The analysis confirms Hypothesis 1, reflecting that an increased level of abdominal fat for a given BMI gives higher health care costs. Hypothesis 2, that BMI had a protective effect for a given WC, was only confirmed in the continuous analysis and for a subgroup of women (BMI, 30 kg/m(2) and WC,88 cm). The relative magnitude of the estimates supports that the regressions including WC as an explanatory factor provide the best fit to the data. Conclusion: The study showed that WC for given levels of BMI predicts increased health costs, whereas BMI for given WC did not predict health costs except for a lower cost in non-obese women with normal WC. Combining WC and BMI does not give a better prediction of costs than WC alone.	[Hojgaard, Betina; Gyrd-Hansen, Dorte; Olsen, Kim Rose; Sogaard, Jes] Danish Inst Hlth Serv Res, Copenhagen, Denmark; [Hojgaard, Betina; Gyrd-Hansen, Dorte] Univ So Denmark, Inst Publ Hlth, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Hojgaard, B (corresponding author), Danish Inst Hlth Serv Res, Copenhagen, Denmark.	beh@dsi.dk	Olsen, Kim Rose/AAU-5526-2020; Gyrd-Hansen, Dorte/A-3161-2011		Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding for this work was provided by sanofi-aventis. The funders were informed and were invited to comment on the work, but had no role in decision-making about conclusions drawn from the results and the decision about how to publish and where to publish the results. The views expressed are solely those of the authors.	Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Ardern CL, 2003, OBES RES, V11, P135, DOI 10.1038/oby.2003.22; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2004, AM J CLIN NUTR, V80, P790; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Cornier MA, 2002, OBES RES, V10, P1167, DOI 10.1038/oby.2002.158; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; FOLMANN NB, 2007, EC OBESITY, P319; Han TS, 2006, BMJ-BRIT MED J, V333, P695, DOI 10.1136/bmj.333.7570.695; Iwao S, 2001, OBES RES, V9, P685, DOI 10.1038/oby.2001.93; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2006, INT J OBESITY, V30, P1223, DOI 10.1038/sj.ijo.0803287; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Johnston J., 1997, ECONOMETRICS METHODS, V4th ed.; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Pronk NP, 1999, JAMA-J AM MED ASSOC, V282, P2235, DOI 10.1001/jama.282.23.2235; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Seidell J C, 1987, World Rev Nutr Diet, V50, P57; Thompson D, 2001, OBES RES, V9, P210, DOI 10.1038/oby.2001.23; Tjonneland A M, 2000, Ugeskr Laeger, V162, P350; Wee CC, 2005, AM J PUBLIC HEALTH, V95, P159, DOI 10.2105/AJPH.2003.027946; *WHO, WHO TECH REP SER, V894, pR1; Wildman RP, 2005, AM J CLIN NUTR, V82, P1195, DOI 10.1093/ajcn/82.6.1195; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	34	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2619	10.1371/journal.pone.0002619	http://dx.doi.org/10.1371/journal.pone.0002619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612430	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800021
J	Paclik, D; Danese, S; Berndt, U; Wiedenmann, B; Dignass, A; Sturm, A				Paclik, Daniela; Danese, Silvio; Berndt, Uta; Wiedenmann, Bertram; Dignass, Axel; Sturm, Andreas			Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle	PLOS ONE			English	Article								Galectin-4 is a carbohydrate-binding protein belonging to the galectin family. Here we provide novel evidence that galectin-4 is selectively expressed and secreted by intestinal epithelial cells and binds potently to activated peripheral and mucosal lamina propria T-cells at the CD3 epitope. The carbohydrate-dependent binding of galectin-4 at the CD3 epitope is fully functional and inhibited T cell activation, cycling and expansion. Galectin-4 induced apoptosis of activated peripheral and mucosal lamina propria T cells via calpain-, but not caspase-dependent, pathways. Providing further evidence for its important role in regulating T cell function, galectin-4 blockade by antisense oligonucleotides reduced TNF-alpha inhibitor induced T cell death. Furthermore, in T cells, galectin-4 reduced pro-inflammatory cytokine secretion including IL-17. In a model of experimental colitis, galectin-4 ameliorated mucosal inflammation, induced apoptosis of mucosal T-cells and decreased the secretion of pro-inflammatory cytokines. Our results show that galectin-4 plays a unique role in the intestine and assign a novel role of this protein in controlling intestinal inflammation by a selective induction of T cell apoptosis and cell cycle restriction. Conclusively, after defining its biological role, we propose Galectin-4 is a novel anti-inflammatory agent that could be therapeutically effective in diseases with a disturbed T cell expansion and apoptosis such as inflammatory bowel disease.	[Paclik, Daniela; Berndt, Uta; Wiedenmann, Bertram; Sturm, Andreas] Charite, Campus Virchow Klinikum, Med Klin Ms Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Danese, Silvio] IRCCS, Ist Clin Humanitas, Div Gastroenterol, Milan, Italy; [Dignass, Axel] Markus Krankenhaus, Medizinische Klin I, Frankfurt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Humanitas Research Hospital	Paclik, D (corresponding author), Charite, Campus Virchow Klinikum, Med Klin Ms Hepatol & Gastroenterol, D-13353 Berlin, Germany.	andreas.sturm@charite.de	Dignass, Axel/AAW-9653-2020; Dignass, Axel/V-5400-2019; Danese, Silvio/ABH-9571-2020	Dignass, Axel/0000-0002-9724-054X; Danese, Silvio/0000-0001-7341-1351; Wiedenmann, Bertram/0000-0002-7890-2552	Broad Medical Research Program of The Eli and Edythe Broad Foundation; Forschungsforderung of the Charite, Universitatsmedizin Berlin	Broad Medical Research Program of The Eli and Edythe Broad Foundation; Forschungsforderung of the Charite, Universitatsmedizin Berlin	This work was supported by a grant from the Broad Medical Research Program of The Eli and Edythe Broad Foundation (A.S.), and by the Forschungsforderung of the Charite, Universitatsmedizin Berlin (A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baumgart DC, 2004, CURR PHARM DESIGN, V10, P4127, DOI 10.2174/1381612043382413; Baumgart DC, 2003, Z GASTROENTEROL, V41, P1017; Braat H, 2007, GUT, V56, P351, DOI 10.1136/gut.2006.099861; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; COOPER HS, 1993, LAB INVEST, V69, P238; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hlavaty T, 2007, INFLAMM BOWEL DIS, V13, P372, DOI 10.1002/ibd.20024; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Nio J, 2005, J HISTOCHEM CYTOCHEM, V53, P1323, DOI 10.1369/jhc.5A6685.2005; NORTON SD, 1991, J IMMUNOL, V146, P1125; Pace KE, 1999, J IMMUNOL, V163, P3801; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; RACHMILEWITZ D, 1995, GASTROENTEROLOGY, V108, pA897; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; ROTH MS, 1988, BLOOD, V71, P1744; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Siegmund B, 2004, GUT, V53, P965, DOI 10.1136/gut.2003.027136; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Sturm A, 2002, J CLIN INVEST, V109, P1481, DOI 10.1172/JCI14967	39	83	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2629	10.1371/journal.pone.0002629	http://dx.doi.org/10.1371/journal.pone.0002629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612433	gold, Green Submitted, Green Published			2022-12-25	WOS:000264065800031
J	Si, XN; Gao, G; Wong, J; Wang, YH; Zhang, JC; Luo, HL				Si, Xiaoning; Gao, Guang; Wong, Jerry; Wang, Yahong; Zhang, Jingchun; Luo, Honglin			Ubiquitination Is Required for Effective Replication of Coxsackievirus B3	PLOS ONE			English	Article								Background: Protein ubiquitination and/or degradation by the ubiquitin/proteasome system (UPS) have been recognized as critical mechanisms in the regulation of numerous essential cellular functions. The importance of the UPS in viral pathogenesis has become increasingly apparent. Using murine cardiomyocytes, we have previously demonstrated that the UPS plays a key role in the replication of coxsackievirus B3 (CVB3), an important human pathogen associated with various diseases. To further elucidate the underlying mechanisms, we examined the interplay between the UPS and CVB3, focusing on the role of ubiquitination in viral lifecycle. Methodology/Principal Findings: As assessed by in situ hybridization, Western blot, and plaque assay, we showed that proteasome inhibition decreased CVB3 RNA replication, protein synthesis, and viral titers in HeLa cells. There were no apparent changes in 20S proteasome activities following CVB3 infection. However, we found viral infection led to an accumulation of protein-ubiquitin conjugates, accompanied by a decreased protein expression of free ubiquitin, implicating an important role of ubiquitination in the UPS-mediated viral replication. Using small-interfering RNA, we demonstrated that gene-silencing of ubiquitin significantly reduced viral titers, possibly through downregulation of protein ubiquitination and subsequent alteration of protein function and/or degradation. Inhibition of deubiquitinating enzymes apparently enhances the inhibitory effects of proteasome inhibitors on CVB3 replication. Finally, by immunoprecipitation, we showed that coxsackieviral polymerase 3D was post-translationally modified by ubiquitination and such modification might be a prerequisite for its function in transcriptional regulation of viral genome. Conclusion: Coxsackievirus infection promotes protein ubiquitination, contributing to effective viral replication, probably through ubiquitin modification of viral polymerase.	[Si, Xiaoning; Gao, Guang; Wong, Jerry; Wang, Yahong; Zhang, Jingchun; Luo, Honglin] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Dept Pathol & Lab Med, Providence Heart Lung Inst,St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada; [Wang, Yahong] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Cardiol, Chinese Internal Med Lab, Beijing, Peoples R China	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Beijing University of Chinese Medicine	Si, XN (corresponding author), Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Dept Pathol & Lab Med, Providence Heart Lung Inst,St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada.	hluo@mrl.ubc.ca	Wong, Tse Yuan/G-3029-2011		Canadian Institutes of Health Research (CIHR) [Post-Doctoral Fellowship, Michael Smith Fellowship, New Investigator]; Heart and Stroke Foundation of Canada (HSFC) [Post-Doctoral Fellowship, Research Fellowship, Doctoral Traineeship]; Michael Smith Foundation for Health Research (MSFHR) [Doctoral Traineeship]; St. Paul's Hospital Foundation Award [New Investigator]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); St. Paul's Hospital Foundation Award	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada (HSFC) (to HL). XS is a recipient of the CIHR/HSFC IMPACT Post-Doctoral Fellowship, CIHR Michael Smith Fellowship and the HSFC Research Fellowship. GG is a recipient of a Doctoral Traineeship from the HSFC and the MSFHR. HL is a New Investigator of the CIHR/St. Paul's Hospital Foundation Award and a Scholar of the Michael Smith Foundation for Health Research (MSFHR).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Cunningham KA, 2003, VIRUS RES, V92, P179, DOI 10.1016/S0168-1702(03)00044-3; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Fan Z, 2006, J MED VIROL, V78, P1365, DOI 10.1002/jmv.20707; Furman MH, 2002, J CLIN INVEST, V110, P875, DOI 10.1172/JCI200216831; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; Kirschner LS, 2000, BIOCHEM BIOPH RES CO, V270, P1106, DOI 10.1006/bbrc.2000.2568; Lawson TG, 1999, J BIOL CHEM, V274, P9871, DOI 10.1074/jbc.274.14.9871; Lawson TG, 2001, J BIOL CHEM, V276, P39629, DOI 10.1074/jbc.M102659200; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Losick VP, 2003, VIROLOGY, V309, P306, DOI 10.1016/S0042-6822(03)00071-0; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; Luo HL, 2003, J VIROL, V77, P1, DOI 10.1128/JVI.77.1.1-9.2003; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Opavsky MA, 2002, J CLIN INVEST, V109, P1561, DOI 10.1172/JCI200213971; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHULENBURG JM, 2000, HEPAC, V1, P2; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shackelford J, 2004, MOL CELL BIOL, V24, P5089, DOI 10.1128/MCB.24.12.5089-5093.2004; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	41	61	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2585	10.1371/journal.pone.0002585	http://dx.doi.org/10.1371/journal.pone.0002585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612413	gold, Green Published			2022-12-25	WOS:000264065800006
J	Takasuka, TE; Cioffi, A; Stein, A				Takasuka, Taichi E.; Cioffi, Alfred; Stein, Arnold			Sequence Information Encoded in DNA that May Influence Long-Range Chromatin Structure Correlates with Human Chromosome Functions	PLOS ONE			English	Article							NUCLEOSOME POSITIONING SIGNALS; ALPHA-SATELLITE DNA; RECOMBINATION RATES; ORGANIZATION; MAP; CENTROMERE; FIBERS; MOUSE; MODEL	Little is known about the possible function of the bulk of the human genome. We have recently shown that long-range regular oscillation in the motif non-T, A/T, G (VWG) existing at ten-nucleotide multiples influences large-scale nucleosome array formation. In this work, we have determined the locations of all 100 kb regions that are predicted to form distinctive chromatin structures throughout each human chromosome (except Y). Using these data, we found that a significantly greater fraction of 300 kb sequences lacked annotated transcripts in genomic DNA regions >= 300 kb that contained nearly continuous chromatin organizing signals than in control regions. We also found a relationship between the meiotic recombination frequency and the presence of strong VWG chromatin organizing signals. Large (>= 300 kb) genomic DNA regions having low average recombination frequency are enriched in chromatin organizing signals. As additional controls, we show using chromosome 1 that the VWG motif signals are not enriched in randomly selected DNA regions having the mean size of the recombination coldspots, and that non-VWG motif sets do not generate signals that are enriched in recombination coldspots. We also show that tandemly repeated alpha satellite DNA contains strong VWG signals for the formation of distinctive nucleosome arrays, consistent with the low recombination activity of centromeres. Our correlations cannot be explained simply by variations in the GC content. Our findings suggest that a specific set of periodic DNA motifs encoded in genomic DNA, which provide signals for chromatin organization, influence human chromosome function.	[Takasuka, Taichi E.; Cioffi, Alfred; Stein, Arnold] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Takasuka, TE (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	steina@purdue.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924				Baldi P, 1996, J MOL BIOL, V263, P503, DOI 10.1006/jmbi.1996.0592; BERNARDI G, 2004, N COMP BIOC, V37, P3; BROWN FL, 1979, J MOL BIOL, V131, P777, DOI 10.1016/0022-2836(79)90201-8; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Cioffi A, 2004, BIOCHEMISTRY-US, V43, P6709, DOI 10.1021/bi049717f; Cioffi A, 2006, NUCLEIC ACIDS RES, V34, P1974, DOI 10.1093/nar/gkl078; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2005, NUCLEIC ACIDS RES, V33, P934, DOI 10.1093/nar/gki224; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; FITTLER F, 1979, NUCLEIC ACIDS RES, V7, P1, DOI 10.1093/nar/7.1.1; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent AM, 2003, HUM MOL GENET, V12, P2229, DOI 10.1093/hmg/ddg220; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pearson H, 2006, NATURE, V444, P259, DOI 10.1038/444259a; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; PRUNELL A, 1982, J MOL BIOL, V154, P515, DOI 10.1016/S0022-2836(82)80010-7; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stein A, 2002, NUCLEIC ACIDS RES, V30, P5103, DOI 10.1093/nar/gkf671; Stein A, 1999, NUCLEIC ACIDS RES, V27, P848, DOI 10.1093/nar/27.3.848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; WARBURTON PE, 1993, MOL CELL BIOL, V13, P6520, DOI 10.1128/MCB.13.10.6520; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; ZHANG XY, 1983, NUCLEIC ACIDS RES, V11, P4287, DOI 10.1093/nar/11.13.4287; ZLATANOVA J, 1994, P NATL ACAD SCI USA, V91, P5277, DOI 10.1073/pnas.91.12.5277	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2643	10.1371/journal.pone.0002643	http://dx.doi.org/10.1371/journal.pone.0002643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612465	Green Published, gold			2022-12-25	WOS:000264065800045
J	Valenzuela, MJ; Sachdev, P; Wen, W; Chen, XH; Brodaty, H				Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua; Brodaty, Henry			Lifespan Mental Activity Predicts Diminished Rate of Hippocampal Atrophy	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; COGNITIVE IMPAIRMENT; BRAIN RESERVE; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; TRANSGENIC MICE; MECHANISMS; DEMENTIA; CREATINE	Objective: Epidemiological studies suggest that complex mental activity may reduce the risk for dementia, however an underlying mechanism remains unclear. Our objective was to determine whether individual differences in lifespan complex mental activity are linked to altered rates of hippocampal atrophy independent of global measures of neurodegeneration. Methods: Thirty seven healthy older individuals had their complex mental activity levels estimated using the Lifetime of Experiences Questionnaire (LEQ) and completed serial MRI investigations at baseline and three years follow-up. Hippocampal volume and semi-automatic quantitation of whole brain volume (WBV) and white matter hyperintensities (WMHs) were compared at both time points. Results: Higher LEQ scores were correlated with hippocampal volume independent of covariates at the three year follow-up stage (r = 0.43, p = 0.012). Moreover, those with higher LEQ scores experienced less hippocampal atrophy over the follow-up period (r = 0.41, p = 0.02). High LEQ individuals had less than half the hippocampal volume decline of low LEQ individuals in a multivariate analysis (F = 4.47, p = 0.042). No parallel changes were found in measures of WBV and WMHs. Conclusions: High level of complex mental activity across the lifespan was correlated with a reduced rate of hippocampal atrophy. This finding could not be explained by general differences in intracranial volume, larger hippocampi at baseline, presence of hypertensive disease, gender or low mood. Our results suggest that neuroprotection in medial temporal lobe may be one mechanism underlying the link between mental activity and lower rates of dementia observed in population-based studies. Additional studies are required to further explore this novel finding.	[Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua; Brodaty, Henry] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia; [Brodaty, Henry] Prince Wales Hosp, Aged Care Psychiat, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Primary Dementia Collaborative Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Valenzuela, MJ (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	michaelv@unsw.edu.au	Brodaty, Henry/E-2753-2010; Sachdev, Perminder/ABC-1137-2020	Brodaty, Henry/0000-0001-9487-6617; Sachdev, Perminder/0000-0002-9595-3220; Wen, Wei/0000-0003-2753-3870; Valenzuela, Michael/0000-0001-7162-6607	National Health and Medical Research Council of Australia [350833]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a Program Grant from the National Health and Medical Research Council of Australia (ID# 350833).	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Anstey KJ, 2004, NEUROREPORT, V15, P2825; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brustovetsky N, 2001, J NEUROCHEM, V76, P425, DOI 10.1046/j.1471-4159.2001.00052.x; COYLE J, 2003, NEW ENGL J MED, V348, P25; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JANOWSKY J, 2005, J NEUROSCI, V25, P5217; Kempermann G, 2006, ADULT NEUROGENESIS; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Trollor JN, 2001, AUST NZ J PSYCHIAT, V35, P788, DOI 10.1046/j.1440-1614.2001.00969.x; VALENZUELA M, 2008, AM J GERIAT IN PRESS; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Valenzuela MJ, 2003, NEUROREPORT, V14, P1333, DOI 10.1097/01.wnr.0000077548.91466.05; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027	36	161	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2598	10.1371/journal.pone.0002598	http://dx.doi.org/10.1371/journal.pone.0002598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612379	Green Published, gold			2022-12-25	WOS:000264065800011
J	Hu, J; Barlet, X; Deslandes, L; Hirsch, J; Feng, DX; Somssich, I; Marco, Y				Hu, Jian; Barlet, Xavier; Deslandes, Laurent; Hirsch, Judith; Feng, Dong Xin; Somssich, Imre; Marco, Yves			Transcriptional Responses of Arabidopsis thaliana during Wilt Disease Caused by the Soil-Borne Phytopathogenic Bacterium, Ralstonia solanacearum	PLOS ONE			English	Article							GENE-EXPRESSION; LEAF SENESCENCE; INNATE IMMUNITY; RESISTANCE; VIRULENCE; IDENTIFICATION; EFFECTORS; NETWORKS; REVEALS; MODELS	Bacterial wilt is a common disease that causes severe yield and quality losses in many plants. In the present study, we used the model Ralstonia solanacearum-Arabidopsis thaliana pathosystem to study transcriptional changes associated with wilt disease development. Susceptible Col-5 plants and RRS1-R-containing resistant Nd-1 plants were root-inoculated with R. solanacearum strains harbouring or lacking the matching PopP2 avirulence gene. Gene expression was marginally affected in leaves during the early stages of infection. Major changes in transcript levels took place between 4 and 5 days after pathogen inoculation, at the onset of appearance of wilt symptoms. Up-regulated genes in diseased plants included ABA-, senescence- and basal resistance-associated genes. The influence of the plant genetic background on disease-associated gene expression is weak although some genes appeared to be specifically up-regulated in Nd-1 plants. Inactivation of some disease-associated genes led to alterations in the plant responses to a virulent strain of the pathogen. In contrast to other pathosystems, very little overlap in gene expression was detected between the early phases of the resistance response and the late stages of disease development. This observation may be explained by the fact that above-ground tissues were sampled for profiling whereas the bacteria were applied to root tissues. This exhaustive analysis of Arabidopsis genes whose expression is modulated during bacterial wilt development paves the way for dissecting plant networks activated by recognition of R. solanacearum effectors in susceptible plants.	[Hu, Jian; Barlet, Xavier; Deslandes, Laurent; Marco, Yves] INRA, CNRS, UMR 2594 441, LIPM, Castanet Tolosan, France; [Hu, Jian] China Agr Univ, Coll Biol Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Hirsch, Judith] Campus Int Baillarguet, Interactions Riz parasites, UMR BGPI CIRAD TA A 54K, Montpellier, France; [Feng, Dong Xin] Chinese Acad Agr Sci, Dept Int Cooperat, Beijing, Peoples R China; [Somssich, Imre] Max Planck Inst Zuchtungsforschung, Abteilung Biochem, Cologne, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; China Agricultural University; CIRAD; Chinese Academy of Agricultural Sciences; Max Planck Society	Hu, J (corresponding author), INRA, CNRS, UMR 2594 441, LIPM, Castanet Tolosan, France.	yves.marco@toulouse.inra.fr	Somssich, Imre/GLT-3738-2022; Deslandes, Laurent/N-5752-2017	Somssich, Imre/0000-0003-3066-5794; Barlet, Xavier/0000-0002-9899-6859	Agence Nationale de la Recherche (ANR) [05GPLA 020]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by funding from the Agence Nationale de la Recherche (ANR), Grant ANR 05GPLA 020 (AFINDIS).	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Gentlemen R, 2005, BIOINFORMATICS COMPU; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hirsch J, 2002, PHYTOPATHOLOGY, V92, P1142, DOI 10.1094/PHYTO.2002.92.10.1142; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; LAMB CJ, 1992, BIO-TECHNOL, V10, P1436, DOI 10.1038/nbt1192-1436; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Occhialini A, 2005, MOL PLANT MICROBE IN, V18, P938, DOI 10.1094/MPMI-18-0938; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	45	69	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2589	10.1371/journal.pone.0002589	http://dx.doi.org/10.1371/journal.pone.0002589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596930	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200048
J	Juste, RA; Elguezabal, N; Garrido, JM; Pavon, A; Geijo, MV; Sevilla, I; Cabriada, JL; Tejada, A; Garcia-Campos, F; Casado, R; Ochotorena, I; Izeta, A; Greenstein, RJ				Juste, Ramon A.; Elguezabal, Natalia; Garrido, Joseba M.; Pavon, Andres; Geijo, Maria V.; Sevilla, Iker; Cabriada, Jose-Luis; Tejada, Angel; Garcia-Campos, Francisco; Casado, Roberto; Ochotorena, Itziar; Izeta, Ander; Greenstein, Robert J.			On the Prevalence of M. avium Subspecies paratuberculosis DNA in the Blood of Healthy Individuals and Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article								Background: Mycobacteria, such as M. leprae and M. tuberculosis infect billions of humans. However, because of appropriate immune responses and antibiotic therapy, overt mycobacterial diseases occur far less frequently. M. avium subspecies paratuberculosis ( MAP) causes Johne's disease in ruminants, an affliction evocative of inflammatory bowel disease (IBD). Several agents used to treat IBD (5-ASA, methotrexate, azathioprine and its metabolite 6-MP) have recently been shown to be antiMAP antibiotics. We herein evaluate the prevalence of MAP DNA in healthy individuals and compare them with IBD patients on antiMAP antibiotics. Methods: We studied 100 healthy individuals (90 blood donors) and 246 patients with IBD. IS900 MAP DNA was identified using a nested primer PCR in the buffy coat of blood. Positive signal was confirmed as MAP by DNA sequence analysis. PCR positive results frequencies were compared according to medications used. Significance was accepted at p < 0.05. Results: 47% (47/100) healthy controls and 16% (40/246) IBD patients were IS900 positive (p < 0.0001). MAP DNA was identified in 17% of 143 patients receiving mesalamine and 6% of 16 receiving sulfasalazine. None of the IBD patients receiving methotrexate (n = 9), 6-MP (n = 3), ciprofloxacin (n = 5) or Tacrolimus (R) (n = 3) had MAP DNA detectable in their blood. Discussion: We found a disquietingly large percentage of healthy individuals have MAP DNA in their blood, the significance of which remains to be determined. Counter-intuitively, the incidence of MAP DNA was significantly lower in patients with IBD. Agents with the most potent in vitro antiMAP activity were associated with clearance of blood MAP DNA. We posit that the use antiMAP antibiotics was responsible for the decreased prevalence of MAP DNA in patients with IBD.	[Juste, Ramon A.; Elguezabal, Natalia; Garrido, Joseba M.; Geijo, Maria V.; Sevilla, Iker] Inst Vasco Invest & Desarrollo Agr NEIKER Tecnlia, Dept Prod & Sanidad Anim, Derio, Bizkaia, Spain; [Pavon, Andres; Casado, Roberto; Ochotorena, Itziar; Izeta, Ander] Fdn INBIOMED, San Sebastian, Spain; [Cabriada, Jose-Luis] Hosp Galdakao, Serv Aparato Digestivo, Galdakao, Spain; [Tejada, Angel] Clin Quiron Donostia, Serv Aparato Digestivo, San Sebastian, Spain; [Garcia-Campos, Francisco] Hosp Txagorritxu, Serv Aparato Digestivo, Vitoria, Spain; [Greenstein, Robert J.] VA Med Ctr, Dept Surg, Bronx, NY USA	Galdakao Hospital; University Hospital of Araba	Juste, RA (corresponding author), Inst Vasco Invest & Desarrollo Agr NEIKER Tecnlia, Dept Prod & Sanidad Anim, Derio, Bizkaia, Spain.	rjuste@neiker.net	Izeta, Ander/ABG-8973-2020; Izeta, Ander/H-6376-2011; Juste, Ramon A./C-3570-2008; Geijo, Maria V./K-6717-2014; Elguezabal, Natalia/ABF-8199-2021; Sevilla, Iker A/O-6060-2014; GARRIDO, JOSEBA M/L-3202-2014; Geijo, Maria V./ABC-5808-2021	Izeta, Ander/0000-0003-1879-7401; Juste, Ramon A./0000-0001-6037-5873; Geijo, Maria V./0000-0002-3120-1038; Sevilla, Iker A/0000-0003-3968-3390; Geijo, Maria V./0000-0002-3120-1038; Elguezabal, Natalia/0000-0002-8765-5477; Joseba M., Garrido/0000-0002-7559-0653; Cabriada, Jose Luis/0000-0002-3068-5659	Departamento de Industria, Comercio y Turismo of the Gobierno Vasco [ETORTEK grant]; Marie Curie [MERG-CT-2004-004323]	Departamento de Industria, Comercio y Turismo of the Gobierno Vasco(Basque Government); Marie Curie(European Commission)	This work was supported by an ETORTEK grant from the Departamento de Industria, Comercio y Turismo of the Gobierno Vasco. A.I. was supported by a Marie Curie European Reintegration Grant (MERG-CT-2004-004323) within the 6th European Community RTD Framework Programme. Sponsors have not participated in the design or execution of any part of this manuscript.	[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Ayele WY, 2005, APPL ENVIRON MICROB, V71, P1210, DOI 10.1128/AEM.71.3.1210-1214.2005; BARROW WW, 1993, ANTIMICROB AGENTS CH, V37, P652, DOI 10.1128/AAC.37.4.652; BERARDI RR, 1996, TXB THERAPEUTICS DRU, P483; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DALZEIL TK, 1913, BRIT MED J, V2, P1068; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Farinha NJ, 2000, J INFECTION, V41, P61, DOI 10.1053/jinf.2000.0692; Grant IR, 2002, APPL ENVIRON MICROB, V68, P602, DOI 10.1128/AEM.68.2.602-607.2002; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Ivnitski D, 2003, BIOTECHNIQUES, V35, P862, DOI 10.2144/03354ss03; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Lindler LE, 2003, MOL CELL PROBE, V17, P41, DOI 10.1016/S0890-8508(02)00111-1; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; Ramaprasad P, 1997, LEPROSY REV, V68, P301; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; Spencer CM, 1997, DRUGS, V54, P925, DOI 10.2165/00003495-199754060-00009; Stewart-Tull DES., 1982, BIOL MYCOBACTERIA, V1, P273; Svartz N, 1942, ACTA MED SCAND, V110, P577; Zanetti Stefania, 2006, Ann Clin Microbiol Antimicrob, V5, P27, DOI 10.1186/1476-0711-5-27; [No title captured], DOI DOI 10.1002/14651858.CD002244; 2003, WKLY EPIDEMIOL REC, V78, P122	34	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2537	10.1371/journal.pone.0002537	http://dx.doi.org/10.1371/journal.pone.0002537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596984	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200009
J	Sahin, A; Daignan-Fornier, B; Sagot, I				Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle			Polarized Growth in the Absence of F-Actin in Saccharomyces cerevisiae Exiting Quiescence	PLOS ONE			English	Article								Background: Polarity establishment and maintenance are crucial for morphogenesis and development. In budding yeast, these two intricate processes involve the superposition of regulatory loops between polarity landmarks, RHO GTPases, actin-mediated vesicles transport and endocytosis. Deciphering the chronology and the significance of each molecular step of polarized growth is therefore very challenging. Principal Findings: We have taken advantage of the fact that yeast quiescent cells display actin bodies, a non polarized actin structure, to evaluate the role of F-actin in bud emergence. Here we show that upon exit from quiescence, actin cables are not required for the first steps of polarized growth. We further show that polarized growth can occur in the absence of actin patch-mediated endocytosis. We finally establish, using latrunculin-A, that the first steps of polarized growth do not require any F-actin containing structures. Yet, these structures are required for the formation of a bona fide daughter cell and cell cycle completion. We propose that upon exit from quiescence in the absence of F-actin, secretory vesicles randomly reach the plasma membrane but preferentially dock and fuse where polarity cues are localized, this being sufficient to trigger polarized growth.	[Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle] Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle] CNRS, UMR5095, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Sahin, A (corresponding author), Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France.	isabelle.sagot@ibgc.u-bordeaux2.fr			Agence Nationale pour la Recherche [JC05_42065]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This worked was supported by a Young Investigator Grant from the Agence Nationale pour la Recherche JC05_42065 to I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727; Lew DJ, 2005, CURR BIOL, V15, pR994, DOI 10.1016/j.cub.2005.11.048; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; MADDEN K, 1992, MOL BIOL CELL, V3, P1025, DOI 10.1091/mbc.3.9.1025; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Wedlich-Soldner R, 2004, EXP CELL RES, V301, P8, DOI 10.1016/j.yexcr.2004.08.011; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	41	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2556	10.1371/journal.pone.0002556	http://dx.doi.org/10.1371/journal.pone.0002556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596916	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200023
J	Winborn, BJ; Travis, SM; Todi, SV; Scaglione, KM; Xu, P; Williams, AJ; Cohen, RE; Peng, JM; Paulson, HL				Winborn, Brett J.; Travis, Sue M.; Todi, Sokol V.; Scaglione, K. Matthew; Xu, Ping; Williams, Aislinn J.; Cohen, Robert E.; Peng, Junmin; Paulson, Henry L.			The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys(63) linkages in mixed linkage ubiquitin chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; POLYUBIQUITIN CHAINS; JOSEPHIN DOMAIN; RETROTRANSLOCATION; TETRAUBIQUITIN; SPECIFICITY; RECOGNIZES; PROTEASOME; BINDING; LIGASE	Ubiquitin chain complexity in cells is likely regulated by a diverse set of deubiquitinating enzymes (DUBs) with distinct ubiquitin chain preferences. Here we show that the polyglutamine disease protein, ataxin-3, binds and cleaves ubiquitin chains in a manner suggesting that it functions as a mixed linkage, chain-editing enzyme. Ataxin-3 cleaves ubiquitin chains through its amino-terminal Josephin domain and binds ubiquitin chains through a carboxyl-terminal cluster of ubiquitin interaction motifs neighboring the pathogenic polyglutamine tract. Ataxin-3 binds both Lys48- or Lys63-linked chains yet preferentially cleaves Lys63 linkages. Ataxin-3 shows even greater activity toward mixed linkage polyubiquitin, cleaving Lys63 linkages in chains that contain both Lys48 and Lys63 linkages. The ubiquitin interaction motifs regulate the specificity of this activity by restricting what can be cleaved by the protease domain, demonstrating that linkage specificity can be determined by elements outside the catalytic domain of a DUB. These findings establish ataxin-3 as a novel DUB that edits topologically complex chains.	[Paulson, Henry L.] Univ Iowa, Program Mol & Cellular Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Travis, Sue M.; Paulson, Henry L.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Winborn, Brett J.; Todi, Sokol V.; Scaglione, K. Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI 48108 USA; [Xu, Ping; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Williams, Aislinn J.] Univ Iowa, Carver Coll Med, Program Neurosci & Med Scientist Training Program, Iowa City, IA 52242 USA; [Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University of Iowa; University of Iowa; University of Michigan System; University of Michigan; Emory University; University of Iowa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 4001 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	henryp@umich.edu	Williams, Aislinn/T-5661-2017; Peng, Junmin/N-2614-2018; Williams, Aislinn/V-2742-2019	Williams, Aislinn/0000-0002-8139-2303; Peng, Junmin/0000-0003-0472-7648; Williams, Aislinn/0000-0002-8139-2303; Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [NS038712, AG025688]; National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS038712 (to H. L. P.) and AG025688 (to J. P.). This work was also supported by a National Ataxia Foundation grant (to S. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P149; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	54	190	192	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26436	26443		10.1074/jbc.M803692200	http://dx.doi.org/10.1074/jbc.M803692200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18599482	Green Published, hybrid			2022-12-25	WOS:000259341600018
J	Wang, GL; Salisbury, E; Shi, XR; Timchenko, L; Medrano, EE; Timchenko, NA				Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Lubov; Medrano, Estela E.; Timchenko, Nikolai A.			HDAC1 cooperates with C/EBP alpha in the inhibition of liver proliferation in old mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING-PROTEIN; CELL-CYCLE; INCREASES TRANSLATION; REGENERATING LIVER; BETA; TRANSCRIPTION; EXPRESSION; AGE; OVEREXPRESSION; REPRESSION	Epigenetic control of liver proliferation involves cooperation between transcription factors and chromatin-remodeling proteins. In this work, we found that the levels of HDAC1 (histone deacetylase 1) are increased in quiescent livers of old mice. The elevation of HDAC1 in liver is mediated by the RNA-binding protein CUGBP1. We found that the age-associated CUGBP1-eIF2 complex binds to the 5' region of HDAC1 mRNA and increases translation of HDAC1 in the liver. Further analyses showed that CUGBP1 also increases expression of HDAC1 in cultured cells, in the livers of CUGBP1 transgenic mice, and in the livers of mice injected with cyclin D3, which enhances the formation of the CUGBP1-eIF2 complex. In livers of old mice, HDAC1 interacts with the transcription factor C/EBP alpha and is recruited by this protein to E2F-dependent promoters as a component of high M-r C/EBP alpha-Brm complexes. The recruitment of HDAC1 to c-Myc and FoxM1B promoters leads to deacetylation of histone H3 at Lys-9 on these E2F-dependent promoters. We show that HDAC1 is an important mediator of growth-inhibitory activity of C/EBP alpha and that small interfering RNA-mediated inhibition of HDAC1 reduces the ability of C/EBP alpha to inhibit cell proliferation. In addition, we have found that both elevation of HDAC1 and interaction of C/EBP alpha with HDAC1 are controlled by cyclin D3-dependent mechanisms. Treatment of old mice with growth hormone, which reduces cyclin D3 levels, leads to the reduction of the CUGBP1-eIF2 complex, normalization of HDAC1 levels, and inhibition of interactions of HDAC1 with C/EBP alpha-Brm complexes. Thus, our data demonstrate that translational elevation of HDAC1 in livers of old mice is involved in the assembly of high Mr protein-protein complexes that inhibit liver proliferation.	[Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Medrano, Estela E.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Salisbury, Elizabeth/0000-0003-3607-2367	National Institutes of Health [GM55188, CA100070, AG20752, AR49222, AR052781, AR44387, AG032135]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049222, R01AR044387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032135, P01AG020752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.); AR49222, AR052781, and AR44387 (to L.T.T.); and AG032135. This work was also supported by an Ellison Medical Foundation grant (to E.E.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCHER NLR, 1964, CANCER RES, V24, P509; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Demarco IA, 2006, NAT METHODS, V3, P519, DOI 10.1038/NMETH889; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052; Tan EH, 2005, CANCER RES, V65, P10330, DOI 10.1158/0008-5472.CAN-04-4486; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Wang AG, 2005, BIOL PHARM BULL, V28, P1966, DOI 10.1248/bpb.28.1966; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	28	68	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26169	26178		10.1074/jbc.M803544200	http://dx.doi.org/10.1074/jbc.M803544200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18622015	Green Published, hybrid			2022-12-25	WOS:000259200100045
J	Barreras, M; Salinas, SR; Abdian, PL; Kampel, MA; Ielpi, L				Barreras, Maximo; Salinas, Silvina R.; Abdian, Patricia L.; Kampel, Matias A.; Ielpi, Luis			Structure and mechanism of GumK, a membrane-associated glucuronosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHAN POLYSACCHARIDE SYNTHESIS; CARBOHYDRATE-BINDING MODULES; CAMPESTRIS PV. CAMPESTRIS; XANTHOMONAS-CAMPESTRIS; CRYSTAL-STRUCTURE; BETA-GLUCOSYLTRANSFERASE; ESCHERICHIA-COLI; GLYCOSYLTRANSFERASES; SUBSTRATE; COMPLEX	Xanthomonas campestris GumK (beta-1,2-glucuronosyltransferase) is a 44-kDa membrane-associated protein that is involved in the biosynthesis of xanthan, an exopolysaccharide crucial for this bacterium's phytopathogenicity. Xanthan also has many important industrial applications. The GumK enzyme is the founding member of the glycosyltransferase family 70 of carbohydrate-active enzymes, which is composed of bacterial glycosyltransferases involved in exopolysaccharide synthesis. No x-ray structures have been reported for this family. To better understand the mechanism of action of the bacterial glycosyltransferases in this family, the x-ray crystal structure of apo-GumK was solved at 1.9 angstrom resolution. The enzyme has two well defined Rossmann domains with a catalytic cleft between them, which is a typical feature of the glycosyltransferase B superfamily. Additionally, the crystal structure of GumK complexed with UDP was solved at 2.28 angstrom resolution. We identified a number of catalytically important residues, including Asp(157), which serves as the general base in the transfer reaction. Residues Met(231), Met(273), Glu(272), Tyr(292), Met(306), Lys(307), and Gln(310) interact with UDP, and mutation of these residues affected protein activity both in vitro and in vivo. The biological and structural data reported here shed light on the molecular basis for donor and acceptor selectivity in this glycosyltransferase family. These results also provide a rationale to obtain new polysaccharides by varying residues in the conserved alpha/beta/alpha structural motif of GumK.	[Barreras, Maximo; Salinas, Silvina R.; Abdian, Patricia L.; Kampel, Matias A.; Ielpi, Luis] IIBBA Consejo Nacl Invest Cientificas & Tecnicas, Lab Bacterial Genet, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Ielpi, L (corresponding author), IIBBA Consejo Nacl Invest Cientificas & Tecnicas, Lab Bacterial Genet, Fdn Inst Leloir, Av Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	Lielpi@leloir.org.ar	Abdian, Patricia/AAW-2420-2020	Abdian, Patricia/0000-0002-8366-8115; Salinas, Silvina/0000-0002-2285-3886	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1-11703]; Universidad de Buenos Aires ( Argentina) [UBACyT X-193]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires ( Argentina)(University of Buenos Aires)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 1-11703 and Universidad de Buenos Aires ( Argentina) Grant UBACyT X-193. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Barreras M, 2004, GLYCOBIOLOGY, V14, P233, DOI 10.1093/glycob/cwh056; Barreras M, 2006, ACTA CRYSTALLOGR F, V62, P880, DOI 10.1107/S1744309106028764; Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Doores KJ, 2006, CHEM-EUR J, V12, P656, DOI 10.1002/chem.200500557; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faijes M, 2007, CARBOHYD RES, V342, P1581, DOI 10.1016/j.carres.2007.06.015; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P602, DOI 10.1016/j.sbi.2003.09.001; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; He YQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r218; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; IELPI L, 1993, J BACTERIOL, V175, P2490, DOI 10.1128/JB.175.9.2490-2500.1993; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Rosen ML, 2004, J BIOL CHEM, V279, P38683, DOI 10.1074/jbc.M402925200; SCOTT J. E., 1965, METHOD CARBOHYD CHEM, V5, P38; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Watts Andrew G, 2004, Biochem J, V380, pe9, DOI 10.1042/BJ20040633; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151	45	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25027	25035		10.1074/jbc.M801227200	http://dx.doi.org/10.1074/jbc.M801227200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596046	hybrid, Green Published			2022-12-25	WOS:000258820000061
J	Chen, JK; Chen, JC; Imig, JD; Wei, S; Hachey, DL; Guthi, JS; Falck, JR; Capdevila, JH; Harris, RC				Chen, Jian-Kang; Chen, Jianchun; Imig, John D.; Wei, Shouzuo; Hachey, David L.; Guthi, Jagadeesh Setti; Falck, John R.; Capdevila, Jorge H.; Harris, Raymond C.			Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXYEICOSATRIENOIC ACIDS; CB1 RECEPTOR; EPOXYGENASE METABOLITES; 20-HYDROXYEICOSATETRAENOIC ACID; TYROSINE PHOSPHORYLATION; ENDOCANNABINOID SYSTEM; INTERNATIONAL UNION; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS	Arachidonic acid is an essential constituent of cell membranes that is esterified to the sn-2-position of glycerophospholipids and is released from selected lipid pools by phospholipase cleavage. The released arachidonic acid can be metabolized by three enzymatic pathways: the cyclooxygenase pathway forming prostaglandins and thromboxanes, the lipoxygenase pathway generating leukotrienes and lipoxins, and the cytochrome P450 (cP450) pathway producing epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids. The present study describes a novel group of cP450 epoxygenase-dependent metabolites of arachidonic acid, termed 2-epoxyeicosatrienoylglycerols (2-EG), including two regioisomers, 2-(11,12-epoxyeicosatrienoyl) glycerol (2-11,12-EG) and 2-(14,15-epoxyeicosatrienoyl)glycerol (2-14,15-EG), which are both produced in the kidney and spleen, whereas 2-11,12-EG is also detected in the brain. Both 2-11,12-EG and 2-14,15-EG activated the two cannabinoid (CB) receptor subtypes, CB1 and CB2, with high affinity and elicited biological responses in cultured cells expressing CB receptors and in intact animals. In contrast, the parental arachidonic acid and epoxyeicosatrienoic acids failed to activate CB1 or CB2 receptors. Thus, these cP450 epoxygenase-dependent metabolites are a novel class of endogenously produced, biologically active lipid mediators with the characteristics of endocannabinoids. This is the first evidence of a cytochrome P450-dependent arachidonate metabolite that can activate G-protein-coupled cell membrane receptors and suggests a functional link between the cytochrome P450 enzyme system and the endocannabinoid system.	[Hachey, David L.; Capdevila, Jorge H.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Harris, Raymond C.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Imig, John D.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Guthi, Jagadeesh Setti; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Harris, RC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, S-3223 Med Ctr N, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Imig, John/0000-0002-9668-2899	NIDDK NIH HHS [P01 DK038226-210011, DK38226, P01 DK038226] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abood ME, 1997, BIOCHEM PHARMACOL, V53, P207, DOI 10.1016/S0006-2952(96)00727-7; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Chen JC, 2007, MOL CELL BIOL, V27, P3023, DOI 10.1128/MCB.01482-06; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Chen JR, 2000, J BIOL CHEM, V275, P13789, DOI 10.1074/jbc.275.18.13789; Coutts AA, 2004, CURR OPIN PHARMACOL, V4, P572, DOI 10.1016/j.coph.2004.05.007; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DEWEY WL, 1986, PHARMACOL REV, V38, P151; Di Marzo V, 2006, ANNU REV MED, V57, P553, DOI 10.1146/annurev.med.57.011205.135648; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Holla VR, 1999, J CLIN INVEST, V104, P751, DOI 10.1172/JCI7013; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2001, J VASC RES, V38, P247, DOI 10.1159/000051053; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; KARARA A, 1991, J BIOL CHEM, V266, P7561; Kishimoto S, 2003, J BIOL CHEM, V278, P24469, DOI 10.1074/jbc.M301359200; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McGiff JC, 2001, CURR OPIN NEPHROL HY, V10, P231, DOI 10.1097/00041552-200103000-00012; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; MORRISON AR, 1981, P NATL ACAD SCI-BIOL, V78, P7375, DOI 10.1073/pnas.78.12.7375; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; OLIW EH, 1981, J BIOL CHEM, V256, P9924; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Sarkis A, 2004, CURR OPIN NEPHROL HY, V13, P205, DOI 10.1097/00041552-200403000-00009; Schramm NL, 2001, J NEUROSCI, V21, P4875, DOI 10.1523/JNEUROSCI.21-13-04875.2001; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Thomas BF, 1998, J PHARMACOL EXP THER, V285, P285; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	70	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24514	24524		10.1074/jbc.M709873200	http://dx.doi.org/10.1074/jbc.M709873200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606824	hybrid, Green Published			2022-12-25	WOS:000258820000026
J	Greaves, J; Salaun, C; Fukata, Y; Fukata, M; Chamberlain, LH				Greaves, Jennifer; Salaun, Christine; Fukata, Yuko; Fukata, Masaki; Chamberlain, Luke H.			Palmitoylation and membrane interactions of the neuroprotective chaperone cysteine-string protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; GABA(A) RECEPTORS; PLASMA-MEMBRANE; BREFELDIN-A; H-RAS; DROSOPHILA; GOLGI; TRANSFERASE; TRAFFICKING; DOMAIN	Cysteine-string protein (CSP) is an extensively palmitoylated DnaJ-family chaperone, which exerts an important neuroprotective function. Palmitoylation is required for the intracellular sorting and function of CSP, and thus it is important to understand how this essential modification of CSP is regulated. Recent work identified 23 putative palmitoyl transferases containing a conserved DHHC domain in mammalian cells, and here we show that palmitoylation of CSP is enhanced specifically by co-expression of the Golgi-localized palmitoyl transferases DHHC3, DHHC7, DHHC15, or DHHC17. Indeed, these DHHC proteins promote stable membrane attachment of CSP, which is otherwise cytosolic. An inverse correlation was identified between membrane affinity of unpalmitoylated CSP mutants and subsequent palmitoylation: mutants with an increased membrane affinity localize to the endoplasmic reticulum ( ER) and are physically separated from the Golgi-localized DHHC proteins. Palmitoylation of an ER-localized mutant could be rescued by brefeldin A treatment, which promotes the mixing of ER and Golgi membranes. Interestingly though, the palmitoylated mutant remained at the ER following brefeldin A washout and did not traffic to more distal membrane compartments. We propose that CSP has a weak membrane affinity that allows the protein to locate its partner Golgi-localized DHHC proteins directly by membrane "sampling." Mutations that enhance membrane association prevent sampling and lead to accumulation of CSP on cellular membranes such as the ER. The coupling of CSP palmitoylation to Golgi membranes may thus be an important requirement for subsequent sorting.	[Greaves, Jennifer; Chamberlain, Luke H.] Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Salaun, Christine] INSERM, U845, Fac Med Paris Descartes, F-75730 Paris 15, France; [Fukata, Yuko; Fukata, Masaki] Natl Inst Physiol Sci, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan; [Fukata, Yuko; Fukata, Masaki] Japan Sci & Technol Agcy, Tokyo 1020075, Japan	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Chamberlain, LH (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	Luke.Chamberlain@ed.ac.uk	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Salaun, Christine/0000-0003-3002-6810; Greaves, Jennifer/0000-0001-8445-789X; Fukata, Yuko/0000-0001-7724-8643	Wellcome Trust Research Career Development; Medical Research Council; Tenovus Scotland [S06/1]; Medical Research Council [G0601597] Funding Source: researchfish; MRC [G0601597] Funding Source: UKRI	Wellcome Trust Research Career Development(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Research Career Development fellowship ( to L. H. C.), by an Medical Research Council Senior Research fellowship ( to L. H. C.), and by Tenovus Scotland ( Grant S06/1 to L. H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boal F, 2007, BBA-MOL CELL RES, V1773, P109, DOI 10.1016/j.bbamcr.2006.08.054; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chamberlain LH, 2001, J CELL SCI, V114, P445; Coppola T, 1996, FEBS LETT, V391, P269, DOI 10.1016/0014-5793(96)00750-8; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Eberle KK, 1998, CELL TISSUE RES, V294, P203, DOI 10.1007/s004410051170; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Mastrogiacomo A, 1998, FEBS LETT, V436, P85, DOI 10.1016/S0014-5793(98)01092-8; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; vandeGoor J, 1996, FEBS LETT, V380, P251, DOI 10.1016/0014-5793(96)00026-9; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	43	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25014	25026		10.1074/jbc.M802140200	http://dx.doi.org/10.1074/jbc.M802140200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596047	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000258820000060
J	Vives-Bauza, C; Anand, M; Shirazi, AK; Magrane, J; Gao, JP; Vollmer-Snarr, HR; Manfredi, G; Finnemann, SC				Vives-Bauza, Cristofol; Anand, Monika; Shirazi, Arash K.; Magrane, Jordi; Gao, Junping; Vollmer-Snarr, Heidi R.; Manfredi, Giovanni; Finnemann, Silvia C.			The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-RETINYLIDENE ETHANOLAMINE; LIPOFUSCIN FLUOROPHORE; MACULAR DEGENERATION; RPE CELLS; DNA; DYSTROPHY; COMPONENT; BINDING; GENE; BIOSYNTHESIS	Accumulation of indigestible lipofuscin and decreased mitochondrial energy production are characteristic age-related changes of post-mitotic retinal pigment epithelial (RPE) cells in the human eye. To test whether these two forms of age-related impairment have interdependent effects, we quantified the ATP dependent phagocytic function of RPE cells loaded or not with the lipofuscin component A2E and inhibiting or not mitochondrial ATP synthesis either pharmacologically or genetically. We found that physiological levels of lysosomal A2E reduced mitochondrial membrane potential and inhibited oxidative phosphorylation (OXPHOS) of RPE cells. Furthermore, in media with physiological concentrations of glucose or pyruvate, A2E significantly inhibited phagocytosis. Antioxidants reversed these effects of A2E, suggesting that A2E damage is mediated by oxidative processes. Because mitochondrial mutations accumulate with aging, we generated novel genetic cellular models of RPE carrying mitochondrial DNA point mutations causing either moderate or severe mitochondrial dysfunction. Exploring these mutant RPE cells we found that, by itself, only the severe but not the moderate OXPHOS defect reduces phagocytosis. However, sub-toxic levels of lysosomal A2E are sufficient to reduce phagocytic activity of RPE with moderate OXPHOS defect and cause cell death of RPE with severe OXPHOS defect. Taken together, RPE cells rely on OXPHOS for phagocytosis when the carbon energy source is limited. Our results demonstrate that A2E accumulation exacerbates the effects of moderate mitochondrial dysfunction. They suggest that synergy of sub-toxic lysosomal and mitochondrial changes in RPE cells with age may cause RPE dysfunction that is known to contribute to human retinal diseases like age-related macular degeneration.	[Vives-Bauza, Cristofol; Magrane, Jordi; Manfredi, Giovanni] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10065 USA; [Anand, Monika; Shirazi, Arash K.; Finnemann, Silvia C.] Cornell Univ, Dept Ophthalmol, Weill Med Coll, Dyson Vis Res Inst, New York, NY 10065 USA; [Finnemann, Silvia C.] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10065 USA; [Finnemann, Silvia C.] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10065 USA; [Gao, Junping; Vollmer-Snarr, Heidi R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Cornell University; Cornell University; Dyson; Cornell University; Cornell University; Brigham Young University	Finnemann, SC (corresponding author), Weill Cornell Med Coll, Dyson Vis Res Inst, LC305,Box 233,1300 York Ave, New York, NY 10065 USA.	sfinne@med.cornell.edu	Vives-Bauza, Cristofol/N-7044-2015; Magrané, Jordi/AAJ-2967-2020; Vives-Bauza, Cristofol/AAS-1301-2021	Magrané, Jordi/0000-0002-6785-2166; Vives-Bauza, Cristofol/0000-0001-5735-8335; Vollmer-Snarr, Heidi/0000-0002-7312-4907	National Institutes of Health [R01-EY13295, K02-NS47306]; NATIONAL EYE INSTITUTE [R01EY013295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS047306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY13295 (to S. C. F.) and K02-NS47306 (to G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this study.	Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; BULLOCK WE, 1987, J EXP MED, V165, P195, DOI 10.1084/jem.165.1.195; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Robertson Carolyn, 2003, J Am Dent Assoc, V134 Spec No, p16S; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Schutt F, 2007, GRAEF ARCH CLIN EXP, V245, P391, DOI 10.1007/s00417-006-0376-5; Shaban H, 2001, ARCH BIOCHEM BIOPHYS, V394, P111, DOI 10.1006/abbi.2001.2535; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	53	119	122	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24770	24780		10.1074/jbc.M800706200	http://dx.doi.org/10.1074/jbc.M800706200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621729	Green Published, hybrid			2022-12-25	WOS:000258820000045
J	Schirra, HJ; Anderson, CG; Wilson, WJ; Kerr, L; Craik, DJ; Waters, MJ; Lichanska, AM				Schirra, Horst Joachim; Anderson, Cameron G.; Wilson, William J.; Kerr, Linda; Craik, David J.; Waters, Michael J.; Lichanska, Agnieszka M.			Altered Metabolism of Growth Hormone Receptor Mutant Mice: A Combined NMR Metabonomics and Microarray Study	PLOS ONE			English	Article								Background: Growth hormone is an important regulator of post-natal growth and metabolism. We have investigated the metabolic consequences of altered growth hormone signalling in mutant mice that have truncations at position 569 and 391 of the intracellular domain of the growth hormone receptor, and thus exhibit either low (around 30% maximum) or no growth hormone-dependent STAT5 signalling respectively. These mutations result in altered liver metabolism, obesity and insulin resistance. Methodology/Principal Findings: The analysis of metabolic changes was performed using microarray analysis of liver tissue and NMR metabonomics of urine and liver tissue. Data were analyzed using multivariate statistics and Gene Ontology tools. The metabolic profiles characteristic for each of the two mutant groups and wild-type mice were identified with NMR metabonomics. We found decreased urinary levels of taurine, citrate and 2-oxoglutarate, and increased levels of trimethylamine, creatine and creatinine when compared to wild-type mice. These results indicate significant changes in lipid and choline metabolism, and were coupled with increased fat deposition, leading to obesity. The microarray analysis identified changes in expression of metabolic enzymes correlating with alterations in metabolite concentration both in urine and liver. Similarity of mutant 569 to the wild-type was seen in young mice, but the pattern of metabolites shifted to that of the 391 mutant as the 569 mice became obese after six months age. Conclusions/Significance: The metabonomic observations were consistent with the parallel analysis of gene expression and pathway mapping using microarray data, identifying metabolites and gene transcripts involved in hepatic metabolism, especially for taurine, choline and creatinine metabolism. The systems biology approach applied in this study provides a coherent picture of metabolic changes resulting from impaired STAT5 signalling by the growth hormone receptor, and supports a potentially important role for taurine in enhancing beta-oxidation.	[Schirra, Horst Joachim; Anderson, Cameron G.; Kerr, Linda; Craik, David J.; Waters, Michael J.; Lichanska, Agnieszka M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wilson, William J.] CSIRO Math & Informat Sci, Stat Bioinformat, N Ryde, NSW, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schirra, HJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	h.schirra@uq.edu.au	Wilson, William/A-3631-2009; Stitt, Alan/A-9842-2009; Schirra, Horst Joachim/B-4210-2009; Craik, David/B-1695-2010; waters, michael j/C-9582-2014	Wilson, William/0000-0001-5658-0997; Stitt, Alan/0000-0002-8647-9918; Schirra, Horst Joachim/0000-0002-7541-246X; Craik, David/0000-0003-0007-6796; 	Australian Research Council (ARC) [Professorial Fellow]; National Health and Medical Research Council (NHMRC) [Senior Principal Research Fellow]; Queensland Smart State Fellow; Queensland State Govenment	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart State Fellow; Queensland State Govenment	This work was supported by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). HJS is a Queensland Smart State Fellow. DJC is an ARC Professorial Fellow. MJW is a NHMRC Senior Principal Research Fellow. The 700 MHz wide-bore NMR spectrometer is part of the Queensland NMR Network, which was established with funding from the Queensland State Govenment.	ASATOOR AM, 1965, BIOCHIM BIOPHYS ACTA, V111, P384, DOI 10.1016/0304-4165(65)90048-6; BAKER JR, 1962, J BIOL CHEM, V237, P1309; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Bouillanne O, 1996, FUNDAM CLIN PHARM, V10, P416, DOI 10.1111/j.1472-8206.1996.tb00596.x; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CAVANAGH J, 1990, J MAGN RESON, V87, P110, DOI 10.1016/0022-2364(90)90089-R; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Cheng J, 2004, BIOINFORMATICS, V20, P1462, DOI 10.1093/bioinformatics/bth087; Clayton TA, 2004, ARCH TOXICOL, V78, P86, DOI 10.1007/s00204-003-0515-2; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Connor SC, 2004, BIOMARKERS, V9, P156, DOI 10.1080/13547500410001720767; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163; FRANCONI F, 1995, AM J CLIN NUTR, V61, P1115, DOI 10.1093/ajcn/61.5.1115; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; HARVEY S, 1995, GROWTH HORMONE, P1; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Ho Ken K. Y., 1996, Endocrine Journal, V43, pS57; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Holmes E, 2002, ANALYST, V127, P1549, DOI 10.1039/b208254n; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAISAKIA PJ, 1995, BBA-GENE STRUCT EXPR, V1262, P79, DOI 10.1016/0167-4781(95)00058-O; Kiiveri HT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-195; Lang DH, 2000, BRIT J CLIN PHARMACO, V50, P311, DOI 10.1046/j.1365-2125.2000.00265.x; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006; Marion A.F., 1883, ANN MUS HIST NAT M, V1, P1; Mizushima S, 1996, ADV EXP MED BIOL, V403, P615; MOLLER N, 1991, HORM RES, V36, P32, DOI 10.1159/000182185; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Norrelund H, 2003, AM J PHYSIOL-ENDOC M, V285, pE737, DOI 10.1152/ajpendo.00092.2003; Norrelund H, 2001, J CLIN ENDOCR METAB, V86, P3120, DOI 10.1210/jc.86.7.3120; Norrelund H, 2001, DIABETES, V50, P96, DOI 10.2337/diabetes.50.1.96; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; Olsson B, 2003, AM J PHYSIOL-ENDOC M, V285, pE504, DOI 10.1152/ajpendo.00444.2002; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Richelsen B., 1999, Journal of Endocrinological Investigation, V22, P10; Richelsen B, 1997, HORM RES, V48, P105, DOI 10.1159/000191338; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Rudling M, 1999, GROWTH HORM IGF RES, V9, P1, DOI 10.1016/S1096-6374(99)80002-1; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SCHUETZ EG, 1990, J BIOL CHEM, V265, P1188; SIMPSON DP, 1983, AM J PHYSIOL, V244, pF223, DOI 10.1152/ajprenal.1983.244.3.F223; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Timbrell JA, 1996, ADV EXP MED BIOL, V403, P125; Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308; Tollet-Egnell P, 2004, PHYSIOL GENOMICS, V16, P261, DOI 10.1152/physiolgenomics.00093.2002; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; Voet D., 2005, BIOCHEMISTRY-US; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	66	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2764	10.1371/journal.pone.0002764	http://dx.doi.org/10.1371/journal.pone.0002764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648510	gold, Green Submitted, Green Published			2022-12-25	WOS:000264302900034
J	Solomon, SE; Bacci, M; Martins, J; Vinha, GG; Mueller, UG				Solomon, Scott E.; Bacci, Mauricio, Jr.; Martins, Joaquim, Jr.; Vinha, Giovanna Goncalves; Mueller, Ulrich G.			Paleodistributions and Comparative Molecular Phylogeography of Leafcutter Ants (Atta spp.) Provide New Insight into the Origins of Amazonian Diversity	PLOS ONE			English	Article							LEAF-CUTTING ANTS; CLIMATE-CHANGE; GENETIC-STRUCTURE; HISTORICAL DIVERSIFICATION; SPECIES DISTRIBUTIONS; POPULATION-GROWTH; RIVERINE BARRIERS; PLANT DIVERSITY; RACE FORMATION; SOUTH-AMERICA	The evolutionary basis for high species diversity in tropical regions of the world remains unresolved. Much research has focused on the biogeography of speciation in the Amazon Basin, which harbors the greatest diversity of terrestrial life. The leading hypotheses on allopatric diversification of Amazonian taxa are the Pleistocene refugia, marine incursion, and riverine barrier hypotheses. Recent advances in the fields of phylogeography and species-distribution modeling permit a modern re-evaluation of these hypotheses. Our approach combines comparative, molecular phylogeographic analyses using mitochondrial DNA sequence data with paleodistribution modeling of species ranges at the last glacial maximum (LGM) to test these hypotheses for three co-distributed species of leafcutter ants (Atta spp.). The cumulative results of all tests reject every prediction of the riverine barrier hypothesis, but are unable to reject several predictions of the Pleistocene refugia and marine incursion hypotheses. Coalescent dating analyses suggest that population structure formed recently (Pleistocene-Pliocene), but are unable to reject the possibility that Miocene events may be responsible for structuring populations in two of the three species examined. The available data therefore suggest that either marine incursions in the Miocene or climate changes during the Pleistocene-or both-have shaped the population structure of the three species examined. Our results also reconceptualize the traditional Pleistocene refugia hypothesis, and offer a novel framework for future research into the area.	[Solomon, Scott E.; Mueller, Ulrich G.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Solomon, Scott E.] Smithsonian Inst, Dept Entomol, Washington, DC USA; [Solomon, Scott E.; Bacci, Mauricio, Jr.; Martins, Joaquim, Jr.; Vinha, Giovanna Goncalves] Sao Paulo State Univ, Ctr Study Social, Sao Paulo, Brazil	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Estadual Paulista	Solomon, SE (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	solomons@si.edu	Martins, Joaquim/G-1319-2010; Bacci, Mauricio/C-4960-2013	Martins, Joaquim/0000-0002-6559-8045; Bacci, Mauricio/0000-0002-5619-1411; Solomon, Scott/0000-0002-6376-5671	National Science Foundation [DEB 0407772]; The University of Texas at Austin [graduate fellowships]; Amazon Conservation Association; NSF [07012333]; FAPESP [06/00185-7, 05/54250-1]; CAPES [Aux-UT-165/2005]; CNPq [310826/2006-3, 479990/2006-9];  [DEB-0110073]	National Science Foundation(National Science Foundation (NSF)); The University of Texas at Austin; Amazon Conservation Association; NSF(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	S.E.S. was funded by a DDIG grant from the National Science Foundation (DEB 0407772), the IGERT program in computational phylogenetics at The University of Texas at Austin, graduate fellowships from the Section of Integrative Biology at The University of Texas at Austin, and a grant from the Amazon Conservation Association and the NSF International Reseach Fellowship Program (IRFP #07012333). MBJ was funded by FAPESP (06/00185-7), CAPES (Aux-UT-165/2005) and CNPq (310826/2006-3 and 479990/2006-9). J.M.J. was funded by CAPES (Brazil). G.G.V was funded by FAPESP (05/54250-1). Additional funding was provided by NSF IRCEB Grant DEB-0110073 to U.G.M.	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; Aleixo A, 2006, BIOL J LINN SOC, V89, P383, DOI 10.1111/j.1095-8312.2006.00703.x; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; AUTUORI M, 1947, ARQUIVOS I BIOL SAO, V187, P39; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BERMINGHAM E, 2005, TROPICAL RAINFORESTS; Bonaccorso E, 2006, DIVERS DISTRIB, V12, P157, DOI 10.1111/j.1366-9516.2005.00212.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown K.S. Jr, 1982, P255; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; CARNAVAL AC, 2008, J BIOGEOGRAPHY  0328; Carnaval AC, 2007, EVOLUTION, V61, P2942, DOI 10.1111/j.1558-5646.2007.00241.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Cherrett J.M., 1986, P165; Cherrett J.M., 1986, P10; CHERRETT JM, 1976, ANN APPL BIOL, V84, P124, DOI 10.1111/j.1744-7348.1976.tb01741.x; CHERRETT JM, 1986, BIOL PEST STATUS CON, P1; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Colinvaux PA, 2001, AMAZONIANA, V16, P609; Coyne JA, 2004, SPECIATION, V37; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; ERWIN TL, 1991, CONSERV BIOL, V5, P330, DOI 10.1111/j.1523-1739.1991.tb00145.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Funk WC, 2007, MOL PHYLOGENET EVOL, V44, P825, DOI 10.1016/j.ympev.2007.01.012; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Garrettson M, 1998, J TROP ECOL, V14, P17, DOI 10.1017/S0266467498000029; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gonalves CR, 1967, ATAS S BIOTA AMAZON, V5; GONCALVES CR, 1960, DIVULGACAO AGRONOMIC, V12, P2; Goulding M, 2003, SMITHSONIAN ATLAS AM; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hall JPW, 2002, EVOLUTION, V56, P1489; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Hershkovitz P., 1977, LIVING NEW WORLD MON; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillis David M., 1996, P515; Holldobler B., 1990, pi; Hovikoski J, 2005, GEOLOGY, V33, P177, DOI 10.1130/G21102.1; Hovikoski J, 2007, PALAEOGEOGR PALAEOCL, V243, P23, DOI 10.1016/j.palaeo.2006.07.013; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Knowles LL, 2004, J EVOLUTION BIOL, V17, P1, DOI 10.1046/j.1420-9101.2003.00644.x; KOSCINSKI D, MOL ECOLOGY, V17, P2012; Latrubesse EM, 2007, J S AM EARTH SCI, V23, P61, DOI 10.1016/j.jsames.2006.09.021; Lewinsohn TM, 2005, CONSERV BIOL, V19, P640, DOI 10.1111/j.1523-1739.2005.00682.x; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; MANTEL N, 1967, CANCER RES, V27, P209; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Matocq MD, 2000, EVOLUTION, V54, P1423; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; MAYR E, 1986, EVOLUTION, V40, P55, DOI 10.1111/j.1558-5646.1986.tb05717.x; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; MOSER JC, 1967, INSECT SOC, V14, P295, DOI 10.1007/BF02252831; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Nielsen R, 2001, GENETICS, V158, P885; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Schneider S, 1999, GENETICS, V152, P1079; SCHULTZ TR, 2008, P NATL ACAD SCI 0324; SCHULTZ TR, 2008, P NATL ACAD IN PRESS; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMPSON BB, 1978, ANNU REV ECOL SYST, V9, P497, DOI 10.1146/annurev.es.09.110178.002433; SLATKIN M, 1991, GENETICS, V129, P555; Smith TB, 2001, GENETICA, V112, P383, DOI 10.1023/A:1013312510860; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P597; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; TOLLEY KA, 2008, J BIOGEOGRAPHY  0328; VASCONCELOS HL, 1995, STUD NEOTROP FAUNA E, V30, P107, DOI 10.1080/01650529509360947; Vonhof HB, 2003, GEOL SOC AM BULL, V115, P983, DOI 10.1130/B25058.1; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; WEBER NA, 1969, ECOLOGY, V50, P141; Weber NA., 1972, GARDENING ANTS; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilson EO, 1999, DIVERSITY LIFE; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; WILSON S, 1987, METHODS COMPUTATIONA, V1, P251; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	133	75	76	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2738	10.1371/journal.pone.0002738	http://dx.doi.org/10.1371/journal.pone.0002738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648512	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900009
J	Kuiper, EJ; Van Nieuwenhoven, FA; de Smet, MD; van Meurs, JC; Tanck, MW; Oliver, N; Klaassen, I; Van Noorden, CJF; Goldschmeding, R; Schlingemann, RO				Kuiper, Esther J.; Van Nieuwenhoven, Frans A.; de Smet, Marc D.; van Meurs, Jan C.; Tanck, Michael W.; Oliver, Noelynn; Klaassen, Ingeborg; Van Noorden, Cornelis J. F.; Goldschmeding, Roel; Schlingemann, Reinier O.			The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article								Background: In proliferative diabetic retinopathy (PDR), vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) cause blindness by neovascularization and subsequent fibrosis, but their relative contribution to both processes is unknown. We hypothesize that the balance between levels of pro-angiogenic VEGF and pro-fibrotic CTGF regulates angiogenesis, the angio-fibrotic switch, and the resulting fibrosis and scarring. Methods/Principal Findings: VEGF and CTGF were measured by ELISA in 68 vitreous samples of patients with proliferative DR (PDR, N = 32), macular hole (N = 13) or macular pucker (N = 23) and were related to clinical data, including degree of intra-ocular neovascularization and fibrosis. In addition, clinical cases of PDR (n = 4) were studied before and after pan-retinal photocoagulation and intra-vitreal injections with bevacizumab, an antibody against VEGF. Neovascularization and fibrosis in various degrees occurred almost exclusively in PDR patients. In PDR patients, vitreous CTGF levels were significantly associated with degree of fibrosis and with VEGF levels, but not with neovascularization, whereas VEGF levels were associated only with neovascularization. The ratio of CTGF and VEGF was the strongest predictor of degree of fibrosis. As predicted by these findings, patients with PDR demonstrated a temporary increase in intra-ocular fibrosis after anti-VEGF treatment or laser treatment. Conclusions/Significance: CTGF is primarily a pro-fibrotic factor in the eye, and a shift in the balance between CTGF and VEGF is associated with the switch from angiogenesis to fibrosis in proliferative retinopathy.	[Kuiper, Esther J.; de Smet, Marc D.; Klaassen, Ingeborg; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Ocular Angiogenesis Grp, Dept Ophthalmol, Acad Med Ctr, Amsterdam, Netherlands; [Van Nieuwenhoven, Frans A.; Goldschmeding, Roel] Academ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Meurs, Jan C.] Rotterdam Eye Hosp, Dept Ophthalmol, Rotterdam, Netherlands; [Tanck, Michael W.] Univ Amsterdam, Academ Med Ctr, Dept Clin Epidemiol Stat, Amsterdam, Netherlands; [Oliver, Noelynn] FibroGen Inc, San Francisco, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Rotterdam Eye Hospital; University of Amsterdam; Academic Medical Center Amsterdam; FibroGen	Kuiper, EJ (corresponding author), Univ Amsterdam, Ocular Angiogenesis Grp, Dept Ophthalmol, Acad Med Ctr, Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Goldschmeding, Roel/I-1723-2014; Klaassen, Ingeborg/F-7333-2015; De Smet, Marc D./E-2451-2013	De Smet, Marc D./0000-0002-9217-5603; Tanck, Michael/0000-0001-9828-4459; Klaassen, Ingeborg/0000-0003-1695-9403; van Nieuwenhoven, Frans/0000-0002-5757-0069	Diabetes Fonds Nederland [2001 042]; Edmond and Marianne Blaauw Fonds	Diabetes Fonds Nederland; Edmond and Marianne Blaauw Fonds	This study was supported by grants from the Diabetes Fonds Nederland (grant 2001 042) and by the Edmond and Marianne Blaauw Fonds.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Babic AM, 1999, MOL CELL BIOL, V19, P2958; CAMPOCHIARO PA, 2001, RETINA, P2221; Chang CC, 2006, JNCI-J NATL CANCER I, V98, P984, DOI 10.1093/jnci/djj242; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; FRANK RN, 1994, NEW ENGL J MED, V331, P1519, DOI 10.1056/NEJM199412013312212; Franklin TJ, 1997, INT J BIOCHEM CELL B, V29, P79, DOI 10.1016/S1357-2725(96)00121-5; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Goldschmeding R, 2000, NEPHROL DIAL TRANSPL, V15, P296, DOI 10.1093/ndt/15.3.296; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; He S, 2003, ARCH OPHTHALMOL-CHIC, V121, P1283, DOI 10.1001/archopht.121.9.1283; HE S, 2008, INVEST 0430 IN PRESS; Hinton DR, 2004, DIABETES CARE, V27, P758, DOI 10.2337/diacare.27.3.758; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hofman P, 2000, CURR EYE RES, V21, P637, DOI 10.1076/0271-3683(200008)21:2;1-V;FT637; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; Kita T, 2007, DIABETES, V56, P1421, DOI 10.2337/db06-1644; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Kuiper EJ, 2004, BRIT J OPHTHALMOL, V88, P1082, DOI 10.1136/bjo.2003.032045; Kuiper EJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1139, DOI 10.1369/jhc.7A7258.2007; Kuiper EJ, 2007, INVEST OPHTH VIS SCI, V48, P4267, DOI 10.1167/iovs.06-0804; Kuiper EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1457, DOI 10.1001/archopht.124.10.1457; MAGETO Y, CHEST, V126, pS773; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Schlingemann RO, 1997, BRIT J OPHTHALMOL, V81, P501, DOI 10.1136/bjo.81.6.501; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; van Nieuwenhoven FA, 2005, NEPHROL DIAL TRANSPL, V20, P6, DOI 10.1093/ndt/gfh570; Watanabe D, 2005, RETINA-J RET VIT DIS, V25, P911, DOI 10.1097/00006982-200510000-00015; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yokoi H, 2004, J AM SOC NEPHROL, V15, P1430, DOI 10.1097/01.ASN.0000130565.69170.85; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422	51	166	182	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2675	10.1371/journal.pone.0002675	http://dx.doi.org/10.1371/journal.pone.0002675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628999	gold, Green Submitted, Green Published			2022-12-25	WOS:000264057200020
J	Wang, SC; Oelze, B; Schumacher, A				Wang, Sun-Chong; Oelze, Beatrice; Schumacher, Axel			Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease	PLOS ONE			English	Article								Despite an enormous research effort, most cases of late-onset Alzheimer's disease (LOAD) still remain unexplained and the current biomedical science is still a long way from the ultimate goal of revealing clear risk factors that can help in the diagnosis, prevention and treatment of the disease. Current theories about the development of LOAD hinge on the premise that Alzheimer's arises mainly from heritable causes. Yet, the complex, non-Mendelian disease etiology suggests that an epigenetic component could be involved. Using MALDI-TOF mass spectrometry in post-mortem brain samples and lymphocytes, we have performed an analysis of DNA methylation across 12 potential Alzheimer's susceptibility loci. In the LOAD brain samples we identified a notably age-specific epigenetic drift, supporting a potential role of epigenetic effects in the development of the disease. Additionally, we found that some genes that participate in amyloid-beta processing (PSEN1, APOE) and methylation homeostasis (MTHFR, DNMT1) show a significant interindividual epigenetic variability, which may contribute to LOAD predisposition. The APOE gene was found to be of bimodal structure, with a hypomethylated CpG-poor promoter and a fully methylated 3'-CpG-island, that contains the sequences for the epsilon 4-haplotype, which is the only undisputed genetic risk factor for LOAD. Aberrant epigenetic control in this CpG-island may contribute to LOAD pathology. We propose that epigenetic drift is likely to be a substantial mechanism predisposing individuals to LOAD and contributing to the course of disease.	[Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Schumacher, Axel] Klin rechts der Isar, Dept Med 2, Epigenet Lab, Munich, Germany; [Oelze, Beatrice] Sequenom GmbH, Hamburg, Germany	National Central University	Wang, SC (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	Axel.Schumacher@lrz.tu-muenchen.de			German National Genome Network (NGFN); Klinikum Rechts der Isar	German National Genome Network (NGFN); Klinikum Rechts der Isar	This work was funded in parts by the German National Genome Network (NGFN) and the Klinikum Rechts der Isar. Funders had no influence in design or conduct of the study.	Basha MR, 2005, J NEUROSCI, V25, P823, DOI 10.1523/JNEUROSCI.4335-04.2005; Bassett SS, 2006, AM J MED GENET B, V141B, P537, DOI 10.1002/ajmg.b.30350; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; BOTTIGLIERI T, 1990, J NEUROL NEUROSUR PS, V53, P1096, DOI 10.1136/jnnp.53.12.1096; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COOK RH, 1981, ARCH NEUROL-CHICAGO, V38, P300, DOI 10.1001/archneur.1981.00510050066011; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DOLINOY DC, 2007, PEDIAT RES; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guidi I, 2005, NEUROBIOL AGING, V26, P789, DOI 10.1016/j.neurobiolaging.2004.07.003; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kristiansen M, 2005, EUR J HUM GENET, V13, P599, DOI 10.1038/sj.ejhg.5201398; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Lehmann M, 1999, DEMENT GERIATR COGN, V10, P12, DOI 10.1159/000017092; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Liddell MB, 2001, BRIT J PSYCHIAT, V178, P7, DOI 10.1192/bjp.178.1.7; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; MILICI A, 1990, BIOCHEM BIOPH RES CO, V169, P46, DOI 10.1016/0006-291X(90)91430-Z; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Nee LE, 1999, DEMENT GERIATR COGN, V10, P148, DOI 10.1159/000017115; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Payao SLM, 1998, GERONTOLOGY, V44, P267; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Raina AK, 2001, MECH AGEING DEV, V123, P3, DOI 10.1016/S0047-6374(01)00333-5; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; ROGAEV EI, 1994, GENOMICS, V22, P340, DOI 10.1006/geno.1994.1393; SCHWOB NG, 1990, ANN NEUROL, V28, P91, DOI 10.1002/ana.410280117; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008	51	328	351	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2698	10.1371/journal.pone.0002698	http://dx.doi.org/10.1371/journal.pone.0002698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628954	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200041
J	Husain, S; Yildirim-Toruner, C; Rubio, JP; Field, J; Schwalb, M; Cook, S; Devoto, M; Vitale, E				Husain, Seema; Yildirim-Toruner, Cagri; Rubio, Justin P.; Field, Judith; Schwalb, Marvin; Cook, Stuart; Devoto, Marcella; Vitale, Emilia		So MS Genetics Consortium	Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis	PLOS ONE			English	Article								Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown etiology with both genetic and environmental factors playing a role in susceptibility. To date, the HLA DR15/DQ6 haplotype within the major histocompatibility complex on chromosome 6p, is the strongest genetic risk factor associated with MS susceptibility. Additional alleles of IL7 and IL2 have been identified as risk factors for MS with small effect. Here we present two independent studies supporting an allelic association of MS with polymorphisms in the ST8SIA1 gene, located on chromosome 12p12 and encoding ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1. The initial association was made in a single three-generation family where a single-nucleotide polymorphism (SNP) rs4762896, was segregating together with HLA DR15/DQ6 in MS patients. A study of 274 family trios (affected child and both unaffected parents) from Australia validated the association of ST8SIA1 in individuals with MS, showing transmission disequilibrium of the paternal alleles for three additional SNPs, namely rs704219, rs2041906, and rs1558793, with p = 0.001, p = 0.01 and p = 0.01 respectively. These findings implicate ST8SIA1 as a possible novel susceptibility gene for MS.	[Husain, Seema; Yildirim-Toruner, Cagri; Schwalb, Marvin; Vitale, Emilia] UMDNJ, New Jersey Med Sch, Inst Genom Med, Newark, NJ USA; [Rubio, Justin P.; Field, Judith] Univ Melbourne, Howard Florey Inst, Parkville, Vic, Australia; [Cook, Stuart] UMDNJ, New Jersey Med Sch, Dept Neurosci, Newark, NJ USA; [Devoto, Marcella] Univ Penn, Sch Med, CHOP, CCEB, Philadelphia, PA USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Vitale, Emilia] CNR Inst Cybernet, Naples, Italy	Rutgers State University New Brunswick; Rutgers State University Medical Center; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR)	Husain, S (corresponding author), UMDNJ, New Jersey Med Sch, Inst Genom Med, Newark, NJ USA.	vitaleem@umdnj.edu	vitale, emilia/A-5282-2011; Devoto, Marcella/AAP-7595-2021	Stankovich, Jim/0000-0001-9344-7749; DEVOTO, MARCELLA/0000-0002-4431-5114; Field, Judith/0000-0002-7089-0999; Vitale, Emilia/0000-0003-4651-3875; RUBIO, JUSTIN/0000-0003-3750-917X	MS National Multiple Sclerosis Society; Wadsworth Foundation for Multiple Sclerosis Research; Foundation of UMDNJ; National Health and Medical Research Council of Australia [R. D. Wright Fellow]	MS National Multiple Sclerosis Society(National Multiple Sclerosis Society); Wadsworth Foundation for Multiple Sclerosis Research; Foundation of UMDNJ; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the MS National Multiple Sclerosis Society, the Wadsworth Foundation for Multiple Sclerosis Research Grant and the Foundation of UMDNJ(E.V.) and by Segal Family, L'Hommedieu and Kushner Family Grants (S.C.). JPR is an R. D. Wright Fellow of The National Health and Medical Research Council of Australia.	Barnett MH, 2006, CURR OPIN NEUROL, V19, P242, DOI 10.1097/01.wco.0000227032.47458.cb; Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Compston A, 1999, PHILOS T R SOC B, V354, P1623, DOI 10.1098/rstb.1999.0507; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Herrera BM, 2007, NEUROLOGY, V69, P1208, DOI 10.1212/01.wnl.0000268486.40851.d6; Kantarci OH, 2006, NEUROLOGY, V67, P305, DOI 10.1212/01.wnl.0000225070.13682.11; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Lassmann H, 1998, MULT SCLER J, V4, P93, DOI 10.1191/135245898678909367; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Lundmark F, 2007, J NEUROIMMUNOL, V192, P171, DOI 10.1016/j.jneuroim.2007.08.015; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Marrosu MG, 2004, NEUROLOGY, V63, P1084, DOI 10.1212/01.WNL.0000138493.04890.7C; Matsuda Y, 1996, GENOMICS, V32, P137, DOI 10.1006/geno.1996.0090; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RAMAGOPALAN SV, 2007, HUM GENET; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Vitale E, 2002, HUM MOL GENET, V11, P295, DOI 10.1093/hmg/11.3.295	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2653	10.1371/journal.pone.0002653	http://dx.doi.org/10.1371/journal.pone.0002653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612409	Green Accepted, Green Published, gold			2022-12-25	WOS:000264065800055
J	Koelsch, S; Sammler, D				Koelsch, Stefan; Sammler, Daniela			Cognitive Components of Regularity Processing in the Auditory Domain	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MUSIC PERCEPTION; LANGUAGE; BRAIN; SYNTAX; MEMORY; ERP; NEGATIVITY; CHORDS; RULES	Background: Music-syntactic irregularities often co-occur with the processing of physical irregularities. In this study we constructed chord-sequences such that perceived differences in the cognitive processing between regular and irregular chords could not be due to the sensory processing of acoustic factors like pitch repetition or pitch commonality (the major component of 'sensory dissonance'). Methodology/Principal Findings: Two groups of subjects (musicians and nonmusicians) were investigated with electroencephalography (EEG). Irregular chords elicited an early right anterior negativity (ERAN) in the event-related brain potentials (ERPs). The ERAN had a latency of around 180 ms after the onset of the music-syntactically irregular chords, and had maximum amplitude values over right anterior electrode sites. Conclusions/Significance: Because irregular chords were hardly detectable based on acoustical factors (such as pitch repetition and sensory dissonance), this ERAN effect reflects for the most part cognitive (not sensory) components of regularity-based, music-syntactic processing. Our study represents a methodological advance compared to previous ERP-studies investigating the neural processing of music-syntactically irregular chords.	[Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton, E Sussex, England; [Koelsch, Stefan; Sammler, Daniela] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Sussex; Max Planck Society	Koelsch, S (corresponding author), Univ Sussex, Dept Psychol, Brighton, E Sussex, England.	koelsch@cbs.mpg.de	Sammler, Daniela/V-9044-2019; Koelsch, Stefan/AAV-1556-2020	Sammler, Daniela/0000-0001-7458-0229; 				Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; KOELSCH S, 2005, CURRENT OPINION NEUR, V15, P1; KOELSCH S, 2008, PSYCHOPHYSI IN PRESS; KOELSCH S, 2008, SHORT TERM EFFECTS P; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; Leman M, 2000, MUSIC PERCEPT, V17, P481; LEMAN M., 2005, IPEM TOOLBOX PERCEPT; LOUI P, 2005, COG BRAIN RES, V25, P589; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Naatanen R., 2018, ATTENTION BRAIN FUNC; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel A. D., 2007, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Piston W., 1948, HARMONY, V5th ed.; Poulin-Charronnat B, 2006, J COGNITIVE NEUROSCI, V18, P1545, DOI 10.1162/jocn.2006.18.9.1545; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Riemann H, 1877, MUSIKALISCHE SYNTAXI; Schonberg A, 1969, STRUCTURAL FUNCTIONS; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252	35	20	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2650	10.1371/journal.pone.0002650	http://dx.doi.org/10.1371/journal.pone.0002650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612421	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800052
J	Medina, RJ; O'Neill, CL; Devine, AB; Gardiner, TA; Stitt, AW				Medina, Reinhold J.; O'Neill, Christina L.; Devine, Adrian B.; Gardiner, Tom A.; Stitt, Alan W.			The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies	PLOS ONE			English	Article								Background: Current guidelines encourage the use of statins to reduce the risk of cardiovascular disease in diabetic patients; however the impact of these drugs on diabetic retinopathy is not well defined. Moreover, pleiotropic effects of statins on the highly specialised retinal microvascular endothelium remain largely unknown. The objective of this study was to investigate the effects of clinically relevant concentrations of simvastatin on retinal endothelium in vitro and in vivo. Methods and Findings: Retinal microvascular endothelial cells (RMECs) were treated with 0.01-10 mu M simvastatin and a biphasic dose-related response was observed. Low concentrations enhanced microvascular repair with 0.1 mu M simvastatin significantly increasing proliferation (p < 0.05), and 0.01 mu M simvastatin significantly promoting migration (p < 0.05), sprouting (p < 0.001), and tubulogenesis (p < 0.001). High concentration of simvastatin (10 mu M) had the opposite effect, significantly inhibiting proliferation (p < 0.01), migration (p < 0.01), sprouting (p < 0.001), and tubulogenesis (p < 0.05). Furthermore, simvastatin concentrations higher than 1 mu M induced cell death. The mouse model of oxygen-induced retinopathy was used to investigate the possible effects of simvastatin treatment on ischaemic retinopathy. Low dose simvastatin(0.2 mg/Kg) promoted retinal microvascular repair in response to ischaemia by promoting intra-retinal revascularisation (p < 0.01). By contrast, high dose simvastatin(20 mg/Kg) significantly prevented re-vascularisation (p < 0.01) and concomitantly increased pathological neovascularisation (p < 0.01). We also demonstrated that the pro-vascular repair mechanism of simvastatin involves VEGF stimulation, Akt phosphorylation, and nitric oxide production; and the antivascular repair mechanism is driven by marked intracellular cholesterol depletion and related disorganisation of key intracellular structures. Conclusions: A beneficial effect of low-dose simvastatin on ischaemic retinopathy is linked to angiogenic repair reducing ischaemia, thereby preventing pathological neovascularisation. High-dose simvastatin may be harmful by inhibiting reparative processes and inducing premature death of retinal microvascular endothelium which increases ischaemia-induced neovascular pathology. Statin dosage should be judiciously monitored in patients who are diabetic or are at risk of developing other forms of proliferative retinopathy.	[Medina, Reinhold J.; O'Neill, Christina L.; Devine, Adrian B.; Gardiner, Tom A.; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Medina, RJ (corresponding author), Queens Univ Belfast, Ctr Vis Sci, Belfast, Antrim, North Ireland.	a.stitt@qub.ac.uk	Stitt, Alan/A-9842-2009; Medina, Reinhold J/A-7949-2015	Stitt, Alan/0000-0002-8647-9918; Medina, Reinhold J/0000-0003-4351-7010; Gardiner, Tom/0000-0003-4907-2630	Jules Thorn Trust; TBF Thompson Trust; Juvenile Diabetes Research Foundation; Guide Dogs for the Blind Association	Jules Thorn Trust; TBF Thompson Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Guide Dogs for the Blind Association	This work was supported by the Jules Thorn Trust, the TBF Thompson Trust and the Juvenile Diabetes Research Foundation. In vitro experiments for this work were supported by the Guide Dogs for the Blind Association.	Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Badr GA, 2000, DIABETES, V49, P1016, DOI 10.2337/diabetes.49.6.1016; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Boukhtouche F, 2004, ARTERIOSCL THROM VAS, V24, P637, DOI 10.1161/01.ATV.0000119355.56036.de; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Chen SD, 2005, ANN NY ACAD SCI, V1042, P357, DOI 10.1196/annals.1338.033; Cheung BMY, 2008, LANCET, V371, P94, DOI 10.1016/S0140-6736(08)60081-1; Coleman G, 2007, GRAEF ARCH CLIN EXP, V245, P581, DOI 10.1007/s00417-006-0396-1; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Frick M, 2003, ATHEROSCLEROSIS, V170, P229, DOI 10.1016/S0021-9150(03)00299-5; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GORDON B, 1991, AM J OPHTHALMOL, V112, P385, DOI 10.1016/S0002-9394(14)76244-0; Ii M, 2007, VASC PHARMACOL, V46, P1, DOI 10.1016/j.vph.2006.06.012; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lilja JJ, 2004, BRIT J CLIN PHARMACO, V58, P56, DOI 10.1111/j.1365-2125.2004.02095.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuno H, 2004, J CARDIOVASC PHARM, V43, P333, DOI 10.1097/00005344-200403000-00002; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; *NIH, 2006, STAT PREV CARD EV TE; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; PEDERSEN TR, 1994, LANCET, V344, P1383; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sen K, 2002, DIABETES RES CLIN PR, V56, P1, DOI 10.1016/S0168-8227(01)00341-2; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tawfik HE, 2006, J PHARMACOL EXP THER, V319, P386, DOI 10.1124/jpet.106.106823; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Watkins PJ, 2003, BRIT MED J, V326, P924, DOI 10.1136/bmj.326.7395.924; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Zhang J, 2007, ARCH OPHTHALMOL-CHIC, V125, P1096, DOI 10.1001/archopht.125.8.1096	46	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2584	10.1371/journal.pone.0002584	http://dx.doi.org/10.1371/journal.pone.0002584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612412	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800005
J	Ishikita, H				Ishikita, Hiroshi			Light-induced hydrogen bonding pattern and driving force of electron transfer in AppA BLUF domain photoreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-SPHAEROIDES; CLOSTRIDIUM-BEIJERINCKII; REDOX POTENTIALS; REACTION CENTERS; GENE-EXPRESSION; TYROSINE; MECHANISM; OXIDATION; PROTEIN; PROTON	The AppA BLUF (blue light sensing using FAD) domain from Rhodobacter sphaeroides serves as a blue light-sensing photoreceptor. The charge separation process between Tyr-21 and flavin plays an important role in the light signaling state by transforming the dark state conformation to the light state one. By solving the linearized Poisson-Boltzmann equation, I calculated E(m) for Tyr-21, flavin, and redox-active Trp-104 and revealed the electron transfer (ET) driving energy. Rotation of the Gln-63 side chain that converts protein conformation from the dark state to the light state is responsible for the decrease of 150 mV in E(m) for Tyr-21, leading to the significantly larger ET driving energy in the light state conformation. The pK(alpha) values of protonation for flavin anions are essentially the same in both dark and light state crystal structures. In contrast to the ET via Tyr-21, formation of the W.(+) state results in generation of only the dark state conformation (even if the initial conformation is in the light state); this could explain why Trp-104-mediated ET deactivates the light-sensing yield and why the activity of W104A mutant is similar to that of the light-adapted native BLUF.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Ishikita, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hiro@iam.u-tokyo.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150				Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Grinstead JS, 2006, J AM CHEM SOC, V128, P15066, DOI 10.1021/ja0660103; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Han YC, 2004, P NATL ACAD SCI USA, V101, P12306, DOI 10.1073/pnas.0403547101; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2008, BIOCHEMISTRY-US, V47, P4394, DOI 10.1021/bi702151k; Ishikita H, 2007, J AM CHEM SOC, V129, P11146, DOI 10.1021/ja072708k; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ishikita H, 2006, BIOPHYS J, V90, P3886, DOI 10.1529/biophysj.105.076984; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; Kumler WD, 1943, J AM CHEM SOC, V65, P2355, DOI 10.1021/ja01252a028; Laan W, 2006, BIOCHEMISTRY-US, V45, P51, DOI 10.1021/bi051367p; Laan W, 2003, PHOTOCHEM PHOTOBIOL, V78, P290, DOI 10.1562/0031-8655(2003)078<0290:ICOTPP>2.0.CO;2; Masuda S, 2005, BIOCHEMISTRY-US, V44, P1215, DOI 10.1021/bi047876t; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Muh F, 1998, BIOCHEMISTRY-US, V37, P13066, DOI 10.1021/bi980799f; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Unno M, 2006, J AM CHEM SOC, V128, P5638, DOI 10.1021/ja060633z	33	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30618	30623		10.1074/jbc.M803864200	http://dx.doi.org/10.1074/jbc.M803864200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18647748	Green Published, hybrid			2022-12-25	WOS:000260544800085
J	Nagaoka, M; Hagiwara, Y; Takemura, K; Murakami, Y; Li, JX; Duncan, SA; Akaike, T				Nagaoka, Masato; Hagiwara, Yuko; Takemura, Keiko; Murakami, Yuta; Li, Jixuan; Duncan, Stephen A.; Akaike, Toshihiro			Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-INHIBITORY FACTOR; SELF-RENEWAL; ES CELLS; CELLULAR-RESPONSES; FACTOR-RECEPTOR; FACTOR LIF; EXPRESSION; PLURIPOTENCY; DIFFERENTIATION; CULTURE	Embryonic stem (ES) cells are pluripotent-undifferentiated cells that have a great interest for the investigation of developmental biology. Murine ES cells maintain their pluripotency by the supplementation of the leukemia inhibitory factor (LIF). LIF is reported to act as a matrix-anchored form, and immobilized cytokines are useful to sustain their signaling on target cells. In this study, we used the immobilizable fusion protein composed of LIF and IgG-Fc region, which was used as a model of the matrix-anchored form of LIF to establish a novel system for ES cell culture and to investigate the effect of immobilized LIF on maintenance of ES cell pluripotency. Mouse ES cells maintained their undifferentiated state on the surface coated with LIF-Fc. Furthermore, when cultured on the co-immobilized surface with LIF-Fc and E-cadherin-Fc, mouse ES cells showed characteristic scattering morphologies without colony formation, and they could maintain their undifferentiated state and pluripotency without additional LIF supplementation. The activation of LIF signaling was sustained on the co-immobilized surface. These results indicate that immobilized LIF and E-cadherin can maintain mouse ES cells efficiently and that the immobilizable LIF-Fc fusion protein is useful for the investigation of signaling pathways of an immobilized form of LIF in the maintenance of ES cell pluripotency.	[Hagiwara, Yuko; Takemura, Keiko; Murakami, Yuta; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nagaoka, Masato; Li, Jixuan; Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Tokyo Institute of Technology; Medical College of Wisconsin	Akaike, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B-57 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	takaike@bio.titech.ac.jp	Nagaoka, Masato/GRF-5030-2022; Nagaoka, Masato/J-1551-2014	Duncan, Stephen/0000-0002-2507-7827	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the 21st Century Centers of Excellence Program and a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; BAUMANN H, 1989, J IMMUNOL, V143, P1163; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blanchard F, 2000, J BIOL CHEM, V275, P28793, DOI 10.1074/jbc.M003986200; Cetinkaya G, 2007, J BIOMED MATER RES A, V81A, P911, DOI 10.1002/jbm.a.31107; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Duncan SA, 1997, DEVELOPMENT, V124, P279; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FERRARA N, 1992, P NATL ACAD SCI USA, V89, P698, DOI 10.1073/pnas.89.2.698; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; METCALF D, 1988, LEUKEMIA, V2, P216; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; Nagaoka M, 2008, J CELL BIOCHEM, V103, P296, DOI 10.1002/jcb.21406; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Ogiwara K, 2006, BIOCHEM BIOPH RES CO, V345, P255, DOI 10.1016/j.bbrc.2006.04.001; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AB, 2004, J CELL SCI, V117, P1365, DOI 10.1242/jcs.01037; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	40	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26468	26476		10.1074/jbc.M805037200	http://dx.doi.org/10.1074/jbc.M805037200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18614540	hybrid, Green Published			2022-12-25	WOS:000259341600022
J	Pless, O; Kowenz-Leutz, E; Knoblich, M; Lausen, J; Beyermann, M; Walsh, MJ; Leutz, A				Pless, Ole; Kowenz-Leutz, Elisabeth; Knoblich, Maria; Lausen, Joern; Beyermann, Michael; Walsh, Martin J.; Leutz, Achim			G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; IN-VITRO; HEPATOCYTE PROLIFERATION; SUBSTRATE-SPECIFICITY; P53 ACTIVITY; KINASE-A; NF-M; PHOSPHORYLATION; G9A; TRANSCRIPTION	The functional capacity of the transcriptional regulatory CCAAT/enhancer-binding protein-beta (C/EBP beta) is governed by protein interactions and post-translational protein modifications. In a proteome-wide interaction screen, the histone-lysine N-methyltransferase, H3 lysine 9-specific 3 (G9a), was found to directly interact with the C/EBP beta transactivation domain (TAD). Binding between G9a and C/EBP beta was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation. Metabolic labeling showed that C/EBP beta is post-translationally modified by methylation in vivo. Aconserved lysine residue in the C/EBP beta TADserved as a substrate for G9a-mediated methylation. G9a, but not a methyltransferase-defective G9a mutant, abrogated the transactivation potential of wild type C/EBP beta. A C/EBP beta TAD mutant that contained a lysine-toalanine exchange was resistant to G9a-mediated inhibition. Moreover, the same mutation conferred super-activation of a chromatin-embedded, endogenous C/EBP beta target gene. Our data identify C/EBP beta as a direct substrate of G9a-mediated post-translational modification that alters the functional properties of C/EBP beta during gene regulation.	[Pless, Ole; Kowenz-Leutz, Elisabeth; Knoblich, Maria; Leutz, Achim] Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Beyermann, Michael] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Lausen, Joern] Georg Speyer Haus, D-60596 Frankfurt, Germany; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Leutz, A (corresponding author), Humboldt Univ, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	aleutz@mdc-berlin.de	Pless, Ole/E-8348-2016; Leutz, Achim/K-9643-2013; Horstmann, Britta/C-2154-2008	Pless, Ole/0000-0002-1468-316X; Leutz, Achim/0000-0001-8259-927X; 				ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; BEUG H, 1982, J CELL PHYSIOL, P195; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chin HG, 2005, BIOCHEMISTRY-US, V44, P12998, DOI 10.1021/bi0509907; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; COMB DG, 1966, J BIOL CHEM, V241, P1857; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huq MDM, 2007, MOL CELL PROTEOMICS, V6, P677, DOI 10.1074/mcp.M600223-MCP200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lausen J, 2006, ONCOGENE, V25, P1349, DOI 10.1038/sj.onc.1209181; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Screpanti I, 1996, J EXP MED, V184, P1561, DOI 10.1084/jem.184.4.1561; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STERNECK E, 1992, MOL CELL BIOL, V12, P1728, DOI 10.1128/MCB.12.4.1728; STERNECK E, 1992, EMBO J, V11, P115, DOI 10.1002/j.1460-2075.1992.tb05034.x; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094	56	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26357	26363		10.1074/jbc.M802132200	http://dx.doi.org/10.1074/jbc.M802132200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18647749	Green Published, hybrid			2022-12-25	WOS:000259341600009
J	Wu, SR; Haag, L; Sjoberg, M; Garoff, H; Hammar, L				Wu, Shang-Rung; Haag, Lars; Sjoberg, Mathilda; Garoff, Henrik; Hammar, Lena			The dynamic envelope of a fusion class II virus E3 - Domain of glycoprotein E2 precursor in semliki forest virus provides a unique contact with the fusion protein E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; CRYOELECTRON MICROSCOPY; CONFORMATIONAL-CHANGE; SPIKE COMPLEX; OLIGOMERIZATION; ORGANIZATION; ACTIVATION; PH; ALPHAVIRUSES; MATURATION	In alphaviruses, here represented by Semliki Forest virus, infection requires an acid-responsive spike configuration to facilitate membrane fusion. The creation of this relies on the chaperon function of glycoprotein E2 precursor (p62) and its maturation cleavage into the small external E3 and the membrane-anchored E2 glycoproteins. To reveal how the E3 domain of p62 exerts its control of spike functions, we determine the structure of a p62 cleavage-impaired mutant virus particle (SQL) by electron cryomicroscopy. A comparison with the earlier solved wild type virus structure reveals that the E3 domain of p62(SQL) forms a bulky side protrusion in the spike head region. This establishes a gripper over part of domain II of the fusion protein, with a cotter-like connection downward to a hydrophobic cluster in its central beta-sheet. This finding reevaluates the role of the precursor from being only a provider of a shield over the fusion loop to a structural playmate in formation of the fusogenic architecture.	[Wu, Shang-Rung; Haag, Lars; Sjoberg, Mathilda; Garoff, Henrik; Hammar, Lena] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Wu, SR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	Shang-Rung.Wu@ki.se		Sjoberg, Mathilda/0000-0002-7434-520X	Swedish Medical Research Council, European Union 6th Framework Program [512740]; Karolinska Institutet, Sweden	Swedish Medical Research Council, European Union 6th Framework Program(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Sweden(Karolinska Institutet)	This work has been supported by Swedish Medical Research Council, European Union 6th Framework Program (Project 512740) and by The Swedish Knowledge Foundation together with Crystal Research AB (Lund, Sweden), through the Industrial Ph. D. program in Medical Bioinformatics (to S.-R. W.) at the Karolinska Institutet, Sweden. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson H, 1997, J VIROL, V71, P9654, DOI 10.1128/JVI.71.12.9654-9663.1997; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BARTH BU, 1995, J CELL BIOL, V128, P283, DOI 10.1083/jcb.128.3.283; BERGLUND P, 1993, BIO-TECHNOL, V11, P916, DOI 10.1038/nbt0893-916; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; CHENG RH, 1995, CELL, V80, P621; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; GAROFF H, 1994, ARCH VIROL, P329; GAROFF H, 1990, J CELL BIOL, V111, P867, DOI 10.1083/jcb.111.3.867; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Gibbons DL, 2004, J VIROL, V78, P3514, DOI 10.1128/JVI.78.7.3514-3523.2004; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GLASGOW GM, 1991, VIROLOGY, V185, P741, DOI 10.1016/0042-6822(91)90545-M; Glomb-Reinmund S, 1998, J VIROL, V72, P4281, DOI 10.1128/JVI.72.5.4281-4287.1998; Haag L, 2002, EMBO J, V21, P4402, DOI 10.1093/emboj/cdf442; HAAG L, 2006, THESIS KAROLINSKA I; Hammar L, 2003, J BIOL CHEM, V278, P7189, DOI 10.1074/jbc.M206015200; JAIN SK, 1991, J BIOL CHEM, V266, P5756; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LILJESTROM P, 1991, J VIROL, V65, P4107; LOBIGS M, 1990, J VIROL, V64, P5214, DOI 10.1128/JVI.64.10.5214-5218.1990; LOBIGS M, 1990, J VIROL, V6443, P46; Malashkevich VN, 2001, P NATL ACAD SCI USA, V98, P8502, DOI 10.1073/pnas.151254798; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MAYNE JT, 1984, VIROLOGY, V134, P338, DOI 10.1016/0042-6822(84)90302-7; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Tubulekas I, 1998, J VIROL, V72, P2825, DOI 10.1128/JVI.72.4.2825-2831.1998; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; Zhang XY, 2003, J VIROL, V77, P2981, DOI 10.1128/JVI.77.5.2981-2989.2003	45	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26452	26460		10.1074/jbc.M801470200	http://dx.doi.org/10.1074/jbc.M801470200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18596032	Green Published, hybrid			2022-12-25	WOS:000259341600020
J	Bailleul, B; Johnson, X; Finazzi, G; Barber, J; Rappaport, F; Telfer, A				Bailleul, Benjamin; Johnson, Xenie; Finazzi, Giovanni; Barber, James; Rappaport, Fabrice; Telfer, Alison			The thermodynamics and kinetics of electron transfer between cytochrome b(6)f and photosystem I in the chlorophyll d-dominated cyanobacterium, Acaryochloris marina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENIC PHOTOSYNTHETIC PROKARYOTE; CHLAMYDOMONAS-REINHARDTII; REACTION CENTERS; PLASTOQUINONE COMPARTMENTATION; HELIOBACILLUS-MOBILIS; SPINACH-CHLOROPLASTS; LA PHOTOSYNTHESE; ENERGY-TRANSFER; RED ALGAE; FLUORESCENCE	We have investigated the photosynthetic properties of Acaryochloris marina, a cyanobacterium distinguished by having a high level of chlorophyll d, which has its absorption bands shifted to the red when compared with chlorophyll a. Despite this unusual pigment content, the overall rate and thermodynamics of the photosynthetic electron flow are similar to those of chlorophyll a-containing species. The midpoint potential of both cytochrome f and the primary electron donor of photosystem I (P-740) were found to be unchanged with respect to those prevailing in organisms having chlorophyll a, being 345 and 425 mV, respectively. Thus, contrary to previous reports (Hu, Q., Miyashita, H., Iwasaki, I. I., Kurano, N., Miyachi, S., Iwaki, M., and Itoh, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 13319 - 13323), the midpoint potential of the electron donor P740 has not been tuned to compensate for the decrease in excitonic energy in A. marina and to maintain the reducing power of photosystem I. We argue that this is a weaker constraint on the engineering of the oxygenic photosynthetic electron transfer chain than preserving the driving force for plastoquinol oxidation by P-740, via the cytochrome b(6)f complex. We further show that there is no restriction in the diffusion of the soluble electron carrier between cytochrome b(6)f and photosystem I in A. marina, at variance with plants. This difference probably reflects the simplified ultrastructure of the thylakoids of this organism, where no segregation into grana and stroma lamellae is observed. Nevertheless, chlorophyll fluorescence measurements suggest that there is energy transfer between adjacent photosystem II complexes but not from photosystem II to photosystem I, indicating spatial separation between the two photosystems.	[Bailleul, Benjamin; Johnson, Xenie; Finazzi, Giovanni; Rappaport, Fabrice] Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Barber, James; Telfer, Alison] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Imperial College London	Rappaport, F (corresponding author), Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr; a.telfer@imperial.ac.uk	Johnson, Xenie/T-7151-2019	Johnson, Xenie/0000-0003-3424-7047; Rappaport, Fabrice/0000-0001-9377-4934	Biotechnology and Biological Science Research Council, United Kingdom; CNRS; Universite Pierre et marie Curie, Paris 6	Biotechnology and Biological Science Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et marie Curie, Paris 6	This work was supported by the Biotechnology and Biological Science Research Council, United Kingdom, and by CNRS and Universite Pierre et marie Curie, Paris 6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AIBA H, 1981, J BIOL CHEM, V256, P1905; ALBERTSSON PA, 1991, BIOCHIM BIOPHYS ACTA, V1098, P90; ALBERTSSON PA, 1988, Q REV BIOPHYS, V21, P61, DOI 10.1017/S0033583500005023; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; Baymann F, 2001, BIOCHEMISTRY-US, V40, P10570, DOI 10.1021/bi010194a; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Boichenko VA, 2000, PHOTOSYNTH RES, V65, P269, DOI 10.1023/A:1010637631417; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Chen M, 2005, FEBS LETT, V579, P1306, DOI 10.1016/j.febslet.2005.01.023; Chen M, 2002, FEBS LETT, V514, P149, DOI 10.1016/S0014-5793(02)02315-3; DELOSME R, 1959, CR HEBD ACAD SCI, V249, P1409; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Holzwarth AR, 2006, BIOPHYS J, V90, P552, DOI 10.1529/biophysj.105.059824; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Hu Q, 1999, BBA-BIOENERGETICS, V1412, P250, DOI 10.1016/S0005-2728(99)00067-5; Hu Q, 1998, P NATL ACAD SCI USA, V95, P13319, DOI 10.1073/pnas.95.22.13319; HURT E, 1981, EUR J BIOCHEM, V117, P591; Itoh S, 2001, BBA-BIOENERGETICS, V1507, P115, DOI 10.1016/S0005-2728(01)00199-2; Itoh S, 2007, BIOCHEMISTRY-US, V46, P12473, DOI 10.1021/bi7008085; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 1992, BIOCHIM BIOPHYS ACTA, V1101, P1, DOI 10.1016/0167-4838(92)90460-U; KELLER MD, 1987, J PHYCOL, V23, P633; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; KLEINHERENBRINK FAM, 1994, BIOCHEMISTRY-US, V33, P3096, DOI 10.1021/bi00176a044; Kobayashi M, 2007, BBA-BIOENERGETICS, V1767, P596, DOI 10.1016/j.bbabio.2007.02.015; KRAMER DM, 1994, BBA-BIOENERGETICS, V1184, P193, DOI 10.1016/0005-2728(94)90223-2; Kramer DM, 1997, BIOCHEMISTRY-US, V36, P4203, DOI 10.1021/bi962241i; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Kumazaki S, 2002, FEBS LETT, V530, P153, DOI 10.1016/S0014-5793(02)03446-4; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; LAVERGNE J, 1992, BIOCHIM BIOPHYS ACTA, V1101, P13, DOI 10.1016/0167-4838(92)90461-L; Li YJ, 2006, P NATL ACAD SCI USA, V103, P2144, DOI 10.1073/pnas.0506537103; Li YJ, 2004, BIOCHEMISTRY-US, V43, P12634, DOI 10.1021/bi036329p; Manning WM, 1943, J BIOL CHEM, V151, P1; Marquardt J, 1997, FEBS LETT, V410, P428, DOI 10.1016/S0014-5793(97)00631-5; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyashita H, 1997, PLANT CELL PHYSIOL, V38, P274, DOI 10.1093/oxfordjournals.pcp.a029163; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Nakamura A, 2005, FEBS LETT, V579, P2273, DOI 10.1016/j.febslet.2005.02.076; NITSCHKE W, 1995, BIOCHEMISTRY-US, V34, P11831, DOI 10.1021/bi00037a022; OLIVE J, 1986, FEBS LETT, V208, P308, DOI 10.1016/0014-5793(86)81039-0; PETTIGREW GW, 1987, CYTOCHROMES C, P14; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Rappaport F, 2007, BBA-BIOENERGETICS, V1767, P56, DOI 10.1016/j.bbabio.2006.10.002; SCHENDERLEIN MC, 2007, 14 INT C PHOT RES, P215; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0; Schlodder E, 2007, BBA-BIOENERGETICS, V1767, P589, DOI 10.1016/j.bbabio.2007.02.018; Swingley WD, 2005, APPL ENVIRON MICROB, V71, P8606, DOI 10.1128/AEM.71.12.8606-8610.2005; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tomo T, 2008, J BIOL CHEM, V283, P18198, DOI 10.1074/jbc.M801805200; Trebst A., 1980, METH ENZYMOL, V69, P675, DOI DOI 10.1016/S0076-6879(80)69067-3; VOS MH, 1990, BIOPHYS J, V58, P1547, DOI 10.1016/S0006-3495(90)82499-1; Witt H, 2003, J BIOL CHEM, V278, P46760, DOI 10.1074/jbc.M304776200; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9	60	14	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25218	25226		10.1074/jbc.M803047200	http://dx.doi.org/10.1074/jbc.M803047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635535	hybrid			2022-12-25	WOS:000259012700014
J	Chandrasekar, B; Boylston, WH; Venkatachalam, K; Webster, NJG; Prabhu, SD; Valente, AJ				Chandrasekar, Bysani; Boylston, William H.; Venkatachalam, Kaliyamurthi; Webster, Nicholas J. G.; Prabhu, Sumanth D.; Valente, Anthony J.			Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-kappa B/PTEN Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; B ACTIVATION; STIMULATES ANGIOGENESIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; FUNCTIONAL IL-18; HIGH-GLUCOSE	The adipocyte-derived cytokine adiponectin is known to exert anti-inflammatory and anti-apoptotic effects. In patients with atherosclerotic cardiovascular disease, circulating levels of adiponectin correlate inversely with those of the proinflammatory, proapoptotic cytokine interleukin (IL)-18. The opposing actions of IL-18 and adiponectin on both cell survival and inflammation led us to investigate whether adiponectin signaling antagonizes IL-18-mediated endothelial cell death and to identify the underlying molecular mechanisms. Treatment with IL-18 suppressed Akt phosphorylation and its associated kinase activity, induced I kappa B kinase (IKK)-NF-kappa B-dependent PTEN activation, and promoted endothelial cell death. Pretreatment with adiponectin stimulated APPL1-dependent AMPK activation, reversed Akt inhibition in a phosphatidylinositol 3-kinase-dependent manner, blocked IKK-NF-kappa B-PTEN signaling, reduced caspase-3 activity, blocked Bax translocation, and inhibited endothelial cell death. The cytoprotective effect of adiponectin signaling was recapitulated by treatment with the pharmacological AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-riboside. Collectively, these results demonstrated that adiponectin reverses IL-18-mediated endothelial cell death through an AMPK-associated mechanism, which may thus have therapeutic potential for diminishing IL-18-dependent vascular injury and inflammation.	[Chandrasekar, Bysani; Valente, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chandrasekar, Bysani; Venkatachalam, Kaliyamurthi] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Boylston, William H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Prabhu, Sumanth D.] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA; [Prabhu, Sumanth D.] Louisville Vet Affairs Med Ctr, Med Serv, Louisville, KY 40292 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of Louisville	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Prabhu, Sumanth/D-5223-2009; Venkatachalam, Kaliyamurthi/GXM-4890-2022; Webster, Nick/AAI-8410-2021		Research Service of the Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Research Service of the Department of Veterans Affairs.	Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chen MC, 2007, HEART VESSELS, V22, P371, DOI 10.1007/s00380-007-0991-z; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Frigerio S, 2002, HORM RES, V57, P94, DOI 10.1159/000057959; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Goldstein Barry J, 2007, Curr Diab Rep, V7, P25, DOI 10.1007/s11892-007-0006-6; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kadowaki Takashi, 2007, Novartis Found Symp, V286, P164; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Lin LY, 2004, FEBS LETT, V574, P106, DOI 10.1016/j.febslet.2004.08.012; Lu M, 2008, MOL ENDOCRINOL, V22, P760, DOI 10.1210/me.2007-0330; Mallat Z, 2002, HEART, V88, P467, DOI 10.1136/heart.88.5.467; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Qin SF, 2008, INVEST OPHTH VIS SCI, V49, P1274, DOI 10.1167/iovs.07-1109; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012	49	120	133	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24889	24898		10.1074/jbc.M804236200	http://dx.doi.org/10.1074/jbc.M804236200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18632660	Green Published, hybrid			2022-12-25	WOS:000271617300007
J	Villone, D; Fritsch, A; Koch, M; Bruckner-Tuderman, L; Hansen, U; Bruckner, P				Villone, Daniela; Fritsch, Anja; Koch, Manuel; Bruckner-Tuderman, Leena; Hansen, Uwe; Bruckner, Peter			Supramolecular interactions in the dermo-epidermal junction zone - Anchoring fibril-collagen VII tightly binds to banded collagen fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; HUMAN-SKIN; MONOCLONAL-ANTIBODY; PROCOLLAGEN-VII; CROSS-LINKING; NC1 DOMAIN; MEMBRANE; IDENTIFICATION; LAMININ-5; ADHERENCE	The dermis and the epidermis of normal human skin are functionally separated by a basement membrane but, together, form a stable structural continuum. Anchoring fibrils reinforce this connection by insertion into the basement membrane and by intercalation with banded collagen fibrils of the papillary dermis. Structural abnormalities in collagen VII, the major molecular constituent of anchoring fibrils, lead to a congenital skin fragility condition, dystrophic epidermolysis bullosa, associated with skin blistering. Here, we characterized the molecular basis of the interactions between anchoring fibrils and banded collagen fibrils. Suprastructural fragments of the dermo-epidermal junction zone were generated by mechanical disruption and by separation with magnetic Immunobeads. Anchoring fibrils were tightly attached to banded collagen fibrils. In vitro binding studies demonstrated that a von Willebrand factor A-like motif in collagen VII was essential for binding of anchoring fibrils to reconstituted collagen I fibrils. Since collagen I and VII molecules reportedly undergo only weak interactions, the attachment of anchoring fibrils to collagen fibrils depends on supramolecular organization of their constituents. This complex is stabilized in situ and resists dissociation by strong denaturants.	[Villone, Daniela; Hansen, Uwe; Bruckner, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Dept Dermatol, D-50931 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Fritsch, Anja; Bruckner-Tuderman, Leena] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany	University of Munster; University of Cologne; University of Cologne; University of Freiburg	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019; Koch, Manuel/AAG-9914-2021	Bruckner, Peter/0000-0002-5566-5611; Koch, Manuel/0000-0002-2962-7814	Deutsche Forschungsgemeinschaft SFB [A2, KO 2247/3-1, Br 1475/8-2]	Deutsche Forschungsgemeinschaft SFB(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 492 Grants A2 (to P. B.), KO 2247/3-1 (to M. K.), and Br 1475/8-2 (to L. B.-T.).	Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BENTZ H, 1983, P NATL ACAD SCI-BIOL, V80, P3168, DOI 10.1073/pnas.80.11.3168; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CLERMONT Y, 1988, ANAT REC, V221, P482, DOI 10.1002/ar.1092210105; ELLISON J, 1984, J CELL SCI, V72, P163; Gayraud B, 1997, J BIOL CHEM, V272, P9531; GESELOWITZ DA, 1995, BIOCONJUGATE CHEM, V6, P502, DOI 10.1021/bc00034a021; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; HEAGERTY AHM, 1986, BRIT J DERMATOL, V115, P125, DOI 10.1111/j.1365-2133.1986.tb05707.x; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; PALADE GE, 1965, J CELL BIOL, V27, P215, DOI 10.1083/jcb.27.1.215; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Shimizu H, 1997, LAB INVEST, V76, P753	32	92	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24506	24513		10.1074/jbc.M802415200	http://dx.doi.org/10.1074/jbc.M802415200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599485	Green Published, hybrid			2022-12-25	WOS:000258820000025
J	Gao, Z; Tseng, CH; Strober, BE; Pei, ZH; Blaser, MJ				Gao, Zhan; Tseng, Chi-hong; Strober, Bruce E.; Pei, Zhiheng; Blaser, Martin J.			Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions	PLOS ONE			English	Article							MOLECULAR ANALYSIS; HUMAN SKIN; MICROBIOTA; DIVERSITY; SEQUENCE; INFECTIONS; MICROFLORA; COMMENSAL; DISEASE; ARCHAEA	For psoriasis, an idiopathic inflammatory disorder of the skin, the microbial biota has not been defined using cultivation-independent methods. We used broad-range 16S rDNA PCR for archaea and bacteria to examine the microbiota of normal and psoriatic skin. From 6 patients, 19 cutaneous samples (13 from diseased skin and 6 from normal skin) were obtained. Extracted DNA was subjected to the broad range PCR, and 1,925 cloned products were compared with 2,038 products previously reported from healthy persons. Using 98% sequence identity as a species boundary, 1,841 (95.6%) clones were similar to known bacterial 16S rDNA, representing 6 phyla, 86 genera, or 189 species-level operational taxonomic unit (SLOTU); 84 (4.4%) clones with <98% identity probably represented novel species. The most abundant and diverse phylum populating the psoriatic lesions was Firmicutes (46.2%), significantly (P<0.001) overrepresented, compared to the samples from uninvolved skin of the patients (39.0%) and healthy persons (24.4%). In contrast, Actinobacteria, the most prevalent and diverse phylum in normal skin samples from both healthy persons (47.6%) and the patients (47.8%), was significantly (P<0.01) underrepresented in the psoriatic lesion samples (37.3%). Representation of Propionibacterium species were lower in the psoriatic lesions (2.9+/-5.5%) than from normal persons (21.1+/-18.2%; P<0.001), whereas normal skin from the psoriatic patients showed intermediate levels (12.3+/-21.6%). We conclude that psoriasis is associated with substantial alteration in the composition and representation of the cutaneous bacterial biota.	[Gao, Zhan; Tseng, Chi-hong; Pei, Zhiheng; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Tseng, Chi-hong] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Strober, Bruce E.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY USA; [Pei, Zhiheng; Blaser, Martin J.] New York Harbor Vet Affairs Med Ctr, New York, NY USA	New York University; New York University; New York University; New York University; New York University	Gao, Z (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	Martin.blaser@med.nyu.edu	Strober, Bruce/AAQ-6953-2020	Strober, Bruce/0000-0002-8394-2057; Pei, Zhiheng/0000-0001-8570-6747	Ellison Medical Foundation [Senior Scholar Award]; Diane Belfer Program in Human Microbial Ecology in Health and Disease; NIH/NCRR [M01 RR00096];  [R01 GM63270];  [CA97946];  [AI063477]; NATIONAL CANCER INSTITUTE [R01CA097946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Diane Belfer Program in Human Microbial Ecology in Health and Disease; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Senior Scholar Award from the Ellison Medical Foundation; by Diane Belfer Program in Human Microbial Ecology in Health and Disease; Grants R01 GM63270, CA97946, and AI063477; and by General Clinical Research Center Core Grant NIH/NCRR M01 RR00096 from the National Institutes of Health.	Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Davies CE, 2001, WOUND REPAIR REGEN, V9, P332, DOI 10.1046/j.1524-475x.2001.00332.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eady E. A., 1994, Reviews in Medical Microbiology, V5, P163; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fearon U, 2001, CLIN EXP DERMATOL, V26, P333, DOI 10.1046/j.1365-2230.2001.00792.x; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kremers HM, 2007, J AM ACAD DERMATOL, V57, P347, DOI 10.1016/j.jaad.2007.02.007; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Okubo Y, 2002, J DERMATOL, V29, P547, DOI 10.1111/j.1346-8138.2002.tb00179.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Siqueira JF, 2005, J ENDODONT, V31, P719, DOI 10.1097/01.don.0000155224.00781.6c; Skov L, 2000, CLIN EXP DERMATOL, V25, P57; Talanin NY, 1997, ACTA DERM-VENEREOL, V77, P175; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Weisenseel P, 2005, ARCH DERMATOL RES, V296, P573, DOI 10.1007/s00403-005-0559-7	42	284	301	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2719	10.1371/journal.pone.0002719	http://dx.doi.org/10.1371/journal.pone.0002719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648509	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900006
J	Sevillano, D; Aguilar, L; Alou, L; Gimenez, MJ; Gonzalez, N; Torrico, M; Cafini, F; Fenoll, A; Coronel, P; Prieto, J				Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Fenoll, Asuncion; Coronel, Pilar; Prieto, Jose			High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation	PLOS ONE			English	Article								Although protein binding is a reversible phenomenon, it is assumed that antibacterial activity is exclusively exerted by the free (unbound) fraction of antibiotics. Methodology/Principal Findings: Activity of cefditoren, a highly protein bound 3(rd) generation cephalosporin, over 24h after an oral 400 mg cefditoren-pivoxil bid regimen was studied against six S. pneumoniae strains (penicillin/cefditoren MICs; mu g/ml): S1 (0.12/0.25), S2 (0.25/0.25), S3 and S4 (0.5/0.5), S5 (1/0.5) and S6 (4/0.5). A computerized pharmacodynamic simulation with media consisting in 75% human serum and 25% broth (mean albumin concentrations = 4.85 +/- 60.12 g/dL) was performed. Protein binding was measured. The cumulative percentage of a 24h-period that drug concentrations exceeded the MIC for total (T>MIC) and unbound concentrations (fT>MIC), expressed as percentage of the dosing interval, were determined. Protein binding was 87.1%. Bactericidal activity (>= 99.9% initial inocula reduction) was obtained against strains S1 and S2 at 24h (T>MIC = 77.6%, fT>MIC = 23.7%). With T>MIC of 61.6% (fT>MIC = 1.7%), reductions against S3 and S4 ranged from 90% to 97% at 12h and 24h; against S5, reduction was 45.1% at 12h and up to 85.0% at 24h; and against S6, reduction was 91.8% at 12h, but due to regrowth of 52.9% at 24h. Cefditoren physiological concentrations exerted antibacterial activity against strains exhibiting MICs of 0.25 and 0.5 mu g/ml under protein binding conditions similar to those in humans. Conclusions/Significance: The results of this study suggest that, from the pharmacodynamic perspective, the presence of physiological albumin concentrations may not preclude antipneumococcal activity of highly bound cephalosporins as cefditoren.	[Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Prieto, Jose] Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain; [Fenoll, Asuncion] Inst Salud Carlos III, Spanish Natl Reference Pneumococcal Lab, Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Sci Dept, Madrid, Spain	Complutense University of Madrid; Instituto de Salud Carlos III	Sevillano, D (corresponding author), Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Hidalgo, Natalia González/X-6840-2018; Sevillano, David/G-5661-2010; Prieto, José/G-5644-2010; Alou, Luis/B-8170-2011; Cafini, Fabio/AAA-7938-2020; Gimenez, Maria Jose/GXF-2237-2022	Hidalgo, Natalia González/0000-0002-6874-954X; Alou, Luis/0000-0002-0859-008X; Cafini, Fabio/0000-0002-5442-1674; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano Fernandez, David/0000-0003-0212-2194	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alou L, 2007, J ANTIMICROB CHEMOTH, V59, P652, DOI 10.1093/jac/dkm015; Alvarez-Sala JL, 2006, ANTIMICROB AGENTS CH, V50, P1762, DOI 10.1128/AAC.50.5.1762-1767.2006; Andrews J.M., 1999, CLIN ANTIMICROBIAL A, P35; AzoulayDupuis E, 1996, ANTIMICROB AGENTS CH, V40, P941, DOI 10.1128/AAC.40.4.941; Boswell FJ, 2002, J ANTIMICROB CHEMOTH, V50, P525, DOI 10.1093/jac/dkf155; Casal J, 2002, J ANTIMICROB CHEMOTH, V50, P83, DOI 10.1093/jac/dkf502; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2006, M7A5 CLSI; CRAIG W. A., 1991, ANTIBIOTICS LAB MED, P367, DOI Williams & Wilkins; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Fenoll A, 2007, J ANTIMICROB CHEMOTH, V60, P323, DOI 10.1093/jac/dkm209; Fenoll A, 2007, INT J ANTIMICROB AG, V29, P224, DOI 10.1016/j.ijantimicag.2006.08.046; Firsov AA, 2006, J ANTIMICROB CHEMOTH, V58, P1185, DOI 10.1093/jac/dkl387; Granizo JJ, 2008, INT J ANTIMICROB AG, V31, P396, DOI 10.1016/j.ijantimicag.2007.10.024; GRASSO S, 1978, ANTIMICROB AGENTS CH, V13, P570, DOI 10.1128/AAC.13.4.570; Granizo JJ, 2006, CLIN THER, V28, P2061, DOI 10.1016/j.clinthera.2006.12.010; MacGowan AP, 2004, ANTIMICROB AGENTS CH, V48, P2599, DOI 10.1128/AAC.48.7.2599-2603.2004; MOELLERING RC, 2005, MANDELL DOUGLAS BENN, P242; MULFORD D, 2000, 40 INT C ANT AG CHEM; PALMER SM, 1995, ANTIMICROB AGENTS CH, V39, P1764, DOI 10.1128/AAC.39.8.1764; Perez-Trallero E, 2007, CLIN MICROBIOL INFEC, V13, P937, DOI 10.1111/j.1469-0691.2007.01777.x; Sadaba B, 2007, REV ESP QUIM, V20, P51; Sevillano D, 2007, J ANTIMICROB CHEMOTH, V60, P156, DOI 10.1093/jac/dkm115; Sevillano D, 2004, J ANTIMICROB CHEMOTH, V54, P1148, DOI 10.1093/jac/dkh463; Wellington K, 2004, DRUGS, V64, P2597, DOI 10.2165/00003495-200464220-00009	28	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2717	10.1371/journal.pone.0002717	http://dx.doi.org/10.1371/journal.pone.0002717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648650	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900004
J	Aksglaede, L; Olsen, LW; Sorensen, TIA; Juul, A				Aksglaede, Lise; Olsen, Lina W.; Sorensen, Thorkild I. A.; Juul, Anders			Forty Years Trends in Timing of Pubertal Growth Spurt in 157,000 Danish School Children	PLOS ONE			English	Article							WEIGHT HEIGHT VELOCITY; ADOLESCENT GROWTH; SECULAR TRENDS; MATHEMATICAL-MODELS; EARLIER MENARCHE; INDIAN BOYS; US GIRLS; AGE; BIRTH; MATURATION	Background: Entering puberty is an important milestone in reproductive life and secular changes in the timing of puberty may be an important indicator of the general reproductive health in a population. Too early puberty is associated with several psychosocial and health problems. The aim of our study was to determine if the age at onset of pubertal growth spurt (OGS) and at peak height velocity (PHV) during puberty show secular trends during four decades in a large cohort of school children. Methods and Findings: Annual measurements of height were available in all children born from 1930 to 1969 who attended primary school in the Copenhagen Municipality. 135,223 girls and 21,612 boys fulfilled the criteria for determining age at OGS and age at PHV. These physiological events were used as markers of pubertal development in our computerized method in order to evaluate any secular trends in pubertal maturation during the study period (year of birth 1930 to 1969). In this period, age at OGS declined statistically significantly by 0.2 and 0.4 years in girls and boys, respectively, whereas age at PHV declined statistically significantly by 0.5 and 0.3 years in girls and boys, respectively. The decline was non-linear with a levelling off in the children born between 1940 and 1955. The duration of puberty, as defined by the difference between age at OGS and age at PHV, increased slightly in boys, whereas it decreased in girls. Conclusion: Our finding of declining age at OGS and at PHV indicates a secular trend towards earlier sexual maturation of Danish children born between 1930 and 1969. Only minor changes were observed in duration of puberty assessed by the difference in ages at OGS and PHV.	[Aksglaede, Lise; Juul, Anders] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Olsen, Lina W.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Society, Inst Prevent Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Aksglaede, L (corresponding author), Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark.	ajuul@rh.dk	Aksglaede, Lise/AAI-7163-2020; Juul, Anders/F-5864-2013	Juul, Anders/0000-0002-0534-4350; Aksglaede, Lise/0000-0001-7885-7467	Danish Medical Research Council; Faculty of Health Sciences, University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Sciences, University of Copenhagen	The study was funded by grants from the Danish Medical Research Council (LWO) and the Faculty of Health Sciences, University of Copenhagen (LA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2006, HUM REPROD UPDATE, V12, P341, DOI 10.1093/humupd/dml018; ANDERSEN E, 1968, ACTA PAEDIAT SCAND S; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Angell-Andersen E, 2004, ANN HUM BIOL, V31, P342, DOI 10.1080/03014460410001685304; BAKER JL, 2008, INT J EPIDE IN PRESS; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; BOJLEN K, 1954, Acta Obstet Gynecol Scand, V33, P404; Bonat S, 2002, PEDIATRICS, V110, P743, DOI 10.1542/peds.110.4.743; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FOSTER TA, 1977, AM J CLIN NUTR, V30, P582, DOI 10.1093/ajcn/30.4.582; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; HAUSPIE RC, 1989, REV EPIDEMIOL SANTE, V37, P461; Helm P, 1998, ACTA OBSTET GYN SCAN, V77, P198, DOI 10.1034/j.1600-0412.1998.770213.x; HELM P, 1984, ACTA OBSTET GYN SCAN, V63, P633, DOI 10.3109/00016348409155552; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kaplowitz PB, 1999, PEDIATRICS, V104, P936, DOI 10.1542/peds.104.4.936; KAPRIO J, 1995, HUM BIOL, V67, P739; KARLBERG J, 1987, ACTA PAEDIATR SCAND, V76, P478, DOI 10.1111/j.1651-2227.1987.tb10503.x; LEE P A, 1980, Journal of Adolescent Health Care, V1, P26, DOI 10.1016/S0197-0070(80)80005-2; Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E; Martin DD, 2005, HORM RES, V63, P95, DOI 10.1159/000084156; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Papadimitriou A, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e65; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Persson I, 1999, AM J EPIDEMIOL, V150, P747; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; REYNOLDS EL, 1948, AM J DIS CHILD, V75, P329; SATYANARAYANA K, 1989, ANN HUM BIOL, V16, P289, DOI 10.1080/03014468900000422; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; TANNER J M, 1953, Lect Sci Basis Med, V1, P308; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; TANNER JM, 1976, ANN HUM BIOL, V3, P109, DOI 10.1080/03014467600001231; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Taranger J, 1976, Acta Paediatr Scand Suppl, P121; Thomis M, 2005, J PEDIATR-US, V146, P239, DOI 10.1016/j.jpeds.2004.09.026; VANNOORD PAH, 1991, ANN HUM BIOL, V18, P57, DOI 10.1080/03014469100001402; Virani N, 2005, ANN HUM BIOL, V32, P259, DOI 10.1080/03014460500068261; WEMBER T, 1992, ANN HUM BIOL, V19, P361, DOI 10.1080/03014469200002232; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; ZACHARIAS L, 1983, ANN HUM BIOL, V10, P209, DOI 10.1080/03014468300006381	44	128	128	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2728	10.1371/journal.pone.0002728	http://dx.doi.org/10.1371/journal.pone.0002728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628945	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200066
J	Chastagner, P; Israel, A; Brou, C				Chastagner, Patricia; Israel, Alain; Brou, Christel			AIP4/Itch Regulates Notch Receptor Degradation in the Absence of Ligand	PLOS ONE			English	Article								Background: The regulation of Notch signaling heavily relies on ubiquitination events. Drosophila Su(dx), a member of the HECT family of ubiquitin-ligases, has been described as a negative regulator of Notch signaling, acting on the post-endocytic sorting of Notch. The mammalian ortholog of Su(dx), Itch/AIP4, has been shown to have multiple substrates, including Notch, but the precise events regulated by Itch/AIP4 in the Notch pathway have not been identified yet. Methodology/ Principal Findings: Using Itch-/- fibroblasts expressing the Notch1 receptor, we show that Itch is not necessary for Notch activation, but rather for controlling the degradation of Notch in the absence of ligand. Itch is indeed required after the early steps of Notch endocytosis to target it to the lysosomes where it is degraded. Furthermore Itch/AIP4 catalyzes Notch polyubiquitination through unusual K29-linked chains. We also demonstrate that although Notch is associated with Itch/AIP4 in cells, their interaction is not detectable in vitro and thus requires either a post-translational modification, or a bridging factor that remains to be identified. Conclusions/Significance: Taken together our results identify a specific step of Notch regulation in the absence of any activation and underline differences between mammalian and Drosophila Notch pathways.	[Chastagner, Patricia; Israel, Alain; Brou, Christel] Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chastagner, P (corresponding author), Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	cbrou@pasteur.fr						Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BUSSEAU I, 1994, GENETICS, V136, P585; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Cornell M, 1999, GENETICS, V152, P567; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fostier M, 1998, GENETICS, V150, P1477; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lallemand F, 2005, J BIOL CHEM, V280, P27645, DOI 10.1074/jbc.M500188200; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014	44	106	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2735	10.1371/journal.pone.0002735	http://dx.doi.org/10.1371/journal.pone.0002735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628966	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200071
J	Choi, SI; Han, KS; Kim, CW; Ryu, KS; Kim, BH; Kim, KH; Kim, SI; Kang, TH; Shin, HC; Lim, KH; Kim, HK; Hyun, JM; Seong, BL				Choi, Seong Il; Han, Kyoung Sim; Kim, Chul Woo; Ryu, Ki-Sun; Kim, Byung Hee; Kim, Kyun-Hwan; Kim, Seo-Il; Kang, Tae Hyun; Shin, Hang-Cheol; Lim, Keo-Heun; Kim, Hyo Kyung; Hyun, Jeong-Min; Seong, Baik L.			Protein Solubility and Folding Enhancement by Interaction with RNA	PLOS ONE			English	Article								While basic mechanisms of several major molecular chaperones are well understood, this machinery has been known to be involved in folding of only limited number of proteins inside the cells. Here, we report a chaperone type of protein folding facilitated by interaction with RNA. When an RNA-binding module is placed at the N-terminus of aggregation-prone target proteins, this module, upon binding with RNA, further promotes the solubility of passenger proteins, potentially leading to enhancement of proper protein folding. Studies on in vitro refolding in the presence of RNA, coexpression of RNA molecules in vivo and the mutants with impaired RNA binding ability suggests that RNA can exert chaperoning effect on their bound proteins. The results suggest that RNA binding could affect the overall kinetic network of protein folding pathway in favor of productive folding over off-pathway aggregation. In addition, the RNA binding-mediated solubility enhancement is extremely robust for increasing soluble yield of passenger proteins and could be usefully implemented for high-throughput protein expression for functional and structural genomic research initiatives. The RNA-mediated chaperone type presented here would give new insights into de novo folding in vivo.	[Choi, Seong Il; Seong, Baik L.] Yonsei Univ, Inst Life Sci & Biotechnol, Seoul, South Korea; [Choi, Seong Il; Han, Kyoung Sim; Kim, Chul Woo; Ryu, Ki-Sun; Kim, Byung Hee; Kim, Seo-Il; Kang, Tae Hyun; Lim, Keo-Heun; Kim, Hyo Kyung; Hyun, Jeong-Min; Seong, Baik L.] Yonsei Univ, Coll Engn, Dept Biotechnol, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Diagnost Med, Sch Med, Seoul, South Korea; [Shin, Hang-Cheol] Soongsil Univ, CAMDRC, Dept Bioinformat & Life Sci, Seoul, South Korea	Yonsei University; Yonsei University; Konkuk University; Konkuk University Medical Center; Soongsil University	Choi, SI (corresponding author), Yonsei Univ, Inst Life Sci & Biotechnol, Seoul, South Korea.	blseong@yonsei.ac.kr	Kim, Chulwoo/AAL-8854-2021	Kim, Chulwoo/0000-0001-5736-8170; Kim, Kyun-Hwan/0000-0001-5266-072X	21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology, Republic of Korea [MG05-0306-3-0]; Korea Research Foundation [KRF-2004-005-C00148]	21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology (Grant MG05-0306-3-0), Republic of Korea, and by the Korea Research Foundation (Grant KRF-2004-005-C00148).	Alexandrescu AT, 1999, J MOL BIOL, V289, P1041, DOI 10.1006/jmbi.1999.2813; Braun P, 2003, TRENDS BIOTECHNOL, V21, P383, DOI 10.1016/S0167-7799(03)00189-6; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen J, 1998, BIOCHEMISTRY-US, V37, P13643, DOI 10.1021/bi981098l; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; COMMANS S, 1995, J MOL BIOL, V253, P100, DOI 10.1006/jmbi.1995.0539; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; ELLSI RJ, 1999, CURR OPIN STRUC BIOL, V9, P102; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kim NS, 2004, GENOMICS, V83, P1024, DOI 10.1016/j.ygeno.2003.12.002; Korber P, 1999, J BIOL CHEM, V274, P249, DOI 10.1074/jbc.274.1.249; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Lee J, 1999, BIOTECHNOL PROGR, V15, P884, DOI 10.1021/bp9900918; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; MILLER MS, 1994, INT J ONCOL, V4, P5; Moore PB, 2001, BIOCHEMISTRY-US, V40, P3243, DOI 10.1021/bi0029402; Nasoff M, 2000, METHOD ENZYMOL, V328, P515, DOI 10.1016/S0076-6879(00)28416-4; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569; Su Y, 2007, J BIOTECHNOL, V129, P373, DOI 10.1016/j.jbiotec.2007.01.015; Tickle I, 2004, CHEM SOC REV, V33, P558, DOI 10.1039/b314510g; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; WALL JG, 1995, CURR OPIN BIOTECH, V6, P507, DOI 10.1016/0958-1669(95)80084-0; Wang CC, 2000, J BIOL CHEM, V275, P17180, DOI 10.1074/jbc.M001057200; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	48	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2677	10.1371/journal.pone.0002677	http://dx.doi.org/10.1371/journal.pone.0002677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628952	gold, Green Submitted, Green Published			2022-12-25	WOS:000264057200022
J	Wang, R; Wan, Q; Kozhaya, L; Fujii, H; Unutmaz, D				Wang, Rui; Wan, Qi; Kozhaya, Lina; Fujii, Hodaka; Unutmaz, Derya			Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression	PLOS ONE			English	Article								Regulatory T (T-reg) cells control immune activation and maintain tolerance. How T-regs mediate their suppressive function is unclear. Here we identified a cell surface molecule, called GARP, (or LRRC32), which within T cells is specifically expressed in Tregs activated through the T cell receptor (TCR). Ectopic expression of GARP in human naive T (T-N) cells inhibited their proliferation and cytokine secretion upon TCR activation. Remarkably, GARP over-expression in T-N cells induced expression of T-reg master transcription factor Foxp3 and endowed them with a partial suppressive function. The extracellular but not the cytoplasmic region of GARP, was necessary for these functions. Silencing Foxp3 in human Treg cells reduced expression of GARP and attenuated their suppressive function. However, GARP function was not affected when Foxp3 was downregulated in GARP-overexpressing cells, while silencing GARP in Foxp3-overexpressing cells reduced their suppressive activity. These findings reveal a novel cell surface molecule-mediated regulatory mechanism, with implications for modulating aberrant immune responses.	[Wang, Rui; Wan, Qi; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY USA; [Fujii, Hodaka] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Wang, R (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY USA.	Derya@mac.com	Wan, Qi/F-1694-2013; Fujii, Hodaka/A-2420-2008; Fujii, Hodaka/N-9792-2019	Wan, Qi/0000-0003-3726-5187; Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256	NIH [R01 AI065303, R01 AI059315]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, R01AI059315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI065303 to Derya Unutmaz and NIH Grant R01 AI059315 to Hodaka Fujii.	Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hoshino A, 2007, FEBS LETT, V581, P975, DOI 10.1016/j.febslet.2007.01.083; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; MAHNKE K, 2007, EUR J IMMUNOL; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; OLLENDORFF V, 1992, MAMM GENOME, V2, P195, DOI 10.1007/BF00302877; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PANDIYAN P, 2007, CD4 CD25 FOXP3 REGUL; Pugsley AP, 1990, CURR OPIN CELL BIOL, V2, P609, DOI 10.1016/0955-0674(90)90101-J; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roubin R, 1996, INT J DEV BIOL, V40, P545; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zenclussen Ana Claudia, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000294	28	117	124	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2705	10.1371/journal.pone.0002705	http://dx.doi.org/10.1371/journal.pone.0002705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628982	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200048
J	Chae, YK; Kang, SK; Kim, MS; Woo, J; Lee, J; Chang, S; Kim, DW; Kim, M; Park, S; Kim, I; Keam, B; Rhee, J; Koo, NH; Park, G; Kim, SH; Jang, SE; Kweon, IY; Sidransky, D; Moon, C				Chae, Young Kwang; Kang, Sung Koo; Kim, Myoung Sook; Woo, Janghee; Lee, Juna; Chang, Steven; Kim, Dong-Wook; Kim, Myungshin; Park, Seonyang; Kim, Inho; Keam, Bhumsuk; Rhee, Jiyoung; Koo, Nam Hee; Park, Gyeongsin; Kim, Soo-Hyun; Jang, Se-Eun; Kweon, Il-Young; Sidransky, David; Moon, Chulso			Human AQP5 Plays a Role in the Progression of Chronic Myelogenous Leukemia (CML)	PLOS ONE			English	Article							WATER PERMEABILITY; BCR-ABL; EXPRESSION; AQUAPORIN-1; CELLS; ANGIOGENESIS; LOCALIZATION; RESISTANCE; APOPTOSIS	Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. In addition, AQP5 expression level increased with the emergence of imatinib mesylate resistance in paired samples (p = 0.047). We have found that the overexpression of AQP5 in K562 cells resulted in increased cell proliferation. In addition, small interfering RNA (siRNA) targeting AQP5 reduced the cell proliferation rate in both K562 and LAMA84 CML cells. Moreover, by immunoblotting and flow cytometry, we show that phosphorylation of BCR-ABL1 is increased in AQP5-overexpressing CML cells and decreased in AQP5 siRNA-treated CML cells. Interestingly, caspase9 activity increased in AQP5 siRNA-treated cells. Finally, FISH showed no evidence of AQP5 gene amplification in CML from bone marrow. In summary, we report for the first time that AQP5 is overexpressed in CML cells and plays a role in promoting cell proliferation and inhibiting apoptosis. Furthermore, our findings may provide the basis for a novel CML therapy targeting AQP5.	[Chae, Young Kwang; Kang, Sung Koo; Kim, Myoung Sook; Woo, Janghee; Lee, Juna; Chang, Steven; Sidransky, David; Moon, Chulso] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Lee, Juna; Moon, Chulso] Johns Hopkins Univ, Sch Med, Grad Program Human Genet, Baltimore, MD USA; [Kim, Dong-Wook; Kim, Soo-Hyun; Jang, Se-Eun; Kweon, Il-Young] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Myungshin] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Seonyang; Kim, Inho; Keam, Bhumsuk; Rhee, Jiyoung; Koo, Nam Hee] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Gyeongsin; Moon, Chulso] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea; [Moon, Chulso] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Catholic University of Korea; Johns Hopkins University	Chae, YK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	cmoon5@jhmi.edu	Kim, Myungshin/AAP-9262-2020; Kim, Myungshin/AAK-1544-2021; woo, janghee/CAG-2114-2022; Kim, In Ho/J-5428-2012	Kim, Myungshin/0000-0001-8632-0168; Kim, Myungshin/0000-0001-8632-0168; Rhee, Jiyoung/0000-0002-7787-4852	SPORE [P50 CA96784-01]; Pyung-Ya Foundation; Basic Research Program Grant of the Korea Science & Engineering Foundation [R21-2007-000-10041-0]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER	SPORE; Pyung-Ya Foundation; Basic Research Program Grant of the Korea Science & Engineering Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the SPORE grant (P50 CA96784-01), Cancer Research Grant from Pyung-Ya Foundation (C.M.) and the Basic Research Program Grant of the Korea Science & Engineering Foundation (R21-2007-000-10041-0, 2007) (D.K.).	Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; CHAE YK, 2008, PLOS ONE IN PRESS; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Kageyama Y, 1996, J UROLOGY, V156, P291, DOI 10.1016/S0022-5347(01)66019-1; Kang HY, 2006, HAEMATOLOGICA, V91, P659; KANG SK, 2008, AM J PATHOL IN PRESS; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2003, CYTOTHERAPY, V5, P169, DOI 10.1080/14653240310001073; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Litzow MR, 2006, ARCH PATHOL LAB MED, V130, P669; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Ravandi F, 2001, CANCER-AM CANCER SOC, V91, P1964, DOI 10.1002/1097-0142(20010601)91:11<1964::AID-CNCR1221>3.0.CO;2-B; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; WOO J, CANC LETT IN PRESS; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054	28	52	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2594	10.1371/journal.pone.0002594	http://dx.doi.org/10.1371/journal.pone.0002594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612408	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800007
J	Laopaiboon, M; Lumbiganon, P; McDonald, SJ; Henderson-Smart, DJ; Green, S; Crowther, CA; Laopaiboon, M; McDonald, SJ; Lumbiganon, P; Festin, MR; Ho, JJ; Hakimi, M; Henderson-Smart, DJ; Green, S; Crowther, CA; McDonald, SJ; Thomas, M; Narash, N; Ewens, M; Hakimi, M; Supriyah; Amanah, L; Lukitasari, D; Astuti, D; Amanah, L; Amanah, L; Lukitasari, D; Astuti, D; Ho, JJ; Cham, SS; Cham, SS; Aw, ET; Cham, SS; Lumbiganon, P; Khianman, B; Pharprapa, A; Nachaipet, J; Narash, N; Poombankor, R; Saenrien, B; Srisutthikamol, N; Panikom, S; Khunudom, C; Thipawat, S; Choonhapran, S; Nuanbuddee, S; Jarudphan, P; Hempira, A; Narash, N; Poombankor, R; Tharnprisan, P; Sarapon, P; Ponpun, O; Narash, N; Poombankor, R; Festin, MR; Ubaldo-Anzures, C; Canete, LN; Festin, JL; Torralba, E; Canete, LN; Magsipoc; Festin, JL; Henderson-Smart, D; Green, S; Crowther, CA; McDonald, SJ				Laopaiboon, M.; Lumbiganon, P.; McDonald, S. J.; Henderson-Smart, D. J.; Green, S.; Crowther, C. A.; Laopaiboon, M.; McDonald, S. J.; Lumbiganon, P.; Festin, M. R.; Ho, J. J.; Hakimi, M.; Henderson-Smart, D. J.; Green, S.; Crowther, C. A.; McDonald, S. J.; Thomas, M.; Narash, N.; Ewens, M.; Hakimi, M.; Supriyah; Amanah, L.; Lukitasari, D.; Astuti, D.; Amanah, L.; Amanah, L.; Lukitasari, D.; Astuti, D.; Ho, J. J.; Cham, S. S.; Cham, S. S.; Aw, E. T.; Cham, S. S.; Lumbiganon, P.; Khianman, B.; Pharprapa, A.; Nachaipet, J.; Narash, N.; Poombankor, R.; Saenrien, B.; Srisutthikamol, N.; Panikom, S.; Khunudom, C.; Thipawat, S.; Choonhapran, S.; Nuanbuddee, S.; Jarudphan, P.; Hempira, A.; Narash, N.; Poombankor, R.; Tharnprisan, P.; Sarapon, P.; Ponpun, O.; Narash, N.; Poombankor, R.; Festin, M. R.; Ubaldo-Anzures, C.; Canete, L. N.; Festin, J. L.; Torralba, E.; Canete, L. N.; Magsipoc; Festin, J. L.; Henderson-Smart, D.; Green, S.; Crowther, C. A.; McDonald, S. J.			Use of Evidence-Based Practices in Pregnancy and Childbirth: South East Asia Optimising Reproductive and Child Health in Developing Countries Project	PLOS ONE			English	Article								Background: The burden of mortality and morbidity related to pregnancy and childbirth remains concentrated in developing countries. SEA-ORCHID ( South East Asia Optimising Reproductive and Child Health In Developing countries) is evaluating whether a multifaceted intervention to strengthen capacity for research synthesis, evidence-based care and knowledge implementation improves adoption of best clinical practice recommendations leading to better health for mothers and babies. In this study we assessed current practices in perinatal health care in four South East Asian countries and determined whether they were aligned with best practice recommendations. Methodology/Principal Findings: We completed an audit of 9550 medical records of women and their 9665 infants at nine hospitals; two in each of Indonesia, Malaysia and The Philippines, and three in Thailand between January-December 2005. We compared actual clinical practices with best practice recommendations selected from the Cochrane Library and the World Health Organization Reproductive Health Library. Evidence-based components of the active management of the third stage of labour and appropriately treating eclampsia with magnesium sulphate were universally practiced in all hospitals. Appropriate antibiotic prophylaxis for caesarean section, a beneficial form of care, was practiced in less than 5% of cases in most hospitals. Use of the unnecessary practices of enema in labour ranged from 1% to 61% and rates of episiotomy for vaginal birth ranged from 31% to 95%. Other appropriate practices were commonly performed to varying degrees between countries and also between hospitals within the same country. Conclusions/Significance: Whilst some perinatal health care practices audited were consistent with best available evidence, several were not. We conclude that recording of clinical practices should be an essential step to improve quality of care. Based on these findings, the SEA-ORCHID project team has been developing and implementing interventions aimed at increasing compliance with evidence-based clinical practice recommendations to improve perinatal practice in South East Asia.					Ho, Jacqueline/E-5690-2015; Ho, Jacqueline J/AAN-4341-2020; Lumbiganon, Pisake/E-8634-2010; Hakimi, Mohammad/GOV-6587-2022; Withinunthakit, Siriporn/E-6131-2010; McDonald, Steve/AAE-1613-2020	Ho, Jacqueline/0000-0001-9939-7551; Ho, Jacqueline J/0000-0001-9939-7551; Lumbiganon, Pisake/0000-0001-9372-0071; McDonald, Steve/0000-0003-2832-5205	National Health and Medical Research Council of Australia [307703]; Wellcome Trust, United Kingdom [071672/Z/03/Z]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, United Kingdom(Wellcome Trust)	This study is jointly funded by an International Collaborative Research Grant from the National Health and Medical Research Council of Australia (No. 307703) and Wellcome Trust, United Kingdom (071672/Z/03/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basevi V, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001236; Brown H, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-7; Carroli G., 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000081, DOI 10.1002/14651858.CD000081]; *CHOIC CHALL CHANG, 2005, INT J OBSTET GYNECOL, V112, P1270; *COCHR LIB, 2004, CHICH; Cuervo L, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000330; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; C-L D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006116.pub2; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000127; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000128; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; *GLOB HLTH COUNC, 2002, MAK CHILDB SAF PROM; Henderson-Smart DJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-43; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; Khalil K, 2005, BIRTH-ISS PERINAT C, V32, P283, DOI 10.1111/j.0730-7659.2005.00385.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Qian Xu, 2001, BMC Pregnancy Childbirth, V1, P1, DOI 10.1186/1471-2393-1-1; *RES WHO DEP REPR, MAT MORT 2000 EST DE; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; *STATACORP, 2003, STAT STAT SOFTW REL; *WHO REPR HLTH LIB, 2004, UPD SOFTW, V7; S AFRICAN MED J, V94, P117	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2646	10.1371/journal.pone.0002646	http://dx.doi.org/10.1371/journal.pone.0002646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612381	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800048
J	Pantano, S; Zonta, F; Mammano, F				Pantano, Sergio; Zonta, Francesco; Mammano, Fabio			A Fully Atomistic Model of the Cx32 Connexon	PLOS ONE			English	Article								Connexins are plasma membrane proteins that associate in hexameric complexes to form channels named connexons. Two connexons in neighboring cells may dock to form a "gap junction'' channel, i.e. an intercellular conduit that permits the direct exchange of solutes between the cytoplasm of adjacent cells and thus mediate cell-cell ion and metabolic signaling. The lack of high resolution data for connexon structures has hampered so far the study of the structure-function relationships that link molecular effects of disease-causing mutations with their observed phenotypes. Here we present a combination of modeling techniques and molecular dynamics (MD) to infer side chain positions starting from low resolution structures containing only C alpha atoms. We validated this procedure on the structure of the KcsA potassium channel, which is solved at atomic resolution. We then produced a fully atomistic model of a homotypic Cx32 connexon starting from a published model of the C alpha carbons arrangement for the connexin transmembrane helices, to which we added extracellular and cytoplasmic loops. To achieve structural relaxation within a realistic environment, we used MD simulations inserted in an explicit solvent-membrane context and we subsequently checked predictions of putative side chain positions and interactions in the Cx32 connexon against a vast body of experimental reports. Our results provide new mechanistic insights into the effects of numerous spontaneous mutations and their implication in connexin-related pathologies. This model constitutes a step forward towards a structurally detailed description of the gap junction architecture and provides a structural platform to plan new biochemical and biophysical experiments aimed at elucidating the structure of connexin channels and hemichannels.	[Pantano, Sergio] Inst Pasteur Montevideo, Montevideo, Uruguay; [Pantano, Sergio; Zonta, Francesco; Mammano, Fabio] Venetian Inst Mol Med, Padua, Italy; [Pantano, Sergio; Zonta, Francesco; Mammano, Fabio] Consorzio Nazl Interuniver Sci Fisiche Materia, Rome, Italy; [Mammano, Fabio] Univ Padua, Dipartimento Fis, Padua, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Veneto Institute Molecular Medicine; University of Padua	Pantano, S (corresponding author), Inst Pasteur Montevideo, Montevideo, Uruguay.	spantano@pasteur.edu.uy; fabio.mammano@unipd.it	Zonta, Francesco/GXW-1979-2022; Mammano, Fabio/AAM-3902-2020; Mammano, Fabio/I-5064-2012	Zonta, Francesco/0000-0001-8729-1071; Mammano, Fabio/0000-0003-3751-1691; Mammano, Fabio/0000-0003-3751-1691; Pantano, Sergio/0000-0001-6435-4543	Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy [GGP05131]; European commission FP6 Integrated Project EuroHear [LSHG-CT-20054-512063]	Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy(Fondazione TelethonFondazione Cariparo); European commission FP6 Integrated Project EuroHear(European CommissionEuropean Commission Joint Research Centre)	This work has been funded by grants to F.M. from Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy (GGP05131) and the European commission FP6 Integrated Project EuroHear (LSHG-CT-20054-512063) under the Sixth Research Frame Program of The European Union. Computer simulations were performed at the CINECA supercomputer center thanks to computer-time grants from the Italian CNISM (Consorzio Nazionale Interuniversitario per le Scienze fisiche della Materia).	Abrams CK, 2001, BRAIN RES, V900, P9, DOI 10.1016/S0006-8993(00)03327-8; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bicego M, 2006, NEUROBIOL DIS, V21, P607, DOI 10.1016/j.nbd.2005.09.005; Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; CASCIO M, 1995, J BIOL CHEM, V270, P18643, DOI 10.1074/jbc.270.31.18643; CASE DA, 2004, AMBER 8 0; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eiberger J, 2001, CELL COMMUN ADHES, V8, P163, DOI 10.3109/15419060109080717; Faraldo-Gomez JD, 2004, PROTEINS, V57, P783, DOI 10.1002/prot.20257; Fleishman SJ, 2006, J BIOL CHEM, V281, P28958, DOI 10.1074/jbc.M605764200; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Frei K, 2002, EUR J HUM GENET, V10, P427, DOI 10.1038/sj.ejhg.5200826; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hernandez VH, 2007, NAT METHODS, V4, P353, DOI 10.1038/NMETH1031; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kovacs JA, 2007, PROG BIOPHYS MOL BIO, V94, P15, DOI 10.1016/j.pbiomolbio.2007.03.013; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Locke D, 2005, BIOCHEMISTRY-US, V44, P13027, DOI 10.1021/bi050495a; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Murgia A, 1999, J MED GENET, V36, P829; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.3.CO;2-N; Nunn RS, 2001, MICROSC RES TECHNIQ, V52, P344, DOI 10.1002/1097-0029(20010201)52:3<344::AID-JEMT1018>3.3.CO;2-W; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Pantano S, 2004, EUR BIOPHYS J BIOPHY, V33, P344, DOI 10.1007/s00249-003-0358-z; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Ressot C, 1996, HUM GENET, V98, P172, DOI 10.1007/s004390050183; Ressot C, 1998, J NEUROSCI, V18, P4063; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Rouger H, 1997, HUM MUTAT, V10, P443, DOI 10.1002/(SICI)1098-1004(1997)10:6<443::AID-HUMU5>3.3.CO;2-K; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, CURR OPIN BIOTECH, V6, P437, DOI 10.1016/0958-1669(95)80074-3; Sansom MSP, 2005, BIOCHEM SOC T, V33, P916, DOI 10.1042/BST0330916; Silander K, 1997, HUM GENET, V100, P391, DOI 10.1007/s004390050522; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Tan CC, 1996, HUM MUTAT, V7, P167, DOI 10.1002/(SICI)1098-1004(1996)7:2<167::AID-HUMU14>3.3.CO;2-#; Thonnissen E, 2002, HUM GENET, V111, P190, DOI 10.1007/s00439-002-0750-2; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	77	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2614	10.1371/journal.pone.0002614	http://dx.doi.org/10.1371/journal.pone.0002614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648547	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200063
J	Senf, SM; Dodd, SL; McClung, JM; Judge, AR				Senf, Sarah M.; Dodd, Stephen L.; McClung, Joseph M.; Judge, Andrew R.			Hsp70 overexpression inhibits NF-kappa B and Foxo3a transcriptional activities and prevents skeletal muscle atrophy	FASEB JOURNAL			English	Article						atrogin-1/MAFbx; MuRF1; immobilization	UBIQUITIN LIGASES; OXIDATIVE STRESS; PROTEIN; EXPRESSION; ACTIVATION; MASS; DEGRADATION; ATROGIN-1; PATHWAY; ALPHA	Heat shock protein 70 (Hsp70) is a highly conserved and ubiquitous protein that is reported to provide cytoprotection in various cell types and tissues. However, the importance of Hsp70 expression during skeletal muscle atrophy, when Hsp70 levels are significantly decreased, is not known. The current study aimed to determine whether plasmid-mediated overexpression of Hsp70, in the soleus muscle of rats, was sufficient to regulate specific atrophy signaling pathways and attenuate skeletal muscle disuse atrophy. We found that Hsp70 overexpression prevented disuse muscle fiber atrophy and inhibited the increased promoter activities of atrogin-1 and MuRF1. Importantly, the transcriptional activities of Foxo3a and NF-kappa B, which are implicated in the regulation of atrogin-1 and MuRF1, were abolished by Hsp70. These data suggest that Hsp70 may regulate key atrophy genes through inhibiting Foxo3a and NF-kappa B activities during disuse. Indeed, we show that specific inhibition of Foxo3a prevented the increases in both atrogin-1 and MuRF1 promoter activities during disuse. However, inhibition of NF-kappa B did not affect the activation of either promoter, suggesting its requirement for disuse atrophy is through its regulation of other atrophy genes. We conclude that overexpression of Hsp70 is sufficient to inhibit key atrophy signaling pathways and prevent skeletal muscle atrophy.-Senf, S. M., Dodd, S. L., McClung, J. M., Judge, A. R. Hsp70 overexpression inhibits NF-kappa B and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 22, 3836-3845 (2008)	[Senf, Sarah M.; Dodd, Stephen L.; McClung, Joseph M.; Judge, Andrew R.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Judge, AR (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, 25 Stadium Rd, Gainesville, FL 32611 USA.	ajudge@hhp.ufl.edu		Judge, Sarah/0000-0002-3974-0247	NIAMS NIH HHS [R03 AR056418] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR056418] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahtikoski AM, 2003, ACTA PHYSIOL SCAND, V177, P473, DOI 10.1046/j.1365-201X.2003.01061.x; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BOOTH FW, 1973, J APPL PHYSIOL, V34, P404, DOI 10.1152/jappl.1973.34.3.404; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Costelli P, 2003, CURR OPIN CLIN NUTR, V6, P407, DOI 10.1097/01.mco.0000078984.18774.02; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; KU Z, 1995, AM J PHYSIOL-CELL PH, V268, pC1369, DOI 10.1152/ajpcell.1995.268.6.C1369; Lawler JM, 2006, MUSCLE NERVE, V33, P200, DOI 10.1002/mus.20454; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Liu YF, 2006, FRONT BIOSCI-LANDMRK, V11, P2802, DOI 10.2741/2011; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Mitchell-Felton H, 1999, AM J PHYSIOL-CELL PH, V277, pC1269, DOI 10.1152/ajpcell.1999.277.6.C1269; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Oishi Y, 2003, JPN J PHYSIOL, V53, P281, DOI 10.2170/jjphysiol.53.281; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Selsby JT, 2007, J APPL PHYSIOL, V102, P1702, DOI 10.1152/japplphysiol.00722.2006; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; THOMASON DB, 1989, AM J PHYSIOL, V257, pR300, DOI 10.1152/ajpregu.1989.257.2.R300; Thompson HS, 2001, ACTA PHYSIOL SCAND, V171, P187, DOI 10.1046/j.1365-201x.2001.00795.x; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; ZHENG Z, 2007, J CEREB BLOOD FLOW M	54	218	227	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3836	3845		10.1096/fj.08-110163	http://dx.doi.org/10.1096/fj.08-110163			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18644837	Green Published			2022-12-25	WOS:000260503000012
J	Roepke, TK; Kontogeorgis, A; Ovanez, C; Xu, XH; Young, JB; Purtell, K; Goldstein, PA; Christini, DJ; Peters, NS; Akar, FG; Gutstein, DE; Lerner, DJ; Abbott, GW				Roepke, Torsten K.; Kontogeorgis, Andrianos; Ovanez, Christopher; Xu, Xianghua; Young, Jeffrey B.; Purtell, Kerry; Goldstein, Peter A.; Christini, David J.; Peters, Nicholas S.; Akar, Fadi G.; Gutstein, David E.; Lerner, Daniel J.; Abbott, Geoffrey W.			Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I-K,I-slow1 and I-to,I-f	FASEB JOURNAL			English	Article						cardiac arrhythmia; Kv1.5; Kv4.2; long QT syndrome; MiRP1; potassium channel	LONG-QT SYNDROME; TRANSIENT OUTWARD CURRENT; KV4 ALPHA-SUBUNIT; INDUCED CARDIAC-ARRHYTHMIA; GATED POTASSIUM CHANNEL; MINK-RELATED PEPTIDE-1; RECTIFIER K+ CURRENT; MOLECULAR-BASIS; CAENORHABDITIS-ELEGANS; HEART DEVELOPMENT	Mutations in human KCNE2, which encodes the MiRP1 potassium channel ancillary subunit, associate with long QT syndrome (LQTS), a defect in ventricular repolarization. The precise cardiac role of MiRP1 remains controversial, in part, because it has marked functional promiscuity in vitro. Here, we disrupted the murine kcne2 gene to define the role of MiRP1 in murine ventricles. kcne2 disruption prolonged ventricular action potential duration (APD), suggestive of reduced repolarization capacity. Accordingly, kcne2 (-/-) ventricles exhibited a 50% reduction in I-K,I-slow1, generated by Kv1.5-a previously unknown partner for MiRP1. I-to,I-f, generated by Kv4 alpha subunits, was also diminished, by similar to 25%. Ventricular MiRP1 protein coimmunoprecipitated with native Kv1.5 and Kv4.2 but not Kv1.4 or Kv4.3. Unexpectedly, kcne2 (-/-) ventricular membrane fractions exhibited 50% less mature Kv1.5 protein than wild type, and disruption of Kv1.5 trafficking to the intercalated discs. Consistent with the reduction in ventricular K+ currents and prolonged ventricular APD, kcne2 deletion lengthened the QT(c) under sevoflurane anesthesia. Thus, targeted disruption of kcne2 has revealed a novel cardiac partner for MiRP1, a novel role for MiRPs in alpha subunit targeting in vivo, and a role for MiRP1 in murine ventricular repolarization with parallels to that proposed for the human heart.	[Roepke, Torsten K.; Xu, Xianghua; Young, Jeffrey B.; Purtell, Kerry; Christini, David J.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, New York, NY 10065 USA; [Roepke, Torsten K.; Xu, Xianghua; Young, Jeffrey B.; Purtell, Kerry; Abbott, Geoffrey W.] Cornell Univ, Dept Pharmacol, New York, NY 10065 USA; [Goldstein, Peter A.] Cornell Univ, Weill Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Kontogeorgis, Andrianos; Peters, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Cardiol, London, England; [Kontogeorgis, Andrianos; Gutstein, David E.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY USA; [Gutstein, David E.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Ovanez, Christopher; Akar, Fadi G.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Lerner, Daniel J.] FoxHollow Technol, Redwood City, CA USA	Cornell University; Cornell University; Cornell University; Imperial College London; New York University; New York University; Icahn School of Medicine at Mount Sinai	Abbott, GW (corresponding author), Cornell Univ, Weill Med Coll, Greenberg Div Cardiol, Starr 463,1300 York Ave, New York, NY 10065 USA.	gwa200@med.cornell.edu		Ovanez, Christopher/0000-0001-9175-1966; Christini, David/0000-0003-0852-2922; Abbott, Geoffrey/0000-0003-4552-496X	National Institutes of Health [R01 HL079275]; LAVA [HL081336]; American Heart Association [0830126N]; British Heart Foundation [RG/05/009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081336, R01HL079275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LAVA; American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support was provided by the National Institutes of Health (R01 HL079275, LAVA; HL081336. D.E.G.), the American Heart Association (grant-in-aid, G.W.A., D.E.G.; 0830126N, F.G.A), and the British Heart Foundation (RG/05/009, N.S.P.). We are grateful for advice and technical assistance from Dr. Krista La Perle, Director of the Genetically Engineered Mouse Phenotyping Service Facility at Sloan-Kettering Institute; Leona Cohen-Gould. Director of the Electron Microscopy and Histology Core Facility at Weill Cornell Medical College; the Molecular Cytology Core Facility of of Memorial Sloan Kettering Cancer Center; and Dr. David Wilkes.	Abbott GW, 2007, J ELECTROCARDIOL, V40, pS42, DOI 10.1016/j.jelectrocard.2007.05.021; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anantharam A, 2003, J PHARMACOL EXP THER, V307, P831, DOI 10.1124/jpet.103.054569; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Appleton GO, 2004, J INTERV CARD ELECTR, V11, P5, DOI 10.1023/B:JICE.0000035922.14870.56; Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Brunner M, 2001, AM J PHYSIOL-HEART C, V281, pH1201, DOI 10.1152/ajpheart.2001.281.3.H1201; Chun KRJ, 2004, EXP MOL MED, V36, P367, DOI 10.1038/emm.2004.48; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Folco EJ, 2004, AM J PHYSIOL-HEART C, V287, pH681, DOI 10.1152/ajpheart.00152.2004; Franco D, 2001, CARDIOVASC RES, V52, P65, DOI 10.1016/S0008-6363(01)00349-2; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Gutstein DE, 2005, AM J PHYSIOL-HEART C, V289, pH1091, DOI 10.1152/ajpheart.00095.2005; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kang JS, 2006, ANESTHESIOLOGY, V104, P1015, DOI 10.1097/00000542-200605000-00018; Kobayashi S, 2001, EUR J PHARMACOL, V430, P149, DOI 10.1016/S0014-2999(01)01381-4; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; Kuenszberg E, 2000, EUR J ANAESTH, V17, P662, DOI 10.1046/j.1365-2346.2000.00739.x; Kuryshev YA, 2001, AM J PHYSIOL-CELL PH, V281, pC290, DOI 10.1152/ajpcell.2001.281.1.C290; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li HL, 2004, AM J PHYSIOL-HEART C, V286, pH319, DOI 10.1152/ajpheart.00665.2003; Liu Jie, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1754; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Matsuda T, 2001, LIFE SCI, V68, P2017, DOI 10.1016/S0024-3205(01)01003-7; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Park KH, 2007, J BIOL CHEM, V282, P19799, DOI 10.1074/jbc.M701625200; Perez-Garcia MT, 1999, J GEN PHYSIOL, V113, P897, DOI 10.1085/jgp.113.6.897; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Salama G, 2007, J PHYSIOL-LONDON, V578, P43, DOI 10.1113/jphysiol.2006.118745; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Veugelers M, 2004, P NATL ACAD SCI USA, V101, P14222, DOI 10.1073/pnas.0405535101; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wickenden AD, 1999, CIRC RES, V85, P1067; Wickenden AD, 1999, AM J PHYSIOL-HEART C, V276, pH1599, DOI 10.1152/ajpheart.1999.276.5.H1599; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu HD, 1999, J PHYSIOL-LONDON, V519, P11, DOI 10.1111/j.1469-7793.1999.0011o.x; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	69	83	85	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3648	3660		10.1096/fj.08-110171	http://dx.doi.org/10.1096/fj.08-110171			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18603586	Green Published			2022-12-25	WOS:000259642600026
J	Manna, D; Bhardwaj, N; Vora, MS; Stahelin, RV; Lu, H; Cho, WH				Manna, Debasis; Bhardwaj, Nitin; Vora, Mohsin S.; Stahelin, Robert V.; Lu, Hui; Cho, Wonhwa			Differential roles of phosphatidylserine, PtdIns(4,5)P-2, and PtdIns(3,4,5)P-3 in plasma membrane targeting of C2 domains - Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKC alpha C2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; EFFICIENT GENERATION; PROTEIN INTERACTIONS; AM1-BCC MODEL; PKC-ALPHA; BILAYER; SURFACE; CA2+; LOCALIZATION; MECHANISM	Many cytosolic proteins are recruited to the plasma membrane ( PM) during cell signaling and other cellular processes. Recent reports have indicated that phosphatidylserine ( PS), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) that are present in the PM play important roles for their specific PM recruitment. To systematically analyze how these lipids mediate PM targeting of cellular proteins, we performed biophysical, computational, and cell studies of the Ca2+-dependent C2 domain of protein kinase C alpha(PKC alpha) that is known to bind PS and phosphoinositides. In vitro membrane binding measurements by surface plasmon resonance analysis show that PKC alpha-C2 nonspecifically binds phosphoinositides, including PtdIns(4,5)P-2 and PtdIns(3,4,5)P-3, but that PS and Ca2+ binding is prerequisite for productive phosphoinositide binding. PtdIns(4,5)P-2 or PtdIns(3,4,5)P-3 augments the Ca2+- and PS-dependent membrane binding of PKC alpha-C2 by slowing its membrane dissociation. Molecular dynamics simulations also support that Ca2+-dependent PS binding is essential for membrane interactions of PKC alpha-C2. PtdIns(4,5)P-2 alone cannot drive the membrane attachment of the domain but further stabilizes the Ca2+- and PS-dependent membrane binding. When the fluorescence protein-tagged PKC alpha-C2 was expressed in NIH-3T3 cells, mutations of phosphoinositide-binding residues or depletion of PtdIns(4,5)P-2 and/or PtdIns(3,4,5)P-3 from PM did not significantly affect the PM association of the domain but accelerated its dissociation from PM. Also, local synthesis of PtdIns( 4,5) P2 or PtdIns( 3,4,5) P3 at the PM slowed membrane dissociation of PKC alpha-C2. Collectively, these studies show that PtdIns(4,5)P-2 and PtdIns(3,4,5)P-3 augment the Ca2+- and PS-dependent membrane binding of PKC alpha-C2 by elongating the membrane residence of the domain but cannot drive the PM recruitment of PKC alpha-C2. These studies also suggest that effective PM recruitment of many cellular proteins may require synergistic actions of PS and phosphoinositides.	[Bhardwaj, Nitin; Lu, Hui] Univ Illinois, Dept Bioengn, Bioinformat Program, Chicago, IL 60607 USA; [Manna, Debasis; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Lu, Hui] Univ Notre Dame, Walther Ctr Canc Res, South Bend, IN 46617 USA; [Vora, Mohsin S.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; Walther Cancer Institute; Indiana University System; Indiana University South Bend; University of Notre Dame	Lu, H (corresponding author), Univ Illinois, Dept Bioengn, Bioinformat Program, M-C 563, Chicago, IL 60607 USA.	huilu@uic.edu	Stahelin, Robert/L-3567-2019; Lu, Hui/K-3264-2019	Stahelin, Robert/0000-0001-5443-7863; Manna, Debasis/0000-0002-6920-9000; Lu, Hui/0000-0001-8347-0830	National Institutes of Health [P01AI060915, GM52598, GM68849, GM76581]; Indiana University; American Heart Association [0735350N]; American Cancer Society [IRG-84-002-22]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076581, R01GM052598, R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI060915 (to H.L.) and GM52598, GM68849, and GM76581 (to W.C.). This work was also supported by an Indiana University Biomedical Research Grant, American Heart Association Grant SDG 0735350N, and American Cancer Society Grant IRG-84-002-22) (to R.V.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Berneche S, 1998, BIOPHYS J, V75, P1603, DOI 10.1016/S0006-3495(98)77604-0; Bhardwaj N, 2007, BIOINFORMATICS, V23, P3110, DOI 10.1093/bioinformatics/btm395; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Hauser H, 1992, STRUCTURE BIOL MEMBR, P3; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kohout SC, 2003, BIOCHEMISTRY-US, V42, P1254, DOI 10.1021/bi026596f; Liepina I, 2003, BIOPOLYMERS, V71, P49, DOI 10.1002/bip.10375; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mihailescu D, 2000, BIOPHYS J, V79, P1718, DOI 10.1016/S0006-3495(00)76424-1; Mukhopadhyay P, 2004, BIOPHYS J, V86, P1601, DOI 10.1016/S0006-3495(04)74227-7; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Smondyrev AM, 2002, BIOPHYS J, V82, P1460, DOI 10.1016/S0006-3495(02)75500-8; Smondyrev AM, 2000, BIOPHYS J, V78, P1672, DOI 10.1016/S0006-3495(00)76719-1; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Villarreal MA, 2004, LANGMUIR, V20, P7844, DOI 10.1021/la049485l; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	54	68	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26047	26058		10.1074/jbc.M802617200	http://dx.doi.org/10.1074/jbc.M802617200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621733	Green Published, hybrid			2022-12-25	WOS:000259200100033
J	Omori, E; Morioka, S; Matsumoto, K; Ninomiya-Tsuji, J				Omori, Emily; Morioka, Sho; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun			TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN LIGASE ITCH; KINASE TAK1; SIGNALING PATHWAYS; JNK ACTIVATION; ALPHA; EXPRESSION; INDUCTION; STRESS; INNATE	Mice with a keratinocyte-specific deletion of Tak1 exhibit severe skin inflammation due to hypersensitivity to tumor necrosis factor (TNF) killing. Here we have examined the mechanisms underlying this hypersensitivity. We found that TAK1 deficiency up-regulates reactive oxygen species (ROS) resulting in cell death upon TNF or oxidative stress challenge. Because blockade of NF-kappa B did not increase ROS or did not sensitize cells to oxidative stress in keratinocytes TAK1 regulates ROS mainly through the mechanisms other than those mediated by NF-kappa B. We found that c-Jun was decreased in TAK1-deficient keratinocytes and that ectopic expression of c-Jun could partially inhibit TNF-induced increase of ROS and cell death. Finally, we show that, in an in vivo setting, the antioxidant treatment could reduce an inflammatory condition in keratinocyte-specific Tak1 deletion mice. Thus, TAK1 regulates ROS partially through c-Jun, which is important for preventing ROS-induced skin inflammation.	[Omori, Emily; Morioka, Sho; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Morioka, Sho; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Matsumoto, Kunihiro] Japan Sci & Technol Agcy, SORST, Tokyo, Japan	University of North Carolina; North Carolina State University; Nagoya University; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068812 (to J.N.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kitamura T, 1998, INT J HEMATOL, V67, P351; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	28	79	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26161	26168		10.1074/jbc.M804513200	http://dx.doi.org/10.1074/jbc.M804513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18606807	hybrid, Green Published			2022-12-25	WOS:000259200100044
J	Zeth, K; Romer, C; Patzer, SI; Braun, V				Zeth, Kornelius; Roemer, Christin; Patzer, Silke I.; Braun, Volkmar			Crystal structure of colicin M, a novel phosphatase specifically imported by Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; FHUA RECEPTOR; TONB PROTEIN; TRANSPORT; TRANSDUCTION; INHIBITOR; SEQUENCE; PLASMID; DOMAINS	Colicins are cytotoxic proteins secreted by certain strains of Escherichia coli. Colicin Mis unique among these toxins in that it acts in the periplasm and specifically inhibits murein biosynthesis by hydrolyzing the pyrophosphate linkage between bactoprenol and the murein precursor. We crystallized colicin M and determined the structure at 1.7 A resolution using x-ray crystallography. The protein has a novel structure composed of three domains with distinct functions. The N-domain is a short random coil and contains the exposed TonB box. The central domain includes a hydrophobic alpha-helix and binds presumably to the FhuA receptor. The C-domain is composed of a mixed alpha/beta-fold and forms the phosphatase. The architectures of the individual modules show no similarity to known structures. Amino acid replacements in previously isolated inactive colicin M mutants are located in the phosphatase domain, which contains a number of surface-exposed residues conserved in predicted bacteriocins of other bacteria. The novel phosphatase domain displays no sequence similarity to known phosphatases. The N-terminal and central domains are not conserved among bacteriocins, which likely reflect the distinct import proteins required for the uptake of the various bacteriocins. The homology pattern supports our previous proposal that colicins evolved by combination of distinct functional domains.	[Zeth, Kornelius; Roemer, Christin; Patzer, Silke I.; Braun, Volkmar] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Braun, V (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	volkmar.braun@tuebingen.mpg.de			Department of Protein Evolution	Department of Protein Evolution	We thank Dr. Reinhard Albrecht for very helpful contributions in protein crystallization. We acknowledge Dr. Ehmke Pohl from Beamline PX10 at the Swiss Light Source, Villigen, Switzerland, for excellent technical assistance and the Beamline support, and Karen A. Brune for critically reading the manuscript. This work was carried out in the Department of Protein Evolution, and the support of Dr. Andrei Lupas, head of the department, is greatly acknowledged.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1974, ANTIMICROB AGENTS CH, V5, P520, DOI 10.1128/AAC.5.5.520; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; DREHER R, 1985, ARCH MICROBIOL, V140, P343, DOI 10.1007/BF00446975; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gross P, 1996, MOL GEN GENET, V251, P388, DOI 10.1007/BF02172531; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; HARKNESS RE, 1989, J BIOL CHEM, V264, P14716; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOCK J, 1987, J BACTERIOL, V169, P3358; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; SCHALLER K, 1982, J BACTERIOL, V152, P994; SCHALLER K, 1981, J BACTERIOL, V147, P135, DOI 10.1128/JB.147.1.135-139.1981; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; SCHOFFLER H, 1989, MOL GEN GENET, V217, P378, DOI 10.1007/BF02464907; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; THUMM G, 1988, PLASMID, V20, P75, DOI 10.1016/0147-619X(88)90009-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102	40	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25324	25331		10.1074/jbc.M802591200	http://dx.doi.org/10.1074/jbc.M802591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640984	Green Published, hybrid			2022-12-25	WOS:000259012700026
J	Andres-Hernando, A; Lanaspa, MA; Rivard, CJ; Berl, T				Andres-Hernando, Ana; Lanaspa, Miguel A.; Rivard, Christopher J.; Berl, Tomas			Nucleoporin 88 (Nup88) Is Regulated by Hypertonic Stress in Kidney Cells to Retain the Transcription Factor Tonicity Enhancer-binding Protein (TonEBP) in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; GENE-EXPRESSION; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; RENAL-CELLS; EXPORT; ADAPTATION; DROSOPHILA; ACTIVATOR; CRM1	Antibody microarray technology identified Nup88 (nucleoporin 88) as a highly up-regulated protein in response to osmotic stress in inner medullary collecting duct (IMCD3) cells. Changes in expression were verified by Western blot and quantitative PCR for protein and message expression. In mouse and human kidney, Nup88 expression was substantial in the papilla, whereas it was nearly absent in the cortex. Furthermore, the expression of Nup88 increased 410.4 +/- 22% in the papilla of mice after 36 h of thirsting. Nup88 protein expression in IMCD3 cells was significantly up-regulated in the first 8 h following exposure to acute osmotic stress, indicating that Nup88 is an early response protein. To define the function of Nup88 in the osmotic stress response, the transcription factor associated with hypertonicity, tonicity enhancer-binding protein (TonEBP), was cloned upstream of the green fluorescent protein. Employing this construct, we demonstrate that silencing Nup88 in IMCD3 cells acutely stressed to hypertonic conditions reduces nuclear retention of TonEBP, resulting in a substantial blunting in transcription of important osmotic stress response target genes and reduced cell viability. Finally, we show that in IMCD3 cells, nuclear export of TonEBP under isotonic conditions involves CRM-1 but under hypertonic stress is CRM1-independent. Our data, therefore, suggest that Nup88 is up-regulated in response to hypertonic stress and acts to retain TonEBP in the nucleus, activating transcription of critical osmoprotective genes.	[Andres-Hernando, Ana; Lanaspa, Miguel A.; Rivard, Christopher J.; Berl, Tomas] Univ Colorado, Hlth Sci Ctr, Sch Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Berl, T (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Div Renal Dis & Hypertens, 4200 E 9th Ave, Denver, CO 80262 USA.	tomas.berl@uchsc.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188	National Institutes of Health [DK-19928, DK-66544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066544, P01DK019928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grants DK-19928 and DK-66544 (to T. B.).	Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Capasso JM, 2001, AM J PHYSIOL-RENAL, V280, pF768, DOI 10.1152/ajprenal.2001.280.5.F768; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Ferraris JD, 2006, CONTRIB NEPHROL, V152, P125, DOI 10.1159/000096320; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Uv AE, 2000, GENE DEV, V14, P1945; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, INT REV CYTOL, V215, P189; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Zhang Z, 2003, AM J PHYSIOL-RENAL, V285, pF688, DOI 10.1152/ajprenal.00028.2003	35	13	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25082	25090		10.1074/jbc.M802381200	http://dx.doi.org/10.1074/jbc.M802381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18606815	Green Published, hybrid			2022-12-25	WOS:000271617300013
J	Hager, M; Bigotti, MG; Meszaros, R; Carmignac, V; Holmberg, J; Allamand, V; Akerlund, M; Kalamajski, S; Brancaccio, A; Mayer, U; Durbeej, M				Haeger, Mattias; Bigotti, Maria Giulia; Meszaros, Renata; Carmignac, Virginie; Holmberg, Johan; Allamand, Valerie; Akerlund, Mikael; Kalamajski, Sebastian; Brancaccio, Andrea; Mayer, Ulrike; Durbeej, Madeleine			Cib2 binds integrin alpha 7B beta 1D and is reduced in laminin alpha 2 chain-deficient muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(IIB) CYTOPLASMIC DOMAIN; SKELETAL-MUSCLE; GENE-EXPRESSION; ALPHA-7-BETA-1 INTEGRIN; CHROMOSOME 15Q24; CALCIUM-BINDING; MUTANT MICE; PROTEIN; IDENTIFICATION; REDUCTION	Mutations in the gene encoding laminin alpha 2 chain cause congenital muscular dystrophy type 1A. In skeletal muscle, laminin alpha 2 chain binds at least two receptor complexes: the dystrophin-glycoprotein complex and integrin alpha 7 beta 1. To gain insight into the molecular mechanisms underlying this disorder, we performed gene expression profiling of laminin alpha 2 chain-deficient mouse limb muscle. One of the down-regulated genes encodes a protein called Cib2 (calcium-and integrin-binding protein 2) whose expression and function is unknown. However, the closely related Cib1 has been reported to bind integrin alpha IIb and may be involved in outside-in-signaling in platelets. Since Cib2 might be a novel integrin alpha 7 beta 1-binding protein in muscle, we have studied Cib2 expression in the developing and adult mouse. Cib2 mRNA is mainly expressed in the developing central nervous system and in developing and adult skeletal muscle. In skeletal muscle, Cib2 colocalizes with the integrin alpha 7B subunit at the sarcolemma and at the neuromuscular and myotendinous junctions. Finally, we demonstrate that Cib2 is a calcium-binding protein that interacts with integrin alpha 7B beta 1D. Thus, our data suggest a role for Cib2 as a cytoplasmic effector of integrin alpha 7B beta 1D signaling in skeletal muscle.	[Haeger, Mattias; Meszaros, Renata; Carmignac, Virginie; Holmberg, Johan; Akerlund, Mikael; Kalamajski, Sebastian; Durbeej, Madeleine] Lund Univ, Dept Expt Med Sci, Div Cell & Matrix Biol, S-22184 Lund, Sweden; [Bigotti, Maria Giulia] Univ Roma La Sapienza, Dept Biochem, I-00185 Rome, Italy; [Allamand, Valerie] INSERM, U582, F-75651 Paris, France; [Allamand, Valerie] Univ Paris 06, IFR14, Inst Myol, UMR S582, F-75250 Paris, France; [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol, Ist Biochim Clin, I-00168 Rome, Italy; [Mayer, Ulrike] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Lund University; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of East Anglia	Durbeej, M (corresponding author), Lund Univ, Dept Expt Med Sci, Div Cell & Matrix Biol, BMC B12, S-22184 Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se	Brancaccio, Andrea/C-5876-2009; Allamand, Valerie/M-4333-2017; Allamand, Valérie/AAH-6272-2021	Brancaccio, Andrea/0000-0003-4690-8826; Allamand, Valérie/0000-0001-8997-9742; Kalamajski, Sebastian/0000-0002-6600-9302; Bigotti, Giulia/0000-0001-9595-3338; Durbeej Hjalt, Madeleine/0000-0002-5491-2457; Mayer, Ulrike/0000-0003-2328-0052	Muscular Dystrophy Association and Association Francaise contre les Myopathies; Wenner-Gren Foundations	Muscular Dystrophy Association and Association Francaise contre les Myopathies; Wenner-Gren Foundations	This work was supported by grants from the Muscular Dystrophy Association and Association Francaise contre les Myopathies (to M. D.) and by the Wenner-Gren Foundations (to V. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; Cushman LJ, 2005, AM J MED GENET A, V137A, P65, DOI 10.1002/ajmg.a.30836; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Eftink MR, 1997, METHOD ENZYMOL, V278, P258; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, FEBS LETT, V580, P1759, DOI 10.1016/j.febslet.2006.02.027; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Hodges BL, 1997, J CELL SCI, V110, P2873; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Mitchell SJ, 1998, AM J HUM GENET, V62, P1070, DOI 10.1086/301821; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Ohlendieck K., 2002, BASIC APPL MYOL, V12, P147; PIZARD A, 2004, CURRENT PROTOCOLS MO; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Seki N, 1999, BBA-GENE STRUCT EXPR, V1444, P143, DOI 10.1016/S0167-4781(98)00253-X; Taniguchi M, 2006, BIOCHEM BIOPH RES CO, V342, P489, DOI 10.1016/j.bbrc.2005.12.224; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; van Lunteren E, 2006, PHYSIOL GENOMICS, V25, P85, DOI 10.1152/physiolgenomics.00226.2005; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VOIT T, 2004, MYOLOGY, P1203; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Yamniuk AP, 2006, CALCIUM BINDING PROT, V1, P150; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131	34	32	35	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24760	24769		10.1074/jbc.M801166200	http://dx.doi.org/10.1074/jbc.M801166200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611855	hybrid, Green Published			2022-12-25	WOS:000258820000044
J	Ryan, AJ; Chen, BB; Vennalaganti, PR; Henderson, FC; Tephly, LA; Carter, AB; Mallampalli, RK				Ryan, Alan J.; Chen, Bill B.; Vennalaganti, Prashanth R.; Henderson, Florita C.; Tephly, Linda A.; Carter, A. Brent; Mallampalli, Rama K.			15-deoxy-Delta(12,14)-prostaglandin J(2) impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHINESE-HAMSTER OVARY; PROLIFERATOR-ACTIVATED RECEPTOR; DNA-BINDING; CYCLOPENTENONE PROSTAGLANDINS; PPAR-GAMMA; IN-VIVO; COVALENT MODIFICATION; PROTEIN OXIDATION; RAT-LIVER	Synthesis of phosphatidylcholine, the major phospholipid of animal cell membranes, requires the key enzyme cytidylyltransferase (CCT alpha). Cysteine sulfhydryls within CCT alpha are needed for full catalytic activity. Here we show that prostaglandin 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) inactivates CCT alpha by inducing generation of reactive oxidant species and the appearance of a cross-linked CCT alpha dimer in cells. N-Acetyl-L-cysteine reduced oxidative stress, prevented CCT alpha cross-linking, and restored CCT function in 15d-PGJ(2)-treated cells. 15d-PGJ(2) modified critical cysteine residues within CCT alpha as determined by mutagenesis studies and by incorporation of biotin-15d-PGJ(2) into CCT alpha. These effects of 15d-PGJ(2) were associated with CCT alpha accumulation within the nucleus. The data indicate that bioactive prostanoids significantly impair membrane phospholipid production by promoting cysteine cross-bridging within CCT alpha.	[Vennalaganti, Prashanth R.; Carter, A. Brent; Mallampalli, Rama K.] Univ Iowa, Vet Affairs Med Ctr, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ryan, Alan J.; Henderson, Florita C.; Tephly, Linda A.; Carter, A. Brent; Mallampalli, Rama K.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Mallampalli, RK (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Div Pulm Dis,Crit Care & Occupat Med, C-33K,GH, Iowa City, IA 52242 USA.	rama-mallampalli@uiowa.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080229, R01HL068135, R01HL071040, T32HL007344, R01HL081784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080229, HL081784, T32 HL007344, HL071040, R01 HL068135] Funding Source: Medline; NIEHS NIH HHS [R01 ES014871, ES015981] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; ATSMON J, 1990, CANCER RES, V50, P1879; ATSMON J, 1990, BIOCHEMISTRY-US, V29, P3760, DOI 10.1021/bi00467a023; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; BASS DA, 1983, J IMMUNOL, V130, P1910; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Dahlen SE, 2004, THORAX, V59, P453, DOI 10.1136/thx.2004.026641; Dean RT, 1997, BIOCHEM J, V324, P1; EXTON JH, 1990, J BIOL CHEM, V265, P1; Flaherty DM, 2002, J IMMUNOL, V168, P5675, DOI 10.4049/jimmunol.168.11.5675; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Henderson FC, 2006, J LIPID RES, V47, P2314, DOI 10.1194/jlr.M600284-JLR200; HIRATA Y, 1988, J BIOL CHEM, V263, P16619; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Kim HJ, 2007, CANCER RES, V67, P2595, DOI 10.1158/0008-5472.CAN-06-3043; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; Longo CA, 1997, AM J RESP CELL MOL, V16, P605, DOI 10.1165/ajrcmb.16.5.9160843; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Person EC, 2001, ENDOCRINOLOGY, V142, P551, DOI 10.1210/en.142.2.551; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Rehan VK, 2007, AM J PHYSIOL-LUNG C, V292, pL323, DOI 10.1152/ajplung.00071.2006; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez-Gomez FJ, 2004, MOL PHARMACOL, V66, P1349, DOI 10.1124/mol.104.002824; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	60	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24628	24640		10.1074/jbc.M801167200	http://dx.doi.org/10.1074/jbc.M801167200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614529	Green Published, hybrid			2022-12-25	WOS:000258820000035
J	Caramelli, D; Milani, L; Vai, S; Modi, A; Pecchioli, E; Girardi, M; Pilli, E; Lari, M; Lippi, B; Ronchitelli, A; Mallegni, F; Casoli, A; Bertorelle, G; Barbujani, G				Caramelli, David; Milani, Lucio; Vai, Stefania; Modi, Alessandra; Pecchioli, Elena; Girardi, Matteo; Pilli, Elena; Lari, Martina; Lippi, Barbara; Ronchitelli, Annamaria; Mallegni, Francesco; Casoli, Antonella; Bertorelle, Giorgio; Barbujani, Guido			A 28,000 Years Old Cro-Magnon mtDNA Sequence Differs from All Potentially Contaminating Modern Sequences	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NEANDERTHALS; HUMANS	Background: DNA sequences from ancient speciments may in fact result from undetected contamination of the ancient specimens by modern DNA, and the problem is particularly challenging in studies of human fossils. Doubts on the authenticity of the available sequences have so far hampered genetic comparisons between anatomically archaic (Neandertal) and early modern (Cro-Magnoid) Europeans. Methodology/Principal Findings: We typed the mitochondrial DNA (mtDNA) hypervariable region I in a 28,000 years old Cro-Magnoid individual from the Paglicci cave, in Italy (Paglicci 23) and in all the people who had contact with the sample since its discovery in 2003. The Paglicci 23 sequence, determined through the analysis of 152 clones, is the Cambridge reference sequence, and cannot possibly reflect contamination because it differs from all potentially contaminating modern sequences. Conclusions/Significance:: The Paglicci 23 individual carried a mtDNA sequence that is still common in Europe, and which radically differs from those of the almost contemporary Neandertals, demonstrating a genealogical continuity across 28,000 years, from Cro-Magnoid to modern Europeans. Because all potential sources of modern DNA contamination are known, the Paglicci 23 sample will offer a unique opportunity to get insight for the first time into the nuclear genes of early modern Europeans.	[Caramelli, David; Milani, Lucio; Vai, Stefania; Modi, Alessandra; Pilli, Elena; Lari, Martina] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy; [Vai, Stefania; Bertorelle, Giorgio; Barbujani, Guido] Univ Ferrara, Dipartimento Biol Evoluzione, Ferrara, Italy; [Pecchioli, Elena; Girardi, Matteo] Viote Monte Bondone, Ctr Ecol Alpina Fdn Edmund Mach, Trento, Italy; [Lippi, Barbara; Mallegni, Francesco] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Ronchitelli, Annamaria] Univ Siena, Dipartimento Dipartimento Sci Ambientali, Siena, Italy; [Casoli, Antonella] Univ Parma, Dipartimento Chim Gen Inorgan, Chim Fis, Parma, Italy	University of Florence; University of Ferrara; Fondazione Edmund Mach; University of Pisa; University of Siena; University of Parma	Caramelli, D (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy.	g.barbujani@unife.it	Bertorelle, Giorgio/AAE-9078-2022; Lari, Martina/A-4085-2009; casoli, antonella/H-6953-2016; Barbujani, Guido/ABE-9998-2020	casoli, antonella/0000-0002-9212-9463; Barbujani, Guido/0000-0001-7854-6669; Pilli, Elena/0000-0002-3150-5082; Caramelli, David/0000-0001-6468-1675; VAI, STEFANIA/0000-0003-3844-5147; Girardi, Matteo/0000-0002-1176-0764; Bertorelle, Giorgio/0000-0002-2498-2702	Italian Ministery of the Universities	Italian Ministery of the Universities	Study supported by funds of the Italian Ministery of the Universities (PRIN 2006). No sponsors had any role in any phase of the study, and the authors do not envisage any conflict of interests.	Abbott A, 2003, NATURE, V423, P468, DOI 10.1038/423468b; Barbujani G, 2003, NATURE, V424, P127, DOI 10.1038/424127b; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2000, SCIENCE, V289, P1139; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Gilbert MTP, 2006, INT J OSTEOARCHAEOL, V16, P156, DOI 10.1002/oa.832; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Handt O, 1996, AM J HUM GENET, V59, P368; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MALLEGNI F, 2005, J ANTHROPOL SCI S, V84, P110; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 2008, HEREDITY, V100, P555, DOI 10.1038/hdy.2008.14; Relethford JH, 2001, AM J PHYS ANTHROPOL, V115, P95, DOI 10.1002/ajpa.1060; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TEMPLETON AR, 1992, GENETICS, V132, P619; WOLPOFF MH, 2005, ARCHAEOLOGY KEY CONC, P176; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110	33	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2700	10.1371/journal.pone.0002700	http://dx.doi.org/10.1371/journal.pone.0002700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628960	Green Published, gold			2022-12-25	WOS:000264057200043
J	Kohler, S; Lieleg, O; Bausch, AR				Koehler, Simone; Lieleg, Oliver; Bausch, Andreas R.			Rheological Characterization of the Bundling Transition in F-Actin Solutions Induced by Methylcellulose	PLOS ONE			English	Article								In many in vitro experiments Brownian motion hampers quantitative data analysis. Therefore, additives are widely used to increase the solvent viscosity. For this purpose, methylcellulose (MC) has been proven highly effective as already small concentrations can significantly slow down diffusive processes. Beside this advantage, it has already been reported that high MC concentrations can alter the microstructure of polymer solutions such as filamentous actin. However, it remains to be shown to what extent the mechanical properties of a composite actin/MC gel depend on the MC concentration. In particular, significant alterations might occur even if the microstructure seems unaffected. Indeed, we find that the viscoelastic response of entangled F-actin solutions depends sensitively on the amount of MC added. At concentrations higher than 0.2% (w/v) MC, actin filaments are reorganized into bundles which drastically changes the viscoelastic response. At small MC concentrations the impact of MC is more subtle: the two constituents, actin and MC, contribute in an additive way to the mechanical response of the composite material. As a consequence, the effect of methylcellulose on actin solutions has to be considered very carefully when MC is used in biochemical experiments.	[Koehler, Simone; Lieleg, Oliver; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany	Technical University of Munich	Kohler, S (corresponding author), Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany.	abausch@ph.tum.de		Lieleg, Oliver/0000-0002-6874-7456; Kohler, Simone/0000-0002-1119-8855				Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; COOPER JA, 1987, J CELL BIOL, V104, P491, DOI 10.1083/jcb.104.3.491; El Ghzaoui A, 2001, LANGMUIR, V17, P1453, DOI 10.1021/la000516w; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; JANMEY PA, 1986, J BIOL CHEM, V261, P8357; Kobayashi K, 1999, MACROMOLECULES, V32, P7070, DOI 10.1021/ma990242n; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.088102; LIELEG O, 2008, TRANSIENT BINDING DI; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Luan Y, 2008, BIOPHYS J, V94, P688, DOI 10.1529/biophysj.107.112417; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Popp D, 2006, BIOCHEM BIOPH RES CO, V351, P348, DOI 10.1016/j.bbrc.2006.10.041; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SCHMOLLER KM, 2008, INTERNAL STRES UNPUB; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suzuki A, 1996, BIOCHEMISTRY-US, V35, P5238, DOI 10.1021/bi952693f; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tharmann R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088103; Tharmann R, 2006, BIOPHYS J, V90, P2622, DOI 10.1529/biophysj.105.070458; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103	31	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2736	10.1371/journal.pone.0002736	http://dx.doi.org/10.1371/journal.pone.0002736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629003	gold, Green Published			2022-12-25	WOS:000264057200072
J	Meis, S; Bergado-Acosta, JR; Yanagawa, Y; Obata, K; Stork, O; Munsch, T				Meis, Susanne; Bergado-Acosta, Jorge Ricardo; Yanagawa, Yuchio; Obata, Kunihiko; Stork, Oliver; Munsch, Thomas			Identification of a Neuropeptide S Responsive Circuitry Shaping Amygdala Activity via the Endopiriform Nucleus	PLOS ONE			English	Article							C-FOS; ELECTRICAL-STIMULATION; CONDITIONED FEAR; PIRIFORM CORTEX; MESSENGER-RNA; RAT-BRAIN; EXPRESSION; ORGANIZATION; PROJECTIONS; NEURONS	Neuropeptide S (NPS) and its receptor are thought to define a set of specific brain circuits involved in fear and anxiety. Here we provide evidence for a novel, NPS-responsive circuit that shapes neural activity in the mouse basolateral amygdala (BLA) via the endopiriform nucleus (EPN). Using slice preparations, we demonstrate that NPS directly activates an inward current in 20% of EPN neurons and evokes an increase of glutamatergic excitation in this nucleus. Excitation of the EPN is responsible for a modulation of BLA activity through NPS, characterized by a general increase of GABAergic inhibition and enhancement of spike activity in a subset of BLA projection neurons. Finally, local injection of NPS to the EPN interferes with the expression of contextual, but not auditory cued fear memory. Together, these data suggest the existence of a specific NPS-responsive circuitry between EPN and BLA, likely involved in contextual aspects of fear memory.	[Meis, Susanne; Bergado-Acosta, Jorge Ricardo; Stork, Oliver; Munsch, Thomas] Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Bergado-Acosta, Jorge Ricardo; Stork, Oliver] Otto von Guericke Univ, Inst Biol, Abt Mol Neurobiol, Magdeburg, Germany; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; [Obata, Kunihiko] RIKEN Brain Sci Inst, Obata Res Unit, Neuronal Circuit Mechanisms Res Grp, Wako, Saitama, Japan	Otto von Guericke University; Otto von Guericke University; Gunma University; RIKEN	Meis, S (corresponding author), Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany.	thomas.munsch@med.ovgu.de		Stork, Oliver/0000-0003-4285-7507	Deutsche Forschungsgemeinschaft [SFB 426, TP B8, SFB 779, TP B5]; Land Sachsen-Anhalt; MEXT, Japan [Grant-in-Aids for Scientific Research]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Land Sachsen-Anhalt; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the Deutsche Forschungsgemeinschaft SFB 426, TP B8 (S.M.) and SFB 779, TP B5 (O.S.), Land Sachsen-Anhalt (T.M.) and Grant-in-Aids for Scientific Research from the MEXT, Japan (Y.Y., K.O.).	Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Banks MI, 1996, J NEUROSCI, V16, P3862; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; BECK CHM, 1995, J NEUROSCI, V15, P709; Behan M, 1999, J COMP NEUROL, V408, P532; Brevi S, 2001, J NEUROPHYSIOL, V85, P2076, DOI 10.1152/jn.2001.85.5.2076; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Chen FJ, 2007, NEUROSCIENCE, V144, P472, DOI 10.1016/j.neuroscience.2006.09.037; Demir R, 1999, J NEUROSCI, V19, P1294; Fu W, 2004, NEUROSCIENCE, V126, P1033, DOI 10.1016/j.neuroscience.2004.03.041; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; GEAN PW, 1992, SYNAPSE, V11, P1, DOI 10.1002/syn.890110102; Hoffman WH, 1996, J NEUROPHYSIOL, V76, P1430, DOI 10.1152/jn.1996.76.3.1430; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; KRUKOFF TL, 1992, J NEUROSCI, V12, P3582; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Majak K, 2004, J COMP NEUROL, V476, P414, DOI 10.1002/cne.20233; Majak K, 2002, J COMP NEUROL, V451, P236, DOI 10.1002/cne.10346; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meis S, 2007, MOL CELL NEUROSCI, V35, P356, DOI 10.1016/j.mcn.2007.03.012; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Niimi M, 2006, ENDOCRINE, V30, P75, DOI 10.1385/ENDO:30:1:75; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ponomarenko AA, 2003, BEHAV BRAIN RES, V141, P123, DOI 10.1016/S0166-4328(02)00327-3; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; SMITH MA, 1992, BRAIN RES, V578, P135, DOI 10.1016/0006-8993(92)90240-A; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	37	98	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2695	10.1371/journal.pone.0002695	http://dx.doi.org/10.1371/journal.pone.0002695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628994	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200038
J	Yuhki, N; Mullikin, JC; Beck, T; Stephens, R; O'Brien, SJ				Yuhki, Naoya; Mullikin, James C.; Beck, Thomas; Stephens, Robert; O'Brien, Stephen J.			Sequences, Annotation and Single Nucleotide Polymorphism of the Major Histocompatibility Complex in the Domestic Cat	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; MHC CLASS-I; DIVERGENCE; TOOL; HLA; MAP; EXPRESSION; HAPLOTYPES; DIVERSITY	Two sequences of major histocompatibility complex (MHC) regions in the domestic cat, 2.976 and 0.362 Mbps, which were separated by an ancient chromosome break (55-80 MYA) and followed by a chromosomal inversion were annotated in detail. Gene annotation of this MHC was completed and identified 183 possible coding regions, 147 human homologues, possible functional genes and 36 pseudo/unidentified genes) by GENSCAN and BLASTN, BLASTP RepeatMasker programs. The first region spans 2.976 Mbp sequence, which encodes six classical class II antigens (three DRA and three DRB antigens) lacking the functional DP, DQ regions, nine antigen processing molecules (DOA/DOB, DMA/DMB, TAPASIN, and LMP2/LMP7, TAP1/TAP2), 52 class III genes, nineteen class I genes/gene fragments (FLAI-A to FLAI-S). Three class I genes (FLAI-H, I-K, I-E) may encode functional classical class I antigens based on deduced amino acid sequence and promoter structure. The second region spans 0.362 Mbp sequence encoding no class I genes and 18 cross-species conserved genes, excluding class I, II and their functionally related/ associated genes, namely framework genes, including three olfactory receptor genes. One previously identified feline endogenous retrovirus, a baboon retrovirus derived sequence (ECE1) and two new endogenous retrovirus sequences, similar to brown bat endogenous retrovirus (FERVmlu1, FERVmlu2) were found within a 140 Kbp interval in the middle of class I region. MHC SNPs were examined based on comparisons of this BAC sequence and MHC homozygous 1.9xWGS sequences and found that 11,654 SNPs in 2.84 Mbp (0.00411 SNP per bp), which is 2.4 times higher rate than average heterozygous region in the WGS (0.0017 SNP per bp genome), and slightly higher than the SNP rate observed in human MHC (0.00337 SNP per bp).	[Yuhki, Naoya; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Mullikin, James C.] NIH, Natl Human Genome Res Inst, Genome Technol Branch, Bethesda, MD USA; [Beck, Thomas] NCI, Lab Genom Divers, SAIC Frederick, Frederick, MD USA; [Stephens, Robert] NCI, Advanced Biomed Comp Ctr, SAIC Frederick, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yuhki, N (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21701 USA.	yuhki@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010537] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health.	Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; ALTSCHUL SF, 1990, J MOL BIOL, V268, P78; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck TW, 2005, IMMUNOGENETICS, V56, P702, DOI 10.1007/s00251-004-0742-6; Beck TW, 2001, GENOMICS, V71, P282, DOI 10.1006/geno.2000.6416; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carpenter MA, 1996, J VIROL, V70, P6682, DOI 10.1128/JVI.70.10.6682-6693.1996; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hardy WD, 1980, FELINE LEUKEMIA VIRU; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; KLEIN J, 1986, NATURAL HIST MAJOR H; KLEMENT V, 1972, VIROLOGY, V50, P305, DOI 10.1016/0042-6822(72)90379-0; KOLLER BH, 1988, J IMMUNOL, V141, P897; Krawczyk M, 2004, J IMMUNOL, V173, P6200, DOI 10.4049/jimmunol.173.10.6200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; NELSONRE.WA, 1973, JNCI-J NATL CANCER I, V50, P1129, DOI 10.1093/jnci/50.5.1129; NIMAN HL, 1977, NATURE, V266, P357, DOI 10.1038/266357a0; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PONTIUS J, 2007, GENOME RES UNPUB; Roca AL, 2005, J VIROL, V79, P3979, DOI 10.1128/JVI.79.7.3979-3986.2005; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Troyer JL, 2004, J VIROL, V78, P3777, DOI 10.1128/JVI.78.7.3777-3791.2004; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wilkerson AJP, 2004, CURR BIOL, V14, pR227, DOI 10.1016/j.cub.2004.02.051; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Yuhki N, 1997, J IMMUNOL, V158, P2822; YUHKI N, 1989, J IMMUNOL, V142, P3676; YUHKI N, 1990, J EXP MED, V172, P621, DOI 10.1084/jem.172.2.621; Yuhki N, 2007, J HERED, V98, P390, DOI 10.1093/jhered/esm056	46	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2674	10.1371/journal.pone.0002674	http://dx.doi.org/10.1371/journal.pone.0002674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629345	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200019
J	Ishikawa, Y; Aonuma, H; Miura, T				Ishikawa, Yuki; Aonuma, Hitoshi; Miura, Toru			Soldier-Specific Modification of the Mandibular Motor Neurons in Termites	PLOS ONE			English	Article								Social insects exhibit a variety of caste-specific behavioral tendencies that constitute the basis of division of labor within the colony. In termites, the soldier caste display distinctive defense behaviors, such as aggressively attacking enemies with well-developed mandibles, while the other castes retreat into the colony without exhibiting any aggressive response. It is thus likely that some form of soldier-specific neuronal modification exists in termites. In this study, the authors compared the brain (cerebral ganglion) and the suboesophageal ganglion (SOG) of soldiers and pseudergates (workers) in the damp-wood termite, Hodotermopsis sjostedti. The size of the SOG was significantly larger in soldiers than in pseudergates, but no difference in brain size was apparent between castes. Furthermore, mandibular nerves were thicker in soldiers than in pseudergates. Retrograde staining revealed that the somata sizes of the mandibular motor neurons (MdMNs) in soldiers were more than twice as large as those of pseudergates. The enlargement of MdMNs was also observed in individuals treated with a juvenile hormone analogue (JHA), indicating that MdMNs become enlarged in response to juvenile hormone (JH) action during soldier differentiation. This enlargement is likely to have two functions: a behavioral function in which soldier termites will be able to defend more effectively through relatively faster and stronger mandibular movements, and a developmental function that associates with the development of soldier-specific mandibular muscle morphogenesis in termite head. The soldier-specific enlargement of mandibular motor neurons was observed in all examined species in five termite families that have different mechanisms of defense, suggesting that such neuronal modification was already present in the common ancestor of termites and is significant for soldier function.	[Ishikawa, Yuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Aonuma, Hitoshi] Hokkaido Univ, Res Inst Electron Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ishikawa, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Miura, Toru/P-2456-2019; Aonuma, Hitoshi/D-6540-2012	Miura, Toru/0000-0002-7456-4402; Aonuma, Hitoshi/0000-0001-8380-1820; Ishikawa, Yuki/0000-0002-9873-3143	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid, 15687001, 18047002, 18370007]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for the Scientific Research (Nos. 15687001, 18047002, and 18370007) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	CLAMANN HP, 1976, J NEUROPHYSIOL, V39, P844, DOI 10.1152/jn.1976.39.4.844; CRESPI BJ, 1995, BEHAV ECOL, V6, P109, DOI 10.1093/beheco/6.1.109; Eggleton P, 2001, INSECT SOC, V48, P187, DOI 10.1007/PL00001766; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fernandes JJ, 1998, DEVELOPMENT, V125, P1769; Gillott C., 1995, ENTOMOLOGY; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harano K, 2005, NATURWISSENSCHAFTEN, V92, P310, DOI 10.1007/s00114-005-0631-3; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Kleineidam CJ, 2005, CHEM SENSES, V30, P383, DOI 10.1093/chemse/bji033; Koshikawa S, 2002, INSECT SOC, V49, P245, DOI 10.1007/s00040-002-8309-8; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; LUSCHER M, 1960, ANN NY ACAD SCI, V89, P549, DOI 10.1111/j.1749-6632.1960.tb27577.x; Luscher M., 1972, General and Comparative Endocrinology, P509, DOI 10.1016/0016-6480(72)90181-5; Maekawa Kiyoto, 1998, Entomological Science, V1, P561; Matsumoto T., 1985, Scientific Papers of the College of Arts and Sciences University of Tokyo, V35, P211; Miura T, 2001, INSECT SOC, V48, P216, DOI 10.1007/PL00001769; Miura T, 2004, ECOL RES, V19, P141, DOI 10.1111/j.1440-1703.2003.00618.x; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; NOIROT C, 1987, EXPERIENTIA, V43, P851, DOI 10.1007/BF01951642; Noirot C., 1991, MORPHOGENETIC HORMON, P295; NOIROT C, 1969, GLANDS SECRETIONS, P89; O'Donnell S, 2004, NEUROSCI LETT, V356, P159, DOI 10.1016/j.neulet.2003.11.053; OGINO K, 1993, ZOOL SCI, V10, P361; Paul J, 2002, J INSECT PHYSIOL, V48, P255, DOI 10.1016/S0022-1910(01)00171-8; RICHARD G, 1969, BIOL TERMITES, V1, P161; Sasaki K, 2002, J INSECT PHYSIOL, V48, P1075, DOI 10.1016/S0022-1910(02)00200-7; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; SELVERSTON AI, 1972, J NEUROPHYSIOL, V35, P797, DOI 10.1152/jn.1972.35.6.797; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stuart AM, 1969, BIOL TERMITES, P193; WEESNER FM, 1969, EXTERNAL ANATOMY, P19; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wilson E.O., 1971, INSECT SOC; ZUCKER RS, 1971, SCIENCE, V173, P645, DOI 10.1126/science.173.3997.645	41	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2617	10.1371/journal.pone.0002617	http://dx.doi.org/10.1371/journal.pone.0002617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612458	Green Published, gold			2022-12-25	WOS:000264065800019
J	Xu, J; Deng, XX; Disteche, CM				Xu, Jun; Deng, Xinxian; Disteche, Christine M.			Sex-Specific Expression of the X-Linked Histone Demethylase Gene Jarid1c in Brain	PLOS ONE			English	Article								Jarid1c, an X-linked gene coding for a histone demethylase, plays an important role in brain development and function. Notably, JARID1C mutations cause mental retardation and increased aggression in humans. These phenotypes are consistent with the expression patterns we have identified in mouse brain where Jarid1c mRNA was detected in hippocampus, hypothalamus, and cerebellum. Jarid1c expression and associated active histone marks at its 5'end are high in P19 neurons, indicating that JARID1C demethylase plays an important role in differentiated neuronal cells. We found that XX mice expressed Jarid1c more highly than XY mice, independent of their gonadal types ( testes versus ovaries). This increased expression in XX mice is consistent with Jarid1c escape from X inactivation and is not compensated by expression from the Y-linked paralogue Jarid1d, which is expressed at a very low level compared to the X paralogue in P19 cells. Our observations suggest that sex-specific expression of Jarid1c may contribute to sex differences in brain function.	[Xu, Jun; Deng, Xinxian; Disteche, Christine M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Xu, Jun] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA; [Disteche, Christine M.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; Tufts University; University of Washington; University of Washington Seattle	Xu, J (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	jun.xu@tufts.edu; cdistech@u.washington.edu	Xu, Jun/B-7351-2012		NIH [HD43942, GM46883, GM79537]; Tufts University [seed grant]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046883, R01GM079537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards HD43942 (J. Xu), GM46883 (C.M. Disteche), GM79537 (C.M. Disteche), and a Tufts University seed grant (J. Xu). Funders played no role in conducting the study or preparing the manuscript.	AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Carrel L, 1996, HUM MOL GENET, V5, P1361, DOI 10.1093/hmg/5.9.1361; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hall NM, 2003, MAMM GENOME, V14, P437, DOI 10.1007/s00335-002-3068-4; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lingenfelter PA, 1998, NAT GENET, V18, P212, DOI 10.1038/ng0398-212; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; WU JS, 1994, HUM MOL GENET, V3, P153, DOI 10.1093/hmg/3.1.153; Xu J, 2006, GENE EXPR PATTERNS, V6, P146, DOI 10.1016/j.modgep.2005.06.011; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008	30	93	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2553	10.1371/journal.pone.0002553	http://dx.doi.org/10.1371/journal.pone.0002553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596936	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200020
J	Bourd-Boittin, K; Le Pabic, H; Bonnier, D; L'Helgoualc'h, A; Theret, N				Bourd-Boittin, Katia; Le Pabic, Helene; Bonnier, Dominique; L'Helgoualc'h, Annie; Theret, Nathalie			RACK1, a new ADAM12 interacting protein - Contribution to liver fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-EPSILON; METALLOPROTEASE DISINTEGRIN ADAM12; EPIDERMAL-GROWTH-FACTOR; CYSTEINE-RICH DOMAIN; 12 MELTRIN ALPHA; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; CELL-ADHESION; TUMOR PROGRESSION; STELLATE CELLS	ADAM12 belongs to a disintegrin-like and metalloproteinase-containing protein family that possesses multidomain structures composed of a pro-domain, a metalloprotease, disintegrin-like, cysteine-rich, epidermal growth factor-like, and transmembrane domains, and a cytoplasmic tail. Overexpression of several ADAMs has been reported in human cancer, and we recently described the involvement of ADAM12 in liver injury (Le Pabic, H., Bonnier, D., Wewer, U. M., Coutand, A., Musso, O., Baffet, G., Clement, B., and Theret, N. (2003) Hepatology 37, 1056 - 1066). In this study, we used a yeast two-hybrid screening of a cDNA library from human hepatocellular carcinoma to analyze binding partners of ADAM12. We identify RACK1, a receptor for activated protein kinase C (PKC), as a new ADAM12 interacting protein. RACK1 is up-regulated in patients with hepatocellular carcinoma and is highly expressed by activated hepatic stellate cells. We demonstrate the involvement of RACK1 in mediating the PKC-dependent translocation of ADAM12 to membranes of activated hepatic stellate cells. In particular, treatment of cells with phorbol esters enhances ADAM12 immunostaining in the membrane fractions and the co-immunoprecipitation of ternary complexes containing RACK1, ADAM12, and PKC. By using RNA interference, we demonstrate that inhibition of RACK1 expression diminishes the phorbol 12-myristate 13-acetate-dependent translocation of ADAM12 to membranes of hepatic stellate cells. Finally, hepatic stellate cells cultured on coated type I collagen induces relocalization of ADAM12 in the membrane, suggesting that this major matrix component in liver cancer and fibrogenesis might stimulate ADAM12 translocation to the cell membrane where its shedding activity takes place.	[Bourd-Boittin, Katia; Le Pabic, Helene; Bonnier, Dominique; L'Helgoualc'h, Annie; Theret, Nathalie] Univ Rennes 1, INSERM, U620, IFR140, F-35000 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Theret, N (corresponding author), 2 Av Pr L Bernard, F-35043 Rennes, France.	nathalie.theret@univ-rennes1.fr	theret, nathalie/ABG-6780-2020; Theret, Nathalie/I-2871-2015; le pabic, helene/L-3123-2015	theret, nathalie/0000-0002-5857-7828; Theret, Nathalie/0000-0002-5857-7828; 	INSERM; Region Bretagne PRIR [3193]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bretagne PRIR(Region Bretagne)	This work was supported by INSERM, the Association pour la Recherche contre le Cancer, the Ligue contre le Cancer, and Region Bretagne PRIR Grant 3193. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bartholin L, 2005, BIOL CELL, V97, P577; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Carloni V, 1996, GASTROENTEROLOGY, V110, P1127, DOI 10.1053/gast.1996.v110.pm8613002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chou YC, 1999, BBA-GENE STRUCT EXPR, V1489, P315, DOI 10.1016/S0167-4781(99)00213-4; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Huang CC, 2004, J PATHOL, V202, P172, DOI 10.1002/path.1505; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Imai K, 2000, CELL STRUCT FUNCT, V25, P329, DOI 10.1247/csf.25.329; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kadota N, 2000, J BIOCHEM-TOKYO, V128, P941, DOI 10.1093/oxfordjournals.jbchem.a022845; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Thodeti CK, 2005, EXP CELL RES, V309, P438, DOI 10.1016/j.yexcr.2005.06.020; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Yam JWP, 2004, BLOOD, V103, P1445, DOI 10.1182/blood-2003-07-2452; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zindy P, 2005, FEBS LETT, V579, P95, DOI 10.1016/j.febslet.2004.09.092	63	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26000	26009		10.1074/jbc.M709829200	http://dx.doi.org/10.1074/jbc.M709829200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621736	Green Published, hybrid			2022-12-25	WOS:000259200100028
J	Piekna-Przybylska, D; Przybylski, P; Baudin-Baillieu, AS; Rousset, JP; Fournier, MJ				Piekna-Przybylska, Dorota; Przybylski, Piotr; Baudin-Baillieu, Agne S.; Rousset, Jean-Pierre; Fournier, Maurille J.			Ribosome performance is enhanced by a rich cluster of pseudouridines in the A-site finger region of the large subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; INTERSUBUNIT BRIDGE; PRERIBOSOMAL RNA; CENTRAL FOLD; MINOR MOTIF; CROSS-LINKS; MUTATIONS; PROTEIN	The large subunit rRNA in eukaryotes contains an unusually dense cluster of 8 - 10 pseudouridine (Psi) modifications located in a three-helix structure (H37-H39) implicated in several functions. This region is dominated by a long flexible helix (H38) known as the "A-site finger" (ASF). The ASF protrudes from the large subunit just above the A-site of tRNA binding, interacts with 5 S rRNA and tRNA, andthroughtheterminalloop, forms a bridge (B1a) with the small subunit. In yeast, the three-helix domain contains 10 Psi s and 6 are concentrated in the ASF helix (3 of the ASF Psi s are conserved among eukaryotes). Here, we show by genetic depletion analysis that the Psi s in the ASF helix and adjoining helices are not crucial for cell viability; however, their presence notably enhances ribosome fitness. Depleting different combinations of Psi s suggest that the modification pattern is important and revealed that loss of multiple Psi s negatively influences ribosome performance. The effects observed include slower cell growth ( reduced rates up to 23% at 30 degrees C and 40-50% at 37 degrees C and 11 degrees C), reduced level of the large subunit ( up to 17%), impaired polysome formation ( appearance of half-mers), reduced translation activity (up to 20% at 30 degrees C and 25% at 11 C), and increased sensitivity to ribosome-based drugs. The results indicate that the Psi s in the three-helix region improve fitness of a eukaryotic ribosome.	[Piekna-Przybylska, Dorota; Przybylski, Piotr; Fournier, Maurille J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Baudin-Baillieu, Agne S.; Rousset, Jean-Pierre] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France	University of Massachusetts System; University of Massachusetts Amherst; UDICE-French Research Universities; Universite Paris Saclay	Fournier, MJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Lederle Grad Res Tower, Amherst, MA 01003 USA.	4nier@biochem.umass.edu			United States Public Health Services [GM19351]; Association Francaise contre les Myopathies [12652]; Association pour la Recherche sur le Cancer [3849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019351] Funding Source: NIH RePORTER	United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Services Grant GM19351 (to M.J.F.) and by Association Francaise contre les Myopathies Grant 12652 and Association pour la Recherche sur le Cancer Grant 3849 (to J.P.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; BALAKIN AG, 1993, NUCLEIC ACIDS RES, V21, P5391, DOI 10.1093/nar/21.23.5391; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726; Conrad J, 1998, J BIOL CHEM, V273, P18562, DOI 10.1074/jbc.273.29.18562; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Decatur WA, 2007, METHOD ENZYMOL, V425, P283, DOI 10.1016/S0076-6879(07)25013-X; Dokudovskaya S, 1996, RNA, V2, P146; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Eisinger DP, 1997, MOL CELL BIOL, V17, P5136, DOI 10.1128/MCB.17.9.5136; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; HELSER TL, 1981, MOL CELL BIOL, V1, P51, DOI 10.1128/MCB.1.1.51; Kaiser Chris, 1994; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Komoda T, 2006, J BIOL CHEM, V281, P32303, DOI 10.1074/jbc.M607058200; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; PARKER R, 1988, MOL CELL BIOL, V8, P3150, DOI 10.1128/MCB.8.8.3150; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Razga F, 2005, BIOPHYS J, V88, P3466, DOI 10.1529/biophysj.104.054916; RinkeAppel J, 1995, RNA, V1, P1018; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Yassin A, 2007, J BIOL CHEM, V282, P24329, DOI 10.1074/jbc.M703106200; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	50	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26026	26036		10.1074/jbc.M803049200	http://dx.doi.org/10.1074/jbc.M803049200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18611858	Green Published, hybrid			2022-12-25	WOS:000259200100031
J	Hamilton, BJ; Wang, XW; Collins, J; Bloch, D; Bergeron, A; Henry, B; Terry, BM; Zan, M; Mouland, AJ; Rigby, WFC				Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Bloch, Donald; Bergeron, Alan; Henry, Brian; Terry, Benjamin M.; Zan, Moe; Mouland, Andrew J.; Rigby, William F. C.			Separate cis-trans pathways post-transcriptionally regulate murine CD154 (CD40 ligand) expression - A novel function for CA repeats in the 3 '-untranslated region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRACT-BINDING-PROTEIN; TNF-ALPHA; HNRNP-L; RHEUMATOID-ARTHRITIS; RICH ELEMENTS; T-CELLS; POLYADENYLATION; GENE	We report a role for CA repeats in the 3'-untranslated region (3'-UTR) in regulating CD154 expression. Human CD154 is encoded by an unstable mRNA; this instability is conferred in cis by a portion of its 3'-UTR that includes a polypyrimidine-rich region and CA dinucleotide repeat. We demonstrate similar instability activity with the murine CD154 3'-UTR. This instability element mapped solely to a conserved 100-base CU-rich region alone, which we call a CU-rich response element. Surprisingly, the CA dinucleotide-rich region also regulated reporter expression but at the level of translation. This activity was associated with poly(A) tail shortening and regulated by heterogeneous nuclear ribonucleoprotein L levels. We conclude that the CD154 3'-UTR contains dual cis-acting elements, one of which defines a novel function for exonic CA dinucleotide repeats. These findings suggest a mechanism for the association of 3'-UTR CA-rich response element polymorphisms with CD154 overexpression and the subsequent risk of autoimmune disease.	[Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Henry, Brian; Zan, Moe; Rigby, William F. C.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Henry, Brian; Zan, Moe; Rigby, William F. C.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Bloch, Donald] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Bloch, Donald] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Terry, Benjamin M.] New York Med Coll, Valhalla, NY 10595 USA; [Mouland, Andrew J.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Mouland, Andrew J.] McGill Univ, Montreal, PQ H3T 1E2, Canada	Dartmouth College; Dartmouth College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; New York Medical College; Lady Davis Institute; McGill University; McGill University	Rigby, WFC (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA.	William.Rigby@Dartmouth.edu		Bloch, Donald/0000-0002-6828-4754	National Institutes of Health [R01AR49834, T32AI07363]; American College of Rheumatology Research and Education Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR49834. This work was also supported by a grant from the American College of Rheumatology Research and Education Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported as a postdoctoral fellow on National Institutes of Health Training Grant T32AI07363.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Citores MJ, 2004, ANN RHEUM DIS, V63, P310, DOI 10.1136/ard.2003.006148; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; DAS GJ, 1998, RNA, V4, P766; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Dunn RJ, 1997, J HISTOCHEM CYTOCHEM, V45, P129, DOI 10.1177/002215549704500116; Ford GS, 1999, J IMMUNOL, V162, P4037; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; HOLLENBAUGH D, 1994, IMMUNOL REV, V138, P23, DOI 10.1111/j.1600-065X.1994.tb00845.x; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Martin-Donaire T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2288; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Murakami K, 1999, J IMMUNOL, V163, P2667; Nair APK, 1999, MOL CELL BIOL, V19, P889; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; NOLAN RD, 1969, EUR J BIOCHEM, V9, P445, DOI 10.1111/j.1432-1033.1969.tb00629.x; Peng J, 2005, RNA, V11, P1131, DOI 10.1261/rna.2470905; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Rigby WFC, 1999, J IMMUNOL, V163, P4199; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Singh K, 2004, J IMMUNOL, V173, P976, DOI 10.4049/jimmunol.173.2.976; Suarez A, 1997, EUR J IMMUNOL, V27, P2822, DOI 10.1002/eji.1830271112; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405	51	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25606	25616		10.1074/jbc.M802492200	http://dx.doi.org/10.1074/jbc.M802492200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640985	Green Published, hybrid			2022-12-25	WOS:000259012700056
J	Jeong, W; Lee, DY; Park, S; Rhee, SG				Jeong, Woojin; Lee, Duck-Yeon; Park, Sunjoo; Rhee, Sue Goo			ERp16, an endoplasmic reticulum-resident thiol-disulfide oxidoreductase - Biochemical properties and role in apoptosis induced by endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; HUMAN CASPASE-12; QUALITY-CONTROL; ACTIVE-SITE; THIOREDOXIN; ISOMERASE; ER; ACTIVATION; FAMILY; CELLS	We have characterized the properties and putative role of a mammalian thioredoxin-like protein, ERp16 (previously designated ERp18, ERp19, or hTLP19). The predicted amino acid sequence of the 172-residue human protein contains an NH2-terminal signal peptide, a thioredoxin-like domain with an active site motif (CGAC), and a COOH-terminal endoplasmic reticulum (ER) retention sequence (EDEL). Analyses indicated that the mature protein (comprising 146 residues) is generated by cleavage of the 26-residue signal peptide and is localized in the lumen of the ER. Biochemical experiments with the recombinant mature protein revealed it to be a thioldisulfide oxidoreductase. Its redox potential was about -165 mV; its active site cysteine residue Cys(66) was nucleophilic with a pK(a) value of similar to 6.6; it catalyzed the formation, reduction, and isomerization of disulfide bonds, with the unusual CGAC active site motif being responsible for these activities; and it existed as a dimer and underwent a redox-dependent conformational change. The observations that the redox potential of ERp16 (-165 mV) was within the range of that of the ER (-135 to -185 mV) and that ERp16 catalyzed disulfide isomerization of scrambled ribonuclease A suggest a role for ERp16 in protein disulfide isomerization in the ER. Expression of ERp16 in HeLa cells inhibited the induction of apoptosis by agents that elicit ER stress, including brefeldin A, tunicamycin, and dithiothreitol. In contrast, expression of a catalytically inactive mutant of ERp16 potentiated such apoptosis, as did depletion of ERp16 by RNA interference. Our results suggest that ERp16 mediates disulfide bond formation in the ER and plays an important role in cellular defense against prolonged ER stress.	[Jeong, Woojin; Park, Sunjoo; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Lee, Duck-Yeon] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	rheesg@ewha.ac.kr			Bio RD Program [M10642040002-07N4204-00210, M10642040001-07N4204-00110]; National Honor Scientist Program [R09-2006-000-10002-0]; National Core Research Center Program [R15-2006-020]; Ministry of Education, Science, and Technology; Brain Korea 21 Scholars Program	Bio RD Program; National Honor Scientist Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Core Research Center Program; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Bio R&D Program Grants M10642040002-07N4204-00210 ( to W.J.) and M10642040001-07N4204-00110 ( to S. G. R.), National Honor Scientist Program Grant R09-2006-000-10002- 0 ( to S. G. R.), and National Core Research Center Program Grant R15-2006-020 ( to W.J.) through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science, and Technology, and by the Brain Korea 21 Scholars Program ( to S. P). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; AMARCOSTESEC A, 1974, J CELL BIOL, V61, P201, DOI 10.1083/jcb.61.1.201; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fassio A, 2002, HISTOCHEM CELL BIOL, V117, P151, DOI 10.1007/s00418-001-0364-0; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KREIBICH G, 1974, J CELL BIOL, V61, P789, DOI 10.1083/jcb.61.3.789; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; LOBELLO M, 1993, J BIOL CHEM, V268, P19033; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7	45	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25557	25566		10.1074/jbc.M803804200	http://dx.doi.org/10.1074/jbc.M803804200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628206	Green Published, hybrid			2022-12-25	WOS:000259012700051
J	Kubota, T; Matsuoka, M; Chang, TH; Tailor, P; Sasaki, T; Tashiro, M; Kato, A; Ozato, K				Kubota, Toru; Matsuoka, Mayumi; Chang, Tsung-Hsien; Tailor, Prafullakumar; Sasaki, Tsuguo; Tashiro, Masato; Kato, Atsushi; Ozato, Keiko			Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA PROMOTER; NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; RIG-I; SUMO-1 MODIFICATION; TRANSCRIPTIONAL REPRESSION; ISG15 CONJUGATION; SIGNALING PATHWAY; UBIQUITIN LIGASE	Viral infection activates Toll-like receptor and RIG-I (retinoic acid-inducible gene I) signaling pathways, leading to phosphorylation of IRF3 (interferon regulatory factor 3) and IRF7 and stimulation of type I interferon (IFN) transcription, a process important for innate immunity. We show that upon vesicular stomatitis virus infection, IRF3 and IRF7 are modified not only by phosphorylation but by the small ubiquitin-related modifiers SUMO1, SUMO2, and SUMO3. SUMOylation of IRF3 and IRF7 was dependent on the activation of Toll-like receptor and RIG-I pathways but not on the IFN-stimulated pathway. However, SUMOylation of IRF3 and IRF7 was not dependent on their phosphorylation, and vice versa. We identified Lys(152) of IRF3 and Lys(406) of IRF7 to be their sole small ubiquitin-related modifier (SUMO) conjugation site. IRF3 and IRF7 mutants defective in SUMOylation led to higher levels of IFN mRNA induction after viral infection, relative to the wild type IRFs, indicating a negative role for SUMOylation in IFN transcription. Together, SUMO modification is an integral part of IRF3 and IRF7 activity that contributes to postactivation attenuation of IFN production.	[Kubota, Toru; Tashiro, Masato; Kato, Atsushi] Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan; [Matsuoka, Mayumi; Sasaki, Tsuguo] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan; [Chang, Tsung-Hsien; Tailor, Prafullakumar; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Genom Differentiat Program, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Gakuen 4-7-1, Tokyo 2080011, Japan.	kubota@nih.go.jp	Chang, Tsung-Hsien/AAG-9384-2019	Chang, Tsung-Hsien/0000-0003-4806-7864	National Institutes of Health Intramural Research Program; NICHD; Trans-National Institutes of Health Biodefense Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Trans-National Institutes of Health Biodefense Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NICHD, and the Trans-National Institutes of Health Biodefense Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Caillaud A, 2005, J BIOL CHEM, V280, P17671, DOI 10.1074/jbc.M411389200; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hodges M, 1998, CURR BIOL, V8, pR749, DOI 10.1016/S0960-9822(07)00477-0; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lin JY, 2004, FEBS LETT, V573, P15, DOI 10.1016/j.febslet.2004.07.059; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; LUI B, 2007, CELL, V129, P903; LUI B, 2005, MOL CELL BIOL, V25, P1113; LUI B, 2004, NAT IMMUNOL, V5, P891; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Qi BC, 2007, INT J BIOCHEM CELL B, V39, P287, DOI 10.1016/j.biocel.2006.08.016; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Roth W, 2004, J IMMUNOL, V173, P6189, DOI 10.4049/jimmunol.173.10.6189; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	65	126	127	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25660	25670		10.1074/jbc.M804479200	http://dx.doi.org/10.1074/jbc.M804479200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635538	hybrid, Green Published			2022-12-25	WOS:000259012700061
J	Miyahara, A; Hirani, TA; Oakes, M; Kereszt, A; Kobe, B; Djordjevic, MA; Gresshoff, PM				Miyahara, Akira; Hirani, Tripty A.; Oakes, Marie; Kereszt, Attila; Kobe, Bostjan; Djordjevic, Michael A.; Gresshoff, Peter M.			Soybean nodule autoregulation receptor kinase phosphorylates two kinase-associated protein phosphatases in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-MAX; ARABIDOPSIS-THALIANA; LOTUS-JAPONICUS; GENE ENCODES; MEDICAGO-TRUNCATULA; ROOT DEVELOPMENT; STRUCTURAL BASIS; SHORT-DISTANCE; FHA DOMAIN; CLAVATA1	The NARK (nodule autoregulation receptor kinase) gene, a negative regulator of cell proliferation in nodule primordia in several legumes, encodes a receptor kinase that consists of an extracellular leucine-rich repeat and an intracellular serine/threonine protein kinase domain. The putative catalytic domain of NARK was expressed and purified as a maltose-binding or a glutathione S-transferase fusion protein in Escherichia coli. The recombinant NARK proteins showed autophosphorylation activity in vitro. Several regions of the NARK kinase domain were shown by mass spectrometry to possess phosphoresidues. The kinase-inactive protein K724E failed to autophosphorylate, as did three other proteins corresponding to phenotypically detected mutants defective in whole plant autoregulation of nodulation. A wild-type NARK fusion protein transphosphorylated a kinase-inactive mutant NARK fusion protein, suggesting that it is capable of intermolecular autophosphorylation in vitro. In addition, Ser-861 and Thr-963 in the NARK kinase catalytic domain were identified as phosphorylation sites through site-directed mutagenesis. The genes coding for the kinase-associated protein phosphatases KAPP1 and KAPP2, two putative interacting components of NARK, were isolated. NARK kinase domain phosphorylated recombinant KAPP proteins in vitro. Autophosphorylated NARK kinase domain was, in turn, dephosphorylated by both KAPP1 and KAPP2. Our results suggest a model for signal transduction involving NARK in the control of nodule development.	[Miyahara, Akira; Hirani, Tripty A.; Kereszt, Attila; Gresshoff, Peter M.] Univ Queensland, CILR, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Sch Microbial & Mol Sci, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Oakes, Marie; Djordjevic, Michael A.] Australian Natl Univ, Res Sch Biol Sci, Australian Res Council Ctr Excellence Integrat Le, Canberra, ACT 2601, Australia	University of Queensland; University of Queensland; University of Queensland; Australian National University	Gresshoff, PM (corresponding author), Univ Queensland, CILR, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld 4072, Australia.	p.gresshoff@uq.edu.au	Han, Liqi/K-6127-2013; Kobe, Bostjan/D-1292-2009; Djordjevic, Michael/C-9945-2009	Kobe, Bostjan/0000-0001-9413-9166; Kereszt, Attila/0000-0002-4421-6554; Djordjevic, Michael/0000-0002-9819-1372	Australian Research Council Centre for Integrative Legume Research; Queensland State Government Smart State Innovation Scheme; University of Queensland	Australian Research Council Centre for Integrative Legume Research(Australian Research Council); Queensland State Government Smart State Innovation Scheme; University of Queensland(University of Queensland)	This work was supported by the Australian Research Council Centre for Integrative Legume Research, the Queensland State Government Smart State Innovation Scheme, and the University of Queensland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adereth Y, 2005, BIOTECHNIQUES, V38, P864, DOI 10.2144/05386BM03; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Buzas DM, 2007, J PLANT PHYSIOL, V164, P452, DOI 10.1016/j.jplph.2006.03.006; CARROLL BJ, 1985, P NATL ACAD SCI USA, V82, P4162, DOI 10.1073/pnas.82.12.4162; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Djordjevic MA, 2003, MOL PLANT MICROBE IN, V16, P508, DOI 10.1094/MPMI.2003.16.6.508; Djordjevic MA, 2007, J PROTEOME RES, V6, P3771, DOI 10.1021/pr0606833; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kinkema M, 2006, FUNCT PLANT BIOL, V33, P707, DOI 10.1071/FP06056; KOBE B, 2004, HDB CELL SIGNALING, V1, P539; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Li J, 2000, J CELL SCI, V113, P4143; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Natera SHA, 2000, MOL PLANT MICROBE IN, V13, P995, DOI 10.1094/MPMI.2000.13.9.995; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Nontachalyapoom S, 2007, MOL PLANT MICROBE IN, V20, P769, DOI 10.1094/MPMI-20-7-0769; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oka-Kira E, 2005, PLANT J, V44, P505, DOI 10.1111/j.1365-313X.2005.02543.x; Penmetsa RV, 2003, PLANT PHYSIOL, V131, P998, DOI 10.1104/pp.015677; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Schnabel E, 2005, PLANT MOL BIOL, V58, P809, DOI 10.1007/s11103-005-8102-y; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Sharma VK, 2003, P NATL ACAD SCI USA, V100, P11823, DOI 10.1073/pnas.1834206100; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Shoemaker RC, 1996, GENETICS, V144, P329; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Knaap E, 1999, PLANT PHYSIOL, V120, P559, DOI 10.1104/pp.120.2.559; Walling JG, 2006, GENETICS, V172, P1893, DOI 10.1534/genetics.105.051466; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2006, CELL RES, V16, P427, DOI 10.1038/sj.cr.7310054; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467; Yamamoto E, 2000, BBA-GENE STRUCT EXPR, V1491, P333, DOI 10.1016/S0167-4781(00)00061-0; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101	60	45	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25381	25391		10.1074/jbc.M800400200	http://dx.doi.org/10.1074/jbc.M800400200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606823	hybrid			2022-12-25	WOS:000259012700033
J	Yen, FT; Roitel, O; Bonnard, L; Notet, V; Pratte, D; Stenger, C; Magueur, E; Bihain, BE				Yen, Frances T.; Roitel, Olivier; Bonnard, Lionel; Notet, Veronique; Pratte, Dagmar; Stenger, Christophe; Magueur, Erwan; Bihain, Bernard E.			Lipolysis stimulated lipoprotein receptor - A novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; TRIGLYCERIDE-RICH LIPOPROTEINS; FREE FATTY-ACIDS; LDL-RECEPTOR; CHYLOMICRON REMNANTS; APOLIPOPROTEIN-E; TRANSGENIC MICE; HEPATIC LIPASE; HIGH-AFFINITY	The lipolysis-stimulated lipoprotein receptor, LSR, is a multimeric protein complex in the liver that undergoes conformational changes upon binding of free fatty acids, thereby revealing a binding site(s) that recognizes both apoB and apoE. Complete inactivation of the LSR gene is embryonic lethal in mice. Here we show that removal of a single LSR allele ( LSR-/+) caused statistically significant increases in both plasma triglyceride and cholesterol levels, a 2-fold increase in plasma triglyceride changes during the post-prandial phase, and delayed clearance of lipid emulsions or a high fat meal. The longer postprandial lipoprotein clearance time observed in LSR-/+ mice was further increased in LSR-/+ mice lacking functional low density lipoprotein ( LDL) receptors. LSR-/+ mice placed on a Western-type diet displayed higher plasma triglycerides and cholesterol levels, increased triglyceride-rich lipoproteins and LDL, and increased aorta lipid content, as compared with control mice on the same diet. Furthermore, a direct correlation was observed between the hyperlipidemia and weight gain but only in the LSR-/+ mice. Knockdown of LSR expression by small interfering RNA in mouse Hepa1-6 cells led to decreased internalization of both DiI-labeled cyclohexanedione-LDL and very low density lipoprotein in the presence of oleate. These data led us to conclude that LSR contributes to the physiological clearance of atherogenic triglyceride-rich lipoproteins and LDL. We propose that LSR cooperates with the LDL receptor in the final hepatic processing of apoB-containing lipoproteins and represents a novel therapeutic target for the treatment of hyperlipidemia associated with obesity and atherosclerosis.	[Yen, Frances T.; Stenger, Christophe] Nancy Univ, Inst Natl Polytech Lorraine, Lipidomix JE2482, F-54500 Vandoeuvre Les Nancy, France; [Roitel, Olivier; Bonnard, Lionel; Notet, Veronique; Pratte, Dagmar; Magueur, Erwan; Bihain, Bernard E.] Genclis SAS, F-54500 Vandoeuvre Les Nancy, France	Universite de Lorraine	Yen, FT (corresponding author), Nancy Univ, Inst Natl Polytech Lorraine, Lipidomix JE2482, 15 Rue Bois Champelle, F-54500 Vandoeuvre Les Nancy, France.	frances.yenpotin@mtm.nancy.inserm.fr	Yen, Frances T/G-9175-2014	Yen, Frances T/0000-0001-8740-4304	French Ministry of Higher Education and Research; Region Lorraine; Communaute Urbaine du Grand Nancy; Genclis SAS	French Ministry of Higher Education and Research; Region Lorraine(Region Grand-Est); Communaute Urbaine du Grand Nancy(Region Grand-Est); Genclis SAS	This work was supported by the French Ministry of Higher Education and Research, the Region Lorraine, the Communaute Urbaine du Grand Nancy, and Genclis SAS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; ATTIE AD, 1982, HEPATOLOGY, V2, P269; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; BIHAIN BE, 1992, BIOCHEMISTRY-US, V31, P4628, DOI 10.1021/bi00134a013; BIHAIN BE, 1989, J BIOL CHEM, V264, P17316; deFaria E, 1996, J LIPID RES, V37, P197; FOLCH J, 1957, J BIOL CHEM, V226, P497; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; GHOSH RN, 1994, J CELL SCI, V107, P2177; HAVEL RJ, 1995, METABOLIC MOL BASES, V7; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Innerarity T L, 1986, Methods Enzymol, V129, P542; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JI ZS, 1993, J BIOL CHEM, V268, P10160; Ji ZS, 1997, J BIOL CHEM, V272, P31285, DOI 10.1074/jbc.272.50.31285; KITA T, 1982, P NATL ACAD SCI-BIOL, V79, P3623, DOI 10.1073/pnas.79.11.3623; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; MAHLEY RW, 1995, METABOLIC MOL BASES, P1953; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MANN CJ, 1995, BIOCHEMISTRY-US, V34, P10421, DOI 10.1021/bi00033a014; Markwell M A, 1981, Methods Enzymol, V72, P296; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; PAIGEN B, 1995, AM J CLIN NUTR, V62, P458; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; Shepherd J, 1986, Methods Enzymol, V129, P566; SHEPHERD J, 1979, J LIPID RES, V20, P999; SHERRILL BC, 1978, J BIOL CHEM, V253, P1859; SIMONS LA, 1975, ATHEROSCLEROSIS, V21, P283, DOI 10.1016/0021-9150(75)90087-8; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TROUSSARD AA, 1995, J BIOL CHEM, V270, P17068, DOI 10.1074/jbc.270.29.17068; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; ZAMBON A, 1993, J LIPID RES, V34, P1021	42	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25650	25659		10.1074/jbc.M801027200	http://dx.doi.org/10.1074/jbc.M801027200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644789	hybrid			2022-12-25	WOS:000259012700060
J	Watson, MR; Lagow, RD; Xu, KX; Zhang, B; Bonini, NM				Watson, Melanie R.; Lagow, Robert D.; Xu, Kexiang; Zhang, Bing; Bonini, Nancy M.			A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; GREEN FLUORESCENT PROTEIN; TRANSGENIC MICE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; AXONAL-TRANSPORT; FAMILIAL ALS; LIFE-SPAN; IN-VITRO; MUTATIONS	Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that leads to loss of motor function and early death. About 5% of cases are inherited, with the majority of identified linkages in the gene encoding copper, zinc-superoxide dismutase (SOD1). Strong evidence indicates that the SOD1 mutations confer dominant toxicity on the protein. To provide new insight into mechanisms of ALS, we have generated and characterized a model for familial ALS in Drosophila with transgenic expression of human SOD1. Expression of wild type or disease-linked (A4V, G85R) mutants of human SOD1 selectively in motor neurons induced progressive climbing deficits. These effects were accompanied by defective neural circuit electrophysiology, focal accumulation of human SOD1 protein in motor neurons, and a stress response in surrounding glia. However, toxicity was not associated with oligomerization of SOD1 and did not lead to neuronal loss. These studies uncover cell-autonomous injury by SOD1 to motor neurons in vivo, as well as non-autonomous effects on glia, and provide the foundation for new insight into injury and protection of motor neurons in ALS.	[Xu, Kexiang; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Leidy Lab 306, Dept Biol, Philadelphia, PA 19104 USA; [Watson, Melanie R.; Bonini, Nancy M.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Lagow, Robert D.; Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Oklahoma System; University of Oklahoma - Norman	Bonini, NM (corresponding author), Univ Penn, Howard Hughes Med Inst, Leidy Lab 306, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu		Bonini, Nancy/0000-0003-0226-5291	National Institutes of Health [AG09215]; NIA; NIEHS [ES014441]; Systems and Integrated Biology Training; Developmental Biology Training; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Systems and Integrated Biology Training; Developmental Biology Training; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG09215 from the NIA ( to N. M. B.) and National Institutes of Health Grant ES014441 from the NIEHS ( to B. Z.). This work was also supported by the Systems and Integrated Biology Training Grant and the Developmental Biology Training Grant ( to M. R. W.) and a grant from the David and Lucile Packard Foundation ( to N. M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BRADLEY WG, 1987, MUSCLE NERVE, V10, P490, DOI 10.1002/mus.880100603; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cassina P, 2005, J NEUROCHEM, V93, P38, DOI 10.1111/j.1471-4159.2004.02984.x; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; de Aguilar JL, 1999, EUR J NEUROSCI, V11, P4179, DOI 10.1046/j.1460-9568.1999.00840.x; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Robinson MB, 2005, J NEUROSCI, V25, P9735, DOI 10.1523/JNEUROSCI.1912-05.2005; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Shulman JM, 2003, CURR OPIN NEUROL, V16, P443, DOI 10.1097/01.wco.0000084220.82329.60; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TRIMARCHI JR, 1995, J COMP PHYSIOL A, V176, P355, DOI 10.1007/BF00219061; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	64	113	115	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24972	24981		10.1074/jbc.M804817200	http://dx.doi.org/10.1074/jbc.M804817200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596033	Green Published, hybrid			2022-12-25	WOS:000258820000058
J	Shaked, M; Weissmuller, K; Svoboda, H; Hortschansky, P; Nishino, N; Wolfl, S; Tucker, KL				Shaked, Maya; Weissmueller, Kathrin; Svoboda, Hanno; Hortschansky, Peter; Nishino, Norikazu; Woelfl, Stefan; Tucker, Kerry L.			Histone Deacetylases Control Neurogenesis in Embryonic Brain by Inhibition of BMP2/4 Signaling	PLOS ONE			English	Article								Background: Histone-modifying enzymes are essential for a wide variety of cellular processes dependent upon changes in gene expression. Histone deacetylases (HDACs) lead to the compaction of chromatin and subsequent silencing of gene transcription, and they have recently been implicated in a diversity of functions and dysfunctions in the postnatal and adult brain including ocular dominance plasticity, memory consolidation, drug addiction, and depression. Here we investigate the role of HDACs in the generation of neurons and astrocytes in the embryonic brain. Principal Findings: As a variety of HDACs are expressed in differentiating neural progenitor cells, we have taken a pharmacological approach to inhibit multiple family members. Inhibition of class I and II HDACs in developing mouse embryos with trichostatin A resulted in a dramatic reduction in neurogenesis in the ganglionic eminences and a modest increase in neurogenesis in the cortex. An identical effect was observed upon pharmacological inhibition of HDACs in in vitro-differentiating neural precursors derived from the same brain regions. A reduction in neurogenesis in ganglionic eminence-derived neural precursors was accompanied by an increase in the production of immature astrocytes. We show that HDACs control neurogenesis by inhibition of the bone morphogenetic protein BMP2/4 signaling pathway in radial glial cells. HDACs function at the transcriptional level by inhibiting and promoting, respectively, the expression of Bmp2 and Smad7, an intracellular inhibitor of BMP signaling. Inhibition of the BMP2/4 signaling pathway restored normal levels of neurogenesis and astrogliogenesis to both ganglionic eminence-and cortex-derived cultures in which HDACs were inhibited. Conclusions: Our results demonstrate a transcriptionally-based regulation of BMP2/4 signaling by HDACs both in vivo and in vitro that is critical for neurogenesis in the ganglionic eminences and that modulates cortical neurogenesis. The results also suggest that HDACs may regulate the developmental switch from neurogenesis to astrogliogenesis that occurs in late gestation.	[Shaked, Maya; Weissmueller, Kathrin; Svoboda, Hanno; Tucker, Kerry L.] Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-6900 Heidelberg, Germany; [Hortschansky, Peter] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany; [Nishino, Norikazu] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka, Japan; [Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Hans Knoll Institute (HKI); Kyushu Institute of Technology; Ruprecht Karls University Heidelberg	Shaked, M (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-6900 Heidelberg, Germany.	kerry.tucker@urz.uni-hd.de			German Research Foundation [SFB 488]; University of Heidelberg; BMBF [0311786, 0312558]; Minerva Stiftung of the Max Planck Society; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); University of Heidelberg; BMBF(Federal Ministry of Education & Research (BMBF)); Minerva Stiftung of the Max Planck Society; Studienstiftung des deutschen Volkes	This work was funded by the German Research Foundation (DFG, SFB 488, Teilprojekt B7), the University of Heidelberg, the BMBF (Grants 0311786 & 0312558 to P.H.), the Minerva Stiftung of the Max Planck Society (M.S.), and the Studienstiftung des deutschen Volkes (H.S.).	Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Bayer S.A., 1991, NEOCORTICAL DEV; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brachmann I, 2007, DEV DYNAM, V236, P3514, DOI 10.1002/dvdy.21386; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Gulacsi A, 2003, J NEUROSCI, V23, P9862; GURLEY LR, 1974, J CELL BIOL, V60, P356, DOI 10.1083/jcb.60.2.356; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORTSCHANSKY P, 2001, Patent No. 19944626; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nervi C, 2001, CANCER RES, V61, P1247; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stowell John C., 1995, Journal of Medicinal Chemistry, V38, P1411; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Tucker KL, 2001, NEURON, V30, P649, DOI 10.1016/S0896-6273(01)00325-7; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang DM, 1998, J NEUROSCI, V18, P3314	87	58	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2668	10.1371/journal.pone.0002668	http://dx.doi.org/10.1371/journal.pone.0002668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628975	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200014
J	Widschwendter, M; Apostolidou, S; Raum, E; Rothenbacher, D; Fiegl, H; Menon, U; Stegmaier, C; Jacobs, IJ; Brenner, H				Widschwendter, Martin; Apostolidou, Sophia; Raum, Elke; Rothenbacher, Dietrich; Fiegl, Heidi; Menon, Usha; Stegmaier, Christa; Jacobs, Ian J.; Brenner, Hermann			Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study	PLOS ONE			English	Article								Background: Epigenetic changes are emerging as one of the most important events in carcinogenesis. Two alterations in the pattern of DNA methylation in breast cancer (BC) have been previously reported; active estrogen receptor-a (ER-a) is associated with decreased methylation of ER-a target (ERT) genes, and polycomb group target (PCGT) genes are more likely than other genes to have promoter DNA hypermethylation in cancer. However, whether DNA methylation in normal unrelated cells is associated with BC risk and whether these imprints can be related to factors which can be modified by the environment, is unclear. Methodology/Principal Findings: Using quantitative methylation analysis in a case-control study (n = 1,083) we found that DNA methylation of peripheral blood cell DNA provides good prediction of BC risk. We also report that invasive ductal and invasive lobular BC is characterized by two different sets of genes, the latter particular by genes involved in the differentiation of the mesenchyme (PITX2, TITF1, GDNF and MYOD1). Finally we demonstrate that only ERT genes predict ER positive BC; lack of peripheral blood cell DNA methylation of ZNF217 predicted BC independent of age and family history (odds ratio 1.49; 95% confidence interval 1.12-1.97; P = 0.006) and was associated with ER-a bioactivity in the corresponding serum. Conclusion/Significance: This first large-scale epigenotyping study demonstrates that DNA methylation may serve as a link between the environment and the genome. Factors that can be modulated by the environment (like estrogens) leave an imprint in the DNA of cells that are unrelated to the target organ and indicate the predisposition to develop a cancer. Further research will need to demonstrate whether DNA methylation profiles will be able to serve as a new tool to predict the risk of developing chronic diseases with sufficient accuracy to guide preventive measures.	[Widschwendter, Martin; Apostolidou, Sophia; Fiegl, Heidi; Menon, Usha; Jacobs, Ian J.] UCL, Dept Gynecol Oncol, Inst Womens Hlth, London, England; [Raum, Elke; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Ageing Res, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany	University of London; University College London; Helmholtz Association; German Cancer Research Center (DKFZ)	Widschwendter, M (corresponding author), UCL, Dept Gynecol Oncol, Inst Womens Hlth, London, England.	M.Widschwendter@ucl.ac.uk	Menon, Usha/C-4716-2008; Brenner, Hermann/ABE-6383-2020; Jacobs, Ian J/F-1743-2013; Brenner, Hermann/B-4627-2017; Fiegl, Heidi/K-4445-2017	Menon, Usha/0000-0003-3708-1732; Brenner, Hermann/0000-0002-6129-1572; Jacobs, Ian J/0000-0002-8112-4624; Brenner, Hermann/0000-0002-6129-1572; Apostolidou, Sophia/0000-0003-2659-0451; Widschwendter, Martin/0000-0002-7778-8380; Rothenbacher, Dietrich/0000-0002-3563-2791; Fiegl, Heidi/0000-0002-1236-6806; Jacobs, Ian/0000-0002-5005-2672	The Eve Appeal; The Oak Foundation; European Union; FWF Austrian Science Fund; Baden-Wurttemberg Ministry of Research, Science and Arts	The Eve Appeal; The Oak Foundation; European Union(European Commission); FWF Austrian Science Fund(Austrian Science Fund (FWF)); Baden-Wurttemberg Ministry of Research, Science and Arts	The work described in this manuscript was supported by The Eve Appeal and The Oak Foundation and grants from the European Union and the FWF Austrian Science Fund (awarded to M. Widschwendter) and by a grant from the Baden-Wurttemberg Ministry of Research, Science and Arts (awarded to H. Brenner). The funders did not play any role in the design or conduct of the study.	Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P746, DOI 10.1111/j.1469-1809.2007.00384.x; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Hasenbrink G, 2006, FASEB J, V20, P1552, DOI 10.1096/fj.05-5413fje; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Nonet GH, 2001, CANCER RES, V61, P1250; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; Sievernich A, 2004, J STEROID BIOCHEM, V92, P455, DOI 10.1016/j.jsbmb.2004.09.004; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Terry P, 2002, INT J CANCER, V97, P864, DOI 10.1002/ijc.10138; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	36	115	132	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2656	10.1371/journal.pone.0002656	http://dx.doi.org/10.1371/journal.pone.0002656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628976	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200002
J	Gratwicke, B; Mills, J; Dutton, A; Gabriel, G; Long, B; Seidensticker, J; Wright, B; You, W; Zhang, L				Gratwicke, Brian; Mills, Judy; Dutton, Adam; Gabriel, Grace; Long, Barney; Seidensticker, John; Wright, Belinda; You, Wang; Zhang, Li			Attitudes Toward Consumption and Conservation of Tigers in China	PLOS ONE			English	Article								A heated debate has recently emerged between tiger farmers and conservationists about the potential consequences of lifting the ban on trade in farmed tiger products in China. This debate has caused unfounded speculation about the extent of the potential market for tiger products. To fill this knowledge gap, we surveyed 1880 residents from a total of six Chinese cities to understand Urban Chinese tiger consumption behavior, knowledge of trade issues and attitudes towards tiger conservation. We found that 43% of respondents had consumed some product alleged to contain tiger parts. Within this user-group, 71% said that they preferred wild products over farmed ones. The two predominant products used were tiger bone plasters (38%) and tiger bone wine (6.4%). 88% of respondents knew that it was illegal to buy or sell tiger products, and 93% agreed that a ban in trade of tiger parts was necessary to conserve wild tigers. These results indicate that while Urban Chinese people are generally supportive of tiger conservation, there is a huge residual demand for tiger products that could resurge if the ban on trade in tiger parts is lifted in China. We suspect that the current supply of the market is predominantly met by fakes or substitutes branded as tiger medicines, but not listing tiger as an ingredient. We suggest that the Traditional Chinese Medicine community should consider re-branding these products as bone-healing medicines in order to reduce the residual demand for real tiger parts over the long-term. The lifting of the current ban on trade in farmed tiger parts may cause a surge in demand for wild tiger parts that consumers say are better. Because of the low input costs associated with poaching, wild-sourced parts would consistently undercut the prices of farmed tigers that could easily be laundered on a legal market. We therefore recommend that the Chinese authorities maintain the ban on trade in tiger parts, and work to improve the enforcement of the existing ban.	[Gratwicke, Brian; Mills, Judy] Natl Fish & Wildlife Fdn, Save The Tiger Fund, Washington, DC 20008 USA; [Dutton, Adam] Univ Oxford, Dept Zool, Oxford, England; [Gabriel, Grace] Int Fund For Anim Welfare, Yarmouth Port, MA USA; [Long, Barney] World Wildlife Fund, Washington, DC USA; [Wright, Belinda] Wildlife Protect Soc India, New Delhi, India; [You, Wang] Horizon key, Beijing, Peoples R China; [Zhang, Li] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Seidensticker, John] Smithsonian Inst, Natl Zool Park, Washington, DC USA	University of Oxford; World Wildlife Fund; Beijing Normal University; Smithsonian Institution	Gratwicke, B (corresponding author), Natl Fish & Wildlife Fdn, Save The Tiger Fund, Washington, DC 20008 USA.	brian.gratwicke@gmail.com		Gratwicke, Brian/0000-0002-7332-4060	Rufford Foundation; Critical Ecosystem Partnership Fund; ExxonMobil Foundation	Rufford Foundation; Critical Ecosystem Partnership Fund; ExxonMobil Foundation(Exxon Mobil Corporation)	Financial support was provided by the Rufford Foundation, the Critical Ecosystem Partnership Fund and the ExxonMobil Foundation.	Banks D., 2006, SKINNING CAT CRIME P; Chen X. M, 2006, CHINA INFORM, V20, P519; *CITES, 2007, DEC C PART CITES EFF; Conrad K., 2007, TIGER CONSERVATION I; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Gratwicke B, 2008, CONSERV BIOL, V22, P222, DOI 10.1111/j.1523-1739.2007.00802.x; Hemley Ginette, 1999, P217; *IFAW, 2007, MAD CHIN FARM TIG EX; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; KISH J, 1987, STAT DESIGN RES; Mills J.A., 1994, KILLED CURE REV WORL; Nowell K., 2007, TAMING TIGER TRADE; SAMBROOK PN, 1988, ARTHRITIS RHEUM, V31, P973, DOI 10.1002/art.1780310805; Seidensticker J., 1999, RIDING TIGER TIGER C; SEIDENSTICKER J, 2007, TIGERS WORLD; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Wetton JH, 2002, FORENSIC SCI INT, V126, P137, DOI 10.1016/S0379-0738(02)00045-2; World Population Prospects, 2007, WORLD POPULATION PRO; Yonzon Prasanna S., 2006, P84; 2005, SARISKA TIGERS MISSI; 2007, NATL ACCOUNTS MAIN A; 2007, 2006 POPULATION CENS	22	64	66	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2544	10.1371/journal.pone.0002544	http://dx.doi.org/10.1371/journal.pone.0002544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596926	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200016
J	Hsiao, EC; Yoshinaga, Y; Nguyen, TD; Musone, SL; Kim, JE; Swinton, P; Espineda, I; Manalac, C; deJong, PJ; Conklin, BR				Hsiao, Edward C.; Yoshinaga, Yuko; Nguyen, Trieu D.; Musone, Stacy L.; Kim, Judy E.; Swinton, Paul; Espineda, Isidro; Manalac, Carlota; deJong, Pieter J.; Conklin, Bruce R.			Marking Embryonic Stem Cells with a 2A Self-Cleaving Peptide: A NKX2-5 Emerald GFP BAC Reporter	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FUNCTIONAL-ANALYSIS; EXPRESSION; TRANSCRIPTION; VECTORS; DIFFERENTIATION; GENERATION; PROMOTERS; TRANSGENE; CLONING	Background: Fluorescent reporters are useful for assaying gene expression in living cells and for identifying and isolating pure cell populations from heterogeneous cultures, including embryonic stem (ES) cells. Multiple fluorophores and genetic selection markers exist; however, a system for creating reporter constructs that preserve the regulatory sequences near a gene's native ATG start site has not been widely available. Methodology: Here, we describe a series of modular marker plasmids containing independent reporter, bacterial selection, and eukaryotic selection components, compatible with both Gateway recombination and lambda prophage bacterial artificial chromosome (BAC) recombineering techniques. A 2A self-cleaving peptide links the reporter to the native open reading frame. We use an emerald GFP marker cassette to create a human BAC reporter and ES cell reporter line for the early cardiac marker NKX2-5. NKX2-5 expression was detected in differentiating mouse ES cells and ES cell-derived mice. Conclusions: Our results describe a NKX2-5 ES cell reporter line for studying early events in cardiomyocyte formation. The results also demonstrate that our modular marker plasmids could be used for generating reporters from unmodified BACs, potentially as part of an ES cell reporter library.	[Hsiao, Edward C.; Nguyen, Trieu D.; Swinton, Paul; Espineda, Isidro; Manalac, Carlota; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Hsiao, Edward C.; Kim, Judy E.; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Yoshinaga, Yuko; deJong, Pieter J.] Childrens Hosp, Oakland Res Inst, Oakland, CA USA; [Musone, Stacy L.] Univ Calif San Francisco, Grad Program Pharm Sci & Pharmacogenom, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hsiao, EC (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	ehsiao@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	National Institute of Health [2T32DK07418-26, HL60664, HL66621]; California Institute of Regenerative Medicine/J. David Gladstone Institutes [T2-00003]; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664, U01HL066621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine/J. David Gladstone Institutes(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support to ECH was from a National Institute of Health Fellowship Training Grant (2T32DK07418-26) and the California Institute of Regenerative Medicine/J. David Gladstone Institutes CIRM Fellowship Program (Grant T2-00003). BRC received support from the NIH (grants HL60664 and HL66621). The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01.	Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Chi X, 2003, GENESIS, V35, P220, DOI 10.1002/gene.10181; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Conklin BR, 2007, P NATL ACAD SCI USA, V104, P4777, DOI 10.1073/pnas.0700913104; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Coyne C, 1999, DEV GENES EVOL, V209, P63, DOI 10.1007/s004270050228; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dorak M. T., 2006, REAL TIME PCR ADV ME; Douin V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-16; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; HOSLER BA, 1993, MOL CELL BIOL, V13, P2919, DOI 10.1128/MCB.13.5.2919; Jacobson KA, 2001, J MED CHEM, V44, P4125, DOI 10.1021/jm010232o; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lien CL, 1999, DEVELOPMENT, V126, P75; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Parsley TB, 2002, EUKARYOT CELL, V1, P401, DOI 10.1128/EC.1.3.401-413.2002; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TOKUNAGA T, 1992, DEV GROWTH DIFFER, V34, P561; Tomishima MJ, 2007, STEM CELLS, V25, P39, DOI 10.1634/stemcells.2006-0173; Triccas JA, 2002, RES MICROBIOL, V153, P379, DOI 10.1016/S0923-2508(02)01327-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	43	47	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2532	10.1371/journal.pone.0002532	http://dx.doi.org/10.1371/journal.pone.0002532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596956	gold, Green Submitted, Green Published			2022-12-25	WOS:000263288200005
J	Ngo, Y; Benhamou, Y; Thibault, V; Ingiliz, P; Munteanu, M; Lebray, P; Thabut, D; Morra, R; Messous, D; Charlotte, F; Imbert-Bismut, F; Rousselot-Bonnefont, D; Moussalli, J; Ratziu, V; Poynard, T				Ngo, Yen; Benhamou, Yves; Thibault, Vincent; Ingiliz, Patrick; Munteanu, Mona; Lebray, Pascal; Thabut, Dominique; Morra, Rachel; Messous, Djamila; Charlotte, Frederic; Imbert-Bismut, Francoise; Rousselot-Bonnefont, Dominique; Moussalli, Joseph; Ratziu, Vlad; Poynard, Thierry			An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load	PLOS ONE			English	Article								Background: The combination of transaminases (ALT), biopsy, HBeAg and viral load have classically defined the inactive status of carriers of chronic hepatitis B. The use of FibroTest (FT) and ActiTest (AT), biomarkers of fibrosis and necroinflammatory activity, has been previously validated as alternatives to biopsy. We compared the 4-year prognostic value of combining FT-AT and viral load for a better definition of the inactive carrier status. Methods and Findings: 1,300 consecutive CHB patients who had been prospectively followed since 2001 were preincluded. The main endpoint was the absence of liver-related complications, transplantation or death. We used the manufacturers' definitions of normal FT (< = 0.27), normal AT (< = 0.29) and 3 standard classes for viral load. The adjustment factors were age, sex, HBeAg, ethnic origin, alcohol consumption, HIV-Delta-HCV co-infections and treatment. Results: 1,074 patients with baseline FT-AT and viral load were included: 41 years old, 47% African, 27% Asian, 26% Caucasian. At 4 years follow-up, 50 complications occurred (survival without complications 93.4%), 36 deaths occurred (survival 95.0%), including 27 related to HBV (survival 96.1%). The prognostic value of FT was higher than those of viral load or ALT when compared using area under the ROC curves [0.89 (95% CI 0.84-0.93) vs 0.64 (0.55-0.71) vs 0.53 (0.46-0.60) all P < 0.001], survival curves and multivariate Cox model [regression coefficient 5.2 (3.5-6.9; P < 0.001) vs 0.53 (0.15-0.92; P = 0.007) vs -0.001 (-0.003-0.000; P = 0.052)] respectively. A new definition of inactive carriers was proposed with an algorithm combining "zero'' scores for FT-AT (F0 and A0) and viral load classes. This new algorithm provides a 100% negative predictive value for the prediction of liver related complications or death. Among the 275 patients with the classic definition of inactive carrier, 62 (23%) had fibrosis presumed with FT, and 3 died or had complications at 4 year. Conclusion: In patients with chronic hepatitis B, a combination of FibroTest-ActiTest and viral load testing accurately defined the prognosis and the inactive carrier status.	[Ngo, Yen; Benhamou, Yves; Ingiliz, Patrick; Lebray, Pascal; Thabut, Dominique; Morra, Rachel; Moussalli, Joseph; Ratziu, Vlad; Poynard, Thierry] Univ Paris 06, Grp Hosp Pitie Salpetriere, CNRS, Serv Hepatogastroenterol,UMR 8149, Paris, France; [Thibault, Vincent] Grp Hospp Pitie Salpetriere, Lab Virol, Paris, France; [Munteanu, Mona] Biopredictive, Paris, France; [Messous, Djamila; Imbert-Bismut, Francoise; Rousselot-Bonnefont, Dominique] Grp Hosp Pitie Salpetriere, Fed Biochim, Paris, France; [Charlotte, Frederic] Grp Hosp Pitie Salpetriere, Serv Anatom Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Ngo, Y (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, CNRS, Serv Hepatogastroenterol,UMR 8149, Paris, France.	tpoynard@teaser.fr	THIBAULT, Vincent/J-7193-2015; Hug, Balthasar L./G-1568-2010; Poynard, Thierry/C-1355-2010; THIBAULT, Vincent/AAB-5241-2020	THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-3726-7230; THIBAULT, Vincent/0000-0001-6517-2901; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; Munteanu, Mona/0000-0003-4517-2757; Poynard, Thierry/0000-0002-2050-640X; Charlotte, Frederic/0000-0003-2803-6606	Association pour la Recherche sur les Maladies Hepatiques et Virales	Association pour la Recherche sur les Maladies Hepatiques et Virales	The collection of data was supported by the Association pour la Recherche sur les Maladies Hepatiques et Virales.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Cacoub P, 2008, J HEPATOL, V48, P765, DOI 10.1016/j.jhep.2008.01.025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong Zhong, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P129; Ederer F, 1959, INSTRUCTIONS IBM 650; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ferard G, 2006, CLIN CHEM LAB MED, V44, P400, DOI 10.1515/CCLM.2006.078; Ferard G, 2005, CLIN CHEM LAB MED, V43, P549, DOI 10.1515/CCLM.2005.095; Gigi E, 2007, J GASTROINTEST LIVER, V16, P19; HINTZE JL, 2003, NCSS 2003 USER GUIDE; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058; Kelloff GJ, 2005, EUR J CANCER, V41, P491, DOI 10.1016/j.ejca.2004.12.006; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mahtab MA, 2007, HEPATOB PANCREAT DIS, V6, P483; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Poynard T, 2007, J HEPATOL, V46, pS298; Poynard T, 2005, AM J GASTROENTEROL, V100, P1970, DOI 10.1111/j.1572-0241.2005.41957.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; TAKANO S, 1995, HEPATOLOGY, V21, P650; TEMPLE RJ, 1995, CLIN MEASUREMENT DRU, P1; Vallin J., 2001, TABLES MORTALITE FRA; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	42	62	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2573	10.1371/journal.pone.0002573	http://dx.doi.org/10.1371/journal.pone.0002573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596917	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200038
J	Scholl, HPN; Issa, PC; Walier, M; Janzer, S; Pollok-Kopp, B; Borncke, F; Fritsche, LG; Chong, NV; Fimmers, R; Wienker, T; Holz, FG; Weber, BHF; Oppermann, M				Scholl, Hendrik P. N.; Issa, Peter Charbel; Walier, Maja; Janzer, Stefanie; Pollok-Kopp, Beatrix; Boerncke, Florian; Fritsche, Lars G.; Chong, Ngaihang V.; Fimmers, Rolf; Wienker, Thomas; Holz, Frank G.; Weber, Bernhard H. F.; Oppermann, Martin			Systemic Complement Activation in Age-Related Macular Degeneration	PLOS ONE			English	Article								Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility.	[Scholl, Hendrik P. N.; Issa, Peter Charbel; Janzer, Stefanie; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany; [Walier, Maja; Fimmers, Rolf; Wienker, Thomas] Univ Bonn, Inst Med Biomet, Informat & Epidemiol, Bonn, Germany; [Pollok-Kopp, Beatrix; Boerncke, Florian; Oppermann, Martin] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Fritsche, Lars G.; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Chong, Ngaihang V.] Univ Oxford, Oxford Eye Hosp, Oxford, England	University of Bonn; University of Bonn; University of Gottingen; University of Regensburg; University of Oxford	Scholl, HPN (corresponding author), Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany.	mopperm@gwdg.de	Fritsche, Lars G/AAF-9387-2019; Issa, Peter Charbel/E-8935-2018; Issa, Peter Charbel/F-9603-2011; Issa, Peter Charbel/O-2580-2019; Mohammed, Imran/J-8271-2012; Chong, Ngaihang V/A-5141-2009; Chong, Victor/Q-6565-2018	Fritsche, Lars G/0000-0002-2110-1690; Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673; Mohammed, Imran/0000-0002-8412-0768; Chong, Victor/0000-0002-7693-522X; Weber, Bernhard H.F./0000-0002-8808-7723	European Commission (EU FP6), Integrated Project "EVIGENORET" [LSHG-CT-2005-512036]; German Research Foundation (DFG) Heisenberg Fellowship [SCHO 734/2-1, HO 1926/1-3]	European Commission (EU FP6), Integrated Project "EVIGENORET"(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG) Heisenberg Fellowship(German Research Foundation (DFG))	Pro Retina Foundation Pro-Re/Seed/Issa.1; European Commission (EU FP6), Integrated Project "EVIGENORET" (LSHG-CT-2005-512036); German Research Foundation (DFG) Heisenberg Fellowship SCHO 734/2-1, HO 1926/1-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; BOURKE BE, 1982, CLIN EXP IMMUNOL, V48, P726; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Comitato A, 2007, HUM MOL GENET, V16, P1699, DOI 10.1093/hmg/ddm118; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DERODRIGUEZ CS, 2004, MOL IMMUNOL, V41, P355; Despriet DDG, 2007, ARCH OPHTHALMOL-CHIC, V125, P1270, DOI 10.1001/archopht.125.9.1270; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Huang SJ, 2003, RETINA-J RET VIT DIS, V23, P429, DOI 10.1097/00006982-200306000-00036; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MOLLNES TE, 1986, ARTHRITIS RHEUM, V29, P715, DOI 10.1002/art.1780290603; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; OPPERMANN M, 1991, KIDNEY INT, V40, P939, DOI 10.1038/ki.1991.298; OPPERMANN M, 1990, J IMMUNOL METHODS, V133, P181, DOI 10.1016/0022-1759(90)90358-3; OPPERMANN M, 1992, IMMUNOPHARMACOLOGY, V24, P119, DOI 10.1016/0162-3109(92)90018-8; OPPERMANN M, 1991, COMPLEMENT INFLAMMAT, V8, P13, DOI 10.1159/000463173; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Scholl HPN, 2004, OPHTHALMOLOGY, V111, P125, DOI 10.1016/j.ophtha.2003.05.003; Scholl HPN, 2003, GRAEF ARCH CLIN EXP, V241, P39, DOI 10.1007/s00417-002-0602-8; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; WURZNER R, 1991, COMPLEMENT INFLAMMAT, V8, P328; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	41	297	317	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2593	10.1371/journal.pone.0002593	http://dx.doi.org/10.1371/journal.pone.0002593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596911	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200052
J	de la Tour, CB; Amrani, L; Cossard, R; Neuman, KC; Serre, MC; Duguet, M				de la Tour, Claire Bouthier; Amrani, Laila; Cossard, Raynald; Neuman, Keir C.; Serre, Marie Claude; Duguet, Michel			Mutational analysis of the helicase-like domain of Thermotoga maritima reverse gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DEPENDENT ATPASE; TOPOISOMERASE-III; CRYSTAL-STRUCTURE; I TOPOISOMERASE; PROTEIN; SULFOLOBUS; MECHANISM; CLEAVAGE; BINDING; ARCHAEBACTERIA	Reverse gyrase is a unique type IA topoisomerase that is able to introduce positive supercoils into DNA in an ATP-dependent process. ATP is bound to the helicase-like domain of the enzyme that contains most of the conserved motifs found in helicases of the SF1 and SF2 superfamilies. In this paper, we have investigated the role of the conserved helicase motifs I, II, V, VI, and Q by generating mutants of the Thermotoga maritima reverse gyrase. We show that mutations in motifs I, II, V, and VI completely eliminate the supercoiling activity of reverse gyrase and that a mutation in the Qmotif significantly reduces this activity. Further analysis revealed that for most mutants, the DNA binding and cleavage properties are not significantly changed compared with the wild type enzyme, whereas their ATPase activity is impaired. These results clearly show that the helicase motifs are tightly involved in the coupling of ATP hydrolysis to the topoisomerase activity. The zinc finger motif located at the N-terminal end of reverse gyrases was also mutated. Our results indicate that this motif plays an important role in DNA binding.	[de la Tour, Claire Bouthier; Amrani, Laila; Cossard, Raynald; Neuman, Keir C.; Serre, Marie Claude; Duguet, Michel] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	de la Tour, CB (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, Bat 409, F-91405 Orsay, France.	claire.bouthier@igmors.u-psud.fr	Serre, Marie-Claude/B-4159-2008; Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671; SERRE, Marie-Claude/0000-0002-7899-9833	CNRS; Universite Paris-Sud 11 [UMR8621]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001056, ZIAHL001056] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud 11; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by CNRS and Universite Paris-Sud 11 Grant UMR8621 and by a CNRS grant (Physique et Chimie du Vivant). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; De la Tour CB, 1998, J BACTERIOL, V180, P274, DOI 10.1128/JB.180.2.274-281.1998; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; DELATOUR CB, 1990, J BACTERIOL, V172, P6803, DOI 10.1128/jb.172.12.6803-6808.1990; DELATOUR CB, 1991, J BACTERIOL, V173, P3921, DOI 10.1128/JB.173.12.3921-3923.1991; Duguet M, 1997, J CELL SCI, V110, P1345; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; FORTERRE P, 1985, EMBO J, V4, P2123, DOI 10.1002/j.1460-2075.1985.tb03902.x; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; JAXEL C, 1989, EMBO J, V8, P3135, DOI 10.1002/j.1460-2075.1989.tb08466.x; Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x; Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KOVALSKY OI, 1990, NUCLEIC ACIDS RES, V18, P2801, DOI 10.1093/nar/18.9.2801; Lilley DMJ., 1995, NUCL ACIDS MOL BIOL, P84; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Serre MC, 2003, PROG NUCLEIC ACID RE, V74, P37, DOI 10.1016/S0079-6603(03)01010-9; SHIBATA T, 1987, J BIOL CHEM, V262, P10419; SLESAREV AI, 1990, J BIOMOL STRUCT DYN, V7, P935, DOI 10.1080/07391102.1990.10508533; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tse-Dinh YC, 1998, BBA-GENE STRUCT EXPR, V1400, P19, DOI 10.1016/S0167-4781(98)00125-0; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	43	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27395	27402		10.1074/jbc.M800867200	http://dx.doi.org/10.1074/jbc.M800867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18614530	hybrid			2022-12-25	WOS:000259719200007
J	Dow, LE; Elsum, IA; King, CL; Kinross, KM; Richardson, HE; Humbert, PO				Dow, L. E.; Elsum, I. A.; King, C. L.; Kinross, K. M.; Richardson, H. E.; Humbert, P. O.			Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling	ONCOGENE			English	Article						scribble; invasion; cancer; Ras	BREAST EPITHELIAL-CELLS; LARGE TUMOR-SUPPRESSOR; PROTEASOME-MEDIATED DEGRADATION; PAPILLOMAVIRUS E6 PROTEINS; EPIDERMAL-GROWTH-FACTOR; DISCS-LARGE; TGF-BETA; MALIGNANT PROGRESSION; ONCOGENIC RAS; CYCLE ARREST	Activating mutations in genes of the Ras-mitogen-activated protein kinase (MAPK) pathway occur in approximately 30% of all human cancers; however, mutation of Ras alone is rarely sufficient to induce tumour development. Scribble is a polarity regulator recently isolated from a Drosophila screen for events that cooperate with Ras mutation to promote tumour progression and cell invasion. In mammals, Scribble regulates directed cell migration and wound healing in vivo; however, no role has been identified for mammalian Scribble in oncogenic transformation. Here we show that in human epithelial cells expressing oncogenic Ras or Raf, loss of Scribble promotes invasion of cells through extracellular matrix in an organotypic culture system. Further, we show that the mechanism by which this occurs is in the regulation of MAPK signalling by Scribble. The suppression of MAPK signalling is a highly conserved function of Scribble as it also prevents Raf-mediated defects in Drosophila wing development. Our data identify Scribble as an important mediator of MAPK signalling and provide a molecular basis for the observation that Scribble expression is decreased in many invasive human cancers.	[Dow, L. E.; Elsum, I. A.; King, C. L.; Kinross, K. M.; Humbert, P. O.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 8006, Australia; [Richardson, H. E.] Peter MacCallum Canc Ctr, Div Res, Cell Cycle & Dev Labs, Melbourne, Vic 8006, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, Div Res, Locked Bag 1,A'Beckett St, Melbourne, Vic 8006, Australia.	patrick.humbert@petermac.org	Richardson, Helena E/A-8080-2013; Humbert, Patrick O/L-4264-2016	Richardson, Helena E/0000-0003-3852-4953; Humbert, Patrick O/0000-0002-1366-6691; Elsum, Imogen/0000-0003-4525-0727; Dow, Lukas/0000-0001-7048-1418				Abdelilah-Seyfried S, 2003, DEVELOPMENT, V130, P1927, DOI 10.1242/dev.00420; AGUILARCORDOVA E, 1991, ONCOGENE, V6, P1601; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dow LE, 2007, ONCOGENE, V26, P5692, DOI 10.1038/sj.onc.1210639; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Dow LE, 2007, INT REV CYTOL, V262, P253, DOI 10.1016/S0074-7696(07)62006-3; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Giunciuglio D, 1995, INT J CANCER, V63, P815, DOI 10.1002/ijc.2910630612; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Joiakim A, 2003, DRUG METAB DISPOS, V31, P1279, DOI 10.1124/dmd.31.11.1279; Kamei Y, 2007, HUM PATHOL, V38, P1273, DOI 10.1016/j.humpath.2007.01.026; Kim ES, 2005, CYTOKINE, V29, P84, DOI 10.1016/j.cyto.2004.10.001; Kim ES, 2004, INT J ONCOL, V25, P1375; Kim MS, 2003, CANCER RES, V63, P5454; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lin HT, 2004, GYNECOL ONCOL, V93, P422, DOI 10.1016/j.ygyno.2004.01.025; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa S, 2004, BRIT J CANCER, V90, P194, DOI 10.1038/sj.bjc.6601465; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schreiber K, 2004, ONCOGENE, V23, P3972, DOI 10.1038/sj.onc.1207507; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seton-Rogers SE, 2004, CELL CYCLE, V3, P597, DOI 10.4161/cc.3.5.886; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Settle M, 2003, ONCOGENE, V22, P1916, DOI 10.1038/sj.onc.1206240; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STOREY A, 1993, ONCOGENE, V8, P919; Thomas M, 2005, ONCOGENE, V24, P6222, DOI 10.1038/sj.onc.1208757; Woodhouse E, 1998, DEV GENES EVOL, V207, P542, DOI 10.1007/s004270050145; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Woodworth CD, 2000, CANCER RES, V60, P4397; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	59	122	126	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 9	2008	27	46					5988	6001		10.1038/onc.2008.219	http://dx.doi.org/10.1038/onc.2008.219			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	358BO	18641685	Green Accepted			2022-12-25	WOS:000259891600002
J	Bussolati, B; Bruno, S; Grange, C; Ferrando, U; Camussi, G				Bussolati, Benedetta; Bruno, Stefania; Grange, Cristina; Ferrando, Ugo; Camussi, Giovanni			Identification of a tumor-initiating stem cell population in human renal carcinomas	FASEB JOURNAL			English	Article						angiogenesis; CD105; tumorigenesis; kidney tumor; progenitors; mesenchymal stem cells	IN-VITRO PROPAGATION; BREAST-CANCER CELLS; PROGENITOR CELLS; STROMAL CELLS; HUMAN KIDNEY; ANGIOGENESIS; CONTRIBUTE; MUTATIONS; MARROW; MICE	The purpose of the present study was to search for the presence of a tumor-initiating stem cell population in renal carcinomas. Based on the recent identification of mesenchymal stem cells in normal kidneys, we sorted cells expressing the mesenchymal stem cell marker CD105 from 5 human renal carcinomas. Because the CD105(+) but not the CD105(-) population showed enhanced tumorigenicity when injected in severely compromised immunodeficient (SCID) mice, we cloned and characterized CD105(+) cells and evaluated their stemness, differentiative ability, and serial tumor generation. Characterization of the phenotype of CD105(+) clones revealed several stem cell properties: 1) clonogenic ability, 2) expression of nestin, Nanog, Oct4 stem cell markers, and lack of differentiative epithelial markers, 3) ability to grow in non-adhesive spheroids, 4) an vitro differentiation into epithelial and endothelial cell types, and 5) generation in vivo of serially transplantable carcinomas containing an undifferentiated CD105(+) tumorigenic and a differentiated CD105(-) nontumorigenic population. In addition, some vessels present in carcinomas generated from CD105(+) clones were of human origin, suggesting the capability of tumor-initiating stem cells to in vivo differentiate also in endothelial cells. In conclusion, we demonstrate that CD105(+) cells and clones derived from renal carcinomas were enriched in tumor-initiating cells with stem characteristics.	Ctr Mol Biotechnol, Dept Internal Med, Turin, Italy; Ctr Res Expt Med, Turin, Italy		Camussi, G (corresponding author), Osped Maggiore G Giovanni Battista, Cattedra Nefrol, Dipartimento Med Interna, Corso Dogliotti 14, I-10126 Turin, Italy.	giovanni.camussi@unito.it	Camussi, Giovanni/J-7624-2016; Bussolati, Benedetta/AAA-9058-2022	Camussi, Giovanni/0000-0003-2795-232X; Bussolati, Benedetta/0000-0002-3663-5134; BRUNO, Stefania/0000-0002-8879-9536; GRANGE, CRISTINA/0000-0002-6960-5476	Associazione Italian, per la Ricerca sin Cancro (AIRC); Italian Ministry of University and Research (MIUR) COFIN; MIUR; Italian Ministry of Health (Ricerca Finalizzata 02; Progetto S. Paolo Oncologia; Progetti Finalizzati Regione Piemonte, Oncoprot	Associazione Italian, per la Ricerca sin Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (MIUR) COFIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Ricerca Finalizzata 02(Ministry of Health, Italy); Progetto S. Paolo Oncologia; Progetti Finalizzati Regione Piemonte, Oncoprot	This work was supported by the Associazione Italian, per la Ricerca sin Cancro (AIRC), Italian Ministry of University and Research (MIUR) COFIN and MIUR ex60% grants, the Italian Ministry of Health (Ricerca Finalizzata 02), the Progetto S. Paolo Oncologia, and the Progetti Finalizzati Regione Piemonte, Oncoprot.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aractingi S, 2005, CANCER RES, V65, P1755, DOI 10.1158/0008-5472.CAN-04-2783; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; BUSSOLATI B, 2008, J CELL MOL MED  0409; Cantley LG, 2005, NAT CLIN PRACT NEPHR, V1, P22, DOI 10.1038/ncpneph0021; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Galie M, 2008, ONCOGENE, V27, P2542, DOI 10.1038/sj.onc.1210920; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Khoury Joseph D, 2002, Ann Diagn Pathol, V6, P154, DOI 10.1053/adpa.2002.33901; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lane BR, 2005, CURR OPIN UROL, V15, P289, DOI 10.1097/01.mou.0000178336.94991.17; Larkin JMG, 2007, NAT CLIN PRACT ONCOL, V4, P470, DOI 10.1038/ncponc0901; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Liu BB, 2005, J CANCER RES CLIN, V131, P631, DOI 10.1007/s00432-005-0007-2; Liu L, 2007, ARCH PATHOL LAB MED, V131, P1290; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plotkin MD, 2006, AM J PHYSIOL-RENAL, V291, pF902, DOI 10.1152/ajprenal.00396.2005; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128	41	246	262	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3696	3705		10.1096/fj.08-102590	http://dx.doi.org/10.1096/fj.08-102590			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18614581				2022-12-25	WOS:000259642600030
J	Chakrabarti, A; Sadler, AJ; Kar, N; Young, HA; Silverman, RH; Williams, BRG				Chakrabarti, Arindam; Sadler, Anthony J.; Kar, Niladri; Young, Howard A.; Silverman, Robert H.; Williams, Bryan R. G.			Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; IL-10 GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-3; HUMAN T-CELLS; HUMAN MONOCYTES; RIG-I; ANTIINFLAMMATORY CYTOKINES; TRANSCRIPTION FACTOR	The double-stranded RNA-activated protein kinase R (PKR) is an important component of antiviral defense. PKR participates in different signaling pathways in response to various stimuli to regulate translation via phosphorylation of the eukaryotic initiation factor 2 alpha, and transcription via activating NF-kappa B and IRF-1, to induce pro-inflammatory cytokines. Here we show PKR regulates interleukin-10 induction in response to double-stranded RNA, bacterial lipopolysaccaride, and Sendai virus infection. Using chemical inhibitors, dominant negative constructs, and genetic knockouts, we demonstrate that the PKR-mediated interleukin-10 induction engages JNK and NF-kappa B. Together, our data demonstrate the role of PKR in regulating an anti-inflammatory cytokine. The findings have significance in antiviral as well as broader innate immune responses.	[Sadler, Anthony J.; Williams, Bryan R. G.] Monash Univ, Monash Med Ctr, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Chakrabarti, Arindam; Kar, Niladri; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Kar, Niladri] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Young, Howard A.] NCI, Expt Immunol Lab, NIH, Frederick, MD 21702 USA	Monash University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Williams, BRG (corresponding author), Monash Univ, Monash Med Ctr, Monash Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	bryan.williams@med.monash.edu.au	sadler, anthony/ABA-5572-2020; Williams, Bryan R. G./A-5021-2009; Young, Howard/R-5140-2019; Young, Howard/A-6350-2008	sadler, anthony/0000-0002-7970-8030; Williams, Bryan R. G./0000-0002-4969-1151; Young, Howard/0000-0002-3118-5111	National Institutes of Health [R01 AI034039, P01 CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI034039 and P01 CA062220. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asakura Y, 2007, AM J HEMATOL, V82, P640, DOI 10.1002/ajh.20817; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; Daftarian PM, 1996, J IMMUNOL, V157, P12; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Deb A, 2001, EMBO J, V20, P2487, DOI 10.1093/emboj/20.10.2487; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DING L, 1993, J IMMUNOL, V151, P1224; Dummer W, 1996, INT J CANCER, V66, P607, DOI 10.1002/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.3.CO;2-B; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; GASTL GA, 1993, INT J CANCER, V55, P96, DOI 10.1002/ijc.2910550118; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; GRABSTEIN KH, 1992, J IMMUNOL, V149, P1524; GRUBER MF, 1994, J IMMUNOL, V152, P1354; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Libraty DH, 1997, J CLIN INVEST, V99, P336, DOI 10.1172/JCI119162; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1992, CURR OPIN IMMUNOL, V4, P314, DOI 10.1016/0952-7915(92)90082-P; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Paludan SR, 2001, J VIROL, V75, P8008, DOI 10.1128/JVI.75.17.8008-8015.2001; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; van Furth AM, 1999, INFECT IMMUN, V67, P3714, DOI 10.1128/IAI.67.8.3714-3718.1999; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; WILLIAMS BR, 2006, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A000792.01; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	53	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25132	25139		10.1074/jbc.M804770200	http://dx.doi.org/10.1074/jbc.M804770200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625702	Green Published, hybrid			2022-12-25	WOS:000259012700005
J	Pavlova, O; Mukhopadhyay, J; Sineva, E; Ebright, RH; Severinov, K				Pavlova, Olga; Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.; Severinov, Konstantin			Systematic structure-activity analysis of microcin J25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RNA-POLYMERASE; ESCHERICHIA-COLI; PEPTIDE; TRANSCRIPTION; TAIL	Microcin J25 ( MccJ25) is a 21-residue plasmid-encoded ribosomally synthesized lariat-protoknot antibacterial peptide that targets bacterial RNA polymerase. MccJ25 consists of an 8-residue cycle followed by a 13-residue tail that loops back and threads through the cycle. We have performed systematic mutational scanning of MccJ25, constructing and analyzing more than 380 singly substituted derivatives of MccJ25. The results define residues important for production of MccJ25 ( comprising synthesis of MccJ25 precursor, processing of MccJ25 precursor, export of mature MccJ25, and stability of mature MccJ25), inhibition of RNA polymerase, and inhibition of bacterial growth. The results show that only a small number of residues ( three in the cycle and one in the threaded segment of the tail) are important for MccJ25 production. The results further show that only a small number of additional residues ( two in the cycle and four in the threaded segment of the tail) are important for inhibition of transcription. The results open the way for design and construction of more potent MccJ25-based inhibitors of bacterial growth.	[Pavlova, Olga; Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.; Severinov, Konstantin] Waksman Inst Microbiol, Piscataway, NJ 08844 USA; [Pavlova, Olga; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08904 USA; [Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08904 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08904 USA	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Waksman Inst Microbiol, Piscataway, NJ 08844 USA.	ebright@waksman.rutgers.edu; severik@waksman.rutgers.edu	Ebright, Richard/O-3321-2019; Sineva, Elena/A-5267-2008; Severinov, Konstantin/C-8545-2016	Ebright, Richard/0000-0001-8915-7140; Sineva, Elena/0000-0003-2307-0581; 	National Institutes of Health [GM41376, GM64530]; NIAID Northeast Biodefense [U54-AI057158-Lipkin]; Howard Hughes Medical Institute Investigatorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Northeast Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41376 ( to R. H. E.) and GM64530 ( to K. S.) and by a NIAID Northeast Biodefense center U54-AI057158-Lipkin Grant ( to K. S.). This work was also supported by a Howard Hughes Medical Institute Investigatorship ( to R. H. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adelman K, 2004, MOL CELL, V14, P753, DOI 10.1016/j.molcel.2004.05.017; ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; Bayro MJ, 2003, J AM CHEM SOC, V125, P12382, DOI 10.1021/ja036677e; Blond A, 1999, EUR J BIOCHEM, V259, P747, DOI 10.1046/j.1432-1327.1999.00085.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Rosengren KJ, 2004, BIOCHEMISTRY-US, V43, P4696, DOI 10.1021/bi0361261; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; SALOMON RA, 1993, J BACTERIOL, V175, P7741; SCHLAGECK JG, 1979, J BIOL CHEM, V254, P2074; Semenova E, 2005, J BACTERIOL, V187, P3859, DOI 10.1128/JB.187.11.3859-3863.2005; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Solbiati JO, 1996, J BACTERIOL, V178, P3661, DOI 10.1128/jb.178.12.3661-3663.1996; Solbiati JO, 1999, J BACTERIOL, V181, P2659, DOI 10.1128/JB.181.8.2659-2662.1999; Wilson KA, 2003, J AM CHEM SOC, V125, P12475, DOI 10.1021/JA036756q; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200	20	93	94	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25589	25595		10.1074/jbc.M803995200	http://dx.doi.org/10.1074/jbc.M803995200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18632663	Green Published, hybrid			2022-12-25	WOS:000259012700054
J	Rayapuram, N; Hagenmuller, J; Grienenberger, JM; Bonnard, G; Giege, P				Rayapuram, Naganand; Hagenmuller, Jeremie; Grienenberger, Jean Michel; Bonnard, Geraldine; Giege, Philippe			The three mitochondrial encoded CcmF proteins form a complex that interacts with CCMH and c-type apocytochromes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHAPERONE CCME; PLANT-MITOCHONDRIA; RHODOBACTER-CAPSULATUS; MARCHANTIA-POLYMORPHA; NITRITE REDUCTASE; ESCHERICHIA-COLI; READING FRAMES; GENOME; BIOGENESIS; MATURATION	Three reading frames called ccmF(N1), ccmF(N2), and ccmF(c) are found in the mitochondrial genome of Arabidopsis. These sequences are similar to regions of the bacterial gene ccmF involved in cytochrome c maturation. ccmF genes are always absent from animal and fungi genomes but are found in mitochondrial genomes of land plant and several evolutionary distant eukaryotes. In Arabidopsis, ccmF(N2) despite the absence of a classical initiation codon is not a pseudo gene. The 3 ccmF genes of Arabidopsis are expressed at the protein level. Their products are integral proteins of the mitochondrial inner membrane with in total 11 to 13 predicted transmembrane helices. The conserved WWD domain of CcmF(N2) is localized in the inter membrane space. The 3 CcmF proteins are all detected in a high molecular mass complex of 500 kDa by Blue Native PAGE. Direct interaction between CcmF(N2) and both CcmF(N1) and CcmF(C) is shown with the yeast two-hybrid split ubiquitin system, but no interaction is observed between CcmF(N1) and CcmFC. Similarly, interaction is detected between CcmF(N2) and apocytochrome c but also with apocytochrome c(1). Finally, CcmF(N1) and CcmF(N2) both interact with CCMH previously shown to interact as well with cytochrome c. This strengthens the hypothesis that CcmF and CCMH make a complex that performs the assembly of heme with c-type apocytochromes in plant mitochondria.	[Rayapuram, Naganand; Hagenmuller, Jeremie; Grienenberger, Jean Michel; Bonnard, Geraldine; Giege, Philippe] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giege, P (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	Philippe.Giege@ibmp-ulp.u-strasbg.fr		Giege, Philippe/0000-0003-2285-8190	"Centre National de la Recherche Scientifique."	"Centre National de la Recherche Scientifique."(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by the "Centre National de la Recherche Scientifique." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JWA, 2006, FEBS LETT, V580, P4827, DOI 10.1016/j.febslet.2006.07.073; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; BOCK H, 1994, PLANT MOL BIOL, V24, P811, DOI 10.1007/BF00029863; BOWLER C, 1989, P NATL ACAD SCI USA, V86, P3237, DOI 10.1073/pnas.86.9.3237; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cinege G, 2004, MOL GENET GENOMICS, V271, P171, DOI 10.1007/s00438-003-0968-2; Dong FG, 1998, CURR GENET, V34, P79, DOI 10.1007/s002940050369; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Eaves D, 1998, BIOCHEM SOC T, V26, pS216, DOI 10.1042/bst026s216; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Giege P, 1998, CURR GENET, V34, P313, DOI 10.1007/s002940050401; Giege P, 2000, EMBO REP, V1, P164, DOI 10.1093/embo-reports/kvd024; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Giege P, 2003, PLANT MOL BIOL REP, V21, P133, DOI 10.1007/BF02774240; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GONZALEZ DH, 1993, CURR GENET, V24, P248, DOI 10.1007/BF00351799; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Handa H, 1996, MOL GEN GENET, V252, P292, DOI 10.1007/BF02173775; Hirose T, 1998, FEBS LETT, V430, P257, DOI 10.1016/S0014-5793(98)00673-5; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; KLEIN M, 1994, PLANT J, V6, P447, DOI 10.1046/j.1365-313X.1994.06030447.x; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; KRANZ RG, 1989, J BACTERIOL, V171, P456, DOI 10.1128/jb.171.1.456-464.1989; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Logan DC, 2006, BBA-MOL CELL RES, V1763, P430, DOI 10.1016/j.bbamcr.2006.01.003; Marienfeld JR, 1997, BIOL CHEM, V378, P859, DOI 10.1515/bchm.1997.378.8.859; Menassa R, 1997, CURR GENET, V31, P70, DOI 10.1007/s002940050178; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; ODA K, 1992, BIOSCI BIOTECH BIOCH, V56, P132, DOI 10.1271/bbb.56.132; ODA K, 1992, NUCLEIC ACIDS RES, V20, P3773, DOI 10.1093/nar/20.14.3773; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; Raczynska KD, 2006, FEBS LETT, V580, P5641, DOI 10.1016/j.febslet.2006.09.010; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Rios-Velazquez C, 2003, J BACTERIOL, V185, P422, DOI 10.1128/JB.185.2.422-431.2003; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; SCHUSTER W, 1993, MOL GEN GENET, V239, P49, DOI 10.1007/BF00281600; Spielewoy N, 2001, J BIOL CHEM, V276, P5491, DOI 10.1074/jbc.M008853200; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2	64	43	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25200	25208		10.1074/jbc.M802621200	http://dx.doi.org/10.1074/jbc.M802621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644794	hybrid, Green Published			2022-12-25	WOS:000259012700012
J	Mamillapalli, R; VanHouten, J; Zawalich, W; Wysolmerski, J				Mamillapalli, Ramanaiah; VanHouten, Joshua; Zawalich, Walter; Wysolmerski, John			Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CALCIUM; MAMMARY-GLAND; KINASE-C; MEDIATED PHOSPHORYLATION; CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; ALPHA-SUBUNITS; EXPRESSION; BINDING; CANCER	The calcium-sensing receptor (CaR) is a G-protein-coupled receptor that signals in response to extracellular calcium and regulates parathyroid hormone secretion. The CaR is also expressed on normal mammary epithelial cells (MMECs), where it has been shown to inhibit secretion of parathyroid hormone-related protein (PTHrP) and participate in the regulation of calcium and bone metabolism during lactation. In contrast to normal breast cells, the CaR has been reported to stimulate PTHrP production by breast cancer cells. In this study, we confirmed that the CaR inhibits PTHrP production by MMECs but stimulates PTHrP production by Comma-D cells (immortalized murine mammary cells) and MCF-7 human breast cancer cells. We found that changes in intracellular cAMP, but not phospholipase C or MAPK signaling, correlated with the opposing effects of the CaR on PTHrP production. Pharmacologic stimulation of cAMP accumulation increased PTHrP production by normal and transformed breast cells. Inhibition of protein kinase A activity mimicked the effects of CaR activation on inhibiting PTHrP secretion by MMECs and blocked the effects of the CaR on stimulating PTHrP production in Comma-D and MCF-7 cells. We found that the CaR coupled to G alpha(i) in MMECs but coupled to G alpha(s) in Comma-D and MCF-7 cells. Thus, the opposing effects of the CaR on PTHrP production are because of alternate G-protein coupling of the receptor in normal versus transformed breast cells. Because PTHrP contributes to hypercalcemia and bone metastases, switching of G-protein usage by the CaR may contribute to the pathogenesis of breast cancer.	[Mamillapalli, Ramanaiah; VanHouten, Joshua; Wysolmerski, John] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Zawalich, Walter] Yale Univ, Sch Nursing, New Haven, CT 06520 USA	Yale University; Yale University	Wysolmerski, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu	Mamillapalli, Ramanaiah/K-6357-2019	Mamillapalli, Ramanaiah/0000-0002-4022-8910	National Institutes of Health [DK077565, DK69542, DK41230]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077565, R01DK041230, R01DK069542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077565, DK69542, and DK41230 from the NIDDK.	Abbink W, 2006, J EXP BIOL, V209, P3550, DOI 10.1242/jeb.02399; *APPL BIOS, 1997, US B APPL BIOS, V2; Ardeshirpour L, 2006, BONE, V38, P787, DOI 10.1016/j.bone.2005.11.009; Arthur JM, 1997, AM J PHYSIOL-RENAL, V273, pF129, DOI 10.1152/ajprenal.1997.273.1.F129; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; BANWELL JG, 1970, J CLIN INVEST, V49, P183, DOI 10.1172/JCI106217; BARR AJ, 1999, CRC METH SIG TRANS, P227; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Brown E. M., 2007, V45, P139; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Brown Sue A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P436, DOI 10.1097/MED.0b013e3282f15419; Chattopadhyay N, 2006, AM J PHYSIOL-ENDOC M, V290, pE761, DOI 10.1152/ajpendo.00350.2005; Chattopadhyay N, 2006, MOL GENET METAB, V89, P189, DOI 10.1016/j.ymgme.2006.07.003; Cheng I, 1998, J CLIN ENDOCR METAB, V83, P703, DOI 10.1210/jc.83.2.703; Chilco PJ, 1998, MOL CELL ENDOCRINOL, V138, P173, DOI 10.1016/S0303-7207(97)00239-6; Corbetta S, 2002, J CLIN ENDOCR METAB, V87, P2201, DOI 10.1210/jc.87.5.2201; CRUCIANI RA, 1993, P NATL ACAD SCI USA, V90, P3019, DOI 10.1073/pnas.90.7.3019; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; DeMauro S, 2005, J MAMMARY GLAND BIOL, V10, P157, DOI 10.1007/s10911-005-5398-9; Dvorak MM, 2007, ENDOCRINOLOGY, V148, P3156, DOI 10.1210/en.2007-0147; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hasseldine ARG, 2003, BRIT J PHARMACOL, V138, P1358, DOI 10.1038/sj.bjp.0705191; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Hill SJ, 2003, BRIT J PHARMACOL, V138, P1188, DOI 10.1038/sj.bjp.0705192; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; IKEDA K, 1993, J BIOL CHEM, V268, P1174; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Jahnke GD, 1996, J MOL ENDOCRINOL, V17, P247, DOI 10.1677/jme.0.0170247; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kifor O, 2003, J CLIN ENDOCR METAB, V88, P4455, DOI 10.1210/jc.2002-021427; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; Kovacs CS, 1998, J CLIN INVEST, V101, P2812, DOI 10.1172/JCI2940; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luo X, 1999, J BIOL CHEM, V274, P17684, DOI 10.1074/jbc.274.25.17684; Mackay HJ, 2003, ENDOCR-RELAT CANCER, V10, P389, DOI 10.1677/erc.0.0100389; Martin NP, 2004, CELL SIGNAL, V16, P1397, DOI 10.1016/j.cellsig.2004.05.002; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; Morimoto T, 1997, MOL CELL ENDOCRINOL, V129, P91, DOI 10.1016/S0303-7207(97)04044-6; ORourke J, 1997, J BIOL CHEM, V272, P6291, DOI 10.1074/jbc.272.10.6291; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Quarles LD, 2003, CURR OPIN NEPHROL HY, V12, P349, DOI 10.1097/00041552-200307000-00002; Quinn SJ, 2007, BIOCHEM BIOPH RES CO, V354, P8, DOI 10.1016/j.bbrc.2006.12.160; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Ryan W L, 1974, Adv Cyclic Nucleotide Res, V4, P81; Sanders JL, 2000, ENDOCRINOLOGY, V141, P4357, DOI 10.1210/en.141.12.4357; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; SIDHU A, 1991, J NEUROCHEM, V57, P1445, DOI 10.1111/j.1471-4159.1991.tb08312.x; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Sotgia F, 2006, CANCER RES, V66, P10647, DOI 10.1158/0008-5472.CAN-06-2805; Strewler GJ, 2000, NEW ENGL J MED, V342, P177, DOI 10.1056/NEJM200001203420306; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; VANHOUTEN J, 2005, J MAMMARY GLAND BIOL, V12, P477; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Wang WH, 1997, AM J PHYSIOL-RENAL, V273, pF421, DOI 10.1152/ajprenal.1997.273.3.F421; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wysolmerski JJ, 2007, BONEKEY, V4, P209; Xu JK, 2005, J CELL PHYSIOL, V202, P554, DOI 10.1002/jcp.20159; ZAJAC JD, 1989, MOL CELL ENDOCRINOL, V67, P107, DOI 10.1016/0303-7207(89)90236-0; ZAWALICH W, 1987, DIABETES, V36, P426, DOI 10.2337/diabetes.36.4.426; ZAWALICH WS, 1995, ENDOCRINOLOGY, V136, P4903, DOI 10.1210/en.136.11.4903	77	110	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24435	24447		10.1074/jbc.M801738200	http://dx.doi.org/10.1074/jbc.M801738200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621740	Green Published, hybrid			2022-12-25	WOS:000258820000019
J	Roca, H; Varsos, Z; Pienta, KJ				Roca, Hernan; Varsos, Zachary; Pienta, Kenneth J.			CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INDUCED APOPTOSIS; MACROPHAGE INFILTRATION; KINASE; PATHWAY; PHOSPHORYLATION; BONE; MACROAUTOPHAGY; AKT/PKB; GROWTH	Resistance to cell death is a hallmark of cancer. Autophagy is a survival mechanism activated in response to nutrient deprivation; however, excessive autophagy will ultimately induce cell death in a nonapoptotic manner. The present study demonstrates that CCL2 protects prostate cancer PC3 cells from autophagic death, allowing prolonged survival in serum-free conditions. Upon serum starvation, CCL2 induced survivin up-regulation in PC3, DU 145, and C4-2B prostate cancer cells. Both cell survival and survivin expression were stunted in CCL2-stimulated PC3 cells when treated either with the phosphatidylinositol 3-kinase inhibitor LY294002 (2 mu M) or the Akt-specific inhibitor-X (Akti-X; 2.5 mu M). Furthermore, CCL2 significantly reduced light chain 3-II (LC3-II) in serum-starved PC3; in contrast, treatment with LY294002 or Akti-X reversed the effect of CCL2 on LC3-II levels, suggesting that CCL2 signaling limits autophagy in these cells. Upon serum deprivation, the analysis of LC3 localization by immunofluorescence revealed a remarkable reduction in LC3 punctate after CCL2 stimulation. CCL2 treatment also resulted in a higher sustained mTORC1 activity as measured by an increase in phospho-p70S6 kinase (Thr(389)). Rapamycin, an inducer of autophagy, both down-regulated survivin and decreased PC3 cell viability in serum-deprived conditions. Treatment with CCL2, however, allowed cells to partially resist rapamycin-induced death, which correlated with survivin protein levels. In two stable transfectants expressing survivin-specific short hairpin RNA, generated from PC3, survivin protein levels controlled both cell viability and LC3 localization in response to CCL2 treatment. Altogether, these findings indicate that CCL2 protects prostate cancer PC3 cells from autophagic death via the phosphatidylinositol 3-kinase/Akt/survivin pathway and reveal survivin as a critical molecule in this survival mechanism.	[Roca, Hernan; Varsos, Zachary; Pienta, Kenneth J.] Univ Michigan, Ctr Comprehens Canc, Dept Urol, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roca, H (corresponding author), 1500 E Med Ctr Dr,CCGC Room 7431, Ann Arbor, MI 48109 USA.	rocach@umich.edu	Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186	National Institutes of Health, NCI [SPORE CA69568-06A1]; Comprehensive Cancer Center Core [CA 46592-18, PO1 CA093900]; NATIONAL CANCER INSTITUTE [P01CA093900, P50CA069568, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Comprehensive Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant SPORE CA69568-06A1, Comprehensive Cancer Center Core Grant CA 46592-18, and PO1 CA093900.	Ali SM, 2002, INT J ONCOL, V21, P531; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Leek RD, 1996, CANCER RES, V56, P4625; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lin JQ, 1999, CANCER RES, V59, P2891; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; O'Boyle G, 2007, MOL IMMUNOL, V44, P1944, DOI 10.1016/j.molimm.2006.09.033; Ohta M, 2002, INT J CANCER, V102, P220, DOI 10.1002/ijc.10705; Olie RA, 2000, CANCER RES, V60, P2805; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pienta Kenneth J, 2005, Clin Prostate Cancer, V4, P24, DOI 10.3816/CGC.2005.n.008; Reiland J, 1999, PROSTATE, V41, P78; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Tamm I, 1998, CANCER RES, V58, P5315; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Vanderkerken K, 2002, CLIN EXP METASTAS, V19, P87, DOI 10.1023/A:1013891205989; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang CC, 2003, J BIOL CHEM, V278, P25872, DOI 10.1074/jbc.M301744200; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	60	133	141	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25057	25073		10.1074/jbc.M801073200	http://dx.doi.org/10.1074/jbc.M801073200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18611860	hybrid, Green Published			2022-12-25	WOS:000271617300012
J	Baurle, I; Dean, C				Baurle, Isabel; Dean, Caroline			Differential Interactions of the Autonomous Pathway RRM Proteins and Chromatin Regulators in the Silencing of Arabidopsis Targets	PLOS ONE			English	Article								We have recently shown that two proteins containing RRM-type RNA-binding domains, FCA and FPA, originally identified through their role in flowering time control in Arabidopsis, silence transposons and other repeated sequences in the Arabidopsis genome. In flowering control, FCA and FPA function in the autonomous pathway with conserved chromatin regulators, the histone demethylase FLD and the MSI1-homologue FVE, a conserved WD-repeat protein found in many chromatin complexes. Here, we investigate how the RRM proteins interact genetically with these chromatin regulators at a range of loci in the Arabidopsis genome. We also investigate their interaction with the DNA methylation pathway. In several cases the RRM protein activity at least partially required a chromatin regulator to effect silencing. However, the interactions of the autonomous pathway components differed at each target analysed, most likely determined by certain properties of the target loci and/or other silencing pathways. We speculate that the RNA-binding proteins FCA and FPA function as part of a transcriptome surveillance mechanism linking RNA recognition with chromatin silencing mechanisms.	[Baurle, Isabel; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baurle, I (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Bäurle, Isabel/ABD-6356-2021	Bäurle, Isabel/0000-0001-5633-8068; Dean, Caroline/0000-0002-6555-3525	BBSRC [BBS/E/J/000CA355, BB/D010799/1, BBS/E/J/000CA305, BBS/E/J/000CA344, BB/E009662/1] Funding Source: UKRI; Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA305, BBS/E/J/00000581, BB/C517633/1, BBS/E/J/000CA355, BB/G009562/1, BBS/E/J/000CA376, BB/G01406X/1, BBS/E/J/000CA378, BBS/E/J/0000A219, BBS/E/J/0000A199, BBS/E/J/000CA369, G20334, BB/E009662/1, BBS/E/J/000CA344, BB/D010799/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Henderson IR, 2005, DEVELOPMENT, V132, P3597, DOI 10.1242/dev.01924; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Veley KM, 2008, PLANT PHYSIOL, V147, P682, DOI 10.1104/pp.108.118927; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	40	58	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2733	10.1371/journal.pone.0002733	http://dx.doi.org/10.1371/journal.pone.0002733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628965	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200069
J	Mehra, S; Charaniya, S; Takano, E; Hu, WS				Mehra, Sarika; Charaniya, Salim; Takano, Eriko; Hu, Wei-Shou			A Bistable Gene Switch for Antibiotic Biosynthesis: The Butyrolactone Regulon in Streptomyces coelicolor	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; CHEMICAL REACTOR STABILITY; GAMMA-BUTYROLACTONE; SECONDARY METABOLISM; POSITIVE FEEDBACK; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; CATABOLITE REPRESSION; INDUCER EXCLUSION; GLOBAL ANALYSIS	Many microorganisms, including bacteria of the class Streptomycetes, produce various secondary metabolites including antibiotics to gain a competitive advantage in their natural habitat. The production of these compounds is highly coordinated in a population to expedite accumulation to an effective concentration. Furthermore, as antibiotics are often toxic even to their producers, a coordinated production allows microbes to first arm themselves with a defense mechanism to resist their own antibiotics before production commences. One possible mechanism of coordination among individuals is through the production of signaling molecules. The gamma-butyrolactone system in Streptomyces coelicolor is a model of such a signaling system for secondary metabolite production. The accumulation of these signaling molecules triggers antibiotic production in the population. A pair of repressor-amplifier proteins encoded by scbA and scbR mediates the production and action of one particular gamma-butyrolactone, SCB1. Based on the proposed interactions of scbA and scbR, a mathematical model was constructed and used to explore the ability of this system to act as a robust genetic switch. Stability analysis shows that the butyrolactone system exhibits bistability and, in response to a threshold SCB1 concentration, can switch from an OFF state to an ON state corresponding to the activation of genes in the cryptic type I polyketide synthase gene cluster, which are responsible for production of the hypothetical polyketide. The switching time is inversely related to the inducer concentration above the threshold, such that short pulses of low inducer concentration cannot switch on the system, suggesting its possible role in noise filtering. In contrast, secondary metabolite production can be triggered rapidly in a population of cells producing the butyrolactone signal due to the presence of an amplification loop in the system. S. coelicolor was perturbed experimentally by varying concentrations of SCB1, and the model simulations match the experimental data well. Deciphering the complexity of this butyrolactone switch will provide valuable insights into how robust and efficient systems can be designed using "simple'' two-protein networks.	[Mehra, Sarika] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Charaniya, Salim; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN USA; [Takano, Eriko] Univ Groningen, Dept Microbiol, Groningen, Netherlands	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Minnesota System; University of Minnesota Twin Cities; University of Groningen	Mehra, S (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.	acre@cems.umn.edu		Mehra, Sarika/0000-0003-3844-4726; Takano, Eriko/0000-0002-6791-3256	National Institutes of Health [GM55850]; Graduate School at University of Minnesota [dissertation fellowship]; Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School at University of Minnesota; Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay	This work was supported in part by a grant from the National Institutes of Health (GM55850). SM was supported by a dissertation fellowship from Graduate School at University of Minnesota. SM also thanks the Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay, which supported part of the research.	ARIS R, 1958, CHEM ENG SCI, V7, P121, DOI 10.1016/0009-2509(58)80019-6; ARIS R, 1958, CHEM ENG SCI, V7, P132, DOI 10.1016/0009-2509(58)80020-2; Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bignell DRD, 2007, MOL MICROBIOL, V63, P838, DOI 10.1111/j.1365-2958.2006.05541.x; Butler MJ, 2003, APPL MICROBIOL BIOT, V61, P512, DOI 10.1007/s00253-003-1277-8; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Charaniya S, 2007, NUCLEIC ACIDS RES, V35, P7222, DOI 10.1093/nar/gkm501; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Choi SU, 2004, J BACTERIOL, V186, P3423, DOI 10.1128/JB.186.11.3423-3430.2004; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Folcher M, 2001, J BIOL CHEM, V276, P44297, DOI 10.1074/jbc.M101109200; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Graumann PL, 2006, MOL MICROBIOL, V61, P560, DOI 10.1111/j.1365-2958.2006.05264.x; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; KIERSER T, 2000, PRACTICAL STREPTOMYC; Kim HS, 2004, ARCH MICROBIOL, V182, P44, DOI 10.1007/s00203-004-0697-x; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 1999, J BACTERIOL, V181, P5081, DOI 10.1128/JB.181.16.5081-5084.1999; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kobayashi T, 2003, J THEOR BIOL, V221, P379, DOI 10.1006/jtbi.2003.3190; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Onaka H, 1997, J BACTERIOL, V179, P2748, DOI 10.1128/jb.179.8.2748-2752.1997; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; RUENGJITCHATCHAWALYA M, 1995, J BACTERIOL, V177, P551, DOI 10.1128/jb.177.3.551-557.1995; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o	54	42	42	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2724	10.1371/journal.pone.0002724	http://dx.doi.org/10.1371/journal.pone.0002724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628968	Green Submitted, Green Published, gold			2022-12-25	WOS:000264057200062
J	Thakur, AK; Rao, CM				Thakur, Abhay Kumar; Rao, Ch Mohan			UV-Light Exposed Prion Protein Fails to Form Amyloid Fibrils	PLOS ONE			English	Article								Amyloid fibril formation involves three steps; structural perturbation, nucleation and elongation. We have investigated amyloidogenesis using prion protein as a model system and UV-light as a structural perturbant. We find that UV-exposed prion protein fails to form amyloid fibrils. Interestingly, if provided with pre-formed fibrils as seeds, UV-exposed prion protein formed amyloid fibrils albeit with slightly different morphology. Atomic force microscopy and electron microscopic studies clearly show the formation of fibrils under these conditions. Circular dichroism study shows loss in helicity in UV-exposed protein. UV-exposed prion protein fails to form amyloid fibrils. However, it remains competent for fibril extension, suggesting that UV-exposure results in loss of nucleating capability. This work opens up possibility of segregating nucleation and elongation step of amyloidogenesis, facilitating screening of new drug candidates for specifically inhibiting either of these processes. In addition, the work also highlights the importance of light-induced structural and functional alterations which are important in protein based therapeutics.	[Thakur, Abhay Kumar; Rao, Ch Mohan] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Thakur, AK (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	mohan@ccmb.res.in	Thakur, Abhay/K-4167-2012		Council of Scientific and Industrial Research, New Delhi, India [Senior Research Fellowship]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Abhay Kumar Thakur acknowledges the Council of Scientific and Industrial Research, New Delhi, India for the grant of Senior Research Fellowship.	Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; AIKEN JM, 1990, J VIROL, V64, P3265, DOI 10.1128/JVI.64.7.3265-3268.1990; Andrievskaia O, 2007, ARCH BIOCHEM BIOPHYS, V460, P10, DOI 10.1016/j.abb.2007.02.001; Babcock K., 2004, PHASE IMAGING TOPOGR; Balasubramanian D, 2005, PHOTOCHEM PHOTOBIOL, V81, P498, DOI 10.1562/2004-11-01-RA-354.1; BALASUBRAMANIAN D, 1990, PHOTOCHEM PHOTOBIOL, V52, P761, DOI 10.1111/j.1751-1097.1990.tb08679.x; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BUETTNER GR, 1987, BIOCHIM BIOPHYS ACTA, V923, P501, DOI 10.1016/0304-4165(87)90060-2; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Costa D, 2007, ANAL BIOANAL CHEM, V387, P2071, DOI 10.1007/s00216-006-0998-9; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DEVASAGAYAM TPA, 1991, J PHOTOCH PHOTOBIO B, V9, P105, DOI 10.1016/1011-1344(91)80008-6; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; GROSSWEINER LI, 1984, CURR EYE RES, V3, P137, DOI 10.3109/02713688408997195; Guentchev M, 2002, NEUROBIOL DIS, V9, P275, DOI 10.1006/nbdi.2002.0477; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Hills RD, 2007, J MOL BIOL, V368, P894, DOI 10.1016/j.jmb.2007.02.043; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Konno T, 1999, FEBS LETT, V454, P122, DOI 10.1016/S0014-5793(99)00789-9; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RAO CM, 1987, PHOTOCHEM PHOTOBIOL, V46, P511, DOI 10.1111/j.1751-1097.1987.tb04804.x; RAO SC, 1990, PHOTOCHEM PHOTOBIOL, V51, P357, DOI 10.1111/j.1751-1097.1990.tb01722.x; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; VAN EB, 2004, ACTA NEUROPATHOL BER, V108, P194; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936; Wong BS, 1999, BIOCHEM BIOPH RES CO, V259, P352, DOI 10.1006/bbrc.1999.0802; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Yutani K, 2000, BIOCHEMISTRY-US, V39, P2769, DOI 10.1021/bi991406v	53	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2688	10.1371/journal.pone.0002688	http://dx.doi.org/10.1371/journal.pone.0002688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628989	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200032
J	Sugui, JA; Kim, HS; Zarember, KA; Chang, YC; Gallin, JI; Nierman, WC; Kwon-Chung, KJ				Sugui, Janyce A.; Kim, H. Stanley; Zarember, Kol A.; Chang, Yun C.; Gallin, John I.; Nierman, Willian C.; Kwon-Chung, Kyung J.			Genes Differentially Expressed in Conidia and Hyphae of Aspergillus fumigatus upon Exposure to Human Neutrophils	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; TRANSCRIPTIONAL RESPONSE; GLYOXYLATE CYCLE; BETA-OXIDATION; PARACOCCIDIOIDES-BRASILIENSIS; INVASIVE ASPERGILLOSIS; IRON ASSIMILATION; UP-REGULATION; INTERNALIZATION	Background: Aspergillus fumigatus is the most common etiologic agent of invasive aspergillosis in immunocompromised patients. Several studies have addressed the mechanism involved in host defense but only few have investigated the pathogen's response to attack by the host cells. To our knowledge, this is the first study that investigates the genes differentially expressed in conidia vs hyphae of A. fumigatus in response to neutrophils from healthy donors as well as from those with chronic granulomatous disease (CGD) which are defective in the production of reactive oxygen species. Methodology/Principal Findings: Transcriptional profiles of conidia and hyphae exposed to neutrophils, either from normal donors or from CGD patients, were obtained by using the genome-wide microarray. Upon exposure to either normal or CGD neutrophils, 244 genes were up-regulated in conidia but not in hyphae. Several of these genes are involved in the degradation of fatty acids, peroxisome function and the glyoxylate cycle which suggests that conidia exposed to neutrophils reprogram their metabolism to adjust to the host environment. In addition, the mRNA levels of four genes encoding proteins putatively involved in iron/copper assimilation were found to be higher in conidia and hyphae exposed to normal neutrophils compared to those exposed to CGD neutrophils. Deletants in several of the differentially expressed genes showed phenotypes related to the proposed functions, i.e. deletants of genes involved in fatty acid catabolism showed defective growth on fatty acids and the deletants of iron/copper assimilation showed higher sensitivity to the oxidative agent menadione. None of these deletants, however, showed reduced resistance to neutrophil attack. Conclusion: This work reveals the complex response of the fungus to leukocytes, one of the major host factors involved in antifungal defense, and identifies fungal genes that may be involved in establishing or prolonging infections in humans.	[Sugui, Janyce A.; Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Kim, H. Stanley] Korea Univ, Coll Med, Dept Med, Seoul, South Korea; [Zarember, Kol A.; Gallin, John I.] NIAID, Lab Host Defenses, NIH, Bethesda, MD USA; [Nierman, Willian C.] J Craig Venter Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); J. Craig Venter Institute	Sugui, JA (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	june_kwon-chung@nih.gov		Zarember, Kol/0000-0002-9624-7096	Clinical Center of the National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000155, ZIAAI000155] Funding Source: NIH RePORTER	Clinical Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the Clinical Center of the National Institutes of Health and the intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.	Almyroudis NG, 2005, MED MYCOL, V43, pS247, DOI 10.1080/13693780400025203; ANDERSON GJ, 1992, J INORG BIOCHEM, V47, P249, DOI 10.1016/0162-0134(92)84070-4; Arechabala B, 1999, J APPL TOXICOL, V19, P163, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BABICH H, 1991, APPL ENVIRON MICROB, V57, P2101, DOI 10.1128/AEM.57.7.2101-2103.1991; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Bojunga N, 1998, MOL GEN GENET, V260, P453, DOI 10.1007/s004380050916; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Calera JA, 1997, INFECT IMMUN, V65, P4718, DOI 10.1128/IAI.65.11.4718-4724.1997; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Denning DW, 2002, LANCET INFECT DIS, V2, P251, DOI 10.1016/S1473-3099(02)00243-8; Derengowski LS, 2008, MED MYCOL, V46, P125, DOI 10.1080/13693780701670509; Dinauer Mary C., 2000, Hematology Am Soc Hematol Educ Program, P303; Ebel F, 2006, FUNGAL GENET BIOL, V43, P476, DOI 10.1016/j.fgb.2006.01.015; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HEARN VM, 1992, J MED MICROBIOL, V36, P61, DOI 10.1099/00222615-36-1-61; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; MASON DL, 1979, MYCOPATHOLOGIA, V68, P183, DOI 10.1007/BF00578528; Munoz P, 2006, CLIN MICROBIOL INFEC, V12, P24, DOI 10.1111/j.1469-0691.2006.01603.x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; REX JH, 1990, J INFECT DIS, V162, P523, DOI 10.1093/infdis/162.2.523; Schadeck RJG, 2003, FEMS MICROBIOL LETT, V218, P277, DOI 10.1111/j.1574-6968.2003.tb11529.x; Schobel F, 2007, INFECT IMMUN, V75, P1237, DOI 10.1128/IAI.01416-06; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Wasylnka JA, 2005, MED MYCOL, V43, pS27, DOI 10.1080/13693780400029247; Weber RWS, 1999, HISTOCHEM J, V31, P293, DOI 10.1023/A:1003713901179; Yamamoto A, 2007, EUKARYOT CELL, V6, P1373, DOI 10.1128/EC.00098-07; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367	53	91	354	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2655	10.1371/journal.pone.0002655	http://dx.doi.org/10.1371/journal.pone.0002655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648542	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800057
J	Leppanen, OV; Sievanen, H; Jokihaara, J; Pajamaki, I; Kannus, P; Jarvinen, TLN				Leppanen, Olli V.; Sievanen, Harri; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.			Pathogenesis of Age-Related Osteoporosis: Impaired Mechano-Responsiveness of Bone Is Not the Culprit	PLOS ONE			English	Article								Background: According to prevailing understanding, skeletal mechano-responsiveness declines with age and this apparent failure of the mechano-sensory feedback system has been attributed to the gradual bone loss with aging (age-related osteoporosis). The objective of this study was to evaluate whether the capacity of senescent skeleton to respond to increased loading is indeed reduced as compared to young mature skeleton. Methods and Findings: 108 male and 101 female rats were randomly assigned into Exercise and Control groups. Exercise groups were subjected to treadmill training either at peak bone mass between 47-61 weeks of age ( Mature) or at senescence between 75-102 weeks of age ( Senescent). After the training intervention, femoral necks and diaphysis were evaluated with peripheral quantitative computed tomography (pQCT) and mechanical testing; the proximal tibia was assessed with microcomputed tomography (mu CT). The mu CT analysis revealed that the senescent bone tissue was structurally deteriorated compared to the mature bone tissue, confirming the existence of age-related osteoporosis. As regards the mechano-responsiveness, the used loading resulted in only marginal increases in the bones of the mature animals, while significant exercise-induced increases were observed virtually in all bone traits among the senescent rats. Conclusion: The bones of senescent rats displayed a clear ability to respond to an exercise regimen that failed to initiate an adaptive response in mature animals. Thus, our observations suggest that the pathogenesis of age-related osteoporosis is not attributable to impaired mechano-responsiveness of aging skeleton. It also seems that strengthening of even senescent bones is possible - naturally provided that safe and efficient training methods can be developed for the oldest old.	[Leppanen, Olli V.; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Leppanen, Olli V.; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.] Tampere Univ Hosp, Dept Trauma, Musculoskel Surg & Rehab, Div Orthopaed & Traumatol, Tampere, Finland; [Sievanen, Harri; Kannus, Pekka] UKK Inst, Bone Res Grp, Tampere, Finland; [Jokihaara, Jarkko] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada	Tampere University; Tampere University; Tampere University Hospital; UKK Institute; University of British Columbia	Leppanen, OV (corresponding author), Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.	teppo.jarvinen@uta.fi	Jokihaara, Jarkko/C-5817-2017; Järvinen, Teppo/B-8189-2013	Jokihaara, Jarkko/0000-0001-6153-2180; Järvinen, Teppo/0000-0003-3713-956X; Leppanen, Olli/0000-0002-9782-8730	Competitive research funding of the Pirkanmaa Hospital District; Research Council for Physical Education and Sports; Ministry of Education; Academy of Finland; Sigrid Juselius Foundation; AO Research Fund, Switzerland	Competitive research funding of the Pirkanmaa Hospital District; Research Council for Physical Education and Sports; Ministry of Education; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); AO Research Fund, Switzerland	This study was supported by grants from the Competitive research funding of the Pirkanmaa Hospital District, the Research Council for Physical Education and Sports, Ministry of Education, the Academy of Finland, Sigrid Juselius Foundation, and the AO Research Fund, Switzerland. The study sponsors had no role in study design; collection, analysis, or interpretation of data; writing of the paper; or decision to submit it for publication.	Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Bass S, 1998, J BONE MINER RES, V13, P500, DOI 10.1359/jbmr.1998.13.3.500; BIKLE DD, 1994, J BONE MINER RES, V9, P1789; Buhl KM, 2001, J APPL PHYSIOL, V90, P1359, DOI 10.1152/jappl.2001.90.4.1359; BUREK JD, 1979, PATHOLOGY AGING RATS; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Cheng MZ, 1996, J BONE MINER RES, V11, P502; Cheng MZ, 1997, J BONE MINER RES, V12, P1424, DOI 10.1359/jbmr.1997.12.9.1424; FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Haapasalo H, 1998, J BONE MINER RES, V13, P310, DOI 10.1359/jbmr.1998.13.2.310; HALLORAN BP, 1995, J BONE MINER RES, V10, P1168; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Heinonen A, 2000, OSTEOPOROSIS INT, V11, P1010, DOI 10.1007/s001980070021; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hoshi A, 1998, TOHOKU J EXP MED, V185, P15, DOI 10.1620/tjem.185.15; Hoshi A, 1998, BIOMED ENVIRON SCI, V11, P243; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; Jarvinen TL, 2003, J BONE MINER RES, V18, P1921, DOI 10.1359/jbmr.2003.18.11.1921; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; Jarvinen TLN, 1998, J BONE MINER RES, V13, P1475, DOI 10.1359/jbmr.1998.13.9.1475; Jarvinen TLN, 1998, BONE, V22, P551, DOI 10.1016/S8756-3282(98)00025-8; Jarvinen TLN, 2003, J BONE MINER RES, V18, P1292, DOI 10.1359/jbmr.2003.18.7.1292; Joldersma M, 2001, AM J PHYSIOL-ENDOC M, V280, pE436, DOI 10.1152/ajpendo.2001.280.3.E436; KANNUS P, 1994, J BONE MINER RES, V9, P1613; Kannus P, 1996, J BONE MINER RES, V11, P1339; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Keenan KP, 1997, J NUTR, V127, pS851, DOI 10.1093/jn/127.5.851S; Khan K, 2000, J Sci Med Sport, V3, P150, DOI 10.1016/S1440-2440(00)80077-8; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Kontulainen S, 2002, J BONE MINER RES, V17, P2281, DOI 10.1359/jbmr.2002.17.12.2281; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; MacKelvie KJ, 2001, J PEDIATR-US, V139, P501, DOI 10.1067/mpd.2001.118190; McKay HA, 2000, J PEDIATR-US, V136, P156, DOI 10.1016/S0022-3476(00)70095-3; Mosley JR, 2002, BONE, V30, P314, DOI 10.1016/S8756-3282(01)00626-3; Pajamaki I, 2003, J BONE MINER RES, V18, P544, DOI 10.1359/jbmr.2003.18.3.544; PELKER R R, 1984, Journal of Orthopaedic Research, V1, P405; PENG MT, 1984, PHYSIOL BEHAV, V33, P615, DOI 10.1016/0031-9384(84)90380-9; PRISBY RD, 2007, J BONE MINER RES; RAAB DM, 1990, J APPL PHYSIOL, V68, P130, DOI 10.1152/jappl.1990.68.1.130; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; SEDLIN ED, 1966, ACTA ORTHOP SCAND, V37, P29, DOI 10.3109/17453676608989401; Seeman E, 2004, CALCIFIED TISSUE INT, V75, P100, DOI 10.1007/s00223-004-0289-4; SOGAARD CH, 1994, J BONE MINER RES, V9, P409; Szulc P, 2007, OSTEOPOROSIS INT, V18, P495, DOI 10.1007/s00198-006-0254-3; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; TURNER CH, 1994, J BONE MINER RES, V9, P87; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Turner RT, 1999, LUPUS, V8, P388, DOI 10.1177/096120339900800512; UMEMURA Y, 1995, INT J SPORTS MED, V16, P364, DOI 10.1055/s-2007-973021; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Westerlind KC, 1997, P NATL ACAD SCI USA, V94, P4199, DOI 10.1073/pnas.94.8.4199	65	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2540	10.1371/journal.pone.0002540	http://dx.doi.org/10.1371/journal.pone.0002540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648530	gold, Green Published			2022-12-25	WOS:000263288200012
J	Poliseno, L; Pitto, L; Simili, M; Mariani, L; Riccardi, L; Ciucci, A; Rizzo, M; Evangelista, M; Mercatanti, A; Pandolfi, PP; Rainaldi, G				Poliseno, Laura; Pitto, Letizia; Simili, Marcella; Mariani, Laura; Riccardi, Luisa; Ciucci, Alessia; Rizzo, Milena; Evangelista, Monica; Mercatanti, Alberto; Pandolfi, Pier Paolo; Rainaldi, Giuseppe			The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CHROMOSOME 13Q; TUMOR; MICRORNAS; GENE; HETEROZYGOSITY; EXPRESSION; P53; ANGIOGENESIS; PROGRESSION	MicroRNAs (miRNAs) are short 20-22 nucleotide RNA molecules that act as negative regulators of gene expression via translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis. The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 3'UTR is demonstrated. To validate the interaction miR-20a/3'UTR LRF miR-20a was over-expressed, either by transient transfection or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that other targets are cooperating. As LRF down-regulation/ p19ARF induction is always accompanied by E2F1 down-regulation and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF. Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of view the discovery of new physiological "senescence inducer'' appears to be promising as this molecule could be used as anticancer drug.	[Poliseno, Laura; Pitto, Letizia; Simili, Marcella; Mariani, Laura; Ciucci, Alessia; Rizzo, Milena; Evangelista, Monica; Mercatanti, Alberto; Rainaldi, Giuseppe] CNR, Inst Clin Physiol, Lab Gene & Mol, I-56100 Pisa, Italy; [Poliseno, Laura; Riccardi, Luisa; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Poliseno, Laura; Riccardi, Luisa; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Rainaldi, Giuseppe] Ist Toscano Tumori, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Poliseno, L (corresponding author), CNR, Inst Clin Physiol, Lab Gene & Mol, Via Savi 8, I-56100 Pisa, Italy.	g.rainaldi@ifc.cnr.it	Pitto, Letizia/A-3070-2014; Rizzo, Milena/L-1481-2016; Poliseno, Laura/B-5711-2012	Pitto, Letizia/0000-0002-8660-9516; Rizzo, Milena/0000-0001-5924-8615; Mercatanti, Alberto/0000-0001-5110-9688; EVANGELISTA, MONICA/0000-0002-5674-8523; Poliseno, Laura/0000-0001-6557-955X	Associazione Italiana Ricerca sul Cancro (AIRC); NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by Associazione Italiana Ricerca sul Cancro (AIRC).	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Eiriksdottir G, 1998, EUR J CANCER, V34, P2076, DOI 10.1016/S0959-8049(98)00241-X; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Mason SL, 2002, ONCOGENE, V21, P4220, DOI 10.1038/sj.onc.1205524; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Park C, 2006, INT J MOL MED, V17, P715; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shao JY, 2002, CHINESE MED J-PEKING, V115, P571; SYLVESTRE Y, 2006, J BIOL CHEM; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Tuccoli A, 2006, CELL CYCLE, V5, P2473, DOI 10.4161/cc.5.21.3422; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; WOODS K, 2006, J BIOL CHEM; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yogev O, 2006, J BIOL CHEM, V281, P34475, DOI 10.1074/jbc.M602865200	47	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2542	10.1371/journal.pone.0002542	http://dx.doi.org/10.1371/journal.pone.0002542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596985	gold, Green Published			2022-12-25	WOS:000263288200014
J	Chevallier, J; Chamoun, Z; Jiang, GW; Prestwich, G; Sakai, N; Matile, S; Parton, RG; Gruenberg, J				Chevallier, Julien; Chamoun, Zeina; Jiang, Guowei; Prestwich, Glenn; Sakai, Naomi; Matile, Stefan; Parton, Robert G.; Gruenberg, Jean			Lysobisphosphatidic acid controls endosomal cholesterol levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRANSPORT; BIOGENESIS; VESICLES; ALIX; DEGRADATION; TRAFFICKING; COMPARTMENT; MEMBRANES; PATHWAY	Most cell types acquire cholesterol by endocytosis of circulating low density lipoprotein, but little is known about the mechanisms of intra-endosomal cholesterol transport and about the primary cause of its aberrant accumulation in the cholesterol storage disorder Niemann-Pick type C (NPC). Here we report that lysobisphosphatidic acid (LBPA), an unconventional phospholipid that is only detected in late endosomes, regulates endosomal cholesterol levels under the control of Alix/AlP1, which is an LBPA-interacting protein involved in sorting into multivesicular endosomes. We find that Alix down-expression decreases both LBPA levels and the lumenal vesicle content of late endosomes. Cellular cholesterol levels are also decreased, presumably because the storage capacity of endosomes is affected and thus cholesterol clearance accelerated. Both lumenal membranes and cholesterol can be restored in Alix knockdown cells by exogenously added LBPA. Conversely, we also find that LBPA becomes limiting upon pathological cholesterol accumulation in NPC cells, because the addition of exogenous LBPA, but not of LBPA isoforms or analogues, partially reverts the NPC phenotype. We conclude that LBPA controls the cholesterol capacity of endosomes.	[Chevallier, Julien; Chamoun, Zeina; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Sakai, Naomi] Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland; [Jiang, Guowei; Prestwich, Glenn; Matile, Stefan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Geneva; University of Geneva; Utah System of Higher Education; University of Utah; University of Queensland; University of Queensland	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	Matile, Stefan/AFL-7826-2022; Chevallier, Julien/AAY-9567-2020; Sakai, Naomi/AFN-6204-2022; Parton, Robert G/C-5673-2009	Matile, Stefan/0000-0002-8537-8349; Chevallier, Julien/0000-0002-4423-9502; Sakai, Naomi/0000-0002-9460-1944; Parton, Robert G/0000-0002-7494-5248	Swiss National Science Foundation; Telethon; Australian National Health and Medical Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon(Fondazione Telethon); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Swiss National Science Foundation and the Telethon (to J. G.) and the Australian National Health and Medical Research Council (to R. G. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chevallier J, 2000, ORG LETT, V2, P1859, DOI 10.1021/ol0059246; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Dikic I, 2004, BIOESSAYS, V26, P604, DOI 10.1002/bies.20068; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gallegos AM, 2002, CHEM PHYS LIPIDS, V116, P19, DOI 10.1016/S0009-3084(02)00018-X; GAMBLE W, 1978, J LIPID RES, V19, P1068; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Jiang GW, 2005, ORG LETT, V7, P3837, DOI 10.1021/ol051194w; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lusa S, 2001, J CELL SCI, V114, P1893; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Mobius W, 2003, TRAFFIC, V4, P222; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; PARTON RG, 1992, J CELL SCI, V103, P335; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	51	140	140	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27871	27880		10.1074/jbc.M801463200	http://dx.doi.org/10.1074/jbc.M801463200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18644787	hybrid			2022-12-25	WOS:000259719200058
J	Iwai, T; Murai, J; Yoshikawa, H; Tsumaki, N				Iwai, Takao; Murai, Junko; Yoshikawa, Hideki; Tsumaki, Noriyuki			Smad7 inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN; GENE-EXPRESSION; CRE RECOMBINASE; I RECEPTORS; CARTILAGE DEVELOPMENT; GROWTH-PLATE; MOUSE; CHONDROGENESIS; PROLIFERATION; VIVO	Bone morphogenetic proteins (BMPs) play critical roles at various stages in endochondral bone formation. In vitro studies have demonstrated that Smad7 regulates transforming growth factor-beta and BMP signals by inhibiting Smad pathways in chondrocytes. However, the in vivo roles of Smad7 during cartilage development are unknown. To investigate distinct effects of Smad7 at different stages during chondrocyte differentiation, we generated a series of conditional transgenic mice that overexpress Smad7 in chondrocytes at various steps of differentiation by using the Cre/loxP system. Wegenerated Col11a2-lacZ(floxed)-Smad7 transgenic mice and mated them with three types of Cre transgenic mice to obtain Smad7(Prx1), Smad7(11Enh), and Smad7(11Prom) conditional transgenic mice. Smad7(Prx1) mice overexpressing Smad7 in condensing mesenchymal cells showed disturbed mesenchymal condensation associated with decreased Sox9 expression, leading to poor cartilage formation. Smad7(11Enh) mice overexpressing Smad7 in round chondrocytes showed decreased chondrocyte proliferation rates. Smad7(11Prom) mice overexpressing Smad7 in flat chondrocytes showed inhibited maturation of chondrocytes toward hypertrophy. Micromass culture of mesenchymal cells showed that BMP-induced cartilaginous nodule formation was down-regulated by overexpression of Smad7, but not Smad6. Overexpression of Smad7, but not Smad6, down-regulated the phosphorylation of p38 MAPKs. Our data provide in vivo evidence for distinct effects of Smad7 at different stages during chondrocyte differentiation and suggest that Smad7 in prechondrogenic cells inhibits chondrocyte differentiation possibly by down- regulating BMP- activated p38 MAPK pathways.	[Iwai, Takao; Murai, Junko; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, Suita, Osaka 5650871, Japan; [Iwai, Takao; Murai, Junko; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsumaki, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ntsumaki@dbcb.med.osaka-u.ac.jp	Murai, Junko/AAU-9516-2021	Tsumaki, Noriyuki/0000-0002-0520-3654	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18390415, 19659378]; Health and Labor Sciences of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences of Japan	This work was supported in part by Scientific Research Grants 18390415 and 19659378 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Health and Labor Sciences of Japan research grants. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Bauge C, 2007, ARTHRITIS RHEUM, V56, P3020, DOI 10.1002/art.22840; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; Fujimaki R, 2005, J BONE MINER METAB, V23, P270, DOI 10.1007/s00774-004-0595-y; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Horiki M, 2004, J CELL BIOL, V165, P433, DOI 10.1083/jcb.200311015; Ito Y, 2002, DEV DYNAM, V224, P69, DOI 10.1002/dvdy.10088; Kaiser M, 2004, ARTHRITIS RHEUM-US, V50, P3535, DOI 10.1002/art.20750; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Luukko K, 2001, MECH DEVELOP, V101, P209, DOI 10.1016/S0925-4773(00)00556-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PELTON RW, 1990, DEVELOPMENT, V110, P609; Peters PWJ, 1977, METHODS PRENATAL TOX, P153; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakou T, 1999, J BONE MINER RES, V14, P1145, DOI 10.1359/jbmr.1999.14.7.1145; Scharstuhl A, 2003, OSTEOARTHR CARTILAGE, V11, P773, DOI 10.1016/S1063-4584(03)00165-1; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	45	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27154	27164		10.1074/jbc.M801175200	http://dx.doi.org/10.1074/jbc.M801175200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18644788	hybrid			2022-12-25	WOS:000259586600036
J	Lee, SJ; Chan, TH; Chen, TC; Liao, BK; Hwang, PP; Lee, H				Lee, Shyh-Jye; Chan, Tun-Hao; Chen, Tzu-Cheng; Liao, Bo-Kai; Hwang, Pung-Pung; Lee, Hsinyu			LPA(1) is essential for lymphatic vessel development in zebrafish	FASEB JOURNAL			English	Article						lysophosphatidic acid; G protein-coupled receptor; endothelial cell; thoracic duct; morpholino	LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; SMOOTH-MUSCLE-CELLS; SPHINGOSINE 1-PHOSPHATE; VASCULAR DEVELOPMENT; SIGNALING DEFICITS; ENDOTHELIAL-CELLS; DORSAL AORTA; EXPRESSION; LYSOPHOSPHOLIPIDS	Lysophosphatidic acid (LPA) has long been implicated in regulating vascular development via endothelial cell-expressed G protein-coupled receptors. However, because of a lack of notable vascular defects reported in LPA receptor knockout mouse studies, the regulation of vasculature by LPA receptors in vivo is still uncertain. Using zebrafish as a model, we studied the gene expression patterns and functions of an LPA receptor, LPA(1), during embryonic development, in particular, vascular formation. Whole-mount in situ hybridization experiments revealed that zebrafish lpa(1) (zlpa(1)) was ubiquitously expressed early in development, and its expression domains were later localized to the head region and the vicinity of the dorsal aorta. The expression of zlpa(1) surrounding the dorsal aorta suggests its role in vasculature development. Knocking down of zLPA(1) by injecting morpholino (MO) oligonucleotides at 0.625-1.25 ng per embryo resulted in the absence of thoracic duct and edema in pericardial sac and trunk in a dose-dependent manner. These zlpa(1)-MO-resulted defects could be specifically rescued by ectopic expression of zlpa(1). In addition, overexpression of vegf-c, a well-known lymphangiogenic factor, also partially ameliorated the inhibition of thoracic duct development. Taken together, these results demonstrate that LPA, is necessary for lymphatic vessel formation during embryonic development in zebrafish.	[Lee, Shyh-Jye; Chan, Tun-Hao; Chen, Tzu-Cheng; Lee, Hsinyu] Natl Taiwan Univ, Inst Zool, Taipei 106, Taiwan; [Lee, Shyh-Jye; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Liao, Bo-Kai; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Lee, SJ (corresponding author), Natl Taiwan Univ, Inst Zool, 1 Roosevelt Rd,Sect 4, Taipei 106, Taiwan.	jefflee@ntu.edu.tw; hsinyulee@ntu.edu.tw	Liao, Bo-Kai/ABD-5143-2020; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AAH-1538-2022; Hwang, Pung-Pung/AEQ-4633-2022; Lee, Shyh-Jye/C-6092-2008	Liao, Bo-Kai/0000-0003-4742-4487; Lee, Shyh-Jye/0000-0001-8452-9152; Lee, Hsinyu/0000-0002-1477-0183	National Science Council of Taiwan [NSC95-2311-B-002-015-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC95-2311-B-002-015-MY3) to S.J.L. from the National Science Council of Taiwan.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Cerutis DR, 1997, AM J PHYSIOL-LUNG C, V273, pL10, DOI 10.1152/ajplung.1997.273.1.L10; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Devoto SH, 1996, DEVELOPMENT, V122, P3371; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; Eriksson J, 2000, J MORPHOL, V244, P167, DOI 10.1002/(SICI)1097-4687(200006)244:3<167::AID-JMOR2>3.0.CO;2-J; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hu YL, 2001, J NATL CANCER I, V93, P762, DOI 10.1093/jnci/93.10.762; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lin CI, 2006, J CELL BIOCHEM, V99, P1216, DOI 10.1002/jcb.20963; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Niki T, 2000, CLIN CANCER RES, V6, P2431; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ny A, 2006, EXP CELL RES, V312, P684, DOI 10.1016/j.yexcr.2005.10.018; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Schulze C, 1997, J NEUROCHEM, V68, P991; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Stickney HL, 2000, DEV DYNAM, V219, P287; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Thisse B, 2005, HIGH THROUGHPUT EXPR; Thisse B, 2004, ZFIN DIRECT DATA SUB; THISSE C, 1993, DEVELOPMENT, V119, P1203; Toews ML, 1997, J APPL PHYSIOL, V83, P1216, DOI 10.1152/jappl.1997.83.4.1216; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204, DOI 10.1152/ajpcell.1994.267.1.C204; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Weinstein BM, 2002, SEMIN CELL DEV BIOL, V13, P515, DOI 10.1016/S1084952102001052; Wu WT, 2005, ENDOCRINOLOGY, V146, P3387, DOI 10.1210/en.2004-1654; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	60	31	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3706	3715		10.1096/fj.08-106088	http://dx.doi.org/10.1096/fj.08-106088			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606866	Green Submitted			2022-12-25	WOS:000259642600031
J	Rudrabhatla, P; Zheng, YL; Amin, ND; Kesavapany, S; Albers, W; Pant, HC				Rudrabhatla, Parvathi; Zheng, Ya-Li; Amin, Niranjana D.; Kesavapany, Sashi; Albers, Wayne; Pant, Harish C.			Pin1-dependent Prolyl Isomerization Modulates the Stress-induced Phosphorylation of High Molecular Weight Neurofilament Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Aberrant phosphorylation of neuronal cytoskeletal proteins is a key pathological event in neurodegenerative disorders such as Alzheimer disease (AD) and amyotrophic lateral sclerosis, but the underlying mechanisms are still unclear. Previous studies have shown that Pin1, a peptidylprolyl cis/trans-isomerase, may be actively involved in the regulation of Tau hyperphosphorylation in AD. Here, we show that Pin1 modulates oxidative stressinduced NF-H phosphorylation. In an in vitro kinase assay, the addition of Pin1 substantially increased phosphorylation of NF-H KSP repeats by proline-directed kinases, Erk1/2, Cdk5/p35, and JNK3 in a concentration-dependent manner. In vivo, dominant-negative (DN) Pin1 and Pin1 small interfering RNA inhibited epidermal growth factor-induced NF-H phosphorylation. Because oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, we studied the role of Pin1 in stressed cortical neurons and HEK293 cells. Both hydrogen peroxide (H2O2) and heat stresses induce phosphorylation of NF-H in transfected HEK293 cells and primary cortical cultures. Knockdown of Pin1 by transfected Pin1 short interference RNA and DN-Pin1 rescues the effect of stress-induced NF-H phosphorylation. The H2O2 and heat shock induced perikaryal phospho-NF-H accumulations, and neuronal apoptosis was rescued by inhibition of Pin1 in cortical neurons. JNK3, a brain-specific JNK isoform, is activated under oxidative and heat stresses, and inhibition of Pin1 by Pin1 short interference RNA and DN-Pin1 inhibits this pathway. These results implicate Pin1 as a possible modulator of stress-induced NF-H phosphorylation as seen in neurodegenerative disorders likeAD and amyotrophic lateral sclerosis. Thus, Pin1 may be a potential therapeutic target for these diseases.	[Rudrabhatla, Parvathi; Zheng, Ya-Li; Amin, Niranjana D.; Albers, Wayne; Pant, Harish C.] NINDS, Lab Neurochem, NIH, Bethesda, MD 20892 USA; [Kesavapany, Sashi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117697, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National University of Singapore	Pant, HC (corresponding author), NINDS, Cytoskeletal Prot Regulat Sect, Lab Neurochem, NIH, Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.	panth@ninds.nih.gov		Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health Intramural Research Programs of the NINDS	National Institutes of Health Intramural Research Programs of the NINDS	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the NINDS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barone M. C., 2008, J NEUROCHEM, V274, P5211; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Brownlees J, 2000, J CELL SCI, V113, P401; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Davis R. J., 1997, NATURE, V389, P865; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; ELHANANY E, 1994, J NEUROCHEM, V63, P2324; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P16211, DOI 10.1021/bi981264p; Jaffe H., 1995, J NEUROCHEM, V64, P2681; Julien JP, 1995, BIOCHEM CELL BIOL, V73, P593, DOI 10.1139/o95-064; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; Masaki R, 2000, J NEUROSCI RES, V62, P75, DOI 10.1002/1097-4547(20001001)62:1<75::AID-JNR8>3.0.CO;2-V; McKeith IG, 2000, ANN NY ACAD SCI, V920, P1; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Pant AC, 1997, BRAIN RES, V765, P259, DOI 10.1016/S0006-8993(97)00561-1; Pant HC, 1995, BIOCHEM CELL BIOL, V73, P575, DOI 10.1139/o95-063; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHILLING K, 1989, J HISTOCHEM CYTOCHEM, V37, P241, DOI 10.1177/37.2.2492046; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; SHEA TB, 1989, DEV BRAIN RES, V50, P142, DOI 10.1016/0165-3806(89)90134-X; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Veeranna, 1998, J NEUROSCI, V18, P4008; Weigum SE, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-6; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26737	26747		10.1074/jbc.M801633200	http://dx.doi.org/10.1074/jbc.M801633200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VJ1XW	18635547	hybrid, Green Published			2022-12-25	WOS:000551106800001
J	De Leon, DD; Li, C; Delson, MI; Matschinsky, FM; Stanley, CA; Stoffers, DA				De Leon, Diva D.; Li, Changhong; Delson, Madeleine I.; Matschinsky, Franz M.; Stanley, Charles A.; Stoffers, Doris A.			Exendin-(9-39) corrects fasting hypoglycemia in SUR-1(-/-) mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INDEPENDENT POTENTIATION; KNOCKOUT MICE; GLUCOSE; RECEPTOR; INCRETIN; HYPERINSULINISM; ANTAGONIST; RELEASE; HUMANS	Congenital hyperinsulinism is a disorder of pancreatic beta-cell function characterized by failure to suppress insulin secretion in the setting of hypoglycemia, resulting in brain damage or death if untreated. Loss-of-function mutations in the K-ATP channel (composed of two subunits: Kir6.2 and SUR-1) are responsible for the most common and severe form of congenital hyperinsulinism. Most patients are unresponsive to available medical therapy and require palliative pancreatectomy. Similar to the human condition, the SUR-1(-/)-mouse is hypoglycemic when fasted and hyperglycemic when glucose-loaded. We have previously reported that the glucagon-like peptide-1 receptor antagonist exendin-(9-39) raises fasting blood glucose in normal mice. Here we examine the effect of exendin-(9-39) on fasting blood glucose in SUR-1(-/)-mice. Mice were randomized to receive exendin-(9-39) or vehicle. Fasting blood glucose levels in SUR-1(-/)-mice treated with exendin-(9-39) were significantly higher than in vehicle-treated mice and not different from wild-type littermates. Exendin-(9-39) did not further worsen glucose tolerance and had no effect on body weight and insulin sensitivity. Isolated islet perifusion studies demonstrated that exendin-(9-39) blocked amino acid-stimulated insulin secretion, which is abnormally increased in SUR-1(-/)-islets. Furthermore, cAMP content in SUR-1(-/)-islets was reduced by exendin-(9-39) both basally and when stimulated by amino acids, whereas cytosolic calcium levels were not affected. These findings suggest that cAMP plays a key role in K-ATP-independent insulin secretion and that the GLP-1 receptor is constitutively active in SUR-1(-/)-beta-cells. Our findings indicate that exendin-(9-39) normalizes fasting hypoglycemia in SUR-1(-/)-mice via a direct effect on insulin secretion, thereby raising exendin-(9-39) as a potential therapeutic agent for K-ATP hyperinsulinism.	[De Leon, Diva D.; Li, Changhong; Delson, Madeleine I.; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Dept Pediat, Philadelphia, PA 19104 USA; [De Leon, Diva D.; Matschinsky, Franz M.; Stanley, Charles A.; Stoffers, Doris A.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Stoffers, Doris A.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	De Leon, DD (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol Diabet, Dept Pediat, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	deleon@email.chop.edu; stoffers@mail.med.upenn.edu	De Leon, Diva D./V-8626-2019; Stoffers, Doris/H-6157-2012	De Leon, Diva D./0000-0003-1225-8087; STANLEY, CHARLES/0000-0003-4881-9392	American Diabetes Association Career Development Award; Pediatric Endocrine Career Development award in Diabetes Research [K12 DK063682]; Career Development Award [K23-DK073663]; Penn Diabetes Center [P30 DK 019525, R01DK53012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK063682, P30DK019525, K23DK073663, R01DK053012] Funding Source: NIH RePORTER	American Diabetes Association Career Development Award(American Diabetes Association); Pediatric Endocrine Career Development award in Diabetes Research; Career Development Award; Penn Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by an American Diabetes Association Career Development Award (to D. A. S.), Pediatric Endocrine Career Development award in Diabetes Research K12 DK063682, Career Development Award K23-DK073663, and a Pilot and Feasibility grant from the Penn Diabetes Center P30 DK 019525 (to D. D. L.) and R01DK53012 (to C. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; DAlessio DA, 1996, J CLIN INVEST, V97, P133, DOI 10.1172/JCI118380; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Doliba NM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1507, DOI 10.1152/ajpendo.00282.2006; Doliba NM, 2004, AM J PHYSIOL-ENDOC M, V286, pE834, DOI 10.1152/ajpendo.00292.2003; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Edwards CMB, 1999, DIABETES, V48, P86, DOI 10.2337/diabetes.48.1.86; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Flamez D, 1999, DIABETES, V48, P1979, DOI 10.2337/diabetes.48.10.1979; Fourtner SH, 2006, J PEDIATR-US, V149, P47, DOI 10.1016/j.jpeds.2006.02.033; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; KOLLIGS F, 1995, DIABETES, V44, P16, DOI 10.2337/diabetes.44.1.16; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; LOTEN EG, 1978, J BIOL CHEM, V253, P746; LOTEN EG, 1970, BIOCHEM J, V120, P187, DOI 10.1042/bj1200187; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Nakazaki M, 2002, DIABETES, V51, P3440, DOI 10.2337/diabetes.51.12.3440; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PILKIS SJ, 1975, J BIOL CHEM, V250, P6328; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Senft G, 1968, Diabetologia, V4, P322, DOI 10.1007/BF01211766; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; WANG ZL, 1995, J CLIN INVEST, V95, P417, DOI 10.1172/JCI117671; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006	39	56	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25786	25793		10.1074/jbc.M804372200	http://dx.doi.org/10.1074/jbc.M804372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635551	hybrid, Green Published			2022-12-25	WOS:000259200100004
J	Tomita, T; Kido, T; Kurotani, R; Iemura, SI; Sterneck, E; Natsume, T; Vinson, C; Kimura, S				Tomita, Takeshi; Kido, Taketomo; Kurotani, Reiko; Iemura, Shun-ichiro; Sterneck, Esta; Natsume, Tohru; Vinson, Charles; Kimura, Shioko			CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; HEPATOCYTE NUCLEAR FACTOR-3; SP-A GENE; C/EBP-ALPHA; REGULATES EXPRESSION; EPITHELIAL-CELLS; LUNG DEVELOPMENT; B PROMOTER; RAT LUNG; SURFACTANT	Secretoglobin (SCGB) 3A2 is a small molecular weight secreted protein predominantly expressed in lung airways. We previously demonstrated that the expression of SCGB3A2 is regulated by homeodomain transcription factor NKX2-1. Here we show that CCAAT/enhancer-binding proteins, C/EBP alpha and C/EBP delta, regulate mouse Scgb3a2 gene transcription in vivo and in vitro by binding to specific sites located in the Scgb3a2 promoter and the activity is synergistically enhanced through cooperative interaction with NKX2-1. Six C/EBP binding sites lie within 500 bp of the Scgb3a2 gene promoter, of which two sites, located at -44 to -54 bp and -192 to -201 bp, appear to be critical for the synergistic activation of Scgb3a2 gene transcription with NKX2-1. All three transcription factors, C/EBP alpha, C/EBP delta, and NKX2-1, are expressed in the epithelial cells of airways, particularly the bronchus, where high expression of SCGB3A2 is found. The expression of these transcription factors markedly increases toward the end of gestation, which coincides with the marked increase of SCGB3A2, suggesting the importance of C/EBP alpha and C/EBP delta, and their synergistic interaction with NKX2-1 in mouse Scgb3a2 gene transcription and lung development.	[Tomita, Takeshi; Kido, Taketomo; Kurotani, Reiko; Vinson, Charles; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kurotani, Reiko] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360006, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan; [Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yokohama City University; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bldg 37,Rm 3112B, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Sterneck, Esta/0000-0001-7716-8766; Tomita, Takeshi/0000-0001-6815-2244; Kido, Taketomo/0000-0001-9790-0862	National Cancer Institute, Center for Cancer Research; New Energy and Industrial Technology Development Organization; NATIONAL CANCER INSTITUTE [ZIABC010307, ZIABC005271, ZIABC010449] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, and in part by the New Energy and Industrial Technology Development Organization ( to T. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Berg T, 2006, AM J PHYSIOL-LUNG C, V291, pL683, DOI 10.1152/ajplung.00497.2005; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Cassel TN, 2002, J BIOL CHEM, V277, P36970, DOI 10.1074/jbc.M201293200; Cassel TN, 2000, AM J RESP CELL MOL, V22, P469, DOI 10.1165/ajrcmb.22.4.3916; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; Henson MC, 2004, REPRODUCTION, V127, P87, DOI 10.1530/rep.1.00037; Horster M, 2000, AM J PHYSIOL-RENAL, V279, pF982, DOI 10.1152/ajprenal.2000.279.6.F982; Ikeda K, 1996, MOL CELL BIOL, V16, P3626; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Magdaleno SM, 1997, AM J PHYSIOL-LUNG C, V272, pL1142, DOI 10.1152/ajplung.1997.272.6.L1142; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matlapudi A, 2002, BBA-GENE STRUCT EXPR, V1575, P91, DOI 10.1016/S0167-4781(02)00288-9; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; OGASAWARA Y, 1991, BIOCHIM BIOPHYS ACTA, V1083, P252, DOI 10.1016/0005-2760(91)90079-W; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perrone L, 1999, J BIOL CHEM, V274, P4640, DOI 10.1074/jbc.274.8.4640; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ray MK, 1996, MOL CELL BIOL, V16, P2056; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rosenberg E, 2002, BBA-GENE STRUCT EXPR, V1575, P82, DOI 10.1016/S0167-4781(02)00287-7; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SHIMIZU H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P53, DOI 10.1016/0005-2760(91)90249-H; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yang YS, 2001, AM J RESP CELL MOL, V24, P30, DOI 10.1165/ajrcmb.24.1.4050; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	46	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25617	25627		10.1074/jbc.M805140200	http://dx.doi.org/10.1074/jbc.M805140200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18632661	Green Published, hybrid			2022-12-25	WOS:000259012700057
J	Buscarlet, M; Perin, A; Laing, A; Brickman, JM; Stifani, S				Buscarlet, Manuel; Perin, Alessandro; Laing, Adam; Brickman, Joshua Mark; Stifani, Stefano			Inhibition of cortical neuron differentiation by Groucho/TLE1 requires interaction with WRPW, but not Eh1, repressor peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN-LIKE-ENHANCER; LOOP-HELIX FACTORS; TRANSCRIPTIONAL REPRESSION; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; CEREBRAL HEMISPHERES; DROSOPHILA GROUCHO; CRYSTAL-STRUCTURE; SPECIFICITY GENE; NERVOUS-SYSTEM	In both invertebrates and vertebrates, transcriptional co-repressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family regulate a number of developmental mechanisms, including neuronal differentiation. The pleiotropic activity of Gro/TLE depends on context-specific interactions with a variety of DNA-binding proteins. Most of those factors engage Gro/TLE through two different types of short peptide motifs, the WRP(W/Y) tetrapeptide and the Engrailed homology 1 (Eh1) sequence (FXIXXIL). The aim of this study was to elucidate the contribution of WRP(W/Y) and Eh1 motifs to mammalian Gro/TLE anti-neurogenic activity. Here we describe point mutations within the C-terminal WD40 repeat domain of Gro/TLE1 that do not perturb protein folding but disrupt the ability of Gro/TLE1 to inhibit the differentiation of cerebral cortex neural progenitor cells into neurons. One of those mutations, L743F, selectively blocks binding to Hes1, an anti-neurogenic basic helix-loop-helix protein that harbors a WRPW motif. In contrast, the L743F mutation does not disrupt binding to Engrailed1 and FoxG1, which both contain Eh1 motifs, nor to Tcf3, which binds to the Gro/TLE N terminus. These results demonstrate that the recruitment of transcription factors harboring WRP(W/Y) tetrapeptides is essential to the antineurogenic function of Gro/TLE1.	[Buscarlet, Manuel; Perin, Alessandro; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; [Laing, Adam; Brickman, Joshua Mark] MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	McGill University; University of Edinburgh	Stifani, S (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	stefano.stifani@mcgill.ca	Perin, Alessandro/AAM-6299-2021; Perin, Alessandro/AAC-1316-2019	Perin, Alessandro/0000-0002-6697-9835; Stifani, Stefano/0000-0002-2376-7701; Brickman, Joshua/0000-0003-1580-7491	University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy); MRC; Trust and Scottish Funding Council; Canadian Institutes of Health Research [MOP-13957]; Medical Research Council [G0700711B] Funding Source: researchfish	University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Trust and Scottish Funding Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Residency Fellowship from the University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy) (to A.P.), an MRC Studentship ( to A. L.), by grants from the Wellcome Trust and Scottish Funding Council ( to J.M.B.), and the Canadian Institutes of Health Research (MOP-13957) ( to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Courey AJ, 2001, GENE DEV, V15, P2786; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Friocourt G, 2008, J NEUROSCI, V28, P5794, DOI 10.1523/JNEUROSCI.1067-08.2008; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; MILLER DM, 1993, GENETICS, V135, P741; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Panto MR, 2004, EUR J NEUROSCI, V19, P2893, DOI 10.1111/j.0953-816X.2004.03326.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Toma JG, 2000, J NEUROSCI, V20, P7648; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516	53	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24881	24888		10.1074/jbc.M800722200	http://dx.doi.org/10.1074/jbc.M800722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611861	Green Published, hybrid			2022-12-25	WOS:000258820000053
J	Koszelak-Rosenblum, M; Krol, AC; Simmons, DM; Goulah, CC; Wroblewski, L; Malkowski, MG				Koszelak-Rosenblum, Mary; Krol, Adam C.; Simmons, Danielle M.; Goulah, Christopher C.; Wroblewski, Liliana; Malkowski, Michael G.			His-311 and Arg-559 are key residues involved in fatty acid oxygenation in pathogen-inducible oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; FUNGUS GAEUMANNOMYCES-GRAMINIS; THERMAL SHIFT ASSAYS; ARACHIDONIC-ACID; ALPHA-DIOXYGENASE; HYDROPEROXIDE ISOMERASE; PROTEIN-STABILITY; CRYSTAL-STRUCTURE; DRUG DISCOVERY	Pathogen-inducible oxygenase ( PIOX) oxygenates fatty acids into 2R-hydroperoxides. PIOX belongs to the fatty acid alpha-dioxygenase family, which exhibits homology to cyclooxygenase enzymes (COX-1 and COX-2). Although these enzymes share common catalytic features, including the use of a tyrosine radical during catalysis, little is known about other residues involved in the dioxygenase reaction of PIOX. We generated a model of linoleic acid ( LA) bound to PIOX based on computational sequence alignment and secondary structure predictions with COX-1 and experimental observations that governed the placement of carbon-2 of LA below the catalytic Tyr-379. Examination of the model identified His-311, Arg-558, and Arg-559 as potential molecular determinants of the dioxygenase reaction. Substitutions at His-311 and Arg-559 resulted in mutant constructs that retained virtually no oxygenase activity, whereas substitutions of Arg-558 caused only moderate decreases in activity. Arg-559 mutant constructs exhibited increases of greater than 140-fold in K-m, whereas no substantial change in Km was observed for His-311 or Arg-558 mutant constructs. Thermal shift assays used to measure ligand binding affinity show that the binding of LA is significantly reduced in a Y379F/R559A mutant construct compared with that observed for Y379F/R558A construct. Although Oryza sativa PIOX exhibited oxygenase activity against a variety of 14-20-carbon fatty acids, the enzyme did not oxygenate substrates containing modifications at the carboxylate, carbon-1, or carbon-2. Taken together, these data suggest that Arg-559 is required for high affinity binding of substrates to PIOX, whereas His-311 is involved in optimally aligning carbon-2 below Tyr-379 for catalysis.	[Koszelak-Rosenblum, Mary; Krol, Adam C.; Simmons, Danielle M.; Goulah, Christopher C.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Simmons, Danielle M.; Wroblewski, Liliana; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), 700 Ellicott St, Buffalo, NY 14221 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health [R01GM077176]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM077176. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Gerritse G, 1998, J BIOTECHNOL, V64, P23, DOI 10.1016/S0168-1656(98)00101-1; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hamberg M, 1999, J BIOL CHEM, V274, P24503, DOI 10.1074/jbc.274.35.24503; Hamberg M, 2002, INT CONGR SER, V1233, P307, DOI 10.1016/S0531-5131(02)00158-9; Hamberg M, 2002, PROSTAG OTH LIPID M, V68-9, P363, DOI 10.1016/S0090-6980(02)00040-0; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim YC, 2002, J EXP BOT, V53, P383, DOI 10.1093/jexbot/53.367.383; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Kozak KR, 2003, BIOCHEMISTRY-US, V42, P9041, DOI 10.1021/bi034471k; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Liu W, 2006, PLANT PHYSIOL BIOCH, V44, P284, DOI 10.1016/j.plaphy.2006.06.013; Liu W, 2004, J BIOL CHEM, V279, P29805, DOI 10.1074/jbc.M401779200; Lloyd T, 2006, ACTA CRYSTALLOGR F, V62, P365, DOI 10.1107/S1744309106007305; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tirajoh A, 2005, J EXP BOT, V56, P713, DOI 10.1093/jxb/eri038; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233	43	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24962	24971		10.1074/jbc.M804358200	http://dx.doi.org/10.1074/jbc.M804358200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596034	hybrid, Green Published			2022-12-25	WOS:000258820000057
J	Alieva, NO; Konzen, KA; Field, SF; Meleshkevitch, EA; Hunt, ME; Beltran-Ramirez, V; Miller, DJ; Wiedenmann, J; Salih, A; Matz, MV				Alieva, Naila O.; Konzen, Karen A.; Field, Steven F.; Meleshkevitch, Ella A.; Hunt, Marguerite E.; Beltran-Ramirez, Victor; Miller, David J.; Wiedenmann, Joerg; Salih, Anya; Matz, Mikhail V.			Diversity and Evolution of Coral Fluorescent Proteins	PLOS ONE			English	Article								GFP-like fluorescent proteins (FPs) are the key color determinants in reef-building corals (class Anthozoa, order Scleractinia) and are of considerable interest as potential genetically encoded fluorescent labels. Here we report 40 additional members of the GFP family from corals. There are three major paralogous lineages of coral FPs. One of them is retained in all sampled coral families and is responsible for the non-fluorescent purple-blue color, while each of the other two evolved a full complement of typical coral fluorescent colors (cyan, green, and red) and underwent sorting between coral groups. Among the newly cloned proteins are a "chromo-red'' color type from Echinopora forskaliana (family Faviidae) and pink chromoprotein from Stylophora pistillata (Pocilloporidae), both evolving independently from the rest of coral chromoproteins. There are several cyan FPs that possess a novel kind of excitation spectrum indicating a neutral chromophore ground state, for which the residue E167 is responsible (numeration according to GFP from A. victoria). The chromoprotein from Acropora millepora is an unusual blue instead of purple, which is due to two mutations: S64C and S183T. We applied a novel probabilistic sampling approach to recreate the common ancestor of all coral FPs as well as the more derived common ancestor of three main fluorescent colors of the Faviina suborder. Both proteins were green such as found elsewhere outside class Anthozoa. Interestingly, a substantial fraction of the all-coral ancestral protein had a chromohore apparently locked in a non-fluorescent neutral state, which may reflect the transitional stage that enabled rapid color diversification early in the history of coral FPs. Our results highlight the extent of convergent or parallel evolution of the color diversity in corals, provide the foundation for experimental studies of evolutionary processes that led to color diversification, and enable a comparative analysis of structural determinants of different colors.	[Alieva, Naila O.; Field, Steven F.; Hunt, Marguerite E.; Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Konzen, Karen A.; Meleshkevitch, Ella A.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [Beltran-Ramirez, Victor; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanography Ctr, Southampton, Hants, England; [Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Salih, Anya] Univ W Sydney, Sch Nat Sci, Penrith, NSW, Australia	University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; James Cook University; NERC National Oceanography Centre; University of Southampton; Ulm University; Western Sydney University	Alieva, NO (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819	NIH [R01 GM66243]; Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies; Deutsche Forschungsgemeinschaft [Wi1990 2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grant R01 GM66243 to M.V.M., the Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies to D.J.M, Deutsche Forschungsgemeinschaft grant Wi1990 2-1 to J.W., and ARC/NHMRC Network FABLS Australia (collaborative grant to A.S. et al.)	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Agmon N, 2007, J PHYS CHEM B, V111, P7870, DOI 10.1021/jp071403p; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chan MCY, 2006, J BIOL CHEM, V281, P37813, DOI 10.1074/jbc.M606921200; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P452, DOI 10.1038/nbt0403-452a; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-6; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KARAN M, 2002, CELL VISUAL CHARACTE; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; KAWAGUTI S, 1966, BIOL J OKAYAMA U, V2, P11; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2006, METHOD BIOCHEM ANAL, V47, P121; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Matz M. V., 2003, GENERATION CDNA LIB; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Miller DJ, 2000, BIOESSAYS, V22, P291, DOI 10.1002/(SICI)1521-1878(200003)22:3<291::AID-BIES11>3.0.CO;2-2; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Quillin ML, 2005, BIOCHEMISTRY-US, V44, P5774, DOI 10.1021/bi047644u; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Sun Y, 2004, FEBS LETT, V570, P175, DOI 10.1016/j.febslet.2004.06.043; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wiedenmann J, 2000, P NATL ACAD SCI USA, V97, P14091, DOI 10.1073/pnas.97.26.14091; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	60	215	221	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2680	10.1371/journal.pone.0002680	http://dx.doi.org/10.1371/journal.pone.0002680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648549	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000264057200024
J	Ross, A; Penny, M; Maire, N; Studer, A; Carneiro, I; Schellenberg, D; Greenwood, B; Tanner, M; Smith, T				Ross, Amanda; Penny, Melissa; Maire, Nicolas; Studer, Alain; Carneiro, Ilona; Schellenberg, David; Greenwood, Brian; Tanner, Marcel; Smith, Thomas			Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; DOUBLE-BLIND; ROUTINE VACCINATIONS; TANZANIAN INFANTS; EXPANDED PROGRAM; PARASITE DENSITY; INOCULATION RATE; CONTROLLED-TRIAL; CHILDREN	Background: Trials of intermittent preventive treatment against malaria in infants (IPTi) using sulphadoxine-pyrimethamine (SP) have shown a positive, albeit variable, protective efficacy against clinical malaria episodes. The impact of IPTi in different epidemiological settings and over time is unknown and predictions are hampered by the lack of knowledge about how IPTi works. We investigated mechanisms proposed for the action of IPTi and made predictions of the likely impact on morbidity and mortality. Methods/Principal Findings: We used a comprehensive, individual-based, stochastic model of malaria epidemiology to simulate recently published trials of IPTi using SP with site-specific characteristics as inputs. This baseline model was then modified to represent hypotheses concerning the duration of action of SP, the temporal pattern of fevers caused by individual infections, potential benefits of avoiding fevers on immunity and the effect of sub-therapeutic levels of SP on parasite dynamics. The baseline model reproduced the pattern of results reasonably well. None of the models based on alternative hypotheses improved the fit between the model predictions and observed data. Predictions suggest that IPTi would have a beneficial effect across a range of transmission intensities. IPTi was predicted to avert a greater number of episodes where IPTi coverage was higher, the health system treatment coverage lower, and for drugs which were more efficacious and had longer prophylactic periods. The predicted cumulative benefits were proportionately slightly greater for severe malaria episodes and malaria-attributable mortality than for acute episodes in the settings modelled. Modest increased susceptibility was predicted between doses and following the last dose, but these were outweighed by the cumulative benefits. The impact on transmission intensity was negligible. Conclusions: The pattern of trial results can be accounted for by differences between the trial sites together with known features of malaria epidemiology and the action of SP. Predictions suggest that IPTi would have a beneficial impact across a variety of epidemiological settings.	[Ross, Amanda; Penny, Melissa; Maire, Nicolas; Studer, Alain; Tanner, Marcel; Smith, Thomas] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Carneiro, Ilona; Schellenberg, David; Greenwood, Brian] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of London; London School of Hygiene & Tropical Medicine	Ross, A (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	amanda.ross@unibas.ch	Penny, Melissa A/N-6838-2015; Smith, Thomas/B-5569-2015	Penny, Melissa A/0000-0002-4972-593X; Smith, Thomas/0000-0002-3650-9381; Ross, Amanda/0000-0001-6027-5645; Schellenberg, David/0000-0001-8222-0186	The Bill and Melinda Gates Foundation	The Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by The Bill and Melinda Gates Foundation through the IPTi Consortium. The funders had no role in study design, development of the model, decision to publish, or preparation of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; BINKA FN, 1994, T ROY SOC TROP MED H, V88, P381, DOI 10.1016/0035-9203(94)90391-3; BOYD MARK F., 1940, AMER JOUR TROP MED, V20, P279; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; CHITNIS N, 2008, J BIOL DYNA IN PRESS; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986; DICKO A, 2004, AM J TROP MED HYG S, V71; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Gatton ML, 2004, ANTIMICROB AGENTS CH, V48, P2116, DOI 10.1128/AAC.48.6.2116-2123.2004; GLYNN JR, 1995, T ROY SOC TROP MED H, V89, P281, DOI 10.1016/0035-9203(95)90540-5; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hastings IM, 2006, TRENDS PARASITOL, V22, P71, DOI 10.1016/j.pt.2005.12.011; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; INDEPTH Network, 2002, POP HLTH SURV INDEPT; KOBBE R, 2002, MALARIA J, V6, P163; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; LINES J, 1992, PARASITOL TODAY, V8, P381, DOI 10.1016/0169-4758(92)90176-3; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; MAIRE N, 2008, DISTRIBUTED IN PRESS; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; O'Meara WP, 2006, PLOS MED, V3, P633, DOI 10.1371/journal.pmed.0030141; ODURO A, 2007, TROP MED INT HEALTH, V10, P279; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Ringwald P, 2005, SUSCEPTIBILITY PLASM; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Schellenberg D, 2005, LANCET, V366, P545, DOI 10.1016/S0140-6736(05)67093-6; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SMITH T, 1995, AM J TROP MED HYG, V52, P306, DOI 10.4269/ajtmh.1995.52.306; SMITH T, 2008, PARASITOL IN PRESS; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; ter Kuile FO, 2006, J INFECT DIS, V194, P269, DOI 10.1086/505434; WALTON GA, 1947, ANN TROP MED PARASIT, V41, P380, DOI 10.1080/00034983.1947.11685341; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; 2007, IPTI CONSORTIUM STAT	67	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2661	10.1371/journal.pone.0002661	http://dx.doi.org/10.1371/journal.pone.0002661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628828	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000264057200007
J	Huang, L; Verstrepen, L; Heyninck, K; Wullaert, A; Revets, H; De Baetselier, P; Beyaert, R				Huang, L.; Verstrepen, L.; Heyninck, K.; Wullaert, A.; Revets, H.; De Baetselier, P.; Beyaert, R.			ABINs inhibit EGF receptor-mediated NF-kappa B activation and growth of EGF receptor-overexpressing tumour cells	ONCOGENE			English	Article						ABIN; EGF receptor; NF-kappa B; proliferation; cancer	ADENOVIRAL GENE-TRANSFER; BREAST-CANCER; A20-BINDING INHIBITOR; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET; BINDING-PROTEIN; CYCLIN D1; EXPRESSION; PHOSPHORYLATION; KINASE	The epidermal growth factor receptor (EGFR) is frequently overexpressed in various tumours of epidermal origin and is held responsible for tumourigenicity and tumour persistence. Increased nuclear factor (NF)-kappa B activity has been suggested to be involved in the malignant behaviour of EGFR-overexpressing cells. However, the mechanisms that regulate EGF-induced NF-kappa B activation are still largely unknown. Here we show that EGF can induce NF-kappa B-dependent gene expression independently from I kappa B alpha degradation or p100 processing in EGFR-overexpressing HEK293T cells. Moreover, EGF-induced NF-kappa B activation could be inhibited by overexpression of ABINs, which were previously identified as intracellular inhibitors of tumour necrosis factor, interleukin-1 and lipopolysaccharide-induced NF-kappa B activation. Knockdown of ABIN-1 by RNA interference boosted the NF-kappa B response upon EGF stimulation. The C-terminal ubiquitin-binding domain containing region of ABINs was crucial and sufficient for NF-kappa B inhibition. Adenoviral gene transfer of ABINs reduced constitutive NF-kappa B activity as well as the proliferation of EGFR-overexpressing A431 and DU145 human carcinoma cells. Altogether, these results demonstrate an important role for an ABIN-sensitive non-classical NF-kappa B signalling pathway in the proliferation of EGFR-overexpressing tumour cells, and indicate a potential use for ABIN gene therapy in the treatment of cancer.	[Huang, L.; Verstrepen, L.; Heyninck, K.; Wullaert, A.; Beyaert, R.] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Oost Vlaanderen, Belgium; [Huang, L.; Revets, H.; De Baetselier, P.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Huang, L.; Revets, H.; De Baetselier, P.] VIB, Dept Mol & Cellular Interact, Brussels, Belgium; [Huang, L.; Verstrepen, L.; Heyninck, K.; Wullaert, A.; Beyaert, R.] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ghent University	Beyaert, R (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Technol Pk 927, B-9052 Ghent, Oost Vlaanderen, Belgium.	rudi.beyaert@dmbr.ugent.be	De Baetselier, Patrick/D-3866-2014; Huang, Lieven/B-4630-2008; Wullaert, Andy/R-1924-2019; Beyaert, Rudi/B-2589-2009; Wullaert, Andy/D-2975-2018	Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X; Beyaert, Rudi/0000-0002-5704-582X	Interuniversitaire Attractiepolen [IAP6/18]; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen); GOA of the University of Gent; IWT-Vlaanderen; Emmanuel Vanderschueren Stichting	Interuniversitaire Attractiepolen; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen)(FWO); GOA of the University of Gent; IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Emmanuel Vanderschueren Stichting	This work was supported in part by grants from the 'Interuniversitaire Attractiepolen' (IAP6/18), the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen), the GOA of the University of Gent. LH is a predoctoral research fellow supported by the IWT-Vlaanderen and the Emmanuel Vanderschueren Stichting.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Anto RJ, 2003, J BIOL CHEM, V278, P25490, DOI 10.1074/jbc.M301790200; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen DY, 2003, ONCOGENE, V22, P4348, DOI 10.1038/sj.onc.1206532; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Damiano V, 2006, CLIN CANCER RES, V12, P577, DOI 10.1158/1078-0432.CCR-05-1943; DeValck D, 1997, BIOCHEM BIOPH RES CO, V238, P590, DOI 10.1006/bbrc.1997.7343; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; El Sheikh SS, 2004, NEOPLASIA, V6, P846, DOI 10.1593/neo.04379; FAN Z, 1993, CANCER RES, V53, P4322; Gasparian AV, 2002, J CELL SCI, V115, P141; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Guo GZ, 2004, ONCOGENE, V23, P535, DOI 10.1038/sj.onc.1207149; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haussler U, 2005, AM J PHYSIOL-RENAL, V289, pF808, DOI 10.1152/ajprenal.00434.2003; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Keutgens A, 2006, BIOCHEM PHARMACOL, V72, P1069, DOI 10.1016/j.bcp.2006.06.011; Kirkwood KS, 2003, J GASTROINTEST SURG, V7, P43; KONGER RL, 1993, J CELL PHYSIOL, V156, P515, DOI 10.1002/jcp.1041560310; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Makino K, 2004, ONCOGENE, V23, P3883, DOI 10.1038/sj.onc.1207485; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Meeran SM, 2008, FRONT BIOSCI-LANDMRK, V13, P2191, DOI 10.2741/2834; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Peng D, 1996, CANCER RES, V56, P3666; Reid A, 2007, EUR J CANCER, V43, P481, DOI 10.1016/j.ejca.2006.11.007; Sclabas GM, 2003, J GASTROINTEST SURG, V7, P37, DOI 10.1016/S1091-255X(02)00088-4; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Van Laere SJ, 2007, BRIT J CANCER, V97, P659, DOI 10.1038/sj.bjc.6603906; Verstrepen L, 2008, J CELL MOL MED, V12, P316, DOI 10.1111/j.1582-4934.2007.00187.x; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Zhang SL, 2002, BIOCHEM BIOPH RES CO, V297, P17, DOI 10.1016/S0006-291X(02)02086-7	65	28	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6131	6140		10.1038/onc.2008.208	http://dx.doi.org/10.1038/onc.2008.208			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18622428				2022-12-25	WOS:000260083100006
J	Nilsson, SK; Christensen, S; Raarup, MK; Ryan, RO; Nielsen, MS; Olivecrona, G				Nilsson, Stefan K.; Christensen, Stine; Raarup, Merete K.; Ryan, Robert O.; Nielsen, Morten S.; Olivecrona, Gunilla			Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the Vps10p domain receptor families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; SORTILIN/NEUROTENSIN RECEPTOR-3; BINDS; CHOLESTEROL; SORTILIN; IDENTIFICATION; ASSOCIATION; MICROSCOPY; BRAIN; RISK	Apolipoprotein A-V (apoA-V) is present in low amounts in plasma and has been found to modulate triacylglycerol levels in humans and in animal models. ApoA-V displays affinity for members of the low density lipoprotein receptor (LDL-R) gene family, known as the classical lipoprotein receptors, including LRP1 and SorLA/LR11. In addition to LDL-A binding repeats, the mosaic receptor SorLA/LR11 also possesses a Vps10p domain. Here we show that apoA-V also binds to sortilin, a receptor from the Vsp10p domain gene family that lacks LDL-A repeats. Binding of apoA-V to sortilin was competed by neurotensin, a ligand that binds specifically to the Vps10p domain. To investigate the biological fate of receptor-bound apoA-V, binding experiments were conducted with cultured human embryonic kidney cells transfected with either SorLA/LR11 or sortilin. Compared with nontransfected cells, apoA-V binding to SorLA/LR11-and sortilin-expressing cells was markedly enhanced. Internalization experiments, live imaging studies, and fluorescence resonance energy transfer analyses demonstrated that labeled apoA-V was rapidly internalized, co-localized with receptors in early endosomes, and followed the receptors through endosomes to the trans-Golgi network. The observed decrease of fluorescence signal intensity as a function of time during live imaging experiments suggested ligand uncoupling in endosomes with subsequent delivery to lysosomes for degradation. This interpretation was supported by experiments with I-125-labeled apoA-V, demonstrating clear differences in degradation between transfected and nontransfected cells. We conclude that apoA-V binds to receptors possessing LDL-A repeats and Vsp10p domains and that apoA-V is internalized into cells via these receptors. This could be a mechanism by which apoA-V modulates lipoprotein metabolism in vivo.	[Nilsson, Stefan K.; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Christensen, Stine; Raarup, Merete K.; Nielsen, Morten S.] Univ Aarhus, MIND Ctr, Dept Med Biochem & Stereol, DK-8000 Aarhus, Denmark; [Christensen, Stine; Raarup, Merete K.; Nielsen, Morten S.] Univ Aarhus, Elect Microscopy Res Lab, DK-8000 Aarhus, Denmark; [Ryan, Robert O.] Childrens Hosp, Oakland Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, Oakland, CA 94609 USA	Umea University; Aarhus University; Aarhus University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Olivecrona, G (corresponding author), Umea Univ Hosp Area, Bldg 6M,3rd Floor, SE-90187 Umea, Sweden.		Nielsen, Morten Schallburg/G-9498-2016; Nilsson, Stefan/K-5555-2012	Nielsen, Morten Schallburg/0000-0001-9863-9694; 	National Institutes of Health [HL-073061]; Swedish Research Council [12203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073061. This work was also supported by Swedish Research Council Grant 12203 and King Gustav V and Queen Victoria Research Foundation. The MIND-Center is sponsored by The Lundbeck Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Calandra S, 2006, CURR OPIN LIPIDOL, V17, P122, DOI 10.1097/01.mol.0000217892.00618.54; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang W, 2006, BIOCHEM BIOPH RES CO, V346, P14, DOI 10.1016/j.bbrc.2006.05.072; Hubacek JA, 2005, CLIN CHEM LAB MED, V43, P897, DOI 10.1515/CCLM.2005.153; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Merkel M, 2005, J CLIN INVEST, V115, P2694, DOI 10.1172/JCI26712; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Niculescu LS, 2007, CLIN CHEM LAB MED, V45, P1133, DOI 10.1515/CCLM.2007.257; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Shu X, 2007, J LIPID RES, V48, P1445, DOI 10.1194/jlr.C700002-JLR200; Sun GT, 2006, CHEM PHYS LIPIDS, V143, P22, DOI 10.1016/j.chemphyslip.2006.04.004; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Vaessen SFC, 2006, J LIPID RES, V47, P2064, DOI 10.1194/jlr.M600233-JLR200; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035	42	88	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25920	25927		10.1074/jbc.M802721200	http://dx.doi.org/10.1074/jbc.M802721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18603531	Green Published, hybrid			2022-12-25	WOS:000259200100019
J	Compton, SA; Tolun, G; Kamath-Loeb, AS; Loeb, LA; Griffith, JD				Compton, Sarah A.; Tolun, Goekhan; Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.; Griffith, Jack D.			The Werner syndrome protein binds replication fork and Holliday junction DNAs as an oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECQ; HELICASE; EXONUCLEASE; VISUALIZATION; BLM; COMPLEXES; MECHANISM; DOMAIN; P53; WRN	Werner syndrome is an inherited disease displaying a premature aging phenotype. The gene mutated in Werner syndrome encodes both a 3' -> 35' DNA helicase and a 3' -> 35' DNA exonuclease. Both WRN helicase and exonuclease preferentially utilize DNA substrates containing alternate secondary structures. By virtue of its ability to resolve such DNA structures, WRN is postulated to prevent the stalling and collapse of replication forks that encounter damaged DNA. Using electron microscopy, we visualized the binding of full-length WRN to DNA templates containing replication forks and Holliday junctions, intermediates observed during DNA replication and recombination, respectively. We show that both wild-type WRN and a helicase-defective mutant bind with exceptionally high specificity (> 1000-fold) to DNA secondary structures at the replication fork and at Holliday junctions. Little or no binding is observed elsewhere on the DNA molecules. Calculations of the molecular weight of full-length WRN revealed that, in solution, WRN exists predominantly as a dimer. However, WRN bound to DNA is larger; the mass is consistent with that of a tetramer.	[Compton, Sarah A.; Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451	National Institutes of Health [F32 GM077900, GM31819, ES013773]; Glenn foundation; Genome Network Project [PO1 CA077852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077900, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn foundation; Genome Network Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 GM077900 (to S.A.C.), GM31819 (to J.D.G.), and ES013773 (to J.D.G.), a Glenn foundation award (to J.D.G.), and Genome Network Project Grant PO1 CA077852 (to L.A.L.).	Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Fouche N, 2006, BIOCHEMISTRY-US, V45, P9624, DOI 10.1021/bi060313s; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamath-Loeb Ashwini S., 2006, V47, P435; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Wu L, 2007, DNA REPAIR, V6, P936, DOI 10.1016/j.dnarep.2007.02.007; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	31	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24478	24483		10.1074/jbc.M803370200	http://dx.doi.org/10.1074/jbc.M803370200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596042	hybrid, Green Published			2022-12-25	WOS:000258820000022
J	Cunha, FM; Berti, DA; Ferreira, ZS; Klitzke, CF; Markus, RP; Ferro, ES				Cunha, Fernanda M.; Berti, Denise A.; Ferreira, Zulma S.; Klitzke, Clecio F.; Markus, Regina P.; Ferro, Emer S.			Intracellular peptides as natural regulators of cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 24.15; SOLUBLE METALLOENDOPEPTIDASE; ANTIGENIC PEPTIDES; EC 3.4.24.15; PROTEIN; DEGRADATION; RECEPTOR; LOCALIZATION; NEUROLYSIN	Protein degradation by the ubiquitin proteasome system releases large amounts of oligopeptides within cells. To investigate possible functions for these intracellularly generated oligopeptides, we fused them to a cationic transactivator peptide sequence using reversible disulfide bonds, introduced them into cells, and analyzed their effect on G protein-coupled receptor (GPCR) signal transduction. A mixture containing four of these peptides (20-80 mu M) significantly inhibited the increase in the extracellular acidification response triggered by angiotensin II (ang II) in CHO-S cells transfected with the ang II type 1 receptor (AT1R-CHO-S). Subsequently, either alone or in a mixture, these peptides increased luciferase gene transcription in AT1R-CHO-S cells stimulated with ang II and in HEK293 cells treated with isoproterenol. These peptides without transactivator failed to affect GPCR cellular responses. All four functional peptides were shown in vitro to competitively inhibit the degradation of a synthetic substrate by thimet oligopeptidase. Overexpression of thimet oligopeptidase in both CHO-S and HEK293 cells was sufficient to reduce luciferase activation triggered by a specific GPCR agonist. Moreover, using individual peptides as baits in affinity columns, several proteins involved in GPCR signaling were identified, including alpha-adaptin A and dynamin 1. These results suggest that before their complete degradation, intracellular peptides similar to those generated by proteasomes can actively affect cell signaling, probably representing additional bioactive molecules within cells.	[Klitzke, Clecio F.] Butantan Inst, Ctr Appl Toxinol, CAT CEPID, BR-05503900 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Cunha, Fernanda M.; Berti, Denise A.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol, BR-05508900 Sao Paulo, Brazil; [Cunha, Fernanda M.; Berti, Denise A.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, BR-05508900 Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Ferro, ES (corresponding author), Av Prof Lineu Prestes 1524,Sala 431,Campus Univ, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br	DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; Ferreira, Zulma/D-3200-2012; Markus, Regina P./AAC-1505-2021; Ferro, Emer S/D-3908-2012; Klitzke, Clecio Fernando/A-8920-2010; Markus, Regina P/K-2954-2012; da Cunha, Fernanda M/G-3575-2012	Markus, Regina P./0000-0003-4606-6120; Ferro, Emer S/0000-0003-1651-9192; Klitzke, Clecio Fernando/0000-0001-5973-6088; Markus, Regina P/0000-0003-4606-6120; da Cunha, Fernanda M/0000-0002-1583-5380; Ferreira, Zulma/0000-0001-6571-837X	Sao Paulo State Research Foundation [04/04933-2]; Financiadora de Estudos e Projetos; National Laboratory of Synchrotron Light (Sao Paulo Proteome Network)	Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); National Laboratory of Synchrotron Light (Sao Paulo Proteome Network)	This work was supported by Sao Paulo State Research Foundation Grant 04/04933-2 and grants from Financiadora de Estudos e Projetos and the National Laboratory of Synchrotron Light (Sao Paulo Proteome Network).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson GP, 2006, CLIN REV ALLERG IMMU, V31, P119, DOI 10.1385/CRIAI:31:2:119; Baechle D, 2005, ANAL BIOCHEM, V345, P161, DOI 10.1016/j.ab.2005.06.040; BALL CL, 1995, J CELL SCI, V108, P2865; Band AM, 2001, FEBS LETT, V505, P118, DOI 10.1016/S0014-5793(01)02798-3; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; CAMARGO ACM, 1979, J BIOL CHEM, V254, P5304; Carreno FR, 2005, J NEUROCHEM, V93, P10, DOI 10.1111/j.1471-4159.2004.02967.x; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; CHU TG, 1984, BIOCHEMISTRY-US, V23, P3598, DOI 10.1021/bi00311a005; D'Souza KM, 2008, J THORAC CARDIOV SUR, V135, P172, DOI 10.1016/j.jtcvs.2007.08.035; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; DICKINSON KEJ, 1994, BRIT J PHARMACOL, V113, P179, DOI 10.1111/j.1476-5381.1994.tb16191.x; Dolenc I, 1998, FEBS LETT, V434, P357, DOI 10.1016/S0014-5793(98)01010-2; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fitzgerald LR, 1999, ANAL BIOCHEM, V275, P54, DOI 10.1006/abio.1999.4295; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; HEALY DP, 1992, BRAIN RES, V571, P121, DOI 10.1016/0006-8993(92)90517-D; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Kaspari A, 1996, BBA-PROTEIN STRUCT M, V1293, P147, DOI 10.1016/0167-4838(95)00238-3; Kelemen BR, 2002, J BIOL CHEM, V277, P8741, DOI 10.1074/jbc.M108459200; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lim EJ, 2007, J BIOL CHEM, V282, P9722, DOI 10.1074/jbc.M609897200; Machado MFM, 2006, BIOCHEM BIOPH RES CO, V339, P520, DOI 10.1016/j.bbrc.2005.11.041; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Montiel JL, 1997, J NEUROCHEM, V68, P354; OLIVEIRA EB, 1976, BIOCHEMISTRY-US, V15, P1967, DOI 10.1021/bi00654a026; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; PORTARO FCV, 1999, BIOCHEM BIOPH RES CO, V25, P1292; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Smart D, 2000, BIOCHEM CELL BIOL, V78, P281, DOI 10.1139/bcb-78-3-281; Soughayer JS, 2004, BIOCHEMISTRY-US, V43, P8528, DOI 10.1021/bi036296d; Tullai JW, 2000, J BIOL CHEM, V275, P36514, DOI 10.1074/jbc.M001843200; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Wu Y, 2007, EMBO J, V26, P2981, DOI 10.1038/sj.emboj.7601741; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	74	72	73	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24448	24459		10.1074/jbc.M801252200	http://dx.doi.org/10.1074/jbc.M801252200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617518	Green Published, hybrid			2022-12-25	WOS:000258820000020
J	Freibaum, BD; Counter, CM				Freibaum, Brian D.; Counter, Christopher M.			The protein hSnm1B is stabilized when bound to the telomere-binding protein TRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; COMPLEX; END; POLYADENYLATION; SUSCEPTIBILITY; RECOGNITION; DEGRADATION; PROTEOLYSIS; EXPRESSION	hSnm1B is member of the SNM family of exonucleases involved in DNA processing and is known to be localized to telomeres via binding to the telomere- binding protein TRF2. Here we demonstrate that the C terminus of hSnm1B facilitates the concentration of hSnm1B on telomeres by promoting ubiquitinmediated degradation of hSnm1B that is not localized to telomeres, as well as by blocking protein degradation and fostering localization to telomeres via binding of TRF2. Finally, a mutant of hSnm1B stabilized independently of exogenous TRF2- induced cell death. Taken together, we speculate that sequestering hSnm1B at telomeres by a combination of stabilizing the protein when bound to telomeres and degrading it when not bound to telomeres may be a means to prevent potentially lethal effects of unregulated hSnm1B activity.	Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol & Radial Oncol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Counter, CM (corresponding author), DUMC 3813, Durham, NC 27710 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NCI NIH HHS [CA 082481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahkter S, 2005, MOL CELL BIOL, V25, P10071, DOI 10.1128/MCB.25.22.10071-10078.2005; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bonatto D, 2005, COMPUT BIOL CHEM, V29, P420, DOI 10.1016/j.compbiolchem.2005.09.004; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cabuy E, 2005, RADIAT RES, V164, P53, DOI 10.1667/RR3376; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Freibaum BD, 2006, J BIOL CHEM, V281, P15033, DOI 10.1074/jbc.C600038200; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HENRIQUES JAP, 1980, GENETICS, V95, P273; HENRIQUES JAP, 1990, CURR GENET, V18, P387, DOI 10.1007/BF00309906; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; KIRCHER M, 1983, CHEM-BIOL INTERACT, V44, P27, DOI 10.1016/0009-2797(83)90127-8; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Richie CT, 2002, MOL CELL BIOL, V22, P8635, DOI 10.1128/MCB.22.24.8635-8647.2002; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Zhang XS, 2002, DNA REPAIR, V1, P379, DOI 10.1016/S1568-7864(02)00015-0	34	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23671	23676		10.1074/jbc.M800388200	http://dx.doi.org/10.1074/jbc.M800388200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593705	hybrid, Green Published			2022-12-25	WOS:000258638900020
J	Driemeyer, J; Boyke, J; Gaser, C; Buchel, C; May, A				Driemeyer, Joenna; Boyke, Janina; Gaser, Christian; Buechel, Christian; May, Arne			Changes in Gray Matter Induced by Learning-Revisited	PLOS ONE			English	Article								Background: Recently, activation-dependant structural brain plasticity in humans has been demonstrated in adults after three months of training a visio-motor skill. Learning three-ball cascade juggling was associated with a transient and highly selective increase in brain gray matter in the occipito-temporal cortex comprising the motion sensitive area hMT/V5 bilaterally. However, the exact time-scale of usage-dependant structural changes occur is still unknown. A better understanding of the temporal parameters may help to elucidate to what extent this type of cortical plasticity contributes to fast adapting cortical processes that may be relevant to learning. Principal Findings: Using a 3 Tesla scanner and monitoring whole brain structure we repeated and extended our original study in 20 healthy adult volunteers, focussing on the temporal aspects of the structural changes and investigated whether these changes are performance or exercise dependant. The data confirmed our earlier observation using a mean effects analysis and in addition showed that learning to juggle can alter gray matter in the occipito-temporal cortex as early as after 7 days of training. Neither performance nor exercise alone could explain these changes. Conclusion: We suggest that the qualitative change (i.e. learning of a new task) is more critical for the brain to change its structure than continued training of an already-learned task.	[Driemeyer, Joenna; Boyke, Janina; Buechel, Christian; May, Arne] Univ Hamburg UKE, Dept Syst Neurosci, Hamburg, Germany; [Gaser, Christian] Univ Jena, Dept Psychiat, Jena, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena	Driemeyer, J (corresponding author), Univ Hamburg UKE, Dept Syst Neurosci, Hamburg, Germany.	a.may@uke.uni-hamburg.de	Gaser, Christian/F-5103-2010	Gaser, Christian/0000-0002-9940-099X				ANDERSON BJ, 1994, GLIA, V11, P73, DOI 10.1002/glia.440110110; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Etgen T, 2005, NEUROIMAGE, V24, P1242, DOI 10.1016/j.neuroimage.2004.10.021; Gaser C, 2003, J NEUROSCI, V23, P9240; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720	18	318	323	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2669	10.1371/journal.pone.0002669	http://dx.doi.org/10.1371/journal.pone.0002669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648501	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900001
J	Dugatkin, LA; Dugatkin, AD; Atlas, RM; Perlin, MH				Dugatkin, Lee Alan; Dugatkin, Aaron D.; Atlas, Ronald M.; Perlin, Michael H.			Cheating on the Edge	PLOS ONE			English	Article							GROUP-BENEFICIAL TRAITS; SOCIAL EVOLUTION; COOPERATION	We present the results of an individual agent-based model of antibiotic resistance in bacteria. Our model examines antibiotic resistance when two strategies exist: "producers''-who secrete a substance that breaks down antibiotics-and nonproducers ("cheats'') who do not secrete, or carry the machinery associated with secretion. The model allows for populations of up to 10,000, in which bacteria are affected by their nearest neighbors, and we assume cheaters die when there are no producers in their neighborhood. Each of 10,000 slots on our grid (a torus) could be occupied by a producer or a nonproducer, or could (temporarily) be unoccupied. The most surprising and dramatic result we uncovered is that when producers and nonproducers coexist at equilibrium, nonproducers are almost always found on the edges of clusters of producers.	[Dugatkin, Lee Alan; Atlas, Ronald M.; Perlin, Michael H.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Dugatkin, Aaron D.] Murray Hill Acad, Louisville, KY USA	University of Louisville	Dugatkin, LA (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	lee.dugatkin@louisville.edu			National Institutes of Health [1 R15 AI060667-01A1]; Office of the Vice President for Research at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI060667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partly funded by AREA grant 1 R15 AI060667-01A1 from the National Institutes of Health and by a grant from the Office of the Vice President for Research at the University of Louisville. Funding agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Czaran TL, 2003, P ROY SOC B-BIOL SCI, V270, P1373, DOI 10.1098/rspb.2003.2338; Darwin G., 1871, P423; Darwin C., 1877, DIFFERENT FORMS FLOW; Dawkins R, 1976, SELFISH GENE; Dugatkin LA, 2005, J THEOR BIOL, V236, P392, DOI 10.1016/j.jtbi.2005.03.021; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Dugatkin LA, 2003, J THEOR BIOL, V220, P67, DOI 10.1006/jtbi.2003.3149; Ellis RJ, 2007, ISME J, V1, P92, DOI 10.1038/ismej.2007.11; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; GREIG D, 2004, BIOL LETT, V271, pS25, DOI DOI 10.1098/RSBL.2003.0083; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; LEVIN BR, 1988, PHILOS T R SOC B, V319, P459, DOI 10.1098/rstb.1988.0059; Massey RC, 2002, CURR BIOL, V12, pR686, DOI 10.1016/S0960-9822(02)01205-8; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Sober E, 1998, UNTO OTHERS; Velicer GJ, 2002, ANTON LEEUW INT J G, V81, P155, DOI 10.1023/A:1020546130033; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wilensky U, 1999, NETLOGO; Williams G. C., 1966, P307; Wilson D. S., 1980, NATURAL SELECTION PO	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2763	10.1371/journal.pone.0002763	http://dx.doi.org/10.1371/journal.pone.0002763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648645	gold, Green Submitted, Green Published			2022-12-25	WOS:000264302900033
J	Daubersies, P; Ollomo, B; Sauzet, JP; Brahimi, K; Perlaza, BL; Eling, W; Moukana, H; Rouquet, P; De Taisne, C; Druilhe, P				Daubersies, Pierre; Ollomo, Benjamin; Sauzet, Jean-Pierre; Brahimi, Karima; Perlaza, Blanca-Liliana; Eling, Wijnand; Moukana, Hubert; Rouquet, Pierre; De Taisne, Charles; Druilhe, Pierre			Genetic Immunisation by Liver Stage Antigen 3 Protects Chimpanzees against Malaria despite Low Immune Responses	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; PLASMODIUM-FALCIPARUM; DNA VACCINES; IN-VITRO; IMMUNOGENICITY; SPOROZOITE; INDUCTION; EFFICACY; HELPER; VACCINATION	Background: The true interest of genetic immunisation might have been hastily underestimated based on overall immunogenicity data in humans and lack of parallelism with other, more classical immunisation methods. Principal Findings: Using malaria Liver Stage Antigen-3 (LSA-3), we report that genetic immunization induces in chimpanzees, the closest relative of humans, immune responses which are as scarce as those reported using other DNA vaccines in humans, but which nonetheless confer strong, sterile and reproducible protection. The pattern was consistent in 3/4 immunized apes against two high dose sporozoite challenges performed as late as 98 and 238 days post-immunization and by a heterologous strain. Conclusions: These results should, in our opinion, lead to a revisiting of the value of this unusual means of immunisation, using as a model a disease, malaria, in which virulent challenges of volunteers are ethically acceptable.	[Daubersies, Pierre; Sauzet, Jean-Pierre; Brahimi, Karima; Perlaza, Blanca-Liliana; Druilhe, Pierre] Inst Pasteur, Unite Parasitol Biomed, Paris, France; [Ollomo, Benjamin; Moukana, Hubert; Rouquet, Pierre] Ctr Int Rech Med Franceville, Franceville, Gabon; [Eling, Wijnand] Univ Nijmegen, Dept Med Microbiol, Nijmegen, Netherlands; [De Taisne, Charles] Aventis Pasteur, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Radboud University Nijmegen; Sanofi-Aventis; Sanofi France	Daubersies, P (corresponding author), Inst Pasteur, Unite Parasitol Biomed, Paris, France.	druilhe@pasteur.fr			European Comission Inco-DC [CT-980387]; Centre International de Recherche Medical de Franceville; Aventis Pasteur	European Comission Inco-DC; Centre International de Recherche Medical de Franceville; Aventis Pasteur	This work received support from the European Comission Inco-DC Grant CT-980387, from the Centre International de Recherche Medical de Franceville and from Aventis Pasteur.	Alarcon JB, 1999, ADV PARASIT, V42, P343, DOI 10.1016/S0065-308X(08)60152-9; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; Bottius E, 1996, J IMMUNOL, V156, P2874; Boyer JD, 2000, J INFECT DIS, V181, P476, DOI 10.1086/315229; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Druilhe P., 1998, MALARIA PARASITE BIO; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hedstrom RC, 1998, INT J MOL MED, V2, P29; HERRINGTON DA, 1991, AM J TROP MED HYG, V45, P695, DOI 10.4269/ajtmh.1991.45.695; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Lema OE, 1999, AM J TROP MED HYG, V60, P177, DOI 10.4269/ajtmh.1999.60.177; Lewis PJ, 1999, ADV VIRUS RES, V54, P129, DOI 10.1016/S0065-3527(08)60367-X; MEIS JFGM, 1990, EXP PARASITOL, V70, P1, DOI 10.1016/0014-4894(90)90080-V; MELLOUK S, 1987, J IMMUNOL, V139, P4192; Perlaza BL, 1998, INFECT IMMUN, V66, P3423, DOI 10.1128/IAI.66.7.3423-3428.1998; Perlaza BL, 2003, EUR J IMMUNOL, V33, P1321, DOI 10.1002/eji.200323339; Perlaza BL, 2001, EUR J IMMUNOL, V31, P2200, DOI 10.1002/1521-4141(200107)31:7&lt;2200::AID-IMMU2200&gt;3.0.CO;2-L; PERLAZA BL, 2008, EUR J IMMUNOL UNPUB; PONNUDURAI T, 1989, T ROY SOC TROP MED H, V83, P67, DOI 10.1016/0035-9203(89)90708-6; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Sauzet JP, 2001, INFECT IMMUN, V69, P1202, DOI 10.1128/IAI.69.2.1202-1206.2001; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; Shi FH, 2002, VACCINE, V20, P3629, DOI 10.1016/S0264-410X(02)00398-5; Smooker Peter M, 2004, Biotechnol Annu Rev, V10, P189, DOI 10.1016/S1387-2656(04)10007-0; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 1998, INFECT IMMUN, V66, P4193; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476	35	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2659	10.1371/journal.pone.0002659	http://dx.doi.org/10.1371/journal.pone.0002659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628827	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200005
J	del Fresno, C; Gomez-Pina, V; Lores, V; Soares-Schanoski, A; Fernandez-Ruiz, I; Rojo, B; Alvarez-Sala, R; Caballero-Garrido, E; Garcia, F; Veliz, T; Arnalich, F; Fuentes-Prior, P; Garcia-Rio, F; Lopez-Collazo, E				del Fresno, Carlos; Gomez-Pina, Vanesa; Lores, Vanesa; Soares-Schanoski, Alessandra; Fernandez-Ruiz, Irene; Rojo, Blas; Alvarez-Sala, Rodolfo; Caballero-Garrido, Ernesto; Garcia, Felipe; Veliz, Tania; Arnalich, Francisco; Fuentes-Prior, Pablo; Garcia-Rio, Francisco; Lopez-Collazo, Eduardo			Monocytes from Cystic Fibrosis Patients Are Locked in an LPS Tolerance State: Down-Regulation of TREM-1 as Putative Underlying Mechanism	PLOS ONE			English	Article								Cystic Fibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene that codes for the chloride channel, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). CF patients are frequently colonized by several pathogens, but the mechanisms that allow colonization in spite of apparently functional immune systems are incompletely understood. In this paper we show that blood peripheral monocytes isolated from CF patients are found in an endotoxin tolerance state, yet this is not due to a deficient TLR activation. On the other hand, levels of the amplifier of inflammatory responses, TREM-1 (Triggering Receptor Expressed on Myeloid cells), are notably down-regulated in monocytes from patients, in comparison to those extracted from healthy volunteers. Furthermore, the soluble form of TREM-1 (sTREM-1) was not detected in the sera of patients. Additionally, and in strict contrast to patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), CF monocytes challenged ex vivo with LPS neither up-regulated membrane-anchored TREM-1 nor sTREM-1. Finally, similar levels of PGE(2) expression and p65 translocation into the nucleus were found in both patients and healthy volunteers, thus suggesting that TREM-1 regulation is neither controlled by PGE(2) levels nor by p65 activation in this case. However, PU.1 translocation into the nucleus was significantly higher in CF monocytes than in controls, suggesting a role for this transcription factor in the control of TREM-1 expression. We conclude that down-regulation of TREM-1 expression in cystic fibrosis patients is at least partly responsible for the endotoxin tolerance state in which their monocytes are locked.	[del Fresno, Carlos; Gomez-Pina, Vanesa; Soares-Schanoski, Alessandra; Fernandez-Ruiz, Irene; Caballero-Garrido, Ernesto; Lopez-Collazo, Eduardo] Hosp La Paz, Res Unit, Madrid, Spain; [Lores, Vanesa; Rojo, Blas; Alvarez-Sala, Rodolfo; Garcia-Rio, Francisco] Hosp La Paz, Serv Resp Dis, Madrid, Spain; [Garcia, Felipe] EMPIREO Mol Diagnost, Discover Unit, Madrid, Spain; [Veliz, Tania] Ist Humanitas, Rozzano, Italy; [Arnalich, Francisco] Univ Autonoma Madrid, Hosp La Paz, Med Sch, Dept Med, Emergency Serv, Madrid, Spain; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; IRCCS Humanitas Research Hospital; Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	del Fresno, C (corresponding author), Hosp La Paz, Res Unit, Madrid, Spain.	elopezc.hulp@salud.madrid.org	Del Fresno, Carlos/F-2624-2016; Arnalich, Francisco/J-8184-2017; Garcia-Rio, Francisco/AAC-9981-2020; Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/AAF-5924-2021; Caballero-Garrido, Ernesto/Q-4401-2019; Del Fresno Sánchez, CArlos/AAY-1525-2021; Del Fresno, Carlos/ABD-7766-2020; Schanoski, Alessandra/H-8144-2014; Lopez-Collazo, Eduardo/U-6634-2018	Del Fresno, Carlos/0000-0003-1771-7254; Arnalich, Francisco/0000-0003-2943-0373; Caballero-Garrido, Ernesto/0000-0002-4644-7524; Del Fresno, Carlos/0000-0003-1771-7254; Schanoski, Alessandra/0000-0002-6514-8458; Alvarez-Sala, Rodolfo/0000-0002-3442-670X; Fuentes-Prior, Pablo/0000-0002-6618-3204; Fernandez Ruiz, Irene/0000-0001-5138-1649; Garcia, Felipe/0000-0002-4099-0120; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Garcia-Rio, Francisco/0000-0002-7227-2238	MEC; FMMA	MEC(European Commission); FMMA	MEC and FMMA	Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dehus O, 2006, J ENDOTOXIN RES, V12, P171, DOI 10.1179/096805106X102156; DeKoter RP, 2007, BLOOD CELL MOL DIS, V39, P316, DOI 10.1016/j.bcmd.2007.06.004; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; DORIN JR, 1987, NATURE, V326, P614, DOI 10.1038/326614a0; ELBORN JS, 1992, AM J RESP CELL MOL, V6, P207, DOI 10.1165/ajrcmb/6.2.207; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2006, CURR OPIN INVEST DR, V7, P438; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; GIBOT S, 2007, CLIN MED RES, V39, P604; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Haselmayer P, 2007, BLOOD, V110, P1029, DOI 10.1182/blood-2007-01-069195; Henkel GW, 2002, INT IMMUNOL, V14, P723, DOI 10.1093/intimm/dxf040; Hoefnagel JJ, 2006, MODERN PATHOL, V19, P1270, DOI 10.1038/modpathol.3800650; Horonenko G, 2007, CHEST, V132, P58, DOI 10.1378/chest.06-2731; How CK, 2007, INT J CLIN PRACT; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; Liu CL, 2007, RESP MED, V101, P903, DOI 10.1016/j.rmed.2006.09.021; Lopez-Collazo E, 1998, J IMMUNOL, V160, P2889; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Massengale ARD, 1999, AM J RESP CELL MOL, V20, P1073, DOI 10.1165/ajrcmb.20.5.3243; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; NORMAN D, 1991, THORAX, V46, P91, DOI 10.1136/thx.46.2.91; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Radsak MP, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/52040; Ramsey BW, 1996, NEW ENGL J MED, V335, P179, DOI 10.1056/NEJM199607183350307; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Richeldi L, 2004, EUR RESPIR J, V24, P247, DOI 10.1183/09031936.04.00014204; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; SCHONI MH, 1987, CELL CALCIUM, V8, P53, DOI 10.1016/0143-4160(87)90036-4; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Tejera A, 2007, CYTOKINE, V38, P117, DOI 10.1016/j.cyto.2007.05.002; WILKINSON MM, 1988, J CELL SCI, V91, P221; Xu Y, 2006, J BIOL CHEM, V281, P11279, DOI 10.1074/jbc.M512072200; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270	58	72	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2667	10.1371/journal.pone.0002667	http://dx.doi.org/10.1371/journal.pone.0002667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628981	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200013
J	Kreijveld, E; Koenen, HJPM; van Cranenbroek, B; van Rijssen, E; Joosten, I; Hilbrands, LB				Kreijveld, Ellen; Koenen, Hans J. P. M.; van Cranenbroek, Bram; van Rijssen, Esther; Joosten, Irma; Hilbrands, Luuk B.			Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus	PLOS ONE			English	Article								Background: Transplant patients would benefit from reduction of immunosuppression providing that graft rejection is prevented. We have evaluated a number of immunological markers in blood of patients in whom tacrolimus was withdrawn after renal transplantation. The alloreactive precursor frequency of CD4+ and CD8+ T cells, the frequency of T cell subsets and the functional capacity of CD4+CD25+FoxP3+ regulatory T cells (Treg) were analyzed before transplantation and before tacrolimus reduction. In a case-control design, the results were compared between patients with (n = 15) and without (n = 28) acute rejection after tacrolimus withdrawal. Principal Findings: Prior to tacrolimus reduction, the ratio between memory CD8+ T cells and Treg was higher in rejectors compared to non-rejectors. Rejectors also had a higher ratio between memory CD4+ T cells and Treg, and ratios,20 were only observed in non-rejectors. Between the time of transplantation and the start of tacrolimus withdrawal, an increase in naive T cell frequencies and a reciprocal decrease of effector T cell percentages was observed in rejectors. The proportion of Treg within the CD4+ T cells decreased after transplantation, but anti-donor regulatory capacity of Treg remained unaltered in rejectors and non-rejectors. Conclusions: Immunological monitoring revealed an association between acute rejection following the withdrawal of tacrolimus and 1) the ratio of memory T cells and Treg prior to the start of tacrolimus reduction, and 2) changes in the distribution of naive, effector and memory T cells over time. Combination of these two biomarkers allowed highly specific identification of patients in whom immunosuppression could be safely reduced.	[Kreijveld, Ellen; Koenen, Hans J. P. M.; van Cranenbroek, Bram; van Rijssen, Esther; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Blood Transfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kreijveld, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Blood Transfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	l.hilbrands@nier.umcn.nl	Joosten, Irma/N-4418-2013; Koenen, Hans J.P.M./A-2852-2014; van Rijssen, Esther/K-1049-2016; van Cranenbroek, Bram/K-1549-2016; Hilbrands, Luuk/B-4921-2011	Joosten, Irma/0000-0003-2950-4977; van Rijssen, Esther/0000-0003-1534-5039; van Cranenbroek, Bram/0000-0001-5135-1183; Hilbrands, Luuk/0000-0002-4935-9765				Bakker RC, 2003, KIDNEY INT, V64, P1027, DOI 10.1046/j.1523-1755.2003.00175.x; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Coenen JJA, 2005, TRANSPLANTATION, V79, P147, DOI 10.1097/01.TP.0000147460.93587.87; EL EB, 2006, TRANSPLANTATION, V82, P267; Gregoor PJHS, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013298.11876.BF; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hernandez-Fuentes MP, 2003, IMMUNOL REV, V196, P247, DOI 10.1046/j.1600-065X.2003.00092.x; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Jiang SP, 2006, HUM IMMUNOL, V67, P765, DOI 10.1016/j.humimm.2006.07.013; Kreijveld E, 2006, J IMMUNOL METHODS, V314, P103, DOI 10.1016/j.jim.2006.06.001; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salama AD, 2003, J AM SOC NEPHROL, V14, P1643, DOI 10.1097/01.ASN.0000057540.98231.C1; Segall M, 1996, HUM IMMUNOL, V49, P49, DOI 10.1016/0198-8859(96)00055-9; SHARROCK CEM, 1990, IMMUNOL TODAY, V11, P281, DOI 10.1016/0167-5699(90)90113-N; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Solez K, 1998, TRANSPLANTATION, V66, P1736, DOI 10.1097/00007890-199812270-00029; Speiser DE, 1996, BRIT J HAEMATOL, V93, P935; STEINMANN J, 1994, J CLIN LAB ANAL, V8, P157, DOI 10.1002/jcla.1860080308; Suwelack B, 2004, AM J TRANSPLANT, V4, P655, DOI 10.1111/j.1600-6143.2004.00404.x; Tanaka Y, 2005, TRANSPLANTATION, V79, P1262, DOI 10.1097/01.TP.0000161667.99145.20; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; Weir MR, 2001, KIDNEY INT, V59, P1567, DOI 10.1046/j.1523-1755.2001.0590041567.x; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873	30	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2711	10.1371/journal.pone.0002711	http://dx.doi.org/10.1371/journal.pone.0002711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628993	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200054
J	Wilhelm, E; Pellay, FX; Benecke, A; Bell, B				Wilhelm, Emmanuelle; Pellay, Francois-Xavier; Benecke, Arndt; Bell, Brendan			TAF6 delta Controls Apoptosis and Gene Expression in the Absence of p53	PLOS ONE			English	Article								Background: Life and death decisions of metazoan cells hinge on the balance between the expression of pro-versus antiapoptotic gene products. The general RNA polymerase II transcription factor, TFIID, plays a central role in the regulation of gene expression through its core promoter recognition and co-activator functions. The core TFIID subunit TAF6 acts in vitro as an essential co-activator of transcription for the p53 tumor suppressor protein. We previously identified a splice variant of TAF6, termed TAF6 delta that can be induced during apoptosis. Methodology/Principal Findings: To elucidate the impact of TAF6d on cell death and gene expression, we have employed modified antisense oligonucleotides to enforce expression of endogenous TAF6d. The induction of endogenous TAF6d triggered apoptosis in tumor cell lines, including cells devoid of p53. Microarray experiments revealed that TAF6d activates gene expression independently of cellular p53 status. Conclusions: Our data define TAF6d as a pivotal node in a signaling pathway that controls gene expression programs and apoptosis in the absence of p53.	[Wilhelm, Emmanuelle; Bell, Brendan] Univ Sherbrooke, Fac Med & Sci Sante, RNA Grp, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada; [Pellay, Francois-Xavier; Benecke, Arndt] Univ Lille, Inst Rech Interdisciplin, Inst Hautes Etudes Sci, CNRS USR3078, Bures Sur Yvette, France	University of Sherbrooke; Universite de Lille - ISITE; Universite de Lille	Wilhelm, E (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, RNA Grp, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada.	Brendan.Bell@USherbrooke.ca	Benecke, Arndt G./T-1079-2019		Nausicaa Combat Sa Leucemie association [doctoral fellowship]; European Hematology Association - Jose Carreras Foundation; French Ministry of Research; Natural Sciences and Engineering Research Council of Canada [Discovery grant]	Nausicaa Combat Sa Leucemie association; European Hematology Association - Jose Carreras Foundation; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	F.X.P. is recipient of a doctoral fellowship from the Nausicaa Combat Sa Leucemie association. A.B.'s group received funds from the European Hematology Association - Jose Carreras Foundation, and the French Ministry of Research through the "Complexite du Vivant - Action STICS-Sante" program. Work in B.B.'s laboratory was funded through a Discovery grant from Natural Sciences and Engineering Research Council of Canada. B.B. holds the Canada Research Chair in Genomic Regulation.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Aoyagi N, 2001, MOL CELL BIOL, V21, P6808, DOI 10.1128/MCB.21.20.6808-6819.2001; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; BROU C, 1993, NUCLEIC ACIDS RES, V21, P5, DOI 10.1093/nar/21.1.5; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; DEATO MD, 2007, GENES DEV; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, MOL CELL BIOL, V16, P4295; Fesus L, 1999, CELL DEATH DIFFER, V6, P1144, DOI 10.1038/sj.cdd.4400608; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kumar S, 2004, TRENDS BIOCHEM SCI, V29, P193, DOI 10.1016/j.tibs.2004.02.001; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lago C, 2005, DEV BIOL, V285, P91, DOI 10.1016/j.ydbio.2005.06.006; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MAY E, 1991, ONCOGENE, V6, P1363; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; MIYASHITA T, 1995, CELL, V80, P293; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P212, DOI 10.1016/S1672-0229(07)60002-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Purrello M, 1998, ONCOGENE, V16, P1633, DOI 10.1038/sj.onc.1201673; ROBLES LM, 2007, J EXP BOT; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang W, 2004, MOL CANCER RES, V2, P442; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; WEINZIERL ROJ, 1993, EMBO J, V12, P5303, DOI 10.1002/j.1460-2075.1993.tb06226.x; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	66	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2721	10.1371/journal.pone.0002721	http://dx.doi.org/10.1371/journal.pone.0002721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628956	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200059
J	Dressel, R; Schindehutte, J; Kuhlmann, T; Elsner, L; Novota, P; Baier, PC; Schillert, A; Bickeboller, H; Herrmann, T; Trenkwalder, C; Paulus, W; Mansouri, A				Dressel, Ralf; Schindehuette, Jan; Kuhlmann, Tanja; Elsner, Leslie; Novota, Peter; Baier, Paul Christian; Schillert, Arne; Bickeboeller, Heike; Herrmann, Thomas; Trenkwalder, Claudia; Paulus, Walter; Mansouri, Ahmed			The Tumorigenicity of Mouse Embryonic Stem Cells and In Vitro Differentiated Neuronal Cells Is Controlled by the Recipients' Immune Response	PLOS ONE			English	Article								Embryonic stem (ES) cells have the potential to differentiate into all cell types and are considered as a valuable source of cells for transplantation therapies. A critical issue, however, is the risk of teratoma formation after transplantation. The effect of the immune response on the tumorigenicity of transplanted cells is poorly understood. We have systematically compared the tumorigenicity of mouse ES cells and in vitro differentiated neuronal cells in various recipients. Subcutaneous injection of 1 x 10(6) ES or differentiated cells into syngeneic or allogeneic immunodeficient mice resulted in teratomas in about 95% of the recipients. Both cell types did not give rise to tumors in immunocompetent allogeneic mice or xenogeneic rats. However, in 61% of cyclosporine A-treated rats teratomas developed after injection of differentiated cells. Undifferentiated ES cells did not give rise to tumors in these rats. ES cells turned out to be highly susceptible to killing by rat natural killer (NK) cells due to the expression of ligands of the activating NK receptor NKG2D on ES cells. These ligands were downregulated on differentiated cells. The activity of NK cells which is not suppressed by cyclosporine A might contribute to the prevention of teratomas after injection of ES cells but not after inoculation of differentiated cells. These findings clearly point to the importance of the immune response in this process. Interestingly, the differentiated cells must contain a tumorigenic cell population that is not present among ES cells and which might be resistant to NK cell-mediated killing.	[Dressel, Ralf; Elsner, Leslie; Novota, Peter] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Schindehuette, Jan; Baier, Paul Christian; Trenkwalder, Claudia; Paulus, Walter; Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Kuhlmann, Tanja] Univ Gottingen, Dept Neuropathol, Gottingen, Germany; [Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Schillert, Arne; Bickeboeller, Heike] Univ Gottingen, Dept Genet Epidemiol, Gottingen, Germany; [Schillert, Arne] Univ Lubeck, Inst Med Biomet & Stat, Lubeck, Germany; [Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Munster; University of Gottingen; University of Lubeck; University of Wurzburg; Max Planck Society	Dressel, R (corresponding author), Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany.	rdresse@gwdg.de	Herrmann, Thomas/J-4943-2012; Baier, Paul/F-9765-2010; Bickeböller, Heike/V-2318-2018; Trenkwalder, Claudia/AHD-1232-2022; Trenkwalder, Claudia/ABD-6559-2021; Dressel, Ralf/R-7065-2016; Paulus, Walter/A-3544-2009; Baier, Paul Christian/H-7919-2014	Herrmann, Thomas/0000-0002-1093-0194; Bickeböller, Heike/0000-0002-3361-5488; Trenkwalder, Claudia/0000-0001-6407-1199; Dressel, Ralf/0000-0002-1651-1214; Paulus, Walter/0000-0001-5549-8377; 	Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union [MRTN-CT-2004-512253, TRANS-NET]; Max Planck Society; German Federal Ministry for Research and Technology BMBF [01 GN 0510]; Dr. Helmut Storz and Alte Leipziger Foundation	Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union; Max Planck Society(Max Planck Society); German Federal Ministry for Research and Technology BMBF(Federal Ministry of Education & Research (BMBF)); Dr. Helmut Storz and Alte Leipziger Foundation	This work was supported by grants of the Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union (MRTN-CT-2004-512253, TRANS-NET), the Max Planck Society, the German Federal Ministry for Research and Technology BMBF (01 GN 0510), and the Dr. Helmut Storz and Alte Leipziger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2007, J IMMUNOL, V178, P3390, DOI 10.4049/jimmunol.178.6.3390; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Baier PC, 2004, STEM CELLS, V22, P396, DOI 10.1634/stemcells.22-3-396; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; BRUNNER E, 2002, NONPARAMETRIC ANAL L, P1; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dressel R, 2004, J BIOL CHEM, V279, P20200, DOI 10.1074/jbc.M313108200; Dressel R, 2000, J IMMUNOL, V164, P2362, DOI 10.4049/jimmunol.164.5.2362; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, METHOD ENZYMOL, V420, P391, DOI 10.1016/S0076-6879(06)20019-3; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Fair JH, 2005, P NATL ACAD SCI USA, V102, P2958, DOI 10.1073/pnas.0409840102; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gasser S, 2006, CANCER RES, V66, P3959, DOI 10.1158/0008-5472.CAN-05-4603; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; KODAMA HA, 1982, J CELL PHYSIOL, V112, P89, DOI 10.1002/jcp.1041120114; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Thinyane K, 2005, BRAIN RES, V1045, P80, DOI 10.1016/j.brainres.2005.03.033; Tian L, 1997, BIOL REPROD, V57, P561, DOI 10.1095/biolreprod57.3.561; VANDENBRINK MRM, 1990, J EXP MED, V171, P197, DOI 10.1084/jem.171.1.197; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; WANG H, 2007, BLOOD; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	52	86	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2622	10.1371/journal.pone.0002622	http://dx.doi.org/10.1371/journal.pone.0002622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612432	Green Submitted, Green Published, gold			2022-12-25	WOS:000264065800024
J	Sendina-Nadal, I; Buldu, JM; Leyva, I; Boccaletti, S				Sendina-Nadal, Irene; Buldu, Javier M.; Leyva, Inmaculada; Boccaletti, Stefano			Phase Locking Induces Scale-Free Topologies in Networks of Coupled Oscillators	PLOS ONE			English	Article								An initial unsynchronized ensemble of networking phase oscillators is further subjected to a growing process where a set of forcing oscillators, each one of them following the dynamics of a frequency pacemaker, are added to the pristine graph. Linking rules based on dynamical criteria are followed in the attachment process to force phase locking of the network with the external pacemaker. We show that the eventual locking occurs in correspondence to the arousal of a scale-free degree distribution in the original graph.	[Sendina-Nadal, Irene; Buldu, Javier M.; Leyva, Inmaculada] Univ Rey Juan Carlos, Dept Fis, Madrid, Spain; [Boccaletti, Stefano] Embassy Italy Tel Aviv, Tel Aviv, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy	Universidad Rey Juan Carlos; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Sendina-Nadal, I (corresponding author), Univ Rey Juan Carlos, Dept Fis, Madrid, Spain.	stefano.boccaletti@isc.cnr.it	Buldu, Javier/N-5422-2014; Sendina-Nadal, Irene/M-3083-2013; Leyva, I./M-1820-2013	Buldu, Javier/0000-0002-9345-599X; Sendina-Nadal, Irene/0000-0003-0432-235X; Leyva, I./0000-0001-9634-5385	Spanish Ministry of Science and Technology [FIS2006-08525]; URJC-CM [2006-CET-0643, 2007-CET-1601]; European Project GABA	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); URJC-CM; European Project GABA	Work partly supported by the Spanish Ministry of Science and Technology under Project No. FIS2006-08525, the URJC-CM Projects Nos. 2006-CET-0643 and 2007-CET-1601, and the European Project GABA.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Ebel H, 2002, EVOLUTIONARY GAMES E; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; LEYVA I, UNPUB; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin CY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.047102; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	17	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2644	10.1371/journal.pone.0002644	http://dx.doi.org/10.1371/journal.pone.0002644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612423	gold, Green Submitted, Green Published			2022-12-25	WOS:000264065800046
J	Dusek, JA; Otu, HH; Wohlhueter, AL; Bhasin, M; Zerbini, LF; Joseph, MG; Benson, H; Libermann, TA				Dusek, Jeffery A.; Otu, Hasan H.; Wohlhueter, Ann L.; Bhasin, Manoj; Zerbini, Luiz F.; Joseph, Marie G.; Benson, Herbert; Libermann, Towia A.			Genomic Counter-Stress Changes Induced by the Relaxation Response	PLOS ONE			English	Article							PERIPHERAL-BLOOD; GENE-EXPRESSION; DISEASE; MODULATION; MEDICINE	Background: Mind-body practices that elicit the relaxation response (RR) have been used worldwide for millennia to prevent and treat disease. The RR is characterized by decreased oxygen consumption, increased exhaled nitric oxide, and reduced psychological distress. It is believed to be the counterpart of the stress response that exhibits a distinct pattern of physiology and transcriptional profile. We hypothesized that RR elicitation results in characteristic gene expression changes that can be used to measure physiological responses elicited by the RR in an unbiased fashion. Methods/Principal Findings: We assessed whole blood transcriptional profiles in 19 healthy, long-term practitioners of daily RR practice (group M), 19 healthy controls (group N-1), and 20 N-1 individuals who completed 8 weeks of RR training (group N-2). 2209 genes were differentially expressed in group M relative to group N-1 (p < 0.05) and 1561 genes in group N-2 compared to group N-1 (p, 0.05). Importantly, 433 (p, 10210) of 2209 and 1561 differentially expressed genes were shared among long-term (M) and short-term practitioners (N-2). Gene ontology and gene set enrichment analyses revealed significant alterations in cellular metabolism, oxidative phosphorylation, generation of reactive oxygen species and response to oxidative stress in long-term and short-term practitioners of daily RR practice that may counteract cellular damage related to chronic psychological stress. A significant number of genes and pathways were confirmed in an independent validation set containing 5 N-1 controls, 5 N-2 short-term and 6 M long-term practitioners. Conclusions/Significance: This study provides the first compelling evidence that the RR elicits specific gene expression changes in short-term and long-term practitioners. Our results suggest consistent and constitutive changes in gene expression resulting from RR may relate to long term physiological effects. Our study may stimulate new investigations into applying transcriptional profiling for accurately measuring RR and stress related responses in multiple disease settings.	[Dusek, Jeffery A.; Wohlhueter, Ann L.; Benson, Herbert] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Chestnut Hill, MA USA; [Dusek, Jeffery A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Dusek, Jeffery A.; Otu, Hasan H.; Bhasin, Manoj; Zerbini, Luiz F.; Benson, Herbert; Libermann, Towia A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Division of Interdisciplinary Med & Biotechnol, Boston, MA USA; [Otu, Hasan H.; Bhasin, Manoj; Zerbini, Luiz F.; Joseph, Marie G.; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, BIDMC Genom Ctr, Boston, MA USA; [Benson, Herbert] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Dusek, Jeffery A.] Abbott NW Hosp, Inst Hlth & Healing, Minneapolis, MN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Dusek, JA (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Chestnut Hill, MA USA.	hbenson@partners.org; tliberma@bidmc.harvard.edu	Zerbini, Luiz/B-7720-2015	Zerbini, Luiz/0000-0003-0736-9508; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X; Dusek, Jeffery/0000-0001-9581-0564; Otu, Hasan/0000-0002-9253-8152	Centers for Disease Control and Prevention (CDC) [H75/CCH 19124, H75/CCH 123424, R01 DP000339]; National Institutes of Health [M01 RR01032]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was funded by grants H75/CCH 19124, H75/CCH 123424 and R01 DP000339 (HB) from the Centers for Disease Control and Prevention (CDC) and M01 RR01032 (HB) from the National Institutes of Health (to Harvard-Thorndike BIDMC GCRC).	Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131; BEARY JF, 1974, PSYCHOSOM MED, V36, P115, DOI 10.1097/00006842-197403000-00003; BENSON H, 1975, Journal of Human Stress, V1, P37; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BENSON H, 1981, J FLA MED ASSOC, V68, P265; BENSON H, 1983, TRENDS NEUROSCI, V6, P281, DOI 10.1016/0166-2236(83)90120-0; Benson H, 1978, Cardiovasc Clin, V9, P113; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Dusek JA, 2006, MED SCI MONITOR, V12, pCR1; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Escher JC, 2003, INFLAMM BOWEL DIS, V9, P34, DOI 10.1097/00054725-200301000-00006; GLASER R, 1990, ARCH GEN PSYCHIAT, V47, P707; GLASER R, 1993, BEHAV NEUROSCI, V107, P525, DOI 10.1037/0735-7044.107.3.525; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irie M, 2002, PSYCHOTHER PSYCHOSOM, V71, P90, DOI 10.1159/000049351; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacobs GD, 1996, BIOFEEDBACK SELF-REG, V21, P121, DOI 10.1007/BF02284691; KESTERSON J, 1989, AM J PHYSIOL, V256, pR632, DOI 10.1152/ajpregu.1989.256.3.R632; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lee Norman H, 2007, Methods Mol Biol, V353, P265; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li QZ, 2005, J ALTERN COMPLEM MED, V11, P29, DOI 10.1089/acm.2005.11.29; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Nakao M, 2001, BEHAV MED, V26, P169, DOI 10.1080/08964280109595764; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; PLATT JE, 1995, PROG NEURO-PSYCHOPH, V19, P65, DOI 10.1016/0278-5846(94)00105-Q; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sternberg EM, 1997, NAT MED, V3, P264, DOI 10.1038/nm0397-264; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WALLACE RK, 1971, AM J PHYSIOL, V221, P795, DOI 10.1152/ajplegacy.1971.221.3.795; WARRENBURG S, 1980, Journal of Behavioral Medicine, V3, P73, DOI 10.1007/BF00844915; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V293, P517, DOI 10.1016/S0006-291X(02)00233-4; Zheng KC, 2007, J OCCUP HEALTH, V49, P32, DOI 10.1539/joh.49.32; Zieker J, 2007, MOL PSYCHIATR, V12, P116, DOI 10.1038/sj.mp.4001905	38	150	151	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2576	10.1371/journal.pone.0002576	http://dx.doi.org/10.1371/journal.pone.0002576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596974	Green Published, gold			2022-12-25	WOS:000263288200041
J	Flierl, MA; Rittirsch, D; Chen, AJ; Nadeau, BA; Day, DE; Sarma, JV; Huber-Lang, MS; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Chen, Anthony J.; Nadeau, Brian A.; Day, Danielle E.; Sarma, J. Vidya; Huber-Lang, Markus S.; Ward, Peter A.			The Complement Anaphylatoxin C5a Induces Apoptosis in Adrenomedullary Cells during Experimental Sepsis	PLOS ONE			English	Article							INNATE IMMUNITY; UNITED-STATES; SEPTIC SHOCK; RECEPTOR; DEATH; ANTI-C5A; NERVE; EPIDEMIOLOGY; DYSFUNCTION; RESPONSES	Sepsis remains a poorly understood, enigmatic disease. One of the cascades crucially involved in its pathogenesis is the complement system. Especially the anaphylatoxin C5a has been shown to have numerous harmful effects during sepsis. We have investigated the impact of high levels of C5a on the adrenal medulla following cecal ligation and puncture (CLP)-induced sepsis in rats as well as the role of C5a on catecholamine production from pheochromocytoma-derived PC12 cells. There was significant apoptosis of adrenal medulla cells in rats 24 hrs after CLP, as assessed by the TUNEL technique. These effects could be reversed by dual-blockade of the C5a receptors, C5aR and C5L2. When rats were subjected to CLP, levels of C5a and norepinephrine were found to be antipodal as a function of time. PC12 cell production of norepinephrine and dopamine was significantly blunted following exposure to recombinant rat C5a in a time-dependent and dose-dependent manner. This impaired production could be related to C5a-induced initiation of apoptosis as defined by binding of Annexin V and Propidium Iodine to PC12 cells. Collectively, we describe a C5a-dependent induction of apoptotic events in cells of adrenal medulla in vivo and pheochromocytoma PC12 cells in vitro. These data suggest that experimental sepsis induces apoptosis of adrenomedullary cells, which are responsible for the bulk of endogenous catecholamines. Septic shock may be linked to these events. Since blockade of both C5a receptors virtually abolished adrenomedullary apoptosis in vivo, C5aR and C5L2 become promising targets with implications on future complement-blocking strategies in the clinical setting of sepsis.	[Flierl, Michael A.; Rittirsch, Daniel; Chen, Anthony J.; Nadeau, Brian A.; Day, Danielle E.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Huber-Lang, Markus S.] Univ Ulm, Med Sch, Dept Trauma, Hand & Reconstruct Surg, Ulm, Germany	University of Michigan System; University of Michigan; Ulm University	Flierl, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431	NIH [GM29507, GM61656, HL-31963]; Deutsche Forschungsgemeinschaft [HU 823/202, HU 823/2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R37GM029507, R01GM061656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grants GM29507, GM61656 and HL-31963 (P.A.W.) and Deutsche Forschungsgemeinschaft grants DFG HU 823/202 and HU 823/2-3 (M.H.-L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; BAKER CC, 1983, SURGERY, V94, P331; BARDAKHCH'YAN E A, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P97; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gerard C, 2003, NEW ENGL J MED, V348, P167, DOI 10.1056/NEJMcibr022995; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; HOFFMANN R, 1977, J COMP PATHOL, V87, P231, DOI 10.1016/0021-9975(77)90010-X; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2005, J IMMUNOL, V174, P1104, DOI 10.4049/jimmunol.174.2.1104; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huber-Lang MS, 2001, FASEB J, V15, P568; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Laudes IJ, 2002, AM J PATHOL, V160, P1867, DOI 10.1016/S0002-9440(10)61133-9; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Mahidhara R, 2000, CRIT CARE MED, V28, pN105, DOI 10.1097/00003246-200004001-00013; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Nakae H, 1996, SURG TODAY, V26, P225, DOI 10.1007/BF00311579; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1987, SURG GYNECOL OBSTET, V164, P415; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269	46	42	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2560	10.1371/journal.pone.0002560	http://dx.doi.org/10.1371/journal.pone.0002560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648551	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288200027
J	Perez-Mancera, PA; Bermejo-Rodriguez, C; Sanchez-Martin, M; Abollo-Jimenez, F; Pintado, B; Sanchez-Garcia, I				Perez-Mancera, Pedro A.; Bermejo-Rodriguez, Camino; Sanchez-Martin, Manuel; Abollo-Jimenez, Fernando; Pintado, Belen; Sanchez-Garcia, Isidro			FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPAR gamma and C/EBP alpha and Activating eIF4E	PLOS ONE			English	Article								Background: FUS-DDIT3 is a chimeric protein generated by the most common chromosomal translocation t( 12;16)( q13;p11) linked to liposarcomas, which are characterized by the accumulation of early adipocytic precursors. Current studies indicate that FUS-DDIT3- liposarcoma develops from uncommitted progenitors. However, the precise mechanism whereby FUS-DDIT3 contributes to the differentiation arrest remains to be elucidated. Methodology/Principal Findings: Here we have characterized the adipocyte regulatory protein network in liposarcomas of FUS-DITT3 transgenic mice and showed that PPAR gamma 2 and C/EBP alpha expression was altered. Consistent with in vivo data, FUS-DDIT3 MEFs and human liposarcoma cell lines showed a similar downregulation of both PPAR gamma 2 and C/EBP alpha expression. Complementation studies with gamma but not C/EBP alpha rescued the differentiation block in committed adipocytic precursors expressing FUS-DDIT3. Our results further show that FUS-DDIT3 interferes with the control of initiation of translation by upregulation of the eukaryotic translation initiation factors eIF2 and eIF4E both in FUS-DDIT3 mice and human liposarcomas ;cell lines, explaining the shift towards the truncated p30 isoform of C/EBP alpha in liposarcomas. Suppression of the FUS-DDIT3 transgene did rescue this adipocyte differentiation block. Moreover, eIF4E was also strongly upregulated in normal adipose tissue of FUS-DDIT3 transgenic mice, suggesting that overexpression of eIF4E may be a primary event in the initiation of liposarcomas. Reporter assays showed FUS-DDIT3 is involved in the upregulation of eIF4E in liposarcomas and that both domains of the fusion protein are required for affecting eIF4E expression. Conclusions/Significance: Taken together, this study provides evidence of the molecular mechanisms involve in the disruption of normal adipocyte differentiation program in liposarcoma harbouring the chimeric gene FUS-DDIT3.	[Perez-Mancera, Pedro A.; Bermejo-Rodriguez, Camino; Abollo-Jimenez, Fernando; Sanchez-Garcia, Isidro] Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Cancer, CSIC, E-37008 Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, Dept Med, Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, SEA, Genet Engineered Mouse Facil, Salamanca, Spain; [Pintado, Belen] CSIC, CNB, Genet Engineered Mouse Facil, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Perez-Mancera, PA (corresponding author), Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Cancer, CSIC, E-37008 Salamanca, Spain.	isg@usal.es	Sanchez-Martin, Manuel/N-5327-2016; Jimenez, Fernando A./K-3376-2014; 2008, Ibsal/A-1268-2012; Pintado, Belen/N-3233-2014; SANCHEZ-GARCIA, ISIDRO/A-5631-2019	Sanchez-Martin, Manuel/0000-0001-8370-1336; Jimenez, Fernando A./0000-0003-4363-7653; Pintado, Belen/0000-0002-8485-2520; SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905	FEDER; MEC [SAF2006-03726, PETRI N 95-0913.OP]; Junta de Castilla y Leon [CSI03A05]; FIS [PI050087, PI050116]; Fundacion de Investigacion MMA; Federacion de Cajas de Ahorro Castilla y Leon; CDTEAM project; MEC Consolider-Ingenio 2010 [CSD2007-0017]; Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria [PI04-1271]; Fundacion Manuel Solorzano, University of Salamanca [SA085A06]	FEDER(European Commission); MEC(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); FIS(Instituto de Salud Carlos III); Fundacion de Investigacion MMA; Federacion de Cajas de Ahorro Castilla y Leon; CDTEAM project; MEC Consolider-Ingenio 2010; Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Manuel Solorzano, University of Salamanca	Research in ISG group is supported partially by FEDER and by MEC (SAF2006-03726 and PETRI N 95-0913.OP), Junta de Castilla y Leon (CSI03A05), FIS (PI050087, PI050116), Fundacion de Investigacion MMA, Federacion de Cajas de Ahorro Castilla y Leon (I Convocatoria de Ayudas para Proyectos de Investigacion Biosanitaria con Celulas Madre), CDTEAM project (CENIT-Ingenio 2010) and MEC Consolider-Ingenio 2010 (Ref. CSD2007-0017). MSM is supported by the Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria (FIS PI04-1271), Junta de Castilla y Leon (SA085A06) and Fundacion Manuel Solorzano, University of Salamanca.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Altabef M, 1996, EMBO J, V15, P2707, DOI 10.1002/j.1460-2075.1996.tb00631.x; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; MACK TM, 1995, CANCER-AM CANCER SOC, V75, P211, DOI 10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Perez-Caro M, 2007, ONCOGENE, V26, P1702, DOI 10.1038/sj.onc.1209968; Perez-Losada J, 2000, ONCOGENE, V19, P6015, DOI 10.1038/sj.onc.1204018; Perez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Perez-Mancera PA, 2005, SEMIN CANCER BIOL, V15, P206, DOI 10.1016/j.semcancer.2005.01.006; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Perez-Mancera PA, 2002, ONCOGENE, V21, P1679, DOI 10.1038/sj.onc.1205220; Perez-Mancera PA, 2007, CARCINOGENESIS, V28, P2069, DOI 10.1093/carcin/bgm107; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; Sanchez-Garcia I, 1997, ANNU REV GENET, V31, P429, DOI 10.1146/annurev.genet.31.1.429; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Thelin-Jarnum S, 1999, INT J CANCER, V83, P30, DOI 10.1002/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; *US DEP HHS, 2002, US CANC STAT 1999 IN; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	44	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2569	10.1371/journal.pone.0002569	http://dx.doi.org/10.1371/journal.pone.0002569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596980	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200034
J	Xiang, JH; McLinden, JH; Chang, Q; Jordan, EL; Stapleton, JT				Xiang, Jinhua; McLinden, James H.; Chang, Qing; Jordan, Emma L.; Stapleton, Jack T.			Characterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV Replication	PLOS ONE			English	Article							HEPATITIS-G VIRUS; BLOOD MONONUCLEAR-CELLS; HUMAN LYMPHOID-TISSUE; TYPE-1 REPLICATION; T-LYMPHOCYTE; INFECTION; PROTEIN; EXPRESSION; SURVIVAL; SEQUENCE	Background: GBV-C infection is associated with prolonged survival in HIV-infected people and GBV-C inhibits HIV replication in co-infection models. Expression of the GBV-C nonstructural phosphoprotein 5A (NS5A) decreases surface levels of the HIV co-receptor CXCR4, induces the release of SDF-1 and inhibits HIV replication in Jurkat CD4+ T cell lines. Methodology/Principal Findings: Jurkat cell lines stably expressing NS5A protein and peptides were generated and HIV replication in these cell lines assessed. HIV replication was significantly inhibited in all cell lines expressing NS5A amino acids 152-165. Substitution of an either alanine or glycine for the serine at position 158 (S158A or S158G) resulted in a significant decrease in the HIV inhibitory effect. In contrast, substituting a phosphomimetic amino acid (glutamic acid; S158E) inhibited HIV as well as the parent peptide. HIV inhibition was associated with lower levels of surface expression of the HIV coreceptor CXCR4 and increased release of the CXCR4 ligand, SDF-1 compared to control cells. Incubation of CD4+ T cell lines with synthetic peptides containing amino acids 152-167 or the S158E mutant peptide prior to HIV infection resulted in HIV replication inhibition compared to control peptides. Conclusions/Significance: Expression of GBV-C NS5A amino acids 152 - 165 are sufficient to inhibit HIV replication in vitro, and the serine at position 158 appears important for this effect through either phosphorylation or structural changes in this peptide. The addition of synthetic peptides containing 152 - 167 or the S158E substitution to Jurkat cells resulted in HIV replication inhibition in vitro. These data suggest that GBV-C peptides or a peptide mimetic may offer a novel, cellular-based approach to antiretroviral therapy.	[Xiang, Jinhua; McLinden, James H.; Chang, Qing; Jordan, Emma L.; Stapleton, Jack T.] Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Xiang, JH (corresponding author), Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA.	jack-stapleton@uiowa.edu		Stapleton, Jack/0000-0002-2302-9055	Veterans Administration [Merit Review Grants]; NIH [AI-58740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058740] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Merit Review Grants from the Veterans Administration (JX and JTS), and by an NIH RO1 grant (AI-58740, JTS). The funders of this work had no input into the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Bjorkman P, 2007, AIDS, V21, P1641, DOI 10.1097/QAD.0b013e32823bc9b7; Chang Q, 2007, J GEN VIROL, V88, P3341, DOI 10.1099/vir.0.83198-0; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Feucht HH, 1997, HEPATOLOGY, V26, P491, DOI 10.1002/hep.510260234; Fogeda M, 2000, J VIROL, V74, P7936, DOI 10.1128/JVI.74.17.7936-7942.2000; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Garcia M, 2005, J VIROL, V79, P9197, DOI 10.1128/JVI.79.14.9197-9205.2005; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; HERMANN B, 2007, ANTIMICROB AGENTS CH, V51, P1596; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jungbauer Alois, 2007, Biotechnology Journal, V2, P647, DOI 10.1002/biot.200790060; KENNY MT, 1970, APPL MICROBIOL, V20, P371, DOI 10.1128/AEM.20.3.371-373.1970; Khudyakov YE, 1997, J VIROL, V71, P6875, DOI 10.1128/JVI.71.9.6875-6880.1997; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Madejon A, 1997, GASTROENTEROLOGY, V113, P573, DOI 10.1053/gast.1997.v113.pm9247478; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Pan Y, 2007, BIOCHEM BIOPH RES CO, V359, P70, DOI 10.1016/j.bbrc.2007.05.052; PilotMatias TJ, 1996, VIROLOGY, V225, P282, DOI 10.1006/viro.1996.0602; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Sinn PL, 2003, J VIROL, V77, P5902, DOI 10.1128/JVI.77.10.5902-5910.2003; Stapleton JT, 2004, J CLIN MICROBIOL, V42, P3915, DOI 10.1128/JCM.42.9.3915-3919.2004; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Tacke M, 1997, LANCET, V349, P318, DOI 10.1016/S0140-6736(96)06461-6; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Vanpouille C, 2007, J VIROL, V81, P12458, DOI 10.1128/JVI.00326-07; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Xiang JH, 2005, J INFECT DIS, V192, P2147, DOI 10.1086/498170; Xiang JH, 2005, J INTERF CYTOK RES, V25, P261, DOI 10.1089/jir.2005.25.261; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Xiang WS, 2006, PESTIC BIOCHEM PHYS, V85, P1, DOI 10.1016/j.pestbp.2005.09.001; Yu YJ, 2000, NAT MED, V6, P933, DOI 10.1038/78704; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	49	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2580	10.1371/journal.pone.0002580	http://dx.doi.org/10.1371/journal.pone.0002580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596910	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200044
J	Price, CE; Driessen, AJM				Price, Claire E.; Driessen, Arnold J. M.			YidC is involved in the biogenesis of anaerobic respiratory complexes in the inner membrane of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; FUMARATE REDUCTASE; NITRATE REDUCTASE; STRESS-RESPONSE; ATP SYNTHASE; NUCLEAR GENE; SUBUNIT-C; INSERTION; PATHWAY	YidC of Escherichia coli belongs to the evolutionarily conserved Oxa1/Alb3/YidC family. Members of this family have all been implicated in membrane protein biogenesis of aerobic respiratory and energy-transducing proteins. YidC is essential for the insertion of subunit c of the F1F0-ATP synthase and subunit a of cytochrome o oxidase. The aim of this study was to investigate whether YidC plays a role during anaerobic growth of Escherichia coli, specifically when either nitrate or fumarate are used as terminal electron acceptors or under fermentative conditions. The effect of YidC depletion on the growth, enzyme activities, and protein levels in the inner membrane was determined. YidC is essential for all anaerobic growth conditions tested, and this is not because of the decreased levels of F1F0-ATP synthase in the inner membrane only. The results suggest a role for YidC in the membrane biogenesis of integral membrane parts of the anaerobic respiratory chain.	Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands; Univ Groningen, Kluyver Ctr Genom Ind Microorganisms, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Proteomics Centre; European Community [LSHG-CT-2004-504601]	Netherlands Proteomics Centre; European Community(European Commission)	This work was supported by a grant from the Netherlands Proteomics Centre and by European Community Grant LSHG-CT-2004-504601. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Dubini A, 2003, FEBS LETT, V549, P141, DOI 10.1016/S0014-5793(03)00802-0; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; GARLAND PB, 1975, BIOCHEM J, V152, P547, DOI 10.1042/bj1520547; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LATOUR DJ, 1989, BIOCHEM CELL BIOL, V67, P251, DOI 10.1139/o89-038; LESTER RL, 1971, J BACTERIOL, V105, P1006, DOI 10.1128/JB.105.3.1006-1014.1971; Lin E., 1987, ESCHERICHIA COLI SAL, P201; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; MALONEY PC, 1987, ESCHERICHIA COLI SAL, P222; MCCORMICK KA, 1993, J BIOL CHEM, V268, P24683; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Sambasivarao D, 2001, J BIOL CHEM, V276, P20167, DOI 10.1074/jbc.M010369200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Seo J, 2007, MOL MICROBIOL, V65, P714, DOI 10.1111/j.1365-2958.2007.05821.x; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	47	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26921	26927		10.1074/jbc.M804490200	http://dx.doi.org/10.1074/jbc.M804490200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18635537	hybrid, Green Published			2022-12-25	WOS:000259586600012
J	Saegusa, J; Akakura, N; Wu, CY; Hoogland, C; Ma, Z; Lam, KS; Liu, FT; Takada, YK; Takada, Y				Saegusa, Jun; Akakura, Nobuaki; Wu, Chun-Yi; Hoogland, Case; Ma, Zi; Lam, Kit S.; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu			Pro-inflammatory secretory phospholipase a2 type IIA binds to integrins alpha v beta 3 and alpha 4 beta 1 and induces proliferation of monocytic cells in an integrin-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED DOCKING; MEMBRANE-RECEPTOR; CRYSTAL-STRUCTURE; ONCOGENIC ACTION; PROSTATE-CANCER; MOLECULAR-BASIS; LIGAND-BINDING; A(2); ALPHA(V)BETA(3); PROTEINS	Secretory phospholipase A2 group IIA (sPLA2-IIA) plays an important role in the pathogenesis of inflammatory diseases. Catalytic activity of this enzyme that generates arachidonic acid is a major target for development of anti-inflammatory agents. Independent of its catalytic activity, sPLA2-IIA induces pro-inflammatory signals in a receptor-mediated mechanism (e. g. through the M-type receptor). However, the M-type receptor is species-specific: sPLA2-IIA binds to the M-type receptor in rodents and rabbits, but not in human. Thus sPLA2-IIA receptors in human have not been established. Here we demonstrated that sPLA2-IIA bound to integrin alpha v beta 3 at a high affinity (K-D= 2 x 10(-7) M). We identified amino acid residues in sPLA2-IIA (Arg-74 and Arg-100) that are critical for integrin binding using docking simulation and mutagenesis. The integrin-binding site did not include the catalytic center or the M-type receptor-binding site. sPLA2-IIA also bound to alpha 4 beta 1. We showed that sPLA2-IIA competed with VCAM-1 for binding to alpha 4 beta 1, and bound to a site close to those for VCAM-1 and CS-1 in the alpha 4 subunit. Wild type and the catalytically inactive H47Q mutant of sPLA2-IIA induced cell proliferation and ERK1/2 activation in monocytic cells, but the integrin binding-defective R74E/R100E mutant did not. This indicates that integrin binding is required, but catalytic activity is not required, for sPLA2-IIA-induced proliferative signaling. These results suggest that integrins alpha v beta 3 and alpha 4 beta 1 may serve as receptors for sPLA2-IIA and mediate pro-inflammatory action of sPLA2-IIA, and that integrin sPLA2-IIA interaction is a novel therapeutic target.	[Saegusa, Jun; Akakura, Nobuaki; Hoogland, Case; Ma, Zi; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Wu, Chun-Yi; Lam, Kit S.] Univ Calif Davis, Sch Med, Dept Hematol Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Res 3 Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [AG027350]; American Heart Association [0555102Y]; NATIONAL INSTITUTE ON AGING [R21AG027350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027350 (to Y.T.). This work was also supported by American Heart Association Grant-in-aid 0555102Y. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; Bowton DL, 2005, J ASTHMA, V42, P65, DOI 10.1081/JAS-200044748; Bradley JD, 2005, J RHEUMATOL, V32, P417; Byzova TV, 1998, THROMB HAEMOSTASIS, V80, P726; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Fleming FE, 2007, ARCH VIROL, V152, P1087, DOI 10.1007/s00705-007-0937-x; Fuentes L, 2002, FEBS LETT, V531, P7, DOI 10.1016/S0014-5793(02)03401-4; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Gelb MH, 2000, J BIOL CHEM, V275, P39823, DOI 10.1074/jbc.C000671200; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Jiang JZ, 2002, AM J PATHOL, V160, P667, DOI 10.1016/S0002-9440(10)64886-9; LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Nath D, 1999, J CELL SCI, V112, P579; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; REYNOLDS LJ, 1994, ANAL BIOCHEM, V217, P25, DOI 10.1006/abio.1994.1079; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sartipy P, 2000, CIRC RES, V86, P707, DOI 10.1161/01.RES.86.6.707; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOCHEM, V121, P914; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang HC, 2001, J MED CHEM, V44, P1021, DOI 10.1021/jm000506s; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhang YP, 1999, J BIOL CHEM, V274, P27726, DOI 10.1074/jbc.274.39.27726	53	70	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26107	26115		10.1074/jbc.M804835200	http://dx.doi.org/10.1074/jbc.M804835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635536	Green Published, hybrid			2022-12-25	WOS:000259200100039
J	Roberts, PJ; Mitin, N; Keller, PJ; Chenette, EJ; Madigan, JP; Currin, RO; Cox, AD; Wilson, O; Kirschmeier, P; Der, CJ				Roberts, Patrick J.; Mitin, Natalia; Keller, Patricia J.; Chenette, Emily J.; Madigan, James P.; Currin, Rachel O.; Cox, Adrienne D.; Wilson, Oswald; Kirschmeier, Paul; Der, Channing J.			Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYLTRANSFERASE-I INHIBITORS; FARNESYL-PROTEIN TRANSFERASE; FARNESYLTRANSFERASE INHIBITORS; ALTERNATIVE PRENYLATION; RAS SUPERFAMILY; HA-RAS; K-RAS; N-RAS; PALMITOYLATION; LOCALIZATION	Rho GTPases (20 human members) comprise a major branch of the Ras superfamily of small GTPases, and aberrant Rho GTPase function has been implicated in oncogenesis and other human diseases. Although many of our current concepts of Rho GTPases are based on the three classical members (RhoA, Rac1, and Cdc42), recent studies have revealed the diversity of biological functions mediated by other family members. A key basis for the functional diversity of Rho GTPases is their association with distinct subcellular compartments, which is dictated in part by three posttranslational modifications signaled by their carboxylterminal CAAX( where C represents cysteine, A is an aliphatic amino acid, and X is a terminal amino acid) tetrapeptide motifs. CAAX motifs are substrates for the prenyltransferase-catalyzed addition of either farnesyl or geranylgeranyl isoprenoid lipids, Rce1-catalyzed endoproteolytic cleavage of the AAX amino acids, and Icmt-catalyzed carboxyl methylation of the isoprenylcysteine. We utilized pharmacologic, biochemical, and genetic approaches to determine the sequence requirements and roles of CAAX signal modifications in dictating the subcellular locations and functions of the Rho GTPase family. Although the classical Rho GTPases are modified by geranylgeranylation, we found that a majority of the other Rho GTPases are substrates for farnesyltransferase. We found that the membrane association and/or function of Rho GTPases are differentially dependent on Rce1-and Icmt-mediated modifications. Our results further delineate the sequence requirements for prenyltransferase specificity and functional roles for protein prenylation in Rho GTPase function. We conclude that a majority of Rho GTPases are targets for pharmacologic inhibitors of farnesyltransferase, Rce1, and Icmt.	[Roberts, Patrick J.; Mitin, Natalia; Currin, Rachel O.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, Patrick J.] Univ N Carolina, Div Pharmacol & Expt Therapeut, Chapel Hill, NC 27599 USA; [Mitin, Natalia; Keller, Patricia J.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Keller, Patricia J.; Madigan, James P.; Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Chenette, Emily J.; Madigan, James P.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Wilson, Oswald; Kirschmeier, Paul] Schering Plough Res Inst, Kenilworth, NJ 07033 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company; Schering-Plough Research Institute	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 W Dr,CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Chenette, Emily/0000-0003-0393-395X; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA063071, CA67771, CA92240, CA109550]; NATIONAL CANCER INSTITUTE [U19CA067771, R01CA109550, R01CA063071, R01CA092240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA063071, CA67771, and CA92240 (to C. J. D.) and CA063071, CA67771, and CA109550 (to A. D. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; CARBONI JM, 1995, ONCOGENE, V10, P1905; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El Oualid F, 2006, CURR MED CHEM, V13, P2385, DOI 10.2174/092986706777935078; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; Foster R, 1996, MOL CELL BIOL, V16, P2689; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo WD, 2003, CELL, V113, P315; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Joyce PL, 2003, CANCER RES, V63, P7959; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; Keller PJ, 2005, METHODS, V37, P131, DOI 10.1016/j.ymeth.2005.05.023; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Lebowitz PF, 1997, J BIOL CHEM, V272, P15591, DOI 10.1074/jbc.272.25.15591; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; OHYA Y, 1993, MOL BIOL CELL, V4, P1017, DOI 10.1091/mbc.4.10.1017; Papaharalambus C, 2005, J BIOL CHEM, V280, P18790, DOI 10.1074/jbc.M410081200; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Prendergast GC, 2000, CURR OPIN CELL BIOL, V12, P166, DOI 10.1016/S0955-0674(99)00072-1; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roskoski R, 1998, ARCH BIOCHEM BIOPHYS, V356, P167, DOI 10.1006/abbi.1998.0768; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Sun JZ, 1999, CANCER RES, V59, P4919; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Willumsen BM, 1996, ONCOGENE, V13, P1901; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Zhang FL, 1997, J BIOL CHEM, V272, P10232	67	227	228	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25150	25163		10.1074/jbc.M800882200	http://dx.doi.org/10.1074/jbc.M800882200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614539	Green Published, hybrid			2022-12-25	WOS:000259012700007
J	Weinbaum, JS; Broekelmann, TJ; Pierce, RA; Werneck, CC; Segade, F; Craft, CS; Knutsen, RH; Mecham, RP				Weinbaum, Justin S.; Broekelmann, Thomas J.; Pierce, Richard A.; Werneck, Claudio C.; Segade, Fernando; Craft, Clarissa S.; Knutsen, Russell H.; Mecham, Robert P.			Deficiency in microfibril-associated glycoprotein-1 leads to complex phenotypes in multiple organ systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLIN-CONTAINING MICROFIBRILS; CARBOXYL-TERMINAL DOMAIN; EXTRACELLULAR-MATRIX; IN-VIVO; NONELASTIC TISSUES; RICH MICROFIBRILS; PROTEINS MAGP-1; TERNARY COMPLEX; MARFAN-SYNDROME; CELL-ADHESION	Microfibril-associated glycoprotein-1 (MAGP-1) is a small molecular weight component of the fibrillin-rich microfibril. Gene-targeted inactivation of MAGP-1 reveals a complex phenotype that includes increased body weight and size due to excess body fat, an altered wound healing response in bone and skin, and a bleeding diathesis. Elastic tissues rich in MAGP-1-containing microfibrils develop normally and show normal function. The penetrance of MAGP-1-null phenotypes is highly variable and mouse strain-dependent, suggesting the influence of modifier genes. MAGP-1 was found to bind active transforming growth factor-beta(TGF-beta) and BMP-7 with high affinity, suggesting that it may be an important modulator of microfibril-mediated growth factor signaling. Many of the phenotypic traits observed in MAGP-1-deficient mice are consistent with loss of TGF-beta function and are generally opposite those associated with mutations in fibrillin-1 that result in enhanced TGF-beta signaling. Increased body size and fat deposition in MAGP-1-mutant animals are particularly intriguing given the localization of obesity traits in humans to the region on chromosome 1 containing the MAGP-1 gene.	[Weinbaum, Justin S.; Broekelmann, Thomas J.; Craft, Clarissa S.; Knutsen, Russell H.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pierce, Richard A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Werneck, Claudio C.] Univ Estadual Campinas, Dept Bioquim, BR-13084225 Campinas, SP, Brazil; [Segade, Fernando] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Universidade Estadual de Campinas; University of Pennsylvania	Mecham, RP (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Werneck, Claudio C/C-7568-2012; Weinbaum, Justin S/C-3192-2009	Werneck, Claudio C/0000-0002-9413-0572; Weinbaum, Justin S/0000-0002-0626-6083	National Institutes of Health [HL53325, HL71960, HL74138, HL54049, T32 HL007873]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, R01HL074138, R01HL071960, R29HL054049, R37HL053325, T32HL007873, R01HL054049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL53325, HL71960, HL74138 ( to R. P. M.), HL54049 ( to R. A. P.), and T32 HL007873 ( to J.S.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a National Science Foundation graduate research fellowship.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; CHEN YP, 1993, J BIOL CHEM, V268, P27381; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DAVIS EC, 1993, LAB INVEST, V68, P89; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; GIBSON MA, 1987, IMMUNOL CELL BIOL, V65, P345, DOI 10.1038/icb.1987.39; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; Kielty CM, 2002, J MUSCLE RES CELL M, V23, P581, DOI 10.1023/A:1023479010889; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Kyriakides TR, 2003, BLOOD, V101, P3915, DOI 10.1182/blood.V101.10.3915; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Liu YJ, 2004, J CLIN ENDOCR METAB, V89, P875, DOI 10.1210/jc.2003-030774; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morris BJ, 2005, HYPERTENSION, V46, P1256, DOI 10.1161/01.HYP.0000188055.13764.dc; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pausova Z, 2005, HYPERTENSION, V46, P1280, DOI 10.1161/01.HYP.0000188049.23233.fb; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Puolakkainen PA, 2005, J HISTOCHEM CYTOCHEM, V53, P571, DOI 10.1369/jhc.4A6425.2005; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Ritty TM, 1999, J BIOL CHEM, V274, P8933, DOI 10.1074/jbc.274.13.8933; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Segade F, 2005, BBA-GENE STRUCT EXPR, V1731, P215, DOI 10.1016/j.bbaexp.2005.10.007; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Segade F, 2000, MATRIX BIOL, V19, P671, DOI 10.1016/S0945-053X(00)00115-3; Segade F, 2007, INT J BIOCHEM CELL B, V39, P2303, DOI 10.1016/j.biocel.2007.06.017; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; STARCHER B, 1995, RESPIRATION, V62, P252; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; WITHERS AP, 1994, J MED GENET, V31, P174; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	63	72	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25533	25543		10.1074/jbc.M709962200	http://dx.doi.org/10.1074/jbc.M709962200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625713	Green Published, hybrid			2022-12-25	WOS:000259012700049
J	Gilbert, M; Jung, SR; Reed, BJ; Sweet, IR				Gilbert, Merle; Jung, Seung-Ryoung; Reed, Benjamin J.; Sweet, Ian R.			Islet oxygen consumption and insulin secretion tightly coupled to calcium derived from L-type calcium channels but not from the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PROTEIN-KINASE-C; GLYCEROL-PHOSPHATE DEHYDROGENASE; CA2+ CHANNELS; B-CELLS; DEPENDENT MOBILIZATION; MITOCHONDRIAL CALCIUM; CYTOPLASMIC CA2+; CHROMAFFIN CELLS; HIT-T15 CELLS	The aim of the study was to test whether the source of intracellular calcium (Ca2+) is a determinant of beta cell function. We hypothesized that elevations in cytosolic Ca2+ caused by the release of Ca2+ from the endoplasmic reticulum (ER) have little physiologic impact on oxygen consumption and insulin secretion. Ca2+ release from the ER was induced in isolated rat islets by acetylcholine and response of oxygen consumption rate (OCR), NAD(P) H, cytosolic Ca2+, and insulin secretory rate (ISR) were measured. Glucose increased all four parameters, and thereafter acetylcholine further increased cytosolic Ca2+, OCR, and ISR. To assess the contribution of Ca2+ release from the ER in mediating the effects of acetylcholine, ER Ca2+ stores were first emptied by inhibiting the sarcoendoplasmic reticulum Ca2+-ATPase, which subsequently reduced the effect of acetylcholine on cytosolic Ca2+ but not its effects on OCR or ISR. As predicted, OCR and ISR were acutely sensitive to changes in L-type Ca2+ channel activity; nimodipine completely inhibited glucose-stimulated ISR and suppressed OCR by 36%, despite only inhibiting cytosolic Ca2+ by 46%. Moreover, in the presence of nimodipine and high glucose, acetylcholine still elevated cytosolic Ca2+ levels above those observed in the presence of high glucose alone but did not significantly stimulate ISR. In conclusion, Ca2+ flux through L-type Ca2+ channels was tightly coupled to changes in OCR and ISR. In contrast, the results obtained support the notion that Ca2+ release from the ER has little or no access to the intracellular machinery that regulates OCR and ISR.	[Gilbert, Merle; Jung, Seung-Ryoung; Reed, Benjamin J.; Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sweet, IR (corresponding author), Univ Washington, Dept Med, Box 358055, Seattle, WA 98195 USA.	isweet@u.washington.edu		Gilbert, Merle/0000-0001-8147-3958	National Institutes of Health [DK17047, DK063986]; National Science Foundation [IIP-0750508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063986, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17047 and DK063986. This work was also supported by National Science Foundation Grant IIP-0750508.	AcevedoDuncan M, 1997, NEUROCHEM RES, V22, P775, DOI 10.1023/A:1022071407268; Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; BROWN GC, 1992, BIOCHEM J, V284, P1; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Doliba NM, 2006, AM J PHYSIOL-ENDOC M, V291, pE525, DOI 10.1152/ajpendo.00579.2005; GAO ZY, 1994, ENDOCRINOLOGY, V135, P191, DOI 10.1210/en.135.1.191; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GILON P, 1995, BIOCHEM J, V311, P259, DOI 10.1042/bj3110259; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; HAMAKAWA N, 1995, CELL CALCIUM, V17, P21, DOI 10.1016/0143-4160(95)90099-3; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; HENQUIN JC, 1988, ENDOCRINOLOGY, V122, P2134, DOI 10.1210/endo-122-5-2134; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jamme I, 1997, BRAIN RES, V774, P123, DOI 10.1016/S0006-8993(97)81695-2; Kajikawa M, 2002, DIABETES, V51, P2522, DOI 10.2337/diabetes.51.8.2522; Kennedy ED, 1998, DIABETES METAB, V24, P15; KOBAYASHI K, 1979, CIRC RES, V44, P166, DOI 10.1161/01.RES.44.2.166; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; MCCORMACK JG, 1990, BIOCHEM J, V267, P527, DOI 10.1042/bj2670527; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mears D, 2004, J MEMBRANE BIOL, V197, P59, DOI 10.1007/s00232-003-0642-y; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; Niwa T, 1998, DIABETES, V47, P1699, DOI 10.2337/diabetes.47.11.1699; Rolland JF, 2002, J BIOL CHEM, V277, P38373, DOI 10.1074/jbc.M203888200; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; WENG L, 1993, CELL SIGNAL, V5, P777, DOI 10.1016/0898-6568(93)90038-N; WOLF BA, 1988, AM J PHYSIOL, V254, pE121, DOI 10.1152/ajpendo.1988.254.2.E121; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yanagita T, 1999, J NEUROCHEM, V73, P1749, DOI 10.1046/j.1471-4159.1999.731749.x	45	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24334	24342		10.1074/jbc.M802097200	http://dx.doi.org/10.1074/jbc.M802097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593707	hybrid, Green Published			2022-12-25	WOS:000258820000008
J	Munirajan, AK; Ando, K; Mukai, A; Takahashi, M; Suenaga, Y; Ohira, M; Koda, T; Hirota, T; Ozaki, T; Nakagawara, A				Munirajan, Arasambattu K.; Ando, Kiyohiro; Mukai, Akira; Takahashi, Masato; Suenaga, Yusuke; Ohira, Miki; Koda, Tadayuki; Hirota, Toru; Ozaki, Toshinori; Nakagawara, Akira			KIF1B beta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOZYGOUSLY DELETED REGION; HUMAN NEUROBLASTOMA; COILED-COIL; KINESIN; IDENTIFICATION; PROTEIN; INSTABILITY; EXPRESSION; PRINCIPLES; TRANSPORT	Deletion of the distal region of chromosome 1 frequently occurs in a variety of human cancers, including aggressive neuroblastoma. Previously, we have identified a 500-kb homozygously deleted region at chromosome 1p36.2 harboring at least six genes in a neuroblastoma-derived cell line NB1/C201. Among them, only KIF1B beta, a member of the kinesin superfamily proteins, induced apoptotic cell death. These results prompted us to address whether KIF1B beta could be a tumor suppressor gene mapped to chromosome 1p36 in neuroblastoma. Hemizygous deletion of KIF1B beta in primary neuroblastomas was significantly correlated with advanced stages (p = 0.0013) and MYCN amplification (p < 0.001), whereas the mutation rate of the KIF1B beta gene was infrequent. Although KIF1B beta allelic loss was significantly associated with a decrease in KIF1B beta mRNA levels, its promoter region was not hypermethylated. Additionally, expression of KIF1B beta was markedly down-regulated in advanced stages of tumors (p < 0.001). Enforced expression of KIF1B beta resulted in an induction of apoptotic cell death in association with an increase in the number of cells entered into the G(2)/M phase of the cell cycle, whereas its knockdown by either short interfering RNA or by a genetic suppressor element led to an accelerated cell proliferation or enhanced tumor formation in nude mice, respectively. Furthermore, we demonstrated that the rod region unique to KIF1B beta is critical for the induction of apoptotic cell death in a p53-independent manner. Thus, KIF1B beta may act as a haploinsufficient tumor suppressor, and its allelic loss may be involved in the pathogenesis of neuroblastoma and other cancers.	[Munirajan, Arasambattu K.; Ando, Kiyohiro; Mukai, Akira; Takahashi, Masato; Suenaga, Yusuke; Ohira, Miki; Ozaki, Toshinori; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Chiba 2608717, Japan; [Munirajan, Arasambattu K.; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Res Ctr Funct Genom, Tokyo 1418577, Japan; [Munirajan, Arasambattu K.] Univ Madras, Dr ALM PG Inst Basic Med Sci, Dept Genet, Madras 600113, Tamil Nadu, India; [Hirota, Toru] Inst Canc Res, Dept Expt Pathol, Tokyo 1358550, Japan	Chiba Cancer Center; Hisamitsu Pharmaceutical Co Ltd; University of Madras; Japanese Foundation for Cancer Research	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp	Munirajan, Arasambattu/S-1096-2019; MUNIRAJAN, A K/P-5953-2019	MUNIRAJAN, A K/0000-0003-1337-9008; Suenaga, Yusuke/0000-0001-6902-5386	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Ministry of Health, Labor and Welfare of Japan.	BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bauer A, 2001, GENE CHROMOSOME CANC, V31, P228, DOI 10.1002/gcc.1139; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; CARON H, 1995, MED PEDIATR ONCOL, V24, P215, DOI 10.1002/mpo.2950240402; Caron H, 2001, GENE CHROMOSOME CANC, V30, P168, DOI 10.1002/1098-2264(200102)30:2<168::AID-GCC1072>3.0.CO;2-E; Chen YZ, 2001, GENE CHROMOSOME CANC, V31, P326, DOI 10.1002/gcc.1151; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; Dutta K, 2003, PROTEIN SCI, V12, P257, DOI 10.1110/ps.0223903; Ejeskar K, 2001, MED PEDIATR ONCOL, V36, P61, DOI 10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; GEHRING M, 1995, CANCER RES, V55, P5366; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hogarty MD, 2000, MED PEDIATR ONCOL, V35, P512, DOI 10.1002/1096-911X(20001201)35:6<512::AID-MPO2>3.0.CO;2-D; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; MARTINSSON T, 1995, CANCER RES, V55, P5681; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nagai M, 2000, INT J ONCOL, V16, P907; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Nakagawara A, 2000, MED PEDIATR ONCOL, V35, P516, DOI 10.1002/1096-911X(20001201)35:6<516::AID-MPO3>3.0.CO;2-Z; Nakagawara A, 1998, MED PEDIATR ONCOL, V31, P113, DOI 10.1002/(SICI)1096-911X(199808)31:2<113::AID-MPO14>3.0.CO;2-O; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Ohira M, 2000, ONCOGENE, V19, P4302, DOI 10.1038/sj.onc.1203786; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; White PS, 2001, MED PEDIATR ONCOL, V36, P37, DOI 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	47	80	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24426	24434		10.1074/jbc.M802316200	http://dx.doi.org/10.1074/jbc.M802316200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614535	Green Published, hybrid			2022-12-25	WOS:000258820000018
J	Clerc, I; Polakowski, N; Andre-Arpin, C; Cook, P; Barbeau, B; Mesnard, JM; Lemasson, I				Clerc, Isabelle; Polakowski, Nicholas; Andre-Arpin, Charlotte; Cook, Pamela; Barbeau, Benoit; Mesnard, Jean-Michel; Lemasson, Isabelle			An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; BZIP FACTOR HBZ; NUCLEAR-RECEPTOR; MOLECULAR-INTERACTIONS; ENHANCE TRANSCRIPTION; HTLV-1 TRANSCRIPTION; 21-BASE-PAIR REPEATS; COACTIVATOR CBP; ACTIVATION; GENE	Activation of human T cell leukemia virus type 1 (HTLV-1) transcription is established through the formation of protein complexes on the viral promoter that are essentially composed of the cellular basic leucine zipper (bZIP) transcription factor cAMP-response element-binding protein (CREB (or certain other members of the ATF/CREB family), the HTLV-1-encoded transactivator Tax, and the pleiotropic cellular coactivators p300/CBP. HTLV-1 bZIP factor (HBZ) is a protein encoded by HTLV-1 that contains a bZIP domain and functions to repress HTLV-1 transcription. HBZ has been shown to repress viral transcription by dimerizing with CREB, which occurs specifically through the bZIP domain in each protein, and preventing CREB from binding to the DNA. However, we previously found that HBZ causes only partial removal of CREB from a chromosomally integrated viral promoter, and more importantly, an HBZ mutant lacking the COOH-terminal bZIP domain retains the ability to repress viral transcription. These results suggest that an additional mechanism contributes to HBZ-mediated repression of HTLV-1 transcription. In this study, we show that HBZ binds directly to the p300 and CBP coactivators. Two LXXLL-like motifs located within the NH2-terminal region of HBZ are important for this interaction and specifically mediate binding to the KIX domain of p300/CBP. We provide evidence that this interaction interferes with the ability of Tax to bind p300/CBP and thereby inhibits the association of the coactivators with the viral promoter. Our findings demonstrate that HBZ utilizes a bipartite mechanism to repress viral transcription.	[Polakowski, Nicholas; Cook, Pamela; Lemasson, Isabelle] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] CPBS, Inst Biol, CNRS, UMR 5236, F-34965 Montpellier 2, France; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] Univ Montpellier 1, F-34965 Montpellier, France; [Barbeau, Benoit] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] Univ Montpellier 2, CPBS, F-34095 Montpellier, France	University of North Carolina; East Carolina University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Quebec; University of Quebec Montreal; Universite de Montpellier	Mesnard, JM (corresponding author), CPBS, Inst Biol, CNRS, UMR 5236, CS 69033,4 Bd Henri 4, F-34965 Montpellier 2, France.	jean-michel.mesnard@univ-montp1.fr; lemassoni@ecu.edu	Lemasson, Isabelle/N-1355-2013; Barbeau, Benoit/A-1174-2010	Barbeau, Benoit/0000-0002-4108-8155; Mesnard, Jean-Michel/0000-0003-3344-5367; Clerc, Isabelle/0000-0002-7140-7049; polakowski, Nicholas/0000-0003-4949-5799	East Carolina University; CNRS; Universite Montpellier 1; Association pour la Recherche sur le Cancer [3606]; Fondation Recherche Medicale (Comite Languedoc); Ligue Contre le Cancer (Comite de l'Herault)	East Carolina University; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Montpellier 1; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Recherche Medicale (Comite Languedoc); Ligue Contre le Cancer (Comite de l'Herault)	This work was supported by a Research Development Grant Program Award from East Carolina University (to I. C.) and by institutional grants from CNRS and the Universite Montpellier 1 (UM 1) and grants from the Association pour la Recherche sur le Cancer (Grant 3606), the Fondation Recherche Medicale (Comite Languedoc), and the Ligue Contre le Cancer (Comite de l'Herault) (to J. M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Barbeau B, 2007, INT REV IMMUNOL, V26, P283, DOI 10.1080/08830180701690843; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bayly R, 2004, J BIOL CHEM, V279, P55362, DOI 10.1074/jbc.M408654200; Bayly R, 2006, MOL CELL BIOL, V26, P6442, DOI 10.1128/MCB.02025-05; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Chan HM, 2001, J CELL SCI, V114, P2363; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Frangioni JV, 2000, NAT BIOTECHNOL, V18, P1080, DOI 10.1038/80280; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gachon F, 2002, VIROLOGY, V299, P271, DOI 10.1006/viro.2002.1501; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Goodman RH, 2000, GENE DEV, V14, P1553; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Hivin P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-14; Hivin P, 2006, NUCLEIC ACIDS RES, V34, P2761, DOI 10.1093/nar/gkl375; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kimzey AL, 1998, J BIOL CHEM, V273, P13768, DOI 10.1074/jbc.273.22.13768; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Langlois M, 2004, VIROLOGY, V329, P395, DOI 10.1016/j.virol.2004.09.003; LAROCCA D, 1989, BIOCHEM BIOPH RES CO, V163, P1006, DOI 10.1016/0006-291X(89)92322-X; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lemasson I, 2001, J BIOL CHEM, V276, P15720, DOI 10.1074/jbc.M100131200; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Li M, 2007, J VIROL METHODS, V142, P159, DOI 10.1016/j.jviromet.2007.01.023; Lu HX, 2002, MOL CELL BIOL, V22, P4450, DOI 10.1128/MCB.22.13.4450-4462.2002; Lundblad JR, 1998, J BIOL CHEM, V273, P19251, DOI 10.1074/jbc.273.30.19251; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Mesnard JM, 2006, BLOOD, V108, P3979, DOI 10.1182/blood-2006-03-007732; Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006; Okada M, 2002, J VIROL, V76, P12564, DOI 10.1128/JVI.76.24.12564-12573.2002; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Yan JP, 1998, J MOL BIOL, V281, P395, DOI 10.1006/jmbi.1998.1951; Yin MJ, 1996, MOL CELL BIOL, V16, P3156; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	65	106	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23903	23913		10.1074/jbc.M803116200	http://dx.doi.org/10.1074/jbc.M803116200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18599479	Green Published, hybrid			2022-12-25	WOS:000258638900045
J	Badaeva, TN; Malysheva, DN; Korchagin, VI; Ryskov, AP				Badaeva, Tatiana N.; Malysheva, Daria N.; Korchagin, Vitaly I.; Ryskov, Alexei P.			Genetic Variation and De Novo Mutations in the Parthenogenetic Caucasian Rock Lizard Darevskia unisexualis	PLOS ONE			English	Article							MICROSATELLITE LOCI; LACERTA; GERMLINE; DIVERSITY; EVOLUTION; DAHLI; AGE	Unisexual all-female lizards of the genus Darevskia that are well adapted to various habitats are known to reproduce normally by true parthenogenesis. Although they consist of unisexual lineages and lack effective genetic recombination, they are characterized by some level of genetic polymorphism. To reveal the mutational contribution to overall genetic variability, the most straightforward and conclusive way is the direct detection of mutation events in pedigree genotyping. Earlier we selected from genomic library of D. unisexualis two polymorphic microsatellite containg loci Du281 and Du215. In this study, these two loci were analyzed to detect possible de novo mutations in 168 parthenogenetic offspring of 49 D. unisexualis mothers and in 147 offspring of 50 D. armeniaca mothers. No mutant alleles were detected in D. armeniaca offspring at both loci, and in D. unisexualis offspring at the Du215 locus. There were a total of seven mutational events in the germ lines of four of the 49 D. unisexualis mothers at the Du281 locus, yielding the mutation rate of 0.1428 events per germ line tissue. Sequencing of the mutant alleles has shown that most mutations occur via deletion or insertion of single microsatellite repeat being identical in all offspring of the family. This indicates that such mutations emerge at the early stages of embryogenesis. In this study we characterized single highly unstable (GATA)(n) containing locus in parthenogenetic lizard species D. unisexualis. Besides, we characterized various types of mutant alleles of this locus found in the D. unisexualis offspring of the first generation. Our data has shown that microsatellite mutations at highly unstable loci can make a significant contribution to population variability of parthenogenetic lizards.	[Badaeva, Tatiana N.; Malysheva, Daria N.; Korchagin, Vitaly I.; Ryskov, Alexei P.] Russian Acad Sci, Lab Genome Org, Inst Gene Biol, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Badaeva, TN (corresponding author), Russian Acad Sci, Lab Genome Org, Inst Gene Biol, Moscow, Russia.	badaeva_t@mail.ru	Ryskov, Alexey/F-1179-2016; Korchagin, Vitaly/B-8635-2011	Ryskov, Alexey/0000-0002-4159-0671; Korchagin, Vitaly/0000-0003-2264-6294	Leading Scientific School and Program of President of Russian Federation [02.120.11.23498, MK-4748.2007.4, MK-2106.2008.4]	Leading Scientific School and Program of President of Russian Federation	This work was partly supported by the Leading Scientific School and Program of President of Russian Federation for financial support of young scientist 02.120.11.23498 MK-4748.2007.4. and MK-2106.2008.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Arribas Oscar J., 1999, Russian Journal of Herpetology, V6, P1; Brohede J, 2002, NUCLEIC ACIDS RES, V30, P1997, DOI 10.1093/nar/30.9.1997; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; DAREVSKY IS, 1966, J HERPETOL, V2, P65; Darevsky IS, 1985, BIOL REPTILIA, V15, P413; Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu JZ, 1998, J MOL EVOL, V46, P127, DOI 10.1007/PL00013146; Gardner MG, 2000, J EVOLUTION BIOL, V13, P551; Grebelnyi S. D., 2005, INVERTEBR ZOOL, V2, P79; Kan NG, 1998, MOL BIOL+, V32, P672; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; MaCCulloch RD, 1995, GENOME, V38, P1057, DOI 10.1139/g95-141; MAHTANI MM, 1993, HUM MOL GENET, V2, P431, DOI 10.1093/hmg/2.4.431; Malysheva DN, 2007, RUSS J GENET+, V43, P116, DOI 10.1134/S1022795407020032; Martirosyan IA, 2002, RUSS J GENET+, V38, P691, DOI 10.1023/A:1016000219576; MITANI K, 1990, J BIOL CHEM, V265, P15203; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x; PARKER ED, 1976, GENETICS, V84, P791; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Ryskov AP, 2003, RUSS J GENET+, V39, P986, DOI 10.1023/A:1025762731634; Tokarskaya ON, 2004, MOL GENET GENOMICS, V270, P509, DOI 10.1007/s00438-003-0936-x; Tokarskaya ON, 2001, MOL GENET GENOMICS, V265, P812, DOI 10.1007/s004380100475; UZZELL T, 1975, COPEIA, P204; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2730	10.1371/journal.pone.0002730	http://dx.doi.org/10.1371/journal.pone.0002730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648496	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900008
J	Patel, AV; Cheng, I; Canzian, F; Le Marchand, L; Thun, MJ; Berg, CD; Buring, J; Calle, EE; Chanock, S; Clavel-Chapelon, F; Cox, DG; Dorronsoro, M; Dossus, L; Haiman, CA; Hankinson, SE; Henderson, BE; Hoover, R; Hunter, DJ; Kaaks, R; Kolonel, LN; Kraft, P; Linseisen, J; Lund, E; Manjer, J; McCarty, C; Peeters, PHM; Pike, MC; Pollak, M; Riboli, E; Stram, DO; Tjonneland, A; Travis, RC; Trichopoulos, D; Tumino, R; Yeager, M; Ziegler, RG; Feigelson, HS				Patel, Alpa V.; Cheng, Iona; Canzian, Federico; Le Marchand, Loic; Thun, Michael J.; Berg, Christine D.; Buring, Julie; Calle, Eugenia E.; Chanock, Stephen; Clavel-Chapelon, Francoise; Cox, David G.; Dorronsoro, Miren; Dossus, Laure; Haiman, Christopher A.; Hankinson, Susan E.; Henderson, Brian E.; Hoover, Robert; Hunter, David J.; Kaaks, Rudolf; Kolonel, Laurence N.; Kraft, Peter; Linseisen, Jakob; Lund, Eiliv; Manjer, Jonas; McCarty, Catherine; Peeters, Petra H. M.; Pike, Malcolm C.; Pollak, Michael; Riboli, Elio; Stram, Daniel O.; Tjonneland, Anne; Travis, Ruth C.; Trichopoulos, Dimitrios; Tumino, Rosario; Yeager, Meredith; Ziegler, Regina G.; Feigelson, Heather Spencer			IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)	PLOS ONE			English	Article							GROWTH-FACTOR-I; GENETIC-VARIATION; BINDING-PROTEINS; MAMMARY-GLAND; INSULIN; ASSOCIATION; GENOTYPE; ANGELES; SYSTEM; WOMEN	IGF-1 has been shown to promote proliferation of normal epithelial breast cells, and the IGF pathway has also been linked to mammary carcinogenesis in animal models. We comprehensively examined the association between common genetic variation in the IGF1, IGFBP1, and IGFBP3 genes in relation to circulating IGF-1 and IGFBP-3 levels and breast cancer risk within the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). This analysis included 6,912 breast cancer cases and 8,891 matched controls (n = 6,410 for circulating IGF-1 and 6,275 for circulating IGFBP-3 analyses) comprised primarily of Caucasian women drawn from six large cohorts. Linkage disequilibrium and haplotype patterns were characterized in the regions surrounding IGF1 and the genes coding for two of its binding proteins, IGFBP1 and IGFBP3. In total, thirty haplotype-tagging single nucleotide polymorphisms (htSNP) were selected to provide high coverage of common haplotypes; the haplotype structure was defined across four haplotype blocks for IGF1 and three for IGFBP1 and IGFBP3. Specific IGF1 SNPs individually accounted for up to 5% change in circulating IGF-1 levels and individual IGFBP3 SNPs were associated up to 12% change in circulating IGFBP-3 levels, but no associations were observed between these polymorphisms and breast cancer risk. Logistic regression analyses found no associations between breast cancer and any htSNPs or haplotypes in IGF1, IGFBP1, or IGFBP3. No effect modification was observed in analyses stratified by menopausal status, family history of breast cancer, body mass index, or postmenopausal hormone therapy, or for analyses stratified by stage at diagnosis or hormone receptor status. In summary, the impact of genetic variation in IGF1 and IGFBP3 on circulating IGF levels does not appear to substantially influence breast cancer risk substantially among primarily Caucasian postmenopausal women.	[Patel, Alpa V.; Thun, Michael J.; Calle, Eugenia E.; Feigelson, Heather Spencer] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Cheng, Iona] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, San Francisco, CA USA; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr, Epidemiol Program, Honolulu, HI USA; [Berg, Christine D.] NCI, Div Canc Prevent, Bethesda, MD USA; [Buring, Julie] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; [Chanock, Stephen; Hoover, Robert; Yeager, Meredith] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, Villejuif, France; [Cox, David G.; Hunter, David J.; Kraft, Peter] Harvard Sch Publ Hlth, Epidemiol Dept, Program Mol & Genet Epidemiol, Boston, MA USA; [Dorronsoro, Miren] Dept Publ Hlth Guipuzcoa, San Sebastian, Spain; [Dossus, Laure; Kaaks, Rudolf; Linseisen, Jakob] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Haiman, Christopher A.; Henderson, Brian E.; Pike, Malcolm C.; Stram, Daniel O.] USC, Los Angeles, CA USA; [Hankinson, Susan E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Lund, Eiliv] Univ Tromso, Inst Community Med, Tromso, Norway; [Manjer, Jonas] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [McCarty, Catherine] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Peeters, Petra H. M.; Riboli, Elio] Imperial Coll, Dept Epidemiol & Publ Hlth, London, England; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Travis, Ruth C.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England; [Trichopoulos, Dimitrios] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Tumino, Rosario] Canc Registry Azienda Ospedaliera Civile MP Arezzo, Ragusa, Italy; [Ziegler, Regina G.] NIH, NCI, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD USA	American Cancer Society; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UiT The Arctic University of Tromso; Lund University; Skane University Hospital; Utrecht University; Utrecht University Medical Center; McGill University; Imperial College London; Danish Cancer Society; Cancer Research UK; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Civile M.P. Arezzo Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Patel, AV (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA.	apatel@cancer.org	Dossus, Laure/AAW-9097-2021; Clavel-Chapelon, Francoise/G-6733-2014; Cox, David G/A-2023-2009; Pollak, Michael/G-9094-2011; Canzian, Federico/I-2804-2014; Cox, David/ABA-7454-2020; Dossus, Laure/B-2875-2013; Yeager, Meredith/AAA-5322-2020; Linseisen, Jakob/B-5353-2014	Dossus, Laure/0000-0003-2716-5748; Cox, David G/0000-0002-2152-9259; Pollak, Michael/0000-0003-3047-0604; Dossus, Laure/0000-0003-2716-5748; Linseisen, Jakob/0000-0002-9386-382X; Riboli, Elio/0000-0001-6795-6080; Lund, Eiliv/0000-0002-8071-8711; Cox, David/0000-0003-2047-4687; Tjonneland, Anne/0000-0003-4385-2097; McCarty, Catherine/0000-0003-1089-0142; Canzian, Federico/0000-0002-4261-4583; tumino, rosario/0000-0003-2666-414X	National Cancer Institute [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.; NATIONAL CANCER INSTITUTE [U01CA098216, U01CA098710, U01CA098758, U01CA098233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support from National Cancer Institute cooperative agreements U01-CA98233, U01-CA98710, U01-CA98216, and U01-CA98758 and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Allen NE, 2005, BRIT J CANCER, V92, P1283, DOI 10.1038/sj.bjc.6602471; BAXTER RC, 1994, HORM RES, V42, P140, DOI 10.1159/000184186; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P500, DOI 10.1002/cncr.10197; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Cheng I, 2006, JNCI-J NATL CANCER I, V98, P123, DOI 10.1093/jnci/djj013; Cheng I, 2006, CANCER EPIDEM BIOMAR, V15, P1993, DOI 10.1158/1055-9965.EPI-06-0361; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; DeLellis K, 2003, BRIT J CANCER, V88, P277, DOI 10.1038/sj.bjc.6600728; Feigelson HS, 2006, CANCER RES, V66, P2468, DOI 10.1158/0008-5472.CAN-05-3574; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hadsell DL, 2000, J MAMMARY GLAND BIOL, V5, P19, DOI 10.1023/A:1009559014703; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Johansson M, 2007, J CLIN ENDOCR METAB, V92, P4820, DOI 10.1210/jc.2007-0887; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Setiawan VW, 2006, CANCER EPIDEM BIOMAR, V15, P172, DOI 10.1158/1055-9965.EPI-05-0625; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; VERHEUS M, 2007, BREAST CANC RES TREA; Wagner WR, 2005, ACTA BIOMATER, V1, P3, DOI 10.1016/j.actbio.2004.09.010; Wood TL, 2000, J MAMMARY GLAND BIOL, V5, P1, DOI 10.1023/A:1009580913795; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	31	99	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2578	10.1371/journal.pone.0002578	http://dx.doi.org/10.1371/journal.pone.0002578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596909	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200042
J	Wang, WH; Hullinger, RL; Andrisani, OM				Wang, Wen-Horng; Hullinger, Ronald L.; Andrisani, Ourania M.			Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; CELL-LINES; HEPATOCELLULAR-CARCINOMA; MOLECULAR PATHOGENESIS; TARGET GENES; CHECKPOINT; EXPRESSION; TRANSCRIPTION	Hepatitis B virus (HBV) X protein (pX) is implicated in hepatocellular carcinoma (HCC) pathogenesis by an unknown mechanism. Deletions or mutations of genes involved in the p53 pathway are often associated with HBV-mediated HCC, indicating rescue from p53 apoptosis is a likely mechanism in HBV-HCC pathogenesis. Herein, we determined the mechanism by which pX sensitizes hepatocytes to p53-mediated apoptosis. Although it is well established that the Rb/E2F/ARF pathway stabilizes p53, and the DNA damage-activated ATM/ATR kinases activate p53, the mechanism that coordinates these two pathways has not been determined. We demonstrate that the p38MAPK pathway activated by pX serves this role in p53 apoptosis. Specifically, the activated p38MAPK pathway stabilizes p53 via E2F1-mediated ARF expression, and also activates the transcriptional function of p53 by activating ATR. Knockdown of p53, E2F1, ATR, or p38MAPK alpha abrogates pX-mediated apoptosis, demonstrating that E2F1, ATR, and p38MAPK alpha are all essential in p53 apoptosis in response to pX. Specifically, in response to pX expression, the p38MAPK pathway activates Cdk4 and Cdk2, leading to phosphorylation of Rb, release of E2F1, and transcription of ARF. The p38MAPK pathway also activates ATR, leading to phosphorylation of p53 on Ser-18 and Ser-23, transcription of pro-apoptotic genes Bax, Fas, and Noxa, and apoptosis. In conclusion, pX sensitizes hepatocytes to p53 apoptosis via activation of the p38MAPK pathway, which couples p53 stabilization and p53 activation, by E2F1 induction and ATR activation, respectively.	[Wang, Wen-Horng; Hullinger, Ronald L.; Andrisani, Ourania M.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, OM (corresponding author), Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu		Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [044533]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044533, R01DK044533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDDK 044533 (to O.M.A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrisani OM, 1999, INT J ONCOL, V15, P373; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Benjanirut C, 2006, J BIOL CHEM, V281, P2969, DOI 10.1074/jbc.M503939200; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Brown EJ, 2000, GENE DEV, V14, P397; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cerrato JA, 2004, INT J ONCOL, V24, P409; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kinzler KW, 1997, NATURE, V386, P763; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Liu QH, 2000, GENE DEV, V14, P1448; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	51	69	74	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25455	25467		10.1074/jbc.M801934200	http://dx.doi.org/10.1074/jbc.M801934200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606816	hybrid, Green Published			2022-12-25	WOS:000259012700041
J	Liu, JY; Versaw, WK; Pumplin, N; Gomez, SK; Blaylock, LA; Harrison, MJ				Liu, Jinyuan; Versaw, Wayne K.; Pumplin, Nathan; Gomez, S. Karen; Blaylock, Laura A.; Harrison, Maria J.			Closely related members of the Medicago truncatula PHT1 phosphate transporter gene family encode phosphate transporters with distinct biochemical activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; PLASMA-MEMBRANE; PLANT; EXPRESSION; ARABIDOPSIS; IDENTIFICATION; CLONING; MICRORNA399; REVEALS; PATHWAY	Phosphorus is one of the essential mineral nutrients required by all living cells. Plants assimilate phosphate (P-i) from the soil, and their root systems encounter tremendous variation in P-i concentration, both temporally and spatially. Genome sequence data indicate that plant genomes contain large numbers of genes predicted to encode P-i transporters, the functions of which are largely unexplored. Here we present a comparative analysis of four very closely related P-i transporters of the PHT1 family of Medicago truncatula. Based on their sequence similarity and locations in the genome, these four genes probably arose via recent gene duplication events, and they form a small subfamily within the PHT1 family. The four genes are expressed in roots with partially overlapping but distinct spatial expression patterns, responses to P-i and expression during arbuscular mycorrhizal symbiosis. The proteins are located in the plasma membrane. Three members of the subfamily, MtPT1, MtPT2, and MtPT3, show low affinities for P-i. MtPT5 shares 84% amino acid identity with MtPT1, MtPT2, and MtPT3 but shows a high affinity for P-i with an apparent Km in yeast of 13 mu M. Sequence comparisons and protein modeling suggest that amino acid residues that differ substantially between MtPT5 and the other three transporters are clustered in two regions of the protein. The data provide the first clues as to amino acid residues that impact transport activity of plant P-i transporter proteins.	[Liu, Jinyuan; Pumplin, Nathan; Gomez, S. Karen; Blaylock, Laura A.; Harrison, Maria J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Versaw, Wayne K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Cornell University; Boyce Thompson Institute for Plant Research; Texas A&M University System; Texas A&M University College Station	Harrison, MJ (corresponding author), Tower Rd, Ithaca, NY 14853 USA.	mjh78@cornell.edu	Pumplin, Nathan/F-5539-2016	Pumplin, Nathan/0000-0003-4492-5358; Harrison, Maria J/0000-0001-8716-1875	United States National Science Foundation [IBN-0343975]; Samuel Roberts Noble Foundation; National Science Foundation [DBI-0618969]	United States National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation; National Science Foundation(National Science Foundation (NSF))	The work was supported by United States National Science Foundation Grant IBN-0343975 and The Samuel Roberts Noble Foundation. Microscopy analyses were carried out in the BTI Plant Cell Imaging Center using instrumentation purchased with an award from National Science Foundation Grant DBI-0618969. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Balestrini R, 2007, MOL PLANT MICROBE IN, V20, P1055, DOI 10.1094/MPMI-20-9-1055; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; BUN YM, 1991, MOL CELL BIOL, V11, P3229; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Glassop D, 2005, PLANTA, V222, P688, DOI 10.1007/s00425-005-0015-0; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Kai M, 2002, PLANT SCI, V163, P837, DOI 10.1016/S0168-9452(02)00233-9; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Knappe S, 2003, PLANT PHYSIOL, V131, P1178, DOI 10.1104/pp.016519; Lang I, 2004, PROTOPLASMA, V224, P231, DOI 10.1007/s00709-004-0062-6; Lang-Pauluzzi I, 2000, J MICROSC-OXFORD, V198, P188, DOI 10.1046/j.1365-2818.2000.00677.x; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JY, 2004, CAN J BOT, V82, P1177, DOI [10.1139/b04-048, 10.1139/B04-048]; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Lynch M, 2000, GENETICS, V154, P459; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Mitsukawa N, 1997, P NATL ACAD SCI USA, V94, P7098, DOI 10.1073/pnas.94.13.7098; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Okumura S, 1998, DNA Res, V5, P261, DOI 10.1093/dnares/5.5.261; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Scott A, 1999, BIOTECHNIQUES, V26, P1125, DOI 10.2144/99266st04; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Smith FW, 1997, PLANT J, V11, P83, DOI 10.1046/j.1365-313X.1997.11010083.x; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; VERSAW WK, 1995, GENE, V153, P135, DOI 10.1016/0378-1119(94)00814-9; Xiao K, 2006, PLANT BIOLOGY, V8, P439, DOI 10.1055/s-2005-873053; Yang J, 2007, PLANTA, V226, P169, DOI 10.1007/s00425-007-0478-2; Zhao LM, 2003, NEW PHYTOL, V157, P291, DOI 10.1046/j.1469-8137.2003.00677.x	54	70	84	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24673	24681		10.1074/jbc.M802695200	http://dx.doi.org/10.1074/jbc.M802695200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596039	Green Published, hybrid			2022-12-25	WOS:000258820000037
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Arginines in the first transmembrane segment promote maturation of a P-glycoprotein processing mutant by hydrogen bond interactions with tyrosines in transmembrane segment 11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; DRUG-BINDING DOMAIN; DISRUPTS PACKING; ATP HYDROLYSIS; MUTATIONS; TRANSPORT; MEMBRANE; DELTA-F508; RHODAMINE; RESIDUES	A key goal is to correct defective folding of mutant ATP binding cassette (ABC) transporters, as they cause diseases such as cystic fibrosis. P-glycoprotein (ABCB1) is a useful model system because introduction of an arginine at position 65 of the first transmembrane (TM) segment could repair folding defects. To determine the mechanism of arginine rescue, we first tested the effects of introducing arginines at other positions in TM1 ( residues 52-72) of a P-glycoprotein processing mutant (G251V) that is defective in folding and trafficking to the cell surface (20% maturation efficiency). We found that arginines introduced into one face of the TM1 helix ( positions 52, 55, 56, 59, 60, 62, 63, 66, and 67) inhibited maturation, whereas arginines on the opposite face of the helix promoted ( positions 64, 65, 68, and 71) or had little effect ( positions 61, and 69) on maturation. Arginines at positions 61, 64, 65, and 68 appeared to lie close to the drug binding sites as they reduced the apparent affinity for drug substrates such as vinblastine and verapamil. Therefore, arginines that promoted maturation may face an aqueous drug translocation pathway, whereas those that inhibited maturation may face the lipid bilayer. The highest maturation efficiencies (60-85%) were observed with the Arg-65 and Arg-68 mutants. Mutations that removed hydrogen bond acceptors (Y950F/Y950A or Y953F/Y953A) in TM11 predicted to lie close to Arg-65 or Arg- 68 inhibited maturation but did not affect maturation of the G251V parent. Therefore, arginine may rescue defective folding by promoting packing of the TM segments through hydrogen bond interactions.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	National Cancer Institute of Canada; Canadian Institutes of Health Research [62832, 25043]; Cystic Fibrosis Foundation [CLARKE-08GO]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by grants from the National Cancer Institute of Canada through the Canadian Cancer Society, Canadian Institutes of Health Research Grants 62832 and 25043, and Cystic Fibrosis Foundation Grant CLARKE-08GO. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen Y, 2001, CANCER RES, V61, P7763; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; HOOF T, 1994, J BIOL CHEM, V269, P20575; Li L, 2008, BIOPHYS J, V94, pL11, DOI 10.1529/biophysj.107.121566; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Loo TW, 2002, J BIOL CHEM, V277, P27585, DOI 10.1074/jbc.C200330200; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Taguchi Y, 1997, FEBS LETT, V413, P142, DOI 10.1016/S0014-5793(97)00899-5; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	51	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24860	24870		10.1074/jbc.M803351200	http://dx.doi.org/10.1074/jbc.M803351200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596043	Green Published, hybrid			2022-12-25	WOS:000258820000052
J	Luo, YQ; Lathia, J; Mughal, M; Mattson, MP				Luo, Yongquan; Lathia, Justin; Mughal, Mohammed; Mattson, Mark P.			SDF1 alpha/CXCR4 Signaling, via ERKs and the Transcription Factor Egr1, Induces Expression of a 67-kDa Form of Glutamic Acid Decarboxylase in Embryonic Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; CELL-DERIVED FACTOR-1; CENTRAL-NERVOUS-SYSTEM; DENTATE GRANULE CELLS; GENE-EXPRESSION; STEM-CELLS; PROGENITOR CELLS; RAT HIPPOCAMPUS; MESSENGER-RNAS; NEURAL STEM	Stromal cell-derived factor alpha(SDF1 alpha) and its cognate receptor CXCR4 play an important role in neuronal development in the hippocampus, but the genes directly regulated by SDF1 alpha/CXCR4 signaling are unknown. To study the role of CXCR4 targeted genes in neuronal development, we used neuronal cultures established from embryonic day 18 rats. Hippocampal neurons express CXCR4 receptor proteins and are stimulated by SDF1 alpha resulting in activation of extracellular signal-regulated kinase (ERK) 1/2 and the transcription factor cAMP-response element-binding protein. SDF1 alpha rapidly induces the expression of the early growth response gene Egr1, a transcription factor involved in activity-dependent neuronal responses, in a concentration-dependent manner. Gel-shift analysis showed that SDF1 alpha enhances DNA binding activity to the Egr1-containing promoter for GAD67. Chromatin immunoprecipitation analysis using an Egr1 antibody indicated that SDF1 alpha stimulation increases binding of Egr1 to a GAD67 promoter DNA sequence. SDF1 alpha stimulation increases the expression of GAD67 at both them RNA and protein levels, and increases the amount and neurite localization of gamma-aminobutyric acid (GABA) in neurons already expressing GABA. SDF1 alpha-induced Egr1/GAD67 expression is mediated by the G protein-coupled CXCR4 receptor and activation of the ERK pathway. Reduction of Egr1 gene expression using small interfering RNA technology lowers the level of GAD67 transcripts and inhibits SDF1 alpha-induced GABA production. Inhibition of CXCR4 activation in the developing mouse brain in utero greatly reduced Egr1 and GAD67 mRNA levels and GAD67 protein levels, suggesting a pivotal role for CXCR4 signaling in the development of GABAergic neurons in vivo. Our data suggest that SDF1 alpha/CXCR4/G protein/ERK signaling induces the expression of the GAD67 system via Egr1 activation, a mechanism that may promote the maturation of GABAergic neurons during development.	[Luo, Yongquan; Lathia, Justin; Mughal, Mohammed; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), Rm 4F01,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012; Lathia, Justin/AHB-8296-2022		NIA, Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000324, Z01AG000324] Funding Source: NIH RePORTER	NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NIA, Intramural Research Program.	Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bajetto A, 1999, J NEUROCHEM, V73, P2348, DOI 10.1046/j.1471-4159.1999.0732348.x; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Cheng AW, 2007, J NEUROCHEM, V100, P1515, DOI 10.1111/j.1471-4159.2006.07337.x; Dent G, 2007, BRAIN RES, V1138, P1, DOI 10.1016/j.brainres.2006.04.082; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Ishikawa H, 2007, J MOL ENDOCRINOL, V39, P333, DOI 10.1677/JME-06-0069; Kasyanov A, 2006, EUR J NEUROSCI, V23, P1120, DOI 10.1111/j.1460-9568.2006.04646.x; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Klein RS, 2001, DEVELOPMENT, V128, P1971; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Luo YQ, 2005, J NEUROCHEM, V93, P452, DOI 10.1111/j.1471-4159.2005.03049.x; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Odemis V, 2005, MOL CELL NEUROSCI, V30, P494, DOI 10.1016/j.mcn.2005.07.019; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; Pedersen AA, 2001, DNA SEQUENCE, V11, P485, DOI 10.3109/10425170109041332; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Szabo G, 1996, DNA CELL BIOL, V15, P1081, DOI 10.1089/dna.1996.15.1081; Szabo G, 2000, NEUROSCIENCE, V100, P287, DOI 10.1016/S0306-4522(00)00275-X; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; THIEL G, 1994, J BIOL CHEM, V269, P15294; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Yanagawa Y, 1997, BIOCHEM J, V326, P573, DOI 10.1042/bj3260573; Yau JLW, 1996, MOL BRAIN RES, V42, P354, DOI 10.1016/S0169-328X(96)00220-3; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	65	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24789	24800		10.1074/jbc.M800649200	http://dx.doi.org/10.1074/jbc.M800649200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18606818	Green Published, hybrid			2022-12-25	WOS:000271617300005
J	Okumura, F; Lenschow, DJ; Zhang, DE				Okumura, Fumihiko; Lenschow, Deborah J.; Zhang, Dong-Er			Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; NITRIC-OXIDE SYNTHASE; EIF4E COGNATE 4EHP; VIRAL REPLICATION; MESSENGER-RNA; E2 ENZYME; INTERFERON; LIGASE; VIRUS; CELLS	The expression of the ubiquitin-like molecule ISG15 (UCRP) and protein modification by ISG15 (ISGylation) are strongly activated by interferon, genotoxic stress, and pathogen infection, suggesting that ISG15 plays an important role in innate immune responses. Inducible nitric-oxide synthase (iNOS) is induced by the similar stimuli as ISG15 and enhances the production of nitric oxide (NO), a pleiotropic free radical with anti-pathogen activity. Here, we report that cysteine residues (Cys-76 and -143 in mouse, Cys-78 in human) of ISG15 can be modified by NO, and the NO modification of ISG15 decreases the dimerization of ISG15. The mutation of the cysteine residue of ISG15 to serine improves total ISGylation. The NO synthase inhibitor S-ethylisothiourea reduces endogenous ISGylation. Furthermore, ectopic expression of iNOS enhanced total ISGylation. Together, these results suggest that nitrosylation of ISG15 enhances target protein ISGylation. This is the first report of a relationship between ISGylation and nitrosylation.	[Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, San Diego, CA 92093 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Okumura, Fumihiko; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Scripps Research Institute	Zhang, DE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, Mail Stop 0815,Rm 5328,3855 Hlth Sci Dr, San Diego, CA 92093 USA.	d7zhang@ucsd.edu			National Institutes of Health [GM66955, CA102625]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA102625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM66955 and CA102625 (to D.-E.Z.). This work was also supported by a Uehara Memorial Foundation postdoctoral fellowship (to F.O.). This is manuscript 19193 from The Scripps Research Institute.	BENZ D, 2002, MED SCI MONITOR, V8, P1; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, J IMMUNOL, V157, P4100; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Fernandez JA, 2000, VIRAL IMMUNOL, V13, P287, DOI 10.1089/08828240050144626; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; KNIGHT E, 1991, J IMMUNOL, V146, P2280; KOK K, 1993, P NATL ACAD SCI USA, V90, P6071, DOI 10.1073/pnas.90.13.6071; KORANT BD, 1984, J BIOL CHEM, V259, P4835; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Payabvash S, 2006, FREE RADICAL BIO MED, V41, P1817, DOI 10.1016/j.freeradbiomed.2006.09.010; RECHT M, 1991, J IMMUNOL, V147, P2617; Reiss CS, 1998, J VIROL, V72, P4547, DOI 10.1128/JVI.72.6.4547-4551.1998; Sorensen CM, 2007, BIOCHEMISTRY-US, V46, P772, DOI 10.1021/bi061408x; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Zaragoza C, 1999, J IMMUNOL, V163, P5497; Zaragoza C, 1998, P NATL ACAD SCI USA, V95, P2469, DOI 10.1073/pnas.95.5.2469; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	42	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24484	24488		10.1074/jbc.M803795200	http://dx.doi.org/10.1074/jbc.M803795200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606809	hybrid, Green Published			2022-12-25	WOS:000258820000023
J	Westbye, MP; Feyzi, E; Aas, PA; Vagbo, CB; Talstad, VA; Kavli, B; Hagen, L; Sundheim, O; Akbari, M; Liabakk, NB; Slupphaug, G; Otterlei, M; Krokan, HE				Westbye, Marianne Pedersen; Feyzi, Emadoldin; Aas, Per Arne; Vagbo, Cathrine Broberg; Talstad, Vivi Anita; Kavli, Bodil; Hagen, Lars; Sundheim, Ottar; Akbari, Mansour; Liabakk, Nina-Beate; Slupphaug, Geir; Otterlei, Marit; Krokan, Hans Einar			Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI; ALKYLATION DAMAGE; OXIDATIVE DEMETHYLATION; ENZYME ALKB; METHYLATION DAMAGE; UNG GENE; NUCLEAR; URACIL; CELLS	The Escherichia coli AlkB protein and human homologs hABH2 and hABH3 are 2-oxoglutarate (2OG)/Fe(II)-dependent DNA/RNA demethylases that repair 1-methyladenine and 3-methylcytosine residues. Surprisingly, hABH1, which displays the strongest homology to AlkB, failed to show repair activity in two independent studies. Here, we show that hABH1 is a mitochondrial protein, as demonstrated using fluorescent fusion protein expression, immunocytochemistry, and Western blot analysis. A fraction is apparently nuclear and this fraction increases strongly if the fluorescent tag is placed at the N-terminal end of the protein, thus interfering with mitochondrial targeting. Molecular modeling of hABH1 based upon the sequence and known structures of AlkB and hABH3 suggested an active site almost identical to these enzymes. hABH1 decarboxylates 2OG in the absence of a prime substrate, and the activity is stimulated by methylated nucleotides. Employing three different methods we demonstrate that hABH1 demethylates 3-methylcytosine in single-stranded DNA and RNA in vitro. Site-specific mutagenesis confirmed that the putative Fe( II) and 2OG binding residues are essential for activity. In conclusion, hABH1 is a functional mitochondrial AlkB homolog that repairs 3-methylcytosine in single-stranded DNA and RNA.	[Westbye, Marianne Pedersen; Feyzi, Emadoldin; Aas, Per Arne; Vagbo, Cathrine Broberg; Talstad, Vivi Anita; Kavli, Bodil; Hagen, Lars; Sundheim, Ottar; Akbari, Mansour; Liabakk, Nina-Beate; Slupphaug, Geir; Otterlei, Marit; Krokan, Hans Einar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Krokan, HE (corresponding author), Erling Skjalgssons Gt 1, NO-7489 Trondheim, Norway.	Hans.Krokan@ntnu.no	kavli, bodil/ABC-8889-2020; Vågbø, Cathrine Broberg/N-3226-2017; Slupphaug, Geir/AAN-3794-2020	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Monsen, Vivi Talstad/0000-0003-2821-5145; Akbari, Mansour/0000-0002-6490-7766; Otterlei, Marit/0000-0002-5232-1186; Slupphaug, Geir/0000-0002-7498-3500	National Programme for Research in Functional Genomics in Norway (FUGE); European Community [LSHG-CT-2005-512113]; Norwegian Cancer Association; Olav's Hospital, Trondheim; Svanhild and Arne Must Fund for Medical Research	National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); European Community(European Commission); Norwegian Cancer Association; Olav's Hospital, Trondheim; Svanhild and Arne Must Fund for Medical Research	This work was supported by the National Programme for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway, European Community Integrated Project DNA Repair Grant LSHG-CT-2005-512113, The Norwegian Cancer Association, The Cancer Fund at St. Olav's Hospital, Trondheim, and the Svanhild and Arne Must Fund for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Akbari M, 2007, NEUROSCIENCE, V145, P1201, DOI 10.1016/j.neuroscience.2006.10.010; Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Harrison JF, 2007, GLIA, V55, P1416, DOI 10.1002/glia.20556; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henshaw TF, 2004, J INORG BIOCHEM, V98, P856, DOI 10.1016/j.jinorgbio.2003.10.021; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lambert AJ, 2007, AGING CELL, V6, P417, DOI 10.1111/j.1474-9726.2007.00316.x; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Nilsen H, 2000, NUCLEIC ACIDS RES, V28, P2277, DOI 10.1093/nar/28.12.2277; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7468; Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Singer B., 1983, MOL BIOL MUTAGENS CA; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	46	132	136	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25046	25056		10.1074/jbc.M803776200	http://dx.doi.org/10.1074/jbc.M803776200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18603530	Green Published, hybrid			2022-12-25	WOS:000258820000062
J	Yu, Y; Ge, NL; Xie, M; Sun, WJ; Burlingame, S; Pass, AK; Nuchtern, JG; Zhang, DK; Fu, SB; Schneider, MD; Fan, J; Yang, JH				Yu, Yang; Ge, Ningling; Xie, Min; Sun, Wenjing; Burlingame, Susan; Pass, Amy K.; Nuchtern, Jed G.; Zhang, Dekai; Fu, Songbin; Schneider, Michael D.; Fan, Jia; Yang, Jianhua			Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NF kappa B and AP-1 Activation as Well as IL-6 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE KINASE KINASE; BETA SIGNAL-TRANSDUCTION; INNATE IMMUNE-RESPONSES; MAP KINASE; CHARACTERIZING PHOSPHOPROTEINS; MASS-SPECTROMETRY; STRUCTURAL BASIS; PROTEIN TAB1; PATHWAY; DROSOPHILA	TAK1 (transforming growth factor-beta-activated kinase 1), a mitogen-activated protein kinase kinase kinase, is activated by various cytokines, including interleukin-1 (IL-1). However, the precise regulation for TAK1 activation at the molecular level is still not fully understood. Here we report that dual phosphorylation of Thr-178 and Thr-184 residues within the kinase activation loop of TAK1 is essential for TAK1-mediated NF kappa B and AP-1 activation. Once co-overexpressed with TAB1, TAK1 mutant with alanine substitution of these two residues fails to activate IKK beta-mediated NF kappa B and JNK-mediated AP-1, whereas TAK1 mutant with replacement of these two sites with acidic residues acts like the TAK1 wild type. Consistently, TAK1 mutant with alanine substitution of these two residues severely inhibits IL-1-induced NF kappa B and AP-1 activities, whereas TAK1 mutant with replacement of these two sites with acidic residues slightly enhances IL-1-induced NF kappa B and AP-1 activities compared with theTAK1 wild-type. IL-1 induces the phosphorylation of endogenous TAK1 at Thr-178 and Thr-184. Reconstitution of TAK1-deficient mouse embryo fibroblast cells with wild-type TAK1 or a TAK1 mutant containing threonine 178 and 184 to alanine mutations revealed the importance of these two sites in IL-1-mediated IKK-NF kappa B and JNK-AP-1 activation as well as IL-1-induced IL-6 gene expression. Our finding is the first report that substitution of key serine/threonine residues with acidic residues mimics the phosphorylated state of TAK1 and renders TAK1 active during its induced activation.	[Yu, Yang; Ge, Ningling; Sun, Wenjing; Pass, Amy K.; Yang, Jianhua] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Xie, Min; Schneider, Michael D.] Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; [Burlingame, Susan; Nuchtern, Jed G.] Baylor Coll Med, Dan L Duncan Canc Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; [Ge, Ningling; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China; [Yu, Yang; Fu, Songbin] Harbin Med Univ, Lab Med Genet, Harbin 150081, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Fudan University; Harbin Medical University	Yang, JH (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	jianhuay@bcm.tmc.edu	Xie, Min/AAY-3426-2020; Fan, Jia/C-6689-2017	Xie, Min/0000-0002-2967-3490; Schneider, Michael/0000-0001-9645-1938	National Institutes of Health [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; NCI; T32 Training [1T32CA115303-01A1]; NATIONAL CANCER INSTITUTE [T32CA115303, R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T32 Training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2 (to J. Y.). This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J. Y.).; Supported by NCI, National Institutes of Health, T32 Training Grant 1T32CA115303-01A1.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DAVIS RJ, 1994, BIOCH SOC S, V64, P1; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Gafken PR, 2006, CELL COMMUN ADHES, V13, P249, DOI 10.1080/15419060601077917; Goshe Michael B., 2006, Briefings in Functional Genomics & Proteomics, V4, P363, DOI 10.1093/bfgp/eli007; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	48	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24497	24505		10.1074/jbc.M802825200	http://dx.doi.org/10.1074/jbc.M802825200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617512	Green Published, hybrid			2022-12-25	WOS:000258820000069
J	Hoarau, C; Martin, L; Faugaret, D; Baron, C; Dauba, A; Aubert-Jacquin, C; Velge-Roussel, F; Lebranchu, Y				Hoarau, Cyrille; Martin, Laurence; Faugaret, Delphine; Baron, Christophe; Dauba, Audrey; Aubert-Jacquin, Cecile; Velge-Roussel, Florence; Lebranchu, Yvon			Supernatant from Bifidobacterium Differentially Modulates Transduction Signaling Pathways for Biological Functions of Human Dendritic Cells	PLOS ONE			English	Article								Background: Probiotic bacteria have been shown to modulate immune responses and could have therapeutic effects in allergic and inflammatory disorders. However, the signaling pathways engaged by probiotics are poorly understood. We have previously reported that a fermentation product from Bifidobacterium breve C50 (BbC50sn) could induce maturation, high IL-10 production and prolonged survival of DCs via a TLR2 pathway. We therefore studied the roles of mitogen-activated protein kinases (MAPK), glycogen synthase kinase-3 (GSK3) and phosphatidylinositol 3-kinase (PI3K) pathways on biological functions of human monocyte-derived DCs treated with BbC50sn. Methodology/Principal Findings: DCs were differentiated from human monocytes with IL-4 and GM-CSF for 5 days and cultured with BbC50sn, lipopolysaccharide (LPS) or Zymosan, with or without specific inhibitors of p38MAPK (SB203580), ERK (PD98059), PI3K (LY294002) and GSK3 (SB216763). We found that 1) the PI3K pathway was positively involved in the prolonged DC survival induced by BbC50sn, LPS and Zymosan in contrast to p38MAPK and GSK3 which negatively regulated DC survival; 2) p38MAPK and PI3K were positively involved in DC maturation, in contrast to ERK and GSK3 which negatively regulated DC maturation; 3) ERK and PI3K were positively involved in DC-IL-10 production, in contrast to GSK3 that was positively involved in DC-IL-12 production whereas p38MAPK was positively involved in both; 4) BbC50sn induced a PI3K/Akt phosphorylation similar to Zymosan and a p38MAPK phosphorylation similar to LPS. Conclusion/Significance: We report for the first time that a fermentation product of a bifidobacteria can differentially activate MAPK, GSK3 and PI3K in order to modulate DC biological functions. These results give new insights on the fine-tuned balance between the maintenance of normal mucosal homeostasis to commensal and probiotic bacteria and the specific inflammatory immune responses to pathogen bacteria.	[Hoarau, Cyrille; Martin, Laurence; Faugaret, Delphine; Baron, Christophe; Dauba, Audrey; Velge-Roussel, Florence; Lebranchu, Yvon] Univ Tours, UPRES EA Cellules Dendrit & Greffes 4245, Tours, France; [Aubert-Jacquin, Cecile] Dept Rech Dev Bledina, Villefranche, France; [Velge-Roussel, Florence] Univ Tours, UFR Sci Pharm, Tours, France	Universite de Tours; Universite de Tours	Hoarau, C (corresponding author), Univ Tours, UPRES EA Cellules Dendrit & Greffes 4245, Tours, France.	cdg@med.univ-tours.fr						Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Braat H, 2004, J MOL MED, V82, P197, DOI 10.1007/s00109-003-0509-9; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dillon TJ, 2003, J BIOL CHEM, V278, P35940, DOI 10.1074/jbc.M301506200; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Foey AD, 1998, J IMMUNOL, V160, P920; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Loscher CE, 2005, J IMMUNOL, V175, P4990, DOI 10.4049/jimmunol.175.8.4990; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Moro G, 2007, ARCH DIS CHILD, V92, P655; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Strobel S, 2006, CURR OPIN ALLERGY CL, V6, P207, DOI 10.1097/01.all.0000225162.98391.81; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047	51	57	84	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2753	10.1371/journal.pone.0002753	http://dx.doi.org/10.1371/journal.pone.0002753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648505	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900023
J	Bai, BK; Hu, QX; Hu, H; Zhou, P; Shi, ZL; Meng, J; Lu, BJ; Huang, Y; Mao, PY; Wang, H				Bai, Bingke; Hu, Qinxue; Hu, Hui; Zhou, Peng; Shi, Zhengli; Meng, Jin; Lu, Baojing; Huang, Yi; Mao, Panyong; Wang, Hanzhong			Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SPIKE PROTEIN; TARGETED RECOMBINATION; MURINE CORONAVIRUS; IMMUNE-RESPONSES; VACCINE; GENE; IDENTIFICATION; GLYCOPROTEIN; DETERMINANT	The pathogenesis of SARS coronavirus (CoV) remains poorly understood. In the current study, two recombinant baculovirus were generated to express the spike (S) protein of SARS-like coronavirus (SL-CoV) isolated from bats (vAcBS) and the envelope (E) and membrane (M) proteins of SARS-CoV, respectively. Co-infection of insect cells with these two recombinant baculoviruses led to self-assembly of virus- like particles (BVLPs) as demonstrated by electron microscopy. Incorporation of S protein of vAcBS (BS) into VLPs was confirmed by western blot and immunogold labeling. Such BVLPs up-regulated the level of CD40, CD80, CD86, CD83, and enhanced the secretion of IL-6, IL-10 and TNF-alpha in immature dendritic cells (DCs). Immune responses were compared in immature DCs inoculated with BVLPs or with VLPs formed by S, E and M proteins of human SARS-CoV. BVLPs showed a stronger ability to stimulate DCs in terms of cytokine induction as evidenced by 2 to 6 fold higher production of IL-6 and TNF-alpha. Further study indicated that IFN-gamma+ and IL-4+ populations in CD4+ T cells increased upon co-cultivation with DCs pre-exposed with BVLPs or SARS-CoV VLPs. The observed difference in DC- stimulating activity between BVLPs and SARS CoV VLPs was very likely due to the S protein. In agreement, SL-CoV S DNA vaccine evoked a more vigorous antibody response and a stronger T cell response than SARS-CoV S DNA in mice. Our data have demonstrated for the first time that SL-CoV VLPs formed by membrane proteins of different origins, one from SL-CoV isolated from bats (BS) and the other two from human SARS-CoV (E and M), activated immature DCs and enhanced the expression of costimulatory molecules and the secretion of cytokines. Finding in this study may provide important information for vaccine development as well as for understanding the pathogenesis of SARS-like CoV.	[Bai, Bingke; Hu, Qinxue; Hu, Hui; Zhou, Peng; Shi, Zhengli; Meng, Jin; Lu, Baojing; Huang, Yi; Wang, Hanzhong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Zhou, Peng; Meng, Jin; Lu, Baojing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Bai, Bingke; Mao, Panyong] Inst Infect Dis, Dept Virol, Beijing, Peoples R China; [Bai, Bingke] Chinese Peoples Liberat Army, Postgrad Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, BK (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	wanghz@wh.iov.cn	Zhou, Peng/I-8578-2015; Shi, Zhengli/A-1013-2013	Zhou, Peng/0000-0003-1938-8255; Shi, Zhengli/0000-0001-8089-163X; Hu, Qinxue/0000-0002-4594-9215	Ministry of Science and Technology, People's Republic of China [2005CB523000, 2006CB933102]; Chinese Academy of Sciences [KSCX1-YW-R-07]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by National "973 Project" grants (2005CB523000, 2006CB933102) from the Ministry of Science and Technology, People's Republic of China and by Chinese Academy of Sciences (grant no. KSCX1-YW-R-07).	Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Buchholz UJ, 2004, P NATL ACAD SCI USA, V101, P9804, DOI 10.1073/pnas.0403492101; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Cui W, 2003, CLIN INFECT DIS, V37, P857, DOI 10.1086/378587; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Farcas GA, 2005, J INFECT DIS, V191, P193, DOI 10.1086/426870; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; HARRIS R, 1997, FOCUS, V19, P72; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; Ho JC, 2003, AM J RESP CRIT CARE, V168, P1449, DOI 10.1164/rccm.200306-766OC; Ho Y, 2004, BIOCHEM BIOPH RES CO, V318, P833, DOI 10.1016/j.bbrc.2004.04.111; Hsueh PR, 2004, EMERG INFECT DIS, V10, P489, DOI 10.3201/eid1003.030571; JACOBS DM, 1977, J IMMUNOL, V118, P21; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leparc-Goffart I, 1998, J VIROL, V72, P9628, DOI 10.1128/JVI.72.12.9628-9636.1998; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu XY, 2007, IMMUNOLOGY, V122, P496, DOI 10.1111/j.1365-2567.2007.02676.x; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Nakajima N, 2003, JPN J INFECT DIS, V56, P139; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Ren W, 2006, J GEN VIROL, V87, P3355, DOI 10.1099/vir.0.82220-0; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez CM, 1999, J VIROL, V73, P7607; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Spiegel M, 2006, J GEN VIROL, V87, P1953, DOI 10.1099/vir.0.81624-0; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Ye L, 2006, VIROLOGY, V351, P260, DOI 10.1016/j.virol.2006.03.021; Zhao P, 2004, ACTA BIOCH BIOPH SIN, V36, P37, DOI 10.1093/abbs/36.1.37	49	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2685	10.1371/journal.pone.0002685	http://dx.doi.org/10.1371/journal.pone.0002685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628832	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200029
J	Riising, EM; Boggio, R; Chiocca, S; Helin, K; Pasini, D				Riising, Eva Madi; Boggio, Roberto; Chiocca, Susanna; Helin, Kristian; Pasini, Diego			The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; EZH2; PROLIFERATION; METHYLATION; NUCLEAR; GASTRULATION; LYSINE-27; PROTEINS; ENHANCER	Background: The Polycomb Repressive Complex 2 ( PRC2) functions as a transcriptional repressor through a mechanism that involves methylation of Histone H3 at lysine 27. The PRC2 complex activity is essential for cellular proliferation, development, and cell fate decisions. PRC2 target genes include important regulators of development and proliferation as well as tumor suppressor genes. Consistent with this, the activity of several Polycomb group (PcG) proteins is deregulated in human cancer suggesting an important role for PcGs in tumor development. Whereas the downstream functions of PcGs are well characterized, the mechanisms of their recruitment to target genes and the regulation of their activity are not fully understood. Principal Findings: Here we show that the two PRC2 components SUZ12 and EZH2 are sumoylated in vitro and in vivo. Among several putative sumoylation sites we have mapped the major site of SUZ12 sumoylation. Furthermore, we show that SUZ12 interacts with the E2-conjugating enzyme UBC9 both in vitro and in vivo and that mutation of the SUZ12 sumoylation site does not abolish this binding. Finally, we provide evidence that the E3-ligase PIASX beta interacts and enhances the sumoylation of SUZ12 in vivo suggesting that PIASXb could function as an E3-ligase for SUZ12. Conclusions: Taken together, our data identify sumoylation as a novel post-translational modification of components of the PRC2 complex, which could suggest a potential new mechanism to modulate PRC2 repressive activity. Further work aimed to identify the physiological conditions for these modifications will be required to understand the role of SUZ12 and EZH2 sumoylation in PcG-mediated epigenetic regulation of transcription.	[Riising, Eva Madi; Helin, Kristian; Pasini, Diego] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Riising, Eva Madi; Helin, Kristian; Pasini, Diego] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Boggio, Roberto; Chiocca, Susanna] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Copenhagen; University of Copenhagen; IRCCS European Institute of Oncology (IEO)	Riising, EM (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	kristian.helin@bric.dk	Pasini, Diego/J-9674-2012; Helin, Kristian/K-2526-2019; Chiocca, Susanna/K-5233-2016; Helin, Kristian/HDM-8306-2022; Chiocca, Susanna/AAC-8863-2019	Pasini, Diego/0000-0002-9879-6486; Chiocca, Susanna/0000-0002-9721-0850; Helin, Kristian/0000-0003-1975-6097; Madi Riising, Eva/0000-0003-3152-5769	Danish Medical Research Council [post-doctoral fellowship]; Danish Cancer Society; Novo Nordisk Foundation; Danish Natural Science Research Council; Danish National Research Foundation; International Association for Cancer Research	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); International Association for Cancer Research	D.P. was supported by a post-doctoral fellowship from the Danish Medical Research Council. The work in the Helin lab was supported by grants from the Danish Cancer Society, the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Natural Science Research Council, the Danish National Research Foundation, and the International Association for Cancer Research.	Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jacobs, 1999, Curr Infect Dis Rep, V1, P13, DOI 10.1007/s11908-999-0004-8; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2004, CELL CYCLE, V3, P396; PASINI D, 2007, MOL CELL BIOL; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Yan W, 2003, GENE EXPR PATTERNS, V3, P301, DOI 10.1016/S1567-133X(03)00045-0; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; CELL, V121, P425	49	44	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2704	10.1371/journal.pone.0002704	http://dx.doi.org/10.1371/journal.pone.0002704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628979	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200047
J	Itrat, A; Khan, A; Javaid, S; Kamal, M; Khan, H; Javed, S; Kalia, S; Khan, AH; Sethi, MI; Jehan, I				Itrat, Ahmed; Khan, Abdullah; Javaid, Sunniya; Kamal, Mahwash; Khan, Hassan; Javed, Sannia; Kalia, Saira; Khan, Adil Haleem; Sethi, Muhammad Imran; Jehan, Imtiaz			Knowledge, Awareness and Practices Regarding Dengue Fever among the Adult Population of Dengue Hit Cosmopolitan	PLOS ONE			English	Article								Background: The World health Organization (WHO) declares dengue and dengue hemorrhagic fever to be endemic in South Asia. Despite the magnitude of problem, no documented evidence exists in Pakistan which reveals the awareness and practices of the country's adult population regarding dengue fever, its spread, symptoms, treatment and prevention. This study was conducted to assess the level of knowledge, attitudes and practices regarding dengue fever in people visiting tertiary care hospitals in Karachi, Pakistan. Methods: A cross-sectional pilot study was conducted among people visiting tertiary care hospitals in Karachi. Through convenience sampling, a pre-tested and structured questionnaire was administered through a face-to-face unprompted interview with 447 visitors. Knowledge was recorded on a scale of 1-3. Results: About 89.9% of individuals interviewed had heard of dengue fever. Sufficient knowledge about dengue was found to be in 38.5% of the sample, with 66% of these in Aga Khan University Hospital and 33% in Civil Hospital Karachi. Literate individuals were relatively more well-informed about dengue fever as compared to the illiterate people (p < 0.001). Knowledge based upon preventive measures was found to be predominantly focused towards prevention of mosquito bites (78.3%) rather than eradication of mosquito population (17.3%). Use of anti-mosquito spray was the most prevalent (48.1%) preventive measure. Television was considered as the most important and useful source of information on the disease. Conclusion: Adult population of Karachi has adequate knowledge related to the disease 'dengue' on isolated aspects, but the overall prevalence of 'sufficient knowledge' based on our criteria is poor. We demonstrated adequate prevalence of preventive practices against the disease. Further studies correlating the association between knowledge and its effectiveness against dengue will be helpful in demonstrating the implications of awareness campaigns.	[Itrat, Ahmed; Khan, Abdullah; Javaid, Sunniya; Kamal, Mahwash; Khan, Hassan; Javed, Sannia; Kalia, Saira; Khan, Adil Haleem; Sethi, Muhammad Imran] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Jehan, Imtiaz] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Itrat, A (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	drhasankhan@gmail.com	Khan, Hassan/D-6267-2013	Khan, Hassan/0000-0003-1468-8654				Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114; *FED BUR STAT GOV, 2003, PAK INT HLTH SURV; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Halstead SB, 1999, LANCET, V353, P1100, DOI 10.1016/S0140-6736(05)76460-6; Jamil B, 2005, T ROY SOC TROP MED H, V99, P577, DOI 10.1016/j.trstmh.2005.03.002; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Khan E, 2007, T ROY SOC TROP MED H, V101, P1114, DOI 10.1016/j.trstmh.2007.06.016; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Kubik K, 2004, AM J OBSTET GYNECOL, V191, P188, DOI 10.1016/j.ajog.2004.03.084; McArthur L, 2001, INT J OBESITY, V25, P1262, DOI 10.1038/sj.ijo.0801674; Paul R E, 1998, Int J Infect Dis, V2, P197, DOI 10.1016/S1201-9712(98)90052-2; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; Potvin L, 2000, CAN MED ASSOC J, V162, pS5; Rai MA, 2007, J CLIN VIROL, V38, P269, DOI 10.1016/j.jcv.2006.12.010; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; WHO, 1997, DENG HAEM FEV DIAGN; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927	23	85	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2620	10.1371/journal.pone.0002620	http://dx.doi.org/10.1371/journal.pone.0002620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612437	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800022
J	van Beveren, NJM; de Haan, L				van Beveren, Nico J. M.; de Haan, Lieuwe			A Visual Metaphor Describing Neural Dynamics in Schizophrenia	PLOS ONE			English	Article							TO-NOISE RATIO; NETWORK MODEL; HALLUCINATED VOICES; WORKING-MEMORY; PSYCHIATRY; DOPAMINE; PERCEPTION; BEHAVIOR; BIOLOGY; SYSTEMS	Background: In many scientific disciplines the use of a metaphor as an heuristic aid is not uncommon. A well known example in somatic medicine is the 'defense army metaphor' used to characterize the immune system. In fact, probably a large part of the everyday work of doctors consists of 'translating' scientific and clinical information (i.e. causes of disease, percentage of succes versus risk of side-effects) into information tailored to the needs and capacities of the individual patient. The ability to do so in an effective way is at least partly what makes a clinician a good communicator. Schizophrenia is a severe psychiatric disorder which affects approximately 1% of the population. Over the last two decades a large amount of molecular-biological, imaging and genetic data have been accumulated regarding the biological underpinnings of schizophrenia. However, it remains difficult to understand how the characteristic symptoms of schizophrenia such as hallucinations and delusions are related to disturbances on the molecular-biological level. In general, psychiatry seems to lack a conceptual framework with sufficient explanatory power to link the mental-and molecular-biological domains. Methodology/ Principal Findings: Here, we present an essay-like study in which we propose to use visualized concepts stemming from the theory on dynamical complex systems as a 'visual metaphor' to bridge the mental- and molecular-biological domains in schizophrenia. We first describe a computer model of neural information processing; we show how the information processing in this model can be visualized, using concepts from the theory on complex systems. We then describe two computer models which have been used to investigate the primary theory on schizophrenia, the neurodevelopmental model, and show how disturbed information processing in these two computer models can be presented in terms of the visual metaphor previously described. Finally, we describe the effects of dopamine neuromodulation, of which disturbances have been frequently described in schizophrenia, in terms of the same visualized metaphor. Conclusions/Significance: The conceptual framework and metaphor described offers a heuristic tool to understand the relationship between the mental- and molecular-biological domains in an intuitive way. The concepts we present may serve to facilitate communication between researchers, clinicians and patients.	[van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [de Haan, Lieuwe] Academ Med Ctr de Meren, Dept Psychiat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Beveren, NJM (corresponding author), Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands.	l.dehaan@amc.uva.nl						Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Andreasen NC, 2000, BRAIN RES REV, V31, P106, DOI 10.1016/S0165-0173(99)00027-2; Arbib MA, 1995, HDB BRAIN THEORY NEU; Barch DM, 2006, NEUROSCIENCE, V139, P73, DOI 10.1016/j.neuroscience.2005.09.013; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Bender W, 2006, PHARMACOPSYCHIATRY, V39, pS4, DOI 10.1055/s-2006-931482; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Draaisma D, 2001, NATURE, V414, P153, DOI 10.1038/35102645; Draaisma Douwe, 1995, METAFORENMACHINE GES; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 2006, PHARMACOPSYCHIATRY, V39, pS72, DOI 10.1055/s-2006-931499; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; ERDI P, 1993, THEOR MED, V14, P137, DOI 10.1007/BF00997272; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; FREEMAN WJ, 1991, SCI AM, V264, P78, DOI 10.1038/scientificamerican0291-78; Freeman WJ, 2000, J PHYSIOLOGY-PARIS, V94, P303, DOI 10.1016/S0928-4257(00)01090-1; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; GLOBUS GG, 1994, BIOL PSYCHIAT, V35, P352, DOI 10.1016/0006-3223(94)90039-6; GOODMAN A, 1991, AM J PSYCHIAT, V148, P553; Hertz J., 1995, HDB BRAIN THEORY NEU, P230; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; HOFFMAN RE, 1987, ARCH GEN PSYCHIAT, V44, P178; Hoffman RE, 1997, AM J PSYCHIAT, V154, P1683, DOI 10.1176/ajp.154.12.1683; HOFFMAN RE, 1995, J COGNITIVE NEUROSCI, V7, P479, DOI 10.1162/jocn.1995.7.4.479; Hoffman RE, 2001, NEUROSCIENTIST, V7, P441, DOI 10.1177/107385840100700513; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P15, DOI 10.1093/schbul/19.1.15; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jeffery KJ, 1997, AM J PSYCHIAT, V154, P156; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kelso J.A.S., 1995, DYNAMIC PATTERNS; MADORE BF, 1987, AM SCI, V75, P252; MANDELL J, 1992, BIOL PSYCHIAT, V32, P299, DOI 10.1016/0006-3223(92)90034-W; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Ouzounis C, 2006, BIOSYSTEMS, V85, P6, DOI 10.1016/j.biosystems.2006.02.007; Peled A, 2004, MED HYPOTHESES, V63, P110, DOI 10.1016/j.mehy.2004.02.010; Peled A, 2000, MED HYPOTHESES, V54, P367, DOI 10.1054/mehy.1999.0853; Peled A, 2000, INT J NEUROSCI, V104, P49, DOI 10.3109/00207450009035008; PORT RF, 1995, MIND MOTION; PRIGOGINE Ilya, 1985, ORDER OUT CHAOS MANS; PRITCHARD WS, 1992, INT J NEUROSCI, V67, P31, DOI 10.3109/00207459208994774; ROBERTSON R, 1995, CHAOS THEORY PSYCHOL; Rumelhart D., 1986, PARALLEL DISTRIBUTED; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Tretter F, 2006, PHARMACOPSYCHIATRY, V39, pS26, DOI 10.1055/s-2006-931486; WANG X, 1995, HDB BRAIN THEORY NEU, P339; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2577	10.1371/journal.pone.0002577	http://dx.doi.org/10.1371/journal.pone.0002577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18648540	Green Published, gold			2022-12-25	WOS:000264065800001
J	Fishman, Y; Zlotkin, E; Sher, D				Fishman, Yelena; Zlotkin, Eliahu; Sher, Daniel			Expulsion of Symbiotic Algae during Feeding by the Green Hydra - a Mechanism for Regulating Symbiont Density?	PLOS ONE			English	Article								Background: Algal-cnidarian symbiosis is one of the main factors contributing to the success of cnidarians, and is crucial for the maintenance of coral reefs. While loss of the symbionts (such as in coral bleaching) may cause the death of the cnidarian host, over-proliferation of the algae may also harm the host. Thus, there is a need for the host to regulate the population density of its symbionts. In the green hydra, Chlorohydra viridissima, the density of symbiotic algae may be controlled through host modulation of the algal cell cycle. Alternatively, Chlorohydra may actively expel their endosymbionts, although this phenomenon has only been observed under experimentally contrived stress conditions. Principal Findings: We show, using light and electron microscopy, that Chlorohydra actively expel endosymbiotic algal cells during predatory feeding on Artemia. This expulsion occurs as part of the apocrine mode of secretion from the endodermal digestive cells, but may also occur via an independent exocytotic mechanism. Significance: Our results demonstrate, for the first time, active expulsion of endosymbiotic algae from cnidarians under natural conditions. We suggest this phenomenon may represent a mechanism whereby cnidarians can expel excess symbiotic algae when an alternative form of nutrition is available in the form of prey.	[Fishman, Yelena; Zlotkin, Eliahu; Sher, Daniel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Anim Biol, Jerusalem, Israel	Hebrew University of Jerusalem	Fishman, Y (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Anim Biol, Jerusalem, Israel.	dsher@mit.edu			Israel Science Foundation [476/01, 750/04]	Israel Science Foundation(Israel Science Foundation)	This study was supported by grants 476/01 and 750/04 from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; BOSSERT P, 1986, J CELL SCI, V85, P187; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Lenhoff H.M., 1983, P29; MCAULEY PJ, 1981, J EXP ZOOL, V217, P23, DOI 10.1002/jez.1402170104; MCAULEY PJ, 1982, J CELL SCI, V58, P423; MCAULEY PJ, 1985, J CELL SCI, V77, P225; MCAULEY PJ, 1986, J CELL SCI, V85, P63; MCAULEY PJ, 1981, J CELL SCI, V47, P197; MCAULEY PJ, 1985, J CELL SCI, V77, P241; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; PARDY RL, 1983, HYDRA RES METHODS; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sher D, 2008, FASEB J, V22, P207, DOI 10.1096/fj.07-9133com	18	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2603	10.1371/journal.pone.0002603	http://dx.doi.org/10.1371/journal.pone.0002603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596972	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200056
J	Marti, D; Deco, G; Mattia, M; Gigante, G; Del Giudice, P				Marti, Daniel; Deco, Gustavo; Mattia, Maurizio; Gigante, Guido; Del Giudice, Paolo			A Fluctuation-Driven Mechanism for Slow Decision Processes in Reverberant Networks	PLOS ONE			English	Article							PERCEPTUAL DECISION; REACTION-TIMES; VISUAL-MOTION; NEURAL BASIS; AREA LIP; MODEL; NEURONS; CORTEX; INTEGRATION; POPULATION	The spike activity of cells in some cortical areas has been found to be correlated with reaction times and behavioral responses during two-choice decision tasks. These experimental findings have motivated the study of biologically plausible winner-take-all network models, in which strong recurrent excitation and feedback inhibition allow the network to form a categorical choice upon stimulation. Choice formation corresponds in these models to the transition from the spontaneous state of the network to a state where neurons selective for one of the choices fire at a high rate and inhibit the activity of the other neurons. This transition has been traditionally induced by an increase in the external input that destabilizes the spontaneous state of the network and forces its relaxation to a decision state. Here we explore a different mechanism by which the system can undergo such transitions while keeping the spontaneous state stable, based on an escape induced by finite-size noise from the spontaneous state. This decision mechanism naturally arises for low stimulus strengths and leads to exponentially distributed decision times when the amount of noise in the system is small. Furthermore, we show using numerical simulations that mean decision times follow in this regime an exponential dependence on the amplitude of noise. The escape mechanism provides thus a dynamical basis for the wide range and variability of decision times observed experimentally.	[Marti, Daniel; Deco, Gustavo] Univ Pompeu Fabra, Computat Neurosci Unit, Barcelona, Spain; [Deco, Gustavo] ICREA, Barcelona, Spain; [Mattia, Maurizio; Gigante, Guido; Del Giudice, Paolo] Ist Superiore Sanita, Dept Technol & Hlth, Rome, Italy; [Mattia, Maurizio; Del Giudice, Paolo] Ist Nazl Fis Nucl, Sezione Roma I, Rome, Italy	Pompeu Fabra University; ICREA; Istituto Superiore di Sanita (ISS); Istituto Nazionale di Fisica Nucleare (INFN)	Marti, D (corresponding author), Univ Pompeu Fabra, Computat Neurosci Unit, Barcelona, Spain.	daniel.marti@upf.edu	Mattia, Maurizio/A-4716-2011; Del Giudice, Paolo/N-4655-2015; DECO, GUSTAVO/A-6341-2008	Mattia, Maurizio/0000-0002-2356-4509; Del Giudice, Paolo/0000-0002-5633-8241; DECO, GUSTAVO/0000-0002-8995-7583; Gigante, Guido/0000-0003-1899-4579	STREP "Decisions-in-Motion" [IST-027198]; ICREA Funding Source: Custom	STREP "Decisions-in-Motion"; ICREA(ICREA)	This research has been partially supported STREP "Decisions-in-Motion" (IST-027198).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; BURBECK SL, 1982, PERCEPT PSYCHOPHYS, V32, P117, DOI 10.3758/BF03204271; Deco G, 2007, J NEUROSCI, V27, P11192, DOI 10.1523/JNEUROSCI.1072-07.2007; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; HAAKE F, 1981, PHYS REV A, V23, P3255, DOI 10.1103/PhysRevA.23.3255; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HOHLE RH, 1965, J EXP PSYCHOL, V69, P382, DOI 10.1037/h0021740; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kitano K, 2003, BIOL CYBERN, V88, P387, DOI 10.1007/s00422-002-0390-6; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce R.D., 1991, RESPONSE TIMES THEIR; Mascaro M, 1999, NETWORK-COMP NEURAL, V10, P351, DOI 10.1088/0954-898X/10/4/305; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; Mattia M, 2000, NEURAL COMPUT, V12, P2305, DOI 10.1162/089976600300014953; Mattia M, 2003, SCI MATH JAPONICAE, V58, P335; MITZ AR, 1991, J NEUROSCI, V11, P1855; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Okamoto H, 2001, PHYS REV LETT, V86, P3919, DOI 10.1103/PhysRevLett.86.3919; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Ruthruff E, 1996, PERCEPT PSYCHOPHYS, V58, P56, DOI 10.3758/BF03205475; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Spiridon M, 1999, NETWORK-COMP NEURAL, V10, P257, DOI 10.1088/0954-898X/10/3/304; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Van Zandt T, 2000, PSYCHON B REV, V7, P424, DOI 10.3758/BF03214357; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Xu XM, 2006, P NATL ACAD SCI USA, V103, P17490, DOI 10.1073/pnas.0608502103; ZIPSER D, 1993, J NEUROSCI, V13, P3406	44	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2534	10.1371/journal.pone.0002534	http://dx.doi.org/10.1371/journal.pone.0002534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596965	Green Published, gold			2022-12-25	WOS:000263288200006
J	Nishimura, T; Ishima, T; Iyo, M; Hashimoto, K				Nishimura, Tomoko; Ishima, Tamaki; Iyo, Masaomi; Hashimoto, Kenji			Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways	PLOS ONE			English	Article								Background: Selective serotonin reuptake inhibitors (SSRIs) have been widely used and are a major therapeutic advance in psychopharmacology. However, their pharmacology is quite heterogeneous. The SSRI fluvoxamine, with sigma-1 receptor agonism, is shown to potentiate nerve-growth factor (NGF)-induced neurite outgrowth in PC 12 cells. However, the precise cellular and molecular mechanisms underlying potentiation by fluvoxamine are not fully understood. In this study, we examined the roles of cellular signaling pathways in the potentiation of NGF-induced neurite outgrowth by fluvoxamine and sigma-1 receptor agonists. Methods and Findings: The effects of three SSRIs ( fluvoxamine, sertraline, paroxetine) and three sigma-1 receptor agonists (SA4503, 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), and dehydroepiandrosterone (DHEA)-sulfate) on NGF-induced neurite outgrowth in PC12 cells were examined. Also examined were the effects of the sigma-1 receptor antagonist NE-100, inositol 1,4,5-triphosphate (IP3) receptor antagonist, and specific inhibitors of signaling pathways in the potentiation of NGF-induced neurite outgrowth by selective sigma-1 receptor agonist SA4503. Fluvoxamine ( but not sertraline or paroxetine) and the sigma-1 receptor agonists SA4503, PPBP, and DHEA-sulfate significantly potentiated NGF-induced neurite outgrowth in PC12 cells in a concentration-dependent manner. The potentiation by fluvoxamine and the three sigma-1 receptor agonists was blocked by co-administration of the selective sigma-1 receptor antagonist NE-100, suggesting that sigma-1 receptors play a role in blocking the enhancement of NGF-induced neurite outgrowth. Moreover, the potentiation by SA4503 was blocked by co-administration of the IP3 receptor antagonist xestospongin C. In addition, the specific inhibitors of phospholipase C (PLC-gamma), phosphatidylinositol 3-kinase (PI3K), p38MAPK, c-Jun N-terminal kinase (JNK), and the Ras/Raf/mitogen-activated protein kinase ( MAPK) signaling pathways blocked the potentiation of NGF-induced neurite outgrowth by SA4503. Conclusion: These findings suggest that stimulation of sigma-1 receptors and subsequent interaction with IP3 receptors, PLC-gamma, PI3K, p38MAPK, JNK, and the Ras/Raf/MAPK signaling pathways are involved in the mechanisms of action of sigma-1 receptor agonists such as fluvoxamine and SA4503.	[Nishimura, Tomoko; Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehab, Chiba, Japan; [Nishimura, Tomoko; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University; Chiba University	Nishimura, T (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K.H.); this funding had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Bermack JE, 2005, J PHARMACOL SCI, V97, P317, DOI 10.1254/jphs.CRJ04005X; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Carrasco JL, 2005, INT J CLIN PRACT, V59, P1428, DOI 10.1111/j.1368-5031.2005.00681.x; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Goodnick PJ, 1998, J PSYCHOPHARMACOL, V12, pS5, DOI 10.1177/0269881198012003021; Goyagi T, 2001, STROKE, V32, P1613, DOI 10.1161/01.STR.32.7.1613; Harukuni I, 2000, STROKE, V31, P976, DOI 10.1161/01.STR.31.4.976; HASHIMOTO K, 1995, SYNAPSE, V20, P85, DOI 10.1002/syn.890200112; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2008, EXPERT OPIN THER TAR, V12, P45, DOI 10.1517/14728222.12.1.45; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Matsuno K, 1997, BEHAV BRAIN RES, V83, P221, DOI 10.1016/S0166-4328(97)86074-3; Matsuno Kiyoshi, 1998, CNS Drug Reviews, V4, P1, DOI 10.1111/j.1527-3458.1998.tb00038.x; Maurice T, 2001, BRIT J PHARMACOL, V134, P1731, DOI 10.1038/sj.bjp.0704355; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; Nemeroff CB, 2004, CNS SPECTRUMS, V9, P23, DOI 10.1017/S1092852900025475; Noda Y, 2000, NEUROPSYCHOPHARMACOL, V23, P276, DOI 10.1016/S0893-133X(00)00103-2; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Okuyama S., 1996, CNS DRUG REV, V2, P226, DOI 10.1111/j.1527-3458.1996.tb00299.x; Owens MJ, 2004, J CLIN PSYCHIAT, V65, P5; Price RD, 2005, EUR J PHARMACOL, V509, P11, DOI 10.1016/j.ejphar.2004.12.023; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stahl SM, 1998, J CLIN PSYCHIAT, V59, P343; Stahl SM, 1998, J CLIN PSYCHIAT, V59, P642, DOI 10.4088/JCP.v59n1201; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; TAKAHASHI H, 1995, STROKE, V26, P1676, DOI 10.1161/01.STR.26.9.1676; Takahashi H, 1996, STROKE, V27, P2120, DOI 10.1161/01.STR.27.11.2120; Takebayashi M, 2004, PHARMACOPSYCHIATRY, V37, pS208, DOI 10.1055/s-2004-832679; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Urani A, 2002, PSYCHOPHARMACOLOGY, V163, P26, DOI 10.1007/s00213-002-1150-y; Westenberg HGM, 2006, INT J CLIN PRACT, V60, P482, DOI 10.1111/j.1368-5031.2006.00865.x	44	107	113	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2558	10.1371/journal.pone.0002558	http://dx.doi.org/10.1371/journal.pone.0002558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596927	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200025
J	Second, G; Rouhan, G				Second, Gerard; Rouhan, Germinal			Human-Mediated Emergence as a Weed and Invasive Radiation in the Wild of the CD Genome Allotetraploid Rice Species (Oryza, Poaceae) in the Neotropics	PLOS ONE			English	Article							PHYLOGENY; EVOLUTION; SEQUENCE; ORIGIN; WHEAT; DIVERSITY; DNA; DIVERSIFICATION; BIOGEOGRAPHY; CHLOROPLAST	Background: The genus Oryza is being used as a model in plant genomic studies although there are several issues still to be resolved regarding the spatio-temporal evolution of this ancient genus. Particularly contentious is whether undated transoceanic natural dispersal or recent human interference has been the principal agent determining its present distribution and differentiation. In this context, we studied the origin and distribution history of the allotetraploid CD rice genome. It is endemic to the Neotropics but the genus is thought to have originated in the Paleotropics, and there is relatively little genetic divergence between some orthologous sequences of the C genome component and their Old World counterparts. Methodology/Principal Findings: Because of its allotetraploidy, there are several potential pitfalls in trying to date the formation of the CD genome using molecular data and this could lead to erroneous estimates. Therefore, we rather chose to rely on historical evidence to determine whether or not the CD genome was present in the Neotropics before the arrival of Columbus. We searched early collections of herbarium specimens and studied the reports of explorers of the tropical Americas for references to rice. In spite of numerous collectors traveling inland and collecting Oryza, plants determined as CD genome species were not observed away from cultivated rice fields until 1869. Various arguments suggest that they only consisted of weedy forms until that time. Conclusions/Significance: The spatio-temporal distribution of herbarium collections fits a simple biogeographical scenario for the emergence in cultivated rice fields followed by radiation in the wild of the CD genome in the Neotropics during the last four centuries. This probably occurred from species introduced to the Americas by humans and we found no evidence that the CD genome pre-existed in the Old World. We therefore propose a new evolutionary hypothesis for such a recent origin of the CD genome. Moreover, we exemplify how an historical approach can provide potentially important information and help to disentangle the timing of evolutionary events in the history of the Oryza genomes.	[Second, Gerard] IRD, UMR DIAPC, Montpellier, France; [Rouhan, Germinal] Natl Mus Nat Hist, IRD, US84, Paris, France; [Rouhan, Germinal] Inst System Bot, New York Botanical Garden, New York, NY USA	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); New York Botanical Garden	Second, G (corresponding author), IRD, UMR DIAPC, Montpellier, France.	gerard.second@mpl.ird.fr	Rouhan, Germinal/P-4717-2019	Rouhan, Germinal/0000-0002-0751-5352	Institut de la Recherche pour le Developement (IRD)	Institut de la Recherche pour le Developement (IRD)	The Institut de la Recherche pour le Developement (IRD) entirely supported this work.	ABE Y, 2007, RIZ MAISON SCI HOMME, P588; ALADREN MPS, 2000, AGRULA NOPAL EXPEDIC, P229; ALADREN MPS, 1992, MUTIS ROYAL BOT EXPE, P221; ALLSTON RFW, 1854, ANN M HELD COL CAP S, P46; AMES GJ, 2008, GLOBE ENCOMPASSED AG, P208; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; BANCROFT J, 1884, P R SOC QLD, V1, P104; Bao Y, 2004, PLANT SYST EVOL, V249, P55, DOI 10.1007/s00606-004-0173-8; BATES HW, 1863, NATURALIST RIVER AMZ; BOXER CR, 1965, DUTCH SEABORNE EMPIR, P326; CALMANT S, 2006, CARTE FONDS OCEANIQU; CARNEY J, 2001, BLACK RICE AFRICAN O, P240; Carney Judith A., 2003, Journal of Ethnobiology, V23, P167; Carney Judith A., 2004, SLAVERY ABOLIT, V25, P1, DOI DOI 10.1080/0144039042000220900; CASCUDO LC, 1983, HIST ALIMENTACAO PES; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chang TT, 2002, W CROP SCI, P3; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; CHEVALIER A., 1932, Revue de Botanique Appliquee et d'Agriculture Tropicale, V12, P1014; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; COLLINGRIDGE G, 1906, 1 DISCOVERY AUSTR NE, P136; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; DASILVA P, 1974, GABRIEL SOARES SOUSA, P489; David JL, 2004, BIOL J LINN SOC, V82, P503, DOI 10.1111/j.1095-8312.2004.00336.x; DESVAUX NA, 1813, J BOT APPL AGR PHARM, V1, P63; DICIENSON J, 1996, RICHARD DPRUCE, P65; DOLL JC, 1971, FLORA BRASILINESIS, P5; DUISTERMAAT H, 1987, BLUMEA, V32, P157; Federici MT, 2002, ELECTRON J BIOTECHN, V5, P173; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; GARDNER G, 1846, TRAVELS INTERIOR BRA, P562; GARMENDIA FM, 2003, BOT SERVICIO CORONO, P220; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; GYRORY J, 2001, GUINAA CURRENT OCEAN; HAIR PE, 1992, BARBOT GUINEA WRITIN, P916; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; HILAIRE AS, 1830, VOYAGES INTERIEIUR B; HOBSON JB, 2004, E ORIGINS W CIVILISA, P392; HOLMGREN PK, 1998, INDEX HERBARIORUM GL; Humboldt A, 1805, ESSAI GEOGRAPHIE PLA, DOI DOI 10.5962/BHL.TITLE.9309; KANNO A, 1992, THEOR APPL GENET, V83, P791, DOI 10.1007/BF00226699; KATAYAMA T, 1982, JPN J GENET, V57, P613, DOI 10.1266/jjg.57.613; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KUNTH CS, 1829, REV GRAMINEES PUBLIC, P666; KUNTH CS, 1822, SYNOPSIS PLANTOANUM; KURATA N, 2008, CHROMOSOEM GENOME EV, P235; Ledru, 1810, VOYAGE ILES TENERIFF; LEVATHES L, 1994, CHINA RULED SEAS TRE, P256; LEVISTRAUSS C, 1950, SMITHSONIAN I BUREAU, V143, P465; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Mahe L, 2007, GENOME, V50, P316, DOI 10.1139/G07-011; MARTIUS CFP, 1840, FLROA BRAISLILNISIS; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; MAURIZIO A, 1932, HIST ALIMENTATION VE, P663; MCCINTOSH B, 1984, SCIENCE, V226, P792; Metcalf Alida C., 1992, FAMILY FRONTIER COLO; Mullins IM, 2002, THEOR APPL GENET, V105, P841, DOI 10.1007/s00122-002-1056-4; Multani DS, 2003, THEOR APPL GENET, V107, P395, DOI 10.1007/s00122-003-1214-3; MUTCH TD, 1942, 1 DISCOVERY AUSTR AC, P56; NUNEZ MF, 1994, TRAS DORADO VEGETAL, P441; Oka H. I., 1988, Origin of cultivated rice.; Ozkan H, 2002, ISRAEL J PLANT SCI, V50, pS65, DOI 10.1560/E282-PV55-G4XT-DRWJ; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; PINTO E, 1958, MUXARABIS BALCOES; PORTERES R., 1960, Journal d'Agriculture tropicale, V7, P441; PORTERES R., 1956, Journal d'Agriculture tropicale, V3, P341; Prodoehl A, 1922, BOT ARCH, V1, P211; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; RAMSEY J, 1998, ANN REV ECOL SYST, V29; ROTH WE, 1901, N QUEENSLAND ETHNOGR, V3, P1; Sanchez E, 2006, REV BIOL TROP, V54, P377; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Second G., 1985, Relations evolutives chez le genre Oryzaet processus de domestication des riz.; Second G., 1992, Genetic Resources and Crop Evolution, V39, P125; SECOND G, 1991, BIOTECHNOLOGY AGR FO, V14, P469; SECOND G, 1991, RICE GENETICS, V2, P475; SHU LH, 1989, PLANT TISSUE CULTRUE, V6, P14; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SPIX JB, 1828, REISE BRAISLIEEN; SPRING A, 1871, ANN ACAD ROY BELGIQU, V37, P1; SPRUCE R, 1908, NOTES BOT AMZON ANDE; STICKNEY GP, 1896, AM ANTHROPOL, V9, P115; SWADLING P, 1996, PLUMES PARADISE TRAD, P352; TRINUS KB, 1820, FUNDAMNETA AGROFSTRH; VARNEY J, 2005, SLAVERY ABOLITION, V26, P325; Vaughan D.A., 1994, WILD RELATIVES RICE, P137; Vaughan DA, 2005, BREEDING SCI, V55, P113, DOI 10.1270/jsbbs.55.113; Vaughan Duncan A., 2008, V62, P219; Voeks RA, 1995, GEOGR REV, V85, P115, DOI 10.2307/215565; VONESENBECK CGD, 1829, AGROSTOLGOIAS BRASIL; Wallace A.R., 1853, NARRATIVE TRAVELS AM, P541; Zamora A, 2003, GENET RESOUR CROP EV, V50, P855, DOI 10.1023/A:1025998801637; Zhang LB, 2007, MOL BIOL EVOL, V24, P769, DOI 10.1093/molbev/msl204; ZOHARY D, 1962, EVOLUTION, V16, P44, DOI 10.2307/2406265; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	101	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2613	10.1371/journal.pone.0002613	http://dx.doi.org/10.1371/journal.pone.0002613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596981	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200062
J	Holguin, S; Martinez, J; Chow, C; Wurtman, R				Holguin, Sarah; Martinez, Joseph; Chow, Camille; Wurtman, Richard			Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils	FASEB JOURNAL			English	Article						choline; omega-3 fatty acids; pyrimidines; behavior	POLYUNSATURATED FATTY-ACIDS; SPATIAL TASK-PERFORMANCE; ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; RANDOMIZED-TRIAL; IMPOVERISHED RATS; VISUAL-ATTENTION; CYTIDINE KINASE; BRAIN-FUNCTION; BREAST-MILK	This study examined the effects on cognitive behaviors of giving normal adult gerbils three compounds, normally in the circulation, which interact to increase brain phosphatides, synaptic proteins, dendritic spines, and neurotransmitter release. Animals received supplemental uridine (as its monophosphate, UMP; 0.5%) and choline (0.1%) via the diet, and docosahexaenoic acid (DHA; 300 mg/kg/day) by gavage, for 4 wk, and then throughout the subsequent period of behavioral training and testing. As shown previously, giving all three compounds caused highly significant (P < 0.001) increases in total brain phospholipids and in each major phosphatide; giving DHA or UMP ( plus choline) produced smaller increases in some of the phosphatides. DHA plus choline improved performance on the four-arm radial maze, T-maze, and Y-maze tests; coadministering UMP further enhanced these increases. ( Uridine probably acts by generating both CTP, which can be limiting in phosphatide synthesis, and UTP, which activates P2Y receptors coupled to neurite outgrowth and protein synthesis. All three compounds also act by enhancing the substrate-saturation of phosphatide-synthesizing enzymes.) These findings demonstrate that a treatment that increases synaptic membrane content can enhance cognitive functions in normal animals. -Holguin, S., Martinez, J., Chow, C., Wurtman, R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 22, 3938-3946 (2008)	[Holguin, Sarah; Martinez, Joseph; Chow, Camille; Wurtman, Richard] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wurtman, R (corresponding author), MIT, Dept Brain & Cognit Sci, 43 Vassar St,46-5023, Cambridge, MA 02139 USA.	dick@mit.edu		Chow, Camille/0000-0002-4859-0957	National Institutes of Health [MH-28283]; Center for Brain Sciences; Metabolism Charitable Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Brain Sciences; Metabolism Charitable Trust	We thank Lisa Teather for advice and assistance in preparing this paper, and Tim Maher for providing the rotarod testing apparatus. We also thank Rona Stephanopoulos and Paul Jaffe for their assistance with behavior and biochemistry assays. This study was supported by National Institutes of Health grant MH-28283 and the Center for Brain Sciences and Metabolism Charitable Trust.	Anderson EP, 1973, ENZYMES, P49; Auestad N, 2003, PEDIATRICS, V112, pE177, DOI 10.1542/peds.112.3.e177; BELL MV, 1989, BIOCHEM J, V264, P909, DOI 10.1042/bj2640909; Birch EE, 2007, EARLY HUM DEV, V83, P279, DOI 10.1016/j.earlhumdev.2006.11.003; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; Cansev M, 2007, NEUROSCIENCE, V148, P421, DOI 10.1016/j.neuroscience.2007.06.016; Cansev M, 2005, BRAIN RES, V1058, P101, DOI 10.1016/j.brainres.2005.07.054; Carlson SE, 1996, LIPIDS, V31, P85, DOI 10.1007/BF02522416; COHEN BM, 1995, JAMA-J AM MED ASSOC, V274, P902, DOI 10.1001/jama.274.11.902; Eilander A, 2007, PROSTAG LEUKOTR ESS, V76, P189, DOI 10.1016/j.plefa.2007.01.003; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALLI C, 1993, PROSTAG LEUKOTR ESS, V48, P51, DOI 10.1016/0952-3278(93)90009-L; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Gilani GS, 2007, J AOAC INT, V90, P1440; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Green P, 2001, BBA-MOL CELL BIOL L, V1532, P203, DOI 10.1016/S1388-1981(01)00132-9; GREENBERG N, 1977, BIOCHEM J, V164, P379, DOI 10.1042/bj1640379; Hart SL, 2006, J PEDIATR PSYCHOL, V31, P221, DOI 10.1093/jpepsy/jsj069; Holguin S, 2008, BEHAV BRAIN RES, V191, P11, DOI 10.1016/j.bbr.2008.02.042; Ikemoto A, 2001, J LIPID RES, V42, P1655; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; LABARCA C, 1980, ANAL BIOCHEM, V102, P4; Levant B, 2004, BEHAV BRAIN RES, V152, P49, DOI 10.1016/j.bbr.2003.09.029; Li JY, 2001, J CEREBR BLOOD F MET, V21, P929, DOI 10.1097/00004647-200108000-00005; Lim SY, 2005, J NEUROCHEM, V95, P848, DOI 10.1111/j.1471-4159.2005.03427.x; Lopez-Garcia E, 2004, J NUTR, V134, P1806, DOI 10.1093/jn/134.7.1806; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Marszalek JR, 2005, J BIOL CHEM, V280, P10817, DOI 10.1074/jbc.M411750200; MILLINGTON WR, 1982, J NEUROCHEM, V38, P1748, DOI 10.1111/j.1471-4159.1982.tb06658.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; ORENGO A, 1969, J BIOL CHEM, V244, P2204; OTT T, 1978, MED BIOL, V56, P133; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Ropp PA, 1998, ARCH BIOCHEM BIOPHYS, V359, P63, DOI 10.1006/abbi.1998.0890; Ropp PA, 1996, ARCH BIOCHEM BIOPHYS, V336, P105, DOI 10.1006/abbi.1996.0537; Ross BM, 1997, LIPIDS, V32, P351, DOI 10.1007/s11745-997-0044-x; Sakamoto T, 2007, BRAIN RES, V1182, P50, DOI 10.1016/j.brainres.2007.08.089; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; SKOLD O, 1960, J BIOL CHEM, V274, P902; SPANNER S, 1979, BIOCHEM J, V178, P753, DOI 10.1042/bj1780753; Suzuki NN, 2004, STRUCTURE, V12, P751, DOI 10.1016/j.str.2004.02.038; SVANBORG A, 1961, ACTA MED SCAND, V169, P43; Teather LA, 2006, J NUTR, V136, P2834, DOI 10.1093/jn/136.11.2834; ULUS IH, 1989, BRAIN RES, V484, P217, DOI 10.1016/0006-8993(89)90364-8; Wainwright P E, 1998, Nutr Neurosci, V1, P281, DOI 10.1080/1028415X.1998.11747238; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Werkman SH, 1996, LIPIDS, V31, P91, DOI 10.1007/BF02522417; Willatts P, 1998, LIPIDS, V33, P973, DOI 10.1007/s11745-998-0294-7; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; Xiao Y, 2006, BIOMED ENVIRON SCI, V19, P474	56	76	80	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3938	3946		10.1096/fj.08-112425	http://dx.doi.org/10.1096/fj.08-112425			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18606862	Green Published			2022-12-25	WOS:000260503000022
J	Kim, MJ; Chia, IV; Costantini, F				Kim, Min Jung; Chia, Ian V.; Costantini, Frank			SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability	FASEB JOURNAL			English	Article						Wnt signaling; disheveled; beta-catenin	RECEPTOR-RELATED PROTEIN-5; WNT SIGNALING PATHWAY; BETA-CATENIN; SUMO-1 MODIFICATION; DOMAINS; ARKADIA; PHOSPHORYLATION; DEGRADATION; ACTIVATION; MODIFIER-1	Axin is a scaffold protein for the beta-catenin destruction complex, and a negative regulator of canonical Wnt signaling. Previous studies implicated the six C-terminal amino acids (C6 motif) in the ability of Axin to activate c-Jun N-terminal kinase, and identified them as a SUMOylation target. Deletion of the C6 motif of mouse Axin in vivo reduced the steady-state protein level, which caused embryonic lethality. Here, we report that this deletion (Axin-Delta C6) causes a reduced half-life in mouse embryonic fibroblasts and an increased susceptibility to ubiquitination in HEK 293T cells. We confirmed the C6 motif as a SUMOylation target in vitro, and found that mutating the C-terminal SUMOylation target residues increased the susceptibility of Axin to polyubiquitination and reduced its steady-state level. Heterologous SUMOylation target sites could replace C6 in providing this protective effect. These findings suggest that SUMOylation of the C6 motif may prevent polyubiquitination, thus increasing the stability of Axin. Although C6 deletion also caused increased association of Axin with Dvl-1, this interaction was not altered by mutating the lysine residues in C6, nor could heterologous SUMOylation motifs replace the C6 motif in this assay. Therefore, some other specific property of the C6 motif seems to reduce the interaction of Axin with Dvl-1.-Kim, M. J., Chia, I. V., Costantini, F. SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability. FASEB J. 22, 3785-3794 (2008)	[Kim, Min Jung; Chia, Ian V.; Costantini, Frank] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA	Columbia University	Costantini, F (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, 701 W 168th St, New York, NY 10032 USA.	fdc3@columbia.edu			National Institute of Child Health and Human Development [HD44265]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044265] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD44265 to F. C. from the National Institute of Child Health and Human Development. We thank Zaiqi Wu for excellent technical assistance, David Virshup (Huntsman Cancer Institute, Salt Lake City, UT, USA) for the anti-Axin antiserum, and Eek-hoon Jho (University of Seoul, Seoul, South Korea) and Wei Hsu (University of Rochester, Rochester, NY, USA) for comments on the manuscript.	Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	35	37	39	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3785	3794		10.1096/fj.08-113910	http://dx.doi.org/10.1096/fj.08-113910			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18632848	Green Published			2022-12-25	WOS:000260503000007
J	Castelle, C; Guiral, M; Malarte, G; Ledgham, F; Leroy, G; Brugna, M; Giudici-Orticoni, MT				Castelle, Cindy; Guiral, Marianne; Malarte, Guillaume; Ledgham, Fouzia; Leroy, Gisele; Brugna, Myriam; Giudici-Orticoni, Marie-Therese			A new iron-oxidizing/O-2-reducing supercomplex spanning both inner and outer membranes, isolated from the extreme acidophile Acidithiobacillus ferrooxidans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM THIOBACILLUS-FERROOXIDANS; ELECTRON-TRANSFER; AQUIFEX-AEOLICUS; BC(1) COMPLEXES; IRON OXIDATION; PROTEIN; OXIDASE; PROKARYOTES	The iron respiratory chain of the acidophilic bacterium Acidithiobacillus ferrooxidans involves various metalloenzymes. Here we demonstrate that the oxygen reduction pathway from ferrous iron (named downhill pathway) is organized as a super-complex constituted of proteins located in the outer and inner membranes as well as in the periplasm. For the first time, the outer membrane-bound cytochrome c Cyc2 was purified, and we showed that it is responsible for iron oxidation and determined that its redox potential is the highest measured to date for a cytochrome c. The organization of metalloproteins inside the supramolecular structure was specified by protein-protein interaction experiments. The isolated complex spanning the two membranes had iron oxidase as well as oxygen reductase activities, indicating functional electron transfer between the first iron electron acceptor, Cyc2, and the Cu-A center of cytochrome c oxidase aa3. This is the first characterization of a respirasome from an acidophilic bacterium. In Acidithiobacillus ferrooxidans, O-2 reduction from ferrous iron must be coupled to the energy-consuming reduction of NAD(+)(P) from ferrous iron (uphill pathway) required for CO2 fixation and other anabolic processes. Besides the proteins involved in the O-2 reduction, there were additional proteins in the supercomplex, involved in uphill pathway (bc complex and cytochrome Cyc(42)), suggesting a possible physical link between these two pathways.	[Castelle, Cindy; Guiral, Marianne; Malarte, Guillaume; Ledgham, Fouzia; Leroy, Gisele; Brugna, Myriam; Giudici-Orticoni, Marie-Therese] IBSM CNRS, Lab Bioengn & Ingn Prot, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Giudici-Orticoni, MT (corresponding author), IBSM CNRS, Lab Bioengn & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	giudici@ibsm.cnrs-mrs.fr		Castelle, Cindy/0000-0002-0751-9804				Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; ARREDONDO R, 1994, APPL ENVIRON MICROB, V60, P2846, DOI 10.1128/AEM.60.8.2846-2851.1994; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Brasseur G, 2004, BBA-BIOENERGETICS, V1656, P114, DOI 10.1016/j.bbabio.2004.02.008; Brasseur G, 2002, BBA-BIOENERGETICS, V1555, P37, DOI 10.1016/S0005-2728(02)00251-7; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Bruscella P, 2007, MICROBIOL-SGM, V153, P102, DOI 10.1099/mic.0.2006/000067-0; Chen FP, 2007, J REPROD MED, V52, P317; CROAL LR, 2007, ANNU REV GENET, V38, P175; Dutton P L, 1978, Methods Enzymol, V54, P411; EDMONSO DG, 1993, CURRENT PROTOCOLS MO, P1; Elbehti A, 2000, J BACTERIOL, V182, P3602, DOI 10.1128/JB.182.12.3602-3606.2000; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Jeans C, 2008, ISME J, V2, P542, DOI 10.1038/ismej.2008.17; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P493, DOI 10.1016/S0966-842X(00)01831-X; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rohwerder T, 2003, APPL MICROBIOL BIOT, V63, P239, DOI 10.1007/s00253-003-1448-7; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6; YEATES TO, 2007, BIOCHEM SOC T, V35	32	129	133	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25803	25811		10.1074/jbc.M802496200	http://dx.doi.org/10.1074/jbc.M802496200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632666	Green Published, hybrid			2022-12-25	WOS:000259200100006
J	De-La-Pena, C; Lei, Z; Watson, BS; Sumner, LW; Vivanco, JM				De-la-Pena, Clelia; Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.; Vivanco, Jorge M.			Root-microbe communication through protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PV. TOMATO DC3000; MEDICAGO-TRUNCATULA; EXTRACELLULAR PROTEINS; 2-DIMENSIONAL ELECTROPHORESIS; SINORHIZOBIUM-MELILOTI; ANTIMICROBIAL PROTEINS; GENE-EXPRESSION; ALFALFA SEEDS; NOD GENES; RHIZOBIUM	Biotic interactions in the rhizosphere are biologically important, and although many of those interactions have been well studied, the role of secreted proteins in the cross-talk between microbes and roots has not been investigated. Here, protein secretion was studied during the communication between the roots of two plants (Medicago sativa and Arabidopsis thaliana) and the bacterial symbiont of one of these species (Sinorhizobium meliloti strain Rm1021) and an opportunistic bacterial pathogen of A. thaliana (Pseudomonas syringae pv. tomato DC3000) using a proteomic approach. It was found that protein exudation in the M. sativa-S. meliloti interaction caused an increase in the secretion of seven plant proteins, such as hydrolases, peptidases, and peroxidases among others in two or more time points compared with the plant control. In addition, four proteins, all of bacterial origin, were increased 1.5-fold more in this interaction compared with S. meliloti alone. However, these proteins were not induced when M. sativa was inoculated with P. syringae DC3000. The interaction between A. thaliana and P. syringae DC3000 highly induced the secretion of several plant proteins related to defense soon after initial contact with P. syringae, but these proteins were not secreted in the incompatible interaction with S. meliloti. The results of this study reveal a specific, protein level cross-talk between roots and microbes. These results suggest that secreted proteins may be a critical component in the process of signaling and recognition that occurs between compatible and incompatible interactions.	[De-la-Pena, Clelia; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [De-la-Pena, Clelia; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Ardmore, OK 73401 USA	Colorado State University; Colorado State University; Noble Research Institute	Vivanco, JM (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, 217 Shepardson Bldg, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Sumner, Lloyd W/A-3270-2013	Sumner, Lloyd W/0000-0002-4086-663X; De-la-Pena, Clelia/0000-0002-9093-9489; Watson, Bonnie/0000-0003-2222-8156	National Science Foundation [MCB-0542642]	National Science Foundation(National Science Foundation (NSF))	These studies were supported by National Science Foundation Grant MCB-0542642 (to J. M. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; ANTELMANN H, 2006, MICROBIAL PROTEOMICS; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; BARON C, 1995, TRENDS BIOTECHNOL, V13, P356, DOI 10.1016/S0167-7799(00)88981-7; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boekhorst J, 2006, MICROBIOL-SGM, V152, P3175, DOI 10.1099/mic.0.29217-0; BOHLOOL BB, 1974, SCIENCE, V185, P269, DOI 10.1126/science.185.4147.269; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bueno P, 2001, NEW PHYTOL, V152, P91, DOI 10.1046/j.0028-646x.2001.00246.x; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; COOK D, 1995, PLANT CELL, V7, P43, DOI 10.1105/tpc.7.1.43; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; CURRIER WW, 1976, PLANT PHYSIOL, V57, P820, DOI 10.1104/pp.57.5.820; Den Herder J, 2007, PLANT PHYSIOL, V144, P717, DOI 10.1104/pp.107.098764; EGELHOFF TT, 1985, J BACTERIOL, V164, P591, DOI 10.1128/JB.164.2.591-599.1985; ESNAULT R, 1993, MOL PLANT MICROBE IN, V6, P655, DOI 10.1094/MPMI-6-655; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Goormachtig S, 1998, PLANT CELL, V10, P905, DOI 10.1105/tpc.10.6.905; Gramss G, 1998, NEW PHYTOL, V138, P401, DOI 10.1046/j.1469-8137.1998.00128.x; HALVERSON LJ, 1984, PLANT PHYSIOL, V74, P84, DOI 10.1104/pp.74.1.84; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; HARTWIG UA, 1989, PLANT PHYSIOL, V91, P1138, DOI 10.1104/pp.91.3.1138; Hause B, 2007, PHYTOCHEMISTRY, V68, P101, DOI 10.1016/j.phytochem.2006.09.025; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P759, DOI 10.1104/pp.97.2.759; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keith RC, 2003, MICROBIOL-SGM, V149, P1127, DOI 10.1099/mic.0.26109-0; Kiely PD, 2006, MICROB ECOL, V51, P257, DOI 10.1007/s00248-006-9019-y; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lei Z, 2005, MOL CELL PROTEOMICS, V4, P1812, DOI 10.1074/mcp.D500005-MCP200; Lin CC, 1999, BIOL FERT SOILS, V30, P83, DOI 10.1007/s003740050591; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Loyola-Vargas VM, 2007, PLANTA, V225, P301, DOI 10.1007/s00425-006-0349-2; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; MAXWELL CA, 1989, PLANT PHYSIOL, V91, P842, DOI 10.1104/pp.91.3.842; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MOORE RA, 1989, CAN J MICROBIOL, V35, P910, DOI 10.1139/m89-151; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oldroyd GED, 2007, SCIENCE, V315, P52, DOI 10.1126/science.1137588; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Prayitno J, 2006, J PROTEOME RES, V5, P3084, DOI 10.1021/pr0602646; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; SAMAC DA, 1990, PLANT PHYSIOL, V93, P907, DOI 10.1104/pp.93.3.907; Santos R, 2000, MOL MICROBIOL, V38, P750, DOI 10.1046/j.1365-2958.2000.02178.x; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; STAEHELIN C, 1995, PLANT PHYSIOL, V108, P1607, DOI 10.1104/pp.108.4.1607; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Sumner LW, 2002, RAPID COMMUN MASS SP, V16, P160, DOI 10.1002/rcm.555; Takeda N, 2007, PHYTOCHEMISTRY, V68, P111, DOI 10.1016/j.phytochem.2006.09.022; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Taylor CB, 1998, PLANT CELL, V10, P873; Teplitski M, 2000, MOL PLANT MICROBE IN, V13, P637, DOI 10.1094/MPMI.2000.13.6.637; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Turrini A, 2004, NEW PHYTOL, V163, P393, DOI 10.1111/j.1469-8137.2004.01107.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Watt M, 2006, ANN BOT-LONDON, V97, P839, DOI 10.1093/aob/mcl028; Weis VM, 1996, P NATL ACAD SCI USA, V93, P13683, DOI 10.1073/pnas.93.24.13683; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Xie ZP, 1999, J EXP BOT, V50, P327, DOI 10.1093/jexbot/50.332.327; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	90	109	112	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25247	25255		10.1074/jbc.M801967200	http://dx.doi.org/10.1074/jbc.M801967200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635546	hybrid			2022-12-25	WOS:000259012700017
J	Dutta, D; Ray, S; Vivian, JL; Paul, S				Dutta, Debasree; Ray, Soma; Vivian, Jay L.; Paul, Soumen			Activation of the VEGFR1 chromatin domain - An angiogenic signal-ETS1/HIF-2 alpha regulatory axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; ETS TRANSCRIPTION FACTORS; TYROSINE KINASE; FACTOR RECEPTOR; BONE-MARROW; VASCULAR DEVELOPMENT; TUMOR ANGIOGENESIS; HUMAN GLIOMAS; FLT-1	Angiogenesis is induced by multiple growth factors including vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2). In vascular endothelium VEGF signals through two receptor-tyrosine kinases, VEGFR1 and VEGFR2. The VEGFR1 gene encodes both a receptor-tyrosine kinase and a secreted splice variant, soluble VEGFR1. Whereas VEGFR1 is essential for vascular development, mechanisms that regulate VEGFR1 expression in endothelial cells are poorly understood. We demonstrate here that in endothelial cells, FGF2 and epidermal growth factor (EGF) signaling induce VEGFR1 mRNA expression in a combinatorial fashion. EGF/FGF2-mediated VEGFR1 induction is mediated via functional interaction of transcription factors ETS1 and HIF-2 alpha. Mechanistic analyses revealed that in endothelial cells EGF/FGF2 signaling induces ETS1 expression, increases HIF-2 alpha protein level in absence of hypoxia, and recruits both ETS1 and HIF-2 alpha to the VEGFR1 chromatin domain. Knockdown of ETS1 and HIF-2 alpha by RNA interference inhibits EGF/FGF2-induced VEGFR1 expression, and loss of expression is associated with impaired RNA-polymerase II recruitment and histone modifications at the VEGFR1 promoter region. In addition, using a mouse embryonic stem cell in vitro differentiation system, we found that induction of VEGFR1 in embryoid bodies is also associated with ETS1 and HIF-2 alpha recruitment to the VEGFR1 locus. These results establish an angiogenic signal-ETS1/HIF-2 alpha axis that regulates the VEGFR1 chromatin domain to induce VEGFR1 transcription in endothelial cells and in differentiating embryonic stem cells.	[Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu			National Institutes of Health [P20 RR16475]; University of Kansas Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR024214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR16475 (Kansas INBRE). This work was also supported by the University of Kansas Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Barleon B, 1997, CANCER RES, V57, P5421; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Botella LM, 2001, J BIOL CHEM, V276, P34486, DOI 10.1074/jbc.M011611200; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO;2-Q; Cuenda A, 2000, METH MOL B, V99, P161; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Huang L, 2008, J BIOL CHEM, V283, P7616, DOI 10.1074/jbc.M705839200; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simon MC, 2008, ANNU REV PHYSIOL, V70, P51, DOI 10.1146/annurev.physiol.70.113006.100526; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Valter MM, 1999, CANCER RES, V59, P5608; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; WERNERT N, 1992, AM J PATHOL, V140, P119; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218	59	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25404	25413		10.1074/jbc.M804349200	http://dx.doi.org/10.1074/jbc.M804349200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625704	hybrid, Green Published			2022-12-25	WOS:000259012700035
J	Islam, A; Jones, H; Hiroi, T; Lam, J; Zhang, J; Moss, J; Vaughan, M; Levine, SJ				Islam, Aminul; Jones, Heather; Hiroi, Toyoko; Lam, Jonathan; Zhang, Jing; Moss, Joel; Vaughan, Martha; Levine, Stewart J.			cAMP-dependent protein kinase a (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RII beta to BIG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-BINDING-PROTEIN; CELL-DERIVED-EXOSOMES; BREFELDIN-A; MULTIVESICULAR BODY; FACTOR RECEPTOR; AKAP BINDING; PATHWAY; SPECIFICITY; MECHANISM	The 55-kDa TNFR1 (type I tumor necrosis factor receptor) can be released to the extracellular space by two mechanisms, the proteolytic cleavage and shedding of soluble receptor ectodomains and the release of full-length receptors within exosome-like vesicles. We have shown that the brefeldin A-inhibited guanine nucleotide exchange protein BIG2 associates with TNFR1 and selectively modulates the release of TNFR1 exosome-like vesicles via an ARF1- and ARF3-dependent mechanism. Here, we assessed the role of BIG2 A kinase-anchoring protein (AKAP) domains in the regulation of TNFR1 exosome-like vesicle release from human vascular endothelial cells. We show that 8-bromo-cyclic AMP induced the release of full-length, 55-kDa TNFR1 within exosome-like vesicles via a protein kinase A (PKA)-dependent mechanism. Using RNA interference to decrease specifically the levels of individual PKA regulatory subunits, we demonstrate that RII beta modulates both the constitutive and cAMP-induced release of TNFR1 exosome-like vesicles. Consistent with its AKAP function, BIG2 was required for the cAMP-induced PKA-dependent release of TNFR1 exosome-like vesicles via a mechanism that involved the binding of RII beta to BIG2 AKAP domains B and C. We conclude that both the constitutive and cAMP-induced release of TNFR1 exosome-like vesicles occur via PKA-dependent pathways that are regulated by the anchoring of RII beta to BIG2 via AKAP domains B and C. Thus, BIG2 regulates TNFR1 exosome-like vesicle release by two distinct mechanisms, as a guanine nucleotide exchange protein that activates class I ADP-ribosylation factors and as an AKAP for RII beta that localizes PKA signaling within cellular TNFR1 trafficking pathways.	[Islam, Aminul; Lam, Jonathan; Zhang, Jing; Levine, Stewart J.] NHLBI, Pulm & Vasc Med Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Jones, Heather; Hiroi, Toyoko; Moss, Joel; Vaughan, Martha] NHLBI, Translat Med Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, SJ (corresponding author), NHLBI, Pulm & Vasc Med Branch, Natl Inst Hlth, Bldg 10,Rm 6D03,MSC 1590, Bethesda, MD 20892 USA.	levines@nhlbi.nih.gov			Division of Intramural Research; NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002544, ZIAHL000627, Z01HL000627, ZIAHL002544] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Division of Intramural Research, NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Denzer K, 2000, J CELL SCI, V113, P3365; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; OLSSON I, 1989, EUR J HAEMATOL, V42, P270, DOI 10.1111/j.1600-0609.1989.tb00111.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SECKINGER P, 1989, J BIOL CHEM, V264, P11966; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WALLACH D, 1991, TUMOR NECROSIS FACTO; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	46	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25364	25371		10.1074/jbc.M804966200	http://dx.doi.org/10.1074/jbc.M804966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625701	hybrid, Green Published			2022-12-25	WOS:000259012700031
J	Novgorodov, SA; Gudz, TI; Obeid, LM				Novgorodov, Sergei A.; Gudz, Tatyana I.; Obeid, Lina M.			Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; RAT-LIVER MITOCHONDRIA; APOPTOTIC CELL-DEATH; ADENINE-NUCLEOTIDE TRANSLOCASE; DEPENDENT ANION CHANNEL; 2 SEPARATE SITES; CYCLOPHILIN-D; PROTEIN PHOSPHATASE; CYCLOSPORINE-A	The sphingolipid ceramide has been implicated in mediating cell death that is accompanied by mitochondrial functional alterations. Moreover, ceramide has been shown to accumulate in mitochondria upon induction of apoptotic processes. In this study, we sought to evaluate the effects of natural, highly hydrophobic long-chain ceramides on mitochondrial function in vitro. Ceramide in a dodecane/ethanol delivery system inhibited the opening of the mitochondrial permeability transition pore (PTP) induced by either oxidative stress, SH group cross-linking, or high Ca2+ load, suggesting that the inhibitory point is at a level at which major PTP regulatory pathways converge. Moreover, ceramide had no effect on well known mitochondrial components that modulate PTP activity, such as cyclophilin D, voltage-dependent anion channel, adenine nucleotide transporter, and ATP synthase. The inhibitory effect of ceramide on PTP was not stereospecific, nor was there a preference for ceramide over dihydroceramide. However, the effect of ceramide on PTP was significantly influenced by the fatty acid moiety chain length. These studies are the first to show that long-chain ceramide can influence PTP at physiologically relevant concentrations, suggesting that it is the only known potent natural inhibitor of PTP. These results suggest a novel mechanism of ceramide regulation of mitochondrial function.	[Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Gudz, Tatyana I.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,POB 250779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [AG16583, P20 RR 17677-04, CO6 RR018823]; Veterans Affairs Merit Awards; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG16583 (to L. M. O.), National Institutes of Health Grant P20 RR 17677-04 (to T. I. G.), and National Institutes of Health Grant CO6 RR018823. This work was also supported by Veterans Affairs Merit Awards (to T. I. G. and L. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoyama M, 1998, BIOCHEM J, V336, P727, DOI 10.1042/bj3360727; Ardail D, 2002, BBA-MOL CELL BIOL L, V1583, P305, DOI 10.1016/S1388-1981(02)00252-4; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen Quan, 2003, Korean Journal of Biological Sciences, V7, P1; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gamard CJ, 1997, J BIOL CHEM, V272, P16474, DOI 10.1074/jbc.272.26.16474; GARCIAECHEVERRIA C, 1993, BIOCHEM BIOPH RES CO, V191, P70, DOI 10.1006/bbrc.1993.1185; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Grabowski DR, 1998, BIOCHEM PHARMACOL, V56, P345, DOI 10.1016/S0006-2952(98)00159-2; GRAHAM JM, 1999, CURRENT PROTOCOLS CE; Gudz T, 1997, ARCH BIOCHEM BIOPHYS, V342, P143, DOI 10.1006/abbi.1997.0113; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HAWORTH RA, 1980, J MEMBRANE BIOL, V54, P231, DOI 10.1007/BF01870239; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LENARTOWICZ E, 1991, J BIOENERG BIOMEMBR, V23, P679, DOI 10.1007/BF00785817; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; McFarlane SM, 2000, MOL CELL BIOCHEM, V211, P19, DOI 10.1023/A:1007189911897; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Mimeault M, 2002, FEBS LETT, V530, P9, DOI 10.1016/S0014-5793(02)03432-4; Montes LR, 2002, J BIOL CHEM, V277, P11788, DOI 10.1074/jbc.M111568200; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; NOVGORODOV SA, 1989, FEBS LETT, V247, P255, DOI 10.1016/0014-5793(89)81347-X; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rabkin SW, 2002, CELL BIOL INT, V26, P433, DOI 10.1006/cbir.2002.0876; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; SanchezAlcazar JA, 1997, J BIOL CHEM, V272, P30167, DOI 10.1074/jbc.272.48.30167; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Simon CG, 1998, BIOCHEMISTRY-US, V37, P2059, DOI 10.1021/bi9710636; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soriano ME, 2004, J BIOL CHEM, V279, P36803, DOI 10.1074/jbc.M405297200; Stoica BA, 2003, MOL CELL NEUROSCI, V22, P365, DOI 10.1016/S1044-7431(02)00028-3; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yuan H, 2003, MITOCHONDRION, V2, P237, DOI 10.1016/S1567-7249(02)00106-X; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	115	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24707	24717		10.1074/jbc.M801810200	http://dx.doi.org/10.1074/jbc.M801810200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596045	Green Published, hybrid			2022-12-25	WOS:000258820000040
J	Sakiyama, H; Wynn, RM; Lee, WR; Fukasawa, M; Mizuguchi, H; Gardner, KH; Repa, JJ; Uyeda, K				Sakiyama, Haruhiko; Wynn, R. Max; Lee, Wan-Ru; Fukasawa, Masashi; Mizuguchi, Hiroyuki; Gardner, Kevin H.; Repa, Joyce J.; Uyeda, Kosaku			Regulation of Nuclear Import/Export of Carbohydrate Response Element-binding Protein (ChREBP) INTERACTION OF AN alpha-HELIX OF ChREBP WITH THE 14-3-3 PROTEINS AND REGULATION BY PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; IMPORTIN-BETA; GLUCOSE; METABOLISM; MLX; LOCALIZATION; INVOLVEMENT; ACTIVATION; PREDICTION; MECHANISM	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in the glucose-mediated induction of gene products involved in hepatic glycolysis and lipogenesis. Glucose affects the activity of ChREBP largely through post-translational mechanisms involving phosphorylation-dependent cellular localization. In this work we show that the N-terminal region of ChREBP (residues 1-251) regulates its subcellular localization via an interaction with 14-3-3. 14-3-3 binds an alpha-helix in this region (residues 125-135) to retain ChREBP in the cytosol, and binding of 14-3-3 is facilitated by phosphorylation of nearby Ser-140 and Ser-196. Phosphorylation of ChREBP at these sites was essential for its interaction with CRM1 for export to the cytosol, whereas nuclear import of ChREBP requires dephosphorylated ChREBP to interact with importin alpha. Notably, 14-3-3 appears to compete with importin alpha for ChREBP binding. 14-3-3 beta bound to a synthetic peptide spanning residues 125-144 and bearing a phosphate at Ser-140 with a dissociation constant of 1.1 mu M, as determined by isothermal calorimetry. The interaction caused a shift in the fluorescence maximum of the tryptophan residues of the peptide. The corresponding unphosphorylated peptide failed to bind 14-3-3 beta. These results suggest that interactions with importin alpha and 14-3-3 regulate movement of ChREBP into and out of the nucleus, respectively, and that these interactions are regulated by the ChREBP phosphorylation status.	[Sakiyama, Haruhiko; Wynn, R. Max; Lee, Wan-Ru; Fukasawa, Masashi; Gardner, Kevin H.; Uyeda, Kosaku] Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; [Mizuguchi, Hiroyuki] Univ Tokushima, Dept Pharmaceut Sci, Tokushima, Japan; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokushima University	Uyeda, K (corresponding author), Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	Kosaku.Uyeda@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019; Mizuguchi, Hiroyuki/B-5676-2013	Gardner, Kevin H./0000-0002-8671-2556; Mizuguchi, Hiroyuki/0000-0001-7055-316X; Wynn, Richard/0000-0002-1879-2136				Bodnar RJ, 1999, J BIOL CHEM, V274, P33474, DOI 10.1074/jbc.274.47.33474; Bridges D, 2004, SCI STKE, pre10; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu YQ, 1996, BIOCHEM BIOPH RES CO, V221, P554, DOI 10.1006/bbrc.1996.0634; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; NISHIMURA M, 1994, J BIOL CHEM, V269, P26100; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	33	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24899	24908		10.1074/jbc.M804308200	http://dx.doi.org/10.1074/jbc.M804308200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606808	Green Published, hybrid			2022-12-25	WOS:000258820000074
J	Kondas, K; Szlama, G; Trexler, M; Patthy, L				Kondas, Katalin; Szlama, Gyoergy; Trexler, Maria; Patthy, Laszlo			Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE INHIBITOR DOMAIN; BETA SUPERFAMILY; MYOSTATIN GENE; EXPRESSION ANALYSIS; MULTIPLE TYPES; MUSCLE; GDF11; CARDIOMYOCYTES; PROTEINS; ADIPOGENESIS	WFIKKN1 and WFIKKN2 are large extracellular multidomain proteins consisting of a WAP, a follistatin, an immunoglobulin, two Kunitz- type protease inhibitor domains, and an NTR domain. Recent experiments have shown that WFIKKN2 protein binds mature GDF8/ myostatin and myostatin propeptide and inhibits the biological activity of myostatin ( Hill, J. J., Qiu, Y., Hewick, R. M., and Wolfman, N. M. ( 2003) Mol. Endocrinol. 17, 1144 - 1154). Here we show that the paralogue of this protein, WFIKKN1, also binds to both myostatin and myostatin propeptide and that both WFIKKN1 and WFIKKN2 bind GDF11, the growth and differentiation factor most closely related to myostatin, with high affinity. Structure- function studies onWFIKKN1have revealed that the follistatin domain is primarily responsible for the binding of mature growth factor, whereas the NTR domain contributes most significantly to the interaction with myostatin propeptide. Analysis of the evolutionary histories of WFIKKN1/ WFIKKN2 and GDF8/ GDF11 proteins indicates that the functional association of an ancestral WFIKKNprotein with an ancestor of GDF8/ 11 may date back to cephalochordates/ urochordates. Although duplication of the corresponding genes gave rise to WFIKKN1/ WFIKKN2 and GDF8/ GDF11 in early vertebrates, the data presented here suggest that there is significant functional overlap of the paralogous proteins.	[Kondas, Katalin; Szlama, Gyoergy; Trexler, Maria; Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Patthy, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary.	patthy@enzim.hu	Patthy, Laszlo/Q-6058-2019; Patthy, Laszlo/A-2353-2013					Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Biga PR, 2005, COMP BIOCHEM PHYS B, V141, P218, DOI 10.1016/j.cbpc.2005.03.004; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dichmann DS, 2006, DEV DYNAM, V235, P3016, DOI 10.1002/dvdy.20953; Esquela AF, 2003, DEV BIOL, V257, P356, DOI 10.1016/S0012-1606(03)00100-3; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Gamer LW, 2001, DEV BIOL, V229, P407, DOI 10.1006/dbio.2000.9981; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Garikipati DK, 2007, ENDOCRINOLOGY, V148, P2106, DOI 10.1210/en.2006-1299; Garikipati DK, 2006, J ENDOCRINOL, V190, P879, DOI 10.1677/joe.1.06866; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hamrick MW, 2007, BONE, V40, P1544, DOI 10.1016/j.bone.2007.02.012; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Helterline DLI, 2007, GEN COMP ENDOCR, V151, P90, DOI 10.1016/j.ygcen.2006.12.023; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Ji SQ, 1998, AM J PHYSIOL-REG I, V275, pR1265, DOI 10.1152/ajpregu.1998.275.4.R1265; Kocabas AM, 2002, BBA-GENE STRUCT EXPR, V1575, P99, DOI 10.1016/S0167-4781(02)00289-0; Kubota K, 2007, COMP BIOCHEM PHYS A, V148, P550, DOI 10.1016/j.cbpa.2007.07.004; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liepinsh E, 2006, J BIOMOL NMR, V35, P73, DOI 10.1007/s10858-006-9013-1; Lin X, 2006, INT J MOL MED, V17, P833; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Nomura T, 2008, BIOCHEM BIOPH RES CO, V365, P863, DOI 10.1016/j.bbrc.2007.11.087; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ostbye TK, 2001, EUR J BIOCHEM, V268, P5249, DOI 10.1046/j.0014-2956.2001.02456.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Roberts SB, 2003, MOL CELL ENDOCRINOL, V210, P9, DOI 10.1016/j.mce.2003.09.002; Roberts SB, 2001, FEBS LETT, V491, P212, DOI 10.1016/S0014-5793(01)02196-2; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Sundaresan NR, 2008, RES VET SCI, V85, P86, DOI 10.1016/j.rvsc.2007.09.014; Thies RS, 2001, GROWTH FACTORS, V18, P251; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xing F, 2007, DEV GENES EVOL, V217, P549, DOI 10.1007/s00427-007-0162-3; Ye HQ, 2007, MAR BIOTECHNOL, V9, P262, DOI 10.1007/s10126-006-6093-6; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	50	50	56	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23677	23684		10.1074/jbc.M803025200	http://dx.doi.org/10.1074/jbc.M803025200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596030	Green Published, hybrid			2022-12-25	WOS:000258638900021
J	Banerjee, R; Mosley, RL; Reynolds, AD; Dhar, A; Jackson-Lewis, V; Gordon, PH; Przedborski, S; Gendelman, HE				Banerjee, Rebecca; Mosley, R. Lee; Reynolds, Ashley D.; Dhar, Alok; Jackson-Lewis, Vernice; Gordon, Paul H.; Przedborski, Serge; Gendelman, Howard E.			Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MOTOR-NEURON DEGENERATION; MOUSE MODEL; GLATIRAMER ACETATE; T-CELLS; MURINE MODEL; SPINAL-CORD; THERAPEUTIC IMMUNIZATION; LYMPHOCYTE POPULATIONS; DOPAMINERGIC-NEURONS	Background: Innate neuroimmune dysfunction is a pathobiological feature of amyotrophic lateral sclerosis (ALS). However, links, if any, between disease and adaptive immunity are poorly understood. Thus, the role of T cell immunity in disease was investigated in human G93A superoxide dismutase 1 (SOD1) transgenic (Tg) mice and subsequently in ALS patients. Methods and Findings: Quantitative and qualitative immune deficits in lymphoid cell and T cell function were seen in G93A-SOD1 Tg mice. Spleens of Tg animals showed reductions in size, weight, lymphocyte numbers, and morphological deficits at terminal stages of disease compared to their wild-type (Wt) littermates. Spleen sizes and weights of presymptomatic Tg mice were unchanged, but deficits were readily seen in T cell proliferation coincident with increased annexin-V associated apoptosis and necrosis of lymphocytes. These lymphoid deficits paralleled failure of Copolymer-1 (COP-1) immunization to affect longevity. In addition, among CD4(+) T cells in ALS patients, levels of CD45RA(+) (naive) T cells were diminished, while CD45RO(+) (memory) T cells were increased compared to age-matched caregivers. In attempts to correct mutant SOD1 associated immune deficits, we reconstituted SOD1 Tg mice with unfractionated naive lymphocytes or anti-CD3 activated CD4(+)CD25(+) T regulatory cells (Treg) or CD4(+)CD25(-) T effector cells (Teff) from Wt donor mice. While naive lymphocytes failed to enhance survival, both polyclonal-activated Treg and Teff subsets delayed loss of motor function and extended survival; however, only Treg delayed neurological symptom onset, whereas Teff increased latency between disease onset and entry into late stage. Conclusions: A profound and progressive immunodeficiency is operative in G93A-SOD1 mice and is linked to T cell dysfunction and the failure to elicit COP-1 neuroprotective immune responses. In preliminary studies T cell deficits were also observed in human ALS. These findings, taken together, suggest caution in ascribing vaccination outcomes when these animal models of human ALS are used for study. Nonetheless, the abilities to improve neurological function and life expectancy in G93A-SOD1 Tg mice by reconstitution with activated T cells do provide opportunities for therapeutic intervention.	[Banerjee, Rebecca; Mosley, R. Lee; Reynolds, Ashley D.; Dhar, Alok; Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA; [Jackson-Lewis, Vernice; Gordon, Paul H.; Przedborski, Serge] Columbia Univ, Eleanor & Lou Gehrig MDA ALS Res Ctr, Ctr Motor Neuron Biol & Dis, Dept Neurol, New York, NY USA	University of Nebraska System; University of Nebraska Medical Center; Columbia University	Banerjee, R (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA.	rlmosley@unmc.edu; SP30@Columbia.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012	Gordon, Paul/0000-0001-5714-9875	National Institute of Neurological Disorders and Stroke [NS36136, NS43985, NS007488, NS42269, NS38370, NS11766, NS049264]; National Institute of Mental Health [MH64570]; National Institute of Aging [AG021617]; National Institute of Environmental Health Sciences [ES013177]; U.S. Department of Defense [17-03-1]; Parkinson's Disease Foundation [CU51523606]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, T32NS007488, P50NS038370, R21NS049264, P01NS043985, R01NS042269, P01NS011766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke Grants (NS36136, NS43985, NS007488, NS42269, NS38370, NS11766 and NS049264); National Institute of Mental Health (MH64570); National Institute of Aging (AG021617); National Institute of Environmental Health Sciences (ES013177); U.S. Department of Defense Grant (17-03-1); the Parkinson's Disease Foundation (CU51523606) and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Arnon R, 2003, J MOL RECOGNIT, V16, P412, DOI 10.1002/jmr.628; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Bakalash S, 2005, J MOL MED, V83, P904, DOI 10.1007/s00109-005-0689-6; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Baron P, 2005, MUSCLE NERVE, V32, P541, DOI 10.1002/mus.20376; Bas J, 2001, J NEUROIMMUNOL, V113, P146, DOI 10.1016/S0165-5728(00)00422-7; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Buttarelli FR, 2006, EUR J NEUROL, V13, P416, DOI 10.1111/j.1468-1331.2006.01235.x; Casal JA, 2003, CLIN BIOCHEM, V36, P553, DOI 10.1016/S0009-9120(03)00093-6; Cereda C, 2006, NEUROL SCI, V27, P312, DOI 10.1007/s10072-006-0702-z; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Filion LG, 2003, CLIN EXP IMMUNOL, V131, P324, DOI 10.1046/j.1365-2249.2003.02053.x; Goldknopf IL, 2006, BIOCHEM BIOPH RES CO, V342, P1034, DOI 10.1016/j.bbrc.2006.02.051; Gorantla S, 2008, GLIA, V56, P223, DOI 10.1002/glia.20607; Gorantla S, 2007, J IMMUNOL, V179, P4345, DOI 10.4049/jimmunol.179.7.4345; Gordon PH, 2006, NEUROLOGY, V66, P1117, DOI 10.1212/01.wnl.0000204235.81272.e2; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habisch HJ, 2007, EXP NEUROL, V206, P288, DOI 10.1016/j.expneurol.2007.05.007; Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; HOFFMAN PM, 1983, J GERONTOL, V38, P414, DOI 10.1093/geronj/38.4.414; HOFFMAN PM, 1981, ANN NEUROL, V10, P193, DOI 10.1002/ana.410100210; HOFFMAN PM, 1978, NEW ENGL J MED, V299, P680, DOI 10.1056/NEJM197809282991302; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Kuzmenok OI, 2006, J NEUROIMMUNOL, V172, P132, DOI 10.1016/j.jneuroim.2005.11.015; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; Liu J, 2007, EUR J IMMUNOL, V37, P3143, DOI 10.1002/eji.200737398; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; NAGATA T, 2007, NEUROL RES; Neuhaus O, 2001, NEUROLOGY, V56, P702, DOI 10.1212/WNL.56.6.702; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Poulopoulou C, 2005, ANN NEUROL, V58, P946, DOI 10.1002/ana.20675; PROVINCIALI L, 1988, ACTA NEUROL SCAND, V78, P449, DOI 10.1111/j.1600-0404.1988.tb03686.x; Rentzos M, 2007, AMYOTROPH LATERAL SC, V8, P283, DOI 10.1080/17482960701419232; REYNOLDS AD, 2007, J LEUKOC BIOL; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scali C, 2002, NEUROBIOL AGING, V23, P523, DOI 10.1016/S0197-4580(01)00346-3; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sengun IS, 2003, J NEUROIMMUNOL, V142, P137, DOI 10.1016/S0165-5728(03)00263-7; SHALIT F, 1995, CLIN IMMUNOL IMMUNOP, V75, P246, DOI 10.1006/clin.1995.1078; Shi N, 2007, J NEUROIMMUNOL, V182, P232, DOI 10.1016/j.jneuroim.2006.10.001; Sinha S, 2004, J NEUROL SCI, V224, P97, DOI 10.1016/j.jns.2004.06.006; Teitelbaum D, 2003, MULT SCLER J, V9, P592, DOI 10.1191/1352458503ms963oa; Town T, 2002, J NEUROIMMUNOL, V132, P49, DOI 10.1016/S0165-5728(02)00307-7; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Verma A, 2006, J NEUROL SCI, V240, P59, DOI 10.1016/j.jns.2005.09.005; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wilms H, 2003, J NEUROIMMUNOL, V144, P139, DOI 10.1016/j.jneuroim.2003.08.042; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x	81	141	148	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2740	10.1371/journal.pone.0002740	http://dx.doi.org/10.1371/journal.pone.0002740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648532	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900011
J	Swinkels, DW; Girelli, D; Laarakkers, C; Kroot, J; Campostrini, N; Kemna, EHJM; Tjalsma, H				Swinkels, Dorine W.; Girelli, Domenico; Laarakkers, Coby; Kroot, Joyce; Campostrini, Natascia; Kemna, Erwin H. J. M.; Tjalsma, Harold			Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SERUM HEPCIDIN; IRON; QUANTIFICATION; INFLAMMATION; PLASMA; CANCER; ALPHA; REGULATOR; DISCOVERY	Assays for the detection of the iron regulatory hormone hepcidin in plasma or urine have not yet been widely available, whereas quantitative comparisons between hepcidin levels in these different matrices were thus far even impossible due to technical restrictions. To circumvent these limitations, we here describe several advances in time-of flight mass spectrometry (TOF MS), the most important of which concerned spiking of a synthetic hepcidin analogue as internal standard into serum and urine samples. This serves both as a control for experimental variation, such as recovery and matrix-dependent ionization and ion suppression, and at the same time allows value assignment to the measured hepcidin peak intensities. The assay improvements were clinically evaluated using samples from various patients groups and its relevance was further underscored by the significant correlation of serum hepcidin levels with serum iron indices in healthy individuals. Most importantly, this approach allowed kinetic studies as illustrated by the paired analyses of serum and urine samples, showing that more than 97% of the freely filtered serum hepcidin can be reabsorbed in the kidney. Thus, the here reported advances in TOF MS-based hepcidin measurements represent critical steps in the accurate quantification of hepcidin in various body fluids and pave the way for clinical studies on the kinetic behavior of hepcidin in both healthy and diseased states.	[Swinkels, Dorine W.; Laarakkers, Coby; Kroot, Joyce; Kemna, Erwin H. J. M.; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6525 ED Nijmegen, Netherlands; [Girelli, Domenico; Campostrini, Natascia] Univ Verona, Dept Clin & Expt Med, Sect Internal Med, Verona, Italy	Radboud University Nijmegen; University of Verona	Swinkels, DW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6525 ED Nijmegen, Netherlands.	D.Swinkels@akc.umcn.nl	Swinkels, Dorine W./H-8098-2014; Tjalsma, Harold/I-7146-2012; Girelli, Domenico/B-1183-2008	Swinkels, Dorine W./0000-0002-1040-9446; Girelli, Domenico/0000-0001-9684-1899	Telethon Italy [GGP06213]; Cariverona Foundation, Verona, Italy	Telethon Italy(Fondazione Telethon); Cariverona Foundation, Verona, Italy(Fondazione Cariverona)	This work was in part supported by grants from Telethon Italy (no. GGP06213) and the Cariverona Foundation, Verona, Italy (to D.G).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bozzini C, 2008, BLOOD CELL MOL DIS, V40, P347, DOI 10.1016/j.bcmd.2007.10.001; Cohen SL, 2006, ANAL CHEM, V78, P4352, DOI 10.1021/ac052263n; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Dallalio G, 2003, BRIT J HAEMATOL, V122, P996, DOI 10.1046/j.1365-2141.2003.04516.x; FINCH CA, 1986, WESTERN J MED, V145, P657; GANZ T, 2006, HEMATOL-AM SOC HEMAT, V507, P29, DOI DOI 10.1182/ASHEDUCATION-2006.1.29; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jacobs EMG, 2005, ANAL BIOCHEM, V341, P241, DOI 10.1016/j.ab.2005.03.008; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Melino S, 2005, J PEPT RES, V66, P65, DOI 10.1111/j.1747-0285.2006.00328.x; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peronnet E, 2006, PROTEOMICS, V6, P6288, DOI 10.1002/pmic.200600158; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; Song J, 2006, CLIN CHEM, V52, P1045, DOI 10.1373/clinchem.2005.065722; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; Tjalsma H, 2008, PROTEOM CLIN APPL, V2, P167, DOI 10.1002/prca.200780012; Tjalsma H, 2006, INT J CANCER, V119, P2127, DOI 10.1002/ijc.22116; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560	37	171	176	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2706	10.1371/journal.pone.0002706	http://dx.doi.org/10.1371/journal.pone.0002706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628991	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200049
J	Zheng, XC; Zhang, HM; Yin, LJ; Wang, CR; Liu, Y; Zheng, P				Zheng, Xincheng; Zhang, Huiming; Yin, Lijie; Wang, Chyung-Ru; Liu, Yang; Zheng, Pan			Modulation of NKT Cell Development by B7-CD28 Interaction: An Expanding Horizon for Costimulation	PLOS ONE			English	Article								It has been demonstrated that the development of NKT cells requires CD1d. The contribution of costimulatory molecules in this process has not been studied. Here we show that in mice with targeted mutations of B7-1/2 and CD28, the TCR beta(+)alpha-Galcer/CD1d(+) (iV alpha 14 NKT) subset is significantly reduced in the thymus, spleen and liver. This is mainly due to decreased cell proliferation; although increased cell death in the thymi of CD28-deficient mice was also observed. Moreover, in the B7-1/2- and CD28-deficient mice, we found a decreased percentage of the CD4(-) NK1.1(+) subset and a correspondingly increased portion of the CD4(+)NK1.1(-) subset. In addition, the mice with a targeted mutation of either B7 or CD28 had a reduced susceptibility to Con A induced hepatitis, which is known to be mediated by NKT cells. Our results demonstrate that the development, maturation and function of NKT cell are modulated by the costimulatory pathway and thus expand the horizon of costimulation into NKT, which is widely viewed as a bridge between innate and adaptive immunity. As such, costimulation may modulate all major branches of cell-mediated immunity, including T cells, NK cells and NKT cells.	[Zheng, Xincheng; Zhang, Huiming; Yin, Lijie; Liu, Yang; Zheng, Pan] Univ Michigan, Dept Surg, Ctr Comprehens Canc, Program Mol Mech Dis, Ann Arbor, MI 48109 USA; [Zheng, Xincheng] OncoImmune Ltd, Columbus, OH USA; [Wang, Chyung-Ru] Univ Chicago, Dept Pathol, Chicago, IL USA	University of Michigan System; University of Michigan; University of Chicago	Zheng, XC (corresponding author), Univ Michigan, Dept Surg, Ctr Comprehens Canc, Program Mol Mech Dis, Ann Arbor, MI 48109 USA.	panz@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	NIH [AI 51342]; Department of Defense [DAMD17-03-1-0013, W81XWH-07-1-0169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043407, R01AI051342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by an NIH grant (AI 51342 to YL) and grants from the Department of Defense (DAMD17-03-1-0013 and W81XWH-07-1-0169 to PZ).	Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Eberl G, 1999, J IMMUNOL, V162, P6410; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Gao JX, 2002, J EXP MED, V195, P959, DOI 10.1084/jem.20011948; GAO JX, 2003, BLOOD; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; ISSACHERGUI B, 1988, DIABETOLOGIA, V31, P675, DOI 10.1007/BF00278751; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Louis H, 2002, GASTROENTEROLOGY, V122, P2001, DOI 10.1053/gast.2002.33620; MacDonald HR, 2002, CURR OPIN IMMUNOL, V14, P250, DOI 10.1016/S0952-7915(02)00329-1; MacDonald HR, 2002, SCIENCE, V296, P481, DOI 10.1126/science.1071492; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; NORTON SD, 1992, J IMMUNOL, V149, P1556; Pellicci DG, 2003, EUR J IMMUNOL, V33, P1816, DOI 10.1002/eji.200323894; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Swann J, 2004, IMMUNOL CELL BIOL, V82, P323, DOI 10.1111/j.1440-1711.2004.01254.x; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Van Dommelen SLH, 2004, IMMUNOL CELL BIOL, V82, P332, DOI 10.1111/j.0818-9641.2004.01261.x; Van Kaer L, 2004, IMMUNOL CELL BIOL, V82, P315, DOI 10.1111/j.0818-9641.2004.01252.x; Zheng XC, 2004, J IMMUNOL, V173, P2253, DOI 10.4049/jimmunol.173.4.2253	50	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2703	10.1371/journal.pone.0002703	http://dx.doi.org/10.1371/journal.pone.0002703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628995	gold, Green Submitted, Green Published			2022-12-25	WOS:000264057200046
J	Chodanowski, P; Grosdidier, A; Feytmans, E; Michielin, O				Chodanowski, Pierre; Grosdidier, Aurelien; Feytmans, Ernest; Michielin, Olivier			Local Alignment Refinement Using Structural Assessment	PLOS ONE			English	Article							PROTEIN-STRUCTURE; FREE-ENERGIES; MODELS; HOMOLOGY; ERRORS; DISCRIMINATION; CLASSIFICATION; RECOGNITION; PROGRESS	Homology modeling is the most commonly used technique to build a three-dimensional model for a protein sequence. It heavily relies on the quality of the sequence alignment between the protein to model and related proteins with a known three dimensional structure. Alignment quality can be assessed according to the physico-chemical properties of the three dimensional models it produces. In this work, we introduce fifteen predictors designed to evaluate the properties of the models obtained for various alignments. They consist of an energy value obtained from different force fields (CHARMM, ProsaII or ANOLEA) computed on residue selected around misaligned regions. These predictors were evaluated on ten challenging test cases. For each target, all possible ungapped alignments are generated and their corresponding models are computed and evaluated. The best predictor, retrieving the structural alignment for 9 out of 10 test cases, is based on the ANOLEA atomistic mean force potential and takes into account residues around misaligned secondary structure elements. The performance of the other predictors is significantly lower. This work shows that substantial improvement in local alignments can be obtained by careful assessment of the local structure of the resulting models.	[Chodanowski, Pierre; Grosdidier, Aurelien; Feytmans, Ernest; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Grosdidier, Aurelien; Michielin, Olivier] Ludwig Inst Canc Res, Epalinges, Switzerland; [Michielin, Olivier] CHU Vaudois, Ctr Pluridisciplin Oncol, Lausanne, Switzerland	Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chodanowski, P (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	Olivier.Michielin@isb-sib.ch	Michielin, Olivier/ABE-7924-2020	Grosdidier, Aurelien/0000-0001-9873-3461	Swiss National Science Foundation [3232B0-103172, 3200B0-103173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the Swiss Institute of Bioinformatics and particularly Hamid Hussain-Khan for providing us assistance in exploiting the computational facilities of the Cluster versus Cancer Project (www.clusterVScancer.org) of the Lausanne University. We thank Vincent Zoete and Theres Fagerberg for interesting comments and careful reading of the manuscript. This work was supported by SCORE funds (3232B0-103172 and 3200B0-103173 to O. M.) from the Swiss National Science Foundation.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fleming PJ, 2006, PROTEIN SCI, V15, P1829, DOI 10.1110/ps.062305106; Gatchell DW, 2000, PROTEINS, V41, P518, DOI 10.1002/1097-0134(20001201)41:4<518::AID-PROT90>3.3.CO;2-Y; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARTIRENOM MA, 2003, MODELING PROTEIN STR; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; MELO F, UNPUB; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; POTTS JT, 1963, J BIOL CHEM, V238, P2593; Qiu J, 2006, PROTEINS, V62, P881, DOI 10.1002/prot.20854; READ RJ, 1984, BIOCHEMISTRY-US, V23, P6570, DOI 10.1021/bi00321a045; REIHER WE, 1985, THESIS HARVARD U CAM; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Sanchez R, 2000, METH MOL B, V143, P97; SAQI MAS, 1992, PROTEIN ENG, V5, P305, DOI 10.1093/protein/5.4.305; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; TANIUCHI H, 1971, J BIOL CHEM, V246, P2291; Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530; Venclovas C, 2003, PROTEINS, V53, P380, DOI 10.1002/prot.10591; Vorobjev YN, 2001, PROTEIN SCI, V10, P2498, DOI 10.1110/ps.ps.15501; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; WYCKOFF HW, 1970, J BIOL CHEM, V245, P305	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2645	10.1371/journal.pone.0002645	http://dx.doi.org/10.1371/journal.pone.0002645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612410	gold, Green Published, Green Submitted			2022-12-25	WOS:000264065800047
J	Wilson, KD; Li, ZJ; Wagner, R; Yue, P; Tsao, P; Nestorova, G; Huang, M; Hirschberg, DL; Yock, PG; Quertermous, T; Wu, JC				Wilson, Kitchener D.; Li, Zongjin; Wagner, Roger; Yue, Patrick; Tsao, Phillip; Nestorova, Gergana; Huang, Mei; Hirschberg, David L.; Yock, Paul G.; Quertermous, Thomas; Wu, Joseph C.			Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality	PLOS ONE			English	Article								Background: Recently, the type 2 diabetesmedication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling and imaging studies of a murine model of type 2 diabetes, the C57BL/KLS-lepr(db)/lepr(db) (db/db) mouse. Methods and Findings: We compared cardiac gene expression profiles from three groups: untreated db/db mice, db/db mice after rosiglitazone treatment, and non-diabetic db/+ mice. Prior to sacrifice, we also performed cardiac magnetic resonance (CMR) and echocardiography. As expected, overall the db/db gene expression signature was markedly different from control, but to our surprise was not significantly reversed with rosiglitazone. In particular, we have uncovered a number of rosiglitazone modulated genes and pathways that may play a role in the pathophysiology of the increase in cardiac mortality as seen in several recent meta-analyses. Specifically, the cumulative upregulation of (1) a matrix metalloproteinase gene that has previously been implicated in plaque rupture, (2) potassium channel genes involved in membrane potential maintenance and action potential generation, and (3) sphingolipid and ceramide metabolism-related genes, together give cause for concern over rosiglitazone's safety. Lastly, in vivo imaging studies revealed minimal differences between rosiglitazone-treated and untreated db/db mouse hearts, indicating that rosiglitazone's effects on gene expression in the heart do not immediately turn into detectable gross functional changes. Conclusions: This study maps the genomic expression patterns in the hearts of the db/db murine model of diabetes and illustrates the impact of rosiglitazone on these patterns. The db/db gene expression signature was markedly different from control, and was not reversed with rosiglitazone. A smaller number of unique and interesting changes in gene expression were noted with rosiglitazone treatment. Further study of these genes and molecular pathways will provide important insights into the cardiac decompensation associated with both diabetes and rosiglitazone treatment.	[Wilson, Kitchener D.; Li, Zongjin; Huang, Mei; Wu, Joseph C.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Wagner, Roger; Yue, Patrick; Tsao, Phillip; Yock, Paul G.; Quertermous, Thomas; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA USA; [Wilson, Kitchener D.; Yock, Paul G.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA; [Nestorova, Gergana; Hirschberg, David L.] Stanford Univ, Sch Med, Human Immune Monitoring Ctr, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Wilson, KD (corresponding author), Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Li, Zongjin/A-1115-2014; Li, Zongjin/G-3118-2010; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Li, Zongjin/0000-0002-4603-3743; Li, Zongjin/0000-0002-4603-3743; Quertermous, Thomas/0000-0002-7645-9067; Wu, Joseph/0000-0002-6068-8041; Nestorova, Gergana/0000-0002-9960-9435	Burroughs Wellcome Foundation Career Award in Medical Scientist; Stanford University Bio-X Graduate Student Fellowship; Society of Nuclear Medicine Student Fellowship	Burroughs Wellcome Foundation Career Award in Medical Scientist(Burroughs Wellcome Fund); Stanford University Bio-X Graduate Student Fellowship; Society of Nuclear Medicine Student Fellowship	Funding for this work was supplied in part by research grants from Burroughs Wellcome Foundation Career Award in Medical Scientist (JCW). KDW is a recipient of a Stanford University Bio-X Graduate Student Fellowship and Society of Nuclear Medicine Student Fellowship. This study was designed by JCW in collaboration with his academic colleagues. This investigation did not have separate industry funding. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Albrektsen T, 2002, DIABETES, V51, P1042, DOI 10.2337/diabetes.51.4.1042; Baranowski M, 2007, PROSTAG OTH LIPID M, V83, P99, DOI 10.1016/j.prostaglandins.2006.10.004; Bauters C, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-1; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Beyzade S, 2003, J AM COLL CARDIOL, V41, P2130, DOI 10.1016/S0735-1097(03)00482-0; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Carley AN, 2004, AM J PHYSIOL-ENDOC M, V286, pE449, DOI 10.1152/ajpendo.00329.2003; Chatterjee S, 2006, CURR OPIN INVEST DR, V7, P219; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Hug C, 2005, CURR OPIN PHARMACOL, V5, P129, DOI 10.1016/j.coph.2005.01.001; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Kelly DP, 2003, CIRC RES, V92, P482, DOI 10.1161/01.RES.0000064382.46274.95; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Levade T, 2001, CIRC RES, V89, P957, DOI 10.1161/hh2301.100350; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu LS, 1998, ENDOCRINOLOGY, V139, P4531, DOI 10.1210/en.139.11.4531; Makino H, 2006, DIABETES, V55, P2747, DOI 10.2337/db05-1683; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Natarajan R, 2008, J CARDIOVASC PHARM, V51, P178, DOI 10.1097/FJC.0b013e31815f248d; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Parton LE, 2004, AM J PHYSIOL-ENDOC M, V287, pE390, DOI 10.1152/ajpendo.00016.2004; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Shimoni Y, 2001, J PHYSIOL-LONDON, V537, P83, DOI 10.1111/j.1469-7793.2001.0083k.x; Sidell RJ, 2002, DIABETES, V51, P1110, DOI 10.2337/diabetes.51.4.1110; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	45	45	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2609	10.1371/journal.pone.0002609	http://dx.doi.org/10.1371/journal.pone.0002609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648539	Green Submitted, Green Published, gold			2022-12-25	WOS:000264065800015
J	Gu, P; Reid, JG; Gao, XL; Shaw, CA; Creighton, C; Tran, PL; Zhou, XC; Drabek, RB; Steffen, DL; Hoang, DM; Weiss, MK; Naghavi, AO; El-Daye, J; Khan, MF; Legge, GB; Wheeler, DA; Gibbs, RA; Miller, JN; Cooney, AJ; Gunaratne, PH				Gu, Peili; Reid, Jeffrey G.; Gao, Xiaolian; Shaw, Chad A.; Creighton, Chad; Tran, Peter L.; Zhou, Xiaochuan; Drabek, Rafal B.; Steffen, David L.; Hoang, David M.; Weiss, Michelle K.; Naghavi, Arash O.; El-Daye, Jad; Khan, Mahjabeen F.; Legge, Glen B.; Wheeler, David A.; Gibbs, Richard A.; Miller, Jonathan N.; Cooney, Austin J.; Gunaratne, Preethi H.			Novel MicroRNA Candidates and miRNA-mRNA Pairs in Embryonic Stem (ES) Cells	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; DEVELOPMENTAL REGULATORS; SELF-RENEWAL; MOUSE; PLURIPOTENCY; EXPRESSION; DISCOVERY; GENES; DICER; SPECIFICATION	Background: MicroRNAs (miRNAs: a class of short non-coding RNAs) are emerging as important agents of post transcriptional gene regulation and integral components of gene networks. MiRNAs have been strongly linked to stem cells, which have a remarkable dual role in development. They can either continuously replenish themselves (self-renewal), or differentiate into cells that execute a limited number of specific actions (pluripotence). Methodology/Principal Findings: In order to identify novel miRNAs from narrow windows of development we carried out an in silico search for micro-conserved elements (MCE) in adult tissue progenitor transcript sequences. A plethora of previously unknown miRNA candidates were revealed including 545 small RNAs that are enriched in embryonic stem (ES) cells over adult cells. Approximately 20% of these novel candidates are down-regulated in ES (Dicer(-/-)) ES cells that are impaired in miRNA maturation. The ES-enriched miRNA candidates exhibit distinct and opposite expression trends from mmu-mirs (an abundant class in adult tissues) during retinoic acid (RA)-induced ES cell differentiation. Significant perturbation of trends is found in both miRNAs and novel candidates in ES (GCNF(-/-)) cells, which display loss of repression of pluripotence genes upon differentiation. Conclusion/Significance: Combining expression profile information with miRNA target prediction, we identified miRNA-mRNA pairs that correlate with ES cell pluripotence and differentiation. Perturbation of these pairs in the ES (GCNF(-/-)) mutant suggests a role for miRNAs in the core regulatory networks underlying ES cell self-renewal, pluripotence and differentiation.	[Gu, Peili; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Gao, Xiaolian; Tran, Peter L.; Drabek, Rafal B.; Hoang, David M.; Weiss, Michelle K.; Naghavi, Arash O.; El-Daye, Jad; Khan, Mahjabeen F.; Legge, Glen B.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Reid, Jeffrey G.; Gao, Xiaolian] Univ Houston, Dept Chem, Houston, TX USA; [Miller, Jonathan N.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX USA; [Reid, Jeffrey G.; Drabek, Rafal B.; Wheeler, David A.; Gibbs, Richard A.; Miller, Jonathan N.; Gunaratne, Preethi H.] Baylor Coll Med, Dept Human Genome Sequencing Ctr, Houston, TX USA; [Shaw, Chad A.; Steffen, David L.] Baylor Colle Med, Dept Mol & Human Genet, Houston, TX USA; [Steffen, David L.] Baylor Coll Med, Bioinformat Res Ctr, Houston, TX USA; [Creighton, Chad] Baylor Coll Med, Duncan Canc Ctr, Houston, TX USA; [Reid, Jeffrey G.] WM Keck Ctr Interdisciplin Biosci Training, Houston, TX USA; [Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Gu, Peili] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Gu, P (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA.	phgunaratne@uh.edu	Naghavi, Arash/AHB-4226-2022; Wheeler, David A/M-9740-2018; Miller, Jonathan/M-4389-2014; Steffen, David L/B-2751-2013	Wheeler, David A/0000-0002-9056-6299; Miller, Jonathan/0000-0003-2190-6824; Steffen, David L/0000-0001-9363-2629; Shaw, Chad/0000-0001-7267-5398	NIDDK/SCGAP [RFA-DK-02-027]; The Keck Center for Interdisciplinary Bioscience Training; NIH NIDDK [73524]; NIH/NHGRI [2 U54 HG003273-04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NIDDK/SCGAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); The Keck Center for Interdisciplinary Bioscience Training; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from NIDDK/SCGAP RFA-DK-02-027 to P.H.G, R.A.G. and D.L.S, The Keck Center for Interdisciplinary Bioscience Training to J.G.R, NIH NIDDK 73524 grant to A.J.C. and NIH/NHGRI 2 U54 HG003273-04 grant to D. A. W. and R.A.G.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P21021, DOI 10.1073/pnas.0711071105; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; JOHN B, 2005, MIRANDA ALGORITHM HU; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Matsui Y, 2005, BIOESSAYS, V27, P136, DOI 10.1002/bies.20178; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Salerno W, 2006, P NATL ACAD SCI USA, V103, P13121, DOI 10.1073/pnas.0605735103; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; Tran T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl173; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; ZHU Q, METHODS MOL IN PRESS	55	43	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2548	10.1371/journal.pone.0002548	http://dx.doi.org/10.1371/journal.pone.0002548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648548	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200017
J	Keil, MS; Lapedriza, A; Masip, D; Vitria, J				Keil, Matthias S.; Lapedriza, Agata; Masip, David; Vitria, Jordi			Preferred Spatial Frequencies for Human Face Processing Are Associated with Optimal Class Discrimination in the Machine	PLOS ONE			English	Article							NATURAL SCENES; RECOGNITION; RETINA; EXPLANATION; INFORMATION; STATISTICS; BRIGHTNESS; PERCEPTION; IMAGES; COST	Psychophysical studies suggest that humans preferentially use a narrow band of low spatial frequencies for face recognition. Here we asked whether artificial face recognition systems have an improved recognition performance at the same spatial frequencies as humans. To this end, we estimated recognition performance over a large database of face images by computing three discriminability measures: Fisher Linear Discriminant Analysis, Non-Parametric Discriminant Analysis, and Mutual Information. In order to address frequency dependence, discriminabilities were measured as a function of (filtered) image size. All three measures revealed a maximum at the same image sizes, where the spatial frequency content corresponds to the psychophysical found frequencies. Our results therefore support the notion that the critical band of spatial frequencies for face recognition in humans and machines follows from inherent properties of face images, and that the use of these frequencies is associated with optimal face recognition performance.	[Keil, Matthias S.] Univ Barcelona, Basic Psychol Dept, Fac Psychol, Barcelona, Spain; [Lapedriza, Agata] Autonomous Univ Barcelona, Comp Vision Ctr, Comp Sci Dept, Bellaterra, Spain; [Masip, David] Univ Oberta Catalunya, Dept Comp Sci, Barcelona, Spain; [Vitria, Jordi] Univ Barcelona, Dept Appl Math & Anal, Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona; Centre de Visio per Computador (CVC); UOC Universitat Oberta de Catalunya; University of Barcelona	Keil, MS (corresponding author), Univ Barcelona, Basic Psychol Dept, Fac Psychol, Barcelona, Spain.	mats@cvc.uab.es	Vitria, Jordi/C-7072-2008; Vitrià, Jordi/AAF-9668-2020; Masip, David/B-1709-2009	Vitria, Jordi/0000-0003-1484-539X; Vitrià, Jordi/0000-0003-1484-539X; Lapedriza, Agata/0000-0002-5248-0443; Masip Rodo, David/0000-0001-7898-1847	Spanish Government; MCyT [SEJ2006-15095]; MEC [TIC2006-15308-C02-01]; CONSOLIDER-INGENIO 2010 [CSD2007-00018]	Spanish Government(Spanish GovernmentEuropean Commission); MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEC(European Commission); CONSOLIDER-INGENIO 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MSK was partially supported by a Juan de la Cierva post-doctoral contract from the Spanish Government. Further support was granted by the MCyT grant SEJ2006-15095, MEC grant TIC2006-15308-C02-01 and CONSOLIDER-INGENIO 2010 (CSD2007-00018).	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; Duda R.O., 2000, PATTERN CLASSIFICATI; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; FUKUNAGA K, 1983, IEEE T PATTERN ANAL, V5, P671, DOI 10.1109/TPAMI.1983.4767461; FUKUNAGA K, 1990, INTRO STAT PATTERN; GUORONGXUAN, 2005, IEEE 7 WORKSH MULT S, P1; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; Keil MS, 2008, P ROY SOC B-BIOL SCI, V275, P2095, DOI 10.1098/rspb.2008.0486; KEINOSUKEFUKUNA, 1995, ELECT COMPUTER ENG T; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; LINSKER R, 1988, IEEE COMPUT, V21, P105, DOI DOI 10.1109/2.36; Lotto RB, 2000, P NATL ACAD SCI USA, V97, P12834, DOI 10.1073/pnas.210369597; Lotto RB, 1999, P NATL ACAD SCI USA, V96, P5245, DOI 10.1073/pnas.96.9.5245; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Nundy S, 2002, P NATL ACAD SCI USA, V99, P14482, DOI 10.1073/pnas.172520399; Ojanpaa H, 2003, VISION RES, V43, P2505, DOI 10.1016/S0042-6989(03)00459-0; PELI E, 1994, J OPT SOC AM A, V11, P1929, DOI 10.1364/JOSAA.11.001929; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Torkkola K., 2003, Journal of Machine Learning Research, V3, P1415, DOI 10.1162/153244303322753742; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71	36	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2590	10.1371/journal.pone.0002590	http://dx.doi.org/10.1371/journal.pone.0002590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596932	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200049
J	Loarie, SR; Carter, BE; Hayhoe, K; McMahon, S; Moe, R; Knight, CA; Ackerly, DD				Loarie, Scott R.; Carter, Benjamin E.; Hayhoe, Katharine; McMahon, Sean; Moe, Richard; Knight, Charles A.; Ackerly, David D.			Climate Change and the Future of California's Endemic Flora	PLOS ONE			English	Article							BIOCLIMATE ENVELOPE MODELS; SPECIES DISTRIBUTIONS; EXTINCTION RISK; BIODIVERSITY; IMPACTS; RANGE; DIVERSITY; HABITAT; PLANTS; UNCERTAINTY	The flora of California, a global biodiversity hotspot, includes 2387 endemic plant taxa. With anticipated climate change, we project that up to 66% will experience >80% reductions in range size within a century. These results are comparable with other studies of fewer species or just samples of a region's endemics. Projected reductions depend on the magnitude of future emissions and on the ability of species to disperse from their current locations. California's varied terrain could cause species to move in very different directions, breaking up present-day floras. However, our projections also identify regions where species undergoing severe range reductions may persist. Protecting these potential future refugia and facilitating species dispersal will be essential to maintain biodiversity in the face of climate change.	[Loarie, Scott R.; McMahon, Sean] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA; [Carter, Benjamin E.; Knight, Charles A.] Calif Polytechnic State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA USA; [Hayhoe, Katharine] Texas Tech Univ, Dept Geosci, Lubbock, TX USA; [Carter, Benjamin E.; Moe, Richard; Ackerly, David D.] Univ Calif Berkeley, Jepson Herbarium, Berkeley, CA USA; [Carter, Benjamin E.; Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA USA	Duke University; California State University System; California Polytechnic State University San Luis Obispo; Texas Tech University System; Texas Tech University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Loarie, SR (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA.	scott.loarie@duke.edu	Ackerly, David/A-1247-2009	Ackerly, David/0000-0002-1847-7398				Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Barbour M, 1977, TERRESTRIAL VEGETATI; Bomhard B, 2005, GLOBAL CHANGE BIOL, V11, P1452, DOI 10.1111/j.1365-2486.2005.00997.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Chapin FS, 1997, CLIMATIC CHANGE, V35, P449, DOI 10.1023/A:1005337705025; CSUTI B, 1996, GAP ANAL LANDSCAPE A, P135; Daly C, 2000, ECOL APPL, V10, P449, DOI 10.1890/1051-0761(2000)010[0449:DSOTGI]2.0.CO;2; Dettinger M, 2005, SAN FRANCISCO ESTUAR, V3; Dole KP, 2003, GLOBAL PLANET CHANGE, V36, P137, DOI 10.1016/S0921-8181(02)00179-0; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gelman A., 2007, DATA ANAL USING REGR; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halpin PN, 1997, ECOL APPL, V7, P828; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harrison S, 2006, ECOL MONOGR, V76, P41, DOI 10.1890/05-0910; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Iverson LR, 2002, FOREST ECOL MANAG, V155, P205, DOI 10.1016/S0378-1127(01)00559-X; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; *OSU HERB, 2004, CORV OR STAT U ONL H; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Raven P.H., 1978, ORIGIN RELATIONSHIPS; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; SCHNEIDER SH, 2001, WILDLIFE RESPONSES C; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; STEBBINS GL, 1965, ECOL MONOGR, V35, P1, DOI 10.2307/1942216; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Wiggins I. L., 1980, Flora of Baja California.; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	65	310	322	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2502	10.1371/journal.pone.0002502	http://dx.doi.org/10.1371/journal.pone.0002502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18648541	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288000024
J	Bezin, S; Charpentier, G; Lee, HC; Baux, G; Fossier, P; Cancela, JM				Bezin, Stephanie; Charpentier, Gilles; Lee, Hon Cheung; Baux, Gerard; Fossier, Philippe; Cancela, Jose-Manuel			Regulation of nuclear Ca2+ signaling by translocation of the Ca2+ messenger synthesizing enzyme ADP-ribosyl cyclase during neuronal depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM-MOBILIZING METABOLITE; PANCREATIC-ACINAR-CELLS; ELEMENT-BINDING PROTEIN; INOSITOL TRISPHOSPHATE; NUCLEOPLASMIC RETICULUM; RYANODINE RECEPTORS; GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; ENDOPLASMIC-RETICULUM	In neurons, voltage-gated Ca2+ channels and nuclear Ca2+ signaling play important roles, such as in the regulation of gene expression. However, the link between electrical activity and biochemical cascade activation involved in the generation of the nuclear Ca2+ signaling is poorly understood. Here we show that depolarization of Aplysia neurons induces the translocation of ADP-ribosyl cyclase, a Ca2+ messenger synthesizing enzyme, from the cytosol into the nucleus. The translocation is dependent on Ca2+ influx mainly through the voltage-dependent L-type Ca2+ channels. We report also that specific nucleoplasmic Ca2+ signals can be induced by three different calcium messengers, cyclic ADP-ribose, nicotinic acid adenine dinucleotide phosphate (NAADP), both produced by the ADP-ribosyl cyclase, and inositol 1,4,5-trisphosphate (IP3). Moreover, our pharmacological data show that NAADP acts on its own receptor, which cooperates with the IP3 and the ryanodine receptors to generate nucleoplasmic Ca2+ oscillations. We propose a new model where voltage-dependent L-type Ca2+ channel-induced nuclear translocation of the cytosolic cyclase is a crucial step in the fine tuning of nuclear Ca2+ signals in neurons.	[Bezin, Stephanie; Charpentier, Gilles; Baux, Gerard; Fossier, Philippe; Cancela, Jose-Manuel] CNRS, Neurobiol Cellulaire & Mol Lab, UPR 9040, F-91198 Gif Sur Yvette, France; [Charpentier, Gilles] Univ Bordeaux 1, Lab DMPFCS, IECB, F-33607 Pessac, France; [Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; University of Hong Kong	Cancela, JM (corresponding author), CNRS, Neurobiol Cellulaire & Mol Lab, UPR 9040, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	jose.cancela@nbcm.cnrs-gif.fr	Lee, Hon Cheung/C-4329-2009	Cancela, Jose-Manuel/0000-0002-6234-1500	Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer	Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer	The work was supported by grants from the Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer (to J.-M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Albrieux M, 1998, J BIOL CHEM, V273, P14566, DOI 10.1074/jbc.273.23.14566; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Antonov I, 2003, NEURON, V37, P135, DOI 10.1016/S0896-6273(02)01129-7; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezin S, 2008, PFLUG ARCH EUR J PHY, V456, P581, DOI 10.1007/s00424-007-0435-8; Bezin S, 2006, J PHYSIOLOGY-PARIS, V99, P111, DOI 10.1016/j.jphysparis.2005.12.007; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Cancela JM, 2003, PFLUG ARCH EUR J PHY, V446, P322, DOI 10.1007/s00424-003-1035-x; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Cardenas C, 2005, J CELL SCI, V118, P3131, DOI 10.1242/jcs.02446; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chamero P, 2002, J BIOL CHEM, V277, P50226, DOI 10.1074/jbc.C200522200; Chawla S, 2002, EUR J PHARMACOL, V447, P131, DOI 10.1016/S0014-2999(02)01837-X; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Fossier P, 1999, TRENDS NEUROSCI, V22, P161, DOI 10.1016/S0166-2236(98)01307-1; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin I, 2003, J NEUROSCI, V23, P7288; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Khoo KM, 2000, J BIOL CHEM, V275, P24807, DOI 10.1074/jbc.M908231199; Knot HJ, 2005, MOL INTERV, V5, P112, DOI 10.1124/mi.5.2.8; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2003, CURR BIOL, V13, pR186, DOI 10.1016/S0960-9822(03)00120-9; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; Marius P, 2006, CELL CALCIUM, V39, P65, DOI 10.1016/j.ceca.2005.09.010; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Santella L, 1997, CELL CALCIUM, V22, P11, DOI 10.1016/S0143-4160(97)90085-3; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Walseth TF, 2005, P NATL ACAD SCI USA, V102, P14941, DOI 10.1073/pnas.0507258102; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200	80	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27859	27870		10.1074/jbc.M804701200	http://dx.doi.org/10.1074/jbc.M804701200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18632662	hybrid			2022-12-25	WOS:000259719200057
J	Fainaru, O; Adini, I; Benny, O; Bazinet, L; Pravda, E; D'Amato, R; Folkman, J				Fainaru, Ofer; Adini, Irit; Benny, Ofra; Bazinet, Lauren; Pravda, Elke; D'Amato, Robert; Folkman, Judah			Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability	FASEB JOURNAL			English	Article						pulmonary edema; angiogenesis; delayed-type hypersensitivity	GROWTH-FACTOR; INTERENDOTHELIAL JUNCTIONS; PERMEABILITY FACTOR; MOLECULAR-BASIS; ANGIOGENESIS; MICE; INTERLEUKIN-2; IMMUNOTHERAPY; SENSITIZATION; MECHANISM	The endothelium lining blood vessels serves as a barrier against vascular hyperpermeability, and its maintenance is critical to organ health. Inflammatory mediators evoke tissue edema by disrupting the expression of membrane junctional proteins, which mediate binding between endothelial cell membranes. Endothelial cell-cell junctions form a diffusion barrier between the intravascular and interstitial space. To prevent the morbidity and mortality caused by exaggerated vascular permeability associated with pathological states (e.g., inflammatory and hypersensitivity disorders, pulmonary edema, traumatic lung injury, cerebral edema resulting from stroke, and others), it is important to develop therapeutic approaches to stabilize these interendothelial junctions. Vascular endothelial growth factor (VEGF), a potent proangiogenic cytokine, was first described as vascular permeability factor (VPF). Doxycycline, a tetracycline derivative, has been shown to inhibit angiogenesis in both humans and animal models. We now report that oral doxycycline prevents VPF/VEGF-induced vascular permeability, interleukin-2-induced pulmonary edema, and delayed-type hypersensitivity (DTH) in mice. Remarkably, doxycycline also inhibits tumor growth and tumor-associated vascular hyperpermeability. Finally, we show that doxycycline targets the adherens junction in vascular endothelial cells by inducing the total amount of VE-cadherin expression while decreasing the degree of its phosphorylation. The potential of doxycyline as a therapeutic inhibitor of vascular hyperpermeability in human clinical conditions is promising and warrants further studies.	[Fainaru, Ofer; Benny, Ofra; Bazinet, Lauren; Pravda, Elke; D'Amato, Robert; Folkman, Judah] Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program,Dept Surg, Boston, MA 02115 USA; [Adini, Irit; D'Amato, Robert] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Fainaru, O (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Vasc Biol Program,Dept Surg, 300 Longnwood Ave, Boston, MA 02115 USA.	ofer.fainaru@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021		Fulbright and Rothschild Foundations; European Molecular Biology Organization (EMBO) Fellowship; Department of Defense award [W81XWH-05-1-0115]	Fulbright and Rothschild Foundations; European Molecular Biology Organization (EMBO) Fellowship(European Molecular Biology Organization (EMBO)); Department of Defense award(United States Department of Defense)	This research was supported by the Fulbright and Rothschild Foundations and the European Molecular Biology Organization (EMBO) Fellowship (O.F.), and Department of Defense award W81XWH-05-1-0115) (to J.F). We thank Dr. Harold Dvorak for helpful discussions and pathological slide analysis. Dr. Donald Ingber for critically reviewing the manuscript, Kristin Johnson for photography and graphic art, and Steven A. Rosenberg for the generous gift of IL-2.	ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; BERTHIAUME Y, 1995, AM J RESP CRIT CARE, V152, P329, DOI 10.1164/ajrccm.152.1.7599842; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P., 2000, ANN NY ACAD SCI, V902, P62; Chen B, 2006, CLIN CANCER RES, V12, P917, DOI 10.1158/1078-0432.CCR-05-1673; Claffey KP, 1996, CANCER RES, V56, P172; DVORAK AM, 1984, CLIN IMMUNOL IMMUNOP, V32, P142, DOI 10.1016/0090-1229(84)90116-8; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Esser S, 1998, J CELL SCI, V111, P1853; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GAD SC, 1986, TOXICOL APPL PHARM, V84, P93, DOI 10.1016/0041-008X(86)90419-9; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GILBERTSONBEADLING S, 1995, CANCER CHEMOTH PHARM, V36, P418, DOI 10.1007/BF00686191; Golub L M, 1998, Adv Dent Res, V12, P12; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Han XN, 2004, AM J PHYSIOL-LUNG C, V286, pL259, DOI 10.1152/ajplung.00187.2003; Hoyt JC, 2006, J IMMUNOL, V176, P567, DOI 10.4049/jimmunol.176.1.567; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Leach L, 2005, ADV MOL CEL, V35, P251, DOI 10.1016/S1569-2558(05)35009-0; Lim MJ, 2001, MICROVASC RES, V62, P366, DOI 10.1006/mvre.2001.2355; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; MIER JW, 1988, PATHOL IMMUNOPATH R, V7, P459, DOI 10.1159/000157075; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; ROSENBERG SA, 1986, ANNU REV IMMUNOL, V4, P681, DOI 10.1146/annurev.immunol.4.1.681; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; SUOMALAINEN K, 1992, ANTIMICROB AGENTS CH, V36, P227, DOI 10.1128/AAC.36.1.227; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Zhao XY, 2001, AM J PHYSIOL-LUNG C, V281, pL879, DOI 10.1152/ajplung.2001.281.4.L879	37	55	59	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3728	3735		10.1096/fj.08-110494	http://dx.doi.org/10.1096/fj.08-110494			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606869				2022-12-25	WOS:000259642600033
J	Klaavuniemi, T; Yamashiro, S; Ono, S				Klaavuniemi, Tuula; Yamashiro, Sawako; Ono, Shoichiro			Caenorhabditis elegans gelsolin-like protein 1 is a novel actin filament-severing protein with four gelsolin-like repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR/COFILIN PROTEINS; PLASMA-GELSOLIN; INTERACTING PROTEIN-1; BINDING PROTEIN; F-ACTIN; ESCHERICHIA-COLI; SKELETAL-MUSCLE; ATP-ACTIN; ADP-ACTIN; GENE	The gelsolin family of proteins is a major class of actin regulatory proteins that sever, cap, and nucleate actin filaments in a calcium-dependent manner and are involved in various cellular processes. Typically, gelsolin-related proteins have three or six repeats of gelsolin-like (G) domain, and each domain plays a distinct role in severing, capping, and nucleation. The Caenorhabditis elegans gelsolin-like protein-1 (gsnl-1) gene encodes an unconventional gelsolin-related protein with four G domains. Sequence alignment suggests that GSNL-1 lacks two G domains that are equivalent to fourth and fifth G domains of gelsolin. In vitro, GSNL-1 severed actin filaments and capped the barbed end in a calcium-dependent manner. However, unlike gelsolin, GSNL-1 remained bound to the side of F-actin with a submicromolar affinity and did not nucleate actin polymerization, although it bound to G-actin with high affinity. These results indicate that GSNL-1 is a novel member of the gelsolin family of actin regulatory proteins and provide new insight into functional diversity and evolution of gelsolin-related proteins.	[Klaavuniemi, Tuula; Yamashiro, Sawako; Ono, Shoichiro] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398; Yamashiro, Sawako/0000-0002-5980-0470	National Institutes of Health [R01 AR48615]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR48615. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Allen PG, 1996, J BIOL CHEM, V271, P4665; BROWN SS, 1982, J CELL BIOL, V93, P205, DOI 10.1083/jcb.93.1.205; BRYAN J, 1986, J CELL BIOL, V102, P1439, DOI 10.1083/jcb.102.4.1439; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CASELLA JF, 1987, J CELL BIOL, V105, P371, DOI 10.1083/jcb.105.1.371; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Deng H, 2007, GENETICS, V177, P847, DOI 10.1534/genetics.107.078964; DISSMANN E, 1994, EUR J CELL BIOL, V63, P336; DITSCH A, 1994, EUR J BIOCHEM, V224, P223, DOI 10.1111/j.1432-1033.1994.tb20015.x; DOI Y, 1984, J BIOL CHEM, V259, P1868; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fujita H, 1997, EUR J BIOCHEM, V248, P834, DOI 10.1111/j.1432-1033.1997.00834.x; Gloss A, 2003, MOL BIOL CELL, V14, P2716, DOI 10.1091/mbc.E02-12-0827; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; HARRIS HE, 1984, FEBS LETT, V177, P184, DOI 10.1016/0014-5793(84)81280-6; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawamoto S, 2002, FEBS LETT, V516, P234, DOI 10.1016/S0014-5793(02)02540-1; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; OHTSUKA Y, 1994, ZOOL SCI, V11, P407; Ohtsuka Y, 1998, BBA-PROTEIN STRUCT M, V1383, P219, DOI 10.1016/S0167-4838(97)00211-2; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; ONO S, 1994, J BIOL CHEM, V269, P15280; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PORTE F, 1986, EUR J BIOCHEM, V154, P87, DOI 10.1111/j.1432-1033.1986.tb09362.x; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Southwick FS, 2000, P NATL ACAD SCI USA, V97, P6936, DOI 10.1073/pnas.97.13.6936; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; Yamashiro S, 2007, J CELL SCI, V120, P3022, DOI 10.1242/jcs.013516; YIN HL, 1981, J BIOL CHEM, V256, P9693; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YIN HL, 1990, FEBS LETT, V264, P78, DOI 10.1016/0014-5793(90)80769-F	60	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26071	26080		10.1074/jbc.M803618200	http://dx.doi.org/10.1074/jbc.M803618200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640981	Green Published, hybrid			2022-12-25	WOS:000259200100035
J	Wang, JR; Lian, HQ; Zhao, Y; Kauss, MA; Spindel, S				Wang, Jianrong; Lian, Huiqin; Zhao, Ying; Kauss, Mara A.; Spindel, Samantha			Vitamin D3 induces autophagy of human myeloid leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTIC DIFFERENTIATION; BH3-LIKE DOMAIN; RETINOIC ACID; CANCER-CELLS; APOPTOSIS; DEATH; INDUCTION; BCL-2; PHOSPHORYLATION; MATURATION	Vitamin D3 causes potent suppression of various cancer cells; however, significant supraphysiological concentrations of this compound are required for antineoplastic effects. Current combinatorial therapies with vitamin D3 are restricted to differentiation effects. It remains uncertain if autophagy is involved in vitamin D3 inhibition on leukemia cells. Here we show that besides triggering differentiation and inhibiting apoptosis, which was previously known, vitamin D3 triggers autophagic death in human myeloid leukemia cells. Inhibiting differentiation does not efficiently diminish vitamin D3 suppression on leukemia cells. Vitamin D3 up-regulates Beclin1, which binds to class III phosphatidylinositol 3-kinase to trigger autophagy. Vitamin D3 phosphorylates Bad in its BH3 domain, resulting in disassociation of the apoptotic Bad-Bcl-xL complex and association of Bcl-xL with Beclin1 and ultimate suppression of apoptotic signaling. Knockdown of Beclin1 eliminates vitamin D3-induced autophagy and inhibits differentiation but activates apoptosis, suggesting that Beclin1 is required for both autophagy and differentiation, and autophagy cooperates with differentiation but excludes apoptosis, in which Beclin1 acts as an interface for these three different cascades. Moreover, additional up-regulation of autophagy, but not apoptosis, dramatically improves vitamin D3 inhibition on leukemia cells. These findings extend our understanding of the action of vitamin D3 in antineoplastic effects and the role of Beclin1 in regulating multiple cellular cascades and suggest a potentially promising strategy with a significantly better antileukemia effect.	[Wang, Jianrong; Lian, Huiqin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Wang, Jianrong; Lian, Huiqin] Treman Res Inst, Ithaca, NY 14850 USA; [Zhao, Ying; Kauss, Mara A.; Spindel, Samantha] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Wang, JR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jw99@cornell.edu			Unimed Foundation	Unimed Foundation	This work was supported in part by a grant from the Unimed Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; BEER TM, 2003, J CLIN ONCOL, V28, P8; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; BRACKMAN D, 1995, J LEUKOCYTE BIOL, V58, P547, DOI 10.1002/jlb.58.5.547; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Bursch W, 2000, J CELL SCI, V113, P1189; Capiati DA, 2004, J CELL BIOCHEM, V93, P384, DOI 10.1002/jcb.20165; Danilenko M, 2001, JNCI-J NATL CANCER I, V93, P1224, DOI 10.1093/jnci/93.16.1224; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Drenou B, 1999, J IMMUNOL, V163, P4115; ELSTNER E, 1994, BLOOD, V84, P1960; Flanagan L, 2003, J STEROID BIOCHEM, V84, P181, DOI 10.1016/S0960-0760(03)00028-1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guyton KZ, 2003, NUTR REV, V61, P227, DOI 10.1301/nr.2003.jul.227-238; Guzey M, 2002, MOL CANCER THER, V1, P667; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Iguchi T, 2005, INT J ONCOL, V27, P893; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; James SY, 1996, J STEROID BIOCHEM, V58, P395, DOI 10.1016/0960-0760(96)00048-9; Johnson CS, 2002, UROLOGY, V60, P123, DOI 10.1016/S0090-4295(02)01591-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Mathiasen IS, 1999, CANCER RES, V59, P4848; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; OBERG F, 1993, J IMMUNOL, V150, P3487; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Wagner N, 2003, EXP EYE RES, V77, P1, DOI 10.1016/s0014-4835(03)00108-8; WANG J, 2008, EUR J CELL IN PRESS; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YAN J, 2004, CANCER RES, V64, P370; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang YY, 2006, CELL CYCLE, V5, P447, DOI 10.4161/cc.5.4.2467; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	54	106	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25596	25605		10.1074/jbc.M801716200	http://dx.doi.org/10.1074/jbc.M801716200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628207	hybrid			2022-12-25	WOS:000259012700055
J	Hu, B; Kong, LL; Matthews, RT; Viapiano, MS				Hu, Bin; Kong, Leopold L.; Matthews, Russell T.; Viapiano, Mariano S.			The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED HYALURONAN-BINDING; CHONDROITIN SULFATE PROTEOGLYCANS; GROWTH-FACTOR RECEPTOR; INVASION IN-VIVO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MALIGNANT GLIOMAS; PG-M/VERSICAN; UP-REGULATION; BRAIN	The adult neural parenchyma contains a distinctive extracellular matrix that acts as a barrier to cell and neurite motility. Nonneural tumors that metastasize to the central nervous system almost never infiltrate it and instead displace the neural tissue as they grow. In contrast, invasive gliomas disrupt the extracellular matrix and disperse within the neural tissue. A major inhibitory component of the neural matrix is the lectican family of chondroitin sulfate proteoglycans, of which brevican is the most abundant member in the adult brain. Interestingly, brevican is also highly up-regulated in gliomas and promotes glioma dispersion by unknown mechanisms. Here we show that brevican secreted by glioma cells enhances cell adhesion and motility only after proteolytic cleavage. At the molecular level, brevican promotes epidermal growth factor receptor activation, increases the expression of cell adhesion molecules, and promotes the secretion of fibronectin and accumulation of fibronectin microfibrils on the cell surface. Moreover, the N-terminal cleavage product of brevican, but not the full-length protein, associates with fibronectin in cultured cells and in surgical samples of glioma. Taken together, our results provide the first evidence of the cellular and molecular mechanisms that may underlie the motility-promoting role of brevican in primary brain tumors. In addition, these results underscore the important functional implications of brevican processing in glioma progression.	[Hu, Bin; Viapiano, Mariano S.] Ohio State Univ, Ctr Mol Neurobiol, Ctr Med, Columbus, OH 43210 USA; [Viapiano, Mariano S.] Ohio State Univ, Dept Neurol Surg, Ctr Med, Columbus, OH 43210 USA; James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kong, Leopold L.] Yale Univ, Coll Med, Dept Neurobiol, New Haven, CT 06510 USA; [Matthews, Russell T.] SUNY Stony Brook, Sch Med, Dept Physiol & Neurosci, Syracuse, NY 13210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Viapiano, MS (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Ctr Med, 226B Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	viapiano.1@osu.edu	Viapiano, Mariano/AAE-5787-2019; Viapiano, Mariano/B-8095-2009; Hu, Bin/H-8804-2013	Viapiano, Mariano/0000-0002-8756-388X; Kong, Leopold/0000-0001-7456-1773	Accelerate Brain Cancer Cure Foundation; American Brain Tumor Association; Dardinger Center	Accelerate Brain Cancer Cure Foundation; American Brain Tumor Association; Dardinger Center	This work was supported by research grants from the Accelerate Brain Cancer Cure Foundation ( to R.T.M.), the American Brain Tumor Association ( Butler Family Foundation Fellowship to M. S. V. and Joel A. Gringras J. Fellowship to B. H.) and the Dardinger Center Fund for Neuro-Oncology Research at the Ohio State University Medical Center ( to M. S. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Barami Kaveh, 2006, Neurosurg Focus, V21, pE13; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bello L, 2003, NEUROSURGERY, V52, P177, DOI 10.1097/00006123-200301000-00023; Binder DK, 2002, J NEURO-ONCOL, V56, P149, DOI 10.1023/A:1014566604005; Boon K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-39; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; Heron PM, 2007, J NEUROSCI METH, V159, P203, DOI 10.1016/j.jneumeth.2006.07.013; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Iwamoto H, 1999, J LAB CLIN MED, V134, P83, DOI 10.1016/S0022-2143(99)90057-4; Jaworski DM, 2000, J NEUROSCI RES, V61, P396, DOI 10.1002/1097-4547(20000815)61:4<396::AID-JNR6>3.0.CO;2-S; Jaworski DM, 1996, CANCER RES, V56, P2293; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mercuri FA, 2000, J BIOL CHEM, V275, P33038, DOI 10.1074/jbc.275.42.33038; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; NAKAMURA M, 1994, J CELL PHYSIOL, V159, P415, DOI 10.1002/jcp.1041590305; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; Nutt CL, 2001, NEUROSCIENTIST, V7, P113, DOI 10.1177/107385840100700206; Nutt CL, 2001, CANCER RES, V61, P7056; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Pearlman A L, 1996, Prog Brain Res, V108, P117; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pilkington GJ, 1997, ANTICANCER RES, V17, P4103; Properzi F, 2004, NEWS PHYSIOL SCI, V19, P33, DOI 10.1152/nips.01449.2003; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Subramanian A, 2002, LANCET ONCOL, V3, P498, DOI 10.1016/S1470-2045(02)00819-7; Tatenhorst L, 2005, BRAIN PATHOL, V15, P46; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TORP SH, 1995, J CLIN PATHOL-CL MOL, V48, pM191; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; Zhang H, 1998, J NEUROSCI, V18, P2370; Zhang J, 2005, J PATHOL, V207, P402, DOI 10.1002/path.1846; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	71	67	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24848	24859		10.1074/jbc.M801433200	http://dx.doi.org/10.1074/jbc.M801433200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611854	Green Published, hybrid			2022-12-25	WOS:000258820000051
J	Rallabhandi, P; Nhu, QM; Toshchakov, VY; Piao, W; Medvedev, AE; Hollenberg, MD; Fasano, A; Vogel, SN				Rallabhandi, Prasad; Nhu, Quan M.; Toshchakov, Vladimir Y.; Piao, Wenji; Medvedev, Andrei E.; Hollenberg, Morley D.; Fasano, Alessio; Vogel, Stefanie N.			Analysis of proteinase-activated receptor 2 and TLR4 signal transduction - A novel paradigm for receptor cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-ACTIVATED RECEPTORS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; LUNG EPITHELIAL-CELLS; INFLAMMATORY RESPONSES; ENDOGENOUS LIGANDS; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; INNATE IMMUNITY; MAJOR ROLE	Proteinase-activated receptor 2 (PAR(2)), a seven-transmembrane G protein-coupled receptor, is activated at inflammatory sites by proteolytic cleavage of its extracellular N terminus by trypsin-like enzymes, exposing a tethered, receptor-activating ligand. Synthetic agonist peptides (AP) that share the tethered ligand sequence also activate PAR(2), often measured by Ca2+ release. PAR(2) contributes to inflammation through activation of NF-kappa B-regulated genes; however, the mechanism by which this occurs is unknown. Overexpression of human PAR(2) in HEK293T cells resulted in concentration-dependent, PAR(2) AP-inducible NF-kappa B reporter activation that was protein synthesis-independent, yet blocked by inhibitors that uncouple G(i) proteins or sequester intracellular Ca2+. Because previous studies described synergistic PAR(2)- and TLR4-mediated cytokine production, we hypothesized that PAR(2) and TLR4 might interact at the level of signaling. In the absence of TLR4, PAR(2)-induced NF-kappa B activity was inhibited by dominant negative (DN)-TRIF or DN-TRAM constructs, but not by DN-MyD88, findings confirmed using cell-permeable, adapter-specific BB loop blocking peptides. Co-expression of TLR4/MD-2/CD14 with PAR(2) in HEK293T cells led to a synergistic increase in AP-induced NF-kappa B signaling that was MyD88-dependent and required a functional TLR4, despite the fact that AP exhibited no TLR4 agonist activity. Co-immunoprecipitation of PAR(2) and TLR4 revealed a physical association that was AP-dependent. The response to AP or lipopolysaccharide was significantly diminished in TLR4(-/-) and PAR(2)(-/)-macrophages, respectively, and SW620 colonic epithelial cells exhibited synergistic responses to co-stimulation with AP and lipopolysaccharide. Our data suggest a unique interaction between two distinct innate immune response receptors and support a novel paradigm of receptor cooperativity in inflammatory responses.	[Rallabhandi, Prasad; Nhu, Quan M.; Toshchakov, Vladimir Y.; Piao, Wenji; Medvedev, Andrei E.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Calgary; University of Calgary	Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, 660 W Redwood St,Rm 324, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Hollenberg, Morley/AFV-6966-2022; Fasano, Alessio/K-5486-2016; Toshchakov, Vladimir/C-2798-2014	Fasano, Alessio/0000-0002-2134-0261; Toshchakov, Vladimir/0000-0002-7942-2294	National Institutes of Health [R37 AI-18797, R01 AI-059524, R01 DK048373, T32 AI-07540]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524, R37AI018797, T32AI007540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 AI-18797 (to S. N. V.), R01 AI-059524 (to A. E. M.), R01 DK048373 (to A. F.), and T32 AI-07540 (to Q. M. N.), and a Canadian Institutes of Health Research operating grant (to M. H.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bushell T, 2007, J PHYSIOL-LONDON, V581, P7, DOI 10.1113/jphysiol.2007.129577; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; Chi LQ, 2001, J INTERF CYTOK RES, V21, P231, DOI 10.1089/107999001750169871; Chignard M, 2006, AM J RESP CELL MOL, V34, P394, DOI 10.1165/rcmb.2005-0250TR; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Cicala C, 1999, CIRCULATION, V99, P2590, DOI 10.1161/01.CIR.99.19.2590; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Devlin MG, 2007, PARASITOL RES, V101, P105, DOI 10.1007/s00436-007-0467-1; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hamilton JR, 2001, CIRC RES, V89, P92, DOI 10.1161/hh1301.092661; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; Holzhausen M, 2006, AM J PATHOL, V168, P1189, DOI 10.2353/ajpath.2006.050658; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawabata A, 2005, J PHARMACOL SCI, V97, P20, DOI 10.1254/jphs.FMJ04005X4; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; McIntosh KA, 2007, CURR OPIN PHARMACOL, V7, P334, DOI 10.1016/j.coph.2007.01.002; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moretti S, 2008, MUCOSAL IMMUNOL, V1, P156, DOI 10.1038/mi.2007.13; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Neurath H, 1999, P NATL ACAD SCI USA, V96, P10962, DOI 10.1073/pnas.96.20.10962; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Vergnolle N, 2000, ALIMENT PHARM THER, V14, P257; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	80	112	117	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24314	24325		10.1074/jbc.M804800200	http://dx.doi.org/10.1074/jbc.M804800200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18622013	Green Published, hybrid			2022-12-25	WOS:000258820000006
J	Rubio, A; Rambla, JL; Santaella, M; Gomez, MD; Orzaez, D; Granell, A; Gomez-Gomez, L				Rubio, Angela; Rambla, Jose Luis; Santaella, Marcella; Gomez, M. Dolores; Orzaez, Diego; Granell, Antonio; Gomez-Gomez, Lourdes			Cytosolic and plastoglobule-targeted carotenoid dioxygenases from Crocus sativus are both involved in beta-ionone release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; CLEAVAGE DIOXYGENASE; FUNCTIONAL-CHARACTERIZATION; RAIN-FOREST; ARABIDOPSIS; GENES; IDENTIFICATION; VOLATILE; TOMATO; ACCUMULATION	Saffron, the processed stigma of Crocus sativus, is characterized by the presence of several apocarotenoids that contribute to the color, flavor, and aroma of the spice. However, little is known about the synthesis of aroma compounds during the development of the C. sativus stigma. The developing stigma is nearly odorless, but before and at anthesis, the aromatic compound beta-ionone becomes the principal norisoprenoid volatile in the stigma. In this study, four carotenoid cleavage dioxygenase (CCD) genes, CsCCD1a, CsCCD1b, CsCCD4a, and CsCCD4b, were isolated from C. sativus. Expression analysis showed that CsCCD1a was constitutively expressed, CsCCD1b was unique to the stigma tissue, but only CsCCD4a and -b had expression patterns consistent with the highest levels of beta-carotene and emission of beta-ionone derived during the stigma development. The CsCCD4 enzymes were localized in plastids and more specifically were present in the plastoglobules. The enzymatic activities of CsCCD1a, CsCCD1b, and CsCCD4 enzymes were determined by Escherichia coli expression, and subsequent analysis of the volatile products was generated by GC/MS. The four CCDs fell in two phylogenetically divergent dioxygenase classes, but all could cleave beta-carotene at the 9,10(9', 10') positions to yield beta-ionone. The data obtained suggest that all four C. sativus CCD enzymes may contribute in different ways to the production of beta-ionone. In addition, the location and precise timing of beta-ionone synthesis, together with its known activity as a fragrance and insect attractant, suggest that this volatile may have a role in Crocus pollination.	[Rubio, Angela; Santaella, Marcella; Gomez-Gomez, Lourdes] Univ Castilla La Mancha, ETSIA, Inst Desarrollo Reg, Secc Biotecnol, Albacete 02071, Spain; [Rambla, Jose Luis; Gomez, M. Dolores; Orzaez, Diego; Granell, Antonio] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez-Gomez, L (corresponding author), Univ Castilla La Mancha, ETSIA, Inst Desarrollo Reg, Secc Biotecnol, Campus Univ S-N, Albacete 02071, Spain.	marialourdes.gomez@uclm.es	Gomez/K-8775-2014; Rubio, Angel/M-7387-2019; Granell, Antonio/G-3664-2010; Orzaez, Diego/H-3457-2012; Rambla, José L./B-5881-2011; Gomez-Gomez, Lourdes/AAF-2371-2020; ORZAEZ, DIEGO/X-2915-2019	Gomez/0000-0001-9445-2056; Rubio, Angel/0000-0002-3274-2450; Orzaez, Diego/0000-0003-1662-5403; Rambla, José L./0000-0003-4704-2534; Gomez-Gomez, Lourdes/0000-0003-2586-4457; ORZAEZ, DIEGO/0000-0003-1662-5403; Rubio-Moraga, Angela/0000-0002-2162-2314	Ministerio de Educacio n y Ciencia [BIO2003-05259, BIO2006-00841]	Ministerio de Educacio n y Ciencia(Spanish GovernmentEuropean Commission)	This work was supported by Ministerio de Educacio n y Ciencia Grants BIO2003-05259 and BIO2006-00841. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Baldermann S, 2005, FOOD RES INT, V38, P833, DOI 10.1016/j.foodres.2005.02.009; Beveridge CA, 2006, CURR OPIN PLANT BIOL, V9, P35, DOI 10.1016/j.pbi.2005.11.006; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Chichiricco G, 1999, GRANA, V38, P31, DOI 10.1080/001731300750044681; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; D'Auria M, 2006, J CHROMATOGR SCI, V44, P18, DOI 10.1093/chromsci/44.1.18; Cancino AD, 2007, PLANT SPEC BIOL, V22, P129, DOI 10.1111/j.1442-1984.2007.00185.x; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Grilli M, 2004, PLANT BIOSYST, V138, P43, DOI DOI 10.1080/11263500410001684116; GRILLICAIOLA M, 1999, SAFFRON, P31; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P913, DOI 10.1093/oxfordjournals.aob.a085387; Ibdah M, 2006, PHYTOCHEMISTRY, V67, P1579, DOI 10.1016/j.phytochem.2006.02.009; Kanakis CD, 2004, J AGR FOOD CHEM, V52, P4515, DOI 10.1021/jf049808j; KATONOGUCHI H, 1993, PHYSIOL PLANTARUM, V89, P423, DOI 10.1111/j.1399-3054.1993.tb05193.x; Kaup MT, 2002, PLANT PHYSIOL, V129, P1616, DOI 10.1104/pp.003087; Kirk J., 1978, PLASTIDS THEIR CHEM, P217; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; LICHTENTHALER HK, 1968, ENDEAVOUR, V27, P144; Locy RD, 1996, PLANT PHYSIOL, V110, P321, DOI 10.1104/pp.110.1.321; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; MATHEW B, 1999, REPROD BIOL SAFFRON, P19; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; McKee J, 1998, BOT J LINN SOC, V128, P369; MIKHLIN E D, 1983, Prikladnaya Biokhimiya i Mikrobiologiya, V19, P795; Milet-Pinheiro P, 2005, REV BRAS ZOOL, V22, P853, DOI 10.1590/S0101-81752005000400008; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Naested H, 2004, J CELL SCI, V117, P4807, DOI 10.1242/jcs.01360; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Negbi M., 1999, SAFFRON CROCUS SATIV, DOI [10.1201/9780203303665, DOI 10.1201/9780203303665]; Nemesio A, 2006, NEOTROP ENTOMOL, V35, P313, DOI 10.1590/S1519-566X2006000300004; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Rey P, 2000, PLANT J, V21, P483, DOI 10.1046/j.1365-313x.2000.00699.x; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Siddique MA, 2006, PLANT CELL PHYSIOL, V47, P1663, DOI 10.1093/pcp/pcl033; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; Sitte P, 1980, PIGMENTS PLANTS, P117; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TARANTILIS PA, 1994, J CHROMATOGR A, V664, P55, DOI 10.1016/0021-9673(94)80628-4; Tarantilis PA, 1997, J AGR FOOD CHEM, V45, P459, DOI 10.1021/jf960105e; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; Tieman DM, 2006, J EXP BOT, V57, P887, DOI 10.1093/jxb/erj074; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Vishnevetsky M, 1999, TRENDS PLANT SCI, V4, P232, DOI 10.1016/S1360-1385(99)01414-4; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Winterhalter P, 2000, FOOD REV INT, V16, P39, DOI 10.1081/FRI-100100281; Wrischer Mercedes, 2007, Acta Botanica Croatica, V66, P81; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	68	196	211	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24816	24825		10.1074/jbc.M804000200	http://dx.doi.org/10.1074/jbc.M804000200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611853	Green Published, hybrid			2022-12-25	WOS:000258820000048
J	Sprouse, RO; Shcherbakova, I; Cheng, HY; Jamison, E; Brenowitz, M; Auble, DT				Sprouse, Rebekka O.; Shcherbakova, Inna; Cheng, Huiyong; Jamison, Elizabeth; Brenowitz, Michael; Auble, David T.			Function and structural organization of Mot1 bound to a natural target promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; TRANSCRIPTION IN-VIVO; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; GENE-EXPRESSION; REPRESSES TRANSCRIPTION; FOOTPRINTING ANALYSIS; BASAL TRANSCRIPTION; YEAST	Mot1 is an essential, conserved TATA-binding protein (TBP)-associated factor in Saccharomyces cerevisiae and a member of the Snf2/Swi2 ATPase family. Mot1 uses ATP hydrolysis to displace TBP from DNA, an activity that can be readily reconciled with its global role in gene repression. Less well understood is how Mot1 directly activates gene expression. It has been suggested that Mot1-mediated activation can occur by displacement of inactive TBP-containing complexes from promoters, thereby permitting assembly of functional transcription complexes. Mot1 may also activate transcription by other mechanisms that have not yet been defined. A gap in our understanding has been the absence of biochemical information related to the activity of Mot1 on natural target genes. Using URA1 as a model Mot1-activated promoter, we show striking differences in the way that both TBP and Mot1 interact with DNA compared with other model DNA substrates analyzed previously. These differences are due at least in part to the propensity of TBP alone to bind to the URA1 promoter in the wrong orientation to direct appropriate assembly of the URA1 preinitiation complex. The results suggest that Mot1-mediated activation of URA1 transcription involves at least two steps, one of which is the removal of TBP bound to the promoter in the opposite orientation required for URA1 transcription.	[Sprouse, Rebekka O.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Shcherbakova, Inna; Cheng, Huiyong; Jamison, Elizabeth; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Virginia; Yeshiva University; Albert Einstein College of Medicine	Auble, DT (corresponding author), 1340 Jefferson Pk Ave,Rm 6213, Charlottesville, VA 22908 USA.	dta4n@virginia.edu			National Institutes of Health [GM55763, GM39929]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R01GM039929, R29GM039929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55763 ( to D. T. A.) and GM39929 ( to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BRENOWITZ M, 1993, FOOTPRINTING TECHNIQ, P1; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Faiger H, 2006, NUCLEIC ACIDS RES, V34, P104, DOI 10.1093/nar/gkj414; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; Hsieh M, 1996, METHOD ENZYMOL, V274, P478; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Fusheng, 2002, Methods Mol Biol, V182, P19; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Liu YC, 2001, BIOCHEMISTRY-US, V40, P6257, DOI 10.1021/bi0019794; LOSSON R, 1985, J MOL BIOL, V185, P65, DOI 10.1016/0022-2836(85)90183-4; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Pastor N, 2000, J MOL BIOL, V304, P55, DOI 10.1006/jmbi.2000.4173; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; Ranish JA, 1996, CURR OPIN GENET DEV, V6, P151, DOI 10.1016/S0959-437X(96)80044-X; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; ROY A, 1990, MOL CELL BIOL, V10, P5257, DOI 10.1128/MCB.10.10.5257; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Spencer JV, 2002, MOL CELL BIOL, V22, P8744, DOI 10.1128/MCB.22.24.8744-8755.2002; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Takamoto K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh117; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982	54	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24935	24948		10.1074/jbc.M803749200	http://dx.doi.org/10.1074/jbc.M803749200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606810	Green Published, hybrid			2022-12-25	WOS:000258820000056
J	Wu, Z; Zhang, W; Chen, GB; Cheng, L; Liao, J; Jia, N; Gao, Y; Dai, HM; Yuan, JD; Cheng, LZ; Xiao, L				Wu, Zhao; Zhang, Wei; Chen, Guibin; Cheng, Lu; Liao, Jing; Jia, Nannan; Gao, Yuan; Dai, Huiming; Yuan, Jinduo; Cheng, Linzhao; Xiao, Lei			Combinatorial signals of Activin/Nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-RENEWAL; HUMAN BLASTOCYSTS; MOUSE EMBRYO; IN-VITRO; DIFFERENTIATION; PLURIPOTENCY; TROPHOBLAST; INHIBITION; MAINTAINS	Cell fate commitment of pre-implantation blastocysts, to either the inner cell mass or trophoblast, is the first step in cell lineage segregation of the developing human embryo. However, the intercellular signals that control fate determination of these cells remain obscure. Human embryonic stem cells (hESCs) provide a unique model for studying human early embryonic development. We have previously shown that Activin/Nodal signaling contributes to maintaining pluripotency of hESCs, which are derivatives of the inner cell mass. Here we further demonstrate that the inhibition of Activin/Nodal signaling results in the loss of hESC pluripotency and trophoblast differentiation, similar to BMP4-induced trophoblast differentiation from hESCs. We also show that the trophoblast induction effect of BMP4 correlates with and depends on the inhibition of Activin/Nodal signaling. However, the activation of BMP signaling is still required for trophoblast differentiation when Activin/Nodal signaling is inhibited. These data reveal that the early lineage segregation of hESCs is determined by the combinatorial signals of Activin/Nodal and BMP.	[Wu, Zhao; Zhang, Wei; Cheng, Lu; Liao, Jing; Jia, Nannan; Gao, Yuan; Dai, Huiming; Xiao, Lei] Chinese Acad Sci, Mol Cell Biol Lab, Key Lab Stem Cell Biol,Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,Cell Bank Stem Cell Bank, Shanghai 200031, Peoples R China; [Zhang, Wei; Yuan, Jinduo] Shandong Normal Univ, Dept Biotechnol, Coll Life Sci, Jinan 250014, Peoples R China; [Chen, Guibin; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Chen, Guibin; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shandong Normal University; Johns Hopkins University; Johns Hopkins University	Xiao, L (corresponding author), 320 Yue Yang Rd,Bldg 41,Rm 625, Shanghai 200031, Peoples R China.	leixiao@sibs.ac.cn	Liao, Jing/J-4620-2014		Ministry of Science and Technology [2007CB947100, 2006CB943900]; National Natural Science Foundation of China [30600306]; Shanghai Institutes for Biological Sciences [2007KIP101]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology Grants 2007CB947100 and 2006CB943900, National Natural Science Foundation of China Grant 30600306, and Shanghai Institutes for Biological Sciences Grant 2007KIP101. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Cheng LZ, 2006, NATURE, V440, P992, DOI 10.1038/440992b; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Reppel M, 2004, CELL PHYSIOL BIOCHEM, V14, P187, DOI 10.1159/000080326; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	45	75	80	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24991	25002		10.1074/jbc.M803893200	http://dx.doi.org/10.1074/jbc.M803893200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596037	hybrid, Green Published			2022-12-25	WOS:000258820000059
J	Lafourcade, C; Sobo, K; Kieffer-Jaquinod, S; Garin, J; van der Goot, FG				Lafourcade, Celine; Sobo, Komla; Kieffer-Jaquinod, Sylvie; Garin, Jerome; van der Goot, F. Gisou			Regulation of the V-ATPase along the Endocytic Pathway Occurs through Reversible Subunit Association and Membrane Localization	PLOS ONE			English	Article								The lumen of endosomal organelles becomes increasingly acidic when going from the cell surface to lysosomes. Luminal pH thereby regulates important processes such as the release of internalized ligands from their receptor or the activation of lysosomal enzymes. The main player in endosomal acidification is the vacuolar ATPase (V-ATPase), a multi-subunit transmembrane complex that pumps protons from the cytoplasm to the lumen of organelles, or to the outside of the cell. The active V-ATPase is composed of two multi-subunit domains, the transmembrane V(0) and the cytoplasmic V(1). Here we found that the ratio of membrane associated V(1)/Vo varies along the endocytic pathway, the relative abundance of V(1) being higher on late endosomes than on early endosomes, providing an explanation for the higher acidity of late endosomes. We also found that all membrane-bound V-ATPase subunits were associated with detergent resistant membranes (DRM) isolated from late endosomes, raising the possibility that association with lipid-raft like domains also plays a role in regulating the activity of the proton pump. In support of this, we found that treatment of cells with U18666A, a drug that leads to the accumulation of cholesterol in late endosomes, affected acidification of late endosome. Altogether our findings indicate that the activity of the vATPase in the endocytic pathway is regulated both by reversible association/dissociation and the interaction with specific lipid environments.	[Lafourcade, Celine; Sobo, Komla; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Kieffer-Jaquinod, Sylvie; Garin, Jerome] INSERM U880, Lab Etude Dynamique Proteomes, IRTSV, CEA, DSV, Grenoble, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lafourcade, C (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X	Swiss National Science foundation; Novartis Consumer Health Foundation; Roche Research Foundation [post-doctoral fellowship]; Howard Hughes Medical Institute [International Fellow]	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Consumer Health Foundation; Roche Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Swiss National Science foundation and from a grant from Novartis Consumer Health Foundation to G.v.d.G. C.L is a recipient of a Roche Research Foundation post-doctoral fellowship. G.v.d.G is an international Fellow of the Howard Hughes Medical Institute.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Blonder J, 2004, ELECTROPHORESIS, V25, P1307, DOI 10.1002/elps.200405891; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown D, 2000, J EXP BIOL, V203, P137; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Dixon N, 2004, BBA-BIOMEMBRANES, V1665, P177, DOI 10.1016/j.bbamem.2004.08.001; Dixon N, 2008, BIOPHYS J, V94, P506, DOI 10.1529/biophysj.107.111781; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; HINTON A, 2007, V ATPASE FUNCTIONS N; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 2007, J BIOENERG BIOMEMBR; Karsan A, 2005, J PROTEOME RES, V4, P349, DOI 10.1021/pr049824w; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; MARSHANSKY V, 2008, CURR OPIN CELL BIOL; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Roy CR, 2005, NAT IMMUNOL, V6, P546, DOI 10.1038/ni0605-546; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van der Goot FG, 1997, ELECTROPHORESIS, V18, P2689, DOI 10.1002/elps.1150181426; Van Dyke Rebecca W, 2004, BMC Physiol, V4, P1, DOI 10.1186/1472-6793-4-1; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yoshinaka K, 2004, NEUROSCI LETT, V363, P168, DOI 10.1016/j.neulet.2004.04.002	74	136	141	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2758	10.1371/journal.pone.0002758	http://dx.doi.org/10.1371/journal.pone.0002758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648502	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900028
J	Matz, C; Webb, JS; Schupp, PJ; Phang, SY; Penesyan, A; Egan, S; Steinberg, P; Kjelleberg, S				Matz, Carsten; Webb, Jeremy S.; Schupp, Peter J.; Phang, Shui Yen; Penesyan, Anahit; Egan, Suhelen; Steinberg, Peter; Kjelleberg, Staffan			Marine Biofilm Bacteria Evade Eukaryotic Predation by Targeted Chemical Defense	PLOS ONE			English	Article								Many plants and animals are defended from predation or herbivory by inhibitory secondary metabolites, which in the marine environment are very common among sessile organisms. Among bacteria, where there is the greatest metabolic potential, little is known about chemical defenses against bacterivorous consumers. An emerging hypothesis is that sessile bacterial communities organized as biofilms serve as bacterial refuge from predation. By testing growth and survival of two common bacterivorous nanoflagellates, we find evidence that chemically mediated resistance against protozoan predators is common among biofilm populations in a diverse set of marine bacteria. Using bioassay-guided chemical and genetic analysis, we identified one of the most effective antiprotozoal compounds as violacein, an alkaloid that we demonstrate is produced predominately within biofilm cells. Nanomolar concentrations of violacein inhibit protozoan feeding by inducing a conserved eukaryotic cell death program. Such biofilm-specific chemical defenses could contribute to the successful persistence of biofilm bacteria in various environments and provide the ecological and evolutionary context for a number of eukaryote-targeting bacterial metabolites.	[Matz, Carsten; Phang, Shui Yen; Penesyan, Anahit; Egan, Suhelen; Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Matz, Carsten] Helmholtz Ctr Infect Res, Div Cell a& Immune Biol, Braunschweig, Germany; [Webb, Jeremy S.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Schupp, Peter J.] Univ Guam, Marine Lab, Mangilao, GU USA; [Steinberg, Peter] Univ New S Wales, Ctr Marine BioInnovat, Sch Biol, Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Helmholtz Association; Helmholtz-Center for Infection Research; University of Southampton; University of Guam; University of New South Wales Sydney	Matz, C (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	carsten.matz@helmholtz-hzi.de	Schupp, Peter j/D-3296-2015; Kjelleberg, Staffan/AAB-4641-2020; Kjelleberg, Staffan/C-9229-2015; Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012	Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Webb, Jeremy/0000-0003-2068-8589; Egan, Suhelen/0000-0003-3286-4279; Schupp, Peter Josef/0000-0003-4831-2751; Steinberg, Peter/0000-0002-1781-0726	German Research Foundation; Alexander von Humboldt Foundation; Australian Research Council; Australian Cooperative Research Centre for Environmental Biotechnology; Centre for Marine Bio-Innovation of the University of New South Wales	German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Australian Research Council(Australian Research Council); Australian Cooperative Research Centre for Environmental Biotechnology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Centre for Marine Bio-Innovation of the University of New South Wales	This research was supported by grants from the German Research Foundation (to C.M.), the Alexander von Humboldt Foundation (to P.J.S.), the Australian Research Council (to S.K.), the Australian Cooperative Research Centre for Environmental Biotechnology (to S.K. and C.M.) and by the Centre for Marine Bio-Innovation of the University of New South Wales.	August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; CHRZANOWSKI TH, 1990, LIMNOL OCEANOGR, V35, P1429, DOI 10.4319/lo.1990.35.7.1429; CORPE WA, 1953, J BACTERIOL, V66, P470, DOI 10.1128/JB.66.4.470-477.1953; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Egan S, 2000, ENVIRON MICROBIOL, V2, P343, DOI 10.1046/j.1462-2920.2000.00107.x; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; FENCHEL T, 1987, ECOLOGY PROTOZOA BIO; Ferreira CV, 2004, BLOOD, V104, P1459, DOI 10.1182/blood-2004-02-0594; Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P25; Halda-Alija L, 1999, CAN J MICROBIOL, V45, P879, DOI 10.1139/cjm-45-10-879; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hay ME, 2002, J CHEM ECOL, V28, P2001, DOI 10.1023/A:1020797827806; HAY ME, 1988, ANNU REV ECOL SYST, V19, P111, DOI 10.1146/annurev.es.19.110188.000551; Hild E, 2000, J BACTERIOL, V182, P6964, DOI 10.1128/JB.182.24.6964-6974.2000; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kiorboe T, 2003, APPL ENVIRON MICROB, V69, P3036, DOI 10.1128/AEM.69.6.3036-3047.2003; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Nakamura Y, 2002, BIOCHEM ENG J, V12, P79, DOI 10.1016/S1369-703X(02)00079-7; Parry JD, 2004, ADV APPL MICROBIOL, V54, P167, DOI 10.1016/S0065-2164(04)54007-8; PATTERSON DJ, FLAGELLATES UNITY DI, P269; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Pernthaler J, 1996, AQUAT MICROB ECOL, V10, P255, DOI 10.3354/ame010255; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Rhoades D.F., 1979, HERBIVORES THEIR INT, P1; RIVEROS R, 1988, ARQ BIOL TECNOL, V31, P475; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; VAATANEN P, 1976, W A DENOTTBECK F SCI, V1, P1; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x	51	146	150	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2744	10.1371/journal.pone.0002744	http://dx.doi.org/10.1371/journal.pone.0002744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648491	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000264302900015
J	Barribeau, SM; Villinger, J; Waldman, B				Barribeau, Seth M.; Villinger, Jandouwe; Waldman, Bruce			Major Histocompatibility Complex Based Resistance to a Common Bacterial Pathogen of Amphibians	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; EMERGING INFECTIOUS-DISEASE; CLASS IIB ALLELES; IMMUNE-SYSTEM; AEROMONAS-HYDROPHILA; FITNESS CONSEQUENCES; POPULATION DECLINES; MHC POLYMORPHISM; SIZE VARIABILITY; ATLANTIC SALMON	Given their well-developed systems of innate and adaptive immunity, global population declines of amphibians are particularly perplexing. To investigate the role of the major histocompatibilty complex (MHC) in conferring pathogen resistance, we challenged Xenopus laevis tadpoles bearing different combinations of four MHC haplotypes (f, g, j, and r) with the bacterial pathogen Aeromonas hydrophila in two experiments. In the first, we exposed ff, fg, gg, gj, and jj tadpoles, obtained from breeding MHC homozygous parents, to one of three doses of A. hydrophila or heat-killed bacteria as a control. In the second, we exposed ff, fg, fr, gg, rg, and rr tadpoles, obtained from breeding MHC heterozygous parents and subsequently genotyped by PCR, to A. hydrophila, heat-killed bacteria or media alone as controls. We thereby determined whether the same patterns of MHC resistance emerged within as among families, independent of non-MHC heritable differences. Tadpoles with r or g MHC haplotypes were more likely to die than were those with f or j haplotypes. Growth rates varied among MHC types, independent of exposure dose. Heterozygous individuals with both susceptible and resistant haplotypes were intermediate to either homozygous genotype in both size and survival. The effect of the MHC on growth and survival was consistent between experiments and across families. MHC alleles differentially confer resistance to, or tolerance of, the bacterial pathogen, which affects tadpoles' growth and survival.	[Barribeau, Seth M.; Villinger, Jandouwe; Waldman, Bruce] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	University of Canterbury	Barribeau, SM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	seth.barribeau@emory.edu; jandouwe@gmail.com; waldmanb@lincoln.ac.nz	Waldman, Bruce/A-1269-2009; Barribeau, Seth M/C-3977-2011; Villinger, Jandouwe/ABH-2172-2020	Waldman, Bruce/0000-0003-0006-5333; Barribeau, Seth M/0000-0001-6643-0562; Villinger, Jandouwe/0000-0002-5097-6605	Marsden Grant of New Zealand	Marsden Grant of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by the Marsden Grant of New Zealand (to BW). No funding agency was involved in the design or interpretation of this study.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; BROCKELMAN WY, 1969, ECOLOGY, V50, P632, DOI 10.2307/1936252; Carey C, 2000, ENVIRON HEALTH PERSP, V108, P143, DOI 10.2307/3454639; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; CRUMP ML, 1981, AM NAT, V117, P724, DOI 10.1086/283755; CRUMP ML, 1984, COPEIA, P302, DOI 10.2307/1445185; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Dziminski MA, 2006, J EVOLUTION BIOL, V19, P144, DOI 10.1111/j.1420-9101.2005.00978.x; Dziminski MA, 2005, OECOLOGIA, V146, P98, DOI 10.1007/s00442-005-0177-2; Edwards Scott V., 1996, P214; Flajnik MF, 1999, J IMMUNOL, V163, P3826; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FRYE FL, 1985, J AM VET MED ASSOC, V187, P1223; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; HAZEN TC, 1978, APPL ENVIRON MICROB, V36, P731, DOI 10.1128/AEM.36.5.731-738.1978; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HIRD DW, 1981, LAB ANIM SCI, V31, P166; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; HUGHES AL, 1991, CONSERV BIOL, V5, P249, DOI 10.1111/j.1523-1739.1991.tb00130.x; KAPLAN RH, 1984, AM NAT, V123, P393, DOI 10.1086/284211; KAPLAN RH, 1980, EVOLUTION, V34, P51, DOI 10.1111/j.1558-5646.1980.tb04788.x; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Lewis K, 1998, J THEOR BIOL, V193, P359, DOI 10.1006/jtbi.1998.0725; Linder G, 2003, AMPHIBIAN DECLINE IN; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Liu Y, 2002, DEV COMP IMMUNOL, V26, P735, DOI 10.1016/S0145-305X(02)00034-4; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Mauel MJ, 2002, J VET DIAGN INVEST, V14, P431, DOI 10.1177/104063870201400515; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Miller KM, 2004, ENVIRON BIOL FISH, V69, P307, DOI 10.1023/B:EBFI.0000022874.48341.0f; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; NYMAN S, 1986, J HERPETOL, V20, P196, DOI 10.2307/1563944; Pearman PB, 2004, J WILDLIFE DIS, V40, P660, DOI 10.7589/0090-3558-40.4.660; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rollins-Smith LA, 2006, DEV COMP IMMUNOL, V30, P831, DOI 10.1016/j.dci.2005.10.005; RUSSELL FH, 1898, JAMA-J AM MED ASSOC, V30, P1442; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamouza R, 2002, HUM IMMUNOL, V63, P194, DOI 10.1016/S0198-8859(01)00378-0; Taylor Sharon K., 2001, P159; Taylor SK, 1999, J WILDLIFE DIS, V35, P536, DOI 10.7589/0090-3558-35.3.536; Todd BD, 2007, AM NAT, V170, P793, DOI 10.1086/521958; TRAVIS J, 1984, ECOLOGY, V65, P1155, DOI 10.2307/1938323; VILLINGER J, 2007, THESIS U CANTERBURY; Villinger J, 2008, P ROY SOC B-BIOL SCI, V275, P1225, DOI 10.1098/rspb.2008.0022; Waldman B, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P394; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; WILBUR HM, 1982, ECOLOGY, V63, P278, DOI 10.2307/1938942; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; WILBUR HM, 1976, ECOLOGY, V57, P1289, DOI 10.2307/1935053	80	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2692	10.1371/journal.pone.0002692	http://dx.doi.org/10.1371/journal.pone.0002692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629002	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200035
J	Genoud, T; Cruz, MTS; Kulisic, T; Sparla, F; Fankhauser, C; Metraux, JP				Genoud, Thierry; Cruz, Marcela Trevino Santa; Kulisic, Tea; Sparla, Francesca; Fankhauser, Christian; Metraux, Jean-Pierre			The Protein Phosphatase 7 Regulates Phytochrome Signaling in Arabidopsis	PLOS ONE			English	Article							BLUE-LIGHT RECEPTORS; TRANSCRIPTION FACTOR; CROSS-TALK; PP7; CRYPTOCHROME; GENE; PHOTORECEPTORS; TRANSDUCTION; EXPRESSION; RESPONSES	The psi2 mutant of Arabidopsis displays amplification of the responses controlled by the red/far red light photoreceptors phytochrome A (phyA) and phytochrome B (phyB) but no apparent defect in blue light perception. We found that loss-of-function alleles of the protein phosphatase 7 (AtPP7) are responsible for the light hypersensitivity in psi2 demonstrating that AtPP7 controls the levels of phytochrome signaling. Plants expressing reduced levels of AtPP7 mRNA display reduced blue-light induced cryptochrome signaling but no noticeable deficiency in phytochrome signaling. Our genetic analysis suggests that phytochrome signaling is enhanced in the AtPP7 loss of function alleles, including in blue light, which masks the reduced cryptochrome signaling. AtPP7 has been found to interact both in yeast and in planta assays with nucleotide-diphosphate kinase 2 (NDPK2), a positive regulator of phytochrome signals. Analysis of ndpk2-psi2 double mutants suggests that NDPK2 plays a critical role in the AtPP7 regulation of the phytochrome pathway and identifies NDPK2 as an upstream element involved in the modulation of the salicylic acid (SA)-dependent defense pathway by light. Thus, cryptochrome-and phytochrome-specific light signals synchronously control their relative contribution to the regulation of plant development. Interestingly, PP7 and NDPK are also components of animal light signaling systems.	[Genoud, Thierry; Fankhauser, Christian] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Cruz, Marcela Trevino Santa] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL USA; [Kulisic, Tea] Univ Split, Fac Chem Technol, Dept Biochem, Split, Croatia; [Sparla, Francesca] Univ Bologna, Dept Biol, Lab Plant Physiol, Bologna, Italy; [Metraux, Jean-Pierre] Univ Fribourg, Dept Biol, Unit Plant Biol, Fribourg, Switzerland	University of Lausanne; State University System of Florida; Florida Gulf Coast University; University of Split; University of Bologna; University of Fribourg	Genoud, T (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	thierry.genoud@unil.ch	Fankhauser, Christian/C-4291-2018; Bilusic, Tea/E-2689-2017; Metraux, Jean-Pierre JP/C-1111-2012; Fankhauser, Christian/ABE-8757-2021	Fankhauser, Christian/0000-0003-4719-5901; Bilusic, Tea/0000-0001-8834-9562; Fankhauser, Christian/0000-0003-4719-5901; Sparla, Francesca/0000-0002-2103-4870	Swiss National Science Foundation [3100A0-104224]; HFSP [RGY0016/2004-C]; Swiss Federal Commission of Scholarships for Foreign Students	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HFSP(Human Frontier Science Program); Swiss Federal Commission of Scholarships for Foreign Students	Swiss National Science Foundation (grant 3100A0-104224 to J.P.M.) HFSP (grant RGY0016/2004-C to C.F.) Swiss Federal Commission of Scholarships for Foreign Students	Andreeva AV, 1998, BIOCHEM MOL BIOL INT, V44, P703; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BECKER DM, 1994, CURRENT PROTOCOLS MO; Bolter B, 2007, PLANTA, V226, P1059, DOI 10.1007/s00425-007-0549-4; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Fankhauser C, 2004, PLANT J, V39, P747, DOI 10.1111/j.1365-313X.2004.02148.x; FEDOROFF NV, 1993, PLANT J, V3, P273, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; Franklin KA, 2003, PLANT CELL, V15, P1981, DOI 10.1105/tpc.015164; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; Genoud T, 1998, PLANT CELL, V10, P889, DOI 10.1105/tpc.10.6.889; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hsieh HL, 2000, GENE DEV, V14, P1958; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kang XJ, 2005, PLANT CELL, V17, P822, DOI 10.1105/tpc.104.029165; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kutuzov MA, 2001, BIOCHEM BIOPH RES CO, V289, P634, DOI 10.1006/bbrc.2001.6020; Kutuzov MA, 1998, FEBS LETT, V440, P147, DOI 10.1016/S0014-5793(98)01428-8; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Liu HT, 2007, PLANT CELL ENVIRON, V30, P156, DOI 10.1111/j.1365-3040.2006.01613.x; Long Deborah, 1998, V82, P315; Miller JH, EXPT MOL GENETICS; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Neff MM, 2000, GENE DEV, V14, P257; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Sharrock RA, 2003, PLANT MOL BIOL, V52, P135, DOI 10.1023/A:1023901718508; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Swarup R, 2002, PLANT MOL BIOL, V49, P411; WANG H, 2002, ARABIDOPSIS BOOK; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Zhang H, 1997, BBA-GENE STRUCT EXPR, V1353, P199, DOI 10.1016/S0167-4781(97)00096-1	56	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2699	10.1371/journal.pone.0002699	http://dx.doi.org/10.1371/journal.pone.0002699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628957	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200042
J	Singh, R; Lemire, J; Mailloux, RJ; Appanna, VD				Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.			A Novel Strategy Involved Anti-Oxidative Defense: The Conversion of NADH into NADPH by a Metabolic Network	PLOS ONE			English	Article								The reduced nicotinamide adenine dinucleotide phosphate (NADPH) is pivotal to the cellular anti-oxidative defence strategies in most organisms. Although its production mediated by different enzyme systems has been relatively well-studied, metabolic networks dedicated to the biogenesis of NADPH have not been fully characterized. In this report, a metabolic pathway that promotes the conversion of reduced nicotinamide adenine dinucleotide (NADH), a pro-oxidant into NADPH has been uncovered in Pseudomonas fluorescens exposed to oxidative stress. Enzymes such as pyruvate carboxylase (PC), malic enzyme (ME), malate dehydrogenase (MDH), malate synthase (MS), and isocitrate lyase (ICL) that are involved in disparate metabolic modules, converged to create a metabolic network aimed at the transformation of NADH into NADPH. The downregulation of phosphoenol carboxykinase (PEPCK) and the upregulation of pyruvate kinase (PK) ensured that this metabolic cycle fixed NADH into NADPH to combat the oxidative stress triggered by the menadione insult. This is the first demonstration of a metabolic network invoked to generate NADPH from NADH, a process that may be very effective in combating oxidative stress as the increase of an anti-oxidant is coupled to the decrease of a pro-oxidant.	[Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Singh, R (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca		Appanna, Vasu/0000-0002-0138-5665; Mailloux, Ryan/0000-0003-3986-9830	Northern Ontario Heritage Fund; Ontario Center of Excellence	Northern Ontario Heritage Fund; Ontario Center of Excellence	This project was funded by Northern Ontario Heritage Fund and Ontario Center of Excellence.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2008, CURR MED CHEM, V15, P650; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Maia L, 2007, J BIOL INORG CHEM, V12, P777, DOI 10.1007/s00775-007-0229-7; Mailloux RJ, 2008, ELECTROPHORESIS, V29, P1484, DOI 10.1002/elps.200700697; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marino D, 2007, PLANTA, V225, P413, DOI 10.1007/s00425-006-0354-5; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; SATTERLEE J, 1991, BIOCHIM BIOPHYS ACTA, V1079, P247, DOI 10.1016/0167-4838(91)90065-8; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Sugiyama N, 1997, PHYTOCHEMISTRY, V44, P571, DOI 10.1016/S0031-9422(96)00629-2; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yoshihara T, 2001, J HISTOCHEM CYTOCHEM, V49, P1123, DOI 10.1177/002215540104900906; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P1766, DOI 10.1073/pnas.90.5.1766	26	94	96	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2682	10.1371/journal.pone.0002682	http://dx.doi.org/10.1371/journal.pone.0002682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628998	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200026
J	Palmer, C; Duan, XB; Hawley, S; Scholler, N; Thorpe, JD; Sahota, RA; Wong, MQ; Wray, A; Bergan, LA; Drescher, CW; McIntosh, MW; Brown, PO; Nelson, BH; Urban, N				Palmer, Chana; Duan, Xiaobo; Hawley, Sarah; Scholler, Nathalie; Thorpe, Jason D.; Sahota, Rob A.; Wong, May Q.; Wray, Andrew; Bergan, Lindsay A.; Drescher, Charles W.; McIntosh, Martin W.; Brown, Patrick O.; Nelson, Brad H.; Urban, Nicole			Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer	PLOS ONE			English	Article								Background: Epithelial ovarian cancer is a significant cause of mortality both in the United States and worldwide, due largely to the high proportion of cases that present at a late stage, when survival is extremely poor. Early detection of epithelial ovarian cancer, and of the serous subtype in particular, is a promising strategy for saving lives. The low prevalence of ovarian cancer makes the development of an adequately sensitive and specific test based on blood markers very challenging. We evaluated the performance of a set of candidate blood markers and combinations of these markers in detecting serous ovarian cancer. Methods and Findings: We selected 14 candidate blood markers of serous ovarian cancer for which assays were available to measure their levels in serum or plasma, based on our analysis of global gene expression data and on literature searches. We evaluated the performance of these candidate markers individually and in combination by measuring them in overlapping sets of serum ( or plasma) samples from women with clinically detectable ovarian cancer and women without ovarian cancer. Based on sensitivity at high specificity, we determined that 4 of the 14 candidate markers-MUC16, WFDC2, MSLN and MMP7-warrant further evaluation in precious serum specimens collected months to years prior to clinical diagnosis to assess their utility in early detection. We also reported differences in the performance of these candidate blood markers across histological types of epithelial ovarian cancer. Conclusions: By systematically analyzing the performance of candidate blood markers of ovarian cancer in distinguishing women with clinically apparent ovarian cancer from women without ovarian cancer, we identified a set of serum markers with adequate performance to warrant testing for their ability to identify ovarian cancer months to years prior to clinical diagnosis. We argued for the importance of sensitivity at high specificity and of magnitude of difference in marker levels between cases and controls as performance metrics and demonstrated the importance of stratifying analyses by histological type of ovarian cancer. Also, we discussed the limitations of studies (like this one) that use samples obtained from symptomatic women to assess potential utility in detection of disease months to years prior to clinical detection.	[Palmer, Chana; Hawley, Sarah] Canary Fdn, Sci Programs, San Jose, CA USA; [Duan, Xiaobo; Sahota, Rob A.; Wong, May Q.; Wray, Andrew; Nelson, Brad H.] Trev & Joyce Deeley Res Ctr, British Columbia Canc Agcy, Victoria, BC, Canada; [Scholler, Nathalie] Univ Penn, Sch Med, Philadelphia, PA USA; [Thorpe, Jason D.; Bergan, Lindsay A.; Drescher, Charles W.; McIntosh, Martin W.; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA USA	British Columbia Cancer Agency; University of Pennsylvania; Fred Hutchinson Cancer Center; Stanford University	Palmer, C (corresponding author), Canary Fdn, Sci Programs, San Jose, CA USA.	nurban@fhcrc.org	Nelson, Brad H/K-2622-2014	Nelson, Brad/0000-0002-4445-5539	Canary Foundation; Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer [P50 CA83636]; NIH/NCI [1 RO1 CA75494]; British Columbia Cancer Foundation; Howard Hughes Medical Institute [investigator]; NATIONAL CANCER INSTITUTE [R01CA075494, P50CA083636] Funding Source: NIH RePORTER	Canary Foundation; Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); British Columbia Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for generous funding from the Canary Foundation, the Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer (P50 CA83636, N.U.), NIH/NCI Grant 1 RO1 CA75494 (QUEST), and the British Columbia Cancer Foundation. POB is an investigator of the Howard Hughes Medical Institute. CP and SJH are employees of the Canary Foundation and were involved in design of the study, analysis and interpretation of the data, and preparation of the manuscript.	AGARWAL R, 2007, AM J OBSTET GYNECOL, V348, pE341; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bjorge T, 2004, BRIT J CANCER, V91, P1829, DOI 10.1038/sj.bjc.6602199; Cass R, 2005, OBSTET GYNECOL, V106, P1327, DOI 10.1097/01.AOG.0000187892.78392.3f; Dupont J, 2004, J CLIN ONCOL, V22, P3330, DOI 10.1200/JCO.2004.09.112; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Hellstrom I, 2003, CANCER RES, V63, P3695; JACOBS I, 1988, LANCET, V1, P268; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kioi M, 2006, CANCER-AM CANCER SOC, V107, P1407, DOI 10.1002/cncr.22134; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; McIntosh MW, 2004, GYNECOL ONCOL, V95, P9, DOI 10.1016/j.ygyno.2004.07.039; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2005, EPIDEMIOLOGY, V16, P598, DOI 10.1097/01.ede.0000173041.03470.8b; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ries LAG, 2007, SEER SURVIVAL MONOGR, P133; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scholler N, 2008, CLIN CANCER RES, V14, P2647, DOI 10.1158/1078-0432.CCR-07-1442; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; So J, 2004, GYNECOL ONCOL, V95, P314, DOI 10.1016/j.ygyno.2004.08.001; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Surveillance E and End Results ( SEER) Program, 2007, SEER STAT DAT INC SE; Tanimoto H, 1999, TUMOR BIOL, V20, P88, DOI 10.1159/000030051; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; van Haaften-Day C, 2001, CANCER-AM CANCER SOC, V92, P2837, DOI 10.1002/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO;2-5; Venkatraman ES, 1996, BIOMETRIKA, V83, P835, DOI 10.1093/biomet/83.4.835; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; ZURAWSKI VR, 1988, INT J CANCER, V42, P677, DOI 10.1002/ijc.2910420507	36	66	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2633	10.1371/journal.pone.0002633	http://dx.doi.org/10.1371/journal.pone.0002633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612378	gold, Green Published, Green Submitted			2022-12-25	WOS:000264065800035
J	Togbe, D; de Sousa, PL; Fauconnier, M; Boissay, V; Fick, L; Scheu, S; Pfeffer, K; Menard, R; Grau, GE; Doan, BT; Beloeil, JC; Renia, L; Hansen, AM; Ball, HJ; Hunt, NH; Ryffel, B; Quesniaux, VFJ				Togbe, Dieudonnee; de Sousa, Paulo Loureiro; Fauconnier, Mathilde; Boissay, Victorine; Fick, Lizette; Scheu, Stefanie; Pfeffer, Klaus; Menard, Robert; Grau, Georges E.; Doan, Bich-Thuy; Beloeil, Jean Claude; Renia, Laurent; Hansen, Anna M.; Ball, Helen J.; Hunt, Nicholas H.; Ryffel, Bernhard; Quesniaux, Valerie F. J.			Both Functional LT beta Receptor and TNF Receptor 2 Are Required for the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article								Background: TNF-related lymphotoxin alpha (LT alpha) is essential for the development of Plasmodium berghei ANKA (PbA)-induced experimental cerebral malaria (ECM). The pathway involved has been attributed to TNFR2. Here we show a second arm of LT alpha-signaling essential for ECM development through LT beta-R, receptor of LT alpha 1 beta 2 heterotrimer. Methodology/Principal Findings: LT beta R deficient mice did not develop the neurological signs seen in PbA induced ECM but died at three weeks with high parasitaemia and severe anemia like LT alpha beta deficient mice. Resistance of LT alpha beta or LT beta R deficient mice correlated with unaltered cerebral microcirculation and absence of ischemia, as documented by magnetic resonance imaging and angiography, associated with lack of microvascular obstruction, while wild-type mice developed distinct microvascular pathology. Recruitment and activation of perforin(+) CD8(+) T cells, and their ICAM-1 expression were clearly attenuated in the brain of resistant mice. An essential contribution of LIGHT, another LT beta R ligand, could be excluded, as LIGHT deficient mice rapidly succumbed to ECM. Conclusions/Significance: LT beta R expressed on radioresistant resident stromal, probably endothelial cells, rather than hematopoietic cells, are essential for the development of ECM, as assessed by hematopoietic reconstitution experiment. Therefore, the data suggest that both functional LT beta R and TNFR2 signaling are required and non-redundant for the development of microvascular pathology resulting in fatal ECM.	[Togbe, Dieudonnee; Fauconnier, Mathilde; Boissay, Victorine; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, Orleans, France; [de Sousa, Paulo Loureiro; Doan, Bich-Thuy; Beloeil, Jean Claude] CNRS CBM, Orleans, France; [Fick, Lizette] Inst Infect Dis & Mol Med, Cape Town, South Africa; [Scheu, Stefanie; Pfeffer, Klaus] Univ Duesseldorf, Dusseldorf, Germany; [Menard, Robert] Pasteur Inst Paris, Paris, France; [Grau, Georges E.; Renia, Laurent; Hansen, Anna M.; Ball, Helen J.; Hunt, Nicholas H.] Univ Sydney, Dept Pathol, Camperdown, NSW, Australia; [Renia, Laurent] Inserm, U567, Paris, France	Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); University of Cape Town; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Togbe, D (corresponding author), Univ Orleans, Orleans, France.	bryffel@cnrs-orleans.fr; quesniaux@cnrs-orleans.fr	Hunt, Nick H/A-3636-2011; Scheu, Stefanie/H-3670-2019; Ball, Helen J/A-4242-2010; Grau, Georges/AGR-7139-2022; Togbe, Dieudonnee/AAE-1135-2020; Renia, Laurent/E-2117-2011; , Beloeil/I-5451-2014	Scheu, Stefanie/0000-0002-9707-8191; Ball, Helen J/0000-0003-3733-9748; Grau, Georges/0000-0002-0442-0462; Togbe, Dieudonnee/0000-0001-6658-414X; Renia, Laurent/0000-0003-0349-1557; , Beloeil/0000-0002-1474-3898; DOAN, Bich-Thuy/0000-0002-7148-9515; Pfeffer, Klaus/0000-0002-5652-6330	CNRS; MIE from the French Research Minister; European FP6 MPCM project	CNRS(Centre National de la Recherche Scientifique (CNRS)); MIE from the French Research Minister; European FP6 MPCM project	Work supported by CNRS, the interdisciplinary program MIE from the French Research Minister, and European FP6 MPCM project.	Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1988, IMMUNOLOGY, V65, P501; Hall N, 2005, CURR OPIN GENET DEV, V15, P609, DOI 10.1016/j.gde.2005.09.001; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kuprash DV, 1999, J IMMUNOL, V163, P6575; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Muller M, 1996, MOL MED, V2, P247, DOI 10.1007/BF03401621; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rudin W, 1997, AM J PATHOL, V150, P257; Ryffel B, 1997, J IMMUNOL, V158, P2126; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stoelcker B, 2002, INFECT IMMUN, V70, P5857, DOI 10.1128/IAI.70.10.5857-5859.2002; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; Voza T, 2005, INFECT IMMUN, V73, P4777, DOI 10.1128/IAI.73.8.4777-4786.2005; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Wunderlich F, 2005, MICROBES INFECT, V7, P399, DOI 10.1016/j.micinf.2004.11.016	50	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2608	10.1371/journal.pone.0002608	http://dx.doi.org/10.1371/journal.pone.0002608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612394	Green Submitted, Green Published, gold			2022-12-25	WOS:000264065800014
J	Kalita, MK; Nandal, UK; Pattnaik, A; Sivalingam, A; Ramasamy, G; Kumar, M; Raghava, GPS; Gupta, D				Kalita, Mridul K.; Nandal, Umesh K.; Pattnaik, Ansuman; Sivalingam, Anandhan; Ramasamy, Gowthaman; Kumar, Manish; Raghava, Gajendra P. S.; Gupta, Dinesh			CyclinPred: A SVM-Based Method for Predicting Cyclin Protein Sequences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CELL-CYCLE; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; COUPLED RECEPTORS; NEURAL-NETWORKS; MESSENGER-RNA; GENE; FOLD; MATURATION	Functional annotation of protein sequences with low similarity to well characterized protein sequences is a major challenge of computational biology in the post genomic era. The cyclin protein family is once such important family of proteins which consists of sequences with low sequence similarity making discovery of novel cyclins and establishing orthologous relationships amongst the cyclins, a difficult task. The currently identified cyclin motifs and cyclin associated domains do not represent all of the identified and characterized cyclin sequences. We describe a Support Vector Machine (SVM) based classifier, CyclinPred, which can predict cyclin sequences with high efficiency. The SVM classifier was trained with features of selected cyclin and non cyclin protein sequences. The training features of the protein sequences include amino acid composition, dipeptide composition, secondary structure composition and PSI-BLAST generated Position Specific Scoring Matrix (PSSM) profiles. Results obtained from Leave-One-Out cross validation or jackknife test, self consistency and holdout tests prove that the SVM classifier trained with features of PSSM profile was more accurate than the classifiers based on either of the other features alone or hybrids of these features. A cyclin prediction server-CyclinPred has been setup based on SVM model trained with PSSM profiles. CyclinPred prediction results prove that the method may be used as a cyclin prediction tool, complementing conventional cyclin prediction methods.	[Kalita, Mridul K.; Nandal, Umesh K.; Pattnaik, Ansuman; Sivalingam, Anandhan; Ramasamy, Gowthaman; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India; [Kumar, Manish; Raghava, Gajendra P. S.] Inst Microb Technol, Bioinformat Ctr, Chandigarh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kalita, MK (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Kumar, Manish/AGP-1250-2022; Gupta, Dinesh/C-1079-2009; Raghava, Gajendra/B-1717-2009; Gupta, Dinesh/AAW-4243-2020; Raghava, Gajendra P.S./AAA-2413-2022	Kumar, Manish/0000-0002-7936-9892; Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835; Raghava, Gajendra P.S./0000-0002-8902-2876	Department of Biotechnology (DBT, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India)	The work was supported by Department of Biotechnology (DBT, India) grant award to DG.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bazan JF, 1996, PROTEINS, V24, P1; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Busuttil Steven, 2004, Genome Inform, V15, P191; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P946, DOI 10.1093/nar/22.6.946; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NICHOLAS J, 1992, NATURE, V355, P362, DOI 10.1038/355362a0; Nieduszynski CA, 2002, GENOME BIOL, V3; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; RECZKO M, 1994, NUCLEIC ACIDS RES, V22, P3616; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Scholkopf B., 1999, ADV KERNEL METHODS S; Shepherd AJ, 1999, PROTEIN SCI, V8, P1045, DOI 10.1110/ps.8.5.1045; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1998, STAT LEARNING THEORY; Vlahovicek K, 2005, NUCLEIC ACIDS RES, V33, pD223; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176; Zhang QD, 2005, BIOINFORMATICS, V21, P2370, DOI 10.1093/bioinformatics/bti358	46	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2605	10.1371/journal.pone.0002605	http://dx.doi.org/10.1371/journal.pone.0002605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596929	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200058
J	Wei, Y; Qu, MH; Wang, XS; Chen, L; Wang, DL; Liu, Y; Hua, Q; He, RQ				Wei, Yan; Qu, Mei-Hua; Wang, Xing-Sheng; Chen, Lan; Wang, Dong-Liang; Liu, Ying; Hua, Qian; He, Rong-Qiao			Binding to the Minor Groove of the Double-Strand, Tau Protein Prevents DNA from Damage by Peroxidation	PLOS ONE			English	Article								Tau, an important microtubule associated protein, has been found to bind to DNA, and to be localized in the nuclei of both neurons and some non-neuronal cells. Here, using electrophoretic mobility shifting assay ( EMSA) in the presence of DNA with different chain-lengths, we observed that tau protein favored binding to a 13 bp or a longer polynucleotide. The results from atomic force microscopy also showed that tau protein preferred a 13 bp polynucleotide to a 12 bp or shorter polynucleotide. In a competitive assay, a minor groove binder distamycin A was able to replace the bound tau from the DNA double helix, indicating that tau protein binds to the minor groove. Tau protein was able to protect the double-strand from digestion in the presence of DNase I that was bound to the minor groove. On the other hand, a major groove binder methyl green as a negative competitor exhibited little effect on the retardation of tau-DNA complex in EMSA. This further indicates the DNA minor groove as the binding site for tau protein. EMSA with truncated tau proteins showed that both the proline-rich domain ( PRD) and the microtubule-binding domain ( MTBD) contributed to the interaction with DNA; that is to say, both PRD and MTBD bound to the minor groove of DNA and bent the double-strand, as observed by electron microscopy. To investigate whether tau protein is able to prevent DNA from the impairment by hydroxyl free radical, the chemiluminescence emitted by the phen-Cu/H2O2/ascorbate was measured. The emission intensity of the luminescence was markedly decreased when tau protein was present, suggesting a significant protection of DNA from the damage in the presence of hydroxyl free radical.	[Wei, Yan; Qu, Mei-Hua; Wang, Xing-Sheng; Chen, Lan; Wang, Dong-Liang; Liu, Ying; Hua, Qian; He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Wei, Yan; Wang, Dong-Liang; He, Rong-Qiao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hua, Qian] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing University of Chinese Medicine	Wei, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn	Liu, Ying/D-8933-2013; Qu, Mei-Hua/ABE-5521-2020	Liu, Ying/0000-0003-0802-3832; Qu, Mei-Hua/0000-0003-2464-6773	NSFC [90206041]; 973-Project [2006CB500703, 2006CB911003]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-119-1]	NSFC(National Natural Science Foundation of China (NSFC)); 973-Project(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	The work was supported by NSFC (90206041), 973-Project (2006CB500703 and 2006CB911003), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-119-1).	Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; ARCAMONE FM, 1989, J MED CHEM, V32, P774, DOI 10.1021/jm00124a008; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRUCE A, 2002, MOL BIOL CELL, P381; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CORCES VG, 1980, EUR J BIOCHEM, V105, P7; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Delacourte A, 1997, INT REV CYTOL, V171, P167; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENWOOD JA, 1995, EXP CELL RES, V220, P332, DOI 10.1006/excr.1995.1323; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Johnson GVW, 2002, J ALZHEIMERS DIS, V4, P375, DOI 10.3233/JAD-2002-4505; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; KUMAR KA, 1992, J BIOL CHEM, V260, P24824; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Li FX, 2008, PROG BIOCHEM BIOPHYS, V35, P393; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; Li W, 2005, BBA-GEN SUBJECTS, V1726, P280, DOI 10.1016/j.bbagen.2005.08.014; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Ma WJ, 1998, J PHOTOCH PHOTOBIO B, V44, P63, DOI 10.1016/S1011-1344(98)00120-1; Michaelis ML, 2002, J MOL NEUROSCI, V19, P289, DOI 10.1385/JMN:19:3:289; Mitsouras K, 2002, MOL CELL BIOL, V22, P4390, DOI 10.1128/MCB.22.12.4390-4401.2002; MORAGA DM, 1993, J NEUROCHEM, V61, P979, DOI 10.1111/j.1471-4159.1993.tb03611.x; MORTON RE, 1992, ANAL BIOCHEM, V204, P332, DOI 10.1016/0003-2697(92)90248-6; Nie Chun Lai, 2007, BMC Neurosci, V8, P9, DOI 10.1186/1471-2202-8-9; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425; PORSCHKE D, 1991, J MOL BIOL, V222, P423, DOI 10.1016/0022-2836(91)90220-Z; PUTNAM FW, 1953, PROTEINS, P893; Qu MH, 2004, NEUROREPORT, V15, P2723; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; Rogers Faye A., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P319, DOI 10.2174/1568011054222300; Roy KB, 1996, INDIAN J BIOCHEM BIO, V33, P83; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Tuite E, 1997, EUR J BIOCHEM, V243, P482, DOI 10.1111/j.1432-1033.1997.0482a.x; Wang XS, 2006, PROTEIN PEPTIDE LETT, V13, P679, DOI 10.2174/092986606777790566; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; WISEMAN H, 1995, CANCER LETT, V93, P113, DOI 10.1016/0304-3835(95)03792-U; Wojtuszewski K, 2004, PROTEIN SCI, V13, P2416, DOI 10.1110/ps.04730204; YAMAUCHI PS, 1993, BIOCHEM BIOPH RES CO, V190, P710, DOI 10.1006/bbrc.1993.1107	51	85	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2600	10.1371/journal.pone.0002600	http://dx.doi.org/10.1371/journal.pone.0002600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596978	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200053
J	Sobotka, R; Duerhring, U; Komenda, J; Peter, E; Gardian, Z; Tichy, M; Grimm, B; Wilde, A				Sobotka, Roman; Duerhring, Ulf; Komenda, Josef; Peter, Enrico; Gardian, Zdenko; Tichy, Martin; Grimm, Bernhard; Wilde, Annegret			Importance of the cyanobacterial GUN4 protein for chlorophyll metabolism and assembly of photosynthetic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; SP. PCC 6803; PHOTOSYSTEM-II; TETRAPYRROLE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; IN-VIVO; MUTANT; LIGHT; FERROCHELATASE	Gun4 is a porphyrin-binding protein that activates magnesium chelatase, a multimeric enzyme catalyzing the first committed step in chlorophyll biosynthesis. In plants, GUN4 has been implicated in plastid-to-nucleus retrograde signaling processes that coordinate both photosystem II and photosystem I nuclear gene expression with chloroplast function. In this work we present the functional analysis of Gun4 from the cyanobacterium Synechocystis sp. PCC 6803. Affinity co-purification of the FLAG-tagged Gun4 with the ChlH subunit of the magnesium chelatase confirmed the association of Gun4 with the enzyme in cyanobacteria. Inactivation of the gun4 gene abolished photoautotrophic growth of the resulting gun4 mutant strain that exhibited a decreased activity of magnesium chelatase. Consequently, the cellular content of chlorophyll-binding proteins was highly inadequate, especially that of proteins of photosystem II. Immunoblot analyses, blue native polyacrylamide gel electrophoresis, and radiolabeling of the membrane protein complexes suggested that the availability of the photosystem II antenna protein CP47 is a limiting factor for the photosystem II assembly in the gun4 mutant.	[Sobotka, Roman; Komenda, Josef; Tichy, Martin] Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic; [Sobotka, Roman; Komenda, Josef; Tichy, Martin] Inst Microbiol, Dept Autotroph Microorg, Trebon 37971, Czech Republic; [Grimm, Bernhard; Wilde, Annegret] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Gardian, Zdenko] Inst Plant Mol Biol, Ceske Budejovice 37005, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Humboldt University of Berlin	Wilde, A (corresponding author), Univ Giessen, Inst Microbiol & Mol Biol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	Annegret.Wilde@mikro.bio.uni-giessen.de	Gardian, Zdeno/AAU-7904-2020; Gardian, Zdenko/G-9476-2014; Sobotka, Roman/J-3077-2014; Komenda, Josef/H-4083-2014; Tichy, Martin/B-6545-2008	Gardian, Zdeno/0000-0003-1578-2773; Sobotka, Roman/0000-0001-5909-3879; Komenda, Josef/0000-0003-4588-0382; Tichy, Martin/0000-0003-2814-1959	Deutsche Forschungsgemeinschaft [SFB429, TPA8]; Institutional Research Concept [AV0Z50200510]; Ministry of Education of the Czech Republic project [MSM6007665808]; Grant Agency of the Czech Academy of Sciences [IAA500200713]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institutional Research Concept; Ministry of Education of the Czech Republic project(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB429 and TPA8 (to A. W. and B. G.), by Institutional Research Concept AV0Z50200510, by Ministry of Education of the Czech Republic project MSM6007665808 (to J.K.), and by Grant Agency of the Czech Academy of Sciences project IAA500200713 (to R. S. and M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Brusslan JA, 2002, PHOTOSYNTH RES, V71, P185, DOI 10.1023/A:1015539109209; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Grossman AR, 2004, ANNU REV GENET, V38, P119, DOI 10.1146/annurev.genet.38.072902.092328; He QF, 1998, EUR J BIOCHEM, V253, P161, DOI 10.1046/j.1432-1327.1998.2530161.x; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kada S, 2003, PLANT MOL BIOL, V51, P225, DOI 10.1023/A:1021195226978; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RIPPKA R, 1979, J GEN MICROBIOL, V11, P419; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; YANG HJ, 1995, P NATL ACAD SCI USA, V92, P7332, DOI 10.1073/pnas.92.16.7332	32	60	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25794	25802		10.1074/jbc.M803787200	http://dx.doi.org/10.1074/jbc.M803787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18625715	Green Published, hybrid			2022-12-25	WOS:000259200100005
J	Borodina, I; Siebring, J; Zhang, J; Smith, CP; van Keulen, G; Dijkhuizen, L; Nielsen, J				Borodina, Irina; Siebring, Jeroen; Zhang, Jie; Smith, Colin P.; van Keulen, Geertje; Dijkhuizen, Lubbert; Nielsen, Jens			Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS H37RV; SECONDARY METABOLISM; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; MORPHOLOGICAL-DIFFERENTIATION; GLYCOLYTIC PATHWAY; LIVIDANS TK24; RECX GENE; IN-VIVO	Streptomycetes are exploited for production of a wide range of secondary metabolites, and there is much interest in enhancing the level of production of these metabolites. Secondary metabolites are synthesized in dedicated biosynthetic routes, but precursors and co-factors are derived from the primary metabolism. High level production of antibiotics in streptomycetes therefore requires engineering of the primary metabolism. Here we demonstrate this by targeting a key enzyme in glycolysis, phosphofructokinase, leading to improved antibiotic production in Streptomyces coelicolor A3(2). Deletion of pfkA2 (SCO5426), one of three annotated pfkA homologues in S. coelicolor A3(2), resulted in a higher production of the pigmented antibiotics actinorhodin and undecylprodigiosin. The pfkA2 deletion strain had an increased carbon flux through the pentose phosphate pathway, as measured by C-13 metabolic flux analysis, establishing the ATP-dependent PfkA2 as a key player in determining the carbon flux distribution. The increased pentose phosphate pathway flux appeared largely because of accumulation of glucose 6-phosphate and fructose 6-phosphate, as experimentally observed in the mutant strain. Through genome-scale metabolic model simulations, we predicted that decreased phosphofructokinase activity leads to an increase in pentose phosphate pathway flux and in flux to pigmented antibiotics and pyruvate. Integrated analysis of gene expression data using a genome-scale metabolic model further revealed transcriptional changes in genes encoding redox co-factor-dependent enzymes as well as those encoding pentose phosphate pathway enzymes and enzymes involved in storage carbohydrate biosynthesis.	[Borodina, Irina; Zhang, Jie; Nielsen, Jens] Tech Univ Denmark, BioCtr, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Siebring, Jeroen; Dijkhuizen, Lubbert] Univ Groningen, Dept Microbiol, Groningen Biotechnol & Biomol Sci Inst, NL-9750 AA Haren, Netherlands; [Smith, Colin P.] Univ Surrey, Fac Sci Hlth & Med Sci, Funct Genom Lab, Guildford GU2 7XH, Surrey, England; [van Keulen, Geertje] Univ Coll Swansea, Sch Environm & Soc, Swansea SA2 8PP, W Glam, Wales	Technical University of Denmark; University of Groningen; University of Surrey; Swansea University	Nielsen, J (corresponding author), Tech Univ Denmark, BioCtr, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	jn@biocentrum.dtu.dk	Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019; Borodina, Irina/G-5587-2013; Smith, Colin/AAL-4507-2021; Nielsen, Jens/Q-1347-2017	Dijkhuizen, Lubbert/0000-0003-2312-7162; Nielsen, Jens/0000-0002-9955-6003; Borodina, Irina/0000-0002-8452-1393; Zhang, Jie/0000-0003-4119-9442	European Union 6FP ActinoGEN Project [LSHM-CT-2004-005224]; Biotechnology and Biological Sciences Research Council [G18886] Funding Source: researchfish	European Union 6FP ActinoGEN Project(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was sponsored in part by European Union 6FP ActinoGEN Project (Contract LSHM-CT-2004-005224). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alves AMCR, 1997, APPL ENVIRON MICROB, V63, P956, DOI 10.1128/AEM.63.3.956-961.1997; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BRUTON CJ, 1995, MOL MICROBIOL, V18, P89, DOI 10.1111/j.1365-2958.1995.mmi_18010089.x; Butler MJ, 2002, APPL ENVIRON MICROB, V68, P4731, DOI 10.1128/AEM.68.10.4731-4739.2002; Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chouayekh H, 2002, MOL MICROBIOL, V43, P919, DOI 10.1046/j.1365-2958.2002.02557.x; Christensen B, 1999, METAB ENG, V1, P282, DOI 10.1006/mben.1999.0117; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; DAVIDSON A, 1992, THESIS U GLASGOW GLA; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Galvao CW, 2003, CAN J MICROBIOL, V49, P145, DOI [10.1139/w03-010, 10.1139/W03-010]; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Gunnarsson N, 2004, ADV BIOCHEM ENG BIOT, V88, P137, DOI 10.1007/b992690; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HEATH EC, 1958, J BIOL CHEM, V231, P1009; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Karandikar A, 1997, MICROBIOL-SGM, V143, P3581, DOI 10.1099/00221287-143-11-3581; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kieser T., 2000, PRACTICAL STREPTOMYC, P408; LAMPEN JO, 1951, J BACTERIOL, V61, P97, DOI 10.1128/JB.61.1.97-98.1951; LESSIE TG, 1972, J BACTERIOL, V110, P1107, DOI 10.1128/JB.110.3.1107-1117.1972; Li RF, 2006, METAB ENG, V8, P240, DOI 10.1016/j.ymben.2006.01.003; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Natsume R, 2003, ACTA CRYSTALLOGR D, V59, P2313, DOI 10.1107/S0907444903020766; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; OLUKOSHI ER, 1992, BIOCHEM SOC T, V20, P99; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Orban JI, 2000, J MICROBIOL METH, V40, P221, DOI 10.1016/S0167-7012(00)00133-0; Packter NM, 1995, ARCH MICROBIOL, V164, P420, DOI 10.1007/BF02529740; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; ROLLIN C, 1995, EUR J BIOCHEM, V227, P488, DOI 10.1111/j.1432-1033.1995.tb20414.x; Rossa CA, 2002, METAB ENG, V4, P138, DOI 10.1006/mben.2001.0217; Ryu YG, 2006, APPL ENVIRON MICROB, V72, P7132, DOI 10.1128/AEM.01308-06; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Sheng DH, 2005, DNA REPAIR, V4, P671, DOI 10.1016/j.dnarep.2005.02.006; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2892, DOI 10.1128/AEM.70.5.2892-2897.2004; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; van Keulen G, 2004, J MICROBIOL METH, V58, P139, DOI 10.1016/j.mimet.2004.03.014; Vierling S, 2000, J BACTERIOL, V182, P4005, DOI 10.1128/JB.182.14.4005-4011.2000; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; VINING LC, 1992, GENE, V115, P135, DOI 10.1016/0378-1119(92)90551-Y; Viollier PH, 2001, J BACTERIOL, V183, P3193, DOI 10.1128/JB.183.10.3193-3203.2001; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; YANG YH, 2001, P SPIE, V4266	63	113	122	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25186	25199		10.1074/jbc.M803105200	http://dx.doi.org/10.1074/jbc.M803105200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606812	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000259012700011
J	Nieto, FL; Pescio, LG; Favale, NO; Adamo, AM; Sterin-Speziale, NB				Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Adamo, Ana M.; Sterin-Speziale, Norma B.			Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE; SPHINGOSINE KINASE; INDUCED APOPTOSIS; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; PATHWAY; DIFFERENTIATION; BIOSYNTHESIS; 1-PHOSPHATE; INHIBITION	The present report was addressed to study the influence of sphingolipid metabolism in determining cellular fate. In non-stimulated proliferating Madin-Darby canine kidney ( MDCK) cells, sphingolipid de novo synthesis is branched mainly to a production of sphingomyelin and ceramide, with a minor production of sphingosylphosphocholine, ceramide 1-phosphate, and sphingosine 1-phosphate. Experiments with P-32 as a radioactive precursor showed that sphingosine 1-phosphate is produced mainly by a de novo independent pathway. Enzymatic inhibition of the de novo pathway and ceramide synthesis affected cell number and viability only slightly, without changing sphingosine 1-phosphate production. By contrast, inhibition of sphingosine kinase-1 activity provoked a significant reduction in both cell number and viability in a dose-dependent manner. When sphingolipid metabolism was studied, an increase in de novo formed ceramide was found, which correlated with the concentration of enzyme inhibitor and the reduction in cell number and viability. Knockdown of sphingosine kinase-1 expression also induced an accumulation of de novo synthesized ceramide, provoking a slight reduction in cell number and viability similar to that induced by a low concentration of the sphingosine kinase inhibitor. Taken together, our results indicate that the level of de novo formed ceramide is controlled by the synthesis of sphingosine 1-phosphate, which appears to occur through a de novo synthesis-independent pathway, most probably the salvage pathway, that is responsible for the MDCK cell fate, suggesting that under proliferating conditions, a dynamic interplay exists between the de novo synthesis and the salvage pathway.	[Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Sterin-Speziale, Norma B.] Univ Buenos Aires, Dept Cell Biol, Sch Pharm & Biochem, RA-1113 Buenos Aires, DF, Argentina; [Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Adamo, Ana M.; Sterin-Speziale, Norma B.] Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisioquim Biol, Buenos Aires, DF, Argentina; [Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Sterin-Speziale, Norma B.] Univ Buenos Aires, Dept Biol Chem, Sch Pharm & Biochem, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sterin-Speziale, NB (corresponding author), Univ Buenos Aires, Dept Cell Biol, Sch Pharm & Biochem, Junin 956,1er Piso, RA-1113 Buenos Aires, DF, Argentina.	speziale@ffyb.uba.ar	Adamo, Ana M/U-7961-2019		University of Buenos Aires [UBACyT TB068]; Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5557]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 33154]	University of Buenos Aires(University of Buenos Aires); Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Grants UBACyT TB068 from the University of Buenos Aires, PIP 5557 from Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and PICT 33154 from Agencia Nacional de Promocion Cientifica y Tecnologica. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Edsall L, 2000, METHOD ENZYMOL, V312, P9; Facchinetti MM, 2003, BIOL NEONATE, V84, P243, DOI 10.1159/000072308; Furuya S, 1998, J NEUROCHEM, V71, P366; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gomez-Munoz A, 2005, FEBS LETT, V579, P3744, DOI 10.1016/j.febslet.2005.05.067; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Jung EM, 1998, J INVEST DERMATOL, V110, P318, DOI 10.1046/j.1523-1747.1998.00137.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lee JY, 1998, BIOCHEM J, V334, P457, DOI 10.1042/bj3340457; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; MERRILL AH, 1985, J LIPID RES, V26, P617; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2000, METHOD ENZYMOL, V311, P215; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; WANG E, 1991, J BIOL CHEM, V266, P14486; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhu XF, 2003, CANCER LETT, V193, P149, DOI 10.1016/S0304-3835(03)00050-8	33	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25682	25691		10.1074/jbc.M804437200	http://dx.doi.org/10.1074/jbc.M804437200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625703	hybrid			2022-12-25	WOS:000259012700063
J	Cox, JM; Li, H; Wood, EA; Chitteni-Pattu, S; Inman, RB; Cox, MM				Cox, Julia M.; Li, Hao; Wood, Elizabeth A.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.			Defective dissociation of a "Slow" RecA mutant protein imparts an Escherichia coli growth defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; REPLICATION FORKS; NUCLEOSIDE TRIPHOSPHATE; GENETIC-RECOMBINATION; BINDING-PROTEIN; NTP HYDROLYSIS; IN-VIVO; REPAIR	The RecA and some related proteins possess a simple motif, called (KR)X(KR), that ( in RecA) consists of two lysine residues at positions 248 and 250 at the subunit-subunit interface. This study and previous work implicate this RecA motif in the following: (a)catalyzing ATP hydrolysis in trans, (b) coordinating the ATP hydrolytic cycles of adjacent subunits, ( c) governing the rate of ATP hydrolysis, and (d) coupling the ATP hydrolysis to work ( in this case DNA strand exchange). The conservative K250R mutation leaves RecA nucleoprotein filament formation largely intact. However, ATP hydrolysis is slowed to less than 15% of the wild-type rate. DNA strand exchange is also slowed commensurate with the rate of ATP hydrolysis. The results reinforce the idea of a tight coupling between ATP hydrolysis and DNA strand exchange. When a plasmid-borne RecA K250R protein is expressed in a cell otherwise lacking RecA protein, the growth of the cells is severely curtailed. The slow growth defect is alleviated in cells lacking RecFOR function, suggesting that the defect reflects loading of RecA at stalled replication forks. Suppressors occur as recA gene alterations, and their properties indicate that limited dissociation by RecA K250R confers the slow growth phenotype. Overall, the results suggest that recombinational DNA repair is a common occurrence in cells. RecA protein plays a sufficiently intimate role in the bacterial cell cycle that its properties can limit the growth rate of a bacterial culture.	[Cox, Julia M.; Li, Hao; Wood, Elizabeth A.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, JM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu	Li, Hao/AAS-9804-2020	Li, Hao/0000-0002-6652-4793	National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leipe DD, 2000, GENOME RES, V10, P5; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MacFarland KJ, 1997, J BIOL CHEM, V272, P17675, DOI 10.1074/jbc.272.28.17675; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; NGUYEN TT, 1993, J BIOL CHEM, V268, P3107; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rothstein R, 2000, GENE DEV, V14, P1; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Schnos M, 2000, MOL BIOTECHNOL, V16, P77, DOI 10.1385/MB:16:1:77; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1998, MOL CELL, V1, P309, DOI 10.1016/S1097-2765(00)80031-3; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; UMEZU K, 1994, J BIOL CHEM, V269, P30005; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003	68	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24909	24921		10.1074/jbc.M803934200	http://dx.doi.org/10.1074/jbc.M803934200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18603529	Green Published, hybrid			2022-12-25	WOS:000258820000054
J	Manfredi, C; Carrasco, B; Ayora, S; Alonso, JC				Manfredi, Candela; Carrasco, Begona; Ayora, Silvia; Alonso, Juan C.			Bacillus subtilis RecO nucleates RecA onto SsbA-coated single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY-JUNCTION RESOLVASE; ESCHERICHIA-COLI RECF; REPLICATION PROTEIN-A; BINDING PROTEIN; BREAK REPAIR; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; RAD51 RECOMBINASE; FILAMENTS; SSDNA	Subsaturating amounts of Bacillus subtilis SsbA, independently of the order of addition, partially inhibit the single-stranded DNA-dependent dATPase activity of RecA. This negative effect is fully overcome when a substoichiometric amount of RecO is added. SsbA added prior to RecA does not stimulate the dATP-dependent DNA strand exchange activity; however, added after RecA it enhances the extent of strand exchange. The addition of RecO stimulates RecA-mediated joint molecule formation, although it limits the accumulation of final recombination products. Thus we suggest that RecO has a dual activity: RecO acts as a RecA mediator enabling RecA to utilize SsbA-coated single-stranded DNA as a polymerization substrate and controls RecA-mediated DNA strand exchange by limiting its extent. We herein discuss the possible mechanisms of RecO involvement in the regulation of double strand break repair and genetic transformation.	[Manfredi, Candela; Carrasco, Begona; Ayora, Silvia; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, C Darwin 3,Campus Univ Autonoma Madrid, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Ayora, Silvia/D-2552-2009; Alonso, Juan Carlos/D-2595-2009	Ayora, Silvia/0000-0003-3121-1786; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296	Ministerio de Ciencia e Innovacio n (MCI); Direccio n General de Investigacio n (DGI) [BFU2006-01062]; MCI-DGI [BFU2006-02907]	Ministerio de Ciencia e Innovacio n (MCI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccio n General de Investigacio n (DGI)(Spanish Government); MCI-DGI	This work was supported by Ministerio de Ciencia e Innovacio n (MCI), Direccio n General de Investigacio n (DGI) Grant BFU2006-01062 (to J. C. A.) and BFU2006-02907 from MCI-DGI (to S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO JC, 1993, J BIOL CHEM, V268, P1424; ALONSO JC, 1991, BIOCHIMIE, V73, P277, DOI 10.1016/0300-9084(91)90213-K; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Ayora S, 1997, MOL GEN GENET, V254, P54, DOI 10.1007/s004380050390; Ayora S, 1997, MOL MICROBIOL, V23, P639, DOI 10.1046/j.1365-2958.1997.2431611.x; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bianco P R, 1998, Front Biosci, V3, pD570; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; CANOSI U, 1978, MOL GEN GENET, V166, P259, DOI 10.1007/BF00267617; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2001, J BACTERIOL, V183, P5772, DOI 10.1128/JB.183.19.5772-5777.2001; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Fernandez S, 1999, MOL GEN GENET, V261, P567, DOI 10.1007/s004380051002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; GASSEL M, 1989, MOL MICROBIOL, V3, P1269, DOI 10.1111/j.1365-2958.1989.tb00277.x; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; MORRICAL SW, 1985, BIOCHEMISTRY-US, V24, P760, DOI 10.1021/bi00324a034; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Sanchez H, 2005, GENETICS, V171, P873, DOI 10.1534/genetics.105.045906; SANCHEZ H, 2007, TOP CURR GENET, V17, P27; Sanchez H, 2007, DYNAMICS DNA DOUBLE; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Steffen SE, 1999, J BIOL CHEM, V274, P25990, DOI 10.1074/jbc.274.37.25990; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; WEISE F, 1994, VIROLOGY, V202, P1046, DOI 10.1006/viro.1994.1436; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	57	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24837	24847		10.1074/jbc.M802002200	http://dx.doi.org/10.1074/jbc.M802002200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599486	hybrid, Green Published			2022-12-25	WOS:000258820000050
J	Masuda-Sasa, T; Polaczek, P; Peng, XP; Chen, L; Campbell, JL				Masuda-Sasa, Taro; Polaczek, Piotr; Peng, Xiao P.; Chen, Lu; Campbell, Judith L.			Processing of G4 DNA by Dna2 helicase/nuclease and replication protein a (RPA) provides insights into the mechanism of Dna2/RPA substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; TELOMERIC G-QUADRUPLEXES; SACCHAROMYCES-CEREVISIAE; IN-VIVO; ENZYMATIC-PROPERTIES; SYNDROME HELICASE; BINDING PROTEIN; YEAST; ENDONUCLEASE; FLAP	The polyguanine-rich DNA sequences commonly found at telomeres and in rDNA arrays have been shown to assemble into structures known as G quadruplexes, or G4 DNA, stabilized by base-stacked G quartets, an arrangement of four hydrogen-bonded guanines. G4 DNA structures are resistant to the many helicases and nucleases that process intermediates arising in the course of DNA replication and repair. The lagging strand DNA replication protein, Dna2, has demonstrated a unique localization to telomeres and a role in de novo telomere biogenesis, prompting us to study the activities of Dna2 on G4 DNA-containing substrates. We find that yeast Dna2 binds with 25-fold higher affinity to G4 DNA formed from yeast telomere repeats than to single-stranded DNA of the same sequence. Human Dna2 also binds G4 DNAs. The helicase activities of both yeast and human Dna2 are effective in unwinding G4 DNAs. On the other hand, the nuclease activities of both yeast and human Dna2 are attenuated by the formation of G4 DNA, with the extent of inhibition depending on the topology of the G4 structure. This inhibition can be overcome by replication protein A. Replication protein A is known to stimulate the 5'- to 3'-nuclease activity of Dna2; however, we go on to show that this same protein inhibits the 3'- to 5'-exo/endonuclease activity of Dna2. These observations are discussed in terms of possible roles for Dna2 in resolving G4 secondary structures that arise during Okazaki fragment processing and telomere lengthening.	[Masuda-Sasa, Taro; Polaczek, Piotr; Peng, Xiao P.; Chen, Lu; Campbell, Judith L.] CALTECH, Braun Labs 147 75, Pasadena, CA 91125 USA	California Institute of Technology	Campbell, JL (corresponding author), CALTECH, Braun Labs 147 75, Pasadena, CA 91125 USA.	jcampbel@its.caltech.edu			National Institutes of Health [GM087666]; Philip Morris External Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program	This work was supported, in whole or in part, by National Institutes of Health Grant GM087666 from the USPHS and a research grant from the Philip Morris External Research Program.	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; LIU ZP, 1993, P NATL ACAD SCI USA, V90, P3157, DOI 10.1073/pnas.90.8.3157; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Sharma S, 2004, HUM MOL GENET, V13, P2247, DOI 10.1093/hmg/ddh234; Singer MS, 1998, GENETICS, V150, P613; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Weitao T, 2003, MUTAT RES-FUND MOL M, V532, P157, DOI 10.1016/j.mrfmmm.2003.08.015; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	47	64	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24359	24373		10.1074/jbc.M802244200	http://dx.doi.org/10.1074/jbc.M802244200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593712	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000258820000010
J	Buck, M				Buck, Martina			Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures	PLOS ONE			English	Article							LIVER-CANCER; C/EBP-BETA; GROWTH-FACTOR; LOW-DENSITY; CELL-LINE; EXPRESSION; ACTIVATION; PHOSPHORYLATION; BINDING; ENTRY	Background: Hepatitis C virus (HCV) infection afflicts about 170 million individuals worldwide. However, the HCV life cycle is only partially understood because it has not been possible to infect normal human hepatocytes in culture. The current Huh-7 systems use cloned, synthetic HCV RNA expressed in hepatocellular carcinoma cells to produce virions, but these cells cannot be infected with naturally occurring HCV obtained from infected patients. Methodology/Principal Findings: Here, we describe a human hepatocyte culture permissible to the direct infection with naturally occurring HCV genotypes 1, 2, 3 and 4 in the blood of HCV-infected patients. The culture system mimics the biology and kinetics of HCV infection in humans, and produces infectious virions that can infect naive human hepatocytes. Conclusions/Significance: This culture system should complement the existing systems, and may facilitate the understanding of the HCV life cycle, its effects in the natural host cell, the hepatocyte, as well as the development of novel therapeutics and vaccines.	[Buck, Martina] Univ Calif, Dept Med & Moores Canc Ctr, La Jolla, CA USA; [Buck, Martina] VA Healthcare Ctr, Dept Med, San Diego, CA USA	University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif, Dept Med & Moores Canc Ctr, La Jolla, CA USA.	mbuck@ucsd.edu			National Institutes of Health [R37-DK-46071, DK-38652, CA-96932]; Department of Veterans Affairs; Medical Research Foundation, University of California, San Diego; National Cancer Institute [Howard Temin Award]; NATIONAL CANCER INSTITUTE [K01CA096932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Medical Research Foundation, University of California, San Diego; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (R37-DK-46071, DK-38652, and CA-96932), the Department of Veterans Affairs (Merit Review) and the Medical Research Foundation, University of California, San Diego. M.B. is a recipient of the Howard Temin Award from the National Cancer Institute. None of these funders had any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Buck M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001372; Cho MK, 2003, HEPATOLOGY, V37, P686, DOI 10.1053/jhep.2003.50078; CHUNG R, 2007, AASLD, P306; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; De Vos R, 2002, J HEPATOL, V37, P370, DOI 10.1016/S0168-8278(02)00236-2; Durantel D, 2007, J HEPATOL, V46, P1, DOI 10.1016/j.jhep.2006.10.005; Fournier C, 1998, J GEN VIROL, V79, P2367, DOI 10.1099/0022-1317-79-10-2367; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; HEPATITIS C, WKLY EPIDEMIOL REC, V72, P341; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jung CR, 2006, HEPATOLOGY, V43, P1042, DOI 10.1002/hep.21137; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; MIYAMOTO H, 1992, J GEN VIROL, V73, P715, DOI 10.1099/0022-1317-73-3-715; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Mueller S, 2006, GASTROENTEROLOGY, V130, P2229, DOI 10.1053/j.gastro.2006.05.006; Murakami K, 2006, VIROLOGY, V351, P381, DOI 10.1016/j.virol.2006.03.038; Nagao K, 2005, INT J MOL MED, V15, P683; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Patel Keyur, 2005, Clin Liver Dis, V9, P399, DOI 10.1016/j.cld.2005.05.007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimizu YK, 1996, HEPATOLOGY, V23, P205; Shimotohno K, 2000, SEMIN CANCER BIOL, V10, P233, DOI 10.1006/scbi.2000.0322; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; *US DEP HHS, 2004, 045491 US DEP HLTH H, P61; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Williams BRG, 2003, SCIENCE, V300, P1100, DOI 10.1126/science.1085277; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yokoo H, 2004, HEPATOLOGY, V40, P609, DOI 10.1002/hep.20372; Zhao XP, 2002, J CLIN INVEST, V109, P221, DOI 10.1172/JCI13011; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	60	51	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2660	10.1371/journal.pone.0002660	http://dx.doi.org/10.1371/journal.pone.0002660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628977	Green Submitted, Green Published, gold			2022-12-25	WOS:000264057200006
J	Doostzadeh, J; Shokralla, S; Absalan, F; Jalili, R; Mohandessi, S; Langston, JW; Davis, RW; Ronaghi, M; Gharizadeh, B				Doostzadeh, Julie; Shokralla, Shadi; Absalan, Farnaz; Jalili, Roxana; Mohandessi, Sharareh; Langston, James W.; Davis, Ronald W.; Ronaghi, Mostafa; Gharizadeh, Baback			High Throughput Automated Allele Frequency Estimation by Pyrosequencing	PLOS ONE			English	Article								Pyrosequencing is a DNA sequencing method based on the principle of sequencing-by-synthesis and pyrophosphate detection through a series of enzymatic reactions. This bioluminometric, real-time DNA sequencing technique offers unique applications that are cost-effective and user-friendly. In this study, we have combined a number of methods to develop an accurate, robust and cost efficient method to determine allele frequencies in large populations for association studies. The assay offers the advantage of minimal systemic sampling errors, uses a general biotin amplification approach, and replaces dTTP for dATP-apha-thio to avoid non-uniform higher peaks in order to increase accuracy. We demonstrate that this newly developed assay is a robust, cost-effective, accurate and reproducible approach for large-scale genotyping of DNA pools. We also discuss potential improvements of the software for more accurate allele frequency analysis.	[Doostzadeh, Julie; Mohandessi, Sharareh; Langston, James W.] Parkinsons Inst, Sunnyvale, CA USA; [Shokralla, Shadi; Jalili, Roxana; Davis, Ronald W.; Ronaghi, Mostafa; Gharizadeh, Baback] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA USA; [Absalan, Farnaz] Princeton Univ, Dept Mol Biol, Princeton, NJ USA	Stanford University; Princeton University	Doostzadeh, J (corresponding author), Parkinsons Inst, Sunnyvale, CA USA.	baback@stanford.edu			National Institutes of Health [R01HG003571, R01HG00205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG003571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants from National Institutes of Health R01HG003571 and R01HG00205	Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Farkas DH, 1996, ARCH PATHOL LAB MED, V120, P591; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Lavebratt C, 2004, HUM MUTAT, V23, P92, DOI 10.1002/humu.10292; Neve B, 2002, BIOTECHNIQUES, V32, P1138, DOI 10.2144/02325dd03; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04	11	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2693	10.1371/journal.pone.0002693	http://dx.doi.org/10.1371/journal.pone.0002693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628978	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200036
J	Fischer, NO; Tok, JBH; Tarasow, TM				Fischer, Nicholas O.; Tok, Jeffrey B. -H.; Tarasow, Theodore M.			Massively Parallel Interrogation of Aptamer Sequence, Structure and Function	PLOS ONE			English	Article								Background: Optimization of high affinity reagents is a significant bottleneck in medicine and the life sciences. The ability to synthetically create thousands of permutations of a lead high-affinity reagent and survey the properties of individual permutations in parallel could potentially relieve this bottleneck. Aptamers are single stranded oligonucleotides affinity reagents isolated by in vitro selection processes and as a class have been shown to bind a wide variety of target molecules. Methodology/Principal Findings: High density DNA microarray technology was used to synthesize, in situ, arrays of approximately 3,900 aptamer sequence permutations in triplicate. These sequences were interrogated on-chip for their ability to bind the fluorescently-labeled cognate target, immunoglobulin E, resulting in the parallel execution of thousands of experiments. Fluorescence intensity at each array feature was well resolved and shown to be a function of the sequence present. The data demonstrated high intra- and inter-chip correlation between the same features as well as among the sequence triplicates within a single array. Consistent with aptamer mediated IgE binding, fluorescence intensity correlated strongly with specific aptamer sequences and the concentration of IgE applied to the array. Conclusion and Significance: The massively parallel sequence-function analyses provided by this approach confirmed the importance of a consensus sequence found in all 21 of the original IgE aptamer sequences and support a common stem: loop structure as being the secondary structure underlying IgE binding. The microarray application, data and results presented illustrate an efficient, high information content approach to optimizing aptamer function. It also provides a foundation from which to better understand and manipulate this important class of high affinity biomolecules.	[Fischer, Nicholas O.; Tok, Jeffrey B. -H.] Lawrence Livermore Natl Lab, Chem Mat Earth & Life Sci Directorate, Livermore, CA 94550 USA; [Tarasow, Theodore M.] Tethys Biosci Inc, Emeryville, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Fischer, NO (corresponding author), Lawrence Livermore Natl Lab, Chem Mat Earth & Life Sci Directorate, Livermore, CA 94550 USA.	ttarasow@tethysbio.com	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390	Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory; Tethys Bioscience	Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory; Tethys Bioscience	This work was supported by the Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory and by Tethys Bioscience. Sponsors reviewed and approved manuscript.	Bock C, 2004, PROTEOMICS, V4, P609, DOI 10.1002/pmic.200300631; Brody EN, 1999, MOL DIAGN, V4, P381, DOI 10.1016/S1084-8592(99)80014-9; Cho EJ, 2006, ANAL CHIM ACTA, V564, P82, DOI 10.1016/j.aca.2005.12.038; Collett JR, 2005, METHODS, V37, P4, DOI 10.1016/j.ymeth.2005.05.009; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hamula CLA, 2006, TRAC-TREND ANAL CHEM, V25, P681, DOI 10.1016/j.trac.2006.05.007; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Liu JW, 2006, ANGEW CHEM INT EDIT, V45, P90, DOI 10.1002/anie.200502589; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Proske D, 2005, APPL MICROBIOL BIOT, V69, P367, DOI 10.1007/s00253-005-0193-5; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wiegand TW, 1996, J IMMUNOL, V157, P221; Xiao Y, 2005, ANGEW CHEM INT EDIT, V44, P5456, DOI 10.1002/anie.200500989; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2720	10.1371/journal.pone.0002720	http://dx.doi.org/10.1371/journal.pone.0002720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628955	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200058
J	Nienhaus, A; Schablon, A; Diel, R				Nienhaus, Albert; Schablon, Anja; Diel, Roland			Interferon-Gamma Release Assay for the Diagnosis of Latent TB Infection - Analysis of Discordant Results, when Compared to the Tuberculin Skin Test	PLOS ONE			English	Article							HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; OCCUPATIONAL RISK; RECOMMENDATIONS; DISEASE; BCG	Background: With the Interferon-c release assays (IGRA) a new method for the diagnosis of latent tuberculosis infections (LTBI) is available. Due to the lack of a gold standard for the diagnosis of LTBI, the IGRA is compared to the Mantoux Tuberculin Skin Test (TST), which yields discordant results in varying numbers. Therefore we assessed to which extent discordant results can be explained by potential risk factors such as age, BCG vaccination and migration. Methods and Findings: In this pooled analysis, two German studies evaluating the Quantiferon-Gold In-Tube test (QFT) by comparison with the TST (RT23 of SSI) were combined and logistic regressions for potential risk factors for TST+/QFT- as well as THT2/QFT+ discordance were calculated. The analysis comprises 1,033 participants. Discordant results were observed in 15.4%, most of them being TST+/QFT- combinations. BCG vaccination or migration explained 85.1% of all TST+/QFT- discordance. Age explained 49.1% of all TST-/QFT+ discordance. Agreement between the two tests was 95.6% in German-born persons younger than 40 years and not BCG-vaccinated. Conclusions: After adjustment for potential risk factors for positive or negative TST results, agreement of QFT and TST is excellent with little potential that the TST is more likely to detect old infections than the QFT. In surveillance programs for LTBI in high-income, low TB incidence countries like Germany the QFT is especially suited for persons with BCG vaccination or migrants due to better specificity and in older persons due to its superior sensitivity.	[Nienhaus, Albert; Schablon, Anja] Inst Statutory Accid Insurance & Prevent Hlth & W, Dept Occupat Hlth Res, Hamburg, Germany; [Diel, Roland] Univ Dusseldorf, Inst Med Sociol, Sch Publ Hlth, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Nienhaus, A (corresponding author), Inst Statutory Accid Insurance & Prevent Hlth & W, Dept Occupat Hlth Res, Hamburg, Germany.	albert.nienhaus@bgw-online.de						Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barsegian V, 2008, J HOSP INFECT, V69, P69, DOI 10.1016/j.jhin.2008.02.009; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Diel R, 2007, Pneumologie, V61, P440, DOI 10.1055/s-2007-959219; Diel R, 2006, EUR RESPIR J, V28, P16, DOI 10.1183/09031936.06.00107005; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Franken WPJ, 2007, CLIN VACCINE IMMUNOL, V14, P477, DOI 10.1128/CVI.00463-06; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Infuso A, 2006, Euro Surveill, V11, P6, DOI 10.2807/esm.11.03.00604-en; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Keskiner R, 2004, INFECT CONT HOSP EP, V25, P1067, DOI 10.1086/502345; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; MANTOUX MC, 1912, PRESSE MED, V20, P146; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2005, Indian J Med Microbiol, V23, P151; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Robert Koch-Institut (RKI), 2002, EPIDEM B, V07, P49; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; *SIM GUTL, 1988, PRAX KLIN PNEUMOL, V42, P423; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; World Health Organization, 2008, GLOB TUB CONTR SURV; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	33	93	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2665	10.1371/journal.pone.0002665	http://dx.doi.org/10.1371/journal.pone.0002665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628829	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200011
J	Stein, A; Aloy, P				Stein, Amelie; Aloy, Patrick			Contextual Specificity in Peptide-Mediated Protein Interactions	PLOS ONE			English	Article								Most biological processes are regulated through complex networks of transient protein interactions where a globular domain in one protein recognizes a linear peptide from another, creating a relatively small contact interface. Although sufficient to ensure binding, these linear motifs alone are usually too short to achieve the high specificity observed, and additional contacts are often encoded in the residues surrounding the motif (i.e. the context). Here, we systematically identified all instances of peptide-mediated protein interactions of known three-dimensional structure and used them to investigate the individual contribution of motif and context to the global binding energy. We found that, on average, the context is responsible for roughly 20% of the binding and plays a crucial role in determining interaction specificity, by either improving the affinity with the native partner or impeding non-native interactions. We also studied and quantified the topological and energetic variability of interaction interfaces, finding a much higher heterogeneity in the context residues than in the consensus binding motifs. Our analysis partially reveals the molecular mechanisms responsible for the dynamic nature of peptide-mediated interactions, and suggests a global evolutionary mechanism to maximise the binding specificity. Finally, we investigated the viability of non-native interactions and highlight cases of potential cross-reaction that might compensate for individual protein failure and establish backup circuits to increase the robustness of cell networks.	[Stein, Amelie; Aloy, Patrick] BSC, IRB, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Stein, A (corresponding author), BSC, IRB, Barcelona, Spain.	patrick.aloy@irbbarcelona.org	Aloy, Patrick/AAB-3538-2019; Stein, Amelie/K-1417-2019	Stein, Amelie/0000-0002-5862-1681; Aloy, Patrick/0000-0002-3557-0236	Spanish Ministerio de Educacion y Ciencia [BIO2007-62426, PSE-010000-2007-1]; ICREA Funding Source: Custom	Spanish Ministerio de Educacion y Ciencia(Spanish Government); ICREA(ICREA)	This work has been supported by the Spanish Ministerio de Educacion y Ciencia through the grants BIO2007-62426 and PSE-010000-2007-1.	Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Folkertsma S, 2007, MOL ENDOCRINOL, V21, P30, DOI 10.1210/me.2006-0072; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mahajan A, 2005, J AM CHEM SOC, V127, P14572, DOI 10.1021/ja054538m; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	44	115	116	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2524	10.1371/journal.pone.0002524	http://dx.doi.org/10.1371/journal.pone.0002524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596940	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200004
J	Ng, AKL; Zhang, HM; Tan, KM; Li, ZL; Liu, JH; Chan, PKS; Li, SM; Chan, WY; Au, SWN; Joachimiak, A; Walz, T; Wang, JH; Shaw, PC				Ng, Andy Ka-Leung; Zhang, Hongmin; Tan, Kemin; Li, Zongli; Liu, Jin-Huan; Chan, Paul Kay-Sheung; Li, Sui-Mui; Chan, Wood-Yee; Au, Shannon Wing-Ngor; Joachimiak, Andrzej; Walz, Thomas; Wang, Jia-Huai; Shaw, Pang-Chui			Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design	FASEB JOURNAL			English	Article						protein-RNA interaction; crystal structure; trimerization	CYTOTOXIC T-LYMPHOCYTES; LIMIT ESCAPE; POLYMERASE; IDENTIFICATION; TRANSCRIPTION; ROLES; MODEL	The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-angstrom crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleo-protein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.	[Ng, Andy Ka-Leung; Li, Sui-Mui; Au, Shannon Wing-Ngor; Shaw, Pang-Chui] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Ng, Andy Ka-Leung; Shaw, Pang-Chui] Chinese Univ Hong Kong, Mol Biotechnol Program, Shatin, Hong Kong, Peoples R China; [Ng, Andy Ka-Leung; Li, Sui-Mui; Au, Shannon Wing-Ngor; Shaw, Pang-Chui] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Chan, Paul Kay-Sheung] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Chan, Wood-Yee] Chinese Univ Hong Kong, Dept Anat, Shatin, Hong Kong, Peoples R China; [Li, Zongli; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Zhang, Hongmin; Liu, Jin-Huan; Wang, Jia-Huai] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med,Dept Pediat,Dept Biol Chem & Mol Pharmaco, Boston, MA 02115 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Chan, Paul KS/J-9360-2013; Chan, Wood Yee/R-6692-2018; Li, Zongli/AAB-9100-2020; Zhang, Hongmin/C-4503-2009; Zhang, Hongmin/S-9953-2017	Chan, Paul KS/0000-0002-6360-4608; Chan, Wood Yee/0000-0002-7114-1463; Zhang, Hongmin/0000-0001-6357-4106; Zhang, Hongmin/0000-0003-4356-3615; Walz, Thomas/0000-0003-2606-2835	Chinese University [CUHK 472808]; HK-SAR; National Institutes of Health (NIH); Giovanni Armenise Harvard Center for Strucutural Biology	Chinese University; HK-SAR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise Harvard Center for Strucutural Biology	This work was supported by a Direct Research grant from the Chinese University and a General Research Fund grant (CUHK 472808) from the Research Grants Council of HK-SAR (P.-C.S.), a subcontracted National Institutes of Health (NIH) grant, and the Claudia Adams Barr Program in Cancer Research (J.-H.W.). The molecular EM facility at Harvard Medical School was established with it generous donation from the Giovanni Armenise Harvard Center for Strucutural Biology and is maintained with funds from NIH (T.W.), The authors (flank Professor Ming Luo for advice on the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Berkhoff EGM, 2006, VACCINE, V24, P6594, DOI 10.1016/j.vaccine.2006.05.051; Berkhoff EGM, 2005, J VIROL, V79, P11239, DOI 10.1128/JVI.79.17.11239-11246.2005; BISHOP DHL, 1971, J VIROL, V8, P66, DOI 10.1128/JVI.8.1.66-73.1971; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Boon ACM, 2006, J VIROL, V80, P6024, DOI 10.1128/JVI.00009-06; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano WL, 2002, PYMOL USERS MANUAL; Elton D, 1999, VIROLOGY, V260, P190, DOI 10.1006/viro.1999.9818; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Gschoesser C, 2002, VACCINE, V20, P3731, DOI 10.1016/S0264-410X(02)00355-9; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; KOBAYASHI M, 1994, J VIROL, V68, P8433, DOI 10.1128/JVI.68.12.8433-8436.1994; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Livingston BD, 2006, BIODRUGS, V20, P335, DOI 10.2165/00063030-200620060-00003; Luo M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-72; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Normile D, 2006, SCIENCE, V311, P315, DOI 10.1126/science.311.5759.315; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Prokudina EN, 2004, VIRUS RES, V99, P169, DOI 10.1016/j.virusres.2003.11.008; ProkudinaKantorovich EN, 1996, VIROLOGY, V223, P51, DOI 10.1006/viro.1996.0454; Rimmelzwaan GF, 2004, VIRUS RES, V103, P97, DOI 10.1016/j.virusres.2004.02.020; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; SKORKO R, 1991, VIROLOGY, V180, P668, DOI 10.1016/0042-6822(91)90080-U; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	40	175	187	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3638	3647		10.1096/fj.08-112110	http://dx.doi.org/10.1096/fj.08-112110			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18614582	Green Published			2022-12-25	WOS:000259642600025
J	Troeberg, L; Fushimi, K; Khokha, R; Emonard, H; Ghosh, P; Nagase, H				Troeberg, Linda; Fushimi, Kazunari; Khokha, Rama; Emonard, Herve; Ghosh, Peter; Nagase, Hideaki			Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases	FASEB JOURNAL			English	Article						ADAMTS; LRP; osteoarthitis; cartilage destruction; proteoglycan	MATRIX-METALLOPROTEINASE; TISSUE INHIBITOR; ARTICULAR-CARTILAGE; SULFATED GLYCOSAMINOGLYCANS; PROTEOLYTIC ACTIVITIES; MONOCLONAL-ANTIBODIES; ADAMTS4 AGGRECANASE-1; TIMP-3; OSTEOARTHRITIS; DEGRADATION	Degradation of the cartilage proteoglycan aggrecan is a key early event in the development of osteoarthritis. Adamalysin with thrombospondin motifs (ADAMTS) A and ADAMTS-5 are considered to be the main enzymes responsible for aggrecan breakdown, making them attractive drugs targets. Here we show that calcium pentosan polysulfate (CaPPS), a chemically sulfated xylanopyranose from beechwood, is a multifaceted exosite inhibitor of the aggrecanases and protects cartilage against aggrecan degradation. CaPPS interacts with the noncatalytic spacer domain of ADAMTS4 and the cysteine-rich domain of ADAMTS-5, blocking activity against their natural substrate aggrecan with inhibitory concentration 50 values of 10-40 nM but only weakly inhibiting hydrolysis of a nonglycosylated recombinant protein substrate. In addition, CaPPS increased cartilage levels of tissue inhibitor of metalloproteinases-3 (TIMP-3), an endogenous inhibitor of ADAMTS-4 and -5. This was due to the ability of CaPPS to block endocytosis of TIMP-3 mediated by low-density lipoprotein receptor-related protein. CaPPS also increased the affinity of TIMP-3 for ADAMTS-4 and -5 by more than 100-fold, improving the efficacy of TIMP-3 as an aggrecanase inhibitor. Studies with TIMP-3-null mouse cartilage indicated that CaPPS inhibition of aggrecan degradation is TIMP-3 dependent. These unique properties make CaPPS a prototypic disease-modifying agent for osteoarthritis.	[Troeberg, Linda; Fushimi, Kazunari; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England; [Khokha, Rama] Univ Toronto, Ontario Canc Res, Toronto, ON, Canada; [Emonard, Herve] Univ Reims, Fac Med, Reims, France; [Ghosh, Peter] Inst Nutraceut Res, Sydney, NSW, Australia	Imperial College London; University of Oxford; University of Toronto; Universite de Reims Champagne-Ardenne	Nagase, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	h.nagase@imperial.ac.uk	Emonard, Herve/R-9718-2019; Emonard, Hervé/AAD-5432-2019; Fushimi, Kazunari/AAN-8382-2021	Fushimi, Kazunari/0000-0003-0884-1990; Khokha, Rama/0000-0002-6028-1524; /0000-0003-0939-4651	Wellcome Trust [057508]; National Institutes of Health [AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Wellcome Trust grant. 057508 and U.S. National Institutes of Health grant AR40994 to H.N. We thank Shi-Lu Chia (Kennedy Institute of Rheumatology) for help with mouse explant culture and Bruce Caterson and Clare Hughes of the University of Cardiff (Cardiff, UK) for provision of 2-B-6, BC3, and BC 14 monoclonal antibodies. We are grateful to Jonathan Jones (Heatherwood and Wexham Park Hospitals, Slough, UK) and the Orthopaedic Surgery Department of Charing Cross Hospital (London, UK) for providing human cartilage.	Arris CE, 2003, BBA-MOL BASIS DIS, V1638, P20, DOI 10.1016/S0925-4439(03)00036-X; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bursavich MG, 2007, BIOORG MED CHEM LETT, V17, P5630, DOI 10.1016/j.bmcl.2007.07.048; Bursavich MG, 2007, BIOORG MED CHEM LETT, V17, P1185, DOI 10.1016/j.bmcl.2006.12.027; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; CATERSON B, 1985, FED PROC, V44, P386; Caterson B, 1995, ACTA ORTHOP SCAND, V66, P121, DOI 10.3109/17453679509157666; Edelman J., 1994, OSTEOARTHR CARTIL, V2, P35; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Ghosh P, 2005, CURR THER RES CLIN E, V66, P552, DOI 10.1016/j.curtheres.2005.12.012; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HASCALL VC, 1969, J BIOL CHEM, V244, P2384; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HUGHES CE, 1995, BIOCHEM J, V305, P799, DOI 10.1042/bj3050799; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Lauer-Fields JL, 2008, ANAL BIOCHEM, V373, P43, DOI 10.1016/j.ab.2007.09.014; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Munteanu SE, 2000, ARTHRITIS RHEUM, V43, P2211, DOI 10.1002/1529-0131(200010)43:10<2211::AID-ANR8>3.0.CO;2-D; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Sandy JD, 2006, OSTEOARTHR CARTILAGE, V14, P95, DOI 10.1016/j.joca.2005.09.004; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Takizawa M, 2000, ARTHRITIS RHEUM, V43, P812, DOI 10.1002/1529-0131(200004)43:4<812::AID-ANR11>3.0.CO;2-Y; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	47	85	87	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3515	3524		10.1096/fj.08-112680	http://dx.doi.org/10.1096/fj.08-112680			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18632849	Green Published			2022-12-25	WOS:000259642600014
J	Gross, J; Grass, S; Davis, AE; Gilmore-Erdmann, P; Townsend, RR; Geme, JWS				Gross, Julia; Grass, Susan; Davis, Alan E.; Gilmore-Erdmann, Petra; Townsend, R. Reid; Geme, Joseph W. St., III			The haemophilus influenzae HMW1 adhesin is a glycoprotein with an unusual N-linked carbohydrate modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POST-SOURCE-DECAY; PROTEIN-PHOSPHORYLATION; METASTABLE DECAY; SURFACE-LAYER; IDENTIFICATION; GLYCOSYLATION; GENES; ATTACHMENT; SECRETION; PATHOGENS	The Haemophilus influenzae HMW1 adhesin mediates adherence to respiratory epithelial cells, a critical early step in the pathogenesis of H. influenzae disease. In recent work, we demonstrated that HMW1 undergoes glycosylation. In addition, we observed that glycosylation of HMW1 is essential for HMW1 tethering to the bacterial surface, a prerequisite for HMW1-mediated adherence to host epithelium. In this study, we examined HMW1 proteolytic fragments by mass spectrometry, achieved 89% amino acid sequence coverage, and identified 31 novel modification sites. All of the modified sites were asparagine residues, in all but one case in the conventional consensus sequence of N-linked glycans, viz. NX(S/T). Liquid chromatography-tandem mass spectrometry analysis using a hybrid linear quadrupole ion trap Fourier transform ion cyclotron mass spectrometer, accurate mass measurements, and deuterium exchange studies established that the modifying glycan structures were mono- or dihexoses rather than the N-acetylated chitobiosyl core that is characteristic of N-glycosylation. This unusual carbohydrate modification suggests that HMW1 glycosylation requires a glycosyltransferase with a novel activity.	[Geme, Joseph W. St., III] Duke Univ, Med Ctr, Dept Pediat, Childrens Hlth Ctr, Durham, NC 27710 USA; [Grass, Susan; Geme, Joseph W. St., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Gross, Julia; Davis, Alan E.; Gilmore-Erdmann, Petra; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Duke University; Duke University; Washington University (WUSTL); Washington University (WUSTL)	Geme, JWS (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Childrens Hlth Ctr, Rm T901, Durham, NC 27710 USA.	j.stgeme@duke.edu			United States Public Health Service [DC-02873]; University of Georgia [2-P41-RR05351]; Washington University Mass Spectrometry Resource [P41-RR00954]; William M. Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Georgia; Washington University Mass Spectrometry Resource; William M. Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by United States Public Health Service Grants RO1 DC-02873 (to J.W.S.), 2-P41-RR05351 (to the University of Georgia Complex Carbohydrate Research Center), and P41-RR00954 (to the Washington University Mass Spectrometry Resource) and by the William M. Keck Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; Barenkamp SJ, 1996, INFECT IMMUN, V64, P1246, DOI 10.1128/IAI.64.4.1246-1251.1996; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; Geme JWS, 1998, MOL MICROBIOL, V27, P617; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Gross J, 1998, J AM SOC MASS SPECTR, V9, P866, DOI 10.1016/S1044-0305(98)00058-0; Gross J, 2001, J AM SOC MASS SPECTR, V12, P180, DOI 10.1016/S1044-0305(00)00209-9; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; King JB, 2007, RAPID COMMUN MASS SP, V21, P3443, DOI 10.1002/rcm.3223; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; KUPCU Z, 1984, FEBS LETT, V173, P185, DOI 10.1016/0014-5793(84)81043-1; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; MESSNER P, 1988, FEBS LETT, V228, P317, DOI 10.1016/0014-5793(88)80023-1; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; St Geme JW, 1998, INFECT IMMUN, V66, P364; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; Surana NK, 2004, P NATL ACAD SCI USA, V101, P14497, DOI 10.1073/pnas.0404679101; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Virji M, 1997, GENE, V192, P141, DOI 10.1016/S0378-1119(97)00082-6	27	83	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26010	26015		10.1074/jbc.M801819200	http://dx.doi.org/10.1074/jbc.M801819200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621734	Green Published, hybrid			2022-12-25	WOS:000259200100029
J	MacFarlane, AJ; Liu, XW; Perry, CA; Flodby, P; Allen, RH; Stabler, SP; Stover, PJ				MacFarlane, Amanda J.; Liu, Xiaowen; Perry, Cheryll A.; Flodby, Per; Allen, Robert H.; Stabler, Sally P.; Stover, Patrick J.			Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; FOLATE-DEFICIENCY; GENE; COBALAMIN; MAMMALS	The hydroxymethyl group of serine is a primary source of tetrahydrofolate (THF)-activated one-carbon units that are required for the synthesis of purines and thymidylate and for S-adenosylmethionine (AdoMet)-dependent methylation reactions. Serine hydroxylmethyltransferase (SHMT) catalyzes the reversible and THF-dependent conversion of serine to glycine and 5,10-methylene-THF. SHMT is present in eukaryotic cells as mitochondrial SHMT and cytoplasmic (cSHMT) isozymes that are encoded by distinct genes. In this study, the essentiality of cSHMT-derived THF-activated one-carbons was investigated by gene disruption in the mouse germ line. Mice lacking cSHMT are viable and fertile, demonstrating that cSHMT is not an essential source of THF-activated one-carbon units. cSHMT-deficient mice exhibit altered hepatic AdoMet levels and uracil content in DNA, validating previous in vitro studies that indicated this enzyme regulates the partitioning of methylenetetrahydrofolate between the thymidylate and homocysteine remethylation pathways. This study suggests that mitochondrial SHMT-derived one-carbon units are essential for folate-mediated one-carbon metabolism in the cytoplasm.	[MacFarlane, Amanda J.; Liu, Xiaowen; Perry, Cheryll A.; Flodby, Per; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Div Hematol, Denver, CO 80262 USA	Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the USPHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; STABLER SP, 1993, BLOOD, V81, P3404; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Townsend JH, 2004, AM J PHYSIOL-GASTR L, V286, pG588, DOI 10.1152/ajpgi.00454.2003; Vatcher GP, 1998, J BIOL CHEM, V273, P6066, DOI 10.1074/jbc.273.11.6066; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	17	106	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25846	25853		10.1074/jbc.M802671200	http://dx.doi.org/10.1074/jbc.M802671200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644786	hybrid, Green Published			2022-12-25	WOS:000259200100011
J	Hall, JR; Lee, HO; Bunker, BD; Dorn, ES; Rogers, GC; Duronio, RJ; Cook, JG				Hall, Jonathan R.; Lee, Hyun O.; Bunker, Brandon D.; Dorn, Elizabeth S.; Rogers, Greg C.; Duronio, Robert J.; Cook, Jeanette Gowen			Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RE-REPLICATION; MAMMALIAN-CELLS; PREVENTS REREPLICATION; MULTIPLE MECHANISMS; G(2)/M CHECKPOINT; EUKARYOTIC CELLS; GEMININ; DEGRADATION; STABILITY; PATHWAY	The replication factors Cdt1 and Cdc6 are essential for origin licensing, a prerequisite for DNA replication initiation. Mechanisms to ensure that metazoan origins initiate once per cell cycle include degradation of Cdt1 during S phase and inhibition of Cdt1 by the geminin protein. Geminin depletion or overexpression of Cdt1 or Cdc6 in human cells causes rereplication, a form of endogenous DNA damage. Rereplication induced by these manipulations is however uneven and incomplete, suggesting that one or more mechanisms restrain rereplication once it begins. We find that both Cdt1 and Cdc6 are degraded in geminin-depleted cells. We further show that Cdt1 degradation in cells that have rereplicated requires the PCNA binding site of Cdt1 and the Cu14(DDB1) ubiquitin ligase, and Cdt1 can induce its own degradation when overproduced. Cdc6 degradation in geminin-depleted cells requires Huwe1, the ubiquitin ligase that regulates Cdc6 after DNA damage. Moreover, perturbations that specifically disrupt Cdt1 and Cdc6 degradation in response to DNA damage exacerbate rereplication when combined with geminin depletion, and this enhanced rereplication occurs in both human cells and in Drosophila melanogaster cells. We conclude that rereplication-associated DNA damage triggers Cdt1 and Cdc6 ubiquitination and destruction, and propose that this pathway represents an evolutionarily conserved mechanism that minimizes the extent of rereplication.	[Hall, Jonathan R.; Bunker, Brandon D.; Dorn, Elizabeth S.; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lee, Hyun O.; Duronio, Robert J.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Rogers, Greg C.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.; Cook, Jeanette Gowen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	jean_cook@med.unc.edu		Duronio, Robert/0000-0001-6469-6965; Cook, Jeanette/0000-0003-0849-7405	NATIONAL CANCER INSTITUTE [K01CA094907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA094907, K01 CA 094907, K01 CA094907-04, K01 CA094907-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM083024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blanchard F, 2002, MOL BIOL CELL, V13, P1536, DOI 10.1091/mbc.02-02-0010; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Lee AYL, 2007, J BIOL CHEM, V282, P32243, DOI 10.1074/jbc.M705486200; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	44	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25356	25363		10.1074/jbc.M802667200	http://dx.doi.org/10.1074/jbc.M802667200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617514	hybrid, Green Published			2022-12-25	WOS:000259012700030
J	Tang, ML; Vararattanavech, A; Tan, SM				Tang, Man-Li; Vararattanavech, Ardcharaporn; Tan, Suet-Mien			Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alpha(M)beta(2) headpiece and reorientation of its transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN ALPHA(M)BETA(2); MONOCLONAL-ANTIBODY; I-DOMAIN; COMPLEMENT RECEPTOR-TYPE-3; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; DEFICIENT MICE; A-DOMAIN; MAC-1	The glycosylphosphatidylinositol-linked urokinase- type plasminogen activator receptor (uPAR) interacts with the heterodimer cell adhesion molecules integrins to modulate cell adhesion and migration. Devoid of a cytoplasmic domain, uPAR triggers intracellular signaling via its associated molecules that contain cytoplasmic domains. Interestingly, uPAR changes the ectodomain conformation of one of its partner molecules, integrin alpha(5)beta(1), and elicits cytoplasmic signaling. The separation or reorientation of integrin transmembrane domains and cytoplasmic tails are required for integrin outside-in signaling. However, there is a lack of direct evidence showing these conformational changes of an integrin that interacts with uPAR. In this investigation we used reporter monoclonal antibodies and fluorescence resonance energy transfer analyses to show conformational changes in the alpha(M)beta(2) headpiece and reorientation of its transmembrane domains when alpha(M)beta(2) interacts with uPAR.	[Tang, Man-Li; Vararattanavech, Ardcharaporn; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Tan, Suet/A-2224-2011	Tan, Suet-Mien/0000-0003-2371-8739	Singapore A*STAR BMRC [04/1/22/19/358]	Singapore A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore A*STAR BMRC Grant 04/1/22/19/358. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; ALTIERI DC, 1991, J IMMUNOL, V147, P1891; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4; Annenkov A, 1996, EUR J IMMUNOL, V26, P207, DOI 10.1002/eji.1830260132; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; BARCLAY AN, 1997, LEUKOCYTE FACTS BOOK, P158; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; CAO DR, 1995, J IMMUNOL, V154, P1817; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Cywes C, 1996, INFECT IMMUN, V64, P5373, DOI 10.1128/IAI.64.12.5373-5383.1996; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fu G, 2006, BIOCHEM BIOPH RES CO, V346, P986, DOI 10.1016/j.bbrc.2006.06.015; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Juffermans NP, 2001, INFECT IMMUN, V69, P5182, DOI 10.1128/IAI.69.8.5182-5185.2001; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Plow EF, 1997, J CLIN INVEST, V99, P1145, DOI 10.1172/JCI119267; Pluskota E, 2004, J BIOL CHEM, V279, P18063, DOI 10.1074/jbc.M310462200; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; Rosenkranz AR, 1998, J IMMUNOL, V161, P6463; Shaw JM, 2001, CLIN EXP IMMUNOL, V126, P311, DOI 10.1046/j.1365-2249.2001.01661.x; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; UCIECHOWSKI P, 1989, CLUSTER REPORT CD11; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; VIOLETTE SM, 1995, J IMMUNOL, V155, P3092; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xue W, 1997, CANCER RES, V57, P1682; XUE W, 1994, J IMMUNOL, V152, P4630; Zhang H, 2003, INFLAMM RES, V52, P86, DOI 10.1007/s000110300006; ZHOU MJ, 1993, J IMMUNOL, V150, P3030; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	68	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25392	25403		10.1074/jbc.M802311200	http://dx.doi.org/10.1074/jbc.M802311200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644795	hybrid			2022-12-25	WOS:000259012700034
J	Landgraf, P; Wahle, P; Pape, HC; Gundelfinger, ED; Kreutz, MR				Landgraf, Peter; Wahle, Petra; Pape, Hans-Christian; Gundelfinger, Eckart D.; Kreutz, Michael R.			The Survival-promoting Peptide Y-P30 Enhances Binding of Pleiotrophin to Syndecan-2 and-3 and Supports Its Neuritogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYSIS-INDUCING FACTOR; GROWTH-ASSOCIATED MOLECULE; NF-KAPPA-B; HEPARAN-SULFATE PROTEOGLYCANS; MUSCLE PROTEIN-DEGRADATION; CANCER CACHECTIC FACTOR; HB-GAM; NEURITE OUTGROWTH; BREAST-CANCER; RAT-BRAIN	Y-P30 is a polypeptide produced by peripheral blood mononuclear cells of the maternal immune system during pregnancy. The peptide passes the blood-placenta barrier and accumulates in neurons of the developing infant brain, where it enhances survival of thalamic neurons and displays neuritogenic activities. In this study, we identify pleiotrophin (PTN) and syndecan-2 and -3 as direct binding partners of Y-P30. PTN is known to promote neurite outgrowth of thalamic neurons due to its association with the proteoglycan syndecan-3. Via spontaneous oligomerization Y-P30 can capture large macromolecular complexes containing PTN and potentially syndecans. Accordingly, the neuritogenic activity of Y-P30 in thalamic primary cultures requires the presence of PTN in the media and binding to syndecans. Thus, we propose that the neurite outgrowth promoting actions of Y-P30 during brain development are essentially based on its association with the PTN/syndecan signaling complex. This identifies a new mechanism of communication between the nervous and the immune system that might directly affect the wiring of the brain during development.	[Landgraf, Peter; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Nueorchem Mol Biol, D-39118 Magdeburg, Germany; [Wahle, Petra] Ruhr Univ Bochum, Fac Biol, AG Dev Biol, D-44780 Bochum, Germany; [Pape, Hans-Christian] Univ Munster, Inst Physiol, D-48149 Munster, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Ruhr University Bochum; University of Munster	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuroplast, Brenneckestr 6, D-39118 Magdeburg, Germany.	Kreutz@ifn-magdeburg.de			Bundes ministerium fur Bildung und Forschung [01GA0505]; Deutsche Forschungsgemeinschaft [SFB 779 TPB8]; Leibniz-Society; Land Sachsen-Anhalt [N1/TP4/MRK, N2/TP5]; Schram Foundation; Fonds der Chemischen Industrie	Bundes ministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz-Society; Land Sachsen-Anhalt; Schram Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Bundes ministerium fur Bildung und Forschung (Grant 01GA0505 to M. R. K. and E. D. G.), Deutsche Forschungsgemeinschaft (Grant SFB 779 TPB8), Leibniz-Society (Pakt fur Forschung to M. R. K.), Land Sachsen-Anhalt (Grants N1/TP4/MRK and N2/TP5 to M. R. K. and E. D. G.), the Schram Foundation (to M. R. K.), and Fonds der Chemischen Industrie (to E. D. G.).	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bernard-Pierrot I, 1999, BIOCHEM BIOPH RES CO, V266, P437, DOI 10.1006/bbrc.1999.1835; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Cabal-Manzano R, 2001, BRIT J CANCER, V84, P1599, DOI 10.1054/bjoc.2001.1830; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2000, EXP NEUROL, V163, P457, DOI 10.1006/exnr.2000.7390; Deans DAC, 2006, BRIT J CANCER, V94, P731, DOI 10.1038/sj.bjc.6602989; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Helmuth M, 2001, ANAL BIOCHEM, V293, P149, DOI 10.1006/abio.2001.5107; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Kinnunen A, 1999, EUR J NEUROSCI, V11, P491, DOI 10.1046/j.1460-9568.1999.00457.x; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Landgraf P, 2004, FASEB J, V18, P225, DOI 10.1096/fj.04-1789fje; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lorite MJ, 1998, BRIT J CANCER, V78, P850, DOI 10.1038/bjc.1998.592; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; RAULO E, 1994, J BIOL CHEM, V269, P12999; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RAULO E, 1992, J BIOL CHEM, V267, P11408; Russell ST, 2008, BIOCHEM J, V409, P751, DOI 10.1042/BJ20070688; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Smith HJ, 2003, BRIT J CANCER, V89, P1783, DOI 10.1038/sj.bjc.6601328; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Todorov PT, 1999, BRIT J CANCER, V80, P1734, DOI 10.1038/sj.bjc.6690590; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8; Watchorn TM, 2002, AM J PHYSIOL-ENDOC M, V282, pE763, DOI 10.1152/ajpendo.00408.2001; Watchorn TM, 2001, FASEB J, V15, P562; Whitehouse AS, 2003, BRIT J CANCER, V89, P1116, DOI 10.1038/sj.bjc.6601132; Wyke SM, 2005, BRIT J CANCER, V92, P711, DOI 10.1038/sj.bjc.6602402; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	42	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25036	25045		10.1074/jbc.M800963200	http://dx.doi.org/10.1074/jbc.M800963200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18599487	hybrid, Green Published			2022-12-25	WOS:000271617300011
J	Khalil, A; Muttukrishna, S; Harrington, K; Jauniaux, E				Khalil, Asma; Muttukrishna, Shanthi; Harrington, Kevin; Jauniaux, Eric			Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders	PLOS ONE			English	Article								Background: Antihypertensive drugs are believed to lower blood pressure in pre-eclampsia by direct or central vasodilatory mechanisms. However, they could also act by decreasing production of anti-angiogenic proteins involved in the pathophysiology of hypertension and proteinuria in pre-eclampsia (PE). The aim of our study was to evaluate the impact of antihypertensive therapy with alpha methyldopa on maternal circulating levels and placental production of soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin (sEng), vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in hypertensive disorders of pregnancy. Methodology/Principal Findings: In a study conducted at University College Hospital and the Homerton University Hospital in London, we recruited 51 women with PE, 29 with gestational hypertension (GH), and 80 matched normotensive controls. Eight (16%) of the women with PE had severe disease. Placental samples were obtained from a further 48 women (14 PE, 10 GH and 24 matched controls). Serum levels of angiogenic factors were measured before and 24-48 hours after commencing antihypertensive therapy with alpha methyldopa for clinical indications. The same parameters were measured in placental extracts. In both PE (P < 0.0001) and GH (P < 0.05), serum sFlt-1 was increased and PlGF reduced at all gestations (P < 0.001) compared to controls. Serum sEng levels were also increased in PE. Placental concentration of sFlt-1 and sEng was significantly higher in women with PE compared to controls and women with GH (P < 0.0001). The concentration of PlGF was significantly lower in the placental tissue of women with PE compared to GH (P = 0.008). Antihypertensive treatment was associated with a significant fall in serum and placental content of sFlt1 and sEng in PE only. Conclusions: Our data suggest that alpha methyldopa may have a specific effect on placental and/or endothelial cell function in pre-eclampsia patients, altering angiogenic proteins.	[Khalil, Asma; Harrington, Kevin] Univ London, Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London, England; [Muttukrishna, Shanthi; Jauniaux, Eric] UCL, UCL Inst Womens Hlth, Acad Dept Obstet & Gynaecol, London, England	University of London; Queen Mary University London; University of London; University College London	Khalil, A (corresponding author), Univ London, Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London, England.	asmakhalil79@googlemail.com	Khall, Asma/AAC-1459-2020	Khall, Asma/0000-0003-2802-7670				Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; BELGORE FM, 2001, AM J CARDIOL, V87, pA9; BOTTARI SP, 1983, J CLIN ENDOCR METAB, V57, P937, DOI 10.1210/jcem-57-5-937; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Celik-Ozenci C, 2004, MOL REPROD DEV, V67, P414, DOI 10.1002/mrd.20001; Celik-Ozenci C, 2003, HISTOCHEM CELL BIOL, V120, P383, DOI 10.1007/s00418-003-0586-4; Clark DE, 1998, J ENDOCRINOL, V159, P459, DOI 10.1677/joe.0.1590459; DAY MD, 1973, EUR J PHARMACOL, V21, P271, DOI 10.1016/0014-2999(73)90126-X; Failla CM, 2000, J INVEST DERMATOL, V115, P388, DOI 10.1046/j.1523-1747.2000.00085.x; FALKAY G, 1994, PLACENTA, V15, P661, DOI 10.1016/S0143-4004(05)80412-6; FALKAY G, 1994, J RECEPTOR RES, V14, P187, DOI 10.3109/10799899409066030; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Head GA, 1998, J AUTONOM NERV SYST, V72, P163, DOI 10.1016/S0165-1838(98)00101-5; HENNING M, 1971, J PHARM PHARMACOL, V23, P407, DOI 10.1111/j.2042-7158.1971.tb08671.x; Hollborn M, 2006, GRAEF ARCH CLIN EXP, V244, P732, DOI 10.1007/s00417-005-0154-9; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; MAGLIONE D, 1993, ONCOGENE, V8, P925; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Muthig V, 2007, CIRC RES, V101, P682, DOI 10.1161/CIRCRESAHA.107.151563; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Raab U, 1999, FEBS LETT, V459, P249, DOI 10.1016/S0014-5793(99)01252-1; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Szelenyi J, 2000, ANN NY ACAD SCI, V917, P145; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; VANZWIETEN PA, 1984, AM J MED, V77, P17, DOI 10.1016/S0002-9343(84)80033-9; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VIGLIETTO G, 1995, ONCOGENE, V11, P1569; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823	44	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2766	10.1371/journal.pone.0002766	http://dx.doi.org/10.1371/journal.pone.0002766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648513	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000264302900036
J	Sanz-Blasco, S; Valero, RA; Rodriguez-Crespo, I; Villalobos, C; Nunez, L				Sanz-Blasco, Sara; Valero, Ruth A.; Rodriguez-Crespo, Ignacio; Villalobos, Carlos; Nunez, Lucia			Mitochondrial Ca2+ Overload Underlies A beta Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM; CORTICAL-NEURONS; OXIDATIVE STRESS; CALCIUM; ACTIVATION; INHIBITION; APOPTOSIS	Dysregulation of intracellular Ca2+ homeostasis may underlie amyloid beta peptide (A beta) toxicity in Alzheimer's Disease (AD) but the mechanism is unknown. In search for this mechanism we found that A beta(1-42) oligomers, the assembly state correlating best with cognitive decline in AD, but not A beta fibrils, induce a massive entry of Ca2+ in neurons and promote mitochondrial Ca2+ overload as shown by bioluminescence imaging of targeted aequorin in individual neurons. A beta oligomers induce also mitochondrial permeability transition, cytochrome c release, apoptosis and cell death. Mitochondrial depolarization prevents mitochondrial Ca2+ overload, cytochrome c release and cell death. In addition, we found that a series of nonsteroidal anti-inflammatory drugs (NSAIDs) including salicylate, sulindac sulfide, indomethacin, ibuprofen and R-flurbiprofen depolarize mitochondria and inhibit mitochondrial Ca2+ overload, cytochrome c release and cell death induced by A beta oligomers. Our results indicate that i) mitochondrial Ca2+ overload underlies the neurotoxicity induced by A beta oligomers and ii) inhibition of mitochondrial Ca2+ overload provides a novel mechanism of neuroprotection by NSAIDs against A beta oligomers and AD.	[Sanz-Blasco, Sara; Valero, Ruth A.; Villalobos, Carlos; Nunez, Lucia] Univ Valladolid, IBGM, Valladolid, Spain; [Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quimicas, Dept Bioquim Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Complutense University of Madrid	Sanz-Blasco, S (corresponding author), Univ Valladolid, IBGM, Valladolid, Spain.	carlosv@ibgm.uva.es	nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Villalobos, Carlos/0000-0002-0429-3846; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Nunez, Lucia/0000-0002-9638-5747	Spanish Instituto de Salud Carlos III [PI04/1510, PI07/0766]; Junta de Castilla y Leon [VA022A05]; Ministerio de Educacion y Ciencia [BFU2006-05202]; Consejo Superior de Investigaciones Cientificas (CSIC)	Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC)	This work was supported by public, competitive grants from the spanish Instituto de Salud Carlos III (PI04/1510 and PI07/0766), Junta de Castilla y Leon (VA022A05), Ministerio de Educacion y Ciencia (MEC, BFU2006-05202) and Consejo Superior de Investigaciones Cientificas (CSIC). None of the funding agencies have any role in the design and conduct of the study, collection, analysis or interpretation of the data nor the preparation review or approval of the manuscript.	Abramov AY, 2003, J NEUROSCI, V23, P5088; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; BURDICK D, 1992, J BIOL CHEM, V267, P546; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canu N, 2003, CEREBELLUM, V2, P270, DOI 10.1080/14734220310004289; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Guo Q, 1998, P NATL ACAD SCI USA, V95, P3227, DOI 10.1073/pnas.95.6.3227; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Kawai K, 2001, NEUROPATHOLOGY, V21, P13, DOI 10.1046/j.1440-1789.2001.00362.x; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Mahmud T, 1996, ARTHRITIS RHEUM, V39, P1998, DOI 10.1002/art.1780391208; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; MURPHY TH, 1992, J NEUROSCI, V12, P4834; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Nunez L, 1996, EUR J NEUROSCI, V8, P192, DOI 10.1111/j.1460-9568.1996.tb01180.x; Nunez L, 2007, J PHYSIOL-LONDON, V580, P385, DOI 10.1113/jphysiol.2006.126524; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Simakova O, 2006, BIOCHEMISTRY-US, V45, P5907, DOI 10.1021/bi060148g; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; VALERO RA, 2008, CELL CALCIU IN PRESS; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; Villalobos C, 2001, J BIOL CHEM, V276, P40293, DOI 10.1074/jbc.C100465200; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Xie L, 2005, J CELL BIOL, V168, P911, DOI 10.1083/jcb.200407079; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002	60	165	178	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2718	10.1371/journal.pone.0002718	http://dx.doi.org/10.1371/journal.pone.0002718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648507	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900005
J	Li, YH; Rowland, C; Xiromerisiou, G; Lagier, RJ; Schrodi, SJ; Dradiotis, E; Ross, D; Bui, N; Catanese, J; Aggelakis, K; Grupe, A; Hadjigeorgiou, G				Li, Yonghong; Rowland, Charles; Xiromerisiou, Georgia; Lagier, Robert J.; Schrodi, Steven J.; Dradiotis, Efthimios; Ross, David; Bui, Nam; Catanese, Joseph; Aggelakis, Konstantinos; Grupe, Andrew; Hadjigeorgiou, Georgios			Neither Replication nor Simulation Supports a Role for the Axon Guidance Pathway in the Genetics of Parkinson's Disease	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; LRRK2 G2019S; POLYMORPHISMS; RISK; SUSCEPTIBILITY; IDENTIFICATION; SAMPLES; SEMA5A	Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting PD risk, survival free of the disease and age at disease onset; however the specific models have not undergone independent validation. Here we tested the best proposed risk panel of 23 single nucleotide polymorphisms (SNPs) in two PD sample sets, with a total of 525 cases and 518 controls. By single marker analysis, only one marker was significantly associated with PD risk in one of our sample sets (rs6692804: P = 0.03). Multi-marker analysis using the reported model found a mild association in one sample set (two sided P = 0.049, odds ratio for each score change = 1.07) but no significance in the other (two sided P = 0.98, odds ratio = 1), a stark contrast to the reported strong association with PD risk (P = 4.64 x 10(-38), odds ratio as high as 90.8). Following a procedure similar to that used to build the reported model, simulated multi-marker models containing SNPs from randomly chosen genes in a genome wide PD dataset produced P-values that were highly significant and indistinguishable from similar models where disease status was permuted (3.13 x 10(-23) to 4.90 x 10(-64)), demonstrating the potential for overfitting in the model building process. Together, these results challenge the robustness of the reported panel of genetic markers to predict PD risk in particular and a role of the axon guidance pathway in PD genetics in general.	[Li, Yonghong; Rowland, Charles; Lagier, Robert J.; Schrodi, Steven J.; Ross, David; Bui, Nam; Catanese, Joseph; Grupe, Andrew] Celera, Alameda, CA USA; [Xiromerisiou, Georgia; Dradiotis, Efthimios; Aggelakis, Konstantinos; Hadjigeorgiou, Georgios] Univ Thessaly, Med Sch, Dept Neurol, Larisa, Greece; [Hadjigeorgiou, Georgios] CERETETH, Inst Biomed Res & Technol, Larisa, Greece	University of Thessaly	Li, YH (corresponding author), Celera, Alameda, CA USA.	yonghong.li@celera.com	Schrodi, Steven J./O-4288-2019; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Schrodi, Steven J./0000-0003-2304-8528; Xiromerisiou, Georgia/0000-0001-7162-3588; Li, Yonghong/0000-0001-7326-0717	Celera	Celera	This work was partly supported by Celera.	Bialecka M, 2006, NEUROSCI LETT, V399, P121, DOI 10.1016/j.neulet.2006.01.038; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Shiffman D, 2006, CURR OPIN MOL THER, V8, P493; Shriner D, 2007, SCIENCE, V316, P1840; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; WANG K, 2007, AM J HUM GENET; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Xiromerisiou G, 2007, NEUROSCI LETT, V415, P59, DOI 10.1016/j.neulet.2006.12.038; Xiromerisiou G, 2007, EUR J NEUROL, V14, P7, DOI 10.1111/j.1468-1331.2006.01551.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang J, 2005, EUR NEUROL, V53, P15, DOI 10.1159/000082956	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2707	10.1371/journal.pone.0002707	http://dx.doi.org/10.1371/journal.pone.0002707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628988	gold, Green Published			2022-12-25	WOS:000264057200050
J	Prost, MA; Jahn, A; Floyd, S; Mvula, H; Mwaiyeghele, E; Mwinuka, V; Mhango, T; Crampin, AC; McGrath, N; Fine, PEM; Glynn, JR				Prost, Marc-Andre; Jahn, Andreas; Floyd, Sian; Mvula, Hazzie; Mwaiyeghele, Eleneus; Mwinuka, Venance; Mhango, Thomas; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Glynn, Judith R.			Implication of New WHO Growth Standards on Identification of Risk Factors and Estimated Prevalence of Malnutrition in Rural Malawian Infants	PLOS ONE			English	Article								Background: The World Health Organization (WHO) released new Child Growth Standards in 2006 to replace the current National Center for Health Statistics (NCHS) growth reference. We assessed how switching from the NCHS to the newly released WHO Growth Standards affects the estimated prevalence of wasting, underweight and stunting, and the pattern of risk factors identified. Methodology/Principal Findings: Data were drawn from a village-informant driven Demographic Surveillance System in Northern Malawi. Children (n = 1328) were visited twice at 0-4 months and 11-15 months. Data were collected on the demographic and socio-economic environment of the child, health history, maternal and child anthropometry and child feeding practices. Weight-for-length, weight-for-age and length-for-age were derived in z-scores using the two growth references. In early infancy, prevalence estimates were 2.9, 6.1, and 8.5 fold higher for stunting, underweight, and wasting respectively using the WHO standards compared to NCHS reference (p < 0.001 for all). At one year, prevalence estimates for wasting and stunting did not differ significantly according to reference used, but the prevalence of underweight was half that with the NCHS reference (p < 0.001). Patterns of risk factors were similar with the two growth references for all outcomes at one year although the strength of association was higher with WHO standards. Conclusions/Significance: Differences in prevalence estimates differed in magnitude but not direction from previous studies. The scale of these differences depends on the population's nutritional status thus it should not be assumed a priori. The increase in estimated prevalence of wasting in early infancy has implications for feeding programs targeting lactating mothers and ante-natal multiple micronutrients supplementation to tackle small birth size. Risk factors identified using WHO standards remain comparable with findings based on the NCHS reference in similar settings. Further research should aim to identify whether the young infants additionally diagnosed as malnourished by this new standard are more appropriate targets for interventions than those identified with the NCHS reference.	[Prost, Marc-Andre; Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, London WC1E 7HT, England; [Jahn, Andreas; Mvula, Hazzie; Mwaiyeghele, Eleneus; Mwinuka, Venance; Mhango, Thomas; Crampin, Amelia C.; McGrath, Nuala] Karonga Prevent Study, Chilumba, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Prost, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, Keppel St, London WC1E 7HT, England.	marco@thepep.net	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust; UK Department of Health [Public Health Career Scientist award]	Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health	This work was supported in full by funds from the Wellcome Trust. JRG was supported in part by the UK Department of Health (Public Health Career Scientist award). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165; COLLINS S, 2000, ASSESSMENT NUTR STAT, P8; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; De Onis M, 2004, J PEDIATR-US, V144, P461, DOI 10.1016/j.jpeds.2003.12.034; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Espo M, 2002, ACTA PAEDIATR, V91, P1364, DOI 10.1111/j.1651-2227.2002.tb02835.x; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Hotz C, 2001, EUR J CLIN NUTR, V55, P841, DOI 10.1038/sj.ejcn.1601239; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; *MAL NAT STAT OFF, 2005, MAL DEM HLTH SURV 20, P163; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Maleta K, 2003, ARCH DIS CHILD, V88, P574, DOI 10.1136/adc.88.7.574; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; Onyango AW, 2007, J NUTR, V137, P149, DOI 10.1093/jn/137.1.149; *ORC MACR, 2006, NUTR YOUNG CHILDR MO, P18; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; The World Health Organization, 1995, PHYS STAT US INT ANT, P364; UNICEF, 2003, STAT WORLDS CHILDR 2; UNICEF, 2006, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 1997, STAT WORLDS CHILDR 1; *WHO, 2006, WHO ANTR 2005 SOFTW; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2001, OPT DUR EXCL BREASTF	27	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2684	10.1371/journal.pone.0002684	http://dx.doi.org/10.1371/journal.pone.0002684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628980	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000264057200028
J	Garamszegi, LZ; Eens, M; Torok, J				Garamszegi, Laszlo Zsolt; Eens, Marcel; Toeroek, Janos			Birds Reveal their Personality when Singing	PLOS ONE			English	Article							COLLARED FLYCATCHER; FEMALE CHOICE; FITNESS CONSEQUENCES; EXPLORATORY-BEHAVIOR; AVIAN PERSONALITIES; SEXUAL SELECTION; WILLOW WARBLER; PREDATION RISK; LIFE-HISTORY; SONG	Background: Individual differences in social behaviour may have consequences for mate choice and sexual signalling, because partners should develop preferences for personalities that maximize reproductive output. Here we propose that behavioural traits involved in sexual advertisement may serve as good indicators of personality, which is fundamental for sexual selection to operate on temperament. Bird song has a prominent and well-established role in sexual selection, and it displays considerable variation among individuals with a potentially strong personality component. Therefore, we predicted that features of song would correlate with estimates of personality. Methodology/Principal Findings: In a field study of free-living male collared flycatchers, Ficedula albicollis, we characterised personality based on the exploration of an altered breeding environment, and based on the risk taken when a potential predator was approaching during a simulated territorial interaction. We found that explorative and risk-taker individuals consistently sang at lower song posts than shy individuals in the presence of a human observer. Moreover, males from lower posts established pair-bonds relatively faster than males from higher posts. Conclusions/Significance: Our results may demonstrate that risk taking during singing correlates with risk taking during aggression and with exploration, thus personality may be manifested in different contexts involving sexual advertisement. These findings are in accordance with the hypothesis that the male's balance between investment in reproduction and risk taking is reflected in sexual displays, and it may be important information for choosy females that seek partners with personality traits enhancing breeding success.	[Garamszegi, Laszlo Zsolt; Eens, Marcel] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Toeroek, Janos] Eotvos Lorand Univ, Dept Syst Zool & Ecol, Budapest, Hungary	University of Antwerp; Eotvos Lorand University	Garamszegi, LZ (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	laszlo.garamszegi@ua.ac.be	Garamszegi, Laszlo/M-1488-2015; Eens, Marcel/AAC-8466-2020; Garamszegi, Laszlo Z/B-5089-2011; Torok, Janos/C-6144-2008	Garamszegi, Laszlo/0000-0001-8920-2183; Torok, Janos/0000-0002-4799-5522	FWO Flanders (Belgium) [post-doc fellowship]; University of Antwerp; National Scientific Research Fund, Hungary [T049678, T049650]	FWO Flanders (Belgium)(FWO); University of Antwerp; National Scientific Research Fund, Hungary	During this study LZG received a post-doc fellowship from the FWO Flanders (Belgium). ME was supported by the University of Antwerp and FWO Flanders (Belgium). The fieldwork was supported by the National Scientific Research Fund, Hungary (grants: T049678 and T049650).	Andersson Malte, 1994; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; BENSCH S, 1992, ANIM BEHAV, V44, P301, DOI 10.1016/0003-3472(92)90036-9; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Bradbury Jack W., 1998, pi; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Cramp S., 1994, BIRDS W PALEARCTIC; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; DOWSETTLEMAIRE F, 1979, IBIS, V121, P453, DOI 10.1111/j.1474-919X.1979.tb06685.x; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Forstmeier W, 2002, P ROY SOC B-BIOL SCI, V269, P1479, DOI 10.1098/rspb.2002.2039; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Garamszegi LZ, 2007, BEHAV ECOL, V18, P1001, DOI 10.1093/beheco/arm069; Garamszegi LZ, 2006, BEHAV ECOL, V17, P399, DOI 10.1093/beheco/arj042; Garamszegi LZ, 2005, BEHAV ECOL, V16, P580, DOI 10.1093/beheco/ari029; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; Gil D, 2000, BEHAV ECOL SOCIOBIOL, V47, P319, DOI 10.1007/s002650050672; Gil D, 2000, BEHAVIOUR, V137, P759, DOI 10.1163/156853900502330; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griskevicius V, 2007, J PERS SOC PSYCHOL, V93, P85, DOI 10.1037/0022-3514.93.1.85; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Hale AM, 2004, WILSON BULL, V116, P167, DOI 10.1676/04-015; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HEGYI G, 2008, NATURWISSEN IN PRESS; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; Lundberg A, 1992, PIED FLYCATCHER; Miller GF, 2007, Q REV BIOL, V82, P97, DOI 10.1086/517857; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2006, BEHAV ECOL, V17, P155, DOI 10.1093/beheco/arj010; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Parker TH, 2006, BIRD STUDY, V53, P253, DOI 10.1080/00063650609461440; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; REID ML, 1990, ANIMAL BEHAV, V40; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; Searcy William A., 1996, P454; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; TOROK J, 1988, J ANIM ECOL, V57, P251, DOI 10.2307/4776; Wiley R. H., 1982, ACOUSTIC COMMUNICATI, P131; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	58	73	75	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2647	10.1371/journal.pone.0002647	http://dx.doi.org/10.1371/journal.pone.0002647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612388	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000264065800049
J	Nowotny, T; Levi, R; Selverston, AI				Nowotny, Thomas; Levi, Rafael; Selverston, Allen I.			Probing the Dynamics of Identified Neurons with a Data-Driven Modeling Approach	PLOS ONE			English	Article								In controlling animal behavior the nervous system has to perform within the operational limits set by the requirements of each specific behavior. The implications for the corresponding range of suitable network, single neuron, and ion channel properties have remained elusive. In this article we approach the question of how well-constrained properties of neuronal systems may be on the neuronal level. We used large data sets of the activity of isolated invertebrate identified cells and built an accurate conductance-based model for this cell type using customized automated parameter estimation techniques. By direct inspection of the data we found that the variability of the neurons is larger when they are isolated from the circuit than when in the intact system. Furthermore, the responses of the neurons to perturbations appear to be more consistent than their autonomous behavior under stationary conditions. In the developed model, the constraints on different parameters that enforce appropriate model dynamics vary widely from some very tightly controlled parameters to others that are almost arbitrary. The model also allows predictions for the effect of blocking selected ionic currents and to prove that the origin of irregular dynamics in the neuron model is proper chaoticity and that this chaoticity is typical in an appropriate sense. Our results indicate that data driven models are useful tools for the in-depth analysis of neuronal dynamics. The better consistency of responses to perturbations, in the real neurons as well as in the model, suggests a paradigm shift away from measuring autonomous dynamics alone towards protocols of controlled perturbations. Our predictions for the impact of channel blockers on the neuronal dynamics and the proof of chaoticity underscore the wide scope of our approach.	[Nowotny, Thomas] Univ Sussex, Dept Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Levi, Rafael] Univ Autonoma Madrid, Escuela Politech Superior, Madrid, Spain; [Selverston, Allen I.] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA USA	University of Sussex; Autonomous University of Madrid; University of California System; University of California San Diego	Nowotny, T (corresponding author), Univ Sussex, Dept Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England.	T.Nowotny@sussex.ac.uk	Levi, Rafael/Q-8176-2018; Nowotny, Thomas/C-3883-2012	Levi, Rafael/0000-0002-0144-2295; Nowotny, Thomas/0000-0002-4451-915X	Research Councils of the UK; BBSRC; NSF/NIH; Spanish ministry of education and science; community of Madrid;  [RCUK fellowship];  [BB/F005113/1];  [RO1 NS050945];  [MEC BFU2006-07902/BFI];  [CAM S-SEM-0255-2006]; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050945] Funding Source: NIH RePORTER; BBSRC [BB/F005113/1] Funding Source: UKRI	Research Councils of the UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish ministry of education and science(Spanish Government); community of Madrid(Comunidad de Madrid); ; ; ; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially funded by the Research Councils of the UK under an RCUK fellowship, the BBSRC, grant BB/F005113/1, the NSF/NIH, Grant No. RO1 NS050945, the Spanish ministry of education and science, grant MEC BFU2006-07902/BFI, and the community of Madrid, grant CAM S-SEM-0255-2006. Other than supporting the work financially with research grants, the funding bodies had no role in this work.	Abarbanel HDI, 1996, NEURAL COMPUT, V8, P1567, DOI 10.1162/neco.1996.8.8.1567; Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; ANDERSON WW, 1981, J EXP ZOOL, V216, P187, DOI 10.1002/jez.1402160121; BAL T, 1994, J NEUROSCI, V14, P3019; Baro DJ, 1997, J NEUROSCI, V17, P6597; BENETTIN G, 1978, CR ACAD SCI A MATH, V286, P431; BIDAUT M, 1980, J NEUROPHYSIOL, V44, P1089, DOI 10.1152/jn.1980.44.6.1089; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Bullock T., 1965, STRUCTURE FUNCTION N; Carelli PV, 2005, J NEUROPHYSIOL, V94, P1169, DOI 10.1152/jn.00070.2005; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; De Schutter E, 2005, TRENDS NEUROSCI, V28, P562, DOI 10.1016/j.tins.2005.08.002; EAGER MA, 2007, CONSTRAINING NEURAL; Elson RC, 1999, J NEUROPHYSIOL, V82, P115, DOI 10.1152/jn.1999.82.1.115; Falcke M, 2000, BIOL CYBERN, V82, P517, DOI 10.1007/s004220050604; FOSTER WR, 1993, J NEUROPHYSIOL, V70, P2502, DOI 10.1152/jn.1993.70.6.2502; Giorgilli A., 1980, MECCANICA, V15, P9, DOI 10.1007/BF02128236; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P341, DOI 10.1152/jn.1992.67.2.341; GOLOWASCH J, 1990, CHARACTERIZATION STO; Gruhn M, 2005, J NEUROPHYSIOL, V94, P2888, DOI 10.1152/jn.00434.2005; Guckenheimer J, 1997, J COMPUT NEUROSCI, V4, P257, DOI 10.1023/A:1008871803040; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; GUTENKUNST RN, 2007, ANN NY ACAD SCI; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harris-Warrick RM, 1998, ANN NY ACAD SCI, V860, P155, DOI 10.1111/j.1749-6632.1998.tb09046.x; Haufler D, 2007, NEUROCOMPUTING, V70, P1605, DOI 10.1016/j.neucom.2006.10.041; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Hobbs KH, 2008, J NEUROPHYSIOL, V99, P1871, DOI 10.1152/jn.00032.2008; HORBELT W, 2000, ANAL NONLINEAR DIFFE, P152; Hoyle G., 1977, IDENTIFIED NEURONS B; Huerta R, 2000, BIOL CYBERN, V82, P85, DOI 10.1007/PL00007963; Huys QJM, 2006, J NEUROPHYSIOL, V96, P872, DOI 10.1152/jn.00079.2006; Johnson BR, 2003, J NEUROPHYSIOL, V90, P631, DOI 10.1152/jn.00037.2003; JOHNSON BR, 1990, J NEUROSCI, V10, P2066; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Levi R, 2003, NEUROSCIENCE, V118, P283, DOI 10.1016/S0306-4522(02)00973-9; Liu Z, 1998, J NEUROSCI, V18, P2309; Lopez-Aguado L, 2002, J NEUROPHYSIOL, V88, P2809, DOI 10.1152/jn.00183.2002; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; Mizrahi A, 2001, J NEUROSCI, V21, P7331, DOI 10.1523/JNEUROSCI.21-18-07331.2001; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Prinz AA, 2003, J NEUROSCI, V23, P943; ROSS WN, 1989, P NATL ACAD SCI USA, V86, P1679, DOI 10.1073/pnas.86.5.1679; RUSSELL DF, 1976, BRAIN RES, V101, P582, DOI 10.1016/0006-8993(76)90482-0; Sakaguchi H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.027201; SCHMIDT J, 1992, J EXP BIOL, V171, P329; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Selverston AI, 2000, J PHYSIOLOGY-PARIS, V94, P357, DOI 10.1016/S0928-4257(00)01101-3; Soto-Trevino C, 2005, J NEUROPHYSIOL, V94, P590, DOI 10.1152/jn.00013.2005; STRETTON AO, 1968, SCIENCE, V162, P132, DOI 10.1126/science.162.3849.132; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Szucs A, 2001, J NEUROPHYSIOL, V85, P1623, DOI 10.1152/jn.2001.85.4.1623; Szucs A, 2006, J NEUROBIOL, V66, P1584, DOI 10.1002/neu.20325; Thoby-Brisson M, 2000, J NEUROPHYSIOL, V84, P596, DOI 10.1152/jn.2000.84.1.596; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2107, DOI 10.1152/jn.00026.2006; TOKUDA I, 2002, PARAMETER ESTIMATION; Traub R. D., 1991, NEURAL NETWORKS HIPP; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; Varona P, 2001, NEURAL NETWORKS, V14, P865, DOI 10.1016/S0893-6080(01)00046-6; Varona P, 2001, BIOL CYBERN, V84, P91, DOI 10.1007/s004220000198; Weaver CM, 2006, NEUROCOMPUTING, V69, P1053, DOI 10.1016/j.neucom.2005.12.044; Willms AR, 1999, J COMPUT NEUROSCI, V6, P145, DOI 10.1023/A:1008880518515; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	87	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2627	10.1371/journal.pone.0002627	http://dx.doi.org/10.1371/journal.pone.0002627			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612435	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000264065800029
J	Chen, CA; Druhan, LJ; Varadharaj, S; Chen, YR; Zweier, JL				Chen, Chun-An; Druhan, Lawrence J.; Varadharaj, Saradhadevi; Chen, Yeong-Renn; Zweier, Jay L.			Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; PROTEIN-KINASE-C; SPHINGOSINE 1-PHOSPHATE; ESCHERICHIA-COLI; L-ARGININE; ACTIVATION; MECHANISM; PEROXYNITRITE; IDENTIFICATION; CALMODULIN	In the vasculature, nitric oxide (NO) is generated by endothelial NO synthase (eNOS) in a calcium/calmodulin-dependent reaction. With oxidative stress, the critical cofactor BH4 is depleted, and NADPH oxidation is uncoupled from NO generation, leading to production of (O-2(center dot) over bar). Although phosphorylation of eNOS regulates in vivo NO generation, the effects of phosphorylation on eNOS coupling and O-2(center dot) over bar generation are unknown. Therefore, we phosphorylated recombinant BH4- free eNOS in vitro using native kinases and determined O2 (center dot) over bar generation using EPR spin trapping. Phosphorylation of Ser-1177 by Akt led to an increase (> 50%) in maximal O-2(center dot) over bar generation from eNOS. Moreover, Ser-1177 phosphorylation greatly altered the Ca2+ sensitivity of eNOS, such that O-2(center dot) over bar generation became largely Ca2+-independent. In contrast, phosphorylation of eNOS at Thr-495 by protein kinase C alpha(PKC alpha) had no effect on maximum activity or calcium sensitivity but decreased calmodulin binding and increased association with caveolin. In endothelial cells, eNOS-dependent O-2(center dot) over bar generation was stimulated by vascular endothelial growth factor that induced phosphorylation of Ser-1177. With PKC activation that led to phosphorylation of Thr-495, no inhibition of O-2(center dot) over bar generation occurred. As such, phosphorylation of eNOS at Ser- 1177 is pivotal in the direct regulation of O-2(center dot) over bar and NO generation, altering both the Ca2+ sensitivity of the enzyme and rate of product formation, whereas phosphorylation of Thr-495 indirectly affects this process through regulation of the calmodulin and caveolin interaction. Thus, Akt-mediated phosphorylation modulates eNOS uncoupling and greatly increases O-2(center dot) over bar generation from the enzyme at low Ca2+ concentrations, and PKC alpha-mediated phosphorylation alters the sensitivity of the enzyme to other negative regulatory signals.	[Zweier, Jay L.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	Jay.Zweier@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [HL63744, HL65608, HL38324, HL83237]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R01HL063744, P01HL065608, R29HL038324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J.L.Z.) and HL83237 (Y.-R.C.). This work was also supported by an American Heart Association postdoctoral fellowship (to C.-A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Delgado-Esteban M, 2002, J NEUROCHEM, V82, P1148, DOI 10.1046/j.1471-4159.2002.01055.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fleming I, 2005, CARDIOVASC RES, V65, P897, DOI 10.1016/j.cardiores.2004.11.003; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Maniatis NA, 2006, CIRC RES, V99, P870, DOI 10.1161/01.RES.0000245187.08026.47; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Niki I, 1996, J BIOCHEM, V120, P685; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; POU S, 1992, J BIOL CHEM, V267, P24173; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sun J, 2008, ARCH BIOCHEM BIOPHYS, V471, P126, DOI 10.1016/j.abb.2008.01.003; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Whitsett J, 2006, FREE RADICAL BIO MED, V40, P2056, DOI 10.1016/j.freeradbiomed.2006.02.001; Xia Y, 2004, J AM COLL CARDIOL, V43, p294A, DOI 10.1016/S0735-1097(04)91245-4; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; Zweier JL, 1998, TRANSPL P, V30, P4228, DOI 10.1016/S0041-1345(98)01399-2; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	62	133	136	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27038	27047		10.1074/jbc.M802269200	http://dx.doi.org/10.1074/jbc.M802269200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18622039	hybrid, Green Published			2022-12-25	WOS:000259586600024
J	Ishikawa, Y; Onoyama, I; Nakayama, KI; Nakayama, K				Ishikawa, Y.; Onoyama, I.; Nakayama, K. I.; Nakayama, K.			Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7	ONCOGENE			English	Article						ubiquitin ligase; Fbxw7; Notch; mouse embryonic fibroblast; tumor suppressor; p53	F-BOX PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR; C-MYC; UBIQUITIN LIGASE; GROWTH ARREST; MICE LACKING; ACTIVATION; TRANSCRIPTION; DEGRADATION	The F-box protein Fbxw7 mediates the ubiquitylation and consequent degradation of proteins that regulate cell cycle progression, including cyclin E, c-Myc, c-Jun and Notch. Moreover, certain human cancer cell lines harbor loss-of-function mutations in FBXW7 that result in excessive accumulation of Fbxw7 substrates, implicating Fbxw7 in tumor suppression. To elucidate the physiological function of Fbxw7, we conditionally ablated Fbxw7 in mouse embryonic fibroblasts (MEFs). Unexpectedly, loss of Fbxw7 induced cell cycle arrest and apoptosis that were accompanied by abnormal accumulation of the intracellular domain of Notch1 (NICD1). Forced expression of NICD1 in wild-type MEFs recapitulated the phenotype of the Fbxw7-deficient (Fbxw7D/D) MEFs. Conversely, deletion of Rbpj normalized the phenotype of Fbxw7(Delta/Delta) MEFs, indicating that this phenotype is dependent on the Notch1 RBP-J signaling pathway. Deletion of the p53 gene prevented cell cycle arrest but not the induction of apoptosis in Fbxw7(Delta/Delta) cells. These observations suggest that Fbxw7 does not function as an oncosuppressor in MEFs. Instead, it promotes cell cycle progression and cell survival through degradation of Notch1, with loss of Fbxw7 resulting in NICD1 accumulation, cell cycle arrest and apoptosis.	[Ishikawa, Y.; Nakayama, K.] Tohoku Univ, Grad Sch Med, Dept Dev Genet, Ctr Translat & Adv Anim Res,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ishikawa, Y.; Onoyama, I.; Nakayama, K. I.; Nakayama, K.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Onoyama, I.; Nakayama, K. I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 812, Japan	Tohoku University; Japan Science & Technology Agency (JST); Kyushu University	Nakayama, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Dev Genet, Ctr Translat & Adv Anim Res,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	nakayak2@mail.tains.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; 21st Century Center of Excellence Program	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T Honjo for Rbpj<SUP>F/F</SUP> mice; R Tsunematsu for an NICD1 plasmid; T Kitamura for pMX-puro and Plat-E cells; Y Ono and N Kobayashi for technical assistance; N Ishida and other laboratory members for helpful discussion. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the 21st Century Center of Excellence Program.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; Lopez-Nieva P, 2004, CARCINOGENESIS, V25, P1299, DOI 10.1093/carcin/bgh124; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUNDARAM M, 1993, GENETICS, V135, P765; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	46	44	46	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2008	27	47					6164	6174		10.1038/onc.2008.216	http://dx.doi.org/10.1038/onc.2008.216			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18641686				2022-12-25	WOS:000260083100009
J	Martinez, SE; Heikaus, CC; Klevit, RE; Beavo, JA				Martinez, Sergio E.; Heikaus, Clemens C.; Klevit, Rachel E.; Beavo, Joseph A.			The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY GAMMA-SUBUNIT; CONE PHOTORECEPTOR PHOSPHODIESTERASE; MOLECULAR-GRAPHICS PROJECT; ESCHERICHIA-COLI; CYCLIC-GMP; ROD CGMP-PHOSPHODIESTERASE-6; VISUAL TRANSDUCTION; BACKBONE DYNAMICS; DIMERIZATION; PROTEINS	The photoreceptor phosphodiesterase (PDE6) regulates the intracellular levels of the second messenger cGMP in the outer segments of cone and rod photoreceptor cells. PDE6 contains two regulatory GAF domains, of which one (GAF A) binds cGMP and regulates the activity of the PDE6 holoenzyme. To increase our understanding of this allosteric regulation mechanism, we present the 2.6 angstrom crystal structure of the cGMP-bound GAF A domain of chicken cone PDE6. Nucleotide specificity appears to be provided in part by the orientation of Asn-116, which makes two hydrogen bonds to the guanine ring of cGMP but is not strictly conserved among PDE6 isoforms. The isolated PDE6C GAF A domain is monomeric and does not contain sufficient structural determinants to form a homodimer as found in full-length PDE6C. A highly conserved surface patch on GAF A indicates a potential binding site for the inhibitory subunit P gamma. NMR studies reveal that the apo-PDE6C GAF A domain is structured but adopts a significantly altered structural state indicating a large conformational change with rearrangement of secondary structure elements upon cGMP binding. The presented crystal structure will help to define the cGMP-dependent regulation mechanism of the PDE6 holoenzyme and its inhibition through P gamma binding.	[Martinez, Sergio E.; Beavo, Joseph A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Heikaus, Clemens C.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Beavo, JA (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	beavo@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institutes of Health [R01 DK21723, P01 HL44948]; Boehringer Ingelheim Fonds Ph. D. scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds Ph. D. scholarship(Boehringer Ingelheim); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK21723 (to J.A.B.) and P01 HL44948 (to J.A.B. and R.E K.) and by a Boehringer Ingelheim Fonds Ph. D. scholarship (to C.C.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, J BIOL CHEM, V271, P25382, DOI 10.1074/jbc.271.41.25382; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2007, CYCLIC NUCLEOTIDE PH, P165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov KG, 2003, J BIOL CHEM, V278, P10594, DOI 10.1074/jbc.M208456200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PUGH EN, 1986, VISION RES, V26, P1613, DOI 10.1016/0042-6989(86)90051-9; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	49	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25913	25919		10.1074/jbc.M802891200	http://dx.doi.org/10.1074/jbc.M802891200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18614542	Green Published, hybrid			2022-12-25	WOS:000259200100018
J	Grespin, ME; Bonamy, GMC; Roggero, VR; Cameron, NG; Adam, LE; Atchison, AP; Fratto, VM; Allison, LA				Grespin, Matthew E.; Bonamy, Ghislain M. C.; Roggero, Vincent R.; Cameron, Nicole G.; Adam, Lindsay E.; Atchison, Andrew P.; Fratto, Victoria M.; Allison, Lizabeth A.			Thyroid hormone receptor alpha 1 follows a cooperative CRM1/calreticulin-mediated nuclear export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOPROTEIN V-ERBA; GLUCOCORTICOID-RECEPTOR; NUCLEOCYTOPLASMIC TRANSPORT; SUBCELLULAR-LOCALIZATION; HORMONE-RECEPTORS; RIBOSOMAL-SUBUNIT; BINDING-PROTEIN; CALRETICULIN; EXPRESSION; SIGNALS	The thyroid hormone receptor alpha 1 (TR alpha) exhibits a dual role as an activator or repressor of its target genes in response to thyroid hormone (T-3) .Previously, we have shown that TR alpha, formerly thought to reside solely in the nucleus bound to DNA, actually shuttles rapidly between the nucleus and cytoplasm. An important aspect of the shuttling activity of TR alpha is its ability to exit the nucleus through the nuclear pore complex. TR alpha export is not sensitive to treatment with the CRM1-specific inhibitor leptomycin B ( LMB) in heterokaryon assays, suggesting a role for an export receptor other than CRM1. Here, we have used a combined approach of in vivo fluorescence recovery after photobleaching experiments, in vitro permeabilized cell nuclear export assays, and glutathione S-transferase pull-down assays to investigate the export pathway used by TR alpha. We show that, in addition to shuttling in heterokaryons, TR alpha shuttles rapidly in an unfused monokaryon system as well. Furthermore, our data show that TR alpha directly interacts with calreticulin, and point to the intriguing possibility that TR alpha follows a cooperative export pathway in which both calreticulin and CRM1 play a role in facilitating efficient translocation of TR alpha from the nucleus to cytoplasm.	[Grespin, Matthew E.; Bonamy, Ghislain M. C.; Roggero, Vincent R.; Cameron, Nicole G.; Adam, Lindsay E.; Atchison, Andrew P.; Fratto, Victoria M.; Allison, Lizabeth A.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	William & Mary	Allison, LA (corresponding author), POB 8795,Millington Hall 116, Williamsburg, VA 23187 USA.	laalli@wm.edu		Bonamy, Ghislain/0000-0002-2826-5225	National Institutes of Health [2R15 DK058028-02]; National Science Foundation [MCB-0646506]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK058028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R15 DK058028-02 and National Science Foundation Grant MCB-0646506 ( to L. A. A.). This work was also supported by a Howard Hughes Medical Institute grant through the Undergraduate Biological Sciences Education Program to the College of William & Mary ( to N. G. C., L. E. A., and A. P. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Amazit L, 2003, J BIOL CHEM, V278, P32195, DOI 10.1074/jbc.M300730200; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Bonamy Ghislain M C, 2006, Nucl Recept Signal, V4, pe008; Bonamy GMC, 2005, MOL ENDOCRINOL, V19, P1213, DOI 10.1210/me.2004-0204; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CHANDRAN UR, 1992, MOL ENDOCRINOL, V6, P837, DOI 10.1210/me.6.5.837; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DEDHAR S, 2001, J CELL BIOL, V152, P127; DeLong LJ, 2004, J BIOL CHEM, V279, P15356, DOI 10.1074/jbc.M308214200; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 1998, P NATL ACAD SCI USA, V95, P14739, DOI 10.1073/pnas.95.25.14739; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Jethmalani SM, 1997, J CELL BIOCHEM, V66, P98; Kobayashi S, 2006, CYTOGENET GENOME RES, V115, P10, DOI 10.1159/000094795; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lain S, 1999, EXP CELL RES, V253, P315, DOI 10.1006/excr.1999.4672; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shank LC, 2005, CRIT REV EUKAR GENE, V15, P49, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.40; Sharma A, 2004, PLANT CELL PHYSIOL, V45, P684, DOI 10.1093/pcp/pch077; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Walther RF, 2003, J BIOL CHEM, V278, P37858, DOI 10.1074/jbc.M306356200; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; West M, 2007, J BIOL CHEM, V282, P14028, DOI 10.1074/jbc.M700256200	58	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25576	25588		10.1074/jbc.M710482200	http://dx.doi.org/10.1074/jbc.M710482200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18641393	Green Published, hybrid			2022-12-25	WOS:000259012700053
J	Im, JS; Lee, JK				Im, Jun-Sub; Lee, Joon-Kyu			ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION CHECKPOINT; S-PHASE; CARCINOMA-CELLS; IN-VIVO; PROTEIN; DAMAGE; P53; INITIATION; CISPLATIN; PATHWAY	Cdc7 is a serine/threonine kinase that plays essential roles in the initiation of eukaryotic DNA replication and checkpoint response. In previous studies, depletion of Cdc7 by small interfering RNA was shown to induce an abortive S phase that led to the cell cycle arrest in normal human fibroblasts and apoptotic cell death in various cancer cells. Here we report that stress-activated p38 MAP kinase was activated and responsible for apoptotic cell death in Cdc7-depleted HeLa cells. The activation of p38 MAP kinase in the Cdc7-depleted cells was shown to depend on ATR, a major sensor kinase for checkpoint or DNA damage responses. Only the p38 MAP kinase, and not the other stress-activated kinases such as JNK or ERK, was activated, and both caspase 8 and caspase 9 were activated for the induction of apoptosis. Activation of apoptosis in Cdc7-depleted cells was completely abolished in cells treated with small interfering RNA or an inhibitor of the p38 MAP kinase, suggesting that p38 MAP kinase activation was responsible for apoptotic cell death. Taken together, we suggest that the ATR-dependent activation of the p38 MAP kinase is a major signaling pathway that induces apoptotic cell death after depletion of Cdc7 in cancer cells.	[Im, Jun-Sub; Lee, Joon-Kyu] Seoul Natl Univ, Dept Biol Educ, Seoul 151748, South Korea	Seoul National University (SNU)	Lee, JK (corresponding author), Seoul Natl Univ, Dept Biol Educ, Seoul 151748, South Korea.	joonlee@snu.ac.kr			Cancer Control, Ministry of Health & Welfare, Republic of Korea [0620260]; Korean Government (MOST) [R01-2007-000-20380-0]	Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620260), and the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Government (MOST) (R01-2007-000-20380-0). The costs of publication of this article were defrayed in part by the payment of page charges.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Carrassa L, 2004, CELL CYCLE, V3, P1177; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dohrmann PR, 1999, GENETICS, V151, P965; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kinzel B, 2002, CANCER, V94, P1808, DOI 10.1002/cncr.10383; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lemaire M, 2006, CELL CYCLE, V5, P1649, DOI 10.4161/cc.5.15.3006; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rodriguez-Bravo V, 2006, CANCER RES, V66, P8672, DOI 10.1158/0008-5472.CAN-05-4443; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334	36	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25171	25177		10.1074/jbc.M802851200	http://dx.doi.org/10.1074/jbc.M802851200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625709	hybrid			2022-12-25	WOS:000259012700009
J	Teillet, F; Gaboriaud, C; Lacroix, M; Martin, L; Arlaud, GJ; Thielens, NM				Teillet, Florence; Gaboriaud, Christine; Lacroix, Monique; Martin, Lydie; Arlaud, Gerard J.; Thielens, Nicole M.			Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURALLY-OCCURRING MUTATIONS; SERINE PROTEASES-1 AND-2; ELECTRON-DENSITY MAPS; X-RAY-STRUCTURE; COMPLEMENT PATHWAY; ACTIVATES COMPLEMENT; SERUM LECTIN; PROTEIN; REGION; LOCALIZATION	MASP-1 and MASP-3 are homologous proteases arising from alternative splicing of the MASP1/3 gene. They include an identical CUB1-EGF-CUB2-CCP1-CCP2 module array prolonged by different serine protease domains at the C-terminal end. The x-ray structure of the CUB1-EGF-CUB2 domain of human MASP-1/3, responsible for interaction of MASP-1 and -3 with their partner proteins mannan-binding lectin (MBL) and ficolins, was solved to a resolution of 2.3 angstrom. The structure shows a head-to-tail homodimer mainly stabilized by hydrophobic interactions between the CUB1 module of one monomer and the epidermal growth factor (EGF) module of its counterpart. A Ca2+ ion bound primarily to both EGF modules stabilizes the intra- and inter-monomer CUB1-EGF interfaces. Additional Ca2+ ions are bound to each CUB1 and CUB2 module through six ligands contributed by Glu(49), Asp(57), Asp(102), and Ser(104) (CUB1) and their counterparts Glu(216), Asp(226), Asp(263), and Ser(265) (CUB2), plus one and two water molecules, respectively. To identify the residues involved in interaction of MASP-1 and -3 with MBL and L- and H-ficolins, 27 point mutants of human MASP-3 were generated, and their binding properties were analyzed using surface plasmon resonance spectroscopy. These mutations map two homologous binding sites contributed by modules CUB1 and CUB2, located in close vicinity of their Ca2+-binding sites and stabilized by the Ca2+ ion. This information allows us to propose a model of the MBL-MASP-1/3 interaction, involving a major electrostatic interaction between two acidic Ca2+ ligands of MASP-1/3 and a conserved lysine of MBL. Based on these and other data, a schematic model of a MBL.MASP complex is proposed.	[Teillet, Florence; Lacroix, Monique; Arlaud, Gerard J.; Thielens, Nicole M.] UJF, CEA, CNRS,Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France; [Teillet, Florence; Lacroix, Monique; Arlaud, Gerard J.; Thielens, Nicole M.] UJF, CEA, CNRS,Lab Cristallog & Cristallogenese Proteines, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Thielens, NM (corresponding author), UJF, CEA, CNRS,Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	nicole.thielens@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302	Commissariat a l'Energie Atomique; CNRS; Universite Joseph Fourier, Grenoble, France	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier, Grenoble, France	This work was supported by the Commissariat a l'Energie Atomique, the CNRS, and the Universite Joseph Fourier, Grenoble, France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSBY TF, 1990, BIOCHEMISTRY-US, V29, P4613, DOI 10.1021/bi00471a016; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Endo Y, 2006, ADV EXP MED BIOL, V586, P265; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lacroix M, 1997, BIOCHEMISTRY-US, V36, P6270, DOI 10.1021/bi962719i; Lacroix M, 2007, MOL IMMUNOL, V44, P3930, DOI 10.1016/j.molimm.2007.06.054; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Romao MJ, 1997, J MOL BIOL, V274, P650, DOI 10.1006/jmbi.1997.1423; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	45	66	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25715	25724		10.1074/jbc.M803551200	http://dx.doi.org/10.1074/jbc.M803551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18596036	hybrid			2022-12-25	WOS:000259012700066
J	Wang, Y; Tandan, S; Cheng, J; Yang, C; Nguyen, L; Sugianto, J; Johnstone, JL; Sun, Y; Hill, JA				Wang, Yanggan; Tandan, Samvit; Cheng, Jun; Yang, Chunmei; Nguyen, Lan; Sugianto, Jessica; Johnstone, Janet L.; Sun, Yuyang; Hill, Joseph A.			Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CARDIAC-HYPERTROPHY; CALMODULIN KINASE; VENTRICULAR MYOCYTES; CALCIUM-CHANNELS; SARCOPLASMIC-RETICULUM; HUMAN MYOCARDIUM; FACILITATION; CAMKII; PHOSPHORYLATION; CALCINEURIN	Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity is increased in heart failure (HF), a syndrome characterized by markedly increased risk of arrhythmia. Activation of CaMKII increases peak L-type Ca2+ current (I-Ca) and slows ICa inactivation. Whether these events are linked mechanistically is unknown. ICa was recorded in acutely dissociated subepicardial and subendocardial murine left ventricular (LV) myocytes using the whole cell patch clamp method. Pressure overload heart failure was induced by surgical constriction of the thoracic aorta. ICa density was significantly larger in subepicardial myocytes than in subendocardial/myocytes. Similar patterns were observed in the cell surface expression of alpha 1c, the channel pore-forming subunit. In failing LV, ICa density was increased proportionately in both cell types, and the time course of ICa inactivation was slowed. This typical pattern of changes suggested a role of CaMKII. Consistent with this, measurements of CaMKII activity revealed a 2-3-fold increase (p < 0.05) in failing LV. To test for a causal link, we measured frequency-dependent I-Ca facilitation. In HF myocytes, this CaMKII-dependent process could not be induced, suggesting already maximal activation. Internal application of active CaMKII in failing myocytes did not elicit changes in ICa. Finally, CaMKII inhibition by internal diffusion of a specific peptide inhibitor reduced I-Ca density and inactivation time course to similar levels in control and HF myocytes. ICa density manifests a significant transmural gradient, and this gradient is preserved in heart failure. Activation of CaMKII, a known pro-arrhythmic molecule, is a major contributor to ICa remodeling in load-induced heart failure.	[Wang, Yanggan; Tandan, Samvit; Cheng, Jun; Yang, Chunmei; Nguyen, Lan; Sugianto, Jessica; Johnstone, Janet L.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Dallas, TX 75390 USA; [Sun, Yuyang] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu			National Institutes of Health [HL-075173, HL-080144, T35-DK066141, HL-088168]; Donald W. Reynolds Cardiovascular Clinical Research Center; American Heart Association [0665178Y, 0640084N]; National Heart Foundation [H2007-019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088168, R01HL075173, R01HL080144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center; American Heart Association(American Heart Association); National Heart Foundation(National Heart Foundation of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-075173 (to J.A.H.), HL-080144 (to J.A.H.), T35-DK066141 (to L.N. and J.S.), and HL-088168 (to Y.W.). This work was also supported by grants from the Donald W. Reynolds Cardiovascular Clinical Research Center (to J.A.H.), American Heart Association Grants 0665178Y (to Y.W.) and 0640084N (to J.A.H.), National Heart Foundation Grant H2007-019 (to Y.W.), The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Akar FG, 2005, ANN MED, V37, P44, DOI 10.1080/07853890510007214; Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001; Anderson ME, 2007, CARDIOVASC RES, V73, P657, DOI 10.1016/j.cardiores.2006.12.009; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Bryant SM, 1997, CARDIOVASC RES, V35, P315, DOI 10.1016/S0008-6363(97)00111-9; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Currie S, 1999, FEBS LETT, V459, P244, DOI 10.1016/S0014-5793(99)01254-5; Dzhura I, 2002, J PHYSIOL-LONDON, V545, P399, DOI 10.1113/jphysiol.2002.021881; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Guo JQ, 2006, J PHYSIOL-LONDON, V574, P509, DOI 10.1113/jphysiol.2006.109199; Hagemann D, 2001, MOL CELL BIOCHEM, V220, P69, DOI 10.1023/A:1010899724222; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Maier LS, 2007, CARDIOVASC RES, V73, P629, DOI 10.1016/j.cardiores.2007.01.005; MEWES T, 1994, J MOL CELL CARDIOL, V26, P1307, DOI 10.1006/jmcc.1994.1149; OUADID H, 1995, J CARDIOVASC PHARM, V25, P282, DOI 10.1097/00005344-199502000-00014; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; ROSSNER KL, 1991, AM J PHYSIOL, V260, pH1179, DOI 10.1152/ajpheart.1991.260.4.H1179; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tanskanen AJ, 2005, BIOPHYS J, V88, P85, DOI 10.1529/biophysj.104.051508; Toscano CD, 2005, BRAIN RES, V1044, P51, DOI 10.1016/j.brainres.2005.02.076; VanCoppenolle F, 1997, MOL CELL BIOCHEM, V168, P155; Wang HS, 2003, J PHYSIOL-LONDON, V547, P825, DOI 10.1113/jphysiol.2002.035410; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wang YG, 2000, CARDIOVASC RES, V48, P310, DOI 10.1016/S0008-6363(00)00178-4; Wang YG, 2006, CIRCULATION, V113, P1849, DOI 10.1161/CIRCULATIONAHA.106.615682; Wang YG, 2006, J CARDIOVASC ELECTR, V17, P298, DOI 10.1111/j.1540-8167.2006.00362.x; Wang ZY, 2001, CIRCULATION, V104, P1657, DOI 10.1161/hc3901.095766; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, CIRC RES, V84, P906; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; Yatani A, 2001, J MOL CELL CARDIOL, V33, P249, DOI 10.1006/jmcc.2000.1296; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	58	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25524	25532		10.1074/jbc.M803043200	http://dx.doi.org/10.1074/jbc.M803043200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18622016	Green Published, hybrid			2022-12-25	WOS:000259012700048
J	Sarewicz, M; Borek, A; Daldal, F; Froncisz, W; Osyczka, A				Sarewicz, Marcin; Borek, Arkadiusz; Daldal, Fevzi; Froncisz, Wojciech; Osyczka, Artur			Demonstration of short-lived complexes of cytochrome c with cytochrome bc(1) by EPR spectroscopy - Implications for the mechanism of interprotein electron transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; RHODOBACTER-CAPSULATUS; PHOTOSYNTHETIC GROWTH; TRANSITION-STATE; BINDING-SITES; DOUBLE-MUTANT; SPIN; MEMBRANE; C(2); MITOCHONDRIAL	One of the steps of a common pathway for biological energy conversion involves electron transfer between cytochrome c and cytochrome bc(1). To clarify the mechanism of this reaction, we examined the structural association of those two proteins using the electron transfer-independent electron paramagnetic resonance (EPR) techniques. Drawing on the differences in the continuous wave EPR spectra and saturation recoveries of spin-labeled bacterial and mitochondrial cytochromes c recorded in the absence and presence of bacterial cytochrome bc(1), we have exposed a time scale of dynamic equilibrium between the bound and the free state of cytochrome c at various ionic strengths. Our data show a successive decrease of the bound cytochrome c fraction as the ionic strength increases, with a limit of similar to 120 mM NaCl above which essentially no bound cytochrome c can be detected by EPR. This limit does not apply to all of the interactions of cytochrome c with cytochrome bc(1) because the cytochrome bc(1) enzymatic activity remained high over a much wider range of ionic strengths. We concluded that EPR monitors just the tightly bound state of the association and that an averaged lifetime of this state decreases from over 100 mu s at low ionic strength to less than 400 ns at an ionic strength above 120 mM. This suggests that at physiological ionic strength, the tightly bound complex on average lasts less than the time needed for a single electron exchange between hemes c and c(1), indicating that productive electron transfer requires several collisions of the two molecules. This is consistent with an early idea of diffusion-coupled reactions that link the soluble electron carriers with the membranous complexes, which, we believe, provides a robust means of regulating electron flow through these complexes.	[Sarewicz, Marcin; Borek, Arkadiusz; Froncisz, Wojciech; Osyczka, Artur] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, PL-30387 Krakow, Poland; [Daldal, Fevzi] Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	Jagiellonian University; University of Pennsylvania	Osyczka, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, PL-30387 Krakow, Poland.	osyczkaa@biotka.mol.uj.edu.pl	Froncisz, Wojciech/U-9828-2018; Kumar, Rishabh/P-4667-2017	Froncisz, Wojciech/0000-0002-0287-0988; Borek, Arkadiusz/0000-0003-3195-3579; Sarewicz, Marcin/0000-0001-6813-5997; Osyczka, Artur/0000-0002-1637-2365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038237, GM 38237] Funding Source: Medline; Wellcome Trust [076488] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Axelrod HL, 2005, PHOTOSYNTH RES, V85, P101, DOI 10.1007/s11120-005-1368-8; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Biswas Roopa, 2001, Science Progress, V84, P45, DOI 10.3184/003685001783239050; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; CAFFREY M, 1992, ARCH BIOCHEM BIOPHYS, V292, P419, DOI 10.1016/0003-9861(92)90011-K; Ciurli S, 2005, PHOTOSYNTH RES, V85, P115, DOI 10.1007/s11120-004-6556-4; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Daldal F, 2003, PHOTOSYNTH RES, V76, P127, DOI 10.1023/A:1024999101226; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devanathan S, 2007, BIOCHEMISTRY-US, V46, P7138, DOI 10.1021/bi602649u; Diaz-Moreno I, 2005, BIOCHEMISTRY-US, V44, P3176, DOI 10.1021/bi047855z; Engstrom G, 2003, BIOCHEMISTRY-US, V42, P2816, DOI 10.1021/bi027213g; FEIX JB, 1998, BIO MAGN RE, V14, P251; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; GUNER S, 1993, BIOCHEMISTRY-US, V32, P4793, DOI 10.1021/bi00069a014; GUPTE S, 1984, P NATL ACAD SCI-BIOL, V81, P2606, DOI 10.1073/pnas.81.9.2606; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; HALL J, 1987, BIOCHEMISTRY-US, V26, P4501, DOI 10.1021/bi00388a049; HALL J, 1987, J BIOL CHEM, V262, P14005; Hansen DF, 2003, J MAGN RESON, V163, P215, DOI 10.1016/S1090-7807(03)00062-4; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; HECKERT NA, 2003, NIST HDB, V148; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; ILNICKI J, 1994, MOLECUL PHYS REP, V5, P203; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kooser R. G., 1992, CONCEPT MAGNETIC RES, V4, P145; Kostrzewa A, 2000, BIOCHEMISTRY-US, V39, P6066, DOI 10.1021/bi992559l; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Mailer C, 2005, J PHYS CHEM A, V109, P4049, DOI 10.1021/jp044671l; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Meyer TE, 2003, PHOTOSYNTH RES, V76, P111, DOI 10.1023/A:1024910323089; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; Meyers R. A., 2000, ENCY ANAL CHEM, P5725; Millett F, 2004, PHOTOSYNTH RES, V82, P1, DOI 10.1023/B:PRES.0000040434.77061.ca; Miyashita O, 2004, P NATL ACAD SCI USA, V101, P16174, DOI 10.1073/pnas.0405745101; Moore G. R., 1990, CYTOCHROMES C EVOLUT; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nicholls D., 2002, BIOENERGETICS, V3; Osyczka A, 1999, BIOCHEMISTRY-US, V38, P15779, DOI 10.1021/bi990907d; Osyczka A, 2001, J BIOL CHEM, V276, P24108, DOI 10.1074/jbc.M101141200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; RIEDER R, 1980, J BIOL CHEM, V255, P4732; Sarewicz M, 2008, EUR BIOPHYS J BIOPHY, V37, P483, DOI 10.1007/s00249-007-0240-5; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; Tian H, 2000, J BIOL CHEM, V275, P9587, DOI 10.1074/jbc.275.13.9587; Turyna B, 1998, BBA-PROTEIN STRUCT M, V1386, P50, DOI 10.1016/S0167-4838(98)00059-4; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	64	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24826	24836		10.1074/jbc.M802174200	http://dx.doi.org/10.1074/jbc.M802174200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617515	Green Published, hybrid			2022-12-25	WOS:000258820000049
J	Scragg, JL; Dallas, ML; Wilkinson, JA; Varadi, G; Peers, C				Scragg, Jason L.; Dallas, Mark L.; Wilkinson, Jenny A.; Varadi, Gyula; Peers, Chris			Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; SMOOTH-MUSCLE; RAT-HEART; HYPOXIA; EXPRESSION; MICE; HYPERTENSION; INFARCTION; MOLECULES; MECHANISM	Conditions of stress, such as myocardial infarction, stimulate up-regulation of heme oxygenase (HO-1) to provide cardioprotection. Here, we show that CO, a product of heme catabolism by HO-1, directly inhibits native rat cardiomyocyte L-type Ca2+ currents and the recombinant alpha(1C) subunit of the human cardiac L-type Ca2+ channel. CO (applied via a recognized CO donor molecule or as the dissolved gas) caused reversible, voltage-independent channel inhibition, which was dependent on the presence of a spliced insert in the cytoplasmic C-terminal region of the channel. Sequential molecular dissection and point mutagenesis identified three key cysteine residues within the proximal 31 amino acids of the splice insert required for CO sensitivity. CO-mediated inhibition was independent of nitric oxide and protein kinase G but was prevented by antioxidants and the reducing agent, dithiothreitol. Inhibition of NADPH oxidase and xanthine oxidase did not affect the inhibitory actions of CO. Instead, inhibitors of complex III (but not complex I) of the mitochondrial electron transport chain and a mitochondrially targeted antioxidant (Mito Q) fully prevented the effects of CO. Our data indicate that the cardioprotective effects of HO-1 activity may be attributable to an inhibitory action of CO on cardiac L-type Ca2+ channels. Inhibition arises from the ability of CO to promote generation of reactive oxygen species from complex III of mitochondria. This in turn leads to redox modulation of any or all of three critical cysteine residues in the channel's cytoplasmic C-terminal tail, resulting in channel inhibition.	[Scragg, Jason L.; Dallas, Mark L.; Wilkinson, Jenny A.; Peers, Chris] Univ Leeds, Div Cardiovasc & Neuronal Remodelling, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Varadi, Gyula] RMD Inc, Watertown, MA 02472 USA	University of Leeds	Scragg, JL (corresponding author), Univ Leeds, Div Cardiovasc & Neuronal Remodelling, Leeds Inst Genet Hlth & Therapeut, Level 10,Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England.	J.Scragg@leeds.ac.uk; c.s.peers@leeds.ac.uk	Dallas, Mark/Q-6117-2019; Dallas, Mark L/A-6654-2013	Dallas, Mark/0000-0002-5190-0522; Peers, Chris/0000-0002-8354-346X	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Chatterjee PK, 2007, BRIT J PHARMACOL, V150, P961, DOI 10.1038/sj.bjp.0707185; Christou H, 2000, CIRC RES, V86, P1224, DOI 10.1161/01.RES.86.12.1224; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Durante W, 2002, VASC MED, V7, P195, DOI 10.1191/1358863x02vm424ra; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; EWING JF, 1994, J PHARMACOL EXP THER, V271, P408; Fearon IM, 2000, CIRC RES, V87, P537, DOI 10.1161/01.RES.87.7.537; Fearon IM, 1999, J PHYSIOL-LONDON, V514, P629, DOI 10.1111/j.1469-7793.1999.629ad.x; Fearon IM, 1997, J PHYSIOL-LONDON, V500, P551, DOI 10.1113/jphysiol.1997.sp022041; Grilli A, 2003, ANN CLIN LAB SCI, V33, P208; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Klockner U, 1997, AM J PHYSIOL-HEART C, V272, pH1372, DOI 10.1152/ajpheart.1997.272.3.H1372; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; MCFAUL SJ, 1987, TOXICOL APPL PHARM, V87, P464, DOI 10.1016/0041-008X(87)90252-3; MCGRATH JJ, 1984, PHARMACOL BIOCHEM BE, V21, P99, DOI 10.1016/0091-3057(84)90171-0; MCGRATH JJ, 1984, P SOC EXP BIOL MED, V177, P132; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; PEPINE CJ, 1995, EUR HEART J, V16, P19, DOI 10.1093/eurheartj/16.suppl_H.19; Ravens U, 1999, PHARMACOL RES, V39, P167, DOI 10.1006/phrs.1998.0416; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Scragg JL, 2004, METHOD ENZYMOL, V381, P290; SYLVESTER JT, 1978, CIRC RES, V43, P429, DOI 10.1161/01.RES.43.3.429; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uemura K, 2005, BIOCHEM BIOPH RES CO, V334, P661, DOI 10.1016/j.bbrc.2005.06.142; Wiesel P, 2001, CIRC RES, V88, P1088, DOI 10.1161/hh1001.091521; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang LM, 2004, HYPERTENSION, V43, P1221, DOI 10.1161/01.HYP.0000126287.62060.e6; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	41	107	111	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24412	24419		10.1074/jbc.M803037200	http://dx.doi.org/10.1074/jbc.M803037200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596041	Green Published, hybrid			2022-12-25	WOS:000258820000016
J	Shinoda, Y; Ogata, N; Higashikawa, A; Manabe, I; Shindo, T; Yamada, T; Kugimiya, F; Ikeda, T; Kawamura, N; Kawasaki, Y; Tsushima, K; Takeda, N; Nagai, R; Hoshi, K; Nakamura, K; Chung, UI; Kawaguchi, H				Shinoda, Yusuke; Ogata, Naoshi; Higashikawa, Akiro; Manabe, Ichiro; Shindo, Takayuki; Yamada, Takashi; Kugimiya, Fumitaka; Ikeda, Toshiyuki; Kawamura, Naohiro; Kawasaki, Yosuke; Tsushima, Kensuke; Takeda, Norifumi; Nagai, Ryozo; Hoshi, Kazuto; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi			Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOCHONDRAL BONE-FORMATION; TRANSCRIPTION FACTOR KLF5; DEVELOPING LONG BONES; MONOCLONAL-ANTIBODIES; KEY REGULATOR; MICE LACKING; II COLLAGEN; KAPPA-B; OSSIFICATION	Although degradation of cartilage matrix has been suggested to be a rate-limiting step for endochondral ossification during skeletal development, little is known about the transcriptional regulation. This study investigated the involvement of KLF5 (Kruppel-like factor 5), an Sp/KLF family member, in the skeletal development. KLF5 was expressed in chondrocytes and osteoblasts but not in osteoclasts. The heterozygous deficient (KLF5(+/-)) mice exhibited skeletal growth retardation in the perinatal period. Although chondrocyte proliferation and differentiation were normal, cartilage matrix degradation was impaired in KLF5(+/-) mice, causing delay in replacement of cartilage with bone at the primary ossification center in the embryonic limbs and elongation of hypertrophic chondrocyte layer in the neonatal growth plates. Microarray analyses identified MMP9 (matrix metalloproteinase 9) as a transcriptional target, since it was strongly up-regulated by adenoviral transfection of KLF5 in chondrogenic cell line OUMS27. The KLF5 overexpression caused gelatin degradation by stimulating promoter activity of MMP9 without affecting chondrocyte differentiation or vascular endothelial growth factor expression in the culture of chondrogenic cells; however, in osteoclast precursors, it affected neither MMP9 expression nor osteoclastic differentiation. KLF5 dysfunction by genetic heterodeficiency or RNA interference was confirmed to cause reduction of MMP9 expression in cultured chondrogenic cells. MMP9 expression was decreased in the limbs of KLF5(+/-) embryos, which was correlated with suppression of matrix degradation, calcification, and vascularization. We conclude that KLF5 causes cartilage matrix degradation through transcriptional induction of MMP9, providing the first evidence that transcriptional regulation of a proteinase contributes to endochondral ossification and skeletal development.	[Shinoda, Yusuke; Ogata, Naoshi; Higashikawa, Akiro; Manabe, Ichiro; Shindo, Takayuki; Yamada, Takashi; Kugimiya, Fumitaka; Ikeda, Toshiyuki; Kawamura, Naohiro; Kawasaki, Yosuke; Tsushima, Kensuke; Takeda, Norifumi; Nagai, Ryozo; Hoshi, Kazuto; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi] Univ Tokyo, Tokyo 1138655, Japan	University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Manabe, Ichiro/E-1529-2014; Ikeda, Toshiyuki/GVS-5588-2022; Manabe, Ichiro/AAE-5105-2021; Kawamura, Naohiro/J-8372-2019	TAKEDA, NORIFUMI/0000-0003-4818-3347; Tsushima, Kensuke/0000-0001-7338-7849				Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Colnot C, 2001, DEV BIOL, V229, P203, DOI 10.1006/dbio.2000.9933; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JINGUSHI S, 1995, J ORTHOPAED RES, V13, P761, DOI 10.1002/jor.1100130516; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee ER, 1999, DEV DYNAM, V215, P190, DOI 10.1002/(SICI)1097-0177(199907)215:3<190::AID-AJA2>3.0.CO;2-B; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; TERATO K, 1992, J IMMUNOL, V148, P2103; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	47	42	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24682	24689		10.1074/jbc.M709857200	http://dx.doi.org/10.1074/jbc.M709857200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617520	hybrid, Green Published			2022-12-25	WOS:000258820000038
J	Varfolomeev, E; Goncharov, T; Fedorova, AV; Dynek, JN; Zobel, K; Deshayes, K; Fairbrother, WJ; Vucic, D				Varfolomeev, Eugene; Goncharov, Tatiana; Fedorova, Anna V.; Dynek, Jasmin N.; Zobel, Kerry; Deshayes, Kurt; Fairbrother, Wayne J.; Vucic, Domagoj			c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNF alpha)-induced NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS PROTEINS; CELLULAR INHIBITOR; DEPENDENT APOPTOSIS; KINASE-ACTIVITY; C-IAPS; UBIQUITINATION; PATHWAY; TRAF2; SIGNALS; BINDING	The inhibitor of apoptosis (IAP) proteins are a family of antiapoptotic regulators found in viruses and metazoans. c-IAP1 and c-IAP2 are recruited to tumor necrosis factor receptor 1 (TNFR1)-associated complexes where they can regulate receptor-mediated signaling. Both c-IAP1 and c-IAP2 have been implicated in TNF alpha-stimulated NF-kappa B activation. However, individual c-IAP1 and c-IAP2 gene knock-outs in mice did not reveal changes in TNF signaling pathways, and the phenotype of a combined deficiency of c-IAPs has yet to be reported. Here we investigate the role of c-IAP1 and c-IAP2 in TNF alpha-stimulated activation of NF-kappa B. We demonstrate that TNF alpha-induced NF-kappa B activation is severely diminished in the absence of both c-IAP proteins. In addition, combined absence of c-IAP1 and c-IAP2 rendered cells sensitive to TNF alpha-induced cell death. Using cells with genetic ablation of c-IAP1 or cells where the c-IAP proteins were eliminated using IAP antagonists, we show that TNF alpha-induced RIP1 ubiquitination is abrogated in the absence of c-IAPs. Furthermore, we reconstitute the ubiquitination process with purified components in vitro and demonstrate that c-IAP1, in collaboration with the ubiquitin conjugating enzyme (E2) enzyme UbcH5a, mediates polymerization of Lys-63-linked chains on RIP1. Therefore, c-IAP1 and c-IAP2 are required for TNF alpha-stimulated RIP1 ubiquitination and NF-kappa B activation.	[Varfolomeev, Eugene; Goncharov, Tatiana; Fedorova, Anna V.; Dynek, Jasmin N.; Zobel, Kerry; Deshayes, Kurt; Fairbrother, Wayne J.; Vucic, Domagoj] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Vucic, D (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	domagoj@gene.com						Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Ying SM, 2008, MICROBES INFECT, V10, P97, DOI 10.1016/j.micinf.2007.10.005	35	415	430	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24295	24299		10.1074/jbc.C800128200	http://dx.doi.org/10.1074/jbc.C800128200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621737	Green Published, hybrid			2022-12-25	WOS:000258820000003
J	Verbitskiy, D; van der Merwe, JA; Zehrmann, A; Brennicke, A; Takenaka, M				Verbitskiy, Daniil; van der Merwe, Johannes A.; Zehrmann, Anja; Brennicke, Axel; Takenaka, Mizuki			Multiple specificity recognition motifs enhance plant mitochondrial RNA editing in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; SITE RECOGNITION; CHLOROPLAST TRANSCRIPTS; ELEMENTS; INVOLVEMENT; SEQUENCE; GENOME	Analysis of RNA editing in plant mitochondria has at least in vitro been hampered by very low activity. Consequently, none of the trans-acting factors involved has yet been identified. We here report that in vitro RNA editing increases dramatically when additional cognate recognition motifs are introduced into the template RNA molecule. Substrate RNAs with tandemly repeated recognition elements enhance in vitro RNA editing from 2-3% to 50-80%. The stimulation is not influenced by the editing status of a respective RNA editing site, suggesting that specific recognition of a site can be independent of the edited nucleotide itself. In vivo, attachment of the editing complex may thus be analogously initiated at sequence similarities in the vicinity of bona fide editing sites. This cis-acting enhancement decreases with increasing distance between the duplicated specificity signals; a cooperative effect is detectable up to similar to 200 nucleotides. Such repeated template constructs promise to be powerful tools for the RNA affinity identification of the as yet unknown trans-factors of plant mitochondrial RNA editing.	[Verbitskiy, Daniil; van der Merwe, Johannes A.; Zehrmann, Anja; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	Bolle N, 2006, FEBS LETT, V580, P4443, DOI 10.1016/j.febslet.2006.07.011; Choury D, 2004, NUCLEIC ACIDS RES, V32, P6397, DOI 10.1093/nar/gkh969; Choury D, 2006, CURR GENET, V50, P405, DOI 10.1007/s00294-006-0100-3; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Gagliardi D., 2007, PLANT MITOCHONDRIA, P50, DOI DOI 10.1002/9780470986592.CH3; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Heller WP, 2008, J BIOL CHEM, V283, P7314, DOI 10.1074/jbc.M709595200; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Kobayashi Y, 2008, NUCLEIC ACIDS RES, V36, P311, DOI 10.1093/nar/gkm1026; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2003, J BIOL CHEM, V278, P47526, DOI 10.1074/jbc.M305341200; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2007, FEBS LETT, V581, P2743, DOI 10.1016/j.febslet.2007.05.025; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2006, PLANT J, V47, P408, DOI 10.1111/j.1365-313X.2006.02794.x; WISSINGER B, 1992, TRENDS GENET, V8, P322, DOI 10.1016/0168-9525(92)90265-6	28	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24374	24381		10.1074/jbc.M803292200	http://dx.doi.org/10.1074/jbc.M803292200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596040	hybrid, Green Published			2022-12-25	WOS:000258820000011
J	Zhang, G; Park, MA; Mitchell, C; Walker, T; Hamed, H; Studer, E; Graf, M; Rahmani, M; Gupta, S; Hylemon, PB; Fisher, PB; Grant, S; Dent, P				Zhang, Guo; Park, Margaret A.; Mitchell, Clint; Walker, Teneille; Hamed, Hossein; Studer, Elaine; Graf, Martin; Rahmani, Mohamed; Gupta, Seema; Hylemon, Philip B.; Fisher, Paul B.; Grant, Steven; Dent, Paul			Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CELL-DEATH; RAT HEPATOCYTES; FAS RECEPTOR; P53; ACTIVATION; MDM2; PHOSPHORYLATION; PATHWAYS; ROLES	Previously, using primary hepatocytes residing in early G(1) phase, we demonstrated that expression of the cyclin-dependent kinase (CDK) inhibitor protein p21(Cip-1/WAF1/mda6) (p21) enhanced the toxicity of deoxycholic acid (DCA) + MEK1/2 inhibitor. This study examined the mechanisms regulating this apoptotic process. Overexpression of p21 or p27(Kip-1) (p27) enhanced DCA + MEK1/2 inhibitor toxicity in primary hepatocytes that was dependent on expression of acidic sphingomyelinase and CD95. Overexpression of p21 suppressed MDM2, elevated p53 levels, and enhanced CD95, BAX, NOXA, and PUMA expression; knockdown of BAX/NOXA/PUMA reduced CDK inhibitor-stimulated cell killing. Parallel to cell death processes, overexpression of p21 or p27 profoundly enhanced DCA + MEK1/2 inhibitor-induced expression of ATG5 and GRP78/BiP and phosphorylation of PKR-like endoplasmic reticulum kinase (PERK) and eIF2 alpha, and it increased the numbers of vesicles containing a transfected LC3-GFP construct. Incubation of cells with 3-methyladenine or knockdown of ATG5 suppressed DCA + MEK1/2 inhibitor-induced LC3-GFP vesicularization and enhanced DCA + MEK1/2 inhibitor-induced toxicity. Expression of dominant negative PERK blocked DCA + MEK1/2 inhibitor-induced expression of ATG5, GRP78/BiP, and eIF2 + phosphorylation and prevented LC3-GFP vesicularization. Knock-out or knockdown of p53 or CD95 abolished DCA + MEK1/2 inhibitor-induced PERK phosphorylation and prevented LC3-GFP vesicularization. Thus, CDK inhibitors suppress MDM2 levels and enhance p53 expression that facilitates bile acid-induced, ceramide-dependent CD95 activation to induce both apoptosis and autophagy in primary hepatocytes.	[Zhang, Guo; Park, Margaret A.; Mitchell, Clint; Walker, Teneille; Hamed, Hossein; Rahmani, Mohamed; Dent, Paul] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Mol Biol Hematol Oncol, Richmond, VA 23298 USA; [Studer, Elaine; Gupta, Seema; Hylemon, Philip B.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Graf, Martin] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Fisher, Paul B.; Grant, Steven; Dent, Paul] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Dent, P (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia, 401 Coll St, Richmond, VA 23298 USA.	pdent@vcu.edu		Rahmani, Mohamed/0000-0002-3992-8039; ZHANG, GUO/0000-0001-7755-443X	National Institutes of Health [R01-DK52825, P01-CA104177, R01-CA108520]; USPHS [R01-CA63753, R01-CA77141]; Department of Defense Award [DAMD17-03-1-0262]; V Foundation; Leukemia Society of America [6405-97]; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA108520, R01CA063753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Defense Award(United States Department of Defense); V Foundation; Leukemia Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK52825, P01-CA104177, and R01-CA108520 (to P. D.) and R01-CA63753 and R01-CA77141 (to S. G.) from the USPHS, Department of Defense Award DAMD17-03-1-0262, The V Foundation, and a Leukemia Society of America Grant 6405-97.	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; BENAGE D, 1990, J CLIN GASTROENTEROL, V12, P192, DOI 10.1097/00004836-199004000-00017; BLOOMER JR, 1976, ARCH INTERN MED, V136, P57, DOI 10.1001/archinte.136.1.57; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLT PR, 1972, ARCH INTERN MED, V130, P574, DOI 10.1001/archinte.130.4.574; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Koeppel TA, 1997, HEPATOLOGY, V26, P1085; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Noto H, 1998, ARTIF ORGANS, V22, P300, DOI 10.1046/j.1525-1594.1998.05071.x; PARK MA, 2008, CANC BIOL T IN PRESS; Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697; Poupon R, 2000, J HEPATOL, V32, P129, DOI 10.1016/S0168-8278(00)80421-3; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qiao D, 2001, CARCINOGENESIS, V22, P35, DOI 10.1093/carcin/22.1.35; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Qiao L, 2002, HEPATOLOGY, V36, P39, DOI 10.1053/jhep.2002.33899; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yacoub A, 2008, MOL CANCER THER, V7, P297, DOI 10.1158/1535-7163.MCT-07-2166; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; ZHANG G, 2008, CLIN CANC R IN PRESS; Zhang Z, 2004, CLIN CANCER RES, V10, P1263, DOI 10.1158/1078-0432.CCR-0245-03	40	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24343	24358		10.1074/jbc.M803444200	http://dx.doi.org/10.1074/jbc.M803444200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614532	Green Published, hybrid			2022-12-25	WOS:000258820000009
J	Hunter, GA; Sampson, MP; Ferreira, GC				Hunter, Gregory A.; Sampson, Matthew P.; Ferreira, Gloria C.			Metal ion substrate inhibition of ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE FERROCHELATASE; BACILLUS-SUBTILIS FERROCHELATASE; ACTIVE-SITE RESIDUES; IRON-SULFUR CLUSTER; MAMMALIAN FERROCHELATASE; HEME-BIOSYNTHESIS; 2FE-2S CLUSTER; PORPHYRIN METALATION; DIRECTED MUTAGENESIS; PROTOPORPHYRIN-IX	Ferrochelatase catalyzes the insertion of ferrous iron into protoporphyrin IX to form heme. Robust kinetic analyses of the reaction mechanism are complicated by the instability of ferrous iron in aqueous solution, particularly at alkaline pH values. At pH 7.00 the half-life for spontaneous oxidation of ferrous ion is approximately 2 min in the absence of metal complexing additives, which is sufficient for direct comparisons of alternative metal ion substrates with iron. These analyses reveal that purified recombinant ferrochelatase from both murine and yeast sources inserts not only ferrous iron but also divalent cobalt, zinc, nickel, and copper into protoporphyrin IX to form the corresponding metalloporphyrins but with considerable mechanistic variability. Ferrous iron is the preferred metal ion substrate in terms of apparent kcat and is also the only metal ion substrate not subject to severe substrate inhibition. Substrate inhibition occurs in the order Cu2+ > Zn2+ > Co2+ > Ni2+ and can be alleviated by the addition of metal complexing agents such as beta-mercaptoethanol or imidazole to the reaction buffer. These data indicate the presence of two catalytically significant metal ion binding sites that may coordinately regulate a selective processivity for the various potential metal ion substrates.	[Hunter, Gregory A.; Sampson, Matthew P.; Ferreira, Gloria C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Hunter, GA (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	ghunter@health.usf.edu; gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080270, GM 080270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; BOTTOMLEY SS, 2004, PORPHYRIA, P1057; Brindley AA, 2003, J BIOL CHEM, V278, P22388, DOI 10.1074/jbc.M302468200; BROWN SB, 1976, BIOCHEM J, V153, P279, DOI 10.1042/bj1530279; COCHRAN AG, 1990, SCIENCE, V249, P781, DOI 10.1126/science.2389144; Conn MM, 1996, J AM CHEM SOC, V118, P7012, DOI 10.1021/ja961249c; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7; FERREIRA GC, 1994, J BIOL CHEM, V269, P7062; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; FRANCO R, 1995, J BIOL CHEM, V270, P26352, DOI 10.1074/jbc.270.44.26352; FURUKAWA T, 1995, BIOCHEM J, V310, P533, DOI 10.1042/bj3100533; Gora M, 1996, J BIOL CHEM, V271, P11810, DOI 10.1074/jbc.271.20.11810; GUNTER EW, 1989, CLIN CHEM, V35, P1601; HANSON JW, 1984, BIOCHEM J, V222, P695, DOI 10.1042/bj2220695; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; JONES MS, 1970, BIOCHEM J, V119, P453, DOI 10.1042/bj1190453; Karlberg T, 2002, BIOCHEMISTRY-US, V41, P13499, DOI 10.1021/bi0260785; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Lloyd SG, 1996, J AM CHEM SOC, V118, P9892, DOI 10.1021/ja954000o; MARGALIT R, 1984, BIOCHEM J, V219, P445, DOI 10.1042/bj2190445; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Najahi-Missaoui W, 2005, BLOOD, V106, P1098, DOI 10.1182/blood-2004-12-4661; Nakayama K, 2000, ARCH BIOCHEM BIOPHYS, V375, P240, DOI 10.1006/abbi.1999.1641; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; OKUDA M, 1994, BBA-GEN SUBJECTS, V1200, P123, DOI 10.1016/0304-4165(94)90126-0; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; PORRA RJ, 1967, BIOCHEM J, V104, P321, DOI 10.1042/bj1040321; Schneider-Yin X, 2000, BLOOD, V96, P1545, DOI 10.1182/blood.V96.4.1545.h8001545_1545_1549; Schubert HL, 1999, BIOCHEMISTRY-US, V38, P10660, DOI 10.1021/bi9906773; Sellers VM, 1996, BIOCHEMISTRY-US, V35, P2699, DOI 10.1021/bi952631p; Sellers VM, 2001, BIOCHEMISTRY-US, V40, P9821, DOI 10.1021/bi010012c; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shepherd M, 2006, BIOCHEM J, V397, P47, DOI 10.1042/BJ20051967; Shi Z, 2004, J BIOL CHEM, V279, P19977, DOI 10.1074/jbc.M313821200; STUMM W, 1961, IND ENG CHEM, V53, P143, DOI 10.1021/ie50614a030; SUNG W, 1980, ENVIRON SCI TECHNOL, V14, P561, DOI 10.1021/es60165a006; Suzuki T, 2000, PLANT CELL PHYSIOL, V41, P192, DOI 10.1093/pcp/41.2.192; TAKETANI S, 1982, EUR J BIOCHEM, V127, P443; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yin Jiang, 2006, Journal of Structural and Functional Genomics, V7, P37, DOI 10.1007/s10969-006-9008-x; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yu QY, 1997, ANAL BIOCHEM, V253, P50, DOI 10.1006/abio.1997.2349; ZUMDAHL SS, 2004, CHEM PRINCIPLES, P891	60	42	42	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23685	23691		10.1074/jbc.M803372200	http://dx.doi.org/10.1074/jbc.M803372200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593702	Green Published, hybrid			2022-12-25	WOS:000258638900022
J	Kagawa, W; Kagawa, A; Saito, K; Ikawa, S; Shibata, T; Kurumizaka, H; Yokoyama, S				Kagawa, Wataru; Kagawa, Ako; Saito, Kengo; Ikawa, Shukuko; Shibata, Takehiko; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki			Identification of a second DNA binding site in the human Rad52 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; RECA-PROTEIN; GENETIC-RECOMBINATION; YEAST; REPLICATION; EXCHANGE; REPAIR; RECOGNITION; MEDIATOR	Rad52 plays essential roles in homology-dependent double-strand break repair. Various studies have established the functions of Rad52 in Rad51-dependent and Rad51-independent repair processes. However, the precise molecular mechanisms of Rad52 in these processes remain unknown. In the present study we have identified a novel DNA binding site within Rad52 by a structure-based alanine scan mutagenesis. This site is closely aligned with the putative single-stranded DNA binding site determined previously. Mutations in this site impaired the ability of the Rad52-single-stranded DNA complex to form a ternary complex with double-stranded DNA and subsequently catalyze the formation of D-loops. We found that Rad52 introduces positive supercoils into double-stranded DNA and that the second DNA binding site is essential for this activity. Our findings suggest that Rad52 aligns two recombining DNA molecules within the first and second DNA binding sites to stimulate the homology search and strand invasion processes.	[Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Struct Biol Lab,Shinjuku Ku, Tokyo 1628480, Japan; [Kagawa, Wataru; Kagawa, Ako; Saito, Kengo; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Ikawa, Shukuko; Shibata, Takehiko] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Shibata, Takehiko] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Waseda University; RIKEN; RIKEN; Yokohama City University; University of Tokyo	Yokoyama, S (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Struct Biol Lab,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589; SAITO, Kengo/0000-0002-8714-6285	Targeted Proteins Research Program; RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Targeted Proteins Research Program and the RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baynton K, 2003, J BIOL CHEM, V278, P36476, DOI 10.1074/jbc.M303885200; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bi BY, 2004, P NATL ACAD SCI USA, V101, P9568, DOI 10.1073/pnas.0403205101; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kito K, 1999, BBA-GENE STRUCT EXPR, V1489, P303, DOI 10.1016/S0167-4781(99)00214-6; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P9562, DOI 10.1073/pnas.0403416101; Lloyd JA, 2005, J MOL BIOL, V345, P239, DOI 10.1016/j.jmb.2004.10.065; Macke TJ, 1998, ACS SYM SER, V682, P379; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 2003, EMBO J, V22, P324, DOI 10.1093/emboj/cdg027; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Parsons CA, 2000, EMBO J, V19, P4175, DOI 10.1093/emboj/19.15.4175; Ranatunga W, 2001, J BIOL CHEM, V276, P15876, DOI 10.1074/jbc.M011747200; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; SNOUNOU G, 1983, J MOL BIOL, V167, P211, DOI 10.1016/S0022-2836(83)80043-6; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; STORL K, 1993, FEBS LETT, V334, P49, DOI 10.1016/0014-5793(93)81678-S; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203	40	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24264	24273		10.1074/jbc.M802204200	http://dx.doi.org/10.1074/jbc.M802204200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593704	Green Published, hybrid			2022-12-25	WOS:000258638900080
J	Gonzalez, D; Grillo, MJ; De Miguel, MJ; Ali, T; Arce-Gorvel, V; Delrue, RM; Conde-Alvarez, R; Munoz, P; Lopez-Goni, I; Iriarte, M; Marin, CM; Weintraub, A; Widmalm, G; Zygmunt, M; Letesson, JJ; Gorvel, JP; Blasco, JM; Moriyon, I				Gonzalez, David; Grillo, Maria-Jesus; De Miguel, Maria-Jesus; Ali, Tara; Arce-Gorvel, Vilma; Delrue, Rose-May; Conde-Alvarez, Raquel; Munoz, Pilar; Lopez-Goni, Ignacio; Iriarte, Maite; Marin, Clara-M.; Weintraub, Andrej; Widmalm, Goeran; Zygmunt, Michel; Letesson, Jean-Jacques; Gorvel, Jean-Pierre; Blasco, Jose-Maria; Moriyon, Ignacio			Brucellosis Vaccines: Assessment of Brucella melitensis Lipopolysaccharide Rough Mutants Defective in Core and O-Polysaccharide Synthesis and Export	PLOS ONE			English	Article								Background: The brucellae are facultative intracellular bacteria that cause brucellosis, one of the major neglected zoonoses. In endemic areas, vaccination is the only effective way to control this disease. Brucella melitensis Rev 1 is a vaccine effective against the brucellosis of sheep and goat caused by B. melitensis, the commonest source of human infection. However, Rev 1 carries a smooth lipopolysaccharide with an O-polysaccharide that elicits antibodies interfering in serodiagnosis, a major problem in eradication campaigns. Because of this, rough Brucella mutants lacking the O-polysaccharide have been proposed as vaccines. Methodology/Principal Findings: To examine the possibilities of rough vaccines, we screened B. melitensis for lipopolysaccharide genes and obtained mutants representing all main rough phenotypes with regard to core oligosaccharide and O-polysaccharide synthesis and export. Using the mouse model, mutants were classified into four attenuation patterns according to their multiplication and persistence in spleens at different doses. In macrophages, mutants belonging to three of these attenuation patterns reached the Brucella characteristic intracellular niche and multiplied intracellularly, suggesting that they could be suitable vaccine candidates. Virulence patterns, intracellular behavior and lipopolysaccharide defects roughly correlated with the degree of protection afforded by the mutants upon intraperitoneal vaccination of mice. However, when vaccination was applied by the subcutaneous route, only two mutants matched the protection obtained with Rev 1 albeit at doses one thousand fold higher than this reference vaccine. These mutants, which were blocked in O-polysaccharide export and accumulated internal O-polysaccharides, stimulated weak anti-smooth lipopolysaccharide antibodies. Conclusions/Significance: The results demonstrate that no rough mutant is equal to Rev 1 in laboratory models and question the notion that rough vaccines are suitable for the control of brucellosis in endemic areas.	[Gonzalez, David; Conde-Alvarez, Raquel; Lopez-Goni, Ignacio; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Grillo, Maria-Jesus] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Pamplona, Spain; [De Miguel, Maria-Jesus; Munoz, Pilar; Marin, Clara-M.; Blasco, Jose-Maria] Gobierno Aragon, Sanidad Anim, CITA, Zaragoza, Spain; [Ali, Tara; Widmalm, Goeran] Stockholm Univ, Arrhenius Lab, Stockholm, Sweden; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, Fac Sci Luminy, Ctr Immunol Marseille Luminy, Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] INSERM, U631, Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] CNRS, UMR6102, Marseille, France; [Delrue, Rose-May; Letesson, Jean-Jacques] Fac Univ Notre Dame Paix FUNDP, URBM, Lab Immunol Microbiol, Namur, Belgium; [Weintraub, Andrej] Karolinska Univ Hosp, Div Clin Bacteriol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden; [Zygmunt, Michel] IASP, Infectiol Anim Sante Publ, INRA, UR1282, Nouzilly, France	University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Stockholm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University of Namur; Karolinska Institutet; Karolinska University Hospital; INRAE	Gonzalez, D (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	Imoriyon@unav.es	Moriyon, Ignacio/N-4764-2016; Jean-Jacques, LETESSON/AHB-6921-2022; Gorvel, Jean-Pierre/O-1332-2018; IRIARTE, MAITE/L-9460-2014; González, David/L-4474-2014; Muñoz, Pilar M/K-5877-2014; De Miguel, María Jesús/K-5860-2014; Grilló, María-Jesús/F-9621-2011; López-Goñi, Ignacio/K-2572-2017; Blasco, Julian/A-5319-2008; BLASCO, JOSE M/C-7034-2013; Conde-Álvarez, Raquel/K-5854-2014; Marin, Clara M/S-5531-2017	Moriyon, Ignacio/0000-0002-4288-0195; Gorvel, Jean-Pierre/0000-0002-2829-9804; IRIARTE, MAITE/0000-0002-6726-8920; González, David/0000-0002-7799-2613; Muñoz, Pilar M/0000-0002-7970-4929; De Miguel, María Jesús/0000-0002-5037-3687; Grilló, María-Jesús/0000-0002-1819-0186; López-Goñi, Ignacio/0000-0002-3873-8743; Blasco, Julian/0000-0002-9750-383X; BLASCO, JOSE M/0000-0002-6112-5312; Conde-Álvarez, Raquel/0000-0003-0046-3577; Marin, Clara M/0000-0002-1974-9025; LETESSON, Jean-Jacques/0000-0002-5838-0224; Zygmunt, Michel/0000-0002-1389-6366; Widmalm, Goran/0000-0001-8303-4481; Arce-Gorvel, Vilma/0000-0003-0090-837X; Weintraub, Andrej/0000-0003-3646-247X	European Commission [QLK2-CT-2002-00918]; Ministerio de Ciencia y Tecnologia of Spain [AGL2004-01162/GAN]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the European Commission (Research Contract QLK2-CT-2002-00918) and the Ministerio de Ciencia y Tecnologia of Spain (Proyecto AGL2004-01162/GAN).	Adone R, 2005, INFECT IMMUN, V73, P4198, DOI 10.1128/IAI.73.7.4198-4204.2005; Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BOWDEN RA, 1995, INFECT IMMUN, V63, P3945, DOI 10.1128/IAI.63.10.3945-3952.1995; BOWSER DV, 1974, INFECT IMMUN, V9, P772, DOI 10.1128/IAI.9.4.772-774.1974; BRAUN W, 1958, P SOC EXP BIOL MED, V97, P393, DOI 10.3181/00379727-97-23752; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CAFISO D, 1983, METHOD ENZYMOL, V171, P342; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CLOECKAERT A, 1990, INFECT IMMUN, V58, P3980, DOI 10.1128/IAI.58.12.3980-3987.1990; Cloeckaert A, 2004, VACCINE, V22, P2827, DOI 10.1016/j.vaccine.2004.01.001; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; de Bagues MPJ, 2004, INFECT IMMUN, V72, P2429, DOI 10.1128/IAI.72.4.2429-2433.2004; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; DETILLEUX PG, 1990, VET PATHOL, V27, P317, DOI 10.1177/030098589002700503; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Fernandez-Prada CM, 2001, INFECT IMMUN, V69, P4407, DOI 10.1128/IAI.69.7.4407-4416.2001; FREEMAN BA, 1961, J INFECT DIS, V108, P333, DOI 10.1093/infdis/108.3.333; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Garin-Bastuji B, 1998, VET RES, V29, P255; GARINBASTUJI B, 1990, J CLIN MICROBIOL, V28, P2169, DOI 10.1128/JCM.28.10.2169-2174.1990; Godfroid F, 2000, RES MICROBIOL, V151, P655, DOI 10.1016/S0923-2508(00)90130-X; Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038; Grillo MJ, 2000, BIOLOGICALS, V28, P119, DOI 10.1006/biol.2000.0249; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; Holst O, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P115; Iriarte M., 2004, Brucella: molecular and cellular biology, P159; ITO M, 1993, CARBOHYD RES, V242, P173, DOI 10.1016/0008-6215(93)80032-A; Kahl-McDonagh MM, 2006, INFECT IMMUN, V74, P4048, DOI 10.1128/IAI.01787-05; Kneidinger B, 2003, BIOCHEM J, V371, P989, DOI 10.1042/BJ20030099; KNIREL YA, 1995, EUR J BIOCHEM, V232, P391, DOI 10.1111/j.1432-1033.1995.tb20823.x; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Maudlin I, 2006, CONTROL NEGLECTED ZO; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; MORENO E, 1984, INFECT IMMUN, V43, P779, DOI 10.1128/IAI.43.3.779-782.1984; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Nicoletti P., 1990, Animal brucellosis., P283; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; PERRY MB, 1990, ADVANCES IN BRUCELLOSIS RESEARCH, P76; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; ROJAS N, 1994, CLIN DIAGN LAB IMMUN, V1, P206, DOI 10.1128/CDLI.1.2.206-213.1994; ROSENBERG M, 2007, FEMS MICROBIOL LETT, V9, P33; SANGARI F, 1991, MICROB PATHOGENESIS, V11, P443, DOI 10.1016/0882-4010(91)90040-H; SCHURIG GG, 1981, INFECT IMMUN, V34, P1000, DOI 10.1128/IAI.34.3.1000-1007.1981; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Spink WW, 1956, NATURE BRUCELLOSIS; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Vemulapalli R, 2000, INFECT IMMUN, V68, P3927, DOI 10.1128/IAI.68.7.3927-3932.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Vizcaino N, 2001, INFECT IMMUN, V69, P6738, DOI 10.1128/IAI.69.11.6738-6748.2001; WILSON JB, 1960, ANN NY ACAD SCI, V88, P1155, DOI 10.1111/j.1749-6632.1960.tb20106.x; Winter AJ, 1996, AM J VET RES, V57, P677; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381	71	101	114	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2760	10.1371/journal.pone.0002760	http://dx.doi.org/10.1371/journal.pone.0002760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648644	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900030
J	Hartl, D; Rohe, M; Mao, L; Staufenbiel, M; Zabel, C; Klose, J				Hartl, Daniela; Rohe, Michael; Mao, Lei; Staufenbiel, Matthias; Zabel, Claus; Klose, Joachim			Impairment of Adolescent Hippocampal Plasticity in a Mouse Model for Alzheimer's Disease Precedes Disease Phenotype	PLOS ONE			English	Article								The amyloid precursor protein (APP) was assumed to be an important neuron-morphoregulatory protein and plays a central role in Alzheimer's disease (AD) pathology. In the study presented here, we analyzed the APP-transgenic mouse model APP23 using 2-dimensional gel electrophoresis technology in combination with DIGE and mass spectrometry. We investigated cortex and hippocampus of transgenic and wildtype mice at 1, 2, 7 and 15 months of age. Furthermore, cortices of 16 days old embryos were analyzed. When comparing the protein patterns of APP23 with wildtype mice, we detected a relatively large number of altered protein spots at all age stages and brain regions examined which largely preceded the occurrence of amyloid plaques. Interestingly, in hippocampus of adolescent, two-month old mice, a considerable peak in the number of protein changes was observed. Moreover, when protein patterns were compared longitudinally between age stages, we found that a large number of proteins were altered in wildtype mice. Those alterations were largely absent in hippocampus of APP23 mice at two months of age although not in other stages compared. Apparently, the large difference in the hippocampal protein patterns between two-month old APP23 and wildtype mice was caused by the absence of distinct developmental changes in the hippocampal proteome of APP23 mice. In summary, the absence of developmental proteome alterations as well as a down-regulation of proteins related to plasticity suggest the disturption of a normally occurring peak of hippocampal plasticity during adolescence in APP23 mice. Our findings are in line with the observation that AD is preceded by a clinically silent period of several years to decades. We also demonstrate that it is of utmost importance to analyze different brain regions and different age stages to obtain information about disease-causing mechanisms.	[Hartl, Daniela; Mao, Lei; Zabel, Claus; Klose, Joachim] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Rohe, Michael] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Novartis	Hartl, D (corresponding author), Charite, Inst Human Genet, D-13353 Berlin, Germany.	claus.zabel@charite.de			German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program	German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program(Federal Ministry of Education & Research (BMBF))	This work was supported by the German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Arendt T, 2005, PROG BRAIN RES, V147, P355, DOI 10.1016/S0079-6123(04)47025-3; Arendt T, 2003, PROG NEUROBIOL, V71, P83, DOI 10.1016/j.pneurobio.2003.09.007; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Diedrich M, 2008, PROTEOMICS, V8, P1266, DOI 10.1002/pmic.200700754; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mao L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001218; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Small D H, 1999, J Alzheimers Dis, V1, P275; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sturchler-Pierrat C, 2000, ANN NY ACAD SCI, V920, P134; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Tsuji T, 2002, NEUROCHEM RES, V27, P1245, DOI 10.1023/A:1020941929414; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Vloeberghs E, 2006, NEUROSCI LETT, V407, P6, DOI 10.1016/j.neulet.2006.07.060; ZABEL C, 2007, METHODS MOL IN PRESS; Zabel C, 2008, EXPERT REV PROTEOMIC, V5, P187, DOI 10.1586/14789450.5.2.187; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	45	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2759	10.1371/journal.pone.0002759	http://dx.doi.org/10.1371/journal.pone.0002759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648492	gold, Green Published, Green Accepted			2022-12-25	WOS:000264302900029
J	Martin, B; Brenneman, R; Becker, KG; Gucek, M; Cole, RN; Maudsley, S				Martin, Bronwen; Brenneman, Randall; Becker, Kevin G.; Gucek, Marjan; Cole, Robert N.; Maudsley, Stuart			iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; NEUROFIBRILLARY TANGLES; SYNAPTIC PATHOLOGY; A-BETA; BRAIN; TAU; DEMENTIA; PLAQUES; NEURODEGENERATION; IMMUNOREACTIVITY	Alzheimer's disease (AD) is characterized by progressive cognitive impairment associated with accumulation of amyloid beta-peptide, synaptic degeneration and the death of neurons in the hippocampus, and temporal, parietal and frontal lobes of the cerebral cortex. Analysis of postmortem brain tissue from AD patients can provide information on molecular alterations present at the end of the disease process, but cannot discriminate between changes that are specifically involved in AD versus those that are simply a consequence of neuronal degeneration. Animal models of AD provide the opportunity to elucidate the molecular changes that occur in brain cells as the disease process is initiated and progresses. To this end, we used the 3xTgAD mouse model of AD to gain insight into the complex alterations in proteins that occur in the hippocampus and cortex in AD. The 3xTgAD mice express mutant presenilin-1, amyloid precursor protein and tau, and exhibit AD-like amyloid and tau pathology in the hippocampus and cortex, and associated cognitive impairment. Using the iTRAQ stable-isotope-based quantitative proteomic technique, we performed an in-depth proteomic analysis of hippocampal and cortical tissue from 16 month old 3xTgAD and non-transgenic control mice. We found that the most important groups of significantly altered proteins included those involved in synaptic plasticity, neurite outgrowth and microtubule dynamics. Our findings have elucidated some of the complex proteome changes that occur in a mouse model of AD, which could potentially illuminate novel therapeutic avenues for the treatment of AD and other neurodegenerative disorders.	[Martin, Bronwen; Brenneman, Randall; Maudsley, Stuart] NIA, Neurosci Lab, Intramural Res Program, Biomed Res Ctr, Baltimore, MD 21224 USA; [Becker, Kevin G.] NIA, Biomed Res Ctr, Intramural Res Program, Res Resources Branch, Baltimore, MD USA; [Gucek, Marjan; Cole, Robert N.] Johns Hopkins Sch Med, Proteom Facil, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine	Martin, B (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Biomed Res Ctr, Baltimore, MD 21224 USA.	maudsleyst@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000319, Z01AG000616, ZIAAG000325, Z01AG000325, Z01AG000319, Z01AG000318, ZIAAG000318, ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging.	Alappat SR, 2003, DEV DYNAM, V228, P59, DOI 10.1002/dvdy.10353; Alliegro MC, 2000, EXP CELL RES, V255, P270, DOI 10.1006/excr.1999.4776; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bailey JA, 2006, ANN NY ACAD SCI, V1086, P54, DOI 10.1196/annals.1377.001; BARBACCIA ML, 1986, ARCH GEN PSYCHIAT, V43, P1143; Beal MF, 2004, J BIOENERG BIOMEMBR, V36, P381, DOI 10.1023/B:JOBB.0000041772.74810.92; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1996, ACTA NEUROL SCAND  S, V9, P1107; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Churchill GA, 2001, NAT GENET, V29, P355, DOI 10.1038/ng1201-355; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Dhanasekaran M, 2005, CURR NEUROVASC RES, V2, P447, DOI 10.2174/156720205774962656; Donowitz M, 2007, J PROTEOME RES, V6, P4068, DOI 10.1021/pr0701761; Edgar PF, 1999, MOL PSYCHIATR, V4, P173, DOI 10.1038/sj.mp.4000463; FERRERO P, 1988, J NEUROL SCI, V87, P327, DOI 10.1016/0022-510X(88)90257-2; Graham RLJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r110; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Guo YR, 2007, MOL CELL PROTEOMICS, V6, P689, DOI 10.1074/mcp.M600398-MCP200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; HYMAN BT, 1994, NEUROBIOL AGING, V15, P353, DOI 10.1016/0197-4580(94)90031-0; Kassie F, 2008, CARCINOGENESIS, V29, P610, DOI 10.1093/carcin/bgn014; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; LEIFER D, 1993, J NEUROL SCI, V119, P217, DOI 10.1016/0022-510X(93)90137-N; MASLIAH E, 1995, NEUROBIOL AGING, V16, P280, DOI 10.1016/0197-4580(95)00020-F; Masliah E, 2001, J ALZHEIMERS DIS, V3, P121, DOI 10.3233/JAD-2001-3117; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Minger SL, 2001, J NEUROPATH EXP NEUR, V60, P929, DOI 10.1093/jnen/60.10.929; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Suga K, 2004, BIOCHEM J, V381, P619, DOI 10.1042/BJ20040618; Sugimori K, 2007, PSYCHIAT CLIN NEUROS, V61, P159, DOI 10.1111/j.1440-1819.2007.01631.x; TROJANOWSKI JQ, 1995, NEUROBIOL AGING, V16, P335, DOI 10.1016/0197-4580(94)00176-2; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; WALDVOGEL HJ, 1991, BRAIN RES, V546, P329, DOI 10.1016/0006-8993(91)91497-O; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang EY, 1996, BIOCHEM BIOPH RES CO, V229, P176, DOI 10.1006/bbrc.1996.1776; Zhang SD, 2004, BIOINFORMATICS, V20, P2821, DOI 10.1093/bioinformatics/bth336; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P898	55	94	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2750	10.1371/journal.pone.0002750	http://dx.doi.org/10.1371/journal.pone.0002750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648646	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900021
J	Verdoni, AM; Smith, RS; Ikeda, A; Ikeda, S				Verdoni, Angela M.; Smith, Richard S.; Ikeda, Akihiro; Ikeda, Sakae			Defects in Actin Dynamics Lead to an Autoinflammatory Condition through the Upregulation of CXCL5	PLOS ONE			English	Article								Background: Destrin (DSTN) is a member of the ADF/cofilin family of proteins and is an important regulator of actin dynamics. The primary function of destrin is to depolymerize filamentous actin into its monomeric form and promote filament severing. While progress has been made in understanding the biochemical functions of the ADF/cofilin proteins, the study of an animal model for cells deficient for DSTN provides an opportunity to investigate the physiological processes regulated by proper actin dynamics in vivo. A spontaneous mouse mutant, corneal disease 1(corn1), is deficient for DSTN, which causes epithelial hyperproliferation and neovascularization in the cornea. Dstn(corn1) mice exhibit an actin dynamics defect in the cornea as evidenced by the formation of actin stress fibers in the epithelial cells. Previously, we observed a significant infiltration of leukocytes into the cornea of Dstn(corn1) mice as well as the upregulation of proinflammatory molecules. In this study, we sought to characterize this inflammatory condition and explore the physiological mechanism through which a loss of Dstn function leads to inflammation. Methodology/Principal Findings: Through immunofluorescent analyses, we observed a significant recruitment of neutrophils and macrophages to the Dstn(corn1) cornea, demonstrating that the innate immune system is spontaneously activated in this mutant. The inflammatory chemokine, CXCL5, was ectopically expressed in the corneal epithelial cells of Dstn corn1 mice, and targeting of the receptor for this chemokine inhibited neutrophil recruitment. An inflammatory reaction was not observed in the cornea of allelic mutant strain, Dstn(corn1-2J), which has a milder defect in actin dynamics in the corneal epithelial cells. Conclusions/Significance: This study shows that severe defects in actin dynamics lead to an autoinflammatory condition that is mediated by the expression of CXC chemokines.	[Verdoni, Angela M.; Ikeda, Akihiro; Ikeda, Sakae] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Smith, Richard S.] Jackson Lab, Bar Harbor, ME USA	University of Wisconsin System; University of Wisconsin Madison; Jackson Laboratory	Verdoni, AM (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.	aikeda@wisc.edu		Ikeda, Akihiro/0000-0001-8440-3891	National Institutes of Health [EY011837, EY016108];  [T32 GM07133]; NATIONAL EYE INSTITUTE [R01EY016108, R01EY011837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: National Institutes of Health (NIH; EY011837, EY016108); Support for AMV was provided by the Predoctoral Training Program in Genetics (T32 GM07133). Funders did not play a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	APPELBERG R, 1989, CLIN EXP IMMUNOL, V78, P478; APPELBERG R, 1992, CLIN EXP IMMUNOL, V89, P120; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Feniger-Barish R, 2000, BLOOD, V95, P1551, DOI 10.1182/blood.V95.5.1551.005a36_1551_1559; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; GAZZANIGA S, 2007, J INVEST DERMATOL; Gerberick GF, 2002, TOXICOL SCI, V68, P420, DOI 10.1093/toxsci/68.2.420; Goncalves AS, 2002, SCAND J IMMUNOL, V55, P585, DOI 10.1046/j.1365-3083.2002.01097.x; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hall LR, 1999, J IMMUNOL, V163, P4970; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; IIDA K, 1993, GENE, V124, P115; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Lu PR, 2007, CORNEA, V26, P199, DOI 10.1097/01.ico.0000248385.16896.34; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; MASON DY, 1989, J CLIN PATHOL, V42, P1194, DOI 10.1136/jcp.42.11.1194; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MURAO S, 1988, P NATL ACAD SCI USA, V85, P1232, DOI 10.1073/pnas.85.4.1232; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; PEAKMAN M, 1993, J IMMUNOL METHODS, V158, P87, DOI 10.1016/0022-1759(93)90261-5; PETKOVA SB, 2008, PHYSL GENOM IN PRESS; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1016/S0022-4804(02)00020-3; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Suzuki S, 2002, BLOOD, V99, P1863, DOI 10.1182/blood.V99.5.1863.h8001863_1863_1865; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Verdoni AM, 2008, PHYSIOL GENOMICS, V34, P9, DOI 10.1152/physiolgenomics.00285.2007; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wuyts A, 1996, J IMMUNOL, V157, P1736; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; Zhou JH, 2005, MOL VIS, V11, P414	63	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2701	10.1371/journal.pone.0002701	http://dx.doi.org/10.1371/journal.pone.0002701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628996	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200044
J	Kim, E; Graham, LE				Kim, Eunsoo; Graham, Linda E.			EEF2 Analysis Challenges the Monophyly of Archaeplastida and Chromalveolata	PLOS ONE			English	Article							RED ALGAE; COMPLETE SEQUENCE; PHYLOGENETIC ANALYSIS; EVOLUTIONARY RELATIONSHIPS; EUKARYOTIC PHYLOGENY; CYANOPHORA-PARADOXA; PLASTID ORIGINS; SINGLE ORIGIN; COMMON ORIGIN; MISSING DATA	Background: Classification of eukaryotes provides a fundamental phylogenetic framework for ecological, medical, and industrial research. In recent years eukaryotes have been classified into six major supergroups: Amoebozoa, Archaeplastida, Chromalveolata, Excavata, Opisthokonta, and Rhizaria. According to this supergroup classification, Archaeplastida and Chromalveolata each arose from a single plastid-generating endosymbiotic event involving a cyanobacterium (Archaeplastida) or red alga (Chromalveolata). Although the plastids within members of the Archaeplastida and Chromalveolata share some features, no nucleocytoplasmic synapomorphies supporting these supergroups are currently known. Methodology/Principal Findings: This study was designed to test the validity of the Archaeplastida and Chromalveolata through the analysis of nucleus-encoded eukaryotic translation elongation factor 2 (EEF2) and cytosolic heat-shock protein of 70 kDa (HSP70) sequences generated from the glaucophyte Cyanophora paradoxa, the cryptophytes Goniomonas truncata and Guillardia theta, the katablepharid Leucocryptos marina, the rhizarian Thaumatomonas sp. and the green alga Mesostigma viride. The HSP70 phylogeny was largely unresolved except for certain well- established groups. In contrast, EEF2 phylogeny recovered many well- established eukaryotic groups and, most interestingly, revealed a well- supported clade composed of cryptophytes, katablepharids, haptophytes, rhodophytes, and Viridiplantae (green algae and land plants). This clade is further supported by the presence of a two amino acid signature within EEF2, which appears to have arisen from amino acid replacement before the common origin of these eukaryotic groups. Conclusions/Significance: Our EEF2 analysis strongly refutes the monophyly of the Archaeplastida and the Chromalveolata, adding to a growing body of evidence that limits the utility of these supergroups. In view of EEF2 phylogeny and other morphological evidence, we discuss the possibility of an alternative eukaryotic supergroup.	[Kim, Eunsoo; Graham, Linda E.] University of Wisconsin-Madison, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Kim, E (corresponding author), University of Wisconsin-Madison, Dept Bot, Madison, WI USA.	eunsookim@dal.ca			National Science Foundation [MCB-9977903]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-9977903 from the National Science Foundation. The grant was used to purchase supplies for molecular sequencing.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Bachvaroff TR, 2005, MOL BIOL EVOL, V22, P1772, DOI 10.1093/molbev/msi172; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bhattacharya D, 2006, CURR BIOL, V16, pR1017, DOI 10.1016/j.cub.2006.11.021; BISBY FA, 2007, SPECIES 2000; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Bodyl A, 2007, TRENDS MICROBIOL, V15, P295, DOI 10.1016/j.tim.2007.05.002; Bodyl A, 2006, EUR J PHYCOL, V41, P435, DOI 10.1080/09670260600961080; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bucknam J, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-26; Burger G, 1999, PLANT CELL, V11, P1675, DOI 10.1105/tpc.11.9.1675; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Clay B, 1999, PROTIST, V150, P43, DOI 10.1016/S1434-4610(99)70008-8; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; DOMOZYCH DS, 1992, PROTOPLASMA, V167, P19, DOI 10.1007/BF01353577; DOMOZYCH DS, 1981, J CELL SCI, V52, P351; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Germot A, 1999, J EUKARYOT MICROBIOL, V46, P116, DOI 10.1111/j.1550-7408.1999.tb04594.x; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Graham LE, 2000, ALGAE; Grzebyk D, 2004, SCIENCE, V306, P2191, DOI 10.1126/science.1105297; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; GUPTA RS, 1993, J MOL EVOL, V37, P573; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Inagaki Y, 2004, SYST BIOL, V53, P582, DOI 10.1080/10635150490468756; Jarvis P, 2001, BBA-MOL CELL RES, V1541, P64, DOI 10.1016/S0167-4889(01)00147-1; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Keeling Patrick J, 2004, Science, V306, P2191; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; KIM E, 2008, CHLOROPLAST IN PRESS; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Larkum AWD, 2007, TRENDS PLANT SCI, V12, P189, DOI 10.1016/j.tplants.2007.03.011; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; LEE RE, 1992, BRIT PHYCOL J, V27, P369, DOI 10.1080/00071619200650311; LEE RE, 1991, J PHYCOL, V27, P505, DOI 10.1111/j.0022-3646.1991.00505.x; Loffelhardt W, 1997, PLANT SYST EVOL, P149; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; MCFADDEN GI, 1994, EUR J PHYCOL, V29, P29, DOI 10.1080/09670269400650451; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Moriya M, 2002, PROTIST, V153, P143, DOI 10.1078/1434-4610-00093; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Nozaki H, 2005, J PHYCOL, V41, P652, DOI 10.1111/j.1529-8817.2005.00079.x; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; O'Kelly Charles J., 1993, P269; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; PATTERSON DJ, 2000, LINEAGES EUKARYOTES; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rissler HM, 2005, PLANT CELL PHYSIOL, V46, P416, DOI 10.1093/pcp/pci054; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Sanchez-Puerta MV, 2007, MOL PHYLOGENET EVOL, V44, P885, DOI 10.1016/j.ympev.2007.03.003; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, J MOL EVOL, V57, P408, DOI 10.1007/s00239-003-2490-x; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Steiner JM, 2005, PLANT J, V44, P646, DOI 10.1111/j.1365-313X.2005.02559.x; Stiller JW, 2007, TRENDS PLANT SCI, V12, P391, DOI 10.1016/j.tplants.2007.08.002; Stiller JW, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-71; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Stiller JW, 2003, J PHYCOL, V39, P95, DOI 10.1046/j.1529-8817.2003.02070.x; Stiller JW, 2001, J MOL EVOL, V52, P527, DOI 10.1007/s002390010183; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Stoebe B, 1998, PLANT MOL BIOL REP, V16, P243, DOI 10.1023/A:1007568326120; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Theissen U, 2006, CURR BIOL, V16, pR1016, DOI 10.1016/j.cub.2006.11.020; Tomova C, 2006, BIOL CELL, V98, P535, DOI 10.1042/BC20060028; VORS N, 1992, EUR J PROTISTOL, V28, P369, DOI 10.1016/S0932-4739(11)80001-5; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	104	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2621	10.1371/journal.pone.0002621	http://dx.doi.org/10.1371/journal.pone.0002621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612431	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800023
J	Takagi, H; Sato, MJ; Yanagida, T; Ueda, M				Takagi, Hiroaki; Sato, Masayuki J.; Yanagida, Toshio; Ueda, Masahiro			Functional Analysis of Spontaneous Cell Movement under Different Physiological Conditions	PLOS ONE			English	Article								Cells can show not only spontaneous movement but also tactic responses to environmental signals. Since the former can be regarded as the basis to realize the latter, playing essential roles in various cellular functions, it is important to investigate spontaneous movement quantitatively at different physiological conditions in relation to a cell's physiological functions. For that purpose, we observed a series of spontaneous movements by Dictyostelium cells at different developmental periods by using a single cell tracking system. Using statistical analysis of these traced data, we found that cells showed complex dynamics with anomalous diffusion and that their velocity distribution had power-law tails in all conditions. Furthermore, as development proceeded, average velocity and persistency of the movement increased and as too did the exponential behavior in the velocity distribution. Based on these results, we succeeded in applying a generalized Langevin model to the experimental data. With this model, we discuss the relation of spontaneous cell movement to cellular physiological function and its relevance to behavioral strategies for cell survival.	[Takagi, Hiroaki; Sato, Masayuki J.; Yanagida, Toshio; Ueda, Masahiro] Osaka Univ, Labs Nanobiol, Grad Sch Frontier Biosci, Osaka, Japan; [Takagi, Hiroaki] Nara Med Univ, Sch Med, Dept Phys, Nara, Japan; [Takagi, Hiroaki; Sato, Masayuki J.; Ueda, Masahiro] CREST, Japan Sci & Technol Agcy JST, Osaka, Japan	Osaka University; Nara Medical University; Japan Science & Technology Agency (JST)	Takagi, H (corresponding author), Osaka Univ, Labs Nanobiol, Grad Sch Frontier Biosci, Osaka, Japan.	takagi@naramed-u.ac.jp		Ueda, Masahiro/0000-0002-9354-3404	MEXT, Japan; JSPS, Japan [19870020, Research Fellowships]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Leading Project, MEXT, Japan. H.T. is supported by Grant-in-Aid for Young Scientists (Start-up, no. 19870020), JSPS, Japan. M.S. is supported by Research Fellowships, JSPS, Japan.	Bray D., 2000, CELL MOVEMENTS MOL M; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dormann D, 2006, CURR OPIN GENET DEV, V16, P367, DOI 10.1016/j.gde.2006.06.003; DUNN GA, 1987, J CELL SCI, P81; Miyoshi H, 2003, PROTOPLASMA, V222, P175, DOI 10.1007/s00709-003-0013-7; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shenderov AD, 1997, BIOPHYS J, V72, P2382, DOI 10.1016/S0006-3495(97)78883-0; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	11	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2648	10.1371/journal.pone.0002648	http://dx.doi.org/10.1371/journal.pone.0002648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612377	Green Submitted, Green Published, gold			2022-12-25	WOS:000264065800050
J	Ohta, H; Xu, S; Moriya, T; Iigo, M; Watanabe, T; Nakahata, N; Chisaka, H; Hanita, T; Matsuda, T; Ohura, T; Kimura, Y; Yaegashi, N; Tsuchiya, S; Tei, H; Okamura, K				Ohta, Hidenobu; Xu, Shanhai; Moriya, Takahiro; Iigo, Masayuki; Watanabe, Tatsuya; Nakahata, Norimichi; Chisaka, Hiroshi; Hanita, Takushi; Matsuda, Tadashi; Ohura, Toshihiro; Kimura, Yoshitaka; Yaegashi, Nobuo; Tsuchiya, Shigeru; Tei, Hajime; Okamura, Kunihiro			Maternal Feeding Controls Fetal Biological Clock	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SUPRACHIASMATIC NUCLEUS; NURSING MOTHERS; CONSTANT LIGHT; EXPRESSION; GENES; BRAIN; COORDINATION; OSCILLATIONS; ENDOCRINE	Background: It is widely accepted that circadian physiological rhythms of the fetus are affected by oscillators in the maternal brain that are coupled to the environmental light-dark (LD) cycle. Methodology/Principal Findings: To study the link between fetal and maternal biological clocks, we investigated the effects of cycles of maternal food availability on the rhythms of Per1 gene expression in the fetal suprachiasmatic nucleus (SCN) and liver using a transgenic rat model whose tissues express luciferase in vitro. Although the maternal SCN remained phase-locked to the LD cycle, maternal restricted feeding phase-advanced the fetal SCN and liver by 5 and 7 hours respectively within the 22-day pregnancy. Conclusions/Significance: Our results demonstrate that maternal feeding entrains the fetal SCN and liver independently of both the maternal SCN and the LD cycle. This indicates that maternal-feeding signals can be more influential for the fetal SCN and particular organ oscillators than hormonal signals controlled by the maternal SCN, suggesting the importance of a regular maternal feeding schedule for appropriate fetal molecular clockwork during pregnancy.	[Ohta, Hidenobu; Xu, Shanhai; Watanabe, Tatsuya; Chisaka, Hiroshi; Hanita, Takushi; Matsuda, Tadashi; Okamura, Kunihiro] Tohoku Univ Hosp, Ctr Perinatal Med, Sendai, Miyagi, Japan; [Ohta, Hidenobu; Xu, Shanhai; Chisaka, Hiroshi; Yaegashi, Nobuo; Okamura, Kunihiro] Tohoku Univ Hosp, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Ohta, Hidenobu; Watanabe, Tatsuya; Hanita, Takushi; Matsuda, Tadashi; Ohura, Toshihiro; Tsuchiya, Shigeru] Tohoku Univ Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Moriya, Takahiro; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharm Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan; [Iigo, Masayuki] Utsunomiya Univ, Fac Agr, Dept Appl Biochem, Tochigi, Japan; [Kimura, Yoshitaka] Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi, Japan; [Tei, Hajime] Mitsubishi Kagaku Inst Life Sci, Res Grp Chronogenom, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Utsunomiya University; Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Ohta, H (corresponding author), Tohoku Univ Hosp, Ctr Perinatal Med, Sendai, Miyagi, Japan.	hideohta@mail.tains.tohoku.ac.jp	Iigo, Masayuki/I-7110-2013		Ministry of Education, Science, Sports and Culture [Grants-in-Aid for Scientific Research]; Ministry of Health, Labour and Welfare; Kanzawa Medical Research Foundation	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation)	Grants-in-Aid for Scientific Research (to H.O.) from the Ministry of Education, Science, Sports and Culture and from the Ministry of Health, Labour and Welfare; a grant from Kanzawa Medical Research Foundation (to H.O.)	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; [Anonymous], [No title captured], DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177]; Burgoon PW, 2004, J COMP PHYSIOL A, V190, P167, DOI 10.1007/s00359-003-0486-z; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVIS FC, 1988, J COMP PHYSIOL A, V162, P601, DOI 10.1007/BF01342635; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Kennaway DJ, 2002, TRENDS ENDOCRIN MET, V13, P398, DOI 10.1016/S1043-2760(02)00692-6; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Li XD, 2005, DEV BRAIN RES, V158, P31, DOI 10.1016/j.devbrainres.2005.05.005; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; Mirmiran M, 2000, SEMIN PERINATOL, V24, P247, DOI 10.1053/sper.2000.8593; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Parraguez VH, 1996, ENDOCRINOLOGY, V137, P2355, DOI 10.1210/en.137.6.2355; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; REPPERT SM, 1986, ENDOCRINOLOGY, V119, P1763, DOI 10.1210/endo-119-4-1763; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; SHIBATA S, 1987, DEV BRAIN RES, V34, P311, DOI 10.1016/0165-3806(87)90220-3; Shimomura H, 2001, EUR J NEUROSCI, V13, P687, DOI 10.1046/j.0953-816x.2000.01438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; WEAVER DR, 1986, BRAIN RES DEV BRAIN, V46, P291; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	32	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2601	10.1371/journal.pone.0002601	http://dx.doi.org/10.1371/journal.pone.0002601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596966	gold, Green Submitted, Green Published			2022-12-25	WOS:000263288200054
J	Snaddon, JL; Turner, EC; Foster, WA				Snaddon, Jake L.; Turner, Edgar C.; Foster, William A.			Children's Perceptions of Rainforest Biodiversity: Which Animals Have the Lion's Share of Environmental Awareness?	PLOS ONE			English	Article							BUTTERFLIES; CONSERVATION; EXTINCTION	Globally, natural ecosystems are being lost to agricultural land at an unprecedented rate. This land-use often results in significant reductions in abundance and diversity of the flora and fauna as well as alterations in their composition. Despite this, there is little public perception of which taxa are most important in terms of their total biomass, biodiversity or the ecosystem services they perform. Such awareness is important for conservation, as without appreciation of their value and conservation status, species are unlikely to receive adequate conservation protection. We investigated children's perceptions of rainforest biodiversity by asking primary-age children, visiting the University Museum of Zoology, Cambridge to draw their ideal rainforest. By recording the frequency at which children drew different climatic, structural, vegetative and faunal components of the rainforest, we were able to quantify children's understanding of a rainforest environment. We investigated children's perceptions of rainforest biodiversity by comparing the relative numbers of the taxa drawn with the actual contributions made by these taxa to total rainforest biomass and global biodiversity. We found that children have a sophisticated view of the rainforest, incorporating many habitat features and a diverse range of animals. However, some taxa were over-represented (particularly mammals, birds and reptiles) and others under-represented (particularly insects and annelids) relative to their contribution to total biomass and species richness. Scientists and naturalists must continue to emphasise the diversity and functional importance of lesser-known taxa through public communication and outdoor events to aid invertebrate conservation and to ensure that future generations are inspired to become naturalists themselves.	[Snaddon, Jake L.; Turner, Edgar C.; Foster, William A.] Univ Cambridge, Dept Zool, Cambridge, England; [Turner, Edgar C.] Bedfordshire, Cambridgeshire Wildlife Trusts, Northamptonshire & Peterborough Wildlife Trusts, Bedford, England	University of Cambridge	Snaddon, JL (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ect23@cam.ac.uk	Snaddon, Jake Lanion/C-8800-2011	Snaddon, Jake Lanion/0000-0003-3549-5472; Turner, Edgar/0000-0003-2715-2234				Balmford A, 2002, SCIENCE, V295, P2367; Barraza L, 1999, ENVIRON EDUC RES, V5, P49, DOI DOI 10.1080/1350462990050103; Barrow L.H., 2002, J ELEMENTARY SCI ED, V14, P53, DOI [DOI 10.1007/BF03173848, 10.1007/BF03173848]; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; CHEESMAN OD, 2007, INSECT CONSERVATION; Chen S. H., 1998, P NATL SCI COUNCIL D, V8, P55; Dumbrell AJ, 2005, BIOL CONSERV, V125, P123, DOI 10.1016/j.biocon.2005.02.016; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Fontaine B, 2007, BIOL CONSERV, V139, P167, DOI 10.1016/j.biocon.2007.06.012; GREAVES E, 1993, J BIOL EDUC, V27, P189, DOI 10.1080/00219266.1993.9655332; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grimaldi David, 2005, pi; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Leather SR, 2008, INSECT CONSERV DIVER, V1, P1, DOI 10.1111/j.1752-4598.2007.00009.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Matthews RW, 1997, ANNU REV ENTOMOL, V42, P269, DOI 10.1146/annurev.ento.42.1.269; MCGAVIN GC, 2000, INSECTS SPIDERS OTHE; Measham TG, 2006, ENVIRON MANAGE, V38, P426, DOI 10.1007/s00267-005-0205-3; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Prokop P, 2008, INT J SCI EDUC, V30, P431, DOI 10.1080/09500690701206686; Pyle R. M., 1993, THUNDER TREE LESSONS; Samways M.J., 2005, INSECT DIVERSITY CON; Shepardson DP, 2007, J RES SCI TEACH, V44, P327, DOI 10.1002/tea.20161; Shepardson DP, 2002, INT J SCI EDUC, V24, P627, DOI 10.1080/09500690110074765; Shepardson DP, 1997, J RES SCI TEACH, V34, P873, DOI 10.1002/(SICI)1098-2736(199711)34:9<873::AID-TEA3>3.0.CO;2-R; Snaddon JL, 2007, ENVIRON CONSERV, V34, P33, DOI 10.1017/S0376892907003669; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; STROMMEN E, 1995, J RES SCI TEACH, V32, P683, DOI 10.1002/tea.3660320704; Tarlowski A, 2006, COGNITIVE DEV, V21, P249, DOI 10.1016/j.cogdev.2006.02.001; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Tomkins S, 2007, J BIOL EDUC, V41, P150, DOI 10.1080/00219266.2007.9656090; Tunnicliffe SD, 1999, J BIOL EDUC, V33, P142, DOI 10.1080/00219266.1999.9655654; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; WILSON E O, 1992; Wilson E.O, 1990, SUCCESS DOMINANCE EC	37	59	63	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2579	10.1371/journal.pone.0002579	http://dx.doi.org/10.1371/journal.pone.0002579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596931	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000263288200043
J	Brown, K; Sacks, SH; Wong, W				Brown, Kathryn; Sacks, Steven H.; Wong, Wilson			Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation	FASEB JOURNAL			English	Article						antigen presentation; molecular exchange; surface molecules	CD4(+) T-CELLS; MHC-CLASS-II; ANTIGEN-PRESENTING CELLS; DENDRITIC-CELLS; INTERCELLULAR TRANSFER; IMMUNOLOGICAL SYNAPSE; CARDIAC ALLOGRAFTS; RENAL-ALLOGRAFTS; CUTTING EDGE; LIVE CELLS	Intercellular transfer of surface molecules has been demonstrated in vitro, or in vivo under artificial situations. Transplantation is a unique clinical situation in which foreign major histocompatibility complex (MHC) molecules are deliberately introduced. This provides a model to study intercellular MHC transfer because donor MHC molecules can easily be tracked. Here we describe the bidirectional transfer of MHC class II molecules between donor and recipient cells after transplantation of vascularized kidney and cardiac allografts in mice. Cells that are positive for both donor and recipient MHC class II accounted for up to 30% of the donor MHC class II+ population, suggesting that they play a significant role in the antigen presentation process. The majority of these cells were dendritic cells, but macrophages and B cells were also able to acquire foreign MHC molecules. Most double-positive cells were also positive for costimulatory molecules, indicating a capability to elicit a T-cell response. This transfer of MHC molecules between donor and recipient cells provides a link between the direct and indirect pathways of alloantigen presentation and suggests that MHC transfer is also likely to occur under normal physiological conditions, which has implications in the fields of infection, vaccination, and tumor immunology.-Brown, K., Sacks, S. H., Wong, W. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J. 22, 3776-3784 (2008)	[Brown, Kathryn; Sacks, Steven H.; Wong, Wilson] Kings Coll London, Guys Kings & St Thomas Hosp, MRC, Ctr Transplant,Sch Med, London, England	University of London; King's College London	Wong, W (corresponding author), Guys Hosp, MRC, Ctr Transplantat, 5th Floor,Tower Wing,Great Maze Pond, London SE1 9RT, England.	wilson.wong@kcl.ac.uk		Sacks, Steven/0000-0001-6361-9095	Genzyme renal innovative program; Medical Research Council, UK; Medical Research Council [G0600698B] Funding Source: researchfish	Genzyme renal innovative program(Sanofi-AventisGenzyme Corporation); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Genzyme renal innovative program and the Medical Research Council, UK.	Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Baba E, 2001, J IMMUNOL, V167, P875, DOI 10.4049/jimmunol.167.2.875; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bickerstaff AA, 2001, J IMMUNOL, V167, P4821, DOI 10.4049/jimmunol.167.9.4821; Brown K, 2007, AM J PATHOL, V171, P1915, DOI 10.2353/ajpath.2007.070396; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Han WR, 1999, MICROSURG, V19, P272, DOI 10.1002/(SICI)1098-2752(1999)19:6<272::AID-MICR3>3.0.CO;2-L; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Patel DM, 1999, J IMMUNOL, V163, P5201; Patel DM, 2001, CELL IMMUNOL, V214, P165, DOI 10.1006/cimm.2001.1897; Russo V, 2000, BLOOD, V95, P3473, DOI 10.1182/blood.V95.11.3473.011k06_3473_3477; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SCHRIER SL, 1971, BIOCHIM BIOPHYS ACTA, V233, P26, DOI 10.1016/0005-2736(71)90354-3; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Smyth LA, 2007, AM J TRANSPLANT, V7, P1442, DOI 10.1111/j.1600-6143.2007.01816.x; Tsang JYS, 2002, TRANSPLANT P, V34, P2849, DOI 10.1016/S0041-1345(02)03532-7; Wetzel SA, 2005, J IMMUNOL, V174, P80, DOI 10.4049/jimmunol.174.1.80; Yamada A, 2001, J IMMUNOL, V167, P5522, DOI 10.4049/jimmunol.167.10.5522	28	38	38	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3776	3784		10.1096/fj.08-107441	http://dx.doi.org/10.1096/fj.08-107441			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18632850				2022-12-25	WOS:000260503000006
J	Arolas, JL; Pantoja-Uceda, D; Ventura, S; Blanco, FJ; Aviles, FX				Arolas, Joan L.; Pantoja-Uceda, David; Ventura, Salvador; Blanco, Francisco J.; Aviles, Francesc X.			The NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; TORSION ANGLE DYNAMICS; PROTEIN STRUCTURES; DISULFIDE; PROGRAM; STATE; LYSOZYME; BINDING; ANALOG; RATES	There is a lack of experimental structural information about folding intermediates of multidomain proteins. Tick carboxypeptidase inhibitor (TCI) is a small, disulfide-rich protein consisting of two domains that fold and unfold autonomously through the formation of two major intermediates, IIIa and IIIb. Each intermediate contains three native disulfide bonds in one domain and six free cysteines in the other domain. Here we have determined the NMR structures of these two intermediates trapped and isolated at acidic pH in which they are stable and compared their structures with that of the native protein analyzed under the same conditions. Both IIIa and IIIb were found to contain a folded region that corresponds to the N- and C-terminal domains of TCI, respectively, with structures very similar to the corresponding regions of the native protein. The remainder of the polypeptide chains of the intermediates was shown to be unfolded in a random coil conformation. Solvent exchange measurements further indicated that the two protein domains are not completely independent, but affect each other in terms of dynamics and stability, in agreement with reported inhibitory activity data. The derived results provide structural evidence for symmetric TCI folding and unfolding mechanisms that converge in IIIa and IIIb and reveal the structural basis that accounts for the strong and simultaneous accumulation of both intermediates. Altogether, this work has important implications for a better understanding of the folding mechanisms of multidomain, disulfide-rich proteins.	[Arolas, Joan L.; Ventura, Salvador; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain; [Arolas, Joan L.; Ventura, Salvador; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain; [Pantoja-Uceda, David] CSIC, Inst Quim Fis Rocasolano, Dept Espect & Estruct Mol, E-28006 Madrid, Spain; [Blanco, Francisco J.] CIC bioGUNE, Struct Biol Unit, Derio 48160, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIC bioGUNE	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain.	fblanco@cicbiogune.es; francescxavier.aviles@uab.es	cancer, biogune/H-7276-2012; Pantoja-Uceda, David/J-8097-2014; Avilés, Francesc Xavier/A-2664-2015; Ventura, Salvador/AAY-3170-2021; Ventura, Salvador/C-7021-2008; Blanco, Francisco J/D-4401-2009; Aviles, Francesc Xavier/F-3482-2019	Avilés, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Blanco, Francisco J/0000-0003-2545-4319; Aviles, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016; Pantoja-Uceda, David/0000-0003-4390-6972	Ministerio de Educacion y Ciencia, Spain [BIO2007-68046, GEN2003-20642-C09-05]; EU-Grant 3D repertoire [LSHG-CT-2005-512028]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); EU-Grant 3D repertoire	This work was supported in part by the Ministerio de Educacion y Ciencia, Spain, Grants BIO2007-68046 (to F.X.A.) and GEN2003-20642-C09-05 (to F.J.B. and F.X.A.) and by EU-Grant 3D repertoire, Contract LSHG-CT-2005-512028 (to F.J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arolas JL, 2005, STRUCTURE, V13, P1193, DOI 10.1016/j.str.2005.05.008; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cemazar M, 2006, J BIOL CHEM, V281, P8224, DOI 10.1074/jbc.M513399200; Cemazar M, 2008, STRUCTURE, V16, P842, DOI 10.1016/j.str.2008.02.023; Chang JY, 2004, BIOCHEMISTRY-US, V43, P4522, DOI 10.1021/bi0360354; CHANG JY, 1995, J BIOL CHEM, V270, P11992, DOI 10.1074/jbc.270.20.11992; Chang JY, 1996, BIOCHEMISTRY-US, V35, P11702, DOI 10.1021/bi9606915; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Creighton TE, 1997, BIOL CHEM, V378, P731; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kortemme T, 1996, J MOL BIOL, V257, P188, DOI 10.1006/jmbi.1996.0155; Laity JH, 1997, BIOCHEMISTRY-US, V36, P12683, DOI 10.1021/bi970878b; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LINDERSTROMLANG KU, 1955, CHEM SOC SPEC PUBL, V2, P1; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; NARDETZKY O, 1996, CHEMTRACTS BIOCH MOL, V6, P1; Noda Y, 2002, BIOCHEMISTRY-US, V41, P2130, DOI 10.1021/bi0113418; Pantoja-Uceda D, 2005, PROTEIN SCI, V14, P224, DOI 10.1110/ps.041138705; Pantoja-Uceda D, 2008, BIOCHEMISTRY-US, V47, P7066, DOI 10.1021/bi800403m; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Sato A, 2000, J PEPT RES, V56, P218, DOI 10.1034/j.1399-3011.2000.00769.x; Shimotakahara S, 1997, BIOCHEMISTRY-US, V36, P6915, DOI 10.1021/bi963024k; van den Berg B, 1999, J MOL BIOL, V290, P781, DOI 10.1006/jmbi.1999.2915; VANMIERLO CPM, 1994, J MOL BIOL, V235, P1044, DOI 10.1006/jmbi.1994.1056; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Yokota A, 2004, BIOCHEMISTRY-US, V43, P6663, DOI 10.1021/bi049967w	54	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27110	27120		10.1074/jbc.M803978200	http://dx.doi.org/10.1074/jbc.M803978200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18640980	hybrid, Green Published			2022-12-25	WOS:000259586600032
J	Burgess, NK; Dao, TP; Stanley, AM; Fleming, KG				Burgess, Nancy K.; Dao, Thuy P.; Stanley, Ann Marie; Fleming, Karen G.			beta-barrel proteins that reside in the Escherichia coli outer membrane in vivo demonstrate varied folding behavior in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYER; SALMONELLA-TYPHIMURIUM; DODECYL-SULFATE; CHANNEL; INSERTION; MECHANISM; OMPA; ENVELOPE; FORMS; PHOSPHATIDYLCHOLINE	Little is known about the dynamic process of membrane protein folding, and few models exist to explore it. In this study we doubled the number of Escherichia coli outer membrane proteins (OMPs) for which folding into lipid bilayers has been systematically investigated. We cloned, expressed, and folded nine OMPs: outer membrane protein X (OmpX), OmpW, OmpA, the crcA gene product (PagP), OmpT, outer membrane phospholipase A (OmpLa), the fadl gene product (FadL), the yaet gene product (Omp85), and OmpF. These proteins fold into the same bilayer in vivo and share a transmembrane beta-barrel motif but vary in sequence and barrel size. We quantified the ability of these OMPs to fold into a matrix of bilayer environments. Several trends emerged from these experiments: higher pH values, thinner bilayers, and increased bilayer curvature promote folding of all OMPs. Increasing the incubation temperature promoted folding of several OMPs but inhibited folding of others. We discovered that OMPs do not have the same ability to fold into any single bilayer environment. This suggests that although environmental factors influence folding, OMPs also have intrinsic qualities that profoundly modulate their folding. To rationalize the differences in folding efficiency, we performed kinetic and thermal denaturation experiments, the results of which demonstrated that OMPs employ different strategies to achieve the observed folding efficiency.	[Burgess, Nancy K.; Dao, Thuy P.; Stanley, Ann Marie; Fleming, Karen G.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Fleming, KG (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	karen.fleming@jhu.edu	Fleming, Karen/E-7892-2011		National Science Foundation [MCB0423807]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB0423807 from the National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Basle A, 2004, BBA-BIOMEMBRANES, V1664, P100, DOI 10.1016/j.bbamem.2004.04.009; BLACK PN, 1987, J BIOL CHEM, V262, P1412; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Casadio R, 2002, FEBS LETT, V520, P1, DOI 10.1016/S0014-5793(02)02758-8; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072; INOUYE M, 1973, J BACTERIOL, V113, P304, DOI 10.1128/JB.113.1.304-312.1973; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; KHALID S, 2007, BIOCH BIOPHYS ACTA; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P4996, DOI 10.1021/bi9824644; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mahalakshmi R, 2007, BBA-BIOMEMBRANES, V1768, P3216, DOI 10.1016/j.bbamem.2007.08.008; Meindl-Beinker NM, 2006, EMBO REP, V7, P1111, DOI 10.1038/sj.embor.7400818; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Pilsl H, 1999, J BACTERIOL, V181, P3578, DOI 10.1128/JB.181.11.3578-3581.1999; Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060; Pocanschi CL, 2006, BIOPHYS J, V91, pL75, DOI 10.1529/biophysj.106.091439; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; SEYDEL U, 1989, J MEMBRANE BIOL, V109, P95, DOI 10.1007/BF01870848; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024; Stegmeier JF, 2006, J BIOCHEM, V140, P275, DOI 10.1093/jb/mvj147; SURREY T, 1995, J BIOL CHEM, V270, P28199; Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	54	172	176	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26748	26758		10.1074/jbc.M802754200	http://dx.doi.org/10.1074/jbc.M802754200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18641391	Green Published, hybrid			2022-12-25	WOS:000259341600047
J	Huang, QQ; Hossain, MM; Wu, K; Parai, K; Pope, RM; Jin, JP				Huang, Qi-Quan; Hossain, M. Moazzem; Wu, Kaichun; Parai, Kakoli; Pope, Richard M.; Jin, Jian-Ping			Role of h2-calponin in regulating macrophage motility and phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; STRUCTURAL ORGANIZATION; RHEUMATOID-ARTHRITIS; STEM-CELLS; IN-VITRO; CALPONIN; EXPRESSION; ACTIN; GENE; PHOSPHORYLATION	The actin cytoskeleton plays a major role in cell motility that is essential for the function of phagocytes. Calponin is an actin-associated regulatory protein. Here we report the finding of significant levels of the h2 isoform of calponin in peripheral blood cells of myeloid lineage. To study the functional significance, h2-calponin gene (Cnn2) interrupted mice were constructed. Germ line transmission of the Cnn2-flox-neo allele was obtained in chimeras from two independent clones of targeted embryonic stem cells. The insertion of the neo(R) cassette into intron 2 of the Cnn2 gene resulted in a significant knockdown of h2-calponin expression. Removing the frt-flanked neo(R) cassette by FLP1 recombinase rescued the knockdown effect. Cre recombinase-induced deletion of the loxP-flanked exon 2 eliminated the expression of h2-calponin protein. H2-calponin-free mice showed reduced numbers of peripheral blood neutrophils and monocytes. H2-calponin-free macrophages demonstrated a higher rate of proliferation and faster migration than that of h2-calponin-positive cells, consistent with a faster diapedesis of peripheral monocytes and neutrophils. H2-calponin-free macrophages showed reduced spreading in adhesion culture together with decreased tropomyosin in the actin cytoskeleton. The lack of h2-calponin also significantly increased macrophage phagocytotic activity, suggesting a novel mechanism to regulate phagocyte functions.	[Huang, Qi-Quan; Hossain, M. Moazzem; Wu, Kaichun; Parai, Kakoli; Pope, Richard M.; Jin, Jian-Ping] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jin, JP (corresponding author), Evanston NW Healthcare, Sect Mol Cardiol, Evanston, IL 60201 USA.	jpjin@northwestern.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063; Pope, Richard M./0000-0003-2416-8660	National Institutes of Health [HL-086720, AR-049217, AR048269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049217, R01AR048269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-086720 (to J.-P.J.) and AR-049217 and AR048269 ( to R. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Beningo KA, 2002, J CELL SCI, V115, P849; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Conrad M, 2003, BIOTECHNIQUES, V34, P1136, DOI 10.2144/03346bm03; Davies John Q, 2005, Methods Mol Biol, V290, P91; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Gao JM, 1996, BIOCHEM BIOPH RES CO, V218, P292, DOI 10.1006/bbrc.1996.0051; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; HAEBERLE JR, 1994, J BIOL CHEM, V269, P12424; HORIUCHI KY, 1991, BIOCHEM BIOPH RES CO, V176, P1487, DOI 10.1016/0006-291X(91)90455-G; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Hossain MM, 2003, AM J PHYSIOL-CELL PH, V284, pC156, DOI 10.1152/ajpcell.00233.2002; Huang QQ, 2007, ARTHRITIS RHEUM-US, V56, P2192, DOI 10.1002/art.22707; Huang QQ, 1999, GENE, V229, P1, DOI 10.1016/S0378-1119(99)00051-7; Jin JP, 1996, BIOCHEM CELL BIOL, V74, P187, DOI 10.1139/o96-019; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; LE JM, 1988, LYMPHOKINE RES, V7, P99; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin J J, 1997, Int Rev Cytol, V170, P1, DOI 10.1016/S0074-7696(08)61619-8; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; Liu C, 2008, NAT HIST, V117, P70; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miyado K, 1996, BIOCHEM BIOPH RES CO, V225, P427, DOI 10.1006/bbrc.1996.1190; NAKAMURA Y, 1995, CELL MOTIL CYTOSKEL, V31, P273, DOI 10.1002/cm.970310404; Nigam R, 1998, J MUSCLE RES CELL M, V19, P695, DOI 10.1023/A:1005389300151; NISHIDA W, 1993, GENE, V130, P297, DOI 10.1016/0378-1119(93)90435-6; ODA T, 1986, J IMMUNOL METHODS, V88, P175; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; SHIRINSKY VP, 1992, J BIOL CHEM, V267, P15886; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; WALSH MP, 1991, BIOCHEM CELL BIOL, V69, P771, DOI 10.1139/o91-119; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; WILKINSON PC, 1982, IMMUNOBIOLOGY, V161, P376, DOI 10.1016/S0171-2985(82)80095-8; WILKINSON PC, 1980, MONONUCLEAR PHAGOCYT, P475; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; YEH MY, 1979, P NATL ACAD SCI USA, V76, P2927, DOI 10.1073/pnas.76.6.2927	54	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25887	25899		10.1074/jbc.M801163200	http://dx.doi.org/10.1074/jbc.M801163200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18617524	hybrid, Green Published			2022-12-25	WOS:000259200100016
J	Oguchi, Y; Takeda, K; Watanabe, S; Yokota, N; Miki, K; Tokuda, H				Oguchi, Yuki; Takeda, Kazuki; Watanabe, Shoji; Yokota, Naoko; Miki, Kunio; Tokuda, Hajime			Opening and closing of the hydrophobic cavity of LolA coupled to lipoprotein binding and release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; TRANSPORTER; PROTEINS; LOCALIZATION; VIOLACEIN; VIOE; RSEB	Outer membrane-specific lipoproteins of Escherichia coli are released from the inner membrane through the action of Lol-CDE, which leads to the formation of a complex between the lipoprotein and LolA, a periplasmic chaperone. LolA then transfers lipoproteins to LolB, a receptor in the outer membrane. The structures of LolA and LolB are very similar, having an incomplete beta-barrel covered with an alpha-helical lid forming a hydrophobic cavity inside. The cavity of LolA, but not that of LolB, is closed and thus inaccessible to the bulk solvent. Previous studies suggested that Arg at position 43 of LolA is critical for maintaining this closed structure. We show here, through a crystallo-graphic study, that the cavity of the LolA(R43L) mutant, in which Leu replaces Arg-43, is indeed open to the external milieu. We then found that the binding of a fluorescence probe distinguishes the open/close state of the cavity. Furthermore, it was revealed that the hydrophobic cavity of LolA opens upon the binding of lipoproteins. Such a liganded LolA was found to be inactive in the release of lipoproteins from the inner membrane. On the other hand, the liganded LolA became fully functional when lipoproteins were removed from LolA by detergent treatment or transferred to LolB. Free LolA thus formed was inaccessible to a fluorescence probe. These results, taken together, reveal the LolA cycle, in which the hydrophobic cavity undergoes opening and closing upon the binding and release of lipoproteins, respectively.	[Oguchi, Yuki; Watanabe, Shoji; Yokota, Naoko; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Harima Inst, Spring Ctr 8, RIKEN, Mikazuki, Hyogo 6795148, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	University of Tokyo; RIKEN; Kyoto University	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Hirano S, 2008, J BIOL CHEM, V283, P6459, DOI 10.1074/jbc.M708109200; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Osborn M J, 1974, Methods Enzymol, V31, P642; Pastukhov AV, 2003, PROTEINS, V53, P607, DOI 10.1002/prot.10401; Ryan KS, 2008, J BIOL CHEM, V283, P6467, DOI 10.1074/jbc.M708573200; Sambrook J., 1989, MOL CLONING LAB MANU; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Wollmann P, 2007, J MOL BIOL, V372, P927, DOI 10.1016/j.jmb.2007.06.039; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	22	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25414	25420		10.1074/jbc.M804736200	http://dx.doi.org/10.1074/jbc.M804736200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617521	hybrid			2022-12-25	WOS:000259012700036
J	Wu, ZQ; Yang, XM; Weber, G; Liu, XQ				Wu, Zhao-Qiu; Yang, Xiaoming; Weber, Gregory; Liu, Xiaoqi			Plk1 phosphorylation of TRF1 is essential for its binding to telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; PROTEIN PIN2/TRF1; CELLS; END; COMPLEX; LENGTH; DNA; LOCALIZATION; REPLICATION; APOPTOSIS	In a search for Polo-like kinase 1 (Plk1) interaction proteins, we have identified TRF1 (telomeric repeat binding factor 1) as a potential Plk1 target. In this communication we report further characterization of the interaction. We show that Plk1 associates with TRF1, and Plk1 phosphorylates TRF1 at Ser-435 in vivo. Moreover, Cdk1, serving as a priming kinase, phosphorylates TRF1 to generate a docking site for Plk1 toward TRF1. In the presence of nocodazole, ectopic expression of wild type TRF1 but not TRF1 with alanine mutation in the Plk1 phosphorylation site induces apoptosis in cells containing short telomeres but not in cells containing long telomeres. Unexpectedly, down-regulation of TRF1 by RNA interference affects cell proliferation and results in obvious apoptosis in cells with short telomeres but not in cells with long telomeres. Importantly, we observe that telomeric DNA binding ability of TRF1 is cell cycle-regulated and reaches a peak during mitosis. Upon phosphorylation by Plk1 in vivo and in vitro, the ability of TRF1 to bind telomeric DNA is dramatically increased. These results demonstrate that Plk1 interacts with and phosphorylates TRF1 and suggest that Plk1-mediated phosphorylation is involved in both TRF1 overexpression-induced apoptosis and its telomeric DNA binding ability.	[Wu, Zhao-Qiu; Weber, Gregory; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Wu, Zhao-Qiu; Weber, Gregory; Liu, Xiaoqi] Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA; [Yang, Xiaoming] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.Edu			National Institutes of Health [K01 CA114401]; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K01 CA114401 (a Howard Temin Award ( to X. L.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	42	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25503	25513		10.1074/jbc.M803304200	http://dx.doi.org/10.1074/jbc.M803304200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625707	Green Published, hybrid			2022-12-25	WOS:000259012700046
J	Kortlever, RM; Nijwening, JH; Bernards, R				Kortlever, Roderik M.; Nijwening, Jeroen H.; Bernards, Rene			Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; CANCER; SUPPRESSION; PHOSPHORYLATION; P27(KIP1); SMAD4; P53	The cytokine transforming growth factor beta(TGF beta) has strong antiproliferative activity in most normal cells but contributes to tumor progression in the later stages of oncogenesis. It is not fully understood which TGF beta target genes are causally involved in mediating its cytostatic activity. We report here that suppression of the TGF beta target gene encoding plasminogen activator inhibitor-1 (PAI-1) by RNA interference leads to escape from the cytostatic activity of TGF beta both in human keratinocytes (HaCaTs) and primary mouse embryo fibroblasts. Consistent with this, PAI-1 knock-out mouse embryo fibroblasts are also resistant to TGF beta growth arrest. Conversely, we show that ectopic expression of PAI-1 in proliferating HaCaT cells induces a growth arrest. PAI-1 knockdown does not interfere with canonical TGF beta signaling as judged by SMAD phosphorylation and induction of bona fide TGF beta target genes. Instead, knockdown of PAI-1 results in sustained activation of protein kinase B. Significantly, we find that constitutive protein kinase B activity leads to evasion of the growth-inhibitory action of TGF beta. Our data are consistent with a model in which induction of PAI-1 by TGF beta is critical for the induction of proliferation arrest.	Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Canc Genom, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Kortlever, Roderik/AAY-9220-2020	Bernards, Rene/0000-0001-8677-3423; Kortlever, Roderik/0000-0001-5558-2851	European Union 6th Framework (INTACT); Center for Cancer Genomics	European Union 6th Framework (INTACT)(European Commission); Center for Cancer Genomics	This work was supported by a grant from the European Union 6th Framework (INTACT) and by the Center for Cancer Genomics.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Look M, 2003, THROMB HAEMOSTASIS, V90, P538, DOI 10.1160/TH-02-11-0264; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; WIKNER NE, 1990, J INVEST DERMATOL, V95, P607, DOI 10.1111/1523-1747.ep12505603	24	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24308	24313		10.1074/jbc.M803341200	http://dx.doi.org/10.1074/jbc.M803341200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614541	hybrid, Green Published			2022-12-25	WOS:000258820000005
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Monomeric CFTR in plasma membranes in live cells revealed by single molecule fluorescence imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNEL; DRUG DISCOVERY; PROTEIN; MECHANISM; DOMAIN; STOICHIOMETRY; ACTIVATORS; THERAPY	The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel. There is indirect and conflicting evidence about whether CFTR exists in cell membranes as monomers, dimers, or higher order oligomers. We measured fluorescence intensities and photobleaching dynamics of distinct fluorescent spots in cells expressing functional CFTR- green fluorescent protein (GFP) chimeras. Intensity analysis of GFP- labeled CFTR in live cells showed singlecomponent distributions with mean intensity equal to that of purified monomeric GFP, indicating monomeric CFTR in cell membranes. Fluorescent spots showed single- step photobleaching, independently verifying that CFTR is monomeric. Results did not depend on whether GFP was added to the CFTR N terminus or fourth extracellular loop or on whether CFTR chloride conductance was stimulated by cAMP agonists. Control measurements with a CFTR chimera containing two GFPs showed two- step photobleaching and a single- component intensity distribution with mean intensity twice that of monomeric GFP. These results provide direct evidence for monomeric CFTR in live cells.	[Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124, R01DK081355] Funding Source: NIH RePORTER; NEI NIH HHS [EY 13574] Funding Source: Medline; NHLBI NIH HHS [HL 59198, HL 73856] Funding Source: Medline; NIBIB NIH HHS [EB 00415] Funding Source: Medline; NIDDK NIH HHS [DK 72517, DK 35124, DK 081355, R01 DK081355] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Lukacs GL, 1997, BIOCHEM J, V328, P353; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Verkman AS, 2004, CURR OPIN NEPHROL HY, V13, P563, DOI 10.1097/00041552-200409000-00013; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627	33	31	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23510	23513		10.1074/jbc.C800100200	http://dx.doi.org/10.1074/jbc.C800100200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18617526	Green Published, hybrid			2022-12-25	WOS:000258638900003
J	Beer, AL; Heckel, AH; Greenlee, MW				Beer, Anton L.; Heckel, Andreas H.; Greenlee, Mark W.			A Motion Illusion Reveals Mechanisms of Perceptual Stabilization	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL JITTER; PROPRIOCEPTION; LUMINANCE; RESPONSES; STRIATE; OBJECT; SIZE; AREA	Visual illusions are valuable tools for the scientific examination of the mechanisms underlying perception. In the peripheral drift illusion special drift patterns appear to move although they are static. During fixation small involuntary eye movements generate retinal image slips which need to be suppressed for stable perception. Here we show that the peripheral drift illusion reveals the mechanisms of perceptual stabilization associated with these micromovements. In a series of experiments we found that illusory motion was only observed in the peripheral visual field. The strength of illusory motion varied with the degree of micromovements. However, drift patterns presented in the central (but not the peripheral) visual field modulated the strength of illusory peripheral motion. Moreover, although central drift patterns were not perceived as moving, they elicited illusory motion of neutral peripheral patterns. Central drift patterns modulated illusory peripheral motion even when micromovements remained constant. Interestingly, perceptual stabilization was only affected by static drift patterns, but not by real motion signals. Our findings suggest that perceptual instabilities caused by fixational eye movements are corrected by a mechanism that relies on visual rather than extraretinal (proprioceptive or motor) signals, and that drift patterns systematically bias this compensatory mechanism. These mechanisms may be revealed by utilizing static visual patterns that give rise to the peripheral drift illusion, but remain undetected with other patterns. Accordingly, the peripheral drift illusion is of unique value for examining processes of perceptual stabilization.	[Beer, Anton L.; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany; [Beer, Anton L.; Heckel, Andreas H.; Greenlee, Mark W.] Univ Regensburg, Expt & Clin Neurosci Programme, Regensburg, Germany	University of Regensburg; University of Regensburg	Beer, AL (corresponding author), Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany.	anton.beer@psychologie.uni-regensburg.de	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Beer, Anton L./0000-0002-0297-6838	Elite Network Bavaria; Bundesministerium fur Bildung und Forschung [01GW0661-3]; European Union [IST 027198]	Elite Network Bavaria; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Elite Network Bavaria (ENB), the Bundesministerium fur Bildung und Forschung (BMBF, Project "Visuospatial Cognition", 01GW0661-3), and the European Union (FP6, Project "Decisions in Motion", IST 027198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGEMAN B, 1991, VISION RES, V31, P1903, DOI 10.1016/0042-6989(91)90185-8; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Engbert R, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P103, DOI 10.1016/B978-044451020-4/50007-4; Faubert J, 1999, PERCEPTION, V28, P617, DOI 10.1068/p2825; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; Galletti C, 2003, NEUROPSYCHOLOGIA, V41, P1717, DOI 10.1016/S0028-3932(03)00174-X; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Greene E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000871; HELMHOLTZ HV, 1866, HDB PHYSL; Horwitz GD, 2003, J NEUROPHYSIOL, V90, P1333, DOI 10.1152/jn.00146.2003; Kitaoka A, 2006, J 3 DIMENSIONAL IMAG, V20, P9; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Murakami I, 2003, VISION RES, V43, P957, DOI 10.1016/S0042-6989(03)00070-1; Murakami I, 2001, VISION RES, V41, P173, DOI 10.1016/S0042-6989(00)00237-6; Murakami I, 1996, VISION RES, V36, P3629, DOI 10.1016/0042-6989(96)00094-6; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Murakami I, 2006, VISION RES, V46, P2421, DOI 10.1016/j.visres.2006.01.030; Naor-Raz G, 2000, PERCEPTION, V29, P325; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Sasaki Y, 2002, NEURON, V35, P1147, DOI 10.1016/S0896-6273(02)00899-1; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; TANAKA K, 1993, J NEUROPHYSIOL, V69, P128, DOI 10.1152/jn.1993.69.1.128; Tayama T, 2000, PERCEPTION, V29, P761, DOI 10.1068/p3078; Vallines I, 2006, J NEUROSCI, V26, P5965, DOI 10.1523/JNEUROSCI.0817-06.2006; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2741	10.1371/journal.pone.0002741	http://dx.doi.org/10.1371/journal.pone.0002741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648651	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900012
J	Koelsch, S; Kilches, S; Steinbeis, N; Schelinski, S				Koelsch, Stefan; Kilches, Simone; Steinbeis, Nikolaus; Schelinski, Stefanie			Effects of Unexpected Chords and of Performer's Expression on Brain Responses and Electrodermal Activity	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MUSIC; EXPECTANCY; ERP; LANGUAGE; EMOTION; RULES	Background: There is lack of neuroscientific studies investigating music processing with naturalistic stimuli, and brain responses to real music are, thus, largely unknown. Methodology/Principal Findings: This study investigates event-related brain potentials (ERPs), skin conductance responses (SCRs) and heart rate (HR) elicited by unexpected chords of piano sonatas as they were originally arranged by composers, and as they were played by professional pianists. From the musical excerpts played by the pianists ( with emotional expression), we also created versions without variations in tempo and loudness ( without musical expression) to investigate effects of musical expression on ERPs and SCRs. Compared to expected chords, unexpected chords elicited an early right anterior negativity (ERAN, reflecting music-syntactic processing) and an N5 ( reflecting processing of meaning information) in the ERPs, as well as clear changes in the SCRs ( reflecting that unexpected chords also elicited emotional responses). The ERAN was not influenced by emotional expression, whereas N5 potentials elicited by chords in general ( regardless of their chord function) differed between the expressive and the non-expressive condition. Conclusions/Significance: These results show that the neural mechanisms of music-syntactic processing operate independently of the emotional qualities of a stimulus, justifying the use of stimuli without emotional expression to investigate the cognitive processing of musical structure. Moreover, the data indicate that musical expression affects the neural mechanisms underlying the processing of musical meaning. Our data are the first to reveal influences of musical performance on ERPs and SCRs, and to show physiological responses to unexpected chords in naturalistic music.	[Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton, E Sussex, England; [Koelsch, Stefan; Kilches, Simone; Steinbeis, Nikolaus; Schelinski, Stefanie] Max Planck Inst Human Cognit & Brain Sci, Junior Res Grp Neurocognit Music, Leipzig, Germany	University of Sussex; Max Planck Society	Koelsch, S (corresponding author), Univ Sussex, Dept Psychol, Brighton, E Sussex, England.	koelsch@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020		German Research Foundation (Deutsche Forschungsgemeinschaft) [KO 2266/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft) through grant KO 2266/2-1. The Deutsche Forschungsgemeinschaft played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Juslin P.N., 2008, BEHAV BRAIN IN PRESS; Juslin P. N., 2003, MUSIC EMOTION THEORY, P309; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; KOELSCH S, 2005, CURRENT OPINION NEUR, V15, P1; KOELSCH S, 2008, PSYCHOPHYSI IN PRESS; KOELSCH S, 2008, BRAIN RES IN PRESS; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; LOUI P, 2005, COG BRAIN RES, V25, P589; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Poulin-Charronnat B, 2006, J COGNITIVE NEUROSCI, V18, P1545, DOI 10.1162/jocn.2006.18.9.1545; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2002, PERCEPT PSYCHOPHYS, V64, P640, DOI 10.3758/BF03194732	32	59	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2631	10.1371/journal.pone.0002631	http://dx.doi.org/10.1371/journal.pone.0002631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612459	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800033
J	Szklarczyk, A; Ewaleifoh, O; Beique, JC; Wang, Y; Knorr, D; Haughey, N; Malpica, T; Mattson, MP; Huganir, R; Conant, K				Szklarczyk, Arek; Ewaleifoh, Osefame; Beique, Jean-Claude; Wang, Yue; Knorr, David; Haughey, Norman; Malpica, Tanya; Mattson, Mark P.; Huganir, Richard; Conant, Katherine			MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function	FASEB JOURNAL			English	Article						matrilysin; glutamate; synapse; proteolysis	MATRIX-METALLOPROTEINASE ACTIVITY; AMYLOID PROTEIN-PRECURSOR; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SPINAL-CORD; CELL-DEATH; CALCIUM DYSREGULATION; HIPPOCAMPAL SYNAPSES; SYNAPTIC PLASTICITY	Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that play a role in the inflammatory response. These enzymes have been well studied in the context of cancer biology and inflammation. Recent studies, however, suggest that these enzymes also play roles in brain development and neurodegenerative disease. Select MMPs can target proteins critical to synaptic structure and neuronal survival, including integrins and cadherins. Here, we show that one member of the MMP family, MMP-7, which may be released from cells, including microglia, can target a protein critical to synaptic function. Through analysis of extracts from murine cortical slice preparations, we show that MMP-7 cleaves the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor to generate an N-terminal fragment of similar to 65 kDa. Moreover, studies with recombinant protein show that MMP-7-mediated cleavage of NR1 occurs at amino acid 517, which is extracellular and just distal to the first transmembrane domain. Data suggest that NR2A, which shares sequence homology with NR1, is also cleaved following treatment of slices with MMP-7, while select AMPA receptor subunits are not. Consistent with a potential effect of MMP-7 on ligand binding, additional experiments demonstrate that NMDA-mediated calcium flux is significantly diminished by MMP-7 pretreatment of cultures. In addition, the AMPA/NMDA ratio is increased by MMP-7 pretreatment. These data suggest that synaptic function may be altered in neurological conditions associated with increased levels of MMP-7.-Szklarczyk, A., Ewaleifoh, O., Beique, J.-C., Wang, Y., Knorr, D., Haughey, N., Malpica, T., Mattson, M. P., Huganir, R., Conant, K. MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J. 22, 3757-3767 (2008)	[Conant, Katherine] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21287 USA; [Beique, Jean-Claude; Mattson, Mark P.; Huganir, Richard] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21287 USA; [Beique, Jean-Claude; Huganir, Richard] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wang, Yue; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Conant, K (corresponding author), Johns Hopkins Univ, Dept Neurol, Sch Med, Pathol Bldg Rm 625,600 N Wolfe St, Baltimore, MD 21287 USA.	kconant@mail.jhmi.edu	Mattson, Mark P/F-6038-2012		National Institutes of Health [NS052580, DA024447]; Alzheimer's Association; Howard Hughes Medical Institute; NARSAD; National Institute on Aging Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH072534, R01MH077542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023471, R21AG034849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NARSAD(NARSAD); National Institute on Aging Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Jenny Ryu and Jackie Mann for expert technical assistance. We also thank Dr. Yuri Kim and Kee Jun Kim for helpful comments. And we thank Marc Mayer and Yongneng Yao for the NR1 S1/S2 construct. This work was supported, in part, by the National Institutes of Health (NS052580 and DA024447 to K. C.), the Alzheimer's Association (K.C.), the Howard Hughes Medical Institute (J.C.B. and R.H.), NARSAD (J.C.B.), and the National Institute on Aging Intramural Research Program.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bernard-Trifilo JA, 2005, J NEUROCHEM, V93, P834, DOI 10.1111/j.1471-4159.2005.03062.x; Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Campbell SJ, 2004, J NEUROCHEM, V89, P1378, DOI 10.1111/j.1471-4159.2004.02441.x; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; COLLINGRIDGE GL, 1992, CIBA F SYMP, V164, P172; COLLINGRIDGE GL, 1992, CIBA F SYMP, V164, P162; Conant K, 2004, J BIOL CHEM, V279, P8056, DOI 10.1074/jbc.M307051200; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; George SJ, 2004, TRENDS CARDIOVAS MED, V14, P100, DOI 10.1016/j.tcm.2003.12.008; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; GROSSHANS DR, 2002, SCI STKE, pPL8; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Kalbaugh TL, 2004, MOL PHARMACOL, V66, P209, DOI 10.1124/mol.66.2.209; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Leake A, 2000, NEUROSCI LETT, V291, P201, DOI 10.1016/S0304-3940(00)01418-X; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lim GP, 1996, J NEUROCHEM, V67, P251; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Meighan PC, 2007, J NEUROCHEM, V102, P2085, DOI 10.1111/j.1471-4159.2007.04682.x; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Noble LJ, 2002, J NEUROSCI, V22, P7526; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Raymond LA, 1996, MOL CELL NEUROSCI, V7, P102, DOI 10.1006/mcne.1996.0008; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Turgeon VL, 1998, J NEUROSCI, V18, P6882; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vos CMP, 2000, EXP NEUROL, V163, P324, DOI 10.1006/exnr.2000.7388; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239	66	40	42	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3757	3767		10.1096/fj.07-101402	http://dx.doi.org/10.1096/fj.07-101402			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18644839	Green Published			2022-12-25	WOS:000260503000004
J	Upadhyay, G; Goessling, W; North, TE; Xavier, R; Zon, LI; Yajnik, V				Upadhyay, G.; Goessling, W.; North, T. E.; Xavier, R.; Zon, L. I.; Yajnik, V.			Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling	ONCOGENE			English	Article						Wnt/beta-catenin; Rac; GSK3 beta; Axin; APC; DOCK4	NUCLEOTIDE EXCHANGE; PHOSPHORYLATION; GTPASE; MECHANISM; PATHWAY; EMBRYOS; MODEL; GEF; APC; RHO	The canonical Wnt/beta-catenin pathway is a highly conserved signaling cascade that is involved in development and stem cell renewal. The deregulation of this pathway is often associated with increased cell growth and neoplasia. The small GTPase Rac has been shown to influence canonical Wnt signaling by regulating beta-catenin stability through an unknown mechanism. We report that DOCK4, a guanine nucleotide exchange factor (GEF) for Rac and a member of the CDM family of unconventional GEFs, mediates Wnt-induced Rac activation in the canonical Wnt/beta-catenin pathway. DOCK4 expression regulates cellular beta-catenin levels in response to the Wnt signal, in vitro. Biochemical studies demonstrate that DOCK4 interacts with the beta-catenin degradation complex, consisting of the proteins adenomatosis polyposis coli, Axin and glycogen synthase kinase 3 beta (GSK3 beta). This molecular interaction enhances beta-catenin stability and Axin degradation. Furthermore, we observe that DOCK4 is phosphorylated by GSK3 beta, which enhances Wnt-induced Rac activation. Using a T-cell factor reporter zebrafish we confirm that DOCK4 is required for Wnt/beta-catenin activity, in vivo. These results elucidate a novel intracellular signaling mechanism in which a Rac GEF, DOCK4 acts as a scaffold protein in the Wnt/beta-catenin pathway.	[Upadhyay, G.; Goessling, W.; Xavier, R.; Yajnik, V.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Goessling, W.; North, T. E.; Zon, L. I.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yajnik, V (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, 55 Fruit St,GRJ-825, Boston, MA 02114 USA.	gu6@georgetown.edu; vyajnik@partners.org	North, Trista/ABG-4789-2020; Upadhyay, Geeta/AEB-0203-2022	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569	NIH [DK 63933]; MGH GI unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK063933, P30DK040561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH GI unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lars von Buchholtz (NIH, MD, USA), Parool Meelu (MGH, MA, USA), Tiffany M Blake (Georgetown University, DC, USA) and Denver Matthew Lough (Georgetown University, DC, USA) for the help in the preparation of the paper. This study was supported by grant NIH DK 63933 (VY) and MGH GI unit startup funds (VY).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Braga VMM, 2002, NAT CELL BIOL, V4, pE188, DOI 10.1038/ncb0802-e188; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Gingerich JL, 2005, DEV BIOL, V286, P427, DOI 10.1016/j.ydbio.2005.07.031; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hagen T, 2004, BIOCHEM J, V379, P471, DOI 10.1042/BJ20031749; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yan D, 2006, J MOL BIOL, V357, P755, DOI 10.1016/j.jmb.2006.01.017; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	44	44	45	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2008	27	44					5845	5855		10.1038/onc.2008.202	http://dx.doi.org/10.1038/onc.2008.202			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	355QC	18641688	Green Accepted			2022-12-25	WOS:000259722400008
J	Raucci, A; Cugusi, S; Antonelli, A; Barabino, SM; Monti, L; Bierhaus, A; Reiss, K; Saftig, P; Bianchi, ME				Raucci, Angela; Cugusi, Simona; Antonelli, Antonella; Barabino, Silvia M.; Monti, Lucilla; Bierhaus, Angelika; Reiss, Karina; Saftig, Paul; Bianchi, Marco E.			A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)	FASEB JOURNAL			English	Article						cytokines; HMGB1; inflammation; receptor shedding; atherosclerosis; diabetes	CELL-CELL ADHESION; END-PRODUCTS; MIGRATION; PROTEIN; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; EXPRESSION; CADHERIN; PATHWAY	The receptor for advanced glycation endproducts (RAGE) mediates responses to cell danger and stress. When bound by its many ligands (which include advanced glycation endproducts, certain members of the S100/calgranulin family, extracellular high-mobility group box 1, the integrin Mac-1, amyloid (beta-peptide and fibrils), RAGE activates programs responsible for acute and chronic inflammation. RAGE is therefore also involved in cancer progression, diabetes, atherosclerosis, and Alzheimer's disease. RAGE has several isoforms deriving from alternative splicing, including a soluble form called endogenous secretory RAGE (esRAGE). We show here that most soluble RAGE, either produced by cell lines or present in human blood, is not recognized by an anti-esRAGE antibody. Cells transfected with the cDNA for full-length RAGE, and thus not expressing esRAGE, produce a form of soluble RAGE, cleaved RAGE (cRAGE) that derives from proteolytic cleavage of the membrane-bound molecules and acts as a decoy receptor. By screening chemical inhibitors and genetically modified mouse embryonic fibroblasts (MEFs), we identify the sheddase ADAM10 as a membrane protease responsible for RAGE cleavage. Binding of its ligand HMGB1 promotes RAGE shedding. Our data do not disprove the interpretation that high levels of soluble forms of RAGE protect against chronic inflammation, but rather suggest that they correlate with high levels of ongoing inflammation.	[Bianchi, Marco E.] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Raucci, Angela; Antonelli, Antonella; Monti, Lucilla] Ist Sci San Raffaele, I-20132 Milan, Italy; [Cugusi, Simona; Barabino, Silvia M.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Bierhaus, Angelika] Heidelberg Univ, Dept Med & Clin Chem 1, Heidelberg, Germany; [Reiss, Karina; Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Ruprecht Karls University Heidelberg; University of Kiel	Bianchi, ME (corresponding author), Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy.	bianchi.marco@hsr.it	Saftig, Paul/A-7966-2010; Bianchi, Marco Emilio/K-3417-2018; Reiss, Karina/B-3175-2010; Barabino, Silvia/AAC-4674-2021; Monti, Lucilla/AAN-3716-2020; Raucci, Angela/K-3722-2018; Antonelli, Antonella/AAN-1856-2020; ANTONELLI, ANTONELLA/C-6238-2011	Bianchi, Marco Emilio/0000-0002-5329-6445; Raucci, Angela/0000-0003-1333-9671; Antonelli, Antonella/0000-0003-1497-3586	Associazione Italiana Ricerca sul Cancro; Fondazione Cariplo; Italian Ministry of Health; Deutsche Forschungsgemeinschaft [SFB415B9, SFB405]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Dr. Hiroshi Yamamoto (Kanazawa University. K Kanazawa, Japan) for providing the anti-esRAGE antibody. Gianluca Varetti (European Institute of Oncology, Milan. Italy) for construction of pcDNA/FL-RAGE-myc vector. Francesca Sanvito (San Raffaele Scientific Institute, Milan. Italy) for providing human samples, anti Grazisa Rossetti for the helpful discussion. A.R. was supported by a fellowship from Federazione Italiana Ricerca Cancro (FIRC), A.A. 1) v the Ingenio program, and S.C. by Fondazione Cariplo. This work leas been supported by grants from Associazione Italiana Ricerca sul Cancro, Fondazione Cariplo, the Italian Ministry of Health, the 'Targeting Cell Migration in Chronic Inflammationcytokines HMGB1 inflammation receptor shedding atherosclerosis diabetes Network of Excellence, the Deutsche Forschungsgemeinschaft (SFB415B9 and SFB405). and the Belgian Inter-university Attraction Poles Programme. The authors declare no direct financial interest. However, M.E.B. is founder and part owner of HMGBiotech, it company that provides goods and services related to HMGB proteins.	Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BRETT J, 1993, AM J PATHOL, V143, P1699; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Geroldi D, 2005, J HYPERTENS, V23, P1725, DOI 10.1097/01.hjh.0000177535.45785.64; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Humpert PM, 2006, DIABETES CARE, V29, P1111, DOI 10.2337/dc05-2478; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	34	441	453	2	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3716	3727		10.1096/fj.08-109033	http://dx.doi.org/10.1096/fj.08-109033			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18603587				2022-12-25	WOS:000259642600032
J	Westerlund, M; Belin, AC; Anvret, A; Hakansson, A; Nissbrandt, H; Lind, C; Sydow, O; Olson, L; Galter, D				Westerlund, Marie; Belin, Andrea Carmine; Anvret, Anna; Hakansson, Anna; Nissbrandt, Hans; Lind, Charlotta; Sydow, Olof; Olson, Lars; Galter, Dagmar			Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material	FASEB JOURNAL			English	Article						NACP; PARK1; PD1; Western blot	MESSENGER-RNA EXPRESSION; LEWY BODY; GENE; MUTATION; VARIABILITY; DUPLICATION; BRAIN	Alterations of brain and plasma a-synuclein levels and SNCA gene variability have been implicated in the pathogenesis of Parkinson's disease (PD). We therefore measured a-synuclein protein levels in postmortem PD and control cerebellum tissue using Western blot and investigated whether the levels correlated to SNCA genotype. We found markedly decreased a-synuclein levels in PD patients (n=16) compared to gender- and age-matched controls (n=14; P=0.004) normalized to a-tubulin. We also performed an association study of the noncoding polymorphisms rs2737029 (A/G) and rs356204 (A/G) (intron 4), and of rs356219 (T/C) (3'-region) of SNCA in a Swedish PD case-control material. Using a two-sided chi(2) test, we found significant association of rs2737029 (P=0.003; chi(2)=9.07) and rs356204 (P=0.048; chi(2)=3.91) with disease, strengthening the involvement of SNCA polymorphisms in sporadic PD. Stratification of the human postmortem brain material by genotype of the three investigated polymorphisms, did not indicate any influence of genotype on alpha-synuclein protein levels when comparing PD with controls. Taken together, our findings demonstrate that the investigated Parkinson patients have markedly reduced levels of a-synuclein in cerebellum, and that this reduction is general, rather then correlated to the investigated polymorphisms, although two of the polymorphisms also associated with disease in a Swedish material.	[Westerlund, Marie; Belin, Andrea Carmine; Anvret, Anna; Olson, Lars; Galter, Dagmar] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Hakansson, Anna; Nissbrandt, Hans] Univ Gothenburg, Dept Pharmacol, Sahlgrenska Acad, Gothenburg, Sweden; [Lind, Charlotta; Sydow, Olof] Karolinska Univ Hosp, Dept Clin Neurosci, Neurol Sect, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital	Galter, D (corresponding author), Karolinska Inst, Dept Neurosci, Retziusvag 8, S-17177 Stockholm, Sweden.	dagmar.galter@ki.se	Galter, Dagmar/C-4826-2011; Belin, Andrea Carmine/AAV-9933-2021	Galter, Dagmar/0000-0001-6485-6244; Belin, Andrea Carmine/0000-0001-6668-3172; Sydow, Olof/0000-0001-7798-8297	Swedish Research Council; Swedish Brain Foundation; Hallstens Forskningsstiftelse; Swedish Parkinson Foundation; Swedish Brain Power; U.S. Public Health Service; Ahlen's Foundation; Karolinska Institutet Funds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Hallstens Forskningsstiftelse; Swedish Parkinson Foundation; Swedish Brain Power; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ahlen's Foundation; Karolinska Institutet Funds	We thank Silvia Paddock for technical advice and Ann-Christin Thelander, Karin Lundstromer, and Caroline Ran for technical assistance. This work was supported by the Swedish Research Council, Swedish Brain Foundation and Hallstens Forskningsstiftelse, the Swedish Parkinson Foundation, Swedish Brain Power, U.S. Public Health Service grants, the Ahlen's Foundation, and Karolinska Institutet Funds. Human brain tissue samples were provided by the Queen Square Brain Bank for Neurological Disorders (London, UK).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Papapetropoulos S, 2007, MOVEMENT DISORD, V22, P1057, DOI 10.1002/mds.21466; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	28	28	29	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3509	3514		10.1096/fj.08-110148	http://dx.doi.org/10.1096/fj.08-110148			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606870				2022-12-25	WOS:000259642600013
J	Lavrik, IN; Mock, T; Golks, A; Hoffmann, JC; Baumann, S; Krammer, PH				Lavrik, Inna N.; Mock, Thomas; Golks, Alexander; Hoffmann, Julia C.; Baumann, Simone; Krammer, Peter H.			CD95 stimulation results in the formation of a novel death effector domain protein-containing complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECEPTOR-INDUCED APOPTOSIS; INDUCED-PROXIMITY MODEL; SIGNALING COMPLEX; CASPASE-8 ACTIVATION; LIGAND; FLICE; FADD; DISC; TRAIL	Stimulation of CD95(APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIPL, c-FLIPS, c-FLIPR), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.	[Lavrik, Inna N.; Mock, Thomas; Golks, Alexander; Hoffmann, Julia C.; Baumann, Simone; Krammer, Peter H.] German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krammer, PH (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.krammer@dkfz.de	Lavrik, Inna N/C-1700-2009	Lavrik, Inna N/0000-0002-9324-309X	Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany [SB 405]	Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany	This work was supported by Grant SB 405 from Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Golks A, 2006, CELL DEATH DIFFER, V13, P489, DOI 10.1038/sj.cdd.4401766; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517	38	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26401	26408		10.1074/jbc.M800823200	http://dx.doi.org/10.1074/jbc.M800823200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635548	hybrid, Green Published			2022-12-25	WOS:000259341600014
J	Sohet, F; Colin, Y; Genetet, S; Ripoche, P; Metral, S; Le Van Kim, C; Lopez, C				Sohet, Fabien; Colin, Yves; Genetet, Sandrine; Ripoche, Pierre; Metral, Sylvain; Le Van Kim, Caroline; Lopez, Claude			Phosphorylation and ankyrin-G binding of the C-terminal domain regulate targeting and function of the ammonium transporter RhBG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR-ACIDOSIS DRTA; BLOOD-GROUP SYSTEM; TYROSINE PHOSPHORYLATION; RHC GLYCOPROTEIN; INOSITOL 1,4,5-TRISPHOSPHATE; NEONATAL CARDIOMYOCYTES; CRYSTAL-STRUCTURE; INITIAL SEGMENTS; EPITHELIAL-CELLS; CHANNEL ACTIVITY	RhBG, a human member of the Amt/Mep/Rh/superfamily of ammonium transporters, has been shown to facilitate NH3 transport and to be anchored to the basolateral plasma membrane of kidney epithelial cells, via ankyrin-G. We showed here that triple alanine substitution of the (FLD421)-F-419 sequence, which links the cytoplasmic C-terminal domain of RhBG to ankyrin-G, not only disrupted the interaction of RhBG with the spectrin-based skeleton but also delayed its cell surface expression, decreased its plasma membrane stability, and abolished its NH3 transport function in epithelial cell lines. Similarly, we demonstrated that both anchoring to the membrane skeleton and ammonium transport activity are regulated by the phosphorylation status of the C-terminal tail of RhBG. Tyrosine 429, which belongs to the previously reported YED basolateral targeting signal of RhBG, was demonstrated to be phosphorylated in vitro using purified Src and Syk kinases and ex vivo by analyzing the effect of pervanadate treatment on wild-type RhBG or Y429A mutants. Then, we showed that Y429D and Y429E mutations, mimicking constitutive phosphorylation, abolished NH3 transport and enhanced Triton X-100 solubilization of RhBG from the cell membrane. In contrast, the nonphosphorylated/nonphosphorylatable Y429A and Y429F mutants behaved the same as wild-type RhBG. Conversely, Y/A or Y/F but not Y/E or Y/D mutations of residue 429 abolished the exclusive basolateral localization of RhBG in polarized epithelial cells. All these results led to a model in which targeting and ammonium transport function of RhBG are regulated by both phosphorylation and membrane skeleton binding of the C-terminal cytoplasmic domain.	[Colin, Yves] INSERM, U665, F-75015 Paris, France; Inst Natl Transfus Sanguine, F-75015 Paris, France; Univ Paris 07, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Colin, Y (corresponding author), INSERM, U665, F-75015 Paris, France.	yves.colin@inserm.fr	colin, yves/O-1910-2017; METRAL, Sylvain/P-5833-2017; le van kim, caroline/O-7030-2017	colin, yves/0000-0001-5196-4254; METRAL, Sylvain/0000-0001-6244-8546; GENETET, Sandrine/0000-0001-8497-0087; le van kim, caroline/0000-0002-3251-1310	Institut National de la Transfusion Sanguine, INSERM; Universite Paris Diderot- Paris 7	Institut National de la Transfusion Sanguine, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot- Paris 7	This investigation was supported in part by the Institut National de la Transfusion Sanguine, INSERM, and the Universite Paris Diderot- Paris 7. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Conroy MJ, 2005, BRIT J HAEMATOL, V131, P543, DOI 10.1111/j.1365-2141.2005.05786.x; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Handlogten ME, 2005, AM J PHYSIOL-GASTR L, V288, pG1036, DOI 10.1152/ajpgi.00418.2004; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huang CH, 2001, BLOOD CELL MOL DIS, V27, P90, DOI 10.1006/bcmd.2000.0355; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Monahan BJ, 2002, FUNGAL GENET BIOL, V36, P35, DOI 10.1016/S1087-1845(02)00004-X; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Nicolas V, 2006, TRANSFUS CLIN BIOL, V13, P23, DOI 10.1016/j.tracli.2006.02.019; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shirahata E, 2006, J NEUROPHYSIOL, V96, P1347, DOI 10.1152/jn.01264.2005; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stephens DJ, 1997, FEBS LETT, V416, P27, DOI 10.1016/S0014-5793(97)01165-4; Toye AM, 2005, BIOCHEM SOC SYMP, V72, P47, DOI 10.1042/bss0720047; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vela J, 2007, AM J PHYSIOL-CELL PH, V293, pC951, DOI 10.1152/ajpcell.00429.2006; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Wu HY, 2003, J BIOL CHEM, V278, P40425, DOI 10.1074/jbc.C300225200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zidi-Yahiaoui N, 2006, TRANSFUS CLIN BIOL, V13, P128, DOI 10.1016/j.tracli.2006.02.025; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	71	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26557	26567		10.1074/jbc.M803120200	http://dx.doi.org/10.1074/jbc.M803120200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635543	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000259341600032
J	Hiss, JA; Resch, E; Schreiner, A; Meissner, M; Starzinski-Powitz, A; Schneider, G				Hiss, Jan A.; Resch, Eduard; Schreiner, Alexander; Meissner, Michael; Starzinski-Powitz, Anna; Schneider, Gisbert			Domain Organization of Long Signal Peptides of Single-Pass Integral Membrane Proteins Reveals Multiple Functional Capacity	PLOS ONE			English	Article								Targeting signals direct proteins to their extra - or intracellular destination such as the plasma membrane or cellular organelles. Here we investigated the structure and function of exceptionally long signal peptides encompassing at least 40 amino acid residues. We discovered a two-domain organization ("NtraC model") in many long signals from vertebrate precursor proteins. Accordingly, long signal peptides may contain an N-terminal domain (N-domain) and a C-terminal domain (C-domain) with different signal or targeting capabilities, separable by a presumably turn-rich transition area (tra). Individual domain functions were probed by cellular targeting experiments with fusion proteins containing parts of the long signal peptide of human membrane protein shrew-1 and secreted alkaline phosphatase as a reporter protein. As predicted, the N-domain of the fusion protein alone was shown to act as a mitochondrial targeting signal, whereas the C-domain alone functions as an export signal. Selective disruption of the transition area in the signal peptide impairs the export efficiency of the reporter protein. Altogether, the results of cellular targeting studies provide a proof-of-principle for our NtraC model and highlight the particular functional importance of the predicted transition area, which critically affects the rate of protein export. In conclusion, the NtraC approach enables the systematic detection and prediction of cryptic targeting signals present in one coherent sequence, and provides a structurally motivated basis for decoding the functional complexity of long protein targeting signals.	[Hiss, Jan A.; Resch, Eduard; Schreiner, Alexander; Meissner, Michael; Starzinski-Powitz, Anna; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Proteom, Frankfurt, Germany	Goethe University Frankfurt	Hiss, JA (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Proteom, Frankfurt, Germany.	g.schneider@modlab.de		Hiss, Jan Alexander/0000-0003-0559-4330; Schneider, Gisbert/0000-0001-6706-1084; Resch, Eduard/0000-0002-7685-6388	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University; Frankfurt am Main; Sonderforschungsbereich 579 [A11.2]; Sonderforschungsbereich 628 [p7]; Deutsche Forschungsgemeinschaft Sta [187/16-1]	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University; Frankfurt am Main; Sonderforschungsbereich 579; Sonderforschungsbereich 628; Deutsche Forschungsgemeinschaft Sta	This research was supported by the Beilstein-Institut zur Forderung der Chemischen Wissenschaften, the Centre for Membrane Proteomics at Goethe-University, Frankfurt am Main, the Sonderforschungsbereich 579 ("RNA-Ligand Interactions", project A11.2), the Sonderforschungsbereich 628 ("Functional Membrane Proteomics", project p7), and the Deutsche Forschungsgemeinschaft Sta 187/16-1.	Al-Qahtani A, 1998, BIOCHEM J, V331, P521, DOI 10.1042/bj3310521; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bharti S, 2004, MOL BIOL CELL, V15, P397, DOI 10.1091/mbc.E03-05-0281; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feng ZP, 2001, BIOPOLYMERS, V58, P491, DOI 10.1002/1097-0282(20010415)58:5<491::AID-BIP1024>3.0.CO;2-I; Foulquier F, 2002, BIOCHEM J, V362, P491, DOI 10.1042/0264-6021:3620491; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; GRAY L, 1989, J CELL SCI, P45; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Jakob V, 2006, MOL BIOL CELL, V17, P3397, DOI 10.1091/mbc.E05-11-1034; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MEISSNER M, 2008, PROTEINS IN PRESS; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; RAMANUJAN S, 2006, BIOCH SCI, V31, P563; RESCH E, 2008, TRAFFIC IN PRESS; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Schneider G, 2004, PROTEOMICS, V4, P1571, DOI 10.1002/pmic.200300786; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tamura T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-466; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1994, SIGNAL PEPTIDASES; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEIDMANN M, 1984, NATURE, V309, P637, DOI 10.1038/309637a0; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	45	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2767	10.1371/journal.pone.0002767	http://dx.doi.org/10.1371/journal.pone.0002767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648515	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900037
J	Rossner, MJ; Oster, H; Wichert, SP; Reinecke, L; Wehr, MC; Reinecke, J; Eichele, G; Taneja, R; Nave, KA				Rossner, Moritz J.; Oster, Henrik; Wichert, Sven P.; Reinecke, Lisa; Wehr, Michael C.; Reinecke, Johannes; Eichele, Gregor; Taneja, Reshma; Nave, Klaus-Armin			Disturbed Clockwork Resetting in Sharp-1 and Sharp-2 Single and Double Mutant Mice	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; SLEEP PHASE SYNDROME; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; DROSOPHILA; ORANGE; BMAL1; CELLS; METABOLISM; COMPONENT	Background: The circadian system provides the basis to anticipate and cope with daily recurrent challenges to maintain the organisms' homeostasis. De-synchronization of circadian feedback oscillators in humans causes 'jet lag', likely contributes to sleep-, psychiatric-, metabolic disorders and even cancer. However, the molecular mechanisms leading to the disintegration of tissue-specific clocks are complex and not well understood. Methodology/Principal Findings: Based on their circadian expression and cell culture experiments, the basic Helix-Loop-Helix (bHLH) transcription factors SHARP-1(Dec2) and SHARP-2(Stra13/Dec1) were proposed as novel negative regulators of the molecular clock. To address their function in vivo, we generated Sharp-1 and Sharp-2 single and double mutant mice. Our experiments reveal critical roles for both factors in regulating period length, tissue-specific control of clock gene expression and entrainment to external cues. Light-pulse experiments and rapid delays of the light-dark cycle (experimental jet lag) unravel complementary functions for SHARP-1 and SHARP-2 in controlling activity phase resetting kinetics. Moreover, we show that SHARP-1 and 2 can serve dual functions as repressors and co-activators of mammalian clock gene expression in a context-specific manner. This correlates with increased amplitudes of Per2 expression in the cortex and liver and a decrease in the suprachiasmatic nucleus (SCN) of double mutant mice. Conclusions/Significance: The existence of separate mechanisms regulating phase of entrainment, rhythm amplitude and period length has been postulated before. The differential effects of Sharp-deficiency on rhythmicity and behavioral re-entrainment, coupled to tissue-dependent regulatory functions, provide a new mechanistic basis to further understand the complex process of clock synchronizations.	[Rossner, Moritz J.; Wichert, Sven P.; Reinecke, Lisa; Wehr, Michael C.; Reinecke, Johannes; Nave, Klaus-Armin] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Oster, Henrik; Eichele, Gregor] Max Planck Inst Biophys Chem, Gottingen, Germany; [Taneja, Reshma] Mount Sinai Sch Med, New York, NY USA	Max Planck Society; Max Planck Society; Icahn School of Medicine at Mount Sinai	Rossner, MJ (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	rossner@em.mpg.de	Wehr, Michael/J-7989-2019; Nave, Klaus-Armin/C-8883-2011; Oster, Henrik/D-2335-2013; Oster, Henrik/O-4426-2019; Taneja, Reshma/F-9658-2014	Wehr, Michael/0000-0003-1770-8323; Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068; Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177; Rossner, Moritz/0000-0002-0667-3420	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [Emmy Noether fellowship]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Gesellschaft (M.J.R., K.-A.N. and G.E.) and an Emmy Noether fellowship of the Deutsche Forschungsgemeinschaft (H.O.).	Albrecht U, 2001, BEHAV BRAIN RES, V125, P89, DOI 10.1016/S0166-4328(01)00288-1; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Li YX, 2004, BIOCHEM J, V382, P895, DOI 10.1042/BJ20040592; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Mrosovsky N, 1996, CHRONOBIOL INT, V13, P387, DOI 10.3109/07420529609012662; NAKASHIMA A, 2008, MOL CELL BIOL; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richier B, 2008, J BIOL RHYTHM, V23, P103, DOI 10.1177/0748730407313817; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schwab MH, 1998, J NEUROSCI, V18, P1408; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	41	75	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2762	10.1371/journal.pone.0002762	http://dx.doi.org/10.1371/journal.pone.0002762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648504	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900032
J	Tang, JW; Ngai, KLK; Lam, WY; Chan, PKS				Tang, Julian W.; Ngai, Karry L. K.; Lam, Wai Y.; Chan, Paul K. S.			Seasonality of Influenza A(H3N2) Virus: A Hong Kong Perspective (1997-2006)	PLOS ONE			English	Article							A H3N2; EVOLUTION; DYNAMICS; REVEALS; EPIDEMIOLOGY; PATTERNS; MODEL	Background: The underlying basis for the seasonality of influenza A viruses is still uncertain. Phylogenetic studies investigated this phenomenon but have lacked sequences from more subtropical and tropical regions, particularly from Southeast Asia. Methodology/Principal Findings: 281 complete hemagglutinin (HA) and neuraminidase (NA) sequences were obtained from influenza A(H3N2) viruses, collected over 10 years (1997-2006) from Hong Kong. These dated sequences were analyzed with influenza A(H3N2) vaccine strain sequences (Syd/5/97, Mos/10/99, Fuj/411/02, Cal/7/04) and 315 other publicly available dated sequences from elsewhere, worldwide. In addition, the NA sequence alignment was inspected for the presence of any naturally occurring, known, neuraminidase inhibitor (NAI) resistance-associated amino acid mutations (R292K and E119V). Before 2001, the Hong Kong HA and NA sequences clustered more closely with the older vaccine sequences (Syd/5/97, Mos/10/99) than did sequences from elsewhere. After 2001, this trend reversed with significant clusters containing HA and NA sequences from different locations, isolated at different times, suggesting that viral migration may account for much of the influenza A(H3N2) seasonality during this 10-year period. However, at least one example from Hong Kong was found suggesting that in some years, influenza A(H3N2) viruses may persist in the same location, perhaps continuing to circulate, sub-clinically, at low levels between seasons, to re-emerge in the influenza season the following year, relatively unchanged. None of these Hong Kong influenza A(H3N2) NA sequences contained any of the known NAI-resistance associated mutations. Conclusions/Significance: The seasonality of influenza A(H3N2) may be largely due to global migration, with similar viruses appearing in different countries at different times. However, occasionally, some viruses may remain within a single location and continue to circulate within that population, to re-emerge during the next influenza season, with relatively little genetic change. Naturally occurring NAI resistance mutations were absent or, at least, very rare in this population.	[Tang, Julian W.; Ngai, Karry L. K.; Lam, Wai Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Hong Kong Special Adm Region, Shatin, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Tang, JW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China.	jwtang49@hotmail.com	Chan, Paul KS/J-9360-2013; , Julian W Tang/H-2348-2014	Chan, Paul KS/0000-0002-6360-4608; Tang, Julian/0000-0002-4963-1028	Chinese University of Hong Kong [2041215]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded in part by a Direct Grant from The Chinese University of Hong Kong to JWT (Project Code: 2041215). The study sponsors had no influence in the study design, data collection, analysis or interpretation, the writing of the paper and the decision to submit this work for publication.	*AM COLL EP, 2000, ETH GUID I; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Boni MF, 2004, THEOR POPUL BIOL, V65, P179, DOI 10.1016/j.tpb.2003.10.002; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; HAMMOND GW, 1989, REV INFECT DIS, V11, P494; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Russell KL, 2005, VACCINE, V23, P1981, DOI 10.1016/j.vaccine.2004.10.023; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; SHORTRIDGE KF, 1982, LANCET, V2, P812; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; van Nimwegen E, 2006, SCIENCE, V314, P1884, DOI 10.1126/science.1137300; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121	38	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2768	10.1371/journal.pone.0002768	http://dx.doi.org/10.1371/journal.pone.0002768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648550	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900038
J	Kilian, M; Poulsen, K; Blomqvist, T; Havarstein, LS; Bek-Thomsen, M; Tettelin, H; Sorensen, UBS				Kilian, Mogens; Poulsen, Knud; Blomqvist, Trinelise; Havarstein, Leiv S.; Bek-Thomsen, Malene; Tettelin, Herve; Sorensen, Uffe B. S.			Evolution of Streptococcus pneumoniae and Its Close Commensal Relatives	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; GROUP-O-ANTIGEN; GENETIC-TRANSFORMATION; C-POLYSACCHARIDE; NUCLEOTIDE-SEQUENCE; DNA HYBRIDIZATION; VIRULENCE FACTOR; MITIS GROUP; S-MITIS; SP-NOV	Streptococcus pneumoniae is a member of the Mitis group of streptococci which, according to 16S rRNA-sequence based phylogenetic reconstruction, includes 12 species. While other species of this group are considered prototypes of commensal bacteria, S. pneumoniae is among the most frequent microbial killers worldwide. Population genetic analysis of 118 strains, supported by demonstration of a distinct cell wall carbohydrate structure and competence pheromone sequence signature, shows that S. pneumoniae is one of several hundred evolutionary lineages forming a cluster separate from Streptococcus oralis and Streptococcus infantis. The remaining lineages of this distinct cluster are commensals previously collectively referred to as Streptococcus mitis and each represent separate species by traditional taxonomic standard. Virulence genes including the operon for capsule polysaccharide synthesis and genes encoding IgA1 protease, pneumolysin, and autolysin were randomly distributed among S. mitis lineages. Estimates of the evolutionary age of the lineages, the identical location of remnants of virulence genes in the genomes of commensal strains, the pattern of genome reductions, and the proportion of unique genes and their origin support the model that the entire cluster of S. pneumoniae, S. pseudopneumoniae, and S. mitis lineages evolved from pneumococcus-like bacteria presumably pathogenic to the common immediate ancestor of hominoids. During their adaptation to a commensal life style, most of the lineages gradually lost the majority of genes determining virulence and became genetically distinct due to sexual isolation in their respective hosts.	[Kilian, Mogens; Poulsen, Knud; Bek-Thomsen, Malene; Sorensen, Uffe B. S.] Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark; [Blomqvist, Trinelise; Havarstein, Leiv S.] Norwegian Univ Life Sci, Dept Chem, Biotechnol & Food Sci, As, Norway; [Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD USA	Aarhus University; Norwegian University of Life Sciences; University System of Maryland; University of Maryland Baltimore	Kilian, M (corresponding author), Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark.	kilian@microbiology.au		Kilian, Mogens/0000-0002-5861-0472; Havarstein, Leiv Sigve/0000-0001-8250-4322; Sorensen, Uffe B. Skov/0000-0002-6777-054X	Carlsberg foundation; Velux foundation; Karen Elise Jensen foundation; Faculty of Health Sciences, University of Aarhus	Carlsberg foundation(Carlsberg Foundation); Velux foundation(Velux Fonden); Karen Elise Jensen foundation; Faculty of Health Sciences, University of Aarhus	This research was financed by unconditional grants from the Carlsberg, Velux, and Karen Elise Jensen foundations, and from the Faculty of Health Sciences, University of Aarhus.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bergstrom N, 2003, EUR J BIOCHEM, V270, P2157, DOI 10.1046/j.1432-1033.2003.03569.x; Bergstrom N, 2000, EUR J BIOCHEM, V267, P7147, DOI 10.1046/j.1432-1327.2000.01821.x-i2; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Carlsson J, 1968, Odontol Revy, V19, P137; Carvalho MGS, 2003, J CLIN MICROBIOL, V41, P4415, DOI 10.1128/JCM.41.9.4415-4417.2003; CASHION P, 1977, ANAL BIOCHEM, V81, P461, DOI 10.1016/0003-2697(77)90720-5; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; CLAVERYS JP, 1983, P NATL ACAD SCI-BIOL, V80, P5956, DOI 10.1073/pnas.80.19.5956; DELEY J, 1970, EUR J BIOCHEM, V12, P133; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; ESCARA JF, 1980, BIOPOLYMERS, V19, P1315, DOI 10.1002/bip.1980.360190708; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; GILLESPIE SH, 1993, INFECT IMMUN, V61, P3076, DOI 10.1128/IAI.61.7.3076-3077.1993; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; HOHWY J, 1995, ORAL MICROBIOL IMMUN, V10, P19, DOI 10.1111/j.1399-302X.1995.tb00113.x; Hoshino T, 2005, J CLIN MICROBIOL, V43, P6073, DOI 10.1128/JCM.43.12.6073-6085.2005; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Jumas-Bilak E, 1998, MOL MICROBIOL, V27, P99, DOI 10.1046/j.1365-2958.1998.00661.x; KAWAMURA S, 1992, J BIOL CHEM, V267, P7359; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Kawamura Y, 1998, INT J SYST BACTERIOL, V48, P921, DOI 10.1099/00207713-48-3-921; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; KILIAN M, 1995, PEDIATR RES, V38, P182, DOI 10.1203/00006450-199508000-00008; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Knutsen E, 2006, J BACTERIOL, V188, P8307, DOI 10.1128/JB.00850-06; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morrison DA, 1997, MICROB DRUG RESIST, V3, P27, DOI 10.1089/mdr.1997.3.27; Neeleman C, 2004, J CLIN MICROBIOL, V42, P4355, DOI 10.1128/JCM.42.9.4355-4357.2004; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Sambrook J., 1989, MOL CLONING LAB MANU; SanchezBeato AR, 1997, J BACTERIOL, V179, P2459, DOI 10.1128/jb.179.7.2459-2463.1997; Takenouchi-Ohkubo N, 2006, MICROBIOL-SGM, V152, P2171, DOI 10.1099/mic.0.28801-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Yoshida Y, 2006, J BACTERIOL, V188, P4125, DOI 10.1128/JB.01843-05; [No title captured]	67	208	210	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2683	10.1371/journal.pone.0002683	http://dx.doi.org/10.1371/journal.pone.0002683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628950	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200027
J	Pauly, T; Ratliff, M; Pietrowski, E; Neugebauer, R; Schlicksupp, A; Kirsch, J; Kuhse, J				Pauly, Thorsten; Ratliff, Miriam; Pietrowski, Eweline; Neugebauer, Rainer; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Activity-Dependent Shedding of the NMDA Receptor Glycine Binding Site by Matrix Metalloproteinase 3: A PUTATIVE Mechanism of Postsynaptic Plasticity	PLOS ONE			English	Article								Functional and structural alterations of clustered postsynaptic ligand gated ion channels in neuronal cells are thought to contribute to synaptic plasticity and memory formation in the human brain. Here, we describe a novel molecular mechanism for structural alterations of NR1 subunits of the NMDA receptor. In cultured rat spinal cord neurons, chronic NMDA receptor stimulation induces disappearance of extracellular epitopes of NMDA receptor NR1 subunits, which was prevented by inhibiting matrix metalloproteinases (MMPs). Immunoblotting revealed the digestion of solubilized NR1 subunits by MMP-3 and identified a fragment of about 60 kDa as MMPs-activity-dependent cleavage product of the NR1 subunit in cultured neurons. The expression of MMP-3 in the spinal cord culture was shown by immunoblotting and immunofluorescence microscopy. Recombinant NR1 glycine binding protein was used to identify MMP-3 cleavage sites within the extracellular S1 and S2-domains. N-terminal sequencing and site-directed mutagenesis revealed S542 and L790 as two putative major MMP-3 cleavage sites of the NR1 subunit. In conclusion, our data indicate that MMPs, and in particular MMP-3, are involved in the activity dependent alteration of NMDA receptor structure at postsynaptic membrane specializations in the CNS.	[Pauly, Thorsten] Univ Ulm, Dept Anat & Cellular Neurobiol, Ulm, Germany; [Ratliff, Miriam; Pietrowski, Eweline; Neugebauer, Rainer; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Univ Heidelberg, Dept Anat & Cell Biol, Heidelberg, Germany	Ulm University; Ruprecht Karls University Heidelberg	Pauly, T (corresponding author), Univ Ulm, Dept Anat & Cellular Neurobiol, Ulm, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019	Ratliff, Miriam/0000-0002-9464-6544	Deutsche Forschungsgemeinschaft [SFB 497, 577/1, 856/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for supporting this work (SFB 497, Forschergruppe FOR 577/1 and DFG Grant Ku 856/6-1). The sponsors did not contribute to the design or conduct of the study.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Arendt Y, 2007, FEBS LETT, V581, P4723, DOI 10.1016/j.febslet.2007.08.069; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; EGUCHI T, 2008, MOL CELL BIOL   0102; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; Hilgenberg LGW, 2002, MOL CELL NEUROSCI, V19, P97, DOI 10.1006/mcne.2001.1056; Holmes KD, 2002, J BIOL CHEM, V277, P1457, DOI 10.1074/jbc.M107809200; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neugebauer R, 2003, BIOCHEM BIOPH RES CO, V305, P476, DOI 10.1016/S0006-291X(03)00768-X; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Pauly T, 2005, NEUROSCIENCE, V131, P99, DOI 10.1016/j.neuroscience.2004.10.039; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Reeves TM, 2003, J NEUROSCI, V23, P10182; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; VanSaun M, 2000, J NEUROBIOL, V44, P369, DOI 10.1002/1097-4695(20000905)44:3<369::AID-NEU7>3.3.CO;2-Q; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x	36	38	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2681	10.1371/journal.pone.0002681	http://dx.doi.org/10.1371/journal.pone.0002681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629001	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200025
J	Oka, T; Mazack, V; Sudol, M				Oka, Tsutomu; Mazack, Virginia; Sudol, Marius			Mst2 and lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; WARTS-HIPPO PATHWAY; CELL-CYCLE EXIT; WW DOMAIN; ORGAN SIZE; PROMOTES APOPTOSIS; TEAD/TEF FAMILY; PROLIFERATION; DROSOPHILA; GROWTH	The Hippo pathway in Drosophila controls the size and shape of organs. In the fly, activation of this pathway conveys growth-inhibitory signals and promotes apoptosis in epithelial cells. We "reconstituted" the Hippo pathway in a human epithelial cell line and showed that, in contrast to flies, the activation of this pathway results in anti-apoptotic signals. We have shown that in human embryonic kidney (HEK) 293 cells, the complex formation between transcriptional co-activators YAPs (Yes kinase-associated proteins) and Lats kinases requires the intact WW domains of YAPs, as well as intact Pro-Pro-AA-Tyr (where AA is any amino acid) motifs in Lats kinases. These kinases cooperate with the upstream Mst2 kinase to phosphorylate YAPs at Ser127. Overexpression of YAP2 in HEK293 cells promoted apoptosis, whereas the Mst2/Lats1-induced phosphorylation of YAP partially rescued the cells from apoptotic death. Apoptotic signaling of YAP2 was mediated via stabilization of p73, which formed a complex with YAP2. All components of the Hippo pathway that we studied were localized in the cytoplasm, with the exception of YAP, which also localized in the nucleus. The localization of YAP2 in the nucleus was negatively controlled by the Lats1 kinase. Our apoptotic "readout" of the Hippo pathway in embryonic kidney cells represents a useful experimental system for the identification of the putative upstream receptor, membrane protein, or extracellular factor that initiates an entire signaling cascade and ultimately controls the size of organs.	[Oka, Tsutomu; Mazack, Virginia; Sudol, Marius] Weis Ctr Res, Geisinger Clin, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sudol, M (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	msudol1@geisinger.edu			Breast Cancer Coalition	Breast Cancer Coalition	This work was supported by two Breast Cancer Coalition grants from the Pennsylvania Department of Health (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Leevers SJ, 2005, CURR OPIN CELL BIOL, V17, P604, DOI 10.1016/j.ceb.2005.09.008; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Matallanas D, 2008, CELL CYCLE, V7, P879, DOI 10.4161/cc.7.7.5630; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; O'Neill EE, 2005, CANCER RES, V65, P5485, DOI 10.1158/0008-5472.CAN-05-1453; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sun SG, 2008, DEV DYNAM, V237, P270, DOI 10.1002/dvdy.21411; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	66	269	276	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27534	27546		10.1074/jbc.M804380200	http://dx.doi.org/10.1074/jbc.M804380200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18640976	hybrid			2022-12-25	WOS:000259719200024
J	Oshima, Y; Akiyama, T; Hikita, A; Iwasawa, M; Nagase, Y; Nakamura, M; Wakeyama, H; Kawamura, N; Ikeda, T; Chung, U; Hennighausen, L; Kawaguchi, H; Nakamura, K; Tanaka, S				Oshima, Yasushi; Akiyama, Toru; Hikita, Atsuhiko; Iwasawa, Mitsuyasu; Nagase, Yuichi; Nakamura, Masaki; Wakeyama, Hidetoshi; Kawamura, Naohiro; Ikeda, Toshiyuki; Chung, Ung-il; Hennighausen, Lothar; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae			Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; AVIAN GROWTH-PLATE; CELL-DEATH; ENDOCHONDRAL OSSIFICATION; CONDITIONAL DELETION; EXTRACELLULAR-MATRIX; X GENE; BNIP3; MICE; EXPRESSION	During endochondral ossification, chondrocytes undergo hypertrophic differentiation and die by apoptosis. The level of inorganic phosphate (P-i) elevates at the site of cartilage mineralization, and when chondrocytes were treated with P-i, they underwent rapid apoptosis. Gene silencing of the proapoptotic Bcl-2 homology 3-only molecule bnip3 significantly suppressed P-i-induced apoptosis. Conversely, overexpression of Bcl-xL suppressed, and its knockdown promoted, the apoptosis of chondrocytes. Bnip3 was associated with Bcl-xL in chondrocytes stimulated with Pi. Bcl-xL was expressed uniformly in the growth plate chondrocytes, whereas Bnip3 expression was exclusively localized in the hypertrophic chondrocytes. Finally, we generated chondrocyte-specific bcl-x knock-out mice using the Cre-loxP recombination system, and we provided evidence that the hypertrophic chondrocyte layer was shortened in those mice because of an increased apoptosis of prehypertrophic and hypertrophic chondrocytes, with the mice afflicted with dwarfism as a result. These results suggest the pivotal role of Bcl-2 family members in the regulation of chondrocyte apoptosis.	[Oshima, Yasushi; Akiyama, Toru; Iwasawa, Mitsuyasu; Nagase, Yuichi; Nakamura, Masaki; Wakeyama, Hidetoshi; Kawamura, Naohiro; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Hikita, Atsuhiko] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr, Dept Pathomech, Kanagawa 2288522, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hennighausen, Lothar] NIH, Lab Genet & Physiol, Bethesda, MD 20892 USA	University of Tokyo; University of Tokyo; National Institutes of Health (NIH) - USA	Tanaka, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Kawamura, Naohiro/J-8372-2019; Akiyama, Toru/AAA-5887-2020; Tanaka, Sakae/Y-3061-2019; Ikeda, Toshiyuki/GVS-5588-2022	Akiyama, Toru/0000-0001-9493-4768; Tanaka, Sakae/0000-0001-9210-9414; Hennighausen, Lothar/0000-0001-8319-9841	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, Z01DK061000] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and health science research grants from the Ministry of Health, Labor, and Welfare of Japan (to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; ANDERSON HC, 1975, AM J PATHOL, V79, P237; BOYDE A, 1980, HISTOCHEMISTRY, V69, P85, DOI 10.1007/BF00508369; Colnot C, 2001, DEV BIOL, V229, P203, DOI 10.1006/dbio.2000.9933; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; FARNUM CE, 1987, ANAT REC, V219, P221, DOI 10.1002/ar.1092190303; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216; Hon H, 2004, J IMMUNOL, V173, P4425, DOI 10.4049/jimmunol.173.7.4425; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Lee H, 2006, MOL CELLS, V21, P1; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Miyagishi Makoto, 2004, Methods Mol Biol, V252, P483; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Riedlinger G, 2002, BIOL REPROD, V66, P438, DOI 10.1095/biolreprod66.2.438; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Srinivas V, 2006, AUTOPHAGY, V2, P215, DOI 10.4161/auto.2649; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Walton KD, 2001, MECH DEVELOP, V109, P281, DOI 10.1016/S0925-4773(01)00549-4; WU LNY, 1995, J CELL BIOCHEM, V57, P218, DOI 10.1002/jcb.240570206; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	46	31	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26499	26508		10.1074/jbc.M800933200	http://dx.doi.org/10.1074/jbc.M800933200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18632667	hybrid, Green Published			2022-12-25	WOS:000259341600026
J	Prasad, A; Paruchuri, V; Preet, A; Latif, F; Ganju, RK				Prasad, Anil; Paruchuri, Vikram; Preet, Anju; Latif, Farida; Ganju, Ramesh K.			Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY-BULB AXONS; COLORECTAL-CANCER; ROBO RECEPTORS; EPIGENETIC INACTIVATION; EXPRESSION PATTERNS; SIGNALING PATHWAYS; LUNG DEVELOPMENT; VERTEBRATE SLIT; CARCINOMA CELLS; WNT PATHWAY	SLIT-2 is considered as a candidate tumor suppressor gene, because it is frequently inactivated in various cancers due to hypermethylation of its promoter region and allelic loss. However, the exact mechanism of its tumor-suppressive effect has not been elucidated. Here, we observed that Slit-2-overexpressing breast cancer cells exhibited decreased proliferation and migration capabilities compared with control cells under in vitro conditions. These results were confirmed in vivo in mouse model systems. Mice injected with MCF-7/Slit-2 cells showed a 60-70% reduction in tumor size compared with mice injected with MCF-7/VC cells both in the absence and presence of estrogen. Upon further elucidation, we observed that Slit-2 mediates the tumor-suppressive effect via a coordinated regulation of the beta-catenin and PI3K signaling pathways and by enhancing beta-catenin/E-cadherin-mediated cell-cell adhesion. Our study for the first time reveals that Slit-2-overexpressing breast cancer cells exhibit tumor suppressor capabilities through the novel mechanism of beta-catenin modulation.	[Prasad, Anil; Paruchuri, Vikram; Preet, Anju; Ganju, Ramesh K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02115 USA; [Latif, Farida] Univ Birmingham, Inst Biomed Res, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Birmingham	Prasad, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Med, HIM 342, Boston, MA 02115 USA.	abailugu@bidmc.harvard.edu	Thomson, Axel/A-7893-2013		National Institutes of Health [CA109527]; NATIONAL CANCER INSTITUTE [R01CA109527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109527. This work was also supported by the Susan G. Komen Breast Cancer Foundation (to R. K. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anselmo MA, 2003, GENE EXPR PATTERNS, V3, P13, DOI 10.1016/S1567-133X(02)00095-9; Astuti D, 2004, BRIT J CANCER, V90, P515, DOI 10.1038/sj.bjc.6601447; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fearon ER, 2000, JNCI-J NATL CANCER I, V92, P515, DOI 10.1093/jnci/92.7.515; Fujiwara M, 2006, VASC MED, V11, P115, DOI 10.1191/1358863x06vm658ra; Georgas K, 1999, CYTOGENET CELL GENET, V86, P246, DOI 10.1159/000015351; Gilles C, 2003, CANCER RES, V63, P2658; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Grone J, 2006, ONCOL REP, V15, P1437; Guan HB, 2003, J IMMUNOL, V171, P6519, DOI 10.4049/jimmunol.171.12.6519; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Katoh Y, 2005, ONCOL REP, V14, P1351; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Mhashilkar AM, 2003, MOL THER, V8, P207, DOI 10.1016/S1525-0016(03)00170-9; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ray G, 2005, ONCOL REP, V13, P445; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Sundaresan V, 1998, ONCOGENE, V17, P1723, DOI 10.1038/sj.onc.1202103; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Watson PH, 1996, CURR TOP MICROBIOL, V213, P267; Werbowetski-Ogilvie TE, 2006, ONCOGENE, V25, P5103, DOI 10.1038/sj.onc.1209524; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	63	87	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26624	26633		10.1074/jbc.M800679200	http://dx.doi.org/10.1074/jbc.M800679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18611862	hybrid, Green Published			2022-12-25	WOS:000259341600038
J	Jing, XF; Zhao, DM; Waldschmidt, TJ; Xue, HH				Jing, Xuefang; Zhao, Dong-Mei; Waldschmidt, Thomas J.; Xue, Hai-Hui			GABP beta 2 is dispensible for normal lymphocyte development but moderately affects B cell responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GA-BINDING-PROTEIN; TRANSCRIPTION FACTOR GABP; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; NEUROMUSCULAR-JUNCTION; GERMINAL CENTER; T-CELLS; ALPHA; PROMOTER; COMPLEX	GA-binding protein (GABP) is the only Ets family transcription factor that functions as a heterodimer. The GABP alpha subunit binds to DNA, and the GABP beta subunit possesses the ability to transactivate target genes. Inactivation of GABP alpha caused embryonic lethality and defective lymphocyte development and immune responses. There are 3 isoforms of the GABP beta subunit, but whether they have distinct functions has not been addressed. In this study, we selectively ablated the expression of GABP beta 2 using a gene trap strategy. GABP beta 2-deficient mice were viable and had normal T and B cell development, suggesting that loss of GABP beta 2 is compensated for by other GABP beta isoforms during these processes. GABP beta 2-deficient T cells can be activated and proliferate similarly to wild-type controls. In contrast, B cells lacking GABP beta 2 showed 2-3-fold increases in proliferation in response to B cell receptor stimulation. In addition, GABP beta 2-deficient mice exhibited moderately increased antibody production and germinal center responses when challenged with T-dependent antigens. These results indicate that albeit GABP beta isoforms are redundant in lymphocyte development, GABP beta 2 has a distinct role in restraining B cell expansion and humoral responses.	[Waldschmidt, Thomas J.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Jing, Xuefang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Xue, HH (corresponding author), 51 Newton Rd BSB 3-710, Iowa City, IA 52246 USA.	hai-huixue@uiowa.edu		Waldschmidt, Thomas/0000-0001-6147-6991; Xue, Hai-Hui/0000-0002-9163-7669				Avots A, 1997, MOL CELL BIOL, V17, P4381, DOI 10.1128/MCB.17.8.4381; Bannert N, 1999, P NATL ACAD SCI USA, V96, P1541, DOI 10.1073/pnas.96.4.1541; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DELABROUSSE FC, 1994, GENE DEV, V8, P1853, DOI 10.1101/gad.8.15.1853; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hauck L, 2002, MOL CELL BIOL, V22, P2147, DOI 10.1128/MCB.22.7.2147-2158.2002; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Li XR, 1999, J BIOL CHEM, V274, P35203, DOI 10.1074/jbc.274.49.35203; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; SAWADA J, 1994, EMBO J, V13, P1396, DOI 10.1002/j.1460-2075.1994.tb06393.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shiio Y, 1996, ONCOGENE, V12, P1837; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Sowa Y, 1997, CANCER RES, V57, P3145; Suzuki F, 1998, J BIOL CHEM, V273, P29302, DOI 10.1074/jbc.273.45.29302; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Xue HH, 2008, MOL CELL BIOL, V28, P4300, DOI 10.1128/MCB.01855-07; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Xue HH, 2002, INT IMMUNOL, V14, P1263, DOI 10.1093/intimm/dxf101; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	34	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24326	24333		10.1074/jbc.M804487200	http://dx.doi.org/10.1074/jbc.M804487200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18628204	hybrid, Green Published			2022-12-25	WOS:000258820000007
J	Rossi, MJ; Mazin, AV				Rossi, Matthew J.; Mazin, Alexander V.			Rad51 protein stimulates the branch migration activity of Rad54 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION FACTORS RAD51; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; ATPASE ACTIVITY; RAD51-DSDNA FILAMENT; HOLLIDAY JUNCTIONS; CHROMATIN; YEAST; BINDING	The Rad51 and Rad54 proteins play important roles during homologous recombination in eukaryotes. Rad51 forms a nucleoprotein filament on single-stranded DNA and performs the initial steps of double strand break repair. Rad54 belongs to the Swi2/Snf2 family of ATP-dependent DNA translocases. We previously showed that Rad54 promotes branch migration of Holliday junctions. Here we find that human Rad51 (hRad51) significantly stimulates the branch migration activity of hRad54. The stimulation appears to be evolutionarily conserved, as yeast Rad51 also stimulates the branch migration activity of yeast Rad54. We further investigated the mechanism of this stimulation. Our results demonstrate that the stimulation of hRad54-promoted branch migration by hRad51 is driven by specific protein-protein interactions, and the active form of the hRad51 filament is more stimulatory than the inactive one. The current results support the hypothesis that the hRad51 conformation state has a strong effect on interaction with hRad54 and ultimately on the function of hRad54 in homologous recombination.	[Rossi, Matthew J.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,NCB,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu		Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [CA100839, MH084119]; Leukemia and Lymphoma Society [1054-09]; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 and MH084119. This work was also supported by the Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NAT PROTOCOLS; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kiianitsa K, 2002, J BIOL CHEM, V277, P46205, DOI 10.1074/jbc.M207967200; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; RADDING CM, 1993, CURR BIOL, V3, P358, DOI 10.1016/0960-9822(93)90200-8; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	36	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24698	24706		10.1074/jbc.M800839200	http://dx.doi.org/10.1074/jbc.M800839200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617519	hybrid, Green Published			2022-12-25	WOS:000258820000039
J	Galliano, MF; Toulza, E; Jonca, N; Gonias, SL; Serre, G; Guerrin, M				Galliano, Marie-Florence; Toulza, Eve; Jonca, Nathalie; Gonias, Steven L.; Serre, Guy; Guerrin, Marina			Binding of alpha 2ML1 to the Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) Reveals a New Role for LRP1 in the Human Epidermis	PLOS ONE			English	Article								Background: The multifunctional receptor LRP1 has been shown to bind and internalize a large number of protein ligands with biological importance such as the pan-protease inhibitor alpha 2-macroglobulin (alpha 2M). We recently identified A2ML1, a new member of the alpha 2M gene family, expressed in epidermis. alpha 2ML1 might contribute to the regulation of desquamation through its inhibitory activity towards proteases of the chymotrypsin family, notably KLK7. The expression of LRP1 in epidermis as well as its ability to internalize alpha 2ML1 was investigated. Methods and Principal Findings: In human epidermis, LRP1 is mainly expressed within the granular layer of the epidermis, which gathers the most differentiated keratinocytes, as shown by immunohistochemistry and immunofluorescence using two different antibodies. By using various experimental approaches, we show that the receptor binding domain of alpha 2ML1 (RBDI) is specifically internalized into the macrophage-like cell line RAW and colocalizes with LRP1 upon internalization. Coimmunoprecipitation assays demonstrate that RBDl binds LRP1 at the cell surface. Addition of RAP, a universal inhibitor of ligand binding to LRP1, prevents RBDl binding at the cell surface as well as internalization into RAW cells. Silencing Lrp1 expression with specific siRNA strongly reduces RBDl internalization. Conclusions and Significance: Keratinocytes of the upper differentiated layers of epidermis express LRP1 as well as alpha 2ML1. Our study also reveals that alpha 2ML1 is a new ligand for LRP1. Our findings are consistent with endocytosis by LRP1 of complexes formed between alpha 2ML1 and proteases. LRP1 may thus control desquamation by regulating the biodisponibility of extracellular proteases.	[Galliano, Marie-Florence; Toulza, Eve; Jonca, Nathalie; Serre, Guy; Guerrin, Marina] CHU PURPAN, UMR UDEAR CNRS UPS 165, Toulouse, France; [Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Diego	Galliano, MF (corresponding author), CHU PURPAN, UMR UDEAR CNRS UPS 165, Toulouse, France.	mweber@udear.cnrs.fr	Jonca, Nathalie/AAX-3870-2020; Toulza, Eve/A-9919-2012	Jonca, Nathalie/0000-0003-3602-0102; Toulza, Eve/0000-0003-2049-2279	Centre National de la Recherche Scientifique; Toulouse III Paul Sabatier University	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Toulouse III Paul Sabatier University	This work was supported in part by grants from the "Centre National de la Recherche Scientifique" and the Toulouse III Paul Sabatier University.	Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arandjelovic S, 2007, J NEUROCHEM, V103, P694, DOI 10.1111/j.1471-4159.2007.04800.x; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Birkenmeier G, 1998, ARCH DERMATOL RES, V290, P561, DOI 10.1007/s004030050352; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; FELDMAN SR, 1992, ACTA DERM-VENEREOL, V72, P331; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grey A, 2004, MOL ENDOCRINOL, V18, P2268, DOI 10.1210/me.2003-0456; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAMARRE J, 1991, LAB INVEST, V65, P3; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rozen S, 2000, Methods Mol Biol, V132, P365; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Verges M, 2004, J BIOL CHEM, V279, P9030, DOI 10.1074/jbc.M312908200; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Wu SM, 1998, J IMMUNOL, V161, P4356	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2729	10.1371/journal.pone.0002729	http://dx.doi.org/10.1371/journal.pone.0002729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648652	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900007
J	Hayman, DTS; Suu-Ire, R; Breed, AC; McEachern, JA; Wang, LF; Wood, JLN; Cunningham, AA				Hayman, David T. S.; Suu-Ire, Richard; Breed, Andrew C.; McEachern, Jennifer A.; Wang, Linfa; Wood, James L. N.; Cunningham, Andrew A.			Evidence of Henipavirus Infection in West African Fruit Bats	PLOS ONE			English	Article							NIPAH VIRUS; ENCEPHALITIS	Henipaviruses are emerging RNA viruses of fruit bat origin that can cause fatal encephalitis in man. Ghanaian fruit bats (megachiroptera) were tested for antibodies to henipaviruses. Using a Luminex multiplexed microsphere assay, antibodies were detected in sera of Eidolon helvum to both Nipah (39%, 95% confidence interval: 27-51%) and Hendra (22%, 95% CI: 11-33%) viruses. Virus neutralization tests further confirmed seropositivity for 30% (7/23) of Luminex positive serum samples. Our results indicate that henipavirus is present within West Africa.	[Hayman, David T. S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Suu-Ire, Richard] Wildlife Div Forestry Commission, Accra, Ghana; [Breed, Andrew C.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Breed, Andrew C.; McEachern, Jennifer A.; Wang, Linfa] Australian Biosecurity Cooperat Res Ctr, Geelong, Vic, Australia; [McEachern, Jennifer A.; Wang, Linfa] Australian Anim Hlth Lab, CSIRO Livestock Industries, Geelong, Vic, Australia	Zoological Society of London; University of Cambridge; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hayman, DTS (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	A.Cunningham@ioz.ac.uk	Breed, Andrew C/A-5682-2011; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; Wood, James/A-1626-2008; Cunningham, Andrew A/E-7536-2010; Barr, Jennifer A/H-9254-2013	Breed, Andrew C/0000-0002-3439-9510; Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Barr, Jennifer/0000-0001-5266-9142; Hayman, David/0000-0003-0087-3015	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge(University of Cambridge)	This work was funded by the Institute of Zoology, Zoological Society of London and the Cambridge Infectious Diseases Consortium, University of Cambridge. Personnel (AAC, JLNW & DTSH) from both funding organisations conceived of, and conducted, the work and wrote the manuscript.	Alvarez Y, 1999, MOL BIOL EVOL, V16, P1061, DOI 10.1093/oxfordjournals.molbev.a026195; ANDERSON R M, 1991; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; DEFREES SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Rosevear D., 1965, BATS W AFRICA; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; THRUSFIELD MT, 1997, VET EPIDEMIOLOGY	17	158	163	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2739	10.1371/journal.pone.0002739	http://dx.doi.org/10.1371/journal.pone.0002739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648649	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900010
J	Nieberding, CM; de Vos, H; Schneider, MV; Lassance, JM; Estramil, N; Andersson, J; Bang, J; Hedenstrom, E; Lofstedt, C; Brakefield, PM				Nieberding, Caroline M.; de Vos, Helene; Schneider, Maria V.; Lassance, Jean-Marc; Estramil, Natalia; Andersson, Jimmy; Bang, Joakim; Hedenstroem, Erik; Loefstedt, Christer; Brakefield, Paul M.			The Male Sex Pheromone of the Butterfly Bicyclus anynana: Towards an Evolutionary Analysis	PLOS ONE			English	Article							COLIAS-PHILODICE LEPIDOPTERA; ORIENTAL FRUIT MOTHS; HELIOTHIS-VIRESCENS; EVO-DEVO; MATE CHOICE; IDENTIFICATION; EURYTHEME; GENETICS; BIOSYNTHESIS; SELECTION	Background: Female sex pheromones attracting mating partners over long distances are a major determinant of reproductive isolation and speciation in Lepidoptera. Males can also produce sex pheromones but their study, particularly in butterflies, has received little attention. A detailed comparison of sex pheromones in male butterflies with those of female moths would reveal patterns of conservation versus novelty in the associated behaviours, biosynthetic pathways, compounds, scent-releasing structures and receiving systems. Here we assess whether the African butterfly Bicyclus anynana, for which genetic, genomic, phylogenetic, ecological and ethological tools are available, represents a relevant model to contribute to such comparative studies. Methodology/Principal Findings: Using a multidisciplinary approach, we determined the chemical composition of the male sex pheromone (MSP) in the African butterfly B. anynana, and demonstrated its behavioural activity. First, we identified three compounds forming the presumptive MSP, namely (Z)-9-tetradecenol (Z9-14:OH), hexadecanal (16:Ald) and 6,10,14-trimethylpentadecan-2-ol (6,10,14-trime-15-2-ol), and produced by the male secondary sexual structures, the androconia. Second, we described the male courtship sequence and found that males with artificially reduced amounts of MSP have a reduced mating success in semi-field conditions. Finally, we could restore the mating success of these males by perfuming them with the synthetic MSP. Conclusions/Significance: This study provides one of the first integrative analyses of a MSP in butterflies. The toolkit it has developed will enable the investigation of the type of information about male quality that is conveyed by the MSP in intraspecific communication. Interestingly, the chemical structure of B. anynana MSP is similar to some sex pheromones of female moths making a direct comparison of pheromone biosynthesis between male butterflies and female moths relevant to future research. Such a comparison will in turn contribute to understanding the evolution of sex pheromone production and reception in butterflies.	[Nieberding, Caroline M.; de Vos, Helene; Schneider, Maria V.; Estramil, Natalia; Brakefield, Paul M.] Leiden Univ, Evolutionary Biol Grp, Inst Biol, Leiden, Netherlands; [Nieberding, Caroline M.] Univ Liege, Inst Botany, Zoogeographical Res Unit, Liege, Belgium; [Lassance, Jean-Marc; Loefstedt, Christer] Lund Univ, Dept Ecol, Lund, Sweden; [Andersson, Jimmy; Bang, Joakim; Hedenstroem, Erik] Mid Sweden Univ, Dept Nat Sci, Chem Lab, Sundsvall, Sweden	Leiden University; Leiden University - Excl LUMC; University of Liege; Lund University; Mid-Sweden University	Nieberding, CM (corresponding author), Leiden Univ, Evolutionary Biol Grp, Inst Biol, Leiden, Netherlands.	c.m.nieberding@biology.leidenuniv.nl	Schneider, Maria Victoria/E-6317-2010; Lassance, Jean-Marc/AAF-3933-2020; Löfstedt, Christer/G-2016-2014	Lassance, Jean-Marc/0000-0002-3675-6956; Löfstedt, Christer/0000-0002-3116-6922; Estramil, Natalia/0000-0002-7487-7062; Schneider, Maria Victoria/0000-0002-7114-2060	Marie Curie [FP6-2005-Mobility-5 nr039083]; Belgian "Fonds National de la Recherche Scientifique"; Swedish Council; Leiden University	Marie Curie(European Commission); Belgian "Fonds National de la Recherche Scientifique"(Fonds de la Recherche Scientifique - FNRS); Swedish Council(Swedish Research Council); Leiden University	Marie Curie International European Fellowship to C.N. (FP6-2005-Mobility-5 nr039083); Belgian "Fonds National de la Recherche Scientifique" to C.N (mandat Chargee de Recherches); European objective 1 the region of South Forest Countries to E.H., the Swedish Council (Lansstyrelsen i Vasternorrlands lan to E.H., VR and Formas grants to C.L.); Leiden University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; [Anonymous], 2014, PHEROMONES ANIMAL BE; BAKER TC, 1981, SCIENCE, V214, P1359, DOI 10.1126/science.214.4527.1359; Beldade P, 2008, HEREDITY, V100, P150, DOI 10.1038/sj.hdy.6800934; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; BIRCH MC, 1990, ANNU REV ENTOMOL, V35, P25, DOI 10.1146/annurev.en.35.010190.000325; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 2001, J EVOLUTION BIOL, V14, P148, DOI 10.1046/j.1420-9101.2001.00248.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brakefield PM, 2003, ANNU REV ECOL EVOL S, V34, P633, DOI 10.1146/annurev.ecolsys.34.011802.132425; BROOKS CJW, 1973, ANAL CHEM, V45, P896, DOI 10.1021/ac60328a033; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Choi MY, 2005, ARCH INSECT BIOCHEM, V59, P53, DOI 10.1002/arch.20051; Condamin M., 1973, MONOGRAPHIE GENRE BI; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; DESS DB, 1983, J ORG CHEM, V48, P4155, DOI 10.1021/jo00170a070; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; Groot AT, 2004, J CHEM ECOL, V30, P2495, DOI 10.1007/s10886-004-7946-y; GRULA JW, 1980, J CHEM ECOL, V6, P241, DOI 10.1007/BF00987543; HEATH RR, 1992, J CHEM ECOL, V18, P441, DOI 10.1007/BF00994243; Hedenstrom E, 2002, J CHEM SOC PERK T 1, P1810, DOI 10.1039/b201395a; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; Iyengar VK, 2001, BEHAV ECOL SOCIOBIOL, V49, P283, DOI 10.1007/s002650000292; JACQUIN E, 1991, J CHEM ECOL, V17, P239, DOI 10.1007/BF00994436; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kemp DJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1017, DOI 10.1007/s00265-007-0529-5; Kimura T, 1999, APPL ENTOMOL ZOOL, V34, P147, DOI 10.1303/aez.34.147; LARSEN T, 1999, BUTTERFLIES W AFRICA; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LINN CE, 1989, CHEM SENSES, V14, P421, DOI 10.1093/chemse/14.3.421; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; Lundh M, 1996, TETRAHEDRON-ASYMMETR, V7, P3277, DOI 10.1016/0957-4166(96)00428-4; Mori K, 2004, TOP CURR CHEM, V239, P1, DOI 10.1007/b95448; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; MYERS J, 1972, AM ZOOL, V12, P545; Nishida R, 1996, J CHEM ECOL, V22, P949, DOI 10.1007/BF02029947; NISHIDA R, 1982, J CHEM ECOL, V8, P947, DOI 10.1007/BF00987661; Phelan P. Larry, 1997, P240, DOI 10.1017/CBO9780511721946.015; PHELAN PL, 1986, J CHEM ECOL, V12, P135, DOI 10.1007/BF01045597; PLISKE TE, 1969, SCIENCE, V164, P1170, DOI 10.1126/science.164.3884.1170; Rafaeli A, 2005, ENTOMOL EXP APPL, V115, P7, DOI 10.1111/j.1570-7458.2005.00292.x; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P14599, DOI 10.1073/pnas.1233767100; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; SAPPINGTON TW, 1990, J CHEM ECOL, V16, P2755, DOI 10.1007/BF00988084; SAPPINGTON TW, 1990, P NATL ACAD SCI USA, V87, P6132, DOI 10.1073/pnas.87.16.6132; SAPPINGTON TW, 1990, J CHEM ECOL, V16, P2771, DOI 10.1007/BF00988085; Sasaerila Y, 2003, CHEMOECOLOGY, V13, P89, DOI 10.1007/s00049-003-0233-5; SCHNEIDER MV, 1998, THESIS U ROME TORVER; Sheck AL, 2006, J EVOLUTION BIOL, V19, P600, DOI 10.1111/j.1420-9101.2005.00999.x; SHIELDS O, 1976, Journal of Research on the Lepidoptera, V15, P132; Svensson GP, 2002, J CHEM ECOL, V28, P1447, DOI 10.1023/A:1016204820674; Svensson M, 1996, BIOL REV, V71, P113, DOI 10.1111/j.1469-185X.1996.tb00743.x; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; TAYLOR OR, 1973, ANN ENTOMOL SOC AM, V66, P621, DOI 10.1093/aesa/66.3.621; TEAL PEA, 1989, J CHEM ECOL, V15, P413, DOI 10.1007/BF02027801; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235	71	104	107	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2751	10.1371/journal.pone.0002751	http://dx.doi.org/10.1371/journal.pone.0002751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648495	Green Published, gold			2022-12-25	WOS:000264302900022
J	Toupet, K; Compan, V; Crozet, C; Mourton-Gilles, C; Mestre-Frances, N; Ibos, F; Corbeau, P; Verdier, JM; Perrier, V				Toupet, Karine; Compan, Valerie; Crozet, Carole; Mourton-Gilles, Chantal; Mestre-Frances, Nadine; Ibos, Francoise; Corbeau, Pierre; Verdier, Jean-Michel; Perrier, Veronique			Effective Gene Therapy in a Mouse Model of Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRP GENOTYPE; PENTOSAN POLYSULFATE; BLOOD-TRANSFUSION; SURVIVAL TIMES; SCRAPIE; PROTEIN; SHEEP; REPLICATION; ASSOCIATION	Classical drug therapies against prion diseases have encountered serious difficulties. It has become urgent to develop radically different therapeutic strategies. Previously, we showed that VSV-G pseudotyped FIV derived vectors carrying dominant negative mutants of the PrP gene are efficient to inhibit prion replication in chronically prion-infected cells. Besides, they can transduce neurons and cells of the lymphoreticular system, highlighting their potential use in gene therapy approaches. Here, we used lentiviral gene transfer to deliver PrPQ167R virions possessing anti-prion properties to analyse their efficiency in vivo. Since treatment for prion diseases is initiated belatedly in human patients, we focused on the development of a curative therapeutic protocol targeting the late stage of the disease, either at 35 or 105 days post-infection (d.p.i.) with prions. We observed a prolongation in the lifespan of the treated mice that prompted us to develop a system of cannula implantation into the brain of prion-infected mice. Chronic injections of PrPQ167R virions were done at 80 and 95 d.p.i. After only two injections, survival of the treated mice was extended by 30 days (20%), accompanied by substantial improvement in behaviour. This delay was correlated with: (i) a strong reduction of spongiosis in the ipsilateral side of the brain by comparison with the contralateral side; and (ii) a remarkable decrease in astrocytic gliosis in the whole brain. These results suggest that chronic injections of dominant negative lentiviral vectors into the brain, may be a promising approach for a curative treatment of prion diseases.	[Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] Univ Montpellier 2, Montpellier, France; [Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] Inserm, U710, Montpellier, France; [Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] EPHE, Paris, France; [Compan, Valerie] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Crozet, Carole] CNRS, Inst Genet Humaine, UPR 1142, Montpellier, France; [Mourton-Gilles, Chantal] CNRS, FRE3009 BioRad, Grabels, France; [Corbeau, Pierre] CNRS, UPR 1142, Lab Lentivirus Transfert Genes, Montpellier, France	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Toupet, K (corresponding author), Univ Montpellier 2, Montpellier, France.	veronique.perrier@univ-montp2.fr	crozet, carole/ABB-5877-2021; Perrier, Veronique/AAK-3594-2020; Mestre-Francés, Nadine/V-6289-2019	Mestre-Francés, Nadine/0000-0002-6856-3067; Crozet, Carole/0000-0002-7292-7046; COMPAN, Valerie/0000-0002-4634-2765; VERDIER, Jean-Michel/0000-0002-7252-1556; perrier, veronique/0000-0002-6570-7504	GIS "Infections a prions" [A62]; Inserm; Biotherapy Prize 2008 from Thermo Fisher Scientific	GIS "Infections a prions"; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Biotherapy Prize 2008 from Thermo Fisher Scientific	GIS "Infections a prions" project number A62 in 2001, Inserm dotation, VP has received the Biotherapy Prize 2008 from Thermo Fisher Scientific.	Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; ANDREOLOTTI O, 2004, METHODS TOOLS BIOSCI, P82; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Crozet C, 2004, J CELL SCI, V117, P5591, DOI 10.1242/jcs.01484; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GENOUD N, 2008, AM J PATHOL; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Haik S, 2004, NEUROLOGY, V63, P2413, DOI 10.1212/01.WNL.0000148596.15681.4D; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; KITAMOTO T, 1994, PHILOS T R SOC B, V343, P391, DOI 10.1098/rstb.1994.0034; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; LEE CI, 2007, PROTEIN SCI; Lowenstein PR, 2007, CURR GENE THER, V7, P347, DOI 10.2174/156652307782151498; Marella M, 2005, J BIOL CHEM, V280, P1529, DOI 10.1074/jbc.M410966200; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Whittle IR, 2006, ACTA NEUROCHIR, V148, P677, DOI 10.1007/s00701-006-0772-y; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	39	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2773	10.1371/journal.pone.0002773	http://dx.doi.org/10.1371/journal.pone.0002773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648643	Green Published, gold			2022-12-25	WOS:000264302900043
J	Liu, H; Rahman, A; Semino-Mora, C; Doi, SQ; Dubois, A				Liu, Hui; Rahman, Arifur; Semino-Mora, Cristina; Doi, Sonia Q.; Dubois, Andre			Specific and Sensitive Detection of H-pylori in Biological Specimens by Real-Time RT-PCR and In Situ Hybridization	PLOS ONE			English	Article								PCR detection of H. pylori in biological specimens is rendered difficult by the extensive polymorphism of H. pylori genes and the suppressed expression of some genes in many strains. The goal of the present study was to (1) define a domain of the 16S rRNA sequence that is both highly conserved among H. pylori strains and also specific to the species, and (2) to develop and validate specific and sensitive molecular methods for the detection of H. pylori. We used a combination of in silico and molecular approaches to achieve sensitive and specific detection of H. pylori in biologic media. We sequenced two isolates from patients living in different continents and demonstrated that a 546-bp domain of the H. pylori 16S rRNA sequence was conserved in those strains and in published sequences. Within this conserved sequence, we defined a 229-bp domain that is 100% homologous in most H. pylori strains available in GenBank and also is specific for H. pylori. This sub-domain was then used to design (1) a set of high quality RT-PCR primers and probe that encompassed a 76-bp sequence and included at least two mismatches with other Helicobacter sp. 16S rRNA; and (2) in situ hybridization antisense probes. The sensitivity and specificity of the approaches were then demonstrated by using gastric biopsy specimens from patients and rhesus monkeys. This H. pylori-specific region of the 16S rRNA sequence is highly conserved among most H. pylori strains and allows specific detection, identification, and quantification of this bacterium in biological specimens.	[Liu, Hui; Rahman, Arifur; Semino-Mora, Cristina; Doi, Sonia Q.; Dubois, Andre] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Liu, H (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	adubois@usuhs.edu			USUHS [R0-83GM]; NIH [R01-CA082312]; NATIONAL CANCER INSTITUTE [R01CA082312] Funding Source: NIH RePORTER	USUHS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work supported in part by USUHS grant R0-83GM and by NIH Grant R01-CA082312.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P6221, DOI 10.1093/nar/20.23.6221; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; *APPL CORP, 2001, PRIM EXPR SOFTW V2 0; Aspholm M, 2006, METHOD ENZYMOL, V417, P293, DOI 10.1016/S0076-6879(06)17020-2; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Avenaud P, 2000, CANCER, V89, P1431, DOI 10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.3.CO;2-X; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Camorlinga-Ponce M, 2004, J CLIN PATHOL, V57, P822, DOI 10.1136/jcp.2004.017087; Castera L, 2006, WORLD J GASTROENTERO, V12, P7278, DOI 10.3748/wjg.v12.i45.7278; Chong SKF, 1996, J CLIN MICROBIOL, V34, P2728, DOI 10.1128/JCM.34.11.2728-2730.1996; Contreras M, 2007, LETT APPL MICROBIOL, V45, P553, DOI 10.1111/j.1472-765X.2007.02227.x; Doi SQ, 2005, VET MICROBIOL, V108, P133, DOI 10.1016/j.vetmic.2005.04.003; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; DRAZEK ES, 1994, J CLIN MICROBIOL, V32, P1799, DOI 10.1128/JCM.32.7.1799-1804.1994; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; ECKLOFF BW, 1994, INT J SYST BACTERIOL, V44, P320, DOI 10.1099/00207713-44-2-320; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Forman D, 2000, BRIT MED J, V320, P1682, DOI 10.1136/bmj.320.7251.1682; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; GENTA RM, 1994, HUM PATHOL, V25, P221, DOI 10.1016/0046-8177(94)90191-0; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gorkiewicz G, 2003, J CLIN MICROBIOL, V41, P2537, DOI 10.1128/JCM.41.6.2537-2546.2003; GRAY MW, 1984, NUCLEIC ACIDS RES, V12, P5837, DOI 10.1093/nar/12.14.5837; HANDT LK, 1994, INFECT IMMUN, V62, P2367, DOI 10.1128/IAI.62.6.2367-2374.1994; HO SA, 1991, J CLIN MICROBIOL, V29, P2543, DOI 10.1128/JCM.29.11.2543-2549.1991; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; LIU H, 2006, GASTROENTEROLOGY, V130, pT1608; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Riley LK, 1996, J CLIN MICROBIOL, V34, P942, DOI 10.1128/JCM.34.4.942-946.1996; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Smith JG, 1996, CLIN DIAGN LAB IMMUN, V3, P66, DOI 10.1128/CDLI.3.1.66-72.1996; Smith SI, 2004, WORLD J GASTROENTERO, V10, P1958; Sturegard E, 2004, ALIMENT PHARM THER, V19, P613, DOI 10.1111/j.1365-2036.2004.01880.x; Suerbaum S, 2002, INT J SYST EVOL MICR, V52, P437, DOI 10.1099/00207713-52-2-437; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4	38	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2689	10.1371/journal.pone.0002689	http://dx.doi.org/10.1371/journal.pone.0002689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648543	Green Submitted, gold, Green Published			2022-12-25	WOS:000264057200033
J	Zhao, M; Amiel, SA; Ajami, S; Jiang, J; Rela, M; Heaton, N; Huang, GC				Zhao, Min; Amiel, Stephanie A.; Ajami, Sanaz; Jiang, Jie; Rela, Mohamed; Heaton, Nigel; Huang, Guo Cai			Amelioration of Streptozotocin-Induced Diabetes in Mice with Cells Derived from Human Marrow Stromal Cells	PLOS ONE			English	Article								Background: Pluri-potent bone marrow stromal cells (MSCs) provide an attractive opportunity to generate unlimited glucose-responsive insulin-producing cells for the treatment of diabetes. We explored the potential for human MSCs (hMSCs) to be differentiated into glucose-responsive cells through a non-viral genetic reprogramming approach. Methods and Findings: Two hMSC lines were transfected with three genes: PDX-1, NeuroD1 and Ngn3 without subsequent selection, followed by differentiation induction in vitro and transplantation into diabetic mice. Human MSCs expressed mRNAs of the archetypal stem cell markers: Sox2, Oct4, Nanog and CD34, and the endocrine cell markers: PDX-1, NeuroD1, Ngn3, and Nkx6.1. Following gene transfection and differentiation induction, hMSCs expressed insulin in vitro, but were not glucose regulated. After transplantation, hMSCs differentiated further and similar to 12.5% of the grafted cells expressed insulin. The graft bearing kidneys contained mRNA of insulin and other key genes required for the functions of beta cells. Mice transplanted with manipulated hMSCs showed reduced blood glucose levels (from 18.9+/-0.75 to 7.63+/-1.63 mM). 13 of the 16 mice became normoglycaemic (6.9+/-0.64 mM), despite the failure to detect the expression of SUR1, a K(+)-ATP channel component required for regulation of insulin secretion. Conclusions: Our data confirm that hMSCs can be induced to express insulin sufficient to reduce blood glucose in a diabetic mouse model. Our triple gene approach has created cells that seem less glucose responsive in vitro but which become more efficient after transplantation. The maturation process requires further study, particularly the in vivo factors influencing the differentiation, in order to scale up for clinical purposes.	[Zhao, Min; Amiel, Stephanie A.; Ajami, Sanaz; Huang, Guo Cai] Kings Coll London, Sch Med, Diabet Res Grp, London WC2R 2LS, England; [Jiang, Jie] Kings Coll London, Sch Med, Dept Haematol Med, London, England; [Rela, Mohamed; Heaton, Nigel] Kings Coll Hosp, Inst Liver Studies, London, England	University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Zhao, M (corresponding author), Kings Coll London, Sch Med, Diabet Res Grp, London WC2R 2LS, England.	guo.huang@kcl.ac.uk	Heaton, Nigel/AAK-8363-2020		King's College Hospital Charity Trust; Juvenile Diabetes Research Foundation International [1-2004-357]; Medical Research Council [G0600698B] Funding Source: researchfish	King's College Hospital Charity Trust; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by funding from King's College Hospital Charity Trust and partially by a research grants from Juvenile Diabetes Research Foundation International: 1-2004-357. The funding bodies and authors do not have conflict of interest with this publication.	Armanios M, 2005, COLD SH Q B, V70, P205, DOI 10.1101/sqb.2005.70.030; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Butler AE, 2007, DIABETES, V56, P1810, DOI 10.2337/db06-1385; Corti S, 2002, J NEUROSCI RES, V70, P721, DOI 10.1002/jnr.10455; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gumus-Akay G, 2007, GENET MOL RES, V6, P41; HALL PA, 1988, J PATHOL, V154, P223, DOI 10.1002/path.1711540305; HOBBS SM, 1997, ARTIFICAL DNA UNPUB; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Iwata H, 2007, FRONT BIOSCI, V12, P4157, DOI 10.2741/2377; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kobune M, 2003, EXP HEMATOL, V31, P715, DOI 10.1016/S0301-472X(03)00177-2; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; MacFarlane WM, 1999, J BIOL CHEM, V274, P34059, DOI 10.1074/jbc.274.48.34059; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Pascucci L, 2006, VET DERMATOL, V17, P244, DOI 10.1111/j.1365-3164.2006.00527.x; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rajagopal J, 2003, SCIENCE, V299, P363; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharma A, 1999, MOL CELL BIOL, V19, P704; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Tayaramma T, 2006, STEM CELLS, V24, P2858, DOI 10.1634/stemcells.2006-0109; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Zhao M, 2005, DIABETOLOGIA, V48, P2051, DOI 10.1007/s00125-005-1888-y; Zhao M, 2002, TRANSPLANTATION, V73, P1454, DOI 10.1097/00007890-200205150-00015; Zhao M, 2007, J ENDOCRINOL, V195, P407, DOI 10.1677/JOE-07-0436; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	48	35	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2666	10.1371/journal.pone.0002666	http://dx.doi.org/10.1371/journal.pone.0002666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628974	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200012
J	Bunnell, TM; Jaeger, MA; Fitzsimons, DP; Prins, KW; Ervasti, JM				Bunnell, Tina M.; Jaeger, Michele A.; Fitzsimons, Daniel P.; Prins, Kurt W.; Ervasti, James M.			Destabilization of the Dystrophin-Glycoprotein Complex without Functional Deficits in alpha-Dystrobrevin Null Muscle	PLOS ONE			English	Article								alpha-Dystrobrevin is a component of the dystrophin-glycoprotein complex (DGC) and is thought to have both structural and signaling roles in skeletal muscle. Mice deficient for alpha-dystrobrevin (adbn(-/-)) exhibit extensive myofiber degeneration and neuromuscular junction abnormalities. However, the biochemical stability of the DGC and the functional performance of adbn(-/-) muscle have not been characterized. Here we show that the biochemical association between dystrophin and beta-dystroglycan is compromised in adbn(-/-) skeletal muscle, suggesting that alpha-dystrobrevin plays a structural role in stabilizing the DGC. However, despite muscle cell death and DGC destabilization, costamere organization and physiological performance is normal in adbn(-/-) skeletal muscle. Our results demonstrate that myofiber degeneration alone does not cause functional deficits and suggests that more complex pathological factors contribute to the development of muscle weakness in muscular dystrophy.	[Bunnell, Tina M.; Prins, Kurt W.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Jaeger, Michele A.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Fitzsimons, Daniel P.] Univ Wisconsin, Dept Physiol, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bunnell, TM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020	Prins, Kurt/0000-0002-0364-6742	AHA [predoctoral fellowship]; NIH [AR049899, AR042423]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042423, R01AR049899] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by an AHA predoctoral fellowship to M.A.J and NIH grants AR049899 and AR042423 to J.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; CARLSON CG, 1990, MUSCLE NERVE, V13, P480, DOI 10.1002/mus.880130603; Chao DS, 1998, J NEUROCHEM, V71, P784; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; DWYER TM, 1995, FEBS LETT, V375, P91, DOI 10.1016/0014-5793(95)01176-F; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; GORDON T, 1988, MUSCLE NERVE, V11, P819, DOI 10.1002/mus.880110804; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hack AA, 2000, J CELL SCI, V113, P2535; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; MARTINEZ P, 2007, MOL BIOL CELL, V18, P2904; MCCULLAGH KJ, 2007, NEUROMUSCUL DISORD; Mizuno Y, 2001, P NATL ACAD SCI USA, V98, P6156, DOI 10.1073/pnas.111153298; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; O'Neill A, 2002, MOL BIOL CELL, V13, P2347, DOI 10.1091/mbc.01-12-0576; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Poon E, 2002, J BIOL CHEM, V277, P3433, DOI 10.1074/jbc.M105273200; Reed P, 2005, NEUROMUSCULAR DISORD, V15, P552, DOI 10.1016/j.nmd.2005.03.007; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; Sasaoka T, 2003, NEUROMUSCULAR DISORD, V13, P193, DOI 10.1016/S0960-8966(02)00220-1; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Warner LE, 2002, HUM MOL GENET, V11, P1095, DOI 10.1093/hmg/11.9.1095; Williams MW, 1999, J CELL BIOL, V144, P1259, DOI 10.1083/jcb.144.6.1259; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033	44	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2604	10.1371/journal.pone.0002604	http://dx.doi.org/10.1371/journal.pone.0002604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596960	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200057
J	Roh, M; Franco, OE; Hayward, SW; van der Meer, R; Abdulkadir, SA				Roh, Meejeon; Franco, Omar E.; Hayward, Simon W.; van der Meer, Riet; Abdulkadir, Sarki A.			A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial Cells	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; ANEUPLOIDY; PIM-1; EXPRESSION; CANCER; P53; OVEREXPRESSION; SUPPRESSION; PROGRESSION; PROTEIN	Background: Polyploidy is a prominent feature of many human cancers, and it has long been hypothesized that polyploidy may contribute to tumorigenesis by promoting genomic instability. In this study, we investigated whether polyploidy per se induced by a relevant oncogene can promote genomic instability and tumorigenicity in human epithelial cells. Principal Findings: When the oncogenic serine-threonine kinase Pim-1 is overexpressed in immortalized, non-tumorigenic human prostate and mammary epithelial cells, these cells gradually converted to polyploidy and became tumorigenic. To assess the contribution of polyploidy to tumorigenicity, we obtained sorted, matched populations of diploid and polyploid cells expressing equivalent levels of the Pim-1 protein. Spectral karyotyping revealed evidence of emerging numerical and structural chromosomal abnormalities in polyploid cells, supporting the proposition that polyploidy promotes chromosomal instability. Polyploid cells displayed an intact p53/p21 pathway, indicating that the viability of polyploid cells in this system is not dependent on the inactivation of the p53 signaling pathway. Remarkably, only the sorted polyploid cells were tumorigenic in vitro and in vivo. Conclusions: Our results support the notion that polyploidy can promote chromosomal instability and the initiation of tumorigenesis in human epithelial cells.	[Roh, Meejeon; van der Meer, Riet; Abdulkadir, Sarki A.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Roh, M (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.	sarki.abdulkadir@vanderbilt.edu		Hayward, Simon/0000-0002-6059-6550	National Cancer Institute [RO1CA123484]; NATIONAL CANCER INSTITUTE [R01CA123484] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Cancer Institute grant RO1CA123484. Sponsors had no role in the design, collection, analysis or interpretation of data or preparation, review or approval of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Ai H, 2001, LARYNGOSCOPE, V111, P1853, DOI 10.1097/00005537-200110000-00034; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; BUTZ K, 1995, ONCOGENE, V10, P927; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Cardoso J, 2006, CANCER RES, V66, P2514, DOI 10.1158/0008-5472.CAN-05-2407; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; DEITCH AD, 1993, CANCER, V72, P1692, DOI 10.1002/1097-0142(19930901)72:5<1692::AID-CNCR2820720533>3.0.CO;2-8; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Doak SH, 2004, MUTAT RES-FUND MOL M, V547, P133, DOI 10.1016/j.mrfmmm.2003.12.009; Duensing S, 2003, CRIT REV EUKAR GENE, V13, P9, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.20; Duesberg P, 2005, SCIENCE, V307, P41; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FORSSLUND G, 1990, CANCER RES, V50, P4281; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Jung YJ, 2007, EUR J HAEMATOL, V78, P131, DOI 10.1111/j.1600-0609.2006.00791.x; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Mendelin J, 1999, LAB INVEST, V79, P387; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Mogal AP, 2007, J BIOL CHEM, V282, P25790, DOI 10.1074/jbc.M702438200; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; OTTESEN GL, 1995, BRIT J CANCER, V72, P832, DOI 10.1038/bjc.1995.421; Pihan GA, 2003, CANCER RES, V63, P1398; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Sagulenko E, 2007, CANCER LETT, V257, P65, DOI 10.1016/j.canlet.2007.07.003; Thomas M, 1996, ONCOGENE, V13, P471; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Visscher DW, 1996, CANCER, V77, P315, DOI 10.1002/(SICI)1097-0142(19960115)77:2<315::AID-CNCR14>3.0.CO;2-4; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410	47	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2572	10.1371/journal.pone.0002572	http://dx.doi.org/10.1371/journal.pone.0002572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596907	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200037
J	Saayman, S; Barichievy, S; Capovilla, A; Morris, KV; Arbuthnot, P; Weinberg, MS				Saayman, Sheena; Barichievy, Samantha; Capovilla, Alexio; Morris, Kevin V.; Arbuthnot, Patrick; Weinberg, Marc S.			The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA	PLOS ONE			English	Article								RNA Interference (RNAi) effectors have been used to inhibit rogue RNAs in mammalian cells. However, rapidly evolving sequences such as the human immunodeficiency virus type 1 (HIV-1) require multiple targeting approaches to prevent the emergence of escape variants. Expressed long hairpin RNAs (lhRNAs) have recently been used as a strategy to produce multiple short interfering RNAs (siRNAs) targeted to highly variant sequences. We aimed to characterize the ability of expressed lhRNAs to generate independent siRNAs that silence three non-contiguous HIV-1 sites by designing lhRNAs comprising different combinations of siRNA-encoding sequences. All lhRNAs were capable of silencing individual target sequences. However, silencing efficiency together with concentrations of individual lhRNA-derived siRNAs diminished from the stem base (first position) towards the loop side of the hairpin. Silencing efficacy against HIV-1 was primarily mediated by siRNA sequences located at the base of the stem. Improvements could be made to first and second position siRNAs by adjusting spacing arrangements at their junction, but silencing of third position siRNAs remained largely ineffective. Although lhRNAs offer advantages for combinatorial RNAi, we show that good silencing efficacy across the span of the lhRNA duplex is difficult to achieve with sequences that encode more than two adjacent independent siRNAs.	[Saayman, Sheena; Barichievy, Samantha; Arbuthnot, Patrick; Weinberg, Marc S.] Univ Witwatersrand, Dept Mol Med & Haematol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa; [Capovilla, Alexio] Univ Witwatersrand, Dept Mol Med & Haematol, HIV Pathogenesis Lab, Johannesburg, South Africa; [Morris, Kevin V.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA	University of Witwatersrand; University of Witwatersrand; Scripps Research Institute	Saayman, S (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa.	marc.weinberg@wits.ac.za	Weinberg, Marc/B-4669-2009; morris, kevin v/B-5481-2011	Weinberg, Marc/0000-0002-1997-2171; Morris, Kevin/0000-0002-0157-0553	Ernst and Ethel Eriksen Trust [postgraduate scholarship]; German Academic Exchange; National Research Foundation (NRF); Medical Research Council (MRC); Poliomyelitis Research Foundation (PRF); Sixth Research Framework Programme of the European Union, Project RIGHT [LSHB-CT-2004-005276]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084406] Funding Source: NIH RePORTER	Ernst and Ethel Eriksen Trust; German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); National Research Foundation (NRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Poliomyelitis Research Foundation (PRF); Sixth Research Framework Programme of the European Union, Project RIGHT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SS holds a postgraduate scholarship from the Ernst and Ethel Eriksen Trust and German Academic Exchange (DAAD). This work was supported by grants from the National Research Foundation (NRF), Medical Research Council (MRC), Poliomyelitis Research Foundation (PRF), and from funding under the Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004-005276).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akashi H, 2005, MOL BIOSYST, V1, P382, DOI 10.1039/b510159j; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Barichievy S, 2007, OLIGONUCLEOTIDES, V17, P419, DOI 10.1089/oli.2007.0095; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Diallo M, 2003, OLIGONUCLEOTIDES, V13, P381, DOI 10.1089/154545703322617069; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; Grimm D, 2007, MOL THER, V15, P878, DOI 10.1038/sj.mt.6300116; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Henry SD, 2006, MOL THER, V14, P485, DOI 10.1016/j.ymthe.2006.04.012; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu YP, 2007, NUCLEIC ACIDS RES, V35, P5683, DOI 10.1093/nar/gkm596; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Nishida K, 2006, IEEJ T ELECTR ELECTR, V1, P80, DOI 10.1002/tee.20012; Park WS, 2002, NUCLEIC ACIDS RES, V30, P4830, DOI 10.1093/nar/gkf627; Passman M, 2000, BIOCHEM BIOPH RES CO, V268, P728, DOI 10.1006/bbrc.2000.2209; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Robbins MA, 2006, NAT BIOTECHNOL, V24, P566, DOI 10.1038/nbt1206; Sano M, 2008, MOL THER, V16, P170, DOI 10.1038/sj.mt.6300298; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Strat A, 2006, NUCLEIC ACIDS RES, V34, P3803, DOI 10.1093/nar/gkl532; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tran N, 2004, FEBS LETT, V573, P127, DOI 10.1016/j.febslet.2004.07.075; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Weinberg MS, 2007, MOL THER, V15, P534, DOI 10.1038/sj.mt.6300077; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Xia XG, 2006, BIOTECHNIQUES, V41, P64, DOI 10.2144/000112198; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	49	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2602	10.1371/journal.pone.0002602	http://dx.doi.org/10.1371/journal.pone.0002602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596982	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200055
J	Zetola, NM; Grijalva, CG; Gertler, S; Hare, CB; Kaplan, B; Dowling, T; Colfax, G; Katz, MH; Klausner, JD				Zetola, Nicola M.; Grijalva, Carlos G.; Gertler, Sarah; Hare, C. Bradley; Kaplan, Beth; Dowling, Teri; Colfax, Grant; Katz, Mitchell H.; Klausner, Jeffrey D.			Simplifying Consent for HIV Testing Is Associated with an Increase in HIV Testing and Case Detection in Highest Risk Groups, San Francisco January 2003-June 2007	PLOS ONE			English	Article								Background: Populations at highest risk for HIV infection face multiple barriers to HIV testing. To facilitate HIV testing procedures, the San Francisco General Hospital Medical Center eliminated required written patient consent for HIV testing in its medical settings in May 2006. To describe the change in HIV testing rates in different hospital settings and populations after the change in HIV testing policy in the SFDH medical center, we performed an observational study using interrupted time series analysis. Methods: Data from all patients aged 18 years and older seen from January 2003 through June 2007 at the San Francisco Department of Public Health (SFDPH) medical care system were included in the analysis. The monthly HIV testing rate per 1000 hadpatient-visits was calculated for the overall population and stratified by hospital setting, age, sex, race/ethnicity, homelessness status, insurance status and primary language. Results: By June 2007, the average monthly rate of HIV tests per 1000 patient-visits increased 4.38 (CI, 2.17-6.60, p < 0.001) over the number predicted if the policy change had not occurred (representing a 44% increase). The monthly average number of new positive HIV tests increased from 8.9 (CI, 6.3-11.5) to 14.9 (CI, 10.6-19.2, p < 0.001), representing a 67% increase. Although increases in HIV testing were seen in all populations, populations at highest risk for HIV infection, particularly men, the homeless, and the uninsured experienced the highest increases in monthly HIV testing rates after the policy change. Conclusions: The elimination of the requirement for written consent in May 2006 was associated with a significant and sustained increase in HIV testing rates and HIV case detection in the SFDPH medical center. Populations facing the higher barriers to HIV testing had the highest increases in HIV testing rates and case detection in response to the policy change.	[Zetola, Nicola M.; Klausner, Jeffrey D.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; [Grijalva, Carlos G.] Vanderbilt Univ, Sch Med, Dept Preventive Med, Nashville, TN USA; [Gertler, Sarah] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Hare, C. Bradley] Univ Calif San Francisco, Positive Hlth Program, San Francisco, CA USA; [Kaplan, Beth] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA USA; [Dowling, Teri; Colfax, Grant; Katz, Mitchell H.; Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health	Zetola, NM (corresponding author), Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA.	nzetola@gmail.com		Grijalva, Carlos/0000-0002-2329-7797	General Clinical Research Center at San Francisco General Hospital; Division of Research Resources, National Institutes of Health [5-MO1-RR00083]; California HIV Research Program [CH05-SMCHC-612]; San Francisco Department of Public Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER	General Clinical Research Center at San Francisco General Hospital(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California HIV Research Program; San Francisco Department of Public Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was carried out in part through the General Clinical Research Center at San Francisco General Hospital, supported by Grant 5-MO1-RR00083 from the Division of Research Resources, National Institutes of Health, by the California HIV Research Program Grant CH05-SMCHC-612 and the San Francisco Department of Public Health. In the past 12 months Dr. Klausner has received funding for research or educational purposes from Gen-Probe, Inc., and Gilead Sciences, Inc.	[Anonymous], 2006, MMWR RECOMM REP; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cook T.C., 1979, QUASIEXPERIMENTATION; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kellock DJ, 1998, INT J STD AIDS, V9, P263, DOI 10.1258/0956462981922188; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Troccoli K, 2002, OBSTET GYNECOL, V100, P420, DOI 10.1016/S0029-7844(02)02120-8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zetola NM, 2007, JAMA-J AM MED ASSOC, V297, P1061, DOI 10.1001/jama.297.10.1061	12	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2591	10.1371/journal.pone.0002591	http://dx.doi.org/10.1371/journal.pone.0002591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596933	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200050
J	Becker, D; Woltersdorf, R; Boldt, W; Schmitz, S; Braam, U; Schmalzing, G; Markwardt, F				Becker, Daniel; Woltersdorf, Ronja; Boldt, Wolfgang; Schmitz, Stephan; Braam, Ursula; Schmalzing, Gurnther; Markwardt, Fritz			The P2X(7) carboxyl tail is a regulatory module of P2X(7) receptor channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; C-TERMINAL DOMAIN; NUCLEOTIDE RECEPTOR; FUNCTIONAL EVIDENCE; CYTOLYTIC PORE; GATING RING; K+ CHANNEL; ATP; ACTIVATION	P2X(7) receptors are ATP-gated cation channels composed of three identical subunits, each having intracellular amino and carboxyl termini and two transmembrane segments connected by a large ectodomain. Within the P2X family, P2X(7) subunits are unique in possessing an extended carboxyl tail. We expressed the human P2X(7) subunit as two complementary fragments, a carboxyl tail-truncated receptor channel core ( residues 1-436 or 1-505) and a tail extension ( residues 434-595) in Xenopus laevis oocytes. P2X(7) channel core subunits efficiently assembled as homotrimers that appeared abundantly at the oocyte surface, yet produced only similar to 5% of the full-length P2X(7) receptor current. Co- assembly of channel core subunits with full-length P2X(7) subunits inhibited channel current, indicating that the lack of a single carboxyl tail domain is dominant-negative for P2X(7) receptor activity. Co- expression of the tail extension as a discrete protein increased ATP-gated current amplitudes of P2X(7) channel cores 10-20-fold, fully reconstituting the wild type electrophysiological phenotype of the P2X(7) receptor. Chemical cross-linking revealed that the discrete tail extension bound with unity stoichiometry to the carboxyl tail of the P2X(7) channel core. We conclude that a non-covalent association of crucial functional importance exists between the carboxyl tail of the channel core and the tail extension. Using a slightly shorter P2X(7) subunit core and subfragments of the tail extension, this association could be narrowed down to include residues 409-436 and 434-494 of the split receptor. Together, these results identify the tail extension as a regulatory gating module, potentially making P2X(7) channel gating sensitive to intracellular regulation.	[Becker, Daniel; Boldt, Wolfgang; Markwardt, Fritz] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06097 Halle, Germany; [Woltersdorf, Ronja; Schmitz, Stephan; Braam, Ursula; Schmalzing, Gurnther] Univ Aachen, Rhein Westfal TH Aachen, Dept Mol Pharmacol, D-52074 Aachen, Germany	Martin Luther University Halle Wittenberg; RWTH Aachen University	Schmalzing, G (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06097 Halle, Germany.	gschmalzing@ukaachen.de; Fritz.Markwardt@medizin.uni-halle.de	Markwardt, Fritz/F-7693-2013	Markwardt, Fritz/0000-0001-6761-2923	Deutsche Forschungsgemeinschaft [Ma1581/12-1, Schm536/6-3, SFB 542]; Medical Faculty of the Martin-Luther-University Roux Program [5/09, 10/01, 13/07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the Martin-Luther-University Roux Program	This work was supported by Deutsche Forschungsgemeinschaft Grants Ma1581/12-1 ( to F. M.), Schm536/6-3 and SFB 542 ( to G. S.), and Medical Faculty of the Martin-Luther-University Roux Program Grants 5/09, 10/01, and 13/07 ( to F. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Faria RX, 2005, AM J PHYSIOL-CELL PH, V288, pC260, DOI 10.1152/ajpcell.00215.2004; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC755, DOI 10.1152/ajpcell.1999.277.4.C755; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029	43	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25725	25734		10.1074/jbc.M803855200	http://dx.doi.org/10.1074/jbc.M803855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617511	hybrid			2022-12-25	WOS:000259012700067
J	Hu, ZL; Chen, J; Wei, Q; Xia, Y				Hu, Zhuangli; Chen, Juan; Wei, Qin; Xia, Yong			Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function - Co-commitment and interplay of Akt and AMPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT PHOSPHORYLATION; PHOSPHATASE 2A; DYSFUNCTION; DEPHOSPHORYLATION; MECHANISMS; STRESS; CELLS	Endothelial NO synthase (eNOS) is critically modulated by kinases via the phosphorylation of its Ser(1179) (bovine) or Ser(1177) (human) residue. Reactive oxygen species such as H2O2 was reported to activate Akt, leading to increased eNOS Ser(1179) phosphorylation and activity. But reactive oxygen species are also known to attenuate eNOS function in cardiovascular diseases. Prior studies showing H2O2-stimulated eNOS phosphorylation were performed on serum-starved cells, and only the short term effect of H2O2 was examined. Here we found that the effects of H2O2 on eNOS Ser(1179) phosphorylation and function were bidirectional. With endothelial cells cultured with serum, H2O2 initially raised eNOSSer(1179) phosphorylation and activity. However, after the peak increase at 30 min, eNOS Ser(1179) phosphorylation dramatically declined. Parallel to the alterations of eNOS Ser(1179) phosphorylation, Akt was transiently activated by H2O2 and subsequently became dormant. In contrast, AMP-activated protein kinase (AMPK) was progressively activated in H2O2-treated cells. Blocking Akt activation abolished the initial rise of eNOS Ser(1179) phosphorylation after H2O2 treatment. In long term H2O2-treated cells where Akt was deactivated, significant amounts of Ser(1179)-phosphorylated eNOS remained. AMPK inhibition eradicated the remaining eNOS Ser(1179) phosphorylation. Taken together, these studies revealed that Akt and AMPK orchestrated a bidirectional action on eNOS Ser(1179) phosphorylation in H2O2-treated cells. Long term H2O2 exposure decreased eNOS Ser(1179) phosphorylation, and this might account for the loss of eNOS function in cardiovascular diseases where chronic oxidative injury occurs.	[Hu, Zhuangli; Chen, Juan; Wei, Qin; Xia, Yong] Ohio State Univ, Dept Mol & Cellular Biochem, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Xia, Y (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 605, 473 W 12th Ave, Columbus, OH 43210 USA.	yong.xia@osumc.edu			National Institutes of Health [HL77575, HL86965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77575 and HL86965. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2003, MOL PHARMACOL, V63, P325, DOI 10.1124/mol.63.2.325; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Xia Y, 1997, P NATL ACAD SCI USA, V94, P12705, DOI 10.1073/pnas.94.23.12705; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25256	25263		10.1074/jbc.M802455200	http://dx.doi.org/10.1074/jbc.M802455200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617528	Green Published, hybrid			2022-12-25	WOS:000259012700018
J	Simoneau, M; Boulanger, J; Coulombe, G; Renaud, MA; Duchesne, C; Rivard, N				Simoneau, Melanie; Boulanger, Jim; Coulombe, Genevieve; Renaud, Marc-Andre; Duchesne, Cathia; Rivard, Nathalie			Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE PHOSPHATASE; NEGATIVE REGULATION; ANTIGEN RECEPTOR; MESSENGER-RNAS; PROTEIN-KINASE; CYCLIN E-CDK2; MOTH-EATEN; C-KIT; PHOSPHORYLATION; EXPRESSION	SHP-1 is expressed in the nuclei of intestinal epithelial cells (IECs). Increased SHP-1 expression and phosphatase activity coincide with cell cycle arrest and differentiation in these cells. Suspecting the tumor-suppressive properties of SHP-1, a yeast two-hybrid screen of an IEC cDNA library was conducted using the full-length SHP-1 as bait. Characterization of many positive clones revealed sequences identical to a segment of the Cdk2 cDNA sequence. Interaction between SHP-1 and Cdk2 was confirmed by co-immunoprecipitations whereby co-precipitated Cdk2 phosphorylated SHP- 1 protein. Inhibition of Cdk2 (roscovitine) or proteasome (MG132) was associated with an enhanced nuclear punctuate distribution of SHP-1. Double labeling localization studies with signature proteins of subnuclear domains revealed a co-localization between the splicing factor SC35 and SHP-1 in bright nucleoplasmic foci. Using Western blot analyses with the anti-SHP-1 antibody recognizing the C terminus, a lower molecular mass species of 45 kDa was observed in addition to the full-length 64-65-kDa SHP-1 protein. Treatment with MG132 led to an increase in expression of the full-length SHP- 1 protein while concomitantly leading to a decrease in the levels of the lower mass 45-kDa molecular species. Further Western blots revealed that the 45-kDa protein corresponds to the C-terminal portion of SHP- 1 generated from proteasome activity. Mutational analysis of Tyr(208) and Ser(591) (a Cdk2 phosphorylation site) residues on SHP- 1 abolished the expression of the amino-truncated 45-kDa SHP-1 protein. In conclusion, our results indicate that Cdk2-associated complexes, by targeting SHP-1 for proteolysis, counteract the ability of SHP-1 to block cell cycle progression of IECs.	[Simoneau, Melanie; Boulanger, Jim; Coulombe, Genevieve; Renaud, Marc-Andre; Duchesne, Cathia; Rivard, Nathalie] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada.	Nathalie.Rivard@USherbrooke.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to N.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Student scholar from the Natural Sciences and Engineering Research Council of Canada. Student scholar from the Fonds pour la Recherche en Sante du Quebec.	BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Chen M, 2002, MOL BIOL CELL, V13, P3576, DOI 10.1091/mbc.02-05-0083; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Craggs G, 2001, J BIOL CHEM, V276, P23719, DOI 10.1074/jbc.M102846200; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Delibrias CC, 1997, J EXP MED, V186, P1575, DOI 10.1084/jem.186.9.1575; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Fabunmi RP, 2001, J CELL SCI, V114, P29; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; He DD, 2005, J CELL BIOCHEM, V94, P944, DOI 10.1002/jcb.20307; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Keilhack H, 2000, J BIOL CHEM, V275, P26376, DOI 10.1074/jbc.M001315200; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Ko TK, 2001, J CELL SCI, V114, P2591; Kojima T, 2001, J BIOL CHEM, V276, P32247, DOI 10.1074/jbc.M103790200; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Leon F, 2002, LEUKEMIA, V16, P1470, DOI 10.1038/sj.leu.2402546; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu Y, 2007, J LEUKOCYTE BIOL, V82, P742, DOI 10.1189/jlb.1206736; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Park CS, 2004, J BIOL CHEM, V279, P19592, DOI 10.1074/jbc.M314208200; PEI DH, 1993, P NATL ACAD SCI USA, V90, P1092, DOI 10.1073/pnas.90.3.1092; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; TAUCHI T, 1995, J BIOL CHEM, V270, P5631, DOI 10.1074/jbc.270.10.5631; TAUCHI T, 1994, J BIOL CHEM, V269, P25206; Tintignac LA, 2000, EXP CELL RES, V259, P300, DOI 10.1006/excr.2000.4973; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Uesugi Y, 1999, EUR J HAEMATOL, V62, P239; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; VAMBUTAS V, 1995, J BIOL CHEM, V270, P25629, DOI 10.1074/jbc.270.43.25629; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	76	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25544	25556		10.1074/jbc.M804177200	http://dx.doi.org/10.1074/jbc.M804177200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617527	hybrid			2022-12-25	WOS:000259012700050
J	Talior-Volodarsky, I; Randhawa, VK; Zaid, H; Klip, A				Talior-Volodarsky, Ilana; Randhawa, Varinder K.; Zaid, Hilal; Klip, Amira			alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-ACTININ; GLUCOSE-TRANSPORTER-4 GLUT4; MOUSE MACROPHAGES; PLASMA-MEMBRANE; SKELETAL-MUSCLE; PROTEIN COMPLEX; CROSS-LINKING; AMINO-ACIDS	Insulin induces GLUT4 translocation to the muscle cell surface. Using differential amino acid labeling and mass spectrometry, we observed insulin-dependent co-precipitation of actinin-4 (ACTN4) with GLUT4 (Foster, L. J., Rudich, A., Talior, I., Patel, N., Huang, X., Furtado, L. M., Bilan, P. J., Mann, M., and Klip, A. (2006) J. Proteome Res. 5, 64 -75). ACTN4 links F-actin to membrane proteins, and actin dynamics are essential for GLUT4 translocation. We hypothesized that ACTN4 may contribute to insulin-regulated GLUT4 traffic. In L6 muscle cells insulin, but not platelet-derived growth factor, increased co-precipitation of ACTN4 with GLUT4. Small interfering RNA-mediated ACTN4 knockdown abolished the gain in surface-exposed GLUT4 elicited by insulin but not by platelet-derived growth factor, membrane depolarization, or mitochondrial uncoupling. In contrast, knockdown of alpha-actinin-1 (ACTN1) did not prevent GLUT4 translocation by insulin. GLUT4 colocalized with ACTN4 along the insulin-induced cortical actin mesh and ACTN4 knockdown prevented GLUT4-actin colocalization without impeding actin remodeling or Akt phosphorylation, maintaining GLUT4 in a tight perinuclear location. We propose that ACTN4 contributes to GLUT4 traffic, likely by tethering GLUT4 vesicles to the cortical actin cytoskeleton.	[Talior-Volodarsky, Ilana; Randhawa, Varinder K.; Zaid, Hilal; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Randhawa, Varinder K.; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research [MT 7307]; Banting and Best Diabetes Center; Hospital for Sick Children Research Training Centre; Canadian Institutes of Health Research, Banting and Best Diabetes Center; Research Training Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Center; Hospital for Sick Children Research Training Centre; Canadian Institutes of Health Research, Banting and Best Diabetes Center(Canadian Institutes of Health Research (CIHR)); Research Training Centre	This work was supported by Canadian Institutes of Health Research Grant MT 7307 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1. Supported by research fellowship awards from the Banting and Best Diabetes Center and the Hospital for Sick Children Research Training Centre.; 2 Supported by doctoral awards from Canadian Institutes of Health Research, Banting and Best Diabetes Center, Research Training Centre, and Ontario Graduate Scholarship.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Araki N, 2000, J CELL SCI, V113, P3329; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; CHUNQIU HJ, 2003, MOL BIOL CELL, V14, P3578; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; DOHM GL, 1991, AM J PHYSIOL, V260, pE459, DOI 10.1152/ajpendo.1991.260.3.E459; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Dugani CB, 2008, EUR J CELL BIOL, V87, P337, DOI 10.1016/j.ejcb.2008.02.009; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Geiger PC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1258, DOI 10.1152/ajpendo.00273.2006; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Goode NP, 2004, NEPHROL DIAL TRANSPL, V19, P844, DOI 10.1093/ndt/gfg620; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2004, ONCOGENE, V23, P5257, DOI 10.1038/sj.onc.1207652; IMAMURA M, 1994, EUR J BIOCHEM, V223, P395, DOI 10.1111/j.1432-1033.1994.tb19006.x; IMAMURA M, 1992, J BIOL CHEM, V267, P25927; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; KANAI F, 1993, J BIOL CHEM, V268, P14523; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487; Khayat ZA, 2000, J CELL SCI, V113, P279; Khayat ZA, 2002, CAN J APPL PHYSIOL, V27, P129, DOI 10.1139/h02-010; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; KLIP A, 1990, BIOCHEM BIOPH RES CO, V172, P728, DOI 10.1016/0006-291X(90)90735-6; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; Pascual J, 1997, BIOESSAYS, V19, P811, DOI 10.1002/bies.950190911; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Torok D, 2004, J CELL SCI, V117, P5447, DOI 10.1242/jcs.01421; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Tsao TS, 1999, DIABETES, V48, P775, DOI 10.2337/diabetes.48.4.775; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	74	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25115	25123		10.1074/jbc.M801750200	http://dx.doi.org/10.1074/jbc.M801750200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617516	hybrid			2022-12-25	WOS:000259012700003
J	Argraves, KM; Gazzolo, PJ; Groh, EM; Wilkerson, BA; Matsuura, BS; Twal, WO; Hammad, SM; Argraves, WS				Argraves, Kelley M.; Gazzolo, Patrick J.; Groh, Eric M.; Wilkerson, Brent A.; Matsuura, Bryan S.; Twal, Waleed O.; Hammad, Samar M.; Argraves, W. Scott			High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; COUPLED RECEPTOR EDG-1; MAMMALIAN-CELLS; LUNG INJURY; IN-VIVO; INTEGRITY; ENDOTOXIN; SPHINGOSINE-1-PHOSPHATE; PHOSPHORYLATION; ACTIVATION	High density lipoproteins (HDL) are major plasma carriers of sphingosine 1-phosphate (S1P). Here we show that HDL increases endothelial barrier integrity as measured by electric cell substrate impedance sensing. S1P was implicated as the mediator in this process through findings showing that pertussis toxin, an inhibitor of G(i)-coupled S1P receptors, as well as antagonists of the S1P receptor, S1P1, inhibited barrier enhancement by HDL. Additional findings show that HDL stimulates endothelial cell activation of Erk1/2 and Akt, signaling pathway intermediates that have been implicated in S1P-dependent endothelial barrier activity. HDL was also found to promote endothelial cell motility, a process that may also relate to endothelial barrier function in the context of a vascular injury response. The effects of HDL on endothelial cell Erk1/2 and Akt activation and motility were suppressed by pertussis toxin and S1P1 antagonists. However, both HDL-induced barrier enhancement and HDL-induced motility showed a greater dependence on Akt activation as compared with Erk1/2 activation. Together, the findings indicate that HDL has endothelial barrier promoting activities, which are attributable to its S1P component and signaling through the S1P1/Akt pathway.	[Argraves, Kelley M.; Gazzolo, Patrick J.; Groh, Eric M.; Wilkerson, Brent A.; Matsuura, Bryan S.; Twal, Waleed O.; Hammad, Samar M.; Argraves, W. Scott] Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Argraves, KM (corresponding author), Med Univ S Carolina, Dept Anat & Cell Biol, 171 Ashley Ave, Charleston, SC 29425 USA.	argravek@musc.edu		Wilkerson, Brent/0000-0002-3532-3075; Hammad, Samar/0000-0002-1313-2542	National Institutes of Health [HL80404, RR107677, HL52813, HL079274]; American Heart Association-Jon DeHaan Foundation Scientist Development [0230245N]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079274, P01HL052813, R01HL080404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Jon DeHaan Foundation Scientist Development(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80404 and RR107677 ( to K. M. A.), HL52813 ( to W. S. A.), and HL079274 ( to S. M. H.). This work was also supported by American Heart Association-Jon DeHaan Foundation Scientist Development Grant in Angiogenesis 0230245N ( to K. M. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bohm SK, 1997, BIOCHEM J, V322, P1; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Cockerill GW, 2001, FASEB J, V15, P1941, DOI 10.1096/fj.01-0075com; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kataoka N, 2002, P NATL ACAD SCI USA, V99, P15638, DOI 10.1073/pnas.242590799; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Thiemermann C, 2003, J AM SOC NEPHROL, V14, P1833, DOI 10.1097/01.ASN.0000075552.97794.8C; Vogel C, 2007, J CELL PHYSIOL, V212, P236, DOI 10.1002/jcp.21022; Wachtel M, 2002, BIOCHEM J, V367, P873, DOI 10.1042/BJ20020746; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; XU M, 2007, AM J PHYSIOL, V4, pC1309	30	91	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25074	25081		10.1074/jbc.M801214200	http://dx.doi.org/10.1074/jbc.M801214200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606817	Green Published, hybrid			2022-12-25	WOS:000258820000063
J	Yahi, H; Fritsch, L; Philipot, O; Guasconi, V; Souidi, M; Robin, P; Polesskaya, A; Losson, R; Harel-Bellan, A; Ait-Si-Ali, S				Yahi, Hakima; Fritsch, Lauriane; Philipot, Ophelie; Guasconi, Valentina; Souidi, Mouloud; Robin, Philippe; Polesskaya, Anna; Losson, Regine; Harel-Bellan, Annick; Ait-Si-Ali, Slimane			Differential cooperation between heterochromatin protein HP1 isoforms and MyoD in myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; H3 LYSINE-9 METHYLATION; HISTONE H3; MYOGENIC DIFFERENTIATION; MAMMALIAN-CELLS; TERMINAL DIFFERENTIATION; CHROMATIN-STRUCTURE; GENE ACTIVITY; STEM-CELLS; BINDING	Mechanisms of transcriptional repression are important during cell differentiation. Mammalian heterochromatin protein 1 isoforms HP1 alpha, HP1 beta, and HP1 gamma play important roles in the regulation of chromatin structure and function. We explored the possibility of different roles for the three HP1 isoforms in an integrated system, skeletalmuscleterminaldifferentiation. Inthissystem, terminal differentiation is initiated by the transcription factor MyoD, whose target genes remain mainly silent until myoblasts are induced to differentiate. Here we show that HP1 beta and HP1 gamma isoforms, but not HP1 alpha, interact withMyoDin myoblasts. This interaction is direct, as shown using recombinant proteins in vitro. A gene reporter assay revealed that HP1 alpha and HP1 beta, but not HP1 gamma, inhibit MyoD transcriptional activity, suggesting a model in which MyoD could serve as a bridge between nucleosomes and chromatinbinding proteins such as HDACs and HP1. Chromatin immunoprecipitationassaysshowapreferentialrecruitmentofHP1proteins on MyoD target genes in proliferating myoblasts. Finally, modulation ofHP1protein level impairsMyoDtarget gene expression and muscle terminal differentiation. Together, our data show a nonconventional interaction between HP1 and a tissue- specific transcription factor, MyoD. In addition, they strongly suggest that HP1 isoforms play important roles during muscle terminal differentiation in an isoform- dependent manner.	[Yahi, Hakima; Fritsch, Lauriane; Philipot, Ophelie; Guasconi, Valentina; Souidi, Mouloud; Robin, Philippe; Polesskaya, Anna; Harel-Bellan, Annick; Ait-Si-Ali, Slimane] Univ Paris Sud, CNRS, FRE 2944, Inst Andre Lwoff, F-94801 Villejuif, France; [Losson, Regine] Univ Strasbourg 1, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France; [Losson, Regine] Univ Strasbourg 1, Coll France, INSERM, U 596, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ait-Si-Ali, S (corresponding author), Univ Paris Sud, CNRS, FRE 2944, Inst Andre Lwoff, 7 Rue Guy Moquet,94800 Villejuif, F-94801 Villejuif, France.	aitsiali@vjf.cnrs.fr	Harel-Bellan, Annick/M-9795-2015; SOUIDI, Mouloud/ABI-1444-2020	Harel-Bellan, Annick/0000-0002-2339-153X				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Demarco IA, 2006, NAT METHODS, V3, P519, DOI 10.1038/NMETH889; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Guasconi V, 2005, CANCER BIOL THER, V4, P134; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Ito H, 2001, EXP CELL RES, V266, P213, DOI 10.1006/excr.2001.5220; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Sharma GG, 2003, MOL CELL BIOL, V23, P8363, DOI 10.1128/MCB.23.22.8363-8376.2003; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	49	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23692	23700		10.1074/jbc.M802647200	http://dx.doi.org/10.1074/jbc.M802647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18599480	Green Published, hybrid			2022-12-25	WOS:000258638900023
J	Garst, AD; Heroux, A; Rambo, RP; Batey, RT				Garst, Andrew D.; Heroux, Annie; Rambo, Robert P.; Batey, Robert T.			Crystal structure of the lysine riboswitch regulatory mRNA element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; RECOGNITION; MOTIF; BIOSYNTHESIS; MECHANISMS; SCATTERING; BACTERIA; ANALOGS; TARGETS; LIGAND	Riboswitches are metabolite-sensitive elements found in mRNAs that control gene expression through a regulatory secondary structural switch. Along with regulation of lysine biosynthetic genes, mutations within the lysine-responsive riboswitch (L-box) play a role in the acquisition of resistance to antimicrobiallysine analogs. To understand the structural basis for lysine binding, we have determined the 2.8 angstrom resolution crystal structure of lysine bound to the Thermotoga maritima asd lysine riboswitch ligand-binding domain. The structure reveals a complex architecture scaffolding a binding pocket completely enveloping lysine. Mutations conferring antimicrobial resistance cluster around this site as well as highly conserved long range interactions, indicating that they disrupt lysine binding or proper folding of the RNA. Comparison of the free and bound forms by x-ray crystallography, small angle x-ray scattering, and chemical probing reveals almost identical structures, indicating that lysine induces only limited and local conformational changes upon binding.	[Garst, Andrew D.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Rambo, Robert P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073850] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ataide SF, 2007, ACS CHEM BIOL, V2, P819, DOI 10.1021/cb7002253; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo F, 2006, RNA, V12, P387, DOI 10.1261/rna.2198206; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Laederach A, 2007, RNA, V13, P643, DOI 10.1261/rna.381407; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; LU Y, 1992, FEMS MICROBIOL LETT, V92, P23, DOI 10.1016/0378-1097(92)90536-W; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patte JC, 1998, FEMS MICROBIOL LETT, V169, P165, DOI 10.1016/S0378-1097(98)00479-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Russell R, 2002, P NATL ACAD SCI USA, V99, P4266, DOI 10.1073/pnas.072589599; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	42	147	149	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22347	22351		10.1074/jbc.C800120200	http://dx.doi.org/10.1074/jbc.C800120200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18593706	hybrid, Green Published			2022-12-25	WOS:000258321000002
J	Martinez, GQ; Maduke, M				Martinez, Gilbert Q.; Maduke, Merritt			A Cytoplasmic Domain Mutation in ClC-Kb Affects Long-Distance Communication Across the Membrane	PLOS ONE			English	Article								Background: ClC-Kb and ClC-Ka are homologous chloride channels that facilitate chloride homeostasis in the kidney and inner ear. Disruption of ClC-Kb leads to Bartter's Syndrome, a kidney disease. A point mutation in ClC-Kb, R538P, linked to Bartter's Syndrome and located in the C-terminal cytoplasmic domain was hypothesized to alter electrophysiological properties due to its proximity to an important membrane-embedded helix. Methodology/Principal Findings: Two-electrode voltage clamp experiments were used to examine the electrophysiological properties of the mutation R538P in both ClC-Kb and ClC-Ka. R538P selectively abolishes extracellular calcium activation of ClC-Kb but not ClC-Ka. In attempting to determine the reason for this specificity, we hypothesized that the ClC-Kb C-terminal domain had either a different oligomeric status or dimerization interface than that of ClC-Ka, for which a crystal structure has been published. We purified a recombinant protein corresponding to the ClC-Kb C-terminal domain and used multi-angle light scattering together with a cysteine-crosslinking approach to show that the dimerization interface is conserved between the ClC-Kb and ClC-Ka C-terminal domains, despite the fact that there are several differences in the amino acids that occur at this interface. Conclusions: The R538P mutation in ClC-Kb, which leads to Bartter's Syndrome, abolishes calcium activation of the channel. This suggests that a significant conformational change - ranging from the cytoplasmic side of the protein to the extracellular side of the protein - is involved in the Ca(2+)-activation process for ClC-Kb, and shows that the cytoplasmic domain is important for the channel's electrophysiological properties. In the highly similar ClC-Ka (90% identical), the R538P mutation does not affect activation by extracellular Ca(2+). This selective outcome indicates that ClC-Ka and ClC-Kb differ in how conformational changes are translated to the extracellular domain, despite the fact that the cytoplasmic domains share the same quaternary structure.	[Martinez, Gilbert Q.; Maduke, Merritt] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Martinez, GQ (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	maduke@stanford.edu		Maduke, Merritt/0000-0001-7787-306X	American Heart Association [0435056N]; Mathers Foundation	American Heart Association(American Heart Association); Mathers Foundation	This work was supported by the American Heart Association (0435056N) and the Mathers Foundation.	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Beck CL, 1996, P NATL ACAD SCI USA, V93, P11248, DOI 10.1073/pnas.93.20.11248; Carr G, 2003, BIOCHEM BIOPH RES CO, V310, P600, DOI 10.1016/j.bbrc.2003.09.057; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Cox JPD, 1999, J BONE MINER RES, V14, P1536, DOI 10.1359/jbmr.1999.14.9.1536; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2002, CURR OPIN STRUC BIOL, V12, P531, DOI 10.1016/S0959-440X(02)00358-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Fukuyama S, 2004, J CLIN ENDOCR METAB, V89, P5847, DOI 10.1210/jc.2004-0775; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Heils Armin, 2005, Adv Neurol, V95, P265; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1995, SOC GEN PHY, V50, P149; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KONDO Y, 1988, AM J PHYSIOL, V254, pF232, DOI 10.1152/ajprenal.1988.254.2.F232; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Mupanomunda MM, 2000, AM J PHYSIOL-RENAL, V278, pF644, DOI 10.1152/ajprenal.2000.278.4.F644; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; Nozu K, 2008, J MED GENET, V45, P182, DOI 10.1136/jmg.2007.052944; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Rodriguez-Soriano J, 2005, PEDIATR NEPHROL, V20, P891, DOI 10.1007/s00467-005-1867-z; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Stogmann E, 2006, NEUROGENETICS, V7, P265, DOI 10.1007/s10048-006-0057-x; Uchida S, 2005, ANNU REV PHYSIOL, V67, P759, DOI 10.1146/annurev.physiol.67.032003.153547; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Zelikovic I, 2003, KIDNEY INT, V63, P24, DOI 10.1046/j.1523-1755.2003.00730.x; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605	59	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2746	10.1371/journal.pone.0002746	http://dx.doi.org/10.1371/journal.pone.0002746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648499	gold, Green Submitted, Green Published			2022-12-25	WOS:000264302900017
J	van Aerde, KI; Heistek, TS; Mansvelder, HD				van Aerde, Karlijn I.; Heistek, Tim S.; Mansvelder, Huibert D.			Prelimbic and Infralimbic Prefrontal Cortex Interact during Fast Network Oscillations	PLOS ONE			English	Article								Background: The medial prefrontal cortex has been implicated in a variety of cognitive and executive processes such as decision making and working memory. The medial prefrontal cortex of rodents consists of several areas including the prelimbic and infralimbic cortex that are thought to be involved in different aspects of cognitive performance. Despite the distinct roles in cognitive behavior that have been attributed to prelimbic and infralimbic cortex, little is known about neuronal network functioning of these areas, and whether these networks show any interaction during fast network oscillations. Methodology/Principal Findings: Here we show that fast network oscillations in rat infralimbic cortex slices occur at higher frequencies and with higher power than oscillations in prelimbic cortex. The difference in oscillation frequency disappeared when prelimbic and infralimbic cortex were disconnected. Conclusions/Significance: Our data indicate that neuronal networks of prelimbic and infralimbic cortex can sustain fast network oscillations independent of each other, but suggest that neuronal networks of prelimbic and infralimbic cortex are interacting during these oscillations.	[van Aerde, Karlijn I.; Heistek, Tim S.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Aerde, KI (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands.	huibert.mansvelder@cncr.vu.nl	Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	Dutch Medical Research Council [912.04.022, 917.76.360]; Royal Netherlands Academy of Arts and Sciences; NeuroBsik	Dutch Medical Research Council(Danish Medical Research Council); Royal Netherlands Academy of Arts and Sciences; NeuroBsik	This work was supported by grants from the Dutch Medical Research Council (912.04.022, 917.76.360) and the Royal Netherlands Academy of Arts and Sciences to HDM, and by NeuroBsik (www.neurobsik.nl). They did not have any influence on the study performed.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Marquis JP, 2007, EUR J NEUROSCI, V25, P559, DOI 10.1111/j.1460-9568.2006.05295.x; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Paulsen O, 2006, J NEUROSCI, V26, P1661, DOI 10.1523/JNEUROSCI.3737-05a.2006; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; RAGOZZINO M, 2007, ANN N Y ACAD SCI; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; Shimono K, 2001, NEUROCOMPUTING, V38, P899, DOI 10.1016/S0925-2312(01)00392-7; STERIADE M, 1990, J NEUROSCI, V10, P2560; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; VANDENOEVER MC, 2008, NATURE NEUR IN PRESS; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302	32	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2725	10.1371/journal.pone.0002725	http://dx.doi.org/10.1371/journal.pone.0002725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628964	Green Submitted, Green Published, gold			2022-12-25	WOS:000264057200063
J	Chiang, YJ; Hsiao, SJ; Yver, D; Cushman, SW; Tessarollo, L; Smith, S; Hodes, RJ				Chiang, Y. Jeffrey; Hsiao, Susan J.; Yver, Dena; Cushman, Samuel W.; Tessarollo, Lino; Smith, Susan; Hodes, Richard J.			Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development	PLOS ONE			English	Article							SISTER TELOMERE ASSOCIATION; REPEAT-BINDING FACTOR-1; POLY(ADP-RIBOSE) POLYMERASE; LENGTH MAINTENANCE; IRAP; TRF1; REQUIREMENTS; EXPRESSION; CONTAINS; ACCEPTOR	Tankyrases are proteins with poly(ADP-ribose) polymerase activity. Human tankyrases post-translationally modify multiple proteins involved in processes including maintenance of telomere length, sister telomere association, and trafficking of glut4-containing vesicles. To date, however, little is known about in vivo functions for tankyrases. We recently reported that body size was significantly reduced in mice deficient for tankyrase 2, but that these mice otherwise appeared developmentally normal. In the present study, we report generation of tankyrase 1-deficient and tankyrase 1 and 2 double-deficient mice, and use of these mutant strains to systematically assess candidate functions of tankyrase 1 and tankyrase 2 in vivo. No defects were observed in development, telomere length maintenance, or cell cycle regulation in tankyrase 1 or tankyrase 2 knockout mice. In contrast to viability and normal development of mice singly deficient in either tankyrase, deficiency in both tankyrase 1 and tankyrase 2 results in embryonic lethality by day 10, indicating that there is substantial redundancy between tankyrase 1 and tankyrase 2, but that tankyrase function is essential for embryonic development.	[Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD USA; [Hsiao, Susan J.; Smith, Susan] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA; [Yver, Dena; Cushman, Samuel W.] NIDDKD, NIH, Bethesda, MD USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chiang, YJ (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov		Smith, Susan/0000-0002-8213-5915	NIH [GM07238, RO1 CA95099]; National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZICBC010904, Z01BC009255, ZIABC009405, R01CA095099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.J.H. was supported by the NIH Predoctoral Training Grant (GM07238). S.S. was supported by the NIH (RO1 CA95099). This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute.	Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baerlocher GM, 2002, CYTOMETRY, V47, P89, DOI 10.1002/cyto.10053; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; CHANG P, 2005, NAT CELL BIOL; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; GLIEMANN J, 1984, BIOCHIM BIOPHYS ACTA, V804, P68, DOI 10.1016/0167-4889(84)90100-9; Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Kuimov AN, 2001, GENES IMMUN, V2, P52, DOI 10.1038/sj.gene.6363722; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Tessarollo L, 2000, METH MOL B, V158, P47; Xu XL, 1998, DEVELOPMENT, V125, P753; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793	30	113	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2639	10.1371/journal.pone.0002639	http://dx.doi.org/10.1371/journal.pone.0002639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612384	Green Submitted, gold, Green Published			2022-12-25	WOS:000264065800041
J	Klompas, M; Haney, G; Church, D; Lazarus, R; Hou, XL; Platt, R				Klompas, Michael; Haney, Gillian; Church, Daniel; Lazarus, Ross; Hou, Xuanlin; Platt, Richard			Automated Identification of Acute Hepatitis B Using Electronic Medical Record Data to Facilitate Public Health Surveillance	PLOS ONE			English	Article								Background: Automatic identification of notifiable diseases from electronic medical records can potentially improve the timeliness and completeness of public health surveillance. We describe the development and implementation of an algorithm for prospective surveillance of patients with acute hepatitis B using electronic medical record data. Methods: Initial algorithms were created by adapting Centers for Disease Control and Prevention diagnostic criteria for acute hepatitis B into electronic terms. The algorithms were tested by applying them to ambulatory electronic medical record data spanning 1990 to May 2006. A physician reviewer classified each case identified as acute or chronic infection. Additional criteria were added to algorithms in serial fashion to improve accuracy. The best algorithm was validated by applying it to prospective electronic medical record data from June 2006 through April 2008. Completeness of case capture was assessed by comparison with state health department records. Findings: A final algorithm including a positive hepatitis B specific test, elevated transaminases and bilirubin, absence of prior positive hepatitis B tests, and absence of an ICD9 code for chronic hepatitis B identified 112/113 patients with acute hepatitis B ( sensitivity 97.4%, 95% confidence interval 94-100%; specificity 93.8%, 95% confidence interval 87-100%). Application of this algorithm to prospective electronic medical record data identified 8 cases without false positives. These included 4 patients that had not been reported to the health department. There were no known cases of acute hepatitis B missed by the algorithm. Conclusions: An algorithm using codified electronic medical record data can reliably detect acute hepatitis B. The completeness of public health surveillance may be improved by automatically identifying notifiable diseases from electronic medical record data.	[Klompas, Michael; Platt, Richard] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; [Klompas, Michael; Lazarus, Ross; Hou, Xuanlin; Platt, Richard] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Haney, Gillian; Church, Daniel] Massachusetts Dept Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Department of Public Health	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019	lazarus, ross/0000-0003-3939-1961	Centers for Disease Control and Prevention [PH000238D]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by grant PH000238D from the Centers for Disease Control and Prevention. The funding organization had no role in the study design, data collection, analysis, interpretation, writing or submission of this manuscript.	DAVIS GL, 1985, ANN INTERN MED, V102, P762, DOI 10.7326/0003-4819-102-6-762; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Effler P, 1999, JAMA-J AM MED ASSOC, V282, P1845, DOI 10.1001/jama.282.19.1845; Gonzalez R, 2006, TRANSFUSION, V46, P1138, DOI 10.1111/j.1537-2995.2006.00863.x; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Klompas M., 2008, Morbidity and Mortality Weekly Report, V57, P373; Klompas M., 2007, ADV DIS SURV, V3, P1; Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x; McHugh L. A., 2008, Morbidity and Mortality Weekly Report, V57, P42; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Panackal AA, 2002, EMERG INFECT DIS, V8, P685, DOI 10.3201/eid0807.010493; Poulos Roslyn G, 2004, Commun Dis Intell Q Rep, V28, P392; Ramsay ME, 1998, VACCINE, V16, pS76, DOI 10.1016/S0264-410X(98)00303-X; van De Garde EMW, 2007, J CLIN EPIDEMIOL, V60, P834, DOI 10.1016/j.jclinepi.2006.10.018; Ward M, 2005, Euro Surveill, V10, P7, DOI 10.2807/esm.10.01.00513-en; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; Weber B, 2005, J CLIN VIROL, V32, P67, DOI 10.1016/j.jcv.2004.09.018	17	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2626	10.1371/journal.pone.0002626	http://dx.doi.org/10.1371/journal.pone.0002626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612462	Green Submitted, Green Published, gold			2022-12-25	WOS:000264065800028
J	Fox, AS; Shelton, SE; Oakes, TR; Davidson, RJ; Kalin, NH				Fox, Andrew S.; Shelton, Steven E.; Oakes, Terrence R.; Davidson, Richard J.; Kalin, Ned H.			Trait-Like Brain Activity during Adolescence Predicts Anxious Temperament in Primates	PLOS ONE			English	Article							PERFORMANCE EVALUATION; BEHAVIORAL-INHIBITION; HIGH-RESOLUTION; RHESUS-MONKEYS; PET SCANNER; ANXIETY; AMYGDALA; EMOTION; REGISTRATION; MICROPET	Early theorists (Freud and Darwin) speculated that extremely shy children, or those with anxious temperament, were likely to have anxiety problems as adults. More recent studies demonstrate that these children have heightened responses to potentially threatening situations reacting with intense defensive responses that are characterized by behavioral inhibition (BI) (inhibited motor behavior and decreased vocalizations) and physiological arousal. Confirming the earlier impressions, data now demonstrate that children with this disposition are at increased risk to develop anxiety, depression, and comorbid substance abuse. Additional key features of anxious temperament are that it appears at a young age, it is a stable characteristic of individuals, and even in non-threatening environments it is associated with increased psychic anxiety and somatic tension. To understand the neural underpinnings of anxious temperament, we performed imaging studies with 18-fluoro-deoxyglucose (FDG) high-resolution Positron Emission Tomography (PET) in young rhesus monkeys. Rhesus monkeys were used because they provide a well validated model of anxious temperament for studies that cannot be performed in human children. Imaging the same animal in stressful and secure contexts, we examined the relation between regional metabolic brain activity and a trait-like measure of anxious temperament that encompasses measures of BI and pituitary-adrenal reactivity. Regardless of context, results demonstrated a trait-like pattern of brain activity (amygdala, bed nucleus of stria terminalis, hippocampus, and periaqueductal gray) that is predictive of individual phenotypic differences. Importantly, individuals with extreme anxious temperament also displayed increased activity of this circuit when assessed in the security of their home environment. These findings suggest that increased activity of this circuit early in life mediates the childhood temperamental risk to develop anxiety and depression. In addition, the findings provide an explanation for why individuals with anxious temperament have difficulty relaxing in environments that others perceive as non-stressful.	[Fox, Andrew S.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Shelton, Steven E.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Fox, Andrew S.; Oakes, Terrence R.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behavior, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fox, AS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	nkalin@wisc.edu		Kalin, Ned/0000-0003-1184-0868; Davidson, Richard/0000-0002-8506-4964	HealthEmotions Research Institute and Meriter Hospital [MH046729, MH052354, MH069315]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046729, P50MH052354, P50MH069315] Funding Source: NIH RePORTER	HealthEmotions Research Institute and Meriter Hospital; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants MH046729, MH052354, MH069315, The HealthEmotions Research Institute and Meriter Hospital.	BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Biederman J, 2001, AM J PSYCHIAT, V158, P1673, DOI 10.1176/appi.ajp.158.10.1673; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Chatziioannou AF, 1999, J NUCL MED, V40, P1164; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DREVETS WC, 1992, SCIENCE, V256, P1696, DOI 10.1126/science.256.5064.1696; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Farquhar TH, 1998, IEEE T MED IMAGING, V17, P1073, DOI 10.1109/42.746722; Fox AS, 2005, P NATL ACAD SCI USA, V102, P4176, DOI 10.1073/pnas.0409470102; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jernigan TL, 2003, HUM BRAIN MAPP, V19, P90, DOI 10.1002/hbm.10108; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kagan J, 2008, DEV PSYCHOBIOL, V50, P4, DOI 10.1002/dev.20267; Kalin NH, 2005, BIOL PSYCHIAT, V58, P796, DOI 10.1016/j.biopsych.2005.05.021; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Knoess C, 2003, EUR J NUCL MED MOL I, V30, P737, DOI 10.1007/s00259-002-1052-6; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Paxinos G., 2000, RHESUS MONKEY BRAIN; PHELPS ME, 1978, J NUCL MED, V19, P1311; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	35	110	111	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2570	10.1371/journal.pone.0002570	http://dx.doi.org/10.1371/journal.pone.0002570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596957	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200035
J	Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Haemmerle, M; Rainer, C; Deisenhammer, F; Schocke, M; Berger, T; Reindl, M				Kuenz, Bettina; Lutterotti, Andreas; Ehling, Rainer; Gneiss, Claudia; Haemmerle, Monika; Rainer, Carolyn; Deisenhammer, Florian; Schocke, Michael; Berger, Thomas; Reindl, Markus			Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis	PLOS ONE			English	Article								Background: There is accumulating evidence from immunological, pathological and therapeutic studies that B cells are key components in the pathophysiology of multiple sclerosis (MS). Methodology/Principal Findings: In this prospective study we have for the first time investigated the differences in the inflammatory response between relapsing and progressive MS by comparing cerebrospinal fluid (CSF) cell profiles from patients at the onset of the disease (clinically isolated syndrome, CIS), relapsing-remitting (RR) and chronic progressive (CP) MS by flow cytometry. As controls we have used patients with other neurological diseases. We have found a statistically significant accumulation of CSF mature B cells (CD19+CD138-) and plasma blasts (CD19+CD138+) in CIS and RRMS. Both B cell populations were, however, not significantly increased in CPMS. Further, this accumulation of B cells correlated with acute brain inflammation measured by magnetic resonance imaging and with inflammatory CSF parameters such as the number of CSF leukocytes, intrathecal immunoglobulin M and G synthesis and intrathecal production of matrix metalloproteinase (MMP)-9 and the B cell chemokine CxCL-13. Conclusions: Our data support an important role of CSF B cells in acute brain inflammation in CIS and RRMS.	[Kuenz, Bettina; Lutterotti, Andreas; Ehling, Rainer; Gneiss, Claudia; Haemmerle, Monika; Rainer, Carolyn; Deisenhammer, Florian; Berger, Thomas; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Schocke, Michael] Innsbruck Med Univ, Dept Radiol 1, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Kuenz, B (corresponding author), Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria.	markus.reindl@i-med.ac.at	Berger, Thomas U/HGA-3594-2022; Reindl, Markus/ABE-5880-2020; Schocke, Michael/AAC-3666-2020	Haemmerle, Monika/0000-0003-3145-0541; Reindl, Markus/0000-0003-2817-1402	Gemeinnuetzige Hertiestiftung (Frankfurt, Germany); Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University; Schering-Berlex (Germany, USA)	Gemeinnuetzige Hertiestiftung (Frankfurt, Germany); Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University; Schering-Berlex (Germany, USA)	This study was supported by research grants of the Gemeinnuetzige Hertiestiftung (Frankfurt, Germany), the Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University and Schering-Berlex (Germany, USA). The sponsors or funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cepok S, 2003, ARCH NEUROL-CHICAGO, V60, P849, DOI 10.1001/archneur.60.6.849; Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195; Cepok S, 2006, J NEUROIMMUNOL, V180, P33, DOI 10.1016/j.jneuroim.2006.06.031; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Di Girolamo N, 1998, EUR J IMMUNOL, V28, P1773, DOI 10.1002/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Liuzzi GM, 2002, MULT SCLER, V8, P222, DOI 10.1191/1352458502ms800oa; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Trocme C, 1998, J BIOL CHEM, V273, P20677, DOI 10.1074/jbc.273.32.20677; Uccelli A, 2005, TRENDS IMMUNOL, V26, P254, DOI 10.1016/j.it.2005.02.009; Yong VW, 1998, TRENDS NEUROSCI, V21, P75	39	85	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2559	10.1371/journal.pone.0002559	http://dx.doi.org/10.1371/journal.pone.0002559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596942	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200026
J	Gellerich, FN; Gizatullina, Z; Nguyen, HP; Trumbeckaite, S; Vielhaber, S; Seppet, E; Zierz, S; Landwehrmeyer, B; Riess, O; von Horsten, S; Striggow, F				Gellerich, Frank N.; Gizatullina, Zemfira; Nguyen, Huu P.; Trumbeckaite, Sonata; Vielhaber, Stefan; Seppet, Enn; Zierz, Stephan; Landwehrmeyer, Bernhard; Riess, Olaf; von Hoersten, Stephan; Striggow, Frank			Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A; SUBCELLULAR-LOCALIZATION; MEMBRANE; LIVER; IDENTIFICATION; EXPRESSION; GENE; BIOENERGETICS; SENSITIVITY	Huntington disease ( HD) is characterized by polyglutamine expansions of huntingtin (htt), but the underlying pathomechanisms have remained unclear. We studied brain mitochondria of transgenic HD rats with 51 glutamine repeats (htt(51Q)), modeling the adult form of HD. Ca-free(2+) up to 2 mu M activated state 3 respiration of wild type mitochondria with glutamate/malate or pyruvate/malate as substrates. Ca-free(2+) above 2 mu M inhibited respiration via cyclosporin A-dependent permeability transition (PT). Ruthenium red, an inhibitor of the mitochondrial Ca2+ uniporter, did not affect the Ca2+ -dependent activation of respiration but reduced Ca2+ -induced inhibition. Thus, Ca2+ activation was mediated exclusively by extramitochondrial Ca2+, whereas inhibition was promoted also by intramitochondrial Ca2+. In contrast, htt(51Q) mitochondria showed a deficient state 3 respiration, a lower sensitivity to Ca2+ activation, and a higher susceptibility to Ca2+ -dependent inhibition. Furthermore htt(51Q) mitochondria exhibited a diminished membrane potential stability in response to Ca2+, lower capacities and rates of Ca2+ accumulation, and a decreased Ca2+ threshold for PT in a substrate-independent but cyclosporin A-sensitive manner. Compared with wild type, Ca2+ -induced inhibition of respiration of htt(51Q) mitochondria was less sensitive to ruthenium red, indicating the involvement of extramitochondrial Ca2+. In conclusion, we demonstrate a novel mechanism of mitochondrial regulation by extramitochondrial Ca2+. We suggest that specific regulatory Ca2+ binding sites on the mitochondrial surface, e. g. the glutamate/aspartate carrier (aralar), mediate this regulation. Interactions between htt(51Q) and distinct targets such as aralar and/or the PT pore may underlie mitochondrial dysregulation leading to energetic depression, cell death, and tissue atrophy in HD.	[Gellerich, Frank N.; Gizatullina, Zemfira; Striggow, Frank] KeyNeurotek Pharmaceut AG, D-39120 Magdeburg, Germany; [Nguyen, Huu P.; Riess, Olaf] Univ Tubingen, Dept Med Genet, D-72076 Tubingen, Germany; [Trumbeckaite, Sonata] Kaunas Univ Med, Inst Biomed Res, LT-50009 Kaunas, Lithuania; [Vielhaber, Stefan] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39120 Magdeburg, Germany; [Seppet, Enn] Univ Tartu, Ctr Mol & Clin Med, Dept Pathophysiol, EE-50411 Tartu, Estonia; [Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany; [Landwehrmeyer, Bernhard] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [von Hoersten, Stephan] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany	Eberhard Karls University of Tubingen; Lithuanian University of Health Sciences; Otto von Guericke University; University of Tartu; Martin Luther University Halle Wittenberg; Ulm University; University of Erlangen Nuremberg	Gellerich, FN (corresponding author), KeyNeurotek Pharmaceut AG, ZENIT Technol Pk,Leipziger Str 44, D-39120 Magdeburg, Germany.	gellerich@keyneurotek.de	von Hörsten, Stephan/G-9005-2015; Nguyen, Huu Phuc/HDO-3462-2022; Nguyen, Huu Phuc/F-5390-2015	von Hörsten, Stephan/0000-0001-6409-0664; Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X	European Huntington network; Deutsche Forschungsgemeinschaft [Ge 664/11-2]; Estonian Science Foundation [7117]; European Community [MTKD-CT-2004517176]; HighQ	European Huntington network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Estonian Science Foundation; European Community(European Commission); HighQ	This work was supported by the European Huntington network, Deutsche Forschungsgemeinschaft Grant Ge 664/11-2, Estonian Science Foundation Grant 7117 (to E. S.), European Community Contract MTKD-CT-2004517176 ( to (E. S.), and by HighQ (to S. v. H. and O. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Brustovetsky N, 2005, J NEUROCHEM, V93, P1361, DOI 10.1111/j.1471-4159.2005.03036.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Hagen T, 2003, AM J PHYSIOL-GASTR L, V285, pG274, DOI 10.1152/ajpgi.00052.2003; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; HOEK JB, 1983, J BIOL CHEM, V258, P54; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Kowaltowski AJ, 1997, BBA-BIOENERGETICS, V1322, P221, DOI 10.1016/S0005-2728(97)00078-9; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Panov AV, 2003, ARCH BIOCHEM BIOPHYS, V410, P1, DOI 10.1016/S0003-9861(02)00585-4; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Roesch K, 2004, HUM MOL GENET, V13, P2101, DOI 10.1093/hmg/ddh217; SCHOOLWERTH AC, 1980, INT J BIOCHEM, V12, P145, DOI 10.1016/0020-711X(80)90058-0; SCHOOLWERTH AC, 1978, J BIOL CHEM, V253, P6177; SEPPET E, 2007, MOL SYSTEM BIOENERGE, P479, DOI DOI 10.1002/9783527621095.CH15; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; UTO A, 1991, CELL CALCIUM, V12, P29, DOI 10.1016/0143-4160(91)90082-P; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1	50	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30715	30724		10.1074/jbc.M709555200	http://dx.doi.org/10.1074/jbc.M709555200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18606820	Green Published, hybrid			2022-12-25	WOS:000260544800027
J	Gubern, A; Casas, J; Barcelo-Torns, M; Barneda, D; de la Rosa, X; Masgrau, R; Picatoste, F; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Casas, Javier; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			Group IVA phospholipase A(2) is necessary for the biogenesis of lipid droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; VISIBLE LIPIDS; CELLULAR-REGULATION; BODY FORMATION; C6 CELLS; NILE RED; A(2); MEMBRANE; INHIBITION	Lipid droplets (LD) are organelles present in all cell types, consisting of a hydrophobic core of triacylglycerols and cholesteryl esters, surrounded by a monolayer of phospholipids and cholesterol. This work shows that LD biogenesis induced by serum, by long-chain fatty acids, or the combination of both in CHO-K1 cells was prevented by phospholipase A(2) inhibitors with a pharmacological profile consistent with the implication of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha). Knocking down cPLA(2)alpha expression with short interfering RNA was similar to pharmacological inhibition in terms of enzyme activity and LD biogenesis. A Chinese hamster ovary cell clone stably expressing an enhanced green fluorescent protein-cPLA(2)alpha fusion protein (EGFP-cPLA(2)) displayed higher LD occurrence under basal conditions and upon LD induction. Induction of LD took place with concurrent phosphorylation of cPLA(2)alpha at Ser(505). Transfection of a S505A mutant cPLA(2)alpha showed that phosphorylation at Ser(505) is key for enzyme activity and LD formation. cPLA(2)alpha contribution to LD biogenesis was not because of the generation of arachidonic acid, nor was it related to neutral lipid synthesis. cPLA(2)alpha inhibition in cells induced to form LD resulted in the appearance of tubulo-vesicular profiles of the smooth endoplasmic reticulum, compatible with a role of cPLA(2)alpha in the formation of nascent LD from the endoplasmic reticulum.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, E-47003 Valladolid, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M2,Campus Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Gubern, Albert/C-9902-2011; Balsinde, Jesús/C-7833-2018; Balboa, María A./V-9493-2018; Masgrau, Roser/D-3047-2011; Casas, Javier/K-7190-2015; Claro, Enrique/D-5612-2009	Gubern, Albert/0000-0001-6458-1498; Balsinde, Jesús/0000-0002-4157-6714; Balboa, María A./0000-0002-2130-5298; Masgrau, Roser/0000-0002-6722-5939; Casas, Javier/0000-0002-6413-8127; Claro, Enrique/0000-0002-7592-7906; Barneda, David/0000-0002-4436-4100	Spanish Ministry of Education and Science [SAF 2004-01698, SAF 200760055]; Spanish Ministry of Health [PI03/0528]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Grants SAF 2004-01698 and SAF 200760055 from the Spanish Ministry of Education and Science and Grant PI03/0528 from the Spanish Ministry of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Saffar NMS, 2002, BRIT J CANCER, V86, P963, DOI 10.1038/sj/bjc/6600188; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; Bozza PT, 2001, PROSTAG LEUKOTR ESS, V64, P227, DOI 10.1054/plef.2001.0264; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chang TY, 2001, J LIPID RES, V42, P1933; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; FIGUEIREDO PD, 2001, J BIOL CHEM, V276, P47361; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Lennartz MR, 1997, J CELL SCI, V110, P2041; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; Meadows JW, 2005, J CLIN ENDOCR METAB, V90, P2344, DOI 10.1210/jc.2004-1199; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SPECTOR AA, 1980, PROG LIPID RES, V19, P155; Staneva G, 2004, CHEM PHYS LIPIDS, V129, P53, DOI 10.1016/j.chemphyslip.2003.11.005; Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yasugi E, 2006, DEV GROWTH DIFFER, V48, P177, DOI 10.1111/j.1440-169x.2006.00855.x; Yu WG, 1998, AM J PATHOL, V152, P759	65	70	71	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27369	27382		10.1074/jbc.M800696200	http://dx.doi.org/10.1074/jbc.M800696200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18632668	hybrid, Green Published			2022-12-25	WOS:000259719200005
J	Granger, A; Abdullah, I; Huebner, F; Stout, A; Wang, T; Huebner, T; Epstein, JA; Gruber, PJ				Granger, Anne; Abdullah, Ibrahim; Huebner, Faith; Stout, Andrea; Wang, Tao; Huebner, Thomas; Epstein, Jonathan A.; Gruber, Peter J.			Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice	FASEB JOURNAL			English	Article						heart; hypoxia inducible factor 1; cardiomyocytes	VESICULO-VACUOLAR ORGANELLES; VASCULAR-PERMEABILITY; ACETYLATION; APOPTOSIS; HEART; EPIGENETICS; MECHANISMS; EXPRESSION; SIGNALS; STROKE	Limitation of infarct size is a major goal of therapy for acute coronary syndromes, and research has focused on achieving rapid patency of infarct-related vessels. However, new understandings of epigenetic modifications during ischemia suggest additional targeted approaches that have not been extensively explored. Here, we show that ischemia induces histone deacetylase (HDAC) activity in the heart with deacetyladon of histones H3/4 in vitro and in vivo. We show, utilizing a standard murine model of ischemia-reperfusion, that chemical HDAC inhibitors significantly reduce infarct area, even when delivered 1 h after the ischemic insult. We demonstrate that HDAC inhibitors prevent ischemia-induced activation of gene programs that include hypoxia inducible factor-lot, cell death, and vascular permeability in vivo and in vitro, thus providing potential mechanisms to explain reduced vascular leak and myocardial injury. In vitro, siRNA knockdown experiments implicate HDAC4 as a mediator of the effects in ischemic cardiac myocytes. These results demonstrate that HDAC inhibitors alter the response to ischemic injury in the heart and reduce infarct size, suggesting novel therapeutic approaches for acute coronary syndromes.	[Granger, Anne; Abdullah, Ibrahim; Huebner, Faith; Huebner, Thomas; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Granger, Anne; Stout, Andrea; Wang, Tao; Epstein, Jonathan A.; Gruber, Peter J.] Penn Cardiovasc Inst, Philadelphia, PA USA; [Epstein, Jonathan A.; Gruber, Peter J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Gruber, PJ (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd,Ste 8527 Main, Philadelphia, PA 19104 USA.	pgruber@mail.med.upenn.edu	GRANGER, Anne/A-9748-2010	Epstein, Jonathan/0000-0001-8637-4465	McCabe Foundation; University Research Foundation; Division of Pediatric Cardiothoracic Surgery; Children's Hospital of Philadelphia; National Institutes of Health [R01 HL071546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER	McCabe Foundation; University Research Foundation; Division of Pediatric Cardiothoracic Surgery; Children's Hospital of Philadelphia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Sherrie Vassallo for administrative and secretarial support and Thomas L. Spray for departmental support. This study was supported by the McCabe Foundation, University Research Foundation, and the Division of Pediatric Cardiothoracic Surgery, Children's Hospital of Philadelphia (P.J.G.), and National Institutes of Health grant R01 HL071546 (J.A.E.). P.J.G., J.A.E, and I.A. have filed U.S. Patent Application R-3701: Inhibition of histone deactylase activity as treatment, and preventive therapy for ischemic injury/inhibition of DNA methyl transferase activity its treatments and preventive therapy for ischemic injury.	Abdullah I, 2005, WOUND REPAIR REGEN, V13, P205, DOI 10.1111/j.1067-1927.2005.130212.x; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Fath DM, 2006, J BIOL CHEM, V281, P13612, DOI 10.1074/jbc.M600456200; Feng D, 1996, J EXP MED, V183, P1981, DOI 10.1084/jem.183.5.1981; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Guimaraes CL, 2002, CLIN SCI, V103, p340S, DOI 10.1042/CS103S340S; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Pratt JR, 2006, TRANSPL P, V38, P3344, DOI 10.1016/j.transproceed.2006.10.112; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; ROSAMOND W, 2006, HEART DIS STROKE STA; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Simard B, 2002, CAN J PHYSIOL PHARM, V80, P1203, DOI 10.1139/Y02-153; Strawn W B, 2000, J Renin Angiotensin Aldosterone Syst, V1, P11, DOI 10.3317/jraas.2000.001; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Webster KA, 1999, J CLIN INVEST, V104, P239; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Yamamura K, 2006, BRIT J HAEMATOL, V135, P242, DOI 10.1111/j.1365-2141.2006.06275.x; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010	45	222	233	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3549	3560		10.1096/fj.08-108548	http://dx.doi.org/10.1096/fj.08-108548			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606865	Green Published			2022-12-25	WOS:000259642600017
J	Trivedi, CM; Lu, MM; Wang, QH; Epstein, JA				Trivedi, Chinmay M.; Lu, Min Min; Wang, Qiaohong; Epstein, Jonathan A.			Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; COMPLEX; GROWTH; EXPRESSION; DELETION; FAMILY; CANCER; ROLES	Class I and II histone deacetylases (HDACs) play vital roles in regulating cardiac development, morphogenesis, and hypertrophic responses. Although the roles of Hdac1 and Hdac2, class I HDACs, in cardiac hyperplasia, growth, and hypertrophic responsiveness have been reported, the role in the heart of Hdac3, another class I HDAC, has been less well explored. Here we report that myocyte-specific overexpression of Hdac3 in mice results in cardiac abnormalities at birth. Hdac3 overexpression produces thickening of ventricular myocardium, especially the interventricular septum, and reduction of both ventricular cavities in newborn hearts. Our data suggest that increased thickness of myocardium in Hdac3-transgenic (Hdac3-Tg) mice is due to increased cardiomyocyte hyperplasia without hypertrophy. Hdac3 overexpression inhibits several cyclin-dependent kinase inhibitors, including Cdkn1a, Cdkn1b, Cdkn1c, Cdkn2b, and Cdkn2c. Hdac3-Tg mice did not develop cardiac hypertrophy at 3 months of age, unlike previously reported Hdac2-Tg mice. Further, Hdac3 overexpression did not augment isoproterenol-induced cardiac hypertrophy when compared with wild-type littermates. These findings identify Hdac3 as a novel regulator of cardiac myocyte proliferation during cardiac development.	[Trivedi, Chinmay M.; Wang, Qiaohong; Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Trivedi, Chinmay M.; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Epstein, JA (corresponding author), 1154 BRB 2,421 Curie Blvd, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu	Riddoch, Jane/F-7968-2010; Trivedi, Chinmay M/ABA-4097-2021	Epstein, Jonathan/0000-0001-8637-4465; Trivedi, Chinmay/0000-0002-3544-0474	National Institutes of Health [RO1HL071546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL071546 (to J. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2000, GENE DEV, V14, P1048; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, ATHEROSCLEROSIS, V195, pE50, DOI 10.1016/j.atherosclerosis.2007.04.055; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	36	80	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26484	26489		10.1074/jbc.M803686200	http://dx.doi.org/10.1074/jbc.M803686200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18625706	hybrid, Green Published			2022-12-25	WOS:000259341600024
J	Hewavitharana, T; Deng, XX; Wang, YJ; Ritchie, MF; Girish, GV; Soboloff, J; Gill, DL				Hewavitharana, Thamara; Deng, Xiaoxiang; Wang, Youjun; Ritchie, Michael F.; Girish, Gannareddy V.; Soboloff, Jonathan; Gill, Donald L.			Location and function of STIM1 in the activation of Ca2+ entry signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; INTERACTION MOLECULE-1 STIM1; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CRAC CHANNEL; STORE DEPLETION; CALCIUM INFLUX; ORAI1; PROTEINS; SENSOR	Store-operated channels (SOCs) mediate Ca2+ entry signals in response to endoplasmic reticulum (ER) Ca2+ depletion in most cells. STIM1 senses decreased ER luminal Ca2+ through its EF-hand Ca2+-binding motif and aggregates in near-plasma membrane (PM) ER junctions to activate PM Orai1, the functional SOC. STIM1 is also present in the PM, although its role there is unknown. STIM1-mediated coupling was examined using the stable EF20 HEK293 cell line expressing the STIM1-D76A/E87A EF-hand mutant (STIM1(EF)) deficient in Ca2+ binding. EF20 cells were viable despite constitutive Ca2+ entry, allowing study of SOC activation without depleting ER Ca2+. STIM1(EF) was exclusively in stable near-PM junctions, 3.5-fold larger than formed with STIM1(WT). STIMEF-expressing cells had normal ER Ca2+ levels but substantially reduced ER Ca2+ leak. Expression of antiapoptotic Bcl-2 proteins (BCl-2, MCL-1, BCL-XL) were increased 2-fold in EF20 cells, probably reflecting survival of EF20 cells but not accounting for decreased ER Ca2+ leak. Surface biotinylation and streptavidin pull-down of cells expressing STIM1(WT) or STIM1(EF) revealed strong PM interactions of both proteins. Although surface expression of STIM1(WT) was clearly detectable, STIM1(EF) was undetectable at the cell surface. Thus, the Ca2+ binding-defective STIM1(EF) mutant exists exclusively in aggregates within near-PM junctions but, unlike STIM1WT, is not trafficked to the PM. Although not inserted in the PM, external application of a monoclonal anti-N-terminal STIM1 antibody blocked constitutive STIMEF-mediated Ca2+ entry, but only in cells expressing endogenous STIM1(WT) and not in DT40 STIM1 knock-out cells devoid of STIMWT. This suggests that PM-STIM1 may play a regulatory role in SOC activation.	[Hewavitharana, Thamara; Deng, Xiaoxiang; Wang, Youjun; Ritchie, Michael F.; Girish, Gannareddy V.; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu; dgill@temple.edu	Wang, Youjun/H-4016-2013; Soboloff, Jonathan/I-6995-2012	Wang, Youjun/0000-0003-0961-1716; Soboloff, Jonathan/0000-0001-5192-1297	National Institutes of Health [HL55426, AI058173]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part, by National Institutes of Health Grants HL55426 (to D. L. G.) AI058173 (to D. L. G.). This work was also supported by the American Heart Association (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Marchant JS, 2005, CURR BIOL, V15, pR493, DOI 10.1016/j.cub.2005.06.035; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	51	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26252	26262		10.1074/jbc.M802239200	http://dx.doi.org/10.1074/jbc.M802239200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635545	Green Published, hybrid			2022-12-25	WOS:000259200100053
J	Hewitson, KS; Holmes, SL; Ehrismann, D; Hardy, AP; Chowdhury, R; Schofield, CJ; McDonough, MA				Hewitson, Kirsty S.; Holmes, Samantha L.; Ehrismann, Dominic; Hardy, Adam P.; Chowdhury, Rasheduzzaman; Schofield, Christopher J.; McDonough, Michael A.			Evidence that two enzyme-derived histidine ligands are sufficient for iron binding and catalysis by factor inhibiting HIF (FIH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; VON-HIPPEL-LINDAU; ASPARAGINYL HYDROXYLASE; 2-OXOGLUTARATE OXYGENASES; PROLYL 4-HYDROXYLASE; FAMILY; HALOGENASE; ASCORBATE; SITES	A 2-His-1-carboxylate triad of iron binding residues is present in many non-heme iron oxygenases including the Fe(II) and 2-oxoglutarate (2OG)-dependent dioxygenases. Three variants (D201A, D201E, and D201G) of the iron binding Asp-201 residue of an asparaginyl hydroxylase, factor inhibiting HIF (FIH), were made and analyzed. FIH-D201A and FIH-D201E did not catalyze asparaginyl hydroxylation, but in the presence of a reducing agent, they displayed enhanced 2OG turnover when compared with wild-type FIH. Turnover of 2OG by FIH-D201A was significantly stimulated by the addition of HIF-1 alpha(786-826) peptide. Like FIH-D201A and D201E, the D201G variant enhanced 2OG turnover but rather unexpectedly catalyzed asparaginyl hydroxylation. Crystal structures of the FIH-D201A and D201G variants in complex with Fe(II)/Zn(II), 2OG, and HIF-1 alpha(786-826/788-806) implied that only two FIH-based residues (His-199 and His-279) are required for metal binding. The results indicate that variation of 2OG-dependent dioxygenase iron-ligating residues as a means of functional assignment should be treated with caution. The results are of mechanistic interest in the light of recent biochemical and structural analyses of non-heme iron and 2OG-dependent halogenases that are similar to the FIH-D201A/G variants in that they use only two His-residues to ligate iron.	[Hewitson, Kirsty S.; Holmes, Samantha L.; Ehrismann, Dominic; Hardy, Adam P.; Chowdhury, Rasheduzzaman; Schofield, Christopher J.; McDonough, Michael A.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; michael.mcdonough@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; McDonough, Michael/N-8913-2019; McDonough, Michael A/G-2744-2013	Chowdhury, Rashed/0000-0002-8058-6149; McDonough, Michael/0000-0003-4664-6942; McDonough, Michael A/0000-0003-4664-6942; Schofield, Christopher/0000-0002-0290-6565	Wellcome Trust; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust, the Engineering and Physical Sciences Research Council, and the Biotechnology and Biological Sciences Research Council for funding. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Gaspard S, 1997, BIOCHEMISTRY-US, V36, P4852, DOI 10.1021/bi9616864; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Knowles HJ, 2003, CANCER RES, V63, P1764; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Sim J, 2000, BIOSCI BIOTECH BIOCH, V64, P828, DOI 10.1271/bbb.64.828; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	39	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25971	25978		10.1074/jbc.M804999200	http://dx.doi.org/10.1074/jbc.M804999200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18611856	hybrid, Green Published			2022-12-25	WOS:000259200100025
J	Nakamaru-Ogiso, E; Matsuno-Yagi, A; Yoshikawa, S; Yagi, T; Ohnishi, T				Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yoshikawa, Shinya; Yagi, Takao; Ohnishi, Tomoko			Iron-sulfur cluster N5 is coordinated by an HXXXCXXCXXXXXC motif in the NuoG subunit of Escherichia coli NADH : quinone oxidoreductase (complex I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; DEHYDROGENASE FRAGMENT; THERMUS-THERMOPHILUS; YARROWIA-LIPOLYTICA; PYROCOCCUS-FURIOSUS; NITRATE REDUCTASE; RESPIRATORY-CHAIN; 4FE-4S CLUSTER; FE4S4 CLUSTER	NADH:quinone oxidoreductase (complex I) plays a central role in cellular energy metabolism, and its dysfunction is found in numerous human mitochondrial diseases. Although the understanding of its structure and function has been limited, the x-ray crystal structure of the hydrophilic part of Thermus thermophilus complex I recently became available. It revealed the localization of all redox centers, including 9 iron-sulfur clusters and their coordinating ligands, and confirmed the predictions mostly made by Ohnishi et al. (Ohnishi, T., and Nakamaru-Ogiso, E. (2008) Biochim. Biophys. Acta 1777, 703-710) based on various EPR studies. Recently, Yakovlev et al. (Yakovlev, G., Reda, T., and Hirst, J. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 12720-12725) claimed that the EPR signals from clusters N4, N5, and N6b were misassigned. Here we identified and characterized cluster N5 in the Escherichia coli complex I whose EPR signals had never been detected by any group. Using homologous recombination, we constructed mutant strains of H101A, H101C, H101A/C114A, and cluster N5 knock-out. Although mutant NuoEFG subcomplexes were dissociated from complex I, we successfully recovered these mutant NuoCDEFG subcomplexes by expressing the His-tagged NuoCD subunit, which had a high affinity to NuoG. The W221A mutant was used as a control subcomplex carrying wild-type clusters. By lowering temperatures to around 3 K, we finally succeeded in detecting cluster N5 signals in the control for the first time. However, no cluster N5 signals were found in any of the N5 mutants, whereas EPR signals from all other clusters were detected. These data confirmed that, contrary to the misassignment claim, cluster N5 has a unique coordination with His(Cys)(3) ligands in NuoG.	[Nakamaru-Ogiso, Eiko; Ohnishi, Tomoko] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Div Biochem, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Yoshikawa, Shinya] Univ Hyogo, Dept Life Sci, Kamigohri Akoh, Hyogo 6781297, Japan	University of Pennsylvania; Scripps Research Institute; University of Hyogo	Nakamaru-Ogiso, E (corresponding author), 215 Anat Chem Bldg,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu			Sam and Rose Stein Endowment Fund; National Institutes of Health [R01GM30736]; United States Public Health Service [R01GM33712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030736] Funding Source: NIH RePORTER	Sam and Rose Stein Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. S. Tsuyoshi Ohnishi for assistance. Synthesis of oligonucleotides and DNA sequencing were supported in part by the Sam and Rose Stein Endowment Fund.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM30736 (to T.O.) and R01GM33712 (to T.Y.) from the United States Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AASA R, 1975, BIOCHIM BIOPHYS ACTA, V391, P259, DOI 10.1016/0005-2744(75)90249-1; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Bungert S, 1999, FEBS LETT, V460, P207, DOI 10.1016/S0014-5793(99)01341-1; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; DOEG KA, 1962, ARCH BIOCHEM BIOPHYS, V97, P37, DOI 10.1016/0003-9861(62)90041-3; HEKMAN C, 1991, J BIOL CHEM, V266, P13564; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Nakashima Y, 2002, J BIOENERG BIOMEMBR, V34, P11, DOI 10.1023/A:1013862502185; OHNISHI T, 1993, J BIOENERG BIOMEMBR, V25, P325, DOI 10.1007/BF00762457; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; OHNISHI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P475, DOI 10.1016/0005-2728(75)90087-0; Ohnishi T., 1979, MEMBRANE PROTEINS EN, P1; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SLED VD, 1993, J BIOENERG BIOMEMBR, V25, P347, DOI 10.1007/BF00762460; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920, DOI 10.1128/jb.172.6.2920-2929.1990; VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H; Waletko A, 2005, J BIOL CHEM, V280, P5622, DOI 10.1074/jbc.M411488200; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; Zickermann V, 2007, BBA-BIOENERGETICS, V1767, P393, DOI 10.1016/j.bbabio.2007.03.005	45	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25979	25987		10.1074/jbc.M804015200	http://dx.doi.org/10.1074/jbc.M804015200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18603533	Green Published, hybrid			2022-12-25	WOS:000259200100026
J	Tokarska-Schlattner, M; Boissan, M; Munier, A; Borot, C; Mailleau, C; Speer, O; Schlattner, U; Lacombe, ML				Tokarska-Schlattner, Malgorzata; Boissan, Mathieu; Munier, Annie; Borot, Caroline; Mailleau, Christiane; Speer, Oliver; Schlattner, Uwe; Lacombe, Marie-Lise			The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE; CONTACT SITES; INTERMEMBRANE SPACE; OUTER-MEMBRANE; LOCALIZATION; MATRIX; GENES; PHOSPHORYLATION; DIPHOSPHOKINASE; CARCINOMA	Nucleoside diphosphate kinase (NDPK/Nm23), responsible for intracellular di- and triphosphonucleoside homeostasis, plays multiple roles in cellular energetics, signaling, proliferation, differentiation and tumor invasion. The only human NDPK with a mitochondrial targeting sequence is NDPK-D, the NME4 gene product, which is a peripheral protein of mitochondrial membranes. Subfractionation of rat liver and HEK 293 cell mitochondria revealed that NDPK-D is essentially bound to the inner membrane. Surface plasmon resonance analysis of the interaction using recombinant NDPK-D and model liposomes showed that NDPK-D interacts electrostatically with anionic phospholipids, with highest affinity observed for cardiolipin. Mutation of the central arginine (Arg-90) in a surface-exposed basic RRK motif unique to NDPK-D strongly reduced interaction with anionic phospholipids. Due to its symmetrical hexameric structure, NDPK-D was able to cross-link anionic phospholipid-containing liposomes, suggesting that NDPK-D could promote intermembrane contacts. Latency assays with isolated mitochondria and antibody binding to mitoplasts indicated a dual orientation for NDPK-D. In HeLa cells, stable expression of wild type but not of the R90D mutant led to membrane-bound enzyme in vivo. Respiration was significantly stimulated by the NDPK substrate TDP in mitochondria containing wild-type NDPK-D, but not in those expressing the R90D mutant, which is catalytically equally active. This indicates local ADP regeneration in the mitochondrial intermembrane space and a tight functional coupling of NDPK-D with oxidative phosphorylation that depends on its membrane-bound state.	[Tokarska-Schlattner, Malgorzata; Schlattner, Uwe] Univ Grenoble 1, INSERM, U884, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France; [Boissan, Mathieu; Munier, Annie; Mailleau, Christiane; Lacombe, Marie-Lise] Univ Paris 06, UMPC, INSERM, UMRS 893,CdR St Antoine, F-75012 Paris, France; [Borot, Caroline] Univ Denis Diderot Paris 07, EA 3106, Lab Biol & Biochim Cellulaire Viellissement, F-75005 Paris, France; [Speer, Oliver; Schlattner, Uwe] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schlattner, U (corresponding author), Univ Grenoble 1, INSERM, U884, Lab Bioenerget Fondamentale & Appl, BP 53, F-38041 Grenoble, France.	uwe.schlattner@ujf-grenoble.fr; Lacombe@inserm.fr	Schlattner, Uwe/D-1267-2009	Schlattner, Uwe/0000-0003-1159-5911; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050	Germaine de Stael Program for Franco-Swiss collaboration; Agence Nationale de la Recherche; European Community; INSERM; Groupement des Entreprises Francaises contre le Cancer; Association pour la Recherche contre le Cancer	Germaine de Stael Program for Franco-Swiss collaboration; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Groupement des Entreprises Francaises contre le Cancer; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Germaine de Stael Program for Franco-Swiss collaboration (to U.S. and M.-L.L.), the Agence Nationale de la Recherche (Chaire d'Excellence (to U.S.)), the Marie Curie Intraeuropean Fellowship of the European Community (to M.T.-S.), INSERM, and grants from the Groupement des Entreprises Francaises contre le Cancer and from the Association pour la Recherche contre le Cancer (to M.-L.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agarwal R P, 1978, Methods Enzymol, V51, P376; Amutha B, 2003, BIOCHEM J, V370, P805, DOI 10.1042/BJ20021415; Anderca MI, 2002, PLANT CELL PHYSIOL, V43, P1276, DOI 10.1093/pcp/pcf155; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; CHERRADI N, 1994, ENDOCRINOLOGY, V134, P1358, DOI 10.1210/en.134.3.1358; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Erent M, 2001, EUR J BIOCHEM, V268, P1972, DOI 10.1046/j.1432-1327.2001.2076.doc.x; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Galvis MLE, 1999, BIOCHIMIE, V81, P1089, DOI 10.1016/S0300-9084(99)00353-3; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Hayer J, 2001, ANTICANCER RES, V21, P2821; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; JACOBUS WE, 1977, J BIOL CHEM, V252, P4232; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Knorpp C, 2003, FEBS LETT, V555, P363, DOI 10.1016/S0014-5793(03)01288-2; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; KREBS HA, 1978, BIOCHEM J, V174, P297, DOI 10.1042/bj1740297; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lambeth David O, 2002, IUBMB Life, V54, P143; Lambeth DO, 1997, J BIOL CHEM, V272, P24604, DOI 10.1074/jbc.272.39.24604; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; Liu JH, 2005, BIOCHEM BIOPH RES CO, V330, P865, DOI 10.1016/j.bbrc.2005.03.048; Masse K, 2002, GENE, V296, P87, DOI 10.1016/S0378-1119(02)00836-3; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; MUHONEN WW, 1995, COMP BIOCHEM PHYS B, V110, P211, DOI 10.1016/0305-0491(94)00123-C; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; PEDERSEN PL, 1973, J BIOL CHEM, V248, P3956; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Sadek CM, 2003, J BIOL CHEM, V278, P13133, DOI 10.1074/jbc.M300369200; SAKS VA, 1980, J BIOL CHEM, V255, P755; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlattner U, 2000, J BIOENERG BIOMEMBR, V32, P123, DOI 10.1023/A:1005576831968; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2004, ENCY BIOL CHEM, P646; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Speer O, 2005, BIOCHEM J, V385, P445, DOI 10.1042/BJ20040386; Stachowiak O, 1996, BIOCHEMISTRY-US, V35, P15522, DOI 10.1021/bi961838v; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Sweetlove LJ, 2001, FEBS LETT, V508, P272, DOI 10.1016/S0014-5793(01)03069-1; TROLL H, 1993, J BIOL CHEM, V268, P25469; Walzel B, 2002, J BIOL CHEM, V277, P37503, DOI 10.1074/jbc.M201168200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	57	68	69	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26198	26207		10.1074/jbc.M803132200	http://dx.doi.org/10.1074/jbc.M803132200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635542	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000259200100048
J	Duncan, RE; Sarkadi-Nagy, E; Jaworski, K; Ahmadian, M; Sul, HS				Duncan, Robin E.; Sarkadi-Nagy, Eszter; Jaworski, Kathy; Ahmadian, Maryam; Sul, Hei Sook			Identification and functional characterization of adipose-specific phospholipase A(2) (AdPLA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TUMOR-SUPPRESSOR; LECITHIN-RETINOL ACYLTRANSFERASE; ACTIVATED RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; INHIBITORS; EXPRESSION; MECHANISM; H-REV107; FAMILY; CELLS	Phospholipases A(2) (PLA(2)s) catalyze hydrolysis of fatty acids from the sn-2 position of phospholipids. Here we report the identification and characterization of a membrane-associated intracellular calcium-dependent, adipose-specific PLA(2) that we named AdPLA (adipose-specific phospholipase A(2)). We found that AdPLA was highly expressed specifically in white adipose tissue and was induced during preadipocyte differentiation into adipocytes. Clearance of AdPLA by immunoprecipitation significantly decreased PLA activity in white adipose tissue lysates but had no effect on liver lysates, where expression was hardly detectable. In characterizing AdPLA, we employed radiochemical assays with TLC analysis of the enzyme activity of lysates from COS-7 cells overexpressing AdPLA. For kinetic studies, we produced purified recombinant AdPLA for use in a lipoxidase-coupled spectrophotometric assay. AdPLA generated free fatty acid and lysophospholipid from phosphatidylcholine with a preference for hydrolysis at the sn-2 position. Although we found low but detectable lysophospholipase activity, AdPLA showed no significant activity against a variety of other lipid substrates. Calcium was found to activate AdPLA but was not essential for activity. Studies with known phospholipase inhibitors, including bromoenolactone, methyl arachidonyl fluorophosphate, AACOCF(3), 7,7-dimethyl-5,8-eicosadienoic acid, and thioetheramide, supported that AdPLA is a phospholipase. Mutational studies showed that His-23 and Cys-113 are critical for activity of AdPLA and suggested that AdPLA is likely a His/Cys PLA(2). Overall, although AdPLA is similar to other histidine phospholipases in pH and calcium dependence, AdPLA showed different characteristics in many regards, including predicted catalytic mechanism. AdPLA may therefore represent the first member of a new group of PLA(2)s, group XVI.	[Duncan, Robin E.; Sarkadi-Nagy, Eszter; Jaworski, Kathy; Ahmadian, Maryam; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 219 Morgan Hall, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Han, Zaiqi/AAI-2233-2019; Duncan, Robin/AAH-7465-2021	Jaworski, Kathy/0000-0001-6014-5066	National Institutes of Health [DK075682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075682, T32DK061918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK075682 (to H. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; COHENLURIA R, 1992, CELL SIGNAL, V4, P331, DOI 10.1016/0898-6568(92)90073-H; DECARVALHO MGS, 1995, J BIOL CHEM, V270, P20439, DOI 10.1074/jbc.270.35.20439; DePetrocellis L, 1997, BIOCHEM BIOPH RES CO, V231, P82, DOI 10.1006/bbrc.1997.6000; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; DIEZ E, 1992, J BIOL CHEM, V267, P18342; Fain JN, 2000, J LIPID RES, V41, P1689; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jimenez M, 2003, ANAL BIOCHEM, V319, P131, DOI 10.1016/S0003-2697(03)00331-2; KATHER H, 1979, J CLIN INVEST, V64, P609, DOI 10.1172/JCI109500; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Nazarenko I, 2007, J CELL SCI, V120, P1393, DOI 10.1242/jcs.000018; Nazarenko I, 2006, AM J PATHOL, V169, P1427, DOI 10.2353/ajpath.2006.051341; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Roder K, 2002, BIOCHEM BIOPH RES CO, V293, P793, DOI 10.1016/S0006-291X(02)00274-7; Roder K, 2002, J BIOL CHEM, V277, P30543, DOI 10.1074/jbc.M111891200; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Xue LL, 2004, BIOCHEMISTRY-US, V43, P6120, DOI 10.1021/bi049556f; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; YU L, 1990, J BIOL CHEM, V265, P2657; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	37	114	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25428	25436		10.1074/jbc.M804146200	http://dx.doi.org/10.1074/jbc.M804146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614531	hybrid, Green Published			2022-12-25	WOS:000259012700038
J	Fan, TC; Fang, SL; Hwang, CS; Hsu, CY; Lu, XA; Hung, SC; Lin, SC; Chang, MDT				Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lu, Xin-an; Hung, Shang-cheng; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr			Characterization of molecular interactions between eosinophil cationic protein and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSAMINOGLYCAN INTERACTIONS; HIV-1 TAT; IN-VITRO; RNASE 3; SULFATE; PROLIFERATION; MEMBRANE; GROWTH; DOMAIN; ELECTROPHORESIS	Eosinophil cationic protein (ECP) is currently used as a biomarker for airway inflammation. It is a heparin-binding ribonuclease released by activated eosinophils. Its cytotoxicity toward cancer cell lines is blocked by heparin. The objective of this study was to locate the heparin binding site of ECP by site-directed mutagenesis and construction of a synthetic peptide derived from this region. Synthetic heparin with >= 5 monosaccharide units showed strong inhibition of ECP binding to the cell surface. Analysis of ECP mt1 (R34A/W35A/R36A/K38A) showed that these charged and aromatic residues were involved in ECP binding to heparin and the cell surface. A potential binding motif is located in the loop L3 region between helix alpha 2 and strand beta 1, outside the RNA binding domain. The synthetic peptide derived from the loop L3 region displayed strong pentasaccharide binding affinity and blocked ECP binding to cells. In addition, ECP mt1 showed reduced cytotoxicity. Thus, the tight interaction between ECP and heparin acts as the primary step for ECP endocytosis. These results provide new insights into the structure and function of ECP for anti-asthma therapy.	[Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Hwang, Chi-Shin] Taipei City Hosp, Dept Neurol, Zhong Xiao Branch, Taipei 10341, Taiwan; [Hung, Shang-cheng] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Lu, Xin-an; Hung, Shang-cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; Taipei City Hospital; Academia Sinica - Taiwan; National Tsing Hua University	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101 Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	dtchang@life.nthu.edu.tw						Boix E, 1999, J BIOL CHEM, V274, P15605, DOI 10.1074/jbc.274.22.15605; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carreras E, 2003, BIOCHEMISTRY-US, V42, P6636, DOI 10.1021/bi0273011; Carreras E, 2005, MOL CELL BIOCHEM, V272, P1, DOI 10.1007/s11010-005-4777-2; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Ferro V, 2002, CARBOHYD RES, V337, P139, DOI 10.1016/S0008-6215(01)00300-7; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; KIMATA H, 1992, CELL IMMUNOL, V141, P422, DOI 10.1016/0008-8749(92)90160-Q; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Liang CT, 2007, J COMP PATHOL, V136, P57, DOI 10.1016/j.jcpa.2006.11.002; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Maeda T, 2002, EUR J BIOCHEM, V269, P307, DOI 10.1046/j.0014-2956.2001.02653.x; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; Parish CR, 1999, CANCER RES, V59, P3433; PETERSON CGB, 1986, IMMUNOBIOLOGY, V171, P1; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Venge P, 1998, INT J BIOCHEM CELL B, V30, P433, DOI 10.1016/S1357-2725(97)00127-1; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Yu GL, 2002, EUR J MED CHEM, V37, P783, DOI 10.1016/S0223-5234(02)01347-8; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	34	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25468	25474		10.1074/jbc.M803516200	http://dx.doi.org/10.1074/jbc.M803516200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18593710	hybrid			2022-12-25	WOS:000259012700042
J	Gregori, C; Schurller, C; Frohner, IE; Ammerer, G; Kuchler, K				Gregori, Christa; Schuerller, Christoph; Frohner, Ingrid E.; Ammerer, Gustav; Kuchler, Karl			Weak organic acids trigger conformational changes of the yeast transcription factor War1 in vivo to elicit stress adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE UTILIZATION PATHWAY; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; AMINO-ACID; FUNCTIONAL DISSECTION; PHENOTYPIC ANALYSIS; REGULATORY GENE; ACTIVATION; BINDING	The Saccharomyces cerevisiae zinc cluster regulator War1 mediates an essential transcriptional and adaptive response to weak organic acid stress. Here we investigate the mechanism of War1 activation upon weak acid stress. We identified several gain-of-function WAR1 alleles mapping to the central War1 region. These mutations constitutively increase levels of the plasma membrane ABC transporter Pdr12, the main War1 target mediating stress adaptation. Functional analysis of War1 reveals that the central region and its C-terminal activation domain are required for function. Notably, the native DNA-binding and dimerization domains appear dispensable for War1 activity, because they can be replaced by a LexA DNA-binding domain. Chromatin immunoprecipitation demonstrates elevated promoter affinity of activated War1, because its PDR12 promoter association increases upon stress. Hyperactive WAR1 alleles have constitutively high PDR12 promoter association. Furthermore, fluorescence resonance energy transfer of functional CFP-War1-YFP proteins also demonstrates conformational changes of stress-activated War1 in vivo. Our results suggest a mechanism whereby War1 activation is accompanied by conformational changes enhancing promoter association, thus initiating the adaptation process.	[Gregori, Christa; Frohner, Ingrid E.; Kuchler, Karl] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Schuerller, Christoph; Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schurller, C (corresponding author), Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria.	Christoph.Schueller@univie.ac.at; karl.kuchler@meduniwien.ac.at	kuchler, karl/AAL-6937-2020	kuchler, karl/0000-0003-2719-5955; Schuller, Christoph/0000-0002-1649-1217; Frohner, Ingrid/0000-0002-0200-449X	Austrian Science Foundation [P-15934-B08]; Vienna Biocenter [SFB35-04]; Austrian Science Fund (FWF) [F 3504] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Vienna Biocenter; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Foundation Grant P-15934-B08 and in part by Grant SFB35-04 ( to K. K.) and by Vienna Biocenter Ph.D. program grant ( to I. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; des Etages SAG, 2001, MOL MICROBIOL, V40, P890, DOI 10.1046/j.1365-2958.2001.02432.x; desEtages SAG, 1996, GENETICS, V142, P1069; El Alami M, 2002, MOL MICROBIOL, V43, P1629; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Flynn PJ, 1999, MOL CELL BIOL, V19, P882; FRIDEN P, 1989, MOL CELL BIOL, V9, P4056, DOI 10.1128/MCB.9.9.4056; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gregori C, 2007, FEBS J, V274, P3094, DOI 10.1111/j.1742-4658.2007.05837.x; Hallstrom TC, 2001, J BIOL CHEM, V276, P23674, DOI 10.1074/jbc.M101568200; Hatzixanthis K, 2003, YEAST, V20, P575, DOI 10.1002/yea.981; Hazelwood LA, 2006, FEMS YEAST RES, V6, P937, DOI 10.1111/j.1567-1364.2006.00094.x; Holyoak CD, 1999, J BACTERIOL, V181, P4644, DOI 10.1128/JB.181.15.4644-4652.1999; Huang HL, 2000, MOL CELL BIOL, V20, P892, DOI 10.1128/MCB.20.3.892-899.2000; Kaiser C., 1994, METHODS YEAST GENETI; KIRKPATRICK CR, 1995, MOL CELL BIOL, V15, P4021; Kolaczkowska A, 2002, MOL GENET GENOMICS, V267, P96, DOI 10.1007/s00438-002-0642-0; Kolaczkowska A, 1999, DRUG RESIST UPDATE, V2, P403, DOI 10.1054/drup.1999.0113; KREBS HA, 1983, BIOCHEM J, V214, P657, DOI 10.1042/bj2140657; Kren A, 2003, MOL CELL BIOL, V23, P1775, DOI 10.1128/MCB.23.5.1775-1785.2003; Lebel K, 2006, YEAST, V23, P249, DOI 10.1002/yea.1346; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; MARCZAK JE, 1989, MOL CELL BIOL, V9, P4696, DOI 10.1128/MCB.9.11.4696; MARCZAK JE, 1991, MOL CELL BIOL, V11, P2609, DOI 10.1128/MCB.11.5.2609; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Reece RJ, 2006, BIOCHEM SOC SYMP, V73, P85; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; Schuller C, 2004, MOL BIOL CELL, V15, P706, DOI 10.1091/mbc.E03-05-0322; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2003, EMBO J, V22, P5147, DOI 10.1093/emboj/cdg480; SIKORSKI RS, 1989, GENETICS, V122, P19; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Wang D, 1999, J BIOL CHEM, V274, P19017, DOI 10.1074/jbc.274.27.19017; Wang D, 1997, J BIOL CHEM, V272, P19383, DOI 10.1074/jbc.272.31.19383; ZHOU KM, 1990, NUCLEIC ACIDS RES, V18, P291, DOI 10.1093/nar/18.2.291	49	26	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25752	25764		10.1074/jbc.M803095200	http://dx.doi.org/10.1074/jbc.M803095200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18621731	Green Published, hybrid			2022-12-25	WOS:000259012700069
J	Haraguchi, M; Okubo, T; Miyashita, Y; Miyamoto, Y; Hayashi, M; Crotti, TN; McHugh, KP; Ozawa, M				Haraguchi, Misako; Okubo, Tadashi; Miyashita, Yayoi; Miyamoto, Yasunori; Hayashi, Masao; Crotti, Tania N.; McHugh, Kevin P.; Ozawa, Masayuki			Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; MESENCHYMAL TRANSITIONS; COLORECTAL-CANCER; TUMOR-REGRESSION; SUPPRESSION; GENE; ACTIVATION; PROMOTER; SURVIVAL; CONFERS	Snail, a transcriptional repressor of E-cadherin expression, plays a role in the process of epithelial-mesenchymal transition. However, the molecular basis of the role of snail in epithelial-mesenchymal transition has not been fully clarified. Here we show that the expression of snail in epithelial Madin-Darby canine kidney (MDCK) and A431 cells enhances both cell detachment and attachment. Snail did not confer resistance to anoikis induced by loss of contact but instead enhanced cell attachment to extracellular matrices such as fibronectin. This attachment was inhibited by Arg-Gly-Asp (RGD) peptides. Up-regulation of the promoter activity of integrin V was observed in snail-expressing MDCK (MDCK/snail) cells. Snail also enhanced MDCK cell migration toward osteopontin that is a ligand for integrin V 3. We confirmed the reduction of basement membrane proteins such as laminin (LN) alpha 3, beta 3, and gamma 2 (laminin-5/LN-5) and of receptors for LN-5 such as integrins alpha 3, alpha 6, or alpha 4 in MDCK/snail or in snail-expressing A431 (A431/snail) cells. Nevertheless, suppression of LN-gamma 3 chain by transient transfection of small interference RNAs resulted in no enhancement of cell detachment. We also found an induction of matrix metalloproteinase-3 in MDCK/snail and A431/snailcells. However, the inhibition of matrix metalloproteinase-3 showed no significant effect on the detachment of MDCK/snail cells. These results suggest that snail enhances cell detachment by multiple mechanism and leads to cell migration and reattachment at a second site, at least in part, by changing the expression of integrins in the cells.	[Haraguchi, Misako; Okubo, Tadashi; Miyashita, Yayoi; Ozawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan; [Miyamoto, Yasunori; Hayashi, Masao] Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Crotti, Tania N.; McHugh, Kevin P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02115 USA	Kagoshima University; Ochanomizu University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Haraguchi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	haraguci@m3.kufm.kagoshima-u.ac.jp	Miyamoto, Yasunori/M-4825-2019	Miyamoto, Yasunori/0000-0001-9192-4281; Crotti, Tania/0000-0002-5422-3758				Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; BIRCHMEIER C, 1996, ACTA ANAT, V156, P17; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO;2-L; Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kambe M, 1998, BBA-GENE STRUCT EXPR, V1395, P209, DOI 10.1016/S0167-4781(97)00152-8; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kolachala VL, 2007, J BIOL CHEM, V282, P32965, DOI 10.1074/jbc.M704388200; Mak GZ, 2006, MOL BIOL CELL, V17, P3664, DOI 10.1091/mbc.E05-11-1070; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Uchimiya H, 2002, CANCER RES, V62, P2834; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	35	79	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23514	23523		10.1074/jbc.M801125200	http://dx.doi.org/10.1074/jbc.M801125200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593711	Green Published, hybrid			2022-12-25	WOS:000258638900004
J	Matsushima, Y; Farr, CL; Fan, L; Kaguni, LS				Matsushima, Yuichi; Farr, Carol L.; Fan, Li; Kaguni, Laurie S.			Physiological and biochemical defects in carboxyl-terminal mutants of mitochondrial DNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; MULTIPLE DELETIONS; BACTERIOPHAGE T7; GENE-4 HELICASE; BINDING PROTEIN; COPY NUMBER; TWINKLE; DOMAIN	Mitochondrial DNA helicase, also called Twinkle, is essential for mtDNA maintenance. Its helicase domain shares high homology with helicases from superfamily 4. Structural analyses of helicases from this family indicate that carboxyl-terminal residues contribute to NTP hydrolysis required for translocation and DNA unwinding, yet genetic and biochemical information is very limited. Here, we evaluate the effects of overexpression in Drosophila cell culture of variants carrying a series of deletion and alanine substitution mutations in the carboxyl terminus and identify critical residues between amino acids 572 and 596 of the 613 amino acid polypeptide that are essential for mitochondrial DNA helicase function in vivo. Likewise, amino acid substitution mutants K574A, R576A, Y577A, F588A, and F595A show dose-dependent dominant-negative phenotypes. Arg-576 and Phe-588 are analogous to the arginine finger and base stack of other helicases, including the bacteriophage T7 gene 4 protein and bacterial DnaB helicase, respectively. We show here that representative human recombinant proteins that are analogous to the alanine substitution mutants exhibit defects in nucleotide hydrolysis. Our findings may be applicable to understand the role of the carboxyl-terminal region in superfamily 4 DNA helicases in general.	[Matsushima, Yuichi; Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fan, Li] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Michigan State University; Scripps Research Institute	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [GM45295, RO1 CA112093, PO1 CA92584]; NATIONAL CANCER INSTITUTE [R01CA112093, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45295 (to L.S.K.) and RO1 CA112093 and PO1 CA92584 (NCI; to John A. Tainer in support of L. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Leipe DD, 2000, GENOME RES, V10, P5; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790	35	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23964	23971		10.1074/jbc.M803674200	http://dx.doi.org/10.1074/jbc.M803674200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593709	hybrid, Green Published			2022-12-25	WOS:000258638900052
J	Mouillet-Richard, S; Nishida, N; Pradines, E; Laude, H; Schneider, B; Feraudet, C; Grassi, J; Launay, JM; Lehmann, S; Kellermann, O				Mouillet-Richard, Sophie; Nishida, Noriyuki; Pradines, Elodie; Laude, Hubert; Schneider, Benoit; Feraudet, Cecile; Grassi, Jacques; Launay, Jean-Marie; Lehmann, Sylvain; Kellermann, Odile			Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSSIBLE RELEVANCE; SCRAPIE INFECTION; OXIDATIVE STRESS; PROTEIN PRPC; BRAIN; DISEASE; TRANSPORTERS; TRANSMISSION; HYDROXYLASE; RESISTANT	The conversion of the cellular prion protein, PrPC, to an abnormal isoform, PrPSc, is a central event leading to neurodegeneration in prion diseases. Deciphering the molecular and cellular changes imparted by PrPSc accumulation remains an arduous task due to the small number of cell lines supporting prion replication. Here we introduce the 1C11 cell line as a new in vitro model to investigate prion pathogenesis. This cell line is a committed neuroectodermal progenitor able to differentiate into fully functional serotonergic or catecholaminergic neurons. 1C11 cells, which naturally express PrPC from the undifferentiated state, can be chronically infected with various prion strains. Prion infection does not promote any noticeable phenotypic change in the progenitor cells nor prevent the onset of the serotonergic and catecholaminergic differentiation programs. Pathogenic prions, however, deviate the overall neurotransmitter-metabolism in both pathways by decreasing bioamine synthesis, storage, and transport, and enhancing catabolism. Noteworthy, oxidized derivatives of both serotonin and catecholamines are selectively detected in the differentiated progenies of infected cells and contribute to irreversible impairment in bioamine synthesis. Finally, the level of PrPSc accumulation, that of infectivity, and the extent of all prion-induced changes in infected cells appear to be correlated. The report of such specific effects of infection on neuronal functions provides a foundation for dissecting the events underlying loss of neuronal homeostasis in prion diseases.	[Mouillet-Richard, Sophie; Pradines, Elodie; Schneider, Benoit; Kellermann, Odile] CNRS, Inst Pasteur, INSERM, U747,FRE 2937, F-94801 Villejuif, France; [Nishida, Noriyuki; Lehmann, Sylvain] CNRS, Inst Human Genet, UPR 1142, F-34396 Montpellier 5, France; [Laude, Hubert] INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Feraudet, Cecile; Grassi, Jacques] CEA Saclay, Serv Pharmacol & Immunoanalyse, iBiTecS, F-91191 Gif Sur Yvette, France; [Launay, Jean-Marie] Hoffmann Roche AG, Pharma Res Dept, CH-4070 Basel, Switzerland; [Launay, Jean-Marie] Hop Lariboisiere, Serv Biochim, EA3621, F-75009 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Roche Holding; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Mouillet-Richard, S (corresponding author), CNRS, Inst Pasteur, INSERM, U747,FRE 2937, 7 Rue Guy Moquet, F-94801 Villejuif, France.	mouillet@vjf.cnrs.fr	Mouillet, Sophie/E-4960-2017; Lehmann, Sylvain/P-1301-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; Lehmann, Sylvain/0000-0001-6117-562X; Schneider, Benoit/0000-0002-1377-2670	Groupement d'interet scientifique Infections a prions; CNRS; Fondation de la Recherche Medicale; European Community [TSE Biotech BIO4CT98-6064, Neuroprion FOOD-CT-2004-506579]	Groupement d'interet scientifique Infections a prions; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); European Community(European Commission)	This work was supported by grants from the Groupement d'interet scientifique "Infections a prions," the CNRS, the Fondation de la Recherche Medicale, and the European Community (TSE Biotech BIO4CT98-6064, Neuroprion FOOD-CT-2004-506579). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumgarten HG, 2004, NEUROTOX RES, V6, P589, DOI 10.1007/BF03033455; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CHEN JC, 1989, J PHARMACOL EXP THER, V250, P141; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fleckenstein AE, 2000, EUR J PHARMACOL, V406, P1, DOI 10.1016/S0014-2999(00)00639-7; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kloppel S, 2002, J NEURAL TRANSM, V109, P1105, DOI 10.1007/s007020200093; Kocisko DA, 2004, J GEN VIROL, V85, P2479, DOI 10.1099/vir.0.80082-0; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; Larsen KE, 2002, J NEUROSCI, V22, P8951; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; LEVINE RA, 1984, ANAL BIOCHEM, V143, P205, DOI 10.1016/0003-2697(84)90577-3; LIN PYT, 1984, J LIQ CHROMATOGR, V7, P509, DOI 10.1080/01483918408073983; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Milhavet O, 2006, STEM CELLS, V24, P2284, DOI 10.1634/stemcells.2006-0088; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROSA LFBPC, 1995, BIOCHEM J, V310, P709, DOI 10.1042/bj3100709; RUBENSTEIN R, 1991, J GEN VIROL, V72, P1279, DOI 10.1099/0022-1317-72-6-1279; Schatzl HM, 1997, J VIROL, V71, P8821; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; TATEISHI J, 1984, ACTA NEUROPATHOL, V64, P85, DOI 10.1007/BF00695613; Thiriot DS, 2001, J BIOL CHEM, V276, P27304, DOI 10.1074/jbc.M103947200; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; WOLF WA, 1988, J NEUROCHEM, V50, P534, DOI 10.1111/j.1471-4159.1988.tb02944.x; WOLF WA, 1985, EUR J PHARMACOL, V109, P381, DOI 10.1016/0014-2999(85)90399-1; Wong BS, 2001, J NEUROCHEM, V79, P689, DOI 10.1046/j.1471-4159.2001.00625.x; WRONA MZ, 1995, J NEUROCHEM, V64, P1390; Wrona MZ, 2001, CHEM RES TOXICOL, V14, P1184, DOI 10.1021/tx010037c; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Zeidler M, 1997, LANCET, V350, P908, DOI 10.1016/S0140-6736(97)03148-6	47	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23782	23790		10.1074/jbc.M802433200	http://dx.doi.org/10.1074/jbc.M802433200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18617522	Green Published, hybrid			2022-12-25	WOS:000258638900032
J	van der Sande, M; Teunis, P; Sabel, R				van der Sande, Marianne; Teunis, Peter; Sabel, Rob			Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population	PLOS ONE			English	Article								Background: Governments are preparing for a potential influenza pandemic. Therefore they need data to assess the possible impact of interventions. Face-masks worn by the general population could be an accessible and affordable intervention, if effective when worn under routine circumstances. Methodology: We assessed transmission reduction potential provided by personal respirators, surgical masks and home-made masks when worn during a variety of activities by healthy volunteers and a simulated patient. Principal Findings: All types of masks reduced aerosol exposure, relatively stable over time, unaffected by duration of wear or type of activity, but with a high degree of individual variation. Personal respirators were more efficient than surgical masks, which were more efficient than home-made masks. Regardless of mask type, children were less well protected. Outward protection (mask wearing by a mechanical head) was less effective than inward protection (mask wearing by healthy volunteers). Conclusions/Significance: Any type of general mask use is likely to decrease viral exposure and infection risk on a population level, in spite of imperfect fit and imperfect adherence, personal respirators providing most protection. Masks worn by patients may not offer as great a degree of protection against aerosol transmission.	[van der Sande, Marianne; Teunis, Peter] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Teunis, Peter] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Glob Hlth, Atlanta, GA USA; [Sabel, Rob] Netherlands Org Appl Sci Res TNO, Rijswijk, Netherlands	Netherlands National Institute for Public Health & the Environment; Emory University; Rollins School Public Health; Netherlands Organization Applied Science Research	van der Sande, M (corresponding author), Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands.	marianne.van.der.sande@rivm.nl		van der Sande, Marianne AB/0000-0002-4778-6739	Netherlands Ministry of Health, Welfare and Sports	Netherlands Ministry of Health, Welfare and Sports	The study was funded by the Netherlands Ministry of Health, Welfare and Sports. The sponsor had no role in design and conduct of the study, in the collection, analysis and interpretation, nor in the preparation, review or approval of the manuscript.	Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; DIEKMAN O, 2000, WILEY SERIES MATH CO; Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Wilder-Smith Annelies, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P481; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730	16	254	261	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2618	10.1371/journal.pone.0002618	http://dx.doi.org/10.1371/journal.pone.0002618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612429	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800020
J	He, XS; Holmes, TH; Sasaki, S; Jaimes, MC; Kemble, GW; Dekker, CL; Arvin, AM; Greenberg, HB				He, Xiao-Song; Holmes, Tyson H.; Sasaki, Sanae; Jaimes, Maria C.; Kemble, George W.; Dekker, Cornelia L.; Arvin, Ann M.; Greenberg, Harry B.			Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; VIRUS INFECTION; NK CELLS; IMMUNE-RESPONSES; LIVE; CHILDREN; ADULTS; VACCINATION; SAFETY	Background: Factors affecting immune responses to influenza vaccines have not been studied systematically. We hypothesized that T-cell and antibody responses to the vaccines are functions of pre-existing host immunity against influenza antigens. Methodology/Principal Findings: During the 2004 and 2005 influenza seasons, we have collected data on cellular and humoral immune reactivity to influenza virus in blood samples collected before and after immunization with inactivated or live attenuated influenza vaccines in healthy children and adults. We first used cross-validated lasso regression on the 2004 dataset to identify a group of candidate baseline correlates with T-cell and antibody responses to vaccines, defined as fold-increase in influenza-specific T-cells and serum HAI titer after vaccination. The following baseline parameters were examined: percentages of influenza-reactive IFN-gamma(+) cells in T and NK cell subsets, percentages of influenza-specific memory B-cells, HAI titer, age, and type of vaccine. The candidate baseline correlates were then tested with the independent 2005 dataset. Baseline percentage of influenza-specific IFN-gamma(+) CD4 T-cells was identified as a significant correlate of CD4 and CD8 T- cell responses, with lower baseline levels associated with larger T- cell responses. Baseline HAI titer and vaccine type were identified as significant correlates for HAI response, with lower baseline levels and the inactivated vaccine associated with larger HAI responses. Previously we reported that baseline levels of CD56(dim) NK reactivity against influenza virus inversely correlated with the immediate T- cell response to vaccination, and that NK reactivity induced by influenza virus depended on IL-2 produced by influenza-specific memory T- cells. Taken together these results suggest a novel mechanism for the homeostasis of virus-specific T- cells, which involves interaction between memory helper T-cells, CD56(dim) NK and DC. Significance: These results demonstrate that assessment of baseline biomarkers may predict immunologic outcome of influenza vaccination and may reveal some of the mechanisms responsible for variable immune responses following vaccination and natural infection.	[He, Xiao-Song; Sasaki, Sanae; Jaimes, Maria C.; Greenberg, Harry B.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [He, Xiao-Song; Sasaki, Sanae; Jaimes, Maria C.; Greenberg, Harry B.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Holmes, Tyson H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Biostat, Stanford, CA USA; [Kemble, George W.; Arvin, Ann M.] MedImmune Vaccines, Mountain View, CA USA; [Dekker, Cornelia L.; Arvin, Ann M.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; AstraZeneca; Medimmune; Stanford University; Stanford University	He, XS (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	xiaosong@Stanford.edu		greenberg, harry/0000-0002-2128-9080	(National Center for Research Resources), National Institutes of Health [U19 AI057229, M01 RR-00070]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	(National Center for Research Resources), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	U19 AI057229 and M01 RR-00070 (National Center for Research Resources), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2001, PHILOS T ROY SOC B, V356, P1947, DOI 10.1098/rstb.2001.0982; BELSHE RB, 2004, VACCINES; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Bot A, 1996, J VIROL, V70, P5668, DOI 10.1128/JVI.70.8.5668-5672.1996; Couch R B, 2003, Dev Biol (Basel), V115, P25; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; ENNIS FA, 1981, LANCET, V2, P891; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; GRUBER WC, 1990, AM J DIS CHILD, V144, P595, DOI 10.1001/archpedi.1990.02150290089035; Gruber WC, 1996, J INFECT DIS, V173, P1313, DOI 10.1093/infdis/173.6.1313; Harrell FE, 2001, REGRESSION MODELING; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; HE XS, 2008, J INFECT DIS; HOLM S, 1979, SCAND J STAT, V43, P223; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; KILBOURNE ED, 1999, VACCINES, P531; Kutza J, 1996, CLIN DIAGN LAB IMMUN, V3, P105, DOI 10.1128/CDLI.3.1.105-108.1996; Lamb RA, 2001, FIELDS VIROLOGY, P1533; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MILLIKEN G, 1998, ANAL MESSY DATA DESI; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; NAGLER A, 1989, J IMMUNOL, V143, P3183; NETER J, 1996, APPL LINEAR STAT MOD, P724; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Perez OD, 2006, IMMUNOL REV, V210, P208, DOI 10.1111/j.0105-2896.2006.00364.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SCHAPIRO JM, 1990, J MED VIROL, V30, P196, DOI 10.1002/jmv.1890300310; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	53	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2574	10.1371/journal.pone.0002574	http://dx.doi.org/10.1371/journal.pone.0002574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596908	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200039
J	Engel, R; Westphal, AH; Huberts, DHEW; Nabuurs, SM; Lindhoud, S; Visser, AJWG; van Mierlo, CPM				Engel, Ruchira; Westphal, Adrie H.; Huberts, Daphne H. E. W.; Nabuurs, Sanne M.; Lindhoud, Simon; Visser, Antonie J. W. G.; van Mierlo, Carlo P. M.			Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; AZOTOBACTER-VINELANDII APOFLAVODOXIN; INCLUSION-BODY FORMATION; PROTEIN STABILITY; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; REFRACTIVE-INDEX; SELF-ASSOCIATION; CREATINE-KINASE	To understand how proteins fold in vivo, it is important to investigate the effects of macromolecular crowding on protein folding. Here, the influence of crowding on in vitro apoflavodoxin folding, which involves a relatively stable off-pathway intermediate with molten globule characteristics, is reported. To mimic crowded conditions in cells, dextran 20 at 30% (w/v) is used, and its effects are measured by a diverse combination of optical spectroscopic techniques. Fluorescence correlation spectroscopy shows that unfolded apoflavodoxin has a hydrodynamic radius of 37 +/- 3 angstrom at 3M guanidine hydrochloride. Forster resonance energy transfer measurements reveal that subsequent addition of dextran 20 leads to a decrease in protein volume of about 29%, which corresponds to an increase in protein stability of maximally 1.1 kcal mol(-1). The compaction observed is accompanied by increased secondary structure, as far-UV CD spectroscopy shows. Due to the addition of crowding agent, the midpoint of thermal unfolding of native apoflavodoxin rises by 2.9 degrees C. Although the stabilization observed is rather limited, concomitant compaction of unfolded apoflavodoxin restricts the conformational space sampled by the unfolded state, and this could affect kinetic folding of apoflavodoxin. Most importantly, crowding causes severe aggregation of the off-pathway folding intermediate during apoflavodoxin folding in vitro. However, apoflavodoxin can be over expressed in the cytoplasm of Escherichia coli, where it efficiently folds to its functional native form at high yield without noticeable problems. Apparently, in the cell, apoflavodoxin requires the help of chaperones like Trigger Factor and the DnaK system for efficient folding.	[Engel, Ruchira; Westphal, Adrie H.; Huberts, Daphne H. E. W.; Nabuurs, Sanne M.; Lindhoud, Simon; van Mierlo, Carlo P. M.] Univ Wageningen & Res Ctr, Biochem Lab, MicroSpect Ctr, NL-6703 HA Wageningen, Netherlands; [Visser, Antonie J. W. G.] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Biol Struct, NL-1081 HV Amsterdam, Netherlands	Wageningen University & Research; Vrije Universiteit Amsterdam	van Mierlo, CPM (corresponding author), Univ Wageningen & Res Ctr, Biochem Lab, MicroSpect Ctr, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016; Engel, Ruchira/A-5394-2010; Westphal, Adrie Herman/L-3517-2019	vanMierlo, Carlo p/0000-0002-5358-8392; Westphal, Adrie Herman/0000-0003-4264-6267; Engel, Ruchira/0000-0002-0630-5767	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research "From Molecule to Cell" program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BABUL J, 1969, ANAL BIOCHEM, V28, P216, DOI 10.1016/0003-2697(69)90172-9; Betts S, 1997, ADV PROTEIN CHEM, V50, P243, DOI 10.1016/S0065-3233(08)60323-X; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Despa F, 2005, ANN NY ACAD SCI, V1066, P54, DOI 10.1196/annals.1363.005; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gellerich FN, 1998, EUR J BIOCHEM, V254, P172, DOI 10.1046/j.1432-1327.1998.2540172.x; Hall D, 2006, FEBS LETT, V580, P2584, DOI 10.1016/j.febslet.2006.04.005; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hink MA, 2003, METHOD ENZYMOL, V361, P93; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Knox RS, 2002, J PHYS CHEM B, V106, P5289, DOI 10.1021/jp013927+; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LAURENT TC, 1963, BIOCHEM J, V89, P253, DOI 10.1042/bj0890253; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Martin J, 2002, BIOCHEMISTRY-US, V41, P5050, DOI 10.1021/bi015925l; McPhie P, 2006, J MOL BIOL, V361, P7, DOI 10.1016/j.jmb.2006.05.075; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Muralidhara BK, 2004, BIOCHEMISTRY-US, V43, P12855, DOI 10.1021/bi048944e; Nienhaus GU, 2006, MACROMOL BIOSCI, V6, P907, DOI 10.1002/mabi.200600158; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; Spencer DS, 2005, J MOL BIOL, V351, P219, DOI 10.1016/j.jmb.2005.05.029; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331; ZIMMERMAN SB, 1988, BIOCHIM BIOPHYS ACTA, V949, P297, DOI 10.1016/0167-4781(88)90155-8	74	62	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27383	27394		10.1074/jbc.M802393200	http://dx.doi.org/10.1074/jbc.M802393200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18640986	Green Published, hybrid			2022-12-25	WOS:000259719200006
J	Flores, M; Saavedra, R; Bautista, R; Viedma, R; Tenorio, EP; Leng, L; Sanchez, Y; Juarez, I; Satoskar, AA; Shenoy, AS; Terrazas, LI; Bucala, R; Barbi, J; Satoskar, AR; Rodriguez-Sosa, M				Flores, Marcos; Saavedra, Rafael; Bautista, Rocio; Viedma, Rubi; Tenorio, Eda P.; Leng, Lin; Sanchez, Yuriko; Juarez, Imelda; Satoskar, Anjali A.; Shenoy, Asha S.; Terrazas, Luis I.; Bucala, Richard; Barbi, Joseph; Satoskar, Abhay R.; Rodriguez-Sosa, Miriam			Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii	FASEB JOURNAL			English	Article						proinflammatory cytokines; innate immunity; cerebral toxoplasmosis	CELL-MEDIATED-IMMUNITY; DENDRITIC CELLS; PITUITARY-HORMONE; LEISHMANIA-MAJOR; IL-12 PRODUCTION; INFECTED MICE; CUTTING EDGE; TNF-ALPHA; EXPRESSION; GENE	Macrophage migration inhibitory factor (MIF) exerts either a protective or a deleterious role in the immune response to different pathogens. We analyzed herein the role of MIF in the host control of toxoplasmosis using MIF-/- mice backcrossed to either the BALB/c or the C57BL/6 genetic backgrounds. Both, wild-type (WT) BALB/c and MIF-/- BALB/c mice were susceptible to infection with highly virulent RH as well as moderately virulent ME49 strains of T. gondii. MIF-/- mice, however, showed greater liver damage and more brain cysts, produced less proinflammatory cytokines, and succumbed significantly faster than WT mice. Bone marrow-derived dendritic cells (BMDCs) from MIF-/- mice produced less interleukin-1 beta, interleukin-12, and tumor necrosis factor-alpha than WT BMDCs after stimulation with soluble Toxoplasma antigen (STAB). Similar observations were made in CD11c(+) low-density cells isolated from the spleens of MIF-/- mice challenged with STAB. MIF-/- C57BL/6 mice succumbed to ME49 infection faster than their WT counterparts. C57BL/6 mice that succumbed to infection with the ME49 strain produced less MIF than resistant BALB/c mice similarly infected. Interestingly, an analysis of brains from patients with cerebral toxoplasmosis showed low levels of MIF expression. Together, these findings demonstrate that MIF plays a critical role in mediating host resistance against T. Gondii.	[Barbi, Joseph; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Flores, Marcos; Bautista, Rocio; Viedma, Rubi; Sanchez, Yuriko; Juarez, Imelda; Terrazas, Luis I.; Rodriguez-Sosa, Miriam] Univ Nacl Autonoma Mexico, Unidad Biomed, FES Iztacala, Mexico City 04510, DF, Mexico; [Saavedra, Rafael; Tenorio, Eda P.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Shenoy, Asha S.] Seth GS Med Coll, Dept Pathol, Bombay, Maharashtra, India; [Shenoy, Asha S.] King Edward Mem Hosp, Bombay, Maharashtra, India; [Satoskar, Anjali A.] Ohio State Univ, Dept Pathol, Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Yale University; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; University System of Ohio; Ohio State University	Rodriguez-Sosa, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	satoskar.2@osu.edu; rodriguezm@campus.iztacala.unam.mx	Satoskar, Abhay/AAB-7748-2019; Terrazas, Luis I/AAV-8858-2020; Zumárraga, Dra. Eda Patricia Tenorio/ABE-8294-2020; Flores-Alamo, Marcos/A-3906-2019	Leng, Lin/0000-0002-0605-358X; Terrazas, Luis I./0000-0003-1635-9467; Tenorio, Eda/0000-0002-4725-2286; Flores-Alamo, Marcos/0000-0002-2996-7616; Sanchez Zamora, Yuriko Itzel/0000-0002-0769-8523; Rodriguez-Sosa, Miriam/0000-0003-2911-9390	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; UNAM (PAPIIT-UNAM) [IN208606]; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA) FES-Iztacala; UNAM, Consejo Nacional de Ciencia y Tecnologia (CONACYT) [49812-Q]; U.S. National Institutes of Health	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); UNAM (PAPIIT-UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA) FES-Iztacala; UNAM, Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Universidad Nacional Autonoma de Mexico); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Flores and T.Villamar for their excellent care of the animals. This work was supported by grants from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, UNAM (PAPIIT-UNAM) (IN208606), Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion (PAPCA) FES-Iztacala. UNAM, Consejo Nacional de Ciencia y Tecnologia (CONACYT) to M.R.S (49812-Q), and the U.S. National Institutes of Health to A.R.S. and R.B.	Abe R, 2001, J IMMUNOL, V166, P747, DOI 10.4049/jimmunol.166.2.747; Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; Bacher M, 2002, VIROLOGY, V299, P32, DOI 10.1006/viro.2002.1464; Bellan C, 2002, DIAGN MOL PATHOL, V11, P2, DOI 10.1097/00019606-200203000-00002; Bernhagen J, 1995, BIOTHERAPY, V8, P123, DOI 10.1007/BF01878495; Bliss SK, 1999, J IMMUNOL, V162, P7369; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BUCALA R, 1994, IMMUNOL LETT, V43, P23, DOI 10.1016/0165-2478(94)00152-9; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2003, J INFECT DIS, V187, pS385, DOI 10.1086/374752; CHAO CC, 1993, CLIN IMMUNOL IMMUNOP, V67, P178, DOI 10.1006/clin.1993.1062; Chen M, 2002, J PARASITOL, V88, P1017, DOI 10.1645/0022-3395(2002)088[1017:IOMIHD]2.0.CO;2; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Del Rio L, 2004, J IMMUNOL, V172, P6954, DOI 10.4049/jimmunol.172.11.6954; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Juttner S, 1998, J IMMUNOL, V161, P2383; Kibiki GS, 2007, CLIN IMMUNOL, V123, P60, DOI 10.1016/j.clim.2006.12.004; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Matsumoto K, 2001, AM J NEPHROL, V21, P455, DOI 10.1159/000046649; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Murakami H, 2002, CLIN EXP IMMUNOL, V128, P504, DOI 10.1046/j.1365-2249.2002.01838.x; Nakano Y, 2002, MICROBES INFECT, V4, P1, DOI 10.1016/S1286-4579(01)01503-9; Nguyen TD, 2003, J MED MICROBIOL, V52, P869, DOI 10.1099/jmm.0.04860-0; Oddo M, 2005, INFECT IMMUN, V73, P3783, DOI 10.1128/IAI.73.6.3783-3786.2005; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Saavedra R, 2004, PARASITE IMMUNOL, V26, P67, DOI 10.1111/j.0141-9838.2004.00684.x; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SchartonKersten T, 1995, RES IMMUNOL, V146, P539, DOI 10.1016/0923-2494(96)83029-X; SNIDER HM, 2007, MIF MOST INTERESTING; Stavitsky AB, 2003, PARASITE IMMUNOL, V25, P369, DOI 10.1046/j.1365-3024.2003.00641.x; Suzuki T, 2000, BBA-GENE STRUCT EXPR, V1517, P100, DOI 10.1016/S0167-4781(00)00262-1; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Toh ML, 2006, J IMMUNOL, V177, P4818, DOI 10.4049/jimmunol.177.7.4818; Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	54	53	55	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2008	22	10					3661	3671		10.1096/fj.08-111666	http://dx.doi.org/10.1096/fj.08-111666			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18606868	Green Published			2022-12-25	WOS:000259642600027
J	Bottomley, MJ; Lo Surdo, P; Di Giovine, P; Cirillo, A; Scarpelli, R; Ferrigno, F; Jones, P; Neddermann, P; De Francesco, R; Steinkuhler, C; Gallinari, P; Carfi, A				Bottomley, Matthew J.; Lo Surdo, Paola; Di Giovine, Paolo; Cirillo, Agostino; Scarpelli, Rita; Ferrigno, Federica; Jones, Philip; Neddermann, Petra; De Francesco, Raffaele; Steinkuhler, Christian; Gallinari, Paola; Carfi, Andrea			Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; HISTONE DEACETYLASE HOMOLOG; CRYSTAL-STRUCTURE; CLASS IIHDACS; TRANSCRIPTION; ACETYLATION; INSIGHTS; COMPLEX	Histone deacetylases (HDACs) regulate chromatin status and gene expression, and their inhibition is of significant therapeutic interest. To date, no biological substrate for class IIa HDACs has been identified, and only low activity on acetylated lysines has been demonstrated. Here, we describe inhibitor-bound and inhibitor-free structures of the histone deacetylase-4 catalytic domain (HDAC4cd) and of an HDAC4cd active site mutant with enhanced enzymatic activity toward acetylated lysines. The structures presented, coupled with activity data, provide the molecular basis for the intrinsically low enzymatic activity of class IIa HDACs toward acetylated lysines and reveal active site features that may guide the design of class-specific inhibitors. In addition, these structures reveal a conformationally flexible structural zinc-binding domain conserved in all class IIa enzymes. Importantly, either the mutation of residues coordinating the structural zinc ion or the binding of a class IIa selective inhibitor prevented the association of HDAC4 with the N-CoR center dot HDAC3 repressor complex. Together, these data suggest a key role of the structural zinc-binding domain in the regulation of class IIa HDAC functions.	[Bottomley, Matthew J.; Lo Surdo, Paola; Di Giovine, Paolo; Cirillo, Agostino; Scarpelli, Rita; Ferrigno, Federica; Jones, Philip; Neddermann, Petra; De Francesco, Raffaele; Steinkuhler, Christian; Gallinari, Paola; Carfi, Andrea] Ist Ric Biol Mol P Angeletti, Merck Res Labs, I-00040 Rome, Italy	Merck & Company	Carfi, A (corresponding author), Ist Ric Biol Mol P Angeletti, Merck Res Labs, Via Pontina Km 30-600, I-00040 Rome, Italy.		Gallinari, Paola/ABE-8238-2021; Scarpelli, Rita/A-2985-2012; De Francesco, Raffaele/J-6003-2012	De Francesco, Raffaele/0000-0001-8754-5123				Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Illi B, 2007, CIRC RES, V101, P1205; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jones P, 2008, BIOORG MED CHEM LETT, V18, P3456, DOI 10.1016/j.bmcl.2008.02.026; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Moreth K, 2007, BIOCHEM J, V401, P659, DOI 10.1042/BJ20061239; Nielsen TK, 2007, ACTA CRYSTALLOGR F, V63, P270, DOI 10.1107/S1744309107012377; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	35	233	254	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26694	26704		10.1074/jbc.M803514200	http://dx.doi.org/10.1074/jbc.M803514200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18614528	hybrid, Green Published			2022-12-25	WOS:000259341600043
J	Guerrini, M; Guglieri, S; Casu, B; Torri, G; Mourier, P; Boudier, C; Viskov, C				Guerrini, Marco; Guglieri, Sara; Casu, Benito; Torri, Giangiacomo; Mourier, Pierre; Boudier, Christian; Viskov, Christian			Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction - Evidence for very high affinity induced by an unusual Glucuronic acid residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; TRANSFER DIFFERENCE NMR; FACTOR XA; MECHANISM; ACTIVATION; LIGAND; OLIGOSACCHARIDES; ACCELERATION; CONFORMATION; SPECTROSCOPY	The antithrombotic activity of low molecular weight heparins (LMWHs) is largely associated with the antithrombin ( AT)binding pentasaccharide sequence AGA*IA (GlcN(NAc/NS),(6S)-GlcA-GlcN(NS),(3,6S)-IdoUA(2S)-GlcN(NS,6S)). The location of the AGA*IA sequences along the LMWH chains is also expected to influence binding to AT. This study was aimed at investigating the role of the structure and molecular conformation of different disaccharide extensions on both sides of the AGA*IA sequence in modulating the affinity for AT. Four high purity octasaccharides isolated by size exclusion chromatography, high pressure liquid chromatography, and AT-affinity chromatography from the LMWH enoxaparin were selected for the study. All the four octasaccharides terminate at their nonreducing end with 4,5-unsaturated uronic acid residues (Delta U). In two octasaccharides, AGA*IA was elongated at the reducing end by units IdoUA(2S)-GlcN(NS,6S) (OCTA- 1) or IdoUA-GlcN(NAc),(6S) (OCTA-2). In the other two octasaccharides (OCTA-3 and OCTA-4), AGA*IA was elongated at the nonreducing side by units GlcN(NS),(6S)-IdoUA and GlcN(NS),(6S)-GlcA, respectively. Extensions increased the affinity for AT of octasaccharides with respect to pentasaccharide AGA*IA, as also confirmed by fluorescence titration. Two- dimensional NMR and docking studies clearly indicated that, although elongation of the AGA*IA sequence does not substantially modify the bound conformation of the AGA*IA segment, extensions promote additional contacts with the protein. It should be noted that, as not previously reported, the unusual GlcA residue that precedes the AGA*IA sequence in OCTA-4 induced an unexpected 1 order of magnitude increase in the affinity to AT with respect to its IdoUA- containing homolog OCTA-3. Such a residue was found to orientate its two hydroxyl groups at close distance to residues of the protein. Besides the well established ionic interactions, nonionic interactions may thus contribute to strengthen oligosaccharideAT complexes.	[Guerrini, Marco; Guglieri, Sara; Casu, Benito; Torri, Giangiacomo] G Ronzoni Inst Chem & Biochem Res, I-20133 Milan, Italy; [Mourier, Pierre; Viskov, Christian] Sanofi Aventis, F-94403 Vitry Sur Seine, France; [Boudier, Christian] Univ Strasbourg 1, Fac Pharm, Dept Physicochim & Pharmacochim Interact Mol & Ce, CNRS,UMR 7175, F-67401 Illkirch Graffenstaden, France	Sanofi-Aventis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guerrini, M (corresponding author), G Ronzoni Inst Chem & Biochem Res, Via G Colombo 81, I-20133 Milan, Italy.	guerrini@ronzoni.it; Christian.Viskov@sanofi-aventis.com	Boudier, Christian/N-3841-2018	Boudier, Christian/0000-0002-5534-6389; Torri, Giangiacomo/0000-0002-2077-1203; Guerrini, Marco/0000-0001-7246-9113				Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091; Belzar KJ, 2000, J BIOL CHEM, V275, P8733, DOI 10.1074/jbc.275.12.8733; Boudier C, 2001, BIOCHEMISTRY-US, V40, P9962, DOI 10.1021/bi010701o; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B, 1999, SEMIN THROMB HEMOST, V25, P17; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; de Kort M, 2005, DRUG DISCOV TODAY, V10, P769, DOI 10.1016/S1359-6446(05)03457-4; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Guerrini M, 2007, SEMIN THROMB HEMOST, V33, P478, DOI 10.1055/s-2007-982078; Guerrini M, 2006, BIOCHEM J, V399, P191, DOI 10.1042/BJ20060656; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hjelm R, 2007, BIOCHEMISTRY-US, V46, P3378, DOI 10.1021/bi6024929; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; Hoppensteadt D., 2005, CHEM BIOL HEPARIN HE, P583; Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; LOGANATHAN D, 1990, BIOCHEMISTRY-US, V29, P4362, DOI 10.1021/bi00470a015; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSELEY HNB, 1995, J MAGN RESON SER B, V108, P243, DOI 10.1006/jmrb.1995.1129; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; RAGAZZI M, 1993, J CARBOHYD CHEM, V12, P523, DOI 10.1080/07328309308019405; RAGAZZI M, 1986, J COMPUT CHEM, V7, P105, DOI 10.1002/jcc.540070203; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Seyrek E, 2007, BIOPOLYMERS, V86, P249, DOI 10.1002/bip.20731; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Toida T, 1996, J BIOL CHEM, V271, P32040, DOI 10.1074/jbc.271.50.32040; VERLI H, 1997, J MOL GRAPH MODEL, V15, P18	40	72	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26662	26675		10.1074/jbc.M801102200	http://dx.doi.org/10.1074/jbc.M801102200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640975	hybrid, Green Published			2022-12-25	WOS:000259341600040
J	Marcellino, D; Ferre, S; Casado, V; Cortes, A; Le Foll, B; Mazzola, C; Drago, F; Saur, O; Stark, H; Soriano, A; Barnes, C; Goldberg, SR; Lluis, C; Fuxe, K; Franco, R				Marcellino, Daniel; Ferre, Sergi; Casado, Vicent; Cortes, Antonio; Le Foll, Bernard; Mazzola, Carmen; Drago, Filippo; Saur, Oliver; Stark, Holger; Soriano, Aroa; Barnes, Chanel; Goldberg, Steven R.; Lluis, Carme; Fuxe, Kjell; Franco, Rafael			Identification of dopamine D-1-D-3 receptor heteromers - Indications for a role of synergistic D-1-D-3 receptor interactions in the striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; LOCOMOTOR-ACTIVITY; CELL-MEMBRANE; D-2 RECEPTORS; MICE; D1; RAT; 7-OH-DPAT; GENE; NEUROTRANSMISSION	The function of dopamine D-3 receptors present in the striatum has remained elusive. In the present study evidence is provided for the existence of dopamine D-1-D-3 receptor heteromers and for an intramembrane D-1-D-3 receptor cross-talk in living cells and in the striatum. The formation of D-1-D-3 receptor heteromers was demonstrated by fluorescence resonance energy transfer and bioluminescence resonance energy transfer techniques in transfected mammalian cells. In membrane preparations from these cells, a synergistic D-1-D-3 intramembrane receptor-receptor interaction was observed, by which D3 receptor stimulation enhances D-1 receptor agonist affinity, indicating that the D-1-D-3 intramembrane receptor-receptor interaction is a biochemical characteristic of the D-1-D-3 receptor heteromer. The same biochemical characteristic was also observed in membrane preparations from brain striatum, demonstrating the striatal co-localization and heteromerization of D-1 and D-3 receptors. According to the synergistic D-1-D-3 intramembrane receptor-receptor interaction, experiments in reserpinized mice showed that D-3 receptor stimulation potentiates D-1 receptor-mediated behavioral effects by a different mechanism than D-2 receptor stimulation. The present study shows that a main functional significance of the D3 receptor is to obtain a stronger dopaminergic response in the striatal neurons that co-express the two receptors.	[Marcellino, Daniel; Fuxe, Kjell] Karolinska Inst, Dept Neurosci, Stockholm 17177, Sweden; [Ferre, Sergi; Barnes, Chanel; Goldberg, Steven R.] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Casado, Vicent; Cortes, Antonio; Soriano, Aroa; Lluis, Carme; Franco, Rafael] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Casado, Vicent; Cortes, Antonio; Soriano, Aroa; Lluis, Carme; Franco, Rafael] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, E-08028 Barcelona, Spain; [Le Foll, Bernard] Univ Toronto, Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON M5S 2S1, Canada; [Mazzola, Carmen; Drago, Filippo] Univ Catania, Sch Med, Dept Expt & Clin Pharmacol, I-95125 Catania, Italy; [Saur, Oliver; Stark, Holger] Univ Frankfurt, Inst Chem Pharmacol, D-60438 Frankfurt, Germany	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Catania; Goethe University Frankfurt	Ferre, S (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Dept Hlth & Human Serv, 251 Bayview Blvd, Baltimore, MD 21224 USA.	sferre@intra.nida.nih.gov	Soriano, Aroa/J-9105-2016; Franco, Rafael/C-3694-2015; Stark, Holger/A-4235-2009; Marcellino, Daniel/HDM-8433-2022; Drago, Francesco/H-7563-2019; Le Foll, Bernard/K-2952-2014; Drago, Filippo/AAC-5090-2022; Ferre, Sergi/K-6115-2014; Casadó, Vicent/K-1660-2014; Drago, Filippo/K-5619-2018	Soriano, Aroa/0000-0001-9659-1471; Franco, Rafael/0000-0003-2549-4919; Stark, Holger/0000-0003-3336-1710; Marcellino, Daniel/0000-0002-4618-7267; Le Foll, Bernard/0000-0002-6406-4973; Ferre, Sergi/0000-0002-1747-1779; Casadó, Vicent/0000-0002-1764-3825; Fuxe, Kjell/0000-0001-8491-4288; Drago, Filippo/0000-0003-2887-5223	National Institute on Drug Abuse; Ministerio de Ciencia y Tecnologia [SAF2006-00170]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000001, Z01DA000001, Z02DA000001, ZIADA000493, ZIFDA000001, Z01DA000493] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Institute on Drug Abuse, Dept. of Health and Human Services. This work was also supported by the Ministerio de Ciencia y Tecnologia (Grants SAF2006-00170). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Bordet R, 1997, P NATL ACAD SCI USA, V94, P3363, DOI 10.1073/pnas.94.7.3363; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; CASADO V, 1990, J NEUROSCI RES, V26, P461, DOI 10.1002/jnr.490260409; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ferre S, 1996, EUR J NEUROSCI, V8, P1545, DOI 10.1111/j.1460-9568.1996.tb01617.x; FERRE S, 1994, EUR J PHARMACOL, V255, P203, DOI 10.1016/0014-2999(94)90099-X; FERRE S, 1993, J NEUROSCI, V13, P5402, DOI 10.1523/JNEUROSCI.13-12-05402.1993; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Franco R, 2003, TRENDS BIOCHEM SCI, V28, P238, DOI 10.1016/S0968-0004(03)00065-3; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; Millan MJ, 2000, J PHARMACOL EXP THER, V293, P1063; Millan MJ, 2004, PSYCHOPHARMACOLOGY, V174, P341, DOI 10.1007/s00213-003-1770-x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mori T, 1997, JPN J PHARMACOL, V73, P251, DOI 10.1254/jjp.73.251; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pritchard LM, 2003, NEUROPSYCHOPHARMACOL, V28, P100, DOI 10.1038/sj.npp.1300018; Pugsley TA, 1995, J PHARMACOL EXP THER, V275, P1355; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ridray S, 1998, EUR J NEUROSCI, V10, P1676, DOI 10.1046/j.1460-9568.1998.00173.x; RUBINSTEIN M, 1988, EUR J PHARMACOL, V148, P419, DOI 10.1016/0014-2999(88)90121-5; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; SCHOEMAKER H, 1993, EUR J PHARMACOL, V242, pR1, DOI 10.1016/0014-2999(93)90259-K; Schwartz JC, 1998, BRAIN RES REV, V26, P236, DOI 10.1016/S0165-0173(97)00046-5; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; STARR MS, 1989, PHARMACOL BIOCHEM BE, V33, P41, DOI 10.1016/0091-3057(89)90426-7; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	43	182	184	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26016	26025		10.1074/jbc.M710349200	http://dx.doi.org/10.1074/jbc.M710349200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644790	hybrid, Green Published			2022-12-25	WOS:000259200100030
J	Wen, WY; Liu, W; Yan, J; Zhang, MJ				Wen, Wenyu; Liu, Wei; Yan, Jing; Zhang, Mingjie			Structure basis and unconventional lipid membrane binding properties of the PH-C1 tandem of Rho kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY KINASE; PLECKSTRIN HOMOLOGY DOMAIN; CDC42-BINDING KINASE; PROTEIN-KINASE; TARGET BINDING; PH DOMAINS; MYOSIN-II; ROCK-I; PHOSPHOLIPASE-C-GAMMA-1; COMPLEX	Rho kinase (ROCK), a downstream effector of Rho GTPase, is a serine/threonine protein kinase that regulates many crucial cellular processes via control of cytoskeletal structures. The C-terminal PH-C1 tandem of ROCKs has been implicated to play an autoinhibitory role by sequestering the N-terminal kinase domain and reducing its kinase activity. The binding of lipids to the pleckstrin homology (PH) domain not only regulates the localization of the protein but also releases the kinase domain from the close conformation and thereby activates its kinase activity. However, the molecular mechanism governing the ROCK PH-C1 tandem-mediated lipid membrane interaction is not known. In this study, we demonstrate that ROCK is a new member of the split PH domain family of proteins. The ROCK split PH domain folds into a canonical PH domain structure. The insertion of the atypical C1 domain in the middle does not alter the structure of the PH domain. We further show that the C1 domain of ROCK lacks the diacylglycerol/phorbol ester binding pocket seen in other canonical C1 domains. Instead, the inserted C1 domain and the PH domain function cooperatively in binding to membrane bilayers via the unconventional positively charged surfaces on each domain. Finally, the analysis of all split PH domains with known structures indicates that split PH domains represent a unique class of tandem protein modules, each possessing distinct structural and functional features.	[Wen, Wenyu; Liu, Wei; Yan, Jing; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	liu, weicheng/D-4173-2013; Yan, Jing/C-3163-2012	Liu, Wei/0000-0001-8250-2562; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, CA07/08.SC01, AoE/B-15/01-II]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of Hong Kong Grants HKUST6419/05M, 6442/06M, 663407, CA07/08.SC01, and AoE/B-15/01-II (to M. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Leung T, 1996, MOL CELL BIOL, V16, P5313; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Ng Y, 2004, J BIOL CHEM, V279, P34156, DOI 10.1074/jbc.M405252200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Selvam RA, 2004, NUCLEIC ACIDS RES, V32, pD193, DOI 10.1093/nar/gkh047; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; VAN AL, 1997, GENE DEV, V11, P2295; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yan J, 2008, J MOL BIOL, V378, P425, DOI 10.1016/j.jmb.2008.02.052; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	45	29	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26263	26273		10.1074/jbc.M803417200	http://dx.doi.org/10.1074/jbc.M803417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640982	Green Published, hybrid			2022-12-25	WOS:000259200100054
J	Kan, H; Kim, CH; Kwon, HM; Park, JW; Roh, KB; Lee, H; Park, BJ; Zhang, R; Zhang, J; Soederhall, K; Ha, NC; Lee, BL				Kan, Hongnan; Kim, Chan-Hee; Kwon, Hyun-Mi; Park, Ji-Won; Roh, Kyung-Baeg; Lee, Hanna; Park, Bum-Joon; Zhang, Rong; Zhang, Jinghai; Soederhall, Kenneth; Ha, Nam-Chul; Lee, Bok Luel			Molecular control of phenoloxidase-induced melanin synthesis in an insect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOTRICHIA-DIOMPHALIA LARVAE; TENEBRIO-MOLITOR LARVAE; PROPHENOLOXIDASE-ACTIVATING ENZYME; PATTERN-RECOGNITION PROTEIN; MASQUERADE-LIKE PROTEIN; FRESH-WATER CRAYFISH; SERINE-PROTEASE; COLEOPTERAN INSECT; ANOPHELES-GAMBIAE; MANDUCA-SEXTA	The melanization reaction induced by activated phenoloxidase in arthropods must be tightly controlled because of excessive formation of quinones and excessive systemic melanization damage to the hosts. However, the molecular mechanism by which phenoloxidase-induced melanin synthesis is regulated in vivo is largely unknown. It is known that the Spatzle-processing enzyme is a key enzyme in the production of cleaved Spatzle from pro-Spatzle in the Drosophila Toll pathway. Here, we provide biochemical evidence that the Tenebrio molitor Spatzle processing enzyme converts both the 79-kDa Tenebrio prophenoloxidase and Tenebrio clip-domain SPH1 zymogen to an active melanization complex. This complex, consisting of the 76-kDa Tenebrio phenoloxidase and an active form of Tenebrio clip-domain SPH1, efficiently produces melanin on the surface of bacteria, and this activity has a strong bactericidal effect. Interestingly, we found the phenoloxidase- induced melanization reaction to be tightly regulated by Tenebrio prophenoloxidase, which functions as a competitive inhibitor of melanization complex formation. These results demonstrate that the Tenebrio Toll pathway and the melanization reaction share a common serine protease for the regulation of these two major innate immune responses.	[Kan, Hongnan; Kim, Chan-Hee; Kwon, Hyun-Mi; Park, Ji-Won; Roh, Kyung-Baeg; Lee, Hanna; Ha, Nam-Chul; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Kan, Hongnan; Zhang, Rong; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Soederhall, Kenneth] Uppsala Univ, Evolutionary Biol Ctr, Dept Comparat Physiol, Ctr Biol, SE-75236 Uppsala, Sweden; [Park, Bum-Joon] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Pusan National University; Shenyang Pharmaceutical University; Uppsala University; Pusan National University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Kim, Chan-Hee/C-6849-2016	Kim, Chan-Hee/0000-0002-5315-4981	National Research Laboratory [M10400000028-04J0000-02]; Ministry of Science and Technology/ Korea Science and Engineering Foundation; Pusan National University	National Research Laboratory(Korea Science and Engineering Foundation); Ministry of Science and Technology/ Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Pusan National University(Pusan National University)	This work was supported by programs of the National Research Laboratory (Grant M10400000028-04J0000-02) of the Ministry of Science and Technology/ Korea Science and Engineering Foundation and in part by the BK21 Program and a 2007 Pusan National University postdoctoral fellowship grant (to C.-H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson A F, 2000, Am J Knee Surg, V13, P19; Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee HS, 1999, FEBS LETT, V444, P255, DOI 10.1016/S0014-5793(99)00067-8; Lee KM, 2000, EUR J BIOCHEM, V267, P3695, DOI 10.1046/j.1432-1327.2000.01402.x; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Matarese G, 2008, TRENDS IMMUNOL, V29, P12, DOI 10.1016/j.it.2007.10.006; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53, DOI 10.1093/oxfordjournals.jbchem.a124502; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nappi AJ, 1998, J PARASITOL, V84, P1150, DOI 10.2307/3284664; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	38	171	181	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25316	25323		10.1074/jbc.M804364200	http://dx.doi.org/10.1074/jbc.M804364200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628205	hybrid			2022-12-25	WOS:000259012700025
J	Prahst, C; Heroult, M; Lanahan, AA; Uziel, N; Kessler, O; Shraga-Heled, N; Simons, M; Neufeld, G; Augustin, HG				Prahst, Claudia; Heroult, Melanie; Lanahan, Anthony A.; Uziel, Noa; Kessler, Ofra; Shraga-Heled, Niva; Simons, Michael; Neufeld, Gera; Augustin, Hellmut G.			Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NERVOUS-SYSTEM; C-TERMINUS; CONTAINING PROTEIN; KINASE-ACTIVITY; CRUCIAL ROLE; RGS-GAIP; EXPRESSION; RECEPTOR; CELLS	Vascular endothelial growth factor (VEGF) acts as a hierarchically high switch of the angiogenic cascade by interacting with its high affinity VEGF receptors and with neuropilin co-receptors. VEGF(165) binds to both Neuropilin-1 (NP-1) and VEGFR-2, and it is believed that ligand binding forms an extracellular bridge between both molecules. This leads to complex formation, thereby enhancing VEGFR-2 phosphorylation and subsequent signaling. We found that inhibition of VEGF receptor (VEGFR) phosphorylation reduced complex formation between NP-1 and VEGFR-2, suggesting a functional role of the cytoplasmic domain of VEGFR-2 for complex formation. Correspondingly, deleting the PDZ-binding domain of NP-1 decreased complex formation, indicating that extracellular VEGF165 binding is not sufficient for VEGFR-2-NP-1 interaction. Synectin is an NP-1 PDZ-binding domain-interacting molecule. Experiments in Synectin-deficient endothelial cells revealed reduced VEGFR-2-NP-1 complex formation, suggesting a role for Synectin in VEGFR-2-NP-1 signaling. Taken together, the experiments have identified a novel mechanism of NP-1 interaction with VEGFR-2, which involves the cytoplasmic domain of NP-1.	[Prahst, Claudia; Heroult, Melanie; Augustin, Hellmut G.] Univ Heidelberg, Med Fac Mannheim CBTM, Joint Res Div Vasc Biol, D-69120 Heidelberg, Germany; [Prahst, Claudia; Heroult, Melanie; Augustin, Hellmut G.] DKFZ, D-69120 Heidelberg, Germany; [Lanahan, Anthony A.; Simons, Michael] Dartmouth Med Sch, Dept Med, Angiogenesis Res Ctr, Lebanon, NH 03756 USA; [Lanahan, Anthony A.; Simons, Michael] Dartmouth Med Sch, Dept Med, Cardiol Sect, Lebanon, NH 03756 USA; [Uziel, Noa; Kessler, Ofra; Shraga-Heled, Niva; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rappaport Res Inst Med Sci, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Dartmouth College; Dartmouth College; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Augustin, HG (corresponding author), Univ Heidelberg, Med Fac Mannheim CBTM, Joint Res Div Vasc Biol, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020; Neufeld, Gera/F-1524-2019; Simons, Michael/G-8553-2014	Augustin, Hellmut/0000-0002-7173-4242; Simons, Michael/0000-0003-0348-7734	Deutsche Forschungsgemeinschaft [SPP1190]; German-Israel-Foundation; National Institutes of Health [HL084619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084619] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israel-Foundation(German-Israeli Foundation for Scientific Research and Development); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP1190 (Au83/9-1; to H. G. A.), the German-Israel-Foundation (to G. N. and H. G. A.), and National Institutes of Health Grant HL084619 (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Cai HB, 1999, J NEUROSCI, V19, P6519; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Moyon D, 2001, DEVELOPMENT, V128, P3359; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Wood JM, 2000, CANCER RES, V60, P2178	28	102	109	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25110	25114		10.1074/jbc.C800137200	http://dx.doi.org/10.1074/jbc.C800137200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628209	Green Published, hybrid			2022-12-25	WOS:000259012700002
J	Watanabe, S; Oguchi, Y; Takeda, K; Miki, K; Tokuda, H				Watanabe, Shoji; Oguchi, Yuki; Takeda, Kazuki; Miki, Kunio; Tokuda, Hajime			Introduction of a lethal redox switch that controls the opening and closing of the hydrophobic cavity in LolA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI LIPOPROTEINS; BINDING CASSETTE TRANSPORTER; MOLECULAR CHAPERONE; INNER MEMBRANE; LOCALIZATION; PROTEIN; RELEASE; LOLCDE	LolA plays a critical role in the outer membrane sorting of Escherichia coli lipoproteins because it carries a hydrophobic lipoprotein from the inner membrane through the hydrophilic periplasm to the outer membrane receptor LolB. LolA has an incomplete beta-barrel structure composed of 11 beta-strands with an alpha-helical lid forming a hydrophobic cavity inside. The accompanying study revealed that the hydrophobic cavity opens and closes upon the binding and release of lipoproteins, respectively. Ile(93) in the alpha-helix and Phe(140) in the beta-strand are located close to each other in the hydrophobic cavity. These two residues were replaced by Cys to construct the I93C/F140C derivative. Expression of I93C/F140C immediately arrested growth whether wild-type LolA was present or not. However, this dominant negative phenotype was abolished by reducing agents, indicating that the intramolecular disulfide bonding between the two Cys residues is lethal. I93C/F140C was unstable, and its periplasmic level was lower than that of wild-type LolA or its single Cys derivative. Reduction of I93C/F140C was essential for the release of lipoproteins from the inner membrane. Moreover, treatment of I93C/F140C with divalent cross-linkers having different side chain lengths revealed that opening of the lid for a sufficient distance is required for the release activity. The binding of a fluorescent probe to the hydrophobic cavity of I93C/F140C also depended on reducing agents. Taken together, these results indicate that the two Cys residues introduced into LolA function as a redox switch, which regulates the opening and closing of the hydrophobic cavity.	[Watanabe, Shoji; Oguchi, Yuki; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Harima Inst, Spring Ctr 8, RIKEN, Mikazuki, Hyogo 6795148, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	University of Tokyo; RIKEN; Kyoto University	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; MIZUSHIMA S, 1984, MOL CELL BIOCHEM, V60, P5; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Oguchi Y, 2008, J BIOL CHEM, V283, P25414, DOI 10.1074/jbc.M804736200; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Sambrook J., 1989, MOL CLONING LAB MANU; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997	28	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25421	25427		10.1074/jbc.M804737200	http://dx.doi.org/10.1074/jbc.M804737200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18621730	hybrid			2022-12-25	WOS:000259012700037
J	Magnone, M; Basile, G; Bruzzese, D; Guida, L; Signorello, MG; Chothi, MP; Bruzzone, S; Millo, E; Qi, AD; Nicholas, RA; Kassack, MU; Leoncini, G; Zocchi, E				Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Qi, Ai-Dong; Nicholas, Robert A.; Kassack, Matthias U.; Leoncini, Giuliana; Zocchi, Elena			Adenylic Dinucleotides Produced by CD38 Are Negative Endogenous Modulators of Platelet Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE INSUFFICIENCY; RIBOSE-SYNTHESIZING CD38; P2Y(11) RECEPTOR; P2 RECEPTORS; CYCLIC-AMP; DIADENOSINE PHOSPHATES; PHOSPHOLIPASE-C; BLOOD-PLATELETS; ADP; ACTIVATION	Diadenosine 5',5'''-P1,P2-diphosphate (Ap2A) is one of the adenylic dinucleotides stored in platelet granules. Along with proaggregant ADP, it is released upon platelet activation and is known to stimulate myocyte proliferation. We have previously demonstrated synthesis of Ap2A and of two isomers thereof, called P18 and P24, from their high pressure liquid chromatography retention time, by the ADP-ribosyl cyclase CD38 in mammalian cells. Here we show that Ap2A and its isomers are present in resting human platelets and are released during thrombin-induced platelet activation. The three adenylic dinucleotides were identified by high pressure liquid chromatography through a comparison with the retention times and the absorption spectra of purified standards. Ap2A, P18, and P24 had no direct effect on platelet aggregation, but they inhibited platelet aggregation induced by physiological agonists (thrombin, ADP, and collagen), with mean IC50 values ranging between 5 and 15 mu M. Moreover, the three dinucleotides did not modify the intracellular calcium concentration in resting platelets, whereas they significantly reduced the thrombin-induced intracellular calcium increase. Through binding to the purinergic receptor P2Y(11), exogenously applied Ap2A, P18, and P24 increased the intracellular cAMP concentration and stimulated platelet production of nitric oxide, the most important endogenous antiaggregant. The presence of Ap2A, P18, and P24 in resting platelets and their release during thrombin-induced platelet activation at concentrations equal to or higher than the respective IC50 value on platelet aggregation suggest a role of these dinucleotides as endogenous negative modulators of aggregation.	[Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Leoncini, Giuliana; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Leoncini, Giuliana; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Guida, Lucrezia; Bruzzone, Santina; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Qi, Ai-Dong; Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kassack, Matthias U.] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	University of Genoa; University of Genoa; University of North Carolina; University of North Carolina Chapel Hill; Heinrich Heine University Dusseldorf	Zocchi, E (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	ezocchi@unige.it	Madhu, Parakkottil Chothi/AAF-8251-2021; Bruzzone, Santina/A-4264-2015; Signorello, Maria Grazia/AGN-4399-2022; Millo, Enrico/K-3218-2018	Madhu, Parakkottil Chothi/0000-0002-3138-1075; Bruzzone, Santina/0000-0003-2034-3716; Signorello, Maria Grazia/0000-0001-5042-6614; Millo, Enrico/0000-0002-4019-0051	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education, University, and Scientific Research [MIUR-PRIN 2003, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF]; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071131] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University, and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro; from the Italian Ministry of Education, University, and Scientific Research (MIUR-PRIN 2003, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR and MIUR FIRB RBLA039LSF); and from the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anfossi G, 2002, THROMB RES, V105, P71, DOI 10.1016/S0049-3848(01)00412-1; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bohme E, 1974, Methods Enzymol, V38, P199; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; COLE B, 1971, ANN NY ACAD SCI, V185, P477; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DEGRAAF JC, 1992, CIRCULATION, V85, P2284, DOI 10.1161/01.CIR.85.6.2284; Gachet C, 2005, SEMIN THROMB HEMOST, V31, P162, DOI 10.1055/s-2005-869521; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Granger DL, 1996, METHOD ENZYMOL, V268, P142; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hechler B, 2005, SEMIN THROMB HEMOST, V31, P150, DOI 10.1055/s-2005-869520; Houston D, 2006, BRIT J PHARMACOL, V147, P459, DOI 10.1038/sj.bjp.0706453; Jankowski J, 2001, J BIOL CHEM, V276, P8904, DOI 10.1074/jbc.M009527200; Keeble JE, 2002, BRIT J PHARMACOL, V137, P295, DOI 10.1038/sj.bjp.0704876; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Leoncini G, 2002, BIOCHEM PHARMACOL, V64, P277, DOI 10.1016/S0006-2952(02)01108-5; LEONCINI G, 1990, EUR J HAEMATOL, V44, P115; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Luo J, 1999, FASEB J, V13, P695, DOI 10.1096/fasebj.13.6.695; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V194, P960, DOI 10.1006/bbrc.1993.1914; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; MURUGANANDAM A, 1994, BBA-GEN SUBJECTS, V1200, P1, DOI 10.1016/0304-4165(94)90019-1; NAKAHATA N, 1987, BIOCHEM J, V241, P337, DOI 10.1042/bj2410337; Nylander S, 2003, THROMB RES, V111, P65, DOI 10.1016/j.thromres.2003.08.021; Ohlmann P, 1998, BIOCHEM J, V331, P431, DOI 10.1042/bj3310431; Qi AD, 2001, BRIT J PHARMACOL, V132, P318, DOI 10.1038/sj.bjp.0703788; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251; Ramaschi G, 1996, BLOOD, V87, P2308, DOI 10.1182/blood.V87.6.2308.bloodjournal8762308; Rao Gundu H. R., 1993, Indian Journal of Physiology and Pharmacology, V37, P263; Riddell DR, 1999, VITAM HORM, V57, P25; Rossi L, 1998, AIDS RES HUM RETROV, V14, P435, DOI 10.1089/aid.1998.14.435; Sage SO, 1997, PROSTAG LEUKOTR ESS, V57, P435, DOI 10.1016/S0952-3278(97)90424-5; SALZMAN EW, 1972, ADV CYCL NUCL RES<D>, V1, P231; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; TOHMATSU T, 1989, BIOCHIM BIOPHYS ACTA, V1013, P190, DOI 10.1016/0167-4889(89)90048-7; Torti M, 1998, FEBS LETT, V428, P200, DOI 10.1016/S0014-5793(98)00516-X; Ullmann H, 2005, J MED CHEM, V48, P7040, DOI 10.1021/jm050301p; vanderGiet M, 1997, BRIT J PHARMACOL, V120, P1453, DOI 10.1038/sj.bjp.0701074; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z; Wang L, 2003, J THROMB HAEMOST, V1, P330, DOI 10.1046/j.1538-7836.2003.00070.x	52	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24460	24468		10.1074/jbc.M710568200	http://dx.doi.org/10.1074/jbc.M710568200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606819	Green Published, hybrid			2022-12-25	WOS:000258820000070
J	Ozawa, Y; Nakao, K; Kurihara, T; Shimazaki, T; Shimmura, S; Ishida, S; Yoshimura, A; Tsubota, K; Okano, H				Ozawa, Yoko; Nakao, Keiko; Kurihara, Toshihide; Shimazaki, Takuya; Shimmura, Shigeto; Ishida, Susumu; Yoshimura, Akihiko; Tsubota, Kazuo; Okano, Hideyuki			Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; ENDOTOXIN-INDUCED UVEITIS; II TYPE-1 RECEPTOR; STAT3 ACTIVATION; PHOTORECEPTOR DIFFERENTIATION; CYTOKINE SIGNALING-3; IN-VIVO; SOCS3; ROD; CELLS	Inflammatory cytokines cause tissue dysfunction. We previously reported that retinal inflammation down-regulates rhodopsin expression and impairs visual function by an unknown mechanism. Here, we demonstrate that rhodopsin levels were preserved by suppressor of cytokine signaling 3 (SOCS3), a negative feedback regulator of STAT3 activation. SOCS3 was expressed mainly in photoreceptor cells in the retina. In the SOCS3-deficient retinas, rhodopsin protein levels dropped sooner, and the reduction was more profound than in the wild type. Visual dysfunction, measured by electroretinogram, was prolonged in retina-specific SOCS3 conditional knockout mice. Visual dysfunction and decreased rhodopsin levels both correlated with increased STAT3 activation enhanced by SOCS3 deficiency. Interleukin 6, one of the inflammatory cytokines found during retinal inflammation, activated STAT3 and decreased rhodopsin protein in adult retinal explants. This was enhanced by inhibiting SOCS3 function in vitro, indicating that rhodopsin reduction was not a secondary effect in the mutant mice. Interestingly, in the inflamed SOCS3-deficient adult retina, rhodopsin decreased post-transcriptionally at least partly through ubiquitin-proteasome-dependent degradation accelerated by STAT3 activation and not transcriptionally as in the developing retina, on which we reported previously. A STAT3-dependent E3 ubiquitin ligase, Ubr1, was responsible for rhodopsin degradation and was up-regulated in the inflamed SOCS3-deficient retinas. These results indicate that in wild-type animals, a decrease in rhodopsin during inflammation is minimized by endogenous SOCS3. However, when STAT3 activation exceeds some threshold beyond the compensatory activity of endogenous SOCS3, rhodopsin levels decrease. These findings suggest SOCS3 as a potential therapeutic target molecule for protecting photoreceptor cell function during inflammation.	[Ozawa, Yoko; Kurihara, Toshihide; Shimmura, Shigeto; Ishida, Susumu; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Ozawa, Yoko; Nakao, Keiko; Kurihara, Toshihide; Shimazaki, Takuya; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Nakao, Keiko] Saitama Med Univ, Fac Med, Dept Physiol, Saitama 3500495, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; [Okano, Hideyuki] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Okano, Hideyuki] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan	Keio University; Keio University; Saitama Medical University; Keio University; Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Okano, H (corresponding author), 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@sc.itc.keio.ac.jp	Shimazaki, Takuya/L-1159-2013; Yoshimura, Akihiko/K-5515-2013; Shimmura, Shigeto/J-4678-2013; Kurihara, Toshihide/ABA-7058-2020; Ozawa, Yoko/AAH-9888-2020; Okano, Hideyuki/I-7584-2019	Shimazaki, Takuya/0000-0002-3936-2098; Kurihara, Toshihide/0000-0002-5457-2720; 				Adegoke OAJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE482, DOI 10.1152/ajpendo.00097.2002; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KURIHARA T, 2008, DIABETES IN PRESS; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ozawa Y, 2004, MOL CELL NEUROSCI, V26, P258, DOI 10.1016/j.mcn.2004.02.001; Ozawa Y, 2007, DEV BIOL, V303, P591, DOI 10.1016/j.ydbio.2006.11.032; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Saliba RS, 2002, J CELL SCI, V115, P2907; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schulz-Key S, 2002, INVEST OPHTH VIS SCI, V43, P3099; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; STRYER L, 1991, J BIOL CHEM, V266, P10711; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; SUZUKI K, 1994, JPN J PHARMACOL, V64, P97, DOI 10.1254/jjp.64.97; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Yang XP, 2005, J HEPATOL, V43, P704, DOI 10.1016/j.jhep.2005.02.048; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	48	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24561	24570		10.1074/jbc.M802238200	http://dx.doi.org/10.1074/jbc.M802238200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614536	hybrid, Green Published			2022-12-25	WOS:000258820000029
J	Piubelli, L; Pedotti, M; Molla, G; Feindler-Boeckh, S; Ghisla, S; Pilone, MS; Pollegioni, L				Piubelli, Luciano; Pedotti, Mattia; Molla, Gianluca; Feindler-Boeckh, Susanne; Ghisla, Sandro; Pilone, Mirella S.; Pollegioni, Loredano			On the oxygen reactivity of flavoprotein oxidases - An oxygen access tunnel and gate in Brevibacterium sterolicum cholesterol oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; RHODOCOCCUS-EQUI; CRYSTAL-STRUCTURE; STREPTOMYCES-HYGROSCOPICUS; OXIDATION-REDUCTION; ACTIVE-SITE; C-OXIDASE; MECHANISM; FLAVINYLATION; FLAVODOXIN	The flavoprotein cholesterol oxidase from Brevibacterium sterolicum (BCO) possesses a narrow channel that links the active center containing the flavin to the outside solvent. This channel has been proposed to serve for the access of dioxygen; it contains at its "bottom" a Glu-Arg pair (Glu-475-Arg-477) that was found by crystallographic studies to exist in two forms named "open" and "closed," which in turn was suggested to constitute a gate functioning in the control of oxygen access. Most mutations of residues that flank the channel have minor effects on the oxygen reactivity. Mutations of Glu-311, however, cause a switch in the basic kinetic mechanism of the reaction of reduced BCO with dioxygen; wild-type BCO and most mutants show a saturation behavior with increasing oxygen concentration, whereas for Glu-311 mutants a linear dependence is found that is assumed to reflect a "simple" second order process. This is taken as support for the assumption that residue Glu-311 finely tunes the Glu-475-Arg-477 pair, forming a gate that functions in modulating the access/reactivity of dioxygen.	[Piubelli, Luciano; Pedotti, Mattia; Molla, Gianluca; Pilone, Mirella S.; Pollegioni, Loredano] Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy; [Feindler-Boeckh, Susanne; Ghisla, Sandro] Univ Konstanz, Fachbereich Biol, D-7857 Constance, Germany	University of Insubria; University of Konstanz	Pollegioni, L (corresponding author), Univ Insubria, Dept Biotechnol & Mol Sci, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it		POLLEGIONI, LOREDANO/0000-0003-1733-7243; PIUBELLI, LUCIANO/0000-0003-0805-5121; Molla, Gianluca/0000-0003-3688-3397				Brunori M, 2000, BIOPHYS CHEM, V86, P221, DOI 10.1016/S0301-4622(00)00142-3; Corbin DR, 2001, PLANT PHYSIOL, V126, P1116, DOI 10.1104/pp.126.3.1116; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Fuhrmann H, 2002, J VET MED B, V49, P310, DOI 10.1046/j.1439-0450.2002.00555.x; Gadda G, 1997, EUR J BIOCHEM, V250, P369, DOI 10.1111/j.1432-1033.1997.0369a.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Hofacker I, 1998, PROTEINS, V30, P100, DOI 10.1002/(SICI)1097-0134(199801)30:1<100::AID-PROT9>3.0.CO;2-S; Ladron N, 2003, J CLIN MICROBIOL, V41, P3241, DOI 10.1128/JCM.41.7.3241-3245.2003; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lim L, 2006, BIOCHEM J, V400, P13, DOI 10.1042/BJ20060664; MACHANGU RS, 1991, CAN J VET RES, V55, P332; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200; MULLER F, 1973, BIOCHEMISTRY-US, V12, P4654; Pei YL, 2006, VET MICROBIOL, V118, P240, DOI 10.1016/j.vetmic.2006.08.006; Pollegioni L, 1999, EUR J BIOCHEM, V264, P140, DOI 10.1046/j.1432-1327.1999.00586.x; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sampson NS, 2001, ANTIOXID REDOX SIGN, V3, P839, DOI 10.1089/15230860152665019; SCHOPFER LM, 1988, BIOCHEMISTRY-US, V27, P6599, DOI 10.1021/bi00417a059; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9; WHITBY LG, 1954, BIOCHIM BIOPHYS ACTA, V15, P148, DOI 10.1016/0006-3002(54)90111-0; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	32	39	39	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24738	24747		10.1074/jbc.M802321200	http://dx.doi.org/10.1074/jbc.M802321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614534	Green Published, hybrid			2022-12-25	WOS:000258820000042
J	Cao, RH; Jensen, LDE; Soll, I; Hauptmann, G; Cao, YH				Cao, Renhai; Jensen, Lasse Dahl Ejby; Soell, Iris; Hauptmann, Giselbert; Cao, Yihai			Hypoxia-Induced Retinal Angiogenesis in Zebrafish as a Model to Study Retinopathy	PLOS ONE			English	Article							VASCULAR-PERMEABILITY FACTOR; INHIBITS TUMOR-GROWTH; CELLS; LYMPHANGIOGENESIS; BLOCKADE; VESSELS; FENESTRATIONS; EXPRESSION; PROMOTE; PROTEIN	Mechanistic understanding and defining novel therapeutic targets of diabetic retinopathy and age-related macular degeneration (AMD) have been hampered by a lack of appropriate adult animal models. Here we describe a simple and highly reproducible adult fli-EGFP transgenic zebrafish model to study retinal angiogenesis. The retinal vasculature in the adult zebrafish is highly organized and hypoxia-induced neovascularization occurs in a predictable area of capillary plexuses. New retinal vessels and vascular sprouts can be accurately measured and quantified. Orally active anti-VEGF agents including sunitinib and ZM323881 effectively block hypoxia-induced retinal neovascularization. Intriguingly, blockage of the Notch signaling pathway by the inhibitor DAPT under hypoxia, results in a high density of arterial sprouting in all optical arteries. The Notch suppression-induced arterial sprouting is dependent on tissue hypoxia. However, in the presence of DAPT substantial endothelial tip cell formation was detected only in optic capillary plexuses under normoxia. These findings suggest that hypoxia shifts the vascular targets of Notch inhibitors. Our findings for the first time show a clinically relevant retinal angiogenesis model in adult zebrafish, which might serve as a platform for studying mechanisms of retinal angiogenesis, for defining novel therapeutic targets, and for screening of novel antiangiogenic drugs.	[Cao, Renhai; Jensen, Lasse Dahl Ejby; Cao, Yihai] Karolinska Inst, Dept Microbiol, Stockholm, Sweden; [Soell, Iris; Hauptmann, Giselbert] Sodertorns Univ Coll, Sch Life Sci, Huddinge, Sweden; [Soell, Iris; Hauptmann, Giselbert] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet; Sodertorn University; Karolinska Institutet	Cao, RH (corresponding author), Karolinska Inst, Dept Microbiol, Stockholm, Sweden.	yihai.cao@ki.se		Jensen, Lasse/0000-0003-2338-357X; Hauptmann, Giselbert/0000-0002-1205-1011	Swedish Research Council; Swedish Heart and Lung Foundation; Swedish Cancer Foundation; Karolinska Institute; Soderberg Foundation; EU [504743, 013811]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Foundation; Karolinska Institute(Karolinska Institutet); Soderberg Foundation; EU(European Commission)	Yihai Cao's laboratory is supported by research grants from the Swedish Research Council, the Swedish Heart and Lung Foundation, the Swedish Cancer Foundation, the Karolinska Institute fund, the Soderberg Foundation, the EU integrated projects of Angiotargeting (Contract No. 504743), and VascuPlug (Contract No. STRP 013811). The Swedish Research Council further supports Y. Cao.	Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferris FL, 2004, NEW ENGL J MED, V351, P2863, DOI 10.1056/NEJMe048316; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gardner TW, 2007, NAT MED, V13, P131, DOI 10.1038/nm0207-131; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	44	104	109	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2748	10.1371/journal.pone.0002748	http://dx.doi.org/10.1371/journal.pone.0002748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648503	Green Published, Green Submitted, gold			2022-12-25	WOS:000264302900019
J	Coolen, M; Nicolle, D; Plouhinec, JL; Gombault, A; Sauka-Spengler, T; Menuet, A; Pieau, C; Mazan, S				Coolen, Marion; Nicolle, Delphine; Plouhinec, Jean-Louis; Gombault, Aurelie; Sauka-Spengler, Tatjana; Menuet, Arnaud; Pieau, Claude; Mazan, Sylvie			Molecular Characterization of the Gastrula in the Turtle Emys orbicularis: An Evolutionary Perspective on Gastrulation	PLOS ONE			English	Article								Due to the presence of a blastopore as in amphibians, the turtle has been suggested to exemplify a transition form from an amphibian-to an avian-type gastrulation pattern. In order to test this hypothesis and gain insight into the emergence of the unique characteristics of amniotes during gastrulation, we have performed the first molecular characterization of the gastrula in a reptile, the turtle Emys orbicularis. The study of Brachyury, Lim1, Otx2 and Otx5 expression patterns points to a highly conserved dynamic of expression with amniote model organisms and makes it possible to identify the site of mesoderm internalization, which is a long-standing issue in reptiles. Analysis of Brachyury expression also highlights the presence of two distinct phases, less easily recognizable in model organisms and respectively characterized by an early ring-shaped and a later bilateral symmetrical territory. Systematic comparisons with tetrapod model organisms lead to new insights into the relationships of the blastopore/blastoporal plate system shared by all reptiles, with the blastopore of amphibians and the primitive streak of birds and mammals. The biphasic Brachyury expression pattern is also consistent with recent models of emergence of bilateral symmetry, which raises the question of its evolutionary significance.	[Coolen, Marion; Nicolle, Delphine; Plouhinec, Jean-Louis; Gombault, Aurelie; Sauka-Spengler, Tatjana; Menuet, Arnaud; Mazan, Sylvie] CNRS, Dev & Evolut Vertebres, UMR 6218, F-45071 Orleans, France; [Pieau, Claude] Univ Pierre Marie Curie Paris 6 & 7, CNRS, Inst Jacques Monod, UMR7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Coolen, M (corresponding author), CNRS, Dev & Evolut Vertebres, UMR 6218, F-45071 Orleans, France.	mazan@cnrs-orleans.fr		Sauka-Spengler, Tatjana/0000-0001-9289-0263; Coolen, Marion/0000-0001-5658-5296	Universite Paris Sud; Universite d'Orleans; CNRS; Ministere de la Recherche [PhD fellowships]	Universite Paris Sud; Universite d'Orleans; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by funds from the Universite Paris Sud, Universite d'Orleans and CNRS. J.L P. and T.S.S. were recipients of PhD fellowships from the Ministere de la Recherche and M.C from CNRS.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Arendt D, 1999, MECH DEVELOP, V81, P3, DOI 10.1016/S0925-4773(98)00226-3; BALLYCUIF L, 1995, MECH DEVELOP, V49, P49, DOI 10.1016/0925-4773(94)00301-3; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Coolen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000374; del Pino EM, 2007, P NATL ACAD SCI USA, V104, P11882, DOI 10.1073/pnas.0705092104; Dorizzi M, 1996, DIFFERENTIATION, V60, P193, DOI 10.1046/j.1432-0436.1996.6040193.x; Fritzenwanker JH, 2007, DEV BIOL, V310, P264, DOI 10.1016/j.ydbio.2007.07.029; GAUTHIER JA, 1988, PHYLOGENY CLASSIFICA, V1, P103; Gilland E.H., 2004, P205; GUYOT G, 1994, ANN SCI NAT ZOOL, V15, P115; Holland PWH, 1995, DEVELOPMENT, V121, P4283; Ibrahim H, 2001, DEV BIOL, V240, P108, DOI 10.1006/dbio.2001.0459; Keller R., 2004, P171; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kraus Y, 2007, CURR BIOL, V17, pR874, DOI 10.1016/j.cub.2007.08.017; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Meinhardt H, 2004, NAT REV NEUROSCI, V5, P502, DOI 10.1038/nrn1410; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; MITSUKURI, 1896, J COLL SCI IMP U TOK, V10, P1; Moya IM, 2007, DEV BIOL, V304, P467, DOI 10.1016/j.ydbio.2006.12.036; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; NAYAR MC, 1966, INDIAN JEXPBIO, P131; PANNESE M, 1995, DEVELOPMENT, V121, P707; PASTEELS J, 1937, REPTILES ARCH BIOL, P105; Peichel CL, 2005, DEV DYNAM, V234, P815, DOI 10.1002/dvdy.20564; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Rhinn M, 1998, DEVELOPMENT, V125, P845; Sauka-Spengler T, 2003, DEV BIOL, V263, P296, DOI 10.1016/j.ydbio.2003.07.009; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; STERN CD, 2004, GASTRULATION CELLS E, P219; Taira M, 1997, P NATL ACAD SCI USA, V94, P895, DOI 10.1073/pnas.94.3.895; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Viebahn C, 2002, DEVELOPMENT, V129, P2355; Vignali R, 2000, MECH DEVELOP, V96, P3, DOI 10.1016/S0925-4773(00)00367-1; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207	45	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2676	10.1371/journal.pone.0002676	http://dx.doi.org/10.1371/journal.pone.0002676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628985	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000264057200021
J	Eriksson, D; Tompa, T; Roland, PE				Eriksson, David; Tompa, Tamas; Roland, Per E.			Non-Linear Population Firing Rates and Voltage Sensitive Dye Signals in Visual Areas 17 and 18 to Short Duration Stimuli	PLOS ONE			English	Article							RECEPTIVE-FIELD ORGANIZATION; RETINAL GANGLION-CELLS; AXON FLUORESCENCE; IN-VIVO; NEURONS; CORTEX; DYNAMICS; RESPONSES; REPRESENTATION; ARCHITECTURE	Visual stimuli of short duration seem to persist longer after the stimulus offset than stimuli of longer duration. This visual persistence must have a physiological explanation. In ferrets exposed to stimuli of different durations we measured the relative changes in the membrane potentials with a voltage sensitive dye and the action potentials of populations of neurons in the upper layers of areas 17 and 18. For durations less than 100 ms, the timing and amplitude of the firing and membrane potentials showed several non-linear effects. The ON response became truncated, the OFF response progressively reduced, and the timing of the OFF responses progressively delayed the shorter the stimulus duration. The offset of the stimulus elicited a sudden and strong negativity in the time derivative of the dye signal. All these non-linearities could be explained by the stimulus offset inducing a sudden inhibition in layers II-III as indicated by the strongly negative time derivative of the dye signal. Despite the non-linear behavior of the layer II-III neurons the sum of the action potentials, integrated from the peak of the ON response to the peak of the OFF response, was almost linearly related to the stimulus duration.	[Eriksson, David; Tompa, Tamas; Roland, Per E.] Karolinska Inst, Dept Neurosci, Solna, Sweden	Karolinska Institutet	Eriksson, D (corresponding author), Karolinska Inst, Dept Neurosci, Solna, Sweden.	per.roland@ki.se	Eriksson, David/E-2064-2012		Swedish Science Council	Swedish Science Council	This work was supported by a grant from the Swedish Science Council to P.E.R.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; AHMED B, 2008, CORTICAL DYNAMICS EN; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Anderson JC, 2002, J COMP NEUROL, V443, P56, DOI 10.1002/cne.10100; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; COLHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183; COLONNIER M, 1981, ELECT MISCROSCOPIC A; DAVILA HV, 1973, NATURE-NEW BIOL, V241, P159, DOI 10.1038/newbio241159a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; DUYSEN J, 1985, VISION RES, V25, P171, DOI 10.1016/0042-6989(85)90110-5; Duysens J, 1996, VISION RES, V36, P3243, DOI 10.1016/0042-6989(96)00040-5; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P37, DOI 10.1016/0028-3932(70)90024-2; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Galifret Y, 2006, CR BIOL, V329, P369, DOI 10.1016/j.crvi.2006.03.008; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HEGGELUND P, 1981, EXP BRAIN RES, V42, P99; HEGGELUND P, 1981, EXP BRAIN RES, V42, P89; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Innocenti GM, 2002, CEREB CORTEX, V12, P411, DOI 10.1093/cercor/12.4.411; JUNG R, 1960, STRUCTURE FUNCTION C, P204; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; KONNERTH A, 1986, NEUROSCI LETT, V66, P49, DOI 10.1016/0304-3940(86)90164-3; KONNERTH A, 1988, GLIA, V1, P225, DOI 10.1002/glia.440010308; KRATZ KE, 1990, INT J NEUROSCI, V52, P111, DOI 10.3109/00207459008994252; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LEVICK WR, 1970, J PHYSIOL-LONDON, V206, P677, DOI 10.1113/jphysiol.1970.sp009037; LEVRAM V, 1986, P NATL ACAD SCI USA, V83, P6651, DOI 10.1073/pnas.83.17.6651; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; LOWENSTEIN PR, 1991, J COMP NEUROL, V310, P253, DOI 10.1002/cne.903100209; LUNG JS, 1979, J COMP NEUROL, V184, P599; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Pernberg J, 1998, EUR J NEUROSCI, V10, P3596, DOI 10.1046/j.1460-9568.1998.00364.x; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; ROSS WN, 1977, J MEMBRANE BIOL, V33, P141, DOI 10.1007/BF01869514; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; SINGER W, 1974, EXP BRAIN RES, V19, P507; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1	57	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2673	10.1371/journal.pone.0002673	http://dx.doi.org/10.1371/journal.pone.0002673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628825	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200018
J	Konczak, J; Li, KY; Tuite, PJ; Poizner, H				Konczak, Juergen; Li, Kuan-yi; Tuite, Paul J.; Poizner, Howard			Haptic Perception of Object Curvature in Parkinson's Disease	PLOS ONE			English	Article								Background: The haptic perception of the curvature of an object is essential for adequate object manipulation and critical for our guidance of actions. This study investigated how the ability to perceive the curvature of an object is altered by Parkinson's disease (PD). Methodology/Principal Findings: Eight healthy subjects and 11 patients with mild to moderate PD had to judge, without vision, the curvature of a virtual "box'' created by a robotic manipulandum. Their hands were either moved passively along a defined curved path or they actively explored the curved curvature of a virtual wall. The curvature was either concave or convex (bulging to the left or right) and was judged in two locations of the hand workspace-a left workspace location, where the curved hand path was associated with curved shoulder and elbow joint paths, and a right workspace location in which these joint paths were nearly linear. After exploring the curvature of the virtual object, subjects had to judge whether the curvature was concave or convex. Based on these data, thresholds for curvature sensitivity were established. The main findings of the study are: First, 9 out 11 PD patients (82%) showed elevated thresholds for detecting convex curvatures in at least one test condition. The respective median threshold for the PD group was increased by 343% when compared to the control group. Second, when distal hand paths became less associated with proximal joint paths ( right workspace), haptic acuity was reduced substantially in both groups. Third, sensitivity to hand trajectory curvature was not improved during active exploration in either group. Conclusion/Significance: Our data demonstrate that PD is associated with a decreased acuity of the haptic sense, which may occur already at an early stage of the disease.	[Konczak, Juergen; Li, Kuan-yi] Univ Minnesota, Human Sensorimotor Control Lab, Minneapolis, MN 55455 USA; [Konczak, Juergen; Tuite, Paul J.] Univ Minnesota, Dept Neurol, Minneapolis, MN USA; [Poizner, Howard] Univ Calif San Diego, Inst Neural Computat, San Diego, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Konczak, J (corresponding author), Univ Minnesota, Human Sensorimotor Control Lab, Minneapolis, MN 55455 USA.	jkonczak@umn.edu	Konczak, Jürgen/J-4001-2019; Tuite, Paul/P-3164-2014	Konczak, Jürgen/0000-0002-4422-5610; Tuite, Paul/0000-0003-1413-7924	Academic Health Center at the University of Minnesota Medical School; University of Minnesota Medical Foundation; NIH [2 R01 NS 36449]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036449] Funding Source: NIH RePORTER	Academic Health Center at the University of Minnesota Medical School; University of Minnesota Medical Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the Academic Health Center at the University of Minnesota Medical School and the University of Minnesota Medical Foundation and by NIH grant# 2 R01 NS 36449 to UCSD.	Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529, DOI 10.1152/jn.1985.54.6.1529; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; Fasse ED, 2000, BIOL CYBERN, V82, P69, DOI 10.1007/PL00007962; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gibson JJ., 1966, SENSES CONSIDERED PE; Goldscheider A., 1898, PHYSL MUSKELSINNES; Henriques DYP, 2005, J NEUROPHYSIOL, V93, P3036, DOI 10.1152/jn.00010.2005; Henriques DYP, 2004, J NEUROPHYSIOL, V91, P1808, DOI 10.1152/jn.00998.2003; Henriques DYP, 2003, EXP BRAIN RES, V150, P95, DOI 10.1007/s00221-003-1402-z; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Maschke M, 2005, J NEUROL NEUROSUR PS, V76, P569, DOI 10.1136/jnnp.2004.047324; Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230; Maschke M, 2006, MOVEMENT DISORD, V21, P1013, DOI 10.1002/mds.20876; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; O'Suilleabhain P, 2001, J NEUROL NEUROSUR PS, V71, P607, DOI 10.1136/jnnp.71.5.607; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pratorius B, 2003, NEUROSCI LETT, V346, P173, DOI 10.1016/S0304-3940(03)00582-2; Putzki N, 2006, MOVEMENT DISORD, V21, P754, DOI 10.1002/mds.20799; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; SOECHTING JF, 1982, BRAIN RES, V248, P392, DOI 10.1016/0006-8993(82)90601-1; Song WL, 2004, SOMATOSENS MOT RES, V21, P177, DOI 10.1080/08990220400012422; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zia S, 2003, CLIN ANAT, V16, P241, DOI 10.1002/ca.10100; Zia S, 2002, CLIN ANAT, V15, P23, DOI 10.1002/ca.1087; Zia S, 2000, ANN NEUROL, V47, P218, DOI 10.1002/1531-8249(200002)47:2<218::AID-ANA12>3.3.CO;2-R	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2625	10.1371/journal.pone.0002625	http://dx.doi.org/10.1371/journal.pone.0002625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612466	Green Published, gold			2022-12-25	WOS:000264065800027
J	Arque, G; Fotaki, V; Fernandez, D; de Lagran, MM; Arbones, ML; Dierssen, M				Arque, Gloria; Fotaki, Vassiliki; Fernandez, David; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara			Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)	PLOS ONE			English	Article								Background: Pathogenic aneuploidies involve the concept of dosage-sensitive genes leading to over- and underexpression phenotypes. Monosomy 21 in human leads to mental retardation and skeletal, immune and respiratory function disturbances. Most of the human condition corresponds to partial monosomies suggesting that critical haploinsufficient genes may be responsible for the phenotypes. The DYRK1A gene is localized on the human chromosome 21q22.2 region, and has been proposed to participate in monosomy 21 phenotypes. It encodes a dual-specificity kinase involved in neuronal development and in adult brain physiology, but its possible role as critical haploinsufficient gene in cognitive function has not been explored. Methodology/Principal Findings: We used mice heterozygous for a Dyrk1A targeted mutation (Dyrk1A+/-) to investigate the implication of this gene in the cognitive phenotypes of monosomy 21. Performance of Dyrk1A+/- mice was assayed 1/ in a navigational task using the standard hippocampally related version of the Morris water maze, 2/ in a swimming test designed to reveal potential kinesthetic and stress-related behavioral differences between control and heterozygous mice under two levels of aversiveness (25 degrees C and 17 degrees C) and 3/ in a long-term novel object recognition task, sensitive to hippocampal damage. Dyrk1A+/- mice showed impairment in the development of spatial learning strategies in a hippocampally-dependent memory task, they were impaired in their novel object recognition ability and were more sensitive to aversive conditions in the swimming test than euploid control animals. Conclusions/Significance: The present results are clear examples where removal of a single gene has a profound effect on phenotype and indicate that haploinsufficiency of DYRK1A might contribute to an impairment of cognitive functions and stress coping behavior in human monosomy 21.	[Arque, Gloria; Fotaki, Vassiliki; Fernandez, David; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara] Pompeu Fabra Univ, Genes & Dis Program, Genom Regulat Ctr CRG, Barcelona, Spain; [Arque, Gloria; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara] CIBERER, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Arque, G (corresponding author), Pompeu Fabra Univ, Genes & Dis Program, Genom Regulat Ctr CRG, Barcelona, Spain.	mara.dierssen@crg.es	Dierssen, Mara/G-3552-2015; Arbones, Maria/D-4668-2016; Arque, Gloria/AAT-7266-2020; martinez de lagran, maria/L-2027-2015	Dierssen, Mara/0000-0003-0853-6865; Arbones, Maria/0000-0002-6035-0235; Arque, Gloria/0000-0002-8039-3726; martinez de lagran, maria/0000-0002-0836-6491; Fotaki, Vassiliki/0000-0001-9112-3257	Departament d'Educacio i Universitats; Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya"); Instituto de Salud Carlos III" of the Ministry of Health (CIBERER); Spanish Ministry of Education and Science [GEN2003-20651-C06-03, SAF2004-02808, SAF2007-60827]; Areces Foundations [LSHG-CT-2006-037627]; Marato TV3 [LSHG-CT-2006-037627]; AnEUploidy project [LSHG-CT-2006-037627]; EU [LSHG-CT-2006-037627]	Departament d'Educacio i Universitats; Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya")(Generalitat de Catalunya); Instituto de Salud Carlos III" of the Ministry of Health (CIBERER); Spanish Ministry of Education and Science(Spanish Government); Areces Foundations; Marato TV3; AnEUploidy project; EU(European Commission)	The laboratories of MD and MA are supported by the Departament d'Educacio i Universitats and the Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya"); the "Instituto de Salud Carlos III" of the Ministry of Health (CIBERER). This work was supported by grants from the Spanish Ministry of Education and Science (GEN2003-20651-C06-03, SAF2004-02808,SAF2007-60827), the Marato TV3, Jerome Lejeune, and Areces Foundations and the AnEUploidy project (LSHG-CT-2006-037627). DF was supported by the EU (LSHG-CT-2006-037627).	AHN KJ, 2006, NEUROBIOL DIS; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dierssen M, 2001, J NEURAL TRANSM-SUPP, P131; Ehling D, 2004, AM J MED GENET A, V131A, P265, DOI 10.1002/ajmg.a.30361; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fernandez F, 2008, BEHAV BRAIN RES, V188, P233, DOI 10.1016/j.bbr.2007.09.015; Fernandez F, 2007, NEUROSCI LETT, V421, P137, DOI 10.1016/j.neulet.2007.04.075; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; HURET JL, 1995, CLIN GENET, V48, P140; Kessler RJ, 2004, PSYCHIAT QUART, V75, P99, DOI 10.1023/B:PSAQ.0000007564.35985.55; Kingwell J, 2006, SPACE POLICY, V22, P63, DOI 10.1016/j.spacepol.2005.11.005; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; Li RH, 1997, P NATL ACAD SCI USA, V94, P14506, DOI 10.1073/pnas.94.26.14506; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pellegrini-Calace M, 2006, BIOINFORMATICS, V22, P775, DOI 10.1093/bioinformatics/btl006; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tuschl K, 2007, AM J MED GENET A, V143A, P2065, DOI 10.1002/ajmg.a.31792; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; WHISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979, DOI 10.1037/0735-7044.99.5.979; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; WIENER SI, 1993, J NEUROSCI, V13, P3802; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yao GM, 2006, GENET MED, V8, P1, DOI 10.1097/01.gim.0000195892.60506.3f	55	74	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2575	10.1371/journal.pone.0002575	http://dx.doi.org/10.1371/journal.pone.0002575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648535	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200040
J	Mckeown, L; Burnham, MP; Hodson, C; Jones, OT				Mckeown, Lynn; Burnham, Matthew P.; Hodson, Charlotte; Jones, Owen T.			Identification of an Evolutionarily Conserved Extracellular Threonine Residue Critical for Surface Expression and Its Potential Coupling of Adjacent Voltage-sensing and Gating Domains in Voltage-gated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; ION-CHANNEL; MOLECULAR RELATIONSHIPS; ENDOPLASMIC-RETICULUM; SLOW INACTIVATION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN BRAIN; HEK-293 CELLS; ER EXPORT	The dynamic expression of voltage-gated potassium channels (Kvs) at the cell surface is a fundamental factor controlling membrane excitability. In exploring possible mechanisms controlling Kv surface expression, we identified a region in the extracellular linker between the first and second of the six (S1-S6) transmembrane-spanning domains of the Kv1.4 channel, which we hypothesized to be critical for its biogenesis. Using immunofluorescence microscopy, flow cytometry, patch clamp electrophysiology, and mutagenesis, we identified a single threonine residue at position 330 within the Kv1.4 S1-S2 linker that is absolutely required for cell surface expression. Mutation of Thr-330 to an alanine, aspartate, or lysine prevented surface expression. However, surface expression occurred upon co-expression of mutant and wild type Kv1.4 subunits or mutation of Thr-330 to a serine. Mutation of the corresponding residue (Thr-211) in Kv3.1 to alanine also caused intracellular retention, suggesting that the conserved threonine plays a generalized role in surface expression. In support of this idea, sequence comparisons showed conservation of the critical threonine in all Kv families and in organisms across the evolutionary spectrum. Based upon the Kv1.2 crystal structure, further mutagenesis, and the partial restoration of surface expression in an electrostatic T330K bridging mutant, we suggest that Thr-330 hydrogen bonds to equally conserved outer pore residues, which may include a glutamate at position 502 that is also critical for surface expression. We propose that Thr-330 serves to interlock the voltage-sensing and gating domains of adjacent monomers, thereby yielding a structure competent for the surface expression of functional tetramers.	[Mckeown, Lynn; Burnham, Matthew P.; Hodson, Charlotte; Jones, Owen T.] Univ Manchester, Fac Life Sci, Manchester M13 9PN, Lancs, England	University of Manchester	Jones, OT (corresponding author), Univ Manchester, Fac Life Sci, 2-25 CTF Bldg,46 Grafton St, Manchester M13 9PN, Lancs, England.	owen.t.jones@manchester.ac.uk	McKeown, Lynn/AAC-6037-2020	McKeown, Lynn/0000-0003-2326-7595; Burnham, Matthew/0000-0001-9136-937X				ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Burke NA, 1999, J GEN PHYSIOL, V113, P71, DOI 10.1085/jgp.113.1.71; CRITZ SD, 1993, J NEUROCHEM, V60, P1175, DOI 10.1111/j.1471-4159.1993.tb03273.x; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Eduljee C, 2007, AM J PHYSIOL-CELL PH, V292, pC1041, DOI 10.1152/ajpcell.00274.2006; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones VC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-10; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kupper J, 1998, EUR J NEUROSCI, V10, P3908; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Li DQ, 2000, J BIOL CHEM, V275, P11597, DOI 10.1074/jbc.275.16.11597; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; McKeown L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-15; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mura CV, 2004, J MEMBRANE BIOL, V201, P157, DOI 10.1007/s00232-004-0713-8; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trimmer JS, 1998, METHOD ENZYMOL, V293, P32; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhu J, 2003, BIOCHEM J, V375, P769, DOI 10.1042/BJ20030517; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	51	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30421	30432		10.1074/jbc.M708921200	http://dx.doi.org/10.1074/jbc.M708921200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18640987	Green Published, hybrid			2022-12-25	WOS:000260366900084
J	Machesky, NJ; Zhang, G; Raghavan, B; Zimmerman, P; Kelly, SL; Merrill, AH; Waldman, WJ; Van Brocklyn, JR; Trgovcich, J				Machesky, Nicholas J.; Zhang, Guojuan; Raghavan, Bindu; Zimmerman, Pete; Kelly, Samuel L.; Merrill, Alfred H.; Waldman, W. James; Van Brocklyn, James R.; Trgovcich, Joanne			Human cytomegalovirus regulates bioactive sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SIMPLEX VIRUS TYPE-1; SPHINGOSINE KINASE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE RECEPTORS; FUNCTIONAL-CHARACTERIZATION; CALCIUM MOBILIZATION; SIGNAL-TRANSDUCTION; DISTINCT PATHWAYS	Sphingolipids are present in membranes of all eukaryotic cells. Bioactive sphingolipids also function as signaling molecules that regulate cellular processes such as proliferation, migration, and apoptosis. Human cytomegalovirus ( HCMV) exploits a variety of cellular signaling pathways to promote its own replication. However, whether HCMV modulates lipid signaling pathways is an essentially unexplored area of research in virus-host cell interactions. In this study, we examined the accumulation of the bioactive sphingolipids and the enzymes responsible for the biosynthesis and degradation of these lipids. HCMV infection results in increased accumulation and activity of sphingosine kinase (SphK), the enzyme that generates sphingosine 1-phosphate (S1P) and dihydrosphingosine 1-phosphate (dhS1P). We also utilized a mass spectrometry approach to generate a sphingolipidomic profile of HCMV-infected cells. We show that HCMV infection results in increased levels of dhS1P and ceramide at 24 h, suggesting an enhancement of de novo sphingolipid synthesis. Subsequently dihydrosphingosine and dhS1P decrease at 48 h consistent with attenuation of de novo sphingolipid synthesis. Finally, we present evidence that de novo sphingolipid synthesis and sphingosine kinase activity directly impact virus gene expression and virus growth. Together, these findings demonstrate that host cell sphingolipids are dynamically regulated upon infection with a herpes virus in a manner that impacts virus replication.	[Machesky, Nicholas J.; Zhang, Guojuan; Raghavan, Bindu; Zimmerman, Pete; Waldman, W. James; Van Brocklyn, James R.; Trgovcich, Joanne] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Kelly, Samuel L.; Merrill, Alfred H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Ohio State University; University System of Georgia; Georgia Institute of Technology	Trgovcich, J (corresponding author), 4162 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	Joanne.Trgovcich@osumc.edu	Van Brocklyn, Jim/A-9733-2010	Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health NINDS [R01 NS41517, AI51411, GM069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041517] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grants R01 NS41517 (to J.R.V.B.), AI51411 (to J.T.), and GM069338 (LipidMAPSConsortium) ( to A. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan-Yorke J, 1998, J VIROL, V72, P2316, DOI 10.1128/JVI.72.3.2316-2322.1998; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Bu Shizhong, 2006, FASEB J, V20, P184; Choi OH, 1996, NATURE, V380, P634; Cobbs CS, 2002, CANCER RES, V62, P3347; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Goparaju SK, 2005, MOL CELL BIOL, V25, P4237, DOI 10.1128/MCB.25.10.4237-4249.2005; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miller DM, 2000, TRANSPLANTATION, V69, P687, DOI 10.1097/00007890-200002270-00040; Miller DM, 1999, J IMMUNOL, V162, P6107; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Nokta MA, 1996, J CLIN INVEST, V97, P2635, DOI 10.1172/JCI118713; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Payne SG, 2004, SEMIN CELL DEV BIOL, V15, P521, DOI 10.1016/j.semcdb.2004.05.008; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; RADSAK K, 1984, VIROLOGY, V138, P300, DOI 10.1016/0042-6822(84)90353-2; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; SEDMAK DD, 1990, TRANSPLANTATION, V49, P458, DOI 10.1097/00007890-199002000-00043; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; STEINHART WL, 1984, INTERVIROLOGY, V21, P70, DOI 10.1159/000149504; Stenberg RM, 1996, INTERVIROLOGY, V39, P343, DOI 10.1159/000150505; Stropes MPM, 2004, BIOCHEM CELL BIOL, V82, P636, DOI 10.1139/O04-115; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tamama K, 2001, BIOCHEM J, V353, P139, DOI 10.1042/bj3530139; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; WALDMAN WJ, 1991, ARCH VIROL, V117, P143, DOI 10.1007/BF01310761; WALDMAN WJ, 1992, TRANSPLANTATION, V54, P887, DOI 10.1097/00007890-199211000-00024; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; WENTHWOR.BB, 1970, P SOC EXP BIOL MED, V135, P253, DOI 10.3181/00379727-135-35031; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799; ZUHERINGDORF DM, 1998, EMBO J, V17, P2830	74	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26148	26160		10.1074/jbc.M710181200	http://dx.doi.org/10.1074/jbc.M710181200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644793	hybrid, Green Published			2022-12-25	WOS:000259200100043
J	Song, LN; Gelmann, EP				Song, Liang-Nian; Gelmann, Edward P.			Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PLZF-RAR-ALPHA; NF-KAPPA-B; BETA-CATENIN; ANDROGEN RECEPTOR; HISTONE DEACETYLASE; GENE-EXPRESSION; REGULATED TRANSCRIPTION; COLORECTAL-CANCER; TERMINAL DOMAIN	beta-Catenin is a multifunctional mediator of cellular signaling and an oncogene. Nuclear beta-catenin, when complexed with members of the T-cell factor (TCF)/leukocyte enhancer factor family of DNA-binding proteins, mediates transcriptional activation important for embryonic development and adult cell homeostasis. Deregulation of intracellular levels of beta-catenin is an early event in the development of a variety of cancers. We observed that the proteins silencing mediator for retinoid and thyroid hormone receptor (SMRT) and the nuclear receptor corepressor (NCoR) are negative regulators of transcription induced by the beta-catenin-TCF4 complex. Overexpression of SMRT and NCoR attenuated the transcription of beta-catenin-TCF4-specific reporter gene and of CCND1, an endogenous beta-catenin target gene. Knockdown of endogenous SMRT or NCoR by short interfering RNA augmented the beta-catenin-TCF4-mediated reporter gene expression. Glutathione S-transferase pulldown experiments showed there was a direct physical association of SMRT and NCoR with both beta-catenin and TCF4. DNA-protein interaction studies revealed that the interactions between either SMRT or NCoR and beta-catenin or TCF4 occurred at the promoter regions of CCND1 and other target genes. These findings demonstrate an important role for corepressors SMRT and NCoR in the regulation of beta-catenin-TCF4-mediated gene transcription.	[Song, Liang-Nian; Gelmann, Edward P.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10032 USA	Columbia University	Gelmann, EP (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, MHB 6N-435, New York, NY 10032 USA.	gelmanne@columbia.edu			National Institutes of Health [CA96854]; NATIONAL CANCER INSTITUTE [R01CA096854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96854 from the USPHS (to E. P. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahara H, 1999, MOL CELL BIOL, V19, P8219; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Fernandez-Majada V, 2007, CELL CYCLE, V6, P1748, DOI 10.4161/cc.6.14.4429; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guidez F, 2000, BLOOD, V96, P2557; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huang EY, 2000, GENE DEV, V14, P45; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roh H, 2001, CANCER RES, V61, P6563; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Song LN, 2004, MOL ENDOCRINOL, V18, P70, DOI 10.1210/me.2003-0189; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Truica CI, 2000, CANCER RES, V60, P4709; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	72	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25988	25999		10.1074/jbc.M800325200	http://dx.doi.org/10.1074/jbc.M800325200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632669	Green Published, hybrid			2022-12-25	WOS:000259200100027
J	Zhai, P; Stanworth, C; Liu, S; Silberg, JJ				Zhai, Peng; Stanworth, Crystal; Liu, Shirley; Silberg, Jonathan J.			The human escort protein hep binds to the ATPase domain of mitochondrial Hsp70 and regulates ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE SYSTEM; ESCHERICHIA-COLI; KINETIC CHARACTERIZATION; EXTINCTION COEFFICIENTS; IMPORT MOTOR; IRON; ISCU; CYCLE; HSC66; DNAK	Hsp70 escort proteins (Hep) have been implicated as essential for maintaining the function of yeast mitochondrial hsp70 molecular chaperones (mtHsp70), but the role that escort proteins play in regulating mammalian chaperone folding and function has not been established. We present evidence that human mtHsp70 exhibits limited solubility due to aggregation mediated by its ATPase domain and show that human Hep directly enhances chaperone solubility through interactions with this domain. In the absence of Hep, mtHsp70 was insoluble when expressed in Escherichia coli, as was its isolated ATPase domain and a chimera having this domain fused to the peptide-binding domain of HscA, a soluble monomeric chaperone. In contrast, these proteins all exhibited increased solubility when expressed in the presence of Hep. In vitro studies further revealed that purified Hep regulates the interaction of mtHsp70 with nucleotides. Full-length mtHsp70 exhibited slow intrinsic ATPhydrolysis activity (6.8 +/- 0.2 x 10(-4) s(-1)) at 25 degrees C, which was stimulated up to 49-fold by Hep. Hep also stimulated the activity of the isolated ATPase domain, albeit to a lower maximal extent (11.5-fold). In addition, gel-filtration studies showed that formation of chaperone-escort protein complexes inhibited mtHsp70 self-association, and they revealed that Hep binding to full-length mtHsp70 and its isolated ATPase domain is strongest in the absence of nucleotides. These findings provide evidence that metazoan escort proteins regulate the catalytic activity and solubility of their cognate chaperones, and they indicate that both forms of regulation arise from interactions with the mtHsp70 ATPase domain.	[Zhai, Peng; Stanworth, Crystal; Liu, Shirley; Silberg, Jonathan J.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Silberg, JJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,POB 1892,209 Keck Hall, Houston, TX 77251 USA.	joff@rice.edu	Silberg, Jonathan J/A-3817-2010		Robert A. Welch Foundation [C-1614]	Robert A. Welch Foundation(The Welch Foundation)	This work was supported by the Robert A. Welch Foundation (Grant C-1614 to J.J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Borges JC, 2003, J BIOL CHEM, V278, P35337, DOI 10.1074/jbc.M305083200; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Oliveira CLP, 2006, ARCH BIOCHEM BIOPHYS, V449, P77, DOI 10.1016/j.abb.2006.02.015; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	46	27	27	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26098	26106		10.1074/jbc.M803475200	http://dx.doi.org/10.1074/jbc.M803475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632665	Green Published, hybrid			2022-12-25	WOS:000259200100038
J	Berthelmann, F; Mehner, D; Richter, S; Lindenstrauss, U; Lunsdorf, H; Hause, G; Bruser, T				Berthelmann, Felix; Mehner, Denise; Richter, Silke; Lindenstrauss, Ute; Luensdorf, Heinrich; Hause, Gerd; Brueser, Thomas			Recombinant expression of tatABC and tatAC results in the formation of interacting cytoplasmic TatA tubes in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; BACILLUS-SUBTILIS; MEMBRANE INSERTION; PATHWAY; COMPLEXES; COMPONENTS; SUBUNITS; BACTERIA; BINDING	The twin-arginine translocation (Tat) system of bacteria and plant plastids serves to translocate folded proteins across energized biological membranes. In Escherichia coli, the three components TatA, TatB, and TatC mediate this membrane passage. Here we demonstrate that TatA can assemble to form clusters of tube-like structures in vivo. While the presence of TatC is essential for their formation, TatB is not required. The TatA tubes have uniform outer and inner diameters of about 11.5 nm and 6.7 nm, respectively. They align to form a crystalline-like structure in which each tube is surrounded by six TatA tubes. The tube structures become easily detectable even at only a 15-fold overexpression of the tatABC genes. The TatA tubes could also be visualized by fluorescence when untagged TatA was mixed with low amounts of TatA-GFP. The structures were often found in contact with the cell poles. Because TatC is most likely polar in E. coli, as demonstrated by a RR-dependent targeting of translocation-incompatible Tat substrates to the cell poles, and because TatC is required for the formation of aligned TatA tubes, it is proposed that the TatA tubes are initiated at polarly localized TatC.	[Berthelmann, Felix; Mehner, Denise; Richter, Silke; Lindenstrauss, Ute; Brueser, Thomas] Univ Halle Wittenberg, Inst Biol Microbiol, D-06120 Halle, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Div Vaccinol, D-38124 Braunschweig, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz-Center for Infection Research; Martin Luther University Halle Wittenberg	Bruser, T (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	t.brueser@mikrobiologie.uni-halle.de	Berthelmann, Felix/GQP-2587-2022	Mehner-Breitfeld, Denise/0000-0002-6785-898X; Bruser, Thomas/0000-0002-5889-8306	Deutsche Forschungsgemeinschaft [BR2285/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (BR2285/2-2) ( to T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Hicks MG, 2005, J BACTERIOL, V187, P2920, DOI 10.1128/JB.187.8.2920-2925.2005; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moor H., 1987, CRYOTECHNIQUES BIOL, P175, DOI [10.1007/978-3-642-72815-0_8, DOI 10.1007/978-3-642-72815-0_8]; MULLER D, 1984, SCI BIOL SPECIMEN PR, P131; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042	40	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25281	25289		10.1074/jbc.M707757200	http://dx.doi.org/10.1074/jbc.M707757200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644791	hybrid			2022-12-25	WOS:000259012700021
J	Lin, YP; Raman, R; Sharma, Y; Chang, YF				Lin, Yi-Pin; Raman, Rajeev; Sharma, Yogendra; Chang, Yung-Fu			Calcium binds to leptospiral immunoglobulin-like protein, LigB, and modulates fibronectin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CRYSTALLIN DOMAIN; ESCHERICHIA-COLI; INTERROGANS; MEMBRANE; CA2+; DYE; INVOLVEMENT; ATTACHMENT; EXPRESSION; STABILITY	Pathogenic Leptospira spp. express immunoglobulin-like proteins, LigA and LigB, which serve as adhesins to bind to extracellular matrices and mediate their attachment on host cells. However, nothing is known about the mechanism by which these proteins are involved in pathogenesis. We demonstrate that LigBCen2 binds Ca2+, as evidenced by inductively coupled plasma optical emission spectrometry, energy dispersive spectrometry, Ca-45 overlay, and mass spectrometry, although there is no known motif for Ca2+ binding. LigBCen2 binds four Ca2+ as determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The dissociation constant, K-D, for Ca2+ binding is 7 mu M, as measured by isothermal titration calorimetry and calcium competition experiments. The nature of the Ca2+-binding site in LigB is possibly similar to that seen in the beta gamma-crystallin superfamily, since structurally, both families of proteins possess the Greek key type fold. The conformation of LigBCen2 was significantly influenced by Ca2+ binding as shown by far-and near-UV CD and by fluorescence spectroscopy. In the apo form, the protein appears to be partially unfolded, as seen in the far-UV CD spectrum, and upon Ca2+ binding, the protein acquires significant beta-sheet conformation. Ca2+ binding stabilizes the protein as monitored by thermal unfolding by CD (50.7-54.8 degrees C) and by differential scanning calorimetry (50.0-55.7 degrees C). Ca2+ significantly assists the binding of LigBCen2 to the N-terminal domain of fibronectin and perturbs the secondary structure, suggesting the involvement of Ca2+ in adhesion. We demonstrate that LigB is a novel bacterial Ca2+-binding protein and suggest that Ca2+ binding plays a pivotal role in the pathogenesis of leptospirosis.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Raman, Rajeev; Sharma, Yogendra] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu			Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corporation; Department of Science and Technology, Government of India	Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corporation; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (to C. A. T.), the Biotechnology Research and Development Corporation (to Y. F. C.), and the Department of Science and Technology, Government of India (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dardanelli M, 2003, CAN J MICROBIOL, V49, P399, DOI 10.1139/w03-054; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; GOODE D, 1995, COMPUT CHEM, V19, P65, DOI 10.1016/0097-8485(95)00027-P; Gopalan V, 1997, J MOL BIOL, V267, P818, DOI 10.1006/jmbi.1997.0906; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Izutsu KT, 1996, FEMS MICROBIOL LETT, V144, P145, DOI 10.1111/j.1574-6968.1996.tb08521.x; Jeromin A, 2004, J BIOL CHEM, V279, P27158, DOI 10.1074/jbc.M312172200; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jobby MK, 2007, BIOCHEMISTRY-US, V46, P12298, DOI 10.1021/bi700843q; Jobby MK, 2007, FEBS J, V274, P4135, DOI 10.1111/j.1742-4658.2007.05941.x; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; JOHNSON RC, 1963, J BACTERIOL, V85, P983, DOI 10.1128/JB.85.5.983-985.1963; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; PIATIGORSKY J, 1984, MOL CELL BIOCHEM, V59, P33; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; STRALEY SC, 1993, MOL MICROBIOL, V8, P1005, DOI 10.1111/j.1365-2958.1993.tb01644.x; TISA LS, 1995, P NATL ACAD SCI USA, V92, P10777, DOI 10.1073/pnas.92.23.10777; TISA LS, 1992, P NATL ACAD SCI USA, V89, P11804, DOI 10.1073/pnas.89.24.11804; TROMBE MC, 1994, J BACTERIOL, V176, P1992, DOI 10.1128/jb.176.7.1992-1996.1994; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Werthen M, 2001, J BIOL CHEM, V276, P6468, DOI 10.1074/jbc.M009223200; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	50	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25140	25149		10.1074/jbc.M801350200	http://dx.doi.org/10.1074/jbc.M801350200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625711	hybrid			2022-12-25	WOS:000259012700006
J	Hurd, TR; Requejo, R; Filipovska, A; Brown, S; Prime, TA; Robinson, AJ; Fearnley, IM; Murphy, MP				Hurd, Thomas R.; Requejo, Raquel; Filipovska, Aleksandra; Brown, Stephanie; Prime, Tracy A.; Robinson, Alan J.; Fearnley, Ian M.; Murphy, Michael P.			Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit - Potential role of Cys residues in decreasing oxidative damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUTAREDOXIN THIOLTRANSFERASE; NITRIC-OXIDE; PARKINSONS-DISEASE; UBIQUINONE OXIDOREDUCTASE; S-GLUTATHIONYLATION; MASS-SPECTROMETRY; NATIVE ELECTROPHORESIS; HYDROPHILIC DOMAIN; HYDROGEN-PEROXIDE; PROTEIN COMPLEXES	Complex I has reactive thiols on its surface that interact with the mitochondrial glutathione pool and are implicated in oxidative damage in many pathologies. However, the Cys residues and the thiol modifications involved are not known. Here we investigate complex I thiol modification within oxidatively stressed mammalian mitochondria, containing physiological levels of glutathione and glutaredoxin 2. In mitochondria incubated with the thiol oxidant diamide, complex I is only glutathionylated on the 75-kDa subunit. Of the 17 Cys residues on the 75-kDa subunit, 6 are not involved in iron-sulfur centers, making them plausible candidates for glutathionylation. Mass spectrometry of complex I from oxidatively stressed bovine heart mitochondria showed that only Cys-531 and Cys-704 were glutathionylated. The other four non-iron-sulfur center Cys residues remained as free thiols. Complex I glutathionylation also occurred in response to relatively mild oxidative stress caused by increased superoxide production from the respiratory chain. Although complex I glutathionylation within oxidatively stressed mitochondria correlated with loss of activity, it did not increase superoxide formation, and reversal of glutathionylation did not restore complex I activity. Comparison with the known structure of the 75-kDa ortholog Nqo3 from Thermus thermophilus complex I suggested that Cys-531 and Cys-704 are on the surface of mammalian complex I, exposed to the mitochondrial glutathione pool. These findings suggest that Cys-531 and Cys-704 may be important in preventing oxidative damage to complex I by reacting with free radicals and other damaging species, with subsequent glutathionylation recycling the thiyl radicals and sulfenic acids formed on the Cys residues back to free thiols.	[Hurd, Thomas R.; Requejo, Raquel; Filipovska, Aleksandra; Brown, Stephanie; Prime, Tracy A.; Robinson, Alan J.; Fearnley, Ian M.; Murphy, Michael P.] MRC, Dunn Human Nutr Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Murphy, MP (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust,MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-dunn.cam.ac.uk	Murphy, Michael P/C-2120-2009; Robinson, Alan/A-9956-2009; Requejo-Aguilar, Raquel/M-2360-2014	Murphy, Michael P/0000-0003-1115-9618; Requejo-Aguilar, Raquel/0000-0002-0532-7630; Filipovska, Aleksandra/0000-0002-6998-8403	Medical Research Council (UK); Natural Sciences and Engineering Council of Canada; Medical Research Council [MC_U105663148, MC_U105663142, MC_U105674181] Funding Source: researchfish; MRC [MC_U105674181, MC_U105663148, MC_U105663142] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK) and by a postgraduate research scholarship (to T. R. H.) from the Natural Sciences and Engineering Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akerboom T P, 1981, Methods Enzymol, V77, P373; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bharath S, 2005, ANTIOXID REDOX SIGN, V7, P900, DOI 10.1089/ars.2005.7.900; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kenchappa RS, 2003, FASEB J, V17, P717, DOI 10.1096/fj.02-0771fje; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; LUCAS M, 1992, ANAL BIOCHEM, V206, P273, DOI 10.1016/0003-2697(92)90366-F; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; MCKERNAN TB, 1991, ARCH BIOCHEM BIOPHYS, V288, P653, DOI 10.1016/0003-9861(91)90248-H; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy S, 2000, BIOCHEM J, V347, P821, DOI 10.1042/0264-6021:3470821; Rubino FM, 2006, J MASS SPECTROM, V41, P1578, DOI 10.1002/jms.1143; RUNSWICK MJ, 1989, BIOCHEMISTRY-US, V28, P9452, DOI 10.1021/bi00450a031; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Scarlett JL, 1996, BIOCHEM PHARMACOL, V52, P1047, DOI 10.1016/0006-2952(96)99426-5; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sriram K, 1998, J NEUROSCI, V18, P10287; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	72	157	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24801	24815		10.1074/jbc.M803432200	http://dx.doi.org/10.1074/jbc.M803432200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611857	Green Published, hybrid			2022-12-25	WOS:000258820000047
J	Imanishi, Y; Sun, WY; Maeda, T; Maeda, A; Palczewski, K				Imanishi, Yoshikazu; Sun, Wenyu; Maeda, Tadao; Maeda, Akiko; Palczewski, Krzysztof			Retinyl ester homeostasis in the adipose differentiation-related protein-deficient retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID DROPLET FORMATION; LIGHT-INDUCED DEGENERATION; GATED ION CHANNELS; VISUAL CYCLE; PIGMENT EPITHELIUM; DARK-ADAPTATION; IN-VIVO; MICE; TIP47; RPE65	The retinal pigmented epithelium (RPE) plays an essential role in vision, including storing and converting retinyl esters of the visual chromophore, 11-cis-retinal. Retinyl ester storage structures (RESTs), specialized lipid droplets within the RPE, take up retinyl esters synthesized in the endoplasmic reticulum. Here we report studies of mice lacking exons 2 and 3 of the gene encoding adipose differentiation-related protein (Adfp), a structural component of RESTs. We found that dark adaptation was slower in Adfp(Delta 2-3/Delta 2-3) than in Adfp(+/+) mice and that Adfp(Delta 2-3/Delta 2-3) mice had consistently delayed clearances of all-trans-retinal and all-trans-retinol from rod photoreceptor cells. Two-photon microscopy revealed aberrant trafficking of all-trans-retinyl esters in the RPE of Adfp(Delta 2-3/Delta 2-3) mice, a problem caused by abnormal maintenance of RESTs in the dark-adapted state. Retinyl ester accumulation was also reduced in Adfp(Delta 2-3/Delta 2-3) as compared with Adfp(+/+) mice. These observations suggest that Adfp plays a unique role in vision by maintaining proper storage and trafficking of retinoids within the eye.	[Imanishi, Yoshikazu; Sun, Wenyu; Maeda, Tadao; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836	National Institutes of Health [EY009339, P30 EY11373]; Klaus Tschira Foundation; European Life Scientist Organization; Amgen Inc; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klaus Tschira Foundation; European Life Scientist Organization; Amgen Inc(Amgen); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339 and P30 EY11373. This work was also supported by the Klaus Tschira Foundation, the European Life Scientist Organization, and by an unrestricted grant from Amgen Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dean DM, 2002, P NATL ACAD SCI USA, V99, P8372, DOI 10.1073/pnas.122681899; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Fukushima M, 2005, IN VITRO CELL DEV-AN, V41, P321; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2007, BIOCHEMISTRY-US, V46, P9674, DOI 10.1021/bi701055g; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; McCabe SL, 2004, J GEN PHYSIOL, V123, P521, DOI 10.1085/jgp.200409011; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Serrero G, 2000, BBA-MOL CELL BIOL L, V1488, P245, DOI 10.1016/S1388-1981(00)00128-1; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; Tsuiki E, 2007, INVEST OPHTH VIS SCI, V48, P2858, DOI 10.1167/iovs.06-0768; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	53	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25091	25102		10.1074/jbc.M802981200	http://dx.doi.org/10.1074/jbc.M802981200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606814	Green Published, hybrid			2022-12-25	WOS:000258820000064
J	Lee, EJ; Kim, JM; Lee, MK; Jameson, JL				Lee, Eun Jig; Kim, Jeong Mo; Lee, Mi Kyung; Jameson, J. Larry			Splice Variants of the Forkhead Box Protein AFX Exhibit Dominant Negative Activity and Inhibit AFX alpha-Mediated Tumor Cell Apoptosis	PLOS ONE			English	Article								Background: Loss-of-function in the apoptosis-inducing genes is known to facilitate tumorigenesis. AFX (FOXO4), a member of forkhead transcription factors functions as a tumor suppressor and has 2 isoforms, AFX alpha (505 a.a.) and AFX zeta (450 a.a.). In human cancer cells, we identified an N-terminally deleted form of AFX alpha (alpha 198-505), translated from a downstream start and 2 short N-terminal AFX proteins (90, and 101 a.a.) produced by aberrant splicing. Methods and Findings: We investigated the expression and role of these AFX variants. Cell transduction study revealed that short N-terminal AFX proteins were not stable. Though alpha(198-505) protein expression was detected in the cytoplasm and nucleus, alpha(198-505) expressing cells did not show a nucleocytoplasmic shuttling mediated by PI3 kinase signaling. Whereas, we observed this shuttling in cells expressing either AFX alpha or AFX zeta protein. AFX zeta and alpha(198-505) lost the ability to transactivate BCL6 or suppress cyclin D2 gene expression. These variants did not induce cancer cell death whereas AFX alpha resulted in apoptosis. We found that AFX zeta and alpha(198-505) suppress the AFX alpha stimulation of BCL6 promoter in a dose dependent manner, indicating dominant negative activity. These variants also inhibited AFX alpha induction of apoptosis. Conclusions: Loss of function by aberrant splicing and the dominant negative activity of AFX variants may provide a mechanism for enhanced survival of neoplastic cells.	[Lee, Eun Jig; Kim, Jeong Mo] Yonsei Univ, Coll Med, Seoul, South Korea; [Lee, Eun Jig; Jameson, J. Larry] Northwestern Univ, Feinberg Sch Med, Div Endocrinol, Metabolism, & Mo Med, Chicago, IL USA; [Lee, Mi Kyung] Ilsan Hosp, Natl Hlth Insurance Corp, Koyang, South Korea	Yonsei University; Yonsei University Health System; Northwestern University; Feinberg School of Medicine; NHIS Ilsan Hospital	Lee, EJ (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	ljameson@northwestern.edu		Jameson, James/0000-0001-9538-4059; Lee, Eun Jig/0000-0002-9876-8370	Yonsei University College of Medicine	Yonsei University College of Medicine(General Electric)	CMB-YUHAN Research Grant from Yonsei University College of Medicine (2007-01). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Ciechomska I, 2003, ONCOGENE, V22, P7617, DOI 10.1038/sj.onc.1207137; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ishikawa T, 2004, MOL CELL BIOL, V24, P8323, DOI 10.1128/MCB.24.19.8323-8331.2004; Lee EJ, 1999, J CLIN ENDOCR METAB, V84, P786, DOI 10.1210/jc.84.2.786; Lee EJ, 2001, MOL MED, V7, P773, DOI 10.1007/BF03401968; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Smith PJ, 2002, ENDOCRINOLOGY, V143, P146, DOI 10.1210/en.143.1.146; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Yang ZY, 2002, J BIOL CHEM, V277, P8068, DOI 10.1074/jbc.M106091200	38	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2743	10.1371/journal.pone.0002743	http://dx.doi.org/10.1371/journal.pone.0002743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648506	Green Submitted, gold, Green Published			2022-12-25	WOS:000264302900014
J	Fabian, P; McDevitt, JJ; DeHaan, WH; Fung, ROP; Cowling, BJ; Chan, KH; Leung, GM; Milton, DK				Fabian, Patricia; McDevitt, James J.; DeHaan, Wesley H.; Fung, Rita O. P.; Cowling, Benjamin J.; Chan, Kwok Hung; Leung, Gabriel M.; Milton, Donald K.			Influenza Virus in Human Exhaled Breath: An Observational Study	PLOS ONE			English	Article								Background: Recent studies suggest that humans exhale fine particles during tidal breathing but little is known of their composition, particularly during infection. Methodology/Principal Findings: We conducted a study of influenza infected patients to characterize influenza virus and particle concentrations in their exhaled breath. Patients presenting with influenza-like-illness, confirmed influenza A or B virus by rapid test, and onset within 3 days were recruited at three clinics in Hong Kong, China. We collected exhaled breath from each subject onto Teflon filters and measured exhaled particle concentrations using an optical particle counter. Filters were analyzed for influenza A and B viruses by quantitative polymerase chain reaction (qPCR). Twelve out of thirteen rapid test positive patients provided exhaled breath filter samples (7 subjects infected with influenza B virus and 5 subjects infected with influenza A virus). We detected influenza virus RNA in the exhaled breath of 4 (33%) subjects-three (60%) of the five patients infected with influenza A virus and one (14%) of the seven infected with influenza B virus. Exhaled influenza virus RNA generation rates ranged from <3.2 to 20 influenza virus RNA particles per minute. Over 87% of particles exhaled were under 1 mu m in diameter. Conclusions: These findings regarding influenza virus RNA suggest that influenza virus may be contained in fine particles generated during tidal breathing, and add to the body of literature suggesting that fine particle aerosols may play a role in influenza transmission.	[Fabian, Patricia; McDevitt, James J.; Milton, Donald K.] Univ Massachusetts, Dept Work Environm, Lowell, MA 01854 USA; [Fabian, Patricia; McDevitt, James J.; Milton, Donald K.] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [DeHaan, Wesley H.] Pulmatrix Inc, Lexington, MA USA; [Fung, Rita O. P.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Dept Community Med, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China	University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong	Fabian, P (corresponding author), Univ Massachusetts, Dept Work Environm, Lowell, MA 01854 USA.	patricia_fabian@uml.edu	Milton, Donald K/G-3286-2010; Chan, Kwok Hung/ABD-5399-2021; Cowling, Benjamin John/C-4263-2009	Milton, Donald K/0000-0002-0550-7834; Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Fabian, M. Patricia/0000-0002-1658-3349	US Centers for Disease Control and Prevention [1U01CI000439-01, 1U01CI000446-01]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER) [04-C-ACE-HU]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000439, U01CI000446] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University Grants Committee; U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has received financial support from the US Centers for Disease Control and Prevention (cooperative grants #1U01CI000439-01 and #1U01CI000446-01), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR, and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). This work was also supported by the U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER), Cooperative Agreements 04-C-ACE-HU. Although the FAA and CDC have sponsored this project, they neither endorse nor reject the findings of this research.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Andrewes CH, 1941, BRIT J EXP PATHOL, V22, P91; [Anonymous], PREPARING INFLUENZA; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; COUCH RB, 1970, AM J EPIDEMIOL, V91, P78, DOI 10.1093/oxfordjournals.aje.a121115; COUCH RB, 1966, BACTERIOL REV, V30, P517, DOI 10.1128/MMBR.30.3.517-529.1966; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P615; DUGUID J P, 1945, Edinb Med J, V52, P385; Edward DGF, 1943, J HYG-CAMBRIDGE, V43, P1, DOI 10.1017/S0022172400035828; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; FRANKOVA V, 1975, ACTA VIROL, V19, P29; Gebhart J., 1988, J AEROSOL MED, V1, P196; GERONE PJ, 1966, BACTERIOL REV, V30, P576, DOI 10.1128/MMBR.30.3.576-588.1966; Glover RE, 1941, BRIT J EXP PATHOL, V22, P98; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; KNIGHT V, 1965, ANN INTERN MED, V62, P1307, DOI 10.7326/0003-4819-62-6-1307; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LOOSLI CG, 1970, ARCH ENVIRON HEALTH, V21, P332, DOI 10.1080/00039896.1970.10667248; LOOSLI CG, 1953, T ASSOC AM PHYSICIAN, V66, P222; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; MAIGETTER RZ, 1976, ENVIRON RES, V11, P386, DOI 10.1016/0013-9351(76)90100-6; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; SCHULMAN JL, 1967, J EXP MED, V125, P479, DOI 10.1084/jem.125.3.479; SCHULMAN JL, 1968, AM J PUBLIC HEALTH N, V58, P2092, DOI 10.2105/AJPH.58.11.2092; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; SNYDER MH, 1986, J INFECT DIS, V154, P709, DOI 10.1093/infdis/154.4.709; Squires S, 1975, J Antimicrob Chemother, V1, P35; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; *US DHHS, 2005, HHS PAND INFL PLAN; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008; Wells WF, 1955, AIR HYG ECOL STUDY D	42	334	351	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2691	10.1371/journal.pone.0002691	http://dx.doi.org/10.1371/journal.pone.0002691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628983	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200034
J	Jun, SH; Choi, B; Shahine, L; Westphal, LM; Behr, B; Pera, RAR; Wong, WH; Yao, MWM				Jun, Sunny H.; Choi, Bokyung; Shahine, Lora; Westphal, Lynn M.; Behr, Barry; Pera, Renee A. Reijo; Wong, Wing H.; Yao, Mylene W. M.			Defining Human Embryo Phenotypes by Cohort-Specific Prognostic Factors	PLOS ONE			English	Article							IN-VITRO-FERTILIZATION; STEM-CELL LINES; INTRACYTOPLASMIC SPERM INJECTION; FOLLICLE-STIMULATING-HORMONE; MORPHOLOGICAL ASSESSMENT; BLASTOCYST TRANSFER; PREDICTIVE-VALUE; OVARIAN RESERVE; PREGNANCY; FRAGMENTATION	Background: Hundreds of thousands of human embryos are cultured yearly at in vitro fertilization (IVF) centers worldwide, yet the vast majority fail to develop in culture or following transfer to the uterus. However, human embryo phenotypes have not been formally defined, and current criteria for embryo transfer largely focus on characteristics of individual embryos. We hypothesized that embryo cohort-specific variables describing sibling embryos as a group may predict developmental competence as measured by IVF cycle outcomes and serve to define human embryo phenotypes. Methodology/Principal Findings: We retrieved data for all 1117 IVF cycles performed in 2005 at Stanford University Medical Center, and further analyzed clinical data from the 665 fresh IVF, non-donor cycles and their associated 4144 embryos. Thirty variables representing patient characteristics, clinical diagnoses, treatment protocol, and embryo parameters were analyzed in an unbiased manner by regression tree models, based on dichotomous pregnancy outcomes defined by positive serum beta-human chorionic gonadotropin (beta-hCG). IVF cycle outcomes were most accurately predicted at similar to 70% by four non-redundant, embryo cohort-specific variables that, remarkably, were more informative than any measures of individual, transferred embryos: Total number of embryos, number of 8-cell embryos, rate (percentage) of cleavage arrest in the cohort and day 3 follicle stimulating hormone (FSH) level. While three of these variables captured the effects of other significant variables, only the rate of cleavage arrest was independent of any known variables. Conclusions/Significance: Our findings support defining human embryo phenotypes by non-redundant, prognostic variables that are specific to sibling embryos in a cohort.	[Jun, Sunny H.; Shahine, Lora; Westphal, Lynn M.; Behr, Barry; Pera, Renee A. Reijo; Yao, Mylene W. M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Choi, Bokyung] Stanford Univ, Sch Humanities & Sci, Dept Appl Phys, Stanford, CA USA; [Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat, Ctr Human Embryo & Embryon Stem Cell Res & Educ, Stanford, CA USA; [Wong, Wing H.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Jun, SH (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	mylene.yao@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	NIH [HD057970, HD01249, GM067250]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057970] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.W.M.Y. received support from NIH HD057970 and HD01249; W.H.W. received support from NIH GM067250; R.A.R.P. received support from the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikani M, 1999, FERTIL STERIL, V71, P836, DOI 10.1016/S0015-0282(99)00092-8; ARTLEY JK, 1992, HUM REPROD, V7, P1014, DOI 10.1093/oxfordjournals.humrep.a137761; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Behr B, 1999, HUM REPROD, V14, P5, DOI 10.1093/humrep/14.1.5; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Ebner T, 2003, HUM REPROD UPDATE, V9, P251, DOI 10.1093/humupd/dmg021; Ebner T, 2001, FERTIL STERIL, V76, P281, DOI 10.1016/S0015-0282(01)01904-5; Fisch JD, 1999, FERTIL STERIL, V71, P750, DOI 10.1016/S0015-0282(98)00533-0; Friedman J.H., 1999, GREEDY FUNCTION APPR; Friedman J.H., 1999, STOCHASTIC GRADIENT; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; FRIEDMAN JH, 2002, TUTORIAL GETTING STA; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gardner DK, 1998, HUM REPROD, V13, P3434, DOI 10.1093/humrep/13.12.3434; Gardner DK, 2000, HUM REPROD, V15, P9; GIORGETTI C, 1995, HUM REPROD, V10, P2427; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; Jain T, 2004, FERTIL STERIL, V82, P180, DOI 10.1016/j.fertnstert.2003.11.045; Jun SH, 2006, FERTIL STERIL, V86, P825, DOI 10.1016/j.fertnstert.2006.03.043; Keltz MD, 2006, FERTIL STERIL, V86, P321, DOI 10.1016/j.fertnstert.2006.01.048; Lan KC, 2003, HUM REPROD, V18, P1299, DOI 10.1093/humrep/deg239; LANE M, 1992, HUM REPROD, V7, P558, DOI 10.1093/oxfordjournals.humrep.a137690; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Milki AA, 2002, FERTIL STERIL, V77, P1191, DOI 10.1016/S0015-0282(02)03104-7; Milki AA, 2000, FERTIL STERIL, V73, P126, DOI 10.1016/S0015-0282(99)00485-9; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Nagy ZP, 2003, FERTIL STERIL, V80, P67, DOI 10.1016/S0015-0282(03)00569-7; Neuber E, 2006, FERTIL STERIL, V85, P794, DOI 10.1016/j.fertnstert.2005.08.064; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; Racowsky C, 2000, FERTIL STERIL, V73, P558, DOI 10.1016/S0015-0282(99)00565-8; Racowsky C, 2002, THERIOGENOLOGY, V57, P87, DOI 10.1016/S0093-691X(01)00659-8; Rijnders PM, 1998, HUM REPROD, V13, P2869, DOI 10.1093/humrep/13.10.2869; SCOTT RT, 2007, FERTIL STERIL; Spyropoulou I, 1999, HUM REPROD, V14, P76, DOI 10.1093/humrep/14.1.76; Srouji SS, 2005, FERTIL STERIL, V84, P795, DOI 10.1016/j.fertnstert.2005.02.042; Stone BA, 2005, AM J OBSTET GYNECOL, V192, P2014, DOI 10.1016/j.ajog.2005.02.048; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Volpes A, 2004, FERTIL STERIL, V82, P1330, DOI 10.1016/j.fertnstert.2004.03.067; Watt AH, 2000, J ASSIST REPROD GEN, V17, P264, DOI 10.1023/A:1009458332567; 2006, FERTIL STERIL S, V86, pS51	45	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2562	10.1371/journal.pone.0002562	http://dx.doi.org/10.1371/journal.pone.0002562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596962	Green Submitted, Green Published, gold			2022-12-25	WOS:000263288200029
J	Nikonova, L; Koza, RA; Mendoza, T; Chao, PM; Curley, JP; Kozak, LP				Nikonova, Larissa; Koza, Robert A.; Mendoza, Tamra; Chao, Pei-Min; Curley, James P.; Kozak, Leslie P.			Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance	FASEB JOURNAL			English	Article						nutritional programming; epigenetics; alpha/beta fold hydrolase; imprinted genes; obesity	DIET-INDUCED OBESITY; STEAROYL-COA DESATURASE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; GENE-EXPRESSION; IMPRINTED GENE; PPAR-GAMMA; INSULIN-RESISTANCE; DIABETES-MELLITUS; COLD ENVIRONMENT	A 50-fold variation in mRNA and protein levels of the mesoderm-specific transcript gene (Mest) in white fat of C57BL/6J (B6) mice fed an obesogenic diet is positively correlated with expansion of fat mass. MEST protein was detected only in adipocytes, in which its induction occurred with both unsaturated and saturated dietary fat. To test the hypothesis that MEST modulates fat mass expansion, its expression was compared to that of stearoyl CoA desaturase (Scd1) in B6 mice exposed to diets and environmental temperatures that generated conditions separating the effects of food intake and adiposity. Under a range of conditions, Mest expression was always associated with variations in adiposity, whereas Scd1 expression was associated with the amount of saturated fat in the diet. Mest mRNA was expressed at its highest levels during early postnatal growth at the onset of the most rapid phase of fat mass expansion. MEST is localized to the endoplasmic reticulum/Golgi apparatus where its putative enzymatic properties as a lipase or acyltransferase, predicted from sequence homology with members of the alpha/beta fold hydrolase superfamily, can enable it to function in lipid accumulation under conditions of positive energy balance. Variations in adiposity and Mest expression in genetically identical mice also provides a model of epigenetic regulation. -Nikonova, L., Koza, R. A., Mendoza, T., Chao, P.-M., Curley, J. P., Kozak, L. P. Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance. FASEB J. 22, 3925-3937 (2008)	[Nikonova, Larissa; Koza, Robert A.; Mendoza, Tamra; Chao, Pei-Min; Kozak, Leslie P.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Curley, James P.] Univ Cambridge, Darwin Coll, Madingley, England	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Cambridge	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	kozaklp@pbrc.edu	Chao, Pei-Min/L-8157-2013; Nikonova, Larissa/AAV-5151-2020; chao, P/GSD-8001-2022	Chao, Pei-Min/0000-0002-4846-3245; Curley, James/0000-0001-5546-007X	National Institutes of Health [P-30 DK072476, P20-RR021945]; Leverhulme Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leverhulme Trust(Leverhulme Trust); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Indu Kheterpal and the Proteomic Core for analysis of MEST by mass spectroscopy and Dr. Barbara Kozak for making the photomicrographs. We thank Cody Giardino for excellent technical assistance. This research was supported by a grant from the Health Excellence Fund of the State of Louisiana and grants P-30 DK072476 and P20-RR021945 from the National Institutes of Health. J. P. C. was supported by a fellowship from the Leverhulme Trust.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BARNETT SA, 1984, J PHYSIOL-LONDON, V346, P409, DOI 10.1113/jphysiol.1984.sp015031; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Ren Hong-shan, 2002, APPL MATH E NOTES, V2, P1; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Soukas A, 2000, GENE DEV, V14, P963; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X	49	72	74	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3925	3937		10.1096/fj.08-108266	http://dx.doi.org/10.1096/fj.08-108266			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18644838	Green Published			2022-12-25	WOS:000260503000021
J	Singh, PK; Behrens, ME; Eggers, JP; Cerny, RL; Bailey, JM; Shanmugam, K; Gendler, SJ; Bennett, EP; Hollingsworth, MA				Singh, Pankaj K.; Behrens, Michelle E.; Eggers, John P.; Cerny, Ronald L.; Bailey, Jennifer M.; Shanmugam, Kandavel; Gendler, Sandra J.; Bennett, Eric P.; Hollingsworth, Michael A.			Phosphorylation of MUC1 by met modulates interaction with p53 and MMP1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN PANCREATIC-CANCER; CARCINOMA-ASSOCIATED ANTIGEN; MATRIX METALLOPROTEINASE-1; CELL-LINE; BETA-CATENIN; CYTOPLASMIC TAIL; FACTOR RECEPTOR; METASTATIC PROPERTIES; ADENOCARCINOMA CELLS	MUC1, a transmembrane mucin, is a key modulator of several signaling pathways that affect oncogenesis, motility, and cell morphology. The interaction of MUC1 cytoplasmic tail (MUC1CT) with signal transducers and its nuclear translocation and subsequent biological responses are believed to be regulated by phosphorylation status, but the precise mechanisms by which this occurs remain poorly defined. We detected a novel association between the Met receptor tyrosine kinase and the MUC1CT. Met catalyzed phosphorylation of tyrosine at YHPM in the MUC1CT. Stimulation of S2-013.MUC1F pancreatic cancer cells with hepatocyte growth factor facilitated nuclear localization of MUC1CT, as determined by real time confocal imaging analysis. MUC1 overexpression also facilitated faster turnover of Met. Phosphorylation of MUC1CT by Met enhanced its interaction with p53, which led to suppression of AP1 transcription factor activity through interactions at the MMP1 promoter, ultimately leading to reduced transcription of MMP1. This correlated with a decrease in hepatocyte growth factor-induced invasiveness when MUC1 was overexpressed. The results demonstrate that MUC1 modulates Met-mediated oncogenic signaling in cancer.	[Singh, Pankaj K.; Eggers, John P.; Bailey, Jennifer M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Singh, Pankaj K.; Behrens, Michelle E.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cerny, Ronald L.] Univ Nebraska, Lincoln, NE 68588 USA; [Shanmugam, Kandavel; Gendler, Sandra J.] Mayo Clin, Coll Med, Program Mol Biol, Dept Biochem, Scottsdale, AZ 85259 USA; [Bennett, Eric P.] Univ Copenhagen, Dept Odontol, Sch Dent, DK-2200 Copenhagen N, Denmark	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; Mayo Clinic; Mayo Clinic Phoenix; University of Copenhagen	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 NE Med Ctr, Omaha, NE 68198 USA.	mahollin@unmc.edu		Bennett, Eric Paul/0000-0002-4976-0647; Singh, Pankaj/0000-0001-8903-0131; Bailey-Lundberg, Jennifer/0000-0002-4750-106X	National Institutes of Health [R01 CA57362, U01 CA111294, CA09476, P20 RR15635]; NCI Cancer Center [P30 CA36727]; Nebraska Research Initiative; Danish National Research Council; NATIONAL CANCER INSTITUTE [U01CA111294, T32CA009476, P30CA036727, R01CA057362] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Research Initiative; Danish National Research Council(Danmarks Grundforskningsfond); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA57362, U01 CA111294, CA09476 (training), P20 RR15635 from the COBRE Program of the NCRR, and P30 CA36727 from the NCI Cancer Center. This work was also supported by graduate studies assistantships (to P.K.S., J.P.E., and J.M.B.), the Nebraska Research Initiative, and the Danish National Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BATRA SK, 1991, J CELL SCI, V100, P841; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; DIRENZO MF, 1995, CANCER RES, V55, P1129; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GALIMI F, 1993, STEM CELLS, V11, P22; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Higuchi T, 2004, MOL CELL BIOL, V24, P7456, DOI 10.1128/MCB.24.17.7456-7468.2004; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, J INVEST DERMATOL, V124, P324, DOI 10.1111/j.0022-202X.2004.23601.x; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Kohlgraf KG, 2003, CANCER RES, V63, P5011; LACROIX M, 2008, CANC CHEMOT IN PRESS; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; METZGAR RS, 1982, CANCER RES, V42, P601; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sun YB, 1999, ANN NY ACAD SCI, V878, P638, DOI 10.1111/j.1749-6632.1999.tb07749.x; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; TISHLER RB, 1993, CANCER RES, V53, P2212; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200	38	73	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26985	26995		10.1074/jbc.M805036200	http://dx.doi.org/10.1074/jbc.M805036200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18625714	hybrid, Green Published			2022-12-25	WOS:000259586600019
J	Esteban, R; Vega, L; Fujimura, T				Esteban, Rosa; Vega, Lorena; Fujimura, Tsutomu			20S RNA narnavirus defies the antiviral activity of SKI1/XRN1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; L-A; IN-VIVO; YEAST; VIRUS; REPLICATION; EXORIBONUCLEASE; POLYMERASE; MUTATIONS	20S RNA virus is a persistent positive strand RNA virus found in Saccharomyces cerevisiae. We previously observed that the virus generated in vivo from a launching vector possessed the correct RNA termini without extra sequences. Here we present evidence that the SKI1/XRN1 5'-exonuclease plays a major role in the elimination of the non-viral upstream sequences from the primary transcripts. The virus, once generated, however, is fairly unaffected by overexpression or deletion of SKI1/XRN1. By contrast, the copy number of the L-A double-stranded RNA virus in the same host is greatly increased by the deletion of SKI1/XRN1, and overexpression of the gene cured L-A virus from the cells at a high frequency. 20S RNA virus, unlike L-A virus, has a strong secondary structure at its 5'-end: the first four nucleotides are G, and they are buried at the bottom of a long stem structure, features known to inhibit the SKI1/XRN1 5'-exonuclease progression. Mutations that weakened the 5'-stem structure made 20S RNA virus vulnerable to SKI1/XRN1. These results, together with the data on L-A virus, indicate a strong anti-RNA virus activity of SKI1/XRN1. Given that 20S RNA virus resides and replicates in the cytoplasm without a protective capsid, our results suggest that the strong secondary structure at the 5'-end is crucial for the 20S RNA virus to evade the host SKI1/XRN1 defense.	[Esteban, Rosa; Vega, Lorena; Fujimura, Tsutomu] Univ Salamanca, Inst Microbiol Bioquim, CSIC, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Esteban, R (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Dept Genet & Microbiol, Avda Campo Charro S-N, Salamanca 37007, Spain.	mrosa@usal.es	Esteban, Rosa/K-4356-2014; Fujimura, Tsutomu/K-5807-2014	Esteban, Rosa/0000-0001-6804-7209; Fujimura, Tsutomu/0000-0002-9457-6769	Spanish Ministry of Education and Science [BFU2004-00373, BFU2007-60057]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Grants BFU2004-00373 and BFU2007-60057 from the Spanish Ministry of Education and Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; BALL SG, 1984, GENETICS, V107, P199; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; Esteban R, 2005, J BIOL CHEM, V280, P33725, DOI 10.1074/jbc.M506546200; Esteban R, 2003, P NATL ACAD SCI USA, V100, P2568, DOI 10.1073/pnas.0530167100; Fekete Z, 2008, J BIOL CHEM, V283, P3767, DOI 10.1074/jbc.M709617200; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; Fujimura T, 2007, J BIOL CHEM, V282, P19011, DOI 10.1074/jbc.M702432200; GARCIACUELLAR MP, 1995, J BIOL CHEM, V270, P20084, DOI 10.1074/jbc.270.34.20084; JOHNSON AW, 1995, MOL CELL BIOL, V15, P2719; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; MANIATIS T, 1993, MOL CLONING LAB MANU, P202; MATSUMOTO Y, 1991, J BIOL CHEM, V266, P12779; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mortimer R K, 1975, Methods Cell Biol, V11, P221, DOI 10.1016/S0091-679X(08)60325-8; NEMEROFF ME, 1987, J BIOL CHEM, V262, P6785; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RIDLEY SP, 1984, MOL CELL BIOL, V4, P761, DOI 10.1128/MCB.4.4.761; Rodriguez-Cousino N, 1998, J BIOL CHEM, V273, P20363, DOI 10.1074/jbc.273.32.20363; RODRIGUEZCOUSINO N, 1991, J BIOL CHEM, V266, P12772; SIKORSKI RS, 1989, GENETICS, V122, P19; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; Solorzano A, 2000, J BIOL CHEM, V275, P26428, DOI 10.1074/jbc.M002281200; STEVENS A, 1980, J BIOL CHEM, V255, P3080; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WEJKSNORA PJ, 1978, J BACTERIOL, V134, P246, DOI 10.1128/JB.134.1.246-260.1978; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1986, ANNU REV BIOCHEM, V55, P373, DOI 10.1146/annurev.bi.55.070186.002105; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WIDNER WR, 1991, MOL CELL BIOL, V11, P2905, DOI 10.1128/MCB.11.5.2905; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	41	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25812	25820		10.1074/jbc.M804400200	http://dx.doi.org/10.1074/jbc.M804400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640978	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000259200100007
J	Noble, CG; Dong, JM; Manser, E; Song, HW				Noble, Christian G.; Dong, Jing-Ming; Manser, Edward; Song, Haiwei			Bcl-x(L) and UVRAG cause a monomer-dimer switch in Beclin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; TUMOR-SUPPRESSOR FUNCTION; CELL-DEATH; AUTOPHAGY GENE; DOMAIN; PROTEINS; TUMORIGENESIS; DIMERIZATION; COMPLEX; FAMILY	Beclin1 has a key regulatory role in the initiation of autophagy and is a tumor suppressor. We have examined the interplay between viral or human Bcl-2-like proteins and UVRAG and their opposite effects on Beclin1. We show that Beclin1 forms a dimer in solution via its coiled-coil domain both in vivo and in vitro. Viral Bcl-2 binds independently to two sites on the Beclin1 dimer, one with high affinity and one with lower affinity, whereas human Bcl-x(L) binds both sites equally with relatively low affinity. UVRAG disrupts the Beclin1-dimer interface, forming a heterodimer with Beclin1, suggesting that this is how UVRAG causes its effects on Beclin1 to activate autophagy. Both Bcl-2-like proteins reduce the affinity of UVRAG for Beclin1 similar to 4-fold, suggesting that they stabilize the Beclin1 dimer. Moreover, coimmunoprecipitation assays show that UVRAG substantially reduces Beclin1 dimerization in vivo. These data explain the concentration-dependent interplay between Bcl-2, UVRAG, and Beclin1, as both tumor suppressors, UVRAG and Beclin1, have single-copy mutations in human cancers. Furthermore, our data suggest that an alternative strategy for developing anti-cancer compounds would be to disrupt the Beclin1-dimer interface.	[Noble, Christian G.; Dong, Jing-Ming; Manser, Edward; Song, Haiwei] Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Song, HW (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011; Manser, Edward/ABD-2301-2020		A*STAR; GlaxoSmithKline-IMCB (GSK-IMCB) Singapore	A*STAR(Agency for Science Technology & Research (A*STAR)); GlaxoSmithKline-IMCB (GSK-IMCB) Singapore(GlaxoSmithKline)	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research) (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the GlaxoSmithKline-IMCB (GSK-IMCB) Singapore fund.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Thuduppathy GR, 2006, PROTEIN SCI, V15, P248, DOI 10.1110/ps.051807706; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	25	76	79	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26274	26282		10.1074/jbc.M804723200	http://dx.doi.org/10.1074/jbc.M804723200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18641390	Green Published, hybrid			2022-12-25	WOS:000259200100055
J	Jaitovich, A; Mehta, S; Na, N; Ciechanover, A; Goldman, RD; Ridge, KM				Jaitovich, Ariel; Mehta, Semil; Na, Ni; Ciechanover, Aaron; Goldman, Robert D.; Ridge, Karen M.			Ubiquitin-proteasome-mediated degradation of keratin intermediate filaments in mechanically stimulated A549 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALLORY BODIES; INCLUSION-BODIES; PHOSPHORYLATION; CYTOSKELETON; CYTOKERATIN; MECHANISMS; LIVER; IDENTIFICATION; DISPLACEMENT; ORGANIZATION	We previously reported that shear stress induces phosphorylation and disassembly of keratin intermediate filaments (IFs). Shear stress also induces a time- and strain-dependent degradation of keratin IFs, and the current study examines the mechanisms involved in degradation of keratin proteins in human A549 cells exposed to 0-24 h of shear stress (7.5-30 dynes/ cm(2)). Ubiquitin was found to be covalently associated with keratin proteins immunoprecipitated from shear-stressed cells, and pretreatment with the proteasomal inhibitor MG132 prevented the degradation of the keratin IF network. Importantly, phosphorylation of K8 Ser-73 is required for the shear stress-mediated ubiquitination, disassembly, and degradation of the keratin IF network. Immunofluorescence microscopy revealed that shear stress caused the thin array of keratin fibrils observed in control cells to be reorganized into a perinuclear aggregate, known as an aggresome, and that ubiquitin was also associated with this structure. Finally, the E2 enzymes, UbcH5b, -c, and Ubc3, but not E2-25K are required for the shear stress-mediated ubiquitin-proteasomal degradation of keratin proteins. These data suggest that shear stress promotes the disassembly and degradation of the keratin IF network via phosphorylation and the ubiquitin- proteasome pathway.	[Jaitovich, Ariel; Mehta, Semil; Na, Ni; Goldman, Robert D.; Ridge, Karen M.] Northwestern Univ, Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Goldman, Robert D.; Ridge, Karen M.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel	Northwestern University; Northwestern University; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ridge, KM (corresponding author), Northwestern Univ, Sch Med, Div Pulm & Crit Care Med, 240 E Huron,McGaw M328, Chicago, IL 60611 USA.	kridge@northwestern.edu	Ciechanover, Aaron J/C-9166-2017		National Institutes of Health [P01-HL71643, R01-HL079190, GM 36806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079190, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036806, R01GM036806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL71643 (to R. G. D. and K. M. R.), R01-HL079190 (to K. M. R.), and GM 36806 (to R. G. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; CADRIN M, 1991, EXP MOL PATHOL, V55, P170, DOI 10.1016/0014-4800(91)90050-8; Cadrin M, 1995, BIOCHEM CELL BIOL, V73, P627, DOI 10.1139/o95-069; CADRIN M, 1995, LAB INVEST, V72, P453; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Ciechanover A, 2000, J CELL BIOCHEM, P40; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; HAZAN R, 1986, LAB INVEST, V54, P543; Helmke BP, 2001, BIOPHYS J, V80, P184, DOI 10.1016/S0006-3495(01)76006-7; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JELLINGER K, 1990, ADV NEUROL, V53, P1; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lecuona E, 1999, AM J RESP CRIT CARE, V159, P603, DOI 10.1164/ajrccm.159.2.9805050; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; MICHEL RP, 1982, HUM PATHOL, V13, P81, DOI 10.1016/S0046-8177(82)80143-3; NONOMURA A, 1986, ACTA PATHOL JAPON, V36, P1669; NONOMURA A, 1986, ACTA PATHOL JAPON, V36, P869; OHTA M, 1988, LAB INVEST, V59, P848; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PAINE R, 1988, DEV BIOL, V129, P505, DOI 10.1016/0012-1606(88)90396-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PREISEGGER KH, 1992, LAB INVEST, V66, P193; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; SALMHOFER H, 1994, HEPATOLOGY, V20, P731, DOI 10.1016/0270-9139(94)90111-2; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; SHIMIZU S, 1986, ACTA PATHOL JAPON, V36, P105; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sznajder JI, 1998, LUNG BIOL HEALTH DIS, V116, P413; Toivola DM, 1997, J CELL SCI, V110, P23; WOODCOCKMITCHELL J, 1989, AM REV RESPIR DIS, V139, P343, DOI 10.1164/ajrccm/139.2.343; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; ZATLOUKAL K, 1992, LAB INVEST, V66, P774; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	51	43	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25348	25355		10.1074/jbc.M801635200	http://dx.doi.org/10.1074/jbc.M801635200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617517	hybrid, Green Published			2022-12-25	WOS:000259012700029
J	Jardin, I; Lopez, JJ; Salido, GM; Rosado, JA				Jardin, Isaac; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.			Orai1 mediates the interaction between STIM1 and hTRPC1 and regulates the mode of activation of hTRPC1-forming Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; STORE-OPERATED CHANNEL; HUMAN PLATELETS; ACTIN CYTOSKELETON; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; CRAC CHANNEL; CELLS; RECEPTOR; INFLUX	Orai1 and hTRPC1 have been presented as essential components of store-operated channels mediating highly Ca2+ selective I-CRAC and relatively Ca2+ selective I-SOC, respectively. STIM1 has been proposed to communicate the Ca2+ content of the intracellular Ca2+ stores to the plasma membrane storeoperated Ca2+ channels. Here we present evidence for the dynamic interaction between endogenously expressed Orai1 and both STIM1 and hTRPC1 regulated by depletion of the intracellular Ca2+ stores, using the pharmacological tools thapsigargin plus ionomycin, or by the physiological agonist thrombin, independently of extracellular Ca2+. In addition we report that Orai1 mediates the communication between STIM1 and hTRPC1, which is essential for the mode of activation of hTRPC1-forming Ca2+ permeable channels. Electrotransjection of cells with anti-Orai1 antibody, directed toward the C-terminal region that mediates the interaction with STIM1, and stabilization of an actin cortical barrier with jasplakinolide prevented the interaction between STIM1 and hTRPC1. Under these conditions hTRPC1 was no longer involved in store-operated calcium entry but in diacylglycerol-activated non-capacitative Ca2+ entry. These findings support the functional role of the STIM1-Orai1-hTRPC1 complex in the activation of store-operated Ca2+ entry.	[Jardin, Isaac; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cellular Physiol Res Grp, Dept Physiol, Caceres 10071, Spain	Universidad de Extremadura	Rosado, JA (corresponding author), Univ Extremadura, Cellular Physiol Res Grp, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Lopez, Jose Javier/F-4602-2016; Salido, Gines M./A-4292-2009; rosado, juan/H-3488-2015	Lopez, Jose Javier/0000-0002-5234-1478; Salido, Gines M./0000-0002-8687-2445; rosado, juan/0000-0002-9749-2325; Jardin, Isaac/0000-0003-4575-8264	Spanish Ministry of Education and Science [BFU2007-60104]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grant BFU2007-60104. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; den Dekker E, 2001, BBA-MOL CELL RES, V1539, P243, DOI 10.1016/S0167-4889(01)00112-4; DHAR A, 1994, J BIOL CHEM, V269, P9123; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, BBA-MOL CELL RES, V1783, P84, DOI 10.1016/j.bbamcr.2007.07.007; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Juska A, 2005, BIOCHEM BIOPH RES CO, V334, P779, DOI 10.1016/j.bbrc.2005.07.040; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Lievremont JP, 2004, AM J PHYSIOL-CELL PH, V287, pC1709, DOI 10.1152/ajpcell.00350.2004; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Moneer Z, 2005, BIOCHEM J, V389, P821, DOI 10.1042/BJ20050145; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Putney JW, 2001, J CELL SCI, V114, P2223; Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V347, P183, DOI 10.1042/0264-6021:3470183; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	50	133	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25296	25304		10.1074/jbc.M802904200	http://dx.doi.org/10.1074/jbc.M802904200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644792	hybrid			2022-12-25	WOS:000259012700023
J	Akers, KG; Yang, Z; DelVecchio, DP; Reeb, BC; Romeo, RD; McEwen, BS; Tang, AC				Akers, Katherine G.; Yang, Zhen; DelVecchio, Dominic P.; Reeb, Bethany C.; Romeo, Russell D.; McEwen, Bruce S.; Tang, Akaysha C.			Social Competitiveness and Plasticity of Neuroendocrine Function in Old Age: Influence of Neonatal Novelty Exposure and Maternal Care Reliability	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; VISIBLE BURROW SYSTEM; MALE-RATS; SYNAPTIC PLASTICITY; AGGRESSIVE-BEHAVIOR; ALZHEIMERS-DISEASE; WATER COMPETITION; EARLY STIMULATION; FOOD-COMPETITION; BRAIN ASYMMETRY	Early experience is known to have a profound impact on brain and behavioral function later in life. Relatively few studies, however, have examined whether the effects of early experience remain detectable in the aging animal. Here, we examined the effects of neonatal novelty exposure, an early stimulation procedure, on late senescent rats' ability to win in social competition. During the first 3 weeks of life, half of each litter received daily 3-min exposures to a novel environment while the other half stayed in the home cage. At 24 months of age, pairs of rats competed against each other for exclusive access to chocolate rewards. We found that novelty-exposed rats won more rewards than home-staying rats, indicating that early experience exerts a life-long effect on this aspect of social dominance. Furthermore, novelty-exposed but not home-staying rats exhibited habituation of corticosterone release across repeated days of social competition testing, suggesting that early experience permanently enhances plasticity of the stress response system. Finally, we report a surprising finding that across individual rat families, greater effects of neonatal novelty exposure on stress response plasticity were found among families whose dams provided more reliable, instead of a greater total quantity of, maternal care.	[Akers, Katherine G.; Yang, Zhen; DelVecchio, Dominic P.; Reeb, Bethany C.; Tang, Akaysha C.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Tang, Akaysha C.] Univ New Mexico, Dept Neurosci, Albuquerque, NM USA; [Romeo, Russell D.] Barnard Coll, Dept Psychol & Neurosci, Behavior Program, New York, NY USA; [Romeo, Russell D.; McEwen, Bruce S.] Rockefeller Univ, Lab Neuroendocrinol, New York, NY USA	University of New Mexico; University of New Mexico; Rockefeller University	Akers, KG (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	akaysha@unm.edu	Akers, Katherine G./A-4537-2013; He, Robert/L-9441-2013; He, Hongbo/H-1815-2013; McEwen, Bruce/Z-1630-2019	Akers, Katherine G./0000-0002-4578-6575; 				Akers KG, 2006, EUR J NEUROSCI, V24, P547, DOI 10.1111/j.1460-9568.2006.04921.x; ALBERT FW, HORM BEHAV IN PRESS; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Baamonde C, 2002, STRESS, V5, P137, DOI 10.1080/10253890290027903; BAENNINGER LP, 1970, J COMP PHYSIOL PSYCH, P202; BECKER G, 1969, PSYCHON SCI, V15, P27, DOI 10.3758/BF03336179; BENTON D, 1982, AGGRESSIVE BEHAV, V8, P104, DOI 10.1002/1098-2337(1982)8:2<104::AID-AB2480080203>3.0.CO;2-W; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; BHATNAGAR S, 1995, J NEUROENDOCRINOL, V7, P97, DOI 10.1111/j.1365-2826.1995.tb00672.x; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; BRUCE RH, 1941, J COMP PSYCHOL, V31; Castles DL, 1998, ETHOLOGY, V104, P126; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chapillon P, 2002, DEV PSYCHOBIOL, V41, P373, DOI 10.1002/dev.10066; Cole MA, 2000, J NEUROENDOCRINOL, V12, P1034, DOI 10.1046/j.1365-2826.2000.00555.x; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; DALY M, 1973, BRIT J PSYCHOL, V64, P435, DOI 10.1111/j.2044-8295.1973.tb01370.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Denenberg VH, 1999, DEV PSYCHOBIOL, V34, P1, DOI 10.1002/(SICI)1098-2302(199901)34:1<1::AID-DEV2>3.0.CO;2-U; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; DIGBY L, 1995, BEHAV ECOL SOCIOBIOL, V37, P51, DOI 10.1007/BF00173899; DIJKSTRA H, 1992, PHYSIOL BEHAV, V51, P961, DOI 10.1016/0031-9384(92)90078-G; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; DREWS DR, 1977, PSYCHOL REC, V27, P331, DOI 10.1007/BF03394449; Everson-Rose SA, 2003, AM J EPIDEMIOL, V158, P1083, DOI 10.1093/aje/kwg263; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P233, DOI 10.1016/S0091-3057(02)00787-6; FILE SE, 1986, BEHAV BRAIN RES, V21, P195, DOI 10.1016/0166-4328(86)90237-8; FLANNELLY K, 1975, AGGRESSIVE BEHAV, V1, P331, DOI 10.1002/1098-2337(1975)1:4<331::AID-AB2480010406>3.0.CO;2-8; GENTSCH C, 1990, PSYCHOPHARMACOLOGY, V100, P530, DOI 10.1007/BF02244007; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Gonzalez Jatuff AS, 1999, STRESS, V3, P97; GUNNAR MR, 1989, DEV PSYCHOBIOL, V22, P221, DOI 10.1002/dev.420220304; Haller J, 2000, J NEUROENDOCRINOL, V12, P431; JOLY D, 1991, BEHAV PHARMACOL, V2, P205; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; LEE MHS, 1974, ANIM BEHAV, V22, P679, DOI 10.1016/S0003-3472(74)80016-3; Lehmann J, 2002, NEUROBIOL AGING, V23, P457, DOI 10.1016/S0197-4580(01)00320-7; Lepley WM, 1937, J EXP PSYCHOL, V21, P194, DOI 10.1037/h0060095; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; LUCION A, 1994, INTEGR PHYS BEH SCI, V29, P415, DOI 10.1007/BF02691361; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Malatynska E, 2002, PHARMACOLOGY, V64, P8, DOI 10.1159/000056145; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MEANEY MJ, 1992, NEUROENDOCRINOLOGY, V55, P204, DOI 10.1159/000126116; MEANEY MJ, 1991, NEUROBIOL AGING, V12, P31, DOI 10.1016/0197-4580(91)90036-J; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEZEI TC, 1960, ARCH GEN PSYCHIAT, V3, P53; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; MITCHELL CL, 1991, BEHAV ECOL SOCIOBIOL, V28, P55, DOI 10.1007/BF00172139; MITCHELL JA, 1987, PHARMACOL BIOCHEM BE, V27, P707, DOI 10.1016/0091-3057(87)90198-5; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Nakazawa M, 2006, NEUROSCI LETT, V408, P119, DOI 10.1016/j.neulet.2006.08.064; NATELSON BH, 1988, PHYSIOL BEHAV, V43, P41, DOI 10.1016/0031-9384(88)90096-0; Neumann ID, 2005, NEUROSCIENCE, V132, P867, DOI 10.1016/j.neuroscience.2005.01.034; Parker KJ, 2006, P NATL ACAD SCI USA, V103, P3000, DOI 10.1073/pnas.0506571103; POPOVA NK, 1972, ANIM BEHAV, V20, P108, DOI 10.1016/S0003-3472(72)80179-9; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; RAPAPORT PM, 1978, ANIM LEARN BEHAV, V6, P160, DOI 10.3758/BF03209595; Rosenthal Robert, 1984, ESSENTIALS BEHAV RES; ROWELL TE, 1974, BEHAV BIOL, V11, P131, DOI 10.1016/S0091-6773(74)90289-2; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sapolsky RM, 1992, STRESS AGING BRAIN M; SMOTHERMAN WP, 1983, DEV PSYCHOBIOL, V16, P169, DOI 10.1002/dev.420160303; STANTON ME, 1987, DEV PSYCHOBIOL, V20, P131, DOI 10.1002/dev.420200204; Stefanski V, 2001, J NEUROIMMUNOL, V114, P122, DOI 10.1016/S0165-5728(00)00464-1; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; SYME GJ, 1974, ANIM BEHAV, V22, P931, DOI 10.1016/0003-3472(74)90016-5; SYME GJ, 1974, ANIM BEHAV, V22, P486, DOI 10.1016/S0003-3472(74)80048-5; Tamashiro KLK, 2004, PHYSIOL BEHAV, V80, P683, DOI 10.1016/j.physbeh.2003.12.002; Tang AC, 2004, DEV PSYCHOBIOL, V44, P84, DOI 10.1002/dev.10158; Tang AC, 2003, J NEUROSCI, V23, P8254; Tang AC, 2002, HIPPOCAMPUS, V12, P398, DOI 10.1002/hipo.10017; Tang AC, 2001, LEARN MEMORY, V8, P257, DOI 10.1101/lm.43101; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; WILLIAMS DI, 1975, BEHAV BIOL, V13, P505, DOI 10.1016/S0091-6773(75)91149-9; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P8, DOI 10.1159/000085307; WINSLOW C. N., 1940, COMPAR PSYCHOL MONOGR, V15, P1; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008; Zou B, 2001, DEV BRAIN RES, V130, P1, DOI 10.1016/S0165-3806(01)00173-0	86	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2840	10.1371/journal.pone.0002840	http://dx.doi.org/10.1371/journal.pone.0002840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18641792	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300059
J	Benedetti-Cecchi, L; Bertocci, I; Vaselli, S; Maggi, E; Bulleri, F				Benedetti-Cecchi, Lisandro; Bertocci, Iacopo; Vaselli, Stefano; Maggi, Elena; Bulleri, Fabio			Neutrality and the Response of Rare Species to Environmental Variance	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ABUNDANCE DISTRIBUTIONS; SAMPLING FORMULA; DIVERSITY; NICHE; VARIABILITY; MODEL; INVERTEBRATES; DISTURBANCE; COMPETITION	Neutral models and differential responses of species to environmental heterogeneity offer complementary explanations of species abundance distribution and dynamics. Under what circumstances one model prevails over the other is still a matter of debate. We show that the decay of similarity over time in rocky seashore assemblages of algae and invertebrates sampled over a period of 16 years was consistent with the predictions of a stochastic model of ecological drift at time scales larger than 2 years, but not at time scales between 3 and 24 months when similarity was quantified with an index that reflected changes in abundance of rare species. A field experiment was performed to examine whether assemblages responded neutrally or non-neutrally to changes in temporal variance of disturbance. The experimental results did not reject neutrality, but identified a positive effect of intermediate levels of environmental heterogeneity on the abundance of rare species. This effect translated into a marked decrease in the characteristic time scale of species turnover, highlighting the role of rare species in driving assemblage dynamics in fluctuating environments.	[Benedetti-Cecchi, Lisandro; Bertocci, Iacopo; Maggi, Elena; Bulleri, Fabio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Vaselli, Stefano] Univ Port, Ctr Interdisciplinar Investigacao Marinha Ambie, Lab Coastal Biodivers, Portalegre, Portugal	University of Pisa; Universidade do Porto	Benedetti-Cecchi, L (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	lbenedetti@biologia.unipi.it	Benedetti-Cecchi, Lisandro/J-8225-2019; Bertocci, Iacopo/I-5121-2013; Maggi, Elena/AAR-9910-2021	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Bertocci, Iacopo/0000-0002-1519-1677; MAGGI, Elena/0000-0001-6934-9380; Bulleri, Fabio/0000-0002-7335-6791	University of Pisa; Italian National Inter-University Consortium for Marine Sciences (CoNISMa); Census of Marine Life Programme NaGISA; MARBEF	University of Pisa; Italian National Inter-University Consortium for Marine Sciences (CoNISMa); Census of Marine Life Programme NaGISA; MARBEF	This study was supported by grants from the University of Pisa, the Italian National Inter-University Consortium for Marine Sciences (CoNISMa,) the Census of Marine Life Programme NaGISA and the MARBEF (Marine Biodiversity and Ecosystem Functioning) Network of Excellence funded in the Community's Sixth Framework Programme.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Alonso D, 2007, TRENDS ECOL EVOL, V22, P232, DOI 10.1016/j.tree.2007.02.011; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; [Anonymous], 1996, ERROR GROWTH EXPT KN, DOI DOI 10.7208/CHICAGO/9780226511993.001.0001; Azaele S, 2006, NATURE, V444, P926, DOI 10.1038/nature05320; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Benedetti-Cecchi L, 2007, TRENDS ECOL EVOL, V22, P231, DOI 10.1016/j.tree.2007.02.008; Benton TG, 2001, ECOL LETT, V4, P236, DOI 10.1046/j.1461-0248.2001.00225.x; Bertocci I, 2005, ECOLOGY, V86, P2061, DOI 10.1890/04-1698; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Burnham K. P., 1998, MODEL SELECTION INFE; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2005, ECOL LETT, V8, P493, DOI 10.1111/j.1461-0248.2005.00745.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hu XS, 2007, AM NAT, V170, P844, DOI 10.1086/522935; Hubbell Stephen P., 2001, V32, pi; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; Maurer BA, 1999, UNTANGLING ECOLOGICA; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; Pueyo S, 2007, ECOL LETT, V10, P1017, DOI 10.1111/j.1461-0248.2007.01096.x; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; UGLAND KI, 1982, OIKOS, V39, P171, DOI 10.2307/3544482; Ulrich W, 2006, OIKOS, V114, P338, DOI 10.1111/j.2006.0030-1299.14773.x; VASSEUR A, 2007, IMPACT ENV VARIABILI; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	62	16	16	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2777	10.1371/journal.pone.0002777	http://dx.doi.org/10.1371/journal.pone.0002777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648545	gold, Green Published, Green Submitted			2022-12-25	WOS:000264302900047
J	Meinzer, U; Esmiol-Welterlin, S; Barreau, F; Berrebi, D; Dussaillant, M; Bonacorsi, S; Chareyre, F; Niwa-Kawakita, M; Alberti, C; Sterkers, G; Villard, C; Lesuffleur, T; Peuchmaur, M; Karin, M; Eckmann, L; Giovannini, M; Ollendorff, V; Wolf-Watz, H; Hugot, JP				Meinzer, Ulrich; Esmiol-Welterlin, Sophie; Barreau, Frederick; Berrebi, Dominique; Dussaillant, Monique; Bonacorsi, Stephane; Chareyre, Fabrice; Niwa-Kawakita, Michiko; Alberti, Corinne; Sterkers, Ghislaine; Villard, Claude; Lesuffleur, Thecla; Peuchmaur, Michel; Karin, Michael; Eckmann, Lars; Giovannini, Marco; Ollendorff, Vincent; Wolf-Watz, Hans; Hugot, Jean-Pierre			Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice	PLOS ONE			English	Article								Nucleotide oligomerisation domain 2 (NOD2) is a component of the innate immunity known to be involved in the homeostasis of Peyer patches (PPs) in mice. However, little is known about its role during gut infection in vivo. Yersinia pseudotuberculosis is an enteropathogen causing gastroenteritis, adenolymphitis and septicaemia which is able to invade its host through PPs. We investigated the role of Nod2 during Y. pseudotuberculosis infection. Death was delayed in Nod2 deleted and Crohn's disease associated Nod2 mutated mice orogastrically inoculated with Y. pseudotuberculosis. In PPs, the local immune response was characterized by a higher KC level and a more intense infiltration by neutrophils and macrophages. The apoptotic and bacterial cell counts were decreased. Finally, Nod2 deleted mice had a lower systemic bacterial dissemination and less damage of the haematopoeitic organs. This resistance phenotype was lost in case of intraperitoneal infection. We concluded that Nod2 contributes to the susceptibility to Y. pseudotuberculosis in mice.	[Meinzer, Ulrich; Barreau, Frederick; Dussaillant, Monique; Lesuffleur, Thecla; Hugot, Jean-Pierre] Univ Paris 07, INSERM, Hop Robert Debre, U843, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Hop Robert Debre, Assistance Publ Hop Paris, Serv Gastroenterol Pediat, Paris, France; [Meinzer, Ulrich; Wolf-Watz, Hans] Umea Univ, Dept Mol Biol, Umea, Sweden; [Esmiol-Welterlin, Sophie; Ollendorff, Vincent] Univ Paul Cezanne, UMR CNRS 6263, ISM2 Biosci, Marseille, France; [Esmiol-Welterlin, Sophie; Ollendorff, Vincent] Univ Montpellier II, Differenciation Cellulaire Croissance, INRA, UMR 866, Montpellier, France; [Berrebi, Dominique] Univ Paris 07, Assistance Publ Hop Paris, Hop Robert Debre, Serv Anatom Pathol, Paris, France; [Bonacorsi, Stephane; Peuchmaur, Michel] Univ Paris 07, Assistance Publ Hop Paris, Hop Robert Debre, Serv Microbiol, Paris, France; [Chareyre, Fabrice; Niwa-Kawakita, Michiko] Univ Paris 07, Inst Univ Hematol, INSERM U674, Paris, France; [Alberti, Corinne; Giovannini, Marco] Univ Paris 07, AP HP, Hop Robert Debre, Dept Epidemiol Clin, Paris, France; [Sterkers, Ghislaine] Univ Paris 07, AP HP, Hop Robert Debre, Serv Immunol, Paris, France; [Villard, Claude] UMR911 CRO2 UFR Pharm, Plateau Proteom Timone, Marseille, France; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Expression & Signal Transduct, La Jolla, CA USA; [Eckmann, Lars] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Umea University; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Diego; University of California System; University of California San Diego	Meinzer, U (corresponding author), Univ Paris 07, INSERM, Hop Robert Debre, U843, Paris, France.	jean-pierre.hugot@rdb.aphp.fr	lesuffleur, thecla/AAC-2980-2020; Meinzer, Ulrich/N-4282-2019; Bonacorsi, Stéphane/HGB-3185-2022; Hugot, Jean-Pierre/F-6594-2012; berrebi, dominique/B-1419-2014	Ollendorff, Vincent/0000-0001-9751-2202; Kawakita, Michiko/0000-0002-9450-583X; Hugot, Jean-Pierre/0000-0002-8446-6056; Barreau, Frederick/0000-0002-7150-9619; Villard, claude/0000-0002-6600-0762	INSERM; Region Ile-de-France; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris; Fondation de la Recherche Medicale; MESR [fellowship]; Swedish Research Council; National Institutes of Health	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Ile-de-France(Region Ile-de-France); Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris(Region Ile-de-France); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); MESR(Ministry of Research, France); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support for this study came from the INSERM, Region Ile-de-France, the Broad Medical Research Program, the Association Francois Aupetit, the Mairie de Paris, the Fondation de la Recherche Medicale, a MESR french fellowship to SEM, the Swedish Research Council, and the National Institutes of Health.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ABBOTT M, 1986, J INFECTION, V13, P143, DOI 10.1016/S0163-4453(86)92869-0; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; BOLIN I, 1984, INFECT IMMUN, V43, P72; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Fujimura Y, 1996, GUT, V38, P724, DOI 10.1136/gut.38.5.724; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Handley SA, 2004, INFECT IMMUN, V72, P1645, DOI 10.1128/IAI.72.3.1645-1656.2004; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1993, APMIS, V101, P417, DOI 10.1111/j.1699-0463.1993.tb00130.x; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; IBBOTSON JP, 1992, CLIN EXP IMMUNOL, V87, P224, DOI 10.1111/j.1365-2249.1992.tb02979.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Kallinowski F, 1998, HEPATO-GASTROENTEROL, V45, P1552; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Meinzer U, 2005, INFLAMM BOWEL DIS, V11, P639, DOI 10.1097/01.MIB.0000165114.10687.bf; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Saebo Arve, 2005, Eur J Intern Med, V16, P176, DOI 10.1016/j.ejim.2004.11.008; Stainier Isabelle, 1998, Clin Microbiol Infect, V4, P673, DOI 10.1111/j.1469-0691.1998.tb00650.x; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; VanKruiningen HJ, 1997, J CLIN GASTROENTEROL, V25, P470, DOI 10.1097/00004836-199709000-00017; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	35	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2769	10.1371/journal.pone.0002769	http://dx.doi.org/10.1371/journal.pone.0002769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648508	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900039
J	Cui, YJ; Li, YJ; Gorge, O; Platonov, ME; Yan, YF; Guo, ZB; Pourcel, C; Dentovskaya, SV; Balakhonov, SV; Wang, XY; Song, YJ; Anisimov, AP; Vergnaud, G; Yang, RF				Cui, Yujun; Li, Yanjun; Gorge, Olivier; Platonov, Mikhail E.; Yan, Yanfeng; Guo, Zhaobiao; Pourcel, Christine; Dentovskaya, Svetlana V.; Balakhonov, Sergey V.; Wang, Xiaoyi; Song, Yajun; Anisimov, Andrey P.; Vergnaud, Gilles; Yang, Ruifu			Insight into Microevolution of Yersinia pestis by Clustered Regularly Interspaced Short Palindromic Repeats	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; PLAGUE; IDENTIFICATION; DNA; DIVERSITY; GENETICS; PROVIDES; STRAINS; TOOLS	Background: Yersinia pestis, the pathogen of plague, has greatly influenced human history on a global scale. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR), an element participating in immunity against phages' invasion, is composed of short repeated sequences separated by unique spacers and provides the basis of the spoligotyping technology. In the present research, three CRISPR loci were analyzed in 125 strains of Y. pestis from 26 natural plague foci of China, the former Soviet Union and Mongolia were analyzed, for validating CRISPR-based genotyping method and better understanding adaptive microevolution of Y. pestis. Methodology/Principal Findings: Using PCR amplification, sequencing and online data processing, a high degree of genetic diversity was revealed in all three CRISPR elements. The distribution of spacers and their arrays in Y. pestis strains is strongly region and focus-specific, allowing the construction of a hypothetic evolutionary model of Y. pestis. This model suggests transmission route of microtus strains that encircled Takla Makan Desert and ZhunGer Basin. Starting from Tadjikistan, one branch passed through the Kunlun Mountains, and moved to the Qinghai-Tibet Plateau. Another branch went north via the Pamirs Plateau, the Tianshan Mountains, the Altai Mountains and the Inner Mongolian Plateau. Other Y. pestis lineages might be originated from certain areas along those routes. Conclusions/significance: CRISPR can provide important information for genotyping and evolutionary research of bacteria, which will help to trace the source of outbreaks. The resulting data will make possible the development of very low cost and high-resolution assays for the systematic typing of any new isolate.	[Cui, Yujun; Li, Yanjun; Yan, Yanfeng; Guo, Zhaobiao; Wang, Xiaoyi; Song, Yajun; Yang, Ruifu] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gorge, Olivier; Pourcel, Christine; Vergnaud, Gilles] Univ Paris Sud 11, Inst Genet Microbiol, CNRS, UMR8621, Orsay, France; [Platonov, Mikhail E.; Dentovskaya, Svetlana V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol, Obolensk, Russia; [Balakhonov, Sergey V.] Antiplague Res Inst Siberia & Far East, Irkutsk, Russia; [Vergnaud, Gilles] DGA, D4S Mission Rech Innovat Sci, Bagneux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cui, YJ (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	anisimov@obolensk.org; gilles.vergnaud@u-psud.fr; ruifuyang@gmail.com	Pourcel, Christine/E-4949-2017; Song, Yajun/F-3714-2011; Michael, Platonov/GZG-8615-2022; Vergnaud, Gilles/AAC-1162-2020; Song, Yajun/GQQ-0476-2022; Balakonov, Sergey/AAL-1726-2020; Cui, Yujun/E-7015-2012; Anisimov, Andrey P./H-5257-2012; Anisimov, Andrey P/D-2217-2009; Platonov, Mikhail E/S-1209-2016; Dentovskaya, Svetlana/F-4623-2017; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Song, Yajun/0000-0002-6628-2747; Vergnaud, Gilles/0000-0003-0913-194X; Song, Yajun/0000-0002-6628-2747; Balakonov, Sergey/0000-0003-4201-5828; Anisimov, Andrey P./0000-0002-5499-7999; Anisimov, Andrey P/0000-0002-5499-7999; Dentovskaya, Svetlana/0000-0002-1996-8949; Vergnaud, Gilles/0000-0003-0913-194X; Platonov, Mihail/0000-0003-3946-1755	National Science Fund of China for Distinguished Young Scholars [30525025]; Chinese National 863 Project [2006AA02Z438]; International Science and Technology Center [2426]	National Science Fund of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National 863 Project(National High Technology Research and Development Program of China); International Science and Technology Center	This research was founded by the National Science Fund of China for Distinguished Young Scholars (contract no. 30525025), the Chinese National 863 Project (contract no.2006AA02Z438), and the International Science and Technology Center (project no. 2426).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Barrangou R, 2002, APPL ENVIRON MICROB, V68, P2877, DOI 10.1128/AEM.68.6.2877-2884.2002; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Dai EH, 2005, RES MICROBIOL, V156, P785, DOI 10.1016/j.resmic.2005.02.012; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; DEVEAU H, 2007, J BACTERIOL; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Greenfield RA, 2002, AM J MED SCI, V323, P299, DOI 10.1097/00000441-200206000-00003; GRISSA I, 2007, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKM1360; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grygorczuk Sambor, 2002, Medycyna Pracy, V53, P343; GUIYOULE A, 1994, J CLIN MICROBIOL, V32, P634, DOI 10.1128/JCM.32.3.634-641.1994; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hai Rong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P509; HORVATH P, 2007, J BACTERIOL; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; LUCIER TS, 1992, J BACTERIOL, V174, P2078, DOI 10.1128/JB.174.7.2078-2086.1992; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; SOREK R, 2007, NAT REV MICROBIOL; Tyson K, 1997, ARCH MICROBIOL, V168, P403, DOI 10.1007/s002030050515; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; Wheelis M, 2002, EMERG INFECT DIS, V8, P971, DOI 10.3201/eid0809.010536; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]; Zhou DS, 2004, MICROBES INFECT, V6, P1226, DOI 10.1016/j.micinf.2004.08.002; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	44	120	151	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2652	10.1371/journal.pone.0002652	http://dx.doi.org/10.1371/journal.pone.0002652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612419	gold, Green Published, Green Submitted			2022-12-25	WOS:000264065800054
J	Elemans, CPH; Mead, AF; Rome, LC; Goller, F				Elemans, Coen P. H.; Mead, Andrew F.; Rome, Lawrence C.; Goller, Franz			Superfast Vocal Muscles Control Song Production in Songbirds	PLOS ONE			English	Article							SYRINGEAL MUSCLES; POWER OUTPUT; BIRD; GENERATION; LATERALIZATION; DYNAMICS; PATTERN; DESIGN; SPEED; CODE	Birdsong is a widely used model for vocal learning and human speech, which exhibits high temporal and acoustic diversity. Rapid acoustic modulations are thought to arise from the vocal organ, the syrinx, by passive interactions between the two independent sound generators or intrinsic nonlinear dynamics of sound generating structures. Additionally, direct neuromuscular control could produce such rapid and precisely timed acoustic features if syringeal muscles exhibit rare superfast muscle contractile kinetics. However, no direct evidence exists that avian vocal muscles can produce modulations at such high rates. Here, we show that 1) syringeal muscles are active in phase with sound modulations during song over 200 Hz, 2) direct stimulation of the muscles in situ produces sound modulations at the frequency observed during singing, and that 3) syringeal muscles produce mechanical work at the required frequencies and up to 250 Hz in vitro. The twitch kinematics of these so-called superfast muscles are the fastest measured in any vertebrate muscle. Superfast vocal muscles enable birds to directly control the generation of many observed rapid acoustic changes and to actuate the millisecond precision of neural activity into precise temporal vocal control. Furthermore, birds now join the list of vertebrate classes in which superfast muscle kinetics evolved independently for acoustic communication.	[Elemans, Coen P. H.; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT USA; [Mead, Andrew F.; Rome, Lawrence C.] Univ Penn, Dept Biol, Philadelphia, PA USA; [Rome, Lawrence C.] Marine Biol Lab, Woods Hole, MA USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Marine Biological Laboratory - Woods Hole	Elemans, CPH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT USA.	coen@biology.sdu.dk		Elemans, Coen/0000-0001-6306-5715	NIH [DC04390, DC06876, AR38404-20, AR46125]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038404, R01AR046125, R29AR038404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876, R01DC004390] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by NIH DC04390 and DC06876 to FG, and NIH AR38404-20 and NIH AR46125 to LCR. The work was also supported by a grant from the Pennsylvania Department of Health to LCR. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Briggs MM, 2000, J EXP BIOL, V203, P2485; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; CLOSE RI, 1974, J PHYSIOL-LONDON, V236, P259, DOI 10.1113/jphysiol.1974.sp010434; Conley KE, 1996, NATURE, V383, P71, DOI 10.1038/383071a0; Elemans CPH, 2006, J EXP BIOL, V209, P965, DOI 10.1242/jeb.02066; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fine ML, 2001, J COMP PHYSIOL A, V187, P371, DOI 10.1007/s003590100209; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GOLLER F, 1995, NATURE, V373, P63, DOI 10.1038/373063a0; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Hoh JFY, 2005, ACTA PHYSIOL SCAND, V183, P133, DOI 10.1111/j.1365-201X.2004.01402.x; JOSEPHSON RK, 1985, J EXP BIOL, V114, P493; Larsen ON, 2002, J EXP BIOL, V205, P25; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Marler P., 2004, NATURES MUSIC SCI BI; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; NOTTEBOHM F, 1972, J EXP ZOOL, V179, P35, DOI 10.1002/jez.1401790104; NOWICKI S, 1986, SCIENCE, V231, P1297, DOI 10.1126/science.3945824; Parmentier E, 2003, P ROY SOC B-BIOL SCI, V270, P2301, DOI 10.1098/rspb.2003.2495; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Rome LC, 1996, P NATL ACAD SCI USA, V93, P8095, DOI 10.1073/pnas.93.15.8095; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0; Syme DA, 2002, INTEGR COMP BIOL, V42, P762, DOI 10.1093/icb/42.4.762; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; Trevisan MA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031908; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wilden I., 1998, Bioacoustics, V9, P171; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Young IS, 2001, P ROY SOC B-BIOL SCI, V268, P1965, DOI 10.1098/rspb.2001.1731; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	46	81	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2581	10.1371/journal.pone.0002581	http://dx.doi.org/10.1371/journal.pone.0002581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612467	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800002
J	Hiroi, M; Tanimura, T; Marion-Poll, F				Hiroi, Makoto; Tanimura, Teiichi; Marion-Poll, Frederic			Hedonic Taste in Drosophila Revealed by Olfactory Receptors Expressed in Taste Neurons	PLOS ONE			English	Article								Taste and olfaction are each tuned to a unique set of chemicals in the outside world, and their corresponding sensory spaces are mapped in different areas in the brain. This dichotomy matches categories of receptors detecting molecules either in the gaseous or in the liquid phase in terrestrial animals. However, in Drosophila olfactory and gustatory neurons express receptors which belong to the same family of 7-transmembrane domain proteins. Striking overlaps exist in their sequence structure and in their expression pattern, suggesting that there might be some functional commonalities between them. In this work, we tested the assumption that Drosophila olfactory receptor proteins are compatible with taste neurons by ectopically expressing an olfactory receptor (OR22a and OR83b) for which ligands are known. Using electrophysiological recordings, we show that the transformed taste neurons are excited by odor ligands as by their cognate tastants. The wiring of these neurons to the brain seems unchanged and no additional connections to the antennal lobe were detected. The odor ligands detected by the olfactory receptor acquire a new hedonic value, inducing appetitive or aversive behaviors depending on the categories of taste neurons in which they are expressed i.e. sugar- or bitter-sensing cells expressing either Gr5a or Gr66a receptors. Taste neurons expressing ectopic olfactory receptors can sense odors at close range either in the aerial phase or by contact, in a lipophilic phase. The responses of the transformed taste neurons to the odorant are similar to those obtained with tastants. The hedonic value attributed to tastants is directly linked to the taste neurons in which their receptors are expressed.	[Hiroi, Makoto; Marion-Poll, Frederic] AgroParisTech, UPMC, INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France; [Hiroi, Makoto; Tanimura, Teiichi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka, Japan	AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Kyushu University	Hiroi, M (corresponding author), AgroParisTech, UPMC, INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France.	marion@versailles.inra.fr	Hiroi, Makoto/B-6834-2008; Frederic, Marion-Poll/I-1358-2019	Hiroi, Makoto/0000-0002-0136-5891; Frederic, Marion-Poll/0000-0001-6824-0180	French Ministry of Foreign Affairs; JSPS-INRA, under the Japan-France Research Cooperative Program; Ministry of Education, Culture, Sports and Technology of Japan; Direction Generale de l'Enseignement et de la Recherche of France	French Ministry of Foreign Affairs; JSPS-INRA, under the Japan-France Research Cooperative Program; Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direction Generale de l'Enseignement et de la Recherche of France	This work was supported by a grant from the French Ministry of Foreign Affairs to F.M.P. and to M.H., by a joint JSPS-INRA grant under the Japan-France Research Cooperative Program (T.T. and F.M.P.), by a grant from the Ministry of Education, Culture, Sports and Technology of Japan to T.T., and by a grant from the Direction Generale de l'Enseignement et de la Recherche of France to F.M.P.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Ahamed A, 2001, CHEM SENSES, V26, P507, DOI 10.1093/chemse/26.5.507; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; del Campo ML, 2001, NATURE, V411, P186, DOI 10.1038/35075559; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; EIGENBRODE SD, 1995, ANNU REV ENTOMOL, V40, P171, DOI 10.1146/annurev.en.40.010195.001131; FALK R, 1975, NATURE, V254, P325, DOI 10.1038/254325a0; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galindo K, 2001, GENETICS, V159, P1059; Glendinning JI, 2001, J NEUROSCI, V21, P3688, DOI 10.1523/JNEUROSCI.21-10-03688.2001; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1954, ANAT REC, V120, P718; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Koganezawa M, 2002, CHEM SENSES, V27, P319, DOI 10.1093/chemse/27.4.319; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MITCHELL BK, 1994, J CHEM ECOL, V20, P753, DOI 10.1007/BF02059611; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; Ozaki M, 2003, CHEM SENSES, V28, P349, DOI 10.1093/chemse/28.4.349; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rogers SM, 2003, ADV INSECT PHYSIOL, V31, P141, DOI 10.1016/S0065-2806(03)31003-3; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Silverman J, 1998, J INSECT BEHAV, V11, P93, DOI 10.1023/A:1020870601137; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; STADLER E, 1975, J COMP PHYSIOL, V104, P97; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tsuchihara K, 2005, CHEM SENSES, V30, P559, DOI 10.1093/chemse/bji049; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	67	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2610	10.1371/journal.pone.0002610	http://dx.doi.org/10.1371/journal.pone.0002610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612414	Green Published, gold			2022-12-25	WOS:000264065800016
J	Doering, CJ; Rehak, R; Bonfield, S; Peloquin, JB; Stell, WK; Mema, SC; Sauve, Y; McRory, JE				Doering, Clinton J.; Rehak, Renata; Bonfield, Stephan; Peloquin, Jean B.; Stell, William K.; Mema, Silvina C.; Sauve, Yves; McRory, John E.			Modified Ca(v)1.4 Expression in the Cacna1f(nob2) Mouse Due to Alternative Splicing of an ETn Inserted in Exon 2	PLOS ONE			English	Article								The Cacna1f(nob2) mouse is reported to be a naturally occurring null mutation for the Ca(v)1.4 calcium channel gene and the phenotype of this mouse is not identical to that of the targeted gene knockout model. We found two mRNA species in the Cacna1f(nob2) mouse: approximately 90% of the mRNA represents a transcript with an in-frame stop codon within exon 2 of CACNA1F, while approximately 10% of the mRNA represents a transcript in which alternative splicing within the ETn element has removed the stop codon. This latter mRNA codes for full length Ca(v)1.4 protein, detectable by Western blot analysis that is predicted to differ from wild type Ca(v)1.4 protein in a region of approximately 22 amino acids in the N-terminal portion of the protein. Electrophysiological analysis with either mouse Ca(v)1.4(wt) or Ca(v)1.4(nob2) cDNA revealed that the alternatively spliced protein does not differ from wild type with respect to activation and inactivation characteristics; however, while the wild type N-terminus interacted with filamin proteins in a biochemical pull-down experiment, the alternatively spliced N-terminus did not. The Cacna1f(nob2) mouse electroretinogram displayed reduced b-wave and oscillatory potential amplitudes, and the retina was morphologically disorganized, with substantial reduction in thickness of the outer plexiform layer and sprouting of bipolar cell dendrites ectopically into the outer nuclear layer. Nevertheless, the spatial contrast sensitivity (optokinetic response) of Cacna1f(nob2) mice was generally similar to that of wild type mice. These results suggest the Cacna1f(nob2) mouse is not a CACNA1F knockout model. Rather, alternative splicing within the ETn element can lead to full-length Ca(v)1.4 protein, albeit at reduced levels, and the functional Ca(v)1.4 mutant may be incapable of interacting with cytoskeletal filamin proteins. These changes, do not alter the ability of the Cacna1f(nob2) mouse to detect and follow moving sine-wave gratings compared to their wild type counterparts.	[Doering, Clinton J.; Rehak, Renata; Peloquin, Jean B.; Stell, William K.; McRory, John E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bonfield, Stephan; Stell, William K.] Univ Calgary, Cell Biol & Anat Surg, Calgary, AB, Canada; [Doering, Clinton J.; Bonfield, Stephan; Peloquin, Jean B.; Stell, William K.; McRory, John E.] Univ Calgary, Lions Ctr Retinal Degenerat Res, Calgary, AB, Canada; [Mema, Silvina C.; Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta	Doering, CJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	McRoryj@ucalgary.ca	Mema, Silvina/J-5416-2019	Mema, Silvina/0000-0001-5895-9159	AHFMR [Studentships]; NSERC CGS [Discovery Grant]; University of Calgary [Killam Fellowship]; Lions Sight Centre Fund (University of Calgary); Canadian Institutes of Health Research [151145]; Alberta Heritage Foundation for Medical Research; Canadian National Institute for the Blind (CNIB); The Lena McLaughlin Foundation; Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration; Foundation Fighting Blindness	AHFMR(Alberta Heritage Foundation for Medical Research); NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary; Lions Sight Centre Fund (University of Calgary); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian National Institute for the Blind (CNIB); The Lena McLaughlin Foundation; Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration; Foundation Fighting Blindness(European Commission)	CJD and RR are supported by Studentships from AHFMR. CJD is also supported by NSERC CGS, and a Killam Fellowship from the University of Calgary. WKS and SB are supported by a Discovery Grant from NSERC to WKS, and the OptoMotry system was purchased with a grant from the Lions Sight Centre Fund (University of Calgary) to WKS. YS is supported by a Canadian Institutes of Health Research Grant (151145), an Alberta Heritage Foundation for Medical Research equipment grant, and grants from the Canadian National Institute for the Blind (CNIB) and The Lena McLaughlin Foundation (Mona & Rod McLennan); he is a recipient of the Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration. SCM was supported by the Foundation Fighting Blindness Canada. JEM is supported by an Operating Grant from CIHR.	Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BONFIELD S, 2007, SPATIOTEMPORAL CONTR; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Doering CJ, 2007, CHANNELS, V1; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ekinci FJ, 1999, J BIOL CHEM, V274, P30322, DOI 10.1074/jbc.274.42.30322; GEORGIEV GP, 1984, EUR J BIOCHEM, V145, P203, DOI 10.1111/j.1432-1033.1984.tb08541.x; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Jacobi FK, 2003, AM J OPHTHALMOL, V135, P733, DOI 10.1016/S0002-9394(02)02109-8; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P1610; Nusinowitz S, 2003, EXP EYE RES, V77, P627, DOI 10.1016/S0014-4835(03)00217-3; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Peloquin JB, 2007, NEUROSCIENCE, V150, P335, DOI 10.1016/j.neuroscience.2007.09.021; Petrecca K, 2000, J NEUROSCI, V20, P8736; PRAT AG, 1995, AM J PHYSIOL-CELL PH, V268, pC1552, DOI 10.1152/ajpcell.1995.268.6.C1552; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Schmidt H, 2000, J NEUROCHEM, V74, P414, DOI 10.1046/j.1471-4159.2000.0740414.x; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; SONIGO P, 1987, P NATL ACAD SCI USA, V84, P3768, DOI 10.1073/pnas.84.11.3768; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Umeda T, 2001, J BIOCHEM, V130, P535, DOI 10.1093/oxfordjournals.jbchem.a003016; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; YU M, 2007, DOC OPHTHALMOL; Zeitz C, 2005, MOL VIS, V11, P179; Zito I, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9106	54	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2538	10.1371/journal.pone.0002538	http://dx.doi.org/10.1371/journal.pone.0002538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596967	Green Submitted, gold, Green Published			2022-12-25	WOS:000263288200010
J	Ortega-Gutierrez, S; Leung, D; Ficarro, S; Peters, EC; Cravatt, BF				Ortega-Gutierrez, Silvia; Leung, Donmienne; Ficarro, Scott; Peters, Eric C.; Cravatt, Benjamin F.			Targeted Disruption of the PME-1 Gene Causes Loss of Demethylated PP2A and Perinatal Lethality in Mice	PLOS ONE			English	Article								Background: Phosphoprotein phosphatase 2A (PP2A), a major serine-threonine protein phosphatase in eukaryotes, is an oligomeric protein comprised of structural (A) and catalytic (C) subunits to which a variable regulatory subunit (B) can associate. The C subunit contains a methyl ester post-translational modification on its C-terminal leucine residue, which is removed by a specific methylesterase (PME-1). Methylesterification is thought to control the binding of different B subunits to AC dimers, but little is known about its physiological significance in vivo. Methodology/Principal Findings: Here, we show that targeted disruption of the PME-1 gene causes perinatal lethality in mice, a phenotype that correlates with a virtually complete loss of the demethylated form of PP2A in the nervous system and peripheral tissues. Interestingly, PP2A catalytic activity over a peptide substrate was dramatically reduced in PME-1(-/-) tissues, which also displayed alterations in phosphoproteome content. Conclusions: These findings suggest a role for the demethylated form of PP2A in maintenance of enzyme function and phosphorylation networks in vivo.	[Ortega-Gutierrez, Silvia; Leung, Donmienne; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Ortega-Gutierrez, Silvia; Leung, Donmienne; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA USA; [Ficarro, Scott; Peters, Eric C.] Genom Inst Novartis Fdn, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Novartis	Ortega-Gutierrez, S (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Ortega-Gutierrez, Silvia/ABC-7653-2021; Ortega-Gutierrez, Silvia/I-1935-2017; Peters, Eric/W-2739-2019	Ortega-Gutierrez, Silvia/0000-0002-0257-6754; 	National Institutes of Health [DA015197]; The Skaggs Institute for Chemical Biology; Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents; Fulbright Scholar program and the Spanish Ministry of Science and Education; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Skaggs Institute for Chemical Biology; Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents; Fulbright Scholar program and the Spanish Ministry of Science and Education; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants (DA015197; B.F.C.), The Skaggs Institute for Chemical Biology, the Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents and the Fulbright Scholar program and the Spanish Ministry of Science and Education (S.O.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAYLA X, 1994, J BIOL CHEM, V269, P15668; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Gual P, 2001, ONCOGENE, V20, P156, DOI 10.1038/sj.onc.1204047; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Leulliot N, 2004, J BIOL CHEM, V279, P8351, DOI 10.1074/jbc.M311484200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Maiti T, 1997, J BIOL CHEM, V272, P18333, DOI 10.1074/jbc.272.29.18333; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Maton G, 2005, J CELL SCI, V118, P2485, DOI 10.1242/jcs.02370; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Oliver Carey J., 1998, Frontiers in Bioscience, V3, pD961; Ramakers GMJ, 2000, J BIOL CHEM, V275, P28682, DOI 10.1074/jbc.M003068200; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; ULLOA L, 1993, FEBS LETT, V330, P85, DOI 10.1016/0014-5793(93)80925-K; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; WEI GQ, 2001, P SOC PHOTO-OPT INS, V2, P1570; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu T, 1997, ARCH BIOCHEM BIOPHYS, V339, P210, DOI 10.1006/abbi.1996.9835	56	34	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2486	10.1371/journal.pone.0002486	http://dx.doi.org/10.1371/journal.pone.0002486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596935	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200001
J	Rodriguez-Feo, JA; Hellings, WE; Moll, FL; De Vries, JPPM; van Middelaar, BJ; Algra, A; Sluijter, J; Velema, E; van der Broek, T; Sessa, WC; De Kleijn, DPV; Pasterkamp, G				Rodriguez-Feo, Juan A.; Hellings, Willem E.; Moll, Frans L.; De Vries, Jean-Paul P. M.; van Middelaar, Ben J.; Algra, Ale; Sluijter, Joost; Velema, Evelyn; van der Broek, Theo; Sessa, William C.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard			Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease	PLOS ONE			English	Article								Caveolin-1 (Cav-1) is a regulatory protein of the arterial wall, but its role in human atherosclerosis remains unknown. We have studied the relationships between Cav-1 abundance, atherosclerotic plaque characteristics and clinical manisfestations of atherosclerotic disease. We determined Cav-1 expression by western blotting in atherosclerotic plaques harvested from 378 subjects that underwent carotid endarterectomy. Cav-1 levels were significantly lower in carotid plaques than non-atherosclerotic vascular specimens. Low Cav-1 expression was associated with features of plaque instability such as large lipid core, thrombus formation, macrophage infiltration, high IL-6, IL-8 levels and elevated MMP-9 activity. Clinically, a downregulation of Cav-1 was observed in plaques obtained from men, patients with a history of myocardial infarction and restenotic lesions. Cav-1 levels above the median were associated with absence of new vascular events within 30 days after surgery [0% vs. 4%] and a trend towards lower incidence of new cardiovascular events during longer follow-up. Consistent with these clinical data, Cav-1 null mice revealed elevated intimal hyperplasia response following arterial injury that was significantly attenuated after MMP inhibition. Recombinant peptides mimicking Cav-1 scaffolding domain (Cavtratin) reduced gelatinase activity in cultured porcine arteries and impaired MMP-9 activity and COX-2 in LPS-challenged macrophages. Administration of Cavtratin strongly impaired flow-induced expansive remodeling in mice. This is the first study that identifies Cav-1 as a novel potential stabilizing factor in human atherosclerosis. Our findings support the hypothesis that local down-regulation of Cav-1 in atherosclerotic lesions contributes to plaque formation and/or instability accelerating the occurrence of adverse clinical outcomes. Therefore, given the large number of patients studied, we believe that Cav-1 may be considered as a novel target in the prevention of human atherosclerotic disease and the loss of Cav-1 may be a novel biomarker of vulnerable plaque with prognostic value.	[Rodriguez-Feo, Juan A.; van Middelaar, Ben J.; Sluijter, Joost; Velema, Evelyn; van der Broek, Theo; De Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Med Ctr, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands; [Hellings, Willem E.; Moll, Frans L.] Univ Med Ctr, Dept Vasc Surg, Utrecht, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Algra, Ale] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Algra, Ale] UMC Utrecht, Rudolf Magnus Inst, Dept Neurol, Utrecht, Netherlands; [Sessa, William C.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT USA; [De Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Yale University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Rodriguez-Feo, JA (corresponding author), Univ Med Ctr, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands.	g.pasterkamp@umcutrecht.nl	, van den Broek T/I-9651-2019; Sessa, William C/B-6844-2011	, van den Broek T/0000-0002-2781-5731; Sessa, William C/0000-0001-5759-1938; Sluijter, Joost/0000-0003-2088-9102	Netherlands Organization for Scientific Research [902-16-239, 902-26-213, 902-16-222]; Netherlands Heart Foundation [99-209]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	Netherlands Organization for Scientific Research grants 902-16-239, 902-26-213 and 902-16-222; Netherlands heart Foundation grant 99-209	Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Chow AK, 2007, J MOL CELL CARDIOL, V42, P896, DOI 10.1016/j.yjmcc.2007.01.008; de Kleijn DPV, 2001, FEBS LETT, V501, P37, DOI 10.1016/S0014-5793(01)02622-9; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Frank PG, 2004, CURR OPIN LIPIDOL, V15, P523, DOI 10.1097/00041433-200410000-00005; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GOLUB LM, 1987, J DENT RES, V66, P1310, DOI 10.1177/00220345870660080401; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Halliday A, 2004, LANCET, V363, P1491; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2007, TRENDS CARDIOVAS MED, V17, P162, DOI 10.1016/j.tcm.2007.03.006; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Jasmin JF, 2006, CIRCULATION, V114, P912, DOI 10.1161/CIRCULATIONAHA.106.634709; Karwowski JK, 1999, J SURG RES, V87, P122, DOI 10.1006/jsre.1999.5707; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; North American Symptomatic Carotid Endarterectomy Trial Collaborators, 1991, N ENGL J MED, V325, P445; Pasterkamp G, 2004, ARTERIOSCL THROM VAS, V24, P650, DOI 10.1161/01.ATV.0000120376.09047.fe; Rothwell PM, 2000, LANCET, V355, P19, DOI 10.1016/S0140-6736(99)04470-0; Schwencke C, 2005, CARDIOVASC RES, V68, P128, DOI 10.1016/j.cardiores.2005.05.004; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Smits PC, 1999, HEART, V82, P461, DOI 10.1136/hrt.82.4.461; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Verhoeven B, 2005, J VASC SURG, V42, P1075, DOI 10.1016/j.jvs.2005.08.009; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Watanabe T, 2004, LIFE SCI, V75, P1219, DOI 10.1016/j.lfs.2004.03.004; 1998, LANCET, V351, P1379	38	34	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2612	10.1371/journal.pone.0002612	http://dx.doi.org/10.1371/journal.pone.0002612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596970	gold, Green Published, Green Submitted			2022-12-25	WOS:000263288200061
J	Rueda, P; Balabanian, K; Lagane, B; Staropoli, I; Chow, K; Levoye, A; Laguri, C; Sadir, R; Delaunay, T; Izquierdo, E; Pablos, JL; Lendinez, E; Caruz, A; Franco, D; Baleux, F; Lortat-Jacob, H; Arenzana-Seisdedos, F				Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Laguri, Cedric; Sadir, Rabia; Delaunay, Thierry; Izquierdo, Elena; Luis Pablos, Jose; Lendinez, Elena; Caruz, Antonio; Franco, Diego; Baleux, Francoise; Lortat-Jacob, Hugues; Arenzana-Seisdedos, Fernando			The CXCL12 gamma Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins	PLOS ONE			English	Article								The CXCL12 gamma chemokine arises by alternative splicing from Cxcl12, an essential gene during development. This protein binds CXCR4 and displays an exceptional degree of conservation (99%) in mammals. CXCL12 gamma is formed by a protein core shared by all CXCL12 isoforms, extended by a highly cationic carboxy-terminal (C-ter) domain that encompass four overlapped BBXB heparan sulfate (HS)-binding motifs. We hypothesize that this unusual domain could critically determine the biological properties of CXCL12 gamma through its interaction to, and regulation by extracellular glycosaminoglycans (GAG) and HS in particular. By both RT-PCR and immunohistochemistry, we mapped the localization of CXCL12 gamma both in mouse and human tissues, where it showed discrete differential expression. As an unprecedented feature among chemokines, the secreted CXCL12 gamma strongly interacted with cell membrane GAG, thus remaining mostly adsorbed on the plasmatic membrane upon secretion. Affinity chromatography and surface plasmon resonance allowed us to determine for CXCL12 gamma one of the higher affinity for HS (K-d = 0.9 nM) ever reported for a protein. This property relies in the presence of four canonical HS-binding sites located at the C-ter domain but requires the collaboration of a HS-binding site located in the core of the protein. Interestingly, and despite reduced agonist potency on CXCR4, the sustained binding of CXCL12 gamma to HS enabled it to promote in vivo intraperitoneal leukocyte accumulation and angiogenesis in matrigel plugs with much higher efficiency than CXCL12 alpha. In good agreement, mutant CXCL12 gamma chemokines selectively devoid of HS-binding capacity failed to promote in vivo significant cell recruitment. We conclude that CXCL12 gamma features unique structural and functional properties among chemokines which rely on the presence of a distinctive C-ter domain. The unsurpassed capacity to bind to HS on the extracellular matrix would make CXCL12 gamma the paradigm of haptotactic proteins, which regulate essential homeostatic functions by promoting directional migration and selective tissue homing of cells.	[Rueda, Patricia; Lendinez, Elena; Caruz, Antonio; Franco, Diego] Univ Jaen, Dept Biol Expt, Jaen, Spain; [Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Arenzana-Seisdedos, Fernando] Inst Pasteur, Viral Pathogenesis lab, Paris, France; [Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Arenzana-Seisdedos, Fernando] INSERM U819, Paris, France; [Laguri, Cedric; Sadir, Rabia; Lortat-Jacob, Hugues] Inst Structural Biol, Gagophile lab, UMR 5075 CNRS CEA UJF, Grenoble, France; [Delaunay, Thierry] INRA, Villenave Dornon, France; [Izquierdo, Elena; Luis Pablos, Jose] Hosp Octubre 12, Unidad Investigac, Serv Reumatol, Madrid, Spain; [Baleux, Francoise] Inst Pasteur, Unite Chim Organ, Paris, France	Universidad de Jaen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; INRAE; Hospital Universitario 12 de Octubre; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rueda, P (corresponding author), Univ Jaen, Dept Biol Expt, Jaen, Spain.	farenzan@pasteur.fr	Arenzana-Seisdedos, Fernando/E-5835-2016; Levoye, Angelique/ABC-7892-2021; Izquierdo, Elena/Z-1861-2019; Lagane, Bernard/AAA-2205-2019; Balabanian, Karl/I-2990-2016; Balabanian, Karl/S-6250-2019; Caruz, Antonio/N-5557-2014; Lagane, Bernard/K-8446-2016	Izquierdo, Elena/0000-0002-3355-2798; Lagane, Bernard/0000-0002-3459-7867; Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; Caruz, Antonio/0000-0002-5788-7840; laguri, cedric/0000-0002-5429-6914; Rueda, Patricia/0000-0003-1553-0840; Levoye, Angelique/0000-0002-7125-7327; Franco, Diego/0000-0002-5669-7164	French Agence National pour la Recherche (ANR); Agence National pour la Recherche sur le SIDA (ANRS); Institut National de la Sante et la Recherche Medicale (INSERM); Institut Pasteur; Fondo de Investigaciones Sanitarias [FIS 05/060]; FPDI program sponsored by the Andalucia autonomous government (Spain) [fellowship]; Croucher Foundation (Hong Kong); ANR-Maladies Rares	French Agence National pour la Recherche (ANR)(French National Research Agency (ANR)); Agence National pour la Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); FPDI program sponsored by the Andalucia autonomous government (Spain); Croucher Foundation (Hong Kong); ANR-Maladies Rares(French National Research Agency (ANR))	This work is supported by grants from the French Agence National pour la Recherche (ANR), the Agence National pour la Recherche sur le SIDA (ANRS) Institut National de la Sante et la Recherche Medicale (INSERM), Institut Pasteur and Fondo de Investigaciones Sanitarias (Spain, FIS 05/060). PR is a fellowship recipient from the FPDI program sponsored by the Andalucia autonomous government (Spain). KC and AL are supported by Croucher Foundation (Hong Kong) and ANR-Maladies Rares, respectively. CL is supported by an ANR postdoctoral grant.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kantele JM, 2000, J IMMUNOL, V164, P5035, DOI 10.4049/jimmunol.164.10.5035; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pablos JL, 2003, J IMMUNOL, V170, P2147, DOI 10.4049/jimmunol.170.4.2147; PASSANITI A, 1992, LAB INVEST, V67, P519; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sandhoff R, 2005, BBA-MOL CELL BIOL L, V1687, P52, DOI 10.1016/j.bbalip.2004.11.011; Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; ZIMRIN AB, 1995, BIOCHEM BIOPH RES CO, V213, P630, DOI 10.1006/bbrc.1995.2178; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2543	10.1371/journal.pone.0002543	http://dx.doi.org/10.1371/journal.pone.0002543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648536	Green Published, gold			2022-12-25	WOS:000263288200015
J	Yu, K; Wang, ZM; Li, QZ; Wacholder, S; Hunter, DJ; Hoover, RN; Chanock, S; Thomas, G				Yu, Kai; Wang, Zhaoming; Li, Qizhai; Wacholder, Sholom; Hunter, David J.; Hoover, Robert N.; Chanock, Stephen; Thomas, Gilles			Population Substructure and Control Selection in Genome-Wide Association Studies	PLOS ONE			English	Article								Determination of the relevance of both demanding classical epidemiologic criteria for control selection and robust handling of population stratification ( PS) represents a major challenge in the design and analysis of genome-wide association studies (GWAS). Empirical data from two GWAS in European Americans of the Cancer Genetic Markers of Susceptibility (CGEMS) project were used to evaluate the impact of PS in studies with different control selection strategies. In each of the two original case-control studies nested in corresponding prospective cohorts, a minor confounding effect due to PS ( inflation factor lambda of 1.025 and 1.005) was observed. In contrast, when the control groups were exchanged to mimic a cost-effective but theoretically less desirable control selection strategy, the confounding effects were larger (lambda of 1.090 and 1.062). A panel of 12,898 autosomal SNPs common to both the Illumina and Affymetrix commercial platforms and with low local background linkage disequilibrium (pair-wise r(2)< 0.004) was selected to infer population substructure with principal component analysis. A novel permutation procedure was developed for the correction of PS that identified a smaller set of principal components and achieved a better control of type I error (to lambda of 1.032 and 1.006, respectively) than currently used methods. The overlap between sets of SNPs in the bottom 5% of p-values based on the new test and the test without PS correction was about 80%, with the majority of discordant SNPs having both ranks close to the threshold. Thus, for the CGEMS GWAS of prostate and breast cancer conducted in European Americans, PS does not appear to be a major problem in well-designed studies. A study using suboptimal controls can have acceptable type I error when an effective strategy for the correction of PS is employed.	[Yu, Kai; Wang, Zhaoming; Li, Qizhai; Wacholder, Sholom; Hunter, David J.; Hoover, Robert N.; Chanock, Stephen; Thomas, Gilles] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Wang, Zhaoming] Natl Canc Inst Frederick, SAIC Frederick Inc, Advanced Technol Program, Core Genotyping Facility, Frederick, MD USA; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Hunter, David J.] Harvard Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health	Yu, K (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yuka@mail.nih.gov	Wang, Zhaoming/R-5527-2018	Wang, Zhaoming/0000-0001-7556-3869	Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS [N01-CO-12400]; US NIH [CA65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; NATIONAL CANCER INSTITUTE [Z01CP010181] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. The Nurses' Health Studies (NHS) are supported by US NIH grants CA65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; COX DR, 1982, BIOMETRICS, V38, P541, DOI 10.2307/2530040; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hunter DJ, 2007, CANCER CAUSE CONTROL, V18, P479, DOI 10.1007/s10552-007-0118-y; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; KRUSKAL WILLIAM H., 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P885; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	35	94	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2551	10.1371/journal.pone.0002551	http://dx.doi.org/10.1371/journal.pone.0002551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596976	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200019
J	Trapp, T; Kogler, G; El-Khattouti, A; Sorg, RV; Besselmann, M; Focking, M; Buhrle, CP; Trompeter, I; Fischer, JC; Wernet, P				Trapp, Thorsten; Koegler, Gesine; El-Khattouti, Abdelouahid; Sorg, Ruediger V.; Besselmann, Michael; Foecking, Melanie; Buehrle, Christian P.; Trompeter, Ingo; Fischer, Johannes C.; Wernet, Peter			Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; IN-VITRO; C-MET; BEHAVIORAL DEFICITS; EXPERIMENTAL STROKE; NEUROTROPHIC FACTOR; MOUSE MODEL; RAT-BRAIN	An under-agarose chemotaxis assay was used to investigate whether unrestricted somatic stem cells (USSC) that were recently characterized in human cord blood are attracted by neuronal injury in vitro. USSC migrated toward extracts of post-ischemic brain tissue of mice in which stroke had been induced. Moreover, apoptotic neurons secrete factors that strongly attracted USSC, whereas necrotic and healthy neurons did not. Investigating the expression of growth factors and chemokines in lesioned brain tissue and neurons and of their respective receptors in USSC revealed expression of hepatocyte growth factor (HGF) in post-ischemic brain and in apoptotic but not in necrotic neurons and of the HGF receptor c-MET in USSC. Neuronal lesion-triggered migration was observed in vitro and in vivo only when c-MET was expressed at a high level in USSC. Neutralization of the bioactivity of HGF with an antibody inhibited migration of USSC toward neuronal injury. This, together with the finding that human recombinant HGF attracts USSC, document that HGF signaling is necessary for the tropism of USSC for neuronal injury. Our data demonstrate that USSC have the capacity to migrate toward apoptotic neurons and injured brain. Together with their neural differentiation potential, this suggests a neuroregenerative potential of USSC. Moreover, we provide evidence for a hitherto unrecognized pivotal role of the HGF/c-MET axis in guiding stem cells toward brain injury, which may partly account for the capability of HGF to improve function in the diseased central nervous system.	[Trapp, Thorsten; Koegler, Gesine; El-Khattouti, Abdelouahid; Sorg, Ruediger V.; Trompeter, Ingo; Fischer, Johannes C.; Wernet, Peter] Univ Dusseldorf, Med Ctr, Lab Neuroregenerat, Inst Transplantat Diagnost & Cell Therapeut,ITZ, D-40225 Dusseldorf, Germany; [Trapp, Thorsten; Foecking, Melanie] Univ Med Ctr Munster, European Grad Sch Neurosci, D-48129 Munster, Germany; [Foecking, Melanie] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Psychiat, Dublin 2, Ireland; [Buehrle, Christian P.] Univ Cologne, Dept Stereotaxy & Funct Neurosurg, D-50924 Cologne, Germany; [Besselmann, Michael] Univ Med Ctr Munster, Dept Neurol, D-48129 Munster, Germany	Heinrich Heine University Dusseldorf; University of Munster; Royal College of Surgeons - Ireland; University of Cologne; University of Munster	Trapp, T (corresponding author), Univ Dusseldorf, Med Ctr, Lab Neuroregenerat, Inst Transplantat Diagnost & Cell Therapeut,ITZ, Moorenstr 5,Bldg 14-80, D-40225 Dusseldorf, Germany.	trapp@itz.uni-duesseldorf.de	Foecking, Melanie/G-9491-2011	Foecking, Melanie/0000-0002-6299-2952; Fischer, Johannes/0000-0002-2079-1845	European Community [BIO4-CT98-0293, QLG3-CT-2000-00934, QLK6-CT-2000-60042]	European Community(European Commission)	This work was supported by European Community Grants BIO4-CT98-0293, QLG3-CT-2000-00934, and QLK6-CT-2000-60042 (to the Trapp laboratory). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; BACKHAUSS C, 1992, J PHARMACOL TOXICOL, V27, P27, DOI 10.1016/1056-8719(92)90017-U; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Bowers DC, 2000, CANCER RES, V60, P4277; Buzanska L, 2002, J CELL SCI, V115, P2131; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Date I, 2004, J NEUROSCI RES, V78, P442, DOI 10.1002/jnr.20263; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Ferraro D, 2006, ONCOGENE, V25, P3689, DOI 10.1038/sj.onc.1209409; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hayashi T, 1998, BRAIN RES, V799, P311, DOI 10.1016/S0006-8993(98)00391-6; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Laevsky G, 2001, BIOTECHNIQUES, V31, P1140, DOI 10.2144/01315rr03; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Oshima K, 2004, FASEB J, V18, P212, DOI 10.1096/fj.03-0567fje; Peterson DA, 2004, J CLIN INVEST, V114, P312, DOI 10.1172/jc1200422540; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Trapp T, 1996, J BIOL CHEM, V271, P9879, DOI 10.1074/jbc.271.17.9879; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; Varming T, 1996, J NEUROSCI RES, V44, P40, DOI 10.1002/(SICI)1097-4547(19960401)44:1<40::AID-JNR5>3.0.CO;2-I; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6	51	28	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32244	32253		10.1074/jbc.M800862200	http://dx.doi.org/10.1074/jbc.M800862200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18628208	hybrid			2022-12-25	WOS:000260893700011
J	Khetani, SR; Chen, AA; Ranscht, B; Bhatia, SN				Khetani, Salman R.; Chen, Alice A.; Ranscht, Barbara; Bhatia, Sangeeta N.			T-cadherin modulates hepatocyte functions in vitro	FASEB JOURNAL			English	Article						CHO; fibroblasts; coculture; cytochrome P450	JUNCTIONAL COMMUNICATION; ENDOTHELIAL-CELLS; DRUG-METABOLISM; SMOOTH-MUSCLE; LIVER; COCULTURE; CONTACT; DIFFERENTIATION; IDENTIFICATION; EXPRESSION	Primary hepatocytes from several different species rapidly lose viability and phenotypic functions on isolation from their native microenvironment of the liver. Stromal cells derived from both within and outside the liver can induce phenotypic functions in primary hepatocytes in vitro; however, the molecular mediators underlying this "coculture effect" have not been fully elucidated. We have previously developed a functional genomic screen utilizing cocultures of hepatocytes and 3T3 fibroblasts to identify such candidate hepatocyte-function-inducing molecules. In particular, truncated-cadherin (T-cadherin) was identified as a potential molecule of interest in induction of hepatic functions. Here we demonstrate that liver-specific functions of primary rat hepatocytes are induced on cocultivation with Chinese hamster ovary cells engineered to express T-cadherin on their surface as compared with wild-type controls. Additionally, culture of cells on substrata presenting recombinant T-cadherin protein (acellular presentation) enhanced hepatic functions in both pure hepatocyte cultures and in hepatocyte-stromal cocultures lacking endogenous T-cadherin expression. Collectively, these data indicate that both cellular and acellular presentation of T-cadherin can be used to modulate the hepatocyte phenotype in vitro for tissue engineering applications. Our work suggests potential avenues for investigating the role of T-cadherin on hepatocellular function in vivo in settings such as embryogenesis and liver pathology.-Khetani, S. R., Chen, A. A., Ranscht, B., Bhatia, S. N. T-cadherin modulates hepatocyte functions in vitro. FASEB J. 22, 3768-3775 (2008)	[Bhatia, Sangeeta N.] MIT, Lab Multiscale Regenerat Technol, Div Hlth Sci & Technol Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Chen, Alice A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ranscht, Barbara] Burnham Inst Med Res, La Jolla, CA USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Brigham & Women's Hospital	Bhatia, SN (corresponding author), MIT, Lab Multiscale Regenerat Technol, Div Hlth Sci & Technol Elect Engn & Comp Sci, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.	sbhatia@mit.edu	Yu, weiting/I-7417-2013		National Science Foundation (NSF); National Institutes of Health (NIH) [HD 25938]; NSF CAREER; NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); David and Lucile Packard Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065152] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Jennifer Felix and Kathryn Hudson for rat hepatocyte isolation, Craig Sharp for assistance with cell culture and biochemical assays, Sandra March for critical review of the manuscript, and James Thomson for providing mouse embryonic fibroblasts. Funding was provided by National Science Foundation (NSF) Graduate Fellowships (S.R.K, A.A.C.), National Institutes of Health (NIH) grant HD 25938 (B.R), NSF CAREER, NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the David and Lucile Packard Foundation.	Adachi Y, 2006, VIRCHOWS ARCH, V448, P311, DOI 10.1007/s00428-005-0098-9; Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Brieva TA, 2004, TISSUE ENG, V10, P553, DOI 10.1089/107632704323061915; Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041; Chia SM, 2005, BIOTECHNOL BIOENG, V89, P565, DOI 10.1002/bit.20372; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Eschbach E, 2005, J CELL BIOCHEM, V95, P243, DOI 10.1002/jcb.20360; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684; GOULET F, 1988, HEPATOLOGY, V8, P1010, DOI 10.1002/hep.1840080506; GUGUENGUILLOUZO C, 1983, MOL CELL BIOCHEM, V53-4, P35; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Hamilton GA, 2001, CELL TISSUE RES, V306, P85; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Joshi MB, 2005, FASEB J, V19, P1737, DOI 10.1096/fj.05-3834fje; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; Marrs JA, 1996, INT REV CYTOL, V165, P159, DOI 10.1016/S0074-7696(08)62222-6; MESNIL M, 1987, EXP CELL RES, V173, P524, DOI 10.1016/0014-4827(87)90292-8; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova MP, 1998, FEBS LETT, V429, P207, DOI 10.1016/S0014-5793(98)00598-5; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; REID LM, 1986, ISOLATED CULTURED HE, P226; ROJKIND M, 1995, AM J PATHOL, V146, P1508; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Takeuchi T, 2001, HISTOL HISTOPATHOL, V16, P1287, DOI 10.14670/HH-16.1287; Tkachuk VA, 1998, FEBS LETT, V421, P208, DOI 10.1016/S0014-5793(97)01562-7; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451	37	42	46	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					3768	3775		10.1096/fj.07-105155	http://dx.doi.org/10.1096/fj.07-105155			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18635739	Green Published			2022-12-25	WOS:000260503000005
J	Langston, LD; O'Donnell, M				Langston, Lance D.; O'Donnell, Mike			DNA Polymerase delta Is Highly Processive with Proliferating Cell Nuclear Antigen and Undergoes Collision Release upon Completing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-FACTOR-C; LAGGING-STRAND POLYMERASE; ESCHERICHIA-COLI; III HOLOENZYME; SACCHAROMYCES-CEREVISIAE; SLIDING CLAMPS; IN-VITRO; LEADING-STRAND; FORK; EPSILON	In most cells, 100-1000 Okazaki fragments are produced for each replicative DNA polymerase present in the cell. For fast-growing cells, this necessitates rapid recycling of DNA polymerase on the lagging strand. Bacteria produce long Okazaki fragments (1-2 kb) and utilize a highly processive DNA polymerase III (pol III), which is held to DNA by a circular sliding clamp. In contrast, Okazaki fragments in eukaryotes are quite short, 100 250 bp, and thus the eukaryotic lagging strand polymerase does not require a high degree of processivity. The lagging strand polymerase in eukaryotes, polymerase delta (pol delta), functions with the proliferating cell nuclear antigen ( PCNA) sliding clamp. In this report, Saccharomyces cerevisiae pol delta is examined on model substrates to gain insight into the mechanism of lagging strand replication in eukaryotes. Surprisingly, we find pol delta is highly processive with PCNA, over at least 5 kb, on Replication Protein A (RPA)-coated primed single strand DNA. The high processivity of pol delta observed in this report contrasts with its role in synthesis of short lagging strand fragments, which require it to rapidly dissociate from DNA at the end of each Okazaki fragment. We find that this dilemma is solved by a "collision release" process in which pol delta ejects from PCNA upon extending a DNA template to completion and running into the downstream duplex. The released pol delta transfers to a new primed site, provided the new site contains a PCNA clamp. Additional results indicate that the collision release mechanism is intrinsic to the pol3/pol31 subunits of the pol delta heterotrimer.	[Langston, Lance D.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), 1230 York Ave,Box 288, New York, NY 10065 USA.	odonnel@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214; Langston, Lance/0000-0002-2736-9284	National Institutes of Health [GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38839. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P4585, DOI 10.1073/pnas.79.15.4585; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; FAY PJ, 1981, J BIOL CHEM, V256, P976; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; LEU FP, 2002, THESIS CORNELL MED C; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI S, 1988, J BIOL CHEM, V263, P6555; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; MORRISON A, 1992, NUCLEIC ACIDS RES, V20, P375, DOI 10.1093/nar/20.2.375; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PAN ZQ, 1993, P NATL ACAD SCI USA, V90, P6, DOI 10.1073/pnas.90.1.6; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Turner J, 1995, METHOD ENZYMOL, V262, P442; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	56	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29522	29531		10.1074/jbc.M804488200	http://dx.doi.org/10.1074/jbc.M804488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18635534	hybrid, Green Published			2022-12-25	WOS:000260179900078
J	Ram, N; Weiss, N; Texier-Nogues, I; Aroui, S; Andreotti, N; Pirollet, F; Ronjat, M; Sabatier, JM; Darbon, H; Jacquemond, V; De Waard, M				Ram, Narendra; Weiss, Norbert; Texier-Nogues, Isabelle; Aroui, Sonia; Andreotti, Nicolas; Pirollet, Fabienne; Ronjat, Michel; Sabatier, Jean-Marc; Darbon, Herve; Jacquemond, Vincent; De Waard, Michel			Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; AMINO-ACID-RESIDUES; RYANODINE RECEPTOR; SCORPION TOXINS; CA2+ RELEASE; PEPTIDE; PENETRATION; MAUROTOXIN; BINDING; DEPOLARIZATION	Maurocalcine is a 33-mer peptide initially isolated from the venom of a Tunisian scorpion. It has proved itself valuable as a pharmacological activator of the ryanodine receptor and has helped the understanding of the molecular basis underlying excitation-contraction coupling in skeletal muscles. Because of its positively charged nature, it is also an innovative vector for the cell penetration of various compounds. We report a novel maurocalcine analog with improved properties: (i) the complete loss of pharmacological activity, (ii) preservation of the potent ability to carry cargo molecules into cells, and (iii) coupling chemistries not affected by the presence of internal cysteine residues of maurocalcine. We did this by replacing the six internal cysteine residues of maurocalcine by isosteric 2-aminobutyric acid residues and by adding an additional N-terminal biotinylated lysine (for a proof of concept analog) or an N-terminal cysteine residue (for a chemically competent coupling analogue). Additional replacement of a glutamate residue by alanyl at position 12 further improves the potency of these analogues. Coupling to several cargo molecules or nanoparticles are presented to illustrate the cell penetration potency and usefulness of these pharmacologically inactive analogs.	[Ram, Narendra; Aroui, Sonia; Pirollet, Fabienne; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, Grenoble Inst Neurosci, U836, Res Grp Calcium Channels Funct & Pathol 3, F-38042 Grenoble 09, France; [Weiss, Norbert; Jacquemond, Vincent] Univ Lyon 1, CNRS, UMR Physiol Integrat Cellulaire & Mol 5123, F-69622 Villeurbanne, France; [Texier-Nogues, Isabelle] CEA Grenoble LETI DTBS, F-38054 Grenoble, France; [Andreotti, Nicolas; Sabatier, Jean-Marc] Univ Mediterannee Ambrillia Biopharm, Fac Med Nord ERT62, Marseille 20, France; [Darbon, Herve] Univ Aix Marseille, CNRS, AFMB, UMR 6098, F-13288 Marseille 09, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	De Waard, M (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, U836, Res Grp Calcium Channels Funct & Pathol 3, BP 170, F-38042 Grenoble 09, France.	michel.dewaard@ujf-grenoble.fr	De Waard, Michel/G-7406-2014; Pirollet, Fabienne/L-3088-2013; Weiss, Norbert/G-5330-2014	De Waard, Michel/0000-0002-2782-9615; Weiss, Norbert/0000-0002-0040-1109; Texier, Isabelle/0000-0002-8859-8283; Jacquemond, Vincent/0000-0003-4944-270X; SABATIER, Jean-Marc/0000-0002-9040-5647; Ronjat, Michel/0000-0002-9728-6425	INSERM; CEA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission)	This work was supported in part by INSERM and the Fonds de Valorisation of the CEA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Collet C, 1999, J PHYSIOL-LONDON, V520, P417, DOI 10.1111/j.1469-7793.1999.00417.x; Csernoch L, 1998, BIOPHYS J, V75, P957, DOI 10.1016/S0006-3495(98)77584-8; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; di Luccio E, 2002, BIOCHEM J, V361, P409, DOI 10.1042/0264-6021:3610409; ELHAYEK R, 1995, J BIOL CHEM, V270, P28696, DOI 10.1074/jbc.270.48.28696; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Fajloun Z, 2000, J BIOL CHEM, V275, P13605, DOI 10.1074/jbc.275.18.13605; GALLO V, 1987, J NEUROSCI, V7, P2203; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; KIM DH, 1983, J BIOL CHEM, V258, P9662; Liang JF, 2005, BIOORG MED CHEM LETT, V15, P5071, DOI 10.1016/j.bmcl.2005.07.087; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Shahbazzadeh D, 2007, BIOCHEM J, V404, P89, DOI 10.1042/BJ20061404; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	23	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27048	27056		10.1074/jbc.M804727200	http://dx.doi.org/10.1074/jbc.M804727200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18621738	Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000259586600025
J	Brondello, JM; Pillaire, MJ; Rodriguez, C; Gourraud, PA; Selves, J; Cazaux, C; Piette, J				Brondello, J-M; Pillaire, M. J.; Rodriguez, C.; Gourraud, P-A; Selves, J.; Cazaux, C.; Piette, J.			Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta	ONCOGENE			English	Article						Rev3; DNA damage; Chk2; colon carcinoma	DNA-DAMAGE CHECKPOINTS; STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; ANTICANCER BARRIER; POLYMERASE-KAPPA; MAMMALIAN-CELLS; CANCER; TUMORIGENESIS	Cell cycle checkpoints and DNA repair act in concert to ensure DNA integrity during perturbation of normal replication or in response to genotoxic agents. Deficiencies in these protective mechanisms can lead to cellular transformation and ultimately tumorigenesis. Here we focused on Rev3, the catalytic subunit of the low-fidelity DNA repair polymerase zeta. Rev3 is believed to play a role in double-strand break (DSB)-induced DNA repair by homologous recombination. In line with this hypothesis, we show the accumulation of chromatin-bound Rev3 protein in late S-G2 of untreated cells and in response to clastogenic DNA damage as well as an gamma-H2AX accumulation in Rev3-depleted cells. Moreover, serine 995 of Rev3 is in vitro phosphorylated by the DSB-inducible checkpoint kinase, Chk2. Our data also disclose a significant reduction of rev3 gene expression in 74 colon carcinomas when compared to the normal adjacent tissues. This reduced expression is independent of the carcinoma stages, suggesting that the downregulation of rev3 might have occurred early during tumorigenesis.	[Brondello, J-M] Hop St Eloi, INSERM, U844, F-34091 Montpellier 05, France; [Brondello, J-M; Rodriguez, C.; Piette, J.] Univ Montpellier 1, INSERM, U868, Ctr Reg Cancerol Montpellier,CRCM Val Aurelle Lam, Montpellier 5, France; [Pillaire, M. J.; Cazaux, C.] CNRS, IPBS, UMR 5089, Toulouse, France; [Gourraud, P-A] Univ Toulouse 3, CHU Toulouse, Serv Hosp Epidemiol,Unite Rech Clin, INSERM U558,Fac Med,Dept Epidemiol & Sante Publ, F-31062 Toulouse, France; [Selves, J.] Univ Toulouse 3, INSERM, Ctr Physiopathol Toulouse Purpan, U563, F-31062 Toulouse, France; [Selves, J.] Univ Toulouse 3, Dept Anatomopathol, F-31062 Toulouse, France; [Piette, J.] CNRS, UMR5535, Inst Genet Mol Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Brondello, JM (corresponding author), Hop St Eloi, INSERM, U844, Batiment INM BP74103,80 Rue A Fiche, F-34091 Montpellier 05, France.	jean-marc.brondello@inserm.fr	Gourraud, Pierre-Antoine FD/O-3024-2015; Brondello, Jean-Marc/U-8232-2017; Piette, Jacques/F-7109-2011; Pillaire, Marie-Jeanne/P-1579-2014	Brondello, Jean-Marc/0000-0001-5991-3945; Pillaire, Marie-Jeanne/0000-0001-6866-7416; Gourraud, Pierre-Antoine/0000-0003-1131-9554	Canceropole Grand Sud Ouest; Association pour la Recherche sur le Cancer	Canceropole Grand Sud Ouest; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We gratefully thank Professor CW Lawrence for providing Rev3 cDNA and Dr C Jorgensen for gift of human mesenchymal stem cells. We also greatly thank R Guimbaud and K Gordien (Inserm/CHU Purpan, Toulouse) for collection and annotation of the tumors, as well as JM Maoret from the plateforme de Genomique et Biologie Moleculaire', IFR31 Toulouse for his technical help on the 7900HT fast real-time PCR systems. This work was supported by the Canceropole Grand Sud Ouest grant 2003-2006 and the Association pour la Recherche sur le Cancer.	Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavoux C, 2005, CANCER RES, V65, P325; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Blais V, 2004, MOL BIOL CELL, V15, P552, DOI 10.1091/mbc.E03-08-0580; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Brondello JM, 2007, BIOCHEM BIOPH RES CO, V354, P1028, DOI 10.1016/j.bbrc.2007.01.091; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canitrot Y, 2004, NUCLEIC ACIDS RES, V32, P5104, DOI 10.1093/nar/gkh848; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hochegger H, 2004, BIOESSAYS, V26, P151, DOI 10.1002/bies.10403; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Laiho M, 2003, ANN MED, V35, P391, DOI 10.1080/07853890310014605; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lawrence CW, 1996, CANCER SURV, V28, P21; Lemee F, 2007, ONCOGENE, V26, P3387, DOI 10.1038/sj.onc.1210116; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Liu VF, 1999, MOL CELL BIOL, V19, P1126; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Rattray AJ, 2005, MOL CELL, V20, P658, DOI 10.1016/j.molcel.2005.11.018; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; STRATHERN JN, 1995, GENETICS, V140, P965; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Yamamoto Ken-ichi, 2006, Subcell Biochem, V40, P327; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhu F, 2003, WORLD J GASTROENTERO, V9, P1165, DOI 10.3748/wjg.v9.i6.1165	45	36	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2008	27	47					6093	6101		10.1038/onc.2008.212	http://dx.doi.org/10.1038/onc.2008.212			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	360UJ	18622427				2022-12-25	WOS:000260083100002
J	Wang, FS; Xia, P; Wu, F; Wang, DM; Wang, W; Ward, T; Liu, Y; Aikhionbare, F; Guo, Z; Powell, M; Liu, BY; Bi, F; Shaw, A; Zhu, ZG; Elmoselhi, A; Fan, DM; Cover, TL; Ding, X; Yao, XB				Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Wang, Wei; Ward, Tarsha; Liu, Ya; Aikhionbare, Felix; Guo, Zhen; Powell, Michael; Liu, Bingya; Bi, Feng; Shaw, Andrew; Zhu, Zhenggang; Elmoselhi, Adel; Fan, Daiming; Cover, Timothy L.; Ding, Xia; Yao, Xuebiao			Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SECRETION; TOXIN VACA; EZRIN; INFECTION; PROTEIN; PHOSPHORYLATION; CYTOTOXIN; IDENTIFICATION; CANCER	Helicobacter pylori persistently colonize the human stomach and have been linked to atrophic gastritis and gastric carcinoma. Although it is well known that H. pylori infection can result in hypochlorhydria, the molecular mechanisms underlying this phenomenon remain poorly understood. Here we show that VacA permeabilizes the apical membrane of gastric parietal cells and induces hypochlorhydria. The functional consequences of VacA infection on parietal cell physiology were studied using freshly isolated rabbit gastric glands and cultured parietal cells. Secretory activity of parietal cells was judged by an aminopyrine uptake assay and confocal microscopic examination. VacA permeabilization induces an influx of extracellular calcium, followed by activation of calpain and subsequent proteolysis of ezrin at Met(469) -Thr(470), which results in the liberation of ezrin from the apical membrane of the parietal cells. VacA treatment inhibits acid secretion by preventing the recruitment of H, K-ATPase-containing tubulovesicles to the apical membrane of gastric parietal cells. Electron microscopic examination revealed that VacA treatment disrupts the radial arrangement of actin filaments in apical microvilli due to the loss of ezrin integrity in parietal cells. Significantly, expression of calpain-resistant ezrin restored the functional activity of parietal cells in the presence of VacA. Proteolysis of ezrin in VacA-infected parietal cells is a novel mechanism underlying H. pylori-induced inhibition of acid secretion. Our results indicate that VacA disrupts the apical membrane-cytoskeletal interactions in gastric parietal cells and thereby causes hypochlorhydria.	[Wang, Wei; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Div Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Wang, Fengsong; Ward, Tarsha; Liu, Ya; Aikhionbare, Felix; Guo, Zhen; Powell, Michael; Shaw, Andrew; Elmoselhi, Adel] Morehouse Sch Med, Atlanta, GA 30310 USA; [Bi, Feng] Sichuan Univ, W China Hosp, Dept Abdominal Canc, Chengdu 610041, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Key Lab Canc Biol, Xian 710032, Shanxi, Peoples R China; [Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA; [Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Inst Digest Surg, Shanghai 210026, Peoples R China	Beijing University of Chinese Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Sichuan University; Air Force Military Medical University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Shanghai Jiao Tong University	Ding, X (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.	xding@bucm.edu.cn; yaoxb@ustc.edu.cn	Cover, Timothy/I-3814-2015; Yao, Xuebiao/P-5771-2014; Elmoselhi, Adel B/AAI-3478-2020; Liu, Bingya/GMW-5655-2022	Cover, Timothy/0000-0001-8503-002X; Elmoselhi, Adel B/0000-0003-2152-6629; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA89019, CA132389, AI39657, DK53623, G-12RR03034]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese 973 [2002CB713700, 2007CB914503, 2006CB943603]; Chinese Natural Science Foundation [30270654, 39925018, 30500183, 30570926]; Chinese 863 Project [2001AA215331, 2006AA02A247]; Chinese Minister of Education [200203580851]; NATIONAL CANCER INSTITUTE [P20CA132389, P50CA089019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK053623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese 863 Project(National High Technology Research and Development Program of China); Chinese Minister of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA89019, CA132389, AI39657, DK53623, and G-12RR03034. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10; Chinese 973 project Grants 2002CB713700, 2007CB914503, and 2006CB943603; Chinese Natural Science Foundation Grants 30270654, 39925018, 30500183, and 30570926; Chinese 863 Project Grants 2001AA215331 and 2006AA02A247; Chinese Minister of Education Grant 200203580851 (to X. Y.); 111 Project 07007 (to X. D.); and the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrian M, 2002, J MOL BIOL, V318, P121, DOI 10.1016/S0022-2836(02)00047-5; Agnew BJ, 1999, J CELL SCI, V112, P2639; Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; BLACK JA, 1981, GASTROENTEROLOGY, V81, P509; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; CORREA P, 1992, CANCER RES, V52, P6735; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; COVER TL, 2001, PRINCIPLES BACTERIAL, P510; de Bernard M, 2004, INT J MED MICROBIOL, V293, P589, DOI 10.1078/1438-4221-00299; deBernard M, 1997, MOL MICROBIOL, V26, P665, DOI 10.1046/j.1365-2958.1997.5881952.x; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Furuta T, 1998, SCAND J GASTROENTERO, V33, P357, DOI 10.1080/00365529850170973; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Hasson LE, 1996, NEW ENGL J MED, V335, P242; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; MORRIS A, 1987, AM J GASTROENTEROL, V82, P192; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; URUSHIDANI T, 1999, AM J PHYSIOL, V256, pG1070; WANG KKW, 1999, CALPAIN PHARM TOXICO, P77; YAO X, 1994, MOL CELLULAR MECH H; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; YAO XB, 1993, AM J PHYSIOL, V265, pC36, DOI 10.1152/ajpcell.1993.265.1.C36; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Ye D, 1999, J BIOL CHEM, V274, P9277, DOI 10.1074/jbc.274.14.9277; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	43	50	53	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26714	26725		10.1074/jbc.M800527200	http://dx.doi.org/10.1074/jbc.M800527200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18625712	hybrid, Green Published			2022-12-25	WOS:000259341600045
J	Lapointe, J; Hekimi, S				Lapointe, Jerome; Hekimi, Siegfried			Early mitochondrial dysfunction in long-lived Mclk1(+/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; CYTOCHROME-C-REDUCTASE; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; HYDROGEN-PEROXIDE; CALORIC RESTRICTION; HEART-MITOCHONDRIA; RADICAL GENERATION; ELECTRON-TRANSPORT	Reduced activity of CLK-1/MCLK1 (also known as COQ7), a mitochondrial enzyme that is necessary for ubiquinone biosynthesis, prolongs the lifespan of nematodes and mice by a mechanism that is distinct from that of the insulin signaling pathway. Here we show that 2-fold reduction of MCLK1 expression in mice reveals an additional function for the protein, as this level of reduction does not affect ubiquinone levels yet affects mitochondrial function substantially. Indeed, we observe that the phenotype of young Mclk1(+/-) mutants includes a severe reduction of mitochondrial electron transport, ATP synthesis, and total nicotinamide adenine dinucleotide (NAD(tot)) pool size as well as an alteration in the activity of key enzymes of the tricarboxylic acid cycle. Surprisingly, we also find that Mclk1 heterozygosity leads to a dramatic increase in mitochondrial oxidative stress by a variety of measures. Furthermore, we find that the mitochondrial dysfunction is accompanied by a decrease in oxidative damage to cytosolic proteins as well as by a decrease in plasma isoprostanes, a systemic biomarker of oxidative stress and aging. We propose a mechanism for the conjunction of low ATP levels, high mitochondrial oxidative stress, and low non-mitochondrial oxidative damage in a long-lived mutant. Our model helps to clarify the relationship between energy metabolism and the aging process and suggests the need for a reformulation of the mitochondrial oxidative stress theory of aging.	[Lapointe, Jerome; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	Siegfried.Hekimi@McGill.ca			National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded in part by a grant from the National Science and Engineering Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aguilaniu H, 2005, GENE DEV, V19, P2399, DOI 10.1101/gad.1366505; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; [Anonymous], 1922, BIOL DEATH; AUSTIN J, 1984, J BIOL CHEM, V259, P154; Ballard JWO, 2007, ANN NY ACAD SCI, V1114, P93, DOI 10.1196/annals.1396.011; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; Brys K, 2007, EXP GERONTOL, V42, P845, DOI 10.1016/j.exger.2007.02.004; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; CRINSON M, 1992, BIOCHEM CELL BIOL, V70, P301, DOI 10.1139/o92-047; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Hihi AK, 2003, J BIOL CHEM, V278, P41013, DOI 10.1074/jbc.M305034200; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Maia L, 2005, FREE RADICAL RES, V39, P979, DOI 10.1080/10715760500210962; MCCARTER RJ, 1989, AM J PHYSIOL, V257, pE175, DOI 10.1152/ajpendo.1989.257.2.E175; Morrow JD, 2000, DRUG METAB REV, V32, P377, DOI 10.1081/DMR-100102340; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Schuh RA, 2005, TOXICOL SCI, V88, P495, DOI 10.1093/toxsci/kfi334; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; Sone H, 2004, BIOCHEM BIOPH RES CO, V314, P824, DOI 10.1016/j.bbrc.2003.12.164; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Takahashi M, 2008, MECH AGEING DEV, V129, P291, DOI 10.1016/j.mad.2008.01.008; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; WONG A, 1995, GENETICS, V139, P1247; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YU L, 1982, J BIOL CHEM, V257, P2016; Zini R, 2007, FREE RADICAL RES, V41, P1159, DOI 10.1080/10715760701635074	69	158	160	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26217	26227		10.1074/jbc.M803287200	http://dx.doi.org/10.1074/jbc.M803287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635541	Green Published, hybrid			2022-12-25	WOS:000259200100050
J	Lauer, ME; Erzurum, SC; Mukhopadhyay, D; Vasanji, A; Drazba, J; Wang, AM; Fulop, C; Hascall, VC				Lauer, Mark E.; Erzurum, Serpil C.; Mukhopadhyay, Durba; Vasanji, Amit; Drazba, Judith; Wang, Aimin; Fulop, Csaba; Hascall, Vincent C.			Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR ACTIVATION; BRONCHOALVEOLAR LAVAGE; EXPRESSION; ASTHMA; GROWTH; CD44; LUNG; ER; SECRETIONS; ACID	In this report, we describe a novel method for culturing murine trachea epithelial cells on a native basement membrane at an air-liquid interface to produce a pseudostratified, differentiated airway epithelium composed of ciliated and nonciliated cells. This model was used to examine hyaluronan synthesis by the airway epithelial cells (AECs) in response to poly(I, C) and tunicamycin. The former induces a response similar to viral infection, and the latter is a bacterial toxin known to induce endoplasmic reticulum (ER) stress. We found significant accumulation of hyaluronan on the apical surface of the AECs in response to ER stress, but, unlike previously reported results with smooth muscle cells, no increase in hyaluronan was observed in response to poly(I, C). Monocytic U937 cells adhered at 4 degrees C to the apical surface of the AECs subjected to ER stress by a mechanism almost entirely mediated by hyaluronan. The U937 cells spontaneously released themselves from the abnormal hyaluronan matrix when their metabolism was restored by shifting the temperature from 4 to 37 degrees C in a custom-made flow chamber. Time lapse confocal microscopy permitted live imaging of this interaction between the U937 cells and the hyaluronan matrix and their subsequent response at 37 degrees C. Within 45 min, we observed dynamic protrusions of the U937 cell plasma membrane into nearby hyaluronan matrix, resulting in the degradation of this matrix. Simultaneously, we observed some reorganization of the hyaluronan matrix, from a generalized, apical distribution to localized regions around the AEC tight junctions. We discuss the implications these results might have for the airway epithelium and its relation to airway inflammation and hyperresponsiveness associated with asthma and other airway diseases.	[Lauer, Mark E.; Mukhopadhyay, Durba; Vasanji, Amit; Wang, Aimin; Fulop, Csaba; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Drazba, Judith] Cleveland Clin, Dept Imaging Core, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [PO1 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL081064 Pathology of Asthma. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bals Robert, 2004, J Cyst Fibros, V3 Suppl 2, P49, DOI 10.1016/j.jcf.2004.05.010; Boodoo S, 2006, AM J PHYSIOL-LUNG C, V291, pL479, DOI 10.1152/ajplung.00518.2005; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; HAINES DS, 1991, J CELL BIOCHEM, V46, P9, DOI 10.1002/jcb.240460104; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jorgensen MM, 2003, APMIS, V111, P86; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; LAITINEN A, 1994, AM J RESP CRIT CARE, V150, pS14, DOI 10.1164/ajrccm/150.5_Pt_2.S14; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; MCCARTHY KJ, 2008, J MICROSC RES TECH, V71, P335; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pirinen RT, 1998, INT J CANCER, V79, P251, DOI 10.1002/(SICI)1097-0215(19980619)79:3<251::AID-IJC7>3.0.CO;2-O; Proud D, 2006, AM J RESP CELL MOL, V35, P513, DOI 10.1165/rcmb.2006-0199TR; Reynolds HY, 2000, LUNG, V178, P271, DOI 10.1007/s004080000032; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sahu S, 1978, Inflammation, V3, P149, DOI 10.1007/BF00910736; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; SMITH DL, 1993, AM REV RESPIR DIS, V148, P523, DOI 10.1164/ajrccm/148.2.523; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	39	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26283	26296		10.1074/jbc.M803350200	http://dx.doi.org/10.1074/jbc.M803350200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644783	Green Published, hybrid			2022-12-25	WOS:000259200100056
J	Pastorino, JG; Shulga, N				Pastorino, John G.; Shulga, Nataly			Tumor necrosis factor-alpha can provoke cleavage and activation of sterol regulatory element-binding protein in ethanol-exposed cells via a caspase-dependent pathway that is cholesterol insensitive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ALCOHOLIC LIVER-DISEASE; MOLECULAR-MECHANISMS; HEPATIC STEATOSIS; EXPRESSION; SREBP; METABOLISM; APOPTOSIS; INVIVO; INJURY	Ethanol induces the development of hepatic steatosis, increasingly recognized as causing vulnerability to subsequent liver injury. Ethanol has been shown to activate SREBP-1 ( sterol regulatory element-binding protein) processing through the conventional cholesterol-sensitive pathway ( 1). The present study demonstrates that ethanol can also bring about SREBP-1 cleavage and activation through a novel pathway dependent on the endoplasmic reticulum-localized caspases-4 and -12. Evidence is presented that tumor necrosis factor can stimulate caspase-4 and -12 activation in ethanol-exposed cells, which cleaves SREBP-1 to a transcriptionally active form to induce the synthesis of lipogenic enzymes and triglycerides. Moreover, the caspase-4 and -12-dependent activation of SREBP-1 is insensitive to the normal negative feedback exerted by cholesterol and is mediated by the translocation of the scaffolding protein, TRAF-2, to the endoplasmic reticulum.	[Pastorino, John G.; Shulga, Nataly] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Ctr Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pastorino, JG (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Ctr Sci, Rm 316,2 Med Ctr Dr, Stratford, NJ 08084 USA.	pastorjg@umdnj.edu			National Institutes of Health [R01CA118356, R01AA012897]; NATIONAL CANCER INSTITUTE [R01CA118356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA118356 and R01AA012897. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Crabb DW, 2006, J GASTROEN HEPATOL, V21, pS56, DOI 10.1111/j.1440-1746.2006.04582.x; Diehl AM, 1999, ALCOHOL CLIN EXP RES, V23, P1419, DOI 10.1097/00000374-199909000-00001; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Endo M, 2007, EXP BIOL MED, V232, P614; Enomoto N, 1999, HEPATOLOGY, V29, P1680, DOI 10.1002/hep.510290633; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Higgins ME, 2001, J LIPID RES, V42, P1939; Hoek JB, 2004, SEMIN LIVER DIS, V24, P257, DOI 10.1055/s-2004-832939; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; Kalai M, 2003, J CELL BIOL, V162, P457, DOI 10.1083/jcb.200303157; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Pennington HL, 1997, J GASTROEN HEPATOL, V12, P305, DOI 10.1111/j.1440-1746.1997.tb00426.x; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	37	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25638	25649		10.1074/jbc.M800237200	http://dx.doi.org/10.1074/jbc.M800237200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635549	Green Published, hybrid			2022-12-25	WOS:000259012700059
J	You, ZY; Masai, H				You, Zhiying; Masai, Hisao			Cdt1 forms a complex with the minichromosome maintenance protein (MCM) and activates its helicase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; ESCHERICHIA-COLI DNAB; MCM4/6/7 HELICASE; CHROMOSOMAL DNA; BUDDING YEAST; S-PHASE; INITIATION; GEMININ; BINDING; CHROMATIN	Mcm4/6/7 forms a complex possessing DNA helicase activity, suggesting that Mcm may be a central component for the replicative helicase. Although Cdt1 is known to be essential for loading of Mcm onto the chromatin, its precise role in pre-RC formation and replication initiation is unknown. Using purified proteins, we show that Cdt1 forms a complex with Mcm4/6/7, Mcm2/3/4/5/6/7, and Mcm2/4/6/7 in glycerol gradient fractionation through interaction with Mcm2 and Mcm4/6. In the glycerol gradient fractionation, Mcm4/6/7-Cdt1 forms a complex (speculated to be a (Mcm4/6/7)(2)-Cdt1(3) assembly) in the presence of ATP, which is significantly larger than the Mcm4/6/7-Cdt1 complex generated in its absence. Furthermore, DNA binding and helicase activities of Mcm4/6/7 are significantly stimulated by Cdt1 protein in vitro. We generated a Cdt1 mutant, which fails to stimulate DNA binding and helicase activities of Mcm4/6/7. This mutant Cdt1 showed reduced interaction with Mcm and is deficient in the formation of a high molecular weight complex with Mcm. Thus, a productive interaction between Cdt1 and MCM appears to be essential for efficient loading of MCM onto template DNA, as well as for the efficient unwinding reaction.	[You, Zhiying; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, 18-22 Honkomagome 3-Chome, Tokyo 1138613, Japan.	masai-hs@igakuken.or.jp						Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LANKA E, 1983, NUCLEIC ACIDS RES, V11, P987, DOI 10.1093/nar/11.4.987; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Li SS, 2005, HISTOPATHOLOGY, V46, P307, DOI 10.1111/j.1365-2559.2005.02069.x; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; SEUFERT W, 1987, CELL, V48, P73, DOI 10.1016/0092-8674(87)90357-6; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; SPECK C, 2007, J BIOL CHEM; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003	45	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24469	24477		10.1074/jbc.M803212200	http://dx.doi.org/10.1074/jbc.M803212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606811	Green Published, hybrid			2022-12-25	WOS:000258820000021
J	Tkacik, G; Gregor, T; Bialek, W				Tkacik, Gasper; Gregor, Thomas; Bialek, William			The Role of Input Noise in Transcriptional Regulation	PLOS ONE			English	Article								Gene expression levels fluctuate even under constant external conditions. Much emphasis has usually been placed on the components of this noise that are due to randomness in transcription and translation. Here we focus on the role of noise associated with the inputs to transcriptional regulation; in particular, we analyze the effects of random arrival times and binding of transcription factors to their target sites along the genome. This contribution to the total noise sets a fundamental physical limit to the reliability of genetic control, and has clear signatures, but we show that these are easily obscured by experimental limitations and even by conventional methods for plotting the variance vs. mean expression level. We argue that simple, universal models of noise dominated by transcription and translation are inconsistent with the embedding of gene expression in a network of regulatory interactions. Analysis of recent experiments on transcriptional control in the early Drosophila embryo shows that these results are quantitatively consistent with the predicted signatures of input noise, and we discuss the experiments needed to test the importance of input noise more generally.	[Tkacik, Gasper; Gregor, Thomas; Bialek, William] Princeton Univ, Lewis Sigler Inst Integrat Genom, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Gregor, Thomas] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ USA; [Bialek, William] Princeton Univ, Princeton Ctr Theoretical Phys, Princeton, NJ USA	Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Tkacik, G (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	gtkacik@princeton.edu	Tkacik, Gasper/C-3510-2011	Gregor, Thomas/0000-0001-9460-139X; Tkacik, Gasper/0000-0002-6699-1455	NSF [PHY-0650617]; NIH [P50 GM071508, R01 GM077599]; Burroughs Wellcome Program in Biological Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM077599] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Program in Biological Dynamics(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF Grant PHY-0650617; NIH grants P50 GM071508, R01 GM077599; Burroughs Wellcome Program in Biological Dynamics	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barlow H B, 1971, Vision Res, VSuppl 3, P87; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2006, ARXIVORGQBIOMN060100; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; CONTI F, 1975, J PHYSIOL-LONDON, V248, P45, DOI 10.1113/jphysiol.1975.sp010962; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FATT P, 1950, NATURE, V166, P597, DOI 10.1038/166597a0; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; LECAR H, 1971, BIOPHYS J, V11, P1068, DOI 10.1016/S0006-3495(71)86278-1; LECAR H, 1971, BIOPHYS J, V11, P1048, DOI 10.1016/S0006-3495(71)86277-X; Luria SE, 1943, GENETICS, V28, P491; Ma XG, 1996, DEVELOPMENT, V122, P1195; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Ptashne M., 1992, A GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STEVENS CF, 1972, BIOPHYS J, V12, P1028, DOI 10.1016/S0006-3495(72)86141-1; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; VERVEEN AA, 1965, KYBERNETIK, V2, P152; VERVEEN AA, 1968, PR INST ELECTR ELECT, V56, P906, DOI 10.1109/PROC.1968.6443; Walczak AM, 2005, BIOPHYS J, V88, P828, DOI 10.1529/biophysj.104.050666; Winston RL, 1999, BIOCHEMISTRY-US, V38, P5138, DOI 10.1021/bi982856a; Zhao C, 2002, DEVELOPMENT, V129, P1669	43	66	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2774	10.1371/journal.pone.0002774	http://dx.doi.org/10.1371/journal.pone.0002774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648612	Green Published, gold, Green Submitted			2022-12-25	WOS:000264302900044
J	Harris, CM; Travis, JMJ; Harwood, J				Harris, Catriona M.; Travis, Justin M. J.; Harwood, John			Evaluating the Influence of Epidemiological Parameters and Host Ecology on the Spread of Phocine Distemper Virus through Populations of Harbour Seals	PLOS ONE			English	Article							SPATIAL DYNAMICS; COMMON SEALS; VITULINA; EPIZOOTIOLOGY; TRANSMISSION; PATTERNS; DISEASE; NORTH	Background: Outbreaks of phocine distemper virus (PDV) in Europe during 1988 and 2002 were responsible for the death of around 23,000 and 30,000 harbour seals, respectively. These epidemics, particularly the one in 2002, provided an unusual opportunity to estimate epidemic parameters for a wildlife disease. There were marked regional differences in the values of some parameters both within and between epidemics. Methodology and Principal Findings: We used an individual-based model of seal movement that allowed us to incorporate realistic representations of space, time and animal behaviour into a traditional epidemiological modelling framework. We explored the potential influence of a range of ecological (foraging trip duration, time of epidemic onset, population size) and epidemiological (length of infectious period, contact rate between infectious and susceptible individuals, case mortality) parameters on four readily-measurable epidemic characteristics (number of dead individuals, duration of epidemic, peak mortality date and prevalence) and on the probability that an epidemic would occur in a particular region. We analysed the outputs as if they were the results of a series of virtual experiments, using Generalised Linear Modelling. All six variables had a significant effect on the probability that an epidemic would be recognised as an unusual mortality event by human observers. Conclusions: Regional and temporal variation in contact rate was the most likely cause of the observed differences between the two epidemics. This variation could be a consequence of differences in the way individuals divide their time between land and sea at different times of the year.	[Harris, Catriona M.; Harwood, John] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Harris, Catriona M.; Harwood, John] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [Travis, Justin M. J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of St Andrews; University of St Andrews; University of Aberdeen	Harris, CM (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	catriona@mcs.st-and.ac.uk	Travis, Justin/B-8571-2014	Travis, Justin/0000-0002-5785-4272; Harris, Catriona/0000-0001-9198-2414	UK Natural Environment Research Council	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Catriona Harris was supported by a grant from the UK Natural Environment Research Council. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript	BAKER JR, 1992, SCI TOTAL ENVIRON, V115, P1, DOI 10.1016/0048-9697(92)90027-P; BRASSEUR SM, 2003, MANAGEMENT N SEA HAR, P27; COLIZZA V, J THEORETIC IN PRESS; COSBY SL, 1988, NATURE, V336, P115, DOI 10.1038/336115b0; De Koeijer A, 1998, B MATH BIOL, V60, P585, DOI 10.1006/bulm.1997.0030; DESWART RL, 1995, THESIS ERASMUS U ROT; DIETZ R, 1989, AMBIO, V18, P258; Doran RJ, 2005, PREV VET MED, V70, P133, DOI 10.1016/j.prevetmed.2005.03.002; DUCK CD, 2006, STATUS BRIT COMMON S; EVERARD K, 2004, THESIS U ST ANDREWS; Fuks H, 2001, DISCRETE DYN NAT SOC, V6, P191, DOI 10.1155/S1026022601000206; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Green DG, 2005, ECOL COMPLEX, V2, P117, DOI 10.1016/j.ecocom.2004.11.006; GRENFELL BT, 1992, SCI TOTAL ENVIRON, V115, P15, DOI 10.1016/0048-9697(92)90029-R; Hall AJ, 2006, BIOL CONSERV, V131, P221, DOI 10.1016/j.biocon.2006.04.008; HALL AJ, 1992, SCI TOTAL ENVIRON, V115, P31, DOI 10.1016/0048-9697(92)90030-V; HARDER T, 1990, J VET MED B, V37, P641, DOI 10.1111/j.1439-0450.1990.tb01109.x; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; HARKONEN T, 1990, Z SAUGETIERKD, V55, P233; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harwood J., 1990, Ocean Challenge, V1, P4; HEIDEJORGENSEN MP, 1992, DIS AQUAT ORGAN, V13, P37, DOI 10.3354/dao013037; HEIDEJORGENSEN MP, 1992, J APPL ECOL, V29, P99, DOI 10.2307/2404353; Hess G.R., 2002, P102; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; KENNEDY S, 1990, VET REC, V127, P563; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; LONERGAN ME, DIS AQUATIC IN PRESS; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; Reineking Bettina, 2002, Wadden Sea Newsletter, V2, P3; Ross PS, 2002, HUM ECOL RISK ASSESS, V8, P277, DOI 10.1080/20028091056917; SHARPLES RJ, 2005, DISTRIBUTION MOVEMEN; SHARPLES RJ, 2004, DISTRIBUTION MOVEMEN; SHARPLES RJ, 2005, THESIS U ST ANDREWS; Shirley MDF, 2003, ECOL MODEL, V167, P139, DOI 10.1016/S0304-3800(03)00167-4; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; THOMPSON PM, 1992, SCI TOTAL ENVIRON, V115, P57, DOI 10.1016/0048-9697(92)90032-N; Thompson PM, 2002, VET REC, V151, P609, DOI 10.1136/vr.151.20.609; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1990, J APPL ECOL, V27, P924, DOI 10.2307/2404387	44	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2710	10.1371/journal.pone.0002710	http://dx.doi.org/10.1371/journal.pone.0002710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628992	Green Submitted, Green Published, gold			2022-12-25	WOS:000264057200053
J	Schrempf, A; Heinze, J				Schrempf, Alexandra; Heinze, Juergen			Mating with Stressed Males Increases the Fitness of Ant Queens	PLOS ONE			English	Article							LONGEVITY; EVOLUTION; PROTEINS; BIOLOGY	Background: According to sexual conflict theory, males can increase their own fitness by transferring substances during copulation that increase the short-term fecundity of their mating partners at the cost of the future life expectancy and re-mating capability of the latter. In contrast, sexual cooperation is expected in social insects. Mating indeed positively affects life span and fecundity of young queens of the male-polymorphic ant Cardiocondyla obscurior, even though males neither provide nuptial gifts nor any other care but leave their mates immediately after copulation and die shortly thereafter. Principal Findings: Here, we show that mating with winged disperser males has a significantly stronger impact on life span and reproductive success of young queens of C. obscurior than mating with wingless fighter males. Conclusions: Winged males are reared mostly under stressful environmental conditions, which force young queens to disperse and found their own societies independently. In contrast, queens that mate with wingless males under favourable conditions usually start reproducing in the safety of the established maternal nest. Our study suggests that males of C. obscurior have evolved mechanisms to posthumously assist young queens during colony founding under adverse ecological conditions.	[Schrempf, Alexandra; Heinze, Juergen] Univ Regensburg, Regensburg, Germany	University of Regensburg	Schrempf, A (corresponding author), Univ Regensburg, Regensburg, Germany.	alexandra.schrempf@biologie.uni-regensburg.de			German Science Foundation (DFG) [SCHR 1135-1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	We thank the German Science Foundation (DFG) for financial support (SCHR 1135-1-1).	ARNQVIST G, 2005, SEXUAL CONFLICT, P330; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Colonello NA, 2005, APIDOLOGIE, V36, P231, DOI 10.1051/apido:2005012; Cremer S, 2003, CURR BIOL, V13, P219, DOI 10.1016/S0960-9822(03)00012-5; Du Y, 2007, EUR J ENTOMOL, V104, P243, DOI 10.14411/eje.2007.038; Heinze J, 2006, INSECT SOC, V53, P1, DOI 10.1007/s00040-005-0847-4; Heinze J, 2005, STUD NEOTROP FAUNA E, V40, P187, DOI 10.1080/01650520500175250; Holldobler B., 1990, pi; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liana M, 2005, EXP APPL ACAROL, V35, P173, DOI 10.1007/s10493-004-4301-5; Mercier JL, 2007, INSECT SOC, V54, P403, DOI 10.1007/s00040-007-0960-7; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Simmons L. W., 2001, MG BEH ECOL; Tucic N, 1996, J EVOLUTION BIOL, V9, P485, DOI 10.1046/j.1420-9101.1996.9040485.x	16	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2592	10.1371/journal.pone.0002592	http://dx.doi.org/10.1371/journal.pone.0002592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596983	Green Published, gold, Green Submitted			2022-12-25	WOS:000263288200051
J	Yang, Y; Wu, F; Ward, T; Yan, F; Wu, Q; Wang, ZY; McGlothen, T; Peng, W; You, TP; Sun, MK; Cui, TX; Hu, RM; Dou, Z; Zhu, JD; Xie, W; Rao, ZH; Ding, X; Yao, XB				Yang, Yong; Wu, Fang; Ward, Tarsha; Yan, Feng; Wu, Quan; Wang, Zhaoyang; McGlothen, Tanisha; Peng, Wei; You, Tianpa; Sun, Mingkuan; Cui, Taixing; Hu, Renming; Dou, Zhen; Zhu, Jingde; Xie, Wei; Rao, Zihe; Ding, Xia; Yao, Xuebiao			Phosphorylation of HsMis13 by aurora B kinase is essential for assembly of functional kinetochore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; MICROTUBULE ATTACHMENT; MOLECULAR ANALYSIS; PROTEIN E; CENTROMERES; CHECKPOINT; ANAPHASE; COMPLEX; MIS12; NUF2	Chromosome movements in mitosis are orchestrated by dynamic interactions between spindle microtubules and the kinetochore, a multiprotein complex assembled onto centro-meric DNA of the chromosome. Here we show that phosphorylation of human HsMis13 by Aurora B kinase is required for functional kinetochore assembly in HeLa cells. Aurora B interacts with HsMis13 in vitro and in vivo. HsMis13 is a cognate substrate of Aurora B, and the phosphorylation sites were mapped to Ser-100 and Ser-109. Suppression of Aurora B kinase by either small interfering RNA or chemical inhibitors abrogates the localization of HsMis13 but not HsMis12 to the kinetochore. In addition, non-phosphorylatable but not wild type and phospho-mimicking HsMis13 failed to localize to the kinetochore, demonstrating the requirement of phosphorylation by Aurora B for the assembly of HsMis13 to kinetochore. In fact, localization of HsMis13 to the kinetochore is spatiotemporally regulated by Aurora B kinase, which is essential for recruiting outer kinetochore components such as Ndc80 components and CENP-E for functional kinetochore assembly. Importantly, phospho-mimicking mutant HsMis13 restores the assembly of CENP-E to the kinetochore, and tension developed across the sister kinetochores in Aurora B-inhibited cells. Thus, we reason that HsMis13 phosphorylation by Aurora B is required for organizing a stable bi-oriented microtubule kinetochore attachment that is essential for faithful chromosome segregation in mitosis.	[Yang, Yong; Ward, Tarsha; Yan, Feng; Wu, Quan; McGlothen, Tanisha; Sun, Mingkuan; Dou, Zhen; Ding, Xia] Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA; [Yang, Yong; Wu, Fang; Yan, Feng; Wu, Quan; Wang, Zhaoyang; You, Tianpa; Cui, Taixing; Dou, Zhen; Zhu, Jingde; Ding, Xia; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China; [Yang, Yong; Wu, Fang; Yan, Feng; Wu, Quan; Wang, Zhaoyang; You, Tianpa; Cui, Taixing; Dou, Zhen; Zhu, Jingde; Ding, Xia; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230027, Peoples R China; [Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China; [Sun, Mingkuan; Xie, Wei] Southeast Univ, Sch Med, MOE Key Lab Dev Genes & Human Dis, Nanjing 210009, Peoples R China; [Sun, Mingkuan; Xie, Wei] Beijing Univ Chinese Med, Dept Med, Beijing 100029, Peoples R China; [Peng, Wei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Morehouse School of Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University; Southeast University - China; Beijing University of Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ding, X (corresponding author), Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA.	xding@bucm.edu.cn; yaoxb@ustc.edu.cn	Yang, Yong/U-4781-2019; Sun, Mingkuan/H-6191-2019; Yao, Xuebiao/P-5771-2014; Rao, Zihe/HCH-6944-2022; DOU, ZHEN/N-2022-2013; SUN, Mingkuan/I-7186-2016; Yang, Yong/P-8322-2018	Sun, Mingkuan/0000-0002-4511-5894; SUN, Mingkuan/0000-0002-4511-5894; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA132389, CA92080]; Chinese 973 Project [2002CB713700, 2006CB943603, 2007CB914503]; Chinese Academy of Sciences [KSCX1-YW-R65, KSCX2-YW-H10]; Chinese 863 Project [2006AA02A247]; Chinese Ministry of Education [20020358051, 20050358061]; 111 Project [B07007]; Chinese Natural Science Foundation [90508002, 30121001, 30500183, 30600321]; American Cancer Society [RPG 99-173-1]; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese 863 Project(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); 111 Project(Ministry of Education, China - 111 Project); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); American Cancer Society(American Cancer Society); Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA132389, and CA92080. This work was also supported by grants from Chinese 973 Project (2002CB713700, 2006CB943603, and 2007CB914503), Chinese Academy of Sciences (KSCX1-YW-R65 and KSCX2-YW-H10), Chinese 863 Project (2006AA02A247), Chinese Ministry of Education (20020358051 and 20050358061 and 111 Project B07007 (to X. D.), Chinese Natural Science Foundation (90508002 and 30121001 (to X. Y.), 30500183 (to X. D.), and 30600321 (to Z. D.)), American Cancer Society (RPG 99-173-1), and an Atlanta Clinical and Translational Science Award Chemical Biology grant (to X. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	30	57	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26726	26736		10.1074/jbc.M804207200	http://dx.doi.org/10.1074/jbc.M804207200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640974	Green Published, hybrid			2022-12-25	WOS:000259341600046
J	Scanlon, JAB; Al-Shawi, MK; Nakamoto, RK				Scanlon, Joanne A. Baylis; Al-Shawi, Marwan K.; Nakamoto, Robert K.			A rotor-stator cross-link in the F-1-ATPase blocks the rate-limiting step of rotational catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; F0F1 ATP SYNTHASE; HEART MITOCHONDRIAL ATPASE; GAMMA-SUBUNIT; BETA-SUBUNIT; INORGANIC-PHOSPHATE; ADENOSINE-TRIPHOSPHATASE; DIRECTED MUTAGENESIS; UNCOUPLING MUTATION; NUCLEOTIDE-BINDING	The F0F1-ATP synthase couples the functions of H+ transport and ATP synthesis/hydrolysis through the efficient transmission of energy mediated by rotation of the centrally located gamma, epsilon, and c subunits. To understand the gamma subunit role in the catalytic mechanism, we previously determined the partial rate constants and devised a minimal kinetic model for the rotational hydrolytic mode of the F-1-ATPase enzyme that uniquely fits the pre-steady state and steady state data (Baylis Scanlon, J. A., Al-Shawi, M. K., Le, N. P., and Nakamoto, R. K. (2007) Biochemistry 46, 8785-8797). Here we directly test the model using two single cysteine mutants, beta D380C and beta E381C, which can be used to reversibly inhibit rotation upon formation of a cross-link with the conserved gamma Cys-87. In the pre-steady state, the gamma-beta cross-linked enzyme at high Mg center dot ATP conditions retained the burst of hydrolysis but was not able to release P-i. These data show that the rate-limiting rotation step, k(gamma), occurs after hydrolysis and before P-i release. This analysis provides additional insights into how the enzyme achieves efficient coupling and implicates the beta Glu381 residue for proper formation of the rate-limiting transition state involving gamma subunit rotation.	[Scanlon, Joanne A. Baylis; Al-Shawi, Marwan K.; Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Nakamoto, RK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	rkn3c@virginia.edu			National Institutes of Health [R01-GM50957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50957 from the USPHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AGGELER R, 1992, J BIOL CHEM, V267, P21355; AGGELER R, 1995, J BIOL CHEM, V270, P9185, DOI 10.1074/jbc.270.16.9185; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P878, DOI 10.1021/bi00118a033; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19633; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1975, FEBS LETT, V58, P1, DOI 10.1016/0014-5793(75)80212-2; Boyer PD, 2002, FEBS LETT, V512, P29, DOI 10.1016/S0014-5793(02)02293-7; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CROSS RL, 1982, J BIOL CHEM, V257, P2101; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3728; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; *MICROMATH RES, 1995, MICROMATH SCI EXP DA; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakamoto RK, 2000, BBA-BIOENERGETICS, V1458, P289, DOI 10.1016/S0005-2728(00)00081-5; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NOUMI T, 1987, FEBS LETT, V213, P381, DOI 10.1016/0014-5793(87)81526-0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1992, ARCH BIOCHEM BIOPHYS, V297, P340, DOI 10.1016/0003-9861(92)90682-M; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SUGINO Y, 1964, J BIOL CHEM, V239, P2360; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Weber J, 2001, J BIOL CHEM, V276, P35422, DOI 10.1074/jbc.M104946200; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WISE JG, 1984, BIOCHEMISTRY-US, V23, P1426, DOI 10.1021/bi00302a014; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	77	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26228	26240		10.1074/jbc.M804858200	http://dx.doi.org/10.1074/jbc.M804858200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18628203	Green Published, hybrid			2022-12-25	WOS:000259200100051
J	Hofbauer, K; Schultz, A; Schultz, JE				Hofbauer, Karina; Schultz, Anita; Schultz, Joachim E.			Functional chimeras of the phosphodiesterase 5 and 10 tandem GAF domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CYANOBACTERIAL ADENYLYL-CYCLASE; ALLOSTERIC CGMP-BINDING; CAMP; DIMERIZATION; PDE10A; SITES; LIGAND; PDE5; 2A	The tandem GAF domain of hPDE10A uses cAMP as an allosteric ligand (Gross-Langenhoff, M., Hofbauer, K., Weber, J., Schultz, A., and Schultz, J. E. (2006) J. Biol. Chem. 281, 2841 2846). We used a two-pronged approach to study how discrimination of ligand is achieved in human (h) PDE10A and how domain selection in the phosphodiesterase GAF tandems is determined. First, we examined which functional groups of cAMP are responsible for purine ring discrimination. Changes at the C-6 ring position (removal of the amino group; chloride substitution) and at the N-1 ring position reduced stimulation efficacy by 80%, i. e. marking those positions as decisive for nucleotide discrimination. Second, we generated a GAF tandem chimera that consisted of the cGMP-binding GAF-A unit from hPDE5A1, which signals through cGMP in PDE5, and the GAF-B from hPDE10A1, which signals through cAMP in PDE10. Stimulation of the reporter enzyme exclusively was through the GAF-B domain of hPDE10A1 (EC50 = 7 mu M cAMP) as shown by respective point mutations. The PDE5 GAF-A domain in the chimera did not signal, and its function was reduced to a strictly structural role. Signaling was independent of the origin of the N terminus. Generating 10 additional PDE5/ 10 tandem GAF chimeras surprisingly demonstrated that the length-conserved linker in GAF tandems between GAF-A and GAF-B played an unforeseen decisive role in intramolecular signaling. Swapping the linker sections between PDE5 and PDE10 GAF tandem domains abrogated signaling completely pointing to specific domain interactions within GAF tandems, which are not visible in the available crystal structures with bound ligands.	[Hofbauer, Karina; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, Fak Chem & Pharm, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Fak Chem & Pharm, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Bruder S, 2005, P NATL ACAD SCI USA, V102, P3088, DOI 10.1073/pnas.0409917102; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01686-2; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Huang D, 2004, J BIOL CHEM; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; Kanacher T, 2002, EMBO J, V21, P3672, DOI 10.1093/emboj/cdf375; Linder JU, 2007, FEBS J, V274, P1514, DOI 10.1111/j.1742-4658.2007.05700.x; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Sopory S, 2003, FEBS LETT, V539, P161, DOI 10.1016/S0014-5793(03)00219-9; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	31	11	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25164	25170		10.1074/jbc.M800230200	http://dx.doi.org/10.1074/jbc.M800230200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635550	hybrid			2022-12-25	WOS:000259012700008
J	Ludwig, C; Schwarzer, D; Mootz, HD				Ludwig, Christina; Schwarzer, Dirk; Mootz, Henning D.			Interaction studies and alanine scanning analysis of a semi-synthetic split intein reveal thiazoline ring formation from an intermediate of the protein splicing reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNAB INTEIN; MINI-INTEIN; PEPTIDE; LIGATION; FRAGMENTS; COMPLEMENTATION; IDENTIFICATION; MODULATION; CHEMISTRY	We recently reported an artificially split intein based on the Ssp DnaB mini-intein that consists of a synthetic N-terminal intein fragment (Int(N)) and a recombinant C-terminal part (Int(C)), which are 11 and 143 amino acids in length, respectively. This intein holds great promise for the preparation of semi-synthetic proteins by protein trans-splicing. In this work we synthesized a set of IntN peptide variants to investigate their structure-function relationship with regard to fragment association and promotion of protein trans-splicing. A further truncation of the IntN sequence below 11 amino acids resulted in loss of activity, whereas C-terminal extensions were tolerated. Alanine scanning analysis identified three essential hydrophobic residues, whereas substitutions at other positions were tolerated. We developed assays to monitor association of IntN with an IntC mutant blocked in protein splicing by native PAGE and fluorescence anisotropy. The kinetic parameters of intein complex formation were K-d = 1.1 mu M, k(on) = 16.8 M-1 s(-1), and k(off) = 1.8 x 10(-5) s(-1) for the native Int(N11) sequence. Intriguingly, a G(-1) A substitution, previously known to significantly impair protein splicing, was revealed to result in thiazoline ring formation involving the catalytic Cys-1, likely by aberrant dehydration of a oxythiazolidine intermediate. This finding provides experimental evidence for the postulated intermediate during the initial N/S acyl shift and underlines the delicate spatial and temporal alignment required in the intein active site to prevent side reactions of the protein-splicing pathway.	[Ludwig, Christina; Schwarzer, Dirk; Mootz, Henning D.] Tech Univ Dortmund, Fak Chem Chem Biol, D-44227 Dortmund, Germany	Dortmund University of Technology	Mootz, HD (corresponding author), Tech Univ Dortmund, Fak Chem Chem Biol, Otto Hahn Str 6, D-44227 Dortmund, Germany.	henning.mootz@uni-dortmund.de	Ludwig, Christina/ABD-5196-2021	Schwarzer, Dirk/0000-0002-7477-3319	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Financial support was provided by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie (stipend to C. L. and support of H. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Brenzel S, 2005, J AM CHEM SOC, V127, P4176, DOI 10.1021/ja043501j; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2002, CHEM REV, V102, P4869, DOI 10.1021/cr9601369; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; Ladurner AG, 1997, J MOL BIOL, V273, P317, DOI 10.1006/jmbi.1997.1303; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martinez LMC, 2008, BIOPHYS J, V94, P1575, DOI 10.1529/biophysj.107.119651; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	38	44	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25264	25272		10.1074/jbc.M802972200	http://dx.doi.org/10.1074/jbc.M802972200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625708	hybrid			2022-12-25	WOS:000259012700019
J	Moya, A; Tambutte, S; Bertucci, A; Tambutte, E; Lotto, S; Vullo, D; Supuran, CT; Allemand, D; Zoccola, D				Moya, Aurelie; Tambutte, Sylvie; Bertucci, Anthony; Tambutte, Eric; Lotto, Severine; Vullo, Daniela; Supuran, Claudiu T.; Allemand, Denis; Zoccola, Didier			Carbonic anhydrase in the scleractinian coral Stylophora pistillata - Characterization, localization, and role in biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIFICATION; PHOTOSYNTHESIS; MECHANISMS; EXPRESSION; PREDICTION; ATPASE	Carbonic anhydrases (CA) play an important role in biomineralization from invertebrates to vertebrates. Previous experiments have investigated the role of CA in coral calcification, mainly by pharmacological approaches. This study reports the molecular cloning, sequencing, and immunolocalization of a CA isolated from the scleractinian coral Stylophora pistillata, named STPCA. Results show that STPCA is a secreted form of alpha-CA, which possesses a CA catalytic function, similar to the secreted human CAVI. We localized this enzyme at the calico-blastic ectoderm level, which is responsible for the precipitation of the skeleton. This localization supports the role of STPCA in the calcification process. In symbiotic scleractinian corals, calcification is stimulated by light, a phenomenon called "light-enhanced calcification" (LEC). The mechanism by which symbiont photosynthesis stimulates calcification is still enigmatic. We tested the hypothesis that coral genes are differentially expressed under light and dark conditions. By real-time PCR, we investigated the differential expression of STPCA to determine its role in the LEC phenomenon. Results show that the STPCA gene is expressed 2-fold more during the dark than the light. We suggest that in the dark, up-regulation of the STPCA gene represents a mechanism to cope with night acidosis.	[Moya, Aurelie; Tambutte, Sylvie; Bertucci, Anthony; Tambutte, Eric; Lotto, Severine; Allemand, Denis; Zoccola, Didier] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Vullo, Daniela; Supuran, Claudiu T.] Univ Florence, Dipartimento Chim, I-50019 Florence, Italy	University of Florence	Zoccola, D (corresponding author), Ctr Sci Monaco, Ave Saint-Martin, MC-98000 Monaco, Monaco.	zoccola@centrescientifique.mc	Zoccola, Didier/A-6157-2009; Moya, Aurelie/E-9948-2011; Bertucci, Anthony/O-6974-2014; Tambutté, Eric/A-6644-2009; Supuran, Claudiu T/A-5151-2008; Zoccola, Didier/A-5997-2009	Moya, Aurelie/0000-0002-8776-4710; Bertucci, Anthony/0000-0001-5727-7228; Zoccola, Didier/0000-0002-1524-8098; Supuran, Claudiu/0000-0003-4262-0323	Government of the Principality of Monaco; Centre Scientifique de Monaco	Government of the Principality of Monaco; Centre Scientifique de Monaco	This work was supported in part by the Centre Scientifique de Monaco Research Program, which is supported by the Government of the Principality of Monaco. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from the Centre Scientifique de Monaco.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 1998, CAN J BOT, V76, P925, DOI 10.1139/b98-086; ALLEMAND D, 2007, HDB BIOMINERALIZATIO; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; deBoer ML, 2006, BIOL BULL-US, V211, P18, DOI 10.2307/4134574; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EREZ J, 1978, NATURE, V273, P199, DOI 10.1038/273199a0; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Furla P, 1998, AM J PHYSIOL-REG I, V274, pR303, DOI 10.1152/ajpregu.1998.274.2.R303; Furla P, 2000, J EXP BIOL, V203, P3445; Gattuso JP, 1999, AM ZOOL, V39, P160; GOREAU TF, 1959, BIOL BULL, V116, P59, DOI 10.2307/1539156; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Isa Y., 1984, Galaxea, V3, P25; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Johnston I.S., 1980, International Review of Cytology, V67, P171; Kakei M, 1996, BBA-GEN SUBJECTS, V1289, P226, DOI 10.1016/0304-4165(95)00145-X; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; KINGSLEY RJ, 1987, J EXP ZOOL, V241, P171, DOI 10.1002/jez.1402410203; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love AC, 2007, EVOL DEV, V9, P51, DOI 10.1111/j.1525-142X.2006.00137.x; Marshall AT, 2003, COMP BIOCHEM PHYS A, V136, P417, DOI 10.1016/S1095-6433(03)00201-0; MITSUNAGA K, 1986, CELL DIFFER DEV, V18, P257, DOI 10.1016/0045-6039(86)90057-6; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Payan P, 2004, CR PALEVOL, V3, P535, DOI 10.1016/j.crpv.2004.07.013; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Sanchez S, 2007, FEBS J, V274, P5311, DOI 10.1111/j.1742-4658.2007.06050.x; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; Tambutte E, 1996, J EXP BIOL, V199, P1029; Tambutte S, 2007, MAR BIOL, V151, P71, DOI 10.1007/s00227-006-0452-8; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tohse H, 2006, COMP BIOCHEM PHYS B, V145, P257, DOI 10.1016/j.cbpb.2006.06.011; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; Weis VM, 1999, PHYSIOL BIOCHEM ZOOL, V72, P307, DOI 10.1086/316674; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	52	190	193	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25475	25484		10.1074/jbc.M804726200	http://dx.doi.org/10.1074/jbc.M804726200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617510	hybrid, Green Published			2022-12-25	WOS:000259012700043
J	Song, JH; Kandasamy, K; Kraft, AS				Song, Jin H.; Kandasamy, Karthikeyan; Kraft, Andrew S.			ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BCL-2 FAMILY-MEMBERS; BH3 MIMETIC ABT-737; LIGAND-INDUCED APOPTOSIS; UP-REGULATION; IN-VIVO; TUMORICIDAL ACTIVITY; INHIBITOR ABT-737; CARCINOMA-CELLS; TUMOR-GROWTH	Because Bcl-2 family members inhibit the ability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis, we investigated whether ABT-737, a small molecule Bcl-2 inhibitor, enhances TRAIL killing. We demonstrate that a combination of ABT-737 and TRAIL induced significant cell death in multiple cancer types, including renal, prostate, and lung cancers, although each agent individually had little activity in these tumor cells. All of these cell lines expressed the Mcl-1 protein that is known to block the activity of ABT-737 and TRAIL but did not block the synergy between these agents. However, Bax-deficient cell lines, including DU145 and HCT116 cells and those cell lines expressing low levels of TRAIL receptor, were resistant to apoptosis induced by these agents. To understand how ABT-737 functions to markedly increase TRAIL sensitivity, the levels of specific death-inducing signaling complex components were evaluated. Treatment with ABT-737 did not change the levels of c-FLIP, FADD, and caspase-8 but up-regulated the levels of the TRAIL receptor DR5. DR5 up-regulation induced by ABT-737 treatment occurred through a transcriptional mechanism, and mutagenesis studies demonstrated that the NF-kappa B site found in the DR5 promoter was essential for the ability of ABT-737 to increase the levels of this mRNA. Using luciferase reporter plasmids, ABT-737 was shown to stimulate NF-kappa B activity. Together, these results demonstrate that the ability of ABT-737 and TRAIL to induce apoptosis is mediated through activation of both the extrinsic and intrinsic pathways. Combinations of ABT-737 and TRAIL can be exploited therapeutically where antiapoptotic Bcl-2 family members drive tumor cell resistance to current anticancer therapies.	[Song, Jin H.; Kandasamy, Karthikeyan; Kraft, Andrew S.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina	Kraft, AS (corresponding author), 86 Jonathan Lucas St, Charleston, SC 29425 USA.	kraft@musc.edu		SONG, JIN/0000-0002-0123-2909	National Institutes of Health [R01 CA104710]; NATIONAL CANCER INSTITUTE [R01CA104710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA104710 (to A. S. K.).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Eguchi H, 2000, CELL DEATH DIFFER, V7, P439, DOI 10.1038/sj.cdd.4400675; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kouhara J, 2007, INT J ONCOL, V30, P679; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Munshi A, 2001, ONCOGENE, V20, P3757, DOI 10.1038/sj.onc.1204504; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Romagnoli M, 2007, CLIN CANCER RES, V13, P6010, DOI 10.1158/1078-0432.CCR-07-0140; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Sinicrope FA, 2004, CLIN CANCER RES, V10, P8284, DOI 10.1158/1078-0432.CCR-04-1289; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Song JH, 2004, NEUROPHARMACOLOGY, V46, P984, DOI 10.1016/j.neuropharm.2004.01.001; Song JH, 2003, BRAIN PATHOL, V13, P539; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098	59	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25003	25013		10.1074/jbc.M802511200	http://dx.doi.org/10.1074/jbc.M802511200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18599488	Green Published, hybrid			2022-12-25	WOS:000271617300010
J	Walkey, CJ; Spiegelman, BM				Walkey, Christopher J.; Spiegelman, Bruce M.			A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; GENE-EXPRESSION; NUCLEAR RECEPTORS; DNA-BINDING; FAT PADS; IN-VIVO; DIFFERENTIATION; MUTATIONS; CANCER	The nuclear hormone receptor peroxisome proliferator-activated receptor-gamma ( PPAR gamma) is the central regulator of adipogenesis. Although it is the target for several drugs that function as agonist activators, a high affinity endogenous ligand for this receptor that is involved in regulating adipogenesis has yet to be identified. Here, we investigated the requirement for ligand activation of PPAR gamma in fat cell differentiation, taking advantage of a natural mutant of this receptor that does not bind or become activated by any known natural or synthetic ligand. When ectopically expressed in PPAR gamma-null fibroblasts, this Q286P allele was able to strongly promote morphological adipogenesis, without any significant difference compared with wild-type PPAR gamma. In addition, no significant differences were found in the expression of several adipogenic genes between the wild-type and Q286P mutant alleles. To extend our studies to an in vivo setting, we performed subcutaneous injections of PPAR gamma-expressing fibroblasts into nude mice. We found that both wildtype and Q286P mutant-expressing fibroblasts were able to generate fat pads in the mice. These results suggest that the binding and activation of PPAR gamma by agonist ligands may not be required for adipogenesis under physiological conditions.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, SM958,44 Binney St, Boston, MA 02115 USA.	Bruce_Spiegelman@dfci.harvard.edu			National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK31405.	Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berger J, 2000, MOL CELL ENDOCRINOL, V162, P57, DOI 10.1016/S0303-7207(00)00211-2; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	35	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24290	24294		10.1074/jbc.C800139200	http://dx.doi.org/10.1074/jbc.C800139200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18622018	Green Published, hybrid			2022-12-25	WOS:000258820000002
J	Skibola, CF; Bracci, PM; Halperin, E; Nieters, A; Hubbard, A; Paynter, RA; Skibola, DR; Agana, L; Becker, N; Tressler, P; Forrest, MS; Sankararaman, S; Conde, L; Holly, EA; Smith, MT				Skibola, Christine F.; Bracci, Paige M.; Halperin, Eran; Nieters, Alexandra; Hubbard, Alan; Paynter, Randi A.; Skibola, Danica R.; Agana, Luz; Becker, Nikolaus; Tressler, Patrick; Forrest, Matthew S.; Sankararaman, Sriram; Conde, Lucia; Holly, Elizabeth A.; Smith, Martyn T.			Polymorphisms in the Estrogen Receptor 1 and Vitamin C and Matrix Metalloproteinase Gene Families Are Associated with Susceptibility to Lymphoma	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; HAPLOTYPE RECONSTRUCTION; CYTOCHROME-P450 17A1; TUMOR INVASION; RISK; DATABASE; CANCER; BIOSYNTHESIS; INHIBITORS; EXPRESSION	Background: Non-Hodgkin lymphoma (NHL) is the fifth most common cancer in the U. S. and few causes have been identified. Genetic association studies may help identify environmental risk factors and enhance our understanding of disease mechanisms. Methodology/Principal Findings: 768 coding and haplotype tagging SNPs in 146 genes were examined using Illumina GoldenGate technology in a large population-based case-control study of NHL in the San Francisco Bay Area (1,292 cases 1,375 controls are included here). Statistical analyses were restricted to HIV-participants of white non-Hispanic origin. Genes involved in steroidogenesis, immune function, cell signaling, sunlight exposure, xenobiotic metabolism/oxidative stress, energy balance, and uptake and metabolism of cholesterol, folate and vitamin C were investigated. Sixteen SNPs in eight pathways and nine haplotypes were associated with NHL after correction for multiple testing at the adjusted q<0.10 level. Eight SNPs were tested in an independent case-control study of lymphoma in Germany ( 494 NHL cases and 494 matched controls). Novel associations with common variants in estrogen receptor 1 (ESR1) and in the vitamin C receptor and matrix metalloproteinase gene families were observed. Four ESR1 SNPs were associated with follicular lymphoma (FL) in the U. S. study, with rs3020314 remaining associated with reduced risk of FL after multiple testing adjustments [odds ratio (OR)=0.42, 95% confidence interval (CI) = 0.23-0.77) and replication in the German study (OR = 0.24, 95% CI = 0.06-0.94). Several SNPs and haplotypes in the matrix metalloproteinase-3 (MMP3) and MMP9 genes and in the vitamin C receptor genes, solute carrier family 23 member 1 (SLC23A1) and SLC23A2, showed associations with NHL risk. Conclusions/Significance: Our findings suggest a role for estrogen, vitamin C and matrix metalloproteinases in the pathogenesis of NHL that will require further validation.	[Skibola, Christine F.; Hubbard, Alan; Paynter, Randi A.; Skibola, Danica R.; Agana, Luz; Conde, Lucia; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Halperin, Eran; Sankararaman, Sriram; Conde, Lucia] Int Comp Sci Inst, Berkeley, CA USA; [Nieters, Alexandra; Becker, Nikolaus] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Tressler, Patrick] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Forrest, Matthew S.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Francisco; Wellcome Trust Sanger Institute	Skibola, CF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Conde, Lucia/D-9295-2011; Paynter, Randi/X-7689-2019	Paynter, Randi/0000-0003-2326-7659; Forrest, Matthew/0000-0002-2141-0303; Conde, Lucia/0000-0001-5180-543X	NIH [CA122663, CA104862, CA45614, CA89745, CA87014]; German Jose Carreras Leukaemia foundation [DJCLS_R04/08]; NATIONAL CANCER INSTITUTE [R01CA122663, R03CA089745, R01CA045614, R01CA087014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Jose Carreras Leukaemia foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant numbers CA122663 (CFS), CA104862 (MTS) and CA45614, CA89745, CA87014 (EAH), and the German Jose Carreras Leukaemia foundation (DJCLS_R04/08) (AN).	Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker N, 2004, LEUKEMIA RES, V28, P713, DOI 10.1016/j.leukres.2003.11.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad J, 1976, Sykepleien, V63, P1198; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Breslow NE, 1980, STAT METHODS CANC RE; BRODIE AMH, 1976, J STEROID BIOCHEM, V7, P787, DOI 10.1016/0022-4731(76)90180-1; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Catani MV, 2005, NUTR REV, V63, P81, DOI 10.1111/j.1753-4887.2005.tb00125.x; Chang ET, 2005, CANCER EPIDEM BIOMAR, V14, P512, DOI 10.1158/1055-9965.EPI-04-0451; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; Cohen JI, 2005, BRIT J CANCER, V92, P1593, DOI 10.1038/sj.bjc.6602561; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Forrest MS, 2006, BRIT J HAEMATOL, V134, P180, DOI 10.1111/j.1365-2141.2006.06141.x; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P921, DOI 10.1158/1055-9965.EPI-05-0866; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gallagher CJ, 2007, DIABETES, V56, P675, DOI 10.2337/db06-0303; Greendale GA, 2006, AM J MED, V119, P79, DOI 10.1016/j.amjmed.2006.07.011; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Harakeh S, 2007, ANTICANCER RES, V27, P289; Hartge P, 2006, CANCER CAUSE CONTROL, V17, P1045, DOI 10.1007/s10552-006-0040-8; HARUKI Y, 1983, Tokai Journal of Experimental and Clinical Medicine, V8, P31; Holly EA, 2003, AM J EPIDEMIOL, V158, P432, DOI 10.1093/aje/kwg174; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; JAFFE ESH, 1998, HEMATOPATHOLOGY LOP; Karyotou K, 2005, ARCH BIOCHEM BIOPHYS, V434, P248, DOI 10.1016/j.abb.2004.11.003; Kuittinen O, 2003, EUR J HAEMATOL, V71, P91, DOI 10.1034/j.1600-0609.2003.00101.x; Kuo SM, 2004, J NUTR, V134, P2216; LEE JS, 2008, AM J EPIDEMIOL; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lightfoot TJ, 2005, CANCER EPIDEM BIOMAR, V14, P2999, DOI 10.1158/1055-9965.EPI-05-0515; Lightfoot TJ, 2006, HAEMATOLOGICA, V91, P1222; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; Phillips C, 2007, MOL BIOTECHNOL, V35, P65, DOI 10.1385/MB:35:1:65; Purdue MP, 2007, CANCER CAUSE CONTROL, V18, P989, DOI 10.1007/s10552-007-9039-z; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ribatti D, 2004, STEM CELLS DEV, V13, P484, DOI 10.1089/1547328042417354; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Rui LX, 2006, CURR MOL MED, V6, P291, DOI 10.2174/156652406776894563; SATO H, 1992, ONCOGENE, V7, P77; SAVINI I, 2007, AMINO ACIDS; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skibola CF, 2005, CANCER EPIDEM BIOMAR, V14, P2391, DOI 10.1158/1055-9965.EPI-05-0343; Skibola CF, 2005, BRIT J HAEMATOL, V129, P618, DOI 10.1111/j.1365-2141.2005.05505.x; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Skibola CF, 2004, BLOOD, V104, P2155, DOI 10.1182/blood-2004-02-0557; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2007, CANCER EPIDEM BIOMAR, V16, P392, DOI 10.1158/1055-9965.EPI-06-1081; Skibola DR, 2005, CANCER EPIDEM BIOMAR, V14, P1251, DOI 10.1158/1055-9965.EPI-04-0895; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stavrou I, 2006, HUM REPROD, V21, P554, DOI 10.1093/humrep/dei326; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Talamini R, 2006, INT J CANCER, V118, P2871, DOI 10.1002/ijc.21737; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Willett EV, 2005, BRIT J CANCER, V93, P811, DOI 10.1038/sj.bjc.6602762; Yang C, 2002, ONCOGENE, V21, P2854, DOI 10.1038/sj.onc.1205386; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021	68	67	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2816	10.1371/journal.pone.0002816	http://dx.doi.org/10.1371/journal.pone.0002816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18636124	Green Published, gold			2022-12-25	WOS:000264304300035
J	Lopardo, T; Lo Iacono, N; Marinari, B; Giustizieri, ML; Cyr, DG; Merlo, G; Crosti, F; Costanzo, A; Guerrini, L				Lopardo, Teresa; Lo Iacono, Nadia; Marinari, Barbara; Giustizieri, Maria L.; Cyr, Daniel G.; Merlo, Giorgio; Crosti, Francesca; Costanzo, Antonio; Guerrini, Luisa			Claudin-1 Is a p63 Target Gene with a Crucial Role in Epithelial Development	PLOS ONE			English	Article								The epidermis of the skin is a self-renewing, stratified epithelium that functions as the interface between the human body and the outer environment, and acts as a barrier to water loss. Components of intercellular junctions, such as Claudins, are critical to maintain tissue integrity and water retention. p63 is a transcription factor essential for proliferation of stem cells and for stratification in epithelia, mutated in human hereditary syndromes characterized by ectodermal dysplasia. Both p63 and Claudin-1 null mice die within few hours from birth due to dehydration from severe skin abnormalities. These observations suggested the possibility that these two genes might be linked in one regulatory pathway with p63 possibly regulating Claudin-1 expression. Here we show that silencing of Delta Np63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). Delta Np63 alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene. Accordingly, Claudin-1 expression was absent in the skin of E15.5 p63 null mice and natural p63 mutant proteins, specifically those found in Ankyloblepharon-Ectodermal dysplasia-Clefting (AEC) patients, were indeed altered in their capacity to regulate Claudin-1 transcription. This correlates with deficient Claudin-1 expression in the epidermis of an AEC patient carrying the 1537T p63 mutation. Notably, AEC patients display skin fragility similar to what observed in the epidermis of Claudin-1 and p63 null mice. These findings reinforce the hypothesis that these two genes might be linked in a common regulatory pathway and that Claudin-1 may is an important p63 target gene involved in the pathogenesis of ectodermal dysplasias.	[Lopardo, Teresa; Lo Iacono, Nadia; Guerrini, Luisa] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Marinari, Barbara; Giustizieri, Maria L.; Costanzo, Antonio] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy; [Cyr, Daniel G.] INRS, Inst Armand Frappier, Laval, PQ, Canada; [Merlo, Giorgio] Univ Turin, Mol Biotech Ctr, Dulbecco Telethon Lab, Turin, Italy; [Crosti, Francesca] Med Genet Lab AO San Gerardo, Monza, Italy	University of Milan; University of Rome Tor Vergata; University of Quebec; Institut national de la recherche scientifique (INRS); University of Turin	Lopardo, T (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	luisa.guerrini@unimi.it	Costanzo, Antonio/D-3896-2012; Costanzo, Antonio/GZG-2433-2022; Cyr, Daniel/AIC-9460-2022	Costanzo, Antonio/0000-0001-9697-2557; 	Telethon [GGP05056]; AIRC; PRIN (MIUR)	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN (MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from Telethon (GGP05056) to L.G., by AIRC grant to A.C. and by a PRIN (MIUR) grant to L.G. and A.C.	Alexandre MD, 2005, J CELL SCI, V118, P2683, DOI 10.1242/jcs.02406; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dufresne J, 2007, BIOL REPROD, V76, P825, DOI 10.1095/biolreprod.106.057430; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Lo Iacono M, 2006, CELL CYCLE, V5, P78; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; MARINARI B, 2008, J INVES DER IN PRESS; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; QIAO F, 2005, SCI STKE, V31, pRE7; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; STEVENSON BR, 1988, J CELL BIOL, V107, P2401, DOI 10.1083/jcb.107.6.2401; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; van Bokhoven H, 2002, TRENDS MOL MED, V8, P133, DOI 10.1016/S1471-4914(01)02260-2; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; VANDERHOOFT SL, 1993, PEDIATR DERMATOL, V10, P334, DOI 10.1111/j.1525-1470.1993.tb00394.x; Wessagowit V, 2000, CLIN EXP DERMATOL, V25, P441, DOI 10.1046/j.1365-2230.2000.00683.x; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	39	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2715	10.1371/journal.pone.0002715	http://dx.doi.org/10.1371/journal.pone.0002715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648642	Green Submitted, Green Published, gold			2022-12-25	WOS:000264302900002
J	Sasidharan, R; Smith, A; Gerstein, M				Sasidharan, Rajkumar; Smith, Andrew; Gerstein, Mark			Transmembrane Protein Oxygen Content and Compartmentalization of Cells	PLOS ONE			English	Article								Recently, there was a report that explored the oxygen content of transmembrane proteins over macroevolutionary time scales where the authors observed a correlation between the geological time of appearance of compartmentalized cells with atmospheric oxygen concentration. The authors predicted, characterized and correlated the differences in the structure and composition of transmembrane proteins from the three kingdoms of life with atmospheric oxygen concentrations in geological timescale. They hypothesized that transmembrane proteins in ancient taxa were selectively excluding oxygen and as this constraint relaxed over time with increase in the levels of atmospheric oxygen the size and number of communication-related transmembrane proteins increased. In summary, they concluded that compartmentalized and non-compartmentalized cells can be distinguished by how oxygen is partitioned at the proteome level. They derived this conclusion from an analysis of 19 taxa. We extended their analysis on a larger sample of taxa comprising 309 eubacterial, 34 archaeal, and 30 eukaryotic complete proteomes and observed that one can not absolutely separate the two groups of cells based on partition of oxygen in their membrane proteins. In addition, the origin of compartmentalized cells is likely to have been driven by an innovation than happened 2700 million years ago in the membrane composition of cells that led to the evolution of endocytosis and exocytosis rather than due to the rise in concentration of atmospheric oxygen.	[Sasidharan, Rajkumar; Smith, Andrew; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Smith, Andrew; Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Yale University; Yale University	Sasidharan, R (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.gerstein@yale.edu			Yale CEGS [P50 HG02357]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER	Yale CEGS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Yale CEGS Grant# P50 HG02357 (06-10)	Acquisti C, 2007, NATURE, V445, P47, DOI 10.1038/nature05450; Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; HOLLAND HD, 1990, AM J SCI, V290A, P1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Sagan L, 1967, J Theor Biol, V14, P255; Studholme DJ, 2004, FEMS MICROBIOL LETT, V236, P333, DOI 10.1016/j.femsle.2004.06.007; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Williams RJP, 2007, J R SOC INTERFACE, V4, P1049, DOI 10.1098/rsif.2007.0225	10	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2726	10.1371/journal.pone.0002726	http://dx.doi.org/10.1371/journal.pone.0002726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628944	gold, Green Published, Green Submitted			2022-12-25	WOS:000264057200064
J	Victoria, B; Ahmed, A; Zuerner, RL; Ahmed, N; Bulach, DM; Quinteiro, J; Hartskeerl, RA				Victoria, Berta; Ahmed, Ahmed; Zuerner, Richard L.; Ahmed, Niyaz; Bulach, Dieter M.; Quinteiro, Javier; Hartskeerl, Rudy A.			Conservation of the S10-spc-alpha Locus within Otherwise Highly Plastic Genomes Provides Phylogenetic Insight into the Genus Leptospira	PLOS ONE			English	Article							FAMILY LEPTOSPIRACEAE; RIBOSOMAL-RNA; DNA; INTERROGANS; SEROVARS; EVOLUTION; NOV.; DIFFERENTIATION; BORGPETERSENII; IDENTIFICATION	S10-spc-alpha is a 17.5 kb cluster of 32 genes encoding ribosomal proteins. This locus has an unusual composition and organization in Leptospira interrogans. We demonstrate the highly conserved nature of this region among diverse Leptospira and show its utility as a phylogenetically informative region. Comparative analyses were performed by PCR using primer sets covering the whole locus. Correctly sized fragments were obtained by PCR from all L. interrogans strains tested for each primer set indicating that this locus is well conserved in this species. Few differences were detected in amplification profiles between different pathogenic species, indicating that the S10-spc-alpha locus is conserved among pathogenic Leptospira. In contrast, PCR analysis of this locus using DNA from saprophytic Leptospira species and species with an intermediate pathogenic capacity generated varied results. Sequence alignment of the S10-spc-alpha locus from two pathogenic species, L. interrogans and L. borgpetersenii, with the corresponding locus from the saprophyte L. biflexa serovar Patoc showed that genetic organization of this locus is well conserved within Leptospira. Multilocus sequence typing (MLST) of four conserved regions resulted in the construction of well-defined phylogenetic trees that help resolve questions about the interrelationships of pathogenic Leptospira. Based on the results of secY sequence analysis, we found that reliable species identification of pathogenic Leptospira is possible by comparative analysis of a 245 bp region commonly used as a target for diagnostic PCR for leptospirosis. Comparative analysis of Leptospira strains revealed that strain H6 previously classified as L. inadai actually belongs to the pathogenic species L. interrogans and that L. meyeri strain ICF phylogenetically co-localized with the pathogenic clusters. These findings demonstrate that the S10-spc-alpha locus is highly conserved throughout the genus and may be more useful in comparing evolution of the genus than loci studied previously.	[Victoria, Berta; Quinteiro, Javier] Univ Santiago Compostela, Fac Biol, Dept Biochem & Mol Biol, Galicia, Spain; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, Natl Collaborating Cre Reference Res Leptospirosis, WHO FAO OIE, Amsterdam, Netherlands; [Zuerner, Richard L.] USDA, Agr Res Serv, Natl Anim Dis Ctr, Bacterial Dis Livestock Res Unit, Ames, IA USA; [Ahmed, Niyaz] Ctr DNA Fingerprinting & Diagnost, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India; [Bulach, Dieter M.] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Structural & Funct Microbial Genom, Clayton, Vic, Australia	Universidade de Santiago de Compostela; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Monash University	Victoria, B (corresponding author), Univ Santiago Compostela, Fac Biol, Dept Biochem & Mol Biol, Galicia, Spain.	r.hartskeerl@kit.nl	Bulach, Dieter M/D-5793-2011; Quinteiro, Javier/C-4410-2011; Ahmed, Niyaz/D-2589-2010; Zuerner, Richard/AAG-7645-2021	Bulach, Dieter M/0000-0001-9823-6078; Quinteiro, Javier/0000-0002-8683-9522; Ahmed, Niyaz/0000-0001-6425-7583; 				Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARIL C, 1992, J BACTERIOL, V174, P7566, DOI 10.1128/JB.174.23.7566-7571.1992; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; do Oliveira MAA, 2003, J MED MICROBIOL, V52, P127, DOI 10.1099/jmm.0.04923-0; ELBARADI TTAL, 1987, J MOL BIOL, V195, P909, DOI 10.1016/0022-2836(87)90494-3; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOURSE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2722, DOI 10.1073/pnas.78.5.2722; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Kositanont U, 2007, DIAGN MICR INFEC DIS, V57, P117, DOI 10.1016/j.diagmicrobio.2006.07.014; Letocart M, 1999, INT J SYST BACTERIOL, V49, P231, DOI 10.1099/00207713-49-1-231; Letocart M, 1997, J CLIN MICROBIOL, V35, P248, DOI 10.1128/JCM.35.1.248-253.1997; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; MANIATIS T, 1983, MOL CLONING LAB MANU; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991; Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Priya CG, 2007, J POSTGRAD MED, V53, P236; RAMADASS P, 1992, INT J SYST BACTERIOL, V42, P215, DOI 10.1099/00207713-42-2-215; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rossetti CA, 2005, VET MICROBIOL, V107, P241, DOI 10.1016/j.vetmic.2005.01.015; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VALVEREDE MAD, 2008, INFECTION G IN PRESS; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407; ZUERNER RL, 1993, J BACTERIOL, V175, P5445, DOI 10.1128/JB.175.17.5445-5451.1993; Zuerner RL, 2000, FEMS MICROBIOL LETT, V182, P303, DOI 10.1016/S0378-1097(99)00598-4	42	84	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2752	10.1371/journal.pone.0002752	http://dx.doi.org/10.1371/journal.pone.0002752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648538	Green Published, Green Submitted, gold			2022-12-25	WOS:000264057200074
J	Wang, XJ; Lavrov, DV				Wang, Xiujuan; Lavrov, Dennis V.			Seventeen New Complete mtDNA Sequences Reveal Extensive Mitochondrial Genome Evolution within the Demospongiae	PLOS ONE			English	Article							TRANSFER-RNA GENES; INTRON GAIN; PROTEIN; PHYLOGENY; ENVIRONMENT; DIVERSITY; PORIFERA; PROGRAM; SPONGES; BIOLOGY	Two major transitions in animal evolution - the origins of multicellularity and bilaterality-correlate with major changes in mitochondrial DNA (mtDNA) organization. Demosponges, the largest class in the phylum Porifera, underwent only the first of these transitions and their mitochondrial genomes display a peculiar combination of ancestral and animal-specific features. To get an insight into the evolution of mitochondrial genomes within the Demospongiae, we determined 17 new mtDNA sequences from this group and analyzing them with five previously published sequences. Our analysis revealed that all demosponge mtDNAs are 16- to 25-kbp circular molecules, containing 13 - 15 protein genes, 2 rRNA genes, and 2 - 27 tRNA genes. All but four pairs of sampled genomes had unique gene orders, with the number of shared gene boundaries ranging from 1 to 41. Although most demosponge species displayed low rates of mitochondrial sequence evolution, a significant acceleration in evolutionary rates occurred in the G1 group (orders Dendroceratida, Dictyoceratida, and Verticillitida). Large variation in mtDNA organization was also observed within the G0 group (order Homosclerophorida) including gene rearrangements, loss of tRNA genes, and the presence of two introns in Plakortis angulospiculatus. While introns are rare in modern-day demosponge mtDNA, we inferred that at least one intron was present in cox1 of the common ancestor of all demosponges. Our study uncovered an extensive mitochondrial genomic diversity within the Demospongiae. Although all sampled mitochondrial genomes retained some ancestral features, including a minimally modified genetic code, conserved structures of tRNA genes, and presence of multiple non-coding regions, they vary considerably in their size, gene content, gene order, and the rates of sequence evolution. Some of the changes in demosponge mtDNA, such as the loss of tRNA genes and the appearance of hairpin-containing repetitive elements, occurred in parallel in several lineages and suggest general trends in demosponge mtDNA evolution.	[Wang, Xiujuan; Lavrov, Dennis V.] Dept Ecol Evolut & Organismal Biol, Ames, IA USA		Wang, XJ (corresponding author), Dept Ecol Evolut & Organismal Biol, Ames, IA USA.	dlavrov@iastate.edu	Lavrov, Dennis/V-3699-2019	Lavrov, Dennis/0000-0002-2745-1704	College of Liberal Arts and Sciences at Iowa State University	College of Liberal Arts and Sciences at Iowa State University	The funding for this work came from the College of Liberal Arts and Sciences at Iowa State University.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beagley CT, 1995, PROG CELL R, V5, P149; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Erpenbeck D, 2007, MOL BIOL EVOL, V24, P19, DOI 10.1093/molbev/msl154; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; GOLDERER G, 1995, J BACTERIOL, V177, P5994, DOI 10.1128/jb.177.20.5994-5996.1995; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hooper J. N. A., 2002, SYSTEMA PORIFERA, DOI [10.1007/978-1-4615-0747-5_3, DOI 10.1007/978-1-4615-0747-5_3]; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Lavrov DV, 2005, TRENDS GENET, V21, P129, DOI 10.1016/j.tig.2005.01.004; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Pearson W R, 1994, Methods Mol Biol, V25, P365; Pisera A, 2006, CAN J ZOOL, V84, P242, DOI 10.1139/Z05-169; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, MOL BIOL EVOL, V23, P2259, DOI 10.1093/molbev/msl098; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shao ZY, 2006, GENE, V381, P92, DOI 10.1016/j.gene.2006.06.021; SMITH AE, 1968, J MOL BIOL, V38, P241, DOI 10.1016/0022-2836(68)90409-9; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; SOLLAS WJ, 1885, SCI P R DUBLIN SOC, V5, P12; Sullivan James C, 2006, Genome Inform, V17, P219; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; Van Soest R.W.M., 2005, WORLD PORIFERA DATAB; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Wolstenholme DR, 1992, CURR OPIN GENET DEV, V2, P918, DOI 10.1016/S0959-437X(05)80116-9; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	52	76	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2723	10.1371/journal.pone.0002723	http://dx.doi.org/10.1371/journal.pone.0002723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628961	Green Published, gold, Green Submitted			2022-12-25	WOS:000264057200061
J	Ahmad, F; Banerjee, SK; Lage, ML; Huang, XN; Smith, SH; Saba, S; Rager, J; Conner, DA; Janczewski, AM; Tobita, K; Tinney, JP; Moskowitz, IP; Perez-Atayde, AR; Keller, BB; Mathier, MA; Shroff, SG; Seidman, CE; Seidman, JG				Ahmad, Ferhaan; Banerjee, Sanjay K.; Lage, Michele L.; Huang, Xueyin N.; Smith, Stephen H.; Saba, Samir; Rager, Jennifer; Conner, David A.; Janczewski, Andrzej M.; Tobita, Kimimasa; Tinney, Joseph P.; Moskowitz, Ivan P.; Perez-Atayde, Antonio R.; Keller, Bradley B.; Mathier, Michael A.; Shroff, Sanjeev G.; Seidman, Christine E.; Seidman, J. G.			The Role of Cardiac Troponin T Quantity and Function in Cardiac Development and Dilated Cardiomyopathy	PLOS ONE			English	Article								Background: Hypertrophic (HCM) and dilated (DCM) cardiomyopathies result from sarcomeric protein mutations, including cardiac troponin T (cTnT, TNNT2). We determined whether TNNT2 mutations cause cardiomyopathies by altering cTnT function or quantity; whether the severity of DCM is related to the ratio of mutant to wildtype cTnT; whether Ca(2+) desensitization occurs in DCM; and whether absence of cTnT impairs early embryonic cardiogenesis. Methods and Findings: We ablated Tnnt2 to produce heterozygous Tnnt2(+/-) mice, and crossbreeding produced homozygous null Tnnt2(-/-) embryos. We also generated transgenic mice overexpressing wildtype (TG(WT)) or DCM mutant (TG(K210 Delta)) Tnnt2. Crossbreeding produced mice lacking one allele of Tnnt2, but carrying wildtype ( Tnnt2(+/-)/TG(WT)) or mutant (Tnnt2(+/-)/ TG(K210 Delta)) transgenes. Tnnt2(+/-) mice relative to wildtype had significantly reduced transcript (0.82 +/- 0.06[SD] vs. 1.00 +/- 0.12 arbitrary units; p = 0.025), but not protein (1.01 +/- 0.20 vs. 1.00 +/- 0.13 arbitrary units; p = 0.44). Tnnt2(+/-) mice had normal hearts ( histology, mass, left ventricular end diastolic diameter [LVEDD], fractional shortening [FS]). Moreover, whereas Tnnt2(+/-)/TGK(210 Delta) mice had severe DCM, TGK(210 Delta) mice had only mild DCM (FS 18 +/- 4 vs. 29 +/- 7%; p<0.01). The difference in severity of DCM may be attributable to a greater ratio of mutant to wildtype Tnnt2 transcript in Tnnt2(+/-)/TGK(210 Delta) relative to TGK(210 Delta) mice (2.42 +/- 0.08, p = 0.03). Tnnt2(+/-)/TGK(210 Delta) muscle showed Ca(2+) desensitization (pCa(50) = 5.34 +/- 0.08 vs. 5.58 +/- 0.03 at sarcomere length 1.9 mu m, p<0.01), but no difference in maximum force generation. Day 9.5 Tnnt2(-/-) embryos had normally looped hearts, but thin ventricular walls, large pericardial effusions, noncontractile hearts, and severely disorganized sarcomeres. Conclusions: Absence of one Tnnt2 allele leads to a mild deficit in transcript but not protein, leading to a normal cardiac phenotype. DCM results from abnormal function of a mutant protein, which is associated with myocyte Ca(2+) desensitization. The severity of DCM depends on the ratio of mutant to wildtype Tnnt2 transcript. cTnT is essential for sarcomere formation, but normal embryonic heart looping occurs without contractile activity.	[Ahmad, Ferhaan; Banerjee, Sanjay K.; Lage, Michele L.; Huang, Xueyin N.; Saba, Samir; Rager, Jennifer; Mathier, Michael A.] Univ Pittsburgh, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15260 USA; [Ahmad, Ferhaan] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Ahmad, Ferhaan; Conner, David A.; Seidman, Christine E.; Seidman, J. G.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Boston, MA USA; [Smith, Stephen H.; Janczewski, Andrzej M.; Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Tobita, Kimimasa; Tinney, Joseph P.; Keller, Bradley B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Moskowitz, Ivan P.; Perez-Atayde, Antonio R.] Childrens Hosp, Dept Pathol, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital	Ahmad, F (corresponding author), Univ Pittsburgh, Dept Med, Cardiovasc Inst, 930 Scaife Hall, Pittsburgh, PA 15260 USA.	ahmadf@upmc.edu	Banerjee, Sanjay/F-2677-2019	Janczewski, Andrzej/0000-0001-7209-7188; Banerjee, Sanjay/0000-0002-0008-0480; Ahmad, Ferhaan/0000-0003-2877-4641; Tobita, Kimimasa/0000-0001-5435-8436; Moskowitz, Ivan/0000-0003-0014-4963; Banerjee, Sanjay k/0000-0002-0044-0984	American Heart Association [Postdoctoral Fellowships]; Hillgrove Foundation [Postdoctoral Fellowships]; Howard Hughes Medical Institute; McGinnis Chair Endowment Funds; Cardiovascular Institute of the University of Pittsburgh	American Heart Association(American Heart Association); Hillgrove Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); McGinnis Chair Endowment Funds; Cardiovascular Institute of the University of Pittsburgh	This work was supported by an American Heart Association Scientist Development Grant (FA), American Heart Association and Hillgrove Foundation Postdoctoral Fellowships (SKB), the Howard Hughes Medical Institute (FA, DAC, IPM, CES, JGS), and McGinnis Chair Endowment Funds (SGS). We thank Barry London, M.D., Ph.D., Director, Cardiovascular Institute of the University of Pittsburgh, for institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Ahmad F, 2005, CIRCULATION, V112, P3140, DOI 10.1161/CIRCULATIONAHA.105.550806; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Blanchard EM, 1997, CIRC RES, V81, P1005; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; GULICK J, 1991, J BIOL CHEM, V266, P9180; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Henderson SA, 2004, CIRC RES, V95, P604, DOI 10.1161/01.RES.0000142316.08250.68; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Huang XP, 1999, CIRC RES, V84, P1; Hurtado C, 2005, J MOL CELL CARDIOL, V38, P647, DOI 10.1016/j.yjmcc.2005.02.007; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Rethinasamy P, 1998, CIRC RES, V82, P116; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sirenko SG, 2006, J PHYSIOL-LONDON, V575, P201, DOI 10.1113/jphysiol.2006.107557; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	33	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2642	10.1371/journal.pone.0002642	http://dx.doi.org/10.1371/journal.pone.0002642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612386	Green Accepted, Green Published, gold			2022-12-25	WOS:000264065800044
J	El-Bchiri, J; Guilloux, A; Dartigues, P; Loire, E; Mercier, D; Buhard, O; Sobhani, I; de la Grange, P; Auboeuf, D; Praz, F; Flejou, JF; Duval, A				El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Loire, Etienne; Mercier, Dominique; Buhard, Olivier; Sobhani, Iradj; de la Grange, Pierre; Auboeuf, Didier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex			Nonsense-Mediated mRNA Decay Impacts MSI-Driven Carcinogenesis and Anti-Tumor Immunity in Colorectal Cancers	PLOS ONE			English	Article								Nonsense-mediated mRNA Decay (NMD) degrades mutant mRNAs containing premature termination codon (PTC-mRNAs). Here we evaluate the consequence of NMD activity in colorectal cancers (CRCs) showing microsatellite instability (MSI) whose progression is associated with the accumulation of PTC-mRNAs encoding immunogenic proteins due to frameshift mutations in coding repeat sequences. Inhibition of UPF1, one of the major NMD factors, was achieved by siRNA in the HCT116 MSI CRC cell line and the resulting changes in gene expression were studied using expression microarrays. The impact of NMD activity was also investigated in primary MSI CRCs by quantifying the expression of several mRNAs relative to their mutational status and to endogenous UPF1 and UPF2 expression. Host immunity developed against MSI cancer cells was appreciated by quantifying the number of CD3 epsilon-positive tumor-infiltrating lymphocytes (TILs). UPF1 silencing led to the up-regulation of 1251 genes in HCT116, among which a proportion of them (i.e. 38%) significantly higher than expected by chance contained a coding microsatellite (P < 2 x 10-(16)). In MSI primary CRCs, UPF1 was significantly over-expressed compared to normal adjacent mucosa (P < 0.002). Our data provided evidence for differential decay of PTC-mRNAs compared to wild-type that was positively correlated to UPF1 endogenous expression level (P = 0.02). A negative effect of UPF1 and UPF2 expression on the host's anti-tumor response was observed (P < 0.01). Overall, our results show that NMD deeply influences MSI-driven tumorigenesis at the molecular level and indicate a functional negative impact of this system on anti- tumor immunity whose intensity has been recurrently shown to be an independent factor of favorable outcome in CRCs.	[El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Mercier, Dominique; Buhard, Olivier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex] INSERM, UMR S893, Team Microsatellite Instabil & Canc 13, Paris, France; [El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Mercier, Dominique; Buhard, Olivier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex] Univ Paris 06, UPMC, UMR S893, Paris, France; [Loire, Etienne] Univ Paris 06, UPMC, Atelier Bioinformat, Paris, France; [Loire, Etienne] Univ Paris 06, UPMC, Inst Jacques Monod, UMR 7592, Paris, France; [Sobhani, Iradj] CHU Henri Mondor, Dept GastroEnterol, Creteil, France; [de la Grange, Pierre; Auboeuf, Didier] Hop St Louis, INSERM, U685, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	El-Bchiri, J (corresponding author), INSERM, UMR S893, Team Microsatellite Instabil & Canc 13, Paris, France.	alex.duval@cephb.fr	PRAZ, Françoise/A-7291-2008; Auboeuf, Didier/M-4610-2014; Guilloux, Agathe/T-2577-2017; PRAZ, Françoise/AAF-7761-2020	PRAZ, Françoise/0000-0002-5353-8889; PRAZ, Françoise/0000-0002-5353-8889; Auboeuf, Didier/0000-0002-3757-0002; loire, etienne/0000-0002-3465-7727; de la Grange, Pierre/0000-0001-6361-1878	Association pour la Recherche contre le Cancer [3946]; Ministere Francais de la Recherche [fellowship]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere Francais de la Recherche(Ministry of Research, France)	This work was partly supported by grants from the Association pour la Recherche contre le Cancer (credit number 3946). JEB, EL and PDLG were recipients of a fellowship from the Ministere Francais de la Recherche (MRT).	Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ishikawa T, 2003, CANCER RES, V63, P5564; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; LOTHE RA, 1993, CANCER RES, V53, P5849; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Meyer C, 2005, P NATL ACAD SCI USA, V102, P449, DOI 10.1073/pnas.0406994102; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; SHI T, 2003, MOL CELL, V12, P1187; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109	28	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2583	10.1371/journal.pone.0002583	http://dx.doi.org/10.1371/journal.pone.0002583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612427	Green Published, Green Submitted, gold			2022-12-25	WOS:000264065800004
J	Roumier, A; Pascual, O; Bechade, C; Wakselman, S; Poncer, JC; Real, E; Triller, A; Bessis, A				Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Poncer, Jean-Christophe; Real, Eleonore; Triller, Antoine; Bessis, Alain			Prenatal Activation of Microglia Induces Delayed Impairment of Glutamatergic Synaptic Function	PLOS ONE			English	Article							FETAL-BRAIN-DEVELOPMENT; MATERNAL INFLUENZA INFECTION; NMDA RECEPTORS; KILLER-CELL; INFLAMMATION; SYNAPSES; EXPRESSION; NEURONS; DAMAGE; AMPA	Background: Epidemiological studies have linked maternal infection during pregnancy to later development of neuropsychiatric disorders in the offspring. In mice, experimental inflammation during embryonic development impairs behavioral and cognitive performances in adulthood. Synaptic dysfunctions may be at the origin of cognitive impairments, however the link between prenatal inflammation and synaptic defects remains to be established. Methodology/Principal Findings: In this study, we show that prenatal alteration of microglial function, including inflammation, induces delayed synaptic dysfunction in the adult. DAP12 is a microglial signaling protein expressed around birth, mutations of which in the human induces the Nasu-Hakola disease, characterized by early dementia. We presently report that synaptic excitatory currents in mice bearing a loss-of-function mutation in the DAP12 gene (DAP12(KI) mice) display enhanced relative contribution of AMPA. Furthermore, neurons from DAP12(KI) P0 pups cultured without microglia develop similar synaptic alterations, suggesting that a prenatal dysfunction of microglia may impact synaptic function in the adult. As we observed that DAP12(KI) microglia overexpress genes for IL1 beta, IL6 and NOS2, which are inflammatory proteins, we analyzed the impact of a pharmacologically-induced prenatal inflammation on synaptic function. Maternal injection of lipopolysaccharides induced activation of microglia at birth and alteration of glutamatergic synapses in the adult offspring. Finally, neurons cultured from neonates born to inflamed mothers and cultured without microglia also displayed altered neuronal activity. Conclusion/Significance: Our results demonstrate that prenatal inflammation is sufficient to induce synaptic alterations with delay. We propose that these alterations triggered by prenatal activation of microglia provide a cellular basis for the neuropsychiatric defects induced by prenatal inflammation.	[Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Real, Eleonore; Triller, Antoine; Bessis, Alain] INSERM, U789, Lab Biol Cellulaire Synapse, Paris, France; [Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Real, Eleonore; Triller, Antoine; Bessis, Alain] Dept Biol, Ecole Normale Superieure, Paris, France; [Poncer, Jean-Christophe] INSERM, U839, Avenir Team Plasticity Cortical Networks & Epil, Paris, France; [Poncer, Jean-Christophe] Univ Pierre Marie Curie Paris 6, IFR83, Paris, France; [Bessis, Alain] CNRS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Roumier, A (corresponding author), INSERM, U789, Lab Biol Cellulaire Synapse, Paris, France.	alain.bessis@ens.fr	Pascual, Olivier/E-9533-2017; Poncer, Jean Christophe/R-6362-2016; Pascual, Olivier/AAE-1449-2020; Roumier, Anne/AAG-5878-2021; Bechade, Catherine/K-5528-2017	Pascual, Olivier/0000-0002-5730-9880; Poncer, Jean Christophe/0000-0001-5729-3009; Pascual, Olivier/0000-0002-5730-9880; Roumier, Anne/0000-0002-1369-9231; Real, Dr Eleonore/0000-0002-5523-4408; Bechade, Catherine/0000-0003-2070-2993; TRILLER, Antoine/0000-0002-7530-1233; Bessis, Alain/0000-0001-8362-6874	Fondation pour la Recherche Medicale and of Region Ile-de-France [fellow]; Agence Nationale pour la Recherche [fellow]; Institut de Recherche sur la moelle epiniere et l'Encephale (IRME)	Fondation pour la Recherche Medicale and of Region Ile-de-France; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut de Recherche sur la moelle epiniere et l'Encephale (IRME)	A.R. was a fellow of Fondation pour la Recherche Medicale and of Region Ile-de-France. S.W. was a fellow of Agence Nationale pour la Recherche. Grants received from: Agence Nationale pour la Recherche (ANR-Maladies Rares), Institut de Recherche sur la moelle epiniere et l'Encephale (IRME).	ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; CIARANELLO AL, 1995, ANNU REV NEUROSCI, V18, P101, DOI 10.1146/annurev.ne.18.030195.000533; Dalmau I, 1997, J COMP NEUROL, V377, P70; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gilmore JH, 2003, J NEUROIMMUNOL, V138, P49, DOI 10.1016/S0165-5728(03)00095-X; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Jonakait GM, 2007, INT J DEV NEUROSCI, V25, P415, DOI 10.1016/j.ijdevneu.2007.08.017; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Peters A., 1990, FINE STRUCTURE NERVO, V3rd Edn; Rao A, 1998, J NEUROSCI, V18, P1217; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Zujovic V, 2005, J NEUROSCI RES, V82, P581, DOI 10.1002/jnr.20676	45	100	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2595	10.1371/journal.pone.0002595	http://dx.doi.org/10.1371/journal.pone.0002595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612411	Green Published, gold, Green Submitted			2022-12-25	WOS:000264065800008
J	dos Santos, NR; Williame, M; Gachet, S; Cormier, F; Janin, A; Weih, D; Weih, F; Ghysdael, J				dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Janin, Anne; Weih, Debra; Weih, Falk; Ghysdael, Jacques			RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOTOXIN-BETA-RECEPTOR; MULTIORGAN INFLAMMATION; DIFFERENTIAL REGULATION; TARGETED DISRUPTION; SIGNALING PATHWAY; TRANSGENIC MICE; THYMIC MEDULLA; ACTIVATION	Background: The Rel/NF-kappa B transcription factors are often activated in solid or hematological malignancies. In most cases, NF-kappa B activation is found in malignant cells and results from activation of the canonical NF-kappa B pathway, leading to RelA and/or c-Rel activation. Recently, NF-kappa B activity in inflammatory cells infiltrating solid tumors has been shown to contribute to solid tumor initiation and progression. Noncanonical NF-kappa B activation, which leads to RelB activation, has also been reported in breast carcinoma, prostate cancer, and lymphoid leukemia. Methodology/Principal Findings: Here we report a novel role for RelB in stromal cells that promote T-cell leukemogenesis. RelB deficiency delayed leukemia onset in the TEL-JAK2 transgenic mouse model of human T acute lymphoblastic leukemia. Bone marrow chimeric mouse experiments showed that RelB is not required in the hematopoietic compartment. In contrast, RelB plays a role in radio-resistant stromal cells to accelerate leukemia onset and increase disease severity. Conclusions/Significance: The present results are the first to uncover a role for RelB in the crosstalk between non-hematopoietic stromal cells and leukemic cells. Thus, besides its previously reported role intrinsic to specific cancer cells, the noncanonical NF-kappa B pathway may also play a pro-oncogenic role in cancer microenvironmental cells.	[dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Ghysdael, Jacques] Ctr Rech, Inst Curie, Orsay, France; [dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Ghysdael, Jacques] CNRS UMR146, Orsay, France; [Janin, Anne] Univ Paris 07, Hop Saint Louis, INSERM Unite 728, Paris, France; [Weih, Debra; Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	dos Santos, NR (corresponding author), Ctr Rech, Inst Curie, Orsay, France.	jacques.ghysdael@curie.u-psud.fr	GHYSDAEL, Jacques/F-3377-2013; dos Santos, Nuno Rodrigues/F-4411-2012	dos Santos, Nuno Rodrigues/0000-0001-7347-2592; Cormier, Francoise/0000-0002-6904-5122; GACHET, Stephanie/0000-0003-0491-9949	Ligue Nationale contre le Cancer (Equipe labelisee Ligue); Association for International Cancer Research (AICR) [postdoctoral fellowships]; Institut National du Cancer (INCa); Centre National de la Recherche Scientifique (CNRS); Institut Curie [postdoctoral fellowships]; Ministere de l'Education Nationale et de la Recherche (MENR) [pre-doctoral fellowship]	Ligue Nationale contre le Cancer (Equipe labelisee Ligue)(Ligue nationale contre le cancer); Association for International Cancer Research (AICR); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ministere de l'Education Nationale et de la Recherche (MENR)	This work was supported by funds from the Ligue Nationale contre le Cancer (Equipe labelisee Ligue), Association for International Cancer Research (AICR), Institut National du Cancer (INCa), Centre National de la Recherche Scientifique (CNRS) and Institut Curie. N.R.d.S. is a recipient of postdoctoral fellowships from AICR and Institut Curie. S.G. is a recipient of a pre-doctoral fellowship from the Ministere de l'Education Nationale et de la Recherche (MENR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; Barata JT, 2005, LEUKEMIA LYMPHOMA, V46, P483, DOI 10.1080/10428190400027852; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Carrasco D, 1996, EMBO J, V15, P3640, DOI 10.1002/j.1460-2075.1996.tb00733.x; Carron C, 2000, BLOOD, V95, P3891; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DeKoning J, 1997, J IMMUNOL, V158, P2558; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Derbinski J, 2005, TRENDS IMMUNOL, V26, P503, DOI 10.1016/j.it.2005.07.006; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; dos Santos NR, 2007, BLOOD, V109, P3972, DOI 10.1182/blood-2006-09-048801; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hare KJ, 2000, J IMMUNOL, V165, P2410, DOI 10.4049/jimmunol.165.5.2410; Hare KJ, 1998, J IMMUNOL, V160, P3666; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; LO D, 1992, AM J PATHOL, V141, P1237; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Naquet P, 1999, SEMIN IMMUNOL, V11, P47, DOI 10.1006/smim.1998.0149; O'Neil J, 2003, BLOOD, V102, P2593, DOI 10.1182/blood-2003-01-0090; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Scupoli MT, 2007, HAEMATOLOGICA, V92, P264, DOI 10.3324/haematol.10356; Scupoli MT, 2003, HAEMATOLOGICA, V88, P1229; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Weih F, 1996, J IMMUNOL, V157, P3974; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Winter SS, 2001, BRIT J HAEMATOL, V115, P862, DOI 10.1046/j.1365-2141.2001.03182.x; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; Zhu MZ, 2007, J IMMUNOL, V179, P8069, DOI 10.4049/jimmunol.179.12.8069	59	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2555	10.1371/journal.pone.0002555	http://dx.doi.org/10.1371/journal.pone.0002555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596915	Green Published, Green Submitted, gold			2022-12-25	WOS:000263288200022
J	Joensson, TJ; Murray, MS; Johnson, LC; Lowther, WT				Joensson, Thomas J.; Murray, Michael S.; Johnson, Lynnette C.; Lowther, W. Todd			Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MAMMALIAN SULFIREDOXIN; CRYSTALLOGRAPHY; SULPHIREDOXIN; MECHANISM; RECOVERY	Sulfiredoxin (Srx) catalyzes a novel enzymatic reaction, the reduction of protein cysteine sulfinic acid, Cys-SO2-. This reaction is unique to the typical 2-Cys peroxiredoxins (Prx) and plays a role in peroxide-mediated signaling by regulating the activity of Prxs. Two mechanistic schemes have been proposed that differ regarding the first step of the reaction. This step involves either the direct transfer of the gamma-phosphate of ATP to the Prx molecule or through Srx acting as a phosphorylated intermediary. In an effort to clarify this step of the Srx reaction, we have determined the 1.8 angstrom resolution crystal structure of Srx in complex with ATP and Mg2+. This structure reveals the role of the Mg2+ ion to position the gamma-phosphate toward solvent, thus preventing an in-line attack by the catalytic residue Cys-99 of Srx. A model of the quaternary complex is consistent with this proposal. Furthermore, phosphorylation studies on several site-directed mutants of Srx and Prx, including the Prx-Asp mimic of the Prx-SO2- species, support a mechanism where phosphorylation of Prx-SO2- is the first chemical step.	[Lowther, W. Todd] Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	United States Department of Energy; National Institutes of Health [R01GM072866]; American Heart Association Postdoctoral Fellowship [0725399U]	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W.T.L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T.J.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; We thank the staff of NSLS and beamline X4A for their assistance during data collection and the RapiData course. National Synchrotron Light Source is supported by the United States Department of Energy and National Institutes of Health.	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALMIERI F, 1979, BIOCHIM BIOPHYS ACTA, V555, P531, DOI 10.1016/0005-2736(79)90407-3; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; WEAST RC, 1983, CRC HDB CHEM PHYS, pC719; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	32	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23846	23851		10.1074/jbc.M803244200	http://dx.doi.org/10.1074/jbc.M803244200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579529	Green Published, hybrid			2022-12-25	WOS:000258638900039
J	Coussens, M; Maresh, JG; Yanagimachi, R; Maeda, G; Allsopp, R				Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard			Sirt1 Deficiency Attenuates Spermatogenesis and Germ Cell Function	PLOS ONE			English	Article								In mammals, Sirt1, a member of the sirtuin family of proteins, functions as a nicotinamide adenine dinucleotide-dependent protein deactylase, and has important physiological roles, including the regulation of glucose metabolism, cell survival, and mitochondrial respiration. The initial investigations of Sirt1 deficient mice have revealed a phenotype that includes a reduced lifespan, small size, and an increased frequency of abnormal sperm. We have now performed a detailed analysis of the molecular and functional effects of Sirt1 deficiency in the germ line of Sirt1 knock-out (-/-) mice. We find that Sirt1 deficiency markedly attenuates spermatogenesis, but not oogenesis. Numbers of mature sperm and spermatogenic precursors, as early as d15.5 of development, are significantly reduced (similar to 2-10-fold less; P <= 0.004) in numbers in Sirt1-/- mice, whereas Sirt1 deficiency did not effect the efficiency oocyte production following superovulation of female mice. Furthermore, the proportion of mature sperm with elevated DNA damage (similar to 7.5% of total epididymal sperm; P = 0.02) was significantly increased in adult Sirt1-/- males. Analysis of global gene expression by microarray analysis in Sirt1 deficient testis revealed dysregulated expression of 85 genes, which were enriched (P < 0.05) for genes involved in spermatogenesis and protein sumoylation. To assess the function of Sirt1 deficient germ cells, we compared the efficiency of generating embryos and viable offspring in in vitro fertilization (IVF) experiments using gametes from Sirt1-/- and sibling Sirt1+/- mice. While viable animals were derived in both Sirt1-/- X wild type and Sirt1-/- X Sirt1-/- crosses, the efficiency of producing both 2-cell zygotes and viable offspring was diminished when IVF was performed with Sirt1-/- sperm and/or oocytes. Together, these data support an important role for Sirt1 in spermatogenesis, including spermatogenic stem cells, as well as germ cell function.	[Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Coussens, Matthew; Allsopp, Richard] Univ Hawaii, Inst Biogen Res, Honolulu, HI USA	University of Hawaii System; University of Hawaii System	Coussens, M (corresponding author), Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.	allsopp@hawaii.edu		Whitman, Mary/0000-0001-6297-7499	NIH [P20 RR16467-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant P20 RR16467-05 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; ASHBURNER M, NAT GENET, V25, P25; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Coussens M, 2006, BIOL REPROD, V75, P785, DOI 10.1095/biolreprod.106.052167; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; HOPPE PC, 1973, BIOL REPROD, V8, P420, DOI 10.1093/biolreprod/8.4.420; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nagy A., 2002, MANIPULATING MOUSE E; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; WELCH JE, 1990, BIOL REPROD, V43, P569, DOI 10.1095/biolreprod43.4.569; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	34	129	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1571	10.1371/journal.pone.0001571	http://dx.doi.org/10.1371/journal.pone.0001571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18612420	Green Published, Green Submitted, gold			2022-12-25	WOS:000260535900010
J	Jonsson, TJ; Tsang, AW; Lowther, WT; Furdui, CM				Jonsson, Thomas J.; Tsang, Allen W.; Lowther, W. Todd; Furdui, Cristina M.			Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ESCHERICHIA-COLI; OXIDATIVE STRESS; ENZYME CATALYSIS; MECHANISM	The reversible oxidation of the active site cysteine in typical 2-Cys peroxiredoxins (Prx) to sulfinic acid during oxidative stress plays an important role in peroxide-mediated cell signaling. The catalytic retroreduction of Prx-SO2- by sulfiredoxin (Srx) has been proposed to proceed through two novel reaction intermediates, a sulfinic phosphoryl ester and protein-based thiosulfinate. Two scenarios for the repair mechanism have been suggested that differ in the second step of the reaction. The attack of Srx or GSH on the Prx-SO2PO32- intermediate would result in either the formation of Prx-Cys-S(=O)-S-Cys-Srx or the formation of Prx-Cys-S(=O)-S-G thiosulfinates, respectively. To elucidate the mechanism of Prx repair, we monitored the reduction of human PrxII-SO2- using rapid chemical quench methodology and electrospray ionization time-of-flight mass spectrometry. An O-18 exchange study revealed that the Prx sulfinic acid phosphoryl ester is rapidly formed and hydrolyzed (k = 0.35 min(-1)). Furthermore, we observed the exclusive formation of a thiosulfinate linkage between Prx and Srx(k = 1.4 min(-1)) that collapses to the disulfide-bonded Srx-Prx species (k = 0.14 min(-1)). Thus, the kinetic and chemical competences of the first two steps in the Srx reaction have been demonstrated. It is clear, however, that GSH may influence thiosulfinate formation and that GSH and Srx may play additional roles in the resolution of the thiosulfinate intermediate.	[Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Winston Salem, NC 27157 USA; [Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Tsang, Allen W.; Furdui, Cristina M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu; cfurdui@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01GM072866]; American Heart Association [0725399U, SDG 0730069N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W. T. L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T. J. J.) and American Heart Association Grant SDG 0730069N (to C. M. F.).	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bothner B, 2000, J BIOL CHEM, V275, P13455, DOI 10.1074/jbc.275.18.13455; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Furdui C. M., 2006, MOL CELL, V17, P1; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Jacob C, 2006, NAT PROD REP, V23, P851, DOI 10.1039/b609523m; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; KICE JL, 1974, J AM CHEM SOC, V96, P8015, DOI 10.1021/ja00833a029; Konermann L, 1997, BIOCHEMISTRY-US, V36, P5554, DOI 10.1021/bi970046d; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Li ZL, 2003, J AM CHEM SOC, V125, P9938, DOI 10.1021/ja0354768; Paiva AA, 1997, BIOCHEMISTRY-US, V36, P15472, DOI 10.1021/bi971883i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Shen CX, 2002, J AGR FOOD CHEM, V50, P2644, DOI 10.1021/jf011013e; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	25	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22890	22894		10.1074/jbc.C800124200	http://dx.doi.org/10.1074/jbc.C800124200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579529	Green Published, hybrid			2022-12-25	WOS:000258455400002
J	Wang, X; Sun, Q; McGrath, SD; Mardis, ER; Soloway, PD; Clark, AG				Wang, Xu; Sun, Qi; McGrath, Sean D.; Mardis, Elaine R.; Soloway, Paul D.; Clark, Andrew G.			Transcriptome-Wide Identification of Novel Imprinted Genes in Neonatal Mouse Brain	PLOS ONE			English	Article								Imprinted genes display differential allelic expression in a manner that depends on the sex of the transmitting parent. The degree of imprinting is often tissue-specific and/or developmental stage-specific, and may be altered in some diseases including cancer. Here we applied Illumina/Solexa sequencing of the transcriptomes of reciprocal F1 mouse neonatal brains and identified 26 genes with parent-of-origin dependent differential allelic expression. Allele-specific Pyrosequencing verified 17 of them, including three novel imprinted genes. The known and novel imprinted genes all are found in proximity to previously reported differentially methylated regions (DMRs). Ten genes known to be imprinted in placenta had sufficient expression levels to attain a read depth that provided statistical power to detect imprinting, and yet all were consistent with non-imprinting in our transcript count data for neonatal brain. Three closely linked and reciprocally imprinted gene pairs were also discovered, and their pattern of expression suggests transcriptional interference. Despite the coverage of more than 5000 genes, this scan only identified three novel imprinted refseq genes in neonatal brain, suggesting that this tissue is nearly exhaustively characterized. This approach has the potential to yield an complete catalog of imprinted genes after application to multiple tissues and developmental stages, shedding light on the mechanism, bioinformatic prediction, and evolution of imprinted genes and diseases associated with genomic imprinting.	[Wang, Xu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Life Sci Core Lab Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63130 USA; [Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Washington University (WUSTL); Cornell University	Wang, X (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu	Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020; Wang, Xu/B-4587-2008; Soloway, Paul/T-8243-2019; Tang, Shuang/F-9115-2014	McGrath, Sean David/0000-0001-9064-8449; Wang, Xu/0000-0002-7594-5004; Soloway, Paul/0000-0003-1967-0437; Tang, Shuang/0000-0002-3084-0903; Clark, Andrew/0000-0001-7159-8511; Zheng, Zhi-Ming/0000-0001-5547-7912	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 95713, R01 CA095713, CA 79006, R01 CA094141, CA 94141] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BJORNSSON HT, 2008, GENOME RES; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davies W, 2004, GENE EXPR PATTERNS, V4, P741, DOI 10.1016/j.modgep.2004.03.008; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Evans HK, 2005, MOL BIOL EVOL, V22, P1740, DOI 10.1093/molbev/msi165; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lehmann EL, 2005, TESTING STAT HYPOTHE, pxiv; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Matoba R, 2000, GENE, V241, P125, DOI 10.1016/S0378-1119(99)00457-6; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mergenthaler S, 2001, AM J HUM GENET, V68, P543, DOI 10.1086/318192; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Weinstein LS, 2000, AM J PHYSIOL-RENAL, V278, pF507, DOI 10.1152/ajprenal.2000.278.4.F507; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yamazawa K, 2008, AM J MED GENET A, V146A, P514, DOI 10.1002/ajmg.a.32125; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	74	250	262	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3839	10.1371/journal.pone.0003839	http://dx.doi.org/10.1371/journal.pone.0003839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	19052635	Green Published, Green Submitted, gold			2022-12-25	WOS:000265452200001
